PMID,Sentence,E1,Type_E1,Relation,E2,Type_E2
28470822,"Transforming growth factor beta 1 (TGFB1) is dysregulated in the hereditary SVD, CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).",Transforming growth factor beta,CHEBI,be dysregulated in,subcortical infarcts,DISEASE
28470822,"Transforming growth factor beta 1 (TGFB1) is dysregulated in the hereditary SVD, CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).",Transforming growth factor beta,CHEBI,be dysregulated in,cerebral autosomal recessive,DISEASE
28470822,"Transforming growth factor beta 1 (TGFB1) is dysregulated in the hereditary SVD, CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).",Transforming growth factor beta,CHEBI,be dysregulated in,hereditary SVD,DISEASE
28470822,"Transforming growth factor beta 1 (TGFB1) is dysregulated in the hereditary SVD, CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).",Transforming growth factor beta,CHEBI,be dysregulated in,recessive arteriopathy,DISEASE
28470822,"Transforming growth factor beta 1 (TGFB1) is dysregulated in the hereditary SVD, CARASIL (cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy).",Transforming growth factor beta,CHEBI,be dysregulated in,leukoencephalopathy,DISEASE
28470822,The aim of this study was to characterize signaling abnormalities of BMPs in sporadic SVD.,BMPs,CHEMICAL,have signaling abnormalities in,sporadic SVD,DISEASE
31792039,QUESTION 1: What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acids QUESTION 2: What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levels QUESTION 3: Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparations QUESTION 4: What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD) Answers can be found on page 01.,preserved vitamin E levels?Vitamin E,CHEBI,be added to,rancherosSome vitamin E,CHEBI
31792039,QUESTION 1: What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acids QUESTION 2: What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levels QUESTION 3: Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparations QUESTION 4: What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD) Answers can be found on page 01.,metabolic disorders,DISEASE,be associated with,respiratory chain)Maple syrup urine disease,CHEMICAL
31792039,QUESTION 1: What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acids QUESTION 2: What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levels QUESTION 3: Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparations QUESTION 4: What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD) Answers can be found on page 01.,metabolic disorders,DISEASE,be associated with,respiratory chain)Maple syrup urine disease,DISEASE
31792039,QUESTION 1: What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acids QUESTION 2: What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levels QUESTION 3: Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparations QUESTION 4: What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD) Answers can be found on page 01.,metabolic disorders,DISEASE,be associated with,MSUD,DISEASE
31792039,QUESTION 1: What nutritional/metabolic test(s) would be the next best step?Vitamin B1 (thiamine) levelsCopper and caeruloplasmin levelsBlood spot for acylcarnitine profilePlasma amino acid profileUrine organic acids QUESTION 2: What potentially dangerous feeding issues in paediatric intensive care exist here?Electrolyte levels and supplementationFat composition of feedsAmino acid composition of feedsVitamin levels QUESTION 3: Why might this patient have had preserved vitamin E levels?Vitamin E is added to rancherosSome vitamin E is obtained from sunlightFrench fries are relatively high in vitamin EMultivitamin preparations QUESTION 4: What metabolic disorders are associated with very low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders (disorders of respiratory chain)Maple syrup urine disease (MSUD) Answers can be found on page 01.,metabolic disorders,DISEASE,be associated with,low carnitine levels?Organic acidaemiasFatty acid oxidation disordersMitochondrial disorders,CHEMICAL
31019473,"This is more evident during rapid growth (i.e., perinatal periods and children) in which thiamine deficiency is commonly associated with either malnutrition or genetic defects.",thiamine deficiency,CHEBI,be associated in,malnutrition,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,death,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,sleep disturbances,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,ataxia,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,congestive heart failure,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,confusion,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,muscle atrophy,DISEASE
31019473,"Thiamine deficiency contributes to a number of conditions spanning from mild neurological and psychiatric symptoms (confusion, reduced memory, and sleep disturbances) to severe encephalopathy, ataxia, congestive heart failure, muscle atrophy, and even death.",Thiamine deficiency,CHEBI,contribute to number of,severe encephalopathy,DISEASE
31019473,"This review discusses the current knowledge on thiamine deficiency and associated morbidity of neurological and psychiatric disorders, with special emphasis on the pediatric population, as well as the putative beneficial effect of thiamine supplementation in autism spectrum disorder (ASD) and other neurological conditions.",thiamine supplementation,CHEBI,have the putative beneficial effect in,autism spectrum disorder,MENTAL_HEALTH
21453474,"This is, to the best of our knowledge, the first report in the literature to associate a new plausible mechanism of neurodevelopmental toxicity with a case of autism spectrum disorder through a vitamin deficiency potentiated by concomitant use of herbal supplements and ethanol exposure.",vitamin deficiency,CHEBI,have a case of,autism spectrum disorder,MENTAL_HEALTH
34990378,"Bipolar depression typically has a poor response to antidepressant medication, and also involves the risk of polarity shifts, induction of mixed states, and / or rapid cycle induction.",Bipolar depression,MENTAL_HEALTH,have poor response to,antidepressant medication,CHEMICAL
34990378,"The treatment of bipolar depression is based on the options known from monopolar depression (such as the use of antidepressants, antipsychotics, and certain antiepileptic agents) and their combinations, while in recent years it has been enriched with new pharmaceutical agents and non-pharmacological approaches.",bipolar depression,MENTAL_HEALTH,be based on,antidepressants,CHEMICAL
33564897,"The typical cannabis side effects of tiredness, dizziness, dry mouth, and nausea occur with all cannabis medicines, and correspond to those already known from the product information of the cannabis-based medicinal products authorized under the pharmaceutical law.",dizziness,DISEASE,occur with,cannabis medicines,CHEMICAL
33564897,"The typical cannabis side effects of tiredness, dizziness, dry mouth, and nausea occur with all cannabis medicines, and correspond to those already known from the product information of the cannabis-based medicinal products authorized under the pharmaceutical law.",tiredness,DISEASE,occur with,cannabis medicines,CHEMICAL
33564897,"The typical cannabis side effects of tiredness, dizziness, dry mouth, and nausea occur with all cannabis medicines, and correspond to those already known from the product information of the cannabis-based medicinal products authorized under the pharmaceutical law.",typical cannabis side effects,CHEMICAL,occur with,cannabis medicines,CHEMICAL
35179810,"Treatment-resistant depression (TRD) is characterized by the failure of at least one adequate trial of a major class of antidepressant, with adequate time and dosage.",TRD,DISEASE,be characterized by failure of adequate trial of major class of,antidepressant,CHEMICAL
35179810,"Treatment-resistant depression (TRD) is characterized by the failure of at least one adequate trial of a major class of antidepressant, with adequate time and dosage.",Treatment-resistant depression,MENTAL_HEALTH,be characterized by failure of adequate trial of major class of,antidepressant,CHEMICAL
31214863,"Although only a few studies have associated RTT and TH, TH deficit can lead to neurological deregulation by triggering functional deficiencies during adulthood.",TH deficit,CHEMICAL,trigger,functional deficiencies,DISEASE
2865824,Buspirone seems to be as effective as the benzodiazepines in the alleviation of anxiety and may have less untoward effects.,Buspirone,CHEMICAL,seem to effective as benzodiazepines in alleviation of,anxiety,MENTAL_HEALTH
2865824,Buspirone seems to be as effective as the benzodiazepines in the alleviation of anxiety and may have less untoward effects.,Buspirone,CHEMICAL,seem to effective as,benzodiazepines,CHEMICAL
10374130,"Multiple endocrine neoplasia-type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by parathyroid hyperplasia, pancreatic endocrine tumours and pituitary adenomas.",Multiple endocrine neoplasia-type,CHEBI,characterized by,parathyroid hyperplasia,DISEASE
10374130,"Multiple endocrine neoplasia-type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by parathyroid hyperplasia, pancreatic endocrine tumours and pituitary adenomas.",Multiple endocrine neoplasia-type,CHEBI,characterized by,pancreatic endocrine tumours,CHEBI
10374130,"Multiple endocrine neoplasia-type 1 (MEN1) is an autosomal dominant familial cancer syndrome characterized by parathyroid hyperplasia, pancreatic endocrine tumours and pituitary adenomas.",Multiple endocrine neoplasia-type,CHEBI,characterized by,pituitary adenomas,DISEASE
10374130,"During follow-up, a growing pituitary adenoma caused acromegaly with elevated serum concentrations of growth hormone, insulin-like growth factor 1 (IGF-1), and prolactin.",growing pituitary adenoma,DISEASE,cause during follow-up acromegaly with elevated serum concentrations of,growth hormone,CHEBI
10374130,"During follow-up, a growing pituitary adenoma caused acromegaly with elevated serum concentrations of growth hormone, insulin-like growth factor 1 (IGF-1), and prolactin.",growing pituitary adenoma,DISEASE,cause during,follow-up acromegaly,DISEASE
31244693,"Results: The n-3 index negatively correlated with the severity of general psychopathology, psychotic symptoms, depressive symptoms, and manic symptoms.",n-3 index,CHEMICAL,correlate with severity of,manic symptoms,DISEASE
31244693,"Results: The n-3 index negatively correlated with the severity of general psychopathology, psychotic symptoms, depressive symptoms, and manic symptoms.",n-3 index,CHEMICAL,correlate with severity of,psychotic symptoms,DISEASE
31244693,"Results: The n-3 index negatively correlated with the severity of general psychopathology, psychotic symptoms, depressive symptoms, and manic symptoms.",n-3 index,CHEMICAL,correlate with severity of,depressive symptoms,DISEASE
31244693,The n-6/n-3 PUFA ratio positively correlated with severity of psychotic and depressive symptoms.,PUFA ratio,CHEMICAL,correlate with severity of,psychotic symptoms,DISEASE
31244693,"The n-3 PUFA DHA negatively correlated with the severity of general psychopathology, positive, manic, and depressive symptoms.",n-3 PUFA DHA,CHEMICAL,correlate with severity of,positive symptoms,DISEASE
31244693,"The n-3 PUFA DHA negatively correlated with the severity of general psychopathology, positive, manic, and depressive symptoms.",n-3 PUFA DHA,CHEMICAL,correlate with severity of,manic,DISEASE
31244693,EPA negatively correlated with manic symptoms.,EPA,CHEMICAL,correlate with,manic symptoms,DISEASE
31244693,"Nervonic acid, an n-9 monounsaturated fatty acid, positively correlated with general psychopathology, positive and negative symptoms, depressive symptoms, and manic symptoms.",Nervonic acid,CHEMICAL,correlate with,manic symptoms,DISEASE
31244693,"Nervonic acid, an n-9 monounsaturated fatty acid, positively correlated with general psychopathology, positive and negative symptoms, depressive symptoms, and manic symptoms.",Nervonic acid,CHEMICAL,correlate with,depressive symptoms,DISEASE
31244693,"Nervonic acid, an n-9 monounsaturated fatty acid, positively correlated with general psychopathology, positive and negative symptoms, depressive symptoms, and manic symptoms.",monounsaturated fatty acid,NUTRITION,correlate with,manic symptoms,DISEASE
31244693,"Nervonic acid, an n-9 monounsaturated fatty acid, positively correlated with general psychopathology, positive and negative symptoms, depressive symptoms, and manic symptoms.",monounsaturated fatty acid,NUTRITION,correlate with,depressive symptoms,DISEASE
31244693,"The long-chain saturated fatty acid tetracosanoic acid positively correlated with general psychopathology, positive, manic, and depressive symptoms.",long-chain saturated fatty acid tetracosanoic acid,NUTRITION,correlate with,positive symptoms,DISEASE
31244693,"The long-chain saturated fatty acid tetracosanoic acid positively correlated with general psychopathology, positive, manic, and depressive symptoms.",long-chain saturated fatty acid tetracosanoic acid,NUTRITION,correlate with,manic,DISEASE
31244693,"Conclusions: Partially consistent with a previous study, psychotic symptoms, depressive symptoms, and symptoms of mania were associated with several classes of FAs in the present study.",mania,MENTAL_HEALTH,be associated with several classes of,FAs,CHEMICAL
31244693,These findings support the relevance of membrane fatty acids for the onset of psychotic symptoms and indicate that FAs should be further evaluated as biomarkers in the UHR for psychosis group.,FAs,CHEMICAL,be evaluated as biomarkers in uhr for,psychosis group,MENTAL_HEALTH
28314070,The purpose of this study was to evaluate the extent of short-term memory impairment and schizophrenia-like symptoms in heavy and systematic cannabis users and the association between the severity of abuse and the longevity of its persistent symptoms after refraining from such use.,schizophrenia-like symptoms,DISEASE,have the extent in,heavy cannabis users,CHEMICAL
28314070,The purpose of this study was to evaluate the extent of short-term memory impairment and schizophrenia-like symptoms in heavy and systematic cannabis users and the association between the severity of abuse and the longevity of its persistent symptoms after refraining from such use.,short-term memory impairment,DISEASE,have the extent in,heavy cannabis users,CHEMICAL
2787581,"Although the number of cases in this study was small, the findings support the hypothesis that cannabis does play an aetiological role in schizophrenia.",cannabis,CHEMICAL,play aetiological role in,schizophrenia,MENTAL_HEALTH
28751857,Humans that are carriers of the met-BDNF allele have subclinical memory deficits and reduced hippocampal volume and activation.,carriers,CHEBI,have,subclinical memory deficits,DISEASE
28751857,It is still unclear whether this BDNF SNP affects the clinical outcome of RTT individuals.,BDNF SNP,CHEMICAL,affect clinical outcome of,RTT individuals,DISEASE
28751857,"To evaluate whether this BDNF SNP contributes to RTT pathophysiology, we examined the consequences of expression of either val-BDNF or met-BDNF on dendrite and dendritic spine morphology, and synaptic function in cultured hippocampal neurons from wildtype (WT) and Mecp2 knockout (KO) mice.",BDNF SNP,CHEMICAL,contribute to,RTT pathophysiology,DISEASE
34305715,High scores for the emotionality and self-control dimensions of TEI were strongly associated with membership of the low alexithymia group; high scores for the emotional exhaustion dimension of school burnout were indicative of membership of the high alexithymia group.,self-control dimensions,CHEMICAL,be associated with membership of,low alexithymia group,MENTAL_HEALTH
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",Citrin,CHEMICAL,be,liver-type mitochondrial aspartate-glutamate carrier,CHEBI
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",Citrin,CHEMICAL,be,liver-type mitochondrial aspartate-glutamate carrier,CHEMICAL
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEBI,cause,adult-onset type citrullinemia,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEBI,cause,NICCD,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEBI,cause,CTLN2,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEBI,cause,neonatal intrahepatic cholestasis,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEMICAL,cause,adult-onset type citrullinemia,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEMICAL,cause,NICCD,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEMICAL,cause,CTLN2,DISEASE
16199199,"Citrin, encoded by SLC25A13, is a liver-type mitochondrial aspartate-glutamate carrier (AGC), of which deficiency, in autosomal recessive trait, causes neonatal intrahepatic cholestasis (NICCD) and adult-onset type II citrullinemia (CTLN2).",liver-type mitochondrial aspartate-glutamate carrier,CHEMICAL,cause,neonatal intrahepatic cholestasis,DISEASE
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,galactosemia,DISEASE
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,hypoproteinemia,DISEASE
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,methionine,NUTRITION
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,tyrosine,CHEMICAL
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,multiple aminoacidemia,CHEMICAL
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,threonine,NUTRITION
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,hypoglycemia,DISEASE
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,citrulline,CHEMICAL
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,fatty liver,DISEASE
16199199,"NICCD patients have jaundice, hypoproteinemia, hypoglycemia, galactosemia, growth retardation, fatty liver and multiple aminoacidemia including citrulline, methionine, threonine and tyrosine.",NICCD patients,DISEASE,have,jaundice,DISEASE
16199199,Many CTLN2 patients have been treated with a low protein and high carbohydrate diet and glycerol at the hyperammonemic coma.,Many CTLN2 patients,DISEASE,be treated with low protein and high carbohydrate diet and glycerol at,hyperammonemic coma,DISEASE
16199199,Many CTLN2 patients have been treated with a low protein and high carbohydrate diet and glycerol at the hyperammonemic coma.,Many CTLN2 patients,DISEASE,be treated with,glycerol,CHEMICAL
16199199,"Loss of citrin first cause deficiency of aspartate in the cytosol, which results in an increase in cytosolic NADH/NAD(+) ratio and then activation of fatty acid synthesis pathway to compensate the aberrant ratio.",citrin,DISEASE,cause deficiency of,aspartate,CHEMICAL
23378222,Hypersexuality with compulsive sexual behaviour is a significant source of morbidity for patients with Parkinson's disease receiving dopamine replacement therapies.,compulsive sexual behaviour,DISEASE,be significant source of morbidity for patients with,Parkinson's disease,DISEASE
23378222,Hypersexuality with compulsive sexual behaviour is a significant source of morbidity for patients with Parkinson's disease receiving dopamine replacement therapies.,Hypersexuality,DISEASE,be significant source of morbidity for patients with,Parkinson's disease,DISEASE
23378222,"Patients with Parkinson's disease with hypersexuality were scanned ON and OFF dopamine drugs, and their results were compared with a group of 12 Parkinson's disease control patients without hypersexuality or other impulse control disorders.",hypersexuality,DISEASE,be scanned,dopamine drugs,CHEBI
23378222,"Patients with Parkinson's disease with hypersexuality were scanned ON and OFF dopamine drugs, and their results were compared with a group of 12 Parkinson's disease control patients without hypersexuality or other impulse control disorders.",Parkinson's disease,DISEASE,be scanned,dopamine drugs,CHEBI
34527172,"Phytoestrogens are nonestradiol compounds classified as one of the endocrine-disrupting chemicals (EDCs), meaning that they can potentially disrupt hormonal balance and result in developmental and reproductive abnormalities.",Phytoestrogens,CHEBI,classified as one of,endocrine-disrupting chemicals,CHEMICAL
34527172,"What is intriguing, although classified as EDCs, phytoestrogens seem to have a beneficial influence on Alzheimer's disease symptoms and neuropathologies.",phytoestrogens,CHEBI,have beneficial influence on alzheimer's,neuropathologies,DISEASE
35013866,"This double-blind, randomized controlled trial, tested fatty acid (FA) supplementation in children (ages 2- < 6 years) recently diagnosed with Autism Spectrum Disorder (ASD).",fatty acid FA supplementation,NUTRITION,diagnose with,ASD,DISEASE
35013866,"This double-blind, randomized controlled trial, tested fatty acid (FA) supplementation in children (ages 2- < 6 years) recently diagnosed with Autism Spectrum Disorder (ASD).",fatty acid FA supplementation,NUTRITION,diagnose with,Autism Spectrum Disorder,MENTAL_HEALTH
32201299,These results also suggests the need to test for the concomitant prescription of ketamine and BZD to see whether its sustained antidepressant activity is maintained in TRD patients.,antidepressant activity,CHEMICAL,be maintained in,TRD patients,DISEASE
9605579,"The effect of chronic subcutaneous infusion of the 5-HT2C receptor agonist, m-chlorophenylpiperazine (m-CPP, 10 mg kg(-1), day(-1)), for 14 days was examined on daily food intake, the ability of acute m-CPP (2.5 mg kg(-1), i.p.) to induce hypolocomotion in a novel arena and elevate plasma corticosterone levels and on ex vivo cortical [3H]-mesulergine binding and hippocampal 5-HT2C receptor protein levels.",m-chlorophenylpiperazine m-CPP,CHEMICAL,be examined for days on,daily food intake,NUTRITION
9605579,"The effect of chronic subcutaneous infusion of the 5-HT2C receptor agonist, m-chlorophenylpiperazine (m-CPP, 10 mg kg(-1), day(-1)), for 14 days was examined on daily food intake, the ability of acute m-CPP (2.5 mg kg(-1), i.p.) to induce hypolocomotion in a novel arena and elevate plasma corticosterone levels and on ex vivo cortical [3H]-mesulergine binding and hippocampal 5-HT2C receptor protein levels.",5-HT2C receptor agonist,CHEBI,be examined for days on,daily food intake,NUTRITION
9605579,"In contrast, while m-CPP still elicited this hypolocomotion following 14 days, saline infusion, no such hypolocomotion occurred in rats given chronic m-CPP (10 mg kg(-1) day(-1)), indicating that almost complete tachyphylaxis of this behaviour occurred with chronic 5-HT2C receptor agonist injection.",m-CPP,CHEMICAL,elicit,hypolocomotion,DISEASE
9605579,"Acute challenge with m-CPP following two weeks, treatment still attenuated food intake over the next four hours (by 43% and 30%, respectively from that on the previous day) in saline and m-CPP infusion groups, showing that only partial tolerance to 5-HT2C receptor agonist-induced hypophagia occurred.",m-CPP,CHEMICAL,attenuate food intake over,m-CPP,CHEMICAL
9605579,"Thus the hypophagia produced by m-CPP may involve activation of 5-HT2C receptors in the hypothalamus, where there is a greater receptor reserve or which are more resistant to agonist-induced down-regulation than 5-HT2C receptors in limbic areas (striatum and nucleus accumbens) mediating m-CPP-induced hypolocomotion.",hypophagia,DISEASE,mediate,m-CPP-induced hypolocomotion,DISEASE
35570696,LT3 may also be used in some thyroid cancer patients preparing for radioactive iodine therapy.,LT3,CHEMICAL,be used in,thyroid cancer patients,DISEASE
25709457,Levothyroxine therapy might be potentially useful to attenuate mood instability in this patient group.,Levothyroxine therapy,CHEMICAL,attenuate,mood instability,DISEASE
35255053,To investigate the efficacy and safety of cilostazol for atherosclerosis.,cilostazol,CHEMICAL,have the efficacy and safety for,atherosclerosis,DISEASE
35255053,"According to the difference in intervening measures, the cilostazol group was superior to the control group in inhibiting the progression of carotid intima-media thickness: cilostazol versus placebo (MD, -0.04 mm; 95% CI, -0.06 to -0.02; P < 0.00001), cilostazol versus no antiplatelet drug (MD, -0.14 mm; 95% CI, -0.26 to -0.03; P = 0.02), cilostazol versus aspirin (MD, -0.17 mm; 95% CI, -0.32 to -0.02; P = 0.02), cilostazol + aspirin versus aspirin (MD, -0.08 mm; 95% CI, -0.14 to -0.02; P = 0.007), cilostazol + aspirin versus clopidogrel + aspirin (MD, -0.07 mm; 95% CI, -0.14 to -0.00; P = 0.04), and cilostazol + clopidogrel + aspirin versus clopidogrel + aspirin (MD, -0.16 mm; 95% CI, -0.30 to -0.02; P = 0.03).",cilostazol group,CHEMICAL,according to difference in intervening measures to,clopidogrel,CHEMICAL
35255053,"According to the difference in intervening measures, the cilostazol group was superior to the control group in inhibiting the progression of carotid intima-media thickness: cilostazol versus placebo (MD, -0.04 mm; 95% CI, -0.06 to -0.02; P < 0.00001), cilostazol versus no antiplatelet drug (MD, -0.14 mm; 95% CI, -0.26 to -0.03; P = 0.02), cilostazol versus aspirin (MD, -0.17 mm; 95% CI, -0.32 to -0.02; P = 0.02), cilostazol + aspirin versus aspirin (MD, -0.08 mm; 95% CI, -0.14 to -0.02; P = 0.007), cilostazol + aspirin versus clopidogrel + aspirin (MD, -0.07 mm; 95% CI, -0.14 to -0.00; P = 0.04), and cilostazol + clopidogrel + aspirin versus clopidogrel + aspirin (MD, -0.16 mm; 95% CI, -0.30 to -0.02; P = 0.03).",cilostazol group,CHEMICAL,according to difference in intervening measures to,aspirin,CHEMICAL
35255053,"According to the difference in intervening measures, the cilostazol group was superior to the control group in inhibiting the progression of carotid intima-media thickness: cilostazol versus placebo (MD, -0.04 mm; 95% CI, -0.06 to -0.02; P < 0.00001), cilostazol versus no antiplatelet drug (MD, -0.14 mm; 95% CI, -0.26 to -0.03; P = 0.02), cilostazol versus aspirin (MD, -0.17 mm; 95% CI, -0.32 to -0.02; P = 0.02), cilostazol + aspirin versus aspirin (MD, -0.08 mm; 95% CI, -0.14 to -0.02; P = 0.007), cilostazol + aspirin versus clopidogrel + aspirin (MD, -0.07 mm; 95% CI, -0.14 to -0.00; P = 0.04), and cilostazol + clopidogrel + aspirin versus clopidogrel + aspirin (MD, -0.16 mm; 95% CI, -0.30 to -0.02; P = 0.03).",cilostazol group,CHEMICAL,according to difference in intervening measures to,cilostazol,CHEMICAL
35255053,"According to the difference in intervening measures, the cilostazol group was superior to the control group in inhibiting the progression of carotid intima-media thickness: cilostazol versus placebo (MD, -0.04 mm; 95% CI, -0.06 to -0.02; P < 0.00001), cilostazol versus no antiplatelet drug (MD, -0.14 mm; 95% CI, -0.26 to -0.03; P = 0.02), cilostazol versus aspirin (MD, -0.17 mm; 95% CI, -0.32 to -0.02; P = 0.02), cilostazol + aspirin versus aspirin (MD, -0.08 mm; 95% CI, -0.14 to -0.02; P = 0.007), cilostazol + aspirin versus clopidogrel + aspirin (MD, -0.07 mm; 95% CI, -0.14 to -0.00; P = 0.04), and cilostazol + clopidogrel + aspirin versus clopidogrel + aspirin (MD, -0.16 mm; 95% CI, -0.30 to -0.02; P = 0.03).",cilostazol group,CHEMICAL,according to difference in intervening measures to,antiplatelet drug,CHEBI
35255053,"Cilostazol therapy significantly increased the risk of adverse events of headache (odds ratio, 12.91; 95% CI 5.33-31.29).",Cilostazol therapy,CHEMICAL,increase risk of adverse events of,headache,MENTAL_HEALTH
35087274,Coronavirus disease-19 (COVID-19) is a systemic viral infection.,COVID-19,CHEMICAL,be,systemic viral infection,DISEASE
35087274,Coronavirus disease-19 (COVID-19) is a systemic viral infection.,Coronavirus disease-19,DISEASE,be,systemic viral infection,DISEASE
35087274,"Orexin receptor antagonist drugs have good efficacy in increasing WASO, LPS, and SE with an acceptable safety profile.",Orexin receptor antagonist drugs,CHEBI,increase,SE,DISEASE
35087274,"Orexin receptor antagonist drugs have good efficacy in increasing WASO, LPS, and SE with an acceptable safety profile.",Orexin receptor antagonist drugs,CHEBI,increase,LPS,CHEMICAL
11600000,"An alkylresorcinol, 5-methylresorcinol, also inhibited in vitro growth of A. flavus.",alkylresorcinol 5-methylresorcinol,CHEMICAL,inhibit,A. flavus,DISEASE
11600000,These and other phenolic compounds may contribute to kernel wax inhibition of A. flavus infection/aflatoxin production.,other phenolic compounds,CHEMICAL,contribute to kernel wax inhibition of,A. flavus infection/aflatoxin production,DISEASE
19746561,"Nonsteroidal antiinflammatory drugs have no specific effect; (5) The only two trials assessing tramadol showed little effect; in one study the average pain score was 53 mm in the tramadol group versus 65 mm in the placebo group, on a scale ranging from 0 to 100 mm.",average pain score,DISEASE,be mm in,tramadol group,CHEMICAL
34145727,We hypothesized that duloxetine may reduce the incidence and severity of fasciculation or succinylcholine-induced POM in outpatient surgeries.,duloxetine,CHEMICAL,reduce incidence and severity of,fasciculation POM,DISEASE
34145727,We hypothesized that duloxetine may reduce the incidence and severity of fasciculation or succinylcholine-induced POM in outpatient surgeries.,duloxetine,CHEMICAL,reduce incidence and severity of,succinylcholine-induced,CHEMICAL
33748246,Accidental dural puncture (ADP) and subsequent post-dural puncture headache (PDPH) remain common complications of epidural procedures for obstetric anesthesia and analgesia.,subsequent post-dural puncture headache,MENTAL_HEALTH,remain common complications of epidural procedures for,analgesia,MENTAL_HEALTH
33748246,Accidental dural puncture (ADP) and subsequent post-dural puncture headache (PDPH) remain common complications of epidural procedures for obstetric anesthesia and analgesia.,ADP,CHEMICAL,remain common complications of epidural procedures for,analgesia,MENTAL_HEALTH
23033490,"Then, the effects of dexamethasone on glucocorticoid receptor transcription, cell proliferation, apoptosis/cell cycle, and invasion were examined in bladder cancer lines.",dexamethasone,CHEMICAL,be examined in,bladder cancer lines,DISEASE
23033490,"Finally, mouse xenograft models for bladder cancer were used to assess the efficacy of dexamethasone on tumor progression.",bladder cancer,DISEASE,assess efficacy of dexamethasone on,tumor progression,DISEASE
23033490,"Finally, mouse xenograft models for bladder cancer were used to assess the efficacy of dexamethasone on tumor progression.",bladder cancer,DISEASE,assess efficacy of,dexamethasone,CHEMICAL
23033490,"Finally, mouse xenograft models for bladder cancer were used to assess the efficacy of dexamethasone on tumor progression.",dexamethasone,CHEMICAL,have the efficacy on,tumor progression,DISEASE
23033490,"In addition, dexamethasone increased IκBα protein levels and cytosolic accumulation of NF-κB. In xenograft-bearing mice, dexamethasone slightly augmented the growth of the inoculated tumors but completely prevented the development of bloody ascites, suggestive of peritoneal dissemination of tumor cells, and actual metastasis.",dexamethasone,CHEMICAL,augment growth of,inoculated tumors,DISEASE
15331122,"It was unlikely that the effects of prenatal NLAAM were the result of toxicity, as little chronic toxicity was seen with the lower two doses of NLAAM, doses that yielded significant suppressions of neural-endocrine-immune responses.",prenatal NLAAM,CHEMICAL,be result of,toxicity,DISEASE
35087402,Chronic infection with helminths can result in impaired immune responses to TB as well as enhancing failure to TB therapy and BCG vaccination.,Chronic infection,DISEASE,result in impaired immune responses to,TB,DISEASE
35087402,Chronic infection with helminths can result in impaired immune responses to TB as well as enhancing failure to TB therapy and BCG vaccination.,helminths,DISEASE,result in impaired immune responses to,TB,DISEASE
35087402,"Antimycobacterial activity of the extract and fractions was tested against four non-tuberculous mycobacteria (Mycobacterium smegmatis, M. fortuitum, M. aurum, M. bovis BCG) and pathogenic M. tuberculosis H37Rv while the Egg Hatch Assay (EHA) was used for the anthelmintic test on eggs of Haemonchus contortus.",EHA,CHEMICAL,be used for anthelmintic test on eggs of,Haemonchus contortus,DISEASE
17420219,"Acute exposure to toluene and other volatile organic solvents results in neurotoxicity characterized by nervous system depression, cognitive and motor impairment, and alterations in visual function.",toluene,CHEMICAL,result in,neurotoxicity,DISEASE
12010773,"However, the same concentration of CHPG (10 min perfusion) significantly attenuated the NMDA-induced ventral root depolarization (VRD).",CHPG,CHEMICAL,attenuate,VRD,DISEASE
12010773,"The attenuating effect of CHPG on the NMDA-induced VRD was inhibited by the mGluR5 receptor antagonist, 2-methyl-6-phenyl-ethynylpyridine (MPEP).",CHPG,CHEMICAL,be inhibited by,MPEP,CHEMICAL
12010773,"The attenuating effect of CHPG on the NMDA-induced VRD was inhibited by the mGluR5 receptor antagonist, 2-methyl-6-phenyl-ethynylpyridine (MPEP).",CHPG,CHEMICAL,be inhibited by,2-methyl-6-phenyl-ethynylpyridine,CHEMICAL
12010773,"The attenuating effect of CHPG on the NMDA-induced VRD was inhibited by the mGluR5 receptor antagonist, 2-methyl-6-phenyl-ethynylpyridine (MPEP).",CHPG,CHEMICAL,be inhibited by,mGluR5 receptor antagonist,CHEBI
12010773,"Therefore, activation of mGlu5 receptors located on GABA-ergic interneurones could influence any direct potentiating interaction between mGlu5 and NMDA receptors in spinal cord and result in depression of the VRD.",mGlu5 receptors,CHEMICAL,result in,depression,MENTAL_HEALTH
12010773,"Therefore, activation of mGlu5 receptors located on GABA-ergic interneurones could influence any direct potentiating interaction between mGlu5 and NMDA receptors in spinal cord and result in depression of the VRD.",mGlu5 receptors,CHEMICAL,influence direct potentiating interaction between,mGlu5 receptors,CHEMICAL
12010773,"Therefore, activation of mGlu5 receptors located on GABA-ergic interneurones could influence any direct potentiating interaction between mGlu5 and NMDA receptors in spinal cord and result in depression of the VRD.",mGlu5 receptors,CHEMICAL,influence direct potentiating interaction between,NMDA,CHEMICAL
12010773,"Therefore, activation of mGlu5 receptors located on GABA-ergic interneurones could influence any direct potentiating interaction between mGlu5 and NMDA receptors in spinal cord and result in depression of the VRD.",mGlu5,CHEMICAL,have any direct potentiating interaction with,NMDA receptors,CHEMICAL
12010773,"Therefore, activation of mGlu5 receptors located on GABA-ergic interneurones could influence any direct potentiating interaction between mGlu5 and NMDA receptors in spinal cord and result in depression of the VRD.",NMDA receptors,CHEMICAL,have any direct potentiating interaction with,mGlu5,CHEMICAL
18472959,We have studied the antiapoptotic effects of androgens in prostate cancer cells exposed to different proapoptotic stimuli.,androgens,CHEBI,have the antiapoptotic effects in,prostate cancer cells,DISEASE
18472959,"Terminal deoxynucleotidyl transferase-mediated nick-end labeling and nuclear fragmentation analyses demonstrated that androgens protect LNCaP prostate cancer cells from apoptosis induced by thapsigargin, the phorbol ester 12-O-tetradecanoyl-13-phorbol-acetate, or UV irradiation.",androgens,CHEBI,protect lncap prostate cancer cells from,12-O-tetradecanoyl-13-phorbol-acetate,CHEMICAL
18472959,"Terminal deoxynucleotidyl transferase-mediated nick-end labeling and nuclear fragmentation analyses demonstrated that androgens protect LNCaP prostate cancer cells from apoptosis induced by thapsigargin, the phorbol ester 12-O-tetradecanoyl-13-phorbol-acetate, or UV irradiation.",androgens,CHEBI,protect,LNCaP prostate cancer cells,DISEASE
16004999,"However, the DHT-induced TEC-secreted apoptotic factors could induce thymocyte DNA fragmentation only when DHT was added to the conditioned medium.",DHT-induced TEC-secreted apoptotic factors,DISEASE,induce,thymocyte DNA fragmentation,MENTAL_HEALTH
16004999,It implies that DHT priming of thymocytes is required for the apoptotic effect of DHT-induced TEC-secreted factor.,DHT priming,CHEMICAL,be required for apoptotic effect of,DHT-induced TEC-secreted factor,DISEASE
11070352,"In athymic nude mice, testosterone enanthate prevented the growth of MOP tumors and, when tumors did develop, brought about regression.",tumors,DISEASE,bring about,regression,MENTAL_HEALTH
11070352,"In athymic nude mice, testosterone enanthate prevented the growth of MOP tumors and, when tumors did develop, brought about regression.",testosterone enanthate,CHEMICAL,prevent in athymic nude mice growth of,MOP tumors,DISEASE
11070352,With these cells it was possible to confirm that androgens paradoxically repress the growth of some prostate cancer cells both in culture and in vivo.,androgens,CHEBI,repress growth of,prostate cancer cells,DISEASE
29706030,Preconception planning in women with hypothyroidism should pre-empt and mirror the adaptive changes in the thyroid gland by careful levothyroxine dose adjustments to ensure adequate foetal thyroid hormone delivery in pregnancy.,hypothyroidism,DISEASE,ensure,adequate foetal thyroid hormone delivery,CHEBI
29706030,Women with active disease who are imminently trying to conceive should be switched to propylthiouracil either preconception or at conception in order to minimize the risk of birth defects from carbimazole or methimazole exposure.,active disease,DISEASE,be switched to,propylthiouracil preconception,CHEMICAL
33076712,7-methylxanthine (7-MX) is a molecule that is presently under clinical investigation for the treatment of myopia.,7-methylxanthine,CHEMICAL,be molecule under clinical investigation for treatment of,myopia,DISEASE
33076712,"In sub-chronic treatment, 7-MX showed no mortality and signs for toxicity in any group, whereas 10% and 40% mortality with signs for toxicity were observed in caffeine and theobromine treated groups, respectively.",toxicity,DISEASE,be observed in,caffeine groups,CHEMICAL
34303966,"In this study, neuroprotective potential of theobromine (TBR) was evaluated in 2-vessel occlusion transient global cerebral ischemia-reperfusion (tGCI/R) rat model.",theobromine,NUTRITION,be evaluated in study in,ischemia-reperfusion tGCI/R rat model,DISEASE
35043499,"This has been clinically validated: currently, two Hcrt receptor antagonists are approved to treat insomnia (suvorexant and lemborexant), with a New Drug Application recently submitted to the US Food and Drug Administration for a third drug (daridorexant).",Hcrt receptor antagonists,CHEBI,treat,insomnia,MENTAL_HEALTH
35043499,"This has been clinically validated: currently, two Hcrt receptor antagonists are approved to treat insomnia (suvorexant and lemborexant), with a New Drug Application recently submitted to the US Food and Drug Administration for a third drug (daridorexant).",Drug Application,CHEBI,submit to us food and drug administration for,third drug,CHEBI
35043499,"This has been clinically validated: currently, two Hcrt receptor antagonists are approved to treat insomnia (suvorexant and lemborexant), with a New Drug Application recently submitted to the US Food and Drug Administration for a third drug (daridorexant).",Drug Application,CHEBI,submit to,Drug,CHEBI
10879069,"Twenty AD patients (MMSE score: 18.6 +/- 5.8) received extracts from original KUT herbs, and 7AD patients (MMSE score: 21.3 +/- 2.8) were placed on the combination therapy.",AD patients,DISEASE,receive extracts from,original KUT herbs,CHEMICAL
10879069,"Rate of cognitive decline as measured by change in MMSE score per year was significantly slower (p = 0.04, ANOVA) in the KUT group (1.4 points) and the combination group (0.4 points) as compared to 4.1 points in 32 control AD patients (MMSE score: 20.8 +/- 5.6) who received no medicines for AD.",cognitive decline,DISEASE,be,KUT group,CHEMICAL
2175010,The neurological disorders in AIDS may be caused by dysfunction of cellular cholesterol transport.,AIDS,DISEASE,be caused by dysfunction of,cellular cholesterol transport,NUTRITION
2175010,The neurological disorders in AIDS may be caused by dysfunction of cellular cholesterol transport.,neurological disorders,DISEASE,be caused by dysfunction of,cellular cholesterol transport,NUTRITION
2175010,Substitution of high density lipoprotein is recommended in the treatment of severe polyneuropathy and dementia in AIDS.,high density lipoprotein,NUTRITION,be recommended in treatment of severe polyneuropathy and dementia in,AIDS,DISEASE
2175010,Substitution of high density lipoprotein is recommended in the treatment of severe polyneuropathy and dementia in AIDS.,high density lipoprotein,NUTRITION,be recommended in treatment of,severe polyneuropathy,DISEASE
2175010,Substitution of high density lipoprotein is recommended in the treatment of severe polyneuropathy and dementia in AIDS.,high density lipoprotein,NUTRITION,be recommended in treatment of,dementia,MENTAL_HEALTH
2175010,Substitution of high density lipoprotein is recommended in the treatment of severe polyneuropathy and dementia in AIDS.,severe polyneuropathy,DISEASE,have the treatment in,AIDS,DISEASE
2175010,Substitution of high density lipoprotein is recommended in the treatment of severe polyneuropathy and dementia in AIDS.,dementia,MENTAL_HEALTH,have the treatment in,AIDS,DISEASE
18065267,Marijuana abuse is associated with neurological changes including increases in frontal EEG alpha during abstinence.,Marijuana abuse,MENTAL_HEALTH,including increases in,frontal EEG alpha,NUTRITION
17659836,Cancer patients treated with antimitotic drugs in the taxane and vinca alkaloid classes sometimes develop a chronic painful peripheral neuropathy whose cause is not understood.,Cancer patients,DISEASE,develop,chronic painful peripheral neuropathy,DISEASE
8687048,Secondary myelodysplasia after antimitotic therapy is a rare complication usually observed with alkylating agents.,Secondary myelodysplasia,DISEASE,observed with,alkylating agents,CHEMICAL
8687048,Secondary myelodysplasia after antimitotic therapy is a rare complication usually observed with alkylating agents.,antimitotic therapy,CHEBI,observed with,alkylating agents,CHEMICAL
8394025,"Undifferentiated small cell lung cancer differs from the other types of primary lung cancer in its neuroendocrine origin, its important potential for metastatic dissemination and its sensitivity to antimitotic drugs.",Undifferentiated small cell lung cancer,DISEASE,differ from other types of primary lung cancer in,antimitotic drugs,CHEBI
8394025,"Undifferentiated small cell lung cancer differs from the other types of primary lung cancer in its neuroendocrine origin, its important potential for metastatic dissemination and its sensitivity to antimitotic drugs.",Undifferentiated small cell lung cancer,DISEASE,differ from other types of,primary lung cancer,DISEASE
8394025,"Chemotherapy, which is very active against this type of tumour, forms the basis of the conventional treatment where 2 sets of drug combinations are administered: either anthracycline + epidophyllotoxin + alkylating agent, or platinum salt + epidophyllotoxin.",tumour,DISEASE,form basis of,epidophyllotoxin,CHEMICAL
8394025,"Chemotherapy, which is very active against this type of tumour, forms the basis of the conventional treatment where 2 sets of drug combinations are administered: either anthracycline + epidophyllotoxin + alkylating agent, or platinum salt + epidophyllotoxin.",tumour,DISEASE,form basis of,platinum salt,CHEMICAL
8394025,"Chemotherapy, which is very active against this type of tumour, forms the basis of the conventional treatment where 2 sets of drug combinations are administered: either anthracycline + epidophyllotoxin + alkylating agent, or platinum salt + epidophyllotoxin.",tumour,DISEASE,form basis of,conventional treatment anthracycline,CHEMICAL
34800616,"Two use cases for VBD treatment were identified 1) rapid drug release (<5 min), for use prior to intercourse and 2) long-acting release (≥120 min) for prolonged use and relief throughout the day.",VBD treatment,DISEASE,be identified,rapid drug release,CHEBI
34800616,"Two film formulations (9% w/w HPC with 12% w/w LHC, 5% w/w HEC with 6% w/w LHC) were optimized to meet the two use case scenarios for VBD treatment and moved into in vivo testing.",% w/w HPC,CHEMICAL,meet use case scenarios for,VBD treatment,DISEASE
34800616,"Two film formulations (9% w/w HPC with 12% w/w LHC, 5% w/w HEC with 6% w/w LHC) were optimized to meet the two use case scenarios for VBD treatment and moved into in vivo testing.",w/w LHC,CHEMICAL,meet use case scenarios for,VBD treatment,DISEASE
9111026,The diverse biological actions of retinoic acid (RA) are mediated by retinoic acid receptors (RARs) and retinoid X receptors.,retinoic acid,CHEMICAL,be mediated by,retinoic acid receptors,CHEMICAL
23826114,"Low blood Omega-3 LC-PUFA have been reported in children with ADHD and related behavior/learning difficulties, as have benefits from dietary supplementation.",Low blood Omega-3 LC-PUFA,CHEMICAL,be reported in children with,ADHD,MENTAL_HEALTH
19672626,"For instance, neurocognitive disorders such as attention-deficit hyperactivity disorder (ADHD), dyslexia, dyspraxia and autism spectrum disorders are often associated with a relative lack of omega-3 fatty acids.",attention-deficit hyperactivity disorder,MENTAL_HEALTH,be associated for instance with relative lack of,omega-3 fatty acids,NUTRITION
19672626,"For instance, neurocognitive disorders such as attention-deficit hyperactivity disorder (ADHD), dyslexia, dyspraxia and autism spectrum disorders are often associated with a relative lack of omega-3 fatty acids.",neurocognitive disorders,DISEASE,be associated for instance with relative lack of,omega-3 fatty acids,NUTRITION
19672626,"For instance, neurocognitive disorders such as attention-deficit hyperactivity disorder (ADHD), dyslexia, dyspraxia and autism spectrum disorders are often associated with a relative lack of omega-3 fatty acids.",dyspraxia,MENTAL_HEALTH,be associated for instance with relative lack of,omega-3 fatty acids,NUTRITION
19672626,"For instance, neurocognitive disorders such as attention-deficit hyperactivity disorder (ADHD), dyslexia, dyspraxia and autism spectrum disorders are often associated with a relative lack of omega-3 fatty acids.",dyslexia,MENTAL_HEALTH,be associated for instance with relative lack of,omega-3 fatty acids,NUTRITION
19672626,"For instance, neurocognitive disorders such as attention-deficit hyperactivity disorder (ADHD), dyslexia, dyspraxia and autism spectrum disorders are often associated with a relative lack of omega-3 fatty acids.",ADHD,MENTAL_HEALTH,be associated for instance with relative lack of,omega-3 fatty acids,NUTRITION
19672626,"In addition to a high omega-6 fatty acid intake and, in many cases, an insufficient supply of omega-3 fatty acids among the population, evidence is increasing to suggest that PUFA metabolism can be impaired in individuals with ADHD.",PUFA metabolism,CHEMICAL,be impaired in individuals with,ADHD,MENTAL_HEALTH
19672626,"In this context, PUFA imbalances are being discussed as potential risk factors for neurodevelopmental disorders.",PUFA imbalances,CHEMICAL,be discussed in context as potential risk factors for,neurodevelopmental disorders,DISEASE
15736918,"Increasing evidence, reviewed here, indicates that LC-PUFA deficiencies or imbalances are associated with childhood developmental and psychiatric disorders including ADHD, dyslexia, dyspraxia, and autistic spectrum disorders.",LC-PUFA deficiencies,CHEMICAL,be associated with,autistic spectrum disorders,DISEASE
15736918,"Increasing evidence, reviewed here, indicates that LC-PUFA deficiencies or imbalances are associated with childhood developmental and psychiatric disorders including ADHD, dyslexia, dyspraxia, and autistic spectrum disorders.",LC-PUFA deficiencies,CHEMICAL,be associated with,dyslexia,MENTAL_HEALTH
15736918,"Increasing evidence, reviewed here, indicates that LC-PUFA deficiencies or imbalances are associated with childhood developmental and psychiatric disorders including ADHD, dyslexia, dyspraxia, and autistic spectrum disorders.",LC-PUFA deficiencies,CHEMICAL,be associated with,ADHD,MENTAL_HEALTH
15736918,"Increasing evidence, reviewed here, indicates that LC-PUFA deficiencies or imbalances are associated with childhood developmental and psychiatric disorders including ADHD, dyslexia, dyspraxia, and autistic spectrum disorders.",LC-PUFA deficiencies,CHEMICAL,be associated with,psychiatric disorders,DISEASE
15736918,"Increasing evidence, reviewed here, indicates that LC-PUFA deficiencies or imbalances are associated with childhood developmental and psychiatric disorders including ADHD, dyslexia, dyspraxia, and autistic spectrum disorders.",LC-PUFA deficiencies,CHEMICAL,be associated with,dyspraxia,MENTAL_HEALTH
15736918,Preliminary evidence from controlled trials also suggests that dietary supplementation with LC-PUFA might help in the management of these kinds of childhood behavioral and learning difficulties.,LC-PUFA,CHEMICAL,help in management of kinds of,behavioral difficulties,DISEASE
17099560,"Classical enzymatic inductors, such as antiepileptic molecules (phenobarbital, carbamazepin), antituberculosis compounds (rifampicin), or antiretroviral therapy (efavirenz, nevirapin, ritonavir), could possibly lead to respiratory depression for example.",antiepileptic molecules phenobarbital,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Classical enzymatic inductors, such as antiepileptic molecules (phenobarbital, carbamazepin), antituberculosis compounds (rifampicin), or antiretroviral therapy (efavirenz, nevirapin, ritonavir), could possibly lead to respiratory depression for example.",antituberculosis compounds,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Classical enzymatic inductors, such as antiepileptic molecules (phenobarbital, carbamazepin), antituberculosis compounds (rifampicin), or antiretroviral therapy (efavirenz, nevirapin, ritonavir), could possibly lead to respiratory depression for example.",antiretroviral therapy efavirenz,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",selective serotonin reuptake inhibitors,CHEMICAL,lead to,death,DISEASE
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",selective serotonin reuptake inhibitors,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",fluvoxamine,CHEMICAL,lead to,death,DISEASE
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",fluvoxamine,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",antifungals,CHEBI,lead to,death,DISEASE
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",antifungals,CHEBI,lead to,respiratory depression,MENTAL_HEALTH
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",azol groups,CHEMICAL,lead to,death,DISEASE
17099560,"Metabolism inhibitors such as selective serotonin reuptake inhibitors (fluvoxamine, fluoxetine, paroxetine, sertraline) or antifungals of the azol groups could enhance plasma concentration and may sometimes lead to respiratory depression or death.",azol groups,CHEMICAL,lead to,respiratory depression,MENTAL_HEALTH
18639235,"In animal models often used to study psychiatric illness, KOR agonists produce depressive-like effects (e.g., anhedonia), whereas KOR antagonists produce antidepressant- and anxiolytic-like effects.",KOR agonists,CHEBI,produce in,anhedonia,MENTAL_HEALTH
25888122,We hypothesized that the tissue specificity of SRS arises from differential sensitivity to spermidine toxicity or spermine deficiency.,SRS,DISEASE,arise from differential sensitivity to,spermine deficiency,CHEMICAL
25888122,We hypothesized that the tissue specificity of SRS arises from differential sensitivity to spermidine toxicity or spermine deficiency.,SRS,DISEASE,arise from differential sensitivity to,spermidine toxicity,CHEMICAL
23449602,"Humans with narcolepsy and orexin/ataxin-3 transgenic (TG) mice exhibit extensive, but incomplete, degeneration of hypo-cretin (Hcrt) neurons.",narcolepsy mice,MENTAL_HEALTH,exhibit,hypo-cretin neurons,CHEMICAL
34437008,Loperamide is a non-prescription anti-diarrheal agent targeting μ-opioid receptors in the intestinal tract.,Loperamide,CHEMICAL,targeting in,intestinal tract,DISEASE
33919998,One of the key strategies for effective pain management involves delaying analgesic tolerance.,effective pain management,DISEASE,delay,analgesic tolerance,CHEBI
27112524,"With respect to individual beverages, caffeinated tea intake was associated with slight reductions in fecundability among females, and caffeinated soda and energy drink intake were associated with reduced fecundability among males.",caffeinated tea intake,CHEMICAL,be associated with respect to individual beverages with slight reductions in,fecundability,DISEASE
29432034,"Subjects with nonfluent aphasia had lower scores than CP in memory, executive functions and attention tests, while subjects with fluent aphasia showed lower scores in memory tests only.",nonfluent aphasia,MENTAL_HEALTH,have,CP,CHEMICAL
27041639,"Off-label use of hormonal therapies, particularly oestrogen and testosterone, are the most widely employed for female sexual dysfunction, particularly in post-menopausal women.",oestrogen,CHEBI,be employed for,female sexual dysfunction,MENTAL_HEALTH
21142609,No important changes in the safety or tolerability profile of TTP were revealed with long-term use for up to 4 years in otherwise healthy oophorectomised women with HSDD on concomitant oestrogen.,TTP,DISEASE,be revealed with long-term use for to years in healthy oophorectomised women with,HSDD,DISEASE
21142609,No important changes in the safety or tolerability profile of TTP were revealed with long-term use for up to 4 years in otherwise healthy oophorectomised women with HSDD on concomitant oestrogen.,TTP,DISEASE,be revealed with long-term use for to years in healthy oophorectomised women with,concomitant oestrogen,CHEBI
21142609,No important changes in the safety or tolerability profile of TTP were revealed with long-term use for up to 4 years in otherwise healthy oophorectomised women with HSDD on concomitant oestrogen.,TTP,DISEASE,be revealed with long-term use for to years in,healthy oophorectomised women,DISEASE
35215322,"Although drugs such as megestrol acetate and cyproheptadine are used to decrease this severe feeding disorder, they can also induce side effects, such as diarrhea and somnolence, which limit their widespread use.",megestrol acetate,CHEMICAL,decrease,severe feeding disorder,DISEASE
35215322,"Although drugs such as megestrol acetate and cyproheptadine are used to decrease this severe feeding disorder, they can also induce side effects, such as diarrhea and somnolence, which limit their widespread use.",cyproheptadine,CHEMICAL,decrease,severe feeding disorder,DISEASE
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",Severe psychiatric side effects,DISEASE,be documented including,panic attacks,DISEASE
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",Severe psychiatric side effects,DISEASE,be documented including,persecutory delusions,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",Severe psychiatric side effects,DISEASE,be documented including,dissociative psychosis,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",Severe psychiatric side effects,DISEASE,be documented including,anxiety,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",Severe psychiatric side effects,DISEASE,be documented including,paranoia,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",mefloquine intoxication,CHEMICAL,be documented including,panic attacks,DISEASE
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",mefloquine intoxication,CHEMICAL,be documented including,persecutory delusions,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",mefloquine intoxication,CHEMICAL,be documented including,dissociative psychosis,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",mefloquine intoxication,CHEMICAL,be documented including,anxiety,MENTAL_HEALTH
23771936,"Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia.",mefloquine intoxication,CHEMICAL,be documented including,paranoia,MENTAL_HEALTH
23771936,Exposure to the drug has been associated with acts of violence and suicide.,drug,CHEBI,be associated with acts of,suicide,MENTAL_HEALTH
31384856,"7,8-Dihydroxyflavone (7,8-DHF), as a high-affinity TrkB receptor agonist, has been extensively explored in many human disorders involving brain-derived neurotrophic factor (BDNF) such as Alzheimer's disease, Parkinson's disease, depression, and obesity.",high-affinity TrkB receptor agonist,CHEBI,be explored in,many human disorders,DISEASE
24711296,Ivabradine is a drug used for the treatment of angina and chronic heart failure in cases of intolerance or insufficiency of response to beta-blocker treatment.,Ivabradine,CHEMICAL,used for treatment of angina and chronic heart failure in cases of,beta-blocker treatment,CHEBI
24711296,Ivabradine is a drug used for the treatment of angina and chronic heart failure in cases of intolerance or insufficiency of response to beta-blocker treatment.,Ivabradine,CHEMICAL,used for treatment of,angina heart failure,DISEASE
11206102,"The therapeutic effect of anti-ischemic compounds is related to their ability to improve the oxygen supply-demand balance of the ischemic myocardium by increasing myocardial blood flow (calcium-antagonists), by reducing regional myocardial oxygen consumption (verapamil, betablockers) and increasing peripheral pooling of blood (nitrates, nifedipine).",anti-ischemic compounds,CHEMICAL,reduce,betablockers,CHEMICAL
11206102,"The therapeutic effect of anti-ischemic compounds is related to their ability to improve the oxygen supply-demand balance of the ischemic myocardium by increasing myocardial blood flow (calcium-antagonists), by reducing regional myocardial oxygen consumption (verapamil, betablockers) and increasing peripheral pooling of blood (nitrates, nifedipine).",anti-ischemic compounds,CHEMICAL,reduce,regional myocardial oxygen consumption,DISEASE
11206102,"The therapeutic effect of anti-ischemic compounds is related to their ability to improve the oxygen supply-demand balance of the ischemic myocardium by increasing myocardial blood flow (calcium-antagonists), by reducing regional myocardial oxygen consumption (verapamil, betablockers) and increasing peripheral pooling of blood (nitrates, nifedipine).",anti-ischemic compounds,CHEMICAL,reduce,verapamil,CHEMICAL
11206102,"The therapeutic effect of anti-ischemic compounds is related to their ability to improve the oxygen supply-demand balance of the ischemic myocardium by increasing myocardial blood flow (calcium-antagonists), by reducing regional myocardial oxygen consumption (verapamil, betablockers) and increasing peripheral pooling of blood (nitrates, nifedipine).",anti-ischemic compounds,CHEMICAL,increase peripheral pooling of,nifedipine,CHEMICAL
11206102,The combination of a nitrate with a beta-blocker is particularly useful because it reduces the risk of heart failure by lowering left ventricular end-diastolic pressure and volume and by attenuating the negative inotropic effect of the betablocker.,nitrate,CHEMICAL,have the combination with,beta-blocker,CHEBI
11206102,"In comparison with nifedipine, trimetazidine had similar efficacy in reducing the number of weekly anginal attacks and in increasing the ischemic threshold in a group of 39 patients with stable angina.",trimetazidine,CHEMICAL,reduce number of,weekly anginal attacks,DISEASE
11206102,"In comparison with nifedipine, trimetazidine had similar efficacy in reducing the number of weekly anginal attacks and in increasing the ischemic threshold in a group of 39 patients with stable angina.",trimetazidine,CHEMICAL,have in comparison with,nifedipine similar efficacy,CHEMICAL
11206102,"In comparison with nifedipine, trimetazidine had similar efficacy in reducing the number of weekly anginal attacks and in increasing the ischemic threshold in a group of 39 patients with stable angina.",trimetazidine,CHEMICAL,increase ischemic threshold in group of patients with,stable angina,DISEASE
11206102,The group of Chierchia demonstrated that trimetazidine improved ischemic regional myocardial dysfunction at rest and during stress-induced ischemia in 15 patients with chronic coronary artery disease without affecting the hemodynamic determinants of myocardial oxygen consumption.,trimetazidine,CHEMICAL,improve ischemic regional myocardial dysfunction at rest and during stress-induced ischemia in,chronic coronary artery disease,DISEASE
11206102,The group of Chierchia demonstrated that trimetazidine improved ischemic regional myocardial dysfunction at rest and during stress-induced ischemia in 15 patients with chronic coronary artery disease without affecting the hemodynamic determinants of myocardial oxygen consumption.,trimetazidine,CHEMICAL,improve ischemic regional myocardial dysfunction at rest and during,stress-induced ischemia,DISEASE
11206102,The group of Chierchia demonstrated that trimetazidine improved ischemic regional myocardial dysfunction at rest and during stress-induced ischemia in 15 patients with chronic coronary artery disease without affecting the hemodynamic determinants of myocardial oxygen consumption.,trimetazidine,CHEMICAL,improve,ischemic regional myocardial dysfunction,DISEASE
11206102,There is recent demonstration that trimetazidine improves the contractile response of left ventricular hibernating myocardium in patients with ischemic heart disease.,trimetazidine,CHEMICAL,improve contractile response of left ventricular hibernating myocardium in patients with,ischemic heart disease,DISEASE
11206102,Belardinelli et al. showed that trimetazidine improved the contractile response of dysfunctional myocardial to low-dose dobutamine in patients with ischemic heart disease and left ventricular function.,trimetazidine,CHEMICAL,improve contractile response of dysfunctional myocardial to low-dose dobutamine in patients with,ischemic heart disease,DISEASE
11206102,Belardinelli et al. showed that trimetazidine improved the contractile response of dysfunctional myocardial to low-dose dobutamine in patients with ischemic heart disease and left ventricular function.,trimetazidine,CHEMICAL,improve contractile response of dysfunctional myocardial to,low-dose dobutamine,CHEMICAL
11206102,Belardinelli et al. showed that trimetazidine improved the contractile response of dysfunctional myocardial to low-dose dobutamine in patients with ischemic heart disease and left ventricular function.,low-dose dobutamine,CHEMICAL,in patients with,ischemic heart disease,DISEASE
35570485,Cattle encephalon glycoside and ignotin (CEGI) have been shown to act as multitarget neurotrophic agents in APPswe/PS1dE9 (APP/PS1) transgenic AD mice.,Cattle encephalon glycoside,DISEASE,act as multitarget neurotrophic agents in,APPswe/PS1dE9 transgenic AD mice,DISEASE
35553407,"Hydroxyurea is the only US FDA-approved drug with proven efficacy to induce HbF in SCD patients, yet serious complications have been associated with its use.",Hydroxyurea,CHEMICAL,be,FDA-approved drug,CHEBI
25826750,PS is externalized on cells in the tumor microenvironment when exposed to hypoxia and/or other physiological stressors.,PS,CHEMICAL,expose to,hypoxia,DISEASE
25826750,PS is externalized on cells in the tumor microenvironment when exposed to hypoxia and/or other physiological stressors.,PS,CHEMICAL,be externalized on cells in,tumor microenvironment,DISEASE
25826750,We conducted a phase I clinical trial of bavituximab in combination with paclitaxel in patients with HER2-negative metastatic breast cancer.,paclitaxel,CHEMICAL,in patients with,HER2-negative metastatic breast cancer,DISEASE
25826750,Bavituximab in combination with paclitaxel is well tolerated for treatment of patients with metastatic breast cancer with promising results observed in terms of clinical RRs and PFS.,Bavituximab,CHEMICAL,be tolerated for treatment of patients with,metastatic breast cancer,DISEASE
25826750,Bavituximab in combination with paclitaxel is well tolerated for treatment of patients with metastatic breast cancer with promising results observed in terms of clinical RRs and PFS.,paclitaxel,CHEMICAL,be tolerated for treatment of patients with,metastatic breast cancer,DISEASE
2507164,It has recently been demonstrated by our group that polymorphonuclear cells (PMNs) from cluster headache patients incorporate more arachidonic acid (AA) into phosphatidylserine (PS) than PMNs from controls.,cluster headache patients,MENTAL_HEALTH,incorporate,more arachidonic acid,CHEMICAL
2507164,It has recently been demonstrated by our group that polymorphonuclear cells (PMNs) from cluster headache patients incorporate more arachidonic acid (AA) into phosphatidylserine (PS) than PMNs from controls.,cluster headache patients,MENTAL_HEALTH,incorporate,PS,CHEMICAL
2507164,It has recently been demonstrated by our group that polymorphonuclear cells (PMNs) from cluster headache patients incorporate more arachidonic acid (AA) into phosphatidylserine (PS) than PMNs from controls.,cluster headache patients,MENTAL_HEALTH,incorporate,AA,CHEMICAL
2507164,It has recently been demonstrated by our group that polymorphonuclear cells (PMNs) from cluster headache patients incorporate more arachidonic acid (AA) into phosphatidylserine (PS) than PMNs from controls.,cluster headache patients,MENTAL_HEALTH,incorporate,phosphatidylserine,NUTRITION
2507164,"Incorporation of L-(U-14C)serine into PS was significantly increased (p less than 0.0004) in PMNs from cluster headache patients, whereas no significant difference was seen in other lipids.",L-(U-14C)serine,CHEMICAL,be increased,cluster headache patients,MENTAL_HEALTH
2507164,"Incorporation of L-(U-14C)serine into PS was significantly increased (p less than 0.0004) in PMNs from cluster headache patients, whereas no significant difference was seen in other lipids.",PS,CHEMICAL,be increased,cluster headache patients,MENTAL_HEALTH
35594467,Several formulations of intravaginal oestrogen are available for the treatment of genitourinary syndrome of menopause (GSM).,intravaginal oestrogen,CHEBI,be available for treatment of,genitourinary syndrome,DISEASE
1650740,Serial detection by anterior and posterior projection of the amount of antacid retained in the stomach was performed to determine gastric emptying of antacid.,anterior projection,MENTAL_HEALTH,determine gastric emptying of,antacid,CHEBI
1650740,Serial detection by anterior and posterior projection of the amount of antacid retained in the stomach was performed to determine gastric emptying of antacid.,antacid,CHEBI,determine gastric emptying of,antacid,CHEBI
31417379,"Humans with posttraumatic disorder (PTSD) have widespread upregulation of CB1 receptor density and reduced availability of endogenous cannabinoid anandamide, suggesting a role for the endocannabinoid system in PTSD.",posttraumatic disorder,DISEASE,reduce availability of,endogenous cannabinoid anandamide,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",magnesium ions,CHEMICAL,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",calcitonin,CHEMICAL,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",glucagon,CHEMICAL,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",vasopressin,CHEMICAL,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",beta-adrenergic agonist,CHEBI,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",parathyroid hormone,CHEBI,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",calcium,CHEMICAL,influence,sodium transport,CHEMICAL
10573789,"Multiple agents, including vasopressin, glucagon, calcitonin, parathyroid hormone, beta-adrenergic agonist, insulin, angiotensin II, prostaglandins and calcium and magnesium ions influence sodium transport in the thick ascending limb, indicating that all of these factors may potentially play a role in enuresis.",prostaglandins,CHEMICAL,influence,sodium transport,CHEMICAL
26799942,Pilot studies in unipolar depression report an improvement in depression when omega-3 fatty acids are given with antidepressants.,omega-3 fatty acids,NUTRITION,be given with,antidepressants,CHEMICAL
26799942,"The objective of this study was to investigate whether omega-3 fatty acid supplementation, as an augmentation therapy, improves treatment-resistant major depressive disorder (MDD) in people with MS.",omega-3 fatty acid supplementation,NUTRITION,improve,treatment-resistant major depressive disorder,DISEASE
26799942,"The objective of this study was to investigate whether omega-3 fatty acid supplementation, as an augmentation therapy, improves treatment-resistant major depressive disorder (MDD) in people with MS.",omega-3 fatty acid supplementation,NUTRITION,improve,treatment-resistant major depressive disorder,MENTAL_HEALTH
26799942,"The objective of this study was to investigate whether omega-3 fatty acid supplementation, as an augmentation therapy, improves treatment-resistant major depressive disorder (MDD) in people with MS.",omega-3 fatty acid supplementation,NUTRITION,improve,MDD,DISEASE
22397891,"Magnesium, folate and zinc have all been implicated in depressive illness, however there are few data on these nutrients in anxiety disorders and the data from population-studies are limited.",folate,CHEBI,be implicated in,depressive illness,DISEASE
22397891,"Magnesium, folate and zinc have all been implicated in depressive illness, however there are few data on these nutrients in anxiety disorders and the data from population-studies are limited.",Magnesium,CHEMICAL,be implicated in,depressive illness,DISEASE
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",Folate deficiency,CHEBI,be linked in clinic studies to,persistent depressive symptoms,DISEASE
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",Folate deficiency,CHEBI,be linked in clinic studies to,depression,MENTAL_HEALTH
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",Folate deficiency,CHEBI,be linked in clinic studies to,poor antidepressant response,CHEMICAL
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",low folate status,NUTRITION,be linked in clinic studies to,persistent depressive symptoms,DISEASE
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",low folate status,NUTRITION,be linked in clinic studies to,depression,MENTAL_HEALTH
12601225,"Folate deficiency and low folate status have been linked in clinic studies to depression, persistent depressive symptoms, and poor antidepressant response.",low folate status,NUTRITION,be linked in clinic studies to,poor antidepressant response,CHEMICAL
12601225,This study examined associations between depression and folate status indicators in an ethnically diverse general US population sample aged 15-39 years.,depression,MENTAL_HEALTH,have associations with,folate status indicators,CHEBI
12601225,This study examined associations between depression and folate status indicators in an ethnically diverse general US population sample aged 15-39 years.,folate status indicators,CHEBI,have associations with,depression,MENTAL_HEALTH
34287335,This is a comprehensive review of the literature regarding the use of Aripiprazole lauroxil for schizophrenia.,Aripiprazole lauroxil,CHEMICAL,have the use for,schizophrenia,MENTAL_HEALTH
9397296,Calcium antagonists (except the old short-acting dihydropyridine drugs) reduce microalbuminuria and preserve kidney function in diabetic patients with incipient diabetic nephropathy.,Calcium antagonists,CHEBI,preserve kidney function in diabetic patients with,incipient diabetic nephropathy,DISEASE
9397296,Calcium antagonists (except the old short-acting dihydropyridine drugs) reduce microalbuminuria and preserve kidney function in diabetic patients with incipient diabetic nephropathy.,Calcium antagonists,CHEMICAL,preserve kidney function in diabetic patients with,incipient diabetic nephropathy,DISEASE
9397296,Calcium antagonists (except the old short-acting dihydropyridine drugs) reduce microalbuminuria and preserve kidney function in diabetic patients with incipient diabetic nephropathy.,Calcium antagonists,CHEBI,preserve kidney function in,diabetic patients,DISEASE
9397296,Calcium antagonists (except the old short-acting dihydropyridine drugs) reduce microalbuminuria and preserve kidney function in diabetic patients with incipient diabetic nephropathy.,Calcium antagonists,CHEMICAL,preserve kidney function in,diabetic patients,DISEASE
9397296,Calcium antagonists (except the old short-acting dihydropyridine drugs) reduce microalbuminuria and preserve kidney function in diabetic patients with incipient diabetic nephropathy.,diabetic patients,DISEASE,have kidney function with,incipient diabetic nephropathy,DISEASE
9397296,A recent 1-year randomized double-blind study in hypertensive insulin-dependent diabetic patients with diabetic nephropathy showed a more beneficial effect on the decline rate in the glomerular filtration rate of nisoldipine (long-acting dihydropyridine) than angiotensin-converting-enzyme (ACE) inhibition.,diabetic nephropathy,DISEASE,show beneficial effect on decline rate in glomerular filtration rate of,long-acting dihydropyridine,CHEMICAL
9397296,A recent 1-year randomized double-blind study in hypertensive insulin-dependent diabetic patients with diabetic nephropathy showed a more beneficial effect on the decline rate in the glomerular filtration rate of nisoldipine (long-acting dihydropyridine) than angiotensin-converting-enzyme (ACE) inhibition.,diabetic nephropathy,DISEASE,show beneficial effect on decline rate in glomerular filtration rate of,nisoldipine,CHEMICAL
9397296,A recent 1-year randomized double-blind study in hypertensive insulin-dependent diabetic patients with diabetic nephropathy showed a more beneficial effect on the decline rate in the glomerular filtration rate of nisoldipine (long-acting dihydropyridine) than angiotensin-converting-enzyme (ACE) inhibition.,hypertensive insulin-dependent diabetic patients,DISEASE,show beneficial effect on decline rate in glomerular filtration rate of,long-acting dihydropyridine,CHEMICAL
9397296,A recent 1-year randomized double-blind study in hypertensive insulin-dependent diabetic patients with diabetic nephropathy showed a more beneficial effect on the decline rate in the glomerular filtration rate of nisoldipine (long-acting dihydropyridine) than angiotensin-converting-enzyme (ACE) inhibition.,hypertensive insulin-dependent diabetic patients,DISEASE,show beneficial effect on decline rate in glomerular filtration rate of,nisoldipine,CHEMICAL
9397296,A recent 1-year randomized double-blind study in hypertensive insulin-dependent diabetic patients with diabetic nephropathy showed a more beneficial effect on the decline rate in the glomerular filtration rate of nisoldipine (long-acting dihydropyridine) than angiotensin-converting-enzyme (ACE) inhibition.,hypertensive insulin-dependent diabetic patients,DISEASE,have a recent 1-year randomized double-blind study with,diabetic nephropathy,DISEASE
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",diabetic nephropathy,DISEASE,reveal same beneficial effect of calcium antagonist and ace inhibition on progression of,nephropathy,DISEASE
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",hypertensive noninsulin-dependent patients,DISEASE,reveal same beneficial effect of calcium antagonist and ace inhibition on progression of,nephropathy,DISEASE
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",diabetic nephropathy,DISEASE,reveal same beneficial effect of,calcium antagonist,CHEMICAL
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",diabetic nephropathy,DISEASE,reveal same beneficial effect of,calcium antagonist,CHEBI
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",hypertensive noninsulin-dependent patients,DISEASE,reveal same beneficial effect of,calcium antagonist,CHEMICAL
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",hypertensive noninsulin-dependent patients,DISEASE,reveal same beneficial effect of,calcium antagonist,CHEBI
9397296,"Furthermore, a recent 5-year randomized open study in hypertensive noninsulin-dependent patients with diabetic nephropathy has revealed the same beneficial effect of a calcium antagonist and ACE inhibition on the progression of nephropathy.",hypertensive noninsulin-dependent patients,DISEASE,have a recent 5-year randomized open study with,diabetic nephropathy,DISEASE
12624803,As described elsewhere the oral administration of 5 mg of the 5-HT3-receptor-antagonist Tropisetron in fibromyalgia exhibited less amelioration of pain in patients with a depression in comparison to patients without depression.,Tropisetron,CHEMICAL,have 5 mg in,fibromyalgia,DISEASE
12624803,As described elsewhere the oral administration of 5 mg of the 5-HT3-receptor-antagonist Tropisetron in fibromyalgia exhibited less amelioration of pain in patients with a depression in comparison to patients without depression.,pain,DISEASE,in patients with,depression,MENTAL_HEALTH
9063076,Amitriptyline and imipramine showed significant memory impairment.,Amitriptyline,CHEMICAL,show,significant memory impairment,DISEASE
9063076,Amitriptyline and imipramine showed significant memory impairment.,imipramine,CHEMICAL,show,significant memory impairment,DISEASE
9063076,Fluoxetine with no anticholinergic property may prove to be a better drug in endogenous depression in elderly patients.,Fluoxetine,CHEMICAL,prove to better drug in,endogenous depression,MENTAL_HEALTH
9063076,Fluoxetine with no anticholinergic property may prove to be a better drug in endogenous depression in elderly patients.,Fluoxetine,CHEMICAL,prove to,better drug,CHEBI
35595367,Urea provides pathophysiological information on renal and hepatic disorders.,Urea,CHEMICAL,provide pathophysiological information on,renal disorders,DISEASE
35262925,"Innate disease resistance is a potential option for reducing disease-related mortality in hatchery-reared rainbow trout (Oncorhynchus mykiss, Walbaum).",Innate disease resistance,MENTAL_HEALTH,be potential option for,Oncorhynchus mykiss,NUTRITION
35262925,"Innate disease resistance is a potential option for reducing disease-related mortality in hatchery-reared rainbow trout (Oncorhynchus mykiss, Walbaum).",Innate disease resistance,MENTAL_HEALTH,be potential option for,hatchery-reared rainbow trout,NUTRITION
35231658,"Nano‑selenium (nano-Se) shows high biological activity and low toxicity, and has emerged as an ideal antioxidant.",Nano‑selenium,CHEMICAL,show,low toxicity,DISEASE
35231658,"Nano‑selenium (nano-Se) shows high biological activity and low toxicity, and has emerged as an ideal antioxidant.",nano-Se,CHEMICAL,show,low toxicity,DISEASE
35231658,The results combining analysis of antioxidant enzymes and heat shock proteins further support the notion that nano-Se supplementation inhibited galactose metabolism and activated the glutamate-glutamine metabolic pathway as the key metabolic strategy against heat stress.,nano-Se supplementation,CHEMICAL,inhibit,galactose metabolism,CHEMICAL
35231658,The results combining analysis of antioxidant enzymes and heat shock proteins further support the notion that nano-Se supplementation inhibited galactose metabolism and activated the glutamate-glutamine metabolic pathway as the key metabolic strategy against heat stress.,nano-Se supplementation,CHEMICAL,activate,glutamate-glutamine metabolic pathway,CHEMICAL
35231658,"These data indicated that Nano-Se effectively alleviated stress damage in rainbow trout, in which heat stress interfered with the metabolism of glycerophospholipids and fatty acids significantly, causing liver cell membrane damage and lipid metabolism disorders in rainbow trout.",Nano-Se,CHEMICAL,alleviate stress damage in,rainbow trout,NUTRITION
35231658,"These data indicated that Nano-Se effectively alleviated stress damage in rainbow trout, in which heat stress interfered with the metabolism of glycerophospholipids and fatty acids significantly, causing liver cell membrane damage and lipid metabolism disorders in rainbow trout.",Nano-Se,CHEMICAL,alleviate,stress damage,DISEASE
11097270,We conclude that cholecystokinin receptor mechanism(s) may alter morphine resistance induced by nerve ligation.,cholecystokinin receptor,CHEMICAL,alter,morphine resistance,MENTAL_HEALTH
11097270,We conclude that cholecystokinin receptor mechanism(s) may alter morphine resistance induced by nerve ligation.,cholecystokinin receptor,CHEMICAL,alter,morphine resistance,CHEMICAL
35264727,"In the present study, we hypothesized that CeA CRF interneurons may represent a behaviorally relevant source of CRF to the CeA increasing motivation for alcohol via negative reinforcement.",CeA CRF interneurons,DISEASE,increase motivation for,alcohol,CHEMICAL
35264727,"In the present study, we hypothesized that CeA CRF interneurons may represent a behaviorally relevant source of CRF to the CeA increasing motivation for alcohol via negative reinforcement.",CeA CRF interneurons,DISEASE,represent relevant source of,CRF,DISEASE
35264727,"We then found that chemogenetic activation of CeA CRF neurons in Crh-IRES-Cre mouse brain slices increases gamma-aminobutyric acid (GABA) release in the medial CeA, in part via CRF1 receptor activation.",CeA CRF neurons,DISEASE,increase,gamma-aminobutyric acid release,CHEMICAL
35264727,"We then found that chemogenetic activation of CeA CRF neurons in Crh-IRES-Cre mouse brain slices increases gamma-aminobutyric acid (GABA) release in the medial CeA, in part via CRF1 receptor activation.",CeA CRF neurons,DISEASE,increase,GABA,CHEMICAL
35264727,"Altogether, these findings indicate that CeA CRF neurons produce local release of GABA and CRF and promote hyponeophagia in naïve mice, but do not drive alcohol intake escalation or negative affect in CIE-withdrawn mice.",CeA CRF neurons,DISEASE,produce local release of,GABA,CHEMICAL
35264727,"Altogether, these findings indicate that CeA CRF neurons produce local release of GABA and CRF and promote hyponeophagia in naïve mice, but do not drive alcohol intake escalation or negative affect in CIE-withdrawn mice.",CeA CRF neurons,DISEASE,produce local release of,CRF,DISEASE
33880726,"From the search, it was found that there are 22 Dendrobium species with traditional uses in dermatological disorders, and 131 compounds from Dendrobium plants have been reported to possess anti-inflammatory, antimicrobial, antioxidant, antiaging, anti-psoriasis, and tyrosinase-inhibitory activities, implying that Dendrobium plants are important resources for the discovery of active compounds and the development of new drugs and cosmetics.",Dendrobium plants,CHEMICAL,possess,antimicrobial,CHEBI
27707757,"In conclusion, PPA induces fungal cell death through mitochondria-mediated apoptosis.",PPA,CHEMICAL,induce in,fungal cell death,DISEASE
29728968,"The widespread use of sodium nitrite (NaNO2) as food preservative, rampant use of nitrogenous fertilizers for agricultural practices, and improper disposal of nitrogenous wastes have drastically increased human exposure to high nitrite levels causing various health disorders and death.",food preservative,CHEBI,cause,death,DISEASE
29728968,"The widespread use of sodium nitrite (NaNO2) as food preservative, rampant use of nitrogenous fertilizers for agricultural practices, and improper disposal of nitrogenous wastes have drastically increased human exposure to high nitrite levels causing various health disorders and death.",sodium nitrite,CHEMICAL,cause,death,DISEASE
29728968,"The widespread use of sodium nitrite (NaNO2) as food preservative, rampant use of nitrogenous fertilizers for agricultural practices, and improper disposal of nitrogenous wastes have drastically increased human exposure to high nitrite levels causing various health disorders and death.",food preservative,CHEBI,increase human exposure to,high nitrite levels,CHEMICAL
29728968,"The widespread use of sodium nitrite (NaNO2) as food preservative, rampant use of nitrogenous fertilizers for agricultural practices, and improper disposal of nitrogenous wastes have drastically increased human exposure to high nitrite levels causing various health disorders and death.",sodium nitrite,CHEMICAL,increase human exposure to,high nitrite levels,CHEMICAL
29728968,"Based on further validation from clinical trials, carnosine and NAC can potentially be used as chemo-preventive agents against NaNO2 toxicity.",carnosine,CHEMICAL,be used as chemo-preventive agents against,NaNO2 toxicity,DISEASE
30071445,A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD).,cannabis users,CHEMICAL,develop degree of,Cannabis Use Disorder,DISEASE
30071445,A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD).,cannabis users,CHEMICAL,develop degree of,Cannabis Use Disorder,CHEMICAL
30071445,A subset of cannabis users develop some degree of Cannabis Use Disorder (CUD).,cannabis users,CHEMICAL,develop degree of,CUD,DISEASE
28109827,"In this study, unilateral 6-hydroxydopamine lesions of the substantia nigra in rats induced depressive-like behaviors and led to hyperactivity of LHb neurons compared to sham-operated rats, which attribute to depletion of dopamine, and decreased synthesis and release of GABA and increased release of glutamate in the LHb.",unilateral 6-hydroxydopamine lesions,CHEMICAL,increased release of,glutamate,CHEMICAL
28109827,"In this study, unilateral 6-hydroxydopamine lesions of the substantia nigra in rats induced depressive-like behaviors and led to hyperactivity of LHb neurons compared to sham-operated rats, which attribute to depletion of dopamine, and decreased synthesis and release of GABA and increased release of glutamate in the LHb.",unilateral 6-hydroxydopamine lesions,CHEMICAL,lead to,hyperactivity,MENTAL_HEALTH
28109827,"In this study, unilateral 6-hydroxydopamine lesions of the substantia nigra in rats induced depressive-like behaviors and led to hyperactivity of LHb neurons compared to sham-operated rats, which attribute to depletion of dopamine, and decreased synthesis and release of GABA and increased release of glutamate in the LHb.",unilateral 6-hydroxydopamine lesions,CHEMICAL,induce in,depressive-like behaviors,DISEASE
28109827,"Intra-LHb injection of GABAA receptor agonist muscimol produced antidepressant-like effects, while the injection of GABAA receptor antagonist picrotoxin induced or increased the expression of depressive-like behaviors in sham-operated and the lesioned rats.",GABAA receptor antagonist picrotoxin,CHEBI,increase expression of,depressive-like behaviors,DISEASE
28109827,"Intra-LHb injection of GABAA receptor agonist muscimol produced antidepressant-like effects, while the injection of GABAA receptor antagonist picrotoxin induced or increased the expression of depressive-like behaviors in sham-operated and the lesioned rats.",GABAA receptor antagonist picrotoxin,CHEMICAL,increase expression of,depressive-like behaviors,DISEASE
32476313,"Cheonwangbosim-dan (CBD), a traditional herbal formula that is popular in East Asia, has been commonly used for arterial or auricular flutter, neurosis, insomnia, and cardiac malfunction-induced disease.",Cheonwangbosim-dan,CHEMICAL,be used for,neurosis,MENTAL_HEALTH
32476313,"Cheonwangbosim-dan (CBD), a traditional herbal formula that is popular in East Asia, has been commonly used for arterial or auricular flutter, neurosis, insomnia, and cardiac malfunction-induced disease.",Cheonwangbosim-dan,CHEMICAL,be used for,arterial flutter,DISEASE
32476313,"Cheonwangbosim-dan (CBD), a traditional herbal formula that is popular in East Asia, has been commonly used for arterial or auricular flutter, neurosis, insomnia, and cardiac malfunction-induced disease.",Cheonwangbosim-dan,CHEMICAL,be used for,insomnia,MENTAL_HEALTH
32476313,"Cheonwangbosim-dan (CBD), a traditional herbal formula that is popular in East Asia, has been commonly used for arterial or auricular flutter, neurosis, insomnia, and cardiac malfunction-induced disease.",Cheonwangbosim-dan,CHEMICAL,be used for,malfunction-induced disease,DISEASE
7866710,Screening in employees of enterprise producing antibiotics has revealed higher occurrence of allergic (39.6%) and gastrointestinal diseases.,enterprise producing antibiotics,CHEBI,reveal higher occurrence of,allergic,DISEASE
7866710,Screening in employees of enterprise producing antibiotics has revealed higher occurrence of allergic (39.6%) and gastrointestinal diseases.,enterprise producing antibiotics,CHEBI,reveal higher occurrence of,gastrointestinal diseases,DISEASE
6184135,"Liquid chromatographic studies revealed that apomorphine also elevated the concentrations of both 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in striatum, the projection site for dorsal raphe neurons.",apomorphine,CHEMICAL,elevate concentrations of,5-HIAA,CHEMICAL
6184135,"Liquid chromatographic studies revealed that apomorphine also elevated the concentrations of both 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in striatum, the projection site for dorsal raphe neurons.",apomorphine,CHEMICAL,elevate concentrations of,striatum projection site,MENTAL_HEALTH
6184135,"Liquid chromatographic studies revealed that apomorphine also elevated the concentrations of both 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in striatum, the projection site for dorsal raphe neurons.",apomorphine,CHEMICAL,elevate concentrations of,5-HT,CHEMICAL
6184135,"Liquid chromatographic studies revealed that apomorphine also elevated the concentrations of both 5-HT and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) in striatum, the projection site for dorsal raphe neurons.",apomorphine,CHEMICAL,elevate concentrations of,metabolite 5-hydroxyindoleacetic acid,CHEMICAL
7963449,"The etiology of the illness is still not clearly understood, but the observed therapeutic response in OCD patients to the potent serotonin uptake inhibitor clomipramine hydrochloride (CMI), guided research in the direction of neuronal brain function, and abnormalities of postsynaptic serotonin receptors are currently the leading hypotheses in the pathophysiology of OCD.",postsynaptic serotonin receptors,CHEMICAL,be leading hypotheses in pathophysiology of,OCD,DISEASE
7963449,"The etiology of the illness is still not clearly understood, but the observed therapeutic response in OCD patients to the potent serotonin uptake inhibitor clomipramine hydrochloride (CMI), guided research in the direction of neuronal brain function, and abnormalities of postsynaptic serotonin receptors are currently the leading hypotheses in the pathophysiology of OCD.",OCD patients,DISEASE,have the observed therapeutic response to,potent serotonin uptake inhibitor clomipramine hydrochloride,CHEBI
7963449,"The etiology of the illness is still not clearly understood, but the observed therapeutic response in OCD patients to the potent serotonin uptake inhibitor clomipramine hydrochloride (CMI), guided research in the direction of neuronal brain function, and abnormalities of postsynaptic serotonin receptors are currently the leading hypotheses in the pathophysiology of OCD.",OCD patients,DISEASE,have the observed therapeutic response to,potent serotonin uptake inhibitor clomipramine hydrochloride,CHEMICAL
7963449,"Clomipramine was, for some time, the treatment of choice for OCD given its superiority over other TCAs which lack potent serotonergic effects.",OCD,DISEASE,be given for time its superiority over,other TCAs,CHEMICAL
7963449,"Clomipramine was, for some time, the treatment of choice for OCD given its superiority over other TCAs which lack potent serotonergic effects.",Clomipramine,CHEMICAL,be given for time its superiority over,other TCAs,CHEMICAL
31994339,Human hepatoma cells were subcutaneously injected into right armpit of male nude mice for evaluating the effects of CTB in vivo.,Human hepatoma cells,DISEASE,evaluate effects of,CTB,CHEMICAL
31994339,"We discovered that CTB inhibited aerobic glycolysis and cell acidification by impairing the activity of HK2 in hepatoma cells, accompanied by dissociation of HK2 from mitochondria.",CTB,CHEMICAL,impair activity of,HK2,CHEMICAL
31994339,"We discovered that CTB inhibited aerobic glycolysis and cell acidification by impairing the activity of HK2 in hepatoma cells, accompanied by dissociation of HK2 from mitochondria.",CTB,CHEMICAL,accompany by dissociation of,HK2,CHEMICAL
31994339,"We discovered that CTB inhibited aerobic glycolysis and cell acidification by impairing the activity of HK2 in hepatoma cells, accompanied by dissociation of HK2 from mitochondria.",CTB,CHEMICAL,accompany by,dissociation,MENTAL_HEALTH
25483147,Chronic treatment with levodopa is associated with the development of motor fluctuations and dyskinesias particularly in young Parkinson patients.,levodopa,CHEMICAL,be associated with development of motor fluctuations and dyskinesias in,young Parkinson patients,DISEASE
25483147,Chronic treatment with levodopa is associated with the development of motor fluctuations and dyskinesias particularly in young Parkinson patients.,levodopa,CHEMICAL,be associated with development of,dyskinesias,DISEASE
30731068,"Acamprosate, also known as N-acetyl homotaurine, is an N-methyl-d-aspartate receptor antagonist that is used for treating alcohol dependence.",Acamprosate,CHEMICAL,be,N-methyl-d-aspartate receptor antagonist,CHEBI
30731068,Several studies have demonstrated that acamprosate provides neuroprotection against ischemia-induced brain injury.,acamprosate,CHEMICAL,provide neuroprotection against,ischemia-induced brain injury,DISEASE
30731068,"However, no studies have been performed evaluating the effect of acamprosate on traumatic brain injury (TBI).",acamprosate,CHEMICAL,have the effect on,traumatic brain injury,DISEASE
30731068,"Consequently, this reduced vesicular glutamate and zinc level resulted in a reduction of reactive oxygen species production after TBI.",zinc level,CHEMICAL,result in reduction of reactive oxygen species production after,TBI,DISEASE
30731068,"Consequently, this reduced vesicular glutamate and zinc level resulted in a reduction of reactive oxygen species production after TBI.",zinc level,CHEMICAL,result in reduction of,reactive oxygen species production,CHEMICAL
30731068,"Consequently, this reduced vesicular glutamate and zinc level resulted in a reduction of reactive oxygen species production after TBI.",reduced vesicular glutamate,CHEMICAL,result in reduction of reactive oxygen species production after,TBI,DISEASE
30731068,"Consequently, this reduced vesicular glutamate and zinc level resulted in a reduction of reactive oxygen species production after TBI.",reduced vesicular glutamate,CHEMICAL,result in reduction of,reactive oxygen species production,CHEMICAL
30731068,"When evaluated 24hours after TBI, acamprosate administration reduced the number of degenerating neurons, zinc accumulation, blood-brain barrier disruption, neutrophil infiltration, and dendritic loss.",acamprosate administration,CHEMICAL,evaluate 24hours after,TBI,DISEASE
30731068,"When evaluated 24hours after TBI, acamprosate administration reduced the number of degenerating neurons, zinc accumulation, blood-brain barrier disruption, neutrophil infiltration, and dendritic loss.",acamprosate administration,CHEMICAL,reduce number of,dendritic loss,DISEASE
30731068,Acamprosate also reduced glial activation and neuronal loss at 7days after TBI.,Acamprosate,CHEMICAL,reduce glial activation and neuronal loss at 7days after,TBI,DISEASE
30731068,Acamprosate also reduced glial activation and neuronal loss at 7days after TBI.,Acamprosate,CHEMICAL,reduce,neuronal loss,DISEASE
30731068,The present study demonstrates that acamprosate attenuates TBI-induced brain damage by depletion of vesicular glutamate and zinc levels.,acamprosate,CHEMICAL,attenuate tbi-induced brain damage by depletion of,glutamate zinc levels,CHEMICAL
30731068,The present study demonstrates that acamprosate attenuates TBI-induced brain damage by depletion of vesicular glutamate and zinc levels.,acamprosate,CHEMICAL,attenuate,TBI-induced brain damage,DISEASE
30731068,"Therefore, this study suggests that acamprosate may have high therapeutic potential for prevention of TBI-induced neuronal death.",acamprosate,CHEMICAL,have high therapeutic potential for prevention of,TBI-induced neuronal death,DISEASE
31377587,"In summary, the combination of ketamine with DHA may be a more effective treatment for depression caused by inflammation and is mediated by inhibition of the inflammatory pathway.",ketamine,CHEMICAL,be effective treatment in summary for,depression,MENTAL_HEALTH
31377587,"In summary, the combination of ketamine with DHA may be a more effective treatment for depression caused by inflammation and is mediated by inhibition of the inflammatory pathway.",DHA,CHEMICAL,be effective treatment in summary for,depression,MENTAL_HEALTH
31377587,"In summary, the combination of ketamine with DHA may be a more effective treatment for depression caused by inflammation and is mediated by inhibition of the inflammatory pathway.",ketamine,CHEMICAL,have the combination with,DHA,CHEMICAL
10892514,"It has three defined receptors, but most effects of histamine in allergic reactions are through the H1 receptor.",histamine,CHEMICAL,be through,H1 receptor,CHEMICAL
10892514,"It has three defined receptors, but most effects of histamine in allergic reactions are through the H1 receptor.",allergic reactions,DISEASE,be through,H1 receptor,CHEMICAL
10892514,"It has three defined receptors, but most effects of histamine in allergic reactions are through the H1 receptor.",histamine,CHEMICAL,have but most effects in,allergic reactions,DISEASE
10892514,"Within the central nervous system (CNS), interference with normal histamine binding to the H1 receptor is associated with drowsiness and psychomotor impairment.",normal histamine,CHEMICAL,be associated within,psychomotor impairment,DISEASE
10892514,"Within the central nervous system (CNS), interference with normal histamine binding to the H1 receptor is associated with drowsiness and psychomotor impairment.",normal histamine,CHEMICAL,be associated within,drowsiness,MENTAL_HEALTH
10892514,Clinical trials comparing the efficacy of antihistamines in rhinitis and asthma are reviewed.,antihistamines,CHEBI,have the efficacy in,rhinitis,DISEASE
30677468,"Although sex hormone effects have been implicated in alcohol dependence, research has mostly neglected estrogen activities and female alcohol-dependent patients.",sex hormone effects,CHEBI,be implicated in,alcohol dependence,MENTAL_HEALTH
24824616,"Alcoholism has been reported to affect estrogen receptor signaling; however, identifying the players involved in such multi-faceted syndrome is complex and requires an interdisciplinary approach.",Alcoholism,DISEASE,affect,estrogen receptor signaling,CHEBI
34448208,"Theoretically, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP1-RA) used in patients with obesity and type 2 diabetes mellitus (T2DM) may be efficacious in weight and glycaemic control of PWS patients.",glucagon-like peptide-1 GLP-1 receptor agonists,CHEBI,be efficacious in weight and glycaemic control of,PWS patients,DISEASE
34448208,"Theoretically, glucagon-like peptide-1 (GLP-1) receptor agonists (GLP1-RA) used in patients with obesity and type 2 diabetes mellitus (T2DM) may be efficacious in weight and glycaemic control of PWS patients.",glucagon-like peptide-1 GLP-1 receptor agonists,CHEMICAL,be efficacious in weight and glycaemic control of,PWS patients,DISEASE
32782417,"Inhibition of histone H3 lysine N-methyltransferase, especially G9a, has been recently shown to restore candidate genes from silenced parental chromosomes in the imprinting disorder Prader-Willi syndrome (PWS).",histone H3 lysine N-methyltransferase,CHEMICAL,restore candidate genes from silenced parental chromosomes in,imprinting disorder Prader-Willi syndrome,MENTAL_HEALTH
32782417,"Inhibition of histone H3 lysine N-methyltransferase, especially G9a, has been recently shown to restore candidate genes from silenced parental chromosomes in the imprinting disorder Prader-Willi syndrome (PWS).",histone H3 lysine N-methyltransferase,CHEMICAL,restore candidate genes from silenced parental chromosomes in,PWS,DISEASE
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,increase high-density lipoprotein in,diabetic rats,DISEASE
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,increase,high-density lipoprotein,NUTRITION
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,restore alterations in levels of fasting blood glucose level and body weight loss with,low density lipoprotein,NUTRITION
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,restore alterations in levels of fasting blood glucose level and body weight loss with,cholesterol,NUTRITION
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,restore alterations in levels of fasting blood glucose level and body weight loss with,triglycerides,CHEMICAL
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,restore alterations in levels of,fasting blood glucose level,CHEMICAL
34361617,"In vivo morin at tested doses (2, 10, 15, 30 and 50 mg/kg body weight) significantly restored the alterations in the levels of fasting blood glucose level and body weight loss along with significant decrease in levels of cholesterol, triglycerides, low density lipoprotein, HbA1c level, and significantly increased the high-density lipoprotein in diabetic rats.",In morin,CHEMICAL,restore alterations in levels of,body weight loss,DISEASE
35144110,"Sea buckthorn, an important ecological and economical tree species, have remarkable drought and salt resistance.",important tree species,NUTRITION,have,drought resistance,MENTAL_HEALTH
35144110,"Sea buckthorn, an important ecological and economical tree species, have remarkable drought and salt resistance.",important tree species,NUTRITION,have,salt,CHEMICAL
35144110,"Sea buckthorn, an important ecological and economical tree species, have remarkable drought and salt resistance.",Sea buckthorn,NUTRITION,have,drought resistance,MENTAL_HEALTH
35144110,"Sea buckthorn, an important ecological and economical tree species, have remarkable drought and salt resistance.",Sea buckthorn,NUTRITION,have,salt,CHEMICAL
35144110,"Taken together, the HrTCP20 transcription factor was a positive regulator in drought resistance of sea buckthorn.",HrTCP20 transcription factor,CHEMICAL,be positive regulator in drought resistance of,sea buckthorn,NUTRITION
35144110,"Taken together, the HrTCP20 transcription factor was a positive regulator in drought resistance of sea buckthorn.",HrTCP20 transcription factor,CHEMICAL,be positive regulator in,drought resistance,MENTAL_HEALTH
33184668,"In this study, gene co-expression networks were constructed, and the results suggested that the mutual regulation of ABA and flavonoid signaling contributed to the difference in drought resistance between the different sea buckthorn subspecies.",ABA,CHEMICAL,contribute to difference in drought resistance between,different buckthorn subspecies,NUTRITION
33184668,"In this study, gene co-expression networks were constructed, and the results suggested that the mutual regulation of ABA and flavonoid signaling contributed to the difference in drought resistance between the different sea buckthorn subspecies.",ABA,CHEMICAL,contribute to difference in,drought resistance,MENTAL_HEALTH
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",AAAs tryptophan,NUTRITION,contribute given their impact on synthesis of serotonin and dopamine to expression of,ADHD symptoms,MENTAL_HEALTH
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",AAAs tryptophan,NUTRITION,contribute given their impact on synthesis of,serotonin,CHEMICAL
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",AAAs tryptophan,NUTRITION,contribute given their impact on synthesis of,dopamine,CHEMICAL
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",tyrosine,CHEMICAL,contribute given their impact on synthesis of serotonin and dopamine to expression of,ADHD symptoms,MENTAL_HEALTH
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",tyrosine,CHEMICAL,contribute given their impact on synthesis of,serotonin,CHEMICAL
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",tyrosine,CHEMICAL,contribute given their impact on synthesis of,dopamine,CHEMICAL
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",phenylalanine,CHEMICAL,contribute given their impact on synthesis of serotonin and dopamine to expression of,ADHD symptoms,MENTAL_HEALTH
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",phenylalanine,CHEMICAL,contribute given their impact on synthesis of,serotonin,CHEMICAL
26938936,"Given their impact on the synthesis of serotonin and dopamine, decreased concentrations of the AAAs tryptophan, tyrosine and phenylalanine in blood may contribute to the expression of ADHD symptoms.",phenylalanine,CHEMICAL,contribute given their impact on synthesis of,dopamine,CHEMICAL
34992554,"Thus, carotenoids may potentially play a retarding role in weight gain during the recovery of AN patients.",carotenoids,CHEBI,play retarding role in,weight gain,DISEASE
7753066,Bismuth subsalicylate preparations are over-the-counter products for gastrointestinal complaints.,Bismuth subsalicylate preparations,NUTRITION,be over-the-counter products for,gastrointestinal complaints,DISEASE
7753066,"Bismuth toxicity causes delirium, psychosis, ataxia, myoclonus, and seizures and is reversible over several weeks or months, when bismuth intake is stopped.",Bismuth toxicity,NUTRITION,cause,myoclonus,DISEASE
7753066,"Bismuth toxicity causes delirium, psychosis, ataxia, myoclonus, and seizures and is reversible over several weeks or months, when bismuth intake is stopped.",Bismuth toxicity,NUTRITION,cause,delirium,MENTAL_HEALTH
7753066,"Bismuth toxicity causes delirium, psychosis, ataxia, myoclonus, and seizures and is reversible over several weeks or months, when bismuth intake is stopped.",Bismuth toxicity,NUTRITION,cause,ataxia,DISEASE
7753066,"Bismuth toxicity causes delirium, psychosis, ataxia, myoclonus, and seizures and is reversible over several weeks or months, when bismuth intake is stopped.",Bismuth toxicity,NUTRITION,cause,seizures,DISEASE
7753066,"Bismuth toxicity causes delirium, psychosis, ataxia, myoclonus, and seizures and is reversible over several weeks or months, when bismuth intake is stopped.",Bismuth toxicity,NUTRITION,cause,psychosis,MENTAL_HEALTH
35178926,The results of pentobarbital sodium-induced sleep test and histopathological evaluation(hematoxylin and eosin staining) showed that Ziziphi Spinosae Semen extract had good theraputic effect on insomnia.,extract,CHEMICAL,have good theraputic effect on,insomnia,MENTAL_HEALTH
35178926,"The network pharmacological analysis showed that Ziziphi Spinosae Semen mainly acted on target proteins such as dopamine D2 receptor(DRD2), 5-hydroxytryptamine receptor 1 A(HTR1 A), and alpha-2 A adrenergic receptor(ADRA2 A) in the treatment of insomnia.",Ziziphi Spinosae Semen,CHEMICAL,act on target proteins such as,insomnia,MENTAL_HEALTH
35178926,"The network pharmacological analysis showed that Ziziphi Spinosae Semen mainly acted on target proteins such as dopamine D2 receptor(DRD2), 5-hydroxytryptamine receptor 1 A(HTR1 A), and alpha-2 A adrenergic receptor(ADRA2 A) in the treatment of insomnia.",Ziziphi Spinosae Semen,CHEMICAL,act on target proteins such as,dopamine D2,CHEMICAL
35178926,"The network pharmacological analysis showed that Ziziphi Spinosae Semen mainly acted on target proteins such as dopamine D2 receptor(DRD2), 5-hydroxytryptamine receptor 1 A(HTR1 A), and alpha-2 A adrenergic receptor(ADRA2 A) in the treatment of insomnia.",Ziziphi Spinosae Semen,CHEMICAL,act on target proteins such as,receptor A(HTR1 A,CHEMICAL
35178926,"The network pharmacological analysis showed that Ziziphi Spinosae Semen mainly acted on target proteins such as dopamine D2 receptor(DRD2), 5-hydroxytryptamine receptor 1 A(HTR1 A), and alpha-2 A adrenergic receptor(ADRA2 A) in the treatment of insomnia.",Ziziphi Spinosae Semen,CHEMICAL,act on target proteins such as,5-hydroxytryptamine receptor,CHEMICAL
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",oleic acid,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",N-nornuciferine,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",palmitic acid,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",betulinic acid,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",Magnoflorine,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",Ziziphi Spinosae Semen,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",ceanothic acid,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
35178926,"Magnoflorine, N-nornuciferine, caaverine, oleic acid, palmitic acid, coclaurine, betulinic acid, and ceanothic acid in Ziziphi Spinosae Semen may be potential effective compounds in the treatment of insomnia.",caaverine,CHEMICAL,be potential effective compounds in treatment of,insomnia,MENTAL_HEALTH
11921243,In-source fragmentation followed by CID of the resulting deprotonated aglycone ([A - H](-)) provided product ions for the identification of the unconjugated phenols.,In-source fragmentation,MENTAL_HEALTH,provide product ions for identification of,unconjugated phenols,NUTRITION
15799214,The term 'subclinical hypothyroidism' applies to patients who have mildly increased levels of serum thyrotropin hormone (TSH) and normal levels of thyroxine and liothyronine (triiodiothyronine).,term subclinical hypothyroidism,DISEASE,apply to patients normal levels of,thyroxine,CHEMICAL
15799214,The term 'subclinical hypothyroidism' applies to patients who have mildly increased levels of serum thyrotropin hormone (TSH) and normal levels of thyroxine and liothyronine (triiodiothyronine).,term subclinical hypothyroidism,DISEASE,apply to patients normal levels of,liothyronine,CHEMICAL
15799214,The term 'subclinical hypothyroidism' applies to patients who have mildly increased levels of serum thyrotropin hormone (TSH) and normal levels of thyroxine and liothyronine (triiodiothyronine).,term subclinical hypothyroidism,DISEASE,apply to patients normal levels of,triiodiothyronine,CHEMICAL
15799214,Positive TPO antibodies are a strong indication for therapy because of the high likelihood in these patients of progression to overt hypothyroidism; patients who are already receiving thyroxine should have adjustments of their dosage.,Positive TPO antibodies,DISEASE,be strong indication for,overt hypothyroidism,DISEASE
3003774,"Five peptide fragments of pro-opiomelanocortin (alpha-melanocyte-stimulating hormone, beta-lipoprotin, adrenocorticotropic hormone, beta-endorphin, and the N-terminal fragment of pro-opiomelanocortin) were measured by radioimmunoassay in cerebrospinal fluid (CSF) and plasma from 31 normal volunteers and 26 euthymic lithium-treated bipolar patients (14 of whom provided a second CSF sample in the unmedicated state).",pro-opiomelanocortin alpha-melanocyte-stimulating hormone,CHEBI,be measured by radioimmunoassay in,euthymic lithium-treated bipolar patients,DISEASE
14736877,"Cardiac muscle contraction is regulated by Ca(2+) through the troponin complex consisting of three subunits: troponin C (TnC), troponin T (TnT), and troponin I (TnI).",muscle contraction,DISEASE,be regulated by ca(2 through,troponin T,CHEMICAL
14736877,"Therefore, the fixation of the cardiac TnI Cys(111) allele in the wild turkey population and the corresponding functional effect reflect an increased fitness value, suggesting a novel target for the treatment of TnT myopathies.",wild turkey population,NUTRITION,suggest novel target for treatment of,TnT myopathies,DISEASE
14736877,"Therefore, the fixation of the cardiac TnI Cys(111) allele in the wild turkey population and the corresponding functional effect reflect an increased fitness value, suggesting a novel target for the treatment of TnT myopathies.",fixation,MENTAL_HEALTH,suggest novel target for treatment of,TnT myopathies,DISEASE
34302568,"The repression of JA biosynthesis is accompanied by the induction of ETH, ABA, and SA signaling and pathogenic infection defensive responses, resulting in counteracting JA-induced metabolic reprogramming and decreasing the expression of nicotine biosynthetic genes in vivo.",repression,MENTAL_HEALTH,decrease expression of,nicotine biosynthetic genes,CHEMICAL
34302568,"The repression of JA biosynthesis is accompanied by the induction of ETH, ABA, and SA signaling and pathogenic infection defensive responses, resulting in counteracting JA-induced metabolic reprogramming and decreasing the expression of nicotine biosynthetic genes in vivo.",JA biosynthesis,CHEMICAL,decrease expression of,nicotine biosynthetic genes,CHEMICAL
34302568,This study provides transcriptomic evidence for the regulatory mechanism of the NtARF6-mediated repression of alkaloid biosynthesis and indicates that this ARF transcription factor might act as a regulatory hub to connect different hormone signaling pathways in tobacco.,ARF transcription factor,DISEASE,connect,different hormone signaling pathways,CHEBI
10687276,A novel therapy for tumour repression has been developed using telomerase inhibitors.,tumour repression,MENTAL_HEALTH,use,telomerase inhibitors,CHEBI
10687276,A novel therapy for tumour repression has been developed using telomerase inhibitors.,tumour repression,DISEASE,use,telomerase inhibitors,CHEBI
34910452,The entire conjugated backbone of benzimidazolium is expected to enhance charge carrier transport within the 2D RP perovskite film. And KI can lead to a preferred orientation and less defects in the 2D RP perovskite film.,benzimidazolium,CHEMICAL,enhance,carrier transport,CHEBI
26668065,"The EGFR inhibitor erlotinib is approved for treatment of pancreatic cancer, but has shown modest activity in most patients.",EGFR inhibitor erlotinib,CHEMICAL,be approved for treatment of,pancreatic cancer,DISEASE
26668065,"The EGFR inhibitor erlotinib is approved for treatment of pancreatic cancer, but has shown modest activity in most patients.",EGFR inhibitor erlotinib,CHEBI,be approved for treatment of,pancreatic cancer,DISEASE
27581446,"Cerebellar granule cell GABAA receptor responses to alcohol vary as a function of alcohol consumption phenotype, representing a potential neural mechanism for genetic predilection for alcohol abuse (Kaplan et al., 2013; Mohr et al., 2013).",alcohol,CHEMICAL,represent potential neural mechanism for genetic predilection for,alcohol abuse,MENTAL_HEALTH
29168423,Recent studies showed that vitamin D deficiency may lead to dysfunctional changes in the brain and may be associated with neuropsychiatric diseases.,vitamin D deficiency,CHEBI,be associated with,neuropsychiatric diseases,DISEASE
34743290,"ADT brings adverse effects such as erectile dysfunction, decreased libido, and diminished physical strength.",ADT,CHEMICAL,bring adverse effects such as,erectile dysfunction,MENTAL_HEALTH
34743290,There is concern that impaired cognitive function with ADT is due to loss of testosterone support.,ADT,CHEMICAL,be due to loss of,testosterone support,CHEMICAL
34743290,"While a direct causal relationship between ADT and cognitive decline in prostate cancer patients has not been established, this review describes the controversy surrounding the possible connection between ADT and neurocognitive deterioration.",ADT,CHEMICAL,have a direct causal relationship with,cognitive decline,DISEASE
34743290,"While a direct causal relationship between ADT and cognitive decline in prostate cancer patients has not been established, this review describes the controversy surrounding the possible connection between ADT and neurocognitive deterioration.",cognitive decline,DISEASE,have a direct causal relationship with,ADT,CHEMICAL
30422674,We therefore hypothesized that low-dose spironolactone would ameliorate obesity and IR in estrogen-deprived rats by replenishing estrogen and suppressing elevated glycogen synthase kinase-3 (GSK-3).,low-dose spironolactone,CHEMICAL,ameliorate,obesity,DISEASE
30422674,We therefore hypothesized that low-dose spironolactone would ameliorate obesity and IR in estrogen-deprived rats by replenishing estrogen and suppressing elevated glycogen synthase kinase-3 (GSK-3).,low-dose spironolactone,CHEMICAL,replenish,estrogen,CHEBI
30422674,"Results showed that estrogen deprivation through ovariectomy caused increased body mass gain and visceral adiposity that are accompanied by increased HOMA-IR, HOMA-β, 1-hour postload glucose, glucose intolerance, platelet/lymphocyte ratio, plasma insulin, atherogenic dyslipidemia, uric acid, GSK-3, corticosterone, and aldosterone and depressed 17β-estradiol.",estrogen deprivation,CHEBI,cause increased,body mass gain,DISEASE
30422674,"Taken together, the results demonstrate that treatment with low-dose spironolactone improves obesity and IR, which appears to involve replenishment of estrogen and suppression of GSK-3 along with circulating mineralocorticoid and glucocorticoid.",low-dose spironolactone,CHEMICAL,improve,obesity,DISEASE
12965262,"In tic disorders, increased seroreactivity against neuronal antigens has been demonstrated, without performing molecular characterization of antigens.",neuronal antigens,CHEBI,be demonstrated in,tic disorders,DISEASE
35525633,"Continuous advances in the knowledge of C9orf72 pathophysiology, and the integration of biomarkers in the clinical evaluation of mutation carriers will allow a better diagnostic definition of C9orf72 disease spectrum from the earliest stages, with relevant impact on the possibility of disease prevention.",mutation carriers,CHEBI,allow diagnostic definition of,C9orf72 disease spectrum,DISEASE
35511193,Combined evidence from summary-based Mendelian randomization studies and profiling of human loss-of-function allele carriers showed an inverse relation between TRIM47 expression in the brain and blood vessels and extensive small vessel disease severity.,human loss-of-function allele carriers,CHEBI,show inverse relation between trim47 expression in,extensive small vessel disease severity,DISEASE
21333709,"This depression of synaptic output is insensitive to the N-methyl-d-aspartic acid (NMDA) receptor inhibitor DL-2-amino-5-phosphonopentanoic acid (AP-5, 50μM), but is blocked in slices treated with glycine receptor antagonists (strychnine, 1μM; PMBA, 50μM), nicotinic acetylcholine receptor antagonists (mecamylamine, 10μM; methyllycaconitine citrate (MLA), 40nM), or GABA(A) receptor inhibitors (picrotoxin, 100μM; bicuculline, 2μM, 20μM).",depression,MENTAL_HEALTH,be insensitive to,AP-5 50μM,CHEMICAL
21333709,"This depression of synaptic output is insensitive to the N-methyl-d-aspartic acid (NMDA) receptor inhibitor DL-2-amino-5-phosphonopentanoic acid (AP-5, 50μM), but is blocked in slices treated with glycine receptor antagonists (strychnine, 1μM; PMBA, 50μM), nicotinic acetylcholine receptor antagonists (mecamylamine, 10μM; methyllycaconitine citrate (MLA), 40nM), or GABA(A) receptor inhibitors (picrotoxin, 100μM; bicuculline, 2μM, 20μM).",depression,MENTAL_HEALTH,be insensitive to,N-methyl-d-aspartic acid NMDA receptor inhibitor DL-2-amino-5-phosphonopentanoic acid,CHEMICAL
21271306,"Serotonergic agents, such as the ergot alkaloids, have traditionally been used for the acute and preventive treatment of cluster headache and other primary headaches.",Serotonergic agents,CHEBI,be used for acute and preventive treatment of,cluster headache,MENTAL_HEALTH
21271306,"Serotonergic agents, such as the ergot alkaloids, have traditionally been used for the acute and preventive treatment of cluster headache and other primary headaches.",Serotonergic agents,CHEBI,be used for acute and preventive treatment of,other primary headaches,DISEASE
12172708,"Sumatriptan, a 5-HT(1B/1D/1F) receptor agonist, is used to relieve migraine headache.",5-HT(1B/1D/1F receptor agonist,CHEBI,relieve,migraine headache,MENTAL_HEALTH
12172708,"Sumatriptan, a 5-HT(1B/1D/1F) receptor agonist, is used to relieve migraine headache.",Sumatriptan,CHEMICAL,relieve,migraine headache,MENTAL_HEALTH
12172708,Sumatriptan can cause myocardial ischaemia and myocardial infarction.,Sumatriptan,CHEMICAL,cause,myocardial ischaemia,DISEASE
12172708,Sumatriptan can cause myocardial ischaemia and myocardial infarction.,Sumatriptan,CHEMICAL,cause,myocardial infarction,DISEASE
12172708,"While previous in-vitro studies have shown that sumatriptan has no or only weak contractile activity in human omental arteries, recent clinical studies suggest that sumatriptan may induce mesenteric ischaemia.",sumatriptan,CHEMICAL,induce,mesenteric ischaemia,DISEASE
12172708,These findings suggest that sumatriptan may induce ischaemia in human mesenteric vasculature directly or in the presence of precontractile risk factors.,sumatriptan,CHEMICAL,induce,ischaemia,DISEASE
10563228,"The 'triptan' anti-migraine agents (e.g. sumatriptan, rizatriptan, zolmitriptan naratriptan) are serotonergic agonists that have been shown to act selectively by causing vasoconstriction through 5-HT1B receptors that are expressed in human intracranial arteries and by inhibiting nociceptive transmission through an action at 5-HT1D receptors on peripheral trigeminal sensory nerve terminals in the meninges and central terminals in brain stem sensory nuclei.",anti-migraine agents,CHEMICAL,be,serotonergic agonists,CHEBI
10563228,"The 'triptan' anti-migraine agents (e.g. sumatriptan, rizatriptan, zolmitriptan naratriptan) are serotonergic agonists that have been shown to act selectively by causing vasoconstriction through 5-HT1B receptors that are expressed in human intracranial arteries and by inhibiting nociceptive transmission through an action at 5-HT1D receptors on peripheral trigeminal sensory nerve terminals in the meninges and central terminals in brain stem sensory nuclei.",sumatriptan,CHEMICAL,be,serotonergic agonists,CHEBI
35521635,"A panel of 12 biomarkers composed of chenodeoxycholic acid, vanillic acid, adenosine monophosphate, glycolic acid, histidine, azelaic acid, hydroxypropionic acid, glycine, 3,4-dihydroxymandelic acid, 4-hydroxybenzoic acid, oxoglutaric acid, and homocitrulline were identified by Random Forest (RF), Support Vector Machine (SVM), and Boruta analysis classification model and validated by Gradient Boosting (GB), Logistic Regression (LR), and Random Forest diagnostic model, which were able to discriminate CRC subjects from healthy controls.",homocitrulline,CHEMICAL,validate by,Logistic Regression,MENTAL_HEALTH
33851280,This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities.,vitamin D,CHEBI,be associated with presence or severity of,chronic tic disorders,DISEASE
33851280,This study investigated whether vitamin D is associated with the presence or severity of chronic tic disorders and their psychiatric comorbidities.,vitamin D,CHEBI,be associated with presence or severity of,psychiatric comorbidities,DISEASE
31933522,Vitamin D deficiency has been found in children with chronic tic disorders (CTDs).,Vitamin D deficiency,CHEBI,be found in children with,chronic tic disorders,DISEASE
34523994,"Findings collectively demonstrate (i) that BCWD outbreaks in China studied thus far are caused by F. psychrophilum lineages that are common on other continents (e.g., CC-ST10) and others that have not been reported elsewhere (e.g., ST355, ST356, ST357), (ii) that F. psychrophilum molecular serotypes distinguish isolates from different host fish species, even within STs, and (iii) reduced F. psychrophilum antimicrobial susceptibility against compounds used for BCWD control in China.",psychrophilum molecular serotypes,DISEASE,reduce,psychrophilum antimicrobial susceptibility,CHEBI
25703036,Fetal alcohol spectrum disorders (FASD) result from fetal exposure to alcohol and are the leading cause of mental retardation in the United States.,Fetal alcohol spectrum disorders,DISEASE,result from fetal exposure to,alcohol,CHEMICAL
21063035,"Therefore, chronic in utero ethanol exposure produces a dual state of CNS insulin resistance and oxidative stress, which we postulate plays a major role in ethanol neurobehavioral teratogenesis.",utero ethanol exposure,CHEMICAL,produce dual state of,CNS insulin resistance,MENTAL_HEALTH
24849194,Pregabalin is approved for the treatment of partial epilepsy; generalized anxiety disorder; peripheral and central neuropathic pain and fibromyalgia.,Pregabalin,CHEMICAL,be approved for treatment of,generalized anxiety disorder,MENTAL_HEALTH
24849194,Pregabalin is approved for the treatment of partial epilepsy; generalized anxiety disorder; peripheral and central neuropathic pain and fibromyalgia.,Pregabalin,CHEMICAL,be approved for treatment of,fibromyalgia,DISEASE
24849194,Pregabalin is approved for the treatment of partial epilepsy; generalized anxiety disorder; peripheral and central neuropathic pain and fibromyalgia.,Pregabalin,CHEMICAL,be approved for treatment of,peripheral neuropathic pain,DISEASE
18308797,"The current study tested the hypothesis that chronic loss of inhibitory GABAergic tone in the bed nucleus of the stria terminalis (BNST), a region implicated in anxiety behavior, results in generalized anxiety disorder-like behaviors without panic-like responses (i.e., tachycardia, hypertension and tachypnea) following panicogenic stimuli (e.g., sodium lactate infusions).",chronic loss,DISEASE,result in generalized anxiety disorder-like behaviors without,tachycardia,DISEASE
18308797,"The current study tested the hypothesis that chronic loss of inhibitory GABAergic tone in the bed nucleus of the stria terminalis (BNST), a region implicated in anxiety behavior, results in generalized anxiety disorder-like behaviors without panic-like responses (i.e., tachycardia, hypertension and tachypnea) following panicogenic stimuli (e.g., sodium lactate infusions).",chronic loss,DISEASE,result in generalized anxiety disorder-like behaviors without,hypertension,DISEASE
18308797,"The current study tested the hypothesis that chronic loss of inhibitory GABAergic tone in the bed nucleus of the stria terminalis (BNST), a region implicated in anxiety behavior, results in generalized anxiety disorder-like behaviors without panic-like responses (i.e., tachycardia, hypertension and tachypnea) following panicogenic stimuli (e.g., sodium lactate infusions).",chronic loss,DISEASE,result in generalized anxiety disorder-like behaviors without,tachypnea,DISEASE
18308797,"The current study tested the hypothesis that chronic loss of inhibitory GABAergic tone in the bed nucleus of the stria terminalis (BNST), a region implicated in anxiety behavior, results in generalized anxiety disorder-like behaviors without panic-like responses (i.e., tachycardia, hypertension and tachypnea) following panicogenic stimuli (e.g., sodium lactate infusions).",chronic loss,DISEASE,result in generalized anxiety disorder-like behaviors without,sodium lactate,CHEMICAL
18308797,"The current study tested the hypothesis that chronic loss of inhibitory GABAergic tone in the bed nucleus of the stria terminalis (BNST), a region implicated in anxiety behavior, results in generalized anxiety disorder-like behaviors without panic-like responses (i.e., tachycardia, hypertension and tachypnea) following panicogenic stimuli (e.g., sodium lactate infusions).",chronic loss,DISEASE,result in,generalized disorder-like behaviors,DISEASE
18308797,"These findings demonstrate that GABA inhibition in the BNST elicits anxiety-like behavior without increasing sensitivity to lactate, thus suggesting a behavioral profile similar to that of generalized anxiety-like behavior rather than that of panic.",GABA inhibition,CHEMICAL,elicit anxiety-like behavior without,lactate,CHEMICAL
18308797,"These findings demonstrate that GABA inhibition in the BNST elicits anxiety-like behavior without increasing sensitivity to lactate, thus suggesting a behavioral profile similar to that of generalized anxiety-like behavior rather than that of panic.",GABA inhibition,CHEMICAL,elicit,anxiety-like behavior,DISEASE
18308797,"These findings demonstrate that GABA inhibition in the BNST elicits anxiety-like behavior without increasing sensitivity to lactate, thus suggesting a behavioral profile similar to that of generalized anxiety-like behavior rather than that of panic.",GABA inhibition,CHEMICAL,suggest behavioral profile similar to,panic,DISEASE
18308797,"These findings demonstrate that GABA inhibition in the BNST elicits anxiety-like behavior without increasing sensitivity to lactate, thus suggesting a behavioral profile similar to that of generalized anxiety-like behavior rather than that of panic.",GABA inhibition,CHEMICAL,suggest behavioral profile similar to,generalized anxiety-like behavior,DISEASE
30326484,"Cytokines may play a role in developing emotional dysregulation as in alexithymia, a personality construct characterized by the subclinical inability to identify and describe emotions, often associated with several psychiatric and psychosomatic disorders.",Cytokines,CHEMICAL,develop emotional dysregulation as,alexithymia,MENTAL_HEALTH
8282133,Antidiuretic hormone (ADH) levels were elevated despite severe hyponatremia.,Antidiuretic hormone levels,CHEBI,be,severe hyponatremia,DISEASE
8282133,Mental confusion developed and serum sodium level dropped with urinary sodium concentration above 20mEq/l when thyroid replacement was started with the cessation of saline infusion.,serum sodium level,CHEMICAL,drop with,urinary sodium concentration,CHEMICAL
207218,Mental confusion disappeared and natremia became normal in all patients with therapy with cortisone and thyroid hormones.,natremia,CHEMICAL,become in patients with therapy with,cortisone hormones,CHEBI
207218,Mental confusion disappeared and natremia became normal in all patients with therapy with cortisone and thyroid hormones.,natremia,CHEMICAL,become in patients with therapy with,cortisone hormones,CHEMICAL
9717838,"First, hormone binding initially relieves repression, a property imposed on ER in cis by its ligand-binding domain (EBD).",hormone binding,CHEBI,relieve,repression,MENTAL_HEALTH
9717838,"A fusion protein including ER D, E, and F domains was activated by all the ER ligands tested, demonstrating that both agonists and antagonists serve to relieve initial repression, and that differences between them lie downstream in the activation pathway.",antagonists,CHEBI,relieve,initial repression,MENTAL_HEALTH
9717838,"A fusion protein including ER D, E, and F domains was activated by all the ER ligands tested, demonstrating that both agonists and antagonists serve to relieve initial repression, and that differences between them lie downstream in the activation pathway.",agonists,CHEBI,relieve,initial repression,MENTAL_HEALTH
20488021,"In this study, the effects of insulin-induced hypoglycemia on brain phospholipid metabolism were examined in rats which were prior injected with (32)Pi.",insulin-induced hypoglycemia,DISEASE,have the effects on,phospholipid metabolism,NUTRITION
20488021,"In the cortex, hypoglycemic condition resulted in an increase in (32)Pi uptake into the phospholipids.",hypoglycemic condition,DISEASE,result in cortex in increase in (32)pi uptake into,phospholipids,NUTRITION
20488021,"In the cortex, hypoglycemic condition resulted in an increase in (32)Pi uptake into the phospholipids.",hypoglycemic condition,DISEASE,result in cortex in increase in,(32)Pi uptake,CHEMICAL
23224660,"Further analyses revealed that low self-control significantly (p < .001) predicts at-risk/probable pathological gambling, frequent gambling, strong permissiveness toward gambling, heavy use of tobacco and alcohol, and delinquent involvement, even after controlling for the potential shared correlates of socioeconomic characteristics, parental monitoring and peer delinquency.",low self-control,CHEMICAL,predict,alcohol,CHEMICAL
23224660,"Further analyses revealed that low self-control significantly (p < .001) predicts at-risk/probable pathological gambling, frequent gambling, strong permissiveness toward gambling, heavy use of tobacco and alcohol, and delinquent involvement, even after controlling for the potential shared correlates of socioeconomic characteristics, parental monitoring and peer delinquency.",low self-control,CHEMICAL,predict,at-risk/probable pathological gambling,MENTAL_HEALTH
8501420,Decreased serum vitamin B12 levels occur in up to 20% of patients with acquired immune deficiency syndrome (AIDS) and may adversely contribute to the haematologic and neurologic dysfunction which is frequently attributed to the human immunodeficiency virus.,Decreased serum vitamin B12 levels,CHEBI,contribute to,haematologic dysfunction,DISEASE
8501420,Decreased serum vitamin B12 levels occur in up to 20% of patients with acquired immune deficiency syndrome (AIDS) and may adversely contribute to the haematologic and neurologic dysfunction which is frequently attributed to the human immunodeficiency virus.,Decreased serum vitamin B12 levels,CHEBI,occur in % of patients with,acquired immune deficiency syndrome,DISEASE
8501420,Decreased serum vitamin B12 levels occur in up to 20% of patients with acquired immune deficiency syndrome (AIDS) and may adversely contribute to the haematologic and neurologic dysfunction which is frequently attributed to the human immunodeficiency virus.,Decreased serum vitamin B12 levels,CHEBI,occur in % of patients with,AIDS,DISEASE
8501420,We believe that the AIDS dementia complex represented a reversible adverse synergistic interaction between the human immunodeficiency virus and vitamin B12 deficiency.,AIDS dementia complex,MENTAL_HEALTH,represent reversible adverse synergistic interaction between,virus vitamin B12 deficiency,CHEBI
8501420,We believe that the AIDS dementia complex represented a reversible adverse synergistic interaction between the human immunodeficiency virus and vitamin B12 deficiency.,AIDS dementia complex,MENTAL_HEALTH,represent reversible adverse synergistic interaction between,virus vitamin B12 deficiency,DISEASE
8501420,We believe that the AIDS dementia complex represented a reversible adverse synergistic interaction between the human immunodeficiency virus and vitamin B12 deficiency.,human immunodeficiency virus,DISEASE,have a reversible adverse synergistic interaction with,vitamin B12 deficiency,CHEBI
8501420,We believe that the AIDS dementia complex represented a reversible adverse synergistic interaction between the human immunodeficiency virus and vitamin B12 deficiency.,vitamin B12 deficiency,CHEBI,have a reversible adverse synergistic interaction with,human immunodeficiency virus,DISEASE
34323089,"When supplemented in combination in well-conducted trials, multiple micronutrients ± coenzyme Q10 reduced oxidative stress in chronic fatigue syndrome; in healthy people they increased cerebral blood-flow hemodynamic response, energy expenditure, and fat oxidation; reduced mental and physical fatigue; improved the speed and accuracy of cognitive function during demanding tasks; and reduced stress.",micronutrients ± coenzyme Q10,CHEMICAL,reduce oxidative stress in,chronic fatigue syndrome,MENTAL_HEALTH
34323089,"When supplemented in combination in well-conducted trials, multiple micronutrients ± coenzyme Q10 reduced oxidative stress in chronic fatigue syndrome; in healthy people they increased cerebral blood-flow hemodynamic response, energy expenditure, and fat oxidation; reduced mental and physical fatigue; improved the speed and accuracy of cognitive function during demanding tasks; and reduced stress.",micronutrients ± coenzyme Q10,CHEMICAL,reduce,mental fatigue,MENTAL_HEALTH
33991535,"Oxaliplatin is being used in different malignancies and several side effects are reported for patients taking Oxaliplatin, including peripheral neuropathy, nausea and vomiting, diarrhea, mouth sores, low blood counts, fatigue, loss of appetite, etc.",Oxaliplatin,CHEMICAL,be used in,different malignancies,DISEASE
33991535,"After three days of treatment, the CT26 spheroids at two doses of 500 and 50 μg/mL of U(OX) and FU(OX) showed volume reduction.",FU(OX,CHEMICAL,show after days of,treatment volume reduction,DISEASE
35145415,The PD model for the pharmacological intervention of AMPA receptors was established by the unilateral lesion of the substantia nigra pars compacta (SNc) with 6-hydroxydopamine (6-OHDA).,AMPA receptors,CHEMICAL,be established by unilateral lesion of,6-OHDA,CHEMICAL
35145415,The PD model for the pharmacological intervention of AMPA receptors was established by the unilateral lesion of the substantia nigra pars compacta (SNc) with 6-hydroxydopamine (6-OHDA).,AMPA receptors,CHEMICAL,be established by unilateral lesion of,6-hydroxydopamine,CHEMICAL
24635117,"Bilateral intranigral administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) (100 µg/1 µl/side) produced significant cognitive dysfunctions.",MPTP,CHEMICAL,produce,significant cognitive dysfunctions,DISEASE
24635117,"Bilateral intranigral administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) (100 µg/1 µl/side) produced significant cognitive dysfunctions.","1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine",CHEMICAL,produce,significant cognitive dysfunctions,DISEASE
24635117,PPAR-β/δ agonist GW0742 at a dose of 30 and 100 µg/kg showed significant improvement in cognitive impairments caused by MPTP in rat model of PD as evident from passive avoidance and Morris water maze test.,PPAR-β/δ agonist GW0742,CHEBI,show significant improvement in,cognitive impairments,DISEASE
24635117,MPTP-induced massive oxidative damage and DNA fragmentation was ameliorated by GW0742 treatment as observed after MDA and GSH estimation and TUNEL assay.,MPTP-induced massive oxidative damage,DISEASE,observe after,GSH,CHEMICAL
24635117,MPTP-induced massive oxidative damage and DNA fragmentation was ameliorated by GW0742 treatment as observed after MDA and GSH estimation and TUNEL assay.,MPTP-induced massive oxidative damage,DISEASE,observe after,MDA assay,CHEMICAL
24635117,MPTP-induced massive oxidative damage and DNA fragmentation was ameliorated by GW0742 treatment as observed after MDA and GSH estimation and TUNEL assay.,DNA fragmentation,MENTAL_HEALTH,observe after,GSH,CHEMICAL
24635117,MPTP-induced massive oxidative damage and DNA fragmentation was ameliorated by GW0742 treatment as observed after MDA and GSH estimation and TUNEL assay.,DNA fragmentation,MENTAL_HEALTH,observe after,MDA assay,CHEMICAL
25220242,RTI-118 is a novel NPS receptor antagonist that decreased cocaine self-administration in rats at doses that had little or no effect on food-maintained responding.,RTI-118,CHEMICAL,be,novel NPS receptor antagonist,CHEBI
25220242,RTI-118 is a novel NPS receptor antagonist that decreased cocaine self-administration in rats at doses that had little or no effect on food-maintained responding.,RTI-118,CHEMICAL,be,novel NPS receptor antagonist,DISEASE
25220242,"U69,593 (0.25-0.5mg/kg) also attenuated cocaine effects, but blockade of cocaine effects was incomplete even at a U69,593 dose that alone depressed ICSS.",cocaine effects,CHEMICAL,be incomplete at,"U69,593 dose",CHEMICAL
25220242,"U69,593 (0.25-0.5mg/kg) also attenuated cocaine effects, but blockade of cocaine effects was incomplete even at a U69,593 dose that alone depressed ICSS.","U69,593",CHEMICAL,attenuate,cocaine effects,CHEMICAL
34744005,"L-1 for the rainbow trout, brown trout larvae displayed pericardial edemas and hemorrhages already at 10 or 100 μg.L-1.",rainbow trout,NUTRITION,display,hemorrhages,DISEASE
34744005,"L-1 for the rainbow trout, brown trout larvae displayed pericardial edemas and hemorrhages already at 10 or 100 μg.L-1.",rainbow trout,NUTRITION,display,pericardial edemas,DISEASE
34744005,"L-1 for the rainbow trout, brown trout larvae displayed pericardial edemas and hemorrhages already at 10 or 100 μg.L-1.",trout larvae,NUTRITION,display,hemorrhages,DISEASE
34744005,"L-1 for the rainbow trout, brown trout larvae displayed pericardial edemas and hemorrhages already at 10 or 100 μg.L-1.",trout larvae,NUTRITION,display,pericardial edemas,DISEASE
31107373,Metoprolol is among the most frequently prescribed β-blockers for the treatment of various cardiovascular diseases.,Metoprolol,CHEMICAL,be for treatment among prescribed β-blockers of,various cardiovascular diseases,DISEASE
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Mentha spicata L.,NUTRITION,have,Linum usitatissimum L.,CHEMICAL
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Mentha spicata L.,NUTRITION,have,flaxseed,CHEMICAL
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Spearmint,NUTRITION,contain,phytoestrogen,CHEBI
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Spearmint,NUTRITION,have,Linum usitatissimum L.,CHEMICAL
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Spearmint,NUTRITION,have,flaxseed,CHEMICAL
32197626,Spearmint (Mentha spicata L.) has anti-androgenic activity and flaxseed (Linum usitatissimum L.) contains phytoestrogen and was reported to improve PCOS conditions.,Mentha spicata L.,NUTRITION,contain,phytoestrogen,CHEBI
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,eczema,DISEASE
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,psoriasis,DISEASE
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,insect bites,NUTRITION
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,scabies,DISEASE
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,urticaria,DISEASE
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,inflammation,DISEASE
30529423,"Mint oils are traditionally applied to repel insects and treat various conditions including wounds, skin infections, inflammation, eczema, urticaria, psoriasis, scabies and insect bites.",Mint oils,CHEMICAL,treat,skin infections,DISEASE
29399556,Conclusion: Spearmint has treatment potential on PCOS through inhibition of testosterone and restoration of follicular development in ovarian tissue.,Spearmint,NUTRITION,have treatment potential on pcos through inhibition of,testosterone,CHEMICAL
29399556,Conclusion: Spearmint has treatment potential on PCOS through inhibition of testosterone and restoration of follicular development in ovarian tissue.,Spearmint,NUTRITION,have treatment potential on pcos through inhibition of,ovarian tissue,DISEASE
29399556,Conclusion: Spearmint has treatment potential on PCOS through inhibition of testosterone and restoration of follicular development in ovarian tissue.,Spearmint,NUTRITION,have treatment potential on,PCOS,DISEASE
15121342,"Divalproate (VPA) was the first drug, other than lithium, reported to be efficacious for the treatment of bipolar disorder.",VPA,CHEMICAL,be,lithium,NUTRITION
15121342,"Divalproate (VPA) was the first drug, other than lithium, reported to be efficacious for the treatment of bipolar disorder.",Divalproate,CHEMICAL,be,lithium,NUTRITION
15121342,"In addition, while VPA had superior efficacy versus carbamazepine (CBZ), an anti-manic agent, and equivalent efficacy to the anti-psychotic agent olanzapine (OLZ) in manic patients with psychotic manic features, patients showed much better tolerability to VPA than CBZ, anti-psychotics, and, in particular, lithium.",VPA,CHEMICAL,have,carbamazepine,CHEMICAL
15121342,"In addition, while VPA had superior efficacy versus carbamazepine (CBZ), an anti-manic agent, and equivalent efficacy to the anti-psychotic agent olanzapine (OLZ) in manic patients with psychotic manic features, patients showed much better tolerability to VPA than CBZ, anti-psychotics, and, in particular, lithium.",VPA,CHEMICAL,have,CBZ,CHEMICAL
35422096,"Comparable to ALL patients without DS, tisagenlecleucel produced high remission rates, manageable side-effects, and promising long-term outcomes in pediatric/young adult patients with DS-ALL.",tisagenlecleucel,CHEMICAL,promise long-term outcomes in pediatric/young adult patients with,DS-ALL,DISEASE
35422096,"Comparable to ALL patients without DS, tisagenlecleucel produced high remission rates, manageable side-effects, and promising long-term outcomes in pediatric/young adult patients with DS-ALL.",tisagenlecleucel,CHEMICAL,promise long-term outcomes in,pediatric/young adult,DISEASE
35422096,"Comparable to ALL patients without DS, tisagenlecleucel produced high remission rates, manageable side-effects, and promising long-term outcomes in pediatric/young adult patients with DS-ALL.",pediatric/young adult,DISEASE,have long-term outcomes with,DS-ALL,DISEASE
27229511,This orientation of E236 stabilizes a helical region near the cluster which closes the active site to substrate binding in contrast to the open site found for AurF. A very similar closed structure was observed for the inactive dimanganese form of AurF. The observation of this same structure in different arylamine oxygenases may indicate that there are two structural states that are involved in regulation of the catalytic cycle.,orientation,MENTAL_HEALTH,be observed for inactive dimanganese form of,AurF.,CHEMICAL
26944656,"The increase in monoamine neurotransmitter availability, decrease in hydrogen peroxide production, and neuroprotective effects evoked by MAO inhibitors represent an important approach in the development of new drugs for the treatment of mental disorders and neurodegenerative diseases.",hydrogen peroxide production,CHEMICAL,represent important approach in development of new drugs for,mental disorders,MENTAL_HEALTH
26944656,"The increase in monoamine neurotransmitter availability, decrease in hydrogen peroxide production, and neuroprotective effects evoked by MAO inhibitors represent an important approach in the development of new drugs for the treatment of mental disorders and neurodegenerative diseases.",hydrogen peroxide production,CHEMICAL,represent important approach in development of new drugs for,neurodegenerative diseases,DISEASE
17093977,"Fluoxetine is used to treat unipolar depression and is thought to act by increasing the concentration of serotonin (5-HT) in the synaptic cleft, leading to increased serotonin signaling.",Fluoxetine,CHEMICAL,treat,unipolar depression,MENTAL_HEALTH
14628976,The anticonvulsant lamotrigine was previously shown to be effective for bipolar depression.,anticonvulsant lamotrigine,CHEMICAL,be shown to effective for,bipolar depression,MENTAL_HEALTH
14628976,This study assessed the efficacy and tolerability of lamotrigine and lithium compared with placebo for the prevention of mood episodes in bipolar disorder.,mood episodes,DISEASE,have the prevention in,bipolar disorder,MENTAL_HEALTH
23062763,To evaluate quetiapine in patients with bipolar I disorder with mixed symptoms.,quetiapine,CHEMICAL,in patients with,bipolar disorder,MENTAL_HEALTH
21334374,"In mandarin fish fry cells, ISKNV infection and reproduction could be promoted when the ScSidT2 protein was neutralized with specific antisera.",ISKNV infection,DISEASE,be promoted in,mandarin fish fry cells,NUTRITION
35569709,Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age.,Polycystic ovary syndrome,DISEASE,be,common endocrine disorder,CHEBI
35569709,Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age.,PCOS,DISEASE,be,common endocrine disorder,CHEBI
35569709,"Serum chromium (Cr), mercury (Hg) and copper (Cu) were significantly higher in PCOS patients.",Cr,CHEMICAL,be higher in,PCOS patients,DISEASE
35569709,"Serum chromium (Cr), mercury (Hg) and copper (Cu) were significantly higher in PCOS patients.",mercury,NUTRITION,be higher in,PCOS patients,DISEASE
35569709,"Serum chromium (Cr), mercury (Hg) and copper (Cu) were significantly higher in PCOS patients.",Serum chromium,CHEMICAL,be higher in,PCOS patients,DISEASE
35569709,"In conclusion, the present study shows that PCOS patients exhibited increased serum Cr, Hg and Cu levels, which were related to some sex hormones and lipid-metabolism disturbances and inflammatory cytokines releases, and elevated Cu levels were related to pregnancy failure, suggesting that these heavy metals may provide valuable information to predict PCOS.",PCOS patients,DISEASE,exhibit increased,Hg,CHEMICAL
35525425,"Women with congenital long QT syndrome (LQTS) experience increased cardiac events risk after the onset of adolescence, perhaps stemming from the known modulating effects of sex hormones on the cardiac potassium channels.",congenital long QT syndrome experience,DISEASE,modulating effects of sex hormones on,cardiac potassium channels,CHEMICAL
35525425,"Women with congenital long QT syndrome (LQTS) experience increased cardiac events risk after the onset of adolescence, perhaps stemming from the known modulating effects of sex hormones on the cardiac potassium channels.",congenital long QT syndrome experience,DISEASE,modulating effects of,sex hormones,CHEBI
35525425,"Women with congenital long QT syndrome (LQTS) experience increased cardiac events risk after the onset of adolescence, perhaps stemming from the known modulating effects of sex hormones on the cardiac potassium channels.",LQTS,DISEASE,modulating effects of sex hormones on,cardiac potassium channels,CHEMICAL
35525425,"Women with congenital long QT syndrome (LQTS) experience increased cardiac events risk after the onset of adolescence, perhaps stemming from the known modulating effects of sex hormones on the cardiac potassium channels.",LQTS,DISEASE,modulating effects of,sex hormones,CHEBI
35525425,"Women with congenital long QT syndrome (LQTS) experience increased cardiac events risk after the onset of adolescence, perhaps stemming from the known modulating effects of sex hormones on the cardiac potassium channels.",sex hormones,CHEBI,have effects on,cardiac potassium channels,CHEMICAL
34231526,"The physiological decline in endogenous estrogen can be associated with vasomotor symptoms or hot flashes, sleep disruption, and mood disorders.",endogenous estrogen,CHEBI,be associated with,mood disorders,MENTAL_HEALTH
34154403,The amphipathic toxin candidalysin mediates necrotic host cell damage induced by C. albicans.,amphipathic toxin candidalysin,CHEBI,mediate,necrotic host cell damage,DISEASE
33043210,"Based on proteomic and microscopic analyses, the infection cycle of the Japanese pine sawyer by M. anisopliae JEF-279 was inferred to proceed in the following sequence: (1) host adhesion and germination, (2) epicuticle degradation, (3) growth as blastospore, (4) killing by various fungal toxins (insecticidal metabolites), (5) immune response as defense mechanism, and (6) hyphal extrusion and conidiation.",JEF-279,CHEMICAL,have the infection cycle of,Japanese pine sawyer,CHEMICAL
28713269,Meta-analyses support the adjunctive use of zinc in major depression and a single study now supports zinc for psychotic symptoms.,zinc,CHEMICAL,have the adjunctive use in,major depression,MENTAL_HEALTH
34669122,"Gut dysbiosis, including gut dysbiosis caused by antibiotic treatments, is an especially high risk for neurotoxin entry into the brain to cause late onset neuropathologies.",gut dysbiosis,DISEASE,be high risk for,neurotoxin entry,CHEBI
34669122,"Gut dysbiosis has far-reaching immune system and central nervous system effects, and even a transient gut dysbiosis can act in combination with neurotoxins, such as aluminum, mercury, lead, arsenic, cadmium, selenium, manganese, organophosphate pesticides and organochlorines, to reach neurotoxin blood levels that can initiate a late onset neuropathology, depending on an individual's age and genetic vulnerability.",transient gut dysbiosis,DISEASE,reach,neurotoxin blood levels,CHEBI
33562080,"In addition, AM6545 and AM4113 alleviated the observed swelling and inflammatory cells infiltration in different kidney structures.",AM4113,CHEMICAL,observed,swelling cells,DISEASE
33562080,"In addition, AM6545 and AM4113 alleviated the observed swelling and inflammatory cells infiltration in different kidney structures.",AM6545,CHEMICAL,observed,swelling cells,DISEASE
33562080,"Moreover, AM6545 and AM4113 alleviated the observed histopathological alterations in kidney structure of MetS rats.",AM4113,CHEMICAL,alleviate observed histopathological alterations in kidney structure of,MetS rats,CHEMICAL
33562080,"Moreover, AM6545 and AM4113 alleviated the observed histopathological alterations in kidney structure of MetS rats.",AM6545,CHEMICAL,alleviate observed histopathological alterations in kidney structure of,MetS rats,CHEMICAL
33562080,"In conclusion, AM6545 and AM4113, possess reno-protective effects by interfering with TGFβ1-mediated renal inflammation and fibrosis, via peripheral action.",AM4113,CHEMICAL,interfere with,fibrosis,DISEASE
33562080,"In conclusion, AM6545 and AM4113, possess reno-protective effects by interfering with TGFβ1-mediated renal inflammation and fibrosis, via peripheral action.",AM4113,CHEMICAL,interfere with,TGFβ1-mediated renal inflammation,DISEASE
33562080,"In conclusion, AM6545 and AM4113, possess reno-protective effects by interfering with TGFβ1-mediated renal inflammation and fibrosis, via peripheral action.",AM6545,CHEMICAL,interfere with,fibrosis,DISEASE
33562080,"In conclusion, AM6545 and AM4113, possess reno-protective effects by interfering with TGFβ1-mediated renal inflammation and fibrosis, via peripheral action.",AM6545,CHEMICAL,interfere with,TGFβ1-mediated renal inflammation,DISEASE
22314898,Effect of interaction of melatonin and caffeine on caffeine induced oxidative stress and sleep disorders was studied.,caffeine,CHEMICAL,induce,sleep disorders,DISEASE
22314898,Effect of interaction of melatonin and caffeine on caffeine induced oxidative stress and sleep disorders was studied.,melatonin,CHEMICAL,induce,sleep disorders,DISEASE
22314898,Effect of interaction of melatonin and caffeine on caffeine induced oxidative stress and sleep disorders was studied.,caffeine,CHEMICAL,have interaction on,caffeine,CHEMICAL
22314898,Effect of interaction of melatonin and caffeine on caffeine induced oxidative stress and sleep disorders was studied.,melatonin,CHEMICAL,have interaction on,caffeine,CHEMICAL
10933341,Ketoconazole is an oral antimycotic agent approved by the FDA for the treatment of fungal disease which also blocks the synthesis of adrenocorticosteroids and functions as a glucocorticoid receptor antagonist.,Ketoconazole,CHEMICAL,approved by fda for treatment of,fungal disease,DISEASE
10933341,Ketoconazole is an oral antimycotic agent approved by the FDA for the treatment of fungal disease which also blocks the synthesis of adrenocorticosteroids and functions as a glucocorticoid receptor antagonist.,Ketoconazole,CHEMICAL,approved by,FDA,CHEMICAL
11852294,"The binding of imipramine to plasma proteins was studied in 20 adult patients with endogenous depression, with the purpose of assessing the effect produced by its simultaneous administration with an analgesic.",imipramine,CHEMICAL,be studied in adult patients with,endogenous depression,MENTAL_HEALTH
11852294,"The levels of free imipramine increased when ASA was administered, indicating a displacement on the binding to plasma proteins.",free imipramine,CHEMICAL,indicate,displacement,MENTAL_HEALTH
6091098,The possibility of involvement of these systems in psychiatric illness arises from the psychotogenic and anxiolytic properties of some opiates.,psychiatric illness,DISEASE,arise from,psychotogenic properties,CHEMICAL
6091098,"The endorphin-excess and -deficiency hypotheses of schizophrenia are reviewed in the light of naloxone's small but statistically significant antipsychotic action, and the activation of endorphinergic systems in the course of neuroleptic therapy.",schizophrenia,MENTAL_HEALTH,be reviewed in light of,naloxone,CHEMICAL
35006374,"Children with OSAS also showed increased transaminase, glucose, uric acid, and insulin levels (all p < 0.001) compared to healthy controls.",OSAS,DISEASE,show increased,uric acid,CHEMICAL
35006374,"Children with OSAS also showed increased transaminase, glucose, uric acid, and insulin levels (all p < 0.001) compared to healthy controls.",OSAS,DISEASE,show increased,glucose,CHEMICAL
3310672,"The antipsychotic potency of the partial opiate agonist buprenorphine was evaluated in 10 neuroleptic-free schizophrenic patients suffering from frequent hallucinations, delusions, and severe formal thought disorders.",partial opiate agonist buprenorphine,CHEMICAL,be evaluated in,neuroleptic-free schizophrenic patients,DISEASE
3310672,"The antipsychotic potency of the partial opiate agonist buprenorphine was evaluated in 10 neuroleptic-free schizophrenic patients suffering from frequent hallucinations, delusions, and severe formal thought disorders.",partial opiate agonist buprenorphine,CHEBI,be evaluated in,neuroleptic-free schizophrenic patients,DISEASE
3310672,"Buprenorphine had a pronounced antipsychotic effect, which lasted about 4 hours, in patients with schizophreniform disorders (N = 4) and paranoid schizophrenia (N = 3).",Buprenorphine,CHEMICAL,have,paranoid schizophrenia,MENTAL_HEALTH
3310672,"Buprenorphine had a pronounced antipsychotic effect, which lasted about 4 hours, in patients with schizophreniform disorders (N = 4) and paranoid schizophrenia (N = 3).",Buprenorphine,CHEMICAL,have,schizophreniform disorders =,DISEASE
23756349,Progestin stimulation results in remodeling of these nucleosomes with displacement of histones H1 and H2A/H2B dimers.,Progestin stimulation,CHEBI,result in remodeling of nucleosomes with displacement of,H1,CHEMICAL
23756349,Progestin stimulation results in remodeling of these nucleosomes with displacement of histones H1 and H2A/H2B dimers.,Progestin stimulation,CHEBI,result in remodeling of nucleosomes with,displacement,MENTAL_HEALTH
23177737,Progestin stimulation results in remodeling of these nucleosomes with displacement of histones H1 and H2A/H2B dimers.,Progestin stimulation,CHEBI,result in remodeling of nucleosomes with displacement of,H1,CHEMICAL
23177737,Progestin stimulation results in remodeling of these nucleosomes with displacement of histones H1 and H2A/H2B dimers.,Progestin stimulation,CHEBI,result in remodeling of nucleosomes with,displacement,MENTAL_HEALTH
22815604,The role of lithium and newer mood stabilizers in bipolar disorders are taken as examples to highlight this point.,lithium mood stabilizers,CHEBI,have the role in,bipolar disorders,DISEASE
22815604,The role of lithium and newer mood stabilizers in bipolar disorders are taken as examples to highlight this point.,lithium mood stabilizers,NUTRITION,have the role in,bipolar disorders,DISEASE
3074921,"Routine clinical chemical variables and parameters of the vitamin, iron and zinc status were measured in 20 female patients with anorexia nervosa (AN) and in 10 lean and 10 normal weight, healthy, female control subjects.",vitamin,CHEBI,be measured in female patients with,anorexia nervosa,MENTAL_HEALTH
3074921,"Routine clinical chemical variables and parameters of the vitamin, iron and zinc status were measured in 20 female patients with anorexia nervosa (AN) and in 10 lean and 10 normal weight, healthy, female control subjects.",variables zinc status,CHEMICAL,be measured in female patients with,anorexia nervosa,MENTAL_HEALTH
9530548,Clinical trials have shown that tiagabine is effective as add-on therapy in the management of patients with refractory partial epilepsy.,tiagabine,CHEMICAL,be effective as add-on therapy in management of,refractory partial epilepsy,DISEASE
9530548,Tiagabine appeared to produce a sustained reduction in seizure frequency in studies of up to 12 months' duration.,Tiagabine,CHEMICAL,produce sustained reduction in,seizure frequency,DISEASE
9530548,Skin rash or psychosis occurred with similar frequencies among tiagabine- and placebo-treated patients.,psychosis,MENTAL_HEALTH,occur with similar frequencies among,tiagabine-,CHEMICAL
9530548,Skin rash or psychosis occurred with similar frequencies among tiagabine- and placebo-treated patients.,Skin rash,DISEASE,occur with similar frequencies among,tiagabine-,CHEMICAL
9530548,Further investigation of the efficacy of tiagabine is expected to provide a clearer definition of its place in the treatment of epilepsy and its relative merits in relation to other antiepileptic drugs.,tiagabine,CHEMICAL,provide clearer definition of its place in treatment of,epilepsy,DISEASE
15651493,"Anticholinergics are effective on overactive bladder, the alphablockers on the urethral hypertonia at the price of a higher risk of arterial hypotension in this diathesis.",Anticholinergics,CHEBI,be effective on overactive bladder alphablockers on urethral hypertonia at,arterial hypotension,DISEASE
15651493,"Anticholinergics are effective on overactive bladder, the alphablockers on the urethral hypertonia at the price of a higher risk of arterial hypotension in this diathesis.",Anticholinergics,CHEBI,be effective on overactive bladder alphablockers on urethral hypertonia at,diathesis,DISEASE
15651493,"Anticholinergics are effective on overactive bladder, the alphablockers on the urethral hypertonia at the price of a higher risk of arterial hypotension in this diathesis.",Anticholinergics,CHEBI,be effective on overactive bladder alphablockers on,urethral hypertonia,DISEASE
15651493,"Anticholinergics are effective on overactive bladder, the alphablockers on the urethral hypertonia at the price of a higher risk of arterial hypotension in this diathesis.",Anticholinergics,CHEBI,be effective on,overactive bladder alphablockers,CHEMICAL
15651493,"Anticholinergics are effective on overactive bladder, the alphablockers on the urethral hypertonia at the price of a higher risk of arterial hypotension in this diathesis.",arterial hypotension,DISEASE,have a higher risk in,diathesis,DISEASE
10091618,"We investigated the effect of an anticholinergic (biperiden) and a dopamine agonist (apomorphine) on tremor, rigidity, and akinesia in patients with idiopathic Parkinson's disease.",akinesia,MENTAL_HEALTH,in patients with,idiopathic Parkinson's disease,DISEASE
10091618,"Both single-dose challenges significantly reduced the amplitude of RT, PT, and AT, but only apomorphine significantly reduced UPDRS scores for rigidity and akinesia.",apomorphine,CHEMICAL,reduce updrs scores for,rigidity,DISEASE
10091618,"Both single-dose challenges significantly reduced the amplitude of RT, PT, and AT, but only apomorphine significantly reduced UPDRS scores for rigidity and akinesia.",apomorphine,CHEMICAL,reduce updrs scores for,akinesia,MENTAL_HEALTH
10091618,We therefore conclude that dopaminergic substances are as effective as anticholinergics in patients with parkinsonian tremor and additionally improve other parkinsonian signs.,anticholinergics,CHEBI,in patients with,parkinsonian tremor,DISEASE
22341895,"The spatial orientation of the hydroxyl moiety in 3b, 4b, 2a, and 2b is proposed to be the structural requirement for high μ-opioid receptor binding affinity and their agonist or antagonist activity.",spatial orientation,MENTAL_HEALTH,be proposed to structural requirement for,agonist activity,CHEBI
22341895,"The spatial orientation of the hydroxyl moiety in 3b, 4b, 2a, and 2b is proposed to be the structural requirement for high μ-opioid receptor binding affinity and their agonist or antagonist activity.",spatial orientation,MENTAL_HEALTH,be proposed to structural requirement for,antagonist,CHEBI
22341895,"The spatial orientation of the hydroxyl moiety in 3b, 4b, 2a, and 2b is proposed to be the structural requirement for high μ-opioid receptor binding affinity and their agonist or antagonist activity.",hydroxyl moiety,CHEMICAL,be proposed to structural requirement for,agonist activity,CHEBI
22341895,"The spatial orientation of the hydroxyl moiety in 3b, 4b, 2a, and 2b is proposed to be the structural requirement for high μ-opioid receptor binding affinity and their agonist or antagonist activity.",hydroxyl moiety,CHEMICAL,be proposed to structural requirement for,antagonist,CHEBI
29954354,The effects of the seaweed extract were evaluated on the animal model equivalent of depression compared with a control group treated with the carrier (spring water) and a reference group treated with Imipramine and showed significative effect.,seaweed extract,NUTRITION,be evaluated on animal model equivalent of,depression,MENTAL_HEALTH
26992699,We have shown that dysregulation of the dynorphin/kappa-opioid receptor (DYN/KOR) system contributes to escalated alcohol self-administration in alcohol dependence and that KOR antagonists with extended durations of action selectively reduce escalated alcohol consumption in alcohol-dependent animals.,KOR antagonists,CHEBI,reduce escalated,alcohol consumption,CHEMICAL
33400967,Bromocriptine Mesylate (BRM) acts as a dopamine receptor agonist along with antioxidant effect and is utilized in the treatment of Parkinson's disease (PD).,Bromocriptine Mesylate,CHEMICAL,act as,dopamine receptor agonist,CHEBI
33400967,Bromocriptine Mesylate (BRM) acts as a dopamine receptor agonist along with antioxidant effect and is utilized in the treatment of Parkinson's disease (PD).,Bromocriptine Mesylate,CHEMICAL,be utilized in treatment of parkinson's,PD,DISEASE
26220941,Abnormal dopamine neurotransmission is associated with many different genetic and acquired dystonic disorders.,Abnormal dopamine neurotransmission,CHEMICAL,be associated with,genetic dystonic disorders,DISEASE
26220941,"For instance, mutations in genes critical for the synthesis of dopamine, including GCH1 and TH cause l-DOPA-responsive dystonia.",dopamine,CHEMICAL,cause for,instance l-DOPA-responsive dystonia,DISEASE
26220941,"Mice homozygous for this mutation displayed the core features of the human disorder, including reduced TH activity, dystonia that worsened throughout the course of the active phase, and improvement in the dystonia in response to both l-DOPA and trihexyphenidyl.",dystonia,DISEASE,have and improvement in,trihexyphenidyl,CHEMICAL
26220941,"Mice homozygous for this mutation displayed the core features of the human disorder, including reduced TH activity, dystonia that worsened throughout the course of the active phase, and improvement in the dystonia in response to both l-DOPA and trihexyphenidyl.",dystonia,DISEASE,have and improvement in,l-DOPA,CHEMICAL
26220941,Microinjection of l-DOPA directly into the striatum ameliorated the dystonic movements but cerebellar microinjections of l-DOPA had no effect.,l-DOPA,CHEMICAL,ameliorate dystonic movements but cerebellar microinjections of,l-DOPA,CHEMICAL
26220941,Microinjection of l-DOPA directly into the striatum ameliorated the dystonic movements but cerebellar microinjections of l-DOPA had no effect.,l-DOPA,CHEMICAL,ameliorate,dystonic movements,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D1- D2-like dopamine receptor antagonists,CHEMICAL,reduce,dopamine signalling,CHEMICAL
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D1- D2-like dopamine receptor antagonists,CHEBI,reduce,dopamine signalling,CHEMICAL
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D1-,CHEMICAL,worsen,dystonia,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D1-,CHEMICAL,reduce,dystonic movements,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D2-like dopamine receptor agonists,CHEBI,reduce,dystonic movements,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D2-like dopamine receptor agonists,CHEMICAL,reduce,dystonic movements,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D2-like dopamine receptor agonists,CHEBI,worsen,dystonia,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D2-like dopamine receptor agonists,CHEMICAL,worsen,dystonia,DISEASE
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",dopamine receptor agonists,CHEMICAL,have administration to,dopamine signalling,CHEMICAL
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",D1-,CHEMICAL,have administration to,dopamine signalling,CHEMICAL
26220941,"Administration of D1- or D2-like dopamine receptor agonists to enhance dopamine signalling reduced the dystonic movements, whereas administration of D1- or D2-like dopamine receptor antagonists to further reduce dopamine signalling worsened the dystonia, suggesting that both receptors mediate the abnormal movements.",dopamine receptor agonists,CHEBI,have administration to,dopamine signalling,CHEMICAL
26220941,D2-dopamine receptors exhibited a change in the valence in DRD mice with an increase in adenylate cyclase activity and blunted behavioural responses after challenge with the D2-dopamine receptor agonist quinpirole.,D2-dopamine receptors,CHEMICAL,exhibit change in valence in,DRD mice,DISEASE
26220941,"Together, our findings suggest that the development of dystonia may depend on a reduction in dopamine in combination with specific abnormal receptor responses.",dystonia,DISEASE,depend on reduction in,dopamine,CHEMICAL
16325154,Increased levels of homocysteine have been associated with anger and depression separately.,homocysteine,CHEMICAL,be associated with,depression,MENTAL_HEALTH
16325154,Increased levels of homocysteine have been associated with anger and depression separately.,homocysteine,CHEMICAL,be associated with,anger,DISEASE
16325154,We investigated the association of anger attacks in major depressive disorder (MDD) with serum levels of homocysteine.,anger attacks,DISEASE,have the association in,major depressive disorder,MENTAL_HEALTH
19046188,"Fluorescence in situ hybridization analysis for 22q11.2 deletion and DNA analysis of the protein tyrosine phosphatase, non-receptor type II gene were normal, thus excluding DiGeorge and Noonan syndromes.",22q11.2 deletion,DISEASE,be,DiGeorge syndromes,DISEASE
19046188,"Fluorescence in situ hybridization analysis for 22q11.2 deletion and DNA analysis of the protein tyrosine phosphatase, non-receptor type II gene were normal, thus excluding DiGeorge and Noonan syndromes.",22q11.2 deletion,DISEASE,be,DiGeorge syndromes,MENTAL_HEALTH
19046188,"Fluorescence in situ hybridization analysis for 22q11.2 deletion and DNA analysis of the protein tyrosine phosphatase, non-receptor type II gene were normal, thus excluding DiGeorge and Noonan syndromes.",protein tyrosine phosphatase,CHEMICAL,be,DiGeorge syndromes,DISEASE
19046188,"Fluorescence in situ hybridization analysis for 22q11.2 deletion and DNA analysis of the protein tyrosine phosphatase, non-receptor type II gene were normal, thus excluding DiGeorge and Noonan syndromes.",protein tyrosine phosphatase,CHEMICAL,be,DiGeorge syndromes,MENTAL_HEALTH
14590591,"Forty-two subjects, 27 ADHD adults and 15 control subjects, were administered the Goldman-Fristoe-Woodcock Test of Auditory Discrimination (TOAD), and the Stroop Color and Word Test.",ADHD adults,MENTAL_HEALTH,be administered goldman-fristoe-woodcock test of,TOAD,NUTRITION
25771167,"The BDNF Val66Met SNP has been associated with a number of psychiatric disorders such as depression, anxiety disorders, schizophrenia and related traits.",BDNF SNP,CHEMICAL,be associated with number of psychiatric disorders such as,schizophrenia,MENTAL_HEALTH
25771167,"The BDNF Val66Met SNP has been associated with a number of psychiatric disorders such as depression, anxiety disorders, schizophrenia and related traits.",BDNF SNP,CHEMICAL,be associated with number of psychiatric disorders such as,depression,MENTAL_HEALTH
25771167,"The BDNF Val66Met SNP has been associated with a number of psychiatric disorders such as depression, anxiety disorders, schizophrenia and related traits.",BDNF SNP,CHEMICAL,be associated with number of psychiatric disorders such as,anxiety disorders,MENTAL_HEALTH
25771167,"The BDNF Val66Met SNP has been associated with a number of psychiatric disorders such as depression, anxiety disorders, schizophrenia and related traits.",BDNF SNP,CHEMICAL,be associated with number of,psychiatric disorders,DISEASE
35586367,"The dried root of Angelica sinensis (A. sinensis) has been widely used in Chinese traditional medicine for various diseases such as inflammation, osteoarthritis, infections, mild anemia, fatigue, and high blood pressure.",Angelica sinensis,NUTRITION,be used in chinese traditional medicine for various diseases such as,osteoarthritis,DISEASE
35586367,"The dried root of Angelica sinensis (A. sinensis) has been widely used in Chinese traditional medicine for various diseases such as inflammation, osteoarthritis, infections, mild anemia, fatigue, and high blood pressure.",Angelica sinensis,NUTRITION,be used in chinese traditional medicine for various diseases such as,mild anemia,DISEASE
35586367,"The dried root of Angelica sinensis (A. sinensis) has been widely used in Chinese traditional medicine for various diseases such as inflammation, osteoarthritis, infections, mild anemia, fatigue, and high blood pressure.",Angelica sinensis,NUTRITION,be used in chinese traditional medicine for various diseases such as,fatigue,MENTAL_HEALTH
35586367,"The dried root of Angelica sinensis (A. sinensis) has been widely used in Chinese traditional medicine for various diseases such as inflammation, osteoarthritis, infections, mild anemia, fatigue, and high blood pressure.",Angelica sinensis,NUTRITION,be used in chinese traditional medicine for various diseases such as,infections,DISEASE
35586367,"Glabralactone (5 and 10 mg/kg) exhibited an in vivo anti-inflammatory activity with the reduction of paw edema volume in carrageenan-induced rat model, and the expressions of iNOS and IL-1β proteins were suppressed by glabralactone in the paw soft tissues of the animal model.",Glabralactone,CHEMICAL,exhibit,paw edema volume,DISEASE
35576890,Tripterygium wilfordii genus preparations (TWGP) are widely used in traditional Chinese medicines for the treatment of autoimmune diseases and immune diseases with definite therapeutic effects but high toxicity.,wilfordii genus preparations,CHEMICAL,be used in traditional chinese medicines for treatment of autoimmune diseases and immune diseases with,high toxicity,DISEASE
35576890,Tripterygium wilfordii genus preparations (TWGP) are widely used in traditional Chinese medicines for the treatment of autoimmune diseases and immune diseases with definite therapeutic effects but high toxicity.,wilfordii genus preparations,CHEMICAL,be used in traditional chinese medicines for treatment of,autoimmune diseases,DISEASE
35576890,Tripterygium wilfordii genus preparations (TWGP) are widely used in traditional Chinese medicines for the treatment of autoimmune diseases and immune diseases with definite therapeutic effects but high toxicity.,wilfordii genus preparations,CHEMICAL,be used in traditional chinese medicines for treatment of,immune diseases,DISEASE
35576890,Tripterygium wilfordii genus preparations (TWGP) are widely used in traditional Chinese medicines for the treatment of autoimmune diseases and immune diseases with definite therapeutic effects but high toxicity.,autoimmune diseases,DISEASE,have the treatment with,high toxicity,DISEASE
35576890,Tripterygium wilfordii genus preparations (TWGP) are widely used in traditional Chinese medicines for the treatment of autoimmune diseases and immune diseases with definite therapeutic effects but high toxicity.,immune diseases,DISEASE,have the treatment with,high toxicity,DISEASE
35249316,Uremic toxins may also be directly related to cognitive impairment in CKD.,Uremic toxins,CHEBI,be related to,cognitive impairment,DISEASE
25447298,LI is the normal suppression of a classically conditioned response when the subject is pre-exposed to the conditioned stimulus (CS) before it is paired with the unconditioned stimulus (UCS).,LI,CHEMICAL,be normal suppression of,conditioned response,MENTAL_HEALTH
23064080,These results show that LPS interferes with learning/memory in the anticipatory nausea paradigm in rats that are both LPS tolerant and LPS non-tolerant.,LPS,CHEMICAL,interfere with learning/memory in,anticipatory nausea paradigm,DISEASE
26240334,Regulation of FXR1P by GSK3β also provides a mechanistic framework that may explain how inhibition of GSK3β can contribute to the regulation of mood by psychoactive drugs in mental illnesses such as bipolar disorder.,GSK3β,CHEMICAL,contribute to regulation of mood by psychoactive drugs in,bipolar disorder,MENTAL_HEALTH
20503316,"On the basis of these findings, we decided to evaluate the in vivo efficacy of VPA on ADHD symptoms in FXS patients.",VPA,CHEMICAL,have efficacy on,ADHD symptoms,MENTAL_HEALTH
32588216,"Especially, indole, a metabolite of tryptophan produced by gut bacteria, may be associated with the development of mood disorders.",tryptophan,NUTRITION,be associated with development of,mood disorders,MENTAL_HEALTH
32588216,"Especially, indole, a metabolite of tryptophan produced by gut bacteria, may be associated with the development of mood disorders.",indole,CHEMICAL,be associated with development of,mood disorders,MENTAL_HEALTH
25429,Administration of catecholamine synthesis inhibitors (alpha-methl-p-tyrosine) or serotonin (parachlorphenylalanine) simultaneously with testosterone propionate prevented the anovular sterility in the majority of the neonatally androgenized rats.,testosterone propionate,CHEMICAL,prevent,anovular sterility,DISEASE
25429,Administration of catecholamine synthesis inhibitors (alpha-methl-p-tyrosine) or serotonin (parachlorphenylalanine) simultaneously with testosterone propionate prevented the anovular sterility in the majority of the neonatally androgenized rats.,catecholamine synthesis inhibitors,CHEMICAL,prevent,anovular sterility,DISEASE
25429,Administration of catecholamine synthesis inhibitors (alpha-methl-p-tyrosine) or serotonin (parachlorphenylalanine) simultaneously with testosterone propionate prevented the anovular sterility in the majority of the neonatally androgenized rats.,alpha-methl-p-tyrosine,CHEMICAL,prevent,anovular sterility,DISEASE
25429,Administration of catecholamine synthesis inhibitors (alpha-methl-p-tyrosine) or serotonin (parachlorphenylalanine) simultaneously with testosterone propionate prevented the anovular sterility in the majority of the neonatally androgenized rats.,serotonin,CHEMICAL,prevent,anovular sterility,DISEASE
35085738,"T-cell intracellular antigen (TIA)-1 is a prion-related RNA-binding protein involved in splicing and translational repression, and regulates translation in response to stress conditions by isolating target mRNAs in stress granules (SGs).",antigen (TIA)-1,CHEBI,involved in,splicing repression,MENTAL_HEALTH
21089166,Tricyclic antidepressants (TCA) were used to treat nocturnal enuresis (NE) for decades of years although their real mechanisms are unknown.,TCA,CHEMICAL,treat,NE,CHEMICAL
21089166,Tricyclic antidepressants (TCA) were used to treat nocturnal enuresis (NE) for decades of years although their real mechanisms are unknown.,TCA,CHEMICAL,treat,nocturnal enuresis,MENTAL_HEALTH
21089166,Tricyclic antidepressants (TCA) were used to treat nocturnal enuresis (NE) for decades of years although their real mechanisms are unknown.,Tricyclic antidepressants,CHEMICAL,treat,NE,CHEMICAL
21089166,Tricyclic antidepressants (TCA) were used to treat nocturnal enuresis (NE) for decades of years although their real mechanisms are unknown.,Tricyclic antidepressants,CHEMICAL,treat,nocturnal enuresis,MENTAL_HEALTH
22678941,"Dopaminergic agents are commonly used and effective treatments for restless legs syndrome (RLS), a disabling sensorimotor disorder.",Dopaminergic agents,CHEBI,be used treatments for,sensorimotor disorder,DISEASE
33567423,"The main goal of the trial was to investigate whether an oral calcium administration is able to affect craving, withdrawal, and relapse risk in alcohol-dependent patients.",oral calcium administration,CHEMICAL,affect,craving,MENTAL_HEALTH
35594946,Prenatal exposure to the anticonvulsant drug valproic acid (VPA) is reported to induce ASD in human and ASD-like phenotypes in rodents.,anticonvulsant drug valproic acid,CHEMICAL,induce asd in,ASD-like,DISEASE
35594946,Prenatal exposure to the anticonvulsant drug valproic acid (VPA) is reported to induce ASD in human and ASD-like phenotypes in rodents.,anticonvulsant drug valproic acid,CHEBI,induce asd in,ASD-like,DISEASE
35594946,Prenatal exposure to the anticonvulsant drug valproic acid (VPA) is reported to induce ASD in human and ASD-like phenotypes in rodents.,VPA,CHEMICAL,induce asd in,ASD-like,DISEASE
31017569,"In this study, we investigated whether the addition of vitamin B complex to prime solution for cardiopulmonary bypass (CPB) in cobalamin-deficient patients undergoing on-pump coronary artery bypass grafting (CABG) helps prevent the development of postoperative delirium (POD).",vitamin B complex,CHEBI,prevent development of,postoperative delirium,MENTAL_HEALTH
34996492,"However, effects of exposure to PM2.5 on the finite ovarian follicle pool have hardly been investigated, nor have interactions between ovarian and cardiovascular effects.",finite ovarian follicle pool,NUTRITION,have interactions between,ovarian effects,DISEASE
29305876,"In the control group, more left-sided frontal alpha correlated with higher depression scores, which was not observed in the patient group.",left-sided frontal alpha,DISEASE,correlate in control group with,higher depression scores,MENTAL_HEALTH
29305876,"In the control group, more left-sided frontal alpha correlated with higher depression scores, which was not observed in the patient group.",left-sided frontal alpha,NUTRITION,correlate in control group with,higher depression scores,MENTAL_HEALTH
34280191,Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN).,Angiotensin receptor blockers,CHEMICAL,have protective effects against dementia occurrence in patients with,HTN,DISEASE
34280191,Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN).,Angiotensin receptor blockers,CHEMICAL,have protective effects against dementia occurrence in patients with,hypertension,DISEASE
34280191,Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN).,Angiotensin receptor blockers,CHEMICAL,have protective effects against,dementia occurrence,MENTAL_HEALTH
34280191,Angiotensin receptor blockers (ARBs) may have protective effects against dementia occurrence in patients with hypertension (HTN).,dementia occurrence,MENTAL_HEALTH,in patients with,hypertension,DISEASE
26019617,The nucleotide and amino acid sequences for the DRA genes in gayal (Bofr-DRA) and gaytle (Bofr × BoLA-DRA) were almost identical to those for cattle and yak (99%).,amino acid sequences,CHEMICAL,be identical to,cattle,DISEASE
26019617,The nucleotide and amino acid sequences for the DRA genes in gayal (Bofr-DRA) and gaytle (Bofr × BoLA-DRA) were almost identical to those for cattle and yak (99%).,nucleotide,CHEMICAL,be identical to,cattle,DISEASE
30161001,"Despite the success of approved systemic therapies for estrogen receptor α (ER)-positive breast cancer, drug resistance remains common.",drug resistance,MENTAL_HEALTH,approved systemic therapies for,estrogen receptor α (ER)-positive breast cancer common,DISEASE
30161001,"Despite the success of approved systemic therapies for estrogen receptor α (ER)-positive breast cancer, drug resistance remains common.",drug resistance,MENTAL_HEALTH,approved systemic therapies for,estrogen receptor α (ER)-positive breast cancer common,CHEBI
30161001,"Despite the success of approved systemic therapies for estrogen receptor α (ER)-positive breast cancer, drug resistance remains common.",drug resistance,CHEBI,approved systemic therapies for,estrogen receptor α (ER)-positive breast cancer common,DISEASE
30161001,"Despite the success of approved systemic therapies for estrogen receptor α (ER)-positive breast cancer, drug resistance remains common.",drug resistance,CHEBI,approved systemic therapies for,estrogen receptor α (ER)-positive breast cancer common,CHEBI
30161001,We hypothesized that secreted factors from the human tumor microenvironment could modulate drug resistance.,human tumor microenvironment,DISEASE,modulate,drug resistance,MENTAL_HEALTH
30161001,We hypothesized that secreted factors from the human tumor microenvironment could modulate drug resistance.,human tumor microenvironment,DISEASE,modulate,drug resistance,CHEBI
27510860,The exogenous taurine could mitigate the adverse effect of high ammonia level on fish physiological disorder.,exogenous taurine,CHEMICAL,mitigate adverse effect of high ammonia level on,fish physiological disorder,DISEASE
27510860,The exogenous taurine could mitigate the adverse effect of high ammonia level on fish physiological disorder.,exogenous taurine,CHEMICAL,mitigate adverse effect of,high ammonia level,CHEMICAL
27510860,The exogenous taurine could mitigate the adverse effect of high ammonia level on fish physiological disorder.,high ammonia level,CHEMICAL,have the adverse effect on,fish physiological disorder,DISEASE
17297634,"Treatment with CRF antagonists has been demonstrated to reduce the severity of certain drug withdrawal symptoms, implicating a specific role for activation of CRF neurons in mediating the anxiogenic and stress-like reactions observed after abrupt drug discontinuation.",CRF antagonists,CHEBI,reduce severity of,certain drug withdrawal symptoms,CHEBI
7623152,"Enkephalin-positive projection neurons, somatostatin-positive interneurons, and cholinergic interneurons each have distinct NMDA receptor subunit phenotypes.",Enkephalin-positive projection neurons,MENTAL_HEALTH,have,distinct NMDA receptor subunit phenotypes,CHEMICAL
7623152,Differences in NMDA receptor expression may contribute to the relative resistance of striatal interneurons to the neurotoxic effect of NMDA receptor agonists.,NMDA receptor expression,CHEMICAL,contribute to relative resistance of striatal interneurons to neurotoxic effect of,NMDA receptor agonists,CHEBI
7623152,Differences in NMDA receptor expression may contribute to the relative resistance of striatal interneurons to the neurotoxic effect of NMDA receptor agonists.,NMDA receptor expression,CHEMICAL,contribute to relative resistance of striatal interneurons to,neurotoxic effect,DISEASE
7623152,Differences in NMDA receptor expression may contribute to the relative resistance of striatal interneurons to the neurotoxic effect of NMDA receptor agonists.,NMDA receptor expression,CHEMICAL,contribute to,relative resistance,MENTAL_HEALTH
7907483,"Such an organization could explain some of the behavioural differences between competitive and un-competitive NMDA antagonists, since the binding of competitive NMDA antagonists is inhibited by glutamate, whereas the binding of un-competitive NMDA antagonists is enhanced by the presence of NMDA receptor agonists, a phenomenon called use/agonist dependence.",competitive NMDA antagonists,CHEMICAL,be inhibited by,glutamate,CHEMICAL
7907483,"Such an organization could explain some of the behavioural differences between competitive and un-competitive NMDA antagonists, since the binding of competitive NMDA antagonists is inhibited by glutamate, whereas the binding of un-competitive NMDA antagonists is enhanced by the presence of NMDA receptor agonists, a phenomenon called use/agonist dependence.",competitive NMDA antagonists,CHEBI,be inhibited by,glutamate,CHEMICAL
7907483,"Such an organization could explain some of the behavioural differences between competitive and un-competitive NMDA antagonists, since the binding of competitive NMDA antagonists is inhibited by glutamate, whereas the binding of un-competitive NMDA antagonists is enhanced by the presence of NMDA receptor agonists, a phenomenon called use/agonist dependence.",un-competitive NMDA antagonists,CHEMICAL,be enhanced by presence of,NMDA receptor agonists,CHEBI
7907483,"Such an organization could explain some of the behavioural differences between competitive and un-competitive NMDA antagonists, since the binding of competitive NMDA antagonists is inhibited by glutamate, whereas the binding of un-competitive NMDA antagonists is enhanced by the presence of NMDA receptor agonists, a phenomenon called use/agonist dependence.",un-competitive NMDA antagonists,CHEBI,be enhanced by presence of,NMDA receptor agonists,CHEBI
2982633,"Unilateral injections of Muscimol produced oro-facial akinesia, reduction of the number of eye movements, contralateral head turning, visual neglect mostly (but not only) for ipsilateral visual space.",Muscimol,CHEMICAL,produce,eye movements,DISEASE
2982633,"Unilateral injections of Muscimol produced oro-facial akinesia, reduction of the number of eye movements, contralateral head turning, visual neglect mostly (but not only) for ipsilateral visual space.",Muscimol,CHEMICAL,produce,oro-facial akinesia,MENTAL_HEALTH
22563560,"Germ-tube positive yeast that was isolated from blood and central venous catheter tip cultures formed smooth, white colonies on sheep blood agar and Sabouraud agar plates, indicative of Candida spp.",Germ-tube positive yeast,NUTRITION,form,sheep blood agar,CHEBI
22563560,"Germ-tube positive yeast that was isolated from blood and central venous catheter tip cultures formed smooth, white colonies on sheep blood agar and Sabouraud agar plates, indicative of Candida spp.",Germ-tube positive yeast,NUTRITION,form,Candida spp,DISEASE
22563560,"Germ-tube positive yeast that was isolated from blood and central venous catheter tip cultures formed smooth, white colonies on sheep blood agar and Sabouraud agar plates, indicative of Candida spp.",Germ-tube positive yeast,NUTRITION,form,agar plates indicative,CHEBI
34921998,Vitamin B12 deficiency in pregnancy may be associated with antenatal or postpartum depression along with other neurocognitive symptoms including restless leg syndrome.,Vitamin B12 deficiency,CHEBI,be associated with antenatal or postpartum depression along,restless leg syndrome,DISEASE
34921998,Vitamin B12 deficiency in pregnancy may be associated with antenatal or postpartum depression along with other neurocognitive symptoms including restless leg syndrome.,Vitamin B12 deficiency,CHEBI,be associated with,antenatal depression,MENTAL_HEALTH
32618005,Thymoquinone successfully protected against Con A-induced behavioral despair and anxiety-like behavior.,Thymoquinone,CHEMICAL,protect against,A-induced behavioral despair,DISEASE
32618005,Thymoquinone successfully protected against Con A-induced behavioral despair and anxiety-like behavior.,Thymoquinone,CHEMICAL,protect against,anxiety-like behavior,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Nigella sativa,CHEMICAL,show positive effects in multiple studies against,cancer,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Nigella sativa,CHEMICAL,show positive effects in multiple studies against,neurodegeneration,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Nigella sativa,CHEMICAL,show positive effects in multiple studies against,hepatic injury,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Nigella sativa,CHEMICAL,show positive effects in multiple studies against,arthritis,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Thymoquinone,CHEMICAL,show positive effects in multiple studies against,cancer,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Thymoquinone,CHEMICAL,show positive effects in multiple studies against,neurodegeneration,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Thymoquinone,CHEMICAL,show positive effects in multiple studies against,hepatic injury,DISEASE
32618005,"Thymoquinone, active, and abundant component of Nigella sativa, has shown positive effects in multiple studies against arthritis, asthma, hepatic injury, neurodegeneration, and cancer owing to its immunomodulatory and anti-inflammatory attributes.",Thymoquinone,CHEMICAL,show positive effects in multiple studies against,arthritis,DISEASE
32618005,"Considering inflammation as one of central components involved in pathophysiology of major depressive disorder, thymoquinone has been evaluated in current study for its antidepressant potential.",thymoquinone,CHEMICAL,be evaluated in current study for,antidepressant potential,CHEMICAL
32618005,"Thymoquinone might provide benefits against inflammation-related sickness behavior that is associated with poorer outcome of clinical depression, thus, paving the way for effective drug development against treatment-resistant depression.",Thymoquinone,CHEMICAL,pave way for effective drug development against,treatment-resistant depression,MENTAL_HEALTH
32618005,"Thymoquinone might provide benefits against inflammation-related sickness behavior that is associated with poorer outcome of clinical depression, thus, paving the way for effective drug development against treatment-resistant depression.",Thymoquinone,CHEMICAL,pave way for,effective drug development,CHEBI
28342763,"Dysfunctional developmental plasticity impacts on later-life cognitive and emotional functions, changes of synaptic serotonin levels and receptor levels are coupled with altered synaptic plasticity and neurogenesis.",synaptic serotonin levels,CHEMICAL,be coupled with,neurogenesis,DISEASE
28342763,"Dysfunctional developmental plasticity impacts on later-life cognitive and emotional functions, changes of synaptic serotonin levels and receptor levels are coupled with altered synaptic plasticity and neurogenesis.",Dysfunctional plasticity impacts,DISEASE,be coupled with,neurogenesis,DISEASE
28342763,"Dysfunctional developmental plasticity impacts on later-life cognitive and emotional functions, changes of synaptic serotonin levels and receptor levels are coupled with altered synaptic plasticity and neurogenesis.",later-life cognitive functions,DISEASE,be coupled with,neurogenesis,DISEASE
18069704,"Terpenes, e. g. (+)-alpha-pinene, (-)-camphene, (-)-(-pinene, myrcene, R-(+)-limonene, eucalyptol, (+/-)-linalool, (-)-bornyl acetate, (-)-trans-caryophyllene, and alpha-humulene were determined in leaves of walnut trees from the Juglandaceae family (walnut tree, royal (J. regia L.), black (J. nigra L.), and Siebold (J. sieboldiana, var.",Terpenes,CHEMICAL,be determined in leaves of walnut trees from,walnut tree,NUTRITION
18069704,"Terpenes, e. g. (+)-alpha-pinene, (-)-camphene, (-)-(-pinene, myrcene, R-(+)-limonene, eucalyptol, (+/-)-linalool, (-)-bornyl acetate, (-)-trans-caryophyllene, and alpha-humulene were determined in leaves of walnut trees from the Juglandaceae family (walnut tree, royal (J. regia L.), black (J. nigra L.), and Siebold (J. sieboldiana, var.",g. (+)-alpha-pinene,CHEMICAL,be determined in leaves of walnut trees from,walnut tree,NUTRITION
35592556,"To date, a major quantitative trait locus (QTL) mapped on chromosome (Chr.) 10 plays an essential role in resistance to SRKN in soybean varieties.",resistance,MENTAL_HEALTH,have an essential role in,soybean varieties,NUTRITION
35547737,"Additionally, COVID-19 further enhances the vulnerability of older adults with cognitive damage.",COVID-19,CHEMICAL,enhance vulnerability of older adults with,cognitive damage,DISEASE
35547737,"In this context, we propose bovine Lf (bLf) as a promising preventive therapeutic tool to minimize COVID-19 risk in patients with dementia or AD.",COVID-19 risk,CHEMICAL,in patients with,dementia,MENTAL_HEALTH
30862039,"Thus, tea seed oil (TO) rich in MUFA could prevent obesity, reduce physical fatigue, and improve exercise performance compared with either SO (PUFA)- or LO(SFA)-rich diets in this HFD-induced obese OVX mice model.",MUFA,CHEMICAL,reduce,physical fatigue,MENTAL_HEALTH
30862039,"Thus, tea seed oil (TO) rich in MUFA could prevent obesity, reduce physical fatigue, and improve exercise performance compared with either SO (PUFA)- or LO(SFA)-rich diets in this HFD-induced obese OVX mice model.",seed oil rich,CHEMICAL,reduce,physical fatigue,MENTAL_HEALTH
30862039,"Thus, tea seed oil (TO) rich in MUFA could prevent obesity, reduce physical fatigue, and improve exercise performance compared with either SO (PUFA)- or LO(SFA)-rich diets in this HFD-induced obese OVX mice model.",MUFA,CHEMICAL,prevent,obesity,DISEASE
30862039,"Thus, tea seed oil (TO) rich in MUFA could prevent obesity, reduce physical fatigue, and improve exercise performance compared with either SO (PUFA)- or LO(SFA)-rich diets in this HFD-induced obese OVX mice model.",seed oil rich,CHEMICAL,prevent,obesity,DISEASE
2037797,"The photosensitizing dye merocyanine 540 (MC 540) was evaluated as a means for purging malarially infected red cells from murine blood using the rodent malarial pathogens, Plasmodium yoelii and Plasmodium berghei, as models of human malaria.",photosensitizing dye merocyanine,CHEMICAL,use,Plasmodium berghei,DISEASE
2037797,"The photosensitizing dye merocyanine 540 (MC 540) was evaluated as a means for purging malarially infected red cells from murine blood using the rodent malarial pathogens, Plasmodium yoelii and Plasmodium berghei, as models of human malaria.",photosensitizing dye merocyanine,CHEMICAL,use,Plasmodium yoelii,DISEASE
25083163,"Tadalafil improves significantly the total International Prostate Symptom Score (IPSS), the voiding and storage subscores, the IPSS Quality of Life (QoL) and the BPH Impact Index (BII).",Tadalafil,CHEMICAL,improve,total International Prostate Symptom Score,DISEASE
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",AD patients,DISEASE,respond which to treatment with,milnacipran,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",AD patients,DISEASE,respond which to treatment with,SNRI,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",AD patients,DISEASE,respond which to treatment with,noradrenaline reuptake inhibitor,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",AD patients,DISEASE,respond which to treatment with,selective serotonin,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",depressive symptoms,DISEASE,respond which to treatment with,milnacipran,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",depressive symptoms,DISEASE,respond which to treatment with,SNRI,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",depressive symptoms,DISEASE,respond which to treatment with,noradrenaline reuptake inhibitor,CHEMICAL
19166899,"In addition, to clarify which depressive symptoms of AD patients respond to treatment with the selective serotonin and noradrenaline reuptake inhibitor (SNRI) milnacipran, we compared the HAM-D(17) average score and the score of each HAM-D item, the mini-mental state examination (MMSE) score, and GAF score according to the DSM-IV evaluation of AD-MD patients at baseline and at the endpoint (12 weeks).",depressive symptoms,DISEASE,respond which to treatment with,selective serotonin,CHEMICAL
19166899,"We also found that depressive mood, suicidal tendency, loss of interest, psychomotor retardation, anxiety (psychic), gastrointestinal symptoms, general somatic symptoms, and hypochondriasis remarkably improved in patients of AD-MD treated with milnacipran.",depressive mood,DISEASE,improve in patients of,AD-MD,DISEASE
19166899,"We also found that depressive mood, suicidal tendency, loss of interest, psychomotor retardation, anxiety (psychic), gastrointestinal symptoms, general somatic symptoms, and hypochondriasis remarkably improved in patients of AD-MD treated with milnacipran.",gastrointestinal symptoms,DISEASE,improve in patients of,AD-MD,DISEASE
19166899,Our study also suggests that milnacipran is promising to treat a broad range of depressive symptoms in AD-MD patients.,milnacipran,CHEMICAL,treat broad range of depressive symptoms in,AD-MD patients,DISEASE
19166899,Our study also suggests that milnacipran is promising to treat a broad range of depressive symptoms in AD-MD patients.,milnacipran,CHEMICAL,treat broad range of,depressive symptoms,DISEASE
19166899,Our study also suggests that milnacipran is promising to treat a broad range of depressive symptoms in AD-MD patients.,depressive symptoms,DISEASE,have a broad range in,AD-MD patients,DISEASE
26185093,"Importantly, sialidase inhibitors ameliorate anti-GPIbα-mediated thrombocytopenia in mice.",sialidase inhibitors,CHEBI,ameliorate,thrombocytopenia,DISEASE
22819129,The hypothesis is that methoxetamine can produce rapid antidepressant effects in patients with resistant and non-resistant unipolar and bipolar depression.,methoxetamine,CHEMICAL,produce rapid antidepressant effects in patients with,resistant depression,MENTAL_HEALTH
22819129,The hypothesis is that methoxetamine can produce rapid antidepressant effects in patients with resistant and non-resistant unipolar and bipolar depression.,methoxetamine,CHEMICAL,produce,rapid antidepressant effects,CHEMICAL
31928234,Long-lasting exposure to METH causes psychosis and increases the risk of neurodegeneration.,METH,CHEMICAL,cause,psychosis,MENTAL_HEALTH
31928234,Long-lasting exposure to METH causes psychosis and increases the risk of neurodegeneration.,METH,CHEMICAL,increase risk of,neurodegeneration,DISEASE
31726888,Long-lasting exposure to METH causes psychosis and increases the risk of Parkinson's disease.,METH,CHEMICAL,cause,psychosis,MENTAL_HEALTH
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",Soybean transphosphatidylated phosphatidylserine,NUTRITION,be prepared from,soybean phosphatidylcholine,NUTRITION
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",Soybean transphosphatidylated phosphatidylserine,NUTRITION,be prepared from,soybean phosphatidylcholine,CHEMICAL
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",SB-tPS,CHEMICAL,be prepared from,soybean phosphatidylcholine,NUTRITION
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",SB-tPS,CHEMICAL,be prepared from,soybean phosphatidylcholine,CHEMICAL
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",acids composition,NUTRITION,be compared with,bovine brain cortex-derived phosphatidylserine,NUTRITION
8708821,"Soybean transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean phosphatidylcholine by transphosphatidylation using phospholipase D, and the fatty acids composition and pharmacological properties were compared with those of bovine brain cortex-derived phosphatidylserine (BC-PS) which was reported to improve cognitive disorders of senile dementia patients by oral administration (300 mg/day).",acids composition,NUTRITION,be compared with,BC-PS,CHEMICAL
8708821,"Despite the differences in fatty acid composition, SB-tPS displayed significant activities on the increase in brain glucose concentrations in mice (79 mg/kg, i.v.) and the restoration of scopolamine-induced amnesia in rats (60 mg/kg, i.p.) as did BC-PS.",SB-tPS,CHEMICAL,display,fatty acid significant activities,NUTRITION
8708821,"Despite the differences in fatty acid composition, SB-tPS displayed significant activities on the increase in brain glucose concentrations in mice (79 mg/kg, i.v.) and the restoration of scopolamine-induced amnesia in rats (60 mg/kg, i.p.) as did BC-PS.",SB-tPS,CHEMICAL,display,mg/kg,CHEMICAL
8708821,"Despite the differences in fatty acid composition, SB-tPS displayed significant activities on the increase in brain glucose concentrations in mice (79 mg/kg, i.v.) and the restoration of scopolamine-induced amnesia in rats (60 mg/kg, i.p.) as did BC-PS.",SB-tPS,CHEMICAL,display,scopolamine-induced amnesia,MENTAL_HEALTH
8708821,"Despite the differences in fatty acid composition, SB-tPS displayed significant activities on the increase in brain glucose concentrations in mice (79 mg/kg, i.v.) and the restoration of scopolamine-induced amnesia in rats (60 mg/kg, i.p.) as did BC-PS.",SB-tPS,CHEMICAL,display,brain glucose concentrations,CHEMICAL
8708821,These results suggest the possibility that SB-tPS may prevent and/or improve senile dementia by oral administration.,SB-tPS,CHEMICAL,improve,senile dementia,MENTAL_HEALTH
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",high-affinity choline uptake process,NUTRITION,be used for detection of high-affinity choline carriers in,multi-infarct dementia,MENTAL_HEALTH
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",high-affinity choline uptake process,NUTRITION,be used for detection of high-affinity choline carriers in,other psychiatric patients,DISEASE
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",high-affinity choline uptake process,NUTRITION,be used for detection of high-affinity choline carriers in,Alzheimer's disease,DISEASE
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",high-affinity choline uptake process,NUTRITION,be used for detection of,high-affinity choline carriers,CHEBI
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",high-affinity choline uptake process,NUTRITION,be used for detection of,high-affinity choline carriers,NUTRITION
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",(3H)Hemicholinium-3,CHEMICAL,be used for detection of high-affinity choline carriers in,multi-infarct dementia,MENTAL_HEALTH
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",(3H)Hemicholinium-3,CHEMICAL,be used for detection of high-affinity choline carriers in,other psychiatric patients,DISEASE
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",(3H)Hemicholinium-3,CHEMICAL,be used for detection of high-affinity choline carriers in,Alzheimer's disease,DISEASE
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",(3H)Hemicholinium-3,CHEMICAL,be used for detection of,high-affinity choline carriers,CHEBI
8591807,"(3H)Hemicholinium-3 ((3H)HCh-3), a potent, selective, and competitive inhibitor of the high-affinity choline uptake process was used for the detection of high-affinity choline carriers in the hippocampus (gyrus parahippocampalis), neocortex (gyrus frontalis medius), and cerebellum (lobulus semilunaris inferior) in autopsy samples of people with Alzheimer's disease, multi-infarct dementia and from other psychiatric and nonpsychiatric patients.",(3H)Hemicholinium-3,CHEMICAL,be used for detection of,high-affinity choline carriers,NUTRITION
21161819,"These findings indicate that cranberry phytochemicals can induce apoptosis in prostate cancer cells in vitro, and these findings further establish the potential value of cranberry phytochemicals as possible agents against prostate cancer.",cranberry phytochemicals,NUTRITION,induce apoptosis in,prostate cancer cells,DISEASE
20701402,We report a case of treatment-resistant BDD that was successfully treated with pharmacological augmentation of fluvoxamine with aripiprazole.,fluvoxamine,CHEMICAL,have pharmacological augmentation with,aripiprazole,CHEMICAL
20701402,This case presents some preliminary evidence that addition of the atypical antipsychotic agent aripiprazole may be useful in patients with treatment-resistant BDD.,atypical antipsychotic agent aripiprazole,CHEMICAL,be useful in patients with,treatment-resistant BDD,DISEASE
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,social phobia secondary,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,post-traumatic stress disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,trauma,DISEASE
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,major depressive disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,obsessive compulsive disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",psychiatric disorders,DISEASE,include,dysmorphic disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,social phobia secondary,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,post-traumatic stress disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,trauma,DISEASE
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,major depressive disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,obsessive compulsive disorder,MENTAL_HEALTH
11843209,"Some of the psychiatric disorders that are usually comorbid with dermatological disorders and respond to antidepressants include major depressive disorder, obsessive compulsive disorder, body dysmorphic disorder, social phobia and post-traumatic stress disorder usually secondary to trauma and abuse during early life.",dermatological disorders,DISEASE,include,dysmorphic disorder,MENTAL_HEALTH
11843209,The review indicates that the SSRI antidepressants are potentially beneficial in the management of all the major psychiatric syndromes that are encountered in dermatological disorders.,SSRI antidepressants,CHEBI,be beneficial in management of,major psychiatric syndromes,MENTAL_HEALTH
11843209,"The generally more favourable side-effect profile of the SSRIs, such as lower cardiotoxicity in contrast to the TCAs, has made them the first-line agents for the treatment of depression.",SSRIs,CHEMICAL,make for treatment of,depression,MENTAL_HEALTH
11843209,"The generally more favourable side-effect profile of the SSRIs, such as lower cardiotoxicity in contrast to the TCAs, has made them the first-line agents for the treatment of depression.",lower cardiotoxicity,DISEASE,make for treatment of,depression,MENTAL_HEALTH
11843209,"The generally more favourable side-effect profile of the SSRIs, such as lower cardiotoxicity in contrast to the TCAs, has made them the first-line agents for the treatment of depression.",TCAs,CHEMICAL,make for treatment of,depression,MENTAL_HEALTH
11843209,"Furthermore, some of the pharmacological properties of the antidepressant agents that are not related to their antidepressant activity, such as the histamine H1 blocking effect of TCAs, such as doxepin, amitriptyline and trimipramine, are of benefit in dermatological conditions such as urticaria and pruritus.",antidepressant agents,CHEMICAL,be of benefit in dermatological conditions such as,pruritus,DISEASE
11843209,"Furthermore, some of the pharmacological properties of the antidepressant agents that are not related to their antidepressant activity, such as the histamine H1 blocking effect of TCAs, such as doxepin, amitriptyline and trimipramine, are of benefit in dermatological conditions such as urticaria and pruritus.",antidepressant agents,CHEMICAL,be of benefit in dermatological conditions such as,urticaria,DISEASE
32603263,"To test this hypothesis, mice with diet-induced obesity were treated with morphine at 10 mg/kg subcutaneously and with leptin or placebo intranasally.",diet-induced obesity,DISEASE,be treated with,morphine,CHEMICAL
32603263,Morphine dramatically increased the frequency of apneas and greatly increased the severity of hypoventilation and obstructive sleep apnea.,Morphine,CHEMICAL,increase severity of,hypoventilation apnea,MENTAL_HEALTH
32603263,Morphine dramatically increased the frequency of apneas and greatly increased the severity of hypoventilation and obstructive sleep apnea.,Morphine,CHEMICAL,increase severity of,hypoventilation apnea,DISEASE
21219934,"We conclude that (i) although GP and EP play an important role in the pathophysiology of OCD, these areas may not represent first choice target structures for HFS, (ii) the effectiveness of HFS may depend on different subtypes of OCD, represented in different animal models, and (iii) differential net mechanisms may subserve the effectiveness of HFS and pharmacological inactivation.",HFS,DISEASE,depend,OCD,DISEASE
21219934,"We conclude that (i) although GP and EP play an important role in the pathophysiology of OCD, these areas may not represent first choice target structures for HFS, (ii) the effectiveness of HFS may depend on different subtypes of OCD, represented in different animal models, and (iii) differential net mechanisms may subserve the effectiveness of HFS and pharmacological inactivation.",EP,CHEMICAL,play important role in pathophysiology of,OCD,DISEASE
28313685,Distributional changes of the T. angustifolia stand and the adjacent zone of T. latifolia were measured on aerial photographs (≤13 years) and along ground-level transects (6 years).,T. latifolia,DISEASE,be measured on,≤13 years,CHEMICAL
12003702,The incidence of sexual dysfunction is exacerbated by antihypertensive drug treatment.,sexual dysfunction,MENTAL_HEALTH,be exacerbated by,antihypertensive drug treatment,CHEBI
6274267,"The specific binding of tritiated (3H)-clonidine, an alpha 2-adrenergic receptor agonist, to platelet membranes was measured in normal subjects and in patients with major depressive disorder.",tritiated (3H)-clonidine,CHEMICAL,be measured in normal subjects and in patients with,major depressive disorder,MENTAL_HEALTH
6274267,"The specific binding of tritiated (3H)-clonidine, an alpha 2-adrenergic receptor agonist, to platelet membranes was measured in normal subjects and in patients with major depressive disorder.",2-adrenergic receptor agonist,CHEBI,be measured in normal subjects and in patients with,major depressive disorder,MENTAL_HEALTH
33868638,"In a prospective study, a group of stable patients with idiopathic, heritable, related to drugs, toxins, or treated congenital heart disease pulmonary arterial hypertension underwent a polysomnography and overnight fluid shift measurement by bioelectrical impedance in the month preceding or following a one-day hospitalization according to regular pulmonary arterial hypertension follow-up schedule with a right heart catheterization.",idiopathic heritable related,DISEASE,precede according to,regular pulmonary arterial hypertension follow-up schedule,DISEASE
25939452,"Caffeine (a non-selective adenosine receptor antagonist) prevents memory deficits in aging and Alzheimer's disease, an effect mimicked by adenosine A2 A receptor, but not A1 receptor, antagonists.",Caffeine,CHEMICAL,prevent,memory deficits,DISEASE
25939452,"Caffeine (a non-selective adenosine receptor antagonist) prevents memory deficits in aging and Alzheimer's disease, an effect mimicked by adenosine A2 A receptor, but not A1 receptor, antagonists.",non-selective adenosine receptor antagonist,CHEBI,prevent,memory deficits,DISEASE
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",adenosine receptor agonists,CHEBI,have the effects on,scopolamine-induced memory impairment,CHEMICAL
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",adenosine receptor agonists,CHEBI,have the effects on,scopolamine-induced memory impairment,DISEASE
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",adenosine receptor agonists,CHEMICAL,have the effects on,scopolamine-induced memory impairment,CHEMICAL
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",adenosine receptor agonists,CHEMICAL,have the effects on,scopolamine-induced memory impairment,DISEASE
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",antagonists,CHEBI,have the effects on,scopolamine-induced memory impairment,CHEMICAL
25939452,"Hence, we investigated the effects of adenosine receptor agonists and antagonists on memory performance and scopolamine-induced memory impairment in mice.",antagonists,CHEBI,have the effects on,scopolamine-induced memory impairment,DISEASE
18191838,"Adenosine A2A receptor antagonists alleviate memory deficits caused by aging or by administration of beta-amyloid peptides in rodents, which is in accordance with the beneficial effects of caffeine consumption (an adenosine receptor antagonist) on memory performance in aged individuals and in preventing Alzheimer's disease.",Adenosine A2A receptor antagonists,CHEBI,alleviate,memory deficits,DISEASE
18191838,"Adenosine A2A receptor antagonists alleviate memory deficits caused by aging or by administration of beta-amyloid peptides in rodents, which is in accordance with the beneficial effects of caffeine consumption (an adenosine receptor antagonist) on memory performance in aged individuals and in preventing Alzheimer's disease.",Adenosine A2A receptor antagonists,CHEMICAL,alleviate,memory deficits,DISEASE
18191838,"The selective A2A receptor antagonist SCH58261 (0.05 mg/kg, ip every 24 h, starting 30 min before the noxious stimuli) prevented Abeta1-42-induced amnesia, but failed to modify scopolamine- or MK-801-induced amnesia.",antagonist SCH58261 mg/kg,CHEBI,prevent,42-induced amnesia,MENTAL_HEALTH
18191838,"The selective A2A receptor antagonist SCH58261 (0.05 mg/kg, ip every 24 h, starting 30 min before the noxious stimuli) prevented Abeta1-42-induced amnesia, but failed to modify scopolamine- or MK-801-induced amnesia.",antagonist SCH58261 mg/kg,CHEMICAL,prevent,42-induced amnesia,MENTAL_HEALTH
17007839,"Moreover, caffeine protects cultured neurons against beta-amyloid-induced toxicity, an effect mimicked by adenosine A(2A) but not A(1) receptor antagonists.",caffeine,CHEMICAL,protect cultured neurons against,beta-amyloid-induced toxicity effect,DISEASE
17007839,We now tested if caffeine administration would prevent beta-amyloid-induced cognitive impairment in mice and if this was mimicked by A(2A) receptor blockade.,caffeine administration,CHEMICAL,prevent,beta-amyloid-induced cognitive impairment,DISEASE
17007839,"This provides the first direct in vivo evidence that caffeine and A(2A) receptor antagonists afford a protection against Abeta-induced amnesia, which prompts their interest for managing Alzheimer's disease.",caffeine receptor antagonists,CHEBI,afford protection against,Abeta-induced amnesia,MENTAL_HEALTH
17007839,"This provides the first direct in vivo evidence that caffeine and A(2A) receptor antagonists afford a protection against Abeta-induced amnesia, which prompts their interest for managing Alzheimer's disease.",caffeine receptor antagonists,CHEMICAL,afford protection against,Abeta-induced amnesia,MENTAL_HEALTH
24881331,"More research is needed on the relationship of alcohol consumption to cancers, diabetes, and HIV/AIDS across ethnic groups.",alcohol consumption,CHEMICAL,have the relationship to,cancers,DISEASE
33232716,"Excessive ethanol consumption causes cellular damage, leading to fetal alcohol syndrome and alcohol liver diseases, which are frequently seen with vitamin D (VD) deficiency.",Excessive ethanol consumption,CHEMICAL,lead to,alcohol liver diseases,DISEASE
33232716,"Excessive ethanol consumption causes cellular damage, leading to fetal alcohol syndrome and alcohol liver diseases, which are frequently seen with vitamin D (VD) deficiency.",Excessive ethanol consumption,CHEMICAL,lead to,fetal alcohol syndrome,MENTAL_HEALTH
33232716,"Excessive ethanol consumption causes cellular damage, leading to fetal alcohol syndrome and alcohol liver diseases, which are frequently seen with vitamin D (VD) deficiency.",Excessive ethanol consumption,CHEMICAL,cause,cellular damage,DISEASE
31251050,"The antitumor activity of disulfiram (DSF), a traditional US Food and Drug Administration-approved drug for the treatment of ""alcohol-dependence"", is Cu2+-dependent, but the intrinsic anfractuous biodistribution of copper in the human body and copper toxicity induced by exogenous copper supply have severely hindered its in vivo application.",disulfiram,CHEMICAL,induced by,exogenous copper supply,CHEMICAL
31251050,"Cu2+-doped, DSF-loaded hollow mesoporous silica nanoparticles were constructed for the rapid release of Cu2+ ions induced by the mild acidic conditions of the tumor microenvironment.",Cu2 DSF-loaded hollow mesoporous silica nanoparticles,CHEMICAL,be constructed for rapid release of,Cu2,CHEMICAL
31251050,"The resulting in situ chelation reaction between the coreleased Cu2+ ions and DSF generated toxic CuET products and concurrently, Fenton-like reactions between the generated Cu+ ions and the high levels of H2O2 resulted in the production of reactive oxygen species (ROS) in the acidic tumor microenvironment.",generated Cu+ ions,CHEMICAL,result in production of,reactive oxygen species,CHEMICAL
31251050,"The resulting in situ chelation reaction between the coreleased Cu2+ ions and DSF generated toxic CuET products and concurrently, Fenton-like reactions between the generated Cu+ ions and the high levels of H2O2 resulted in the production of reactive oxygen species (ROS) in the acidic tumor microenvironment.",generated Cu+ ions,CHEMICAL,result in production of,acidic tumor microenvironment,DISEASE
31251050,"The resulting in situ chelation reaction between the coreleased Cu2+ ions and DSF generated toxic CuET products and concurrently, Fenton-like reactions between the generated Cu+ ions and the high levels of H2O2 resulted in the production of reactive oxygen species (ROS) in the acidic tumor microenvironment.",H2O2,CHEMICAL,result in production of,reactive oxygen species,CHEMICAL
31251050,"The resulting in situ chelation reaction between the coreleased Cu2+ ions and DSF generated toxic CuET products and concurrently, Fenton-like reactions between the generated Cu+ ions and the high levels of H2O2 resulted in the production of reactive oxygen species (ROS) in the acidic tumor microenvironment.",H2O2,CHEMICAL,result in production of,acidic tumor microenvironment,DISEASE
35591769,"Here, the effects of ABA on harmaline-induced motor and cognitive impairments were investigated in rats.",ABA,CHEMICAL,have the effects on,harmaline-induced motor,DISEASE
35591769,"Here, the effects of ABA on harmaline-induced motor and cognitive impairments were investigated in rats.",ABA,CHEMICAL,have the effects on,motor impairments,DISEASE
11172215,LAUP results in severe throat pain that usually lasts for 8 to 14 days.,LAUP,CHEMICAL,result in,severe throat pain,DISEASE
11172215,"Sucralfate adheres to proteins at the duodenal ulcer site, forming a protective coating against gastric acid, pepsin, and bile salts, that promotes healing.",Sucralfate,CHEMICAL,form protective coating against,pepsin,CHEMICAL
11172215,"Sucralfate adheres to proteins at the duodenal ulcer site, forming a protective coating against gastric acid, pepsin, and bile salts, that promotes healing.",Sucralfate,CHEMICAL,adhere to proteins at,duodenal ulcer site,DISEASE
11172215,"As a conclusion, sucralfate significantly lowered postoperative pain and the need for analgesic drug use as well as the total number of the days the patients needed to almost reach their normal diet quantity (> or = 80% of normal quantity).",sucralfate,CHEMICAL,need for,analgesic drug,CHEBI
11172215,"As a conclusion, sucralfate significantly lowered postoperative pain and the need for analgesic drug use as well as the total number of the days the patients needed to almost reach their normal diet quantity (> or = 80% of normal quantity).",sucralfate,CHEMICAL,need for,drug use,CHEBI
28066940,Long-term administration of medroxyprogesterone acetate was evaluated for the management of RVVC.,medroxyprogesterone acetate,CHEMICAL,be evaluated for management of,RVVC,DISEASE
28066940,"Gestagen supplementation ameliorated the quality of life for the majority of patients with RVVC and suggested a potential role in the management of this syndrome, even if beneficial effect was evident after longer application, and some patients met with side effects that led to an interruption of therapy.",Gestagen supplementation,CHEBI,ameliorate quality of life for majority of,RVVC,DISEASE
9141149,Premenstrual syndrome (PMS) is characterized by cyclical changes in psychological and physical symptoms related to the formation of the corpus luteum and the fluctuations of gonadal hormones.,Premenstrual syndrome,MENTAL_HEALTH,be characterized by cyclical changes in psychological and physical symptoms related to formation of corpus luteum and fluctuations of,gonadal hormones,CHEBI
9141149,Premenstrual syndrome (PMS) is characterized by cyclical changes in psychological and physical symptoms related to the formation of the corpus luteum and the fluctuations of gonadal hormones.,PMS,CHEMICAL,be characterized by cyclical changes in psychological and physical symptoms related to formation of corpus luteum and fluctuations of,gonadal hormones,CHEBI
9141149,The PMS patients in the luteal phase responded with less increase in sedation change scores following benzodiazepine injections compared with control subjects.,PMS patients,DISEASE,respond with less increase in,benzodiazepine injections,CHEMICAL
20378354,We suggest that ropinirole may be a treatment option for deficits in motivated behavior after prefrontal damage.,ropinirole,CHEMICAL,be treatment option for deficits in motivated behavior after,prefrontal damage,DISEASE
34646371,"Mutations in serotonin pathway genes, especially the serotonergic receptor subunit gene HTR3A, are associated with autism.",serotonin pathway genes,CHEMICAL,be associated with,autism,MENTAL_HEALTH
34646371,"However, the association of HTR3A deficiency with autism and the underlying mechanisms remain unknown.",HTR3A deficiency,DISEASE,have the association with,autism,MENTAL_HEALTH
34646371,The NMDAR antagonist memantine could rescue GABAergic transmission in the hippocampus and ameliorate autistic-like behaviors of the KO mice.,NMDAR antagonist memantine,CHEBI,ameliorate,autistic-like behaviors,DISEASE
34646371,The NMDAR antagonist memantine could rescue GABAergic transmission in the hippocampus and ameliorate autistic-like behaviors of the KO mice.,NMDAR antagonist memantine,CHEMICAL,ameliorate,autistic-like behaviors,DISEASE
31629007,N-methyl-d-aspartate (NMDA) receptor (NMDAR) hypofunction plays a key role in pathophysiology of schizophrenia.,N-methyl-d-aspartate NMDA receptor hypofunction,CHEMICAL,play key role in pathophysiology of,schizophrenia,MENTAL_HEALTH
31629007,"In this review, we first discuss the shared underlying mechanisms of NMDAR hypofunction in NMDAR antagonist models and the anti-NMDAR autoantibody model of schizophrenia and suggest that NMDAR hypofunction could occur in GABAergic neurons in both models.",NMDAR hypofunction,DISEASE,have the shared underlying mechanisms in,NMDAR antagonist models,CHEBI
31629007,"Recent studies suggest that NMDAR hypofunction can also occur in PV-positive GABAergic neurons with alterations of NMDAR-associated proteins, such as neuregulin/ErbB4, α7nAChR, and serine racemase.",NMDAR hypofunction,DISEASE,occur in pv-positive gabaergic neurons with alterations of,NMDAR-associated proteins,CHEMICAL
12475293,"Using saturated anacardic acid as a starting material, analogues of sildenafil [a potent phosphodiesterase-5 (PDE(5)) inhibitor and an orally active drug for the treatment of erectile dysfunction] were synthesized, to observe the effect of the pentadecyl side chain on PDE(5) inhibition.",sildenafil potent phosphodiesterase-5 inhibitor,CHEMICAL,use,saturated anacardic acid,CHEMICAL
12475293,"Using saturated anacardic acid as a starting material, analogues of sildenafil [a potent phosphodiesterase-5 (PDE(5)) inhibitor and an orally active drug for the treatment of erectile dysfunction] were synthesized, to observe the effect of the pentadecyl side chain on PDE(5) inhibition.",erectile dysfunction,MENTAL_HEALTH,use,saturated anacardic acid,CHEMICAL
12475293,"Using saturated anacardic acid as a starting material, analogues of sildenafil [a potent phosphodiesterase-5 (PDE(5)) inhibitor and an orally active drug for the treatment of erectile dysfunction] were synthesized, to observe the effect of the pentadecyl side chain on PDE(5) inhibition.",active drug,CHEBI,use,saturated anacardic acid,CHEMICAL
33720013,"Opioid drugs, like fentanyl, target the mu opioid receptor system and induce potentially lethal respiratory depression.",fentanyl,CHEMICAL,induce,lethal respiratory depression,MENTAL_HEALTH
33720013,"In freely-behaving larval zebrafish, fentanyl depresses the rate of respiratory mandible movements and induces analgesia, effects reversed by μ-opioid receptor antagonists.",fentanyl,CHEMICAL,depress in freely-behaving larval zebrafish rate of,movements effects,DISEASE
33720013,"In freely-behaving larval zebrafish, fentanyl depresses the rate of respiratory mandible movements and induces analgesia, effects reversed by μ-opioid receptor antagonists.",fentanyl,CHEMICAL,induce,analgesia,MENTAL_HEALTH
12975611,The interest in the study of glypicans has increased in the last few years as a result of the discovery that the glypican-3 gene (GPC-3) is mutated in an overgrowth and dysmorphic syndrome.,GPC-3,CHEMICAL,be mutated in,dysmorphic syndrome,MENTAL_HEALTH
20467592,"There is evidence indicating that the nonselective serotonin 5-HT(2A/2C) receptor antagonists, ritanserin, ketanserin, seganserin and ICI-169369, the selective 5-HT(2A) receptor antagonist eplivanserin and the 5-HT(2A) receptor inverse agonist pimavanserin, increase SWS in subjects with normal sleep.",selective 5-HT(2A receptor antagonist eplivanserin,CHEBI,increase,SWS,DISEASE
20467592,"There is evidence indicating that the nonselective serotonin 5-HT(2A/2C) receptor antagonists, ritanserin, ketanserin, seganserin and ICI-169369, the selective 5-HT(2A) receptor antagonist eplivanserin and the 5-HT(2A) receptor inverse agonist pimavanserin, increase SWS in subjects with normal sleep.",selective 5-HT(2A receptor antagonist eplivanserin,CHEMICAL,increase,SWS,DISEASE
20467592,"There is evidence indicating that the nonselective serotonin 5-HT(2A/2C) receptor antagonists, ritanserin, ketanserin, seganserin and ICI-169369, the selective 5-HT(2A) receptor antagonist eplivanserin and the 5-HT(2A) receptor inverse agonist pimavanserin, increase SWS in subjects with normal sleep.",nonselective serotonin 5-HT(2A/2C receptor antagonists,CHEMICAL,increase,SWS,DISEASE
20467592,"There is evidence indicating that the nonselective serotonin 5-HT(2A/2C) receptor antagonists, ritanserin, ketanserin, seganserin and ICI-169369, the selective 5-HT(2A) receptor antagonist eplivanserin and the 5-HT(2A) receptor inverse agonist pimavanserin, increase SWS in subjects with normal sleep.",nonselective serotonin 5-HT(2A/2C receptor antagonists,CHEBI,increase,SWS,DISEASE
20467592,"There is evidence indicating that the nonselective serotonin 5-HT(2A/2C) receptor antagonists, ritanserin, ketanserin, seganserin and ICI-169369, the selective 5-HT(2A) receptor antagonist eplivanserin and the 5-HT(2A) receptor inverse agonist pimavanserin, increase SWS in subjects with normal sleep.",ritanserin,CHEMICAL,increase,SWS,DISEASE
20467592,"In addition, it has been shown that prior administration of ritanserin prevents the nitrazepam-induced suppression of SWS in normal subjects.",ritanserin,CHEMICAL,prevent nitrazepam-induced suppression of,SWS,DISEASE
20467592,"In addition, it has been shown that prior administration of ritanserin prevents the nitrazepam-induced suppression of SWS in normal subjects.",ritanserin,CHEMICAL,prevent,nitrazepam-induced suppression,DISEASE
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of sws in,generalized anxiety disorder,MENTAL_HEALTH
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of sws in,mood disorder,MENTAL_HEALTH
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of sws in,psychiatric patients,DISEASE
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of sws in,chronic primary insomnia,MENTAL_HEALTH
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of sws in,chronic primary insomnia,DISEASE
20467592,"Of note, ritanserin also induced an increase of SWS in poor sleepers, patients with chronic primary insomnia and psychiatric patients with a generalized anxiety disorder or a mood disorder.",ritanserin,CHEMICAL,induce of note increase of,SWS,DISEASE
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,5-HT(2A receptor,CHEMICAL,give rise to similar effect in patients with,chronic primary insomnia,DISEASE
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,5-HT(2A receptor,CHEMICAL,give rise to similar effect in patients with,chronic primary insomnia,MENTAL_HEALTH
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,agonist APD-125,CHEMICAL,give rise to similar effect in patients with,chronic primary insomnia,DISEASE
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,agonist APD-125,CHEMICAL,give rise to similar effect in patients with,chronic primary insomnia,MENTAL_HEALTH
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,agonist APD-125,CHEBI,give rise to similar effect in patients with,chronic primary insomnia,DISEASE
20467592,The 5-HT(2A) receptor inverse agonist APD-125 gave rise to a similar effect in patients with chronic primary insomnia.,agonist APD-125,CHEBI,give rise to similar effect in patients with,chronic primary insomnia,MENTAL_HEALTH
20467592,"Thus, presently available evidence tends to indicate that the association of a 5-HT(2A) receptor antagonist or a 5-HT(2A) receptor inverse agonist with a BZD or a non-BZD hypnotic could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia.",5-HT(2A receptor antagonist,CHEMICAL,be valid alternative to,primary insomnia,MENTAL_HEALTH
20467592,"Thus, presently available evidence tends to indicate that the association of a 5-HT(2A) receptor antagonist or a 5-HT(2A) receptor inverse agonist with a BZD or a non-BZD hypnotic could be a valid alternative to normalize SWS in patients with primary or comorbid insomnia.",5-HT(2A receptor antagonist,CHEBI,be valid alternative to,primary insomnia,MENTAL_HEALTH
35410603,Lithium is a well-known FDA approved treatment for bipolar and mood disorders.,Lithium,NUTRITION,be approved treatment for,bipolar disorders,MENTAL_HEALTH
35410603,"Recent studies highlight the neuroprotective and neurotrophic actions of lithium in amyotrophic lateral sclerosis, Alzheimer's disease, intracerebral hemorrhage, and epilepsy.",lithium,NUTRITION,have the neuroprotective and neurotrophic actions in,amyotrophic lateral sclerosis,DISEASE
35410603,"Of note, lithium holds a significant interest in epilepsy, where the past reports expose its non-specific proconvulsant action, followed lately by numerous studies for anti-convulsant action.",lithium,NUTRITION,note significant interest in,epilepsy,DISEASE
35410603,This review also provides clarity regarding the safety of lithium therapy in epileptic patients.,lithium therapy,NUTRITION,have the safety in,epileptic patients,DISEASE
26574688,Lithium carbonate is primarily used for the treatment of patients with bipolar affective disorders.,Lithium carbonate,NUTRITION,be used for treatment of patients with,bipolar affective disorders,MENTAL_HEALTH
26574688,Meta-analysis of case-control studies showed higher rated hypothyroidism in patients with mood disorders treated with LiCO₃(121/869) than in controls (10/578).,higher rated hypothyroidism,DISEASE,in patients with,mood disorders,MENTAL_HEALTH
23127248,Antagonists of activin receptor signaling may be beneficial for cancer-related anemia and bone disease caused by malignancies such as multiple myeloma and solid tumors.,Antagonists,CHEBI,be beneficial for,anemia bone disease,DISEASE
15638783,"Macrophage-activation stimuli associated with atherosclerotic risk factors include oxidised low density lipoprotein (oxLDL, ""bad cholesterol""), advanced glycosylation end products (AGEs) of diabetes, angiotensin II and endothelin.",Macrophage-activation stimuli,CHEMICAL,include oxidised,low density lipoprotein,NUTRITION
15638783,"Macrophage-activation stimuli associated with atherosclerotic risk factors include oxidised low density lipoprotein (oxLDL, ""bad cholesterol""), advanced glycosylation end products (AGEs) of diabetes, angiotensin II and endothelin.",Macrophage-activation stimuli,CHEMICAL,include oxidised,bad cholesterol,NUTRITION
15638783,"Macrophage-activation stimuli associated with atherosclerotic risk factors include oxidised low density lipoprotein (oxLDL, ""bad cholesterol""), advanced glycosylation end products (AGEs) of diabetes, angiotensin II and endothelin.",Macrophage-activation stimuli,CHEMICAL,include oxidised,diabetes,DISEASE
15638783,Macrophage-derived transforming growth factor beta promotes fibrosis.,Macrophage-derived transforming growth factor beta,CHEBI,promote,fibrosis,DISEASE
23870798,Memantine also reduces binge eating episodes and weight.,Memantine,CHEMICAL,reduce,binge eating episodes,MENTAL_HEALTH
23870798,We investigated whether memantine added on to valproate (VPA) is more effective than VPA alone for treating BP-II depression and improving the patient's metabolic profile.,memantine,CHEMICAL,add to,VPA,CHEMICAL
23870798,We investigated whether memantine added on to valproate (VPA) is more effective than VPA alone for treating BP-II depression and improving the patient's metabolic profile.,memantine,CHEMICAL,add to,valproate,CHEMICAL
31722313,"Disease-specific and site-selective deficiency of an RNA editing enzyme, adenosine deaminase acting on RNA 2 (ADAR2), has been demonstrated in sporadic amyotrophic lateral sclerosis (sALS) motor neurons.",adenosine deaminase,CHEMICAL,be demonstrated in,sclerosis sALS motor neurons,DISEASE
31722313,We considered that AMPA receptor antagonists could strongly prevent excessive Ca2+ influx through AMPA receptors and block motor neuronal degeneration in sALS.,AMPA receptor antagonists,CHEBI,prevent excessive ca2 + influx through,AMPA receptors,CHEMICAL
31722313,"Because of the therapeutic potency of perampanel for sporadic ALS, we have performed a multicenter randomized, double-blinded, placebo-controlled, parallel-group phase 2 clinical trial.",perampanel,CHEMICAL,have the therapeutic potency for,sporadic ALS,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,antagonists GYKI-52466,CHEMICAL,prevent,death,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,antagonists GYKI-52466,CHEMICAL,prevent,paralysis,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,antagonists GYKI-52466,CHEBI,prevent,death,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,antagonists GYKI-52466,CHEBI,prevent,paralysis,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,talampanel,CHEMICAL,prevent,death,DISEASE
27114366,α-Amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor antagonists GYKI-52466 and talampanel protected both hippocampal and motor neurons and prevented paralysis and death.,talampanel,CHEMICAL,prevent,paralysis,DISEASE
18464347,"Qui Jin is closely associated with the attitudes, aspirations and fantasies of modern Western feminism.",Qui Jin,CHEMICAL,be associated with,fantasies,MENTAL_HEALTH
23965302,"Based on the findings from this case, we conclude that use of acupuncture and moxibustion may be an effective treatment for hypersexuality in clinical practice.",acupuncture,CHEMICAL,be effective treatment for,hypersexuality,DISEASE
33998863,"In terms of illicit opioid abuse, fentanyl is the synthetic opioid responsible for the largest number of overdose deaths.",fentanyl,CHEMICAL,be synthetic opioid responsible in terms of illicit opioid abuse for,overdose deaths,DISEASE
33998863,"In terms of illicit opioid abuse, fentanyl is the synthetic opioid responsible for the largest number of overdose deaths.",fentanyl,CHEMICAL,be synthetic opioid responsible in terms of,opioid abuse,MENTAL_HEALTH
33998863,Identification of effective alternate analgesic strategies that lessen the respiratory depression associated with narcotics would also help improve current strategies for pain management.,effective alternate analgesic strategies,CHEBI,improve current strategies for,pain management,DISEASE
33998863,Our laboratory recently reported that the G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppressed chemotherapy-induced neuropathic nociception and attenuated both morphine tolerance and physical dependence in paclitaxel-treated mice.,agonist LY2828360,CHEBI,suppress,chemotherapy-induced neuropathic nociception,DISEASE
33998863,Our laboratory recently reported that the G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppressed chemotherapy-induced neuropathic nociception and attenuated both morphine tolerance and physical dependence in paclitaxel-treated mice.,agonist LY2828360,CHEBI,attenuate,morphine tolerance,CHEMICAL
33998863,Our laboratory recently reported that the G protein-biased CB2 cannabinoid receptor agonist LY2828360 suppressed chemotherapy-induced neuropathic nociception and attenuated both morphine tolerance and physical dependence in paclitaxel-treated mice.,agonist LY2828360,CHEBI,attenuate,physical dependence,DISEASE
33998863,Materials and Methods: We used whole-body plethysmography to assess the impact of the CB2 cannabinoid agonist LY2828360 on fentanyl-induced respiratory depression using wild-type (WT) and CB2 knockout (CB2KO) mice.,agonist LY2828360,CHEBI,have the impact on,fentanyl-induced respiratory depression,MENTAL_HEALTH
33998863,Coadministration of a behaviorally active dose of LY2828360 (3 mg/kg i.p.) with fentanyl (0.2 mg/kg i.p.) attenuated fentanyl-induced respiratory depression in WT mice.,fentanyl,CHEMICAL,attenuate,fentanyl-induced respiratory depression,MENTAL_HEALTH
33998863,Conclusion: The combination of a CB2 agonist with fentanyl may represent a safer adjunctive therapeutic strategy compared with a narcotic analgesic alone by attenuating the development of opioid-induced respiratory depression.,fentanyl,CHEMICAL,attenuate development of,opioid-induced respiratory depression,MENTAL_HEALTH
33998863,Conclusion: The combination of a CB2 agonist with fentanyl may represent a safer adjunctive therapeutic strategy compared with a narcotic analgesic alone by attenuating the development of opioid-induced respiratory depression.,CB2 agonist,CHEBI,attenuate development of,opioid-induced respiratory depression,MENTAL_HEALTH
33998863,Conclusion: The combination of a CB2 agonist with fentanyl may represent a safer adjunctive therapeutic strategy compared with a narcotic analgesic alone by attenuating the development of opioid-induced respiratory depression.,CB2 agonist,CHEBI,have the combination with,fentanyl,CHEMICAL
33998863,"Our findings suggest that the CB2 cannabinoid agonist LY2828360 may provide CB2-mediated protection against fentanyl-induced respiratory depression, a detrimental and unwanted side effect of opioid use and abuse.",agonist LY2828360,CHEBI,provide cb2-mediated protection against,fentanyl-induced respiratory depression,MENTAL_HEALTH
11908919,The discovery that valproic acid is helpful in the management of patients with rapid-cycling bipolar disorder led to an explosion of research culminating in the third-generation anticonvulsants.,valproic acid,CHEMICAL,be helpful in management of patients with,rapid-cycling bipolar disorder,MENTAL_HEALTH
11908919,No studies to date have shown that gabapentin is effective in bipolar mania or hypomania.,gabapentin,CHEMICAL,be effective in,bipolar mania,MENTAL_HEALTH
11908919,No studies to date have shown that gabapentin is effective in bipolar mania or hypomania.,gabapentin,CHEMICAL,be effective in,hypomania,MENTAL_HEALTH
11908919,"Topiramate has shown encouraging results in both depressed and manic bipolar patients, and it may also promote weight loss.",Topiramate,CHEMICAL,show encouraging results in,depressed bipolar patients,DISEASE
10918166,The use of a high dose regimen of interferon-alpha-2b (IFN) has recently been demonstrated to benefit patients with resected high risk melanoma.,interferon-alpha-2b,CHEMICAL,resected,high risk melanoma,DISEASE
30266908,"We demonstrate that the three chemical chaperones 4-phenylbutyrate, sorbitol, and trehalose reverse the deficits caused by mutations in Munc18-1 in vitro and in vivo in multiple models, offering a novel strategy for the treatment of varied encephalopathies.",chemical chaperones 4-phenylbutyrate,CHEMICAL,offer novel strategy for treatment of,varied encephalopathies,DISEASE
35458181,"The blueberry-treated group also exhibited correction of peripheral hyperinsulinemia, p = 0.04, and a modest trend for increased mitochondrial uncoupling, p = 0.11.",blueberry-treated group,CHEMICAL,exhibit correction of,peripheral hyperinsulinemia,DISEASE
35419173,"Thus, the aim of this in situ study was to evaluate the effect of proanthocyanidin-based dentifrices on wear resistance of dentin specimens subjected to erosion associated with abrasion.",proanthocyanidin-based dentifrices,CHEMICAL,have the effect on,resistance,MENTAL_HEALTH
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,renal colic,DISEASE
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,various algesic syndromes,MENTAL_HEALTH
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,muscular pain,DISEASE
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,various algesic syndromes,CHEMICAL
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,nerve compression,DISEASE
24944400,"Lysine clonixinate (LC), an NSAID derived from nicotinic acid, has been proved effective in various algesic syndromes (eg, renal colic, muscular pain, nerve compression, odontalgia).",Lysine clonixinate,CHEMICAL,be proved effective in,odontalgia,DISEASE
11299430,Lysine clonixinate (LC) is a NSAID derived from nicotinic acid that has proven to be effective in various pain syndromes such as renal colic and muscular pain.,Lysine clonixinate,CHEMICAL,derived from,nicotinic acid,CHEBI
11299430,We conclude that the NSAID lysine clonixinate is effective in treating moderately severe migraine attacks.,lysine clonixinate,CHEMICAL,treat,severe migraine attacks,DISEASE
26164717,"PTN or MK signaling through receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ), leads to the activation of extracellular signal-regulated kinases and thymoma viral proto-oncogene.",receptor protein tyrosine phosphatase β/ζ,CHEMICAL,lead to activation of,thymoma viral proto-oncogene,DISEASE
32548443,NLX competitively inhibits opioid-overdose-induced respiratory depression without eliciting any narcotic effect itself.,NLX,CHEMICAL,inhibit,opioid-overdose-induced respiratory depression,MENTAL_HEALTH
32548443,"The decrease in 6-MAM intensity was caused by its displacement by the antagonist and its binding to these receptors in these specific brain regions, consequently enhancing the opioid elimination.",6-MAM intensity,CHEMICAL,be caused by its displacement by,antagonist,CHEBI
32548443,"The decrease in 6-MAM intensity was caused by its displacement by the antagonist and its binding to these receptors in these specific brain regions, consequently enhancing the opioid elimination.",6-MAM intensity,CHEMICAL,be caused by,displacement,MENTAL_HEALTH
32708687,"BRAF and MEK inhibitors (BRAFi and MEKi) are the standard of care for the treatment of metastatic melanoma in patients with BRAFV600E mutations, greatly improving progression-free survival.",inhibitors BRAFi,CHEMICAL,be standard of care for treatment of,metastatic melanoma,DISEASE
32708687,"BRAF and MEK inhibitors (BRAFi and MEKi) are the standard of care for the treatment of metastatic melanoma in patients with BRAFV600E mutations, greatly improving progression-free survival.",MEK,CHEMICAL,be standard of care for treatment of,metastatic melanoma,DISEASE
25987214,"Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer.",estrogen,CHEBI,cause down regulation of,estrogen receptor,CHEBI
25987214,"Previously we have shown that long-term exposure to estrogen in breast cancer cells caused not only down regulation of estrogen receptor (ER) but also overexpression of AhR. The AhR interacts with several cell signaling pathways associated with induction of tyrosine kinases, cytokines and growth factors which may support the survival roles of AhR escaping from apoptosis elicited by a variety of apoptosis inducing agents in breast cancer.",breast cancer cells,DISEASE,cause down regulation of,estrogen receptor,CHEBI
25987214,"The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity.",TCDD,CHEMICAL,increase activity of,immunosuppressive enzyme indoleamine,CHEMICAL
25987214,"The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity.",TCDD,CHEMICAL,be antagonized by treatment with,3'methoxy-4'nitroflavone,CHEMICAL
25987214,"The anti-apoptotic response of TCDD was uniformly antagonized by the treatment with 3'methoxy-4'nitroflavone (MNF), a specific antagonist of AhR. TCDD's survival action of apoptosis was accompanied with the induction of well-known inflammatory genes, such as cyclooxygenase-2 (COX-2) and NF-κB subunit RelB. Moreover, TCDD increased the activity of the immunosuppressive enzyme indoleamine 2, 3-dioxygenase (IDO), which metabolizes tryptophan to kynurenine (Kyn) and mediates tumor immunity.",TCDD,CHEMICAL,be antagonized by treatment with,specific antagonist,CHEBI
25987214,"Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells.",kyn,CHEMICAL,induce anti-apoptotic response in,breast cancer cells,DISEASE
25987214,"Kyn also acts as an AhR ligand like TCDD, and kyn induced an anti-apoptotic response in breast cancer cells.",Kyn,CHEMICAL,act as ahr ligand like,TCDD,CHEMICAL
25987214,"Accordingly, our present study suggests that AhR plays a pivotal role in the development of breast cancer via the suppression of apoptosis, and provides an idea that the use of AhR antagonists with chemotherapeutic agents may effectively synergize the elimination of breast cancer cells.",AhR antagonists,CHEBI,synergize elimination of,breast cancer cells,DISEASE
32126770,Both reaction systems exhibited chemisorption of glutathione derivatives to the MOF by TGA.,glutathione derivatives,CHEMICAL,have chemisorption to,MOF,DISEASE
32126770,"Mass spectrometry analyses revealed that in both systems, GSH was oxidized to GSSG, which chemisorbed to the MOF whereas GSSG remained unchanged during chemisorption.",GSH,CHEMICAL,be oxidized in systems to,GSSG,CHEMICAL
32126770,"For GSNO, chemisorption to the MOF without reaction was observed in the aerobic column setup, whereas conversion to GSSG and subsequent chemisorption was observed in the anaerobic batch setup.",MOF,DISEASE,be observed for,GSNO,CHEMICAL
22294344,Blocking interleukin-1 with anakinra in patients with the autoinflammatory syndrome neonatal-onset multisystem inflammatory disease (NOMID) reduces systemic and organ-specific inflammation.,anakinra,CHEMICAL,in patients with,autoinflammatory syndrome neonatal-onset multisystem inflammatory disease,DISEASE
24049116,"Thus ks is responsive to changes in O2, and the combined effect of hypercapnic hypoxia on ks is more severe than hypoxia alone.",hypercapnic hypoxia,DISEASE,be,hypoxia,DISEASE
20142958,"In 2007, two common single nucleotide polymorphisms in the coding region of the lysyl oxidase-like 1 (LOXL1) gene located on chromosome 15 were specifically associated with XFS and XFG.",common single nucleotide polymorphisms located,CHEMICAL,be associated in 2007 with,XFG,DISEASE
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEMICAL,be associated with rapid but transient antidepressant effects in patients with,TRD,DISEASE
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEMICAL,be associated with rapid but transient antidepressant effects in patients with,resistant unipolar depression,MENTAL_HEALTH
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEBI,be associated with rapid but transient antidepressant effects in patients with,TRD,DISEASE
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEBI,be associated with rapid but transient antidepressant effects in patients with,resistant unipolar depression,MENTAL_HEALTH
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEMICAL,be associated with,antidepressant,CHEMICAL
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,N-methyl-D-aspartate NMDA receptor antagonist ketamine,CHEBI,be associated with,antidepressant,CHEMICAL
30858518,The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid but transient antidepressant effects in patients with treatment resistant unipolar depression (TRD).,transient antidepressant effects,CHEMICAL,in patients with,resistant unipolar depression,MENTAL_HEALTH
30858518,"Forty-seven participants with TRD were enrolled in the study and underwent an initial ketamine infusion, of whom 34 participants were deemed to have at least a partial antidepressant response and were eligible for randomization.",TRD,DISEASE,undergo,initial ketamine infusion,CHEMICAL
35115970,Ketamine has been shown to acutely and rapidly ameliorate depression symptoms and suicidality.,Ketamine,CHEMICAL,ameliorate,suicidality,DISEASE
35115970,Ketamine has been shown to acutely and rapidly ameliorate depression symptoms and suicidality.,Ketamine,CHEMICAL,ameliorate,depression symptoms,MENTAL_HEALTH
35115970,"Lastly, the neuroinflammatory hypothesis of depression is highlighted to help better understand how ovarian hormones might interact with ketamine in the female brain.",ovarian hormones,CHEBI,interact with,ketamine,CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",bicuculline,CHEMICAL,render parkinsonian with,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",bicuculline,CHEMICAL,render parkinsonian with,MPTP,CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",gamma-aminobutyric acid GABA receptor A antagonist substance,CHEMICAL,render parkinsonian with,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",gamma-aminobutyric acid GABA receptor A antagonist substance,CHEMICAL,render parkinsonian with,MPTP,CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",gamma-aminobutyric acid GABA receptor A antagonist substance,CHEBI,render parkinsonian with,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine",CHEMICAL
12390969,"Here we demonstrate that microinjection of gamma-aminobutyric acid (GABA) receptor A antagonist substance, bicuculline, into the PPN of non-human primates (n = 2) rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) results in significant improvement of akinesia.",gamma-aminobutyric acid GABA receptor A antagonist substance,CHEBI,render parkinsonian with,MPTP,CHEMICAL
20036748,"Monoamine reuptake inhibitors treat a wide range of CNS disorders, including depression, obesity, and pain.",Monoamine reuptake inhibitors,CHEMICAL,treat wide range of,pain,DISEASE
20036748,"Monoamine reuptake inhibitors treat a wide range of CNS disorders, including depression, obesity, and pain.",Monoamine reuptake inhibitors,CHEMICAL,treat wide range of,depression,MENTAL_HEALTH
20036748,"Monoamine reuptake inhibitors treat a wide range of CNS disorders, including depression, obesity, and pain.",Monoamine reuptake inhibitors,CHEMICAL,treat wide range of,obesity,DISEASE
15056483,"The presence of the 5-HTT in easily accessible nucleated cells such as peripheral blood lymphocytes might permit molecular genetic studies in mood and anxiety disorder patients, and might enhance the understanding of the different efficacies of antidepressants in depressed patients.",antidepressants,CHEMICAL,have the different efficacies in,depressed patients,DISEASE
18684528,Dissociation of FKBP12.6 from RyR2 is considered as an important molecular event resulting in calcium leak and an increased risk in arrhythmogenesis.,Dissociation,MENTAL_HEALTH,increased risk in,arrhythmogenesis,DISEASE
12598081,We investigated if endothelin (ET)-1 and the renin-angiotensin-aldosterone system play a role in cardiac fibrosis.,endothelin (ET)-1,CHEMICAL,play role in,cardiac fibrosis,DISEASE
33667552,Debilitating neurocognitive deficits are seen in alcohol use disorders (AUD) and Wernicke-Korsakoff's syndrome (WKS).,Debilitating neurocognitive deficits,DISEASE,be seen in,Wernicke-Korsakoff's syndrome,DISEASE
33667552,Debilitating neurocognitive deficits are seen in alcohol use disorders (AUD) and Wernicke-Korsakoff's syndrome (WKS).,Debilitating neurocognitive deficits,DISEASE,be seen in,WKS,DISEASE
33667552,Debilitating neurocognitive deficits are seen in alcohol use disorders (AUD) and Wernicke-Korsakoff's syndrome (WKS).,Debilitating neurocognitive deficits,DISEASE,be seen in,alcohol use disorders,CHEMICAL
33667552,Debilitating neurocognitive deficits are seen in alcohol use disorders (AUD) and Wernicke-Korsakoff's syndrome (WKS).,Debilitating neurocognitive deficits,DISEASE,be seen in,AUD,CHEMICAL
35383554,Antimalarials have been associated with QT prolongation in COVID-19 patients but are generally safe in systemic lupus erythematosus (SLE).We compared the prevalence of QTc prolongation between COVID-19 and SLE patients treated with hydroxychloroquine (HCQ).,Antimalarials,CHEBI,be associated with qt prolongation in,COVID-19 patients,CHEMICAL
1670895,"Membrane preparation from the optic lobe of the giant freshwater prawn, Macrobrachium rosenbergii de Man, was examined for the presence of specific L-(3H) glutamate binding.",giant freshwater prawn,NUTRITION,be examined for presence of,specific L-(3H glutamate binding,CHEMICAL
1670895,L-(3H) glutamate specifically bound to the membrane fraction with a dissociation equilibrium constant (Kd) of 205 nM and maximum number of binding sites (Bmax) of 2.04 n mol/mg protein.,L-(3H glutamate,CHEMICAL,bind to membrane fraction with,dissociation equilibrium,MENTAL_HEALTH
6247025,"Eadie plots of the saturation isotherms for [3H]kainic acid revealed similar kinetics of binding for frog whole brain, rat forebrain and human parietal cortex with two apparent populations of binding sites: KD1 = 25--50 nM and KD2 = 3--14 nM. While binding in the spiny dogfish forebrain and human caudate nucleus occurred exclusively at a high affinity component, the cerebella of chick, rat and man exhibited only a low affinity binding site.",[3H]kainic acid,CHEMICAL,reveal similar kinetics of binding for,rat forebrain,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,metabolic diseases,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,disorders,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,malignancies,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,autoimmune diseases,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,infections,DISEASE
31614690,"Clinical implications of PPAR agonists span across a wide range of health conditions, including metabolic diseases, chronic inflammatory diseases, infections, autoimmune diseases, neurological and psychiatric disorders, and malignancies.",PPAR agonists,CHEBI,span across wide range of,chronic inflammatory diseases,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEBI,show tremendous promises in many non-metabolic disorders like,chronic kidney disease,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEBI,show tremendous promises in many non-metabolic disorders like,autoimmune diseases,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEBI,show tremendous promises in many non-metabolic disorders like,depression,MENTAL_HEALTH
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEBI,show tremendous promises in many non-metabolic disorders like,inflammation,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEMICAL,show tremendous promises in many non-metabolic disorders like,chronic kidney disease,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEMICAL,show tremendous promises in many non-metabolic disorders like,autoimmune diseases,DISEASE
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEMICAL,show tremendous promises in many non-metabolic disorders like,depression,MENTAL_HEALTH
31614690,"PPARγ agonist pioglitazone showed tremendous promises in many non-metabolic disorders like chronic kidney disease, depression, inflammation, and autoimmune diseases.",PPARγ agonist pioglitazone,CHEMICAL,show tremendous promises in many non-metabolic disorders like,inflammation,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",saroglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,type diabetes,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",saroglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,non-alcoholic fatty liver disease,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",saroglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,primary biliary cholangitis,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",saroglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,dyslipidemia,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",dual- agonists,CHEBI,gain momentum with their optimistic outcomes in,type diabetes,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",dual- agonists,CHEBI,gain momentum with their optimistic outcomes in,non-alcoholic fatty liver disease,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",dual- agonists,CHEBI,gain momentum with their optimistic outcomes in,primary biliary cholangitis,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",dual- agonists,CHEBI,gain momentum with their optimistic outcomes in,dyslipidemia,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",chiglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,type diabetes,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",chiglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,non-alcoholic fatty liver disease,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",chiglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,primary biliary cholangitis,DISEASE
31614690,"Interestingly, dual- or pan-PPAR agonists, namely chiglitazar, saroglitazar, elafibranor, and lanifibranor, are gaining momentum with their optimistic outcomes in many diseases including type 2 diabetes, dyslipidemia, non-alcoholic fatty liver disease, and primary biliary cholangitis.",chiglitazar,CHEMICAL,gain momentum with their optimistic outcomes in,dyslipidemia,DISEASE
29873957,"Use of second-generation antipsychotics (SGAs) for treatment of depression has increased, and patients with depression and comorbid diabetes or cardiovascular disease are more likely to use SGAs than those without these conditions.",comorbid diabetes,DISEASE,use,SGAs,DISEASE
29873957,"Use of second-generation antipsychotics (SGAs) for treatment of depression has increased, and patients with depression and comorbid diabetes or cardiovascular disease are more likely to use SGAs than those without these conditions.",depression,MENTAL_HEALTH,use,SGAs,DISEASE
27816317,53.4% of all MDD patients received a selective serotonin reuptake inhibitor (SSRI) and 23.6% a serotonin-norepinephrine reuptake inhibitor (SNRI) as first-line treatment.,MDD patients,DISEASE,receive,% serotonin-norepinephrine reuptake inhibitor,CHEMICAL
27816317,53.4% of all MDD patients received a selective serotonin reuptake inhibitor (SSRI) and 23.6% a serotonin-norepinephrine reuptake inhibitor (SNRI) as first-line treatment.,MDD patients,DISEASE,receive,SNRI,CHEMICAL
27816317,53.4% of all MDD patients received a selective serotonin reuptake inhibitor (SSRI) and 23.6% a serotonin-norepinephrine reuptake inhibitor (SNRI) as first-line treatment.,MDD patients,DISEASE,receive,SSRI,CHEBI
27816317,53.4% of all MDD patients received a selective serotonin reuptake inhibitor (SSRI) and 23.6% a serotonin-norepinephrine reuptake inhibitor (SNRI) as first-line treatment.,MDD patients,DISEASE,receive,selective serotonin reuptake inhibitor,CHEBI
21473108,"In present work, amnesia was induced with MK-801/reminding 24 hours after food aversion conditioning, and antiamnestic effects of NMDA receptor glycine site agonist d-cycloserine were studied at early (3rd day) or late (12th day) stages of amnesia development.",NMDA receptor glycine site agonist d-cycloserine,CHEBI,be studied at,amnesia development,MENTAL_HEALTH
21473108,"In present work, amnesia was induced with MK-801/reminding 24 hours after food aversion conditioning, and antiamnestic effects of NMDA receptor glycine site agonist d-cycloserine were studied at early (3rd day) or late (12th day) stages of amnesia development.",NMDA receptor glycine site agonist d-cycloserine,CHEMICAL,be studied at,amnesia development,MENTAL_HEALTH
21473108,"Thus, for the first time, it is revealed that NMDA receptor agonist d-cycloserine influences the memory restoration processes only at early but not the later stages of amnesia development.",NMDA receptor agonist d-cycloserine,CHEMICAL,influence memory restoration processes at,amnesia development,MENTAL_HEALTH
21473108,"Thus, for the first time, it is revealed that NMDA receptor agonist d-cycloserine influences the memory restoration processes only at early but not the later stages of amnesia development.",NMDA receptor agonist d-cycloserine,CHEBI,influence memory restoration processes at,amnesia development,MENTAL_HEALTH
16753898,"Amnesia induced by pretraining morphine was significantly reversed by pretest administration of L-glutamate (0.0001 and 0.001 microg/mouse, i.c.v.).",Amnesia,MENTAL_HEALTH,be reversed by pretest administration of,L-glutamate,CHEMICAL
16753898,"Amnesia induced by pretraining morphine was increased by pretest administration of MK-801 (2 microg/mouse, i.c.v.).",morphine,CHEMICAL,be increased by pretest administration of,MK-801,CHEMICAL
16753898,"Amnesia induced by pretraining morphine was increased by pretest administration of MK-801 (2 microg/mouse, i.c.v.).",Amnesia,MENTAL_HEALTH,be increased by pretest administration of,MK-801,CHEMICAL
34659286,The Amaryllidaceae alkaloid galanthamine (Gal) in Lycoris longituba is a secondary metabolite that has been used to treat Alzheimer's disease.,Amaryllidaceae alkaloid galanthamine,CHEMICAL,be,secondary metabolite,NUTRITION
34659286,The Amaryllidaceae alkaloid galanthamine (Gal) in Lycoris longituba is a secondary metabolite that has been used to treat Alzheimer's disease.,Lycoris longituba,CHEMICAL,be,secondary metabolite,NUTRITION
25660732,"Compulsive buying disorder and having ""any spectrum disorder"" were more frequent in the PG probands and their first-degree relatives vs. controls and their relatives.",Compulsive buying disorder,DISEASE,be frequent in,PG probands,CHEMICAL
25660732,"Spectrum disorders were significantly more prevalent among PG relatives compared to control relatives (adjusted OR=8.37), though much of this difference was attributable to the contribution from compulsive buying disorder.",Spectrum disorders,DISEASE,be prevalent among,PG relatives,CHEMICAL
25660732,We conclude that compulsive buying disorder is likely part of familial PG spectrum.,compulsive buying disorder,DISEASE,be part of,familial PG spectrum,CHEMICAL
23300105,"Pathological gambling (PG) is a chronic mental disorder, and patients cannot stop gambling despite severe negative consequences, such as huge debts, job loss, family break-up, and so on.",PG,CHEMICAL,be,chronic mental disorder,MENTAL_HEALTH
23300105,"PG has been classified under ""Impulse-Control Disorders Not Elsewhere Classified,"" along with compulsive stealing (kleptomania), starting fires (pyromania) and hair-pulling (trichotillomania), but accumulative evidence suggests that PG has many similarities with substance use disorders.",PG,CHEMICAL,start,trichotillomania,MENTAL_HEALTH
23300105,"PG has been classified under ""Impulse-Control Disorders Not Elsewhere Classified,"" along with compulsive stealing (kleptomania), starting fires (pyromania) and hair-pulling (trichotillomania), but accumulative evidence suggests that PG has many similarities with substance use disorders.",PG,CHEMICAL,start,pyromania,MENTAL_HEALTH
23300105,"PG has been classified under ""Impulse-Control Disorders Not Elsewhere Classified,"" along with compulsive stealing (kleptomania), starting fires (pyromania) and hair-pulling (trichotillomania), but accumulative evidence suggests that PG has many similarities with substance use disorders.",PG,CHEMICAL,start,hair-pulling,DISEASE
23300105,"Therefore, PG is being proposed to be classified under ""Addiction and Related Disorders"" in the DSM-5 draft.",PG,CHEMICAL,be classified under,DSM-5 draft,DISEASE
23300105,"Therefore, PG is being proposed to be classified under ""Addiction and Related Disorders"" in the DSM-5 draft.",PG,CHEMICAL,be classified under,Addiction Disorders,DISEASE
23300105,"In general, PG patients show reduced sensitivity to both monetary reward and loss, increased gamble-related cue reactivity, and increased impulsivity.",PG patients,CHEMICAL,show reduced sensitivity to,increased gamble-related cue reactivity,CHEMICAL
27306922,"Alopecia areata (AA) is a common hair loss disorder of autoimmune aetiology, which often results in pronounced psychological distress.",Alopecia areata,DISEASE,be,common hair loss disorder,DISEASE
33244178,Lipid profile (total cholesterol and lipoprotein fractions) has been found to correlate with depression and cognitive impairment across the lifespan.,total cholesterol fractions,NUTRITION,correlate with,cognitive impairment,DISEASE
33244178,Lipid profile (total cholesterol and lipoprotein fractions) has been found to correlate with depression and cognitive impairment across the lifespan.,total cholesterol fractions,NUTRITION,correlate with,depression,MENTAL_HEALTH
33244178,"Of the lipid profile, only high-density lipoprotein was positively correlated with depressive symptom severity, whereas the other three indices showed negative correlation with both depressive state and cognitive performance.",high-density lipoprotein,NUTRITION,be correlated of lipid profile with,depressive symptom severity,DISEASE
17611904,"Administrations of PPAR alpha agonists significantly raised 24-hour urine pH levels in gout patients in accordance with a reduction in serum triglyceride concentration, probably through their activities to improve insulin resistance.",PPAR alpha agonists,CHEBI,raise 24-hour urine ph levels in gout patients in accordance with,serum triglyceride concentration,CHEMICAL
17611904,"Administrations of PPAR alpha agonists significantly raised 24-hour urine pH levels in gout patients in accordance with a reduction in serum triglyceride concentration, probably through their activities to improve insulin resistance.",PPAR alpha agonists,CHEBI,raise 24-hour urine ph levels in,gout patients,DISEASE
17611904,"Administrations of PPAR alpha agonists significantly raised 24-hour urine pH levels in gout patients in accordance with a reduction in serum triglyceride concentration, probably through their activities to improve insulin resistance.",PPAR alpha agonists,CHEBI,improve,insulin resistance,MENTAL_HEALTH
17611904,Our results suggest that insulin resistance plays an important role in the development of low urinary pH in patients with gout and that PPAR alpha agonist is preferable for raising urinary pH of the gout patients with hypertriglyceridemia.,PPAR alpha agonist,CHEBI,raise urinary ph of gout patients with,hypertriglyceridemia,DISEASE
17611904,Our results suggest that insulin resistance plays an important role in the development of low urinary pH in patients with gout and that PPAR alpha agonist is preferable for raising urinary pH of the gout patients with hypertriglyceridemia.,PPAR alpha agonist,CHEBI,raise urinary ph of,gout patients,DISEASE
17611904,Our results suggest that insulin resistance plays an important role in the development of low urinary pH in patients with gout and that PPAR alpha agonist is preferable for raising urinary pH of the gout patients with hypertriglyceridemia.,insulin resistance,MENTAL_HEALTH,play important role in development of low urinary ph in,gout,DISEASE
33574623,"In summary, it can be said that fish oil capsules in combination with vitamin B 12 have been associated with a positive effect on endometriosis symptoms (particularly of dysmenorrhoea).",vitamin B,CHEBI,be associated with positive effect on,dysmenorrhoea,DISEASE
33574623,"In summary, it can be said that fish oil capsules in combination with vitamin B 12 have been associated with a positive effect on endometriosis symptoms (particularly of dysmenorrhoea).",vitamin B,CHEBI,be associated with positive effect on,endometriosis symptoms,DISEASE
30278111,"L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear.",L-carnitine,CHEMICAL,treat hepatic encephalopathy with,hyperammonemia,DISEASE
30278111,"L-carnitine (L-CA) has been used therapeutically to treat hepatic encephalopathy with hyperammonemia, but the mechanism by which L-CA contributes to ammonia detoxification in the brain is still unclear.",L-carnitine,CHEMICAL,treat,hepatic encephalopathy,DISEASE
31667176,Gonadotropin-releasing hormone agonist (GnRHa) can induce pituitary apoplexy in those patients who have insidious pituitary adenoma coincidentally.,Gonadotropin-releasing hormone agonist,CHEBI,induce,pituitary apoplexy,DISEASE
34590391,The time of onset of manic or hypomanic symptoms varied across TNF-α inhibitors with an early onset for Infliximab and a later onset for Adalimumab and Etanercept.,manic symptoms,DISEASE,vary across tnf-α inhibitors with early onset for,Infliximab,CHEMICAL
34590391,The time of onset of manic or hypomanic symptoms varied across TNF-α inhibitors with an early onset for Infliximab and a later onset for Adalimumab and Etanercept.,manic symptoms,DISEASE,vary across tnf-α inhibitors with early onset for,Etanercept,CHEMICAL
34590391,The time of onset of manic or hypomanic symptoms varied across TNF-α inhibitors with an early onset for Infliximab and a later onset for Adalimumab and Etanercept.,manic symptoms,DISEASE,vary across tnf-α inhibitors with early onset for,Adalimumab,CHEMICAL
34590391,The time of onset of manic or hypomanic symptoms varied across TNF-α inhibitors with an early onset for Infliximab and a later onset for Adalimumab and Etanercept.,manic symptoms,DISEASE,vary across,TNF-α inhibitors,CHEMICAL
30450052,"The occurrence of spontaneous calcium elevations in R33Q atrial myocytes is due to the dysfunction of RyR2 stable subunits, CaMKII hyperactivity, and CaMKII-mediated RyR phosphorylation.",spontaneous calcium elevations,CHEMICAL,be due to dysfunction of,CaMKII hyperactivity,MENTAL_HEALTH
26030405,"Although glycogen synthase kinase 3β (GSK3β) signaling in the nucleus accumbens (NAc) plays a key role in mediating dopamine (DA)-dependent behaviors, there is less direct evidence that how VPA acts on the GSK3β signaling in the functionally distinct sub-regions of the NAc, the NAc core (NAcC) and the NAc shell (NAcSh), during psycho-stimulant-induced hyperactivity.",VPA,CHEMICAL,act on gsk3β signaling in distinct sub-regions of nac during,psycho-stimulant-induced hyperactivity,MENTAL_HEALTH
26030405,"We further investigated whether microinjection of VPA (300 μg/0.5 μl/side, once daily for 7 consecutive days) into NAcC or NAcSh could affect hyperactivity induced by MA.",μl/side,CHEMICAL,affect,hyperactivity,MENTAL_HEALTH
26030405,"We further investigated whether microinjection of VPA (300 μg/0.5 μl/side, once daily for 7 consecutive days) into NAcC or NAcSh could affect hyperactivity induced by MA.",VPA,CHEMICAL,affect,hyperactivity,MENTAL_HEALTH
26030405,Our results suggested that GSK3β activity in NAcC contributes to the inhibitory effects of VPA on MA-induced hyperactivity.,VPA,CHEMICAL,have the inhibitory effects on,MA-induced hyperactivity,MENTAL_HEALTH
22654511,"In particular, it has been shown that the CDP-choline improves the cognitive and mental performance in Alzheimer's dementia and vascular dementia.",CDP-choline,CHEMICAL,improve cognitive and mental performance in alzheimer's,dementia,MENTAL_HEALTH
22654511,"In particular, it has been shown that the CDP-choline improves the cognitive and mental performance in Alzheimer's dementia and vascular dementia.",CDP-choline,CHEMICAL,improve cognitive and mental performance in alzheimer's,vascular dementia,MENTAL_HEALTH
22654511,"In particular, it has been shown that the CDP-choline improves the cognitive and mental performance in Alzheimer's dementia and vascular dementia.",CDP-choline,CHEMICAL,improve,cognitive performance,DISEASE
3964838,Insulin-induced hypoglycemia in normothermic rats caused progressive neurological depression and differentially altered regional cerebral acetylcholine metabolism.,Insulin-induced hypoglycemia,DISEASE,cause,progressive neurological depression,MENTAL_HEALTH
3964838,Insulin-induced hypoglycemia in normothermic rats caused progressive neurological depression and differentially altered regional cerebral acetylcholine metabolism.,Insulin-induced hypoglycemia,DISEASE,cause,altered regional cerebral acetylcholine metabolism,CHEMICAL
3964838,"Reductions of plasma glucose from 7.7 mM (control) to 2.5-1.7 mM (moderate hypoglycemia associated with decreased motor activity) or 1.5 mM (severe hypoglycemia with lethargy progressing to stupor) decreased glucose concentrations in the cerebral cortex, striatum, and hippocampus to less than 10% of control.",mM moderate hypoglycemia,DISEASE,decrease,glucose concentrations,CHEMICAL
3964838,"Reductions of plasma glucose from 7.7 mM (control) to 2.5-1.7 mM (moderate hypoglycemia associated with decreased motor activity) or 1.5 mM (severe hypoglycemia with lethargy progressing to stupor) decreased glucose concentrations in the cerebral cortex, striatum, and hippocampus to less than 10% of control.",plasma glucose,CHEMICAL,decrease,glucose concentrations,CHEMICAL
3964838,"Moderate hypoglycemia diminished acetylcholine concentrations in cortex and striatum (21% and 45%, respectively) and reduced [1-2H2, 2-2H2]choline incorporation into acetylcholine (62% and 41%, respectively).",Moderate hypoglycemia,DISEASE,reduce,acetylcholine,CHEMICAL
3964838,"Moderate hypoglycemia diminished acetylcholine concentrations in cortex and striatum (21% and 45%, respectively) and reduced [1-2H2, 2-2H2]choline incorporation into acetylcholine (62% and 41%, respectively).",Moderate hypoglycemia,DISEASE,reduce,2H2 2H2]choline incorporation,CHEMICAL
3964838,"Moderate hypoglycemia diminished acetylcholine concentrations in cortex and striatum (21% and 45%, respectively) and reduced [1-2H2, 2-2H2]choline incorporation into acetylcholine (62% and 41%, respectively).",Moderate hypoglycemia,DISEASE,diminish,acetylcholine concentrations,CHEMICAL
3964838,"The concentrations of choline rose in the cortex (+53%) and striatum (+130%) of animals that became stuporous but a similar rise in [1-2H2, 2-2H2]choline left the specific activities of choline in these structures unchanged.",choline,NUTRITION,leave specific activities of,choline,NUTRITION
3964838,"The concentrations of choline rose in the cortex (+53%) and striatum (+130%) of animals that became stuporous but a similar rise in [1-2H2, 2-2H2]choline left the specific activities of choline in these structures unchanged.",choline,NUTRITION,rise in,2H2]choline,CHEMICAL
3964838,"Thus, impaired acetylcholine metabolism in selected regions of the brain may contribute to the early symptoms of neurological dysfunction in hypoglycemia.",impaired acetylcholine metabolism,CHEMICAL,contribute to early symptoms of neurological dysfunction in,hypoglycemia,DISEASE
3964838,"Thus, impaired acetylcholine metabolism in selected regions of the brain may contribute to the early symptoms of neurological dysfunction in hypoglycemia.",impaired acetylcholine metabolism,CHEMICAL,contribute to early symptoms of,neurological dysfunction,DISEASE
3964838,"Thus, impaired acetylcholine metabolism in selected regions of the brain may contribute to the early symptoms of neurological dysfunction in hypoglycemia.",neurological dysfunction,DISEASE,have the early symptoms in,hypoglycemia,DISEASE
7463059,"During insulin stupor in mice, acetylcholine levels in cerebral cortex, cerebellum, brainstem, striatum, and hippocampus were unchanged from control values despite brain glucose concentrations 3-10% of normal, whereas choline levels rose 2.4-3.6-fold in all five CNS regions.",acetylcholine levels,CHEMICAL,be unchanged during insulin stupor in mice from,brain glucose concentrations,CHEMICAL
7463059,"During insulin stupor in mice, acetylcholine levels in cerebral cortex, cerebellum, brainstem, striatum, and hippocampus were unchanged from control values despite brain glucose concentrations 3-10% of normal, whereas choline levels rose 2.4-3.6-fold in all five CNS regions.",acetylcholine levels,CHEMICAL,be unchanged during,insulin stupor,MENTAL_HEALTH
27802855,"Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis.",excessive caffeine intake,CHEMICAL,cause,hypertension,DISEASE
27802855,"Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis.",excessive caffeine intake,CHEMICAL,cause,sleeplessness,DISEASE
27802855,"Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis.",excessive caffeine intake,CHEMICAL,cause,nervousness,MENTAL_HEALTH
27802855,"Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis.",excessive caffeine intake,CHEMICAL,cause,arrhythmias,DISEASE
27802855,"Studies have shown that excessive caffeine intake from energy drinks can cause arrhythmias, hypertension, dehydration, sleeplessness, nervousness, and in rare instances, rhabdomyolysis.",excessive caffeine intake,CHEMICAL,cause,dehydration,DISEASE
29632203,Activation of liver X receptors (LXRs) with synthetic agonists promotes reverse cholesterol transport and protects against atherosclerosis in mouse models.,synthetic agonists,CHEBI,protect against,atherosclerosis,DISEASE
29632203,Activation of liver X receptors (LXRs) with synthetic agonists promotes reverse cholesterol transport and protects against atherosclerosis in mouse models.,synthetic agonists,CHEBI,promote,reverse cholesterol transport,NUTRITION
29632203,Most synthetic LXR agonists also cause marked hypertriglyceridemia by inducing the expression of sterol regulatory element-binding protein (SREBP)1c and downstream genes that drive fatty acid biosynthesis.,synthetic LXR agonists,CHEBI,cause,marked hypertriglyceridemia,DISEASE
29632203,Most synthetic LXR agonists also cause marked hypertriglyceridemia by inducing the expression of sterol regulatory element-binding protein (SREBP)1c and downstream genes that drive fatty acid biosynthesis.,synthetic LXR agonists,CHEBI,induce expression of,sterol regulatory element-binding protein,CHEMICAL
32633530,Galloylated oligo- and polymeric PACs were detected in Common Sorrel herb.,Galloylated oligo- PACs,CHEMICAL,be detected in,Sorrel herb,DISEASE
9270175,"Protection of gastric mucosa of the new-born rats from alcohol fetal exposure might depend on polyunsaturated fatty acids (PUFA) dietary supplementation, because of the capability of PUFA to cross placenta; the efficacy in the protection might be monitored by platelet aggregation PGI2-dependent test.",alcohol fetal exposure,CHEMICAL,depend on,PUFA,CHEMICAL
9270175,"Protection of gastric mucosa of the new-born rats from alcohol fetal exposure might depend on polyunsaturated fatty acids (PUFA) dietary supplementation, because of the capability of PUFA to cross placenta; the efficacy in the protection might be monitored by platelet aggregation PGI2-dependent test.",alcohol fetal exposure,CHEMICAL,depend on,acids dietary supplementation,NUTRITION
10074240,It was discovered that there was induction of the differentiation of HL-60 cells by lithium and HT and the induction of HL-60 cells differentiation by HT was markedly enhanced by the addition of low concentration of lithium.,HT,DISEASE,be enhanced by addition of low concentration of,lithium,NUTRITION
10453797,Several lines of evidence suggest that gonadal steroid hormones play a role in the onset and exacerbation of obsessive-compulsive disorder (OCD).,gonadal steroid hormones,CHEMICAL,play role in onset and exacerbation of,OCD,DISEASE
10453797,Several lines of evidence suggest that gonadal steroid hormones play a role in the onset and exacerbation of obsessive-compulsive disorder (OCD).,gonadal steroid hormones,CHEMICAL,play role in onset and exacerbation of,obsessive-compulsive disorder,MENTAL_HEALTH
10453797,Several lines of evidence suggest that gonadal steroid hormones play a role in the onset and exacerbation of obsessive-compulsive disorder (OCD).,gonadal steroid hormones,CHEBI,play role in onset and exacerbation of,OCD,DISEASE
10453797,Several lines of evidence suggest that gonadal steroid hormones play a role in the onset and exacerbation of obsessive-compulsive disorder (OCD).,gonadal steroid hormones,CHEBI,play role in onset and exacerbation of,obsessive-compulsive disorder,MENTAL_HEALTH
12163129,"In addition to the established indication of obesity, 5-HT releasers may help treat psychiatric disorders, such as drug and alcohol dependence, depression, and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,drug dependence,CHEBI
12163129,"In addition to the established indication of obesity, 5-HT releasers may help treat psychiatric disorders, such as drug and alcohol dependence, depression, and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,drug dependence,MENTAL_HEALTH
12163129,"In addition to the established indication of obesity, 5-HT releasers may help treat psychiatric disorders, such as drug and alcohol dependence, depression, and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,psychiatric disorders,DISEASE
12163129,"In addition to the established indication of obesity, 5-HT releasers may help treat psychiatric disorders, such as drug and alcohol dependence, depression, and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,premenstrual syndrome,MENTAL_HEALTH
12163129,"In addition to the established indication of obesity, 5-HT releasers may help treat psychiatric disorders, such as drug and alcohol dependence, depression, and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,depression,MENTAL_HEALTH
11888573,"In this regard, neither trazodone nor mCPP is associated with PPH.",mCPP,CHEMICAL,be associated in regard with,PPH,DISEASE
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,be helpful in addition to established indication of,obesity,DISEASE
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat psychiatric problems such as,premenstrual syndrome,MENTAL_HEALTH
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat psychiatric problems such as,depression,MENTAL_HEALTH
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat psychiatric problems such as,drug dependence,CHEBI
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat psychiatric problems such as,drug dependence,MENTAL_HEALTH
11888573,"In addition to the established indication of obesity, 5-HT releasers may be helpful in treating psychiatric problems such as drug and alcohol dependence, depression and premenstrual syndrome.",5-HT releasers,CHEMICAL,treat,psychiatric problems,DISEASE
27229737,"Upon weight gain, microbial richness increased, however perturbations in intestinal microbiota and short chain fatty acid profiles in addition to several gastrointestinal symptoms did not recover.",short chain fatty acid profiles,NUTRITION,have perturbations in,several gastrointestinal symptoms,DISEASE
18227781,"Furthermore, evidence is now compelling that hypomania in association with antidepressant treatments requires familial bipolar diathesis for bipolar disorder (bipolar III).",hypomania,MENTAL_HEALTH,require familial bipolar diathesis for,bipolar disorder,MENTAL_HEALTH
18227781,"Furthermore, evidence is now compelling that hypomania in association with antidepressant treatments requires familial bipolar diathesis for bipolar disorder (bipolar III).",antidepressant treatments,CHEMICAL,require familial bipolar diathesis for,bipolar disorder,MENTAL_HEALTH
18227781,"Furthermore, evidence is now compelling that hypomania in association with antidepressant treatments requires familial bipolar diathesis for bipolar disorder (bipolar III).",hypomania,MENTAL_HEALTH,require,familial bipolar diathesis,DISEASE
18227781,"Furthermore, evidence is now compelling that hypomania in association with antidepressant treatments requires familial bipolar diathesis for bipolar disorder (bipolar III).",antidepressant treatments,CHEMICAL,require,familial bipolar diathesis,DISEASE
18227781,"These considerations have major implications for clinical practice, methodology of genetic investigations, pharmaceutical trials of putative bipolar agents in affective disorders, and public health.",putative bipolar agents,DISEASE,have pharmaceutical trials in,affective disorders,MENTAL_HEALTH
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,TCAs,CHEMICAL,be prescribed in case of non-response to first-line antidepressants in,Major Depressive Disorder,MENTAL_HEALTH
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,TCAs,CHEMICAL,be prescribed in case of non-response to first-line antidepressants in,MDD,DISEASE
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,TCAs,CHEMICAL,be prescribed in case of non-response to,first-line antidepressants,CHEMICAL
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,Tricyclic antidepressants,CHEMICAL,be prescribed in case of non-response to first-line antidepressants in,Major Depressive Disorder,MENTAL_HEALTH
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,Tricyclic antidepressants,CHEMICAL,be prescribed in case of non-response to first-line antidepressants in,MDD,DISEASE
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,Tricyclic antidepressants,CHEMICAL,be prescribed in case of non-response to,first-line antidepressants,CHEMICAL
35397333,Tricyclic antidepressants (TCAs) are frequently prescribed in case of non-response to first-line antidepressants in Major Depressive Disorder (MDD).,first-line antidepressants,CHEMICAL,have case in,Major Depressive Disorder,MENTAL_HEALTH
16987873,"The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.",mental retardation,MENTAL_HEALTH,be treated with,HMG-CoA reductase inhibitor lavastatin,CHEMICAL
16987873,"The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.",Fragile X syndrome,MENTAL_HEALTH,be treated with,lithium receptor mGluR antagonists,CHEBI
16987873,"The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.",Fragile X syndrome,MENTAL_HEALTH,be treated with,glutamate receptor,CHEMICAL
16987873,"The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.",Fragile X syndrome,MENTAL_HEALTH,be treated with,lithium receptor mGluR antagonists,NUTRITION
16987873,"The first therapeutic treatments of animal models of mental retardation have been reported, a Drosophila model of Fragile X syndrome has been treated with lithium or metabotropic glutamate receptor (mGluR) antagonists and a mouse model of NF1 has been treated with the HMG-CoA reductase inhibitor lavastatin, which improves the learning and memory skills in these models.",Fragile X syndrome,MENTAL_HEALTH,be treated with,NF1,DISEASE
31182576,"These results indicate that persistent CRPS is often contributed to by autoantibodies and highlight a potential therapeutic use for clinically licensed antagonists, such as anakinra, to prevent or treat CRPS via blocking IL-1 actions.",persistent CRPS,DISEASE,highlight potential therapeutic use for,anakinra,CHEMICAL
31182576,"These results indicate that persistent CRPS is often contributed to by autoantibodies and highlight a potential therapeutic use for clinically licensed antagonists, such as anakinra, to prevent or treat CRPS via blocking IL-1 actions.",persistent CRPS,DISEASE,highlight potential therapeutic use for,licensed antagonists,CHEBI
26861708,"The NaV1.7 voltage-gated sodium channel is a highly valued target for the treatment of neuropathic pain due to its expression in pain-sensing neurons and human genetic mutations in the gene encoding NaV1.7, resulting in either loss-of-function (e.g., congenital analgesia) or gain-of-function (e.g., paroxysmal extreme pain disorder) pain phenotypes.",NaV1.7 voltage-gated sodium channel,CHEMICAL,result in,pain phenotypes,DISEASE
26861708,"The NaV1.7 voltage-gated sodium channel is a highly valued target for the treatment of neuropathic pain due to its expression in pain-sensing neurons and human genetic mutations in the gene encoding NaV1.7, resulting in either loss-of-function (e.g., congenital analgesia) or gain-of-function (e.g., paroxysmal extreme pain disorder) pain phenotypes.",NaV1.7 voltage-gated sodium channel,CHEMICAL,result in,congenital analgesia,MENTAL_HEALTH
26861708,"The NaV1.7 voltage-gated sodium channel is a highly valued target for the treatment of neuropathic pain due to its expression in pain-sensing neurons and human genetic mutations in the gene encoding NaV1.7, resulting in either loss-of-function (e.g., congenital analgesia) or gain-of-function (e.g., paroxysmal extreme pain disorder) pain phenotypes.",NaV1.7 voltage-gated sodium channel,CHEMICAL,result in,paroxysmal extreme pain disorder,MENTAL_HEALTH
34412937,Medically-sanctioned testosterone administration has seen increasingly widespread application in the treatment of gender dysphoria (GD).,Medically-sanctioned testosterone administration,CHEMICAL,see widespread application in treatment of,gender dysphoria,MENTAL_HEALTH
34412937,Medically-sanctioned testosterone administration has seen increasingly widespread application in the treatment of gender dysphoria (GD).,Medically-sanctioned testosterone administration,CHEMICAL,see widespread application in treatment of,GD,DISEASE
34412937,"Rather, by stark contrast, those with MD are largely treated with psychological intervention to accept themselves as they physically are and the illicit use of testosterone for muscle-related body perception purposes is generally subject to criminal justice enforcement actions.",testosterone,CHEMICAL,be subject to,criminal enforcement actions,DISEASE
30455236,Invasive pulmonary aspergillosis (IPA) due to Aspergillus fumigatus is a serious fungal infection in the immunosuppressed patient population.,Invasive pulmonary aspergillosis due,DISEASE,be,serious fungal infection,DISEASE
30455236,Invasive pulmonary aspergillosis (IPA) due to Aspergillus fumigatus is a serious fungal infection in the immunosuppressed patient population.,IPA,CHEMICAL,be,serious fungal infection,DISEASE
30455236,"The use of 50 mg/kg 1-aminobenzotriazole (ABT), a suicide inhibitor of cytochrome P450 enzymes, enhanced APX001A exposures (area under the time-concentration curve [AUC]) 16- to 18-fold and enhanced serum half-life from ∼1 to 9 h, more closely mimicking human pharmacokinetics.",suicide inhibitor,MENTAL_HEALTH,enhance serum half-life from,∼1,CHEMICAL
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,endometriosis,DISEASE
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,prostate tumours,DISEASE
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,precocious puberty,DISEASE
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,infertility,DISEASE
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,premenstrual syndrome,MENTAL_HEALTH
15544487,"Peptidic agonists of the GnRH receptor have been known for many years and are currently employed therapeutically in the treatment of prostate and breast tumours, uterine fibroids, precocious puberty, endometriosis, premenstrual syndrome, contraception and infertility.",Peptidic agonists,CHEBI,be employed in treatment of,uterine fibroids,DISEASE
15544487,"Peptidic antagonists to date have only been employed commercially in the treatment of infertility during assisted reproductive therapy; however, many peptidic antagonists are currently in late stage development for many of the aforementioned indications.",Peptidic antagonists,CHEBI,be employed in treatment of,infertility,DISEASE
15564083,Cough variant asthma is typically corticosteroid responsive; leukotriene antagonists and antihistamines also help.,Cough variant asthma,DISEASE,be,antihistamines,CHEBI
15564083,Cough variant asthma is typically corticosteroid responsive; leukotriene antagonists and antihistamines also help.,Cough variant asthma,DISEASE,be,responsive leukotriene antagonists,CHEBI
31309463,These findings are well supported by the pre-clinical studies (ten research studies described in this review) showing that estrogen and phytoestrogens attenuate the deleterious effects of chronic intermittent hypoxia (obstructive apnea in animals) on the genioglossal muscles and on other organs (co-morbidities) in ovariectomized rodents.,estrogen,CHEBI,attenuate deleterious effects of,obstructive apnea,DISEASE
31309463,These findings are well supported by the pre-clinical studies (ten research studies described in this review) showing that estrogen and phytoestrogens attenuate the deleterious effects of chronic intermittent hypoxia (obstructive apnea in animals) on the genioglossal muscles and on other organs (co-morbidities) in ovariectomized rodents.,estrogen,CHEBI,attenuate deleterious effects of,chronic intermittent hypoxia,DISEASE
31309463,These findings are well supported by the pre-clinical studies (ten research studies described in this review) showing that estrogen and phytoestrogens attenuate the deleterious effects of chronic intermittent hypoxia (obstructive apnea in animals) on the genioglossal muscles and on other organs (co-morbidities) in ovariectomized rodents.,phytoestrogens,CHEBI,attenuate deleterious effects of,obstructive apnea,DISEASE
31309463,These findings are well supported by the pre-clinical studies (ten research studies described in this review) showing that estrogen and phytoestrogens attenuate the deleterious effects of chronic intermittent hypoxia (obstructive apnea in animals) on the genioglossal muscles and on other organs (co-morbidities) in ovariectomized rodents.,phytoestrogens,CHEBI,attenuate deleterious effects of,chronic intermittent hypoxia,DISEASE
31309463,"The beneficial effects of estrogen and phytoestrogens on obstructive sleep apnea and its co morbidities have been attributed to increase in thioredoxin, Nrf-2, activation of p38 MAP kinases, inhibition of vagal C fibers, and attenuation of HIF-1α.",estrogen,CHEBI,have the beneficial effects on,obstructive sleep apnea,MENTAL_HEALTH
31309463,"The beneficial effects of estrogen and phytoestrogens on obstructive sleep apnea and its co morbidities have been attributed to increase in thioredoxin, Nrf-2, activation of p38 MAP kinases, inhibition of vagal C fibers, and attenuation of HIF-1α.",phytoestrogens,CHEBI,have the beneficial effects on,obstructive sleep apnea,MENTAL_HEALTH
21410552,"Chronic intermittent hypoxia (CIH) is a frequent feature of obstructive sleep apnea/hypopnea syndrome (OSAHS), and it may alter upper airway muscle endurance.",CIH,CHEMICAL,be frequent feature of,OSAHS,DISEASE
21410552,"Chronic intermittent hypoxia (CIH) is a frequent feature of obstructive sleep apnea/hypopnea syndrome (OSAHS), and it may alter upper airway muscle endurance.",CIH,CHEMICAL,be frequent feature of,obstructive sleep apnea/hypopnea syndrome,DISEASE
21410552,"Chronic intermittent hypoxia (CIH) is a frequent feature of obstructive sleep apnea/hypopnea syndrome (OSAHS), and it may alter upper airway muscle endurance.",Chronic intermittent hypoxia,DISEASE,be frequent feature of,OSAHS,DISEASE
21410552,"Chronic intermittent hypoxia (CIH) is a frequent feature of obstructive sleep apnea/hypopnea syndrome (OSAHS), and it may alter upper airway muscle endurance.",Chronic intermittent hypoxia,DISEASE,be frequent feature of,obstructive sleep apnea/hypopnea syndrome,DISEASE
21410552,We have previously reported the positive effects of estrogen on genioglossus fatigue resistance in rats.,estrogen,CHEBI,have the positive effects on,fatigue resistance,MENTAL_HEALTH
21410552,"Phytoestrogens were found to significantly increase genioglossus fatigue resistance, the effect of genistein being more powerful than that of coumestrol.",Phytoestrogens,CHEBI,increase,fatigue resistance,MENTAL_HEALTH
21410552,"Phytoestrogens were found to significantly increase genioglossus fatigue resistance, the effect of genistein being more powerful than that of coumestrol.",genistein,CHEMICAL,be,coumestrol,CHEMICAL
22221282,"The stereochemical analysis of the phosphonothioate methanolysis was done for the first time with β-cyclodextrin, and it shows complete inversion on the phosphorus center upon methoxide displacement of ethanethiolate.",phosphonothioate methanolysis,CHEMICAL,be done for first time with,β-cyclodextrin,CHEMICAL
18164600,"Antidepressant prescribing patterns and factors influencing the choice of antidepressant for the treatment of depression were examined in the Factors Influencing Depression Endpoints Research (FINDER) study, a prospective, observational study in 12 European countries of 3468 adults about to start antidepressant medication for their first episode of depression or a new episode of recurrent depression.",Antidepressant prescribing patterns,CHEMICAL,be examined in,recurrent depression,MENTAL_HEALTH
18164600,"Antidepressant prescribing patterns and factors influencing the choice of antidepressant for the treatment of depression were examined in the Factors Influencing Depression Endpoints Research (FINDER) study, a prospective, observational study in 12 European countries of 3468 adults about to start antidepressant medication for their first episode of depression or a new episode of recurrent depression.",Antidepressant prescribing patterns,CHEMICAL,be examined in,Depression Endpoints Research,MENTAL_HEALTH
18164600,"Physician factors (age, gender, speciality) and patient factors (severity of depression, age, education, smoking, number of current physical conditions and functional syndromes) were associated with initial antidepressant choice in some models.",depression,MENTAL_HEALTH,be associated with,initial antidepressant choice,CHEMICAL
15600379,Both selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been examined for use in long-term treatment of MDD.,selective serotonin reuptake inhibitors,CHEMICAL,be examined for use in long-term treatment of,MDD,DISEASE
15600379,Both selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been examined for use in long-term treatment of MDD.,serotonin-norepinephrine reuptake inhibitors,CHEMICAL,be examined for use in long-term treatment of,MDD,DISEASE
15600379,Both selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) have been examined for use in long-term treatment of MDD.,SSRIs,CHEMICAL,be examined for use in long-term treatment of,MDD,DISEASE
10446739,"In depressed patients, mirtazapine produces a significant shortening of sleep-onset latency, increases a total sleep time, and leads to a marked improvement in sleep efficiency.",mirtazapine,CHEMICAL,produce in,depressed patients,DISEASE
10446739,Antidepressants with preferential 5-HT2 blocking properties are therefore a good treatment option for depressed patients with marked insomnia.,Antidepressants,CHEMICAL,be good treatment option for depressed patients with,marked insomnia,MENTAL_HEALTH
10446739,Antidepressants with preferential 5-HT2 blocking properties are therefore a good treatment option for depressed patients with marked insomnia.,Antidepressants,CHEMICAL,be good treatment option for,depressed patients,DISEASE
35457225,"Endocannabinoids, the endogenous painkillers, emerged, alternative to plant cannabis, as promising analgesics against migraine pain.",Endocannabinoids,CHEMICAL,emerge as promising analgesics against,migraine pain,DISEASE
35457225,"In this thematic review, we discuss how inhibition of the main endocannabinoid-degrading enzymes, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), could raise the level of endocannabinoids (endoCBs) such as 2-AG and anandamide in order to alleviate migraine pain.",monoacylglycerol lipase,CHEMICAL,alleviate,migraine pain,DISEASE
35457225,"In this thematic review, we discuss how inhibition of the main endocannabinoid-degrading enzymes, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), could raise the level of endocannabinoids (endoCBs) such as 2-AG and anandamide in order to alleviate migraine pain.",monoacylglycerol lipase,CHEMICAL,raise level of,endoCBs,CHEMICAL
35457225,"In this thematic review, we discuss how inhibition of the main endocannabinoid-degrading enzymes, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), could raise the level of endocannabinoids (endoCBs) such as 2-AG and anandamide in order to alleviate migraine pain.",monoacylglycerol lipase,CHEMICAL,raise level of,endocannabinoids,CHEMICAL
35457225,"In this thematic review, we discuss how inhibition of the main endocannabinoid-degrading enzymes, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), could raise the level of endocannabinoids (endoCBs) such as 2-AG and anandamide in order to alleviate migraine pain.",monoacylglycerol lipase,CHEMICAL,raise level of,anandamide,CHEMICAL
35457225,"In this thematic review, we discuss how inhibition of the main endocannabinoid-degrading enzymes, monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), could raise the level of endocannabinoids (endoCBs) such as 2-AG and anandamide in order to alleviate migraine pain.",monoacylglycerol lipase,CHEMICAL,raise level of,2-AG,CHEMICAL
35457225,"The specific distribution and homeostasis of endoCBs in the main regions of the nociceptive system and their generation 'on demand', along with recent availability of MAGL and FAAH inhibitors suggest new perspectives for endoCBs-mediated analgesia in migraine pain.",endoCBs,CHEMICAL,suggest new perspectives for endocbs-mediated analgesia in,migraine pain,DISEASE
35457225,"The specific distribution and homeostasis of endoCBs in the main regions of the nociceptive system and their generation 'on demand', along with recent availability of MAGL and FAAH inhibitors suggest new perspectives for endoCBs-mediated analgesia in migraine pain.",endoCBs,CHEMICAL,suggest new perspectives for,endoCBs-mediated analgesia,MENTAL_HEALTH
19297184,"Five-week-old lettuce (Lactuca sativa L.) plants grown in growth chambers were exposed to mild stresses such as heat shock (40 degrees C for 10 min), chilling (4 degrees C for 1d) or high light intensity (800 micromolm(-2)s(-1) for 1d).",Lactuca sativa L. plants,CHEMICAL,be exposed to mild stresses such as,heat shock,DISEASE
15753639,"A single, acute exposure to ozone has been shown to modify the antioxidant defense mechanism in the respiratory tract.",ozone,CHEMICAL,modify antioxidant defense mechanism in,respiratory tract,DISEASE
15753639,"A single, acute exposure to ozone has been shown to modify the antioxidant defense mechanism in the respiratory tract.",ozone,CHEMICAL,modify,antioxidant defense mechanism,MENTAL_HEALTH
27210746,"Here, we developed an unbiased, genome-wide screening method that identified RhoB as a critical mediator of Vγ9Vδ2 TCR activation in tumor cells.",TCR activation,CHEMICAL,have a critical mediator in,tumor cells,DISEASE
27210746,These complementary events provide further evidence for inside-out signaling as an essential step in the recognition of tumor cells by a Vγ9Vδ2 TCR.,Vγ9Vδ2 TCR,CHEMICAL,have the recognition of,tumor cells,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEBI,be used in patients with nmo for symptomatic treatment of,spasticity,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEBI,be used in patients with nmo for symptomatic treatment of,non-NMO-related indications,CHEMICAL
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEBI,be used in patients with nmo for symptomatic treatment of,insomnia,MENTAL_HEALTH
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEBI,be used in patients with nmo for symptomatic treatment of,epilepsy,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEMICAL,be used in patients with nmo for symptomatic treatment of,spasticity,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEMICAL,be used in patients with nmo for symptomatic treatment of,non-NMO-related indications,CHEMICAL
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEMICAL,be used in patients with nmo for symptomatic treatment of,insomnia,MENTAL_HEALTH
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEMICAL,be used in patients with nmo for symptomatic treatment of,epilepsy,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEBI,be used in patients with,NMO,DISEASE
26323247,"Gamma-aminobutyric acid A receptor (GABAAR) agonists are frequently used in patients with NMO, e.g., for symptomatic treatment of spasticity or epilepsy or for non-NMO-related indications such as treatment of insomnia.",Gamma-aminobutyric acid A receptor GABAAR agonists,CHEMICAL,be used in patients with,NMO,DISEASE
27729414,"Nicotinic α-7 acetylcholine receptor (nAChRα7) is a critical regulator of cholinergic anti-inflammatory actions in several diseases, including acute respiratory distress syndrome (ARDS).",Nicotinic α-7 acetylcholine receptor,CHEMICAL,be critical regulator of cholinergic anti-inflammatory actions in,acute respiratory distress syndrome,DISEASE
27729414,"Nicotinic α-7 acetylcholine receptor (nAChRα7) is a critical regulator of cholinergic anti-inflammatory actions in several diseases, including acute respiratory distress syndrome (ARDS).",Nicotinic α-7 acetylcholine receptor,CHEMICAL,be critical regulator of cholinergic anti-inflammatory actions in,ARDS,DISEASE
27729414,"PNU-282987 treatment, either before or after ALI induction, reduced neutrophil recruitment and IL-1β, TNF-α, IL-6, keratinocyte chemoattractant (KC), and IL-10 cytokine levels in the bronchoalveolar lavage fluid (P + and -2+ cells, whereas the number of tissue inhibitor of metalloproteinase-1+ cells increased (P < 0.05).",ALI induction,DISEASE,reduce,TNF-α,CHEMICAL
27729414,"PNU-282987 treatment, either before or after ALI induction, reduced neutrophil recruitment and IL-1β, TNF-α, IL-6, keratinocyte chemoattractant (KC), and IL-10 cytokine levels in the bronchoalveolar lavage fluid (P + and -2+ cells, whereas the number of tissue inhibitor of metalloproteinase-1+ cells increased (P < 0.05).",PNU-282987 treatment,CHEMICAL,reduce,TNF-α,CHEMICAL
27729414,"The collective results suggest that PNU-282987, an agonist of α7nAChR, reduces LPS-induced experimental ALI, thus supporting the notion that drugs that act on α7nAChRs should be explored for ARDS treatment in humans.-Pinheiro, N. M., Santana, F. P. R., Almeida, R. R., Guerreiro, M., Martins, M. A., Caperuto, L. C., Câmara, N. O. S., Wensing, L. A., Prado, V. F., Tibério, I. F. L. C., Prado, M. A. M., Prado, C. M. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile.",α7nAChR,CHEMICAL,reduce,LPS-induced experimental ALI,DISEASE
27729414,"The collective results suggest that PNU-282987, an agonist of α7nAChR, reduces LPS-induced experimental ALI, thus supporting the notion that drugs that act on α7nAChRs should be explored for ARDS treatment in humans.-Pinheiro, N. M., Santana, F. P. R., Almeida, R. R., Guerreiro, M., Martins, M. A., Caperuto, L. C., Câmara, N. O. S., Wensing, L. A., Prado, V. F., Tibério, I. F. L. C., Prado, M. A. M., Prado, C. M. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile.",agonist,CHEBI,reduce,LPS-induced experimental ALI,DISEASE
27729414,"The collective results suggest that PNU-282987, an agonist of α7nAChR, reduces LPS-induced experimental ALI, thus supporting the notion that drugs that act on α7nAChRs should be explored for ARDS treatment in humans.-Pinheiro, N. M., Santana, F. P. R., Almeida, R. R., Guerreiro, M., Martins, M. A., Caperuto, L. C., Câmara, N. O. S., Wensing, L. A., Prado, V. F., Tibério, I. F. L. C., Prado, M. A. M., Prado, C. M. Acute lung injury is reduced by the α7nAChR agonist PNU-282987 through changes in the macrophage profile.",PNU-282987,CHEMICAL,reduce,LPS-induced experimental ALI,DISEASE
18303489,"The combination of CDP-choline and galantamine was administered to 6 schizophrenic patients with residual symptoms in a 12-week, open-label trial.",CDP-choline,CHEMICAL,be administered to,schizophrenic patients,DISEASE
18303489,"The combination of CDP-choline and galantamine was administered to 6 schizophrenic patients with residual symptoms in a 12-week, open-label trial.",galantamine,CHEMICAL,be administered to,schizophrenic patients,DISEASE
17686216,Microbicides may interfere with detection of Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) in urine samples from women who use microbicides.,Microbicides,CHEBI,interfere with detection of,Chlamydia trachomatis,DISEASE
17686216,Microbicides may interfere with detection of Chlamydia trachomatis (Ct) and Neisseria gonorrhoeae (Ng) in urine samples from women who use microbicides.,Microbicides,CHEBI,interfere with detection of,Ng,CHEMICAL
27335526,Switching over to aripiprazole or adjunctive aripiprazole has been advocated for optimal management of antipsychotic-induced hyperprolactinemia.,adjunctive aripiprazole,CHEMICAL,switch to,aripiprazole,CHEMICAL
27335526,Switching over to aripiprazole or adjunctive aripiprazole has been advocated for optimal management of antipsychotic-induced hyperprolactinemia.,adjunctive aripiprazole,CHEMICAL,switch to,adjunctive aripiprazole,CHEMICAL
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,tick-borne louping encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,sandfly-borne,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Aino disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,African swine fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,equine encephalomyelitides,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Nairobi sheep disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Omsk hemorrhagic fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,epizootic hemorrhagic disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,yellow fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Israel turkey meningoencephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,equine encephalosis,CHEMICAL
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Valley fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Japanese encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,midge-borne,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Thogoto fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Tembusu disease/duck egg-drop syndrome,CHEMICAL
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Wesselsbron disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Soldado fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Cocal disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Murray Valley encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Kotonkan disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Usutu disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Main Drain disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Tyuleniy fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Shuni disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Bhanja fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,West Nile encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,bovine ephemeral fever,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Akabane disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,La Crosse encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,mosquito-borne,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,louping ill,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Snowshoe hare encephalitis,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Schmallenberg disease,DISEASE
24751197,"Arboviral diseases in endotherm animals may therefore be classified as: tick-borne (louping ill and tick-borne encephalitis, Omsk hemorrhagic fever, Kyasanur Forest disease, Tyuleniy fever, Nairobi sheep disease, Soldado fever, Bhanja fever, Thogoto fever, African swine fever), mosquito-borne (Eastern, Western, and Venezuelan equine encephalomyelitides, Highlands J disease, Getah disease, Semliki Forest disease, yellow fever, Japanese encephalitis, Murray Valley encephalitis, West Nile encephalitis, Usutu disease, Israel turkey meningoencephalitis, Tembusu disease/duck egg-drop syndrome, Wesselsbron disease, La Crosse encephalitis, Snowshoe hare encephalitis, Cache Valley disease, Main Drain disease, Rift Valley fever, Peruvian horse sickness, Yunnan disease), sandfly-borne (vesicular stomatitis-Indiana, New Jersey, and Alagoas, Cocal disease), midge-borne (Akabane disease, Aino disease, Schmallenberg disease, Shuni disease, African horse sickness, Kasba disease, bluetongue, epizootic hemorrhagic disease of deer, Ibaraki disease, equine encephalosis, bovine ephemeral fever, Kotonkan disease), and cimicid-borne (Buggy Creek disease).",Arboviral diseases,DISEASE,be classified as,Kasba disease,DISEASE
16699814,"Pycnogenol, an extract from the bark of the French maritime pine, consisting of phenolic acids, catechin, taxifolin and procyanidins, has shown improvement of ADHD in case reports and in an open study.",Pycnogenol,CHEMICAL,show improvement of,ADHD,MENTAL_HEALTH
16699814,"Pycnogenol, an extract from the bark of the French maritime pine, consisting of phenolic acids, catechin, taxifolin and procyanidins, has shown improvement of ADHD in case reports and in an open study.",French maritime pine,CHEMICAL,show improvement of,ADHD,MENTAL_HEALTH
16699814,Aim of the present study was to evaluate the effect of Pycnogenol on ADHD symptoms.,Pycnogenol,CHEMICAL,have the effect on,ADHD symptoms,MENTAL_HEALTH
16699814,"Results show that 1-month Pycnogenol administration caused a significant reduction of hyperactivity, improves attention and visual-motoric coordination and concentration of children with ADHD.",1-month Pycnogenol administration,CHEMICAL,cause significant reduction of,hyperactivity,MENTAL_HEALTH
16699814,"Results show that 1-month Pycnogenol administration caused a significant reduction of hyperactivity, improves attention and visual-motoric coordination and concentration of children with ADHD.",1-month Pycnogenol administration,CHEMICAL,improve attention and visual-motoric coordination and concentration of children with,ADHD,MENTAL_HEALTH
15467973,Some positive therapeutic effects in fibromyalgia syndrome (FS) were reported with both tricyclic and new antidepressant drugs as well as serotonergic agents (5HT2 and 5HT3 receptor blockers).,fibromyalgia syndrome,DISEASE,be reported with,serotonergic agents,CHEBI
15467973,Some positive therapeutic effects in fibromyalgia syndrome (FS) were reported with both tricyclic and new antidepressant drugs as well as serotonergic agents (5HT2 and 5HT3 receptor blockers).,fibromyalgia syndrome,DISEASE,be reported with,5HT2,CHEMICAL
15467973,Some positive therapeutic effects in fibromyalgia syndrome (FS) were reported with both tricyclic and new antidepressant drugs as well as serotonergic agents (5HT2 and 5HT3 receptor blockers).,fibromyalgia syndrome,DISEASE,be reported with,tricyclic antidepressant drugs,CHEMICAL
17725516,"Using a unique preparation with two intact hippocampi placed in a three-compartment chamber in vitro, we have provided direct evidence that seizures beget seizures and that GABA signaling plays a central role in this phenomenon.",seizures,DISEASE,beget,seizures,DISEASE
10100430,"Excessive estrogen influence produces anxiety, agitation, irritability, and lability.",Excessive estrogen influence,CHEBI,produce,anxiety,MENTAL_HEALTH
10100430,"Excessive estrogen influence produces anxiety, agitation, irritability, and lability.",Excessive estrogen influence,CHEBI,produce,agitation,MENTAL_HEALTH
10100430,"Excessive estrogen influence produces anxiety, agitation, irritability, and lability.",Excessive estrogen influence,CHEBI,produce,irritability,DISEASE
10100430,Progesterone and its metabolites inhibit kindling and seizure activity.,Progesterone,CHEMICAL,inhibit,seizure,DISEASE
10100430,Excessive progesterone influence produces sedation and depression.,Excessive progesterone influence,CHEMICAL,produce,depression,MENTAL_HEALTH
10100430,"Testosterone has two major metabolites: estradiol, which can exacerbate seizures, and dihydrotestosterone, which blocks NMDA-type glutamate transmission and may be responsible for antiseizure effects.",Testosterone,CHEMICAL,have,estradiol,CHEMICAL
35165841,"Intravenous (IV) ketamine is increasingly used off-label at subanesthetic doses for its rapid antidepressant effect, and intranasal (IN) esketamine has been recently approved in several countries for treating depression.",Intravenous ketamine,CHEMICAL,be used off-label at subanesthetic doses for,rapid antidepressant effect,CHEMICAL
35165841,"Intravenous (IV) ketamine is increasingly used off-label at subanesthetic doses for its rapid antidepressant effect, and intranasal (IN) esketamine has been recently approved in several countries for treating depression.",Intravenous ketamine,CHEMICAL,be used off-label at,subanesthetic doses,CHEMICAL
35165841,"However, the psychiatric literature has repeatedly cautioned on the addictive potential of ketamine and raised caution for both less supervised and longer-term use of ketamine.",psychiatric literature,DISEASE,raise caution for supervised and longer-term use of,ketamine,CHEMICAL
35165841,Our consortium of mood disorder specialists with significant ketamine prescribing experience considers prescribing of non-parenteral ketamine a reasonable clinical treatment option in select cases of treatment-resistant depression.,significant ketamine prescribing experience,CHEMICAL,consider prescribing of non-parenteral ketamine in select cases of,treatment-resistant depression,MENTAL_HEALTH
35165841,Our consortium of mood disorder specialists with significant ketamine prescribing experience considers prescribing of non-parenteral ketamine a reasonable clinical treatment option in select cases of treatment-resistant depression.,disorder specialists,MENTAL_HEALTH,consider prescribing of non-parenteral ketamine in select cases of,treatment-resistant depression,MENTAL_HEALTH
35165841,Our consortium of mood disorder specialists with significant ketamine prescribing experience considers prescribing of non-parenteral ketamine a reasonable clinical treatment option in select cases of treatment-resistant depression.,significant ketamine prescribing experience,CHEMICAL,consider prescribing of,non-parenteral ketamine,CHEMICAL
35165841,Our consortium of mood disorder specialists with significant ketamine prescribing experience considers prescribing of non-parenteral ketamine a reasonable clinical treatment option in select cases of treatment-resistant depression.,disorder specialists,MENTAL_HEALTH,consider prescribing of,non-parenteral ketamine,CHEMICAL
35165841,Our consortium of mood disorder specialists with significant ketamine prescribing experience considers prescribing of non-parenteral ketamine a reasonable clinical treatment option in select cases of treatment-resistant depression.,disorder specialists,MENTAL_HEALTH,have our consortium with,significant ketamine prescribing experience,CHEMICAL
33915549,"In this study, the antidepressant effect of RIP I was evaluated in an animal model of depression induced by corticosterone (CORT).",antidepressant effect,CHEMICAL,be evaluated in study in animal model of,depression,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",Venlafaxine,CHEMICAL,treat,anxiety,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",Venlafaxine,CHEMICAL,treat,social phobia,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",Venlafaxine,CHEMICAL,treat,depression,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",noradrenaline,CHEMICAL,treat,anxiety,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",noradrenaline,CHEMICAL,treat,social phobia,MENTAL_HEALTH
34420375,"Venlafaxine, a specific inhibitor of both noradrenaline and serotonin, is commonly used in human medicine to treat depression, anxiety and social phobia.",noradrenaline,CHEMICAL,treat,depression,MENTAL_HEALTH
34086104,What is New: • Azygos lobe in children may be complicated with other congenital abnormalities.,• Azygos lobe,CHEMICAL,be,other congenital abnormalities,DISEASE
34086104,• There is no evidence that azygos lobe is associated with recurrent infections.,azygos lobe,DISEASE,be associated with,recurrent infections,DISEASE
24285405,"The relationship between the elevated levels of serum malondialdehyde, depleted level of antioxidants (vitamin A, E and C) and altered level of immunoglobulins (IgA, IgG and IgM) in several psychiatric disorders has been established by various experimental evidences over the past few years.",serum malondialdehyde,CHEMICAL,deplete level of,vitamin A,CHEBI
24285405,"The relationship between the elevated levels of serum malondialdehyde, depleted level of antioxidants (vitamin A, E and C) and altered level of immunoglobulins (IgA, IgG and IgM) in several psychiatric disorders has been established by various experimental evidences over the past few years.",serum malondialdehyde,CHEMICAL,deplete level of,several psychiatric disorders,DISEASE
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Antifungal effects,CHEBI,be observed against,Fusarium fujikuroi,CHEMICAL
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Antifungal effects,CHEBI,be observed against,Fusarium oxysporum,CHEMICAL
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Antifungal effects,CHEBI,be observed against,Botrytis cinerea,DISEASE
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Ld-03,CHEMICAL,be observed against,Fusarium fujikuroi,CHEMICAL
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Ld-03,CHEMICAL,be observed against,Fusarium oxysporum,CHEMICAL
34395628,"Antifungal effects of Ld-03 were observed against Fusarium oxysporum, Botrytis cinerea, Botryosphaeria dothidea, and Fusarium fujikuroi.",Ld-03,CHEMICAL,be observed against,Botrytis cinerea,DISEASE
32295872,All ESBL-E and CPE strains were tested for antimicrobial susceptibilities.,CPE strains,CHEMICAL,be tested for,antimicrobial susceptibilities,CHEBI
32295872,All CPE strains were characterized by whole-genome sequencing and possessed NDM-1 and -5 genes and other resistance determinants.,CPE strains,CHEMICAL,possess,other resistance determinants,MENTAL_HEALTH
33262805,"Despite improved oxygenation and alleviation of respiratory symptoms with antiviral and anti-inflammatory therapies, cerebral injuries progressed, and the patient died due to severe brain damage.",cerebral injuries,DISEASE,improved oxygenation and alleviation of respiratory symptoms with,antiviral therapies,CHEBI
30531673,"CASE REPORT An 83-year-old African American man with end-stage kidney disease (ESRD) and on chronic peritoneal dialysis (PD) developed herpes zoster, for which he received the manufacturer-recommended intravenous dose of acyclovir.",end-stage kidney disease,DISEASE,develop,herpes zoster,DISEASE
30531673,"CASE REPORT An 83-year-old African American man with end-stage kidney disease (ESRD) and on chronic peritoneal dialysis (PD) developed herpes zoster, for which he received the manufacturer-recommended intravenous dose of acyclovir.",ESRD,DISEASE,develop,herpes zoster,DISEASE
35263805,"AAS seems to be related to ""subjective ictal anxiety"" reported by patients.",AAS,CHEMICAL,seem to related to,subjective ictal anxiety,MENTAL_HEALTH
7373324,"Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia.",Oxiperomide,CHEMICAL,be evaluated in blind placebo-controlled trial in patients with,tardive dyskinesia,MENTAL_HEALTH
7373324,"Oxiperomide, a dopaminergic antagonist that has been shown to reduce levodopa-induced dyskinesias without producing an equal aggravation of Parkinsonism, was evaluated in a blind placebo-controlled trial in 10 patients with tardive dyskinesia.",dopaminergic antagonist,CHEBI,be evaluated in blind placebo-controlled trial in patients with,tardive dyskinesia,MENTAL_HEALTH
7373324,"Although oxiperomide is only a palliative suppressing agent in tardive dyskinesia, as the symptoms returned when the drug was stopped, it is an interesting agent in the search for selective dopaminergic receptor blockers.",oxiperomide,CHEMICAL,suppressing agent in,tardive dyskinesia,MENTAL_HEALTH
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",curcumin,CHEMICAL,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",quercetin,CHEMICAL,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",polyphenols,CHEMICAL,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",resveratrol,CHEMICAL,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",spermidine,CHEMICAL,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",trehalose,NUTRITION,limit,brain damage,DISEASE
33072744,"Recent evidence indicates that polyphenols like resveratrol and curcumin, flavonoids, like quercetin, polyamine, like spermidine and sugars, like trehalose, limit brain damage in vitro and in vivo.",polyamine,CHEMICAL,limit,brain damage,DISEASE
33068655,"We identified that these food additives induce gastrotoxicity, hepatotoxicity and alterations in gut microbiota and most evidence points out oxidative stress as the main mechanism of toxicity, however, the role of oxidative stress as the main mechanism needs to be explored further.",food additives,CHEBI,induce,hepatotoxicity,DISEASE
33068655,"We identified that these food additives induce gastrotoxicity, hepatotoxicity and alterations in gut microbiota and most evidence points out oxidative stress as the main mechanism of toxicity, however, the role of oxidative stress as the main mechanism needs to be explored further.",food additives,CHEBI,induce,gut microbiota,DISEASE
25288094,The social hormones oxytocin (OT) and arginine-vasopressin (AVP) both modulate social interaction and therefore may be involved in the pathogenesis of schizophrenia.,hormones oxytocin,CHEMICAL,be involved in pathogenesis of,schizophrenia,MENTAL_HEALTH
25288094,The social hormones oxytocin (OT) and arginine-vasopressin (AVP) both modulate social interaction and therefore may be involved in the pathogenesis of schizophrenia.,hormones oxytocin,CHEBI,be involved in pathogenesis of,schizophrenia,MENTAL_HEALTH
25288094,We investigated whether men with schizophrenia show altered OT and AVP levels compared with healthy controls (HC) and whether autism symptoms are associated with OT levels.,schizophrenia,MENTAL_HEALTH,show,AVP,CHEMICAL
21713109,Pathological gambling (PG) is a highly prevalent and disabling impulse control disorder.,PG,CHEMICAL,be,prevalent impulse control disorder,MENTAL_HEALTH
21713109,Pathological gambling (PG) is a highly prevalent and disabling impulse control disorder.,Pathological gambling,MENTAL_HEALTH,be,prevalent impulse control disorder,MENTAL_HEALTH
8647474,Opioid analgesics are often the mainstay of pain treatment for dying patients.,Opioid analgesics,CHEBI,be mainstay of,pain treatment,DISEASE
7504098,"Pentazocine produced primarily antagonist-like effects, with higher doses (> = 60 mg) producing significant elevations of visual analog scale ratings of Drug Effects, Bad Effects and Sick; of observer ratings of piloerection, restlessness and adjective scores of opioid withdrawal; as well as increases in blood pressure, heart rate and pupil diameter and decreases in skin temperature.",Pentazocine,CHEMICAL,produce antagonist-like effects with,restlessness,MENTAL_HEALTH
7504098,"Pentazocine produced primarily antagonist-like effects, with higher doses (> = 60 mg) producing significant elevations of visual analog scale ratings of Drug Effects, Bad Effects and Sick; of observer ratings of piloerection, restlessness and adjective scores of opioid withdrawal; as well as increases in blood pressure, heart rate and pupil diameter and decreases in skin temperature.",Pentazocine,CHEMICAL,produce antagonist-like effects with,piloerection,DISEASE
34434468,"Enoxaparin therapy was initiated, resulting in no further thrombotic events.",Enoxaparin therapy,CHEMICAL,result in,further thrombotic events,DISEASE
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,glutathione levels antioxidant enzymes,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,uric acid,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,UA,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,GSH,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,E levels,CHEBI
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,GR,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,glutathione reductase,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,CHEMICAL,reduce,superoxide dismutase,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,glutathione levels antioxidant enzymes,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,uric acid,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,UA,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,GSH,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,E levels,CHEBI
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,GR,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,glutathione reductase,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",IL-1β thiobarbituric acid reactive substances-TBARS,CHEMICAL,reduce,superoxide dismutase,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,glutathione levels antioxidant enzymes,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,uric acid,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,UA,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,GSH,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,E levels,CHEBI
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,GR,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,glutathione reductase,CHEMICAL
26207872,"Biomarkers of inflammation (myeloperoxidase activity - MPO and levels of IL-1β and TNF-α) and OS (thiobarbituric acid reactive substances - TBARS, protein carbonyls - PC), reduced glutathione (GSH), uric acid (UA) and vitamin E levels, as well as antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GPx), glutathione reductase (GR), glutathione-S-transferase (GST) and gamma-glutamyltransferase (GGT) activities, were measured after each period.",inflammation myeloperoxidase activity-MPO,DISEASE,reduce,superoxide dismutase,CHEMICAL
35586415,"Hyperammonemic encephalopathy (HAE) is a serious adverse effect of valproate semisodium, which is facilitated by the potential for drug interaction.",Hyperammonemic encephalopathy,DISEASE,be serious adverse effect of,valproate semisodium,CHEMICAL
35586415,"Hyperammonemic encephalopathy (HAE) is a serious adverse effect of valproate semisodium, which is facilitated by the potential for drug interaction.",HAE,DISEASE,be serious adverse effect of,valproate semisodium,CHEMICAL
35546928,"The Swiss Federal Act on Narcotics allows for the restricted medical use of scheduled psychotropic drugs in cases of resistance to standard treatment, and preliminary evidence of efficacy of the scheduled drug for the particular condition.",Narcotics,CHEBI,allow for restricted medical use of scheduled psychotropic drugs in cases of,resistance,MENTAL_HEALTH
32878441,"Specifically, the binding of morphine, methadone, and cocaine to antimorphine, antimethadone, and anticocaine antibodies was measured by SHG, allowing binding affinities and rates of dissociation to be obtained.",cocaine,CHEMICAL,allow binding affinities and rates of,dissociation,MENTAL_HEALTH
32878441,"Specifically, the binding of morphine, methadone, and cocaine to antimorphine, antimethadone, and anticocaine antibodies was measured by SHG, allowing binding affinities and rates of dissociation to be obtained.",antimethadone,CHEMICAL,allow binding affinities and rates of,dissociation,MENTAL_HEALTH
32878441,"Specifically, the binding of morphine, methadone, and cocaine to antimorphine, antimethadone, and anticocaine antibodies was measured by SHG, allowing binding affinities and rates of dissociation to be obtained.",methadone,CHEMICAL,allow binding affinities and rates of,dissociation,MENTAL_HEALTH
32878441,"Specifically, the binding of morphine, methadone, and cocaine to antimorphine, antimethadone, and anticocaine antibodies was measured by SHG, allowing binding affinities and rates of dissociation to be obtained.",morphine,CHEMICAL,allow binding affinities and rates of,dissociation,MENTAL_HEALTH
22365808,"Multiple regression analysis demonstrated that for HL women (β=0.130, p=0.024), higher BMI (β=0.148, p=0.012), and greater fat consumption (β=0.196, p=0.001) were associated with increased binge eating symptoms (R(2)=0.086, F(3,278)=8.715, p<0.001).",BMI β=0.148,CHEMICAL,be associated with,increased binge eating symptoms,MENTAL_HEALTH
22365808,"Multiple regression analysis demonstrated that for HL women (β=0.130, p=0.024), higher BMI (β=0.148, p=0.012), and greater fat consumption (β=0.196, p=0.001) were associated with increased binge eating symptoms (R(2)=0.086, F(3,278)=8.715, p<0.001).",BMI β=0.148,CHEMICAL,be associated with,R(2)=0.086,CHEMICAL
22365808,"Multiple regression analysis demonstrated that for HL women (β=0.130, p=0.024), higher BMI (β=0.148, p=0.012), and greater fat consumption (β=0.196, p=0.001) were associated with increased binge eating symptoms (R(2)=0.086, F(3,278)=8.715, p<0.001).",β=0.130,CHEMICAL,be associated with,increased binge eating symptoms,MENTAL_HEALTH
22365808,"Multiple regression analysis demonstrated that for HL women (β=0.130, p=0.024), higher BMI (β=0.148, p=0.012), and greater fat consumption (β=0.196, p=0.001) were associated with increased binge eating symptoms (R(2)=0.086, F(3,278)=8.715, p<0.001).",β=0.130,CHEMICAL,be associated with,R(2)=0.086,CHEMICAL
34572930,The identification and isolation of the CSC population based on its high aldehyde dehydrogenase activity (ALDH) is widely accepted for prostate cancer (PCa) and many other solid tumors.,CSC population,CHEMICAL,be accepted for,many other solid tumors,DISEASE
34572930,The identification and isolation of the CSC population based on its high aldehyde dehydrogenase activity (ALDH) is widely accepted for prostate cancer (PCa) and many other solid tumors.,CSC population,CHEMICAL,be accepted for,prostate cancer,DISEASE
35447944,"As a result, phytoplankton toxins are a promising strategy for avoiding postponement or cancer treatment.",phytoplankton toxins,CHEBI,avoid,cancer treatment,DISEASE
9073324,"In humans, bisphosphonates are used successfully in diseases with increased bone turnover, such as Paget's disease, tumoural bone disease, as well as in osteoporosis.",bisphosphonates,CHEMICAL,be used in humans in diseases with,tumoural bone disease,DISEASE
9073324,"In humans, bisphosphonates are used successfully in diseases with increased bone turnover, such as Paget's disease, tumoural bone disease, as well as in osteoporosis.",bisphosphonates,CHEMICAL,be used in humans in diseases with,Paget's disease,DISEASE
9073324,"In humans, bisphosphonates are used successfully in diseases with increased bone turnover, such as Paget's disease, tumoural bone disease, as well as in osteoporosis.",bisphosphonates,CHEMICAL,be used in humans in diseases with,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",clodronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",pamidronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",etidronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",ibandronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",tiludronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",Various bisphosphonates,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Various bisphosphonates, such as alendronate, clodronate, etidronate, ibandronate, pamidronate, and tiludronate, have been investigated in osteoporosis.",alendronate,CHEMICAL,be investigated in,osteoporosis,DISEASE
9073324,"Furthermore, bisphosphonates are also effective in preventing bone loss both in corticosteroid-treated and in immobilized patients.",bisphosphonates,CHEMICAL,prevent,bone loss,DISEASE
9073324,The effect on the rate of fractures has recently been proven for alendronate.,fractures,DISEASE,be proven for,alendronate,CHEMICAL
26750431,"One such protein is alpha synuclein, that was found to be the main component of Lewy bodies in the late 1990s, and this discovery reinforced the emerging view that alpha synuclein was intimately linked to diseases characterized by this type of pathology--namely Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB).",alpha synuclein,NUTRITION,be linked to diseases parkinson's,PD,DISEASE
26750431,"One such protein is alpha synuclein, that was found to be the main component of Lewy bodies in the late 1990s, and this discovery reinforced the emerging view that alpha synuclein was intimately linked to diseases characterized by this type of pathology--namely Parkinson's disease (PD) and Dementia with Lewy Bodies (DLB).",alpha synuclein,NUTRITION,be linked to diseases parkinson's,Lewy Bodies,MENTAL_HEALTH
35338920,Fewer antibiotics are available for effective management of bacterial infections to date owing to increasing multiple-drug resistance (MDR).,Fewer antibiotics,CHEBI,increase,multiple-drug resistance,MENTAL_HEALTH
35338920,"The opposite effect of blue light on p-TQ activity unravels a novel, simple strategy to detoxify p-TQ and its combination with blue light as a safe and efficacious bactericidal modality for managing MDR bacterial infections.",blue light,CHEMICAL,unravel,blue light,CHEMICAL
35456936,"To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media.",multidrug resistance mechanisms,MENTAL_HEALTH,underlie pdt resistance in,VIN,CHEMICAL
35456936,"To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media.",multidrug resistance mechanisms,MENTAL_HEALTH,underlie,PDT resistance,MENTAL_HEALTH
35456936,"To investigate whether multidrug resistance mechanisms underlie PDT resistance in VIN, porphyrins were isolated from sensitive and resistant vulvar cancer cells and their culture media.",porphyrins,NUTRITION,be isolated from,sensitive vulvar cancer cells,DISEASE
34836074,Dysbiotic GM could be a contributing factor in the pathogenesis of GID in children with ASD.,Dysbiotic GM,CHEMICAL,be contributing factor in pathogenesis of gid in,ASD,DISEASE
11063599,"Four of the analogues [(+)-8'-acetylene-ABA, (+)-9'-propargyl-ABA, (-)-9'-propargyl-ABA, and (+)-9'-allyl-ABA] proved to be suicide substrates of ABA 8'-hydroxylase.",(+)-9'-allyl-ABA,CHEMICAL,prove to suicide substrates of,ABA 8'-hydroxylase,CHEMICAL
11063599,"Four of the analogues [(+)-8'-acetylene-ABA, (+)-9'-propargyl-ABA, (-)-9'-propargyl-ABA, and (+)-9'-allyl-ABA] proved to be suicide substrates of ABA 8'-hydroxylase.",(+)-9'-allyl-ABA,CHEMICAL,prove to,suicide substrates,MENTAL_HEALTH
9989573,"Monoclonal antibody D8/17 identifies a B lymphocyte antigen with expanded expression in rheumatic fever, Sydenham's chorea, and subgroups of obsessive-compulsive disorder and Tourette's syndrome with repetitive behaviors.",Tourette's syndrome,DISEASE,have and subgroups with,repetitive behaviors,DISEASE
9989573,"Monoclonal antibody D8/17 identifies a B lymphocyte antigen with expanded expression in rheumatic fever, Sydenham's chorea, and subgroups of obsessive-compulsive disorder and Tourette's syndrome with repetitive behaviors.",obsessive-compulsive disorder,MENTAL_HEALTH,have and subgroups with,repetitive behaviors,DISEASE
16815236,Many of these antiretrovirals have well-defined nephrotoxic effects.,antiretrovirals,CHEMICAL,have,well-defined nephrotoxic effects,DISEASE
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,ADHD,MENTAL_HEALTH,have,n-3 PUFA,CHEMICAL
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,ADHD,MENTAL_HEALTH,have,acid levels,NUTRITION
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,Attention Deficit Hyperactivity Disorder,MENTAL_HEALTH,have,n-3 PUFA,CHEMICAL
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,Attention Deficit Hyperactivity Disorder,MENTAL_HEALTH,have,acid levels,NUTRITION
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,Autistic Spectrum Disorder,DISEASE,have,n-3 PUFA,CHEMICAL
27232999,There is evidence that children with Attention Deficit Hyperactivity Disorder (ADHD) and Autistic Spectrum Disorder (ASD) have lower omega-3 polyunsaturated fatty acid (n-3 PUFA) levels compared with controls and conflicting evidence regarding omega-6 (n-6) PUFA levels.,Autistic Spectrum Disorder,DISEASE,have,acid levels,NUTRITION
20503139,Ataxic breathing and CSA are more prominent in NREM- than REM-sleep.,Ataxic breathing,DISEASE,be prominent in,NREM-,CHEMICAL
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,Polyglutamine Binding Peptide-1(QBP1,CHEMICAL
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,Alzheimer's disease,DISEASE
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,Huntington's disease,DISEASE
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,Dentatorubral- pallidoluysian atrophy,DISEASE
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,NAP,CHEMICAL
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,Parkinson's disease,DISEASE
34544337,"Some crucial peptide inhibitors currently in use for neurodegenerative disorders include Aβ (16-20) KLVFF for Alzheimer's disease, NAPVSIPQ (NAP) for Parkinson's disease, towards eukaryotic cells Vasoactive Intestinal Peptides (VIP) for Huntington's disease, Polyglutamine Binding Peptide-1(QBP1) for Dentatorubral- pallidoluysian atrophy (DRPLA).",neurodegenerative disorders,DISEASE,include,DRPLA,DISEASE
22869031,"Latrepirdine (Dimebon; dimebolin) is a neuroactive compound that was associated with enhanced cognition, neuroprotection and neurogenesis in laboratory animals, and has entered phase II clinical trials for both Alzheimer's disease and Huntington's disease (HD).",Latrepirdine,CHEMICAL,enter phase clinical trials for alzheimer's disease and huntington's,HD,DISEASE
22869031,"Latrepirdine (Dimebon; dimebolin) is a neuroactive compound that was associated with enhanced cognition, neuroprotection and neurogenesis in laboratory animals, and has entered phase II clinical trials for both Alzheimer's disease and Huntington's disease (HD).",Dimebon,CHEMICAL,enter phase clinical trials for alzheimer's disease and huntington's,HD,DISEASE
22869031,"We propose that latrepirdine may represent a novel scaffold for discovery of robust pro-autophagic/anti-neurodegeneration compounds, which might yield clinical benefit for synucleinopathies including Parkinson's disease, Lewy body dementia, rapid eye movement (REM) sleep disorder and/or multiple system atrophy, following optimization of its pro-autophagic and pro-neurogenic activities.",latrepirdine,CHEMICAL,represent novel scaffold for discovery of,robust pro-autophagic/anti-neurodegeneration compounds,CHEMICAL
33314621,"Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for more than half a century.",Vitamin K antagonists,CHEBI,remain cornerstone of oral anticoagulation therapy in the prevention and treatment of,thromboembolism,DISEASE
33314621,"Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for more than half a century.",warfarin,CHEMICAL,remain cornerstone of oral anticoagulation therapy in the prevention and treatment of,thromboembolism,DISEASE
33728146,"On postoperative day 6 deep vein thrombosis developed, despite nadroparin profillaxes, early mobilisation and compressive stockings.",deep vein thrombosis,DISEASE,develop on,nadroparin profillaxes,CHEMICAL
33728146,"Our case demonstrated that in patients with congenital thrombophilia, development of the mesenteric venous thrombosis is possible even with VKA induced severe hypocoagulation.",mesenteric venous thrombosis,DISEASE,be possible in patients with,congenital thrombophilia,DISEASE
33728146,"Our case demonstrated that in patients with congenital thrombophilia, development of the mesenteric venous thrombosis is possible even with VKA induced severe hypocoagulation.",mesenteric venous thrombosis,DISEASE,induce,severe hypocoagulation,DISEASE
20478657,A UVB dose of 1000mJ/cm2 produces a highly significant thermal and mechanical hypersensitivity.,UVB dose,CHEMICAL,produce,significant thermal hypersensitivity,DISEASE
33457147,The mood instability and psychosis were reported as having started a week after her third epidural steroid injection for low-back pain associated with a prior fall.,psychosis,MENTAL_HEALTH,start after her third epidural steroid injection for,low-back pain,DISEASE
33457147,The mood instability and psychosis were reported as having started a week after her third epidural steroid injection for low-back pain associated with a prior fall.,psychosis,MENTAL_HEALTH,start after,third epidural steroid injection,CHEMICAL
33457147,The mood instability and psychosis were reported as having started a week after her third epidural steroid injection for low-back pain associated with a prior fall.,mood instability,DISEASE,start after her third epidural steroid injection for,low-back pain,DISEASE
33457147,The mood instability and psychosis were reported as having started a week after her third epidural steroid injection for low-back pain associated with a prior fall.,mood instability,DISEASE,start after,third epidural steroid injection,CHEMICAL
33457147,"Valproic acid was titrated to 500 mg twice a day, yielding a level of 56.2 ug/ml, accompanied by improvement to mild talkativeness and circumstantiality.",Valproic acid,CHEMICAL,accompany by improvement to,mild talkativeness,DISEASE
33457147,"Valproic acid was titrated to 500 mg twice a day, yielding a level of 56.2 ug/ml, accompanied by improvement to mild talkativeness and circumstantiality.",Valproic acid,CHEMICAL,accompany by improvement to,circumstantiality,DISEASE
33457147,"The persistence of this patient's psychosis for nearly one month, and mania for about three months, underscores the importance of careful risk-benefit analysis before initiating epidural steroids.",patient's psychosis,MENTAL_HEALTH,initiate,epidural steroids,CHEMICAL
33457147,"The persistence of this patient's psychosis for nearly one month, and mania for about three months, underscores the importance of careful risk-benefit analysis before initiating epidural steroids.",mania,MENTAL_HEALTH,initiate,epidural steroids,CHEMICAL
19186209,"Clinical development of haloperidol was conducted, primarily, by psychiatric research team at the University of Liège that confirmed its efficacy in the treatment of various psychiatric disorders such as acute and chronic paranoid psychosis, mania, or chronic treatment-resistant schizophrenia.",haloperidol,CHEMICAL,be conducted by,psychiatric research team,DISEASE
33729209,"Selective cannabinoid type 1, cannabinoid type 2, nonselective cannabinoid receptor agonists (including delta-9-tetrahydrocannabinol) and peroxisome proliferator-activated receptor-alpha agonists (predominantly palmitoylethanolamide) significantly attenuated pain-associated behaviours in a broad range of inflammatory and neuropathic pain models.",nonselective cannabinoid receptor agonists,CHEBI,attenuate pain-associated behaviours in broad range of,inflammatory pain models,DISEASE
33729209,"Selective cannabinoid type 1, cannabinoid type 2, nonselective cannabinoid receptor agonists (including delta-9-tetrahydrocannabinol) and peroxisome proliferator-activated receptor-alpha agonists (predominantly palmitoylethanolamide) significantly attenuated pain-associated behaviours in a broad range of inflammatory and neuropathic pain models.",delta-9-tetrahydrocannabinol,CHEMICAL,attenuate pain-associated behaviours in broad range of,inflammatory pain models,DISEASE
33729209,"Selective cannabinoid type 1, cannabinoid type 2, nonselective cannabinoid receptor agonists (including delta-9-tetrahydrocannabinol) and peroxisome proliferator-activated receptor-alpha agonists (predominantly palmitoylethanolamide) significantly attenuated pain-associated behaviours in a broad range of inflammatory and neuropathic pain models.",receptor-alpha agonists,CHEBI,attenuate pain-associated behaviours in broad range of,inflammatory pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",Fatty acid amide hydrolase inhibitors,NUTRITION,yield mixed results in,inflammatory pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",monoacylglycerol lipase inhibitors,CHEMICAL,yield mixed results in,inflammatory pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",cannabidiol,CHEMICAL,yield mixed results in,inflammatory pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",Fatty acid amide hydrolase inhibitors,NUTRITION,attenuate pain-associated behaviours in,neuropathic pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",monoacylglycerol lipase inhibitors,CHEMICAL,attenuate pain-associated behaviours in,neuropathic pain models,DISEASE
33729209,"Fatty acid amide hydrolase inhibitors, monoacylglycerol lipase inhibitors, and cannabidiol significantly attenuated pain-associated behaviours in neuropathic pain models but yielded mixed results in inflammatory pain models.",cannabidiol,CHEMICAL,attenuate pain-associated behaviours in,neuropathic pain models,DISEASE
19150370,"The use of cannabis has been described in classical and recent literature for the treatment of pain, but the potential for psychotropic effects as a result of the activation of central CB(1) receptors places a limitation upon its use.",cannabis,CHEMICAL,be described in classical and recent literature for treatment of,pain,DISEASE
19150370,"Selective CB(2) agonists and peripherally restricted CB(1) or CB(1)/CB(2) dual agonists are being developed for the treatment of inflammatory and neuropathic pain, as they demonstrate efficacy in a range of pain models.",agonists dual agonists,CHEBI,be developed for treatment of,inflammatory pain,DISEASE
19150370,"CB(2) receptors were originally described as being restricted to cells of immune origin, but there is evidence for their expression in human primary sensory neurons, and increased levels of CB(2) receptors reported in human peripheral nerves have been seen after injury, particularly in painful neuromas.",CB(2 receptors,CHEMICAL,be seen after injury in,painful neuromas,DISEASE
19150370,"CB(2) receptor agonists produce antinociceptive effects in models of inflammatory and nociceptive pain, and in some cases these effects involve activation of the opioid system.",CB(2 receptor agonists,CHEBI,produce antinociceptive effects in models of,inflammatory pain,DISEASE
19150370,"CB(2) receptor agonists produce antinociceptive effects in models of inflammatory and nociceptive pain, and in some cases these effects involve activation of the opioid system.",CB(2 receptor agonists,CHEMICAL,produce antinociceptive effects in models of,inflammatory pain,DISEASE
19150370,"In addition, CB receptor agonists enhance the effect of mu-opioid receptor agonists in a variety of models of analgesia, and combinations of cannabinoids and opioids may produce synergistic effects.",CB receptor agonists,CHEMICAL,enhance in addition effect of mu-opioid receptor agonists in variety of,analgesia,MENTAL_HEALTH
19150370,"In addition, CB receptor agonists enhance the effect of mu-opioid receptor agonists in a variety of models of analgesia, and combinations of cannabinoids and opioids may produce synergistic effects.",CB receptor agonists,CHEBI,enhance in addition effect of mu-opioid receptor agonists in variety of,analgesia,MENTAL_HEALTH
19150370,"In addition, CB receptor agonists enhance the effect of mu-opioid receptor agonists in a variety of models of analgesia, and combinations of cannabinoids and opioids may produce synergistic effects.",CB receptor agonists,CHEMICAL,enhance in addition effect of,mu-opioid receptor agonists,CHEBI
19150370,"In addition, CB receptor agonists enhance the effect of mu-opioid receptor agonists in a variety of models of analgesia, and combinations of cannabinoids and opioids may produce synergistic effects.",CB receptor agonists,CHEBI,enhance in addition effect of,mu-opioid receptor agonists,CHEBI
26686256,We aimed to assess the efficacy of thalidomide for the reduction of epistaxis in patients with hereditary haemorrhagic telangiectasia that is refractory to standard therapy.,epistaxis,DISEASE,in patients with,hereditary haemorrhagic telangiectasia,DISEASE
34855939,"Real-time LAMP was used to test 200 raw milk samples for the presence of TAP-harboring P. fluorescens in 3 h, and the coincidence rate of the results with those obtained using the traditional method, which takes at least 5 to 7 days, was 100%.",Real-time LAMP,CHEMICAL,test raw milk samples for presence of,TAP-harboring P. fluorescens,DISEASE
34855939,Real-time LAMP will be a practical and effective method for accurate and rapid identification of TAP-harboring P. fluorescens in raw milk.,Real-time LAMP,CHEMICAL,be practical method for accurate and rapid identification of,TAP-harboring P. fluorescens,DISEASE
18210212,"The biochemical profile, including marked hypermethioninaemia, hyperhomocysteinaemia, and decreased cystine in plasma, is consistent with cystathionine β-synthase deficiency.",marked hypermethioninaemia,DISEASE,be consistent with,cystathionine β-synthase deficiency,CHEMICAL
18210212,"The biochemical profile, including marked hypermethioninaemia, hyperhomocysteinaemia, and decreased cystine in plasma, is consistent with cystathionine β-synthase deficiency.",hyperhomocysteinaemia,DISEASE,be consistent with,cystathionine β-synthase deficiency,CHEMICAL
222892,Initial epileptiform EEG and associated wet-dog shakes occurred following D-enkephalin but not morphine.,associated wet-dog shakes,DISEASE,occur following,D-enkephalin morphine,CHEMICAL
222892,The epileptoid EEG progressed to a continous high-voltage EEG synchrony similar to morphine and was associated with behavioral stupor.,epileptoid EEG,DISEASE,be associated with,behavioral stupor,MENTAL_HEALTH
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,5-HIAA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,dopamine,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,serotonin,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,5-hydroxyindole acetic acid,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,HVA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",coma,DISEASE,have high cerebrospinal fluid concentrations of,homovanillic acid,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,5-HIAA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,dopamine,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,serotonin,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,5-hydroxyindole acetic acid,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,HVA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",stupor,MENTAL_HEALTH,have high cerebrospinal fluid concentrations of,homovanillic acid,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,5-HIAA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,dopamine,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,serotonin,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,5-hydroxyindole acetic acid,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,HVA,CHEMICAL
4817189,"Patients with stupor or coma from fulminant hepatic failure were found to have high cerebrospinal fluid concentrations of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA), metabolites of dopamine and serotonin respectively.",fulminant hepatic failure,DISEASE,have high cerebrospinal fluid concentrations of,homovanillic acid,CHEMICAL
1244356,"Phosphoenolpyruvate and 4-ethyloxalacetate are strong linear competitive inhibitors of the decarboxylase activity with respect to oxalacetate having dissociation constants of 3.2 and 10.2 muM, respectively, while 4-ethyloxalacetate is a linear competitive inhibitor of the pyruvate kinase activity with respect to phosphoenolpyruvate, Ki - 13.5 muM. In addition, both activities exhibit sigmoidal kinetics for substrates.",Phosphoenolpyruvate,CHEMICAL,be strong linear inhibitors of decarboxylase activity with respect to,oxalacetate,CHEMICAL
1244356,"Phosphoenolpyruvate and 4-ethyloxalacetate are strong linear competitive inhibitors of the decarboxylase activity with respect to oxalacetate having dissociation constants of 3.2 and 10.2 muM, respectively, while 4-ethyloxalacetate is a linear competitive inhibitor of the pyruvate kinase activity with respect to phosphoenolpyruvate, Ki - 13.5 muM. In addition, both activities exhibit sigmoidal kinetics for substrates.",4-ethyloxalacetate,CHEMICAL,be linear competitive inhibitor of pyruvate kinase activity with respect to,phosphoenolpyruvate,CHEMICAL
1244356,"Phosphoenolpyruvate and 4-ethyloxalacetate are strong linear competitive inhibitors of the decarboxylase activity with respect to oxalacetate having dissociation constants of 3.2 and 10.2 muM, respectively, while 4-ethyloxalacetate is a linear competitive inhibitor of the pyruvate kinase activity with respect to phosphoenolpyruvate, Ki - 13.5 muM. In addition, both activities exhibit sigmoidal kinetics for substrates.",4-ethyloxalacetate,CHEMICAL,be linear competitive inhibitor of,pyruvate kinase activity,CHEMICAL
18569160,"Swiss-Webster mice given Brucine base, 30 ml/kg, had an acute oral LD(50) of 150 mg/kg, with central nervous system depression followed by convulsions and seizures in some cases.",Brucine base,CHEMICAL,have,central nervous system depression,MENTAL_HEALTH
18569160,"LD(50) for 15 ml/kg of Brucine base was 62.0 mg/kg, with central nervous system depression prior to the onset of convulsions, just as with oral Brucine.",Brucine base,CHEMICAL,be mg/kg with,central nervous system depression,DISEASE
18569160,"LD(50) for 15 ml/kg of Brucine base was 62.0 mg/kg, with central nervous system depression prior to the onset of convulsions, just as with oral Brucine.",Brucine base,CHEMICAL,be mg/kg with,central nervous system depression,MENTAL_HEALTH
18569160,"In two chronic toxicity studies, Denatonium Benzoate was administered (by gavage) at 1.6, 8, and 16 mg/kg/day, one using cynomologus monkeys and the other rats, resulted in no compound-related toxicity.",Denatonium Benzoate,CHEMICAL,be administered in,chronic toxicity studies,DISEASE
18569160,Most of the systemic toxicity of ethanol appears to be associated with chronic abuse of alcohol.,systemic toxicity,DISEASE,be associated with chronic abuse of,alcohol,CHEMICAL
18569160,Most of the systemic toxicity of ethanol appears to be associated with chronic abuse of alcohol.,ethanol,CHEMICAL,be associated with chronic abuse of,alcohol,CHEMICAL
18569160,Most of the systemic toxicity of ethanol appears to be associated with chronic abuse of alcohol.,systemic toxicity,DISEASE,be associated with,chronic abuse,DISEASE
18569160,Most of the systemic toxicity of ethanol appears to be associated with chronic abuse of alcohol.,ethanol,CHEMICAL,be associated with,chronic abuse,DISEASE
1028043,Phetholamine sharply decreased the death of the animals the first 3--4 days after the alloxan administration: only 5.3% of the animals died.,Phetholamine,CHEMICAL,decrease death of animals after,alloxan administration,CHEMICAL
16601939,The treatment was resumed after two months to test the correlation between NCSE and lithium therapy.,NCSE,DISEASE,have the correlation with,lithium therapy,NUTRITION
16601939,The treatment was resumed after two months to test the correlation between NCSE and lithium therapy.,lithium therapy,NUTRITION,have the correlation with,NCSE,DISEASE
16601939,The present data-signalling the temporal correlation of clinical and EEG changes with drug administration and withdrawal-suggest that even in the therapeutic range lithium treatment may trigger NCSE onset in predisposed subjects.,therapeutic range lithium treatment,NUTRITION,trigger,NCSE onset,DISEASE
27033116,"FATP2-driven fatty acid uptake and the subsequent TAG accumulation in gallbladder tissue plays a pivotal role in cholelithiasis, and prevention of this process can protect from gallstone formation, even in the context of supersaturated bile cholesterol levels, thus pointing to new treatment approaches and targets.",FATP2-driven fatty acid uptake,NUTRITION,play pivotal role in,cholelithiasis,DISEASE
15980413,"Biochemical studies also demonstrate that PIP2 and LC-CoA bind with similar affinity to the C-terminal domains of Kir2.1 and Kir6.2 and that PIP2 binding can be competitively antagonized by LC-CoA, suggesting that the mechanism of LC-CoA inhibition involves displacement of PIP2.",PIP2,CHEMICAL,bind with similar affinity to c-terminal domains of,Kir6.2,CHEMICAL
31657737,"In turn, dietary fatty acids can enhance resistance under cold stress.",dietary fatty acids,NUTRITION,enhance in,resistance,MENTAL_HEALTH
27729057,"Reversible left ventricular dysfunction, also termed Takotsubo cardiomyopathy, is rarely reported in Addison's disease after initiation of hormone replacement therapy.",Reversible ventricular dysfunction,DISEASE,be reported in addison's disease after initiation of,hormone replacement therapy,CHEBI
1337244,"Acidosis presents with hyperchloremia, hyperammonemia, hypersulfatemia, increased osmolality and uremia with normal creatininemia and a tendency to develop hypocalcemia, hypophosphoremia and hypomagnesemia.",Acidosis,DISEASE,increased osmolality and uremia with,normal creatininemia,CHEMICAL
1337244,"Acidosis presents with hyperchloremia, hyperammonemia, hypersulfatemia, increased osmolality and uremia with normal creatininemia and a tendency to develop hypocalcemia, hypophosphoremia and hypomagnesemia.",Acidosis,DISEASE,increased,uremia,DISEASE
1337244,"Recent studies performed in our service show that acidosis is basically due to the secretion of sodium bicarbonate by the intestinal segment used in the urinary tract, which causes water-salt depletion that is compensated by secondary hyperaldosteronism.",acidosis,DISEASE,be due to secretion of,sodium bicarbonate,CHEMICAL
21412227,THC (2.0 mg/kg/day) significantly reduced body weight loss and shifted markers of thermogenesis in BAT and lipid metabolism in WAT in directions consistent with reduced energy expenditure and lipolysis.,THC,CHEMICAL,reduce,body weight loss,DISEASE
16506415,"Therefore, mice were subjected daily for 4 wk to chronic mild stress (CMS), and anhedonia was measured by the consumption of 2% sucrose solution.",anhedonia,MENTAL_HEALTH,be measured by consumption of,% sucrose solution,CHEMICAL
1653891,"The responses of alpha T3-1 cells to GnRH appear to have characteristics equivalent to those of primary pituitary gonadotropes, indicating the utility of this cell line as a model system for the study of GnRH responses.",alpha T3 cells,CHEMICAL,have characteristics equivalent to,primary pituitary gonadotropes,DISEASE
1653891,"The responses of alpha T3-1 cells to GnRH appear to have characteristics equivalent to those of primary pituitary gonadotropes, indicating the utility of this cell line as a model system for the study of GnRH responses.",alpha T3 cells,NUTRITION,have characteristics equivalent to,primary pituitary gonadotropes,DISEASE
6092341,The rate of dissociation of the receptor-bound antagonist from pituitary particles and cells was extremely slow in comparison with that of the agonist ligand.,dissociation,MENTAL_HEALTH,be slow in comparison with,agonist ligand,CHEBI
6092341,The rate of dissociation of the receptor-bound antagonist from pituitary particles and cells was extremely slow in comparison with that of the agonist ligand.,receptor-bound antagonist,CHEBI,be slow in comparison with,agonist ligand,CHEBI
25497916,B. subtilis (SG_JW.03) isolated from Indian popcorn showed strong inhibition of Arabidopsis seed mycoflora and enhanced seedling growth.,B. subtilis,DISEASE,show strong inhibition of,Arabidopsis seed mycoflora,CHEMICAL
31440590,"To establish an animal model of amnesia, Sco (0.7 mg/kg), a muscarinic acetylcholine receptor antagonist, was injected into male Wistar rats.",Sco,CHEMICAL,establish animal model of,amnesia,MENTAL_HEALTH
31440590,"To establish an animal model of amnesia, Sco (0.7 mg/kg), a muscarinic acetylcholine receptor antagonist, was injected into male Wistar rats.",muscarinic acetylcholine receptor antagonist,CHEBI,establish animal model of,amnesia,MENTAL_HEALTH
8592970,"Ketamine is a common drug with a potent analgesic effect, which possesses the advantages of good support for the cardiovascular system, because of its sympathomimetic action, and minimal depression of the ventilatory drive.",Ketamine,CHEMICAL,be common drug with,sympathomimetic action,CHEBI
8592970,"Ketamine is a common drug with a potent analgesic effect, which possesses the advantages of good support for the cardiovascular system, because of its sympathomimetic action, and minimal depression of the ventilatory drive.",Ketamine,CHEMICAL,be common drug with,potent analgesic effect,CHEBI
8592970,"Ketamine is a common drug with a potent analgesic effect, which possesses the advantages of good support for the cardiovascular system, because of its sympathomimetic action, and minimal depression of the ventilatory drive.",Ketamine,CHEMICAL,be,common drug,CHEBI
30990550,"In a randomized study, doxepin mouthwash was shown to reduce oral mucositis-related pain.",doxepin mouthwash,CHEMICAL,reduce,oral mucositis-related pain,DISEASE
6372073,"The frequency and severity of night pain and waking were reduced and antacid consumption was lower int he trimipramine group, but initial drowsiness was greater.",antacid consumption,CHEBI,be,lower trimipramine group,CHEMICAL
30573639,Conclusion: Low availability of the α7-nAChR in hippocampus may be linked to recent-onset of psychosis.,α7-nAChR,CHEMICAL,be linked,psychosis,MENTAL_HEALTH
34736259,Peroxisome proliferator-activated receptor gamma (PPARγ) agonists are highly effective in treating insulin resistance.,Peroxisome proliferator-activated receptor gamma PPARγ agonists,CHEBI,treat,insulin resistance,MENTAL_HEALTH
35348980,"PPARγ possibly has effects on the multiple aspects of the pathogenesis of psoriasis, including abnormal lipid metabolism, insulin resistance, immune cells, pro-inflammatory cytokines, keratinocytes, angiogenesis, oxidative stress, microRNAs and nuclear factor kappa B. As defective activation of PPARγ is involved in psoriasis development, PPARγ agonists may be promising agents for treatment of psoriasis.",PPARγ agonists,CHEBI,be promising agents for treatment of,psoriasis,DISEASE
35348980,"Pioglitazone appears an effective and safe option in the treatment of patients with psoriasis, but there are still concerns about its potential side effects.",Pioglitazone,CHEMICAL,appear effective and safe option in treatment of patients with,psoriasis,DISEASE
12975707,This case report describes the treatment of Bulimia Nervosa with reboxetine (4 to 8 mg/day) and its favorable therapeutic results.,Bulimia Nervosa,MENTAL_HEALTH,have the treatment with,reboxetine,CHEMICAL
21093362,The goals of this study were to estimate the prevalence of insomnia symptomatology and diagnoses in the Spanish general population and to determine if certain sleep parameters were related to specific insomnia symptoms.,insomnia symptomatology,MENTAL_HEALTH,have the prevalence in,Spanish general population,NUTRITION
35401264,The dopamine neurotransmitter system is postulated to be involved in the pathogenesis of ADHD.,dopamine neurotransmitter system,CHEMICAL,be involved in pathogenesis of,ADHD,MENTAL_HEALTH
35401264,"Guanfacine, a selective α2A-adrenoceptor agonist, is prescribed for ADHD treatment.",Guanfacine,CHEMICAL,be prescribed for,ADHD treatment,MENTAL_HEALTH
35401264,"Guanfacine, a selective α2A-adrenoceptor agonist, is prescribed for ADHD treatment.",selective α2A-adrenoceptor agonist,CHEBI,be prescribed for,ADHD treatment,MENTAL_HEALTH
35401264,Hyperdopaminergic dopamine transporter knockout (DAT-KO) rats are a valuable model for investigating ADHD.,dopamine transporter,CHEMICAL,investigate,ADHD,MENTAL_HEALTH
35401264,It has been observed that α2A-adrenoceptor agonist Guanfacine (0.25 mg/kg) had only a minimal inhibitory effect on hyperactivity of DAT-KO rats in the maze but significantly ameliorated their perseverative pattern of activity and reduced the time spent in the error zones.,α2A-adrenoceptor agonist Guanfacine,CHEMICAL,have minimal inhibitory effect on,hyperactivity,MENTAL_HEALTH
35401264,It has been observed that α2A-adrenoceptor agonist Guanfacine (0.25 mg/kg) had only a minimal inhibitory effect on hyperactivity of DAT-KO rats in the maze but significantly ameliorated their perseverative pattern of activity and reduced the time spent in the error zones.,α2A-adrenoceptor agonist Guanfacine,CHEBI,have minimal inhibitory effect on,hyperactivity,MENTAL_HEALTH
35401264,Similar mechanisms may be involved in the beneficial effects of Guanfacine on cognitive deficits in ADHD patients.,Guanfacine,CHEMICAL,have the beneficial effects on,cognitive deficits,DISEASE
34649432,"Cyanobacteria can directly utilize CO2, light energy, and inorganic nutrients to synthesize versatile plant-specific photosynthetic intermediates and organic compounds in large-scale photobioreactors with outstanding economic merit.",Cyanobacteria,DISEASE,utilize,CO2,CHEMICAL
24692001,"Statins have been shown to reduce recurrent stroke among patients with various stroke subtypes, including lacunar stroke, which also arises from small vessel disease.",Statins,CHEMICAL,reduce recurrent stroke among patients with,lacunar stroke,DISEASE
24692001,"Statins have been shown to reduce recurrent stroke among patients with various stroke subtypes, including lacunar stroke, which also arises from small vessel disease.",Statins,CHEMICAL,reduce recurrent stroke among patients with,various stroke subtypes,DISEASE
24692001,"Statins have been shown to reduce recurrent stroke among patients with various stroke subtypes, including lacunar stroke, which also arises from small vessel disease.",Statins,CHEMICAL,reduce,recurrent stroke,DISEASE
24692001,Patients (n = 100) were participants of the VITAmins To Prevent Stroke magnetic resonance imaging substudy.,VITAmins,CHEBI,have participants prevent,Stroke magnetic resonance imaging substudy,DISEASE
24692001,"The prestroke statin use group (n = 51) had less WMH volume progression (1.54 ± 4.52 cm(3) vs 5.01 ± 6.00 cm(3), p = 0.02) compared with the prestroke nonstatin use group (n = 30).",statin use,CHEMICAL,have,less WMH volume progression,DISEASE
24692001,"The prestroke statin use group (n = 51) had less WMH volume progression (1.54 ± 4.52 cm(3) vs 5.01 ± 6.00 cm(3), p = 0.02) compared with the prestroke nonstatin use group (n = 30).",statin use,CHEMICAL,have,±,CHEMICAL
24692001,"The prestroke statin use group (n = 51) had less WMH volume progression (1.54 ± 4.52 cm(3) vs 5.01 ± 6.00 cm(3), p = 0.02) compared with the prestroke nonstatin use group (n = 30).",statin use,CHEMICAL,have,cm(3,CHEMICAL
24692001,"Multivariate linear regression modeling identified prestroke statin use as an independent predictor of WMH progression (β = -0.31, p = 0.008).",regression modeling,MENTAL_HEALTH,prestroke statin use as independent predictor of,WMH progression,DISEASE
16455175,"The fact that these disorders share obsessive-compulsive features and evidence similarities in patient characteristics, course, comorbidity, neurobiology, and treatment response raises the question of whether OCD is best conceptualized as an anxiety or an OC spectrum disorder.",OCD,DISEASE,be conceptualized as,anxiety spectrum disorder,MENTAL_HEALTH
16455175,"The fact that these disorders share obsessive-compulsive features and evidence similarities in patient characteristics, course, comorbidity, neurobiology, and treatment response raises the question of whether OCD is best conceptualized as an anxiety or an OC spectrum disorder.",OCD,DISEASE,be conceptualized as,OC,CHEMICAL
34187626,"Of the 36 OFCs with egg yolk, 23 patients had a failed OFC, and of the 17 OFCs with egg white (all tolerant to egg yolk), only 2 patients had a failed result.",OFCs,DISEASE,have and with,egg white,NUTRITION
34187626,"Of the 11 patients with anchovy-triggered FPIES, 6 tolerated sea bass, and 5 tolerated trout, whereas 4 patients with sea bass FPIES tolerated trout.",sea bass FPIES,NUTRITION,tolerate of patients with,tolerated trout,NUTRITION
34187626,"Of the 11 patients with anchovy-triggered FPIES, 6 tolerated sea bass, and 5 tolerated trout, whereas 4 patients with sea bass FPIES tolerated trout.",sea bass FPIES,NUTRITION,tolerate of patients with,trout,NUTRITION
34187626,"Of the 11 patients with anchovy-triggered FPIES, 6 tolerated sea bass, and 5 tolerated trout, whereas 4 patients with sea bass FPIES tolerated trout.",sea bass FPIES,NUTRITION,tolerate of patients with,tolerated sea bass,NUTRITION
31734887,"Thyroid hormones are responsible for normal growth and development during pre- and postnatal life, congenital hypothyroidism (CH) being the most common cause of neonatal thyroid disorders, affecting about one newborn infant in 3500.",congenital hypothyroidism,DISEASE,be common cause of,neonatal thyroid disorders,DISEASE
16002090,"Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known.",Botulism,DISEASE,be caused by,poisonous substance,CHEBI
16002090,"Botulism is caused by botulinum neurotoxin (BoNT), the most poisonous substance known.",Botulism,DISEASE,be caused by,botulinum neurotoxin,CHEBI
16002090,Selection of yeast displayed scFv libraries was performed using methods to select for both increased association rate constant (k(on)) and decreased dissociation rate constants (k(off)).,yeast,NUTRITION,decrease,dissociation rate,MENTAL_HEALTH
22369218,Ninety-three percent met criteria for caffeine dependence when generic DSM-IV-TR substance dependence criteria were applied to caffeine use.,generic DSM-IV-TR substance dependence criteria,MENTAL_HEALTH,be applied to,caffeine use,CHEMICAL
22369218,Ninety-three percent met criteria for caffeine dependence when generic DSM-IV-TR substance dependence criteria were applied to caffeine use.,generic DSM-IV-TR substance dependence criteria,DISEASE,be applied to,caffeine use,CHEMICAL
17472594,The cases suggest that caffeine can produce a clinical dependence syndrome similar to those produced by other psychoactive substances and has a potential for abuse.,caffeine,CHEMICAL,produce,clinical dependence syndrome similar,DISEASE
25305595,"Food supplements based on Vitex agnus castus L. (Verbenaceae) fruits, also known as chasteberry, are routinely used by women against somatic and psychic premenstrual symptoms such as depression, sadness or irritability.",Food supplements,NUTRITION,be used by women against somatic and psychic premenstrual symptoms such as,depression,MENTAL_HEALTH
25305595,"Food supplements based on Vitex agnus castus L. (Verbenaceae) fruits, also known as chasteberry, are routinely used by women against somatic and psychic premenstrual symptoms such as depression, sadness or irritability.",Food supplements,NUTRITION,be used by women against somatic and psychic premenstrual symptoms such as,irritability,DISEASE
25305595,"Food supplements based on Vitex agnus castus L. (Verbenaceae) fruits, also known as chasteberry, are routinely used by women against somatic and psychic premenstrual symptoms such as depression, sadness or irritability.",Food supplements,NUTRITION,be used by women against,somatic premenstrual symptoms,DISEASE
18445253,"The variability in the clinical or pathological presentation of transmissible spongiform encephalopathies (TSEs) in sheep, such as scrapie and bovine spongiform encephalopathy (BSE), has been attributed to prion protein genotype, strain, breed, clinical duration, dose, route and type of inoculum and the age at infection.",transmissible spongiform encephalopathies,DISEASE,be attributed to,infection,DISEASE
35257282,Formaldehyde-induced and Complete Freund's Adjuvant-induced arthritis models were used for the assessment of anti-arthritic activity of ICE and its effects on serum levels of PGE-2 as well as gene expression levels of pro-inflammatory cytokines were studied.,Freund's Adjuvant-induced arthritis models,DISEASE,be used for assessment of anti-arthritic activity of ice and its effects on,PGE-2,CHEMICAL
21207236,The current standard for mandibular condyle bone scintigraphy uses single photon emission computed tomography (SPECT) imaging after intravenous administration of technetium-99m-labeled diphosphates.,mandibular condyle bone scintigraphy,DISEASE,use,technetium-99m-labeled diphosphates,NUTRITION
15228850,To determine the gender based response to fluoxetine HCl medication in relation to tryptophan metabolism in depressed patients.,tryptophan metabolism,NUTRITION,have based response to fluoxetine hcl medication in,depressed patients,DISEASE
25414779,"Therefore, our findings suggest that AX can improve SCO-induced learning and memory impairment possibly through activation of CREB and up-regulation of BDNF levels, thereby exhibiting a cognition-enhancing potential.",AX,CHEMICAL,improve,learning impairment,DISEASE
25414779,"Therefore, our findings suggest that AX can improve SCO-induced learning and memory impairment possibly through activation of CREB and up-regulation of BDNF levels, thereby exhibiting a cognition-enhancing potential.",AX,CHEMICAL,improve,SCO-induced learning,CHEMICAL
32880309,"Smoking cessation is a complex process influenced by factors such as smokers' nicotine dependence levels, socioeconomic status (SES) and other lifestyle behaviours.",Smoking cessation,CHEMICAL,influenced by factors such as smokers ',nicotine dependence levels,MENTAL_HEALTH
27035058,"Buprenorphine, used to treat opioid use disorder and chronic pain, is a partial nociceptin opioid receptor agonist.",Buprenorphine,CHEMICAL,be,partial opioid receptor agonist,CHEBI
27035058,"In preclinical studies, a nociceptin opioid receptor agonist was shown to mitigate PTSD symptoms in acute trauma.",opioid receptor agonist,CHEBI,mitigate ptsd symptoms in,acute trauma,DISEASE
23740896,A selective opioid receptor agonist prevents fear memory consolidation in the amygdala in a mouse model of posttraumatic stress disorder (Andero et al.).,selective opioid receptor agonist,CHEBI,fear memory consolidation in amygdala in mouse model of,posttraumatic stress disorder,MENTAL_HEALTH
33879872,Patients with REM sleep behaviour disorder (RBD) exhibit distinct patterns of α-synuclein pathology propagation and might indicate a body-first subtype rather than a brain-first subtype.,REM sleep behaviour disorder,MENTAL_HEALTH,indicate,body-first subtype,CHEMICAL
32755038,"Controlled studies of amphetamine use for the treatment of ADHD and other indications did not suggest that amphetamines are likely to cause structural malformations, although there are three studies associating medication for ADHD or methamphetamine abuse with gastroschisis.",amphetamines,CHEMICAL,cause,structural malformations,DISEASE
30174215,"Modafinil was later used to treat sleepiness, somnolence and fatigue in a large number of medical conditions.",Modafinil,CHEMICAL,treat,sleepiness,MENTAL_HEALTH
30174215,"Modafinil was later used to treat sleepiness, somnolence and fatigue in a large number of medical conditions.",Modafinil,CHEMICAL,treat,fatigue,MENTAL_HEALTH
30174215,"Modafinil was later used to treat sleepiness, somnolence and fatigue in a large number of medical conditions.",Modafinil,CHEMICAL,treat,somnolence,MENTAL_HEALTH
28007998,"Gilles de la Tourette syndrome is a hereditary, neuropsychiatric movement disorder with reported abnormalities in the neurotransmission of dopamine and γ-aminobutyric acid (GABA).",Gilles de la Tourette syndrome,MENTAL_HEALTH,be hereditary movement disorder with reported abnormalities in neurotransmission of,γ-aminobutyric acid,CHEMICAL
28007998,"Gilles de la Tourette syndrome is a hereditary, neuropsychiatric movement disorder with reported abnormalities in the neurotransmission of dopamine and γ-aminobutyric acid (GABA).",Gilles de la Tourette syndrome,MENTAL_HEALTH,be hereditary movement disorder with reported abnormalities in neurotransmission of,GABA,CHEMICAL
28007998,"Gilles de la Tourette syndrome is a hereditary, neuropsychiatric movement disorder with reported abnormalities in the neurotransmission of dopamine and γ-aminobutyric acid (GABA).",Gilles de la Tourette syndrome,MENTAL_HEALTH,be hereditary movement disorder with reported abnormalities in neurotransmission of,dopamine,CHEMICAL
28007998,"Gilles de la Tourette syndrome is a hereditary, neuropsychiatric movement disorder with reported abnormalities in the neurotransmission of dopamine and γ-aminobutyric acid (GABA).",Gilles de la Tourette syndrome,MENTAL_HEALTH,be,hereditary movement disorder,DISEASE
28007998,Multiple regression analysis revealed a significant negative correlation between (i) striatal Gln and actual tic severity; and (ii) thalamic Glu and premonitory urges.,Multiple regression analysis,MENTAL_HEALTH,reveal significant negative correlation between,striatal Gln,CHEMICAL
9300403,"Also, the pattern of Fos expression in pallidostriatal neurons suggests that dopamine regulates activity in these cells differently than in other projection populations.",dopamine,CHEMICAL,regulate activity in,other projection populations,MENTAL_HEALTH
22038919,"Two carotenoid pigments, crocin and crocetin, are the major components responsible for the various pharmacological activities of C. sativus L. In this study, we examined the sleep-promoting activity of crocin and crocetin by monitoring the locomotor activity and electroencephalogram after administration of these components to mice.",carotenoid pigments,CHEBI,be major components responsible for various pharmacological activities of,C. sativus L.,CHEMICAL
22038919,"Two carotenoid pigments, crocin and crocetin, are the major components responsible for the various pharmacological activities of C. sativus L. In this study, we examined the sleep-promoting activity of crocin and crocetin by monitoring the locomotor activity and electroencephalogram after administration of these components to mice.",crocin,CHEMICAL,examine major components responsible for various pharmacological activities of,C. sativus L.,CHEMICAL
22038919,"Two carotenoid pigments, crocin and crocetin, are the major components responsible for the various pharmacological activities of C. sativus L. In this study, we examined the sleep-promoting activity of crocin and crocetin by monitoring the locomotor activity and electroencephalogram after administration of these components to mice.",crocin,CHEMICAL,examine major components responsible for various pharmacological activities of,crocetin,CHEMICAL
22038919,"Two carotenoid pigments, crocin and crocetin, are the major components responsible for the various pharmacological activities of C. sativus L. In this study, we examined the sleep-promoting activity of crocin and crocetin by monitoring the locomotor activity and electroencephalogram after administration of these components to mice.",crocin,CHEMICAL,examine major components responsible for various pharmacological activities of,crocin,CHEMICAL
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",serotonin-dopamine antagonist,CHEMICAL,prevent,delusions,MENTAL_HEALTH
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",serotonin-dopamine antagonist,CHEMICAL,prevent,hallucinations,MENTAL_HEALTH
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",serotonin-dopamine antagonist,CHEBI,prevent,delusions,MENTAL_HEALTH
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",serotonin-dopamine antagonist,CHEBI,prevent,hallucinations,MENTAL_HEALTH
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",Risperidone,CHEMICAL,prevent,delusions,MENTAL_HEALTH
23678595,"Risperidone, a serotonin-dopamine antagonist, is effective in preventing delusions and hallucinations by D2 receptor antagonism and treating negative symptoms by 5-HT2A receptor antagonism.",Risperidone,CHEMICAL,prevent,hallucinations,MENTAL_HEALTH
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,psychotic features,DISEASE
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,schizotypal personality disorder,MENTAL_HEALTH
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,adolescence adjustment disorders,MENTAL_HEALTH
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,major depression,MENTAL_HEALTH
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,drug use,CHEBI
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with several known psychiatric disorders such as,brief psychotic disorder,MENTAL_HEALTH
28686559,"The clinical expression of APS should be differentiated with several well known psychiatric disorders such as: brief psychotic disorder, schizotypal personality disorder, major depression with psychotic features, adolescence adjustment disorders, drug use, etc.",APS,DISEASE,be differentiated with,several known psychiatric disorders,DISEASE
15629872,Whether the effect of tricyclic antidepressants on Pain Disorder arises from their noradrenergic or serotonergic actions or both remains unclear.,tricyclic antidepressants,CHEMICAL,have the effect on,Pain Disorder,MENTAL_HEALTH
2475733,"Preliminary reports of elevated beta-endorphin-like immunoreactivity in the cerebrospinal fluid of girls with the Rett syndrome, as well as improvement in some of their symptoms during the administration of the opioid antagonist naltrexone, are suggestive of endorphinergic hyperactivity.",Rett syndrome,MENTAL_HEALTH,be suggestive of,endorphinergic hyperactivity,MENTAL_HEALTH
2475733,"Preliminary reports of elevated beta-endorphin-like immunoreactivity in the cerebrospinal fluid of girls with the Rett syndrome, as well as improvement in some of their symptoms during the administration of the opioid antagonist naltrexone, are suggestive of endorphinergic hyperactivity.",opioid antagonist naltrexone,CHEMICAL,be suggestive of,endorphinergic hyperactivity,MENTAL_HEALTH
2475733,"Preliminary reports of elevated beta-endorphin-like immunoreactivity in the cerebrospinal fluid of girls with the Rett syndrome, as well as improvement in some of their symptoms during the administration of the opioid antagonist naltrexone, are suggestive of endorphinergic hyperactivity.",opioid antagonist naltrexone,CHEBI,be suggestive of,endorphinergic hyperactivity,MENTAL_HEALTH
34410857,"Tomato mottle mosaic virus, a new species in the genus Tobamovirus and family Virgaviridae, was first reported on tomato in Mexico in 2013 (Li et al. 2013).",Tomato mottle mosaic virus,DISEASE,be reported on tomato in mexico in,Li et 2013,CHEMICAL
32104529,"Norepinephrine (NE) is the naturally occurring adrenergic agonist that is released in response to hypotension, and it is routinely administered in clinical settings to treat moderate to severe hypotension that may occur during general anesthesia and shock states.",NE,CHEMICAL,be,occurring adrenergic agonist,CHEBI
32104529,"Norepinephrine (NE) is the naturally occurring adrenergic agonist that is released in response to hypotension, and it is routinely administered in clinical settings to treat moderate to severe hypotension that may occur during general anesthesia and shock states.",Norepinephrine,CHEMICAL,be,occurring adrenergic agonist,CHEBI
32104529,"Although NE has incontestable beneficial effects on blood pressure maintenance during hypotensive conditions, deleterious effects of NE on endothelial cell function may occur.",NE,CHEMICAL,have incontestable beneficial effects on blood pressure maintenance during,hypotensive conditions,DISEASE
32104529,"NE increased ROS production, Nox activity, p47phox phosphorylation, Nox2 and Nox4 mRNA content, caspase-3 activation, and RLMEC death.",NE,CHEMICAL,increase,RLMEC death,DISEASE
32104529,PEG-CAT inhibited NE-induced cell death but not caspase-3 activation.,PEG-CAT,CHEMICAL,inhibit,NE-induced cell death,CHEMICAL
32104529,PEG-CAT inhibited NE-induced cell death but not caspase-3 activation.,PEG-CAT,CHEMICAL,inhibit,NE-induced cell death,DISEASE
32104529,"Collectively, these results indicate that NE induces RLMEC death via activation of Nox by α-adrenergic signaling and caspase-3-dependent pathways.",NE,CHEMICAL,induce,RLMEC death,DISEASE
24184415,Hypobaric hypoxia (HH) observed at high altitude causes mild cognitive impairment specifically affecting attention and working memory.,Hypobaric hypoxia,CHEMICAL,cause,mild cognitive impairment,DISEASE
24184415,Modulation of adrenergic mechanisms by GFC may serve as an effective countermeasure in amelioration of prefrontal deficits and neurodegenerative changes during HH.,GFC,CHEMICAL,serve as effective countermeasure in amelioration of,prefrontal deficits,DISEASE
24989644,"The potential benefits of re-opening a dialogue regarding the use of caffeine in ADHD clinical practice are highlighted, along with potential implications for the use of adenosine receptor antagonists in ADHD and other disorders characterised by cognitive impairment.",caffeine,CHEMICAL,have the use in,ADHD clinical practice,MENTAL_HEALTH
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,lactate dehydrogenase,CHEMICAL
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,urea nitrogen suggestive,CHEMICAL
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,total bile acid,DISEASE
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,high-density lipoprotein,NUTRITION
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,aspartate aminotransferase,CHEMICAL
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,low-density lipoprotein,NUTRITION
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,alanine aminotransferase,CHEMICAL
34562083,"Compared with the control group, the serum of iron-overload mice exhibited low levels of urea nitrogen and high-density lipoprotein (HDL), and high concentrations of total bile acid, low-density lipoprotein (LDL), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and lactate dehydrogenase (LDH), suggestive of liver injury.",iron-overload mice,DISEASE,exhibit low levels of,liver injury,DISEASE
31702583,"A high-affinity anti-cocaine monoclonal antibody, designated h2E2, is entering phase 1 clinical trials for cocaine abuse therapy.",high-affinity anti-cocaine monoclonal antibody,CHEMICAL,enter phase clinical trials for,cocaine abuse therapy,MENTAL_HEALTH
22844815,"A questionnairing on 181 people with GID diagnosed in the Okayama University Hospital (Japan) showed that female to male (FTM) transsexuals hoped to begin masculinizing hormone therapy at age of 15.6 +/- 4.0 (mean +/- S.D.) whereas male to female (MTF) transsexuals hoped to begin feminizing hormone therapy as early as age 12.5 +/- 4.0, before presenting secondary sex characters.",male FTM transsexuals,DISEASE,begin,masculinizing hormone therapy,CHEBI
23624141,Our results suggest that Am80 administration effectively improves dementia by activating the hippocampal ADAM10-Notch-Hes5 proliferative pathway.,Am80 administration,CHEMICAL,activate,hippocampal ADAM10-Notch-Hes5 proliferative pathway,CHEMICAL
23624141,Our results suggest that Am80 administration effectively improves dementia by activating the hippocampal ADAM10-Notch-Hes5 proliferative pathway.,Am80 administration,CHEMICAL,improve,dementia,MENTAL_HEALTH
18761074,"It is probable that plants of the genus Sceletium (Mesembryanthemaceae) have been used as masticatories and for the relief of thirst and hunger, to combat fatigue, as medicines, and for social and spiritual purposes by San hunter-gatherers (historically referred to as Bushmen) and Khoi pastoralists (historically referred to as Hottentots) for millennia before the earliest written reports of the uses of these plants by European explorers and settlers.",genus Sceletium,CHEMICAL,be used as masticatories to,combat fatigue,MENTAL_HEALTH
18761074,"Wild resources of Sceletium have also been severely diminished by over-harvesting, poor veld-management, and possibly also by plant diseases.",Sceletium,CHEMICAL,be diminished by,plant diseases,DISEASE
35258100,"Multiple linear regression estimated ln(serum BC) based on reported fatty acid intakes adjusted for age, sex, race/ethnicity, and reported dietary BC intakes.",Multiple linear regression,MENTAL_HEALTH,reported,fatty acid intakes,NUTRITION
35258100,Multiple linear regression showed positive associations between serum BC concentrations and higher reported dietary PUFA consumption.,Multiple linear regression,MENTAL_HEALTH,show positive associations between,dietary PUFA consumption,CHEMICAL
8812590,"The average prevalence of gonadal neoplasms in softshell clams, Mya arenaria, from Whiting Bay, Washington County, Maine, was 19.4% in 1994.",gonadal neoplasms,DISEASE,have the average prevalence in,softshell clams,NUTRITION
8812590,It is concluded that gonadal neoplasms have a negative impact on the reproductive output of the Whiting Bay clam population.,gonadal neoplasms,DISEASE,have negative impact on reproductive output of,Whiting Bay,NUTRITION
31881876,Fetal Alcohol Spectrum Disorder (FASD) is characterized by physical and neurological abnormalities resulting from prenatal alcohol exposure.,Fetal Alcohol Spectrum Disorder,MENTAL_HEALTH,be characterized by,physical abnormalities,DISEASE
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",magnesium,CHEMICAL,have high intake of,potassium vitamin C,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",magnesium,CHEMICAL,have high intake of,potassium vitamin C,CHEBI
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",magnesium,CHEMICAL,have high intake of,K,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",iron,CHEMICAL,have high intake of,potassium vitamin C,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",iron,CHEMICAL,have high intake of,potassium vitamin C,CHEBI
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",iron,CHEMICAL,have high intake of,K,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",selenium,CHEMICAL,have high intake of,potassium vitamin C,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",selenium,CHEMICAL,have high intake of,potassium vitamin C,CHEBI
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",selenium,CHEMICAL,have high intake of,K,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",calcium,CHEMICAL,have high intake of,potassium vitamin C,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",calcium,CHEMICAL,have high intake of,potassium vitamin C,CHEBI
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",calcium,CHEMICAL,have high intake of,K,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",Ca,CHEMICAL,have high intake of,potassium vitamin C,CHEMICAL
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",Ca,CHEMICAL,have high intake of,potassium vitamin C,CHEBI
28074329,"Children with autistic disorder showed low dietary intake of some micronutrients; calcium (Ca), magnesium (Mg), iron (Fe), selenium (Se) and sodium (Na), also they had significantly high intake of potassium (K) and vitamin C compared to healthy controls.",Ca,CHEMICAL,have high intake of,K,CHEMICAL
27495376,"In addition, clear upregulated expression of the inducible NO synthase (iNOS) with high nitrite levels were observed in RTT fibroblasts, justifying the increased nitrotyrosine protein modifications.",high nitrite levels,CHEMICAL,justify increased,nitrotyrosine protein modifications,CHEMICAL
27495376,"In addition, clear upregulated expression of the inducible NO synthase (iNOS) with high nitrite levels were observed in RTT fibroblasts, justifying the increased nitrotyrosine protein modifications.",inducible NO synthase,CHEMICAL,justify increased,nitrotyrosine protein modifications,CHEMICAL
27495376,"Of note, for the first time, it appears that a dysregulation of NO pathway can be associated to RTT pathophysiology.",NO pathway,CHEMICAL,be associated to,RTT pathophysiology,DISEASE
34927260,EGCG has potential antiviral effects against WSSV.,EGCG,CHEMICAL,have,potential antiviral effects,CHEBI
34927260,"We demonstrated that various concentrations (10 μg/g·bw, 20 μg/g·bw and 40 μg/g·bw) of EGCG can suppress WSSV infection in P. clarkii.",EGCG,CHEMICAL,suppress wssv infection in,clarkii,DISEASE
34927260,"We demonstrated that various concentrations (10 μg/g·bw, 20 μg/g·bw and 40 μg/g·bw) of EGCG can suppress WSSV infection in P. clarkii.",EGCG,CHEMICAL,suppress,WSSV infection,DISEASE
34806144,This is the first study to show that obesity in children and adolescents with ASD is associated with the cholesterol synthesis pathway.,ASD,DISEASE,be associated with,cholesterol synthesis pathway,NUTRITION
34806144,This is the first study to show that obesity in children and adolescents with ASD is associated with the cholesterol synthesis pathway.,obesity,DISEASE,be associated with,cholesterol synthesis pathway,NUTRITION
19931777,"Therefore, antibiotic treatment must be evaluated in heat stroke patients.",antibiotic treatment,CHEBI,be evaluated in,stroke patients,DISEASE
17363006,Neither naloxone nor CTOP was able to block the analgesia of M6G.,CTOP,CHEMICAL,block analgesia of,M6 G,CHEMICAL
17363006,Neither naloxone nor CTOP was able to block the analgesia of M6G.,CTOP,CHEMICAL,block,analgesia,MENTAL_HEALTH
30824461,"Although antibiotic and fluid therapy improved her pyuria and renal function, her fever and tremors persisted.",antibiotic therapy,CHEBI,improve,pyuria,DISEASE
30824461,"Thus, dantrolene administration was initiated with a tentative diagnosis of neuroleptic malignant syndrome (NMS).",dantrolene administration,CHEMICAL,be initiated with tentative diagnosis of,neuroleptic malignant syndrome,DISEASE
11834091,Collision-induced dissociation of deprotonated parent TAG with argon was used to produce daughter ion spectra with appropriate fragmentation patterns for structure determination.,Collision-induced dissociation,MENTAL_HEALTH,produce daughter ion spectra with,appropriate fragmentation patterns,MENTAL_HEALTH
11834091,Collision-induced dissociation of deprotonated parent TAG with argon was used to produce daughter ion spectra with appropriate fragmentation patterns for structure determination.,argon,CHEMICAL,produce daughter ion spectra with,appropriate fragmentation patterns,MENTAL_HEALTH
25147302,"In addition, testicular activity of antioxidant enzymes such as superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione-S-transferase suppressed with CCl4 were elevated after P. peruviana juice supplements.",superoxide dismutase,CHEMICAL,be elevated in addition after,P. peruviana juice supplements,DISEASE
25147302,P. peruviana juice supplementation significantly increased the testicular glutathione and significantly decreased the level of lipid peroxidation and the nitric oxide production compared with the CCl4 group.,P. peruviana juice supplementation,DISEASE,increase,testicular glutathione,CHEMICAL
25147302,P. peruviana juice supplementation significantly increased the testicular glutathione and significantly decreased the level of lipid peroxidation and the nitric oxide production compared with the CCl4 group.,P. peruviana juice supplementation,DISEASE,decrease level of,peroxidation oxide production,CHEMICAL
25147302,"In addition, the decline in the activity of antioxidant enzymes after CCl4 was ameliorated by P. peruviana Moreover, degeneration of germ and Leydig cells along with deformities in spermatogenesis induced after CCl4 injections were prevented with the supplementation of P. peruviana juice.",germ,DISEASE,be prevented with supplementation of,P. peruviana juice,DISEASE
25147302,"In addition, the decline in the activity of antioxidant enzymes after CCl4 was ameliorated by P. peruviana Moreover, degeneration of germ and Leydig cells along with deformities in spermatogenesis induced after CCl4 injections were prevented with the supplementation of P. peruviana juice.",spermatogenesis,DISEASE,be prevented with supplementation of,P. peruviana juice,DISEASE
25147302,"In addition, the decline in the activity of antioxidant enzymes after CCl4 was ameliorated by P. peruviana Moreover, degeneration of germ and Leydig cells along with deformities in spermatogenesis induced after CCl4 injections were prevented with the supplementation of P. peruviana juice.",CCl4,CHEMICAL,be ameliorated in addition by,P. peruviana,DISEASE
35559239,Studies have shown that EBHM and its active ingredients have a variety of pharmacological effects with good therapeutic effects and wide application prospects for cognitive disability-related diseases.,EBHM,CHEMICAL,have variety of pharmacological effects with good therapeutic effects and wide application prospects for,cognitive disability-related diseases,DISEASE
34573232,"Recent studies using an AD mouse model have suggested that CBD can reverse cognitive deficits along with Aβ-induced neuroinflammatory, oxidative responses, and neuronal death.",CBD,CHEMICAL,reverse,cognitive deficits,DISEASE
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",pandemic,DISEASE,increase risk of,anxiety,MENTAL_HEALTH
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",pandemic,DISEASE,increase risk of,depression,MENTAL_HEALTH
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",pandemic,DISEASE,increase risk of,post-traumatic stress disorders,MENTAL_HEALTH
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",coronavirus disease,DISEASE,increase risk of,anxiety,MENTAL_HEALTH
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",coronavirus disease,DISEASE,increase risk of,depression,MENTAL_HEALTH
35482687,"The coronavirus disease 2019 (COVID-19) pandemic may have a potentially serious effect on mental health and increase the risk of anxiety, depression, and post-traumatic stress disorders in people.",coronavirus disease,DISEASE,increase risk of,post-traumatic stress disorders,MENTAL_HEALTH
34682970,"Lower morning cortisol level and alterations in its diurnal rhythm were observed in the patients, and antibody and antigen measurements showed no evidence for acute infections by common viral or bacterial pathogens.",morning cortisol level,CHEMICAL,be observed in,antigen,CHEBI
35568093,"Overall, W. cibaria C-10 and B. amyloliquefaciens T-5 could be considered to be developed into microecological preparations for the alternatives of antibiotics in aquaculture.",B. amyloliquefaciens T-5,DISEASE,be developed into microecological preparations for alternatives of,antibiotics,CHEBI
35568093,"Overall, W. cibaria C-10 and B. amyloliquefaciens T-5 could be considered to be developed into microecological preparations for the alternatives of antibiotics in aquaculture.",W. cibaria C-10,DISEASE,be developed into microecological preparations for alternatives of,antibiotics,CHEBI
35567749,The average mortality of largemouth bass infected with Aeromonas hydrophila was significantly influenced by dietary nucleotides.,largemouth bass,NUTRITION,be influenced by,dietary nucleotides,CHEMICAL
35569775,The mode of liver cell death was preferably changed to programed apoptosis rather than uncontrolled necroptosis by application of YD in HCD.,liver cell death,DISEASE,be changed to,YD,CHEMICAL
17658508,"These results suggest that ramosetron, as well as agents used for the treatment of irritable bowel syndrome with diarrhea, has beneficial effects against emotional stress-induced colonic dysfunction.",ramosetron,CHEMICAL,have beneficial effects against,emotional stress-induced colonic dysfunction,DISEASE
17658508,"These results suggest that ramosetron, as well as agents used for the treatment of irritable bowel syndrome with diarrhea, has beneficial effects against emotional stress-induced colonic dysfunction.",irritable bowel syndrome,DISEASE,have the treatment with,diarrhea,DISEASE
17079660,"These results indicate that CRF, specifically within the CeA, plays a role in mediating excessive ethanol consumption in ethanol-dependent animals.",CRF,DISEASE,mediate,excessive ethanol consumption,CHEMICAL
19464315,"Intracerebroventricular (ICV) streptozotocin (STZ) has been shown to cause cognitive impairment, which is associated with increased oxidative stress in the brain of rats.",Intracerebroventricular streptozotocin,CHEMICAL,cause,cognitive impairment,DISEASE
19464315,"Intracerebroventricular (ICV) streptozotocin (STZ) has been shown to cause cognitive impairment, which is associated with increased oxidative stress in the brain of rats.",STZ,CHEMICAL,cause,cognitive impairment,DISEASE
19464315,alpha-Tocopherol as well as tocotrienol treated groups showed significantly less cognitive impairment in both the behavioral paradigms but the effect was more potent with tocotrienol.,alpha-Tocopherol,CHEBI,show,cognitive impairment,DISEASE
19464315,"The study demonstrates the effectiveness of vitamin E isoforms, of which tocotrienol being more potent in preventing the cognitive deficits caused by ICV STZ in rats and suggests its potential in the treatment of neurodegenerative diseases such as Alzheimer's disease.",tocotrienol,CHEBI,prevent,cognitive deficits,DISEASE
25899859,BH4 deficiency is associated with numerous metabolic syndromes and neuropsychological disorders.,BH4 deficiency,CHEMICAL,be associated with,neuropsychological disorders,DISEASE
25899859,BH4 deficiency is associated with numerous metabolic syndromes and neuropsychological disorders.,BH4 deficiency,CHEMICAL,be associated with,numerous metabolic syndromes,MENTAL_HEALTH
24773269,"Sepiapterin is the precursor of tetrahydrobiopterin, an important coenzyme of aromatic amino acid hydroxylases, the lack of which leads to a variety of physiological metabolic diseases or neurological syndromes in humans.",Sepiapterin,CHEMICAL,be precursor of,tetrahydrobiopterin,CHEMICAL
24773269,"Sepiapterin is the precursor of tetrahydrobiopterin, an important coenzyme of aromatic amino acid hydroxylases, the lack of which leads to a variety of physiological metabolic diseases or neurological syndromes in humans.",Sepiapterin,CHEMICAL,be precursor of,aromatic amino acid hydroxylases,CHEMICAL
19140457,That low-dose irradiation influence mostly manifests itself on the initial stages of tumor growth.,low-dose irradiation influence,CHEMICAL,manifest itself on initial stages of,tumor growth,DISEASE
21173882,"Many bipolar patients who cycle primarily on the depressive side for many years carry a misdiagnosis of recurrent major depression, leading to treatment with antidepressants that achieve little or no relief of symptoms.",Many bipolar patients,DISEASE,carry misdiagnosis of,recurrent major depression,MENTAL_HEALTH
21173882,"Many bipolar patients who cycle primarily on the depressive side for many years carry a misdiagnosis of recurrent major depression, leading to treatment with antidepressants that achieve little or no relief of symptoms.",Many bipolar patients,DISEASE,lead to treatment with,antidepressants,CHEMICAL
29433925,"The stereochemistry of one of these methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives was characterized by a single crystal X-ray diffraction study and the acid dissociation constants of these compounds were determined.","methyl 5,5-diphenyl-1-(thiazol-2-yl)pyrrolidine-2-carboxylate derivatives",CHEMICAL,be characterized by,acid dissociation constants,MENTAL_HEALTH
29433925,An antimicrobial screening was performed against different bacterial and fungal strains and against the M. tuberculosis H37Rv strain.,antimicrobial screening,CHEBI,be performed against different bacterial and fungal strains and against,M. tuberculosis H37Rv strain,DISEASE
30556659,"The onset of the symptoms usually occurs in childhood, and previous studies have reported an association between narcolepsy and other endocrine diseases in the pediatric population, such as obesity and precocious puberty.",narcolepsy,MENTAL_HEALTH,have an association with,other endocrine diseases,CHEBI
30556659,"The onset of the symptoms usually occurs in childhood, and previous studies have reported an association between narcolepsy and other endocrine diseases in the pediatric population, such as obesity and precocious puberty.",other endocrine diseases,CHEBI,have an association with,narcolepsy,MENTAL_HEALTH
26161143,Gonadotropin-releasing hormone agonists are widely used as androgen deprivation therapy in many men with locally advanced or metastatic prostate cancer.,Gonadotropin-releasing hormone agonists,CHEBI,be used as androgen deprivation therapy in many men with,advanced prostate cancer,DISEASE
26161143,Gonadotropin-releasing hormone agonists are widely used as androgen deprivation therapy in many men with locally advanced or metastatic prostate cancer.,Gonadotropin-releasing hormone agonists,CHEBI,be used as,androgen deprivation therapy,CHEBI
29100111,"The non-reducing disaccharide trehalose can serve as a protectant against a range of environmental stressors, such as heat, cold, or dehydration, in both prokaryotes and eukaryotes, with the exception of vertebrates.",non-reducing disaccharide trehalose,NUTRITION,serve as protectant against range of,dehydration,DISEASE
22406511,"A recently established rabbit model of high fat diet (HFD)-induced MetS showed hypogonadism and the presence of prostate gland alterations, including inflammation, hypoxia and fibrosis.",diet (HFD)-induced MetS,DISEASE,show hypogonadism and presence of,fibrosis,DISEASE
22406511,"A recently established rabbit model of high fat diet (HFD)-induced MetS showed hypogonadism and the presence of prostate gland alterations, including inflammation, hypoxia and fibrosis.",diet (HFD)-induced MetS,DISEASE,show hypogonadism and presence of,hypoxia,DISEASE
22406511,"A recently established rabbit model of high fat diet (HFD)-induced MetS showed hypogonadism and the presence of prostate gland alterations, including inflammation, hypoxia and fibrosis.",diet (HFD)-induced MetS,DISEASE,show hypogonadism and presence of,prostate gland alterations,DISEASE
22406511,"A recently established rabbit model of high fat diet (HFD)-induced MetS showed hypogonadism and the presence of prostate gland alterations, including inflammation, hypoxia and fibrosis.",diet (HFD)-induced MetS,DISEASE,show hypogonadism and presence of,inflammation,DISEASE
22406511,"A recently established rabbit model of high fat diet (HFD)-induced MetS showed hypogonadism and the presence of prostate gland alterations, including inflammation, hypoxia and fibrosis.",diet (HFD)-induced MetS,DISEASE,show,hypogonadism,DISEASE
22406511,All these HFD-induced bladder alterations were partially blunted by testosterone and almost completely reverted by INT-747.,HFD-induced bladder alterations,DISEASE,be blunted by,testosterone,CHEMICAL
22406511,"In conclusion, HFD-related MetS features are associated to bladder derangements, which are ameliorated by testosterone or INT-747 administration.",HFD-related MetS features,CHEMICAL,be associated in conclusion to,bladder derangements,DISEASE
34324636,"Seltorexant, a selective antagonist of human orexin-2 receptors, demonstrated antidepressant effects in a previous exploratory study in patients with major depressive disorder (MDD).",selective antagonist,CHEBI,demonstrate antidepressant effects in previous exploratory study in patients with,major depressive disorder,MENTAL_HEALTH
34324636,"Seltorexant, a selective antagonist of human orexin-2 receptors, demonstrated antidepressant effects in a previous exploratory study in patients with major depressive disorder (MDD).",selective antagonist,CHEBI,demonstrate antidepressant effects in previous exploratory study in patients with,MDD,DISEASE
34324636,"Seltorexant, a selective antagonist of human orexin-2 receptors, demonstrated antidepressant effects in a previous exploratory study in patients with major depressive disorder (MDD).",selective antagonist,CHEBI,demonstrate,antidepressant effects,CHEMICAL
24593042,Low levels of vitamin D have been described in several psychiatric and neurologic conditions including autism spectrum disorder.,vitamin D,CHEBI,be described in,autism spectrum disorder,MENTAL_HEALTH
24593042,Low levels of vitamin D have been described in several psychiatric and neurologic conditions including autism spectrum disorder.,vitamin D,CHEBI,be described in,several psychiatric conditions,DISEASE
24593042,Alexithymia that shows high comorbidity with autism is also present in the general population as well as hypovitaminosis D.,Alexithymia,MENTAL_HEALTH,be present in,population hypovitaminosis D.,CHEMICAL
29491038,"Unlike beloranib, ZGN-1061 did not increase coagulation markers in dogs, and ZGN-1061 had a greatly improved safety profile in rats relative to beloranib.",ZGN-1061,CHEMICAL,have improved safety profile in rats relative to,beloranib,CHEMICAL
29491038,"In conclusion, ZGN-1061 and beloranib demonstrated similar efficacy in a mouse model of obesity, while ZGN-1061 had a markedly improved safety profile in multiple in vitro and in vivo models.",ZGN-1061,CHEMICAL,demonstrate in conclusion similar efficacy in mouse model of,obesity,DISEASE
29491038,"In conclusion, ZGN-1061 and beloranib demonstrated similar efficacy in a mouse model of obesity, while ZGN-1061 had a markedly improved safety profile in multiple in vitro and in vivo models.",beloranib,CHEMICAL,demonstrate in conclusion similar efficacy in mouse model of,obesity,DISEASE
1921916,"Alcohol, a potent teratogen, has been suggested as an etiologic agent in attention deficit disorder with hyperactivity (ADHD), which is often diagnosed in children with fetal alcohol syndrome (FAS) and in children of alcoholics.",Alcohol,CHEMICAL,be suggested as etiologic agent in attention deficit disorder with,ADHD,MENTAL_HEALTH
1921916,"Alcohol, a potent teratogen, has been suggested as an etiologic agent in attention deficit disorder with hyperactivity (ADHD), which is often diagnosed in children with fetal alcohol syndrome (FAS) and in children of alcoholics.",Alcohol,CHEMICAL,be suggested as etiologic agent in attention deficit disorder with,hyperactivity,MENTAL_HEALTH
35165230,"Among the many people experiencing grief in response to opioid overdose deaths, individuals with opioid use disorder (OUD) bear one of the largest emotional burdens.",OUD,DISEASE,bear among many people in response to,overdose deaths,DISEASE
25349027,We have previously shown that PPAR-γ agonist 15d-PGJ2 inhibited neuronal autophagy after cerebral ischemia/reperfusion injury.,PPAR-γ agonist,CHEMICAL,inhibit neuronal autophagy after,cerebral ischemia/reperfusion injury,DISEASE
25349027,We have previously shown that PPAR-γ agonist 15d-PGJ2 inhibited neuronal autophagy after cerebral ischemia/reperfusion injury.,15d-PGJ2,CHEMICAL,inhibit neuronal autophagy after,cerebral ischemia/reperfusion injury,DISEASE
25349027,"Autophagic inhibitor 3-methyladenine decreased LC3-II levels, increased neuronal cell viability, and mimicked some protective effect of 15d-PGJ2 against OGD/R injury.",Autophagic inhibitor 3-methyladenine,CHEMICAL,decrease,LC3-II levels,CHEMICAL
25349027,"Autophagic inhibitor 3-methyladenine decreased LC3-II levels, increased neuronal cell viability, and mimicked some protective effect of 15d-PGJ2 against OGD/R injury.",Autophagic inhibitor 3-methyladenine,CHEMICAL,mimic protective effect of 15d-pgj2 against,OGD/R injury,CHEMICAL
18761337,Balaglitazone is a novel thiazolidinedione in clinical development for the treatment of type 2 diabetes.,Balaglitazone,CHEMICAL,be novel thiazolidinedione in clinical development for treatment of,type diabetes,DISEASE
18761337,Balaglitazone is a novel thiazolidinedione in clinical development for the treatment of type 2 diabetes.,Balaglitazone,CHEMICAL,be,novel thiazolidinedione,CHEMICAL
18761337,"We have compared impact of equi-efficacious antihyperglycaemic doses of balaglitazone with full PPARgamma agonist rosiglitazone on body fluid accumulation, cardiac enlargement, and adipogenesis.",balaglitazone,CHEMICAL,have equi-efficacious antihyperglycaemic doses with,full PPARgamma agonist rosiglitazone,CHEMICAL
18761337,"We have compared impact of equi-efficacious antihyperglycaemic doses of balaglitazone with full PPARgamma agonist rosiglitazone on body fluid accumulation, cardiac enlargement, and adipogenesis.",balaglitazone,CHEMICAL,have equi-efficacious antihyperglycaemic doses with,full PPARgamma agonist rosiglitazone,CHEBI
18761337,Equi-efficacious antihyperglycaemic doses (ED(90)) of balaglitazone (3 mg/kg/day) and rosiglitazone (6 mg/kg/day) were determined in male diabetic db/db mice.,rosiglitazone,CHEMICAL,be determined in,male diabetic db/db mice,DISEASE
18761337,Equi-efficacious antihyperglycaemic doses (ED(90)) of balaglitazone (3 mg/kg/day) and rosiglitazone (6 mg/kg/day) were determined in male diabetic db/db mice.,balaglitazone,CHEMICAL,be determined in,male diabetic db/db mice,DISEASE
34751120,The pharmacological effect of these agonists may deliver effective clinical responses by protecting vulnerable neurons from Aβ toxicity in Alzheimer's disease (AD) patients.,agonists,CHEBI,protect vulnerable neurons from,Aβ toxicity,DISEASE
34627984,"Byur dMar Nyer lNga Ril Bu (BdNlRB) is a classic Tibetan medicine prescription for treating "" white vein disease"".",Byur dMar Nyer lNga Ril Bu,CHEMICAL,treat,white vein disease,DISEASE
2017444,"NTI (0.01-1.0 micrograms/rat, ICV) dose-dependently attenuated DPDPE-induced analgesia (1.0 micrograms reduced paw-lick latency to baseline), but failed to affect DAGO-induced analgesia at any dose tested.",NTI,CHEMICAL,attenuate,DPDPE-induced analgesia,MENTAL_HEALTH
2017444,A third experiment determined whether the ICV administration of NTI (1.0 micrograms/rat) would attenuate restraint stress-induced potentiation of morphine analgesia as indexed by the tail-flick assay.,NTI,CHEMICAL,attenuate stress-induced potentiation of,morphine analgesia,MENTAL_HEALTH
2017444,A third experiment determined whether the ICV administration of NTI (1.0 micrograms/rat) would attenuate restraint stress-induced potentiation of morphine analgesia as indexed by the tail-flick assay.,NTI,CHEMICAL,attenuate stress-induced potentiation of,morphine analgesia,CHEMICAL
2017444,"Thus, NTI failed to attenuate the analgesia produced by DAGO or morphine (in two assays of antinociception), whereas NTI (0.01-1.0 micrograms, ICV) antagonized dose-dependently DPDPE-induced analgesia.",NTI micrograms,CHEMICAL,antagonize,DPDPE-induced analgesia,MENTAL_HEALTH
31621627,Cerebellar ataxia is a hallmark of coenzyme Q10 (CoQ10) deficiency associated with COQ8A mutations.,Cerebellar ataxia,DISEASE,be hallmark of,Q10 CoQ10 deficiency,CHEMICAL
30327944,TN interferes with daily functioning and is associated with depression and anxiety.,TN,CHEMICAL,be associated with,anxiety,MENTAL_HEALTH
30327944,TN interferes with daily functioning and is associated with depression and anxiety.,TN,CHEMICAL,be associated with,depression,MENTAL_HEALTH
26996926,"The stimulation of locomotor behavior by amphetamine, measured simultaneously with the analytes, was comparably reduced by the PKCβ inhibitors.",amphetamine,CHEMICAL,have the stimulation of,locomotor behavior,DISEASE
34068556,Multiple linear regression analysis indicated the polyphenols and squalene content positively correlated with the antioxidant capacity.,Multiple linear regression analysis,MENTAL_HEALTH,indicate,squalene content,CHEMICAL
27993600,The purpose of this study is to determine whether a novel tumor-targeted vesicular formulation of tocotrienol would suppress the growth of A431 epidermoid carcinoma and B16-F10 melanoma in vitro and in vivo.,tocotrienol,CHEBI,suppress growth of,A431 epidermoid carcinoma,DISEASE
27993600,The purpose of this study is to determine whether a novel tumor-targeted vesicular formulation of tocotrienol would suppress the growth of A431 epidermoid carcinoma and B16-F10 melanoma in vitro and in vivo.,tocotrienol,CHEBI,suppress growth of,B16-F10 melanoma,DISEASE
27993600,"In addition, the intravenous administration of tocotrienol entrapped in transferrin-bearing vesicles resulted in tumor suppression for 30% of A431 and 60% of B16-F10 tumors, without visible toxicity.",tocotrienol,CHEBI,result in addition in tumor suppression for % of,B16-F10 tumors,DISEASE
27993600,"In addition, the intravenous administration of tocotrienol entrapped in transferrin-bearing vesicles resulted in tumor suppression for 30% of A431 and 60% of B16-F10 tumors, without visible toxicity.",tocotrienol,CHEBI,result in addition in tumor suppression for % of,visible toxicity,DISEASE
27993600,"In addition, the intravenous administration of tocotrienol entrapped in transferrin-bearing vesicles resulted in tumor suppression for 30% of A431 and 60% of B16-F10 tumors, without visible toxicity.",tocotrienol,CHEBI,result in addition in,tumor suppression,DISEASE
10958252,Disruption of latent inhibition (LI) has been suggested as a model for a cognitive deficit in schizophrenia (hyperattention to irrelevant stimuli) and is usually associated with an increase in DA release in the n. acc.,LI,CHEMICAL,be associated with increase in,DA release,CHEMICAL
10958252,Disruption of latent inhibition (LI) has been suggested as a model for a cognitive deficit in schizophrenia (hyperattention to irrelevant stimuli) and is usually associated with an increase in DA release in the n. acc.,LI,CHEMICAL,be suggested as model for cognitive deficit in,schizophrenia,MENTAL_HEALTH
10958252,Disruption of latent inhibition (LI) has been suggested as a model for a cognitive deficit in schizophrenia (hyperattention to irrelevant stimuli) and is usually associated with an increase in DA release in the n. acc.,LI,CHEMICAL,be suggested as model for,cognitive deficit,DISEASE
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",NMDA,CHEMICAL,block,neurotoxic,DISEASE
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",NMDA,CHEMICAL,block,amphetamines,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",NMDA,CHEMICAL,block,cocaine,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",non-NMDA,CHEMICAL,block,neurotoxic,DISEASE
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",non-NMDA,CHEMICAL,block,amphetamines,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",non-NMDA,CHEMICAL,block,cocaine,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEBI,block,neurotoxic,DISEASE
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEBI,block,amphetamines,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEBI,block,cocaine,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEMICAL,block,neurotoxic,DISEASE
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEMICAL,block,amphetamines,CHEMICAL
7758407,"Recent evidence has demonstrated that N-methyl-D-aspartic acid (NMDA) and non-NMDA, excitatory amino acid (EAA) receptor antagonists block the motor stimulating, neurotoxic, and rewarding actions of cocaine and the amphetamines.",excitatory amino acid EAA receptor antagonists,CHEMICAL,block,cocaine,CHEMICAL
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,hypertension,DISEASE
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,drug therapy,CHEBI
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,drowsiness,MENTAL_HEALTH
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,dry mouth,DISEASE
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,fatigue,MENTAL_HEALTH
21896146,"•  This class of drugs, however, is currently used mainly as fourth-line (or beyond) drug therapy for hypertension because of side effects of drowsiness, fatigue, and dry mouth.",,CHEMICAL,be used as,fourth-line,CHEMICAL
10817010,"The combination of a reduced dose of HRT and an anxiolytic drug can be an alternative treatment to patients refusing HRT because of cancerophobia or side effects and to those, whom the reduced dose of HRT might be sufficient to avoid climacteric complaints.",HRT,CHEMICAL,be alternative treatment to,cancerophobia effects,MENTAL_HEALTH
10817010,"The combination of a reduced dose of HRT and an anxiolytic drug can be an alternative treatment to patients refusing HRT because of cancerophobia or side effects and to those, whom the reduced dose of HRT might be sufficient to avoid climacteric complaints.",HRT,CHEMICAL,avoid,climacteric complaints,DISEASE
10817010,"The combination of a reduced dose of HRT and an anxiolytic drug can be an alternative treatment to patients refusing HRT because of cancerophobia or side effects and to those, whom the reduced dose of HRT might be sufficient to avoid climacteric complaints.",anxiolytic drug,CHEBI,be alternative treatment to,cancerophobia effects,MENTAL_HEALTH
30504093,AITC also caused the displacement of the tissue.,AITC,CHEMICAL,cause,displacement,MENTAL_HEALTH
30397567,"Serotonergic antidepressant medications are first-line medications for the treatment of most anxiety disorders; however, this can be problematic for a patient with BD.",Serotonergic antidepressant medications,CHEMICAL,be first-line medications for treatment of,anxiety disorders,MENTAL_HEALTH
30397567,Antidepressant use in BD has been associated with a risk of manic switch as well as potential destabilization of mood.,Antidepressant use,CHEMICAL,be associated with risk of,manic switch,DISEASE
30397567,Mood stabilizer therapy should be established for patients with comorbid BD and an anxiety disorder before other medications are added to address the anxiety disorder.,Mood stabilizer therapy,CHEBI,be established for patients with,comorbid BD disorder,MENTAL_HEALTH
30397567,"While benzodiazepine medications are recommended as third-line therapy in the CANMAT task force recommendations, their use should be avoided in patients with comorbid BD, posttraumatic stress disorder, and substance use disorders.",benzodiazepine medications,CHEMICAL,be recommended as third-line therapy in,CANMAT task force,DISEASE
30397567,"While benzodiazepine medications are recommended as third-line therapy in the CANMAT task force recommendations, their use should be avoided in patients with comorbid BD, posttraumatic stress disorder, and substance use disorders.",benzodiazepine medications,CHEMICAL,be recommended as,third-line therapy,CHEMICAL
1742149,"Nocturnal asthma is due to circadian changes in hormonal secretion (catecholamines, cortisol), as well as supine posture, reduced muco-ciliary clearance, gastro-esophageal reflux etc.",Nocturnal asthma,DISEASE,be due to circadian changes in,cortisol,CHEMICAL
1742149,"Nocturnal asthma is due to circadian changes in hormonal secretion (catecholamines, cortisol), as well as supine posture, reduced muco-ciliary clearance, gastro-esophageal reflux etc.",Nocturnal asthma,DISEASE,be due to circadian changes in,catecholamines,CHEMICAL
35217314,"The single SNP association was tested using binary logistic regression, and we performed Classification and Regression Tree (CART) analysis to evaluate genotype combinations' effects on ADHD susceptibility.",single SNP association,CHEMICAL,use,binary logistic regression,MENTAL_HEALTH
35217314,CART analysis showed that the combined effects of genotype GG in rs2144833 and CC in rs10129500 were associated with ADHD (OR = 1.78; CI95% = 1.24-2.55).,CC,CHEMICAL,be associated with,ADHD =,MENTAL_HEALTH
35217314,These results suggest a shared genetic component between cortisol levels and ADHD.,cortisol levels,CHEMICAL,have genetic component with,ADHD,MENTAL_HEALTH
35217314,These results suggest a shared genetic component between cortisol levels and ADHD.,ADHD,MENTAL_HEALTH,have genetic component with,cortisol levels,CHEMICAL
35217314,"HPA dysregulation/altered stress response in ADHD might be mediated by upregulation of corticosteroid binding globulin (CBG, encoded by SERPINA6) expression.",ADHD,MENTAL_HEALTH,be mediated by upregulation of,corticosteroid binding globulin,CHEMICAL
35217314,"HPA dysregulation/altered stress response in ADHD might be mediated by upregulation of corticosteroid binding globulin (CBG, encoded by SERPINA6) expression.",ADHD,MENTAL_HEALTH,be mediated by upregulation of,CBG,CHEMICAL
35589686,"Proteasome inhibitors, such as bortezomib, are first-line therapy against multiple myeloma (MM).",bortezomib,CHEMICAL,be first-line therapy against,MM,DISEASE
35589686,"Proteasome inhibitors, such as bortezomib, are first-line therapy against multiple myeloma (MM).",bortezomib,CHEMICAL,be first-line therapy against,multiple myeloma,DISEASE
34965389,The histamine H3 receptor is a favourable target for the treatment of cognitive deficits.,histamine H3 receptor,CHEMICAL,be favourable target for treatment of,cognitive deficits,DISEASE
34695542,Stressful episodes and high alcohol consumption during adolescence are considered major risk factors for the development of psychiatric disorders in adulthood.,high alcohol consumption,CHEMICAL,be considered major risk factors for development of,psychiatric disorders,DISEASE
33425684,"This binding model could provide logical explanations for the acute inflammatory disorder in patients with COVID-19, which may be linked to severe dysregulation of NCS.",acute inflammatory disorder,DISEASE,in patients with,COVID-19,CHEMICAL
32851581,"Furthermore, α7nAChR agonist PNU 282987 exerts trophic factor-like actions to support pancreatic β-cell survival under conditions of stress resembling diabetes.",α7nAChR agonist PNU,CHEBI,support pancreatic β-cell survival under conditions of,stress resembling diabetes,DISEASE
15890657,"Propionyl-CoA carboxylase (PCC) is a biotin-dependent mitochondrial enzyme that catalyzes the conversion of propionyl-CoA to D-methylmalonyl-CoA. PCC consists of two heterologous subunits, alpha PCC and beta PCC, which are encoded by the nuclear PCCA and PCCB genes, respectively.",biotin-dependent mitochondrial enzyme,CHEMICAL,consist of,alpha PCC,NUTRITION
15890657,"Propionyl-CoA carboxylase (PCC) is a biotin-dependent mitochondrial enzyme that catalyzes the conversion of propionyl-CoA to D-methylmalonyl-CoA. PCC consists of two heterologous subunits, alpha PCC and beta PCC, which are encoded by the nuclear PCCA and PCCB genes, respectively.",biotin-dependent mitochondrial enzyme,CHEMICAL,consist of,beta,CHEBI
34871603,"However, excessive DA dose can lead to impulse control disorder.",excessive DA dose,CHEMICAL,lead to,impulse control disorder,MENTAL_HEALTH
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,hypogonadism,DISEASE
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,galactorrhea,DISEASE
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,visual impairment,DISEASE
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,intracranial hypertension,DISEASE
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,hormone oversecretion,CHEBI
34687915,"Prolactinomas lead to signs and symptoms of hormone oversecretion, such as galactorrhea and hypogonadism, as well as symptoms of mass effect, including visual impairment, headaches and intracranial hypertension.",Prolactinomas,DISEASE,lead to signs and symptoms of,headaches,DISEASE
34687915,Temozolomide may be used for aggressive or malignant carcinomas.,Temozolomide,CHEMICAL,be used for,aggressive carcinomas,DISEASE
33069545,"Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day.",Guanfacine,CHEMICAL,prescribed for attention-deficit hyperactive disorder as,mg,CHEMICAL
33069545,"Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day.",Guanfacine,CHEMICAL,prescribed for attention-deficit hyperactive disorder as,tic disorder,MENTAL_HEALTH
33069545,"Guanfacine is a central alpha-2 agonist often prescribed for Attention-deficit hyperactive disorder as well as tic disorder, with a usual dose of 1-4 mg per day.",Guanfacine,CHEMICAL,prescribed for,Attention-deficit hyperactive disorder,DISEASE
33069545,"Due to its sympatholytic mechanism of action, Guanfacine can cause autonomic instability and hypotension.",Guanfacine,CHEMICAL,cause due its sympatholytic mechanism of,action autonomic instability,DISEASE
33069545,"Due to its sympatholytic mechanism of action, Guanfacine can cause autonomic instability and hypotension.",Guanfacine,CHEMICAL,cause due its sympatholytic mechanism of,hypotension,DISEASE
33069545,"Due to its sympatholytic mechanism of action, Guanfacine can cause autonomic instability and hypotension.",Guanfacine,CHEMICAL,cause due,sympatholytic mechanism,CHEBI
33069545,The authors present a case of a 17 year-old male with an ingestion of 80 mg of extended release Guanfacine with delayed onset cardiogenic pulmonary edema requiring mechanical ventilation.,release Guanfacine,CHEMICAL,have mg with,delayed onset cardiogenic pulmonary edema,DISEASE
33069545,"Previous pediatric ingestions have generated bradycardia, hypotension, and decreased level of consciousness, responsive to intravenous fluids, vasopressors, and occasionally naloxone.",Previous pediatric ingestions,DISEASE,generate,bradycardia,DISEASE
33069545,"Previous pediatric ingestions have generated bradycardia, hypotension, and decreased level of consciousness, responsive to intravenous fluids, vasopressors, and occasionally naloxone.",Previous pediatric ingestions,DISEASE,generate,hypotension,DISEASE
33069545,"However, cardiogenic pulmonary edema from reduced cardiac contractility is a novel consequence of extended release Guanfacine ingestion.",cardiogenic pulmonary edema,DISEASE,be novel consequence of,release Guanfacine ingestion,CHEMICAL
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",Lysergic acid diethylamide,CHEMICAL,be used in,psychiatric research,DISEASE
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",Lysergic acid diethylamide,CHEMICAL,investigate as potential treatment for,anxiety,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",Lysergic acid diethylamide,CHEMICAL,investigate as potential treatment for,depression,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",Lysergic acid diethylamide,CHEMICAL,investigate as potential treatment for,medical disorders,DISEASE
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",Lysergic acid diethylamide,CHEMICAL,investigate as potential treatment for,cluster headache,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",LSD,CHEMICAL,investigate as potential treatment for,anxiety,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",LSD,CHEMICAL,investigate as potential treatment for,depression,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",LSD,CHEMICAL,investigate as potential treatment for,medical disorders,DISEASE
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",LSD,CHEMICAL,investigate as potential treatment for,cluster headache,MENTAL_HEALTH
34515824,"Lysergic acid diethylamide (LSD) is used in psychiatric and psychological research and investigated as a potential treatment for medical and psychiatric disorders, including depression, anxiety, and cluster headache.",LSD,CHEMICAL,be used in,psychiatric research,DISEASE
23983976,"Upon commencing drug therapy with lamotrigine, these complex visual disturbances receded almost completely.",complex visual disturbances,DISEASE,commence drug therapy with,lamotrigine,CHEMICAL
23983976,"Upon commencing drug therapy with lamotrigine, these complex visual disturbances receded almost completely.",complex visual disturbances,DISEASE,commence,drug therapy,CHEBI
12356036,"Thus, inadequate analgesia can become a suicidogen, ie, any factor that causes a patient to want to commit suicide.",inadequate analgesia,MENTAL_HEALTH,become,suicidogen,CHEMICAL
35589643,"Eosinophilic granulomatosis with polyangiitis (EGPA), an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, is a systemic vasculitis syndrome involving inflammatory damage of predominantly small vessels.",EGPA,CHEMICAL,be,systemic vasculitis syndrome,DISEASE
35589643,"Eosinophilic granulomatosis with polyangiitis (EGPA), an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, is a systemic vasculitis syndrome involving inflammatory damage of predominantly small vessels.",polyangiitis,DISEASE,be,systemic vasculitis syndrome,DISEASE
35589643,"Eosinophilic granulomatosis with polyangiitis (EGPA), an antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, is a systemic vasculitis syndrome involving inflammatory damage of predominantly small vessels.",antineutrophil (ANCA)-associated vasculitis,DISEASE,be,systemic vasculitis syndrome,DISEASE
17194747,"A leptin-induced suppression of EPSCs, but not IPSCs, evoked by focal photolytic uncaging of glutamate within the NTS was also observed, supportive of leptin effects on the glutamatergic NTS projection to the DMV.",EPSCs,CHEMICAL,be observed supportive of leptin effects on,NTS projection,MENTAL_HEALTH
27032391,The treatment of early-EW mice with NO donor alleviated depressive-like behaviors and decline of phosphor-CREB.,NO donor,CHEMICAL,alleviate,depressive-like behaviors,DISEASE
27032391,The nNOS inhibitor and NO scavenger caused depressive-like behaviors and reduced phosphor-CREB in HSP mice and late-EW mice.,NO scavenger,CHEMICAL,cause,depressive-like behaviors,DISEASE
27032391,The nNOS inhibitor and NO scavenger caused depressive-like behaviors and reduced phosphor-CREB in HSP mice and late-EW mice.,NO scavenger,CHEMICAL,reduce phosphor-creb in,HSP mice,DISEASE
27032391,The sigma-1 receptor (σ1R) agonist could alleviate depressive-like behaviors and decline of nNOS-NO-CREB in early-EW mice.,sigma-1 receptor σ1R agonist,CHEBI,alleviate,depressive-like behaviors,DISEASE
27032391,The sigma-1 receptor (σ1R) agonist could alleviate depressive-like behaviors and decline of nNOS-NO-CREB in early-EW mice.,sigma-1 receptor σ1R agonist,CHEMICAL,alleviate,depressive-like behaviors,DISEASE
27032391,The pharmacological blockade or deficiency of σ1R in late-EW mice caused depressive-like behaviors with decline of nNOS-NO-CREB.,σ1R,CHEMICAL,cause,depressive-like behaviors,DISEASE
27032391,"The findings indicate that the activation of σ1R can alleviate postpartum ""depression"" through increasing nNOS-NO-CREB activities.",σ1R,CHEMICAL,alleviate,postpartum depression,MENTAL_HEALTH
23006866,"In another group of rats, vasopressin 2 receptor agonist was used peripherally to exclude secondary changes due to diabetes insipidus.",vasopressin receptor agonist,CHEMICAL,exclude secondary changes due to,diabetes insipidus,DISEASE
23006866,"In another group of rats, vasopressin 2 receptor agonist was used peripherally to exclude secondary changes due to diabetes insipidus.",vasopressin receptor agonist,CHEBI,exclude secondary changes due to,diabetes insipidus,DISEASE
19146203,"Menopause, due to the physiological decrease in the estrogens levels, is often associated with many symptoms related to vaginal atrophy such vaginal dryness, dyspareunia, burning, itching, decreasing in libido and therefore a worsening of the quality of life and in particular of the sexual activity.",estrogens levels,CHEBI,be associated with many symptoms related to,dyspareunia,MENTAL_HEALTH
19146203,"Menopause, due to the physiological decrease in the estrogens levels, is often associated with many symptoms related to vaginal atrophy such vaginal dryness, dyspareunia, burning, itching, decreasing in libido and therefore a worsening of the quality of life and in particular of the sexual activity.",estrogens levels,CHEBI,be associated with many symptoms related to,vaginal dryness,DISEASE
19146203,"Menopause, due to the physiological decrease in the estrogens levels, is often associated with many symptoms related to vaginal atrophy such vaginal dryness, dyspareunia, burning, itching, decreasing in libido and therefore a worsening of the quality of life and in particular of the sexual activity.",estrogens levels,CHEBI,be associated with many symptoms related to,vaginal atrophy itching,DISEASE
12464938,"Short-acting beta-adrenergic agonists have been shown to enhance mucociliary clearance rates to varying degrees in patients with various lung diseases (eg, asthma, chronic bronchitis, and cystic fibrosis), although the enhancement is generally less than that seen in the normal lung.",Short-acting beta-adrenergic agonists,CHEBI,enhance mucociliary clearance rates to varying degrees in patients with,various lung diseases,DISEASE
12464938,"Short-acting beta-adrenergic agonists have been shown to enhance mucociliary clearance rates to varying degrees in patients with various lung diseases (eg, asthma, chronic bronchitis, and cystic fibrosis), although the enhancement is generally less than that seen in the normal lung.",Short-acting beta-adrenergic agonists,CHEBI,enhance mucociliary clearance rates to varying degrees in patients with,chronic bronchitis,DISEASE
12464938,"Short-acting beta-adrenergic agonists have been shown to enhance mucociliary clearance rates to varying degrees in patients with various lung diseases (eg, asthma, chronic bronchitis, and cystic fibrosis), although the enhancement is generally less than that seen in the normal lung.",Short-acting beta-adrenergic agonists,CHEBI,enhance mucociliary clearance rates to varying degrees in patients with,cystic fibrosis,DISEASE
30840560,"Whereas schizotypal personality disorder, with its cognitive peculiarities (ideas of reference, odd beliefs, eccentric speech), is closely linked as a genetic condition-""borderline"" to the major condition schizophrenia-BPD is less closely linked to bipolar disorder.",cognitive peculiarities ideas,DISEASE,be linked as,"genetic condition-""borderline",CHEMICAL
30840560,"Whereas schizotypal personality disorder, with its cognitive peculiarities (ideas of reference, odd beliefs, eccentric speech), is closely linked as a genetic condition-""borderline"" to the major condition schizophrenia-BPD is less closely linked to bipolar disorder.",schizotypal personality disorder,MENTAL_HEALTH,be linked as,"genetic condition-""borderline",CHEMICAL
30840560,"Whereas schizotypal personality disorder, with its cognitive peculiarities (ideas of reference, odd beliefs, eccentric speech), is closely linked as a genetic condition-""borderline"" to the major condition schizophrenia-BPD is less closely linked to bipolar disorder.",major condition schizophrenia-BPD,CHEMICAL,be linked to,bipolar disorder,MENTAL_HEALTH
35435568,"Previous data have demonstrated that the levels of homocysteine (Hcy) are significantly elevated in the plasma of stressed animals, which suggests that Hcy is associated with stress and cognitive decline.",Hcy,CHEMICAL,be associated with,stress decline,DISEASE
35435568,"Diet-induced HHcy mimicked the cognitive decline and BDNF downregulation in the same manner as CUMS, while Hcy reduction (by means of vitamin B complex supplements) alleviated the cognitive deficits and BDNF reduction in CUMS rats.",Hcy reduction,CHEMICAL,alleviate,cognitive deficits,DISEASE
35435568,"Diet-induced HHcy mimicked the cognitive decline and BDNF downregulation in the same manner as CUMS, while Hcy reduction (by means of vitamin B complex supplements) alleviated the cognitive deficits and BDNF reduction in CUMS rats.",vitamin B complex supplements,CHEBI,alleviate,cognitive deficits,DISEASE
35435568,"Diet-induced HHcy mimicked the cognitive decline and BDNF downregulation in the same manner as CUMS, while Hcy reduction (by means of vitamin B complex supplements) alleviated the cognitive deficits and BDNF reduction in CUMS rats.",Diet-induced HHcy,DISEASE,mimic cognitive decline and bdnf downregulation in same manner as,CUMS,DISEASE
35435568,"Diet-induced HHcy mimicked the cognitive decline and BDNF downregulation in the same manner as CUMS, while Hcy reduction (by means of vitamin B complex supplements) alleviated the cognitive deficits and BDNF reduction in CUMS rats.",Diet-induced HHcy,DISEASE,mimic,cognitive decline,DISEASE
35435568,These results imply the possibility of a causal role of Hcy in stress-induced cognitive decline.,Hcy,CHEMICAL,have a causal role in,stress-induced cognitive decline,DISEASE
35435568,"Taken together, novel evidence from the present study suggests that Hcy is likely involved in chronic stress-induced BDNF reduction and related cognitive deficits.",Hcy,CHEMICAL,be involved in,cognitive deficits,DISEASE
35435568,The results also suggest the possibility of Hcy as a target for therapy and the potential value of vitamin B intake in preventing stress-induced cognitive decline.,vitamin B intake,CHEBI,have the potential value preventing,stress-induced cognitive decline,DISEASE
27435080,"Our previous data demonstrated that the level of homocysteine (Hcy) was significantly elevated in the plasma of stressed animals, which suggests the possibility that Hcy is a link between stress and cognitive decline.",Hcy,CHEMICAL,be link between,stress decline,DISEASE
27435080,Hcy-targeting intervention experiments were used to verify further the involvement of Hcy in stress-induced APP misprocessing and related cognitive decline.,Hcy,CHEMICAL,have the involvement in,misprocessing decline,DISEASE
27435080,"The results showed that diet-induced HHcy could mimic the cognitive impairment and APP misprocessing in the same manner as CUMS, while Hcy reduction by means of vitamin B complex supplements and betaine could alleviate the cognitive deficits and dysregulation of Aβ metabolism in CUMS rats.",diet-induced HHcy,DISEASE,misprocessing in same manner as,CUMS,DISEASE
27435080,"The results showed that diet-induced HHcy could mimic the cognitive impairment and APP misprocessing in the same manner as CUMS, while Hcy reduction by means of vitamin B complex supplements and betaine could alleviate the cognitive deficits and dysregulation of Aβ metabolism in CUMS rats.",vitamin B complex supplements,CHEBI,alleviate,cognitive deficits,DISEASE
27435080,"The results showed that diet-induced HHcy could mimic the cognitive impairment and APP misprocessing in the same manner as CUMS, while Hcy reduction by means of vitamin B complex supplements and betaine could alleviate the cognitive deficits and dysregulation of Aβ metabolism in CUMS rats.",Hcy reduction,CHEMICAL,alleviate,cognitive deficits,DISEASE
27435080,"Taken together, the novel evidence from our present study suggests that Hcy is likely to be involved in chronic stress-evoked APP misprocessing and related cognitive deficits.",Hcy,CHEMICAL,be involved in,misprocessing deficits,DISEASE
35217671,"Based on the essential role of polyunsaturated fatty acids in brain function and the treatment of schizophrenia, we hypothesize that disordered fatty acid metabolism may contribute to treatment resistance in multi-episode patients.",disordered fatty acid metabolism,NUTRITION,contribute to treatment resistance in,multi-episode patients,DISEASE
35217671,"Based on the essential role of polyunsaturated fatty acids in brain function and the treatment of schizophrenia, we hypothesize that disordered fatty acid metabolism may contribute to treatment resistance in multi-episode patients.",disordered fatty acid metabolism,NUTRITION,contribute to,treatment resistance,MENTAL_HEALTH
35217671,"Results of fatty acid ratios suggested that dysregulations of enzymes such as D6 desaturase, D5 desaturase, and elongases for polyunsaturated fatty acids in patients with multi-episode schizophrenia could account for the differences.",polyunsaturated fatty acids,NUTRITION,in patients with,multi-episode schizophrenia,MENTAL_HEALTH
34735824,"Although studies suggest that concentrations of omega-3 and omega-6 fatty acids are lower in individuals with schizophrenia, evidence for beneficial effects of fatty acid supplementation is scarce.",omega-3,CHEMICAL,be lower in individuals with,schizophrenia,MENTAL_HEALTH
34735824,"Although studies suggest that concentrations of omega-3 and omega-6 fatty acids are lower in individuals with schizophrenia, evidence for beneficial effects of fatty acid supplementation is scarce.",fatty acids,NUTRITION,be lower in individuals with,schizophrenia,MENTAL_HEALTH
34735824,"Therefore, in this study, we aimed to determine whether omega-3 and omega-6 fatty acid concentrations are causally related to schizophrenia.",omega-3 fatty acid concentrations,NUTRITION,be related to,schizophrenia,MENTAL_HEALTH
25667398,"The DNA G+C content was 61.3 mol%, and phylogenetic analysis, based on the 16S rRNA sequence, showed that C. thermophilum sp. nov. belongs to subdivision 4 ( Acidobacteriaceae ) of the Acidobacteria .",sp. nov.,DISEASE,belong to,Acidobacteria,CHEMICAL
25667398,"C. thermophilum sp. nov. produced iso-diabolic acid as its major fatty acid and synthesized three hopanoids (diploptene, bacteriohopanetetrol and bacteriohopanetetrol cyclitol ether).",sp. nov.,DISEASE,produce iso-diabolic acid as,major fatty acid,NUTRITION
25667398,"C. thermophilum sp. nov. produced iso-diabolic acid as its major fatty acid and synthesized three hopanoids (diploptene, bacteriohopanetetrol and bacteriohopanetetrol cyclitol ether).",sp. nov.,DISEASE,produce,iso-diabolic acid,CHEMICAL
25667398,"C. thermophilum sp. nov. produced iso-diabolic acid as its major fatty acid and synthesized three hopanoids (diploptene, bacteriohopanetetrol and bacteriohopanetetrol cyclitol ether).",sp. nov.,DISEASE,synthesize,bacteriohopanetetrol,CHEMICAL
25667398,"C. thermophilum sp. nov. produced iso-diabolic acid as its major fatty acid and synthesized three hopanoids (diploptene, bacteriohopanetetrol and bacteriohopanetetrol cyclitol ether).",sp. nov.,DISEASE,synthesize,diploptene,CHEMICAL
25667398,"C. thermophilum sp. nov. produced iso-diabolic acid as its major fatty acid and synthesized three hopanoids (diploptene, bacteriohopanetetrol and bacteriohopanetetrol cyclitol ether).",sp. nov.,DISEASE,synthesize,bacteriohopanetetrol cyclitol ether,CHEMICAL
1588748,"Plasma Leu-enk, % Leu2a+ Leu15- cells,% Leu3a+ Leu8- cells and % Leu11+ Leu7- cells were higher in patients with a larger number of psycologic complaints in CMI.",Plasma Leu-enk,CHEMICAL,be higher in patients with larger number of,CMI,DISEASE
1588748,"Plasma Leu-enk, % Leu2a+ Leu15- cells,% Leu3a+ Leu8- cells and % Leu11+ Leu7- cells were higher in patients with a larger number of psycologic complaints in CMI.","Leu2a+ Leu15- cells,% Leu3a+ Leu8- cells",CHEMICAL,be higher in patients with larger number of,CMI,DISEASE
2141249,"Rheumatoid arthritis (RA) patients were investigated for relationships between the concentrations of various plasma opioid peptides (beta-endorphin (beta-end), methionine-enkephalin (Met-enk), leucine-enkephalin (Leu-enk) and the lymphocyte subsets, serum immunoglobulins, the patient's mood or emotion, and the RA activity.",Rheumatoid arthritis patients,DISEASE,be investigated for relationships between concentrations of,leucine-enkephalin,CHEMICAL
2141249,"Rheumatoid arthritis (RA) patients were investigated for relationships between the concentrations of various plasma opioid peptides (beta-endorphin (beta-end), methionine-enkephalin (Met-enk), leucine-enkephalin (Leu-enk) and the lymphocyte subsets, serum immunoglobulins, the patient's mood or emotion, and the RA activity.",Rheumatoid arthritis patients,DISEASE,be investigated for relationships between concentrations of,RA activity,DISEASE
2141249,"Rheumatoid arthritis (RA) patients were investigated for relationships between the concentrations of various plasma opioid peptides (beta-endorphin (beta-end), methionine-enkephalin (Met-enk), leucine-enkephalin (Leu-enk) and the lymphocyte subsets, serum immunoglobulins, the patient's mood or emotion, and the RA activity.",Rheumatoid arthritis patients,DISEASE,be investigated for relationships between concentrations of,Leu-enk,CHEMICAL
35306087,"On the combination 0.015 mg/L NPls + 20 mg/L PHE, hyperactivity behavior was found, similar to 0.015 mg/L NPls, and cholinesterase activity was inhibited.",hyperactivity behavior,MENTAL_HEALTH,be found on,mg/L PHE similar,CHEMICAL
28963892,"While DMSO as a carrier medium has a reportedly low toxicity and is routinely employed in ecotoxicology, very little is known about its effect on dynamic behavioral parameters.",carrier medium,CHEBI,have,low toxicity,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",dopamine-receptor agonist,CHEBI,be recommended as first-line treatment of rls/wed for most patients with,cognitive status,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",dopamine-receptor agonist,CHEBI,be recommended as first-line treatment of rls/wed for most patients with,RLS/WED symptoms,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",dopamine-receptor agonist,CHEBI,be recommended as first-line treatment of,RLS/WED,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",α2δ calcium-channel ligand,CHEMICAL,be recommended as first-line treatment of rls/wed for most patients with,cognitive status,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",α2δ calcium-channel ligand,CHEMICAL,be recommended as first-line treatment of rls/wed for most patients with,RLS/WED symptoms,DISEASE
23859128,"The use of either a dopamine-receptor agonist or α2δ calcium-channel ligand is recommended as the first-line treatment of RLS/WED for most patients, with the choice of agent dependent on the patient's severity of RLS/WED symptoms, cognitive status, history, and comorbid conditions.",α2δ calcium-channel ligand,CHEMICAL,be recommended as first-line treatment of,RLS/WED,DISEASE
17017553,"Insomnia can be improved by a better control of night-time disability, restless legs syndrome and dystonia using subthalamic nucleus stimulation or night-time levodopa.",Insomnia,MENTAL_HEALTH,use,night-time levodopa,CHEMICAL
33435749,"Therefore, dietary supplements, including vitamins and minerals, probiotics as well as individual nutritional behaviour can be used as adjuvant therapy together with antiviral medicines in the management of COVID-19 disease.",vitamins,CHEBI,be used as adjuvant therapy with antiviral medicines in management of,COVID-19 disease,DISEASE
33435749,"Therefore, dietary supplements, including vitamins and minerals, probiotics as well as individual nutritional behaviour can be used as adjuvant therapy together with antiviral medicines in the management of COVID-19 disease.",vitamins,CHEBI,be used as adjuvant therapy with,antiviral medicines,CHEBI
35525449,"The pH (3, 5, 7, and 9), temperature (20 °C and 40 °C), and membrane orientation active-layer [AL]-facing FS and AL-DS) were changed, and water flux, reverse salt flux (RSF), rejection rate, and concentration factor (CF) were evaluated for five VFAs.",membrane orientation active-layer [AL]-facing FS,MENTAL_HEALTH,be changed,reverse salt flux,CHEMICAL
35525449,"The pH (3, 5, 7, and 9), temperature (20 °C and 40 °C), and membrane orientation active-layer [AL]-facing FS and AL-DS) were changed, and water flux, reverse salt flux (RSF), rejection rate, and concentration factor (CF) were evaluated for five VFAs.",membrane orientation active-layer [AL]-facing FS,CHEMICAL,be changed,reverse salt flux,CHEMICAL
35447389,A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries.,chloroquine resistance,CHEMICAL,discontinued use for treatment of,uncomplicated malaria,DISEASE
35447389,A wide spread of chloroquine resistance prompted its discontinued use for treatment of uncomplicated malaria in several African countries.,chloroquine resistance,MENTAL_HEALTH,discontinued use for treatment of,uncomplicated malaria,DISEASE
35447389,"However, disappearances of chloroquine-resistant parasites have been reported in areas with restricted use of chloroquine.",chloroquine-resistant parasites,DISEASE,be reported in areas with restricted use of,chloroquine,CHEMICAL
35417045,"The use of clinical antimalarials for the investigational treatment of malignant melanoma has shown only moderate promise, attributed mostly to inhibition of lysosomal-autophagic adaptations of cancer cells, but identification of specific antimalarials displaying single-agent antimelanoma activity has remained elusive.",malignant melanoma,DISEASE,show,specific antimalarials,CHEBI
35417045,"The use of clinical antimalarials for the investigational treatment of malignant melanoma has shown only moderate promise, attributed mostly to inhibition of lysosomal-autophagic adaptations of cancer cells, but identification of specific antimalarials displaying single-agent antimelanoma activity has remained elusive.",clinical antimalarials,CHEBI,show,specific antimalarials,CHEBI
35417045,"In a bioluminescent murine model employing intracranial injection of A375-Luc2 (BRAFV600E /NRASQ61K ) cells, an oral MQ regimen efficiently antagonized brain tumor growth.",oral MQ regimen,CHEMICAL,antagonize in,bioluminescent model brain tumor growth,DISEASE
35417045,"Taken together, these data suggest that the clinical antimalarial MQ may be a valid candidate for drug repurposing aiming at chemotherapeutic elimination of malignant melanoma cells, even if metastasized to the brain and BRAFi-resistant.",clinical antimalarial MQ,CHEMICAL,be valid candidate for,drug repurposing,CHEBI
35417045,"Taken together, these data suggest that the clinical antimalarial MQ may be a valid candidate for drug repurposing aiming at chemotherapeutic elimination of malignant melanoma cells, even if metastasized to the brain and BRAFi-resistant.",clinical antimalarial MQ,CHEBI,be valid candidate for,drug repurposing,CHEBI
32649751,Onion Distribution of Pain and Temperature Sense by Trigeminal Nerve.,Trigeminal Nerve,DISEASE,have onion distribution of,Pain Sense,DISEASE
35288510,"In concurrent work we report that repeated administration of the high-efficacy cannabinoid 1 (CB1) receptor agonist AM2389 to mice for 5 days led to heightened locomotor activity and paw tremor following treatment discontinuation, potentially indicative of spontaneous cannabinoid withdrawal.",AM2389,CHEMICAL,lead to,paw tremor,DISEASE
35288510,"In concurrent work we report that repeated administration of the high-efficacy cannabinoid 1 (CB1) receptor agonist AM2389 to mice for 5 days led to heightened locomotor activity and paw tremor following treatment discontinuation, potentially indicative of spontaneous cannabinoid withdrawal.",high-efficacy cannabinoid CB1 receptor agonist,CHEBI,lead to,paw tremor,DISEASE
32269562,"IAV-induced transcriptional levels of IFN-α, TNF-α, IL-12, IL-6, IFN-α, and RANTES were reduced following factor H treatment for the H1N1 subtype at 6 h post-infection.",IFN-α,CHEMICAL,be reduced following factor h treatment for,H1N1 subtype,DISEASE
32269562,"IAV-induced transcriptional levels of IFN-α, TNF-α, IL-12, IL-6, IFN-α, and RANTES were reduced following factor H treatment for the H1N1 subtype at 6 h post-infection.",IFN-α,CHEMICAL,be reduced following,factor H treatment,CHEMICAL
32269562,"Factor H (50%) and VCP (30%) enhanced the luciferase reporter activity for H3N2, suggesting an entry inhibitory role of factor H and VCP against H1N1, but not H3N2.",Factor H,CHEMICAL,suggest entry inhibitory role of factor h and vcp against,H1N1,DISEASE
32269562,"Factor H (50%) and VCP (30%) enhanced the luciferase reporter activity for H3N2, suggesting an entry inhibitory role of factor H and VCP against H1N1, but not H3N2.",Factor H,CHEMICAL,suggest entry inhibitory role of,VCP,DISEASE
32269562,"Factor H (50%) and VCP (30%) enhanced the luciferase reporter activity for H3N2, suggesting an entry inhibitory role of factor H and VCP against H1N1, but not H3N2.",Factor H,CHEMICAL,suggest entry inhibitory role of,factor H,CHEMICAL
32269562,"Thus, factor H can modulate IAV infection and inflammatory responses, independent of its complement-related functions.",factor H,CHEMICAL,modulate,IAV infection,DISEASE
31083217,"As increasing frequency of serotonergic drug use, SS (serotonin syndrome) occurred more than ever. But clinicians have not enough knowledge and experience about SS as a potentially life-threatening condition.",SS,CHEMICAL,increase frequency of,serotonergic drug use,CHEBI
31083217,"As increasing frequency of serotonergic drug use, SS (serotonin syndrome) occurred more than ever. But clinicians have not enough knowledge and experience about SS as a potentially life-threatening condition.",serotonin syndrome,CHEMICAL,increase frequency of,serotonergic drug use,CHEBI
31083217,SS is usually caused by the increased serotonin activity in the central nervous system which may due to a serotonergic agent overdose or the concomitant use of 2 or more serotonergic antidepressants.,SS,CHEMICAL,be caused by increased serotonin activity in central nervous system concomitant use of,antidepressants,CHEMICAL
31083217,SS is usually caused by the increased serotonin activity in the central nervous system which may due to a serotonergic agent overdose or the concomitant use of 2 or more serotonergic antidepressants.,SS,CHEMICAL,be caused by,increased serotonin activity,CHEMICAL
23213997,"The symptoms of ""Cerebral collaterals injury by toxins"" are preliminary characterized by toxins and blood stasis occluding brain collaterals.",collaterals injury,DISEASE,be characterized by,blood stasis,DISEASE
23213997,"The symptoms of ""Cerebral collaterals injury by toxins"" are preliminary characterized by toxins and blood stasis occluding brain collaterals.",collaterals injury,DISEASE,be characterized by,toxins,CHEBI
23213997,"The symptoms of ""Cerebral collaterals injury by toxins"" are preliminary characterized by toxins and blood stasis occluding brain collaterals.",toxins,CHEBI,be characterized by,blood stasis,DISEASE
23213997,"The symptoms of ""Cerebral collaterals injury by toxins"" are preliminary characterized by toxins and blood stasis occluding brain collaterals.",toxins,CHEBI,be characterized by,toxins,CHEBI
23213997,"""Cerebral collateral injury by toxins"" and ""Governor Vessel occlusion by blood stasis"" are taken as the major pathogeneses of senile dementia.",blood stasis,DISEASE,be taken as major pathogeneses of,senile dementia,MENTAL_HEALTH
23213997,"""Cerebral collateral injury by toxins"" and ""Governor Vessel occlusion by blood stasis"" are taken as the major pathogeneses of senile dementia.",Governor Vessel occlusion,DISEASE,be taken as major pathogeneses of,senile dementia,MENTAL_HEALTH
23213997,"""Cerebral collateral injury by toxins"" and ""Governor Vessel occlusion by blood stasis"" are taken as the major pathogeneses of senile dementia.",Cerebral collateral injury,DISEASE,be taken as major pathogeneses of,senile dementia,MENTAL_HEALTH
23213997,"""Cerebral collateral injury by toxins"" and ""Governor Vessel occlusion by blood stasis"" are taken as the major pathogeneses of senile dementia.",toxins,CHEBI,be taken as major pathogeneses of,senile dementia,MENTAL_HEALTH
12673439,"On the other hand, botulinum toxin injections into the lateral pterygoid muscles offer the option of a predictable and prolonged period without renewed dislocation.",botulinum toxin injections,CHEBI,offer on other hand option of predictable and prolonged period without,renewed dislocation,DISEASE
10591594,Ethanol abuse and liver cirrhosis cause a reduction of glutathione blood levels; liver cirrhosis induces an alteration of the plasma amino acid pattern.,Ethanol abuse,MENTAL_HEALTH,cause reduction of,glutathione blood levels,CHEMICAL
10591594,Ethanol abuse and liver cirrhosis cause a reduction of glutathione blood levels; liver cirrhosis induces an alteration of the plasma amino acid pattern.,liver cirrhosis,DISEASE,induce alteration of,plasma amino acid pattern,CHEMICAL
10591594,Ethanol abuse and liver cirrhosis cause a reduction of glutathione blood levels; liver cirrhosis induces an alteration of the plasma amino acid pattern.,liver cirrhosis,DISEASE,cause reduction of,glutathione blood levels,CHEMICAL
10591594,"We evaluated whether or not ethanol abuse affects amino acid levels, particularly those that are involved in metabolizing glutathione in the plasma and erythrocytes of chronic alcohol abusers with or without liver cirrhosis.",ethanol abuse,MENTAL_HEALTH,affect,amino acid levels,CHEMICAL
23023255,"Five weeks following surgery, treatment with aripiprazole, a partial dopamine agonist, was started to address the delirious state.",partial dopamine agonist,CHEBI,address,delirious state,DISEASE
23023255,"Five weeks following surgery, treatment with aripiprazole, a partial dopamine agonist, was started to address the delirious state.",aripiprazole,CHEMICAL,address,delirious state,DISEASE
23023255,"Five months after initial resection, aripiprazole was discontinued without worsening of cognitive or emotional functions.",aripiprazole,CHEMICAL,be discontinued without worsening of,cognitive functions,DISEASE
15549138,Apomorphine is used in the erectile dysfunction therapy and its action has been ascribed to the stimulation of central dopamine receptor.,Apomorphine,CHEMICAL,be used in,erectile dysfunction therapy,MENTAL_HEALTH
15087502,"Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.",nonselective dopamine receptor agonist,CHEBI,facilitate,penile erection,DISEASE
15087502,"Apomorphine, a nonselective dopamine receptor agonist, facilitates penile erection and is effective in patients suffering from erectile dysfunction.",Apomorphine,CHEMICAL,facilitate,penile erection,DISEASE
15087502,"ABT-724 dose-dependently facilitates penile erection when given s.c. to conscious rats, an effect that is blocked by haloperidol and clozapine but not by domperidone.",ABT-724,CHEMICAL,facilitate,penile erection,DISEASE
15087502,The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.,ABT-724,CHEMICAL,be useful for treatment of,erectile dysfunction,MENTAL_HEALTH
15087502,The ability of ABT-724 to facilitate penile erection together with the favorable side-effect profile indicates that ABT-724 could be useful for the treatment of erectile dysfunction.,ABT-724,CHEMICAL,have the ability to,penile erection,DISEASE
21234712,"In the current study, 77 Parkinson's disease patients and 77 matched healthy controls were analyzed for the presence of seven autoantibodies previously found to be associated with central nervous system manifestations namely: antineuronal-cells, anti-brain lysate, anti-dsDNA, anti-phosphatidylserine, anti-cardiolipin, anti-serotonin, and anti-melanocytes antibodies.",Parkinson's disease patients,DISEASE,be analyzed in,anti-brain lysate,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",TTR,DISEASE,be limited to % of its normal rate at,tafamidis,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",TTR,DISEASE,be limited to % of its normal rate at,µM tolcapone,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",TTR,DISEASE,be limited to % of its normal rate at,µM AG10,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",Dissociation,MENTAL_HEALTH,be limited to % of its normal rate at,tafamidis,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",Dissociation,MENTAL_HEALTH,be limited to % of its normal rate at,µM tolcapone,CHEMICAL
32811187,"Dissociation of TTR can be limited to 10% of its normal rate at concentrations of 5.7 µM AG10, 10.3 µM tolcapone, 12.0 µM tafamidis, and 188 µM diflunisal.",Dissociation,MENTAL_HEALTH,be limited to % of its normal rate at,µM AG10,CHEMICAL
12737231,"Different concentrations of non-phytate phosphorus (NPP, 2.5, 3.0, 3.5, 4.0 and 4.5 g/kg diet) were given to broilers (8 to 42 d of age) to establish regressions between dietary NPP concentration and body weight gain and tibia ash content.",non-phytate phosphorus NPP,CHEMICAL,establish regressions between,weight gain,DISEASE
12737231,"Different concentrations of non-phytate phosphorus (NPP, 2.5, 3.0, 3.5, 4.0 and 4.5 g/kg diet) were given to broilers (8 to 42 d of age) to establish regressions between dietary NPP concentration and body weight gain and tibia ash content.",non-phytate phosphorus NPP,NUTRITION,establish regressions between,weight gain,DISEASE
819474,Depression of plasma calcium by sequestration with a chelating agent was less following low intake of calcium than following adequate calcium intake.,plasma calcium,CHEMICAL,follow,adequate calcium intake,CHEMICAL
819474,Depression of plasma calcium by sequestration with a chelating agent was less following low intake of calcium than following adequate calcium intake.,Depression,MENTAL_HEALTH,follow,adequate calcium intake,CHEMICAL
819474,Depression of plasma calcium by sequestration with a chelating agent was less following low intake of calcium than following adequate calcium intake.,plasma calcium,CHEMICAL,be following low intake of,calcium,CHEMICAL
819474,Depression of plasma calcium by sequestration with a chelating agent was less following low intake of calcium than following adequate calcium intake.,Depression,MENTAL_HEALTH,be following low intake of,calcium,CHEMICAL
24147171,"The heat shock proteins (Hsp), while best known as cancer targets with a number of drug candidates in clinical development, are a family of emerging targets for infectious diseases.",heat shock proteins,DISEASE,be family of emerging targets for,infectious diseases,DISEASE
24147171,"The heat shock proteins (Hsp), while best known as cancer targets with a number of drug candidates in clinical development, are a family of emerging targets for infectious diseases.",drug candidates,CHEBI,be family of emerging targets for,infectious diseases,DISEASE
35591997,"Because dairy cattle are known to shed C. jejuni, we hypothesized that calves in the sick pen were the source of human infections.",dairy cattle,NUTRITION,shed,C. jejuni,DISEASE
35041960,"Thus, the fixed K was considered to repress radiocesium transfer to soybean through both radiocesium fixation and K supply.",fixed K,CHEMICAL,repress radiocesium transfer to,radiocesium fixation,CHEMICAL
35041960,"Thus, the fixed K was considered to repress radiocesium transfer to soybean through both radiocesium fixation and K supply.",fixed K,CHEMICAL,repress radiocesium transfer to,K supply,CHEMICAL
35041960,"Thus, the fixed K was considered to repress radiocesium transfer to soybean through both radiocesium fixation and K supply.",fixed K,CHEMICAL,repress radiocesium transfer to,radiocesium fixation,MENTAL_HEALTH
35041960,"Thus, the fixed K was considered to repress radiocesium transfer to soybean through both radiocesium fixation and K supply.",fixed K,CHEMICAL,repress radiocesium transfer to,soybean,NUTRITION
35041960,"Thus, the fixed K was considered to repress radiocesium transfer to soybean through both radiocesium fixation and K supply.",fixed K,CHEMICAL,repress,radiocesium transfer,CHEMICAL
34954578,"Compared with partial least squares regression (PLSR), support vector machine regression (SVR) analysis exhibited a more satisfying performance on predicting the content of esters, total acids, reducing sugar, salinity and amino acid nitrogen, of which correlation coefficients for prediction (Rp) were about 0.803, 0.949, 0.960, 0.896, 0.923 respectively.",machine regression analysis,MENTAL_HEALTH,reduce,amino acid nitrogen,CHEMICAL
26003667,"Global obesity is a pandemic status, estimated to affect over 2 billion people, that has resulted in an enormous strain on healthcare systems worldwide.",Global obesity,DISEASE,be,pandemic status,CHEMICAL
34920725,"However, the role of LPA signaling in inflammatory neuropathies has remained completely undefined.",LPA signaling,CHEMICAL,have the role in,inflammatory neuropathies,DISEASE
29232991,The drug/drug contaminant (fatty acid or cosmetics) MSI approach could be used by law enforcement personnel to confirm drug abusers of having come into contact with the suspected drug by use of fingerprint scans at time of apprehension which can aid in reducing the work of lab officials.,drug/drug contaminant fatty acid cosmetics MSI approach,NUTRITION,confirm drug abusers by use of fingerprint scans at,apprehension,MENTAL_HEALTH
29232991,The drug/drug contaminant (fatty acid or cosmetics) MSI approach could be used by law enforcement personnel to confirm drug abusers of having come into contact with the suspected drug by use of fingerprint scans at time of apprehension which can aid in reducing the work of lab officials.,drug/drug contaminant fatty acid cosmetics MSI approach,NUTRITION,confirm,drug abusers,CHEBI
34072255,"The involvement of brain mitochondrial dysfunction along with increased reactive oxygen species (ROS) levels, accumulating mtDNA mutations, and attenuated autophagy is implicated in psychiatric and neurodegenerative diseases.",brain mitochondrial dysfunction,DISEASE,be implicated in,psychiatric diseases,DISEASE
34072255,"The involvement of brain mitochondrial dysfunction along with increased reactive oxygen species (ROS) levels, accumulating mtDNA mutations, and attenuated autophagy is implicated in psychiatric and neurodegenerative diseases.",increased reactive oxygen species levels,CHEMICAL,be implicated in,psychiatric diseases,DISEASE
34072255,"In this study, we aimed to find out whether autophagy enhancers (lithium, trehalose, rapamycin, and resveratrol) and/or ROS scavengers [resveratrol, N-acetylcysteine (NAC), and Mn-Tbap) can ameliorate neuronal mild mitochondrial dysfunction.",ROS scavengers,CHEMICAL,ameliorate,neuronal mild mitochondrial dysfunction,DISEASE
34072255,"In this study, we aimed to find out whether autophagy enhancers (lithium, trehalose, rapamycin, and resveratrol) and/or ROS scavengers [resveratrol, N-acetylcysteine (NAC), and Mn-Tbap) can ameliorate neuronal mild mitochondrial dysfunction.",scavengers resveratrol,CHEMICAL,ameliorate,neuronal mild mitochondrial dysfunction,DISEASE
34072255,"In this study, we aimed to find out whether autophagy enhancers (lithium, trehalose, rapamycin, and resveratrol) and/or ROS scavengers [resveratrol, N-acetylcysteine (NAC), and Mn-Tbap) can ameliorate neuronal mild mitochondrial dysfunction.",lithium,NUTRITION,ameliorate,neuronal mild mitochondrial dysfunction,DISEASE
34869674,"Autoimmune-associated AVB, a rare but life-threatening disorder, occurs in 2-5% of pregnancies with positive anti-Ro/SSA (the most common one) and La/SSB antibodies.",Autoimmune-associated AVB,DISEASE,occur in,positive anti-Ro/SSA,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",proanthocyanidins,NUTRITION,be important flavonoids in,Fagopyrum tataricum Gaertn,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",proanthocyanidins,NUTRITION,be important flavonoids in,Tartary buckwheat,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",proanthocyanidins,NUTRITION,be,important flavonoids,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",Anthocyanins,NUTRITION,be important flavonoids in,Fagopyrum tataricum Gaertn,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",Anthocyanins,NUTRITION,be important flavonoids in,Tartary buckwheat,CHEMICAL
32833148,"Anthocyanins and proanthocyanidins (PAs) are important flavonoids in Tartary buckwheat (Fagopyrum tataricum Gaertn.), which provides various vibrant color and stronge abiotic stress resistance.",Anthocyanins,NUTRITION,be,important flavonoids,CHEMICAL
9019317,Obstructive sleep apnea syndrome (OSAS) is characterized by multiple episodes of upper airway (UA) obstruction during sleep.,Obstructive sleep apnea syndrome,MENTAL_HEALTH,be characterized by multiple episodes of,upper airway UA obstruction,CHEMICAL
32544712,"Interestingly, among the 7 closest genes to CADM1, the nicotinamide N-methyltransferase (NNMT) gene is known to be associated with obesity.",nicotinamide N-methyltransferase gene,CHEBI,be associated with,obesity,DISEASE
30503377,"Glucagon-like peptide (GLP-1) is a naturally occurring incretin used as a promising therapeutic agent in the treatment of acute myocardial infarction, dilated cardiomyopathy, and advanced heart failure.",Glucagon-like peptide,CHEMICAL,used as promising therapeutic agent in treatment of,acute myocardial infarction,DISEASE
30503377,"Glucagon-like peptide (GLP-1) is a naturally occurring incretin used as a promising therapeutic agent in the treatment of acute myocardial infarction, dilated cardiomyopathy, and advanced heart failure.",Glucagon-like peptide,CHEMICAL,used as promising therapeutic agent in treatment of,dilated cardiomyopathy,DISEASE
30503377,"However, whether GLP-1 can protect against IH-induced cardiac injury is still unclear.",GLP-1,CHEMICAL,protect against,IH-induced cardiac injury,DISEASE
35437700,"Along with JAK-STAT inhibitors, PPAR-gamma agonists could be used as target therapeutic interventions for autism.",PPAR-gamma agonists,CHEBI,be used along with jak-stat inhibitors as target therapeutic interventions for,autism,MENTAL_HEALTH
35181439,Hyper-inflammatory reaction plays a crucial role in the pathophysiology of depression and anxiety disorders.,Hyper-inflammatory reaction,DISEASE,play crucial role in pathophysiology of,depression,MENTAL_HEALTH
35181439,Hyper-inflammatory reaction plays a crucial role in the pathophysiology of depression and anxiety disorders.,Hyper-inflammatory reaction,DISEASE,play crucial role in pathophysiology of,anxiety disorders,MENTAL_HEALTH
35181439,Administration of an inverse GABAA receptor agonist increased the anxiety of IL-33- deficient mice.,inverse GABAA receptor agonist,CHEBI,increase,anxiety,MENTAL_HEALTH
24098456,"In the highest dose group (160 µg/Kg), TCDD treatment caused a significant reduction of parasite burdens by 10-fold after three weeks while also causing a significant lymphoid atrophy indicating suppression of the non-protective T helper 2 response.",TCDD treatment,CHEMICAL,cause,significant lymphoid atrophy,DISEASE
24098456,These results indicate that TCDD exposure can reduce the severity of leishmanial disease in mice independent of adaptive immunity.,TCDD exposure,CHEMICAL,reduce severity of,leishmanial disease,DISEASE
31256343,"Hypothyroidism reduced the Gsr transcript expression and the activity of CAT and GSR enzymes, while the hyperthyroidism reduced the Gpx4 var2 transcript expression.",Hypothyroidism,DISEASE,reduce,Gsr transcript expression,CHEMICAL
28133506,We conclude that the activation of the Nrf2-Keap 1 antioxidative defense mechanism may play a crucial role in protecting thyroid function from short-term iodide excess in rats.,Nrf2-Keap antioxidative defense mechanism,MENTAL_HEALTH,protect thyroid function from,short-term iodide excess,CHEMICAL
28133506,We conclude that the activation of the Nrf2-Keap 1 antioxidative defense mechanism may play a crucial role in protecting thyroid function from short-term iodide excess in rats.,Nrf2-Keap antioxidative defense mechanism,CHEMICAL,protect thyroid function from,short-term iodide excess,CHEMICAL
18834374,"We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor.",whose's panic disorder,MENTAL_HEALTH,show marked improvement after introduction of,norepinephrine-dopamine reuptake inhibitor,CHEMICAL
18834374,"We report on a 57-year-old woman, diagnosed with Parkinson's disease, whose panic disorder showed marked improvement after introduction of bupropion, a norepinephrine-dopamine reuptake inhibitor.",whose's panic disorder,MENTAL_HEALTH,show marked improvement after introduction of,bupropion,CHEMICAL
18834374,Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.,Bupropion,CHEMICAL,be useful for treatment of patients with,panic disorder,MENTAL_HEALTH
18834374,Bupropion may be useful for the treatment of patients with both panic disorder and Parkinson's disease.,Bupropion,CHEMICAL,be useful for treatment of patients with,Parkinson's disease,DISEASE
15907142,"Five of six double-blind, placebo-controlled trials in schizophrenia, and four of six such trials in depression, have reported therapeutic benefit from omega-3 fatty acids in either the primary or secondary statistical analysis, particularly when EPA is added on to existing psychotropic medication.",depression,MENTAL_HEALTH,report therapeutic benefit from,omega-3 fatty acids,NUTRITION
15907142,"Five of six double-blind, placebo-controlled trials in schizophrenia, and four of six such trials in depression, have reported therapeutic benefit from omega-3 fatty acids in either the primary or secondary statistical analysis, particularly when EPA is added on to existing psychotropic medication.",schizophrenia,MENTAL_HEALTH,report therapeutic benefit from,omega-3 fatty acids,NUTRITION
15907142,Individual clinical trials have suggested benefits of EPA treatment in borderline personality disorder and of combined omega-3 and omega-6 fatty acid treatment for attention-deficit hyperactivity disorder.,omega-3 fatty acid treatment,CHEMICAL,have borderline personality disorder and for,attention-deficit hyperactivity disorder,MENTAL_HEALTH
15907142,Individual clinical trials have suggested benefits of EPA treatment in borderline personality disorder and of combined omega-3 and omega-6 fatty acid treatment for attention-deficit hyperactivity disorder.,omega-3 fatty acid treatment,NUTRITION,have borderline personality disorder and for,attention-deficit hyperactivity disorder,MENTAL_HEALTH
22307992,Traditional management of insomnia relies on general central nervous system (CNS) suppression using GABA modulators.,insomnia,MENTAL_HEALTH,use,GABA modulators,CHEBI
32088382,L-DOPA-induced dyskinesia (LID) is a major complication of long-term dopamine replacement therapy in Parkinson's disease.,L-DOPA-induced dyskinesia,MENTAL_HEALTH,be major complication of,long-term dopamine replacement therapy,CHEMICAL
32088382,L-DOPA-induced dyskinesia (LID) is a major complication of long-term dopamine replacement therapy in Parkinson's disease.,LID,DISEASE,be major complication of,long-term dopamine replacement therapy,CHEMICAL
32088382,L-DOPA-induced dyskinesia (LID) is a major complication of long-term dopamine replacement therapy in Parkinson's disease.,long-term dopamine replacement therapy,CHEMICAL,have a major complication in,Parkinson's disease,DISEASE
32088382,"Glutamate dysregulation plays a critical role in the development of LID, and the group II metabotropic glutamate receptors (mGluR2/3) is believed to regulate the release of glutamate on the presynaptic terminals and inhibits postsynaptic excitation.",group metabotropic glutamate receptors,CHEMICAL,regulate release of,glutamate,CHEMICAL
32088382,"Glutamate dysregulation plays a critical role in the development of LID, and the group II metabotropic glutamate receptors (mGluR2/3) is believed to regulate the release of glutamate on the presynaptic terminals and inhibits postsynaptic excitation.",mGluR2/3,CHEMICAL,regulate release of,glutamate,CHEMICAL
32088382,"Glutamate dysregulation plays a critical role in the development of LID, and the group II metabotropic glutamate receptors (mGluR2/3) is believed to regulate the release of glutamate on the presynaptic terminals and inhibits postsynaptic excitation.",Glutamate dysregulation,CHEMICAL,play critical role in development of,LID,DISEASE
32088382,"We found that pretreatment of NMDA receptor antagonist, amantadine 60 mg/kg, i.p. (AMAN) significantly reduced abnormal involuntary movements (AIMs), in parallel with the reduction of hγ oscillation, and more markedly with a decrease in unstable responses of SPNs.",AMAN,DISEASE,reduce,abnormal involuntary movements,DISEASE
32088382,"We found that pretreatment of NMDA receptor antagonist, amantadine 60 mg/kg, i.p. (AMAN) significantly reduced abnormal involuntary movements (AIMs), in parallel with the reduction of hγ oscillation, and more markedly with a decrease in unstable responses of SPNs.",NMDA receptor antagonist,CHEBI,reduce,abnormal involuntary movements,DISEASE
32088382,"We found that pretreatment of NMDA receptor antagonist, amantadine 60 mg/kg, i.p. (AMAN) significantly reduced abnormal involuntary movements (AIMs), in parallel with the reduction of hγ oscillation, and more markedly with a decrease in unstable responses of SPNs.",mg/kg,CHEMICAL,reduce,abnormal involuntary movements,DISEASE
32088382,"We found that pretreatment of NMDA receptor antagonist, amantadine 60 mg/kg, i.p. (AMAN) significantly reduced abnormal involuntary movements (AIMs), in parallel with the reduction of hγ oscillation, and more markedly with a decrease in unstable responses of SPNs.",amantadine,CHEMICAL,reduce,abnormal involuntary movements,DISEASE
32088382,"In contrast, a mGluR2/3 agonist, LY354740 12 mg/kg, i.p. (LY) significantly shortened the duration of LID but merely exhibited a weak effect in diminishing the intensity of LID or reversing SPN responses.",mGluR2/3 agonist,CHEBI,shorten in contrast duration of,LID,DISEASE
32088382,"In contrast, a mGluR2/3 agonist, LY354740 12 mg/kg, i.p. (LY) significantly shortened the duration of LID but merely exhibited a weak effect in diminishing the intensity of LID or reversing SPN responses.",mGluR2/3 agonist,CHEMICAL,shorten in contrast duration of,LID,DISEASE
32088382,"In contrast, a mGluR2/3 agonist, LY354740 12 mg/kg, i.p. (LY) significantly shortened the duration of LID but merely exhibited a weak effect in diminishing the intensity of LID or reversing SPN responses.",LY,CHEMICAL,shorten in contrast duration of,LID,DISEASE
32088382,"In contrast, a mGluR2/3 agonist, LY354740 12 mg/kg, i.p. (LY) significantly shortened the duration of LID but merely exhibited a weak effect in diminishing the intensity of LID or reversing SPN responses.",LY354740    mg/kg,CHEMICAL,shorten in contrast duration of,LID,DISEASE
10319365,"Rising concentrations of counterregulatory hormones work in concert with cytokines to generate overall insulin and insulin-like growth factor 1 (IGF-1), postreceptor resistance and energy requirements grounded on lipid dependency.",counterregulatory hormones,CHEBI,generate,postreceptor resistance,MENTAL_HEALTH
10319365,"Cytokines stimulate liver 5'-DA and suppress the synthesis of transthyretin (TTR), causing the drop of retinol-binding protein (RBP) and the leakage of increased amounts of T4 and retinol in free form.",Cytokines,CHEMICAL,increased amounts of,retinol,CHEBI
10319365,"The suicidal behavior of thyroxine-binding globulin (TBG), corticosteroid-binding globulin (CBG), and IGFBP-3 allows the occurrence of peak endocrine and mitogenic influences at the site of inflammation.",TBG,CHEMICAL,allow occurrence of,endocrine influences,CHEBI
10319365,"The suicidal behavior of thyroxine-binding globulin (TBG), corticosteroid-binding globulin (CBG), and IGFBP-3 allows the occurrence of peak endocrine and mitogenic influences at the site of inflammation.",suicidal behavior,MENTAL_HEALTH,allow occurrence of,endocrine influences,CHEBI
24646995,"Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children.",quinolones,CHEMICAL,treat,bacterial infections,DISEASE
24646995,"Although quinolones are widely used to treat bacterial infections, some quinolones have unexplained side effects, including deaths among children.",quinolones,CHEMICAL,including,deaths,DISEASE
16533506,"Oral (p.o.) and i.t., but not i.c.v., administration of oxycodone prolonged the tail-flick latency in diabetic mice to a level that was considerably longer than the baseline latency in non-diabetic mice.",oxycodone,CHEMICAL,prolong tail-flick latency in,diabetic mice,DISEASE
16533506,"oxycodone in non-diabetic mice, but not in diabetic mice, was antagonized by pretreatment with a selective mu-opioid receptor antagonist, beta-funaltrexamine.",diabetic mice,DISEASE,be antagonized by pretreatment with,beta-funaltrexamine,CHEMICAL
16533506,"oxycodone in non-diabetic mice, but not in diabetic mice, was antagonized by pretreatment with a selective mu-opioid receptor antagonist, beta-funaltrexamine.",diabetic mice,DISEASE,be antagonized by pretreatment with,selective mu-opioid receptor antagonist,CHEBI
16533506,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the antinociceptive effects of both p.o.- and i.t.-administered oxycodone in diabetic mice.",nor-binaltorphimine,CHEMICAL,abolish on other hand antinociceptive effects of p.o.- and i.t.-administered oxycodone in,diabetic mice,DISEASE
16533506,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the antinociceptive effects of both p.o.- and i.t.-administered oxycodone in diabetic mice.",nor-binaltorphimine,CHEMICAL,abolish on other hand antinociceptive effects of,p.o.- oxycodone,CHEMICAL
16533506,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the antinociceptive effects of both p.o.- and i.t.-administered oxycodone in diabetic mice.",p.o.- oxycodone,CHEMICAL,have the antinociceptive effects in,diabetic mice,DISEASE
16533506,"Naltrindole, a selective delta-opioid receptor antagonist, had no effects on the antinociceptive effect of oxycodone in either non-diabetic or diabetic mice.",oxycodone,CHEMICAL,have the antinociceptive effect in,diabetic,DISEASE
16533506,"These results suggest that the antinociceptive effects of oxycodone may be mediated by spinal kappa-opioid receptors in diabetic mice, whereas it may interact primarily with supraspinal and spinal mu-opioid receptors in non-diabetic mice.",oxycodone,CHEMICAL,be mediated by spinal kappa-opioid receptors in,diabetic mice,DISEASE
16256106,The effect of oxycodone on thermal hyperalgesia in streptozotocin-induced diabetic mice was examined.,oxycodone,CHEMICAL,have the effect on,thermal hyperalgesia,DISEASE
16256106,"When diabetic mice were treated with oxycodone (5 mg/kg, s.c.), the tail-flick latency in diabetic mice was prolonged to the level considerably longer than the baseline latencies of non-diabetic mice.",diabetic mice,DISEASE,be treated with,mg/kg s.c,CHEMICAL
16256106,"When diabetic mice were treated with oxycodone (5 mg/kg, s.c.), the tail-flick latency in diabetic mice was prolonged to the level considerably longer than the baseline latencies of non-diabetic mice.",diabetic mice,DISEASE,be treated with,oxycodone,CHEMICAL
16256106,"Oxycodone, at doses of 1.25-5.0 mg/kg administered s.c., produced a dose-dependent increase in the tail-flick latencies in both diabetic and non-diabetic mice.",Oxycodone,CHEMICAL,produce dose-dependent increase in tail-flick latencies in,diabetic mice,DISEASE
16256106,"The antinociceptive effect of oxycodone was antagonized by pretreatment with a selective delta-opioid receptor antagonist, beta-funaltrexamine (20 mg/kg, s.c.), in both non-diabetic and diabetic mice.",oxycodone,CHEMICAL,be antagonized by pretreatment with,selective delta-opioid receptor antagonist,CHEBI
16256106,"The antinociceptive effect of oxycodone was antagonized by pretreatment with a selective delta-opioid receptor antagonist, beta-funaltrexamine (20 mg/kg, s.c.), in both non-diabetic and diabetic mice.",oxycodone,CHEMICAL,be antagonized by pretreatment with,mg/kg,CHEMICAL
16256106,"The antinociceptive effect of oxycodone was antagonized by pretreatment with a selective delta-opioid receptor antagonist, beta-funaltrexamine (20 mg/kg, s.c.), in both non-diabetic and diabetic mice.",oxycodone,CHEMICAL,be antagonized by pretreatment with,beta-funaltrexamine,CHEMICAL
16256106,"The antinociceptive effect of oxycodone was antagonized by pretreatment with a selective delta-opioid receptor antagonist, beta-funaltrexamine (20 mg/kg, s.c.), in both non-diabetic and diabetic mice.",oxycodone,CHEMICAL,be antagonized by pretreatment with,diabetic,DISEASE
16256106,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the peak (30 min) and persistent (60 and 90 min) antinociceptive effects of oxycodone in diabetic mice.",nor-binaltorphimine,CHEMICAL,abolish on,diabetic mice,DISEASE
16256106,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the peak (30 min) and persistent (60 and 90 min) antinociceptive effects of oxycodone in diabetic mice.",nor-binaltorphimine,CHEMICAL,abolish on,oxycodone,CHEMICAL
16256106,"On the other hand, pretreatment with nor-binaltorphimine practically abolished the peak (30 min) and persistent (60 and 90 min) antinociceptive effects of oxycodone in diabetic mice.",oxycodone,CHEMICAL,have antinociceptive effects in,diabetic mice,DISEASE
16256106,"Naltrindole (35 mg/kg, s.c.), a selective delta-opioid receptor antagonist, had no effects on the antinociceptive effect of oxycodone in both non-diabetic and diabetic mice.",oxycodone,CHEMICAL,have the antinociceptive effect in,diabetic,DISEASE
16256106,"These results suggest that the antinociceptive effects of oxycodone may be mediated by mu- and kappa-opioid receptors in diabetic mice, whereas it may interact primarily with mu-opioid receptors in non-diabetic mice.",oxycodone,CHEMICAL,be mediated by mu- and kappa-opioid receptors in,diabetic mice,DISEASE
31576108,This study was carried out to determine the therapeutic value of air-assisted manual therapeutic deep anterior lamellar keratoplasty (TDALK) in the treatment of fungal keratitis not curable by antifungal chemotherapy.,antifungal chemotherapy,CHEBI,have the treatment of,fungal keratitis curable,DISEASE
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",LTG,CHEMICAL,result in present study in decreased cerebellar mass and level of,VPA,CHEMICAL
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",LTG,CHEMICAL,result in present study in decreased cerebellar mass and level of,proliferating nuclear cell antigen,CHEBI
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",LTG,CHEMICAL,result in present study in,decreased cerebellar mass,DISEASE
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",VPA,CHEMICAL,result in present study in decreased cerebellar mass and level of,VPA,CHEMICAL
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",VPA,CHEMICAL,result in present study in decreased cerebellar mass and level of,proliferating nuclear cell antigen,CHEBI
34942343,"In the present study, exposure of chicken on embryonic day 16 (E16) to LTG or VPA resulted in decreased cerebellar mass and level of proliferating nuclear cell antigen (PCNA) for clinically relevant concentrations of VPA.",VPA,CHEMICAL,result in present study in,decreased cerebellar mass,DISEASE
34951979,6-nitrodopamine (6-ND) is released from rat isolated vas deferens and modulates electrical-field stimulation (EFS) contractions of the rat isolated epididymal vas deferens (RIEVD) via a specific receptor which is blocked by tricyclic antidepressants.,6-nitrodopamine,CHEMICAL,modulate,electrical-field stimulation,DISEASE
34951979,6-nitrodopamine (6-ND) is released from rat isolated vas deferens and modulates electrical-field stimulation (EFS) contractions of the rat isolated epididymal vas deferens (RIEVD) via a specific receptor which is blocked by tricyclic antidepressants.,6-ND,CHEMICAL,modulate,electrical-field stimulation,DISEASE
34951979,"In addition, blockade of the 6-ND receptors by both tricyclic antidepressants and α1-adrenergic receptor antagonists may represent the common mechanism of action responsible for their therapeutic use in the treatment of premature ejaculation.",6-ND receptors,CHEMICAL,represent in addition common mechanism of action responsible for their therapeutic use in,premature ejaculation,MENTAL_HEALTH
34951979,"In addition, blockade of the 6-ND receptors by both tricyclic antidepressants and α1-adrenergic receptor antagonists may represent the common mechanism of action responsible for their therapeutic use in the treatment of premature ejaculation.",tricyclic antidepressants,CHEMICAL,represent in addition common mechanism of action responsible for their therapeutic use in,premature ejaculation,MENTAL_HEALTH
34951979,"In addition, blockade of the 6-ND receptors by both tricyclic antidepressants and α1-adrenergic receptor antagonists may represent the common mechanism of action responsible for their therapeutic use in the treatment of premature ejaculation.",α1-adrenergic receptor antagonists,CHEBI,represent in addition common mechanism of action responsible for their therapeutic use in,premature ejaculation,MENTAL_HEALTH
31223461,Antagonists of the OTR have been reported to inhibit ejaculation in animal models and serve as a potential treatment for premature ejaculation (PE).,Antagonists,CHEBI,serve as potential treatment for,premature ejaculation,MENTAL_HEALTH
10706981,Previous studies in schizophrenia have shown alterations in membrane phospholipids and polyunsaturated fatty acids.,schizophrenia,MENTAL_HEALTH,show alterations in,membrane phospholipids,NUTRITION
10706981,Previous studies in schizophrenia have shown alterations in membrane phospholipids and polyunsaturated fatty acids.,schizophrenia,MENTAL_HEALTH,show alterations in,polyunsaturated fatty acids,NUTRITION
10706981,"Significantly lower amounts of phosphatidylcholine and phosphatidylethanolamine were found in postmortem brain tissue from schizophrenic patients than in those from control groups, even after accounting for potential confounds.",phosphatidylethanolamine,NUTRITION,be found in postmortem brain tissue from,schizophrenic patients,DISEASE
10706981,"Significantly lower amounts of phosphatidylcholine and phosphatidylethanolamine were found in postmortem brain tissue from schizophrenic patients than in those from control groups, even after accounting for potential confounds.",phosphatidylcholine,CHEMICAL,be found in postmortem brain tissue from,schizophrenic patients,DISEASE
10706981,"In addition, strong reductions of total PUFAs and saturated fatty acids were found in schizophrenic brains, relative to control brains.",total PUFAs,CHEMICAL,be found in addition in,schizophrenic brains,DISEASE
10706981,"In addition, strong reductions of total PUFAs and saturated fatty acids were found in schizophrenic brains, relative to control brains.",saturated fatty acids,NUTRITION,be found in addition in,schizophrenic brains,DISEASE
8845691,"Clozapine, an atypical antipsychotic, has been successfully used in the treatment of psychosis in PD patients.",Clozapine,CHEMICAL,be used in treatment of,psychosis,MENTAL_HEALTH
8845691,"The use of clozapine in these patients differs significantly, however, from its use in young, relatively healthy, treatment-resistant schizophrenic patients in the dosage required, side effects, and other aspects of management.",clozapine,CHEMICAL,differ from its use in,young treatment-resistant schizophrenic patients,DISEASE
31233568,"Indeed, a small molecule TrkA partial agonist called D3 normalized TrkA signals and improved memory in cognitive impairment models of ageing and an APP mouse model of Alzheimer's disease.",molecule TrkA partial agonist,CHEBI,improve memory in cognitive impairment models of ageing and app mouse model of,Alzheimer's disease,DISEASE
28686702,"Studies have suggested that benzodiazepines are amnestic drug par excellence, but when taken together, what level of evidence do they generate?",benzodiazepines,CHEMICAL,be,drug par,CHEBI
35510099,"However, chronic health implications can become more apparent as the number of long-term cancer survivors is expected to be increased along with the adverse effect of ADT.",long-term cancer survivors,DISEASE,be increased with adverse effect of,ADT,CHEMICAL
35510099,Previous studies in animals and humans suggest that the level of androgen decreases with age and that cognitive decline occurs with decreases in androgen.,cognitive decline,DISEASE,occur with decreases in,androgen,CHEBI
34978125,The association of testosterone concentrations with dementia risk remains uncertain.,testosterone concentrations,CHEMICAL,have the association with,dementia risk,MENTAL_HEALTH
31421054,"GTS patients showed decreased levels of beta modulation with respect to the healthy controls, during the execution of the task; however, this abnormal pattern returned to be normal when they were explicitly asked to suppress their tics while moving.",GTS patients,DISEASE,show decreased levels of,beta modulation,CHEBI
31421054,This is the first demonstration that voluntary tic suppression in GTS operates through the normalization of the EEG rhythm in the beta frequency range during the execution of a voluntary finger movement.,voluntary tic suppression,DISEASE,operate through normalization of eeg rhythm in,beta frequency range,CHEBI
31421054,This is the first demonstration that voluntary tic suppression in GTS operates through the normalization of the EEG rhythm in the beta frequency range during the execution of a voluntary finger movement.,GTS,DISEASE,operate through normalization of eeg rhythm in,beta frequency range,CHEBI
35361265,Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients.,PAH,CHEMICAL,be second common lung complication in,syndrome patients,DISEASE
35361265,Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients.,PAH,CHEMICAL,be second common lung complication in,APS,DISEASE
35361265,Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients.,Pulmonary arterial hypertension,DISEASE,be second common lung complication in,syndrome patients,DISEASE
35361265,Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients.,Pulmonary arterial hypertension,DISEASE,be second common lung complication in,APS,DISEASE
33395403,"PAH has idiopathic, heritable, and drug/toxin causes and is accompanied by other conditions, including connective tissue disease, congenital heart disease, and portal hypertension.",PAH,CHEMICAL,be accompanied by,portal hypertension,DISEASE
33395403,"PAH has idiopathic, heritable, and drug/toxin causes and is accompanied by other conditions, including connective tissue disease, congenital heart disease, and portal hypertension.",PAH,CHEMICAL,be accompanied by,congenital heart disease,DISEASE
33395403,"PAH has idiopathic, heritable, and drug/toxin causes and is accompanied by other conditions, including connective tissue disease, congenital heart disease, and portal hypertension.",PAH,CHEMICAL,be accompanied by,connective tissue disease,DISEASE
33395403,"PAH has idiopathic, heritable, and drug/toxin causes and is accompanied by other conditions, including connective tissue disease, congenital heart disease, and portal hypertension.",PAH,CHEMICAL,have,idiopathic,DISEASE
33395403,"PAH has idiopathic, heritable, and drug/toxin causes and is accompanied by other conditions, including connective tissue disease, congenital heart disease, and portal hypertension.",PAH,CHEMICAL,have,drug/toxin,CHEMICAL
33395403,"Rarely, portal hypertension causes a type of PAH called portopulmonary hypertension (POPH).",portal hypertension,DISEASE,cause type of,PAH,CHEMICAL
33395403,CASE REPORT A 43-year-old woman with hypopituitarism received hormone replacement therapy after partial hypothalamic resection at age 4 years.,hypopituitarism,DISEASE,receive,hormone replacement therapy,CHEBI
32914681,Pulmonary arterial hypertension (PAH) and interstitial pneumonia (IP) are relatively rare complications of systemic lupus erythematosus (SLE) and are associated with a poor prognosis.,PAH,CHEMICAL,be rare complications of,systemic lupus erythematosus,DISEASE
32914681,Pulmonary arterial hypertension (PAH) and interstitial pneumonia (IP) are relatively rare complications of systemic lupus erythematosus (SLE) and are associated with a poor prognosis.,Pulmonary arterial hypertension,DISEASE,be rare complications of,systemic lupus erythematosus,DISEASE
32914681,Pulmonary arterial hypertension (PAH) and interstitial pneumonia (IP) are relatively rare complications of systemic lupus erythematosus (SLE) and are associated with a poor prognosis.,interstitial pneumonia,DISEASE,be rare complications of,systemic lupus erythematosus,DISEASE
27059687,"Rhodiola rosea L. (roseroot) is a common member of the family Crassulaceae, known as one of the most important popular medicinal plants in the northern region of Europe.",Rhodiola rosea L.,CHEMICAL,be common member of,family Crassulaceae,DISEASE
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",rosavins,CHEMICAL,be responsible in addition for its beneficial effects for,cognitive dysfunction,DISEASE
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",rosavins,CHEMICAL,be responsible in addition for its beneficial effects for,depression,MENTAL_HEALTH
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",rosavins,CHEMICAL,be responsible in addition for its beneficial effects for,fatigue,MENTAL_HEALTH
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",salidroside,CHEMICAL,be responsible in addition for its beneficial effects for,cognitive dysfunction,DISEASE
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",salidroside,CHEMICAL,be responsible in addition for its beneficial effects for,depression,MENTAL_HEALTH
27059687,"In addition, the presence of salidroside, rosavins, and p-tyrosol are responsible for its beneficial effects for the treatment of on depression, fatigue, and cognitive dysfunction.",salidroside,CHEMICAL,be responsible in addition for its beneficial effects for,fatigue,MENTAL_HEALTH
33348035,"Moreover, arsenic toxicity was significantly reduced in HaGSTO1-overexpressing FHM cells, and cell viability increased.",arsenic toxicity,CHEMICAL,be reduced in,HaGSTO1-overexpressing FHM cells,DISEASE
33348035,"Blood HaGSTO1 transcripts were significantly upregulated after Edwardsiella tarda, Streptococcus iniae, lipopolysaccharide, and polyinosinic:polycytidylic acid challenge experiments.",Blood HaGSTO1 transcripts,CHEMICAL,be upregulated after,polyinosinic,CHEMICAL
33348035,"Blood HaGSTO1 transcripts were significantly upregulated after Edwardsiella tarda, Streptococcus iniae, lipopolysaccharide, and polyinosinic:polycytidylic acid challenge experiments.",Blood HaGSTO1 transcripts,CHEMICAL,be upregulated after,lipopolysaccharide,CHEMICAL
33348035,"Blood HaGSTO1 transcripts were significantly upregulated after Edwardsiella tarda, Streptococcus iniae, lipopolysaccharide, and polyinosinic:polycytidylic acid challenge experiments.",Blood HaGSTO1 transcripts,CHEMICAL,be upregulated after,Edwardsiella tarda,DISEASE
33348035,"Collectively, these findings suggest the involvement of HaGSTO1 in the host defense mechanism of seahorses.",HaGSTO1,CHEMICAL,have the involvement in,host defense mechanism,MENTAL_HEALTH
32885282,An adequate supply of calcium as the divalent cation (Ca2+) can hinder STN by inhibiting the accumulation of phenolic compounds and thus programmed cell death.,cation Ca2,CHEMICAL,inhibit accumulation of,phenolic compounds,CHEMICAL
32885282,An adequate supply of calcium as the divalent cation (Ca2+) can hinder STN by inhibiting the accumulation of phenolic compounds and thus programmed cell death.,divalent cation,CHEMICAL,inhibit accumulation of,phenolic compounds,CHEMICAL
32885282,An adequate supply of calcium as the divalent cation (Ca2+) can hinder STN by inhibiting the accumulation of phenolic compounds and thus programmed cell death.,calcium,CHEMICAL,inhibit accumulation of,phenolic compounds,CHEMICAL
28961989,"A strong negative correlation between sucrose and starch content with the severity of continuous light-induced damage quantified as the maximum quantum efficiency of PSII (Fv/Fm) was found across several abnormal light/dark cycles, supporting the hypothesis that carbohydrates play an important role in the continuous light-induced injury.",sucrose,CHEMICAL,have a strong negative correlation with,starch content,NUTRITION
28961989,"A strong negative correlation between sucrose and starch content with the severity of continuous light-induced damage quantified as the maximum quantum efficiency of PSII (Fv/Fm) was found across several abnormal light/dark cycles, supporting the hypothesis that carbohydrates play an important role in the continuous light-induced injury.",starch content,NUTRITION,have a strong negative correlation with,sucrose,CHEMICAL
9461636,"The data suggest that hypochlorite-induced destruction of carotenoids in LDL decreases their resistance to oxidative modification, thus promoting the development of early stages of atherosclerosis.",carotenoids,CHEBI,decrease,resistance,MENTAL_HEALTH
9461636,"The data suggest that hypochlorite-induced destruction of carotenoids in LDL decreases their resistance to oxidative modification, thus promoting the development of early stages of atherosclerosis.",hypochlorite-induced destruction,DISEASE,decrease,resistance,MENTAL_HEALTH
9461636,"The data suggest that hypochlorite-induced destruction of carotenoids in LDL decreases their resistance to oxidative modification, thus promoting the development of early stages of atherosclerosis.",carotenoids,CHEBI,promote development of early stages of,atherosclerosis,DISEASE
9461636,"The data suggest that hypochlorite-induced destruction of carotenoids in LDL decreases their resistance to oxidative modification, thus promoting the development of early stages of atherosclerosis.",hypochlorite-induced destruction,DISEASE,promote development of early stages of,atherosclerosis,DISEASE
35124251,We review the current position of music-based interventions in the treatment of chronic pain and present explanations for the analgesic effects of music through modulation of the primary nociception and discuss the contribution of the mesolimbic dopaminergic system to the affective component of pain perception.,chronic pain,DISEASE,have the treatment for,analgesic effects,CHEBI
30248240,"In contrast to their analgesic properties, excessive use of either opioids or alcohol produces a paradoxical emergence of heightened pain sensitivity to noxious stimuli, termed hyperalgesia, which may promote increased use of opioids or alcohol drinking to manage worsening pain symptoms.",alcohol,CHEMICAL,produce in contrast to their analgesic properties paradoxical emergence of,heightened pain sensitivity,DISEASE
30248240,"In contrast to their analgesic properties, excessive use of either opioids or alcohol produces a paradoxical emergence of heightened pain sensitivity to noxious stimuli, termed hyperalgesia, which may promote increased use of opioids or alcohol drinking to manage worsening pain symptoms.",alcohol,CHEMICAL,produce in contrast to,analgesic properties,CHEBI
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",Low-dose naltrexone,CHEMICAL,be used off-label for treatment of pain and inflammation in,Crohn's disease,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",Low-dose naltrexone,CHEMICAL,be used off-label for treatment of pain and inflammation in,fibromyalgia,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",Low-dose naltrexone,CHEMICAL,be used off-label for treatment of pain and inflammation in,multiple sclerosis,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",Low-dose naltrexone,CHEMICAL,be used off-label for treatment of,inflammation,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",Low-dose naltrexone,CHEMICAL,be used off-label for treatment of,pain,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",inflammation,DISEASE,have treatment in,multiple sclerosis,DISEASE
29377216,"Low-dose naltrexone has been used off-label for treatment of pain and inflammation in multiple sclerosis, Crohn's disease, fibromyalgia, and other diseases.",pain,DISEASE,have treatment in,multiple sclerosis,DISEASE
29377216,Naltrexone is a mu-opioid receptor antagonist indicated by the U.S. Food and Drug Administration for opioid and alcohol dependence.,Naltrexone,CHEMICAL,indicated by u.s. food and drug administration for,opioid dependence,MENTAL_HEALTH
29377216,Naltrexone is a mu-opioid receptor antagonist indicated by the U.S. Food and Drug Administration for opioid and alcohol dependence.,Naltrexone,CHEMICAL,indicated by,Drug,CHEBI
29377216,"Currently, evidence supports the safety and tolerability of low-dose naltrexone in multiple sclerosis, fibromyalgia, and Crohn's disease.",low-dose naltrexone,CHEMICAL,have the safety and tolerability in,multiple sclerosis,DISEASE
25014354,Croaker ZIP9 protein is localized to plasma membranes of croaker granulosa cells and human breast cancer (SKBR-3) cells stably transfected with ZIP9.,Croaker ZIP9 protein,NUTRITION,be localized to plasma membranes of,croaker granulosa cells,NUTRITION
25014354,Croaker ZIP9 protein is localized to plasma membranes of croaker granulosa cells and human breast cancer (SKBR-3) cells stably transfected with ZIP9.,Croaker ZIP9 protein,NUTRITION,be localized to plasma membranes of,human breast cancer SKBR-3 cells,DISEASE
25014354,"Recombinant croaker ZIP9 has a high affinity (dissociation constant, Kd, 12.7 nM), limited capacity (maximal binding capacity 2.8 nM/mg protein), displaceable, single binding site-specific for androgens, characteristic of steroid receptors.",Recombinant croaker ZIP9,NUTRITION,have,dissociation constant,MENTAL_HEALTH
25014354,"Recombinant croaker ZIP9 has a high affinity (dissociation constant, Kd, 12.7 nM), limited capacity (maximal binding capacity 2.8 nM/mg protein), displaceable, single binding site-specific for androgens, characteristic of steroid receptors.",Recombinant croaker ZIP9,NUTRITION,have,androgens,CHEBI
25014354,"Recombinant croaker ZIP9 has a high affinity (dissociation constant, Kd, 12.7 nM), limited capacity (maximal binding capacity 2.8 nM/mg protein), displaceable, single binding site-specific for androgens, characteristic of steroid receptors.",Recombinant croaker ZIP9,NUTRITION,have,steroid receptors,CHEMICAL
34490974,Acquired resistance is a threat to antifungal efficacy in medicine and agriculture.,Acquired resistance,MENTAL_HEALTH,be threat to,antifungal,CHEBI
34156265,"Wheat powdery mildew, caused by Blumeria graminis f. sp. tritici, is managed primarily with cultivar resistance and foliar fungicides.",Wheat powdery mildew,NUTRITION,be managed with,cultivar resistance,MENTAL_HEALTH
34156265,"Wheat powdery mildew, caused by Blumeria graminis f. sp. tritici, is managed primarily with cultivar resistance and foliar fungicides.",Wheat powdery mildew,NUTRITION,be managed with,foliar fungicides,CHEBI
34156265,"Wheat powdery mildew, caused by Blumeria graminis f. sp. tritici, is managed primarily with cultivar resistance and foliar fungicides.",Wheat powdery mildew,DISEASE,be managed with,cultivar resistance,MENTAL_HEALTH
34156265,"Wheat powdery mildew, caused by Blumeria graminis f. sp. tritici, is managed primarily with cultivar resistance and foliar fungicides.",Wheat powdery mildew,DISEASE,be managed with,foliar fungicides,CHEBI
34156265,"While European populations of B. graminis f. sp. tritici are widely insensitive to QoIs, largely because of the cytb mutation G143A, the QoI sensitivity of the U.S. B. graminis f. sp. tritici population had never been evaluated despite years of QoI use on U.S. wheat.",B. graminis f. sp. tritici,DISEASE,be insensitive to,QoIs,CHEBI
34156265,A total of 381 B. graminis f. sp. tritici isolates from 15 central and eastern U.S. states were screened for sensitivity to QoI fungicides pyraclostrobin and picoxystrobin.,B. graminis f. sp. tritici isolates,DISEASE,be screened for sensitivity to,picoxystrobin,CHEMICAL
34156265,A total of 381 B. graminis f. sp. tritici isolates from 15 central and eastern U.S. states were screened for sensitivity to QoI fungicides pyraclostrobin and picoxystrobin.,B. graminis f. sp. tritici isolates,DISEASE,be screened for sensitivity to,fungicides pyraclostrobin,CHEBI
22466348,Cushing's syndrome (CS) is a disorder associated with significant morbidity and mortality due to prolonged exposure to high cortisol concentrations.,Cushing's syndrome,DISEASE,associated with significant morbidity and mortality due to prolonged exposure to,high cortisol concentrations,CHEMICAL
25333319,The role of choline and glycine betaine in nucleophilic displacement reactions was further supported by experiments carried out with stable isotope-labelled precursors (¹³C- and deuterium-labelled).,choline glycine betaine,NUTRITION,have the role in,displacement reactions,MENTAL_HEALTH
18237740,"This analysis attributes anion-specific differences in K(obs), SK(obs), and Delta H degrees (obs) to (i) displacement of a large number of water molecules of hydration [estimated to be 1.0(+/-0.2)x10(3)] from the 5340 A(2) of IHF and H' DNA surface buried in complex formation, and (ii) significant local exclusion of F(-) and Glu(-) from this hydration water, relative to the situation with Cl(-), which we propose is randomly distributed.",H degrees,CHEMICAL,attribute anion-specific differences in,displacement,MENTAL_HEALTH
18237740,"This analysis attributes anion-specific differences in K(obs), SK(obs), and Delta H degrees (obs) to (i) displacement of a large number of water molecules of hydration [estimated to be 1.0(+/-0.2)x10(3)] from the 5340 A(2) of IHF and H' DNA surface buried in complex formation, and (ii) significant local exclusion of F(-) and Glu(-) from this hydration water, relative to the situation with Cl(-), which we propose is randomly distributed.",H degrees,CHEMICAL,attribute anion-specific differences in,Cl(-,CHEMICAL
18237740,"This analysis attributes anion-specific differences in K(obs), SK(obs), and Delta H degrees (obs) to (i) displacement of a large number of water molecules of hydration [estimated to be 1.0(+/-0.2)x10(3)] from the 5340 A(2) of IHF and H' DNA surface buried in complex formation, and (ii) significant local exclusion of F(-) and Glu(-) from this hydration water, relative to the situation with Cl(-), which we propose is randomly distributed.",H degrees,CHEMICAL,attribute anion-specific differences in,F(-,CHEMICAL
18237740,"This analysis attributes anion-specific differences in K(obs), SK(obs), and Delta H degrees (obs) to (i) displacement of a large number of water molecules of hydration [estimated to be 1.0(+/-0.2)x10(3)] from the 5340 A(2) of IHF and H' DNA surface buried in complex formation, and (ii) significant local exclusion of F(-) and Glu(-) from this hydration water, relative to the situation with Cl(-), which we propose is randomly distributed.",H degrees,CHEMICAL,attribute anion-specific differences in,H,CHEMICAL
33833701,"Estimates for lifetime comorbidity of bipolar disorder and alcohol use disorder are substantial and in the range of 40-70%, both for Bipolar I and II disorder, and with male preponderance.",use disorder,DISEASE,be substantial in range of,disorder,DISEASE
33833701,"Estimates for lifetime comorbidity of bipolar disorder and alcohol use disorder are substantial and in the range of 40-70%, both for Bipolar I and II disorder, and with male preponderance.",alcohol use,CHEMICAL,be substantial in range of,disorder,DISEASE
33833701,"Estimates for lifetime comorbidity of bipolar disorder and alcohol use disorder are substantial and in the range of 40-70%, both for Bipolar I and II disorder, and with male preponderance.",bipolar disorder,MENTAL_HEALTH,be substantial in range of,disorder,DISEASE
30734456,"Chemogenetic suppression of mPFC pyramidal neurons significantly attenuated both the acquisition and expression of cocaine CPP, while suppression of mPFC GABAergic neurons affected neither the acquisition nor expression of cocaine CPP.",Chemogenetic suppression,DISEASE,attenuate acquisition and expression of,cocaine CPP,CHEMICAL
33296095,"Despite clear benefits in the management of children with Prader-Willi syndrome (PWS), the role of growth hormone (GH) in adults is unclear.",growth hormone,CHEBI,be,Prader-Willi syndrome,MENTAL_HEALTH
33296095,"Despite clear benefits in the management of children with Prader-Willi syndrome (PWS), the role of growth hormone (GH) in adults is unclear.",growth hormone,CHEBI,be,PWS,DISEASE
30586694,"The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise Capacity) evaluated the efficacy and safety of the endothelin receptor antagonist macitentan in patients with Eisenmenger syndrome.",Eisenmenger Syndrome,DISEASE,evaluate efficacy and safety of endothelin receptor antagonist macitentan in patients with,Eisenmenger syndrome,DISEASE
30586694,"The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise Capacity) evaluated the efficacy and safety of the endothelin receptor antagonist macitentan in patients with Eisenmenger syndrome.",Eisenmenger Syndrome,DISEASE,evaluate efficacy and safety of,endothelin receptor antagonist macitentan,CHEBI
30586694,"The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise Capacity) evaluated the efficacy and safety of the endothelin receptor antagonist macitentan in patients with Eisenmenger syndrome.",Eisenmenger Syndrome,DISEASE,evaluate efficacy and safety of,endothelin receptor antagonist macitentan,CHEMICAL
30586694,"The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise Capacity) evaluated the efficacy and safety of the endothelin receptor antagonist macitentan in patients with Eisenmenger syndrome.",endothelin receptor antagonist macitentan,CHEBI,in patients with,Eisenmenger syndrome,DISEASE
30586694,"The multicenter, double-blind, randomized, placebo-controlled, 16-week, phase III MAESTRO study (Macitentan in Eisenmenger Syndrome to Restore Exercise Capacity) evaluated the efficacy and safety of the endothelin receptor antagonist macitentan in patients with Eisenmenger syndrome.",endothelin receptor antagonist macitentan,CHEMICAL,in patients with,Eisenmenger syndrome,DISEASE
21943933,Bosentan appears to be well tolerated in patients with PAH-CHD with or without Down syndrome.,Bosentan,CHEMICAL,be tolerated in patients with pah-chd with or without,Down syndrome,MENTAL_HEALTH
35592024,"The Panel concluded that: [1] the treatment is of no safety concern, provided that the lactic acid complies with the European Union specifications for food additives; [2] based on the available evidence, it was not possible to conclude on the efficacy of spraying or misting lactic acid on kangaroo, wild pig, goats and sheep carcases; [3] treatment of the above-mentioned carcases with lactic acid may induce reduced susceptibility to the same substance, but this can be minimised; there is currently no evidence that prior exposure of food-borne pathogens to lactic acid leads to the occurrence of resistance levels that compromise antimicrobial therapy; and [4] the release of lactic acid is not of concern for the environment, assuming that wastewaters released by the slaughterhouses are treated on-site, if necessary, to counter the potentially low pH caused by lactic acid, in compliance with local rules.",food-borne pathogens,DISEASE,lead to occurrence of,resistance levels,MENTAL_HEALTH
35592024,"The Panel concluded that: [1] the treatment is of no safety concern, provided that the lactic acid complies with the European Union specifications for food additives; [2] based on the available evidence, it was not possible to conclude on the efficacy of spraying or misting lactic acid on kangaroo, wild pig, goats and sheep carcases; [3] treatment of the above-mentioned carcases with lactic acid may induce reduced susceptibility to the same substance, but this can be minimised; there is currently no evidence that prior exposure of food-borne pathogens to lactic acid leads to the occurrence of resistance levels that compromise antimicrobial therapy; and [4] the release of lactic acid is not of concern for the environment, assuming that wastewaters released by the slaughterhouses are treated on-site, if necessary, to counter the potentially low pH caused by lactic acid, in compliance with local rules.",lactic acid,CHEMICAL,lead to occurrence of,resistance levels,MENTAL_HEALTH
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,seem to effective against,schizophrenia,MENTAL_HEALTH
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,seem to effective against,akathisia,DISEASE
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,seem to effective against,abnormal movements,DISEASE
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",S-adenosylmethionine,CHEMICAL,have,antidepressant properties,CHEMICAL
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",Folate,CHEBI,have,antidepressant properties,CHEMICAL
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",eicosapentaenoic acid,CHEMICAL,have,antidepressant properties,CHEMICAL
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,be beneficial in,ADHD,MENTAL_HEALTH
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,be beneficial in,pyridoxine,CHEBI
25421417,"Folate, S-adenosylmethionine (SAM) and eicosapentaenoic acid (EPA), for instance, seem to have antidepressant properties, zinc may be beneficial in attention deficit hyperactivity disorder (ADHD), vitamin B6 (pyridoxine) could reduce extrapyramidal side effects of antipsychotics and N-acetylcysteine (NAC) seems to be effective against negative symptoms, abnormal movements and akathisia in schizophrenia.",zinc,CHEMICAL,be beneficial in,vitamin B6,CHEBI
25421417,"Psychiatric disorders, in turn, may lead to deficiency of mineral nutrients and vitamins.",Psychiatric disorders,DISEASE,lead in turn to deficiency of,vitamins,CHEBI
25421417,"Although vitamin malnutrition is uncommon in developed countries, vitamin deficiency syndromes, such as pernicious anemia or Wernicke's encephalopathy are still relevant differential diagnoses.",vitamin malnutrition,CHEBI,be uncommon in,pernicious anemia,DISEASE
25421417,"Although vitamin malnutrition is uncommon in developed countries, vitamin deficiency syndromes, such as pernicious anemia or Wernicke's encephalopathy are still relevant differential diagnoses.",vitamin malnutrition,CHEBI,be uncommon in,Wernicke's encephalopathy,DISEASE
25421417,"Although vitamin malnutrition is uncommon in developed countries, vitamin deficiency syndromes, such as pernicious anemia or Wernicke's encephalopathy are still relevant differential diagnoses.",vitamin malnutrition,CHEBI,be uncommon in,vitamin deficiency syndromes,MENTAL_HEALTH
25421417,"Although vitamin malnutrition is uncommon in developed countries, vitamin deficiency syndromes, such as pernicious anemia or Wernicke's encephalopathy are still relevant differential diagnoses.",vitamin malnutrition,CHEBI,be uncommon in,vitamin deficiency syndromes,CHEBI
32457796,The amyloid hypothesis has been the prevailing theory for sporadic AD (SAD) pathogenesis since the discovery of APP gene involvement in familial AD and Down syndrome.,amyloid hypothesis,CHEMICAL,be prevailing theory for,SAD,DISEASE
32457796,The amyloid hypothesis has been the prevailing theory for sporadic AD (SAD) pathogenesis since the discovery of APP gene involvement in familial AD and Down syndrome.,amyloid hypothesis,CHEMICAL,be prevailing theory for,familial AD,DISEASE
32457796,The amyloid hypothesis has been the prevailing theory for sporadic AD (SAD) pathogenesis since the discovery of APP gene involvement in familial AD and Down syndrome.,amyloid hypothesis,CHEMICAL,be prevailing theory for,Down syndrome,MENTAL_HEALTH
22816670,To compare the concentrations of high-energy phosphorus metabolites associated with mitochondrial function in the frontal lobe of depressed adolescents with bipolar disorder (BD) and healthy controls (HC).,depressed adolescents,DISEASE,have the frontal lobe with,bipolar disorder,MENTAL_HEALTH
19621245,"The enzyme pteridine reductase 1 (PTR1) of L. donovani acts as a metabolic bypass for drugs targeting dihydrofolate reductase (DHFR); therefore, for successful antifolate chemotherapy to be developed against Leishmania, it must target both enzyme activities.",enzyme pteridine reductase,CHEMICAL,be developed against,Leishmania,DISEASE
19621245,"The enzyme pteridine reductase 1 (PTR1) of L. donovani acts as a metabolic bypass for drugs targeting dihydrofolate reductase (DHFR); therefore, for successful antifolate chemotherapy to be developed against Leishmania, it must target both enzyme activities.",L. donovani,CHEMICAL,be developed against,Leishmania,DISEASE
19621245,Leishmania cells overexpressing PTR1 tagged at the N-terminal with green fluorescent protein were established to screen for proprietary dihydropyrimidone (DHPM) derivatives of DHFR specificity synthesised in our laboratory.,Leishmania cells,DISEASE,be established to,proprietary dihydropyrimidone DHPM derivatives,CHEMICAL
19621245,Leishmania cells overexpressing PTR1 tagged at the N-terminal with green fluorescent protein were established to screen for proprietary dihydropyrimidone (DHPM) derivatives of DHFR specificity synthesised in our laboratory.,Leishmania cells,DISEASE,be established to,DHFR specificity,CHEMICAL
35589736,"Some amino acids and acylcarnitines were found as potential risk markers for diabetes incidents that reflected the disturbances in the several metabolic pathways among the diabetic population and could be targeted to prevent, diagnose, and treat diabetes.",amino acids,CHEMICAL,be found as potential risk markers for,diabetes incidents,DISEASE
31310849,"However, the potential mechanism of CPF induced kidney toxicity and the roles of miRNAs are still unclear.",CPF,CHEMICAL,induce,kidney toxicity,DISEASE
31310849,We found that CPF could damage the ultrastructure and function of kidney; and also caused antioxidant system disorder.,CPF,CHEMICAL,cause,antioxidant system disorder,DISEASE
31310849,"Taken together, we conclude that CPF causes oxidative stress and miR-19a-AMPK axis disorder, thereby promotes apoptosis and autophagy in common carp kidney.",CPF,CHEMICAL,cause,axis disorder,DISEASE
29892310,"In this study, we found that treatment of Chinese cabbage with β-ocimene inhibited the growth of M. persicae in terms of weight gain and reproduction.",β-ocimene,CHEMICAL,inhibit growth of m. persicae in terms of,weight gain,DISEASE
34994129,Internal damage due to the seven emotions is an important cause of breast cancer and the disorders of hypothalamic-pituitary-adrenal(HPA) axis and endocrine system and the abnormal immune defense mechanism in response to psychological stress all affect the occurrence and development of breast cancer.,abnormal immune defense mechanism,MENTAL_HEALTH,affect occurrence and development of,breast cancer,DISEASE
34994129,Internal damage due to the seven emotions is an important cause of breast cancer and the disorders of hypothalamic-pituitary-adrenal(HPA) axis and endocrine system and the abnormal immune defense mechanism in response to psychological stress all affect the occurrence and development of breast cancer.,breast cancer,DISEASE,affect occurrence and development of,breast cancer,DISEASE
34994129,Internal damage due to the seven emotions is an important cause of breast cancer and the disorders of hypothalamic-pituitary-adrenal(HPA) axis and endocrine system and the abnormal immune defense mechanism in response to psychological stress all affect the occurrence and development of breast cancer.,Internal damage due,DISEASE,be important cause of breast cancer and disorders of,endocrine system,CHEBI
34994129,Internal damage due to the seven emotions is an important cause of breast cancer and the disorders of hypothalamic-pituitary-adrenal(HPA) axis and endocrine system and the abnormal immune defense mechanism in response to psychological stress all affect the occurrence and development of breast cancer.,Internal damage due,DISEASE,be important cause of,breast cancer,DISEASE
26243838,"Nutrition is a modifiable environmental factor that might be important in prevention medicine, which have been applied for many years in the secondary prevention of heart disease with omega-3 PUFAs.",heart disease,DISEASE,have the secondary prevention with,omega-3 PUFAs,CHEMICAL
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,PTSD,DISEASE
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,schizophrenia,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,depression,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,posttraumatic stress disorder,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,dementia,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",dietary PUFA docosahexaenoic acid,CHEMICAL,be associated with onset and progression of,neuropsychiatric illnesses,DISEASE
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,PTSD,DISEASE
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,schizophrenia,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,depression,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,posttraumatic stress disorder,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of neuropsychiatric illnesses such as,dementia,MENTAL_HEALTH
24561447,"Numerous epidemiological studies have shown that deficits in the dietary PUFA docosahexaenoic acid and eicosapentaenoic acid are associated with the onset and progression of neuropsychiatric illnesses such as dementia, schizophrenia, depression, and posttraumatic stress disorder (PTSD).",eicosapentaenoic acid,CHEMICAL,be associated with onset and progression of,neuropsychiatric illnesses,DISEASE
24561447,"Recent clinical trials have offered compelling evidence that suggests that n-3 PUFA could reduce depressive, psychotic, and suicidal symptoms, as well as aggression.",n-3 PUFA,CHEMICAL,reduce,aggression,DISEASE
24561447,"Recent clinical trials have offered compelling evidence that suggests that n-3 PUFA could reduce depressive, psychotic, and suicidal symptoms, as well as aggression.",n-3 PUFA,CHEMICAL,reduce,psychotic,DISEASE
24561447,"Recent clinical trials have offered compelling evidence that suggests that n-3 PUFA could reduce depressive, psychotic, and suicidal symptoms, as well as aggression.",n-3 PUFA,CHEMICAL,reduce,depressive symptoms,DISEASE
24561447,"Although many studies have had the validity of their results questioned because of small sample size, several studies have indicated that n-3 PUFA are useful therapeutic tools for the treatment of dementia, major depression, bipolar disorder, and PTSD.",n-3 PUFA,CHEMICAL,be useful therapeutic tools for treatment of,bipolar disorder,MENTAL_HEALTH
24561447,"Although many studies have had the validity of their results questioned because of small sample size, several studies have indicated that n-3 PUFA are useful therapeutic tools for the treatment of dementia, major depression, bipolar disorder, and PTSD.",n-3 PUFA,CHEMICAL,be useful therapeutic tools for treatment of,PTSD,DISEASE
24561447,"Although many studies have had the validity of their results questioned because of small sample size, several studies have indicated that n-3 PUFA are useful therapeutic tools for the treatment of dementia, major depression, bipolar disorder, and PTSD.",n-3 PUFA,CHEMICAL,be useful therapeutic tools for treatment of,major depression,MENTAL_HEALTH
24561447,"Although many studies have had the validity of their results questioned because of small sample size, several studies have indicated that n-3 PUFA are useful therapeutic tools for the treatment of dementia, major depression, bipolar disorder, and PTSD.",n-3 PUFA,CHEMICAL,be useful therapeutic tools for treatment of,dementia,MENTAL_HEALTH
31981470,"Existing AD drug research and development targets include amyloid, amyloid metabolism/catabolism, tau, inflammation, cholesterol, the cholinergic system, and other neurotransmitters.",Existing AD drug research targets,CHEBI,include,cholesterol,NUTRITION
31981470,"Existing AD drug research and development targets include amyloid, amyloid metabolism/catabolism, tau, inflammation, cholesterol, the cholinergic system, and other neurotransmitters.",Existing AD drug research targets,CHEBI,include,inflammation,DISEASE
31981470,"Existing AD drug research and development targets include amyloid, amyloid metabolism/catabolism, tau, inflammation, cholesterol, the cholinergic system, and other neurotransmitters.",Existing AD drug research targets,CHEBI,include,amyloid metabolism/catabolism,CHEMICAL
28293470,Arginine vasopressin 1B receptor (V1B) antagonists may have utility for the treatment of major depressive disorder (MDD).,Arginine vasopressin 1B receptor antagonists,CHEMICAL,have utility for treatment of,major depressive disorder,MENTAL_HEALTH
28293470,Arginine vasopressin 1B receptor (V1B) antagonists may have utility for the treatment of major depressive disorder (MDD).,Arginine vasopressin 1B receptor antagonists,CHEMICAL,have utility for treatment of,MDD,DISEASE
28293470,Arginine vasopressin 1B receptor (V1B) antagonists may have utility for the treatment of major depressive disorder (MDD).,Arginine vasopressin 1B receptor antagonists,CHEBI,have utility for treatment of,major depressive disorder,MENTAL_HEALTH
28293470,Arginine vasopressin 1B receptor (V1B) antagonists may have utility for the treatment of major depressive disorder (MDD).,Arginine vasopressin 1B receptor antagonists,CHEBI,have utility for treatment of,MDD,DISEASE
33733667,At least 2 V1B receptor antagonists (TS-121 and ABT-436) showed tendencies to reduce the depression scores of patients with major depressive disorder at doses that attenuate HPA axis hyperactivity or block the pituitary V1B receptor.,V1B receptor antagonists TS-121,CHEBI,reduce depression scores of patients with,major depressive disorder,MENTAL_HEALTH
33733667,At least 2 V1B receptor antagonists (TS-121 and ABT-436) showed tendencies to reduce the depression scores of patients with major depressive disorder at doses that attenuate HPA axis hyperactivity or block the pituitary V1B receptor.,V1B receptor antagonists TS-121,CHEBI,reduce,depression scores,MENTAL_HEALTH
33733667,"Importantly, TS-121 showed a clearer efficacy for patients with higher basal cortisol levels than for those with lower basal cortisol levels, which was consistent with the hypothesis that V1B receptor antagonists may be more effective for patients with HPA axis hyperactivity.",V1B receptor antagonists,CHEBI,be effective for patients with,HPA axis hyperactivity,MENTAL_HEALTH
27656352,"The allergic responses are due to IgE antibodies directed against the carbohydrate epitope galactose-α-1,3-galactose (α-Gal) found in mammalian meat.",allergic responses,DISEASE,be due to,IgE antibodies,CHEMICAL
35587421,"The present study determined if the glucocorticoid receptor antagonist PT150 reduces the escalation of fentanyl intake in rats exposed to a ""two-hit"" model of early-life stress (isolation rearing and acute stress).",antagonist PT150,CHEMICAL,reduce escalation of,fentanyl intake,CHEMICAL
35587421,"The present study determined if the glucocorticoid receptor antagonist PT150 reduces the escalation of fentanyl intake in rats exposed to a ""two-hit"" model of early-life stress (isolation rearing and acute stress).",antagonist PT150,CHEBI,reduce escalation of,fentanyl intake,CHEMICAL
31489657,Hericium erinaceus has been used as an anti-atrophic gastritis drug in China with good effect.,Hericium erinaceus,NUTRITION,be used as,anti-atrophic gastritis drug,DISEASE
31489657,Hericium erinaceus has been used as an anti-atrophic gastritis drug in China with good effect.,Hericium erinaceus,NUTRITION,be used as,anti-atrophic gastritis drug,CHEBI
25622751,"The cognitive decline could be rescued by subchronic in vivo treatment with RU486, a glucocorticoid receptor antagonist.",cognitive decline,DISEASE,be rescued by,glucocorticoid receptor antagonist,CHEBI
25622751,"The cognitive decline could be rescued by subchronic in vivo treatment with RU486, a glucocorticoid receptor antagonist.",cognitive decline,DISEASE,be rescued by,RU486,CHEMICAL
23312564,"Here, we analyzed the effects of the glucocorticoid receptor antagonist mifepristone (RU486) in the 3xTg-AD mouse model at an age where hippocampal damage leads to high circulating corticosterone levels.",hippocampal damage,DISEASE,lead to,high circulating corticosterone levels,CHEMICAL
11743984,"In this study, we investigated the effect of a glucocorticoid dexamethasone on glucose deprivation induced cell death of immunostimulated rat primary astrocytes, which is dependent on the production of peroxynitrite from the immunostimulated cells [Choi et al. Glia, 31(2001) 155-164; J. Neuroimmunol. 112 (2001) 55-62].",glucocorticoid dexamethasone,CHEMICAL,have the effect on,glucose deprivation,CHEMICAL
33489024,"W. somnifera is also rich in numerous valued secondary metabolites such as steroids, alkaloids, flavonoids, phenolics, saponins, and glycosides.",W. somnifera,DISEASE,valued secondary metabolites such as,saponins,CHEMICAL
33489024,"W. somnifera is also rich in numerous valued secondary metabolites such as steroids, alkaloids, flavonoids, phenolics, saponins, and glycosides.",W. somnifera,DISEASE,valued secondary metabolites such as,flavonoids,CHEMICAL
33489024,"W. somnifera is also rich in numerous valued secondary metabolites such as steroids, alkaloids, flavonoids, phenolics, saponins, and glycosides.",W. somnifera,DISEASE,valued secondary metabolites such as,steroids,CHEMICAL
7720827,"Parkinsonian symptoms (akinesia, freezing/bracing, sensorimotor neglect) related to the extent of dopamine depletion were evident even in rats with dopamine depletions of only 25%.",dopamine depletion,CHEMICAL,be evident in rats with,dopamine depletions,CHEMICAL
7720827,"Parkinsonian symptoms (akinesia, freezing/bracing, sensorimotor neglect) related to the extent of dopamine depletion were evident even in rats with dopamine depletions of only 25%.",symptoms akinesia related,MENTAL_HEALTH,be evident in rats with,dopamine depletions,CHEMICAL
7720827,"Parkinsonian symptoms (akinesia, freezing/bracing, sensorimotor neglect) related to the extent of dopamine depletion were evident even in rats with dopamine depletions of only 25%.",symptoms akinesia related,DISEASE,be evident in rats with,dopamine depletions,CHEMICAL
35562278,Phenylketonuria (PKU) is a common genetic metabolic disorder that causes phenylalanine accumulation in the blood.,PKU,DISEASE,be,common genetic metabolic disorder,DISEASE
35562278,"These findings indicate that phenylalanine exposure may contribute to microcephaly, abnormal cortical expansion, and myelination lesions in the developing human brain.",phenylalanine exposure,CHEMICAL,contribute to,microcephaly,DISEASE
35562278,"These findings indicate that phenylalanine exposure may contribute to microcephaly, abnormal cortical expansion, and myelination lesions in the developing human brain.",phenylalanine exposure,CHEMICAL,contribute to,myelination lesions,DISEASE
25209836,"α-Synucleinopathies include Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.",α-Synucleinopathies,CHEMICAL,include parkinson's,Lewy bodies,MENTAL_HEALTH
25209836,"α-Synucleinopathies include Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.",α-Synucleinopathies,CHEMICAL,include parkinson's,multiple system atrophy,DISEASE
25209836,Recently accumulation of another member of the synuclein family- γ-synuclein in neurodegenerative diseases compelled the introduction of the term γ-synucleinopathy.,synuclein family- γ-synuclein,CHEMICAL,have another member in,neurodegenerative diseases,DISEASE
26945424,"With respect to AEs, compared with PR, ledipasvir plus sofosbuvir plus PR (OR 2.13, P < 0.001) confer a significant AE in nausea, whereas daclatasvir plus PR (OR 0.20, P < 0.001 and OR 0.18, P < 0.001, respectively) lowered the incidence of fatigue and nausea significantly when compared with ledipasvir plus sofosbuvir plus PR.",ledipasvir,CHEMICAL,confer with respect to aes significant ae in,nausea,DISEASE
26945424,"Daclatasvir plus PR was the most effective in SVR12 and SVR24, but caused an increased AEs profile (headache and insomnia).",Daclatasvir,CHEMICAL,be effective in,SVR24,CHEMICAL
26945424,"Daclatasvir plus PR was the most effective in SVR12 and SVR24, but caused an increased AEs profile (headache and insomnia).",Daclatasvir,CHEMICAL,cause increased,headache,MENTAL_HEALTH
26945424,"Daclatasvir plus PR was the most effective in SVR12 and SVR24, but caused an increased AEs profile (headache and insomnia).",Daclatasvir,CHEMICAL,cause increased,insomnia,MENTAL_HEALTH
26945424,Combined ledipasvir with sofosbuvir or combination of PR was associated with higher incidence of fatigue and nausea.,sofosbuvir,CHEMICAL,be associated with higher incidence of,nausea,DISEASE
26945424,Combined ledipasvir with sofosbuvir or combination of PR was associated with higher incidence of fatigue and nausea.,sofosbuvir,CHEMICAL,be associated with higher incidence of,fatigue,MENTAL_HEALTH
2765932,We have studied the process of acetylcholine receptor desensitization on Aplysia medial pleural neurons under voltage clamp conditions.,acetylcholine receptor desensitization,CHEMICAL,have the process on,Aplysia medial pleural neurons,DISEASE
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",bismuth drugs,NUTRITION,suppress replication of panel of,Human coronavirus 229E,DISEASE
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",bismuth drugs,NUTRITION,suppress replication of panel of,SARS-CoV-2 Alpha variant,NUTRITION
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",bismuth drugs,NUTRITION,suppress replication of panel of,key viral cysteine enzymes/proteases,CHEMICAL
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",bismuth drugs,NUTRITION,suppress replication of panel of,East respiratory syndrome-related coronavirus,DISEASE
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",NAC,CHEMICAL,suppress replication of panel of,Human coronavirus 229E,DISEASE
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",NAC,CHEMICAL,suppress replication of panel of,SARS-CoV-2 Alpha variant,NUTRITION
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",NAC,CHEMICAL,suppress replication of panel of,key viral cysteine enzymes/proteases,CHEMICAL
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",NAC,CHEMICAL,suppress replication of panel of,East respiratory syndrome-related coronavirus,DISEASE
35310492,"Combination of bismuth drugs with NAC suppressed the replication of a panel of medically important coronaviruses including Middle East respiratory syndrome-related coronavirus (MERS-CoV), Human coronavirus 229E (HCoV-229E) and SARS-CoV-2 Alpha variant (B.1.1.7) with broad-spectrum inhibitory activities towards key viral cysteine enzymes/proteases including papain-like protease (PLpro), main protease (Mpro), helicase (Hel) and angiotensin-converting enzyme 2 (ACE2).",bismuth drugs,NUTRITION,have combination with,NAC,CHEMICAL
27256763,"In an open-label pilot study of subjects with alcohol dependence, we tested whether the combination of quetiapine, a weak dopamine D2 receptor antagonist, whose primary metabolite, desalkylquetiapine, is a norepinephrine reuptake inhibitor, and mirtazapine, a potent α2 norepinephrine receptor antagonist, would decrease alcohol drinking and craving.",quetiapine,CHEMICAL,be,norepinephrine reuptake inhibitor,CHEBI
27256763,Twenty very heavy drinkers with alcohol dependence entered a trial of 8 weeks of treatment with quetiapine followed by 8 weeks of treatment with a combination of quetiapine plus mirtazapine.,alcohol dependence,MENTAL_HEALTH,enter trial of weeks of treatment with,quetiapine,CHEMICAL
27256763,Alcohol use was assessed weekly with a Timeline Follow-Back interview and craving with the Penn Alcohol Craving Scale.,Alcohol use,CHEMICAL,crave with,Penn Alcohol Craving Scale,CHEMICAL
27256763,Alcohol use was assessed weekly with a Timeline Follow-Back interview and craving with the Penn Alcohol Craving Scale.,Alcohol use,CHEMICAL,crave with,Penn Alcohol Craving Scale,MENTAL_HEALTH
27256763,"In this open-label pilot study, treatment with quetiapine plus mirtazapine was associated with a decrease in alcohol drinking and craving.",quetiapine,CHEMICAL,be associated in open-label pilot study with decrease in,craving,MENTAL_HEALTH
27256763,"In this open-label pilot study, treatment with quetiapine plus mirtazapine was associated with a decrease in alcohol drinking and craving.",quetiapine,CHEMICAL,be associated in open-label pilot study with decrease in,alcohol drinking,CHEMICAL
27256763,"In this open-label pilot study, treatment with quetiapine plus mirtazapine was associated with a decrease in alcohol drinking and craving.",mirtazapine,CHEMICAL,be associated in open-label pilot study with decrease in,craving,MENTAL_HEALTH
27256763,"In this open-label pilot study, treatment with quetiapine plus mirtazapine was associated with a decrease in alcohol drinking and craving.",mirtazapine,CHEMICAL,be associated in open-label pilot study with decrease in,alcohol drinking,CHEMICAL
31284506,"Glucagon receptor antagonists have indirectly put focus on glucagon's potential role in lipid metabolism, as individuals treated with these antagonists showed dyslipidemia and increased hepatic fat.",Glucagon receptor antagonists,CHEBI,put focus on,glucagon,CHEMICAL
31284506,One emerging field in glucagon biology now seems to include the concept of hepatic glucagon resistance.,glucagon biology,CHEMICAL,include concept of,hepatic glucagon resistance,MENTAL_HEALTH
31284506,One emerging field in glucagon biology now seems to include the concept of hepatic glucagon resistance.,glucagon biology,CHEMICAL,include concept of,hepatic glucagon resistance,CHEMICAL
31284506,"Here, we discuss the roles of glucagon in glucose homeostasis, amino acid metabolism, and lipid metabolism and present speculations on the molecular pathways causing and associating with postulated hepatic glucagon resistance.",glucagon,CHEMICAL,have the roles in,glucose homeostasis,CHEMICAL
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Bup-SR,CHEMICAL,provide stable plasma drug level adequate for,analgesia,MENTAL_HEALTH
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Bup-SR,CHEMICAL,provide,stable plasma drug level,CHEBI
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Bup-HCl,CHEMICAL,fall below therapeutic level by,h. Fent-SR,CHEMICAL
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Carp-SR,CHEMICAL,provide,plasma drug levels similar,CHEBI
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Carp-SR,CHEMICAL,provide,analgesic plasma levels,CHEBI
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Bup-SR,CHEMICAL,provide,plasma drug levels greater,CHEBI
25255070,"Bup-SR provided plasma drug levels greater than the therapeutic level for the first 24 to 48 h after administration, but plasma levels of Bup-HCl fell below the therapeutic level by 4 h. Fent-SR maintained plasma levels greater than reported therapeutic levels for 12 h. Therapeutic levels of the remaining drugs are unknown, but Carp-SR provided plasma drug levels similar to those of Carp for the first 24 h after administration, whereas Melox-SR had greater plasma levels than did Melox for the first 8 h. Butp-SR provided detectable plasma drug levels for the first 24 h, with a dramatic decrease over the first 4 h. These results indicate that Bup-SR provides a stable plasma drug level adequate for analgesia for 24 to 48 h after administration, whereas Carp-SR, Melox-SR, Fent-SR, and Butp-SR would require additional doses to provide analgesic plasma levels beyond 24 h in mice.",Bup-SR,CHEMICAL,provide,detectable plasma drug levels,CHEBI
23207563,"Thus, clenbuterol, a beta-2 adrenergic agonist has recently been shown to partially reverse cardiac remodeling by inducing physiological hypertrophy.",beta-2 adrenergic agonist,CHEBI,induce,physiological hypertrophy,DISEASE
23207563,"Thus, clenbuterol, a beta-2 adrenergic agonist has recently been shown to partially reverse cardiac remodeling by inducing physiological hypertrophy.",clenbuterol,CHEMICAL,induce,physiological hypertrophy,DISEASE
10995307,A free phenolic group on the N-butylphenol moiety was required for high-affinity binding because methoxylated analogues and metabolites glucuronidated at this phenol generally had IC(50) values greater than 200 ng/mL. Ractopamine analogues methoxylated or glucuronidated at the ethanolamine phenol had IC(50) values of 0.7-2.6 ng/mL. Lack of a benzylic hydroxyl group was of less importance to antibody binding than was the correct stereochemical orientation (3R) of ractopamine's N-phenylalkyl group.,N-butylphenol moiety,CHEMICAL,have,benzylic hydroxyl group,CHEMICAL
25713771,"Harmaline, one of the main components of ayahuasca, is a selective and reversible MAO-A inhibitor and a serotonin reuptake inhibitor.",Harmaline,CHEMICAL,be,selective MAO-A inhibitor,DISEASE
25713771,"Harmaline, one of the main components of ayahuasca, is a selective and reversible MAO-A inhibitor and a serotonin reuptake inhibitor.",ayahuasca,CHEMICAL,be,selective MAO-A inhibitor,DISEASE
35506416,"The most consistent findings across studies were higher relative abundances of the genera Streptococcus, Lactobacillus, and Eggerthella and lower relative abundance of the butyrate producing Faecalibacterium in patients with psychiatric disorders.",Faecalibacterium,CHEMICAL,in patients with,psychiatric disorders,DISEASE
35506416,"The most consistent findings across studies were higher relative abundances of the genera Streptococcus, Lactobacillus, and Eggerthella and lower relative abundance of the butyrate producing Faecalibacterium in patients with psychiatric disorders.",butyrate,CHEMICAL,in patients with,psychiatric disorders,DISEASE
16225114,"A female patient aged 22 with fully developed symptoms of anorexia nervosa presented the following metabolic disturbances: persistent hyperuricemia, hyponatruria, (sometimes with sodium lack in urine) as well as frequent hyponatremia and hyper-uricosuria.",anorexia nervosa,MENTAL_HEALTH,following,persistent hyperuricemia,DISEASE
16225114,"A female patient aged 22 with fully developed symptoms of anorexia nervosa presented the following metabolic disturbances: persistent hyperuricemia, hyponatruria, (sometimes with sodium lack in urine) as well as frequent hyponatremia and hyper-uricosuria.",anorexia nervosa,MENTAL_HEALTH,following,frequent hyponatremia,DISEASE
16225114,"A female patient aged 22 with fully developed symptoms of anorexia nervosa presented the following metabolic disturbances: persistent hyperuricemia, hyponatruria, (sometimes with sodium lack in urine) as well as frequent hyponatremia and hyper-uricosuria.",anorexia nervosa,MENTAL_HEALTH,following,sodium lack,CHEMICAL
16225114,"Simultaneously, all the anorexia nervosa symptoms subsided along with sodium metabolism disturbances, while purine metabolism disorders got considerably alleviated.",anorexia nervosa symptoms,MENTAL_HEALTH,subside with,sodium metabolism,CHEMICAL
30123446,Recent literatures indicate that maternal hormone exposure is a risk factor for autism spectrum disorder (ASD).,maternal hormone exposure,CHEBI,be risk factor for,autism spectrum disorder,MENTAL_HEALTH
30123446,Recent literatures indicate that maternal hormone exposure is a risk factor for autism spectrum disorder (ASD).,maternal hormone exposure,CHEBI,be risk factor for,ASD,DISEASE
30123446,"We hypothesize that prenatal progestin exposure may counteract the neuroprotective effect of estrogen and contribute to ASD development, and we aim to develop a method to ameliorate prenatal progestin exposure-induced autism-like behavior.",prenatal progestin exposure,CHEBI,counteract neuroprotective effect of,estrogen,CHEBI
12037206,"BaCl2 superfusion blocked PPN stimulation-induced PRs, suggesting that PRs may be mediated by blockade of potassium channels, in keeping with increased input resistance observed during PRs.",BaCl2 superfusion,CHEMICAL,block,stimulation-induced PRs,CHEMICAL
12037206,"BaCl2 superfusion blocked PPN stimulation-induced PRs, suggesting that PRs may be mediated by blockade of potassium channels, in keeping with increased input resistance observed during PRs.",PRs,CHEMICAL,be mediated by blockade of potassium channels in,increased input resistance,MENTAL_HEALTH
12037206,"BaCl2 superfusion blocked PPN stimulation-induced PRs, suggesting that PRs may be mediated by blockade of potassium channels, in keeping with increased input resistance observed during PRs.",PRs,CHEMICAL,be mediated by blockade of,potassium channels,CHEMICAL
8196526,"To detect the possible existence of depressive disturbances in patients with sickle-cell disease, the Hamilton rating scale for depression (17 items) was used in 30 patients with homozygote sickle-cell disease and 31 carriers of the sickle-cell trait, treated or not with vasodilator drugs.",depression,MENTAL_HEALTH,detect possible existence of depressive disturbances in patients with,sickle-cell disease,DISEASE
8196526,"To detect the possible existence of depressive disturbances in patients with sickle-cell disease, the Hamilton rating scale for depression (17 items) was used in 30 patients with homozygote sickle-cell disease and 31 carriers of the sickle-cell trait, treated or not with vasodilator drugs.",depression,MENTAL_HEALTH,detect possible existence of,depressive disturbances,DISEASE
8196526,"To detect the possible existence of depressive disturbances in patients with sickle-cell disease, the Hamilton rating scale for depression (17 items) was used in 30 patients with homozygote sickle-cell disease and 31 carriers of the sickle-cell trait, treated or not with vasodilator drugs.",depression,MENTAL_HEALTH,be used in patients with,homozygote sickle-cell disease,DISEASE
8196526,"To detect the possible existence of depressive disturbances in patients with sickle-cell disease, the Hamilton rating scale for depression (17 items) was used in 30 patients with homozygote sickle-cell disease and 31 carriers of the sickle-cell trait, treated or not with vasodilator drugs.",depression,MENTAL_HEALTH,be used in patients with,carriers,CHEBI
8196526,"To detect the possible existence of depressive disturbances in patients with sickle-cell disease, the Hamilton rating scale for depression (17 items) was used in 30 patients with homozygote sickle-cell disease and 31 carriers of the sickle-cell trait, treated or not with vasodilator drugs.",depressive disturbances,DISEASE,in patients with,sickle-cell disease,DISEASE
8196526,"Treatment had an effect on agitation in patients, with pentoxyfylline having a soothing effect unlike cinepazide maleate.",pentoxyfylline,CHEMICAL,have soothing effect unlike,cinepazide maleate,CHEMICAL
21604758,The results of sodium dodecylsulfate-polyacrylamide gel electrophoresis show that a recombinant gelatin was successfully expressed in P. pastoris KM71 by methanol induction.,recombinant gelatin,CHEBI,be expressed in,P. pastoris KM71,DISEASE
21604758,The results of sodium dodecylsulfate-polyacrylamide gel electrophoresis show that a recombinant gelatin was successfully expressed in P. pastoris KM71 by methanol induction.,recombinant gelatin,CHEBI,be expressed in,methanol induction,CHEMICAL
21604758,"The results of nuclear magnetic resonance spectroscopy of recombinant gelatin test show that the (1)H and (13)C spectra have many corresponding characteristic displacement peaks, and amino acids composition analysis shows that it contains hydroxyproline and its UV absorption is consistent with the characteristics of gelatin.",(1)H spectra,CHEMICAL,have,many corresponding displacement peaks,MENTAL_HEALTH
33460574,"The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib to adjuvant endocrine therapy improves invasive disease-free survival over endocrine therapy alone in patients with hormone-receptor-positive, HER2-negative, early-stage breast cancer.",palbociclib,CHEMICAL,improve invasive disease-free survival over endocrine therapy in patients with,hormone-receptor-positive early-stage breast cancer,DISEASE
33460574,"The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib to adjuvant endocrine therapy improves invasive disease-free survival over endocrine therapy alone in patients with hormone-receptor-positive, HER2-negative, early-stage breast cancer.",adjuvant endocrine therapy,CHEBI,improve invasive disease-free survival over endocrine therapy in patients with,hormone-receptor-positive early-stage breast cancer,DISEASE
33460574,"The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib to adjuvant endocrine therapy improves invasive disease-free survival over endocrine therapy alone in patients with hormone-receptor-positive, HER2-negative, early-stage breast cancer.",palbociclib,CHEMICAL,improve invasive disease-free survival over,endocrine therapy,CHEBI
33460574,"The PALLAS trial aimed to investigate whether the addition of 2 years of palbociclib to adjuvant endocrine therapy improves invasive disease-free survival over endocrine therapy alone in patients with hormone-receptor-positive, HER2-negative, early-stage breast cancer.",adjuvant endocrine therapy,CHEBI,improve invasive disease-free survival over,endocrine therapy,CHEBI
34104031,COVID-19 is a new global pandemic.,COVID-19,CHEMICAL,be,new global pandemic,DISEASE
34688917,"Cognitive-behavioral therapy (CBT) remains the mainstay treatment for preventing relapse, however, people with chronic cocaine use display cognitive impairments that are associated with poor response to CBT.",chronic cocaine use,CHEMICAL,display,cognitive impairments,DISEASE
26447156,"There are no specific biological treatments for FASDs, but rodent models have shown that prenatal or postnatal choline supplementation reduces cognitive and behavioral deficits.",prenatal choline supplementation,NUTRITION,reduce,cognitive deficits,DISEASE
35360968,The censusADHD Study is a richly phenotyped nationwide cohort of Australian children with attention-deficit/hyperactivity disorder.,censusADHD Study,CHEMICAL,be phenotyped nationwide cohort of australian children with,attention-deficit/hyperactivity disorder,DISEASE
8377009,"Treatment with beta-amyloid caused chronic neurodegenerative changes, including neuronal clumping and dystrophic neurites, whereas glutamate treatment caused rapid neuronal swelling and neurite fragmentation.",glutamate treatment,CHEMICAL,cause,swelling fragmentation,MENTAL_HEALTH
8377009,"Treatment with beta-amyloid caused chronic neurodegenerative changes, including neuronal clumping and dystrophic neurites, whereas glutamate treatment caused rapid neuronal swelling and neurite fragmentation.",glutamate treatment,CHEMICAL,cause,swelling fragmentation,DISEASE
8377009,These results suggest that beta-amyloid is directly neurotoxic to primary human cortical neurons by a mechanism that does not involve excitatory amino acid receptors.,beta-amyloid,CHEMICAL,be,neurotoxic,DISEASE
10723174,"Selective serotonin reuptake inhibitors improve depressive symptoms, compulsions, food craving and disinhibition.",Selective serotonin reuptake inhibitors,CHEMICAL,improve,food craving,MENTAL_HEALTH
10723174,"Selective serotonin reuptake inhibitors improve depressive symptoms, compulsions, food craving and disinhibition.",Selective serotonin reuptake inhibitors,CHEMICAL,improve,compulsions,DISEASE
10723174,"Selective serotonin reuptake inhibitors improve depressive symptoms, compulsions, food craving and disinhibition.",Selective serotonin reuptake inhibitors,CHEMICAL,improve,depressive symptoms,DISEASE
22002961,"Compared with placebo, gaboxadol increased SWS and slow wave activity throughout N1 to N7 (p < 0.05).",gaboxadol,CHEMICAL,increase sws and slow wave activity throughout n1 to,N7,CHEMICAL
22002961,"Compared with placebo, gaboxadol increased SWS and slow wave activity throughout N1 to N7 (p < 0.05).",gaboxadol,CHEMICAL,increase,SWS wave activity,DISEASE
22002961,Increases in SWS correlated with objective and subjective measures of sleep maintenance and subjective sleep quality under placebo and gaboxadol (p < 0.05).,SWS,DISEASE,correlate with objective and subjective measures of sleep maintenance and subjective sleep quality under,gaboxadol,CHEMICAL
22002961,Gaboxadol enhanced SWS and reduced the disruptive effects of noise on sleep initiation and maintenance.,Gaboxadol,CHEMICAL,enhance,SWS,DISEASE
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,NUTRITION,decrease levels of,dehydroepiandrosterone-sulphate,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,NUTRITION,decrease levels of,zinc,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,DISEASE,decrease levels of,dehydroepiandrosterone-sulphate,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,DISEASE,decrease levels of,zinc,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",chronic low grade inflammation,DISEASE,decrease levels of,dehydroepiandrosterone-sulphate,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",chronic low grade inflammation,DISEASE,decrease levels of,zinc,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,NUTRITION,increase,saturated fatty acid levels,NUTRITION
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,NUTRITION,increase,omega-6 PUFA,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,DISEASE,increase,saturated fatty acid levels,NUTRITION
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",tumour necrosis factor alpha,DISEASE,increase,omega-6 PUFA,CHEMICAL
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",chronic low grade inflammation,DISEASE,increase,saturated fatty acid levels,NUTRITION
20038921,"These pathways are: a) chronic low grade inflammation with extended production of nuclear factor kappa B and COX-2 and increased levels of tumour necrosis factor alpha; b) increased O&NS with increased peroxide levels, and phospholipid oxidation including oxidative damage to phosphatidylinositol; c) decreased levels of specific antioxidants, i.e. coenzyme Q10, zinc and dehydroepiandrosterone-sulphate; d) bacterial translocation as a result of leaky gut; e) decreased omega-3 polyunsatutared fatty acids (PUFAs), and increased omega-6 PUFA and saturated fatty acid levels; and f) the presence of viral and bacterial infections and psychological stressors.",chronic low grade inflammation,DISEASE,increase,omega-6 PUFA,CHEMICAL
33869810,"The carotenoids were extracted from mamey and carrot, and their antioxidant capacity were determined via in vitro (ABTS method) and in vivo assays (resistance against oxidative stress in Caenorhabditis elegans).",carotenoids,CHEBI,be extracted from,resistance,MENTAL_HEALTH
2452577,Capsaicin increased specific airway resistance in the unanesthetized guinea pigs and increased insufflation pressure in anesthetized guinea pigs.,Capsaicin,CHEMICAL,increase,specific airway resistance,MENTAL_HEALTH
2452577,"However, intraperitoneal administration of spantide did reduce the effect of the capsaicin aerosol challenge as the specific airway resistance increased.",spantide,CHEMICAL,reduce effect of,capsaicin aerosol challenge,CHEMICAL
2452577,"Because spantide attenuated the effect of capsaicin, increased insufflation pressure and specific airway resistance due to capsaicin challenge in both unanesthetized and anesthetized guinea pigs may be attributed, at least in part, to capsaicin's induction of substance P release or the release of other tachykinins.",spantide,CHEMICAL,attenuate effect of,capsaicin,CHEMICAL
2452577,"Because spantide attenuated the effect of capsaicin, increased insufflation pressure and specific airway resistance due to capsaicin challenge in both unanesthetized and anesthetized guinea pigs may be attributed, at least in part, to capsaicin's induction of substance P release or the release of other tachykinins.",capsaicin challenge,CHEMICAL,be attributed in part to capsaicin's induction of substance p release or release of,other tachykinins,CHEMICAL
2452577,"Because spantide attenuated the effect of capsaicin, increased insufflation pressure and specific airway resistance due to capsaicin challenge in both unanesthetized and anesthetized guinea pigs may be attributed, at least in part, to capsaicin's induction of substance P release or the release of other tachykinins.",capsaicin challenge,CHEMICAL,be attributed in part to,capsaicin,CHEMICAL
2452577,"Because spantide attenuated the effect of capsaicin, increased insufflation pressure and specific airway resistance due to capsaicin challenge in both unanesthetized and anesthetized guinea pigs may be attributed, at least in part, to capsaicin's induction of substance P release or the release of other tachykinins.",specific airway resistance,MENTAL_HEALTH,be attributed in part to capsaicin's induction of substance p release or release of,other tachykinins,CHEMICAL
2452577,"Because spantide attenuated the effect of capsaicin, increased insufflation pressure and specific airway resistance due to capsaicin challenge in both unanesthetized and anesthetized guinea pigs may be attributed, at least in part, to capsaicin's induction of substance P release or the release of other tachykinins.",specific airway resistance,MENTAL_HEALTH,be attributed in part to,capsaicin,CHEMICAL
2441024,It was found that [D-Arg]-SP (3.3 nmol i.t.) reduced mean arterial pressure and cardiac output due to a reduction in stroke volume.,[D-Arg]-SP,CHEMICAL,reduce mean arterial pressure and cardiac output due to reduction in,stroke volume,DISEASE
2441024,"The reduction in spinal cord flow did not appear to be responsible for the [D-Arg]-SP-induced hypotension because kainic acid (i.t.), an agent that interacts with glutamate receptors, produced similar pressor responses in the presence and absence of [D-Arg]-SP.",kainic acid i.t,CHEMICAL,produce similar pressor responses in the presence and absence of,[D-Arg]-SP,CHEMICAL
27133730,"Esculetin significantly reduced LPS-induced elevated levels of pro-inflammatory cytokines including interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in serum and hippocampus.",Esculetin,CHEMICAL,reduce lps-induced elevated levels of,interleukin-1β,CHEMICAL
27133730,"Esculetin significantly reduced LPS-induced elevated levels of pro-inflammatory cytokines including interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in serum and hippocampus.",Esculetin,CHEMICAL,reduce lps-induced elevated levels of,interleukin-6,CHEMICAL
27133730,"Esculetin significantly reduced LPS-induced elevated levels of pro-inflammatory cytokines including interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in serum and hippocampus.",Esculetin,CHEMICAL,reduce lps-induced elevated levels of,tumor necrosis factor-α,DISEASE
27133730,"Esculetin significantly reduced LPS-induced elevated levels of pro-inflammatory cytokines including interleukin-6 (IL-6), interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α) in serum and hippocampus.",Esculetin,CHEMICAL,reduce lps-induced elevated levels of,TNF-α,CHEMICAL
31529334,"DHCB also reversed the depressive-like behavior and memory deficit induced by the glutamatergic antagonist MK-801 in the forced swim and the novel object recognition assays, respectively.",DHCB,CHEMICAL,reverse,behavior deficit,DISEASE
31529334,"The effectiveness of DHCB in reversing responses that mimic negative and cognitive deficits of schizophrenia might suggest that its anti-schizophrenia effects are mediated through modulating the activities of several receptor particularly sigma 1, sigma 2, 5-HT7 and dopamine receptors.",anti-schizophrenia effects,CHEMICAL,modulate activities of,dopamine receptors,CHEMICAL
29800604,"Perturbations of DA signaling in humans are associated with multiple neurodegenerative and behavioral disorders, including Parkinson's disease, attention-deficit/hyperactivity disorder, addiction and schizophrenia.",DA signaling,CHEMICAL,including parkinson's,schizophrenia,MENTAL_HEALTH
29800604,"Perturbations of DA signaling in humans are associated with multiple neurodegenerative and behavioral disorders, including Parkinson's disease, attention-deficit/hyperactivity disorder, addiction and schizophrenia.",DA signaling,CHEMICAL,including parkinson's,attention-deficit/hyperactivity disorder,DISEASE
29800604,"Loss of function mutations in genes that support DA biosynthesis, DA vesicular packaging and DA action at the extrasynaptic D2-type DA receptor DOP-3 suppress Swip in dat-1 animals, consistent with paralysis as arising from excessive DA signaling.",extrasynaptic D2-type DA receptor DOP-3,CHEMICAL,suppress swip in dat-1 animals consistent with,paralysis,DISEASE
29800604,"Loss of function mutations in genes that support DA biosynthesis, DA vesicular packaging and DA action at the extrasynaptic D2-type DA receptor DOP-3 suppress Swip in dat-1 animals, consistent with paralysis as arising from excessive DA signaling.",DA vesicular packaging,CHEMICAL,suppress swip in dat-1 animals consistent with,paralysis,DISEASE
29800604,"Loss of function mutations in genes that support DA biosynthesis, DA vesicular packaging and DA action at the extrasynaptic D2-type DA receptor DOP-3 suppress Swip in dat-1 animals, consistent with paralysis as arising from excessive DA signaling.",function mutations,DISEASE,suppress swip in dat-1 animals consistent with,paralysis,DISEASE
29800604,"Loss of function mutations in genes that support DA biosynthesis, DA vesicular packaging and DA action at the extrasynaptic D2-type DA receptor DOP-3 suppress Swip in dat-1 animals, consistent with paralysis as arising from excessive DA signaling.",DA action,CHEMICAL,suppress swip in dat-1 animals consistent with,paralysis,DISEASE
31136705,"Therefore, Ageritin and α-sarcin can induce resistance not only to insects but also to viruses, bacteria, and fungi.",Ageritin,CHEMICAL,induce,resistance,MENTAL_HEALTH
31136705,"Therefore, Ageritin and α-sarcin can induce resistance not only to insects but also to viruses, bacteria, and fungi.",α-sarcin,CHEMICAL,induce,resistance,MENTAL_HEALTH
31136705,The multiple biological activities of Ageritin could be exploited to improve resistance to different pathogens by engineering transgenic plants.,Ageritin,CHEMICAL,improve,resistance,MENTAL_HEALTH
10681671,"In contrast, uremia is associated with excessive systemic NO release, both in experimental model and in human beings.",uremia,DISEASE,be associated in contrast with,excessive NO release,CHEMICAL
10681671,"A putative cause for excessive NO production in uremia can be guanidinosuccinate, an uremic toxin that accumulates in the circulation of uremic patients and upregulates NO synthesis from cultured endothelial cells.",uremia,DISEASE,be,guanidinosuccinate,CHEMICAL
10681671,"A putative cause for excessive NO production in uremia can be guanidinosuccinate, an uremic toxin that accumulates in the circulation of uremic patients and upregulates NO synthesis from cultured endothelial cells.",excessive NO production,CHEMICAL,be,guanidinosuccinate,CHEMICAL
10681671,Upregulation of systemic NO synthesis might be a defense mechanism against hypertension of uremia.,systemic NO synthesis,CHEMICAL,be defense mechanism against hypertension of,uremia,DISEASE
10681671,Upregulation of systemic NO synthesis might be a defense mechanism against hypertension of uremia.,systemic NO synthesis,CHEMICAL,be defense mechanism against,hypertension,DISEASE
10681671,Upregulation of systemic NO synthesis might be a defense mechanism against hypertension of uremia.,systemic NO synthesis,CHEMICAL,be,defense mechanism,MENTAL_HEALTH
17017939,"The discovery that inhibition of phosphodiesterase-5 (PDE5) reduces the degradation of cGMP, allowing erectile function to occur by relaxation of penile smooth muscle, represents a revolutionary approach or the treatment of erectile dysfunction (ED).",phosphodiesterase-5,CHEMICAL,reduce degradation of,cGMP,CHEMICAL
31281286,"The following variables including age, disease duration, levodopa equivalent daily doses (LEDD), the proportion of males, the proportion of participants using levodopa, dopaminergic agonist, amantadine and entacapone, the proportion of motor fluctuations, scores of Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Unified PD Rating Scale (UPDRS) part III, and Hoehn and Yahr (H&Y) stage were significantly higher in patients with PS compared with patients without PS (P P = 0.030), higher LEDD (OR = 1.002, P P Conclusion: PS is relatively rare (3.6%) in Chinese PD patients.",levodopa equivalent daily doses,CHEMICAL,be higher in patients with,PS,CHEMICAL
31281286,"The following variables including age, disease duration, levodopa equivalent daily doses (LEDD), the proportion of males, the proportion of participants using levodopa, dopaminergic agonist, amantadine and entacapone, the proportion of motor fluctuations, scores of Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Unified PD Rating Scale (UPDRS) part III, and Hoehn and Yahr (H&Y) stage were significantly higher in patients with PS compared with patients without PS (P P = 0.030), higher LEDD (OR = 1.002, P P Conclusion: PS is relatively rare (3.6%) in Chinese PD patients.",PS,CHEMICAL,be rare in,Chinese PD patients,DISEASE
31281286,"The following variables including age, disease duration, levodopa equivalent daily doses (LEDD), the proportion of males, the proportion of participants using levodopa, dopaminergic agonist, amantadine and entacapone, the proportion of motor fluctuations, scores of Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Unified PD Rating Scale (UPDRS) part III, and Hoehn and Yahr (H&Y) stage were significantly higher in patients with PS compared with patients without PS (P P = 0.030), higher LEDD (OR = 1.002, P P Conclusion: PS is relatively rare (3.6%) in Chinese PD patients.",Depression Scale,MENTAL_HEALTH,be higher in patients with,PS,CHEMICAL
35400471,"The D values of S. Enteritidis increased with increasing fat (0-56.7%, w.b.) and decreasing protein contents (83.59-31.81%, w.b.).",S. Enteritidis,DISEASE,decrease,protein contents w.b,CHEMICAL
35400471,"The D values of S. Enteritidis increased with increasing fat (0-56.7%, w.b.) and decreasing protein contents (83.59-31.81%, w.b.).",S. Enteritidis,DISEASE,increasing,fat w.b,CHEMICAL
35315845,Egg white protein ovotransferrin derived peptide IRW (Ile-Arg-Trp) was found to improve tumor necrosis factor alpha (TNF-α) or angiotensin II induced insulin resistance in L6 cells.,Ile-Arg-Trp,CHEMICAL,improve,tumor necrosis factor alpha,NUTRITION
35315845,Egg white protein ovotransferrin derived peptide IRW (Ile-Arg-Trp) was found to improve tumor necrosis factor alpha (TNF-α) or angiotensin II induced insulin resistance in L6 cells.,Ile-Arg-Trp,CHEMICAL,improve,tumor necrosis factor alpha,DISEASE
33237342,This retrospective study suggests that hypophosphatemia commonly occurs among MM patients receiving elotuzumab-containing therapies.,hypophosphatemia,DISEASE,occur among,MM patients,DISEASE
35595506,"Sporulation rates in B. cereus, B. sphaericus, and B. thuringiensis were higher at 30°C than the rates at 37°C at a difference of 5%, 65%, and 20%, respectively.",B. sphaericus,DISEASE,be higher at,° C,CHEMICAL
35592903,"Sorafenib is known as the first-line medication for advanced HCC; however, it only extends the limited benefit for HCC patients as the development of acquired resistance.",Sorafenib,CHEMICAL,be known as first-line medication for,advanced HCC,DISEASE
35592903,Withaferin A exerts broad pharmaceutical applications in several cancers.,Withaferin A,CHEMICAL,exert broad pharmaceutical applications in,several cancers,DISEASE
35592903,Withaferin A exerts broad pharmaceutical applications in several cancers.,Withaferin A,CHEMICAL,exert,broad pharmaceutical applications,CHEBI
35592903,"Consequently, Withaferin A may attenuate the metastatic potential and sorafenib resistance by regulating Keap1/Nrf2-associated EMT and ferroptosis.",Withaferin A,CHEMICAL,attenuate,resistance,MENTAL_HEALTH
35592903,"Consequently, Withaferin A may attenuate the metastatic potential and sorafenib resistance by regulating Keap1/Nrf2-associated EMT and ferroptosis.",Withaferin A,CHEMICAL,attenuate,sorafenib,CHEMICAL
35592903,"Consequently, Withaferin A may attenuate the metastatic potential and sorafenib resistance by regulating Keap1/Nrf2-associated EMT and ferroptosis.",Withaferin A,CHEMICAL,regulate,Keap1/Nrf2-associated EMT,CHEMICAL
35592903,"Thus, Withaferin A may serve as a promising agent for HCC therapy, especially for advanced HCC.",Withaferin A,CHEMICAL,serve as promising agent for hcc therapy for,advanced HCC,DISEASE
35592903,"Thus, Withaferin A may serve as a promising agent for HCC therapy, especially for advanced HCC.",Withaferin A,CHEMICAL,serve as promising agent for,HCC therapy,DISEASE
25856390,"Although alexithymic subjects with GAD may show a CRP and cholesterol dysregulation, this latter seems independent on increased suicide ideation, rather to Difficulty in Identifying Feelings, and subthreshold depressive symptoms.",GAD,DISEASE,show,cholesterol,NUTRITION
8345723,Pharmacotherapy with anticholinergic agents was studied in a total of 80 patients aged 65 years or older with chief complaints of urinary frequency (4 patients) and/or ugency incontinence (76 patients).,anticholinergic agents,CHEBI,be studied in total of patients aged or older with chief complaints of,ugency incontinence,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,temporal lobe pathology,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,Alzheimer type,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,senile dementia,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,dementia syndromes,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,dementia,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as neuroprotective drug for use in patients with,Parkinson's disease,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,temporal lobe pathology,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,Alzheimer type,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,senile dementia,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,dementia syndromes,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,dementia,MENTAL_HEALTH
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as neuroprotective drug for use in patients with,Parkinson's disease,DISEASE
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEBI,be proposed as,neuroprotective drug,CHEBI
7919173,"The antispastic agent and N-methyl-D-aspartate (NMDA) receptor antagonist memantine has recently been proposed as a neuroprotective drug for use in patients with dementia syndromes with primarily temporal lobe pathology, e.g. senile dementia of Alzheimer type or dementia in Parkinson's disease.",N-methyl-D-aspartate NMDA receptor antagonist memantine,CHEMICAL,be proposed as,neuroprotective drug,CHEBI
7919173,"As these inhibition constants are well within the therapeutic concentration range of memantine, antagonism of endogenous glutamate at limbic NMDA receptors may be one molecular mechanism by which memantine is beneficial in dementia syndromes.",endogenous glutamate,CHEMICAL,be molecular mechanism as,memantine,CHEMICAL
7919173,"As these inhibition constants are well within the therapeutic concentration range of memantine, antagonism of endogenous glutamate at limbic NMDA receptors may be one molecular mechanism by which memantine is beneficial in dementia syndromes.",limbic NMDA receptors,CHEMICAL,be molecular mechanism as,memantine,CHEMICAL
7919173,"As these inhibition constants are well within the therapeutic concentration range of memantine, antagonism of endogenous glutamate at limbic NMDA receptors may be one molecular mechanism by which memantine is beneficial in dementia syndromes.",memantine,CHEMICAL,be beneficial by,dementia syndromes,MENTAL_HEALTH
33802719,"Fungicides, which restrict chemical synthesis in fungi, are the strongest controls for plant diseases.",Fungicides,CHEBI,be strongest controls for,plant diseases,DISEASE
33802719,Protection of Rhizoctonia solani viability reached 46.8% for gallnut and 37.88% for clove in water emulsions of 1000 μg/mL gallnut and clove in the presence of 0.1% Tween 80.,Rhizoctonia solani viability,DISEASE,reach % for gallnut and % for clove in,Tween,CHEMICAL
33802719,Protection of Rhizoctonia solani viability reached 46.8% for gallnut and 37.88% for clove in water emulsions of 1000 μg/mL gallnut and clove in the presence of 0.1% Tween 80.,Rhizoctonia solani viability,DISEASE,reach % for gallnut and % for clove in,μg/mL gallnut,CHEMICAL
35562809,We present the case of a carrier of Gaucher disease with gestational thrombocytopenia and anemia that required blood transfusion therapy.,Gaucher disease,DISEASE,have a carrier with,anemia,DISEASE
35562809,We present the case of a carrier of Gaucher disease with gestational thrombocytopenia and anemia that required blood transfusion therapy.,Gaucher disease,DISEASE,have a carrier with,gestational thrombocytopenia,DISEASE
1710460,"Other evidence of the ability of synaptosomes to maintain homeostasis was the failure of mitochondrial inhibitors to significantly reduce pH. The drop in synaptosomal pH effected by amiloride, an inhibitor of Na+/H+ exchange, and the transient rise in pH caused by ammonium chloride further suggested that synaptosomes may be a good model in the study of the regulation of intracellular pH. The elevation of cytosolic pH, and depression of oxygen radical formation by chlordecone, may result from both the attenuation of respiratory metabolism and an impaired capacity of the plasma membrane to maintain ionic gradients.",chlordecone,CHEMICAL,have and depression of,oxygen radical formation,CHEMICAL
24346956,"Drug treatment is the first-line treatment for acute mania with the initial aim of rapid control of agitation, aggression and dangerous behaviour.",Drug treatment,CHEBI,be first-line treatment for acute mania with initial aim of,aggression,DISEASE
24346956,"Drug treatment is the first-line treatment for acute mania with the initial aim of rapid control of agitation, aggression and dangerous behaviour.",Drug treatment,CHEBI,be first-line treatment for acute mania with initial aim of,agitation,MENTAL_HEALTH
24346956,"Drug treatment is the first-line treatment for acute mania with the initial aim of rapid control of agitation, aggression and dangerous behaviour.",Drug treatment,CHEBI,be first-line treatment for acute mania with initial aim of,dangerous behaviour,DISEASE
24346956,"Drug treatment is the first-line treatment for acute mania with the initial aim of rapid control of agitation, aggression and dangerous behaviour.",Drug treatment,CHEBI,be first-line treatment for,acute mania,MENTAL_HEALTH
24346956,"Aripiprazole, an atypical antipsychotic, is used in the treatment of mania both as monotherapy and combined with other medicines.",Aripiprazole,CHEMICAL,be used in treatment of,mania,MENTAL_HEALTH
24346956,"The British Association of Psychopharmacology guidelines report that, in monotherapy placebo-controlled trials, the atypical antipsychotics, including aripiprazole, have been shown to be effective for acute manic or mixed episodes.",aripiprazole,CHEMICAL,be shown in monotherapy placebo-controlled trials to effective for,manic episodes,DISEASE
34109745,"Regardless, two isolates, 'Carnobacterium maltaromaticum sm-2' and 'Arthrobacter citreus sm', showed multi-resistance to two or more antibiotics including ampicillin and streptomycin indicating multiple resistance genes.",Carnobacterium maltaromaticum sm-2,CHEMICAL,show multi-resistance to,ampicillin,CHEMICAL
34109745,"Regardless, two isolates, 'Carnobacterium maltaromaticum sm-2' and 'Arthrobacter citreus sm', showed multi-resistance to two or more antibiotics including ampicillin and streptomycin indicating multiple resistance genes.",Carnobacterium maltaromaticum sm-2,CHEMICAL,show multi-resistance to,streptomycin,CHEMICAL
34109745,"Regardless, two isolates, 'Carnobacterium maltaromaticum sm-2' and 'Arthrobacter citreus sm', showed multi-resistance to two or more antibiotics including ampicillin and streptomycin indicating multiple resistance genes.",Carnobacterium maltaromaticum sm-2,CHEMICAL,show multi-resistance to,antibiotics,CHEBI
34109745,"Regardless, two isolates, 'Carnobacterium maltaromaticum sm-2' and 'Arthrobacter citreus sm', showed multi-resistance to two or more antibiotics including ampicillin and streptomycin indicating multiple resistance genes.",Carnobacterium maltaromaticum sm-2,CHEMICAL,indicate,multiple resistance genes,MENTAL_HEALTH
30170111,"Therefore, the study on the response of pufferfish to the TBT exposure may contribute to reveal toxic injury mechanism of T. obscurus under TBT exposure.",TBT exposure,CHEMICAL,reveal toxic injury mechanism of,TBT exposure,CHEMICAL
30170111,"Therefore, the study on the response of pufferfish to the TBT exposure may contribute to reveal toxic injury mechanism of T. obscurus under TBT exposure.",TBT exposure,CHEMICAL,reveal,toxic injury mechanism,DISEASE
30213874,"The p.R745C variant within the tyrosine kinase domain was associated with defects in platelet aggregation, αIIbβ3 activation, and granule secretion induced by G-protein-coupled receptor (GPCR) agonists and convulxin, as well as in thrombus formation on collagen under flow.",tyrosine kinase domain,CHEMICAL,be associated with defects in,platelet aggregation,DISEASE
30213874,"The p.R745C variant within the tyrosine kinase domain was associated with defects in platelet aggregation, αIIbβ3 activation, and granule secretion induced by G-protein-coupled receptor (GPCR) agonists and convulxin, as well as in thrombus formation on collagen under flow.",tyrosine kinase domain,CHEMICAL,be associated with defects in,thrombus formation,DISEASE
25010374,Nutritional supplements are a feasible intervention for primary prevention and several epidemiological studies have indicated links between low folate status and depressive symptomatology in the general population.,low folate status,NUTRITION,have links with,depressive symptomatology,DISEASE
25010374,Nutritional supplements are a feasible intervention for primary prevention and several epidemiological studies have indicated links between low folate status and depressive symptomatology in the general population.,depressive symptomatology,DISEASE,have links with,low folate status,NUTRITION
23760977,Maternal folate supplementation reduces offspring risk for neural tube defects (NTDs) and other congenital abnormalities.,Maternal folate supplementation,NUTRITION,reduce offspring risk for,other congenital abnormalities,DISEASE
23760977,"Mood disorders (e.g., depression, bipolar disorder) are common among women and can be associated with folate deficiency.",depression,MENTAL_HEALTH,be associated with,folate deficiency,CHEBI
23760977,"Mood disorders (e.g., depression, bipolar disorder) are common among women and can be associated with folate deficiency.",Mood disorders,MENTAL_HEALTH,be associated with,folate deficiency,CHEBI
23760977,"Thus, pregnant women with histories of mood disorders may be prone to RBC folate levels insufficient to provide optimal protection against neural tube defects.",mood disorders,MENTAL_HEALTH,be prone to,RBC folate levels insufficient,NUTRITION
34422484,"However, it is a lesser known fact that glycyrrhizic acid, the active component in licorice, can cause a metabolic syndrome presenting as pseudohyperaldosteronism.",glycyrrhizic acid,CHEMICAL,cause,metabolic syndrome,DISEASE
9311548,"The study findings indicated that exposure to Zn3P2 not only caused mild acute and subacute liver cell damage, but also affected renal function and perhaps B-cells of the pancreas.",Zn3P2,CHEMICAL,cause,mild acute liver cell damage,DISEASE
31682992,The most studied models of PD are based on the use of neurotoxins that induce an almost complete striatal denervation.,PD,DISEASE,be based on use of,neurotoxins,CHEBI
26072303,Hyposmia following dopaminergic deafferentation was reversed by treatment with the D1/D2/D3 dopamine receptor agonist rotigotine.,Hyposmia,DISEASE,be reversed by treatment with,D1/D2/D3 dopamine receptor agonist rotigotine,CHEBI
26072303,Hyposmia following dopaminergic deafferentation was reversed by treatment with the D1/D2/D3 dopamine receptor agonist rotigotine.,Hyposmia,DISEASE,be reversed by treatment with,D1/D2/D3 dopamine receptor agonist rotigotine,CHEMICAL
35580314,"In more recent years, ambroxol has gained interest for its potential usefulness in treating neuropathic pain.",ambroxol,CHEMICAL,treat,neuropathic pain,DISEASE
35580314,"Ambroxol is a commercially available inhibitor of Nav1.8, a crucial player in the pathophysiology of neuropathic pain, and Nav1.7, a particularly exciting target for the treatment of chronic pain.",Ambroxol,CHEMICAL,be available inhibitor of,neuropathic pain,DISEASE
35367871,Dexamethasone has been widely used in clinical practice to promote fetal lung maturity and reduce neonatal respiratory distress syndrome and perinatal mortality.,Dexamethasone,CHEMICAL,reduce,neonatal respiratory distress syndrome,DISEASE
25046456,"The use of topical ketamine, which blocks n-methyl-D-aspartate receptors in a non-competitive fashion, might be a useful tool for the treatment of HS pain.",topical ketamine,CHEMICAL,be useful tool for treatment of,HS pain,DISEASE
25046456,"Nevertheless, topical amitriptyline increase of the tactile and mechanical nociceptive thresholds and can be used for topical pain control in compound mixture of analgesics .",topical amitriptyline increase,CHEMICAL,be used for topical pain control in,compound mixture,CHEBI
25046456,"Nevertheless, topical amitriptyline increase of the tactile and mechanical nociceptive thresholds and can be used for topical pain control in compound mixture of analgesics .",topical amitriptyline increase,CHEMICAL,be used for,topical pain control,DISEASE
3223170,Patients with neurotic disturbances showed activation of peroxidation expressed in increase of its initial and end products and decreased levels of alpha-tocopherol.,neurotic disturbances,DISEASE,decrease levels of,alpha-tocopherol,CHEBI
19025777,"On primary outcome measures, atomoxetine was associated with improved ED based on the Clinical Global Impression-Change Scale (75% positive response rate; 95% CI: 43-95%, P < 05) and behavioral measures of ED [Frontal Systems Behavior Scale (FrSBE) Executive Dysfunction and Connors Adult ADHD Rating Scale (CAARS) inattention/memory subscales].",atomoxetine,CHEMICAL,be associated on primary outcome measures with,ADHD Rating Scale,MENTAL_HEALTH
15614311,BACKGROUND: Mania is a rare but unwelcome side effect of treating depressed patients with antidepressants.,Mania,MENTAL_HEALTH,treat depressed patients with,antidepressants,CHEMICAL
15614311,BACKGROUND: Mania is a rare but unwelcome side effect of treating depressed patients with antidepressants.,Mania,MENTAL_HEALTH,treat,depressed patients,DISEASE
19195453,"This drug is a nonpeptide PI, with a distinct chemical structure that, by conferring it drug with enhanced binding affinity and a slower dissociation rate, makes it more potent than the remaining PIs developed to date.",drug,CHEBI,be,nonpeptide PI,CHEMICAL
32292321,A growing body of evidence suggests that dopamine antagonist medications are effective in reducing the severity of stuttering symptoms.,dopamine antagonist medications,CHEBI,reduce severity of,stuttering symptoms,MENTAL_HEALTH
32292321,"Stuttering shares many similarities to Tourette's Syndrome in that both begin in childhood, follow a similar male to female ratio of 4:1, respond to dopamine antagonists, and symptomatically worsen with dopamine agonists.",Stuttering shares,MENTAL_HEALTH,respond to,dopamine antagonists,CHEBI
32292321,"Stuttering shares many similarities to Tourette's Syndrome in that both begin in childhood, follow a similar male to female ratio of 4:1, respond to dopamine antagonists, and symptomatically worsen with dopamine agonists.",Stuttering shares,MENTAL_HEALTH,respond to,dopamine antagonists,CHEMICAL
32292321,"Stuttering shares many similarities to Tourette's Syndrome in that both begin in childhood, follow a similar male to female ratio of 4:1, respond to dopamine antagonists, and symptomatically worsen with dopamine agonists.",Stuttering shares,MENTAL_HEALTH,worsen with,dopamine agonists,CHEBI
32292321,"Stuttering shares many similarities to Tourette's Syndrome in that both begin in childhood, follow a similar male to female ratio of 4:1, respond to dopamine antagonists, and symptomatically worsen with dopamine agonists.",Stuttering shares,MENTAL_HEALTH,worsen with,dopamine agonists,CHEMICAL
30007887,"NMR reveals that CORM-3 binds cysteine and GSH in a 1:1 stoichiometry with dissociation constants, Kd, of about 5 μM, while histidine, GSSG and methionine are bound less tightly, with Kd values ranging between 800 and 9000 μM. There is a direct positive correlation between protection and amino acid affinity for CORM-3.",CORM-3,CHEMICAL,bind cysteine and gsh in stoichiometry with,dissociation constants,MENTAL_HEALTH
30007887,"NMR reveals that CORM-3 binds cysteine and GSH in a 1:1 stoichiometry with dissociation constants, Kd, of about 5 μM, while histidine, GSSG and methionine are bound less tightly, with Kd values ranging between 800 and 9000 μM. There is a direct positive correlation between protection and amino acid affinity for CORM-3.",CORM-3,CHEMICAL,bind,cysteine,CHEMICAL
30007887,"NMR reveals that CORM-3 binds cysteine and GSH in a 1:1 stoichiometry with dissociation constants, Kd, of about 5 μM, while histidine, GSSG and methionine are bound less tightly, with Kd values ranging between 800 and 9000 μM. There is a direct positive correlation between protection and amino acid affinity for CORM-3.",CORM-3,CHEMICAL,bind,GSH,CHEMICAL
30845636,"Considering global trends in coffee and energy drink consumption, our finding suggest that PS may be useful to relieve transitory insomnia symptoms caused by caffeine consumption, unlike the prescription drug ZPD.",PS,CHEMICAL,relieve,transitory insomnia symptoms,MENTAL_HEALTH
29368365,"In the present study, we investigated whether the phlorotannin supplement could improve sleep in subjects with self-reported sleep disturbances.",phlorotannin supplement,NUTRITION,improve sleep in subjects with,self-reported sleep disturbances,DISEASE
29368365,"Additionally, the respiratory disturbance index during supine rapid eye movement sleep was significantly lower in the phlorotannin group (p = .035).",respiratory disturbance index,DISEASE,be lower in,phlorotannin group,NUTRITION
10940321,"Cyt-4-induced amnesia was reversed by the general opioid antagonist, naloxone, indicating that cyt-4 was acting via an opioid receptor.",Cyt-4-induced amnesia,MENTAL_HEALTH,be reversed by,naloxone,CHEMICAL
10940321,"Cyt-4-induced amnesia was reversed by the general opioid antagonist, naloxone, indicating that cyt-4 was acting via an opioid receptor.",Cyt-4-induced amnesia,MENTAL_HEALTH,be reversed by,general opioid antagonist,CHEBI
26806832,"Osteitis fibrosa is a high-turnover bone disease resulting mainly from secondary hyperparathyroidism, and mixed uremic osteodystrophy is in addition characterized by a mineralization defect most often attributed to vitamin D deficiency.",Osteitis fibrosa,DISEASE,resulting from,secondary hyperparathyroidism,DISEASE
26806832,"The development of high-turnover bone disease would occur only later on, when serum PTH levels are able to overcome peripheral PTH resistance and the other inhibitory factors of bone formation.",serum PTH levels,CHEMICAL,overcome,peripheral PTH resistance,MENTAL_HEALTH
26806832,"The development of high-turnover bone disease would occur only later on, when serum PTH levels are able to overcome peripheral PTH resistance and the other inhibitory factors of bone formation.",serum PTH levels,CHEMICAL,overcome,peripheral PTH resistance,CHEMICAL
30385872,Eighteen medication-free individuals with MDD currently in a major depressive episode were enrolled in an open-label study and received ezogabine up to 900 mg/day orally over the course of 10 weeks.,MDD,DISEASE,receive,ezogabine,CHEMICAL
30385872,Eighteen medication-free individuals with MDD currently in a major depressive episode were enrolled in an open-label study and received ezogabine up to 900 mg/day orally over the course of 10 weeks.,major depressive episode,MENTAL_HEALTH,receive,ezogabine,CHEMICAL
34698218,"Serotonin-norepinephrine reuptake inhibitors can have multiple clinical indications, including as the first-line agents for the management of depression and anxiety, and as analgesics in the treatment of chronic pain.",Serotonin-norepinephrine reuptake inhibitors,CHEMICAL,including as first-line agents for management of,anxiety,MENTAL_HEALTH
34698218,"Serotonin-norepinephrine reuptake inhibitors can have multiple clinical indications, including as the first-line agents for the management of depression and anxiety, and as analgesics in the treatment of chronic pain.",Serotonin-norepinephrine reuptake inhibitors,CHEMICAL,including as first-line agents for management of,depression,MENTAL_HEALTH
34698218,"Serotonin-norepinephrine reuptake inhibitors can have multiple clinical indications, including as the first-line agents for the management of depression and anxiety, and as analgesics in the treatment of chronic pain.",Serotonin-norepinephrine reuptake inhibitors,CHEMICAL,including as first-line agents for management of,chronic pain,DISEASE
35569694,Methicillin resistant Staphylococcus aureus (MRSA) is a prime pathogen responsible for various infections in human beings.,resistant Staphylococcus aureus,DISEASE,be prime pathogen responsible for,various infections,DISEASE
35569694,"CCPL inhibited young biofilm (64.15-72.70%) as well degraded mature biofilm (55.60-63.65%) at ½ and ¼ MIC doses, which was further confirmed by scanning electron microscopy and confocal laser scanning microscope studies.",CCPL,CHEMICAL,inhibit,young biofilm,DISEASE
35569694,"In addition, CCPL inhibited the synthesis of virulence factors like slime production (0.40-0.50 folds), DNase production, hemolytic activity (28.08-49.07%), proteolytic production (14.65-18.04%), lipase production, autolysis and cell auto-aggregation.",CCPL,CHEMICAL,inhibit in addition synthesis of virulence factors like,hemolytic activity,DISEASE
35569694,"In addition, CCPL inhibited the synthesis of virulence factors like slime production (0.40-0.50 folds), DNase production, hemolytic activity (28.08-49.07%), proteolytic production (14.65-18.04%), lipase production, autolysis and cell auto-aggregation.",CCPL,CHEMICAL,inhibit in addition synthesis of,virulence factors,CHEBI
35247432,The increasing drug resistance of plasmodium falciparum even makes the treatment procedure of malaria challenging and more problematic.,drug resistance,MENTAL_HEALTH,make treatment procedure of,malaria,DISEASE
35247432,The increasing drug resistance of plasmodium falciparum even makes the treatment procedure of malaria challenging and more problematic.,plasmodium falciparum,DISEASE,make treatment procedure of,malaria,DISEASE
35247432,The increasing drug resistance of plasmodium falciparum even makes the treatment procedure of malaria challenging and more problematic.,drug resistance,CHEBI,make treatment procedure of,malaria,DISEASE
35247432,"In this study, the encapsulated amphotericin B (Constantinides et al.) in DSPC/DSPE-PEG2000 micelles was investigated as an antimalarial drug against P. falciparum 3D7 strain.",encapsulated amphotericin B Constantinides,CHEMICAL,be investigated in study as antimalarial drug against,P. falciparum 3D7 strain,DISEASE
35247432,"In this study, the encapsulated amphotericin B (Constantinides et al.) in DSPC/DSPE-PEG2000 micelles was investigated as an antimalarial drug against P. falciparum 3D7 strain.",encapsulated amphotericin B Constantinides,CHEMICAL,be investigated in study as,antimalarial drug,CHEBI
35247432,"Moreover, according to the results of this study, the encapsulated AmB drugs are promising nanostructures for malaria treatment.",encapsulated AmB drugs,CHEMICAL,according to results of study nanostructures for,malaria treatment,DISEASE
35247432,Therefore the nanoencapsulation AmB showed promising application for malaria treatment.,nanoencapsulation AmB,CHEMICAL,show promising application for,malaria treatment,DISEASE
23548819,"There, she was diagnosed with a ""Narcissistic Paranoid Personality Disorder"", and it was hypothesized that the SSRI she was taking could have induced hypo/manic episodes and disinhibition in the woman, who had previously been heterosexual.",SSRI,CHEBI,induce,hypo/manic episodes,DISEASE
23548819,"The defending lawyer therefore applied for a forensic psychiatry assessment, claiming that the persecutory behavior against the third girlfriend was induced by taking SSRI.",persecutory behavior,DISEASE,take,SSRI,CHEBI
31729425,Excessive sucrose consumption elicits addiction-like craving that may underpin the obesity epidemic.,Excessive sucrose consumption,CHEMICAL,elicit,addiction-like craving,MENTAL_HEALTH
29253574,"Here we showed that metformin attenuated spatial memory deficit, neuron loss in the hippocampus and enhanced neurogenesis in APP/PS1 mice.",metformin,CHEMICAL,attenuate,spatial deficit neuron loss,DISEASE
29253574,"Our data suggest that metformin can exert functional recovery of memory deficits and neuroprotective effect on APP/PS1 mice via triggering neurogenesis and anti-inflammation mediated by regulating AMPK/mTOR/S6K/Bace1 and AMPK/P65 NF-κB signaling pathways in the hippocampus, which may contribute to improvement in neurological deficits.",metformin,CHEMICAL,exert functional recovery of memory deficits and neuroprotective effect on app/ps1 mice via,triggering neurogenesis,DISEASE
29253574,"Our data suggest that metformin can exert functional recovery of memory deficits and neuroprotective effect on APP/PS1 mice via triggering neurogenesis and anti-inflammation mediated by regulating AMPK/mTOR/S6K/Bace1 and AMPK/P65 NF-κB signaling pathways in the hippocampus, which may contribute to improvement in neurological deficits.",metformin,CHEMICAL,exert functional recovery of,memory deficits,DISEASE
29253574,"Our data suggest that metformin can exert functional recovery of memory deficits and neuroprotective effect on APP/PS1 mice via triggering neurogenesis and anti-inflammation mediated by regulating AMPK/mTOR/S6K/Bace1 and AMPK/P65 NF-κB signaling pathways in the hippocampus, which may contribute to improvement in neurological deficits.",metformin,CHEMICAL,regulate,AMPK/mTOR/S6K/Bace1 signaling pathways,CHEMICAL
34911135,"Our results show that SC and WSC can alleviate cardiovascular dysfunction while promoting sleep, and we further explored their potential mechanisms.",WSC,CHEMICAL,alleviate,cardiovascular dysfunction,DISEASE
7905339,"The ATP-dependent K+ (KATP) channel blocker gliquidone (4-8 micrograms/mouse, i.c.v.) produced a dose-dependent displacement to the right of the clonidine dose-response line, but neither 4-aminopyridine (4-AP) (25-250 ng/mouse, i.c.v.) nor tetraethylammonium (TEA) (10-20 micrograms/mouse, i.c.v.) significantly modified clonidine-induced antinociception.",gliquidone micrograms/mouse,CHEMICAL,produce dose-dependent displacement to,clonidine dose-response line,CHEMICAL
7905339,"The ATP-dependent K+ (KATP) channel blocker gliquidone (4-8 micrograms/mouse, i.c.v.) produced a dose-dependent displacement to the right of the clonidine dose-response line, but neither 4-aminopyridine (4-AP) (25-250 ng/mouse, i.c.v.) nor tetraethylammonium (TEA) (10-20 micrograms/mouse, i.c.v.) significantly modified clonidine-induced antinociception.",K+ KATP channel blocker,CHEMICAL,produce dose-dependent displacement to,clonidine dose-response line,CHEMICAL
7905339,"The ATP-dependent K+ (KATP) channel blocker gliquidone (4-8 micrograms/mouse, i.c.v.) produced a dose-dependent displacement to the right of the clonidine dose-response line, but neither 4-aminopyridine (4-AP) (25-250 ng/mouse, i.c.v.) nor tetraethylammonium (TEA) (10-20 micrograms/mouse, i.c.v.) significantly modified clonidine-induced antinociception.",gliquidone micrograms/mouse,CHEMICAL,produce,dose-dependent displacement,MENTAL_HEALTH
7905339,"The ATP-dependent K+ (KATP) channel blocker gliquidone (4-8 micrograms/mouse, i.c.v.) produced a dose-dependent displacement to the right of the clonidine dose-response line, but neither 4-aminopyridine (4-AP) (25-250 ng/mouse, i.c.v.) nor tetraethylammonium (TEA) (10-20 micrograms/mouse, i.c.v.) significantly modified clonidine-induced antinociception.",K+ KATP channel blocker,CHEMICAL,produce,dose-dependent displacement,MENTAL_HEALTH
7905339,"Both 4-AP (2.5-25 ng/mouse, i.c.v.) and TEA (10-20 micrograms/mouse, i.c.v.) dose-dependently antagonized baclofen antinociception, producing a displacement to the right of the baclofen dose-response line.",TEA,CHEMICAL,produce displacement to,baclofen dose-response line,CHEMICAL
7905339,"Both 4-AP (2.5-25 ng/mouse, i.c.v.) and TEA (10-20 micrograms/mouse, i.c.v.) dose-dependently antagonized baclofen antinociception, producing a displacement to the right of the baclofen dose-response line.",TEA,CHEMICAL,produce,displacement,MENTAL_HEALTH
7905339,"Both 4-AP (2.5-25 ng/mouse, i.c.v.) and TEA (10-20 micrograms/mouse, i.c.v.) dose-dependently antagonized baclofen antinociception, producing a displacement to the right of the baclofen dose-response line.",TEA,CHEMICAL,antagonize,baclofen antinociception,CHEMICAL
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,mental retardation,MENTAL_HEALTH
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,pathological gambling disorder,MENTAL_HEALTH
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,borderline personality disorder,MENTAL_HEALTH
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,self-injurious behaviour,DISEASE
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,alcoholism,DISEASE
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,urge-driven disorders,DISEASE
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,cocaine abuse,MENTAL_HEALTH
12131605,"Opioid antagonists have been effective in treating urge-driven disorders, such as pathological gambling disorder, alcoholism, borderline personality disorder with self-injurious behaviour, cocaine abuse, mental retardation with self-injurious behaviour and eating disorders.",Opioid antagonists,CHEBI,treat,eating disorders,MENTAL_HEALTH
12131605,"Based upon the efficacy of opioid antagonists in treating disorders associated with urges, we hypothesized that naltrexone would reduce both the urges associated with CSB and therefore reduce the sexual behaviour.",naltrexone,CHEMICAL,reduce,sexual behaviour,DISEASE
8188946,"Thus, alpha 1-, alpha 2- and beta-adrenergic receptors were found mainly in the milk purging system and hardly at all in mammary parenchyma.",alpha receptors,NUTRITION,be found in,milk purging system,MENTAL_HEALTH
17921395,Short-chain fatty acids (SCFAs) have a role in maintaining bowel health and can assist in the prevention and treatment of colonic disease.,Short-chain fatty acids,NUTRITION,assist in prevention and treatment of,colonic disease,DISEASE
32545806,The management of disruptions in the phospholipid metabolism and the inflammatory process could potentially become an individualized form of therapy in a subgroup of psychiatric patients.,phospholipid metabolism,NUTRITION,become individualized form of therapy in subgroup of,psychiatric patients,DISEASE
12943941,It has been suggested that patients with bipolar disorder may have an increased sensitivity to dopaminergic (DA) compounds.,bipolar disorder,MENTAL_HEALTH,have increased sensitivity to,dopaminergic DA compounds,CHEMICAL
18420741,We hypothesize that the safety of combined hormone therapy in postmenopausal women may be associated with a dissociation between the uterine and mammary gland activities of the progestin component.,combined hormone therapy,CHEBI,be associated with dissociation between the uterine and mammary gland activities of,progestin component,CHEBI
18420741,We hypothesize that the safety of combined hormone therapy in postmenopausal women may be associated with a dissociation between the uterine and mammary gland activities of the progestin component.,combined hormone therapy,CHEBI,be associated with,dissociation,MENTAL_HEALTH
31833826,Clinical studies that assessed supplemental use of L-methylfolate in patients with usual care-resistant depression found that it resulted in improved outcomes.,L-methylfolate,CHEMICAL,in patients with,usual care-resistant depression,MENTAL_HEALTH
18609422,"SSRIs, currently the most widely prescribed of the antidepressants, are well known for their instigation or exacerbation of insomnia.",SSRIs,CHEMICAL,be known for their instigation or exacerbation of,insomnia,MENTAL_HEALTH
18609422,"SSRIs, currently the most widely prescribed of the antidepressants, are well known for their instigation or exacerbation of insomnia.",SSRIs,CHEMICAL,prescribe of,antidepressants,CHEMICAL
18609422,"The recently introduced novel melatonin agonist and selective serotonin antagonist antidepressant, agomelatine, which has melatonin MT(1) and MT(2) receptor agonist and 5-HT(2c) antagonist properties, has been useful in treating patients with MDD.",novel melatonin agonist,CHEBI,treat patients with,MDD,DISEASE
18609422,"The recently introduced novel melatonin agonist and selective serotonin antagonist antidepressant, agomelatine, which has melatonin MT(1) and MT(2) receptor agonist and 5-HT(2c) antagonist properties, has been useful in treating patients with MDD.",novel melatonin agonist,CHEMICAL,treat patients with,MDD,DISEASE
18609422,"The recently introduced novel melatonin agonist and selective serotonin antagonist antidepressant, agomelatine, which has melatonin MT(1) and MT(2) receptor agonist and 5-HT(2c) antagonist properties, has been useful in treating patients with MDD.",selective serotonin antagonist antidepressant,CHEBI,treat patients with,MDD,DISEASE
18609422,"The recently introduced novel melatonin agonist and selective serotonin antagonist antidepressant, agomelatine, which has melatonin MT(1) and MT(2) receptor agonist and 5-HT(2c) antagonist properties, has been useful in treating patients with MDD.",selective serotonin antagonist antidepressant,CHEMICAL,treat patients with,MDD,DISEASE
18609422,"The recently introduced novel melatonin agonist and selective serotonin antagonist antidepressant, agomelatine, which has melatonin MT(1) and MT(2) receptor agonist and 5-HT(2c) antagonist properties, has been useful in treating patients with MDD.",agomelatine,CHEMICAL,treat patients with,MDD,DISEASE
22514271,Signaling via the intracellular second messenger cyclic AMP (cAMP) has long been implicated in the repression of megakaryocytic differentiation.,cyclic AMP,CHEMICAL,be implicated in,repression,MENTAL_HEALTH
31470076,"Findings from a sample of 352 smokers suggest that among intermittent, non-daily and light daily smokers, TTFC of the day was associated with higher levels of NNK metabolite, an effect which was mediated by urinary cotinine levels, but not by the number of cigarettes smoked per day.",TTFC,DISEASE,be associated with higher levels of,NNK metabolite,CHEMICAL
27133202,"Here, we examine the effects of intracerebroventricular (ICV) injection of dronabinol on serotonin (5-HT)-induced apnea.",dronabinol,CHEMICAL,have injection on,serotonin (5-HT)-induced apnea,DISEASE
27133202,"Here, we examine the effects of intracerebroventricular (ICV) injection of dronabinol on serotonin (5-HT)-induced apnea.",dronabinol,CHEMICAL,have injection on,serotonin (5-HT)-induced apnea,CHEMICAL
50419,Plasma phospholipids were examined in patients with delirium tremens in the acute phase of the disease and after recovery.,Plasma phospholipids,NUTRITION,be examined in patients with,delirium tremens,MENTAL_HEALTH
50419,"Phosphatidylethanolamine, phosphatidylinositol and the total phospholipids were diminished in comparison to patients with liver cirrhoses.",total phospholipids,NUTRITION,be diminished in comparison to patients with,liver cirrhoses,DISEASE
50419,"Phosphatidylethanolamine, phosphatidylinositol and the total phospholipids were diminished in comparison to patients with liver cirrhoses.",Phosphatidylethanolamine,NUTRITION,be diminished in comparison to patients with,liver cirrhoses,DISEASE
50419,Only in the plasma of patients with liver cirrhoses with bad prognosis (hepatic coma) similar low levels of total phospholipids were found.,total phospholipids,NUTRITION,be found in plasma of patients with liver cirrhoses with,hepatic coma,DISEASE
50419,Only in the plasma of patients with liver cirrhoses with bad prognosis (hepatic coma) similar low levels of total phospholipids were found.,total phospholipids,NUTRITION,be found in plasma of patients with,liver cirrhoses,DISEASE
50419,"It is concluded from these results, that the synthesis of phospholipids is reduced during delirium tremens.",phospholipids,NUTRITION,be reduced during,delirium tremens,MENTAL_HEALTH
35543800,This study demonstrated that sinomenine could lessen TMT-induced cognitive dysfunction which is partly due to its attenuation of hippocampal oxidative stress and neuroinflammation.,sinomenine,CHEMICAL,lessen,TMT-induced cognitive dysfunction,DISEASE
33783749,"In this study, β-cryptoxanthin has a variety of health-promoting functions such as the body fat reducing, cosmetic (whitening), and osteoporosis prevention.",β-cryptoxanthin,CHEMICAL,have in study variety of health-promoting functions such as,osteoporosis prevention,DISEASE
33783749,β-Cryptoxanthin has also been shown in human studies to have anti-exercise fatigue and diabetes prevention actions.,β-Cryptoxanthin,CHEMICAL,have,diabetes prevention,DISEASE
33783749,β-Cryptoxanthin has also been shown in human studies to have anti-exercise fatigue and diabetes prevention actions.,β-Cryptoxanthin,CHEMICAL,have,fatigue actions,MENTAL_HEALTH
12581229,"This study examines the single- and multiple-dose pharmacokinetics, safety, and tolerability of talampanel in patients with intractable epilepsy and assesses the potential for pharmacokinetic interaction.",talampanel,CHEMICAL,in patients with,intractable epilepsy,DISEASE
11471480,"The drug categories most commonly associated with a drug-induced permanent disability were antimicrobials, vaccines, central-nervous-system agents, and antineoplastics.",drug categories,CHEBI,be,antimicrobials,CHEBI
32435198,"Moreover, in chronic respiratory diseases, high ATP levels may contribute to cAMP hydrolysis and thus to a decrease in the ciliary beat frequency (CBF).",high ATP levels,CHEMICAL,contribute in chronic respiratory diseases to,cAMP hydrolysis,CHEMICAL
32435198,"Moreover, in chronic respiratory diseases, high ATP levels may contribute to cAMP hydrolysis and thus to a decrease in the ciliary beat frequency (CBF).",high ATP levels,CHEMICAL,contribute in,chronic respiratory diseases,DISEASE
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,diffuse desquamative skin eruption,DISEASE
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,delirium,MENTAL_HEALTH
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,thrombocytopenia,DISEASE
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,acute renal failure,DISEASE
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,prolonged ileus,DISEASE
23992546,"The ingestion of large amounts of boric acid, a component of household insecticides, is a rare occurrence, characterized by a diffuse desquamative skin eruption, neutropenia, thrombocytopenia, delirium, acute renal failure and prolonged ileus.",boric acid,NUTRITION,characterized by,neutropenia,DISEASE
23560306,"Special emphasis has been placed on the possibility that the modest elevation of 'toxic' FMR1 mRNA in the carriers of grey zone alleles may present an additional risk for some neurodegenerative diseases, such as those associated with parkinsonism, by synergizing with either other susceptibility genes or environmental poisons.",toxic FMR1 mRNA,DISEASE,synergize with,environmental poisons,CHEBI
23560306,"Special emphasis has been placed on the possibility that the modest elevation of 'toxic' FMR1 mRNA in the carriers of grey zone alleles may present an additional risk for some neurodegenerative diseases, such as those associated with parkinsonism, by synergizing with either other susceptibility genes or environmental poisons.",carriers,CHEBI,synergize with,environmental poisons,CHEBI
15575851,Carotenemia is a condition characterized by yellow discoloration of the skin and elevated blood carotene levels.,Carotenemia,DISEASE,characterized by yellow discoloration of,skin blood carotene levels,CHEMICAL
34782553,"This review deals with Alzheimer's disease and emphasize on challenges associated with drug delivery to the brain, and how liposomal drug delivery can play an important role as a drug delivery method for the treatment of Alzheimer's disease.",liposomal drug delivery,CHEBI,play important role as drug delivery method for treatment of,Alzheimer's disease,DISEASE
34782553,"This review deals with Alzheimer's disease and emphasize on challenges associated with drug delivery to the brain, and how liposomal drug delivery can play an important role as a drug delivery method for the treatment of Alzheimer's disease.",liposomal drug delivery,CHEBI,play important role as,drug delivery,CHEBI
35594873,Our objective was to investigate how the prion-like and regional vulnerability hypotheses of alpha-synuclein might explain brain atrophy in iRBD.,alpha-synuclein,CHEMICAL,explain,brain atrophy,DISEASE
1534239,The results showed that MK-801 produced anterograde amnesia at doses that did not produce retrograde amnesia or state dependency and did not impair the expression of conditioned or unconditioned branchial suppression responses (BSRs) to the conditioned stimulus.,MK-801,CHEMICAL,produce,anterograde amnesia,MENTAL_HEALTH
14653305,"Variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been associated with anxiety and harm avoidance and is weakly associated with a number of neuropsychiatric disorders, including Type II alcoholism, which has a high rate of comorbidity with antisocial personality disorder.",serotonin gene-linked polymorphic region,CHEMICAL,be associated with,anxiety harm avoidance,MENTAL_HEALTH
14653305,"Variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been associated with anxiety and harm avoidance and is weakly associated with a number of neuropsychiatric disorders, including Type II alcoholism, which has a high rate of comorbidity with antisocial personality disorder.",serotonin gene-linked polymorphic region,CHEMICAL,be associated with number of,Type alcoholism,DISEASE
14653305,"Variation in the serotonin transporter gene-linked polymorphic region (5-HTTLPR) has been associated with anxiety and harm avoidance and is weakly associated with a number of neuropsychiatric disorders, including Type II alcoholism, which has a high rate of comorbidity with antisocial personality disorder.",serotonin gene-linked polymorphic region,CHEMICAL,be associated with number of,neuropsychiatric disorders,DISEASE
14653305,"Macaques with histories of early-life stress have been shown to exhibit impulsive aggression, incompetent social behavior and increased behavioral and endocrine responsivity to stress.",early-life stress,DISEASE,increase,endocrine,CHEBI
14653305,"Macaques with histories of early-life stress have been shown to exhibit impulsive aggression, incompetent social behavior and increased behavioral and endocrine responsivity to stress.",early-life stress,DISEASE,exhibit,impulsive aggression,DISEASE
14653305,"Macaques with histories of early-life stress have been shown to exhibit impulsive aggression, incompetent social behavior and increased behavioral and endocrine responsivity to stress.",early-life stress,DISEASE,exhibit,incompetent social behavior,DISEASE
29350336,"Case reports have demonstrated that dual use of cholinesterase inhibitors (ChIs) and urinary anticholinergics (UAChs) in older adults may be associated with delusions, aggression, changes in cognition, and anxiety, which typically resolve on drug discontinuation.",urinary anticholinergics,CHEBI,be associated with,aggression,DISEASE
29350336,"Case reports have demonstrated that dual use of cholinesterase inhibitors (ChIs) and urinary anticholinergics (UAChs) in older adults may be associated with delusions, aggression, changes in cognition, and anxiety, which typically resolve on drug discontinuation.",urinary anticholinergics,CHEBI,be associated with,delusions,MENTAL_HEALTH
29350336,"Case reports have demonstrated that dual use of cholinesterase inhibitors (ChIs) and urinary anticholinergics (UAChs) in older adults may be associated with delusions, aggression, changes in cognition, and anxiety, which typically resolve on drug discontinuation.",urinary anticholinergics,CHEBI,be associated with,anxiety,MENTAL_HEALTH
31212946,Current theories on the neurobiology of depression were utilized to map tea-mediated mechanisms of antidepressant activity onto an integrated framework of depression pathology.,depression,MENTAL_HEALTH,map tea-mediated mechanisms of antidepressant activity onto integrated framework of,depression pathology,MENTAL_HEALTH
31212946,Current theories on the neurobiology of depression were utilized to map tea-mediated mechanisms of antidepressant activity onto an integrated framework of depression pathology.,depression,MENTAL_HEALTH,map tea-mediated mechanisms of,antidepressant activity,CHEMICAL
31910875,"Moreover, the differentiation from other causes of meningitis/encephalitis is critical because of differences in management such as the need for antiviral or immunosuppressive treatments.",meningitis/encephalitis,DISEASE,be,antiviral treatments,CHEBI
30737780,"Benzene is considered a carcinogen, mostly based on evidence of causality for myeloid leukemia from high levels of exposure in occupational studies.",Benzene,CHEMICAL,be considered,carcinogen,CHEBI
30737780,"Among all participants, ambient benzene was positively associated with myelodysplastic syndromes (HR = 1.16, 95% CI: 1.01-1.33 per μg/m3 ) and T-cell lymphoma (HR = 1.29, 95% CI: 1.08-1.53 per μg/m3 ).",ambient benzene,CHEMICAL,be associated among participants with,T-cell lymphoma =,DISEASE
30737780,"Among all participants, ambient benzene was positively associated with myelodysplastic syndromes (HR = 1.16, 95% CI: 1.01-1.33 per μg/m3 ) and T-cell lymphoma (HR = 1.29, 95% CI: 1.08-1.53 per μg/m3 ).",ambient benzene,CHEMICAL,be associated among participants with,myelodysplastic syndromes,MENTAL_HEALTH
30737780,"Among men, ambient benzene was also positively associated with any hematologic malignancy (HR = 1.07, 95% CI: 1.01-1.15 per μg/m3 ) and follicular lymphoma (HR = 1.28, 95% CI: 1.09-1.50 per μg/m3 ).",ambient benzene,CHEMICAL,be associated among men with,follicular lymphoma =,DISEASE
30737780,"Among men, ambient benzene was also positively associated with any hematologic malignancy (HR = 1.07, 95% CI: 1.01-1.15 per μg/m3 ) and follicular lymphoma (HR = 1.28, 95% CI: 1.09-1.50 per μg/m3 ).",ambient benzene,CHEMICAL,be associated among men with,hematologic malignancy,DISEASE
35551099,"The serotonin syndrome is a life-threatening adverse drug reaction resulting from excess serotonergic agonism due to interactions between multiple drugs, poisoning, or less commonly due to therapeutic action of a single drug.",serotonin syndrome,CHEMICAL,resulting from excess serotonergic agonism due to interactions between,poisoning,DISEASE
35551099,"The serotonin syndrome is a life-threatening adverse drug reaction resulting from excess serotonergic agonism due to interactions between multiple drugs, poisoning, or less commonly due to therapeutic action of a single drug.",serotonin syndrome,CHEMICAL,resulting from excess serotonergic agonism due to interactions between,single drug,CHEBI
35551099,"The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular abnormalities in the context of a patient with new/altered serotonergic therapy, although not all these features are consistently present in all patients.",serotonin syndrome,CHEMICAL,be altered,new/altered serotonergic therapy,CHEMICAL
35551099,"The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular abnormalities in the context of a patient with new/altered serotonergic therapy, although not all these features are consistently present in all patients.",serotonin syndrome,CHEMICAL,be altered,autonomic hyperactivity,MENTAL_HEALTH
35551099,"The central triad of features in serotonin syndrome are altered mental state, autonomic hyperactivity, and neuromuscular abnormalities in the context of a patient with new/altered serotonergic therapy, although not all these features are consistently present in all patients.",serotonin syndrome,CHEMICAL,be altered,neuromuscular abnormalities,DISEASE
35512806,Cannabis products have been perceived and investigated as potential treatments for attention-deficit/hyperactivity disorder (ADHD).,Cannabis products,CHEMICAL,investigate as potential treatments for,ADHD,MENTAL_HEALTH
35512806,Cannabis products have been perceived and investigated as potential treatments for attention-deficit/hyperactivity disorder (ADHD).,Cannabis products,CHEMICAL,investigate as potential treatments for,attention-deficit/hyperactivity disorder,DISEASE
35512806,Mild interactions between MPH and CBD were predicted with multiple oral administrations of CBD.,MPH,CHEMICAL,be predicted with multiple oral administrations of,CBD,CHEMICAL
35512806,Mild interactions between MPH and CBD were predicted with multiple oral administrations of CBD.,CBD,CHEMICAL,be predicted with multiple oral administrations of,CBD,CHEMICAL
35512806,Mild interactions between MPH and CBD were predicted with multiple oral administrations of CBD.,MPH,CHEMICAL,have mild interactions with,CBD,CHEMICAL
35512806,Mild interactions between MPH and CBD were predicted with multiple oral administrations of CBD.,CBD,CHEMICAL,have mild interactions with,MPH,CHEMICAL
8835359,"Withdrawal syndrome (jumping) was precipitated by naloxone (2.5, 5 and 10 mg/kg) which was administered intraperitoneally 2 hr after the last dose of morphine.",Withdrawal syndrome,DISEASE,be precipitated by,naloxone,CHEMICAL
27833088,Overexpression of Nek2 is common in human cancers and suppression can restrict tumor cell growth and promote apoptosis.,Nek2,CHEMICAL,restrict,tumor cell growth,DISEASE
27833088,Overexpression of Nek2 is common in human cancers and suppression can restrict tumor cell growth and promote apoptosis.,Nek2,CHEMICAL,be common in,human cancers,DISEASE
33720743,"Introduction: pellagra is a systemic disease due to deficiency of vitamin B3 or tryptophan, its precursor.",pellagra,DISEASE,be systemic disease due introduction deficiency of,tryptophan,NUTRITION
33720743,"Introduction: pellagra is a systemic disease due to deficiency of vitamin B3 or tryptophan, its precursor.",pellagra,DISEASE,be systemic disease due introduction deficiency of,vitamin B3,CHEBI
33720743,"Introduction: pellagra is a systemic disease due to deficiency of vitamin B3 or tryptophan, its precursor.",pellagra,DISEASE,be,disease due Introduction deficiency,DISEASE
33660202,Treatment with the NMDA receptor antagonist dextromethorphan attenuated chronic IH-induced anxiety-like behavior and GluN2B expression.,NMDA receptor antagonist dextromethorphan,CHEMICAL,attenuate,GluN2B expression,DISEASE
33660202,Treatment with the NMDA receptor antagonist dextromethorphan attenuated chronic IH-induced anxiety-like behavior and GluN2B expression.,NMDA receptor antagonist dextromethorphan,CHEMICAL,attenuate,chronic IH-induced anxiety-like behavior,DISEASE
33660202,Treatment with the NMDA receptor antagonist dextromethorphan attenuated chronic IH-induced anxiety-like behavior and GluN2B expression.,NMDA receptor antagonist dextromethorphan,CHEBI,attenuate,GluN2B expression,DISEASE
33660202,Treatment with the NMDA receptor antagonist dextromethorphan attenuated chronic IH-induced anxiety-like behavior and GluN2B expression.,NMDA receptor antagonist dextromethorphan,CHEBI,attenuate,chronic IH-induced anxiety-like behavior,DISEASE
35569677,"In this manuscript, using solid hot drawing (SHD) technology to fabricate an oriented shish-kebab like structure, furthermore, the interface-oriented grain boundary controlled the nucleation site and cell morphology during low temperature supercritical carbon dioxide (SC-CO2) foaming process, resulted in an oriented microcellular structure which was similar to load-bearing bone.",interface-oriented grain boundary,CHEMICAL,use,solid drawing SHD technology,DISEASE
28202095,"When used as an adjunctive with antipsychotics, certain vitamins and minerals may be effective for improving symptomatic outcomes of schizophrenia, by restoring nutritional deficits, reducing oxidative stress, or modulating neurological pathways.",certain vitamins,CHEBI,improve symptomatic outcomes of,schizophrenia,MENTAL_HEALTH
28202095,"When used as an adjunctive with antipsychotics, certain vitamins and minerals may be effective for improving symptomatic outcomes of schizophrenia, by restoring nutritional deficits, reducing oxidative stress, or modulating neurological pathways.",certain vitamins,CHEBI,restore,nutritional deficits,DISEASE
29158882,"The 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popular recreational drug and a major source of substance abuse, which ultimately leads to sensations of well-being, elation and euphoria, moderate derealization/depersonalization, and cognitive disruptions, as well as intense sensory awareness.",MDMA,CHEMICAL,be,popular recreational drug,CHEBI
29158882,"The 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) is a popular recreational drug and a major source of substance abuse, which ultimately leads to sensations of well-being, elation and euphoria, moderate derealization/depersonalization, and cognitive disruptions, as well as intense sensory awareness.","3,4-methylenedioxymethamphetamine",CHEMICAL,be,popular recreational drug,CHEBI
30503385,We are discussing the putative mechanism of inhibition of the miR-125b expression by vitamin D receptor (VDR) agonists and we suggest that calcitriol and tacalcitol may be used as a miR-125b inhibitor in breast cancer cells expressing VDR.,calcitriol,CHEMICAL,be used as mir-125b inhibitor in,breast cancer cells,DISEASE
30503385,We are discussing the putative mechanism of inhibition of the miR-125b expression by vitamin D receptor (VDR) agonists and we suggest that calcitriol and tacalcitol may be used as a miR-125b inhibitor in breast cancer cells expressing VDR.,tacalcitol,CHEMICAL,be used as mir-125b inhibitor in,breast cancer cells,DISEASE
26513595,The level of the vitamin D receptor (VDR) and cytochrome P450 enzyme 24-hydroxylase (CYP24A1) are crucial in the pathogenesis of secondary hyperparathyroidism (sHPT) in CKD.,vitamin D receptor,CHEBI,be crucial in pathogenesis of,sHPT,DISEASE
26513595,The level of the vitamin D receptor (VDR) and cytochrome P450 enzyme 24-hydroxylase (CYP24A1) are crucial in the pathogenesis of secondary hyperparathyroidism (sHPT) in CKD.,vitamin D receptor,CHEBI,be crucial in pathogenesis of,CKD,DISEASE
26513595,The level of the vitamin D receptor (VDR) and cytochrome P450 enzyme 24-hydroxylase (CYP24A1) are crucial in the pathogenesis of secondary hyperparathyroidism (sHPT) in CKD.,vitamin D receptor,CHEBI,be crucial in pathogenesis of,secondary hyperparathyroidism,DISEASE
27822557,"Nitrates, such as cardiac therapeutics and food additives, are common headache triggers, with nitric oxide playing an important role.",Nitrates,CHEMICAL,be,common headache triggers,MENTAL_HEALTH
27822557,"Nitrates, such as cardiac therapeutics and food additives, are common headache triggers, with nitric oxide playing an important role.",food additives,CHEBI,be,common headache triggers,MENTAL_HEALTH
25759301,"The cardinal motor symptoms of Parkinson's disease (PD) include resting tremor, akinesia, bradykinesia, and rigidity, and these motor abnormalities can be modeled in rodents by administration of the VMAT-2 (type-2 vesicular monoamine transporter) inhibitor tetrabenazine (9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7, 11b hexahydrobenzo[a]quinolizin-2-one; TBZ).",Parkinson's disease,DISEASE,include resting,tremor,DISEASE
25759301,"The cardinal motor symptoms of Parkinson's disease (PD) include resting tremor, akinesia, bradykinesia, and rigidity, and these motor abnormalities can be modeled in rodents by administration of the VMAT-2 (type-2 vesicular monoamine transporter) inhibitor tetrabenazine (9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7, 11b hexahydrobenzo[a]quinolizin-2-one; TBZ).",Parkinson's disease,DISEASE,include resting,rigidity,DISEASE
25759301,"The cardinal motor symptoms of Parkinson's disease (PD) include resting tremor, akinesia, bradykinesia, and rigidity, and these motor abnormalities can be modeled in rodents by administration of the VMAT-2 (type-2 vesicular monoamine transporter) inhibitor tetrabenazine (9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7, 11b hexahydrobenzo[a]quinolizin-2-one; TBZ).",Parkinson's disease,DISEASE,include resting,akinesia,MENTAL_HEALTH
25759301,"Depression is also commonly associated with PD, and clinical data indicate that selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine ((±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; FLX) are frequently used to treat depression in PD patients.",SSRIs,CHEMICAL,treat,depression,MENTAL_HEALTH
25759301,"Depression is also commonly associated with PD, and clinical data indicate that selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine ((±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; FLX) are frequently used to treat depression in PD patients.",(±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride,CHEMICAL,treat,depression,MENTAL_HEALTH
25759301,"Depression is also commonly associated with PD, and clinical data indicate that selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine ((±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; FLX) are frequently used to treat depression in PD patients.",fluoxetine,CHEMICAL,treat,depression,MENTAL_HEALTH
25759301,"Depression is also commonly associated with PD, and clinical data indicate that selective serotonin reuptake inhibitors (SSRIs) such as fluoxetine ((±)-N-methyl-γ-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride; FLX) are frequently used to treat depression in PD patients.",selective serotonin reuptake inhibitors,CHEMICAL,treat,depression,MENTAL_HEALTH
25759301,This low dose of TBZ was selected based on studies with rat models of depressive symptoms.,TBZ,CHEMICAL,be selected based on studies with rat models of,depressive symptoms,DISEASE
25759301,Coadministration of the serotonin 5-HT2A/2C antagonist mianserin (2.5 and 5.0 mg/kg) attenuated the increase in oral tremor induced by coadministration of TBZ (0.75 mg/kg) with FLX (5.0 mg/kg).,serotonin 5-HT2A/2C antagonist mianserin,CHEBI,attenuate increase in,oral tremor,DISEASE
25759301,Coadministration of the serotonin 5-HT2A/2C antagonist mianserin (2.5 and 5.0 mg/kg) attenuated the increase in oral tremor induced by coadministration of TBZ (0.75 mg/kg) with FLX (5.0 mg/kg).,serotonin 5-HT2A/2C antagonist mianserin,CHEMICAL,attenuate increase in,oral tremor,DISEASE
25759301,"These data suggest that SSRI administration in PD patients may result in worsening of motor symptoms, at least in part, by exacerbating existing DA depletions through 5-HT2A/2C-mediated modulation of DA neurotransmission.",PD patients,DISEASE,exacerbate existing da depletions through 5-ht2a/2c-mediated modulation of,DA neurotransmission,CHEMICAL
25759301,"These data suggest that SSRI administration in PD patients may result in worsening of motor symptoms, at least in part, by exacerbating existing DA depletions through 5-HT2A/2C-mediated modulation of DA neurotransmission.",SSRI administration,CHEBI,exacerbate existing da depletions through 5-ht2a/2c-mediated modulation of,DA neurotransmission,CHEMICAL
25759301,"These data suggest that SSRI administration in PD patients may result in worsening of motor symptoms, at least in part, by exacerbating existing DA depletions through 5-HT2A/2C-mediated modulation of DA neurotransmission.",PD patients,DISEASE,exacerbate existing,DA depletions,CHEMICAL
25759301,"These data suggest that SSRI administration in PD patients may result in worsening of motor symptoms, at least in part, by exacerbating existing DA depletions through 5-HT2A/2C-mediated modulation of DA neurotransmission.",SSRI administration,CHEBI,exacerbate existing,DA depletions,CHEMICAL
15129301,"Antioxidants, such as tocopherols and carotenoids, have been implicated in the prevention of degenerative diseases.",tocopherols,NUTRITION,be implicated in prevention of,degenerative diseases,DISEASE
15129301,"Antioxidants, such as tocopherols and carotenoids, have been implicated in the prevention of degenerative diseases.",carotenoids,CHEBI,be implicated in prevention of,degenerative diseases,DISEASE
35569447,GCs are secreted from hair follicles and promote hair follicle regression by inducing cellular apoptosis.,GCs,CHEMICAL,promote,hair follicle regression,NUTRITION
35569447,GCs are secreted from hair follicles and promote hair follicle regression by inducing cellular apoptosis.,GCs,CHEMICAL,promote,hair follicle regression,MENTAL_HEALTH
35569447,"Moreover, the androgen receptor (AR) is abundant in the balding scalp and androgens suppress hair growth by binding to androgen receptor (AR) in androgenetic alopecia (AGA).",androgen receptor,CHEBI,be abundant in,androgens,CHEBI
35569447,"Moreover, the androgen receptor (AR) is abundant in the balding scalp and androgens suppress hair growth by binding to androgen receptor (AR) in androgenetic alopecia (AGA).",androgen receptor,CHEBI,bind to,androgen receptor,CHEBI
35569447,"Moreover, the androgen receptor (AR) is abundant in the balding scalp and androgens suppress hair growth by binding to androgen receptor (AR) in androgenetic alopecia (AGA).",androgen receptor,CHEBI,bind to,androgenetic alopecia,DISEASE
23774281,"The lysosomal Ca2+-depleting agent concanamycin (1 μm) enhanced HPV if applied during hypoxia, but had no effect on HPV during a subsequent hypoxic challenge.",lysosomal agent concanamycin,CHEMICAL,apply during,hypoxia,DISEASE
23774281,Hypoxia for 45 min caused a significant increase in the ratio of oxidised to reduced glutathione (GSSG/GSH).,Hypoxia,DISEASE,cause significant increase in ratio of,reduced glutathione,CHEMICAL
17992285,"LC-MS analysis showed that all conjugates contained one hydrazine moiety bound to Tc, that binding of Tc to HYNIC-peptide and co-ligand occurs with displacement of 5H(+) indicating a Tc formal oxidation state of +5, and that the Tc has no oxo- or halide ligands.",HYNIC-peptide,CHEMICAL,occur with displacement of,5H(+,CHEMICAL
17992285,"LC-MS analysis showed that all conjugates contained one hydrazine moiety bound to Tc, that binding of Tc to HYNIC-peptide and co-ligand occurs with displacement of 5H(+) indicating a Tc formal oxidation state of +5, and that the Tc has no oxo- or halide ligands.",HYNIC-peptide,CHEMICAL,occur with,displacement,MENTAL_HEALTH
31883924,The unpopular concept that PCOS may also be conditioned by a chronic infection leads to a suspicion that water-soluble vitamins may be involved in the struggle against PCOS.,water-soluble vitamins,CHEBI,be involved in struggle against,PCOS,DISEASE
31883924,The unpopular concept that PCOS may also be conditioned by a chronic infection leads to a suspicion that water-soluble vitamins may be involved in the struggle against PCOS.,PCOS,DISEASE,be conditioned by,chronic infection,DISEASE
31883924,Higher concentrations of ascorbic acid were observed in PCOS.,ascorbic acid,CHEBI,be observed in,PCOS,DISEASE
31883924,"Water-soluble vitamins play an important role in the therapy of women with PCOS through the reduction of antioxidative stress and low-intensity inflammation caused by various factors, including chronic infection.",Water-soluble vitamins,CHEBI,play important role in therapy of women with,PCOS,DISEASE
31883924,"Water-soluble vitamins play an important role in the therapy of women with PCOS through the reduction of antioxidative stress and low-intensity inflammation caused by various factors, including chronic infection.",Water-soluble vitamins,CHEBI,play important role in therapy of women with,low-intensity inflammation,DISEASE
30122874,"Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble, water-soluble vitamins and trace elements and should be supplemented appropriately.",Cirrhotic patients,DISEASE,be at high risk for depletion of,various fat-soluble water-soluble vitamins,CHEMICAL
30122874,"Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble, water-soluble vitamins and trace elements and should be supplemented appropriately.",Cirrhotic patients,DISEASE,be at high risk for depletion of,various fat-soluble water-soluble vitamins,CHEBI
30122874,"Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble, water-soluble vitamins and trace elements and should be supplemented appropriately.",obesity,DISEASE,be at high risk for depletion of,various fat-soluble water-soluble vitamins,CHEMICAL
30122874,"Cirrhotic patients with obesity are at high risk for depletion of various fat-soluble, water-soluble vitamins and trace elements and should be supplemented appropriately.",obesity,DISEASE,be at high risk for depletion of,various fat-soluble water-soluble vitamins,CHEBI
27865346,"Inadequate intakes of water-soluble vitamins during pregnancy lead to obesity and characteristics of the metabolic syndrome, concurrent with altered developments in food intake regulatory pathways.",water-soluble vitamins,CHEBI,lead to obesity and characteristics of,metabolic syndrome concurrent,DISEASE
27865346,"Inadequate intakes of water-soluble vitamins during pregnancy lead to obesity and characteristics of the metabolic syndrome, concurrent with altered developments in food intake regulatory pathways.",water-soluble vitamins,CHEBI,lead to,obesity,DISEASE
30299886,"Actually, BMA could also contribute to bone loss through the release of paracrine factors altering osteoblast and/or osteoclast formation and function.",BMA,CHEMICAL,contribute to,bone loss,DISEASE
29369967,Kappa opioid receptor antagonists may provide a new therapeutic strategy for stress-related functional pain disorders.,opioid receptor antagonists,CHEBI,provide new therapeutic strategy for,stress-related functional pain disorders,DISEASE
23640347,"The relative merits of various forms of antidepressant therapy in patients with heart failure (HF) are discussed, including disease-specific pharmacokinetic changes and drug-interaction challenges in current or likely future candidates for heart transplantation.",antidepressant therapy,CHEMICAL,in patients with,heart failure,DISEASE
23254282,"Shoots of H. perforatum revealed more expressive growth depression, concomitantly with the inhibition of PAL activity (-60%) and decrease in soluble phenols and individual phenolic acids in response to AIP.",soluble phenols,NUTRITION,have and in,AIP,DISEASE
23254282,"Shoots of H. perforatum revealed more expressive growth depression, concomitantly with the inhibition of PAL activity (-60%) and decrease in soluble phenols and individual phenolic acids in response to AIP.",individual phenolic acids,CHEMICAL,have and in,AIP,DISEASE
35192423,"Excessive cholesterol accumulation is detrimental to cells and serves as the molecular basis of many diseases, such as atherosclerosis, Alzheimer's disease, and diabetes mellitus.",Excessive cholesterol accumulation,NUTRITION,serve as molecular basis of,atherosclerosis,DISEASE
33986123,"Therefore, we examined the metabolic effect of anti-PD-1 therapy in a murine MEER HNSCC model as well as intratumoral hypoxia in R/M patients.",anti-PD-1 therapy,CHEMICAL,have the metabolic effect in,murine MEER HNSCC model,DISEASE
33986123,Lower tumor hypoxia was independently associated with increased efficacy of anti-PD-1 therapy in patients with R/M HNSCC.,Lower tumor hypoxia,DISEASE,be associated with increased efficacy of,anti-PD-1 therapy,CHEMICAL
29791312,Background The seeds of African crocus (AC) (Curculigo pilosa) and wonderful kola (WK) (Buchholzia coriacea) are commonly used in folklore medicine in managing erectile dysfunction (ED) without the full understanding of the possible mechanism of actions.,Curculigo pilosa,CHEMICAL,manage,erectile dysfunction,MENTAL_HEALTH
31302239,"Muscarinic antagonist scopolamine has been extensively used to model amnesia in lab rodents, but most studies have focused on the effects of pre-training scopolamine administration.",Muscarinic antagonist scopolamine,CHEBI,model,amnesia,MENTAL_HEALTH
31302239,"Muscarinic antagonist scopolamine has been extensively used to model amnesia in lab rodents, but most studies have focused on the effects of pre-training scopolamine administration.",Muscarinic antagonist scopolamine,CHEMICAL,model,amnesia,MENTAL_HEALTH
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",Dapivirine,CHEMICAL,be in development as microbicide for protection of,HIV infection,DISEASE
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",Dapivirine,CHEMICAL,be in development as,microbicide,CHEBI
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",nonnucleoside reverse transcriptase inhibitor,CHEBI,be in development as microbicide for protection of,HIV infection,DISEASE
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",nonnucleoside reverse transcriptase inhibitor,CHEMICAL,be in development as microbicide for protection of,HIV infection,DISEASE
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",nonnucleoside reverse transcriptase inhibitor,CHEBI,be in development as,microbicide,CHEBI
20574411,"Dapivirine, a nonnucleoside reverse transcriptase inhibitor, is in development as a microbicide for the protection of women against HIV infection.",nonnucleoside reverse transcriptase inhibitor,CHEMICAL,be in development as,microbicide,CHEBI
18418294,"This safety study of terameprocol (also called M4N, EM-1421) daily vaginal application in healthy women explores its potential application as a microbicide in interrupting human immunodeficiency virus sexual transmission and additional interruption of human papillomavirus and herpes simplex virus transmission.",terameprocol,CHEMICAL,interrupt human immunodeficiency virus sexual transmission and additional interruption of,papillomavirus herpes simplex virus transmission,DISEASE
18418294,"This safety study of terameprocol (also called M4N, EM-1421) daily vaginal application in healthy women explores its potential application as a microbicide in interrupting human immunodeficiency virus sexual transmission and additional interruption of human papillomavirus and herpes simplex virus transmission.",terameprocol,CHEMICAL,interrupt,human immunodeficiency virus sexual transmission,DISEASE
18418294,"This safety study of terameprocol (also called M4N, EM-1421) daily vaginal application in healthy women explores its potential application as a microbicide in interrupting human immunodeficiency virus sexual transmission and additional interruption of human papillomavirus and herpes simplex virus transmission.",terameprocol,CHEMICAL,explore its potential application as,microbicide,CHEBI
34717776,"Although used for decades in medical implants, including heart valves, breast implants, and as a tamponade for retinal detachment surgery, silicone oil might have deleterious effects.",silicone oil,CHEMICAL,including,retinal detachment surgery,DISEASE
34717776,"Although used for decades in medical implants, including heart valves, breast implants, and as a tamponade for retinal detachment surgery, silicone oil might have deleterious effects.",silicone oil,CHEMICAL,including,tamponade,DISEASE
34717776,Agitation of the syringe to expel air at the moment of drug preparation not only leads to silicone oil release but also to therapeutic protein aggregation.,Agitation,MENTAL_HEALTH,lead to,silicone oil release,CHEMICAL
34717776,"Systemically, silicone oil has been reported in association with autoimmune diseases and skin granuloma after either direct injection of dermal fillers or secondary leakage from silicone breast implant.",silicone oil,CHEMICAL,be reported in association with autoimmune diseases and skin granuloma after direct injection of,breast implant,CHEMICAL
34717776,"Systemically, silicone oil has been reported in association with autoimmune diseases and skin granuloma after either direct injection of dermal fillers or secondary leakage from silicone breast implant.",silicone oil,CHEMICAL,be reported in association with autoimmune diseases and skin granuloma after direct injection of,dermal fillers,CHEBI
34717776,"Systemically, silicone oil has been reported in association with autoimmune diseases and skin granuloma after either direct injection of dermal fillers or secondary leakage from silicone breast implant.",silicone oil,CHEMICAL,be reported in association with,skin granuloma,DISEASE
34717776,"Systemically, silicone oil has been reported in association with autoimmune diseases and skin granuloma after either direct injection of dermal fillers or secondary leakage from silicone breast implant.",silicone oil,CHEMICAL,be reported in association with,autoimmune diseases,DISEASE
34717776,"Few professionals are aware that agitation of a siliconized syringe might lead to silicone oil release, which, in turn, acts an adjuvant to an increased immunogenicity.",agitation,MENTAL_HEALTH,lead to,silicone oil release,CHEMICAL
7816447,Diabetes mellitus is a disorder of glucose metabolism that can be associated with vestibular dysfunction.,Diabetes mellitus,DISEASE,be disorder of,glucose metabolism,CHEMICAL
7816447,Endogenous alterations in concentrations of estrogen and progesterone in the premenstrual syndrome or with the use of exogenous hormones such as oral contraceptives may trigger vertigo.,exogenous hormones,CHEBI,trigger,vertigo,DISEASE
7816447,Endogenous alterations in concentrations of estrogen and progesterone in the premenstrual syndrome or with the use of exogenous hormones such as oral contraceptives may trigger vertigo.,estrogen,CHEBI,trigger,vertigo,DISEASE
7816447,Endogenous alterations in concentrations of estrogen and progesterone in the premenstrual syndrome or with the use of exogenous hormones such as oral contraceptives may trigger vertigo.,premenstrual syndrome,MENTAL_HEALTH,trigger,vertigo,DISEASE
7816447,Endogenous alterations in concentrations of estrogen and progesterone in the premenstrual syndrome or with the use of exogenous hormones such as oral contraceptives may trigger vertigo.,oral contraceptives,CHEMICAL,trigger,vertigo,DISEASE
7816447,"Metabolic evaluations for unexplained vertigo should include a lipoprotein profile, with cholesterol and triglyceride levels, glucose tolerance test, and thyroid hormone measurements.",unexplained vertigo,DISEASE,include,triglyceride,CHEMICAL
7816447,"Metabolic evaluations for unexplained vertigo should include a lipoprotein profile, with cholesterol and triglyceride levels, glucose tolerance test, and thyroid hormone measurements.",unexplained vertigo,DISEASE,include,cholesterol,NUTRITION
2493039,"Recent reports of altered TSH responsiveness to its releasing hormone (TRH) in women with premenstrual syndrome (PMS) suggested that subclinical hypothyroidism may be responsible for the mood changes, such as depression, that occur in these women.",subclinical hypothyroidism,DISEASE,be responsible for,depression,MENTAL_HEALTH
8571507,The cases of diarrhoea were similar to 'July disease' and may have been caused by continuous nematode infections which were only briefly controlled by drenches.,diarrhoea,DISEASE,be caused by,continuous nematode infections,DISEASE
34904508,Lusutrombopag is a thrombopoietin receptor agonist approved to treat thrombocytopenia in patients with chronic liver disease (CLD).,thrombocytopenia,DISEASE,in patients with,chronic liver disease,DISEASE
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,iron,CHEMICAL
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,selenium,CHEMICAL
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,neuromyelopathies,DISEASE
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,iodine,CHEMICAL
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,zinc,CHEMICAL
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,vitamins,CHEBI
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,myelopathies,DISEASE
23829926,"The main nutritional syndromes comprise protein-energy malnutrition (marasmus and kwashiorkor); nutritional neuropathies, myelopathies and neuromyelopathies, as well as specific deficiencies of vitamins and micronutrients including iodine, iron, zinc, and selenium.",main nutritional syndromes,MENTAL_HEALTH,comprise,malnutrition marasmus nutritional neuropathies,DISEASE
19643063,"Vitamin B(6) deficiency in these cases is characterized by anemia, growth retardation and alteration in neuronal function, including neuropathies, hyperirritability, hyperexcitability and convulsions.",Vitamin deficiency,CHEBI,be characterized by,anemia,DISEASE
19643063,"Vitamin B(6) deficiency in these cases is characterized by anemia, growth retardation and alteration in neuronal function, including neuropathies, hyperirritability, hyperexcitability and convulsions.",Vitamin deficiency,CHEBI,be characterized by,convulsions,DISEASE
19643063,"Vitamin B(6) deficiency in these cases is characterized by anemia, growth retardation and alteration in neuronal function, including neuropathies, hyperirritability, hyperexcitability and convulsions.",Vitamin deficiency,CHEBI,be characterized by,hyperexcitability,DISEASE
19643063,"Vitamin B(6) deficiency in these cases is characterized by anemia, growth retardation and alteration in neuronal function, including neuropathies, hyperirritability, hyperexcitability and convulsions.",Vitamin deficiency,CHEBI,be characterized by,neuropathies,DISEASE
19643063,"Vitamin B(6) deficiency in these cases is characterized by anemia, growth retardation and alteration in neuronal function, including neuropathies, hyperirritability, hyperexcitability and convulsions.",Vitamin deficiency,CHEBI,be characterized by,hyperirritability,DISEASE
32219760,"The neurotransmitter acetylcholine (ACh) is involved in memory and cognitive functions, which normally decline with age.",neurotransmitter acetylcholine,CHEMICAL,be involved in,memory functions,DISEASE
32219760,"The neurotransmitter acetylcholine (ACh) is involved in memory and cognitive functions, which normally decline with age.",ACh,CHEMICAL,be involved in,memory functions,DISEASE
9918590,"Therefore, the mechanism of inactivation of CYP-3A4 by mifepristone involves irreversible modification of the apoprotein at the enzyme active site instead of being the result of heme adduct formation or heme fragmentation.",mifepristone,CHEMICAL,be result of,heme fragmentation,MENTAL_HEALTH
33146667,Recent evidence suggests that 1 or 2 administrations of psilocybin with psychological support produces antidepressant effects in patients with cancer and in those with treatment-resistant depression.,psilocybin,CHEMICAL,produce antidepressant effects in patients with cancer and in,treatment-resistant depression,MENTAL_HEALTH
33146667,Recent evidence suggests that 1 or 2 administrations of psilocybin with psychological support produces antidepressant effects in patients with cancer and in those with treatment-resistant depression.,psilocybin,CHEMICAL,produce,antidepressant effects,CHEMICAL
34324063,"The current classification of sporadic Creutzfeldt-Jakob disease (sCJD) includes six major clinicopathological subtypes defined by the physicochemical properties of the protease-resistant core of the pathologic prion protein (PrPSc), defining two major PrPSc types (i.e., 1 and 2), and the methionine (M)/valine (V) polymorphic codon 129 of the prion protein gene (PRNP).",sporadic Creutzfeldt-Jakob disease,DISEASE,define,methionine (M)/valine,NUTRITION
2881522,"All three antihistaminics, at some dosage levels, slightly increased activity when given alone, but strongly enhanced morphine-induced hyperactivity.",antihistaminics,CHEBI,enhance,morphine-induced hyperactivity,MENTAL_HEALTH
1676005,"Furthermore, tripelennamine, diphenhydramine, cyclizine, ranitidine and cimetidine potentiate the buprenorphine-induced hyperactivity.",ranitidine,CHEMICAL,potentiate,buprenorphine-induced hyperactivity,MENTAL_HEALTH
1676005,"Furthermore, tripelennamine, diphenhydramine, cyclizine, ranitidine and cimetidine potentiate the buprenorphine-induced hyperactivity.",diphenhydramine,CHEMICAL,potentiate,buprenorphine-induced hyperactivity,MENTAL_HEALTH
1676005,"Furthermore, tripelennamine, diphenhydramine, cyclizine, ranitidine and cimetidine potentiate the buprenorphine-induced hyperactivity.",cyclizine,CHEMICAL,potentiate,buprenorphine-induced hyperactivity,MENTAL_HEALTH
1676005,"Furthermore, tripelennamine, diphenhydramine, cyclizine, ranitidine and cimetidine potentiate the buprenorphine-induced hyperactivity.",tripelennamine,CHEMICAL,potentiate,buprenorphine-induced hyperactivity,MENTAL_HEALTH
1676005,Previous administration of naloxone blocks the tripelennamine- and diphenhydramine-induced hyperactivity.,naloxone,CHEMICAL,block,tripelennamine- hyperactivity,MENTAL_HEALTH
1676005,Previous administration of naloxone blocks the tripelennamine- and diphenhydramine-induced hyperactivity.,naloxone,CHEMICAL,block,tripelennamine- hyperactivity,CHEMICAL
1676005,"These results suggest that H1- and H2-receptor antagonists effects on locomotor behavior in mice may be related with opioid mechanisms, but not with amphetamine mechanisms.",antagonists effects,CHEBI,be related with,amphetamine mechanisms,CHEMICAL
1676005,"These results suggest that H1- and H2-receptor antagonists effects on locomotor behavior in mice may be related with opioid mechanisms, but not with amphetamine mechanisms.",H1- antagonists,CHEMICAL,be related with,amphetamine mechanisms,CHEMICAL
1676005,"These results suggest that H1- and H2-receptor antagonists effects on locomotor behavior in mice may be related with opioid mechanisms, but not with amphetamine mechanisms.",locomotor behavior,DISEASE,be related with,amphetamine mechanisms,CHEMICAL
3253717,"For what concerns the effects on locomotor activity, it was demonstrated that three histamine H1 receptor antagonists, chlorpheniramine, diphenhydramine and tripelennamine enhance morphine-, but not amphetamine and scopolamine-induced hyperactivity in mice.",chlorpheniramine,CHEMICAL,enhance,morphine- hyperactivity,MENTAL_HEALTH
3253717,"For what concerns the effects on locomotor activity, it was demonstrated that three histamine H1 receptor antagonists, chlorpheniramine, diphenhydramine and tripelennamine enhance morphine-, but not amphetamine and scopolamine-induced hyperactivity in mice.",histamine H1 receptor antagonists,CHEBI,enhance,morphine- hyperactivity,MENTAL_HEALTH
3253717,"For what concerns the effects on locomotor activity, it was demonstrated that three histamine H1 receptor antagonists, chlorpheniramine, diphenhydramine and tripelennamine enhance morphine-, but not amphetamine and scopolamine-induced hyperactivity in mice.",histamine H1 receptor antagonists,CHEMICAL,enhance,morphine- hyperactivity,MENTAL_HEALTH
32688929,"Hexokinase is likely to be involved in the signal pathway, as Suc, Glc, Fru, 2-deoxy-d-glucose and mannose were more effective repressors than 3-O-methylglucose, and the hexokinase inhibitor mannoheptulose reduced repression.",Suc,CHEMICAL,be,3-O-methylglucose,CHEMICAL
32688929,"Hexokinase is likely to be involved in the signal pathway, as Suc, Glc, Fru, 2-deoxy-d-glucose and mannose were more effective repressors than 3-O-methylglucose, and the hexokinase inhibitor mannoheptulose reduced repression.",hexokinase inhibitor mannoheptulose,CHEMICAL,reduce,repression,MENTAL_HEALTH
32029433,The characteristic ophthalmological feature in SS is the presence of recurrent multiple BRAO in the absence of intraocular inflammation.,SS,DISEASE,be presence of recurrent multiple brao in absence of,intraocular inflammation,DISEASE
32029433,The characteristic ophthalmological feature in SS is the presence of recurrent multiple BRAO in the absence of intraocular inflammation.,SS,DISEASE,be presence of,recurrent multiple BRAO,DISEASE
3896744,Deficiencies of specific vitamins produce consistent symptoms of psychiatric disorder.,specific vitamins,CHEBI,produce consistent symptoms of,psychiatric disorder,DISEASE
3896744,"Thiamine deficiency, which is common in alcoholism, can produce confusion and psychotic symptoms, in addition to neurological signs.",alcoholism,DISEASE,produce,confusion symptoms,DISEASE
3896744,"Thiamine deficiency, which is common in alcoholism, can produce confusion and psychotic symptoms, in addition to neurological signs.",Thiamine deficiency,CHEBI,produce,confusion symptoms,DISEASE
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",folate deficiency,CHEBI,contribute symptoms of,depression,MENTAL_HEALTH
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",folate deficiency,CHEBI,contribute symptoms of,disorientation,MENTAL_HEALTH
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",folate deficiency,CHEBI,contribute symptoms of,psychosis,MENTAL_HEALTH
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",Vitamin B12,CHEBI,contribute symptoms of,depression,MENTAL_HEALTH
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",Vitamin B12,CHEBI,contribute symptoms of,disorientation,MENTAL_HEALTH
3896744,"Vitamin B12 and folate deficiency may contribute symptoms of disorientation, depression or psychosis; their measurement is a part of routine dementia work-ups.",Vitamin B12,CHEBI,contribute symptoms of,psychosis,MENTAL_HEALTH
3896744,"The use of vitamins has been most prominent in psychiatry in the treatment of schizophrenia, where large doses of nicotinic acid were initially given alone and later combined with other vitamins and minerals.",nicotinic acid,CHEBI,combine with,other vitamins,CHEBI
3896744,"The use of vitamins has been most prominent in psychiatry in the treatment of schizophrenia, where large doses of nicotinic acid were initially given alone and later combined with other vitamins and minerals.",vitamins,CHEBI,be prominent in psychiatry in treatment of,schizophrenia,MENTAL_HEALTH
3896744,Several theoretical models were described to support the use of vitamins in schizophrenia.,vitamins,CHEBI,have the use in,schizophrenia,MENTAL_HEALTH
3896744,These included: the parallels of schizophrenia to the psychiatric symptoms of pellagra; hypotheses of a defect in adrenaline metabolism; and the accumulation of psychotoxic substances which produce psychotic symptoms.,schizophrenia,MENTAL_HEALTH,have the parallels to,psychiatric symptoms,DISEASE
35566877,poly(HAMAm-b-HEPOMAn)) was synthesized by reversible addition fragmentation chain transfer (RAFT) polymerization.,poly(HAMAm-b-HEPOMAn,CHEMICAL,be synthesized by,reversible addition fragmentation chain transfer,MENTAL_HEALTH
34664221,VD3 supplementation may modulate OS and affect sperm motility in men with asthenozoospermia and serum 25-OH-D3 < 30 ng/ml.,VD3 supplementation,CHEMICAL,affect sperm motility in men with,asthenozoospermia,DISEASE
1244093,The behaviour of some urinary metabolites of tryptophan/nicotinic acid pathway was studied in 7 patients with Parkinson's disease during a 24-day period of levodopa treatment.,tryptophan/nicotinic acid pathway,CHEMICAL,be studied in patients with parkinson's disease during 24-day period of,levodopa treatment,CHEMICAL
35592934,Resveratrol can relieve pain under various pain conditions.,Resveratrol,CHEMICAL,relieve pain under,various pain conditions,DISEASE
35592934,Resveratrol can relieve pain under various pain conditions.,Resveratrol,CHEMICAL,relieve,pain,DISEASE
23296774,"Abnormal dopamine receptor signaling is implicated in several neuropsychiatric disorders, including schizophrenia and attention deficit hyperactivity disorder, as well as drug abuse.",Abnormal dopamine receptor signaling,CHEMICAL,be implicated in,drug abuse,CHEBI
23296774,"Abnormal dopamine receptor signaling is implicated in several neuropsychiatric disorders, including schizophrenia and attention deficit hyperactivity disorder, as well as drug abuse.",Abnormal dopamine receptor signaling,CHEMICAL,be implicated in,schizophrenia,MENTAL_HEALTH
23296774,"Abnormal dopamine receptor signaling is implicated in several neuropsychiatric disorders, including schizophrenia and attention deficit hyperactivity disorder, as well as drug abuse.",Abnormal dopamine receptor signaling,CHEMICAL,be implicated in,several neuropsychiatric disorders,DISEASE
23296774,"Abnormal dopamine receptor signaling is implicated in several neuropsychiatric disorders, including schizophrenia and attention deficit hyperactivity disorder, as well as drug abuse.",Abnormal dopamine receptor signaling,CHEMICAL,be implicated in,attention deficit hyperactivity disorder,MENTAL_HEALTH
19007354,"Methylphenidate hydrochloride (MPH), more commonly known as Ritalin, is a piperidine derivative and is the drug most often used to treat attention deficit/hyperactivity disorder, one of the most common behavioural disorders of children and young adults.",Methylphenidate hydrochloride,CHEMICAL,be,piperidine derivative,CHEMICAL
19007354,"Methylphenidate hydrochloride (MPH), more commonly known as Ritalin, is a piperidine derivative and is the drug most often used to treat attention deficit/hyperactivity disorder, one of the most common behavioural disorders of children and young adults.",MPH,CHEMICAL,be,piperidine derivative,CHEMICAL
35481074,"For example, l-phenylalanine is a biologically active optical isomer involved in crucial biological processes, the lack of which will lead to intellectual disability, while d-phenylalanine only acts as a chiral intermediate.",d-phenylalanine,CHEMICAL,act as,chiral intermediate,CHEMICAL
34388917,These results indicate that the CA model underestimated the mixture toxicity of PFAS with PFOS co-exposures and may have health risk assessment implications.,PFAS,CHEMICAL,have the mixture toxicity with,PFOS co-exposures,CHEMICAL
20885010,"Spermidine and spermine produced partial displacement (approximately 50%) and, at the highest concentration, the effect was reversed.",spermine,CHEMICAL,produce,partial displacement,MENTAL_HEALTH
20885010,"Spermidine and spermine produced partial displacement (approximately 50%) and, at the highest concentration, the effect was reversed.",Spermidine,CHEMICAL,produce,partial displacement,MENTAL_HEALTH
27258254,A sizeable portion of the societal drain from cocaine abuse results from the complications of in utero drug exposure.,cocaine abuse,MENTAL_HEALTH,result from complications of,utero drug exposure,CHEBI
33609766,"For this reason, NAD+ is often studied in the context of aging, cancer, and neurodegenerative and metabolic disorders.",NAD+,CHEMICAL,be studied for reason in context of,cancer,DISEASE
33609766,"For this reason, NAD+ is often studied in the context of aging, cancer, and neurodegenerative and metabolic disorders.",NAD+,CHEMICAL,be studied for reason in context of,aging disorders,DISEASE
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,A-T,DISEASE
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,Werner syndrome,DISEASE
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,WS,DISEASE
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,CSA,CHEMICAL
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,ataxia-telangiectasia,DISEASE
34201700,"Some of these diseases are xeroderma pigmentosum group A (XPA, caused by mutation of XPA), Cockayne syndrome group A and group B (CSA, CSB, and are caused by mutations of CSA and CSB, respectively), ataxia-telangiectasia (A-T, caused by mutation of ATM), and Werner syndrome (WS, with most cases caused by mutations in WRN).",xeroderma pigmentosum group A,DISEASE,be caused by mutations of,CSB,CHEMICAL
35592768,"In XY individuals, the loss of ATRX leads to ATR-X (alpha thalassemia, mental retardation, X-linked) syndrome associated with a wide range of genital abnormalities such as hypospadias, ambiguous genitalia, and small testes with reduced tubule volume [4], [5], [6], [7], [8].",ATRX,DISEASE,lead in xy individuals to,ATR-X alpha thalassemia,DISEASE
35592768,"In XY individuals, the loss of ATRX leads to ATR-X (alpha thalassemia, mental retardation, X-linked) syndrome associated with a wide range of genital abnormalities such as hypospadias, ambiguous genitalia, and small testes with reduced tubule volume [4], [5], [6], [7], [8].",ATRX,DISEASE,lead in xy individuals to,ATR-X alpha thalassemia,NUTRITION
35592768,"In XY individuals, the loss of ATRX leads to ATR-X (alpha thalassemia, mental retardation, X-linked) syndrome associated with a wide range of genital abnormalities such as hypospadias, ambiguous genitalia, and small testes with reduced tubule volume [4], [5], [6], [7], [8].",ATRX,DISEASE,lead in xy individuals to,mental retardation,MENTAL_HEALTH
2905807,"gamma-Aminobutyric acid (GABA) antagonists had almost no effect on benzodiazepine-induced amnesia, whereas the benzodiazepine-receptor antagonist Ro 15-1788 completely and specifically reversed it.",gamma-Aminobutyric acid GABA antagonists,CHEMICAL,have no effect on,benzodiazepine-induced amnesia,MENTAL_HEALTH
2905807,"gamma-Aminobutyric acid (GABA) antagonists had almost no effect on benzodiazepine-induced amnesia, whereas the benzodiazepine-receptor antagonist Ro 15-1788 completely and specifically reversed it.",gamma-Aminobutyric acid GABA antagonists,CHEBI,have no effect on,benzodiazepine-induced amnesia,MENTAL_HEALTH
2905807,Additional work is needed to clarify what aspects of benzodiazepine receptor occupancy mediate amnesia.,benzodiazepine receptor occupancy,CHEMICAL,mediate,amnesia,MENTAL_HEALTH
17489169,The hormone is produced mostly by granulosa cells of the preantral and small antral follicles.,hormone,CHEBI,be produced by granulosa cells of,preantral follicles,DISEASE
7906211,High levels of low density lipoprotein (LDL) and its apolipoprotein B (apoB) are risk factors for atherosclerosis and myocardial infarction (MI).,low density lipoprotein,NUTRITION,be risk factors for,atherosclerosis,DISEASE
7906211,High levels of low density lipoprotein (LDL) and its apolipoprotein B (apoB) are risk factors for atherosclerosis and myocardial infarction (MI).,low density lipoprotein,NUTRITION,be risk factors for,myocardial infarction,DISEASE
33266250,"Conclusions: Besides clinical symptoms of severity, complications of severe odontogenic infection are predicted by measurables and objectives criteria as penicillin allergy, mandibular molar, C-reactive protein level, psychiatric disorders and alcohol abuse.",severe odontogenic infection,DISEASE,be predicted,penicillin allergy,CHEMICAL
33266250,"Conclusions: Besides clinical symptoms of severity, complications of severe odontogenic infection are predicted by measurables and objectives criteria as penicillin allergy, mandibular molar, C-reactive protein level, psychiatric disorders and alcohol abuse.",severe odontogenic infection,DISEASE,be predicted,psychiatric disorders,DISEASE
33266250,"Conclusions: Besides clinical symptoms of severity, complications of severe odontogenic infection are predicted by measurables and objectives criteria as penicillin allergy, mandibular molar, C-reactive protein level, psychiatric disorders and alcohol abuse.",severe odontogenic infection,DISEASE,be predicted,alcohol abuse,MENTAL_HEALTH
31834943,"In conclusion, tree seedlings in this study show root trait syndromes, which vary along gradients of resources and defoliation: seedlings from dry areas invest in deep roots, seedlings from shaded environments optimize shoot investment, and seedlings experiencing frequent defoliation store resources in the roots.",tree seedlings,NUTRITION,show in,conclusion root trait syndromes,MENTAL_HEALTH
33468234,"Due to lack of diagnostic tools, clinical response to bile acid sequestrants is often used to confirm a diagnosis of bile acid diarrhoea in people.",bile acid sequestrants,CHEBI,confirm diagnosis of,bile acid diarrhoea,DISEASE
33468234,"Due to lack of diagnostic tools, clinical response to bile acid sequestrants is often used to confirm a diagnosis of bile acid diarrhoea in people.",bile acid sequestrants,CHEMICAL,confirm diagnosis of,bile acid diarrhoea,DISEASE
35585808,Several studies have been done to illustrate if vitamins and other dietary supplements are effective in treatment and prevention of ASD and ADHD.,vitamins,CHEBI,be effective in treatment and prevention of,ASD,DISEASE
35585808,Several studies have been done to illustrate if vitamins and other dietary supplements are effective in treatment and prevention of ASD and ADHD.,vitamins,CHEBI,be effective in treatment and prevention of,ADHD,MENTAL_HEALTH
12940507,MNGIE is the best characterized of the expanding number of mitochondrial disorders caused by alterations in the metabolism of nucleosides/nucleotides.,MNGIE,DISEASE,expanding number of,mitochondrial disorders,DISEASE
12940507,"Mutations in the deoxynucleotide carrier, a transporter of deoxynucleoside diphosphates, have been identified as a cause of congenital microcephaly.",deoxynucleotide carrier,CHEBI,be identified as cause of,congenital microcephaly,DISEASE
12940507,"Mutations in the deoxynucleotide carrier, a transporter of deoxynucleoside diphosphates, have been identified as a cause of congenital microcephaly.",deoxynucleotide carrier,CHEMICAL,be identified as cause of,congenital microcephaly,DISEASE
12940507,"Mutations in the deoxynucleotide carrier, a transporter of deoxynucleoside diphosphates, have been identified as a cause of congenital microcephaly.",deoxynucleoside diphosphates,CHEMICAL,be identified as cause of,congenital microcephaly,DISEASE
12940507,"Mutations in the deoxynucleotide carrier, a transporter of deoxynucleoside diphosphates, have been identified as a cause of congenital microcephaly.",deoxynucleoside diphosphates,NUTRITION,be identified as cause of,congenital microcephaly,DISEASE
33670344,"In normal rats, dependence of RDD on spinal GABAergic inhibitory function encompassed both GABAA and GABAB receptor sub-types.",RDD,DISEASE,encompass in,GABAB receptor,CHEMICAL
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEBI,do spinal delivery of,carbonic anhydrase inhibitor acetazolamide,CHEMICAL
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEMICAL,do spinal delivery of,carbonic anhydrase inhibitor acetazolamide,CHEMICAL
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEBI,restore rdd and alleviated indices of neuropathic pain in,diabetic rats,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEMICAL,restore rdd and alleviated indices of neuropathic pain in,diabetic rats,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEBI,restore rdd and alleviated indices of,neuropathic pain,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEMICAL,restore rdd and alleviated indices of,neuropathic pain,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEBI,restore,RDD,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",GABAB receptor agonist baclofen,CHEMICAL,restore,RDD,DISEASE
33670344,"Administration of the GABAB receptor agonist baclofen restored RDD and alleviated indices of neuropathic pain in diabetic rats, as did spinal delivery of the carbonic anhydrase inhibitor acetazolamide.",neuropathic pain,DISEASE,have rdd and alleviated indices in,diabetic rats,DISEASE
31607482,The depression from PV neuron terminals is mainly mediated by presynaptic P/N type calcium channels.,depression,MENTAL_HEALTH,be mediated by,presynaptic P/N type calcium channels,CHEMICAL
30574067,"Moreover, the propofol-induced changes in amplitude and PPR of PF-PC EPSCs were abolished by a specific protein kinase A (PKA) inhibitor, KT5720.",propofol-induced changes,DISEASE,be abolished by,KT5720,CHEMICAL
30574067,"Moreover, the propofol-induced changes in amplitude and PPR of PF-PC EPSCs were abolished by a specific protein kinase A (PKA) inhibitor, KT5720.",PF-PC EPSCs,CHEMICAL,be abolished by,KT5720,CHEMICAL
30574067,"These results indicate that application of propofol facilitates presynaptic GABAB receptors, resulting in a depression of PF-PC synaptic transmission via PKA signaling pathway in mouse cerebellar cortex.",propofol,CHEMICAL,result in,depression,MENTAL_HEALTH
35596053,"Based on a broad range of genetic backgrounds like single nucleotide polymorphism (SNPs), GBS is known as a novel technique to facilitate the detection of quantitative trait loci (QTL) regions robustly linked with interested traits compared to genome-wide association study (GWAS) and QTL.",GBS,DISEASE,be known based on broad range of genetic backgrounds like,single nucleotide polymorphism,CHEMICAL
15199138,"In humans, a third copy of DYRK1A is present in Down syndrome (trisomy 21) and has been implicated in the etiology of mental retardation.",DYRK1A,CHEMICAL,be implicated in etiology of,mental retardation,MENTAL_HEALTH
15199138,"In humans, a third copy of DYRK1A is present in Down syndrome (trisomy 21) and has been implicated in the etiology of mental retardation.",DYRK1A,CHEMICAL,be present in humans in,Down syndrome,MENTAL_HEALTH
19876857,"Extracts of the bark of the central African tree Pausinystalia yohimbe contain yohimbine, an indole alkaloid, which is used to treat erectile dysfunction.",tree Pausinystalia yohimbe,CHEMICAL,contain,indole alkaloid,CHEMICAL
19876857,"Extracts of the bark of the central African tree Pausinystalia yohimbe contain yohimbine, an indole alkaloid, which is used to treat erectile dysfunction.",tree Pausinystalia yohimbe,CHEMICAL,contain,yohimbine,CHEMICAL
19876857,"Extracts of the bark of the central African tree Pausinystalia yohimbe contain yohimbine, an indole alkaloid, which is used to treat erectile dysfunction.",tree Pausinystalia yohimbe,NUTRITION,contain,indole alkaloid,CHEMICAL
19876857,"Extracts of the bark of the central African tree Pausinystalia yohimbe contain yohimbine, an indole alkaloid, which is used to treat erectile dysfunction.",tree Pausinystalia yohimbe,NUTRITION,contain,yohimbine,CHEMICAL
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,headache,MENTAL_HEALTH
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,anxiety,MENTAL_HEALTH
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,rash,DISEASE
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,agitation,MENTAL_HEALTH
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,tachycardia,DISEASE
19876857,"The reported side effects of over-the-counter preparations of yohimbine include gastrointestinal upset, anxiety, increased blood pressure, headache, agitation, rash, tachycardia, and frequent urination.",yohimbine,CHEMICAL,include,gastrointestinal upset,DISEASE
35461848,"Batch experiments resulted in an optimum dye removal of 92.72% at a pH of 8, 1 g/L of CP-HAp nps dosage, 20 ppm AB113 concentration, 120 min contact time, 150 rpm agitation speed and at room temperature.",ppm AB113 concentration,CHEMICAL,rpm,agitation speed,MENTAL_HEALTH
35128560,This study examined the association between opioid analgesic prescription initiation and suicidal behavior among young people.,analgesic prescription,CHEBI,have the association with,suicidal behavior,MENTAL_HEALTH
35128560,This study examined the association between opioid analgesic prescription initiation and suicidal behavior among young people.,suicidal behavior,MENTAL_HEALTH,have the association with,analgesic prescription,CHEBI
1745441,An important question that remains to be determined is whether IDPN itself or a putative active metabolite is responsible for the neurotoxic actions of the chemical in vivo.,IDPN,CHEMICAL,be responsible for,neurotoxic actions,DISEASE
1745441,"In conclusion, pretreatment with hepatotoxic dosages of CCl4 leads to increased toxicity of IDPN.",hepatotoxic dosages,DISEASE,lead in conclusion to increased toxicity of,IDPN,CHEMICAL
1745441,"In conclusion, pretreatment with hepatotoxic dosages of CCl4 leads to increased toxicity of IDPN.",CCl4,CHEMICAL,lead in conclusion to increased toxicity of,IDPN,CHEMICAL
1745441,"In conclusion, pretreatment with hepatotoxic dosages of CCl4 leads to increased toxicity of IDPN.",hepatotoxic dosages,DISEASE,lead in conclusion to,increased toxicity,DISEASE
1745441,"In conclusion, pretreatment with hepatotoxic dosages of CCl4 leads to increased toxicity of IDPN.",CCl4,CHEMICAL,lead in conclusion to,increased toxicity,DISEASE
34834493,"Taken together, d,l-leucovorin is associated with improvements in core and associated symptoms of ASD and appears safe and generally well-tolerated, with the strongest evidence coming from the blinded, placebo-controlled studies.",l-leucovorin,CHEMICAL,be associated with improvements in,ASD,DISEASE
19505488,"However, domoic acid poisoning has a significant effect on marine wildlife and multiple poisoning events have occurred in marine birds and mammals over the last few decades.",domoic acid poisoning,CHEMICAL,have significant effect on,multiple poisoning events,DISEASE
9059995,"Domoic acid is a shellfish toxin which produces gastrointestinal distress, followed by neurological symptoms such as headache, confusion, disorientation and severe deficits in short-term memory.",Domoic acid,CHEMICAL,followed by neurological symptoms such as,headache,MENTAL_HEALTH
9059995,"Domoic acid is a shellfish toxin which produces gastrointestinal distress, followed by neurological symptoms such as headache, confusion, disorientation and severe deficits in short-term memory.",Domoic acid,CHEMICAL,followed by neurological symptoms such as,confusion,DISEASE
9059995,"Domoic acid is a shellfish toxin which produces gastrointestinal distress, followed by neurological symptoms such as headache, confusion, disorientation and severe deficits in short-term memory.",Domoic acid,CHEMICAL,followed by neurological symptoms such as,disorientation,MENTAL_HEALTH
9059995,"Domoic acid toxicity was measured in mice as the onset times for scratching behaviour, seizure activity, and death, after the intraperitoneal administration of domoic acid at different pH's.",Domoic acid toxicity,CHEMICAL,be measured in mice as onset times after intraperitoneal administration of,domoic acid,CHEMICAL
9059995,"Results of the present study show that the scratching behaviour, seizure activity, and death, occurred at 12, 40, and 55 min, after intraperitoneal administration of domoic acid at pH 3.7.",death,DISEASE,occur at,domoic acid,CHEMICAL
9059995,"Results of the present study show that the scratching behaviour, seizure activity, and death, occurred at 12, 40, and 55 min, after intraperitoneal administration of domoic acid at pH 3.7.",seizure activity,DISEASE,occur at,domoic acid,CHEMICAL
9059995,"Domoic acid toxicity was lowest at pH 3.7, and highest at pH 7.4, with intermediate toxicity at other pH's.",Domoic acid toxicity,CHEMICAL,be lowest at,intermediate toxicity,DISEASE
9059995,"In contrast, the onset times for seizure activity, and death were significantly affected by pH of domoic acid, toxicity being higher at pH 7.4 than at pH 3.7.",seizure activity,DISEASE,be affected in contrast by ph of,domoic acid,CHEMICAL
9059995,"In contrast, the onset times for seizure activity, and death were significantly affected by pH of domoic acid, toxicity being higher at pH 7.4 than at pH 3.7.",death,DISEASE,be affected in contrast by ph of,domoic acid,CHEMICAL
9059995,"The differential toxicity of domoic acid at different pH may be related to its solubility, rate of absorption, and elimination, depending on the degree of protonation of domoic acid molecule.",domoic acid,CHEMICAL,depending on degree of protonation of,domoic acid molecule,CHEMICAL
9059995,"The differential toxicity of domoic acid at different pH may be related to its solubility, rate of absorption, and elimination, depending on the degree of protonation of domoic acid molecule.",differential toxicity,DISEASE,depending on degree of protonation of,domoic acid molecule,CHEMICAL
32821290,Wernicke encephalopathy (WE) and Wernicke-Korsakoff syndrome (WKS) are well-known disorders caused by thiamine deficiency.,Wernicke-Korsakoff syndrome,DISEASE,caused by,thiamine deficiency,CHEBI
32821290,Wernicke encephalopathy (WE) and Wernicke-Korsakoff syndrome (WKS) are well-known disorders caused by thiamine deficiency.,Wernicke encephalopathy,DISEASE,caused by,thiamine deficiency,CHEBI
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,L-DOPA-induced dyskinesia,MENTAL_HEALTH,be linked to,dopamine transmission,CHEMICAL
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,L-DOPA-induced dyskinesia,MENTAL_HEALTH,be linked to,glutamate,CHEMICAL
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,Parkinson's disease,DISEASE,be linked to,dopamine transmission,CHEMICAL
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,Parkinson's disease,DISEASE,be linked to,glutamate,CHEMICAL
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,LID,DISEASE,be linked to,dopamine transmission,CHEMICAL
19357321,L-DOPA-induced dyskinesia (LID) in Parkinson's disease has been linked to altered dopamine and glutamate transmission within the basal ganglia.,LID,DISEASE,be linked to,glutamate,CHEMICAL
19357321,Dyskinesia and rotarod performance were monitored during chronic drug treatment.,Dyskinesia performance,MENTAL_HEALTH,be monitored during,chronic drug treatment,CHEBI
19357321,"In the acute treatment studies, only MTEP and EMQMCM significantly attenuated L-DOPA-induced phospho-ERK1/2 and/or phospho-MSK-1 expression, with MTEP being the most effective (70-80% reduction).",EMQMCM,CHEMICAL,attenuate in,L-DOPA-induced phospho-ERK1/2,DISEASE
19357321,"In the acute treatment studies, only MTEP and EMQMCM significantly attenuated L-DOPA-induced phospho-ERK1/2 and/or phospho-MSK-1 expression, with MTEP being the most effective (70-80% reduction).",MTEP,CHEMICAL,attenuate in,L-DOPA-induced phospho-ERK1/2,DISEASE
19357321,"In the chronic experiment, only MTEP significantly attenuated dyskinesia without adverse motor effects, whereas EMQMCM and LY379268 inhibited the L-DOPA-induced improvement in rotarod performance.",EMQMCM,CHEMICAL,inhibit,L-DOPA-induced improvement,DISEASE
19357321,"In the chronic experiment, only MTEP significantly attenuated dyskinesia without adverse motor effects, whereas EMQMCM and LY379268 inhibited the L-DOPA-induced improvement in rotarod performance.",LY379268,CHEMICAL,inhibit,L-DOPA-induced improvement,DISEASE
19357321,"In the chronic experiment, only MTEP significantly attenuated dyskinesia without adverse motor effects, whereas EMQMCM and LY379268 inhibited the L-DOPA-induced improvement in rotarod performance.",MTEP,CHEMICAL,attenuate in,chronic experiment dyskinesia,MENTAL_HEALTH
19357321,"Among the pharmacological treatments examined, MTEP was most effective in inhibiting LID and the associated molecular alterations.",MTEP,CHEMICAL,inhibit,LID molecular alterations,DISEASE
11289407,"Delusional themes that are sensitive to sociocultural or political situations include guilt, love/sex, religion, somatic damage, economy/business and politics.",Delusional themes,DISEASE,include,somatic damage,DISEASE
11289407,"Delusional themes that are sensitive to sociocultural or political situations include guilt, love/sex, religion, somatic damage, economy/business and politics.",Delusional themes,DISEASE,include,economy/business,CHEMICAL
35569502,"Lithium is the most effective treatment for bipolar disorder, resulting in strong suicide prevention effects.",Lithium,NUTRITION,result in,suicide prevention,MENTAL_HEALTH
35569502,"Lithium is the most effective treatment for bipolar disorder, resulting in strong suicide prevention effects.",Lithium,NUTRITION,be effective treatment for,bipolar disorder,MENTAL_HEALTH
29559264,"Moreover, 6F-tricin had no cytotoxicity against HEL cells at concentrations up to 10 μM. We further performed detailed analysis on the amino acid contributions to the binding energies and found that the strong binding affinity for 6F-tricin to CDK9 is attributed to the specific binding orientation of 6F-tricin in the ATP-binding site.",6F-tricin,CHEMICAL,binding orientation of,6F-tricin,CHEMICAL
29559264,"Moreover, 6F-tricin had no cytotoxicity against HEL cells at concentrations up to 10 μM. We further performed detailed analysis on the amino acid contributions to the binding energies and found that the strong binding affinity for 6F-tricin to CDK9 is attributed to the specific binding orientation of 6F-tricin in the ATP-binding site.",6F-tricin,CHEMICAL,binding,orientation,MENTAL_HEALTH
25613831,The lectin griffithsin (GRFT) is a potent antiviral agent capable of prevention and treatment of infections caused by a number of enveloped viruses and is currently under development as an anti-HIV microbicide.,GRFT,CHEMICAL,be potent antiviral agent capable of prevention and treatment of,infections,DISEASE
25613831,The lectin griffithsin (GRFT) is a potent antiviral agent capable of prevention and treatment of infections caused by a number of enveloped viruses and is currently under development as an anti-HIV microbicide.,GRFT,CHEMICAL,be,potent antiviral agent capable,CHEBI
25613831,"In addition to its broad antiviral activity, GRFT is stable at high temperature and at a broad pH range, displays little toxicity and immunogenicity, and is amenable to large-scale manufacturing.",GRFT,CHEMICAL,be stable in addition to,broad antiviral activity,CHEBI
25613831,"In addition to its broad antiviral activity, GRFT is stable at high temperature and at a broad pH range, displays little toxicity and immunogenicity, and is amenable to large-scale manufacturing.",GRFT,CHEMICAL,display,little toxicity,DISEASE
25613831,"Previously, we have engineered and analyzed several monomeric forms of this lectin (mGRFT) with anti-HIV EC50 values ranging up to 323 nM. Based on our previous analysis of mGRFT, we hypothesized that the orientation and spacing of the carbohydrate binding domains GRFT were key to its antiviral activity.",GRFT,CHEMICAL,be key to,antiviral activity,CHEBI
25613831,"Previously, we have engineered and analyzed several monomeric forms of this lectin (mGRFT) with anti-HIV EC50 values ranging up to 323 nM. Based on our previous analysis of mGRFT, we hypothesized that the orientation and spacing of the carbohydrate binding domains GRFT were key to its antiviral activity.",orientation,MENTAL_HEALTH,be key to,antiviral activity,CHEBI
11386980,Results of previous studies suggest that estrogen improves somatic and mild depressive symptoms experienced by perimenopausal women.,estrogen,CHEBI,improve,somatic depressive symptoms,DISEASE
21329350,"CPE (100 μg/mL) increased TTP mRNA levels by up to 10-fold, and this stimulation was sustained over 16 h. The levels of VEGF mRNA, a putative target of TTP, were decreased 40-50% by CPE.",CPE,CHEMICAL,be decreased,CPE,CHEMICAL
21329350,"CPE (100 μg/mL) increased TTP mRNA levels by up to 10-fold, and this stimulation was sustained over 16 h. The levels of VEGF mRNA, a putative target of TTP, were decreased 40-50% by CPE.",μg/mL,CHEMICAL,be decreased,CPE,CHEMICAL
24795564,"In 2012, linaclotide was approved in the United States and European Union for the treatment of adult patients with irritable bowel syndrome with constipation.",linaclotide,CHEMICAL,be approved in 2012 in united states and european union for treatment of,irritable bowel syndrome,DISEASE
24795564,"In 2012, linaclotide was approved in the United States and European Union for the treatment of adult patients with irritable bowel syndrome with constipation.",linaclotide,CHEMICAL,be approved in 2012 in united states and european union for treatment of,constipation,DISEASE
34064568,Resveratrol is a phytoalexin produced by many plants as a defense mechanism against stress-inducing conditions.,Resveratrol,CHEMICAL,produced by many plants as,defense mechanism,MENTAL_HEALTH
34064568,Numerous in vitro and in vivo studies demonstrated beneficial effects of resveratrol in cardiovascular diseases (CVD).,resveratrol,CHEMICAL,have beneficial effects in,cardiovascular diseases,DISEASE
31685447,"In conclusion, antibiotic and QAC resistant E. coli are present in the gastrointestinal tract of young calves at the beginning of the fattening period, emphasizing the need for appropriate and reduced use of antibiotics and QAC-containing disinfectants in order to limit further selection of these bacteria during the fattening period.",antibiotic E. coli,CHEBI,be present in conclusion in,gastrointestinal tract,DISEASE
31685447,"In conclusion, antibiotic and QAC resistant E. coli are present in the gastrointestinal tract of young calves at the beginning of the fattening period, emphasizing the need for appropriate and reduced use of antibiotics and QAC-containing disinfectants in order to limit further selection of these bacteria during the fattening period.",antibiotic E. coli,CHEBI,reduced use of,QAC-containing disinfectants,CHEBI
31685447,"In conclusion, antibiotic and QAC resistant E. coli are present in the gastrointestinal tract of young calves at the beginning of the fattening period, emphasizing the need for appropriate and reduced use of antibiotics and QAC-containing disinfectants in order to limit further selection of these bacteria during the fattening period.",antibiotic E. coli,CHEBI,reduced use of,antibiotics,CHEBI
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,breast cancer,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,immune dysfunction,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,dyslexia,MENTAL_HEALTH
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,infertility,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,stammering,MENTAL_HEALTH
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,myocardial infarction,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,migraine,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",testosterone,CHEMICAL,be implicated in,autism,MENTAL_HEALTH
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,breast cancer,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,immune dysfunction,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,dyslexia,MENTAL_HEALTH
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,infertility,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,stammering,MENTAL_HEALTH
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,myocardial infarction,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,migraine,DISEASE
10859702,"Prenatal levels of testosterone and oestrogen have been implicated in infertility, autism, dyslexia, migraine, stammering, immune dysfunction, myocardial infarction and breast cancer.",oestrogen,CHEBI,be implicated in,autism,MENTAL_HEALTH
32654174,Dopamine agonist treatment may result in hypersexuality in men.,Dopamine agonist treatment,CHEBI,result in,hypersexuality,DISEASE
34930854,"Phosphate is present in the 2, 3-diphosphoglycerate (2,3DPG) ester composition, which can shift the O2-Hb dissociation curve to the right.",Phosphate,CHEMICAL,be present in,"3-diphosphoglycerate 2,3DPG ester composition",CHEMICAL
9283087,"The low dissociation constant was confirmed by kinetic studies with a value of 0.16 microM. Specific [3H]-cGMP binding was inhibited by cAMP, cGMP, and cIMP with KD values of 0.22 microM, 0.09 microM, and 0.17 microM, respectively.",low dissociation constant,MENTAL_HEALTH,be inhibited by,cGMP,CHEMICAL
9283087,"The low dissociation constant was confirmed by kinetic studies with a value of 0.16 microM. Specific [3H]-cGMP binding was inhibited by cAMP, cGMP, and cIMP with KD values of 0.22 microM, 0.09 microM, and 0.17 microM, respectively.",low dissociation constant,MENTAL_HEALTH,be inhibited by,cAMP,CHEMICAL
24200542,"In addition mood stabilizers, affecting glutamatergic/gabaminergic balance, serve to the reduction of impulsive aggression, while lithium manifests positive effect on both suicidality and impulsive aggression.",lithium,NUTRITION,manifest positive effect on,impulsive aggression,DISEASE
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",Aristolochic acid,CHEMICAL,cause,aristolochic acid nephropathy,CHEMICAL
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",Aristolochic acid,CHEMICAL,cause,associated urothelial malignancy,DISEASE
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",plant nephrotoxin,CHEBI,be hypothesized to responsible for,Balkan endemic nephropathy,DISEASE
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",plant nephrotoxin,CHEBI,cause,aristolochic acid nephropathy,CHEMICAL
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",plant nephrotoxin,CHEBI,cause,associated urothelial malignancy,DISEASE
23701164,"Aristolochic acid (AA), a plant nephrotoxin and carcinogen, causes aristolochic acid nephropathy (AAN) and its associated urothelial malignancy, and is hypothesized to be responsible for Balkan endemic nephropathy (BEN).",Aristolochic acid,CHEMICAL,be hypothesized to responsible for,Balkan endemic nephropathy,DISEASE
17851120,"Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, is associated with tumor development in patients suffering from Chinese herbs nephropathy (now termed aristolochic acid nephropathy, AAN) and may also be a cause for the development of a similar type of nephropathy, the Balkan endemic nephropathy (BEN).",nephrotoxin,CHEBI,be associated with,tumor development,DISEASE
17851120,"Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, is associated with tumor development in patients suffering from Chinese herbs nephropathy (now termed aristolochic acid nephropathy, AAN) and may also be a cause for the development of a similar type of nephropathy, the Balkan endemic nephropathy (BEN).",Aristolochic acid,CHEMICAL,be associated with,tumor development,DISEASE
17851120,"Prostaglandin H synthase (cyclooxygenase, COX) is another enzyme activating AA in human renal microsomes.",Prostaglandin H synthase cyclooxygenase,CHEMICAL,activating in,human renal microsomes,DISEASE
16125300,"Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been associated with the development of urothelial cancer in humans.",nephrotoxin,CHEBI,be associated with development of,urothelial cancer,DISEASE
16125300,"Aristolochic acid (AA), a naturally occurring nephrotoxin and carcinogen, has been associated with the development of urothelial cancer in humans.",Aristolochic acid,CHEMICAL,be associated with development of,urothelial cancer,DISEASE
16125300,The in silico docking of AAI to the active sites of CYP1A1 and 1A2 indicates that AAI binds as an axial ligand of the heme iron and that the nitro group of AAI is in close vicinity to the heme iron of CYP1A2 in an orientation allowing the efficient reduction of this group observed experimentally.,AAI,CHEMICAL,be in close vicinity to heme iron of cyp1a2 in,orientation,MENTAL_HEALTH
16125300,The in silico docking of AAI to the active sites of CYP1A1 and 1A2 indicates that AAI binds as an axial ligand of the heme iron and that the nitro group of AAI is in close vicinity to the heme iron of CYP1A2 in an orientation allowing the efficient reduction of this group observed experimentally.,AAI,CHEMICAL,be in close vicinity to,heme iron,CHEMICAL
16125300,The orientation of AAI in the active centre of CYP1A1 however causes an interaction of the heme iron with both the nitro- and the carboxylic groups of AAI.,orientation,MENTAL_HEALTH,cause interaction of,heme iron,CHEMICAL
16125300,The orientation of AAI in the active centre of CYP1A1 however causes an interaction of the heme iron with both the nitro- and the carboxylic groups of AAI.,AAI,CHEMICAL,cause interaction of,heme iron,CHEMICAL
26170637,"Several stimulant medications, such as methylphenidate and amphetamine derivatives, are available to treat ADHD in pediatric patients.",amphetamine derivatives,CHEMICAL,treat,ADHD,MENTAL_HEALTH
26170637,"Several stimulant medications, such as methylphenidate and amphetamine derivatives, are available to treat ADHD in pediatric patients.",methylphenidate,CHEMICAL,treat,ADHD,MENTAL_HEALTH
26170637,"The XR formulation of guanfacine, compared with the immediate-release formulation, is more effective for the long-term management of ADHD and is associated with fewer adverse effects.",guanfacine,CHEMICAL,be effective for long-term management of,ADHD,MENTAL_HEALTH
26170637,Guanfacine XR is also labeled for use as an adjuvant to stimulant treatment for ADHD.,Guanfacine XR,CHEMICAL,be labeled for use as adjuvant to stimulant treatment for,ADHD,MENTAL_HEALTH
26170637,"A similar profile of adverse effects as reported with monotherapy is reported when guanfacine XR is ""added on"" to stimulant therapy with somnolence as the most commonly reported adverse event.",guanfacine XR,CHEMICAL,be added to stimulant therapy with,somnolence,MENTAL_HEALTH
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-hydroxybutyrate,CHEMICAL,improve pain sleep disturbance and fatigue in,fibromyalgia FM patients,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",sodium salt,CHEMICAL,improve pain sleep disturbance and fatigue in,fibromyalgia FM patients,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-hydroxybutyrate,CHEMICAL,improve,pain sleep,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-hydroxybutyrate,CHEMICAL,improve,fatigue,MENTAL_HEALTH
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",sodium salt,CHEMICAL,improve,pain sleep,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",sodium salt,CHEMICAL,improve,fatigue,MENTAL_HEALTH
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEBI,improve pain sleep disturbance and fatigue in,fibromyalgia FM patients,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEMICAL,improve pain sleep disturbance and fatigue in,fibromyalgia FM patients,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEBI,improve,pain sleep,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEBI,improve,fatigue,MENTAL_HEALTH
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEMICAL,improve,pain sleep,DISEASE
31647906,"The gamma-aminobutyric acid type B (GABAB) receptor agonist, the sodium salt of gamma-hydroxybutyrate (GHB), significantly improved pain, sleep disturbance and fatigue in fibromyalgia (FM) patients.",gamma-aminobutyric acid type B GABAB receptor agonist,CHEMICAL,improve,fatigue,MENTAL_HEALTH
31647906,"To clarify whether GABAB receptor positive allosteric modulator (PAM) approach would achieve analgesia with less side-effects than GABAB receptor agonist in FM, we investigated the potential of a novel GABAB receptor PAM, ASP8062, for FM treatment.",GABAB receptor positive modulator approach,CHEMICAL,achieve analgesia with,GABAB receptor agonist,CHEBI
31647906,"To clarify whether GABAB receptor positive allosteric modulator (PAM) approach would achieve analgesia with less side-effects than GABAB receptor agonist in FM, we investigated the potential of a novel GABAB receptor PAM, ASP8062, for FM treatment.",GABAB receptor positive modulator approach,CHEMICAL,achieve analgesia with,FM,DISEASE
31647906,"To clarify whether GABAB receptor positive allosteric modulator (PAM) approach would achieve analgesia with less side-effects than GABAB receptor agonist in FM, we investigated the potential of a novel GABAB receptor PAM, ASP8062, for FM treatment.",GABAB receptor positive modulator approach,CHEMICAL,achieve,analgesia,MENTAL_HEALTH
35535373,"Some dietary approaches such as adequate intake of protein, vitamin D, antioxidant nutrients, and long-chain polyunsaturated fatty acid have been shown to have positive effects against sarcopenia.",long-chain polyunsaturated fatty acid,NUTRITION,have positive effects against,sarcopenia,DISEASE
35317992,Cell-membrane fluidity is a fundamental parameter in cold resistance.,Cell-membrane fluidity,CHEMICAL,be fundamental parameter in,cold resistance,MENTAL_HEALTH
12075038,Consultation-liaison psychiatrists need to be well informed about pharmacodynamics and drug interactions in patients with physical/psychiatric comorbidity.,drug interactions,CHEBI,in patients with,physical/psychiatric comorbidity,DISEASE
34742696,Neuroleptic malignant syndrome (NMS) is a rare and potentially fatal drug adverse reaction.,Neuroleptic malignant syndrome,DISEASE,be,rare drug adverse reaction,CHEBI
8269915,A further patient with apparent improvement in seizures in the first week developed complex partial status epilepticus on withdrawal of DCPP-ene.,seizures,DISEASE,develop,complex partial status epilepticus,DISEASE
34776871,This is supported by observing the beneficial effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in both posttraumatic stress disorder and SARS-CoV-2 critical illness.,angiotensin converting enzyme inhibitors,CHEMICAL,have the beneficial effects in,posttraumatic stress disorder,MENTAL_HEALTH
34776871,This is supported by observing the beneficial effects of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in both posttraumatic stress disorder and SARS-CoV-2 critical illness.,angiotensin receptor blockers,CHEMICAL,have the beneficial effects in,posttraumatic stress disorder,MENTAL_HEALTH
28472995,"Although some effects of gene-gene interactions on nicotine-dopamine metabolism for smoking behavior have been reported, polymorphisms of cytochrome P450 (CYP) 2A6 and catechol-O-methyltransferase (COMT) have not been studied together to determine their effects on smokers.",gene-gene interactions,CHEMICAL,have some effects on,nicotine-dopamine metabolism,CHEMICAL
27490263,We aimed to investigate the interaction between dopamine pathway gene scores and nicotine dependence on smoking cessation in a rural Chinese male population.,dopamine pathway gene,CHEMICAL,have the interaction with,nicotine dependence,MENTAL_HEALTH
27490263,We aimed to investigate the interaction between dopamine pathway gene scores and nicotine dependence on smoking cessation in a rural Chinese male population.,nicotine dependence,MENTAL_HEALTH,have the interaction with,dopamine pathway gene,CHEMICAL
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,CHEBI,render certain species of,Mycobacterium difficult nontuberculous Mycobacterium,CHEMICAL
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,CHEBI,render certain species of,Mycobacterium difficult nontuberculous Mycobacterium,DISEASE
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,CHEBI,render certain species of,Mycobacterium abscessus,CHEMICAL
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,MENTAL_HEALTH,render certain species of,Mycobacterium difficult nontuberculous Mycobacterium,CHEMICAL
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,MENTAL_HEALTH,render certain species of,Mycobacterium difficult nontuberculous Mycobacterium,DISEASE
30198506,"Antimicrobial resistance (AMR) has rendered certain species of Mycobacterium difficult to treat clinically, particularly, the nontuberculous Mycobacterium, Mycobacterium abscessus.",Antimicrobial resistance,MENTAL_HEALTH,render certain species of,Mycobacterium abscessus,CHEMICAL
31248181,The commercial antibiotics usage augments antibiotics resistance and creates higher recurrence rates of such communal infections.,antibiotics usage,CHEBI,augment,antibiotics resistance,MENTAL_HEALTH
31248181,The commercial antibiotics usage augments antibiotics resistance and creates higher recurrence rates of such communal infections.,antibiotics usage,CHEBI,augment,antibiotics resistance,CHEBI
31248181,The commercial antibiotics usage augments antibiotics resistance and creates higher recurrence rates of such communal infections.,antibiotics usage,CHEBI,create higher recurrence rates of,communal infections,DISEASE
33331691,"Strategies targeting bacterial virulence factors rather than bacterial survival have attracted increasing interest, since the modulation of virulence factors may prevent the development of drug resistance in bacteria.",virulence factors,CHEBI,prevent development of,drug resistance,MENTAL_HEALTH
33331691,"Strategies targeting bacterial virulence factors rather than bacterial survival have attracted increasing interest, since the modulation of virulence factors may prevent the development of drug resistance in bacteria.",virulence factors,CHEBI,prevent development of,drug resistance,CHEBI
32306464,Obstructive sleep apnea syndrome (OSAS) is an important consequence of chronic intermittent hypoxia (CIH).,Obstructive sleep apnea syndrome,MENTAL_HEALTH,be important consequence of,CIH,CHEMICAL
32306464,Obstructive sleep apnea syndrome (OSAS) is an important consequence of chronic intermittent hypoxia (CIH).,Obstructive sleep apnea syndrome,MENTAL_HEALTH,be important consequence of,chronic intermittent hypoxia,DISEASE
32306464,"However, whether AS-IV can attenuate CIH-induced myocardial injury is unclear.",AS-IV,CHEMICAL,attenuate,CIH-induced myocardial injury,DISEASE
32306464,Results showed that AS-IV attenuated cardiac dysfunction and histological lesions in CIH rats.,AS-IV,CHEMICAL,attenuate cardiac dysfunction and histological lesions in,CIH rats,CHEMICAL
32306464,Results showed that AS-IV attenuated cardiac dysfunction and histological lesions in CIH rats.,AS-IV,CHEMICAL,attenuate,cardiac dysfunction,DISEASE
32306464,"Altogether, these findings indicate that AS-IV modulates Ca2+ homeostasis to inhibit apoptosis, protecting against CIH-induced myocardial injury eventually, suggesting it may be a potential agent for cardiac damage of OSAS patients.",AS-IV,CHEMICAL,protect against,CIH-induced myocardial injury,DISEASE
32306464,"This work suggests that AS-IV can attenuate myocardial apoptosis and calcium disruption, thus protecting against CIH-induced myocardial injury.",AS-IV,CHEMICAL,protect against,CIH-induced myocardial injury,DISEASE
32306464,"This work suggests that AS-IV can attenuate myocardial apoptosis and calcium disruption, thus protecting against CIH-induced myocardial injury.",AS-IV,CHEMICAL,attenuate,calcium disruption,CHEMICAL
35597331,"The reduced synthesis of ethylene in plants further relieves the ethylene inhibition of plant growth and development, and improves plant resistance to various stressors.",ethylene,CHEMICAL,improve,plant resistance,MENTAL_HEALTH
30717348,"Former selective co-receptor antagonists, acting at early stages of infection, are able to impair the receptor functions, preventing the viral spread toward AIDS.",Former selective co-receptor antagonists,CHEBI,prevent viral spread toward,AIDS,DISEASE
30717348,"Due to the capability of HIV to develop resistance by switching from CCR5 to CXCR4, dual co-receptor antagonists could represent the next generation of AIDS prophylaxis drugs.",dual co-receptor antagonists,CHEBI,represent due capability of hiv next generation of,AIDS prophylaxis drugs,DISEASE
34580061,"Aldehyde dehydrogenase 1A1 (ALDH1A1) is a TIC marker in many cancers, including breast cancer.",Aldehyde dehydrogenase,CHEMICAL,be tic marker in,many cancers,DISEASE
34580061,"Aldehyde dehydrogenase 1A1 (ALDH1A1) is a TIC marker in many cancers, including breast cancer.",Aldehyde dehydrogenase,CHEMICAL,be tic marker in,breast cancer,DISEASE
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",chemotherapeutic agent gemcitabine,CHEMICAL,inhibit breast tumor growth and tumorigenesis by,purging T-cell immunity,DISEASE
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",chemotherapeutic agent gemcitabine,CHEMICAL,inhibit breast tumor growth and tumorigenesis by,purging T-cell immunity,MENTAL_HEALTH
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",chemotherapeutic agent gemcitabine,CHEMICAL,inhibit,breast tumor growth,DISEASE
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",ALDH1A1 inhibitor disulfiram,CHEMICAL,inhibit breast tumor growth and tumorigenesis by,purging T-cell immunity,DISEASE
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",ALDH1A1 inhibitor disulfiram,CHEMICAL,inhibit breast tumor growth and tumorigenesis by,purging T-cell immunity,MENTAL_HEALTH
34580061,"Furthermore, the ALDH1A1 inhibitor disulfiram and chemotherapeutic agent gemcitabine cooperatively inhibited breast tumor growth and tumorigenesis by purging ALDH+ TICs and activating T-cell immunity.",ALDH1A1 inhibitor disulfiram,CHEMICAL,inhibit,breast tumor growth,DISEASE
22696884,"After a short review of impotence, the definitions of erectants and aphrodisiacs are presented.",erectants,CHEMICAL,be presented after short review of,impotence,MENTAL_HEALTH
32582624,"As such, potent NTS1 agonists designed on the basis of the minimal C-terminal NT(8-13) bioactive fragment have been shown to produce mild hypothermia and exert neuroprotective effects under various clinically relevant conditions.",potent NTS1 agonists,CHEBI,produce,mild hypothermia,DISEASE
16899523,"As a result, alanine accumulated as the major amino acid in hypoxic seedlings instead of asparagine, in agreement with the involvement of the fermentative AlaAT pathway in hypoxia tolerance.",alanine,CHEMICAL,result as major amino acid in hypoxic seedlings of asparagine in,hypoxia tolerance,DISEASE
16899523,"As a result, alanine accumulated as the major amino acid in hypoxic seedlings instead of asparagine, in agreement with the involvement of the fermentative AlaAT pathway in hypoxia tolerance.",alanine,CHEMICAL,result as major amino acid in hypoxic seedlings of,asparagine,CHEMICAL
16899523,"As a result, alanine accumulated as the major amino acid in hypoxic seedlings instead of asparagine, in agreement with the involvement of the fermentative AlaAT pathway in hypoxia tolerance.",alanine,CHEMICAL,result as,major amino acid,CHEMICAL
35003296,"Oxidation, hydration, reduction, dehydration, glutathione S-conjugation, and acetylcysteine conjugation were the main transformation reactions of GSL in rat serum.",glutathione S-conjugation,CHEMICAL,be main transformation reactions of,GSL,CHEMICAL
35003296,"Oxidation, hydration, reduction, dehydration, glutathione S-conjugation, and acetylcysteine conjugation were the main transformation reactions of GSL in rat serum.",acetylcysteine conjugation,CHEMICAL,be main transformation reactions of,GSL,CHEMICAL
18928419,"Studies regarding the pharmacological treatment of TTM in the adult or pediatric population are sparse, and there is a lack of consensus on drug treatment for TTM.",TTM,DISEASE,be lack of consensus on,drug treatment,CHEBI
35364429,"1,2 diacetyl benzene (DAB) penetrates the blood-brain barrier, causing neuroinflammation, tau hyperphosphorylation, and cognitive impairment.",diacetyl benzene,CHEMICAL,cause,cognitive impairment,DISEASE
35364429,"1,2 diacetyl benzene (DAB) penetrates the blood-brain barrier, causing neuroinflammation, tau hyperphosphorylation, and cognitive impairment.",DAB,CHEMICAL,cause,cognitive impairment,DISEASE
35364429,"Converging evidence supports the anti-inflammatory effects of B vitamins on cognitive impairment, but the effects of B vitamins on cognitive impairment induced by DAB remain unclear.",B vitamins,CHEBI,have the anti-inflammatory effects on,cognitive impairment,DISEASE
35364429,"Here, we investigated the anti-inflammatory properties of B vitamins in DAB-stimulated human neuroblastoma SH-SY5Y cells.",B vitamins,CHEBI,have the anti-inflammatory properties in,DAB-stimulated human neuroblastoma SH-SY5Y cells,CHEMICAL
16265639,Fluconazole is a triazole antifungal used to treat mycotic infections.,Fluconazole,CHEMICAL,be,triazole antifungal,CHEMICAL
16265639,Fluconazole is a triazole antifungal used to treat mycotic infections.,Fluconazole,CHEMICAL,be,triazole antifungal,CHEBI
30192094,"Among concomitant medication strategies, anticholinergic medications for dystonias and parkinsonism are often effective; beta-blockers and anticholinergic medications are useful for akathisia; and metformin may lead to slight to moderate weight loss.",metformin,CHEMICAL,lead to slight to,moderate weight loss,DISEASE
30192094,"Among concomitant medication strategies, anticholinergic medications for dystonias and parkinsonism are often effective; beta-blockers and anticholinergic medications are useful for akathisia; and metformin may lead to slight to moderate weight loss.",beta-blockers,CHEBI,be useful for,akathisia,DISEASE
33159787,Lipidomic analysis revealed that repression of SlKLUH mainly increased the contents of certain non-phosphorus glycerolipids and phospholipids and decreased the contents of four unknown lipids.,repression,MENTAL_HEALTH,increase contents of,phospholipids,NUTRITION
30099276,Psychotic symptoms were assessed with Community Assessment of Psychic Experiences (CAPE) in both groups and with PANSS scale in FEP group.,Psychotic symptoms,DISEASE,be assessed with community assessment of,CAPE,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",phenylpropanoids,NUTRITION,imply,deuterium isotope effects,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",theoretical 2H-distribution,CHEMICAL,imply,deuterium isotope effects,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",phenylpropanoids,NUTRITION,be predicted from,phosphoenolpyruvate,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",phenylpropanoids,NUTRITION,be predicted from,erythrose-4-phosphate,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",theoretical 2H-distribution,CHEMICAL,be predicted from,phosphoenolpyruvate,CHEMICAL
16678227,"The theoretical 2H-distribution in the aromatic ring of phenylpropanoids can be predicted from that of their precursors--erythrose-4-phosphate, phosphoenolpyruvate and NADPH--and by invoking the mechanism of the NIH-shift and implied deuterium isotope effects.",theoretical 2H-distribution,CHEMICAL,be predicted from,erythrose-4-phosphate,CHEMICAL
22335011,Acute intermittent and variegate porphyria are an autosomal dominant hereditary diseases caused by the deficient activity of porphobilinogen deaminase in the haem biosynthesis.,variegate porphyria,DISEASE,caused by deficient activity of,porphobilinogen deaminase,CHEMICAL
22335011,"Direct relationship between plasma oxalic acid and effect of pyridoxal-5-phosphate (PLP), (effect of PLP was in indirect relationship with the concentration of erythrocyte vitamin B6), in AIP patients was found.",pyridoxal-5-phosphate,CHEMICAL,be found in,AIP patients,DISEASE
22335011,"Direct relationship between plasma oxalic acid and effect of pyridoxal-5-phosphate (PLP), (effect of PLP was in indirect relationship with the concentration of erythrocyte vitamin B6), in AIP patients was found.",plasma oxalic acid,CHEMICAL,be in indirect relationship with concentration of,erythrocyte vitamin B6,CHEBI
22335011,"Direct relationship between plasma oxalic acid and effect of pyridoxal-5-phosphate (PLP), (effect of PLP was in indirect relationship with the concentration of erythrocyte vitamin B6), in AIP patients was found.",erythrocyte vitamin B6,CHEBI,be found in,AIP patients,DISEASE
22335011,Deficiency of vitamin B6 was probably a cause of hyperoxalaemia and hyperoxaluria in those patients.,vitamin B6,CHEBI,be cause of,hyperoxaluria,DISEASE
22335011,Deficiency of vitamin B6 was probably a cause of hyperoxalaemia and hyperoxaluria in those patients.,vitamin B6,CHEBI,be cause of,hyperoxalaemia,DISEASE
18042476,Elevated serum homocysteine levels have been associated with the development of Alzheimer's dementia (AD).,Elevated serum homocysteine levels,CHEMICAL,be associated with development of alzheimer's,dementia,MENTAL_HEALTH
33023416,"Further, ATP concentrations were significantly increased after 24 h of treatment with HT as compared with controls.",ATP concentrations,CHEMICAL,be increased after,HT,DISEASE
34997723,Exploration of novel therapeutics for alleviating symptoms of Alzheimer's disease has found promise in plant extracts of functional phenols.,Alzheimer's disease,DISEASE,find promise in plant extracts of,functional phenols,NUTRITION
34997723,"The present results indicate that paeonol significantly relieved amyloid-β deposition and amyloid-β -mediated neuropathology in the brain of APP/PS1 mice, suggesting the potential of paeonol as a preventive and therapeutic agent for Alzheimer's disease.",paeonol,CHEMICAL,suggest potential of paeonol as preventive and therapeutic agent for,Alzheimer's disease,DISEASE
34997723,"The present results indicate that paeonol significantly relieved amyloid-β deposition and amyloid-β -mediated neuropathology in the brain of APP/PS1 mice, suggesting the potential of paeonol as a preventive and therapeutic agent for Alzheimer's disease.",paeonol,CHEMICAL,suggest potential of,paeonol,CHEMICAL
34997723,"The present results indicate that paeonol significantly relieved amyloid-β deposition and amyloid-β -mediated neuropathology in the brain of APP/PS1 mice, suggesting the potential of paeonol as a preventive and therapeutic agent for Alzheimer's disease.",paeonol,CHEMICAL,relieve,-mediated neuropathology,DISEASE
33758690,"While effects were evident in all women, the combination of high trait NA and high progesterone was particularly risky for women with a history of clinically significant binge eating episodes.",NA,CHEMICAL,be risky for women with history of,significant binge eating episodes,MENTAL_HEALTH
26734033,The emergence of a new bacterial disease of J. regia in France called vertical oozing canker (VOC) was previously described and the causal agent was identified as a distinct genetic lineage within the pathovar juglandis.,J. regia,DISEASE,call,vertical oozing canker,DISEASE
26734033,The emergence of a new bacterial disease of J. regia in France called vertical oozing canker (VOC) was previously described and the causal agent was identified as a distinct genetic lineage within the pathovar juglandis.,J. regia,DISEASE,call,VOC,CHEMICAL
26984349,"Thiamine is an essential nutrient, while thiamine deficiency leads to a broad variety of disorders including irritability and symptoms of depression.",thiamine deficiency,CHEBI,lead to broad variety of,depression,MENTAL_HEALTH
26984349,"Thiamine is an essential nutrient, while thiamine deficiency leads to a broad variety of disorders including irritability and symptoms of depression.",thiamine deficiency,CHEBI,lead to broad variety of,irritability,DISEASE
26984349,"Here, we tested the hypothesis that adjuvant thiamine would reduce depression, compared to placebo.",adjuvant thiamine,NUTRITION,reduce,depression,MENTAL_HEALTH
26984349,"Compared to placebo, adjuvant thiamine improved symptoms of depression after 6 week of treatment, and improvements remained fairly stable until the end of the study, though mean differences at week 12 were not statistically significant anymore.",adjuvant thiamine,NUTRITION,improve symptoms of,depression,MENTAL_HEALTH
26984349,Results suggest that among younger patients with MDD adjuvant thiamine alleviated symptoms of depression faster compared to placebo.,MDD adjuvant thiamine,DISEASE,alleviate symptoms of,depression,MENTAL_HEALTH
26984349,Results suggest that among younger patients with MDD adjuvant thiamine alleviated symptoms of depression faster compared to placebo.,MDD adjuvant thiamine,CHEBI,alleviate symptoms of,depression,MENTAL_HEALTH
32147246,"Pitolisant, which is nonscheduled, has undergone multiple RCTs in narcolepsy, showing improvement in subjective and objective EDS and one OSA trial showing improvement in subjective EDS.",Pitolisant,CHEMICAL,show improvement in,OSA trial,DISEASE
32147246,"Pitolisant, which is nonscheduled, has undergone multiple RCTs in narcolepsy, showing improvement in subjective and objective EDS and one OSA trial showing improvement in subjective EDS.",Pitolisant,CHEMICAL,undergo multiple rcts in,narcolepsy,MENTAL_HEALTH
2564633,"Schild analysis of currents evoked by NMDA indicated that the EAA receptor antagonist D-2-amino-5-phosphonovalerate (D-APV) exerted a competitive block of the oocyte NMDA receptor, because the Schild regression was linear with a slope not significantly different from unity (1.03 +/- 0.025) up to 100 microM D-APV.",D-APV,CHEMICAL,exert competitive block of,oocyte NMDA receptor,CHEMICAL
2564633,"Schild analysis of currents evoked by NMDA indicated that the EAA receptor antagonist D-2-amino-5-phosphonovalerate (D-APV) exerted a competitive block of the oocyte NMDA receptor, because the Schild regression was linear with a slope not significantly different from unity (1.03 +/- 0.025) up to 100 microM D-APV.",Schild regression,MENTAL_HEALTH,be linear with slope different from,D-APV,CHEMICAL
2564633,"Schild analysis of currents evoked by NMDA indicated that the EAA receptor antagonist D-2-amino-5-phosphonovalerate (D-APV) exerted a competitive block of the oocyte NMDA receptor, because the Schild regression was linear with a slope not significantly different from unity (1.03 +/- 0.025) up to 100 microM D-APV.",EAA receptor antagonist D-2-amino-5-phosphonovalerate,CHEBI,exert competitive block of,oocyte NMDA receptor,CHEMICAL
2564633,"Schild analysis of currents evoked by NMDA indicated that the EAA receptor antagonist D-2-amino-5-phosphonovalerate (D-APV) exerted a competitive block of the oocyte NMDA receptor, because the Schild regression was linear with a slope not significantly different from unity (1.03 +/- 0.025) up to 100 microM D-APV.",EAA receptor antagonist D-2-amino-5-phosphonovalerate,CHEMICAL,exert competitive block of,oocyte NMDA receptor,CHEMICAL
2564633,The Schild regression was linear up to 30 microM CNQX with a slope of 1.02 +/- 0.014 and a pA2 of 6.53 +/- 0.029.,Schild regression,MENTAL_HEALTH,be linear up,CNQX,CHEMICAL
9277463,"Furthermore, the ecto-5'-nucleotidase inhibitor alpha, beta-methylene-ADP blocks ATP-induced DNA fragmentation.",ecto-5'-nucleotidase inhibitor alpha,NUTRITION,block,ATP-induced DNA fragmentation,MENTAL_HEALTH
9277463,"Furthermore, the ecto-5'-nucleotidase inhibitor alpha, beta-methylene-ADP blocks ATP-induced DNA fragmentation.",beta-methylene-ADP,CHEMICAL,block,ATP-induced DNA fragmentation,MENTAL_HEALTH
25277799,"Idiopathic Parkinson's disease (PD) is a late-onset, chronic, and progressive motor dysfunction attributable to loss of nigrostriatal dopamine neurons.",Idiopathic Parkinson's disease,DISEASE,be late-onset motor dysfunction attributable to loss of,nigrostriatal dopamine neurons,CHEMICAL
25277799,"Idiopathic Parkinson's disease (PD) is a late-onset, chronic, and progressive motor dysfunction attributable to loss of nigrostriatal dopamine neurons.",Idiopathic Parkinson's disease,DISEASE,be,late-onset motor dysfunction attributable,DISEASE
25277799,We aimed to evaluate whether 6-hydroxy-dopamine (6-OHDA)-induced degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc) induces gastric dysmotility via dysfunctions of the brain-gut axis.,6-hydroxy-dopamine (6-OHDA)-induced,CHEMICAL,induce,gastric dysmotility,DISEASE
29041811,"It is shown that this specific fragmentation reaction strongly dominates other fragmentation routes, such as loss of carbon monoxide, formaldehyde and water.",specific fragmentation reaction,MENTAL_HEALTH,dominate,formaldehyde,CHEMICAL
29041811,"It is shown that this specific fragmentation reaction strongly dominates other fragmentation routes, such as loss of carbon monoxide, formaldehyde and water.",specific fragmentation reaction,MENTAL_HEALTH,dominate,carbon monoxide,DISEASE
29041811,"It is shown that this specific fragmentation reaction strongly dominates other fragmentation routes, such as loss of carbon monoxide, formaldehyde and water.",specific fragmentation reaction,MENTAL_HEALTH,dominate,other fragmentation routes,MENTAL_HEALTH
29041811,"In addition, elimination of benzaldehyde occurs as a minor fragmentation channel in most cases.",benzaldehyde,CHEMICAL,occur in addition as,minor fragmentation channel,MENTAL_HEALTH
29041811,"In contrast to these aryl-benzyl ethers, the consecutive two-fold loss of C7H7• is suppressed in the [M + Na]+ ions of dibenzyl ethers derived from multiply benzylated gallocatechin and catechin, where the elimination of benzyl alcohol prevails the primary fragmentation almost completely.",benzyl alcohol,CHEMICAL,prevail,primary fragmentation,MENTAL_HEALTH
19836518,"The principle relies on amplification of the difference in the electrophoretic mobilities of CDCC in sample matrix and background electrolyte (BGE) through complexation of CDCC with borate in a sample matrix of basic pH and dissociation of the complex in a BGE of acidic pH. Meanwhile, CDCC and borate ions electro-injected into the capillary are finally in neutral state, which maintains the pre-filled low conductivity zone and thus allows for longer injection time.",borate ions,CHEMICAL,rely on amplification of difference in electrophoretic mobilities of,dissociation,MENTAL_HEALTH
19836518,"The principle relies on amplification of the difference in the electrophoretic mobilities of CDCC in sample matrix and background electrolyte (BGE) through complexation of CDCC with borate in a sample matrix of basic pH and dissociation of the complex in a BGE of acidic pH. Meanwhile, CDCC and borate ions electro-injected into the capillary are finally in neutral state, which maintains the pre-filled low conductivity zone and thus allows for longer injection time.",borate ions,CHEMICAL,rely on amplification of difference in electrophoretic mobilities of,borate,CHEMICAL
23365453,"However, although some antiretrovirals have been reported to have inhibitory activity against SRV-1 and SRV-2, inhibitors with anti-SRV-4 activity have not yet been studied.",antiretrovirals,CHEMICAL,have inhibitory activity against,SRV-2,DISEASE
23365453,"However, although some antiretrovirals have been reported to have inhibitory activity against SRV-1 and SRV-2, inhibitors with anti-SRV-4 activity have not yet been studied.",antiretrovirals,CHEMICAL,have inhibitory activity against,SRV-1,DISEASE
23365453,"Among these, two HIV reverse transcriptase inhibitors, zidovudine (AZT) and tenofovir disoproxil fumarate (TDF), potently inhibited SRV-4 infection within a submicromolar to nanomolar range, which was similar to or higher than the activities against HIV-1, Moloney murine leukemia virus, and feline immunodeficiency virus.",zidovudine,CHEMICAL,inhibit among,SRV-4 infection,DISEASE
23365453,"Among these, two HIV reverse transcriptase inhibitors, zidovudine (AZT) and tenofovir disoproxil fumarate (TDF), potently inhibited SRV-4 infection within a submicromolar to nanomolar range, which was similar to or higher than the activities against HIV-1, Moloney murine leukemia virus, and feline immunodeficiency virus.",HIV reverse transcriptase inhibitors,CHEBI,inhibit among,SRV-4 infection,DISEASE
23365453,"Importantly, one HIV integrase strand transfer inhibitor, raltegravir (RAL), potently inhibited single-round infection as well as cell-free and cell-to-cell SRV-4 transmission.",raltegravir,CHEMICAL,inhibit,single-round infection,DISEASE
6139012,Adrenergic-neurone blocking drugs and alpha-adrenoceptor antagonists are contraindicated because of the frequency of impaired cardiovascular reflexes in the elderly.,alpha-adrenoceptor antagonists,CHEBI,be contraindicated,impaired cardiovascular reflexes,DISEASE
34976779,"It was confirmed by the method of sanger sequencing after polymerase chain reaction (PCR) that the purulent meningitis was caused by a mixture of four anaerobic bacteria (Finegoldia magna, Campylobacter ureolyticus, Bacteroides fragilis and Porphyromonas bennonis).",purulent meningitis,DISEASE,be caused by mixture of,Bacteroides fragilis,DISEASE
34976779,"It was confirmed by the method of sanger sequencing after polymerase chain reaction (PCR) that the purulent meningitis was caused by a mixture of four anaerobic bacteria (Finegoldia magna, Campylobacter ureolyticus, Bacteroides fragilis and Porphyromonas bennonis).",purulent meningitis,DISEASE,be caused by mixture of,Campylobacter ureolyticus,DISEASE
34976779,"It was confirmed by the method of sanger sequencing after polymerase chain reaction (PCR) that the purulent meningitis was caused by a mixture of four anaerobic bacteria (Finegoldia magna, Campylobacter ureolyticus, Bacteroides fragilis and Porphyromonas bennonis).",purulent meningitis,DISEASE,be caused by mixture of,Porphyromonas bennonis,DISEASE
34976779,"It was confirmed by the method of sanger sequencing after polymerase chain reaction (PCR) that the purulent meningitis was caused by a mixture of four anaerobic bacteria (Finegoldia magna, Campylobacter ureolyticus, Bacteroides fragilis and Porphyromonas bennonis).",purulent meningitis,DISEASE,be caused by,mixture,CHEBI
32311649,Ivabradine is a bradycardic drug used worldwide in the treatment of chronic stable angina and chronic heart failure.,Ivabradine,CHEMICAL,used in treatment of,chronic heart failure,DISEASE
32311649,Ivabradine is a bradycardic drug used worldwide in the treatment of chronic stable angina and chronic heart failure.,Ivabradine,CHEMICAL,used in treatment of,chronic stable angina,DISEASE
32311649,"The ivabradine concentration found in patient post-mortem blood was 1210ng/mL. Ivabradine was also quantified in different viscera like lung (2910ng/g), kidney (1510ng/g), liver (1050ng/g), heart (900ng/g), and brain (110ng/g).",ivabradine concentration,CHEMICAL,be,Ivabradine,CHEMICAL
14578579,"Furthermore, ascorbic acid provided protection to the young animals from scopolamine- and diazepam-induced impairment of memory.",ascorbic acid,CHEBI,provide protection to young animals from,scopolamine- impairment,CHEMICAL
14578579,"Hence, ascorbic acid might prove to be a useful memory-restorative agent in the treatment of dementia seen in elderly individuals.",ascorbic acid,CHEBI,prove to useful memory-restorative agent in treatment of,dementia,MENTAL_HEALTH
22119718,The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.,PPARδ agonist,CHEBI,use,DNA fragmentation assay,MENTAL_HEALTH
22119718,The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.,cytokine-induced death,DISEASE,use,DNA fragmentation assay,MENTAL_HEALTH
22119718,The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.,PPARδ agonist,CHEMICAL,use,DNA fragmentation assay,MENTAL_HEALTH
22119718,The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.,PPARδ agonist,CHEBI,have the inhibitory effect on,cytokine-induced death,DISEASE
22119718,The inhibitory effect of a PPARδ agonist on the cytokine-induced death of human corneal epithelial cells was evaluated using a DNA fragmentation assay kit.,PPARδ agonist,CHEMICAL,have the inhibitory effect on,cytokine-induced death,DISEASE
22119718,"In human corneal epithelial cells, up-regulation of PPARδ and DNA fragmentation was demonstrated by stimulation with cytokines, and the DNA fragmentation was significantly inhibited by pretreatment with a PPARδ agonist.",DNA fragmentation,MENTAL_HEALTH,be inhibited by pretreatment with,PPARδ agonist,CHEBI
22119718,"In human corneal epithelial cells, up-regulation of PPARδ and DNA fragmentation was demonstrated by stimulation with cytokines, and the DNA fragmentation was significantly inhibited by pretreatment with a PPARδ agonist.",DNA fragmentation,MENTAL_HEALTH,be inhibited by pretreatment with,PPARδ agonist,CHEMICAL
22119718,"By using human corneoscleral tissues ex vivo, PPARδ was up-regulated in both healthy corneal epithelia (during re-epithelialization) and diseased corneal epithelia.",PPARδ,CHEMICAL,be up-regulated in healthy corneal epithelia during,diseased corneal epithelia,DISEASE
22119718,"By using human corneoscleral tissues ex vivo, PPARδ was up-regulated in both healthy corneal epithelia (during re-epithelialization) and diseased corneal epithelia.",PPARδ,CHEMICAL,be up-regulated in,healthy corneal epithelia,DISEASE
22119718,Inflammatory stimulation-induced corneal epithelial cell death was inhibited by pretreatment with a PPARδ agonist.,Inflammatory stimulation-induced corneal epithelial cell death,DISEASE,be inhibited by pretreatment with,PPARδ agonist,CHEBI
22119718,Inflammatory stimulation-induced corneal epithelial cell death was inhibited by pretreatment with a PPARδ agonist.,Inflammatory stimulation-induced corneal epithelial cell death,DISEASE,be inhibited by pretreatment with,PPARδ agonist,CHEMICAL
16337160,Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma plays beneficial roles in cardiovascular disorders such as atherosclerosis and heart reperfusion.,peroxisome proliferator-activated receptor alpha,NUTRITION,play beneficial roles in cardiovascular disorders such as,heart reperfusion,DISEASE
16337160,Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma plays beneficial roles in cardiovascular disorders such as atherosclerosis and heart reperfusion.,peroxisome proliferator-activated receptor alpha,NUTRITION,play beneficial roles in cardiovascular disorders such as,atherosclerosis,DISEASE
16337160,Activation of peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma plays beneficial roles in cardiovascular disorders such as atherosclerosis and heart reperfusion.,peroxisome proliferator-activated receptor alpha,NUTRITION,play beneficial roles in,cardiovascular disorders,DISEASE
15248788,"The main untoward effects of short- and long-term AAS abuse that male athletes most often self-report are an increase in sexual drive, the occurrence of acne vulgaris, increased body hair and increment of aggressive behaviour.",short- AAS abuse,DISEASE,increase body hair and increment of,aggressive behaviour,DISEASE
15248788,"The main untoward effects of short- and long-term AAS abuse that male athletes most often self-report are an increase in sexual drive, the occurrence of acne vulgaris, increased body hair and increment of aggressive behaviour.",acne vulgaris,DISEASE,increase body hair and increment of,aggressive behaviour,DISEASE
15248788,"Generally, AAS seem to induce increments of aggression and hostility.",AAS,CHEMICAL,induce increments of,aggression,DISEASE
15248788,"Generally, AAS seem to induce increments of aggression and hostility.",AAS,CHEMICAL,induce increments of,hostility,DISEASE
15248788,AAS dependence or withdrawal effects (such as depression) seem to occur only in a small number of AAS users.,AAS dependence,CHEMICAL,occur in small number of,AAS users,CHEMICAL
15248788,AAS dependence or withdrawal effects (such as depression) seem to occur only in a small number of AAS users.,depression,MENTAL_HEALTH,occur in small number of,AAS users,CHEMICAL
9951575,Patients with affective disorders may demonstrate abnormal levels of sex hormones and gonadotropins.,affective disorders,MENTAL_HEALTH,demonstrate abnormal levels of,gonadotropins,CHEMICAL
9951575,Patients with affective disorders may demonstrate abnormal levels of sex hormones and gonadotropins.,affective disorders,MENTAL_HEALTH,demonstrate abnormal levels of,sex hormones,CHEBI
15027449,"Chronic ethanol abuse is associated with liver injury, neurotoxicity, hypertension, cardiomyopathy, modulation of immune responses and increased risk for cancer, whereas moderate alcohol consumption exerts protective effect on coronary heart disease.",moderate alcohol consumption,CHEMICAL,exert protective effect on,coronary heart disease,DISEASE
15027449,"Chronic ethanol abuse is associated with liver injury, neurotoxicity, hypertension, cardiomyopathy, modulation of immune responses and increased risk for cancer, whereas moderate alcohol consumption exerts protective effect on coronary heart disease.",Chronic ethanol abuse,MENTAL_HEALTH,be associated with,cardiomyopathy,DISEASE
15027449,"Chronic ethanol abuse is associated with liver injury, neurotoxicity, hypertension, cardiomyopathy, modulation of immune responses and increased risk for cancer, whereas moderate alcohol consumption exerts protective effect on coronary heart disease.",Chronic ethanol abuse,MENTAL_HEALTH,be associated with,liver injury,DISEASE
15027449,"Chronic ethanol abuse is associated with liver injury, neurotoxicity, hypertension, cardiomyopathy, modulation of immune responses and increased risk for cancer, whereas moderate alcohol consumption exerts protective effect on coronary heart disease.",Chronic ethanol abuse,MENTAL_HEALTH,be associated with,hypertension,DISEASE
15027449,"Chronic ethanol abuse is associated with liver injury, neurotoxicity, hypertension, cardiomyopathy, modulation of immune responses and increased risk for cancer, whereas moderate alcohol consumption exerts protective effect on coronary heart disease.",Chronic ethanol abuse,MENTAL_HEALTH,be associated with,neurotoxicity,DISEASE
15027449,"Chronic ethanol treatment causes decreased activation of p42/44 MAPK and inhibition of growth factor stimulated p42/44 MAPK activation and these effects of ethanol are correlated to suppression of DNA synthesis, impaired synaptic plasticity and neurotoxicity.",ethanol,CHEMICAL,be correlated to suppression of,neurotoxicity,DISEASE
15027449,"In contrast, chronic ethanol treatment causes potentiation of endotoxin stimulated p42/44 MAPK and p38 MAPK signaling in Kupffer cells leading to increased synthesis of tumor necrosis factor.",chronic ethanol treatment,CHEMICAL,lead to increased synthesis of,tumor necrosis factor,DISEASE
12126453,Adolescents with alcohol use disorders also typically have problems with other substances and comorbid mental disorders.,alcohol use disorders,CHEMICAL,have problems with,comorbid mental disorders,MENTAL_HEALTH
10754268,Reactive oxygen metabolites (ROM) are increased in the inflamed mucosa of inflammatory bowel disease (IBD) and may contribute to loss of intestinal barrier function in this disorder.,Reactive oxygen metabolites,CHEMICAL,be increased in inflamed mucosa of,IBD,DISEASE
10754268,Reactive oxygen metabolites (ROM) are increased in the inflamed mucosa of inflammatory bowel disease (IBD) and may contribute to loss of intestinal barrier function in this disorder.,Reactive oxygen metabolites,CHEMICAL,be increased in inflamed mucosa of,inflammatory bowel disease,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEMICAL,following various acute and chronic injuries to,Alzheimer's disease,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEMICAL,following various acute and chronic injuries to,multiple sclerosis,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEMICAL,following various acute and chronic injuries to,stroke,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEBI,following various acute and chronic injuries to,Alzheimer's disease,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEBI,following various acute and chronic injuries to,multiple sclerosis,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEBI,following various acute and chronic injuries to,stroke,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEMICAL,following,acute injuries,DISEASE
22135673,"Although data regarding PPARδ are limited, studies have demonstrated that administration of PPARδ agonists confers neuroprotection following various acute and chronic injuries to the CNS, such as stroke, multiple sclerosis, and Alzheimer's disease.",PPARδ agonists,CHEBI,following,acute injuries,DISEASE
19874267,Agonists of the peroxisome proliferator activated receptor gamma (PPARgamma) have been shown to reduce inflammatory responses in several animal models of neurological diseases and conditions and to reduce amyloid burden in transgenic mice expressing mutant forms of human amyloid precursor protein.,Agonists,CHEBI,reduce inflammatory responses in several animal models of,neurological diseases,DISEASE
7271377,"The least neural hyperactivity was seen with dextran, while yeast and carrageenan produced comparably high degrees of hyperactivity.",yeast,NUTRITION,produce high degrees of,hyperactivity,MENTAL_HEALTH
7271377,"The least neural hyperactivity was seen with dextran, while yeast and carrageenan produced comparably high degrees of hyperactivity.",neural hyperactivity,MENTAL_HEALTH,be seen with,dextran,CHEMICAL
7271377,Hydrocortisone alcohol (20 mg/kg) provided a significant reduction in hyperactivity at 30-60 min but the duration was much shorter than the other agents which showed protective effects through to the end of the 180-min observation period.,Hydrocortisone alcohol,CHEMICAL,provide significant reduction in,hyperactivity,MENTAL_HEALTH
2410113,"The pathogenesis of AIDS involves the destruction of helper/inducer T-lymphocytes by active viral infection, and drugs which inhibit the replication of HTLV-III or monoclonal antibodies directed at viral antigens may be important components of future therapeutic strategies.",AIDS,DISEASE,involve destruction of helper/inducer t-lymphocytes by,active viral infection,DISEASE
2410113,"This drug has been shown to block the infectivity and cytopathic effect of HTLV-III [Mitsuya, H., Popovic, M., Yarchoan, R., Matsushita, S., Gallo, R. C., and Broder, S. Science (Wash. DC), 266: 172-174, 1984]; in addition, it is able to block the in vitro replication of another member of the HTLV family, HTLV-I, at concentrations of 25 to 75 micrograms/ml.",drug,CHEBI,block infectivity and cytopathic effect of,Matsushita S.,DISEASE
2410113,Evaluation of this and other antiviral treatments for AIDS will optimally involve direct assessment of its effects on HTLV-III replication in vivo.,other antiviral treatments,CHEBI,have evaluation for,AIDS,DISEASE
16037153,"When nociceptive responses were tested at subhypnotic doses, no pronociceptive or antinociceptive phase was identified for propofol, whereas analgesia was induced at ketamine doses larger than 60 mg/kg IP.",analgesia,MENTAL_HEALTH,be induced at,ketamine doses larger,CHEMICAL
24076142,"Recently, we reported that several polymorphisms and haplotypes in the choline acetyltransferase gene (ChAT) are associated with nicotine dependence (ND).",choline acetyltransferase gene,NUTRITION,be associated with,nicotine dependence,MENTAL_HEALTH
24076142,"Recently, we reported that several polymorphisms and haplotypes in the choline acetyltransferase gene (ChAT) are associated with nicotine dependence (ND).",ChAT,NUTRITION,be associated with,nicotine dependence,MENTAL_HEALTH
22879118,To illustrate the beneficial effect of zolpidem on the neuropsychiatric and motor symptoms in a patient with Parkinson disease (PD) after bilateral subthalamic nucleus deep brain stimulation.,zolpidem,CHEMICAL,have the beneficial effect on,neuropsychiatric symptoms,DISEASE
35564852,"In this study, PFASs and covariates such as age, gender, ethnicity, alcohol consumption, smoking, and physical activity were explored using descriptive statistics and logistic regression modeling.",alcohol consumption,CHEMICAL,use,logistic regression,MENTAL_HEALTH
23297567,Angelica archangelica Linn. is widely used in food and liquor preparations and also in Kashmiri folk medicine to reduce anxiety.,Angelica archangelica Linn,NUTRITION,reduce,anxiety,MENTAL_HEALTH
35386324,Cyclic dinucleotides (CDNs) as stimulator of interferon genes (STING) agonists capable of inducing strong antitumor innate immune response are highly promising for tumor immunotherapy.,genes STING agonists capable,CHEBI,be promising for,tumor immunotherapy,DISEASE
35082065,"In addition, heat shock induced an increase proportion of saturated fatty acids (SFA), cyclic fatty acids (CFA) and the ratio of saturated fatty acids to unsaturated fatty acids (SFA/USFA), whereas reducing the proportion of unsaturated fatty acids (USFA).",heat shock,DISEASE,reduce proportion of,unsaturated fatty acids,NUTRITION
35082065,"In addition, heat shock induced an increase proportion of saturated fatty acids (SFA), cyclic fatty acids (CFA) and the ratio of saturated fatty acids to unsaturated fatty acids (SFA/USFA), whereas reducing the proportion of unsaturated fatty acids (USFA).",heat shock,DISEASE,induce in addition increase proportion of,saturated fatty acids,NUTRITION
35082065,"In addition, heat shock induced an increase proportion of saturated fatty acids (SFA), cyclic fatty acids (CFA) and the ratio of saturated fatty acids to unsaturated fatty acids (SFA/USFA), whereas reducing the proportion of unsaturated fatty acids (USFA).",heat shock,DISEASE,induce in addition increase proportion of,unsaturated fatty acids,NUTRITION
35082065,"In addition, heat shock induced an increase proportion of saturated fatty acids (SFA), cyclic fatty acids (CFA) and the ratio of saturated fatty acids to unsaturated fatty acids (SFA/USFA), whereas reducing the proportion of unsaturated fatty acids (USFA).",heat shock,DISEASE,induce in addition increase proportion of,cyclic fatty acids,NUTRITION
16777090,The finding that vigabatrin protected against the development and the expression of cocaine sensitization further supports its therapeutic potential in the treatment of cocaine dependence.,vigabatrin,CHEMICAL,support its therapeutic potential in treatment of,cocaine dependence,MENTAL_HEALTH
16777090,The finding that vigabatrin protected against the development and the expression of cocaine sensitization further supports its therapeutic potential in the treatment of cocaine dependence.,cocaine sensitization,CHEMICAL,support its therapeutic potential in treatment of,cocaine dependence,MENTAL_HEALTH
30954983,"Diagnosis of fetal alcohol syndrome is based on the appearance of growth deficiency, the presence of the three key features of facial dysmorphism (short palpebral fissures, thin upper lip, smooth or flattend philtrum) and/or disorders in the central nervous system (minimum 3) and prenatal exposure to alcohol (confirmed if possible).",fetal alcohol syndrome,MENTAL_HEALTH,be based on appearance of,growth deficiency,DISEASE
18709536,Methylprednisolone minipulse therapy dramatically reduced her proteinuria; however; she then complained of general fatigue with low-grade fever.,Methylprednisolone minipulse therapy,CHEMICAL,reduce,proteinuria,DISEASE
18709536,Micafungin is a recently approved echinocandin-class antifungal agent that is now widely used in Japan because of its minimal toxicity and broadspectrum activity.,Micafungin,CHEMICAL,be,approved echinocandin-class antifungal agent,CHEBI
18709536,"Indeed, breakthrough trichosporonosis is becoming a significant problem in patients with hematological malignancies who are receiving echinocandins.",breakthrough trichosporonosis,DISEASE,become significant problem in patients with,hematological malignancies,DISEASE
18709536,"This case highlights that cryptococcosis should be kept in mind as a possible breakthrough infection during the administration of echinocandins, especially in patients with cellular immunodeficiency.",cryptococcosis,DISEASE,be kept in mind as possible breakthrough infection during administration of,echinocandins,CHEMICAL
18709536,"This case highlights that cryptococcosis should be kept in mind as a possible breakthrough infection during the administration of echinocandins, especially in patients with cellular immunodeficiency.",cryptococcosis,DISEASE,be kept in mind as possible breakthrough infection during administration of,cellular immunodeficiency,DISEASE
18709536,"This case highlights that cryptococcosis should be kept in mind as a possible breakthrough infection during the administration of echinocandins, especially in patients with cellular immunodeficiency.",cryptococcosis,DISEASE,be kept in mind as,possible breakthrough infection,DISEASE
11779241,Molecular dynamics simulations of the LBD complexed with the two antagonists could explain their different action by demonstrating a more drastic displacement of helix 12 through ZK168281 than through ZK159222.,antagonists,CHEBI,demonstrate drastic displacement of helix through,ZK159222,CHEMICAL
11779241,Molecular dynamics simulations of the LBD complexed with the two antagonists could explain their different action by demonstrating a more drastic displacement of helix 12 through ZK168281 than through ZK159222.,antagonists,CHEBI,demonstrate,drastic displacement,MENTAL_HEALTH
611013,"In this study e,140 patients (1,568 men, 1,572 women) were examined in 4 psychiatric hospitals.","e,140 patients",CHEMICAL,be examined in study in,psychiatric hospitals,DISEASE
15053528,The participation of these flavonoids in the defense mechanism of this Citrus species is discussed.,flavonoids,CHEMICAL,have the participation in,defense mechanism,MENTAL_HEALTH
34815178,"Protein fluorescence quenching showed that heparin strongly binds to the Mpro protein with dissociation constants KD of 16.66 and 31.60 μM at 25 and 35 °C, respectively.",heparin,CHEMICAL,bind to mpro protein with,dissociation constants,MENTAL_HEALTH
34156053,"The abuse of ribavirin, an antiviral drug, in poultry breeding can cause quality degradation and drug resistance.",ribavirin,CHEMICAL,cause in,drug resistance,MENTAL_HEALTH
34156053,"The abuse of ribavirin, an antiviral drug, in poultry breeding can cause quality degradation and drug resistance.",ribavirin,CHEMICAL,cause in,drug resistance,CHEBI
34156053,"The abuse of ribavirin, an antiviral drug, in poultry breeding can cause quality degradation and drug resistance.",antiviral drug,CHEBI,cause in,drug resistance,MENTAL_HEALTH
34156053,"The abuse of ribavirin, an antiviral drug, in poultry breeding can cause quality degradation and drug resistance.",antiviral drug,CHEBI,cause in,drug resistance,CHEBI
34156053,"The dissociation constant (Kd) values of APT-1 obtained by the two methods of colorimetric and fluorescence were 34.34 ± 6.038 nmol L-1, 61.19 ± 21.48 nmol L-1, respectively.",dissociation constant values,MENTAL_HEALTH,be,± nmol L-1,CHEMICAL
25104243,Reductions in central serotonin activity with aging might be involved in sleep-related disorders in later life.,central serotonin activity,CHEMICAL,be involved in,sleep-related disorders,DISEASE
27346789,In this study we show for the first time the antimanic properties of endoxifen in patients with bipolar I disorder (BPD I) with current manic or mixed episode.,endoxifen,CHEMICAL,in patients with,bipolar disorder,MENTAL_HEALTH
18220496,The second-generation antipsychotic olanzapine has been shown to be efficacious as a treatment for adults with bipolar disorder and is approved by the United States Food and Drug Administration for the treatment of acute manic or mixed episodes as well as for maintenance treatment in bipolar adults.,antipsychotic olanzapine,CHEMICAL,be shown to efficacious as treatment for adults with,acute manic,DISEASE
18220496,The second-generation antipsychotic olanzapine has been shown to be efficacious as a treatment for adults with bipolar disorder and is approved by the United States Food and Drug Administration for the treatment of acute manic or mixed episodes as well as for maintenance treatment in bipolar adults.,antipsychotic olanzapine,CHEMICAL,be shown to efficacious as treatment for adults with,bipolar adults,DISEASE
18220496,The second-generation antipsychotic olanzapine has been shown to be efficacious as a treatment for adults with bipolar disorder and is approved by the United States Food and Drug Administration for the treatment of acute manic or mixed episodes as well as for maintenance treatment in bipolar adults.,antipsychotic olanzapine,CHEMICAL,be shown to efficacious as treatment for adults with,bipolar disorder,MENTAL_HEALTH
18220496,The second-generation antipsychotic olanzapine has been shown to be efficacious as a treatment for adults with bipolar disorder and is approved by the United States Food and Drug Administration for the treatment of acute manic or mixed episodes as well as for maintenance treatment in bipolar adults.,antipsychotic olanzapine,CHEMICAL,be shown to efficacious as treatment for adults with,Drug,CHEBI
19890443,"Recently, it has been suspected that leukotriene receptor antagonists might be associated with suicide.",leukotriene receptor antagonists,CHEBI,be associated with,suicide,MENTAL_HEALTH
18218968,These results suggest that SPT-modulated programmed cell death plays an important role in the regulation of male gametophyte development.,SPT-modulated programmed cell death,DISEASE,play important role in regulation of,male gametophyte development,NUTRITION
25616531,"In this study, we explore the protective effects of melanocortin 4 receptor agonists in IAH-induced brain injury.",melanocortin receptor agonists,CHEBI,have the protective effects in,IAH-induced brain injury,DISEASE
25616531,"Then, air was injected into the peritoneal cavity of the rats to maintain an intra-abdominal pressure of 20 mm Hg for 4 h. The effects of the melanocortin 4 receptor agonist RO27-3225 in alleviating the rats' IAH brain injuries were observed, which indicated that RO27-3225 could reduce brain edema, the expressions of the IL-1β and TNF-α inflammatory cytokines, the blood-brain barrier's permeability and the aquaporin4 (AQP4) and matrix metalloproteinase 9 (MMP9) levels.",RO27,CHEMICAL,reduce,brain edema,DISEASE
25616531,The MC4R agonist can effectively reduce the intracerebral proinflammatory cytokine gene expression and alleviate the brain injury caused by blood-brain barrier damage following IAH.,MC4R agonist,CHEBI,alleviate,brain injury,DISEASE
22868410,"The ability of nicotine to induce dependence (result in a withdrawal syndrome) is typically thought to require long-term, daily smoking.",nicotine,CHEMICAL,result in,withdrawal syndrome,DISEASE
26503774,These findings suggest that oxalate deposition in kidneys causes metabolic disorder with renal nephropathy.,oxalate deposition,CHEMICAL,cause metabolic disorder with,renal nephropathy,DISEASE
26503774,These findings suggest that oxalate deposition in kidneys causes metabolic disorder with renal nephropathy.,oxalate deposition,CHEMICAL,cause,metabolic disorder,DISEASE
11673585,"Animal and human studies suggest that beta(2)-adrenergic agonists exert anabolic effects on muscles, inducing and preventing atrophy after a variety of insults.",beta(2)-adrenergic agonists,CHEBI,prevent,atrophy,DISEASE
27379379,"Choline supplementation may act through changes in the expression of choline acetyltransferase, an important enzyme in cholinergic signaling, and also through alterations in the lipid metabolite profiles of the RTT neurons.",Choline supplementation,NUTRITION,act through changes in expression of,choline acetyltransferase,NUTRITION
27379379,"Our study elucidates the possible mechanistic pathways for the effect of choline on human RTT cell models, thereby illustrating the potential for using choline as a nutraceutical to treat RTT.",choline,NUTRITION,have the effect on,human RTT cell models,DISEASE
17540552,"Freeze drying (FD) had no effect on EE%, however trehalose decreased EE% possibly due to RIF displacement.",trehalose,NUTRITION,decrease ee% due to,RIF displacement,MENTAL_HEALTH
17540552,"Freeze drying (FD) had no effect on EE%, however trehalose decreased EE% possibly due to RIF displacement.",trehalose,NUTRITION,decrease ee% due to,RIF displacement,CHEMICAL
33714241,Neuroendocrine cancer is an extremely rare malignant tumor that originates from the nervous and the endocrine systems.,Neuroendocrine cancer,DISEASE,be,rare malignant tumor,DISEASE
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEBI,play role in,pain hypersensitivity,DISEASE
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEMICAL,play role in,pain hypersensitivity,DISEASE
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEBI,suggest potential use of σ1 antagonists for treatment of,persistent pain conditions,DISEASE
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEMICAL,suggest potential use of σ1 antagonists for treatment of,persistent pain conditions,DISEASE
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEBI,suggest potential use of,σ1 antagonists,CHEBI
33647709,"The parent compound (-)-MRV3 [(-)-methyl (1S,2R)-2-[(4-hydroxy-4-phenylpiperidin-1-yl)-methyl]-1-phenylcyclopropanecarboxylate], a σ1 antagonist with an improved σ1/σ2 selectivity respect to (+)-MR200, play a role in both central sensitization and pain hypersensitivity, suggesting a potential use of σ1 antagonists for the treatment of persistent pain conditions.",σ1 antagonist,CHEMICAL,suggest potential use of,σ1 antagonists,CHEBI
29311537,"It is well known that PLA₂, due to its hydrolytic activity on phospholipids, takes part in many pathophysiological processes, including inflammation and pain.",phospholipids,NUTRITION,take part in,pain,DISEASE
29311537,"It is well known that PLA₂, due to its hydrolytic activity on phospholipids, takes part in many pathophysiological processes, including inflammation and pain.",phospholipids,NUTRITION,take part in,inflammation,DISEASE
14739538,"Quinacrine was well tolerated, except for liver dysfunction and yellowish pigmentation.",Quinacrine,CHEMICAL,be tolerated,liver dysfunction,DISEASE
35336174,Evidence of viral antigen was found in 7 out of 9 Parkinson's disease cases and in only 1 out of 11 controls (p = 0.005).,viral antigen,CHEBI,be found in,Parkinson's disease cases,DISEASE
35162900,Most participants were aware that BTX could be used for facial esthetic repairs and bruxism treatment but unaware of other therapeutic benefits.,BTX,CHEMICAL,be used for,repairs bruxism treatment,MENTAL_HEALTH
33498233,"Gaultheria procumbens, Mentha arvensis and Eucalyptus dives oils appeared to have a good potential in terms of toxicity/cost ratio for further development of a plant-derived biocide.",Mentha arvensis,NUTRITION,have good potential in terms of toxicity/cost ratio for,plant-derived biocide,CHEMICAL
33498233,"Gaultheria procumbens, Mentha arvensis and Eucalyptus dives oils appeared to have a good potential in terms of toxicity/cost ratio for further development of a plant-derived biocide.",Mentha arvensis,NUTRITION,have good potential in terms of,toxicity/cost ratio,CHEMICAL
33498233,"Gaultheria procumbens, Mentha arvensis and Eucalyptus dives oils appeared to have a good potential in terms of toxicity/cost ratio for further development of a plant-derived biocide.",Gaultheria procumbens,CHEMICAL,have good potential in terms of toxicity/cost ratio for,plant-derived biocide,CHEMICAL
33498233,"Gaultheria procumbens, Mentha arvensis and Eucalyptus dives oils appeared to have a good potential in terms of toxicity/cost ratio for further development of a plant-derived biocide.",Gaultheria procumbens,CHEMICAL,have good potential in terms of,toxicity/cost ratio,CHEMICAL
24468015,"Several double blind, prospective trials have demonstrated an antidepressant augmentation efficacy of aripiprazole in depressed patients unresponsive to standard antidepressant therapy.",aripiprazole,CHEMICAL,have an antidepressant augmentation efficacy in,standard antidepressant therapy,CHEMICAL
24468015,"Several double blind, prospective trials have demonstrated an antidepressant augmentation efficacy of aripiprazole in depressed patients unresponsive to standard antidepressant therapy.",aripiprazole,CHEMICAL,have an antidepressant augmentation efficacy in,depressed patients unresponsive,DISEASE
24468015,"Fourteen depressed patients, who had failed 8 weeks of antidepressant therapy with selective serotonin reuptake inhibitors, underwent FDOPA PET scans before and after aripiprazole augmentation; 11 responded to augmentation.",FDOPA PET,CHEMICAL,scan before and after,aripiprazole augmentation,CHEMICAL
24468015,"Fourteen depressed patients, who had failed 8 weeks of antidepressant therapy with selective serotonin reuptake inhibitors, underwent FDOPA PET scans before and after aripiprazole augmentation; 11 responded to augmentation.",antidepressant therapy,CHEMICAL,have 8 weeks with,selective serotonin reuptake inhibitors,CHEMICAL
25913769,"In this review, we describe the putative role of dopamine in depression, summarize the evidence for the efficacy of dopamine receptor agonists in the treatment of treatment-resistant depression, and discuss the underlying mechanisms by which these medications work.",dopamine,CHEMICAL,have the putative role in,depression,MENTAL_HEALTH
25913769,Further basic research is also necessary to fully understand how dopamine acts in the brain of depressed patients.,dopamine,CHEMICAL,act in brain of,depressed patients,DISEASE
33664474,"Both in vitro and in vivo data show that neurotoxins, which phenotypically mimic PD, increase TSPO to enhance cellular redox-stress, susceptibility to dopamine-induced cell death, and repression of ubiquitin-dependent mitophagy.",neurotoxins,CHEBI,enhance,repression,MENTAL_HEALTH
33664474,"Both in vitro and in vivo data show that neurotoxins, which phenotypically mimic PD, increase TSPO to enhance cellular redox-stress, susceptibility to dopamine-induced cell death, and repression of ubiquitin-dependent mitophagy.",neurotoxins,CHEBI,enhance,cellular redox-stress,CHEMICAL
33664474,"Both in vitro and in vivo data show that neurotoxins, which phenotypically mimic PD, increase TSPO to enhance cellular redox-stress, susceptibility to dopamine-induced cell death, and repression of ubiquitin-dependent mitophagy.",neurotoxins,CHEBI,enhance,dopamine-induced cell death,DISEASE
29945070,"WIN decreased the expression of Capase-3, and improved the learning and memory impairment of VaD rats.",WIN,CHEMICAL,improve learning and memory impairment of,VaD rats,DISEASE
29945070,"WIN decreased the expression of Capase-3, and improved the learning and memory impairment of VaD rats.",WIN,CHEMICAL,improve,learning impairment,DISEASE
29945070,"These data indicate that WIN exerts a neuroprotective effect on the cognitive deficits of VaD rats, which may be associated with the suppression of excessive autophagy and inflammation.",WIN,CHEMICAL,exert neuroprotective effect on cognitive deficits of,VaD rats,DISEASE
29945070,"These data indicate that WIN exerts a neuroprotective effect on the cognitive deficits of VaD rats, which may be associated with the suppression of excessive autophagy and inflammation.",WIN,CHEMICAL,exert neuroprotective effect on,cognitive deficits,DISEASE
19670342,The activity of the tricarboxylic acid cycle diminished so that glutamate synthesis was sustained by the anaplerotic phosphoenolpyruvate carboxylase fixation.,glutamate synthesis,CHEMICAL,be sustained by,phosphoenolpyruvate carboxylase,CHEMICAL
19670342,The activity of the tricarboxylic acid cycle diminished so that glutamate synthesis was sustained by the anaplerotic phosphoenolpyruvate carboxylase fixation.,glutamate synthesis,CHEMICAL,be sustained by,anaplerotic carboxylase fixation,MENTAL_HEALTH
26280233,"Genito-pelvic pain/penetration disorder includes fear or anxiety, marked tightening or tensing of the abdominal and pelvic muscles, or actual pain associated with attempts toward vaginal penetration that is persistent or recurrent for at least six months.",Genito-pelvic pain/penetration disorder,CHEMICAL,include,anxiety,MENTAL_HEALTH
26280233,Estrogen is effective for the treatment of dyspareunia associated with genitourinary syndrome of menopause.,Estrogen,CHEBI,be effective for treatment of,dyspareunia,MENTAL_HEALTH
32369894,The reduced response to TCA during the brief exposure to CuNPs may be a result of either olfactory fatigue or blockage of olfactory sensory neurons (OSNs) by CuNPs.,TCA,CHEMICAL,be result of olfactory fatigue or blockage of,CuNPs,CHEMICAL
32369894,The reduced response to TCA during the brief exposure to CuNPs may be a result of either olfactory fatigue or blockage of olfactory sensory neurons (OSNs) by CuNPs.,CuNPs,CHEMICAL,be result of olfactory fatigue or blockage of,CuNPs,CHEMICAL
32369894,The reduced response to TCA during the brief exposure to CuNPs may be a result of either olfactory fatigue or blockage of olfactory sensory neurons (OSNs) by CuNPs.,TCA,CHEMICAL,be result of,olfactory fatigue,MENTAL_HEALTH
32369894,The reduced response to TCA during the brief exposure to CuNPs may be a result of either olfactory fatigue or blockage of olfactory sensory neurons (OSNs) by CuNPs.,CuNPs,CHEMICAL,be result of,olfactory fatigue,MENTAL_HEALTH
35460216,Intermetallic nanoparticles (NPs) have shown enhanced catalytic properties as compared to their disordered alloy counterparts.,Intermetallic nanoparticles,CHEMICAL,compare to,disordered alloy counterparts,DISEASE
35340717,"Pulmonary fibrosis was induced by intraperitoneal injection of 10 mg/kg NDMA once daily, thrice (consecutively) a week for four weeks, and this condition was treated daily with SYR (50 mg/kg) and ASC (100 mg/kg) acids orally for four weeks.",Pulmonary fibrosis,DISEASE,be induced by intraperitoneal injection of,NDMA thrice,CHEMICAL
2369582,"In the presence of Ca2+, the lipid metabolism favours the biosynthesis of straight-chain fatty acids with depression of branched-chain species, especially at lower temperatures.",straight-chain fatty acids,NUTRITION,have the biosynthesis with,depression,MENTAL_HEALTH
15102251,The prescription of strong opioid analgesics for chronic non-cancer pain (CNCP) is described as controversial and can result in misidentification of patients as drug abusers or individuals with an addiction.,chronic non-cancer pain,DISEASE,result in misidentification of patients as,drug abusers,CHEBI
15102251,The prescription of strong opioid analgesics for chronic non-cancer pain (CNCP) is described as controversial and can result in misidentification of patients as drug abusers or individuals with an addiction.,opioid analgesics,CHEBI,result in misidentification of patients as,drug abusers,CHEBI
15102251,The prescription of strong opioid analgesics for chronic non-cancer pain (CNCP) is described as controversial and can result in misidentification of patients as drug abusers or individuals with an addiction.,opioid analgesics,CHEBI,have the prescription for,chronic non-cancer pain,DISEASE
30802531,Chronic EtOH exposure induced treatment resistance and compulsive-like behavior.,Chronic EtOH exposure,CHEMICAL,induce,treatment resistance,MENTAL_HEALTH
30127821,"The results of macrophage treatment with morphine, imiquimod, and nalmefene demonstrated that most necrosis has occurred in nalmefene group (6.54%).",most necrosis,DISEASE,occur in,nalmefene group,CHEMICAL
14180501,"Numerous reports of chronic renal disease in patients who habitually use phenacetin-containing compounds to excess have aroused considerable controversy over the possible relationship between phenacetin, alone or in combination with other analgesics, and the occurrence of renal damage.",chronic renal disease,DISEASE,arouse considerable controversy over possible relationship between,phenacetin,CHEMICAL
33551685,Many antibiotics have been widely used to treat infectious diseases caused by various pathogenic bacteria.,Many antibiotics,CHEBI,treat,infectious diseases,DISEASE
33551685,"Studies of antimicrobial activity showed that CO2 extract of Portulaca oleracea had the expressed effect against clinically significant microorganisms such as Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and Candida albicans.",Portulaca oleracea,CHEMICAL,have expressed effect against significant microorganisms such as,Staphylococcus aureus,DISEASE
33551685,"Studies of antimicrobial activity showed that CO2 extract of Portulaca oleracea had the expressed effect against clinically significant microorganisms such as Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and Candida albicans.",Portulaca oleracea,CHEMICAL,have expressed effect against significant microorganisms such as,Candida albicans,DISEASE
33551685,"Studies of antimicrobial activity showed that CO2 extract of Portulaca oleracea had the expressed effect against clinically significant microorganisms such as Escherichia coli, Staphylococcus aureus, Bacillus subtilis, and Candida albicans.",Portulaca oleracea,CHEMICAL,have expressed effect against significant microorganisms such as,Bacillus subtilis,DISEASE
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",OSA,DISEASE,be related to,cognitive dysfunction,DISEASE
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",CIH,CHEMICAL,be mediated by,alpha-7 nicotinic acetylcholine receptors,CHEMICAL
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",Chronic intermittent hypoxia,DISEASE,be mediated by,alpha-7 nicotinic acetylcholine receptors,CHEMICAL
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",CIH,CHEMICAL,be related to,cognitive dysfunction,DISEASE
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",Chronic intermittent hypoxia,DISEASE,be related to,cognitive dysfunction,DISEASE
34007230,"Chronic intermittent hypoxia (CIH), the main pathophysiological characteristics of OSA, is closely related to cognitive dysfunction and may be mediated by alpha-7 nicotinic acetylcholine receptors (α7nAChR).",OSA,DISEASE,be mediated by,alpha-7 nicotinic acetylcholine receptors,CHEMICAL
24992547,Montelukast had low risk in hoarseness and insomnia.,Montelukast,CHEMICAL,have low risk in,hoarseness,DISEASE
24992547,Montelukast had low risk in hoarseness and insomnia.,Montelukast,CHEMICAL,have low risk in,insomnia,MENTAL_HEALTH
24992547,"Our meta-analysis suggests that montelukast significantly reduces mild, moderate, and part of severe exacerbations in chronic mild to moderate asthma, but it has inferior efficacy to ICS or ICS plus LABA.",montelukast,CHEMICAL,reduce,severe exacerbations,DISEASE
24460152,We found that addition of pranlukast to the conventional treatment for perennial allergic rhinitis may contribute to improvements in sleep disorder symptoms through a decrease in nasal congestion.,pranlukast,CHEMICAL,contribute to improvements in,disorder symptoms,MENTAL_HEALTH
24460152,We found that addition of pranlukast to the conventional treatment for perennial allergic rhinitis may contribute to improvements in sleep disorder symptoms through a decrease in nasal congestion.,perennial allergic rhinitis,DISEASE,contribute to improvements in,disorder symptoms,MENTAL_HEALTH
30921233,"The AIs of third generation, including anastrazole, letrozole and exemestane, have actually become the standard of care of estrogen-receptor-positive breast cancer in menopausal women and are recommended as adjuvant treatment after surgery in place of/or following tamoxifen.",anastrazole,CHEMICAL,become standard of care of,estrogen-receptor-positive breast cancer,DISEASE
30921233,"The AIs of third generation, including anastrazole, letrozole and exemestane, have actually become the standard of care of estrogen-receptor-positive breast cancer in menopausal women and are recommended as adjuvant treatment after surgery in place of/or following tamoxifen.",AIs,CHEMICAL,become standard of care of,estrogen-receptor-positive breast cancer,DISEASE
30921233,"The AIs of third generation, including anastrazole, letrozole and exemestane, have actually become the standard of care of estrogen-receptor-positive breast cancer in menopausal women and are recommended as adjuvant treatment after surgery in place of/or following tamoxifen.",anastrazole,CHEMICAL,be recommended as adjuvant treatment after surgery in,tamoxifen,CHEMICAL
30921233,"The AIs of third generation, including anastrazole, letrozole and exemestane, have actually become the standard of care of estrogen-receptor-positive breast cancer in menopausal women and are recommended as adjuvant treatment after surgery in place of/or following tamoxifen.",AIs,CHEMICAL,be recommended as adjuvant treatment after surgery in,tamoxifen,CHEMICAL
28302867,Our aim was to investigate how and why European sea bass that had experienced a short episode of moderate hypoxia during their larval stage subsequently exhibited a growth depression at the juvenile stage compared with the control group.,European sea bass,NUTRITION,exhibit growth depression at,juvenile stage,DISEASE
28302867,Our aim was to investigate how and why European sea bass that had experienced a short episode of moderate hypoxia during their larval stage subsequently exhibited a growth depression at the juvenile stage compared with the control group.,European sea bass,NUTRITION,exhibit,growth depression,MENTAL_HEALTH
34761873,"The potent affinity, selectivity, in vivo efficacy and drug like properties together with safety, warrant for further development of this molecule for potential treatment of cognitive disorders associated with Alzheimer's disease.",drug,CHEBI,warrant for further development of molecule for potential treatment of,cognitive disorders,DISEASE
17443019,"During cerebral cortical development, gamma-aminobutyric acidergic (GABAergic) interneurons arise from a different site than projection neurons.",gamma-aminobutyric acidergic GABAergic interneurons,CHEMICAL,arise during cerebral cortical development from,projection neurons,MENTAL_HEALTH
7986343,Our results suggest that the projection domain of MAP2 may play a role in the interaction of tubulin with MAP2 during microtubule assembly.,projection domain,MENTAL_HEALTH,play role in interaction of,tubulin,CHEMICAL
22679158,Dexmedetomidine is a centrally acting selective α2-adrenergic agonist with anaesthetic and sedative properties widely used in intensive care units for sedation in critically ill patients.,Dexmedetomidine,CHEMICAL,be,selective agonist,CHEBI
12741835,"Cycloserine acts as a suicide inhibitor of alanine racemase and as such, serves as an antimicrobial agent.",Cycloserine,CHEMICAL,act as suicide inhibitor of,alanine racemase,CHEMICAL
12741835,"Cycloserine acts as a suicide inhibitor of alanine racemase and as such, serves as an antimicrobial agent.",Cycloserine,CHEMICAL,act as,suicide inhibitor,MENTAL_HEALTH
12741835,"Cycloserine acts as a suicide inhibitor of alanine racemase and as such, serves as an antimicrobial agent.",Cycloserine,CHEMICAL,serve as,antimicrobial agent,CHEBI
8839632,"Since the efficacy of an antimicrobial agent in the therapy of infections depends on the interaction of bacteria, antibiotic and phagocytes, we investigated the effect of amoxycillin/clavulanic acid on the in vitro interaction between human polymorphonuclear cells (PMNs) and beta-lactamase producing strains of Klebsiella pneumoniae and Staphylococcus aureus.",antimicrobial agent,CHEBI,depend on interaction of,antibiotic,CHEBI
8839632,"Since the efficacy of an antimicrobial agent in the therapy of infections depends on the interaction of bacteria, antibiotic and phagocytes, we investigated the effect of amoxycillin/clavulanic acid on the in vitro interaction between human polymorphonuclear cells (PMNs) and beta-lactamase producing strains of Klebsiella pneumoniae and Staphylococcus aureus.",infections,DISEASE,depend on interaction of,antibiotic,CHEBI
8839632,"Interestingly, the presence of the suicide inhibitor, with its beta-lactamase inhibitory properties, potentiated the activity of amoxycillin against the beta-lactamase producing strains of K. pneumoniae and S. aureus in such a manner that bacteria became significantly more susceptible to either phagocytosis or microbicidal activities of human phagocytes, compared to both the control and amoxycillin systems.",suicide inhibitor,MENTAL_HEALTH,potentiate activity of amoxycillin against,K. pneumoniae,DISEASE
8839632,"Interestingly, the presence of the suicide inhibitor, with its beta-lactamase inhibitory properties, potentiated the activity of amoxycillin against the beta-lactamase producing strains of K. pneumoniae and S. aureus in such a manner that bacteria became significantly more susceptible to either phagocytosis or microbicidal activities of human phagocytes, compared to both the control and amoxycillin systems.",suicide inhibitor,MENTAL_HEALTH,potentiate activity of amoxycillin against,S. aureus,DISEASE
8839632,"Interestingly, the presence of the suicide inhibitor, with its beta-lactamase inhibitory properties, potentiated the activity of amoxycillin against the beta-lactamase producing strains of K. pneumoniae and S. aureus in such a manner that bacteria became significantly more susceptible to either phagocytosis or microbicidal activities of human phagocytes, compared to both the control and amoxycillin systems.",suicide inhibitor,MENTAL_HEALTH,potentiate activity of,amoxycillin,CHEMICAL
29024230,"In burning mouth patients, analgesia after oral administration of clonazepam may result from modulation of peripheral γ-aminobutyric acid (GABA) receptors.",analgesia,MENTAL_HEALTH,result from modulation of,peripheral γ-aminobutyric acid GABA receptors,CHEMICAL
29024230,"In burning mouth patients, analgesia after oral administration of clonazepam may result from modulation of peripheral γ-aminobutyric acid (GABA) receptors.",clonazepam,CHEMICAL,result from modulation of,peripheral γ-aminobutyric acid GABA receptors,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",5-HT(1A receptor agonist,CHEBI,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",5-HT(1A receptor agonist,CHEBI,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",5-HT(1A receptor agonist,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",5-HT(1A receptor agonist,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",benzodiazepine receptor agonist,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",benzodiazepine receptor agonist,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",benzodiazepine receptor agonist,CHEBI,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",benzodiazepine receptor agonist,CHEBI,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",serotonin synthesis inhibitor,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",serotonin synthesis inhibitor,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",para-chlorophenylalanine,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",para-chlorophenylalanine,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",diazepam,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",diazepam,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",8-OH-DPAT,CHEMICAL,attenuate,morphine analgesia,MENTAL_HEALTH
12604090,"The benzodiazepine receptor agonist, diazepam, the serotonin synthesis inhibitor, para-chlorophenylalanine (p-CPA), and the 5-HT(1A) receptor agonist, 8-OH-DPAT, were all found to attenuate morphine and U50,488 analgesia.",8-OH-DPAT,CHEMICAL,attenuate,morphine analgesia,CHEMICAL
12604090,"Neither L-5-HTP nor the GABA(A) receptor antagonists were found to affect morphine or U50,488 analgesia per se.",GABA(A receptor antagonists,CHEBI,affect,morphine analgesia,MENTAL_HEALTH
12604090,"Neither L-5-HTP nor the GABA(A) receptor antagonists were found to affect morphine or U50,488 analgesia per se.",GABA(A receptor antagonists,CHEBI,affect,morphine analgesia,CHEMICAL
12604090,"Neither L-5-HTP nor the GABA(A) receptor antagonists were found to affect morphine or U50,488 analgesia per se.",GABA(A receptor antagonists,CHEMICAL,affect,morphine analgesia,MENTAL_HEALTH
12604090,"Neither L-5-HTP nor the GABA(A) receptor antagonists were found to affect morphine or U50,488 analgesia per se.",GABA(A receptor antagonists,CHEMICAL,affect,morphine analgesia,CHEMICAL
12604090,"Thus, these findings indicate that a benzodiazepine-GABAergic agent (diazepam) attenuates opioid analgesia through the serotonergic system, and antiserotonergic agents (8-OH-DPAT, p-CPA) attenuate opioid analgesia through the GABAergic system.",diazepam,CHEMICAL,attenuate opioid analgesia through,antiserotonergic agents,CHEBI
12604090,"Thus, these findings indicate that a benzodiazepine-GABAergic agent (diazepam) attenuates opioid analgesia through the serotonergic system, and antiserotonergic agents (8-OH-DPAT, p-CPA) attenuate opioid analgesia through the GABAergic system.",diazepam,CHEMICAL,attenuate opioid analgesia through,8-OH-DPAT,CHEMICAL
12604090,"Thus, these findings indicate that a benzodiazepine-GABAergic agent (diazepam) attenuates opioid analgesia through the serotonergic system, and antiserotonergic agents (8-OH-DPAT, p-CPA) attenuate opioid analgesia through the GABAergic system.",diazepam,CHEMICAL,attenuate opioid analgesia through,p-CPA,CHEMICAL
12604090,"Thus, these findings indicate that a benzodiazepine-GABAergic agent (diazepam) attenuates opioid analgesia through the serotonergic system, and antiserotonergic agents (8-OH-DPAT, p-CPA) attenuate opioid analgesia through the GABAergic system.",diazepam,CHEMICAL,attenuate,opioid analgesia,MENTAL_HEALTH
12604090,The intimate interactions between GABA and serotonin in the present study further suggest that these neurotransmitters work in complex ways together rather than alone in the modulation of opioid analgesia.,GABA,CHEMICAL,have the intimate interactions with,serotonin,CHEMICAL
12604090,The intimate interactions between GABA and serotonin in the present study further suggest that these neurotransmitters work in complex ways together rather than alone in the modulation of opioid analgesia.,serotonin,CHEMICAL,have the intimate interactions with,GABA,CHEMICAL
28937071,"Age, body mass index, inter-dialytic weight gain, and blood pressure were similar between the two groups, as well as dialytic parameters and drug use.",inter-dialytic weight gain,DISEASE,be similar between,drug use,CHEBI
28179152,Selective serotonin reuptake inhibitors (SSRIs) used as first line of treatment in major depressive disorder (MDD) are known to exert negative effects on the endocrine system and fertility.,SSRIs,CHEMICAL,exert negative effects on,endocrine system,CHEBI
28179152,Selective serotonin reuptake inhibitors (SSRIs) used as first line of treatment in major depressive disorder (MDD) are known to exert negative effects on the endocrine system and fertility.,Selective serotonin reuptake inhibitors,CHEMICAL,exert negative effects on,endocrine system,CHEBI
20735880,"These results provide a straightforward demonstration that a BZT derivative with binding affinity for DAT exhibits high efficacy in animal models of Amph abuse, suggesting that the novel generation of BZT analogs could have wider therapeutic applications in stimulant-spectrum disorders than those previously recognized.",BZT analogs,CHEMICAL,have wider therapeutic applications in,stimulant-spectrum disorders,DISEASE
20735880,"These results provide a straightforward demonstration that a BZT derivative with binding affinity for DAT exhibits high efficacy in animal models of Amph abuse, suggesting that the novel generation of BZT analogs could have wider therapeutic applications in stimulant-spectrum disorders than those previously recognized.",BZT derivative,CHEMICAL,exhibit high efficacy in animal models of,Amph abuse,CHEMICAL
34931070,"Anthrax toxins are composed of protective antigen (PA), which binds to ANTXR2, and the protein cargoes edema factor (EF) and lethal factor (LF).",Anthrax toxins,CHEBI,be composed of,protective antigen,CHEBI
34931070,"Anthrax toxins are composed of protective antigen (PA), which binds to ANTXR2, and the protein cargoes edema factor (EF) and lethal factor (LF).",Anthrax toxins,DISEASE,be composed of,protective antigen,CHEBI
34931070,Intrathecal administration of edema toxin (ET (PA + EF)) targeted DRG neurons and induced analgesia in mice.,edema toxin,CHEBI,induce,analgesia,MENTAL_HEALTH
34931070,Intrathecal administration of edema toxin (ET (PA + EF)) targeted DRG neurons and induced analgesia in mice.,edema toxin,DISEASE,induce,analgesia,MENTAL_HEALTH
34475108,"However, there is a growing body of research showing that LAs act on a wide range of receptors and channel proteins far beyond simple analgesia.",LAs,CHEMICAL,act on wide range of receptors and channel proteins beyond,simple analgesia,MENTAL_HEALTH
29872020,The patients with schizophrenia demonstrated a significantly lower level of LL-37 than those with bipolar disorder (p=0.006) and those with pulmonary TB (p less than 0.001).,schizophrenia,MENTAL_HEALTH,demonstrate lower level of,pulmonary TB,DISEASE
29872020,The patients with schizophrenia demonstrated a significantly lower level of LL-37 than those with bipolar disorder (p=0.006) and those with pulmonary TB (p less than 0.001).,schizophrenia,MENTAL_HEALTH,demonstrate lower level of,bipolar disorder,MENTAL_HEALTH
29872020,The patients with schizophrenia demonstrated a significantly lower level of LL-37 than those with bipolar disorder (p=0.006) and those with pulmonary TB (p less than 0.001).,schizophrenia,MENTAL_HEALTH,demonstrate lower level of,LL-37,CHEMICAL
35436518,"Female-specific expression of mGluR7 in the baroreflex afferent pathway, especially higher expression in Ah-type BRNs, contributes significantly to cardiac analgesia, which may explain that the pathogenesis of silent MI occurs mainly in female patients.",mGluR7,CHEMICAL,contribute to,cardiac analgesia,MENTAL_HEALTH
35436518,"Therefore, higher expression of mGluR7 in female-specific subpopulation of Ah-type BRNs plays a critical role in cardiac analgesia and peripheral nociception.",mGluR7,CHEMICAL,play critical role in,cardiac analgesia,MENTAL_HEALTH
34349001,"Our data also illuminate on some of the outstanding questions in the field, such as the mechanisms underlying sex bias in itch, pain, and opioid analgesia and the paradoxical effects of morphine on pain and itch.",morphine,CHEMICAL,have the paradoxical effects on,itch,DISEASE
34349001,"Our data also illuminate on some of the outstanding questions in the field, such as the mechanisms underlying sex bias in itch, pain, and opioid analgesia and the paradoxical effects of morphine on pain and itch.",morphine,CHEMICAL,have the paradoxical effects on,pain,DISEASE
25956630,Silencing of the fragile X mental retardation 1 (FMR1) gene leads to loss of expression of FMRP and upregulated metabotropic glutamate receptor 5 (mGluR5) signaling resulting in the multiple physical and cognitive deficits associated with fragile X syndrome (FXS).,fragile X mental retardation FMR1 gene,DISEASE,lead to loss of expression of,upregulated metabotropic glutamate receptor,CHEMICAL
25956630,Silencing of the fragile X mental retardation 1 (FMR1) gene leads to loss of expression of FMRP and upregulated metabotropic glutamate receptor 5 (mGluR5) signaling resulting in the multiple physical and cognitive deficits associated with fragile X syndrome (FXS).,fragile X mental retardation FMR1 gene,MENTAL_HEALTH,lead to loss of expression of,upregulated metabotropic glutamate receptor,CHEMICAL
17112370,"These diseases are due to mutations in specific genes, some of which have been identified, such as frataxin in Friedreich ataxia, alpha-tocopherol transfer protein in ataxia with vitamin E deficiency (AVED), aprataxin in ataxia with oculomotor apraxia (AOA1), and senataxin in ataxia with oculomotor apraxia (AOA2).",ataxia,DISEASE,have alpha-tocopherol transfer protein with,vitamin E deficiency,CHEBI
12877306,Osteoporosis and long-term androgen suppression in the treatment of paraphilias has been documented with surgical castration and the use of gonadotropin-releasing hormone agonists.,Osteoporosis androgen suppression,DISEASE,be documented with surgical castration and use of,gonadotropin-releasing hormone agonists,CHEBI
12877306,Osteoporosis and long-term androgen suppression in the treatment of paraphilias has been documented with surgical castration and the use of gonadotropin-releasing hormone agonists.,paraphilias,MENTAL_HEALTH,be documented with surgical castration and use of,gonadotropin-releasing hormone agonists,CHEBI
12877306,Osteoporosis and long-term androgen suppression in the treatment of paraphilias has been documented with surgical castration and the use of gonadotropin-releasing hormone agonists.,Osteoporosis androgen suppression,CHEBI,be documented with surgical castration and use of,gonadotropin-releasing hormone agonists,CHEBI
12877306,"The literature has suggested that the use of cyproterone acetate (CPA) may be protective against osteoporosis, although there are case reports of osteoporosis in men treated with CPA.",CPA,CHEMICAL,be protective against,osteoporosis,DISEASE
12877306,"The literature has suggested that the use of cyproterone acetate (CPA) may be protective against osteoporosis, although there are case reports of osteoporosis in men treated with CPA.",CPA,CHEMICAL,be case reports of,osteoporosis,DISEASE
12877306,"The literature has suggested that the use of cyproterone acetate (CPA) may be protective against osteoporosis, although there are case reports of osteoporosis in men treated with CPA.",cyproterone acetate,CHEMICAL,be protective against,osteoporosis,DISEASE
12877306,"The literature has suggested that the use of cyproterone acetate (CPA) may be protective against osteoporosis, although there are case reports of osteoporosis in men treated with CPA.",cyproterone acetate,CHEMICAL,be case reports of,osteoporosis,DISEASE
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",gonadotropin-releasing hormone agonists,CHEBI,offer promise in treatment of paraphilias with,cyproterone acetate,CHEMICAL
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",gonadotropin-releasing hormone agonists,CHEBI,offer promise in treatment of paraphilias with,medroxyprogesterone acetate,CHEMICAL
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",gonadotropin-releasing hormone agonists,CHEBI,offer promise in treatment of,paraphilias,MENTAL_HEALTH
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",antiandrogen medications,CHEBI,offer promise in treatment of paraphilias with,cyproterone acetate,CHEMICAL
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",antiandrogen medications,CHEBI,offer promise in treatment of paraphilias with,medroxyprogesterone acetate,CHEMICAL
11446201,"A new class of antiandrogen medications, gonadotropin-releasing hormone agonists, offers promise in the treatment of the paraphilias, with substantially less side effects than medroxyprogesterone acetate or cyproterone acetate.",antiandrogen medications,CHEBI,offer promise in treatment of,paraphilias,MENTAL_HEALTH
11446201,Leuprolide acetate resulted in a significant suppression of deviant sexual interests and behavior as measured by self-report and was well tolerated.,Leuprolide acetate,CHEMICAL,result in significant suppression of,deviant sexual interests,DISEASE
11446201,Leuprolide acetate shows promise as a treatment for the paraphilias.,Leuprolide acetate,CHEMICAL,show promise as treatment for,paraphilias,MENTAL_HEALTH
33748630,"Finally, administration of the regioisomeric mixture effectively alleviated carrageenan-induced inflammatory pain in rats.",regioisomeric mixture,CHEBI,alleviate,carrageenan-induced inflammatory pain,DISEASE
35587703,"This clinical case report highlights an association between ceftriaxone and leukocytoclastic vasculitis in a 49-year-old female patient with a history of penicillin allergy, on mirtazapine for anxiety disorder.",ceftriaxone,CHEMICAL,have an association with,leukocytoclastic vasculitis,DISEASE
35587703,"This clinical case report highlights an association between ceftriaxone and leukocytoclastic vasculitis in a 49-year-old female patient with a history of penicillin allergy, on mirtazapine for anxiety disorder.",leukocytoclastic vasculitis,DISEASE,have an association with,ceftriaxone,CHEMICAL
34643856,"Amlodipine is a long-acting dihydropyridine and inappropriate dosage poses a great threat for profound vasodilation, hypotension, and refractory vasopressor-resistant shock.",long-acting dihydropyridine dosage,CHEMICAL,pose great threat for,refractory vasopressor-resistant shock,DISEASE
34643856,"Amlodipine is a long-acting dihydropyridine and inappropriate dosage poses a great threat for profound vasodilation, hypotension, and refractory vasopressor-resistant shock.",long-acting dihydropyridine dosage,CHEMICAL,pose great threat for,hypotension,DISEASE
34643856,"Amlodipine is a long-acting dihydropyridine and inappropriate dosage poses a great threat for profound vasodilation, hypotension, and refractory vasopressor-resistant shock.",Amlodipine,CHEMICAL,be,dihydropyridine dosage,CHEMICAL
34643856,We conclude that euglycemic hyperinsulinemia is a potentially advantageous treatment in CCB toxicity.,euglycemic hyperinsulinemia,DISEASE,be advantageous treatment in,CCB toxicity,CHEMICAL
34932079,Marine omega-3 fatty acid (omega-3) supplements have been used to treat depression but their ability to prevent depression in the general adult population is unknown.,Marine omega-3 fatty acid supplements,NUTRITION,treat,depression,MENTAL_HEALTH
34607054,Higher red blood cell (RBC) DHA in humans is associated with improved cognitive performance and a lower risk for suicide.,Higher red blood cell DHA,CHEMICAL,be associated with improved cognitive performance and lower risk for,suicide,MENTAL_HEALTH
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,benzodiazepine dependence,MENTAL_HEALTH
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,benzodiazepine dependence,CHEMICAL
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,bulimia,MENTAL_HEALTH
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,other organic disorders,DISEASE
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,diabetic neuropathy,DISEASE
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,dementia,MENTAL_HEALTH
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,schizophrenia,MENTAL_HEALTH
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,chronic pain,DISEASE
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,fibromyalgia,DISEASE
26088119,"Other, not officially approved, uses of trazodone include: the treatment of bulimia, benzodiazepine and/or alcohol dependence or abuse, fibromyalgia, degenerative diseases of the central nervous system such as dementia and other organic disorders, schizophrenia, chronic pain, and diabetic neuropathy.",trazodone,CHEMICAL,include treatment of,degenerative diseases,DISEASE
26088119,"In addition, due to its 5HT2A receptor antagonistic action, trazodone may be used to prevent the occurrence of initial and long-term side effects of SSRI, such as anxiety, insomnia and sexual dysfunction.",trazodone,CHEMICAL,prevent occurrence of initial and long-term side effects of,sexual dysfunction,MENTAL_HEALTH
26088119,"In addition, due to its 5HT2A receptor antagonistic action, trazodone may be used to prevent the occurrence of initial and long-term side effects of SSRI, such as anxiety, insomnia and sexual dysfunction.",trazodone,CHEMICAL,prevent occurrence of initial and long-term side effects of,anxiety,MENTAL_HEALTH
26088119,"In addition, due to its 5HT2A receptor antagonistic action, trazodone may be used to prevent the occurrence of initial and long-term side effects of SSRI, such as anxiety, insomnia and sexual dysfunction.",trazodone,CHEMICAL,prevent occurrence of initial and long-term side effects of,SSRI,CHEBI
26088119,"In addition, due to its 5HT2A receptor antagonistic action, trazodone may be used to prevent the occurrence of initial and long-term side effects of SSRI, such as anxiety, insomnia and sexual dysfunction.",trazodone,CHEMICAL,prevent occurrence of initial and long-term side effects of,insomnia,MENTAL_HEALTH
34035975,"Phosphodiesterase type 5 inhibitors (PDE-5i) are the first-line medication for oral erectile dysfunction, which are used according to the prescription of doctors.",PDE-5i,CHEMICAL,be first-line medication for,oral erectile dysfunction,MENTAL_HEALTH
32454761,"As the first FDA-approved phosphodiesterase type 5 inhibitor, sildenafil (SDF) is widely used in the treatment of erectile dysfunction due to its strong pharmacodynamic activity.",sildenafil,CHEMICAL,be used in treatment of,erectile dysfunction due,MENTAL_HEALTH
30215292,"The extract restores mobility of seniors in case of patients suffering from osteoarthritis, Pycnogenol reduces pain and stiffness and use of analgesics.",Pycnogenol,CHEMICAL,reduce,pain,DISEASE
30215292,Urinary symptoms of benign prostatic hyperplasia are reduced by Pycnogenol.,benign prostatic hyperplasia,DISEASE,be reduced by,Pycnogenol,CHEMICAL
30215292,"In combination with L-arginine, Pycnogenol restores erectile function in men with erectile dysfunction.",Pycnogenol,CHEMICAL,restore in combination with l-arginine erectile function in men with,erectile dysfunction,MENTAL_HEALTH
30215292,"In combination with L-arginine, Pycnogenol restores erectile function in men with erectile dysfunction.",Pycnogenol,CHEMICAL,restore in combination with,L-arginine erectile function,CHEMICAL
18420288,"Selegiline, an irreversible inhibitor of monoamine oxidase B used in the treatment of Parkinson's disease, has been demonstrated to have a potential cognition-improving effect in patients with Alzheimer's disease (AD) undergoing treatment with an acetylcholinesterase inhibitor donepezil.",Selegiline,CHEMICAL,undergo treatment with,inhibitor donepezil,CHEMICAL
18420288,"Either donepezil or selegiline alone improved the cognitive impairments in the Y-maze and conditioned fear learning tasks in Abeta(25-35)-injected mice, whereas donepezil, but not selegiline, failed to improve the impairment in a novel object recognition task.",donepezil,CHEMICAL,improve,cognitive impairments,DISEASE
18420288,"Either donepezil or selegiline alone improved the cognitive impairments in the Y-maze and conditioned fear learning tasks in Abeta(25-35)-injected mice, whereas donepezil, but not selegiline, failed to improve the impairment in a novel object recognition task.",selegiline,CHEMICAL,improve,cognitive impairments,DISEASE
18420288,"These results suggest that selegiline potentiates the effect of donepezil on the cognitive impairment, and that the synergistic effect may be mediated through both the cholinergic and dopaminergic systems.",selegiline,CHEMICAL,potentiate effect of donepezil on,cognitive impairment,DISEASE
18420288,"These results suggest that selegiline potentiates the effect of donepezil on the cognitive impairment, and that the synergistic effect may be mediated through both the cholinergic and dopaminergic systems.",selegiline,CHEMICAL,potentiate effect of,donepezil,CHEMICAL
18420288,"These results suggest that selegiline potentiates the effect of donepezil on the cognitive impairment, and that the synergistic effect may be mediated through both the cholinergic and dopaminergic systems.",donepezil,CHEMICAL,have the effect on,cognitive impairment,DISEASE
3216318,"Hospice care of AIDS patients is feasible, humane, and cost effective but problems of the intravenous drug using population require special attention and program modifications if hospice care is to be provided for this substantial and growing AIDS population.",AIDS patients,DISEASE,be provided for,substantial AIDS population,DISEASE
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,multiple cortical/subcortical infarct-like lesions,DISEASE
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,central nerve demyelination,DISEASE
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,% ）,CHEMICAL
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,white matter hyperintensities,DISEASE
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,basal ganglia calcification,DISEASE
34304513,"Temporal CT were normal, but cranial MRI abnormalities were found in 19 cases（67.9%）, including central nerve demyelination, white matter hyperintensities, generalized cerebellar and cerebral atrophy, multiple cortical/subcortical infarct-like lesions, basal ganglia calcification.",cranial MRI abnormalities,DISEASE,be found in,atrophy,DISEASE
14584018,Insufficient folate activity at the time of conception and early pregnancy can result in congenital neural tube defects.,Insufficient folate activity,NUTRITION,result in,congenital tube defects,DISEASE
14584018,"High blood levels of homocysteine have been linked with the risk of arterial disease, dementia and Alzheimer's disease.",homocysteine,CHEMICAL,be linked with risk of,Alzheimer's disease,DISEASE
14584018,"High blood levels of homocysteine have been linked with the risk of arterial disease, dementia and Alzheimer's disease.",homocysteine,CHEMICAL,be linked with risk of,arterial disease,DISEASE
14584018,"High blood levels of homocysteine have been linked with the risk of arterial disease, dementia and Alzheimer's disease.",homocysteine,CHEMICAL,be linked with risk of,dementia,MENTAL_HEALTH
14584018,"There is therefore interest in whether dietary supplements of folic acid (an artificial chemical analogue of naturally occurring folates) can improve cognitive function of people at risk of cognitive decline associated with ageing or dementia, whether by affecting homocysteine metabolism or through other mechanisms.",folic acid artificial chemical analogue,CHEBI,affect,homocysteine metabolism,CHEMICAL
14584018,"There is therefore interest in whether dietary supplements of folic acid (an artificial chemical analogue of naturally occurring folates) can improve cognitive function of people at risk of cognitive decline associated with ageing or dementia, whether by affecting homocysteine metabolism or through other mechanisms.",folic acid artificial chemical analogue,CHEBI,improve cognitive function of people at risk of,cognitive decline,DISEASE
14584018,Vitamin B12 deficiency produces both an anaemia identical to that of folate deficiency but also causes irreversible damage to the central and peripheral nervous systems.,Vitamin B12 deficiency,CHEBI,produce anaemia identical to,folate deficiency,CHEBI
14584018,Vitamin B12 deficiency produces both an anaemia identical to that of folate deficiency but also causes irreversible damage to the central and peripheral nervous systems.,Vitamin B12 deficiency,CHEBI,cause irreversible damage to,central systems,DISEASE
27324876,DM is a heterogeneous metabolic disorder stemming from defective insulin secretion and/or resistance to action of insulin.,DM,CHEMICAL,stemming from,resistance,MENTAL_HEALTH
27324876,"Diabetes is recognized cause of male sexual dysfunction and affects reproductive function in humans and animal models, including the endocrine control of spermatogenesis, erectile dysfunction and ejaculation disorder.",Diabetes,DISEASE,affect reproductive function in,erectile dysfunction,MENTAL_HEALTH
27324876,"Diabetes is recognized cause of male sexual dysfunction and affects reproductive function in humans and animal models, including the endocrine control of spermatogenesis, erectile dysfunction and ejaculation disorder.",Diabetes,DISEASE,affect reproductive function in,spermatogenesis,DISEASE
27324876,"Diabetes is recognized cause of male sexual dysfunction and affects reproductive function in humans and animal models, including the endocrine control of spermatogenesis, erectile dysfunction and ejaculation disorder.",Diabetes,DISEASE,affect reproductive function in,ejaculation disorder,DISEASE
27324876,"Diabetes is recognized cause of male sexual dysfunction and affects reproductive function in humans and animal models, including the endocrine control of spermatogenesis, erectile dysfunction and ejaculation disorder.",Diabetes,DISEASE,affect reproductive function in,endocrine control,CHEBI
27324876,"Diabetes is recognized cause of male sexual dysfunction and affects reproductive function in humans and animal models, including the endocrine control of spermatogenesis, erectile dysfunction and ejaculation disorder.",Diabetes,DISEASE,be recognized cause of,male sexual dysfunction,MENTAL_HEALTH
27324876,Altered testosterone level is another characteristic of diabetic animals.,Altered testosterone level,CHEMICAL,be characteristic of,diabetic animals,DISEASE
27324876,"Studies have demonstrated that DM increases apoptosis in germ cells and lead to the interruption of spermatogenesis, mainly by exerting an influence on Bcl-2 protein and cysteinedependent aspartate-directed proteases.",DM,CHEMICAL,lead to interruption of,spermatogenesis,DISEASE
22252114,Post-weaning multisystemic wasting syndrome significantly increases the mortality and reduces the daily weight gain in weaner pig and/or in finishing pigs.,Post-weaning multisystemic wasting syndrome,DISEASE,reduce daily weight gain in,weaner pig,NUTRITION
22252114,Post-weaning multisystemic wasting syndrome significantly increases the mortality and reduces the daily weight gain in weaner pig and/or in finishing pigs.,Post-weaning multisystemic wasting syndrome,DISEASE,reduce,daily weight gain,DISEASE
20471123,"The multiple linear regression analysis comprised antimicrobial use as the outcome variable with (1) quarter relative to diagnosis of PMWS in the positive herd (same date for the negative match), (2) diagnosis of PMWS (same date used for matched PMWS(-) herd), (3) season and (4) temporal trend as fixed effects.",multiple linear regression analysis,MENTAL_HEALTH,comprise antimicrobial use as outcome variable with,PMWS,DISEASE
20471123,"The multiple linear regression analysis comprised antimicrobial use as the outcome variable with (1) quarter relative to diagnosis of PMWS in the positive herd (same date for the negative match), (2) diagnosis of PMWS (same date used for matched PMWS(-) herd), (3) season and (4) temporal trend as fixed effects.",multiple linear regression analysis,MENTAL_HEALTH,comprise,antimicrobial use,CHEBI
18424846,"Wasting, diarrhoea and respiratory signs were observed in 10 per cent of the weaner pigs (7 to 30 kg) in the case herds compared with 7 per cent in the control herds.",Wasting,DISEASE,be observed in per cent of,weaner pigs,NUTRITION
18424846,"Wasting, diarrhoea and respiratory signs were observed in 10 per cent of the weaner pigs (7 to 30 kg) in the case herds compared with 7 per cent in the control herds.",diarrhoea,DISEASE,be observed in per cent of,weaner pigs,NUTRITION
15290902,"Many forms of human prion disease including variant Creutzfeldt-Jakob disease (vCJD), Gerstmann-Sträussler-Scheinker (GSS) syndrome, and 10% of sporadic CJD cases are associated with amyloid deposition.",sporadic CJD cases,DISEASE,be associated with,amyloid deposition,DISEASE
15290902,"Many forms of human prion disease including variant Creutzfeldt-Jakob disease (vCJD), Gerstmann-Sträussler-Scheinker (GSS) syndrome, and 10% of sporadic CJD cases are associated with amyloid deposition.",variant Creutzfeldt-Jakob disease,DISEASE,be associated with,amyloid deposition,DISEASE
15290902,"Many forms of human prion disease including variant Creutzfeldt-Jakob disease (vCJD), Gerstmann-Sträussler-Scheinker (GSS) syndrome, and 10% of sporadic CJD cases are associated with amyloid deposition.",human prion disease,DISEASE,be associated with,amyloid deposition,DISEASE
32453775,"Two strains of the shipworm symbiotic bacterium, Teredinibacter turnerae, were screened for activity against Toxoplasma gondii and one strain, T7901, exhibited activity against intracellular stages of the parasite.",Teredinibacter turnerae,DISEASE,be screened for activity against,T7901,DISEASE
32453775,"Two strains of the shipworm symbiotic bacterium, Teredinibacter turnerae, were screened for activity against Toxoplasma gondii and one strain, T7901, exhibited activity against intracellular stages of the parasite.",Teredinibacter turnerae,DISEASE,be screened for activity against,Toxoplasma gondii,DISEASE
32453775,"Two strains of the shipworm symbiotic bacterium, Teredinibacter turnerae, were screened for activity against Toxoplasma gondii and one strain, T7901, exhibited activity against intracellular stages of the parasite.",shipworm symbiotic bacterium,NUTRITION,be screened for activity against,T7901,DISEASE
32453775,"Two strains of the shipworm symbiotic bacterium, Teredinibacter turnerae, were screened for activity against Toxoplasma gondii and one strain, T7901, exhibited activity against intracellular stages of the parasite.",shipworm symbiotic bacterium,NUTRITION,be screened for activity against,Toxoplasma gondii,DISEASE
21639405,"As two of these licensed drugs (cholinesterase inhibitors [ChEIs]) are naturally derived (galantamine and rivastigmine), the potential for plants to yield new therapeutic agents has stimulated extensive research to discover new ChEIs together with plant extracts, phytochemicals and their derivatives with other mechanistic effects relevant to dementia treatment.",ChEIs,CHEMICAL,be derived,galantamine,CHEMICAL
21639405,"As two of these licensed drugs (cholinesterase inhibitors [ChEIs]) are naturally derived (galantamine and rivastigmine), the potential for plants to yield new therapeutic agents has stimulated extensive research to discover new ChEIs together with plant extracts, phytochemicals and their derivatives with other mechanistic effects relevant to dementia treatment.",ChEIs,CHEMICAL,be derived,rivastigmine,CHEMICAL
31170482,"Elevated blood serotonin in perinatal development is the most consistent neurochemical finding reported in Autism Spectrum Disorder (ASD), and has been implicated in the pathogenesis of the disorder.",Elevated blood serotonin,CHEMICAL,reported in,ASD,DISEASE
31170482,"Elevated blood serotonin in perinatal development is the most consistent neurochemical finding reported in Autism Spectrum Disorder (ASD), and has been implicated in the pathogenesis of the disorder.",Elevated blood serotonin,CHEMICAL,reported in,Autism Spectrum Disorder,MENTAL_HEALTH
31170482,"Accordingly, pre- and postnatal administration of the non-selective serotonin agonist, 5-methoxytryptamine (5-MT), is hypothesized as a model of developmental hyperserotonemia (DHS) to investigate the behavioral and morphological implications in ASD.",non-selective serotonin agonist,CHEBI,be hypothesized as model of,developmental hyperserotonemia,DISEASE
31170482,"Accordingly, pre- and postnatal administration of the non-selective serotonin agonist, 5-methoxytryptamine (5-MT), is hypothesized as a model of developmental hyperserotonemia (DHS) to investigate the behavioral and morphological implications in ASD.",5-methoxytryptamine,CHEMICAL,be hypothesized as model of,developmental hyperserotonemia,DISEASE
34914708,"We observed that reduced habituation due to knock-down of ChT in MBs causes hypersensitivity towards odour, suggesting that ChT also regulates incoming stimulus suppression.",ChT,CHEMICAL,have habituation due to knock-down in,MBs,CHEMICAL
34914708,"Strikingly, the lack of ChT in MBs shows characteristics similar to the major reported features of Autism spectrum disorders (ASD), including attenuated habituation, sensory hypersensitivity as well as defective GABAergic signalling.",MBs,CHEMICAL,show characteristics similar to,sensory hypersensitivity,DISEASE
34914708,"Strikingly, the lack of ChT in MBs shows characteristics similar to the major reported features of Autism spectrum disorders (ASD), including attenuated habituation, sensory hypersensitivity as well as defective GABAergic signalling.",MBs,CHEMICAL,show characteristics similar to,Autism spectrum disorders,MENTAL_HEALTH
34914708,"Strikingly, the lack of ChT in MBs shows characteristics similar to the major reported features of Autism spectrum disorders (ASD), including attenuated habituation, sensory hypersensitivity as well as defective GABAergic signalling.",ChT,CHEMICAL,show characteristics similar to,sensory hypersensitivity,DISEASE
34914708,"Strikingly, the lack of ChT in MBs shows characteristics similar to the major reported features of Autism spectrum disorders (ASD), including attenuated habituation, sensory hypersensitivity as well as defective GABAergic signalling.",ChT,CHEMICAL,show characteristics similar to,Autism spectrum disorders,MENTAL_HEALTH
34914708,"Strikingly, the lack of ChT in MBs shows characteristics similar to the major reported features of Autism spectrum disorders (ASD), including attenuated habituation, sensory hypersensitivity as well as defective GABAergic signalling.",ChT,CHEMICAL,have the lack in,MBs,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",glutathione S-transferase,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",glutathione S-transferase,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",superoxide dismutase,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",superoxide dismutase,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",Xanthine oxidase,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",Xanthine oxidase,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",malondialdehyde,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",malondialdehyde,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",artesunate,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",artesunate,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",glutathione peroxidase,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",glutathione peroxidase,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",proguanil,CHEMICAL,reduce,GSH,CHEMICAL
30486696,"The effects of artesunate (ART) and proguanil (PRG) on mitochondrial Permeability Transition (mPT), mitochondrial ATPase (mATPase), level of malondialdehyde (MDA) and activities of antioxidant enzymes; catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), Xanthine oxidase (XO), glutathione S-transferase (GST) and reduced glutathione (GSH) were estimated in Plasmodium berghei-infected mice treated with ART and PRG.",proguanil,CHEMICAL,reduce,glutathione,CHEMICAL
30486696,"Oral administration of ART and PRG altered antioxidant enzymes status, Caspases 3 and 9 were significantly activated in PRG-treated groups; there was significant increase in DNA fragmentation in PU and PRG groups compared with the normal control.",DNA fragmentation,MENTAL_HEALTH,have significant increase in,PRG,CHEMICAL
29796929,Variations in specific amino acids have been implicated in the pathophysiology of schizophrenia.,specific amino acids,CHEMICAL,be implicated in pathophysiology of,schizophrenia,MENTAL_HEALTH
35221284,Reserpine was used for the model of behavioral depression.,Reserpine,CHEMICAL,be used for model of,behavioral depression,MENTAL_HEALTH
35221284,"Reserpine could cause cerebral injury and depressive disorder in mice, the mechanism of which is related to steroid hormone biosynthesis, chemical carcinogenesis, nucleotide excision repair and the retinoic acid-inducible gene I-like (RIG-I-like) receptor signaling.",Reserpine,CHEMICAL,cause,depressive disorder,MENTAL_HEALTH
35221284,"Reserpine could cause cerebral injury and depressive disorder in mice, the mechanism of which is related to steroid hormone biosynthesis, chemical carcinogenesis, nucleotide excision repair and the retinoic acid-inducible gene I-like (RIG-I-like) receptor signaling.",Reserpine,CHEMICAL,cause,cerebral injury,DISEASE
35221284,RIG-I mediated neuroinflammation could participate in the process of depression and RIG-I may become a target for berberine against depression.,mediated neuroinflammation,DISEASE,become target for berberine against,depression,MENTAL_HEALTH
35221284,RIG-I mediated neuroinflammation could participate in the process of depression and RIG-I may become a target for berberine against depression.,mediated neuroinflammation,DISEASE,become target for,berberine,CHEMICAL
35221284,RIG-I mediated neuroinflammation could participate in the process of depression and RIG-I may become a target for berberine against depression.,mediated neuroinflammation,DISEASE,participate in process of,depression,MENTAL_HEALTH
35221284,RIG-I mediated neuroinflammation could participate in the process of depression and RIG-I may become a target for berberine against depression.,mediated neuroinflammation,DISEASE,participate in process of,RIG-I,CHEMICAL
3114802,"The precursor and agonists elicited head shakes, forepaw padding, splayed hindlimbs, tremor and Straub tail in the rat.",agonists,CHEBI,elicit,tremor,DISEASE
3114802,"Carbidopa plus 5-HTP potentiated only head shakes, while tranylcypromine (TCP) plus 5-HTP potentiated all the behaviors above.",5-HTP,CHEMICAL,potentiate,head shakes,DISEASE
16593832,"Drechslera maydis, the causal agent of Southern corn leaf blight, and Drechslera sorghicola, the causal agent of leaf spot on Johnson grass, produce a series of phytotoxic sesterterpenoids.",Johnson grass,DISEASE,produce series of,phytotoxic sesterterpenoids,CHEMICAL
27649549,Cysteine proteinase B (CPB) is a significant virulence factor for Leishmania infections.,Cysteine proteinase B,CHEMICAL,be significant virulence factor for,Leishmania infections,DISEASE
27649549,Cysteine proteinase B (CPB) is a significant virulence factor for Leishmania infections.,Cysteine proteinase B,CHEMICAL,be,significant virulence factor,CHEBI
9037412,"Lubeluzole significantly delayed in time before the slices became epileptic, postponed the first SD-like depolarization, allowed the slices to better recover their membrane potential after a larger number of SD-like DC depolarizations, preserved Ca2+ and energy homeostasis, and prevented the neurotoxic effects of veratridine (IC50-value 0.54 microM).",Lubeluzole,CHEMICAL,prevent neurotoxic effects of,veratridine,CHEMICAL
9037412,"Lubeluzole significantly delayed in time before the slices became epileptic, postponed the first SD-like depolarization, allowed the slices to better recover their membrane potential after a larger number of SD-like DC depolarizations, preserved Ca2+ and energy homeostasis, and prevented the neurotoxic effects of veratridine (IC50-value 0.54 microM).",Lubeluzole,CHEMICAL,prevent,neurotoxic effects,DISEASE
9037412,"The ability of lubeluzole to prevent the pathological consequences of excessive Na(+)-influx, without altering normal Na(+)- channel function may be of benefit in stroke.",lubeluzole,CHEMICAL,be of benefit in,stroke,DISEASE
2657505,The effects of glycine on NMDA antagonism by a series of excitatory amino acid antagonists were tested in two functional in vitro models: NMDA induced [3H]GABA release from cultured mouse cortical neurons and NMDA evoked spreading depression in chick retina.,NMDA,CHEMICAL,induce [3h]gaba release from,NMDA,CHEMICAL
2657505,The effects of glycine on NMDA antagonism by a series of excitatory amino acid antagonists were tested in two functional in vitro models: NMDA induced [3H]GABA release from cultured mouse cortical neurons and NMDA evoked spreading depression in chick retina.,NMDA,CHEMICAL,induce,[3H]GABA release,CHEMICAL
2657505,The effects of glycine on NMDA antagonism by a series of excitatory amino acid antagonists were tested in two functional in vitro models: NMDA induced [3H]GABA release from cultured mouse cortical neurons and NMDA evoked spreading depression in chick retina.,glycine,CHEMICAL,have the effects on,NMDA antagonism,CHEMICAL
11033496,"The main purpose of our study was to assess the systemic safety of brimonidine tartrate 0.2%, an alpha 2 highly selective agonist in patients with glaucoma or ocular hypertension",selective agonist,CHEBI,in patients with,glaucoma,DISEASE
8630784,"A substantial decrease in the sympathoadrenal system catecholamines was found to be the case in muscular fatigue (the animals were running on a treadmill to refusal), as evidenced by experimental studies on white rats.",sympathoadrenal system catecholamines,CHEMICAL,be found to,muscular fatigue,MENTAL_HEALTH
8630784,"Sympatholytics bring about marked reduction in the catecholamine content in hypothalamus, cerebral hemispheres and the heart, which fact contributes to the development of muscular fatigue.",Sympatholytics,CHEBI,bring marked reduction in catecholamine content in,muscular fatigue,MENTAL_HEALTH
8630784,"Sympatholytics bring about marked reduction in the catecholamine content in hypothalamus, cerebral hemispheres and the heart, which fact contributes to the development of muscular fatigue.",Sympatholytics,CHEBI,bring marked reduction in,catecholamine content,CHEMICAL
34122316,"Histopathological examination of the retrieved thrombi revealed atheromatous components, including cholesterol clefts, foam cells, and a necrotic core.",retrieved thrombi,DISEASE,reveal,cholesterol clefts,NUTRITION
34122316,"Histopathological examination of the retrieved thrombi revealed atheromatous components, including cholesterol clefts, foam cells, and a necrotic core.",retrieved thrombi,DISEASE,reveal,atheromatous components,DISEASE
34122316,"Histopathological examination of the retrieved thrombi revealed atheromatous components, including cholesterol clefts, foam cells, and a necrotic core.",retrieved thrombi,DISEASE,reveal,necrotic core,DISEASE
32912501,"Cholesterol crystals are the solid, crystalline form of cholesterol that is found in atherosclerosis, but not in cardiac diseases such as atrial fibrillation, valvular diseases, and cardiomyopathy.",Cholesterol crystals,NUTRITION,be solid crystalline form of,cholesterol,NUTRITION
32912501,"Therefore, if a cholesterol crystal is found in a thrombus removed by mechanical thrombectomy (MT), this makes it possible to diagnose a patient as having an atheromatous lesion.",cholesterol crystal,NUTRITION,be found in,thrombus,DISEASE
32912501,"MT was performed 1.5 h after stroke onset, with the thrombus removed and a left occluded MCA completely recanalized.",MT,CHEMICAL,be performed,stroke onset,DISEASE
32912501,Pathological examination of the embolus revealed a cholesterol crystal cleft in the thrombus.,embolus,DISEASE,reveal cholesterol crystal cleft in,thrombus,DISEASE
32912501,Pathological examination of the embolus revealed a cholesterol crystal cleft in the thrombus.,embolus,DISEASE,reveal,cholesterol crystal,NUTRITION
29177306,"Regarding soil chemistry, natural sepiolite increased the soil pH values and shifted the zeta potentials of soil particles to be more negative, enhancing the fixation or sorption of Cd on soil particles, and resulted in the reduction of HCl and DTPA extractable Cd concentrations in paddy soil.",natural sepiolite,CHEMICAL,result in reduction of,DTPA,CHEMICAL
29177306,"Regarding soil chemistry, natural sepiolite increased the soil pH values and shifted the zeta potentials of soil particles to be more negative, enhancing the fixation or sorption of Cd on soil particles, and resulted in the reduction of HCl and DTPA extractable Cd concentrations in paddy soil.",natural sepiolite,CHEMICAL,result in reduction of,HCl extractable Cd concentrations,CHEMICAL
28866741,"In this study, mercapto-grafted palygorskite (MP) as a novel and efficient immobilization agent was utilized for the remediation of Cd-polluted paddy soil in pot trials, and the remediation mechanisms were investigated in the aspect of soil chemistry and plant physiology with different rice cultivars as model plants.",MP,DISEASE,be utilized in study for remediation of,Cd-polluted paddy soil,CHEMICAL
28866741,Both reduced DTPA-extractable Cd contents in rhizosphere and non-rhizosphere soil and decreasing Cd contents in iron plaques on rice root surfaces confirmed that MP was an efficient immobilization agent for Cd pollutant in paddy soil.,MP,DISEASE,be efficient immobilization agent for,Cd pollutant,CHEMICAL
28866741,"In the aspect of soil chemistry, the pH values of rhizosphere and non-rhizosphere soils had no statistical changes in the MP treatment groups, but their zeta potentials decreased obviously, indicating that MP could enhance the fixation or sorption of Cd on soil compositions.",MP,DISEASE,enhance fixation or sorption of,Cd,CHEMICAL
28866741,"In the aspect of soil chemistry, the pH values of rhizosphere and non-rhizosphere soils had no statistical changes in the MP treatment groups, but their zeta potentials decreased obviously, indicating that MP could enhance the fixation or sorption of Cd on soil compositions.",MP,DISEASE,enhance,fixation,MENTAL_HEALTH
28866741,"In the aspect of antioxidant system, MP could increase POD activity of rice roots significantly to alleviate the stress of Cd to roots, and resulted in the decrease of T-AOC, SOD, and CAT activities of rice roots of the selected cultivars.",MP,DISEASE,alleviate stress of,Cd,CHEMICAL
23220040,"Seabream wild-type Pgr shows the highest transactivational response to native euteleostean progestins, 17α,20β-dihydroxy-4-pregnen-3-one and 17α,20β,21-trihydroxy-4-pregnen-3-one, whereas the Pgr_tv3 and Pgr_tv4 isoforms independently regulate novel nuclear and cytosolic mechanisms of dominant-negative repression of Pgr-mediated transcription.",Pgr_tv4,CHEMICAL,regulate novel nuclear and cytosolic mechanisms of,dominant-negative repression,MENTAL_HEALTH
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",primary ovarian explants,DISEASE,regulate temporal expression of,pgr_tv3,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",primary ovarian explants,DISEASE,regulate temporal expression of,pgr,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",primary ovarian explants,DISEASE,regulate temporal expression of,pgr_tv4,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",recombinant piscine follicle-stimulating hormone,CHEBI,regulate temporal expression of,pgr_tv3,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",recombinant piscine follicle-stimulating hormone,CHEBI,regulate temporal expression of,pgr,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",recombinant piscine follicle-stimulating hormone,CHEBI,regulate temporal expression of,pgr_tv4,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",estrogen,CHEBI,regulate temporal expression of,pgr_tv3,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",estrogen,CHEBI,regulate temporal expression of,pgr,CHEMICAL
23220040,"Stimulation of primary ovarian explants in vitro with recombinant piscine follicle-stimulating hormone and estrogen differentially regulated the temporal expression of pgr, pgr_tv3 and pgr_tv4.",estrogen,CHEBI,regulate temporal expression of,pgr_tv4,CHEMICAL
20661027,"The pharmaceutical treatment of akinetic mutism typically includes dopaminergic agents, but the resulting therapeutic effects are often unsatisfactory, and it remains unclear whether late treatment using these medications is effective.",akinetic mutism,MENTAL_HEALTH,include,dopaminergic agents,CHEBI
20661027,"The pharmaceutical treatment of akinetic mutism typically includes dopaminergic agents, but the resulting therapeutic effects are often unsatisfactory, and it remains unclear whether late treatment using these medications is effective.",pharmaceutical treatment,CHEBI,include,dopaminergic agents,CHEBI
20661027,"Thus, we suggest that atomoxetine can be a useful therapeutic option in the treatment of chronic akinetic mutism.",atomoxetine,CHEMICAL,be useful therapeutic option in treatment of,chronic akinetic mutism,DISEASE
20661027,"Thus, we suggest that atomoxetine can be a useful therapeutic option in the treatment of chronic akinetic mutism.",atomoxetine,CHEMICAL,be useful therapeutic option in treatment of,chronic akinetic mutism,MENTAL_HEALTH
34842793,"Anaesthesia was induced by subcutaneous injection of a pre-mixture of fentanyl, midazolam, and medetomidin with the addition of 0.5% isoflurane in oxygen and caudal epidural analgesia.",% isoflurane,CHEMICAL,have the addition in,caudal epidural analgesia,MENTAL_HEALTH
34842793,"Anaesthesia was induced by subcutaneous injection of a pre-mixture of fentanyl, midazolam, and medetomidin with the addition of 0.5% isoflurane in oxygen and caudal epidural analgesia.",% isoflurane,CHEMICAL,have the addition in,oxygen,CHEMICAL
34652905,"The dissociative-hypnotic compound ketamine is being used in an increasingly wide range of therapeutic contexts, including anesthesia, adjunctive analgesia, treatment-resistant depression, but it also continues to be a notable substance of abuse.",dissociative-hypnotic compound ketamine,CHEMICAL,be used in wide range of,treatment-resistant depression,MENTAL_HEALTH
34652905,"The dissociative-hypnotic compound ketamine is being used in an increasingly wide range of therapeutic contexts, including anesthesia, adjunctive analgesia, treatment-resistant depression, but it also continues to be a notable substance of abuse.",dissociative-hypnotic compound ketamine,CHEMICAL,be used in wide range of,adjunctive analgesia,MENTAL_HEALTH
25109873,Aripiprazole has been considered as a dopamine stabilizer and was the first atypical antipsychotic agent approved by the US Food and Drug Administration as an adjunctive to the treatment of unipolar MDD.,Aripiprazole,CHEMICAL,be considered as,dopamine stabilizer,CHEBI
25109873,Aripiprazole has been considered as a dopamine stabilizer and was the first atypical antipsychotic agent approved by the US Food and Drug Administration as an adjunctive to the treatment of unipolar MDD.,Aripiprazole,CHEMICAL,be considered as,dopamine stabilizer,CHEMICAL
25109873,"Therefore, we hypothesize that adjunctive aripiprazole with antidepressant may be an effective treatment for patients with MDD and ND comorbidity.",adjunctive aripiprazole,CHEMICAL,be effective treatment for patients with,MDD comorbidity,DISEASE
25109873,"Therefore, we hypothesize that adjunctive aripiprazole with antidepressant may be an effective treatment for patients with MDD and ND comorbidity.",antidepressant,CHEMICAL,be effective treatment for patients with,MDD comorbidity,DISEASE
20217052,Agonist medications have been proven effective in treating opioid and nicotine dependence; results from clinical studies suggest that the indirect dopamine agonist d-amphetamine may reduce cocaine abuse.,indirect dopamine agonist d-amphetamine,CHEMICAL,reduce,cocaine abuse,MENTAL_HEALTH
20217052,Agonist medications have been proven effective in treating opioid and nicotine dependence; results from clinical studies suggest that the indirect dopamine agonist d-amphetamine may reduce cocaine abuse.,indirect dopamine agonist d-amphetamine,CHEBI,reduce,cocaine abuse,MENTAL_HEALTH
1123650,The molecular structure of cysteine-S-sulfate closely resembles that of glutamate and related acidic amino acids which have both neuroexcitatory and neurotoxic properties (excitotoxic amino acids).,cysteine-S-sulfate,CHEMICAL,resemble,glutamate acidic amino acids,CHEMICAL
1123650,Here we demonstrate that cysteine-S-sulfate induces the glutamate type of neuropathology in the rat central nervous system when administered subcutaneously to infants or intracerebrally to adults.,cysteine-S-sulfate,CHEMICAL,induce glutamate type of,neuropathology,DISEASE
1123650,Here we demonstrate that cysteine-S-sulfate induces the glutamate type of neuropathology in the rat central nervous system when administered subcutaneously to infants or intracerebrally to adults.,cysteine-S-sulfate,CHEMICAL,induce,glutamate type,CHEMICAL
1123650,It is postulated that cysteine-S-sulfate may be the neurotoxic agent responsible for brain damage in sulfite oxidase deficiency.,cysteine-S-sulfate,CHEMICAL,be neurotoxic agent responsible for brain damage in,sulfite oxidase deficiency,CHEMICAL
1123650,It is postulated that cysteine-S-sulfate may be the neurotoxic agent responsible for brain damage in sulfite oxidase deficiency.,cysteine-S-sulfate,CHEMICAL,be neurotoxic agent responsible for,brain damage,DISEASE
1123650,It is postulated that cysteine-S-sulfate may be the neurotoxic agent responsible for brain damage in sulfite oxidase deficiency.,cysteine-S-sulfate,CHEMICAL,be,neurotoxic agent responsible,CHEBI
12849932,Receptor autoradiography of [(3)H]-clonidine binding presented herein compares densities of alpha(2)-adrenoceptors and I-sites (under a noradrenergic-mask) in Brodmann's area 47 of the left orbitofrontal cortex (OFC) and in six amygdaloid nuclei of subjects with major depression (n=12) vs. controls with no psychiatric history (n=11).,[(3)H]-clonidine binding,CHEMICAL,compare densities of alpha(2)-adrenoceptors and i-sites under,noradrenergic-mask,CHEMICAL
12849932,Receptor autoradiography of [(3)H]-clonidine binding presented herein compares densities of alpha(2)-adrenoceptors and I-sites (under a noradrenergic-mask) in Brodmann's area 47 of the left orbitofrontal cortex (OFC) and in six amygdaloid nuclei of subjects with major depression (n=12) vs. controls with no psychiatric history (n=11).,[(3)H]-clonidine binding,CHEMICAL,compare densities of alpha(2)-adrenoceptors and i-sites under,major depression,MENTAL_HEALTH
7647083,Melatonin (MT) release from the pineal gland has been used as a marker for central noradrenergic function in major depression.,Melatonin release,CHEMICAL,be used as marker for central noradrenergic function in,major depression,MENTAL_HEALTH
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",Phosphate release,CHEMICAL,be investigated with pilot plant for,biological phosphorus removal,NUTRITION
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",phosphate fixation,MENTAL_HEALTH,enhanced,biological phosphorus removal plants,NUTRITION
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",phosphate fixation,CHEMICAL,enhanced,biological phosphorus removal plants,NUTRITION
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",Phosphate release,CHEMICAL,enhanced,biological phosphorus removal plants,NUTRITION
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",phosphate fixation,MENTAL_HEALTH,be investigated with pilot plant for,biological phosphorus removal,NUTRITION
11804346,"Phosphate release and phosphate fixation during sludge treatment of waste activated sludge was investigated with a pilot plant for enhanced biological phosphorus removal, complemented by laboratory investigations of sludge samples from different large enhanced biological phosphorus removal plants.",phosphate fixation,CHEMICAL,be investigated with pilot plant for,biological phosphorus removal,NUTRITION
11888971,"beta-Adrenoceptor agonists (beta-agonists) are commonly used to treat obstructive lung diseases, and preliminary studies have suggested they are associated with an increased risk of adverse cardiovascular outcomes.",beta-Adrenoceptor agonists,CHEBI,treat,obstructive lung diseases,DISEASE
11888971,"beta-Adrenoceptor agonists (beta-agonists) are commonly used to treat obstructive lung diseases, and preliminary studies have suggested they are associated with an increased risk of adverse cardiovascular outcomes.",beta-agonists,CHEMICAL,treat,obstructive lung diseases,DISEASE
7934780,However recent reports of psychosis related to qat abuse in Great Britain and the United States have raised new alarm in the Narcotics Commission of the United Nations.,psychosis related,MENTAL_HEALTH,raise new alarm in,Narcotics Commission,CHEBI
7934780,However recent reports of psychosis related to qat abuse in Great Britain and the United States have raised new alarm in the Narcotics Commission of the United Nations.,qat abuse,DISEASE,raise new alarm in,Narcotics Commission,CHEBI
25652946,"Type 2 diabetes is a metabolic disorder affecting millions of people worldwide, and new drug leads or functional foods containing selective α-glucosidase inhibitors are needed.",Type diabetes,DISEASE,be,metabolic disorder,DISEASE
25652946,"Methanol extracts of Cinnamomum zeylanicum bark, Rheum rhabarbarum peel, and Rheum palmatum root and ethyl acetate extracts of C. zeylanicum bark, Allium ascalonicum peel, and R. palmatum root showed IC50 values below 20 μg/mL. Subsequently, high-resolution α-glucosidase profiling was used in combination with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for identification of metabolites responsible for the α-glucosidase inhibitory activity.",Methanol extracts,CHEMICAL,show ic50 values below,μg/mL.,CHEMICAL
25652946,"Methanol extracts of Cinnamomum zeylanicum bark, Rheum rhabarbarum peel, and Rheum palmatum root and ethyl acetate extracts of C. zeylanicum bark, Allium ascalonicum peel, and R. palmatum root showed IC50 values below 20 μg/mL. Subsequently, high-resolution α-glucosidase profiling was used in combination with high-performance liquid chromatography-high-resolution mass spectrometry-solid-phase extraction-nuclear magnetic resonance spectroscopy for identification of metabolites responsible for the α-glucosidase inhibitory activity.",Cinnamomum zeylanicum bark,CHEMICAL,show ic50 values below,μg/mL.,CHEMICAL
35098553,"A total number of 50 male Albino rats were randomly divided into five groups; normal control, STZ-induced diabetic group (65 mg/kg b.w divided into three doses 5 days apart), three other STZ-diabetic groups were treated orally for 6 weeks with metformin (500 mg/kg b.w/day), an avocado fruit ethanolic extract (300 mg/kg b.w/day), or a cinnamon aqueous extract (200 mg/kg b.w/day).",other STZ-diabetic groups,DISEASE,be treated for,cinnamon aqueous extract,CHEMICAL
35098553,"A total number of 50 male Albino rats were randomly divided into five groups; normal control, STZ-induced diabetic group (65 mg/kg b.w divided into three doses 5 days apart), three other STZ-diabetic groups were treated orally for 6 weeks with metformin (500 mg/kg b.w/day), an avocado fruit ethanolic extract (300 mg/kg b.w/day), or a cinnamon aqueous extract (200 mg/kg b.w/day).",other STZ-diabetic groups,DISEASE,be treated for,metformin,CHEMICAL
24133374,"Prevention and correction of hyperphosphatemia is a major goal of chronic kidney disease-mineral and bone disorder (CKD-MBD) management, achievable through avoidance of a positive phosphate balance.",hyperphosphatemia,DISEASE,be major goal of,chronic disorder CKD-MBD management,DISEASE
12818782,"Human prion diseases are very rare diseases including sporadic Creutzfeldt-Jakob disease (the most frequent form manifesting as a presenile dementia), familial transmissible spongiform encephalopathies and two juvenile transmissible forms: iatrogenic Creutzfeldt-Jakob secondary to treatment with human extractive growth hormone and variant Creutzfeldt-Jakob disease resulting from bovine spongiform encephalopathy food transmission.",Human prion diseases,DISEASE,be,iatrogenic Creutzfeldt-Jakob secondary,DISEASE
12818782,"Human prion diseases are very rare diseases including sporadic Creutzfeldt-Jakob disease (the most frequent form manifesting as a presenile dementia), familial transmissible spongiform encephalopathies and two juvenile transmissible forms: iatrogenic Creutzfeldt-Jakob secondary to treatment with human extractive growth hormone and variant Creutzfeldt-Jakob disease resulting from bovine spongiform encephalopathy food transmission.",Human prion diseases,DISEASE,be,human extractive growth hormone,CHEBI
12818782,"Human prion diseases are very rare diseases including sporadic Creutzfeldt-Jakob disease (the most frequent form manifesting as a presenile dementia), familial transmissible spongiform encephalopathies and two juvenile transmissible forms: iatrogenic Creutzfeldt-Jakob secondary to treatment with human extractive growth hormone and variant Creutzfeldt-Jakob disease resulting from bovine spongiform encephalopathy food transmission.",Human prion diseases,DISEASE,be,sporadic Creutzfeldt-Jakob disease,DISEASE
12818782,"Human prion diseases are very rare diseases including sporadic Creutzfeldt-Jakob disease (the most frequent form manifesting as a presenile dementia), familial transmissible spongiform encephalopathies and two juvenile transmissible forms: iatrogenic Creutzfeldt-Jakob secondary to treatment with human extractive growth hormone and variant Creutzfeldt-Jakob disease resulting from bovine spongiform encephalopathy food transmission.",Human prion diseases,DISEASE,be,variant Creutzfeldt-Jakob disease,DISEASE
31721720,"Long term utilization of tramadol is associated with various neurological disorders like seizures, serotonin syndrome, Alzheimer's disease and Parkinson's disease.",tramadol,CHEMICAL,be associated with various neurological disorders like,seizures,DISEASE
31721720,"Long term utilization of tramadol is associated with various neurological disorders like seizures, serotonin syndrome, Alzheimer's disease and Parkinson's disease.",tramadol,CHEMICAL,be associated with various neurological disorders like,serotonin syndrome,CHEMICAL
31721720,"Long term utilization of tramadol is associated with various neurological disorders like seizures, serotonin syndrome, Alzheimer's disease and Parkinson's disease.",tramadol,CHEMICAL,be associated with,various neurological disorders,DISEASE
31721720,"Tramadol produces seizures through inhibition of nitric oxide, serotonin reuptake and inhibitory effects on GABA receptors.",Tramadol,CHEMICAL,produce seizures through inhibition of,nitric oxide,CHEMICAL
31721720,"Tramadol produces seizures through inhibition of nitric oxide, serotonin reuptake and inhibitory effects on GABA receptors.",Tramadol,CHEMICAL,produce seizures through inhibition of,serotonin reuptake,CHEMICAL
31721720,"Tramadol produces seizures through inhibition of nitric oxide, serotonin reuptake and inhibitory effects on GABA receptors.",Tramadol,CHEMICAL,produce seizures through inhibition of,GABA receptors,CHEMICAL
31721720,"Tramadol produces seizures through inhibition of nitric oxide, serotonin reuptake and inhibitory effects on GABA receptors.",Tramadol,CHEMICAL,produce,seizures,DISEASE
31721720,Extensive tramadol intake alters redox balance through elevating lipid peroxidation and free radical leading to neurotoxicity and produces neurobehavioral deficits.,Extensive tramadol intake,CHEMICAL,lead to,neurotoxicity,DISEASE
31721720,Extensive tramadol intake alters redox balance through elevating lipid peroxidation and free radical leading to neurotoxicity and produces neurobehavioral deficits.,Extensive tramadol intake,CHEMICAL,produce,neurobehavioral deficits,DISEASE
31721720,"During Alzheimer's disease progression, low level of intracellular signalling molecules like cGMP, cAMP, PKC and PKA affect both learning and memory.",cGMP,CHEMICAL,affect during alzheimer's,memory,DISEASE
31721720,The reduced level of dopamine may produce bradykinesia and tremors which are chief motor abnormalities in Parkinson's Disease (PD).,dopamine,CHEMICAL,produce bradykinesia and tremors in parkinson's,PD,DISEASE
31721720,The reduced level of dopamine may produce bradykinesia and tremors which are chief motor abnormalities in Parkinson's Disease (PD).,dopamine,CHEMICAL,produce,tremors,DISEASE
28724260,"Pleuropterus multiflorus (Hasuo) is a widely used medicinal plant in Korea and China for treating amnesia, isnomia, heart throbbing etc.",Pleuropterus multiflorus,CHEMICAL,treat,isnomia,CHEMICAL
28724260,"Pleuropterus multiflorus (Hasuo) is a widely used medicinal plant in Korea and China for treating amnesia, isnomia, heart throbbing etc.",Pleuropterus multiflorus,CHEMICAL,treat,amnesia,MENTAL_HEALTH
16879931,These data agree with findings from a clinical trial examining the effects of similar gabapentin doses on cocaine use by treatment-seeking cocaine-dependent individuals and suggest that gabapentin does not show promise as a treatment medication for cocaine dependence.,similar gabapentin doses,CHEMICAL,have the effects on,cocaine use,CHEMICAL
2059245,"Other liver diseases of genetic origin, but with a curious association with alcohol intake, are hemochromatosis and porphyria cutanea tarda.",Other liver diseases,DISEASE,be,hemochromatosis,DISEASE
2059245,"Other liver diseases of genetic origin, but with a curious association with alcohol intake, are hemochromatosis and porphyria cutanea tarda.",alcohol intake,CHEMICAL,be,hemochromatosis,DISEASE
2059245,"Steatosis, the characteristic consequence of excess alcohol intake, is usually macrovesicular and rarely microvesicular.",Steatosis,DISEASE,be,macrovesicular,DISEASE
2059245,"Steatosis, the characteristic consequence of excess alcohol intake, is usually macrovesicular and rarely microvesicular.",excess alcohol intake,CHEMICAL,be,macrovesicular,DISEASE
2059245,"The clinical syndrome of alcoholic liver disease is the result of three factors--parenchymal insufficiency, portal hypertension and the clinical consequences of extrahepatic damage produced by alcohol.",alcoholic liver disease,DISEASE,be result of,extrahepatic damage,DISEASE
2059245,"The clinical syndrome of alcoholic liver disease is the result of three factors--parenchymal insufficiency, portal hypertension and the clinical consequences of extrahepatic damage produced by alcohol.",alcoholic liver disease,DISEASE,be result of,portal hypertension,DISEASE
2059245,"Alcoholic liver injury appears to be generated by the effects of ethanol metabolism and the toxic effects of acetaldehyde, perhaps the immune responses to alcohol- or acetaldehyde-altered proteins, and questionably enhanced by viral hepatitis.",Alcoholic liver injury,DISEASE,be generated by effects of ethanol metabolism and toxic effects of,acetaldehyde,CHEMICAL
2059245,"Alcoholic liver injury appears to be generated by the effects of ethanol metabolism and the toxic effects of acetaldehyde, perhaps the immune responses to alcohol- or acetaldehyde-altered proteins, and questionably enhanced by viral hepatitis.",Alcoholic liver injury,DISEASE,be generated by effects of,ethanol metabolism,CHEMICAL
2059245,"Perhaps the most important facet of the hepatotoxicity of alcohol is its enhancement of the effects of a number of other hepatotoxic agents, among which acetaminophen is the prime example.",hepatotoxicity,DISEASE,be enhancement of effects of number of,other hepatotoxic agents,CHEBI
2059245,"Perhaps the most important facet of the hepatotoxicity of alcohol is its enhancement of the effects of a number of other hepatotoxic agents, among which acetaminophen is the prime example.",alcohol,CHEMICAL,be enhancement of effects of number of,other hepatotoxic agents,CHEBI
19307110,"In order to definitely determine whether fatty acid concentrations were associated with autism, we quantitatively measured 30 fatty acids from seven lipid classes in plasma from a large subset of subjects enrolled in the Childhood Autism Risk from Genetics and the Environment (CHARGE) study.",fatty acid concentrations,NUTRITION,be associated with,autism,MENTAL_HEALTH
17580851,1H NMR spectroscopy was used to investigate the metabolic effects of the hepatotoxin galactosamine (galN) and the mechanism by which glycine protects against such toxicity.,glycine,CHEMICAL,protect by,toxicity,DISEASE
25634485,"Melanoma Differentiation-Associated protein 5 (MDA5) is a member of the retinoic acid-inducible gene I (RIG-I)-like receptor (RLR) family, which is a cytosolic pattern recognition receptor that detects viral nucleic acids.",Melanoma Differentiation-Associated protein,DISEASE,be member of,retinoic acid-inducible gene (RIG-I)-like receptor RLR family,CHEMICAL
26366063,The aim of the present study was to review the pharmacokinetics and pharmacodynamics of this drug and its role in cognitive impairment according to the present medical literature.,drug,CHEBI,have the pharmacokinetics and pharmacodynamics in,cognitive impairment,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,dizziness,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,hepatic degeneration,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,ataxia,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,irritability,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,prostration,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,hyperesthesia,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,enteritis,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,colic,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,hemorrhages,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,headache,MENTAL_HEALTH
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,subepicardium,CHEMICAL
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,muscle tremors,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,necrosis,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,vomiting,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,depression,MENTAL_HEALTH
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,clonic convulsions,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,nausea,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,anxiety,MENTAL_HEALTH
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,splenic congestion,DISEASE
7216895,"Clinical signs and lesions of levamisole toxicosis include: nausea, vomiting, increased salivation, frequent urination and defecation, colic, dizziness, headache, muscle tremors, ataxia, anxiety, hyperesthesia with irritability, clonic convulsions, depression, rapid respiration, dyspnea, prostration, collapse, hemorrhages in the subepicardium and thalamus, enteritis, hepatic degeneration and necrosis, and splenic congestion.",levamisole toxicosis,CHEMICAL,include,dyspnea,DISEASE
7216895,"With levamisole-induced tachyphylaxis, the effects of other ganglionic stimulants dimethylpiperazinium and nicotine are also abolished.",dimethylpiperazinium,CHEMICAL,be abolished with,levamisole-induced tachyphylaxis,DISEASE
26688487,We aimed to identify the maximum tolerated dose (MTD) and the recommended phase 2 dose of the selective Hedgehog antagonist PF-04449913 in myeloid malignancies.,selective Hedgehog antagonist PF-04449913,CHEMICAL,have the recommended phase 2 dose in,myeloid malignancies,DISEASE
26688487,We aimed to identify the maximum tolerated dose (MTD) and the recommended phase 2 dose of the selective Hedgehog antagonist PF-04449913 in myeloid malignancies.,selective Hedgehog antagonist PF-04449913,CHEBI,have the recommended phase 2 dose in,myeloid malignancies,DISEASE
29635040,Both the formation of covalently linked dimers and heat resistance were prevented by N-acetylcysteine.,heat resistance,MENTAL_HEALTH,be prevented by,N-acetylcysteine,CHEMICAL
35306239,"Starch (S) films containing gellan gum (90:10) and polyester (P) blend films (PLA:PHBV, 75:25) with and without ferulic, p-coumaric or protocatechuic acid at 2% (w/w) were obtained by melt-blending and compression moulding for the purposes of obtaining SP bilayers by thermo-compressing both monolayers together.",Starch S,NUTRITION,be obtained by,melt-blending moulding,DISEASE
35306239,"The incorporation of phenolic acids promoted the water vapour and oxygen barrier capacity of bilayers while reducing their stiffness and resistance to break, mainly in the case of protocatechuic acid.",phenolic acids,CHEMICAL,promote water vapour and oxygen barrier capacity of bilayers in case of,protocatechuic acid,CHEMICAL
35306239,"The incorporation of phenolic acids promoted the water vapour and oxygen barrier capacity of bilayers while reducing their stiffness and resistance to break, mainly in the case of protocatechuic acid.",phenolic acids,CHEMICAL,promote,oxygen barrier,CHEMICAL
35306239,"The incorporation of phenolic acids promoted the water vapour and oxygen barrier capacity of bilayers while reducing their stiffness and resistance to break, mainly in the case of protocatechuic acid.",phenolic acids,CHEMICAL,reduce,resistance,MENTAL_HEALTH
26076632,"In addition, GLY and PEG did not cause any sensible Tg depression regarding CTA, whereas DOP and TEC decreased it as much as 46°C and 16°C, respectively.",DOP,CHEMICAL,decrease,it ° C,CHEMICAL
26076632,"In addition, GLY and PEG did not cause any sensible Tg depression regarding CTA, whereas DOP and TEC decreased it as much as 46°C and 16°C, respectively.",DOP,CHEMICAL,decrease,° C,CHEMICAL
8077173,"Serotonin (5-HT) is a neurotransmitter involved in the regulation of mood, arousal, aggression, sleep, learning, nociceptions, nerve growth, and appetitive functions.",5-HT,CHEMICAL,involved in regulation of,aggression,DISEASE
8077173,"Serotonin (5-HT) is a neurotransmitter involved in the regulation of mood, arousal, aggression, sleep, learning, nociceptions, nerve growth, and appetitive functions.",5-HT,CHEMICAL,involved in regulation of,nociceptions,DISEASE
8077173,"Serotonin (5-HT) is a neurotransmitter involved in the regulation of mood, arousal, aggression, sleep, learning, nociceptions, nerve growth, and appetitive functions.",Serotonin,CHEMICAL,involved in regulation of,aggression,DISEASE
8077173,"Serotonin (5-HT) is a neurotransmitter involved in the regulation of mood, arousal, aggression, sleep, learning, nociceptions, nerve growth, and appetitive functions.",Serotonin,CHEMICAL,involved in regulation of,nociceptions,DISEASE
8077173,"Medications that act on 5-HT and its receptors have applications in the treatment of a variety of psychiatric disorders, among them depression, anxiety, psychoses, eating disorders, obsessive compulsive disorder, body dysmorphic disorder, posttraumatic stress disorder, and conditions associated with aggression.",depression,MENTAL_HEALTH,eat,posttraumatic stress disorder,MENTAL_HEALTH
8077173,"Medications that act on 5-HT and its receptors have applications in the treatment of a variety of psychiatric disorders, among them depression, anxiety, psychoses, eating disorders, obsessive compulsive disorder, body dysmorphic disorder, posttraumatic stress disorder, and conditions associated with aggression.",depression,MENTAL_HEALTH,eat,obsessive compulsive disorder,MENTAL_HEALTH
8077173,"Medications that act on 5-HT and its receptors have applications in the treatment of a variety of psychiatric disorders, among them depression, anxiety, psychoses, eating disorders, obsessive compulsive disorder, body dysmorphic disorder, posttraumatic stress disorder, and conditions associated with aggression.",5-HT,CHEMICAL,have applications in treatment of variety of,psychiatric disorders,DISEASE
35334886,"After parturition, the GDM dams were divided into two groups: blood glucose not recovered group (GH group) and blood glucose recovered group (GL group).",GDM dams,DISEASE,be divided after parturition into,glucose recovered group,CHEMICAL
35334886,"After parturition, the GDM dams were divided into two groups: blood glucose not recovered group (GH group) and blood glucose recovered group (GL group).",GDM dams,DISEASE,be divided after parturition into,groups glucose recovered group,CHEMICAL
35334886,"The HPA axis hormone did not show the typical stress state of depression, but the level of 5-HT decreased significantly in serum, prefrontal cortex and hippocampus, and the Kyn/Trp ratio increased significantly in serum and prefrontal cortex, implying the switch of the tryptophan (Trp) metabolism from the 5-HT pathway to the kynurenine (Kyn) pathway.",Kyn/Trp ratio,CHEMICAL,imply switch of,tryptophan Trp metabolism,NUTRITION
35334886,"The HPA axis hormone did not show the typical stress state of depression, but the level of 5-HT decreased significantly in serum, prefrontal cortex and hippocampus, and the Kyn/Trp ratio increased significantly in serum and prefrontal cortex, implying the switch of the tryptophan (Trp) metabolism from the 5-HT pathway to the kynurenine (Kyn) pathway.",Kyn/Trp ratio,CHEMICAL,imply switch of,kynurenine pathway,CHEMICAL
35334886,"The HPA axis hormone did not show the typical stress state of depression, but the level of 5-HT decreased significantly in serum, prefrontal cortex and hippocampus, and the Kyn/Trp ratio increased significantly in serum and prefrontal cortex, implying the switch of the tryptophan (Trp) metabolism from the 5-HT pathway to the kynurenine (Kyn) pathway.",Kyn/Trp ratio,CHEMICAL,imply switch of,Kyn,CHEMICAL
35334886,"The HPA axis hormone did not show the typical stress state of depression, but the level of 5-HT decreased significantly in serum, prefrontal cortex and hippocampus, and the Kyn/Trp ratio increased significantly in serum and prefrontal cortex, implying the switch of the tryptophan (Trp) metabolism from the 5-HT pathway to the kynurenine (Kyn) pathway.",Kyn/Trp ratio,CHEMICAL,imply switch of,tryptophan Trp metabolism,CHEMICAL
35334886,"Lactobacillus and Bacteroides were negatively correlated with 5-HT level and positively correlated with Kyn level, whereas Clostridium XlVa and Ruminococcus were positively correlated with 5-HT level.",Clostridium XlVa,DISEASE,be correlated with,5-HT level,CHEMICAL
35334886,"These results suggest that GDM disrupts both the Trp pathway and the composition of the gut microbiota, which provide a putative physiological basis for PPD.",GDM,DISEASE,disrupt,Trp pathway,CHEMICAL
3479525,"We conducted a six-month, randomized, double-blind trial of lecithin therapy in early-onset Alzheimer's disease.",lecithin therapy,CHEBI,have double-blind trial in,early-onset Alzheimer's disease,DISEASE
23913407,Cocaine sensitization is associated with increased excitability of pyramidal projection neurons in the medial prefrontal cortex.,Cocaine sensitization,CHEMICAL,be associated with increased excitability of,pyramidal projection neurons,MENTAL_HEALTH
31911076,"We previously showed that the plasma level of betaine (N,N,N-trimethylglycine), a methyl-group donor, was significantly decreased in patients with first episode schizophrenia (FESZ).",betaine,CHEMICAL,be decreased in patients with,first episode schizophrenia,MENTAL_HEALTH
10828477,"Six patients with homocystinuria, nonresponsive to pyridoxine, treated only with trimethylglycine (betaine) were injected with a bolus of 20 IU/kg body weight of unfractionated commercial heparin to induce the release of tissue factor pathway inhibitor from the vascular endothelium.",homocystinuria nonresponsive,DISEASE,be injected with bolus of iu/kg body weight of,unfractionated commercial heparin,CHEMICAL
10828477,"Six patients with homocystinuria, nonresponsive to pyridoxine, treated only with trimethylglycine (betaine) were injected with a bolus of 20 IU/kg body weight of unfractionated commercial heparin to induce the release of tissue factor pathway inhibitor from the vascular endothelium.",pyridoxine,CHEBI,be injected with bolus of iu/kg body weight of,unfractionated commercial heparin,CHEMICAL
21518701,"Gonadotropin-releasing hormone (GnRH) agonists, such as leuprorelin, are recommended in the patients with pedophilia at highest risk of offending.",leuprorelin,CHEMICAL,be recommended in patients with,pedophilia,MENTAL_HEALTH
21518701,"Gonadotropin-releasing hormone (GnRH) agonists, such as leuprorelin, are recommended in the patients with pedophilia at highest risk of offending.",Gonadotropin-releasing hormone agonists,CHEBI,be recommended in patients with,pedophilia,MENTAL_HEALTH
26852949,"High-fat diet (HFD) induced obesity is associated not only with metabolic dysregulation, e.g., impaired glucose homeostasis and insulin sensitivity, but also with neurological dysfunction manifested with aberrant behavior and/or neurotransmitter imbalance.",induced obesity,DISEASE,be associated with,neurological dysfunction,DISEASE
26852949,"High-fat diet (HFD) induced obesity is associated not only with metabolic dysregulation, e.g., impaired glucose homeostasis and insulin sensitivity, but also with neurological dysfunction manifested with aberrant behavior and/or neurotransmitter imbalance.",induced obesity,DISEASE,be associated with,impaired glucose homeostasis,CHEMICAL
26916435,"The leaf extract of Urtica dioica L. (UT) has been reported to improve glucose homeostasis in vivo, but definitive studies on efficacy and mechanism of action are lacking.",Urtica dioica L.,CHEMICAL,improve,glucose homeostasis definitive studies,CHEMICAL
26916435,"In myotubes, UT attenuated the ability of FFAs to induce insulin resistance and PP2A hyperactivity without affecting ceramide accumulation and PP2A expression.",FFAs,CHEMICAL,have the ability to,PP2A hyperactivity,MENTAL_HEALTH
26916435,"In myotubes, UT attenuated the ability of FFAs to induce insulin resistance and PP2A hyperactivity without affecting ceramide accumulation and PP2A expression.",FFAs,CHEMICAL,have the ability to,insulin resistance,MENTAL_HEALTH
6617404,"In testing neonatal serum for bilirubin displacement by drugs, the choice of method, drug concentration, and dilution of the sample may influence the interpretation of results.",drug concentration,CHEBI,test neonatal serum for,bilirubin displacement,CHEMICAL
6617404,"In testing neonatal serum for bilirubin displacement by drugs, the choice of method, drug concentration, and dilution of the sample may influence the interpretation of results.",drug concentration,CHEBI,test neonatal serum for,bilirubin displacement,MENTAL_HEALTH
1421049,"We have studied, by ultrafiltration, the interactions between rifampicin (15 and 30 microM) and levamisole (7 microM) since both drugs may be associated for the treatment of brucellosis.",rifampicin,CHEMICAL,be associated for treatment of,brucellosis,DISEASE
1421049,"We have studied, by ultrafiltration, the interactions between rifampicin (15 and 30 microM) and levamisole (7 microM) since both drugs may be associated for the treatment of brucellosis.",levamisole,CHEMICAL,be associated for treatment of,brucellosis,DISEASE
26475148,"LSK complex is a severe deformity consisting of a consecutive repetition of three vertebral deformities: lordosis, scoliosis, and kyphosis.",LSK complex,CHEMICAL,consisting of consecutive repetition of,deformities lordosis,DISEASE
26475148,"LSK complex is a severe deformity consisting of a consecutive repetition of three vertebral deformities: lordosis, scoliosis, and kyphosis.",LSK complex,CHEMICAL,consisting of consecutive repetition of,kyphosis,DISEASE
26475148,"LSK complex is a severe deformity consisting of a consecutive repetition of three vertebral deformities: lordosis, scoliosis, and kyphosis.",LSK complex,CHEMICAL,consisting of consecutive repetition of,scoliosis,DISEASE
19267885,"Although there was a trend towards lower levels of serine, glycine, N, N-dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups.",homocysteine,CHEMICAL,be trend towards lower levels of,serine,CHEMICAL
19267885,"Although there was a trend towards lower levels of serine, glycine, N, N-dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups.",homocysteine,CHEMICAL,be trend towards lower levels of,AD patients,DISEASE
19267885,"Although there was a trend towards lower levels of serine, glycine, N, N-dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups.",homocysteine,CHEMICAL,be trend towards lower levels of,N-dimethylglycine,CHEMICAL
19267885,"Although there was a trend towards lower levels of serine, glycine, N, N-dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups.",homocysteine,CHEMICAL,be trend towards lower levels of,glycine,CHEMICAL
19267885,"Although there was a trend towards lower levels of serine, glycine, N, N-dimethylglycine in AD patients, the plasma levels of these metabolites as well as the levels of homocysteine and cystathionine were not statistically different in any of the ASDs groups.",homocysteine,CHEMICAL,be different in,ASDs groups,DISEASE
69318,The organochlorine pesticide Kepone induces scoliosis in the sheepshead minnow.,organochlorine pesticide Kepone,CHEMICAL,induce scoliosis in,sheepshead minnow,NUTRITION
69318,The organochlorine pesticide Kepone induces scoliosis in the sheepshead minnow.,organochlorine pesticide Kepone,CHEMICAL,induce,scoliosis,DISEASE
69318,The histological syndrome of Kepone poisoning in fish and the clinical syndrome in humans suggest that the nervous system is a primary target for Kepone and that scoliosis is a secondary effect of Kepone poisoning in fish.,scoliosis,DISEASE,be secondary effect of,Kepone poisoning,CHEMICAL
22138808,Known side effects of cocaine-related levamisole ingestion have included agranulocytosis and a cutaneous acral purpura that is histopathologically characterized by a mixture of inflammation (vasculitis) and occlusion (vasculopathy).,cocaine-related levamisole ingestion,CHEMICAL,include,agranulocytosis,DISEASE
22138808,Peripheral vasculitis/vasculopathy with severe necrosis resembling Coumadin necrosis is a relatively recently recognized sequelae from levamisole-adulterated cocaine use.,severe necrosis,DISEASE,be recognized sequelae from,levamisole-adulterated cocaine use,CHEMICAL
22138808,Peripheral vasculitis/vasculopathy with severe necrosis resembling Coumadin necrosis is a relatively recently recognized sequelae from levamisole-adulterated cocaine use.,Peripheral vasculitis/vasculopathy,DISEASE,be recognized sequelae from,levamisole-adulterated cocaine use,CHEMICAL
21973080,"While the rotamer in the (RS,SR)-i-Bu HCl crystal structure exhibits a synclinal orientation for the vicinal pair of adjacent methine protons, the weighted time-averaged arrangement for these protons becomes almost completely antiperiplanar when the crystals are dissolved in D(2)O. Increased steric congestion around the CH-CH bond in the analogous N-methyl tertiary ammonium salts seems to augment the quantity of the preferred rotamer within the mixture.",SR)-i-Bu HCl crystal structure,CHEMICAL,exhibit,synclinal orientation,MENTAL_HEALTH
16634473,"These features may appear also within normal psychology and they becomeclinically important after thein increase of intensity and conspicuousness (los sof hearing, long-term abuse of alcohol and psychostimulants) and organic disorders of the brain may contribute to the development of paranoidity.",organic disorders,DISEASE,contribute to development of,paranoidity,DISEASE
16634473,"These features may appear also within normal psychology and they becomeclinically important after thein increase of intensity and conspicuousness (los sof hearing, long-term abuse of alcohol and psychostimulants) and organic disorders of the brain may contribute to the development of paranoidity.",alcohol,CHEMICAL,contribute to development of,paranoidity,DISEASE
25249569,Loss-of-function mutations in human ether go-go (HERG) potassium channels underlie long QT syndrome type 2 (LQT2) and are associated with fatal ventricular tachyarrhythmia.,human ether go-go HERG potassium channels,CHEMICAL,be associated with,fatal ventricular tachyarrhythmia,DISEASE
33644592,"To improve the biological effects of the lead compound 5'-chloro-2,2'-dihydroxychalcone (Cl-DHC), bicyclic aromatic chalcones were designed, synthesized, and evaluated against androgen-independent prostate cancer (PCa) DU145 and PC-3 cell proliferation.",aromatic chalcones,CHEMICAL,improve biological effects of,Cl-DHC,CHEMICAL
33644592,"To improve the biological effects of the lead compound 5'-chloro-2,2'-dihydroxychalcone (Cl-DHC), bicyclic aromatic chalcones were designed, synthesized, and evaluated against androgen-independent prostate cancer (PCa) DU145 and PC-3 cell proliferation.",aromatic chalcones,CHEMICAL,improve biological effects of,"compound 5'-chloro-2,2'-dihydroxychalcone",CHEMICAL
33644592,"To improve the biological effects of the lead compound 5'-chloro-2,2'-dihydroxychalcone (Cl-DHC), bicyclic aromatic chalcones were designed, synthesized, and evaluated against androgen-independent prostate cancer (PCa) DU145 and PC-3 cell proliferation.",aromatic chalcones,CHEMICAL,evaluate against,cancer DU145,DISEASE
33450087,"Agonists of α2 -adrenoceptors are increasingly being used for the provision of comfort, sedation and the management of delirium in critically ill patients, with and without sepsis.",Agonists,CHEBI,be used for provision of,delirium,MENTAL_HEALTH
33450087,"Agonists of α2 -adrenoceptors are increasingly being used for the provision of comfort, sedation and the management of delirium in critically ill patients, with and without sepsis.",Agonists,CHEBI,be used for provision of,sepsis,DISEASE
33450087,"Agonists of α2 -adrenoceptors are increasingly being used for the provision of comfort, sedation and the management of delirium in critically ill patients, with and without sepsis.",α2 -adrenoceptors,CHEMICAL,be used for provision of,delirium,MENTAL_HEALTH
33450087,"Agonists of α2 -adrenoceptors are increasingly being used for the provision of comfort, sedation and the management of delirium in critically ill patients, with and without sepsis.",α2 -adrenoceptors,CHEMICAL,be used for provision of,sepsis,DISEASE
33450087,"Experimental and clinical studies support the notion that the α2 -adrenoceptor agonists, dexmedetomidine and clonidine, mitigate sympathetic and inflammatory overactivity in sepsis and cardiac surgery requiring cardiopulmonary bypass.",dexmedetomidine,CHEMICAL,mitigate sympathetic and inflammatory overactivity in,sepsis,DISEASE
33450087,"Experimental and clinical studies support the notion that the α2 -adrenoceptor agonists, dexmedetomidine and clonidine, mitigate sympathetic and inflammatory overactivity in sepsis and cardiac surgery requiring cardiopulmonary bypass.",dexmedetomidine,CHEMICAL,mitigate,sympathetic overactivity,DISEASE
33450087,"Experimental and clinical studies support the notion that the α2 -adrenoceptor agonists, dexmedetomidine and clonidine, mitigate sympathetic and inflammatory overactivity in sepsis and cardiac surgery requiring cardiopulmonary bypass.",α2 -adrenoceptor agonists,CHEBI,mitigate sympathetic and inflammatory overactivity in,sepsis,DISEASE
33450087,"Experimental and clinical studies support the notion that the α2 -adrenoceptor agonists, dexmedetomidine and clonidine, mitigate sympathetic and inflammatory overactivity in sepsis and cardiac surgery requiring cardiopulmonary bypass.",α2 -adrenoceptor agonists,CHEBI,mitigate,sympathetic overactivity,DISEASE
33450087,We review the pharmacodynamic mechanisms by which α2 -adrenoceptor agonists might mitigate multi-organ dysfunction arising from pathophysiological conditions associated with excessive inflammatory and adrenergic stress in experimental studies.,α2 -adrenoceptor agonists,CHEBI,mitigate by,multi-organ dysfunction,DISEASE
20233428,"We hypothesized that sedation with dexmedetomidine (an alpha2 adrenoceptor agonist), as compared with lorazepam (a benzodiazepine), would provide greater improvements in clinical outcomes among septic patients than among non-septic patients.",adrenoceptor agonist,CHEBI,provide greater improvements in clinical outcomes among,septic patients,DISEASE
20233428,"We hypothesized that sedation with dexmedetomidine (an alpha2 adrenoceptor agonist), as compared with lorazepam (a benzodiazepine), would provide greater improvements in clinical outcomes among septic patients than among non-septic patients.",dexmedetomidine,CHEMICAL,provide greater improvements in clinical outcomes among,septic patients,DISEASE
20233428,"We hypothesized that sedation with dexmedetomidine (an alpha2 adrenoceptor agonist), as compared with lorazepam (a benzodiazepine), would provide greater improvements in clinical outcomes among septic patients than among non-septic patients.",lorazepam,CHEMICAL,provide greater improvements in clinical outcomes among,septic patients,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",acetylcholine,CHEMICAL,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",acetylcholine,CHEMICAL,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",thyroid hormones,CHEBI,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",thyroid hormones,CHEBI,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",monoamines,CHEMICAL,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",monoamines,CHEMICAL,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",amino acids,CHEMICAL,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",amino acids,CHEMICAL,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",cortisol,CHEMICAL,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",cortisol,CHEMICAL,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",melatonin,CHEMICAL,be involved in pathophysiology of,BPD,DISEASE
20878507,"Current data suggest that monoamines, acetylcholine, amino acids, cortisol, thyroid hormones, and melatonin may be involved in the pathophysiology of bipolar disorder (BPD).",melatonin,CHEMICAL,be involved in pathophysiology of,bipolar disorder,MENTAL_HEALTH
20878507,"Antidepressants, stimulants, anticholinergics, steroids, and thyroid hormone have been reported to cause treatment-emergent mania (TEM) in BPD, but only recently have the traditional antidepressants been systematically studied.",stimulants,CHEMICAL,cause,treatment-emergent mania,MENTAL_HEALTH
20878507,"Antidepressants, stimulants, anticholinergics, steroids, and thyroid hormone have been reported to cause treatment-emergent mania (TEM) in BPD, but only recently have the traditional antidepressants been systematically studied.",stimulants,CHEMICAL,cause,BPD,DISEASE
20878507,"Antidepressants, stimulants, anticholinergics, steroids, and thyroid hormone have been reported to cause treatment-emergent mania (TEM) in BPD, but only recently have the traditional antidepressants been systematically studied.",Antidepressants,CHEMICAL,cause,treatment-emergent mania,MENTAL_HEALTH
20878507,"Antidepressants, stimulants, anticholinergics, steroids, and thyroid hormone have been reported to cause treatment-emergent mania (TEM) in BPD, but only recently have the traditional antidepressants been systematically studied.",Antidepressants,CHEMICAL,cause,BPD,DISEASE
20878507,Paroxetine or bupropion adjunctive therapy to mood stabilizer(s) had a similar risk as placebo for treatment of TEM in real world patients with bipolar depression during continuation treatment.,Paroxetine stabilizer(s,CHEMICAL,have similar risk as placebo for treatment of,bipolar depression,MENTAL_HEALTH
20878507,Paroxetine or bupropion adjunctive therapy to mood stabilizer(s) had a similar risk as placebo for treatment of TEM in real world patients with bipolar depression during continuation treatment.,bupropion adjunctive therapy,CHEMICAL,have similar risk as placebo for treatment of,bipolar depression,MENTAL_HEALTH
6522310,"Antidepressant medications, both TCAs and MAOIs, often help relieve the symptoms of depression that emerge when chronic use of cocaine is discontinued.",Antidepressant medications,CHEMICAL,relieve symptoms of,depression,MENTAL_HEALTH
6522310,"Antidepressant medications, both TCAs and MAOIs, often help relieve the symptoms of depression that emerge when chronic use of cocaine is discontinued.",TCAs,CHEMICAL,relieve symptoms of,depression,MENTAL_HEALTH
31057409,"It is hypothesized that G protein-biased kappa agonists can reduce pain and itch, but exhibit fewer side effects, such as anhedonia and psychosis, that have thus far limited the clinical development of unbiased kappa opioid agonists.",protein-biased kappa agonists,CHEBI,exhibit,anhedonia,MENTAL_HEALTH
31057409,"It is hypothesized that G protein-biased kappa agonists can reduce pain and itch, but exhibit fewer side effects, such as anhedonia and psychosis, that have thus far limited the clinical development of unbiased kappa opioid agonists.",protein-biased kappa agonists,CHEBI,exhibit,psychosis,MENTAL_HEALTH
31057409,"It is hypothesized that G protein-biased kappa agonists can reduce pain and itch, but exhibit fewer side effects, such as anhedonia and psychosis, that have thus far limited the clinical development of unbiased kappa opioid agonists.",protein-biased kappa agonists,CHEBI,reduce,itch,DISEASE
31057409,"It is hypothesized that G protein-biased kappa agonists can reduce pain and itch, but exhibit fewer side effects, such as anhedonia and psychosis, that have thus far limited the clinical development of unbiased kappa opioid agonists.",protein-biased kappa agonists,CHEBI,reduce,pain,DISEASE
12914747,"In dogs, induction of mammary GH production by progestin administration allows for treatment of GH deficiency.",progestin administration,CHEBI,allow in dogs for treatment of,GH deficiency,DISEASE
10793637,"The cell cycle of the lutein cells was measured by the flow cytometric quantification of DNA in single cells, using propidium iodide staining after ethanol fixation and RNAse treatment, and by the detection of the proliferating cell nuclear antigen (PCNA).",lutein cells,CHEBI,use propidium iodide staining after,fixation treatment,MENTAL_HEALTH
10793637,"The cell cycle of the lutein cells was measured by the flow cytometric quantification of DNA in single cells, using propidium iodide staining after ethanol fixation and RNAse treatment, and by the detection of the proliferating cell nuclear antigen (PCNA).",lutein cells,CHEBI,use propidium iodide staining after,ethanol fixation,CHEMICAL
10793637,"The cell cycle of the lutein cells was measured by the flow cytometric quantification of DNA in single cells, using propidium iodide staining after ethanol fixation and RNAse treatment, and by the detection of the proliferating cell nuclear antigen (PCNA).",lutein cells,CHEBI,use,propidium iodide staining,CHEMICAL
3180062,"The effect of the progestin agonist, R5020, and antagonist, RU 486, on PR localization was investigated with the PR-rich T47D human breast cancer cell line.",antagonist,CHEBI,be investigated with,PR-rich T47D human breast cancer cell line,DISEASE
3180062,"The effect of the progestin agonist, R5020, and antagonist, RU 486, on PR localization was investigated with the PR-rich T47D human breast cancer cell line.",progestin agonist,CHEBI,be investigated with,PR-rich T47D human breast cancer cell line,DISEASE
33559838,"The control group received 0.2 ml of PBS/BSA via intramuscular injection (IM), while envenomed animals received 0.75 µg of venom per g of body weight, also via IM.",envenomed animals,DISEASE,receive,venom,CHEBI
33559838,"In conclusion, M. surinamensis venom has a potent cardiotoxic activity eliciting arrhythmogenic effects and heart damage after only 2 h of envenomation.",M. surinamensis venom,CHEBI,have in conclusion potent cardiotoxic activity after,envenomation,DISEASE
33559838,"In conclusion, M. surinamensis venom has a potent cardiotoxic activity eliciting arrhythmogenic effects and heart damage after only 2 h of envenomation.",M. surinamensis venom,CHEBI,have in,conclusion potent cardiotoxic activity,DISEASE
8378412,Controlled double-blind phase-III clinical trials have shown that xantinol-nicotinate is an effective drug in the treatment of dementia.,xantinol-nicotinate,CHEMICAL,be effective drug in treatment of,dementia,MENTAL_HEALTH
8378412,Controlled double-blind phase-III clinical trials have shown that xantinol-nicotinate is an effective drug in the treatment of dementia.,xantinol-nicotinate,CHEMICAL,be,effective drug,CHEBI
2570495,The unexpected high recovery-rate is explained by the fact that all of the patients with additional depression showed a reduction also of the delusional symptomatology after a treatment with antidepressants.,additional depression,MENTAL_HEALTH,show reduction of delusional symptomatology after treatment with,antidepressants,CHEMICAL
2570495,The unexpected high recovery-rate is explained by the fact that all of the patients with additional depression showed a reduction also of the delusional symptomatology after a treatment with antidepressants.,additional depression,MENTAL_HEALTH,show reduction of,delusional symptomatology,DISEASE
20206278,"Polyamines, such as spermidine and spermine, have been reported to improve memory retention through the activation of N-methyl-d-aspartate receptors (NMDAr).",spermidine,CHEMICAL,improve memory retention through activation of,N-methyl-d-aspartate receptors,CHEMICAL
20206278,"Polyamines, such as spermidine and spermine, have been reported to improve memory retention through the activation of N-methyl-d-aspartate receptors (NMDAr).",spermidine,CHEMICAL,improve,memory retention,DISEASE
20206278,"Polyamines, such as spermidine and spermine, have been reported to improve memory retention through the activation of N-methyl-d-aspartate receptors (NMDAr).",spermine,CHEMICAL,improve memory retention through activation of,N-methyl-d-aspartate receptors,CHEMICAL
20206278,"Polyamines, such as spermidine and spermine, have been reported to improve memory retention through the activation of N-methyl-d-aspartate receptors (NMDAr).",spermine,CHEMICAL,improve,memory retention,DISEASE
6631352,"Two specific tricyclic antidepressants, imipramine and desipramine, have been shown to be effective therapeutic agents in treating panic disorder.",specific antidepressants,CHEMICAL,treat,panic disorder,MENTAL_HEALTH
6631352,"Two specific tricyclic antidepressants, imipramine and desipramine, have been shown to be effective therapeutic agents in treating panic disorder.",imipramine,CHEMICAL,treat,panic disorder,MENTAL_HEALTH
15050598,"(1)H MRSI was acquired at 1.5 T and 272 ms echo time in 11 children and adolescents with schizophrenia (aged 7-18 years; seven boys, four girls; all but two medicated) and 20 age-matched healthy controls (10 boys, 10 girls).",(1)H MRSI,CHEMICAL,be acquired at t and ms echo time in children and adolescents with,schizophrenia,MENTAL_HEALTH
15050598,"In schizophrenic patients relative to controls, Cr was 14.3% higher in superior anterior cingulate (mean of left and right hemispheres).",Cr,CHEMICAL,be higher in,schizophrenic patients relative,DISEASE
15050598,Elevated Cr suggests abnormal local cell-energy demand and elevated Cho is consistent with a prior proposal that patients with early age-of-onset schizophrenia exhibit phospholipid membrane disturbances.,Elevated Cr,CHEMICAL,suggest,abnormal local cell-energy demand,CHEMICAL
15050598,Elevated Cr suggests abnormal local cell-energy demand and elevated Cho is consistent with a prior proposal that patients with early age-of-onset schizophrenia exhibit phospholipid membrane disturbances.,Elevated Cr,CHEMICAL,suggest,elevated Cho,CHEMICAL
15050598,Elevated Cr suggests abnormal local cell-energy demand and elevated Cho is consistent with a prior proposal that patients with early age-of-onset schizophrenia exhibit phospholipid membrane disturbances.,early age-of-onset schizophrenia,MENTAL_HEALTH,exhibit,phospholipid membrane disturbances,NUTRITION
33343599,"Fragmentation of a selection of metabolites, which are significantly more upregulated in the Z-3-HAC + Fg treatment, showed D-glucose to be present as a substructure.",Fragmentation,MENTAL_HEALTH,show,D-glucose,CHEMICAL
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",Alcohol-related brain damage,DISEASE,be associated with neurotoxic effects of heavy alcohol use and nutritional deficiency in,particular thiamine deficiency,NUTRITION
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",Alcohol-related brain damage,DISEASE,be associated with neurotoxic effects of heavy alcohol use and nutritional deficiency in,TD,DISEASE
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",Alcohol-related brain damage,DISEASE,be associated with neurotoxic effects of,heavy alcohol use,CHEMICAL
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",Alcohol-related brain damage,DISEASE,be associated with neurotoxic effects of,nutritional deficiency,DISEASE
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",Alcohol-related brain damage,DISEASE,be associated with,neurotoxic effects,DISEASE
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",ARBD,MENTAL_HEALTH,be associated with neurotoxic effects of heavy alcohol use and nutritional deficiency in,particular thiamine deficiency,NUTRITION
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",ARBD,MENTAL_HEALTH,be associated with neurotoxic effects of heavy alcohol use and nutritional deficiency in,TD,DISEASE
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",ARBD,MENTAL_HEALTH,be associated with neurotoxic effects of,heavy alcohol use,CHEMICAL
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",ARBD,MENTAL_HEALTH,be associated with neurotoxic effects of,nutritional deficiency,DISEASE
30589435,"Alcohol-related brain damage (ARBD) is associated with neurotoxic effects of heavy alcohol use and nutritional deficiency, in particular thiamine deficiency (TD), both of which induce inflammatory responses in brain.",ARBD,MENTAL_HEALTH,be associated with,neurotoxic effects,DISEASE
35586548,Cisplatin increased the input resistance and AP frequency but reduced the temporal coding feature of 1-AP and ≥2-APs neurons.,Cisplatin,CHEMICAL,coding feature of,1-AP neurons,CHEMICAL
35586548,Cisplatin increased the input resistance and AP frequency but reduced the temporal coding feature of 1-AP and ≥2-APs neurons.,Cisplatin,CHEMICAL,coding feature of,≥2-APs,CHEMICAL
35586548,Cisplatin increased the input resistance and AP frequency but reduced the temporal coding feature of 1-AP and ≥2-APs neurons.,Cisplatin,CHEMICAL,increase,input resistance,MENTAL_HEALTH
35586548,Studies show a potential new cellular target for chemotherapy-induced peripheral neuropathy and implicate the possible neuroprotective effects of vitamin E in cisplatin chemotherapy.,vitamin E,CHEBI,have the possible neuroprotective effects in,cisplatin chemotherapy,CHEMICAL
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",canagliflozin,CHEMICAL,be avoided in patients with,NAFLD,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",canagliflozin,CHEMICAL,be avoided in patients with,concomitant osteoporosis,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",canagliflozin,CHEMICAL,be avoided in patients with,high fracture risk,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",others pioglitazone,CHEMICAL,be avoided in patients with,NAFLD,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",others pioglitazone,CHEMICAL,be avoided in patients with,concomitant osteoporosis,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",others pioglitazone,CHEMICAL,be avoided in patients with,high fracture risk,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",others pioglitazone,CHEMICAL,be associated with increased risk of,fractures,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",canagliflozin,CHEMICAL,be associated with increased risk of,fractures,DISEASE
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",NAFLD,DISEASE,show,semaglutide,CHEMICAL
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",NAFLD,DISEASE,show,vitamin E,CHEBI
35589613,"Some of the current and emerging pharmacological options for NAFLD have shown possible anti-osteoporotic properties (e.g., vitamin E, obeticholic acid, semaglutide), while others (e.g., pioglitazone, canagliflozin) have been associated with increased risk of fractures and may be avoided in patients with NAFLD and concomitant osteoporosis, especially those at high fracture risk.",NAFLD,DISEASE,show,obeticholic acid,CHEMICAL
35589613,"Vice versa, some anti-osteoporotic medications (denosumab) might benefit NAFLD, while others (raloxifene) might adversely affect it and, consequently, may be avoided in patients with osteoporosis and NAFLD.",denosumab,CHEMICAL,benefit,NAFLD,DISEASE
35589613,"Vice versa, some anti-osteoporotic medications (denosumab) might benefit NAFLD, while others (raloxifene) might adversely affect it and, consequently, may be avoided in patients with osteoporosis and NAFLD.",denosumab,CHEMICAL,be avoided in patients with,NAFLD,DISEASE
35589613,"Vice versa, some anti-osteoporotic medications (denosumab) might benefit NAFLD, while others (raloxifene) might adversely affect it and, consequently, may be avoided in patients with osteoporosis and NAFLD.",denosumab,CHEMICAL,be avoided in patients with,osteoporosis,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,HIV infections,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,neurodegenerative disorders,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,several pathological disorders,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,epilepsy,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,cancer,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,autoimmune disorders,DISEASE
35133568,"The imbalanced state of kynurenine pathways has found a close association to several pathological disorders, including HIV infections, cancer, autoimmune disorders, neurodegenerative and neurological disorders including Parkinson's disease, epilepsy and has found special attention in Alzheimer's disease (AD).",kynurenine pathways,CHEMICAL,find close association to,Parkinson's disease,DISEASE
35133568,"Kynurenine pathway (KP) is intricately linked to AD pathogenesis owing to the influence of kynurenine metabolites on excitotoxic neurotransmission, oxidative stress, uptake of neurotransmitters, and modulation of neuroinflammation, amyloid aggregation, microtubule disruption, and their ability to induce a state of dysbiosis.",Kynurenine pathway,CHEMICAL,owe to influence of,kynurenine metabolites,CHEMICAL
35415204,"Alzheimer's disease (AD) is characterized by neurotoxic immuno-inflammation concomitant with cytotoxic oligomerization of amyloid beta (Aβ) and tau, culminating in concurrent, interdependent immunopathic and proteopathic pathogeneses.",Alzheimer's disease,DISEASE,be characterized by neurotoxic immuno-inflammation concomitant with cytotoxic oligomerization of,amyloid beta,CHEBI
35415204,"Alzheimer's disease (AD) is characterized by neurotoxic immuno-inflammation concomitant with cytotoxic oligomerization of amyloid beta (Aβ) and tau, culminating in concurrent, interdependent immunopathic and proteopathic pathogeneses.",Alzheimer's disease,DISEASE,be characterized by,neurotoxic immuno-inflammation concomitant,DISEASE
14516527,"CRPS is also perpetuated by central mechanisms, with pathophysiologic targets (and possible treatments) including reorientation of dorsal horn terminals (desensitization techniques), functional reduction in inhibitory interneuron activity (tricyclic antidepressants, gabapentin, opioids), central sensitization and increased central excitability (gabapentin, topiramate, spinal cord stimulation, somatosensory blocks), impaired descending nociceptive inhibition (tricyclic antidepressants, opioids), and adaptive changes in the cortical centers underlying the sensory-discriminative and affective-motivational dimensions of pain (psychologic, physical, and occupational therapies).",CRPS,DISEASE,be perpetuated by central mechanisms with,topiramate,CHEMICAL
14516527,"CRPS is also perpetuated by central mechanisms, with pathophysiologic targets (and possible treatments) including reorientation of dorsal horn terminals (desensitization techniques), functional reduction in inhibitory interneuron activity (tricyclic antidepressants, gabapentin, opioids), central sensitization and increased central excitability (gabapentin, topiramate, spinal cord stimulation, somatosensory blocks), impaired descending nociceptive inhibition (tricyclic antidepressants, opioids), and adaptive changes in the cortical centers underlying the sensory-discriminative and affective-motivational dimensions of pain (psychologic, physical, and occupational therapies).",CRPS,DISEASE,be perpetuated by central mechanisms with,tricyclic antidepressants,CHEMICAL
14516527,"CRPS is also perpetuated by central mechanisms, with pathophysiologic targets (and possible treatments) including reorientation of dorsal horn terminals (desensitization techniques), functional reduction in inhibitory interneuron activity (tricyclic antidepressants, gabapentin, opioids), central sensitization and increased central excitability (gabapentin, topiramate, spinal cord stimulation, somatosensory blocks), impaired descending nociceptive inhibition (tricyclic antidepressants, opioids), and adaptive changes in the cortical centers underlying the sensory-discriminative and affective-motivational dimensions of pain (psychologic, physical, and occupational therapies).",CRPS,DISEASE,be perpetuated by central mechanisms with,gabapentin,CHEMICAL
2780070,"Ketanserin, a selective S2 serotonergic antagonist, was assessed against placebo in a double-blind cross-over study of 16 patients with chronic peripheral burning pain.",Ketanserin,CHEMICAL,be assessed against placebo in double-blind cross-over study of patients with,chronic peripheral burning pain,DISEASE
2780070,"Ketanserin, a selective S2 serotonergic antagonist, was assessed against placebo in a double-blind cross-over study of 16 patients with chronic peripheral burning pain.",selective S2 serotonergic antagonist,CHEBI,be assessed against placebo in double-blind cross-over study of patients with,chronic peripheral burning pain,DISEASE
2780070,"Following tourniquet release, drowsiness, shakiness and faintness were reported at a higher (P less than 0.05) frequency after ketanserin than after placebo.",drowsiness,MENTAL_HEALTH,be reported at,ketanserin,CHEMICAL
23874687,"While pioglitazone preserved the constitutive nitric oxide synthesis in the vessel wall, it unexpectedly failed to restore cerebrovascular reactivity in A/T mice and even exacerbated the dilatory deficits.",pioglitazone,CHEMICAL,preserve,constitutive nitric oxide synthesis,CHEMICAL
23874687,"They further suggest a potential benefit of pioglitazone in managing neuroinflammation, cerebral perfusion and glucose metabolism in AD patients devoid of cerebrovascular pathology.",pioglitazone,CHEMICAL,have a potential benefit in,neuroinflammation,DISEASE
22622016,Histamine H(1) receptor antagonists play a vital role in the first line treatment of a broad range of allergic diseases.,Histamine receptor antagonists,CHEBI,play vital role in first line treatment of broad range of,allergic diseases,DISEASE
22622016,Histamine H(1) receptor antagonists play a vital role in the first line treatment of a broad range of allergic diseases.,Histamine receptor antagonists,CHEMICAL,play vital role in first line treatment of broad range of,allergic diseases,DISEASE
22622016,Frequent dosing of the antagonist results in side effects like sedation and cardiovascular toxicity.,antagonist,CHEBI,result in side effects like,cardiovascular toxicity,DISEASE
19140523,"After the detection of osteolytic-osteosclerotic changes in the pelvic region, in areas with intense pain, we started treatment with pamidronate (90 mg at 28-day intervals), and the pain disappeared completely within 3 months of application of the drug.",pain,DISEASE,disappear within months of application of,drug,CHEBI
19140523,"When the bisphosphonate therapy was interrupted, the pain recurred and receded completely after renewal of bisphosphonate administration.",pain,DISEASE,recede after renewal of,bisphosphonate administration,CHEMICAL
18455739,MEM prevented both serotonergic injury induced by MDMA in rat and dopaminergic lesion by METH in mice.,MEM,CHEMICAL,prevent serotonergic injury dopaminergic lesion by,METH,CHEMICAL
18455739,"MEM has a better protective effect in front of MDMA- and METH-induced neurotoxicity than methyllycaconitine (MLA), a specific alpha-7 nAChR antagonist.",MEM,CHEMICAL,have better protective effect in front of,MDMA- neurotoxicity,DISEASE
18455739,"MEM has a better protective effect in front of MDMA- and METH-induced neurotoxicity than methyllycaconitine (MLA), a specific alpha-7 nAChR antagonist.",MEM,CHEMICAL,have better protective effect in front of,methyllycaconitine,CHEMICAL
18455739,"MEM has a better protective effect in front of MDMA- and METH-induced neurotoxicity than methyllycaconitine (MLA), a specific alpha-7 nAChR antagonist.",MEM,CHEMICAL,have better protective effect in front of,MDMA- neurotoxicity,CHEMICAL
18455739,"MEM has a better protective effect in front of MDMA- and METH-induced neurotoxicity than methyllycaconitine (MLA), a specific alpha-7 nAChR antagonist.",MEM,CHEMICAL,have better protective effect in front of,specific alpha-7 nAChR antagonist,CHEBI
18455739,MEM and METH also displace [(3)H]MLA with non-competitive displacement profiles that fit a two-site model.,METH,CHEMICAL,displace,non-competitive displacement profiles,MENTAL_HEALTH
18455739,MEM and METH also displace [(3)H]MLA with non-competitive displacement profiles that fit a two-site model.,MEM,CHEMICAL,displace,non-competitive displacement profiles,MENTAL_HEALTH
18455739,MEM may offer neuroprotection against neurotoxicity induced by MDMA and METH by preventing the deleterious effects of these amphetamine derivatives on their respective transporters.,MEM,CHEMICAL,prevent deleterious effects of,amphetamine derivatives,CHEMICAL
18455739,MEM may offer neuroprotection against neurotoxicity induced by MDMA and METH by preventing the deleterious effects of these amphetamine derivatives on their respective transporters.,MEM,CHEMICAL,offer neuroprotection against,neurotoxicity,DISEASE
18488496,Successive substitution of chlorine atoms for the protons of one aromatic ring in 7 and 5 positions leads to an increase in stacking-interaction energy and a mutual displacement of aromatic rings.,chlorine atoms,CHEMICAL,increase in,stacking-interaction energy,CHEMICAL
18488496,Successive substitution of chlorine atoms for the protons of one aromatic ring in 7 and 5 positions leads to an increase in stacking-interaction energy and a mutual displacement of aromatic rings.,chlorine atoms,CHEMICAL,increase in,mutual displacement,MENTAL_HEALTH
14557721,"N-Methyl-D-aspartate (NMDA) receptor antagonists and amphetamine are known to induce psychotic behaviors and cognitive deficits in animals and humans, often affecting visuo-spatial abilities.",N-Methyl-D-aspartate NMDA receptor antagonists,CHEBI,induce,cognitive deficits,DISEASE
14557721,"N-Methyl-D-aspartate (NMDA) receptor antagonists and amphetamine are known to induce psychotic behaviors and cognitive deficits in animals and humans, often affecting visuo-spatial abilities.",N-Methyl-D-aspartate NMDA receptor antagonists,CHEBI,induce,psychotic behaviors,DISEASE
14557721,"N-Methyl-D-aspartate (NMDA) receptor antagonists and amphetamine are known to induce psychotic behaviors and cognitive deficits in animals and humans, often affecting visuo-spatial abilities.",amphetamine,CHEMICAL,induce,cognitive deficits,DISEASE
14557721,"N-Methyl-D-aspartate (NMDA) receptor antagonists and amphetamine are known to induce psychotic behaviors and cognitive deficits in animals and humans, often affecting visuo-spatial abilities.",amphetamine,CHEMICAL,induce,psychotic behaviors,DISEASE
14557721,"Phencyclidine (PCP), MK-801 and amphetamine (AMPH) have been used in pharmacological animal models of schizophrenia, but none of these models has focused so far on spatial learning after repeated administration of the drugs.",MK-801,CHEMICAL,be used in pharmacological animal models of,schizophrenia,MENTAL_HEALTH
14557721,"Phencyclidine (PCP), MK-801 and amphetamine (AMPH) have been used in pharmacological animal models of schizophrenia, but none of these models has focused so far on spatial learning after repeated administration of the drugs.",PCP,DISEASE,be used in pharmacological animal models of,schizophrenia,MENTAL_HEALTH
14557721,"Phencyclidine (PCP), MK-801 and amphetamine (AMPH) have been used in pharmacological animal models of schizophrenia, but none of these models has focused so far on spatial learning after repeated administration of the drugs.",Phencyclidine,CHEMICAL,be used in pharmacological animal models of,schizophrenia,MENTAL_HEALTH
14557721,"Phencyclidine (PCP), MK-801 and amphetamine (AMPH) have been used in pharmacological animal models of schizophrenia, but none of these models has focused so far on spatial learning after repeated administration of the drugs.",amphetamine,CHEMICAL,be used in pharmacological animal models of,schizophrenia,MENTAL_HEALTH
33129902,"Moreover, the sub-population of TTR molecules undergoes fragmentation that is augmented by Ca2+.",TTR molecules,DISEASE,undergo,fragmentation,MENTAL_HEALTH
16558146,"Hyponatremia is a medical condition characterized by decreased concentration of sodium in the blood, which may occur in participants in endurance and ultraendurance athletic events.",Hyponatremia,DISEASE,characterized by decreased concentration of,sodium,CHEMICAL
31841749,Folate deficiency is shown to be associated with schizophrenia.,Folate deficiency,CHEBI,be associated with,schizophrenia,MENTAL_HEALTH
31841749,Folate profile in patients with psychosis due to stimulant use has not been investigated.,Folate profile,CHEBI,in patients with,psychosis due,MENTAL_HEALTH
31841749,We aim to determine whether there is an association between serum folate level and the presence of psychosis in patients with methamphetamine (METH) use disorder.,psychosis,MENTAL_HEALTH,in patients with,methamphetamine,CHEMICAL
35522327,Lithium is the mood stabilizer of choice for the prevention of bipolar relapse over the perinatal period.,Lithium,NUTRITION,be,mood stabilizer,CHEBI
34836015,Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women.,PCOS,DISEASE,be,common endocrine disorder,CHEBI
34836015,Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive-aged women.,Polycystic ovary syndrome,DISEASE,be,common endocrine disorder,CHEBI
24090486,"The adjusted regression model showed a higher prevalence ratio (PR) of CSR among pregnant women with generalized anxiety disorder (PR=2.70, 95% CI: 1.36-5.37), with ≥ two parturitions (PR=2.46, 95% CI: 1.22-4.93), and with major depressive disorder (PR=2.11, 95% CI: 1.08-4.12).",adjusted regression model,MENTAL_HEALTH,show,major depressive disorder,MENTAL_HEALTH
24090486,"The adjusted regression model showed a higher prevalence ratio (PR) of CSR among pregnant women with generalized anxiety disorder (PR=2.70, 95% CI: 1.36-5.37), with ≥ two parturitions (PR=2.46, 95% CI: 1.22-4.93), and with major depressive disorder (PR=2.11, 95% CI: 1.08-4.12).",adjusted regression model,MENTAL_HEALTH,show,≥ parturitions,CHEMICAL
24090486,"The adjusted regression model showed a higher prevalence ratio (PR) of CSR among pregnant women with generalized anxiety disorder (PR=2.70, 95% CI: 1.36-5.37), with ≥ two parturitions (PR=2.46, 95% CI: 1.22-4.93), and with major depressive disorder (PR=2.11, 95% CI: 1.08-4.12).",adjusted regression model,MENTAL_HEALTH,show,generalized anxiety disorder,MENTAL_HEALTH
30532541,We aimed to evaluate whether high-dose cholecalciferol has beneficial effects on depression in pulmonary tuberculosis (PTB) patients.,high-dose cholecalciferol,CHEBI,have beneficial effects on depression in,tuberculosis patients,DISEASE
30532541,We aimed to evaluate whether high-dose cholecalciferol has beneficial effects on depression in pulmonary tuberculosis (PTB) patients.,high-dose cholecalciferol,CHEBI,have beneficial effects on,depression,MENTAL_HEALTH
27022679,We aim to evaluate whether high-dose vitamin D3 (VD3) supplementation has beneficial effects on depressive symptoms in dialysis patients.,high-dose vitamin D3 supplementation,CHEBI,have beneficial effects on,depressive symptoms,DISEASE
20377970,"Subsequently, several specimens of E. carbunculus of different body weights were collected, and the level of vitamin A in the muscle and liver was determined by high-performance liquid chromatography.",vitamin A,CHEBI,have the level in,liver,DISEASE
32613785,Scombroid food poisoning is caused by eating fish with a high concentration of histamine.,Scombroid food poisoning,DISEASE,eat fish with high concentration of,histamine,CHEMICAL
28923570,Scombroid poisoning is a poorly known type of food poisoning due to the presence of histamine in spoiled fish of the Scombridae family.,Scombroid poisoning,DISEASE,be known type due of food poisoning presence of,histamine,CHEMICAL
28923570,Scombroid poisoning is a poorly known type of food poisoning due to the presence of histamine in spoiled fish of the Scombridae family.,Scombroid poisoning,DISEASE,be known type due of,poisoning presence,DISEASE
7195130,Thin-layer chromatographic examinations of blood lipids and phospholipids were carried out in 28 patients with delirium tremens (at the height of the psychosis) treated and not treated with hemodes.,phospholipids,NUTRITION,be carried in patients with delirium tremens at height of,psychosis,MENTAL_HEALTH
7195130,Thin-layer chromatographic examinations of blood lipids and phospholipids were carried out in 28 patients with delirium tremens (at the height of the psychosis) treated and not treated with hemodes.,phospholipids,NUTRITION,be carried in patients with,delirium tremens,MENTAL_HEALTH
30355118,"Results- Middle cerebral artery occlusion increased α2δ-1 protein glycosylation in the cerebral cortex, hippocampus, and striatum.",Middle cerebral artery occlusion,DISEASE,increase,α2δ-1 protein glycosylation,CHEMICAL
30355118,"Systemic treatment with gabapentin or α2δ-1 C-terminus-interfering peptide or Cacna2d1 genetic knock-out reduced middle cerebral artery occlusion-induced infarct volumes, neurological deficit scores, and calpain/caspase-3 activation in brain tissues.",gabapentin,CHEMICAL,reduce,middle occlusion-induced infarct volumes,DISEASE
30355118,"Systemic treatment with gabapentin or α2δ-1 C-terminus-interfering peptide or Cacna2d1 genetic knock-out reduced middle cerebral artery occlusion-induced infarct volumes, neurological deficit scores, and calpain/caspase-3 activation in brain tissues.",gabapentin,CHEMICAL,reduce,neurological deficit scores,DISEASE
30355118,"Conclusions- α2δ-1 is essential for brain ischemia-induced neuronal NMDAR hyperactivity, and α2δ-1-bound NMDARs mediate brain damage caused by cerebral ischemia.",Conclusions- α2δ-1,CHEMICAL,be essential for,ischemia-induced neuronal NMDAR hyperactivity,DISEASE
30355118,"Conclusions- α2δ-1 is essential for brain ischemia-induced neuronal NMDAR hyperactivity, and α2δ-1-bound NMDARs mediate brain damage caused by cerebral ischemia.",Conclusions- α2δ-1,CHEMICAL,be essential for,ischemia-induced neuronal NMDAR hyperactivity,MENTAL_HEALTH
30355118,"Conclusions- α2δ-1 is essential for brain ischemia-induced neuronal NMDAR hyperactivity, and α2δ-1-bound NMDARs mediate brain damage caused by cerebral ischemia.",α2δ-1-bound NMDARs,CHEMICAL,mediate,brain damage,DISEASE
29437929,"Accompanying working-memory impairment, ketamine enhanced the low-gamma-band (30-60 Hz) and dampened the beta-band (13-30 Hz) oscillatory activities in the LPFC during both delay periods and intertrial intervals.",ketamine,CHEMICAL,enhance accompanying,impairment low-gamma-band,DISEASE
29437929,"SIGNIFICANCE STATEMENT Low doses of ketamine, an NMDAR blocker, produce working memory deficits similar to those observed in schizophrenia.",ketamine,CHEMICAL,produce working,memory deficits similar,DISEASE
29437929,"Ketamine induced stronger gamma (30-60 Hz) and weaker beta (13-30 Hz) oscillations, reflecting local hyperactivity and reduced long-range communications.",Ketamine,CHEMICAL,induce,weaker beta,CHEBI
29437929,"Ketamine induced stronger gamma (30-60 Hz) and weaker beta (13-30 Hz) oscillations, reflecting local hyperactivity and reduced long-range communications.",Ketamine,CHEMICAL,reflect,local hyperactivity,MENTAL_HEALTH
29437929,The ketamine model helps link the molecular and cellular basis of neural oscillatory changes to the working memory deficit in schizophrenia.,ketamine model,CHEMICAL,link molecular and cellular basis of neural oscillatory changes to,schizophrenia,MENTAL_HEALTH
29437929,The ketamine model helps link the molecular and cellular basis of neural oscillatory changes to the working memory deficit in schizophrenia.,ketamine model,CHEMICAL,link molecular and cellular basis of neural oscillatory changes to,memory deficit,DISEASE
8588504,Administration of estrogen as well as prolactin to B. melanostictus resulted in hypercalcemia.,estrogen,CHEBI,result in,hypercalcemia,DISEASE
8588504,Histophysiological manifestation of the parathyroids of treated toads suggests that estrogen and prolactin bring about hypercalcemia by stimulating the parathyroids.,estrogen,CHEBI,bring,hypercalcemia,DISEASE
35163479,"The mood stabilizer lithium represents a cornerstone in the long term treatment of bipolar disorder (BD), although with substantial interindividual variability in clinical response.",mood stabilizer lithium,CHEBI,represent cornerstone in long term treatment of,bipolar disorder,MENTAL_HEALTH
35163479,"The mood stabilizer lithium represents a cornerstone in the long term treatment of bipolar disorder (BD), although with substantial interindividual variability in clinical response.",mood stabilizer lithium,NUTRITION,represent cornerstone in long term treatment of,bipolar disorder,MENTAL_HEALTH
26733500,"Before LNG-IUS insertion, the PCOS group had higher total testosterone levels (P = .04), lower HDL levels (P = .04), and greater ovarian volume (P < .01) than the control group.",PCOS group,DISEASE,have before,higher total testosterone levels,CHEMICAL
27933170,"Surgical debulking of the meningioma was performed and histology demonstrated a meningioma, which stained positive for the progesterone receptor.",meningioma,DISEASE,demonstrate,meningioma,DISEASE
27933170,Progesterone receptor positivity has been described previously in meningiomas.,Progesterone receptor positivity,CHEMICAL,be described in,meningiomas,DISEASE
9692665,The disulfiram-ethanol reaction is a well-known clinical phenomenon occurring as a result of acetaldehyde accumulation in the blood.,disulfiram-ethanol reaction,DISEASE,occurring as result of,acetaldehyde accumulation,CHEMICAL
31359611,Redox imbalance due to hyperglycemia is a causative factor for an increased generation of reactive oxygen species (ROS) that leads to mitochondrial dysfunction and the release of cytochrome-c.,hyperglycemia,DISEASE,be causative factor for increased generation of,reactive oxygen species,CHEMICAL
31359611,"Trolox pretreatment significantly enhanced the GLUT-4 mRNA and antioxidant defense mechanism, suppressed nuclear condensation, and prevented cytochrome-c release, thereby reducing mitochondrial-dependent apoptosis.",Trolox pretreatment,CHEMICAL,enhance,mRNA defense mechanism,MENTAL_HEALTH
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",vitamin D deficiency,CHEBI,be related to mortality in persons with moderate to,advanced chronic kidney disease,DISEASE
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",vitamin D deficiency,CHEBI,be related to mortality in persons with moderate to,CKD,DISEASE
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",traditional syndromes,MENTAL_HEALTH,be related to mortality in persons with moderate to,advanced chronic kidney disease,DISEASE
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",traditional syndromes,MENTAL_HEALTH,be related to mortality in persons with moderate to,CKD,DISEASE
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",secondary hyperparathyroidism,DISEASE,be related to mortality in persons with moderate to,advanced chronic kidney disease,DISEASE
20671739,"Recent evidence suggests that the traditional syndromes known as renal osteodystrophy, secondary hyperparathyroidism, and vitamin D deficiency are related to mortality in persons with moderate to advanced chronic kidney disease (CKD).",secondary hyperparathyroidism,DISEASE,be related to mortality in persons with moderate to,CKD,DISEASE
16778374,"Niemann-Pick disease type C (NPC) is an inherited lipid storage disorder, characterized by a defect in intracellular trafficking of exogenous cholesterol that leads to the lysosomal accumulation of unesterified cholesterol.",Niemann-Pick disease type C,DISEASE,characterized by defect in intracellular trafficking of,exogenous cholesterol,NUTRITION
31220988,Conclusion: The concomitant use of nicotine and areca indicates that betel quid addiction includes a significant component of nicotine dependence.,quid addiction,CHEMICAL,include significant component of,nicotine dependence,MENTAL_HEALTH
22746383,"We review the epidemiology, mechanisms of toxicity, toxicokinetics, clinical features, diagnosis, and management of poisoning due to GHB and its analogs and discuss the features and management of GHB withdrawal.",poisoning due,DISEASE,have and management to,GHB,CHEMICAL
35430059,These results suggest that the overexpression of CYP6DC1 and CYP380C47 contributed to the lambda-cyhalothrin resistance in the pest.,CYP6DC1,CHEMICAL,contribute to,lambda-cyhalothrin resistance,MENTAL_HEALTH
35430059,These results suggest that the overexpression of CYP6DC1 and CYP380C47 contributed to the lambda-cyhalothrin resistance in the pest.,CYP6DC1,CHEMICAL,contribute to,lambda-cyhalothrin resistance,CHEMICAL
34599919,"PTSD+ individuals also reported greater mental health service utilization, more severe psychiatric, medical and drug use consequences, and greater pain severity and interference vs. PTSD- individuals (ps < 0.05).",PTSD+ individuals,DISEASE,report,drug,CHEBI
34599919,"PTSD+ individuals also reported greater mental health service utilization, more severe psychiatric, medical and drug use consequences, and greater pain severity and interference vs. PTSD- individuals (ps < 0.05).",PTSD+ individuals,DISEASE,report,PTSD- individuals,DISEASE
34599919,"PTSD+ individuals also reported greater mental health service utilization, more severe psychiatric, medical and drug use consequences, and greater pain severity and interference vs. PTSD- individuals (ps < 0.05).",PTSD+ individuals,DISEASE,report,greater pain severity,DISEASE
34599919,"PTSD+ individuals also reported greater mental health service utilization, more severe psychiatric, medical and drug use consequences, and greater pain severity and interference vs. PTSD- individuals (ps < 0.05).",PTSD+ individuals,DISEASE,report,psychiatric use consequences,DISEASE
28758767,"OUD is commonly treated with opioid agonist therapies (OAT), which have been shown to be effective for reducing opiate use and related negative health consequences.",OUD,DISEASE,be treated with,opioid agonist therapies,CHEBI
35486527,Depression and suicidality are commonly experienced by Huntington disease (HD) gene carriers.,Depression,MENTAL_HEALTH,be experienced by,Huntington disease HD gene carriers,CHEBI
35486527,Depression and suicidality are commonly experienced by Huntington disease (HD) gene carriers.,Depression,MENTAL_HEALTH,be experienced by,Huntington disease HD gene carriers,DISEASE
35550793,"Thus, in this paper, we investigated the role of neural oscillations toward visuoperceptual deficits to elucidate the neurobiology of sensory impairments in deletion carriers.",sensory impairments,DISEASE,have the neurobiology in,deletion carriers,CHEBI
19400702,"Alcohol craving, addiction, and withdrawal symptoms are affected by serotonin concentrations in the brain, and alleviation of these conditions can be achieved with simultaneous administration of serotonin and dopamine agonists.",Alcohol craving,MENTAL_HEALTH,be affected by,serotonin concentrations,CHEMICAL
19400702,"Alcohol craving, addiction, and withdrawal symptoms are affected by serotonin concentrations in the brain, and alleviation of these conditions can be achieved with simultaneous administration of serotonin and dopamine agonists.",Alcohol craving,CHEMICAL,be affected by,serotonin concentrations,CHEMICAL
21742023,Galphimine-B (G-B) is a nor-seco triterpene with an anxiolytic-like effect obtained from the plant species Galphimia glauca Cav.,Galphimine-B,CHEMICAL,be,nor-seco triterpene,CHEMICAL
21742023,Galphimine-B (G-B) is a nor-seco triterpene with an anxiolytic-like effect obtained from the plant species Galphimia glauca Cav.,G-B,DISEASE,be,nor-seco triterpene,CHEMICAL
33356487,"Forty adults on SSRIs who were diagnosed with OCD participated in a randomized controlled trial in Iran of 12 individual weekly sessions of either ACT+SSRI, ERP+SSRI, or continued SSRI only.",SSRIs,CHEMICAL,participate in randomized controlled trial in iran of individual weekly sessions of,ERP+SSRI,CHEMICAL
33356487,"Forty adults on SSRIs who were diagnosed with OCD participated in a randomized controlled trial in Iran of 12 individual weekly sessions of either ACT+SSRI, ERP+SSRI, or continued SSRI only.",SSRIs,CHEMICAL,participate in randomized controlled trial in iran of individual weekly sessions of,ACT+SSRI,CHEMICAL
33356487,"Forty adults on SSRIs who were diagnosed with OCD participated in a randomized controlled trial in Iran of 12 individual weekly sessions of either ACT+SSRI, ERP+SSRI, or continued SSRI only.",OCD,DISEASE,participate in randomized controlled trial in iran of individual weekly sessions of,ERP+SSRI,CHEMICAL
33356487,"Forty adults on SSRIs who were diagnosed with OCD participated in a randomized controlled trial in Iran of 12 individual weekly sessions of either ACT+SSRI, ERP+SSRI, or continued SSRI only.",OCD,DISEASE,participate in randomized controlled trial in iran of individual weekly sessions of,ACT+SSRI,CHEMICAL
33356487,The results showed significant reductions in OCD symptom severity in ACT+SSRI and ERP+SSRI conditions at posttreatment with significantly greater reductions in both conditions compared to SSRI-only at follow-up.,OCD symptom severity,DISEASE,have significant reductions in,ACT+SSRI conditions,CHEMICAL
35325671,"Existing US treatment guidelines (APA guidelines) suggest that there are three first-line treatments for OCD (SSRI, CBT, SSRI+CBT) and recommends combined treatment for patients with an unsatisfactory response to monotherapy or for patients with severe OCD.",first-line treatments,CHEMICAL,recommend combined treatment for patients with unsatisfactory response to monotherapy or for,severe OCD,DISEASE
35325671,"Existing US treatment guidelines (APA guidelines) suggest that there are three first-line treatments for OCD (SSRI, CBT, SSRI+CBT) and recommends combined treatment for patients with an unsatisfactory response to monotherapy or for patients with severe OCD.",OCD SSRI,DISEASE,recommend combined treatment for patients with unsatisfactory response to monotherapy or for,severe OCD,DISEASE
35325671,"Existing US treatment guidelines (APA guidelines) suggest that there are three first-line treatments for OCD (SSRI, CBT, SSRI+CBT) and recommends combined treatment for patients with an unsatisfactory response to monotherapy or for patients with severe OCD.",OCD SSRI,CHEBI,recommend combined treatment for patients with unsatisfactory response to monotherapy or for,severe OCD,DISEASE
228416,The responsibility of the folate deficiency in some neuropsychiatric disorders is recent knowledge.,folate deficiency,NUTRITION,have the responsibility in,neuropsychiatric disorders,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,pyramidal tract damage,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,organic psychosis,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,spinal cord syndrome,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,pueperal psychosis,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,endogenous depression,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,irritability,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,peripheral neuropathy,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,myelopathy,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,syndromes,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,forgetfulness,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,schizophrenia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,numerous dementia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,insomnia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",folate deficiency,CHEBI,be,restless legs syndrome,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,pyramidal tract damage,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,organic psychosis,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,spinal cord syndrome,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,pueperal psychosis,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,endogenous depression,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,irritability,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,peripheral neuropathy,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,myelopathy,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,syndromes,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,forgetfulness,DISEASE
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,schizophrenia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,numerous dementia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,insomnia,MENTAL_HEALTH
228416,"The neuropsychiatric diseases secondary to the folate deficiency are numerous: dementia, schizophrenia like syndromes, insomnia, irritability, forgetfulness, endogenous depression, organic psychosis, pueperal psychosis, peripheral neuropathy, myelopathy (spinal cord syndrome and/or pyramidal tract damage), restless legs syndrome.",neuropsychiatric diseases secondary,DISEASE,be,restless legs syndrome,DISEASE
228416,The congenital defects in the uptake or utilization of the folate are associated with neuropsychiatric disturbances.,folate,CHEBI,be associated with,neuropsychiatric disturbances,DISEASE
228416,The congenital defects in the uptake or utilization of the folate are associated with neuropsychiatric disturbances.,congenital defects,DISEASE,be associated with,neuropsychiatric disturbances,DISEASE
228416,The treatment is easy and safe if the vitamin B12 deficiency is eliminated and if employed with caution in epileptic patients because folate can induced seizures.,vitamin B12 deficiency,CHEBI,employ with caution in,epileptic patients,DISEASE
228416,The treatment is easy and safe if the vitamin B12 deficiency is eliminated and if employed with caution in epileptic patients because folate can induced seizures.,folate,CHEBI,induce,seizures,DISEASE
34345548,"Fahr's syndrome is a rare condition characterized by deposition of bilateral symmetric calcium deposits in the basal ganglia and cerebellar region, leading to neurological and psychiatric sequelae.",Fahr's syndrome,DISEASE,lead to,neurological sequelae,DISEASE
34345548,"Fahr's syndrome is a rare condition characterized by deposition of bilateral symmetric calcium deposits in the basal ganglia and cerebellar region, leading to neurological and psychiatric sequelae.",Fahr's syndrome,DISEASE,characterized by deposition of,bilateral symmetric calcium deposits,CHEMICAL
33393403,"Intravenous thrombolysis (IVT) for acute brain infarctions caused by aortic dissection (AD) may lead to fatal outcomes; thus, it should be ruled out, especially if hypofibrinogenemia occurs after IVT.",hypofibrinogenemia,DISEASE,occur after,IVT,CHEMICAL
29492362,"Two patients had a robust response to clozapine, two had a moderate response, and treatment was discontinued for one patient due to a side effect of eosinophilia with clozapine, with an eosinophil count increased to 40,000/mm3 (40%).",eosinophilia,DISEASE,have a side effect with,clozapine,CHEMICAL
29492362,"Clozapine has been established to be more beneficial than conventional antipsychotics in patients with treatment-resistant schizophrenia and apparently more useful, based on existing evidence, in managing the negative symptoms of schizophrenia.",Clozapine,CHEMICAL,manage negative symptoms of,schizophrenia,MENTAL_HEALTH
29492362,"Clozapine has been established to be more beneficial than conventional antipsychotics in patients with treatment-resistant schizophrenia and apparently more useful, based on existing evidence, in managing the negative symptoms of schizophrenia.",Clozapine,CHEMICAL,be established to,treatment-resistant schizophrenia,DISEASE
29492362,"Clozapine has been established to be more beneficial than conventional antipsychotics in patients with treatment-resistant schizophrenia and apparently more useful, based on existing evidence, in managing the negative symptoms of schizophrenia.",Clozapine,CHEMICAL,be established to,treatment-resistant schizophrenia,MENTAL_HEALTH
29492362,Five treatment-refractory schizophrenic patients were given a trial of clozapine for 24 weeks and observed.,treatment-refractory schizophrenic patients,DISEASE,be given trial of,clozapine,CHEMICAL
24968782,"The role of dopamine, for example, by using the dopamine stabilizer (-)-OSU6162, in alcohol dependence will be revised.",dopamine,CHEMICAL,use,dopamine stabilizer,CHEBI
24968782,"The role of dopamine, for example, by using the dopamine stabilizer (-)-OSU6162, in alcohol dependence will be revised.",dopamine,CHEMICAL,use,dopamine stabilizer,CHEMICAL
24968782,"The role of dopamine, for example, by using the dopamine stabilizer (-)-OSU6162, in alcohol dependence will be revised.",dopamine,CHEMICAL,be revised in,alcohol dependence,MENTAL_HEALTH
32572355,"Zinc plays a critical role in modulating resistance to infectious agents and reduces the duration, severity, and risk of diarrheal disease via improved regeneration of intestinal epithelium, improved absorption of water and electrolytes, increased levels of brush border enzymes, and, possibly, an enhancement in the immune response allowing better clearance of pathogens.",Zinc,CHEMICAL,modulate resistance to,infectious agents,DISEASE
32572355,"Zinc plays a critical role in modulating resistance to infectious agents and reduces the duration, severity, and risk of diarrheal disease via improved regeneration of intestinal epithelium, improved absorption of water and electrolytes, increased levels of brush border enzymes, and, possibly, an enhancement in the immune response allowing better clearance of pathogens.",Zinc,CHEMICAL,modulate,resistance,MENTAL_HEALTH
32572355,"The objective of this study is a critical review of the molecular and genetic regulation of zinc in various cellular processes and organs, the association between zinc and diarrheal disease, the recommended dietary zinc intake, and the effects of zinc deficiency on the human body.",zinc,CHEMICAL,have the association with,diarrheal disease,DISEASE
32572355,"The objective of this study is a critical review of the molecular and genetic regulation of zinc in various cellular processes and organs, the association between zinc and diarrheal disease, the recommended dietary zinc intake, and the effects of zinc deficiency on the human body.",diarrheal disease,DISEASE,have the association with,zinc,CHEMICAL
28131725,Levodopa-induced dyskinesia (LID) is a disabling motor complication occurring in Parkinson's disease patients (PD) after long-term l-DOPA treatment.,Levodopa-induced dyskinesia,MENTAL_HEALTH,occurring in parkinson's,long-term l-DOPA treatment,CHEMICAL
28131725,Levodopa-induced dyskinesia (LID) is a disabling motor complication occurring in Parkinson's disease patients (PD) after long-term l-DOPA treatment.,LID,DISEASE,occurring in parkinson's,long-term l-DOPA treatment,CHEMICAL
28131725,"Although its etiology remains unclear, there is accumulating evidence that LID relies on an excessive dopamine receptor transmission, particularly at the downstream signaling of D1 receptors.",LID,DISEASE,rely on,excessive dopamine receptor transmission,CHEMICAL
28131725,"Thus, the present study was designed to verify whether the 5AR inhibitor finasteride (FIN) may counteract the dyskinesias induced by dopaminergic agonists in 6-hydroxydopamine (6-OHDA)-lesioned rats.",5AR inhibitor finasteride,CHEMICAL,counteract,dyskinesias,DISEASE
28131725,"The antidyskinetic effect appears to be due to modulation of both D1- and D2/D3-receptor function, as FIN also reduced abnormal involuntary movements induced by the selective D1 receptor agonist SKF-82958 and the D2/D3 receptor agonist ropinirole.",antidyskinetic effect,DISEASE,due to modulation of,D1- function,CHEMICAL
33201007,To examine the effectiveness of low-dose lithium carbonate for managing carbamazepine-induced hyponatremia.,low-dose lithium carbonate,NUTRITION,have the effectiveness for,carbamazepine-induced hyponatremia,DISEASE
34837736,"First identified in black abalone in California after an El Niño event, withering syndrome (WS) has caused large declines in wild black and captive white abalone on the northeastern Pacific coast, but disease resistance levels are species-, and possibly population-specific.",black abalone,NUTRITION,cause large declines in,black white abalone,NUTRITION
31031938,"By 1993, after years of heavy fishing, rising sea surface temperatures (SST), and the spread of withering syndrome (WS), black abalone populations declined dramatically, resulting in the closure of the Alta California fishery.",black abalone populations,NUTRITION,decline by,WS,DISEASE
24132786,"Verapamil, steroids and lithium are used for preventive treatment of cluster headache.",steroids,CHEMICAL,be used for preventive treatment of,cluster headache,MENTAL_HEALTH
24132786,"Verapamil, steroids and lithium are used for preventive treatment of cluster headache.",Verapamil,CHEMICAL,be used for preventive treatment of,cluster headache,MENTAL_HEALTH
24132786,"Hypnic headache patients respond to nightly caffeine, indomethacin, and lithium.",Hypnic headache patients,MENTAL_HEALTH,respond to,lithium,NUTRITION
24132786,"Hypnic headache patients respond to nightly caffeine, indomethacin, and lithium.",Hypnic headache patients,MENTAL_HEALTH,respond to,indomethacin,CHEMICAL
24132786,"Hypnic headache patients respond to nightly caffeine, indomethacin, and lithium.",Hypnic headache patients,MENTAL_HEALTH,respond to,nightly caffeine,CHEMICAL
24132786,Paroxysmal hemicrania responds very well to indomethacin.,Paroxysmal hemicrania,DISEASE,respond to,indomethacin,CHEMICAL
23450267,"The antiproliferative, prodifferentiative, antibacterial, immunomodulatory and anti-inflammatory properties of synthetic VDR agonists could be exploited to treat a variety of chronic inflammatory and autoimmune diseases, including benign prostatic hyperplasia (BPH).",synthetic VDR agonists,CHEBI,treat variety of,diseases,DISEASE
11589921,"This paper has reviewed the documentation on the clinical efficacy of choline alphoscerate, a cholinergic precursor, considered as a centrally acting parasympathomimetic drug in dementia disorders and in acute cerebrovascular disease.",dementia disorders,MENTAL_HEALTH,have acting parasympathomimetic drug in,acute cerebrovascular disease,DISEASE
11589921,"The therapeutic usefulness of choline alphoscerate in relieving cognitive symptoms of chronic cerebral deterioration differentiates this drug from cholinergic precursors used in the past, such as choline and lecithin.",choline alphoscerate,NUTRITION,differentiate drug from,lecithin,CHEBI
11589921,"The therapeutic usefulness of choline alphoscerate in relieving cognitive symptoms of chronic cerebral deterioration differentiates this drug from cholinergic precursors used in the past, such as choline and lecithin.",choline alphoscerate,NUTRITION,differentiate drug from,choline,NUTRITION
11589921,"The therapeutic usefulness of choline alphoscerate in relieving cognitive symptoms of chronic cerebral deterioration differentiates this drug from cholinergic precursors used in the past, such as choline and lecithin.",choline alphoscerate,NUTRITION,differentiate,drug,CHEBI
11589921,"The therapeutic usefulness of choline alphoscerate in relieving cognitive symptoms of chronic cerebral deterioration differentiates this drug from cholinergic precursors used in the past, such as choline and lecithin.",choline alphoscerate,NUTRITION,have the therapeutic usefulness in,cognitive symptoms,DISEASE
11589921,The results of these trials suggest that this drug might favour functional recovery of patients with cerebral stroke and should be confirmed in future investigations aimed at establish the efficacy of the drug in achieving functional recovery of patients with acute cerebrovascular disease.,drug,CHEBI,favour functional recovery of patients with,cerebral stroke,DISEASE
11694624,"Soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean lecithin and L-serine by a transphosphatidylation reaction, and its effect on age-related memory impairment was evaluated in rats by the Morris water maze test.",SB-tPS,CHEMICAL,be prepared from,L-serine,CHEMICAL
11694624,"Soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean lecithin and L-serine by a transphosphatidylation reaction, and its effect on age-related memory impairment was evaluated in rats by the Morris water maze test.",SB-tPS,CHEMICAL,be prepared from,soybean lecithin,NUTRITION
11694624,"Soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean lecithin and L-serine by a transphosphatidylation reaction, and its effect on age-related memory impairment was evaluated in rats by the Morris water maze test.",Soybean lecithin transphosphatidylated phosphatidylserine,NUTRITION,be prepared from,L-serine,CHEMICAL
11694624,"Soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) was prepared from soybean lecithin and L-serine by a transphosphatidylation reaction, and its effect on age-related memory impairment was evaluated in rats by the Morris water maze test.",Soybean lecithin transphosphatidylated phosphatidylserine,NUTRITION,be prepared from,soybean lecithin,NUTRITION
11694624,"Continuous oral administration of SB-tPS (60 mg x kg(-1) x d(-1) for 60 d) to male aged rats (24-25 mo) significantly improved performance in the water maze escape test (P < 0.01 vs. control aged rats) similar to bovine brain cortex-derived phosphatidylserine, which restores cognitive function in patients with senile dementia.",SB-tPS,CHEMICAL,improve performance in,bovine brain cortex-derived phosphatidylserine,NUTRITION
34227869,"In addition, EpoB-loaded PLGA nanoparticles (ENPs) prepared by nanoprecipitation technique and coated with poly-L-lysine (PLL-ENPs) were administered one-time for sustained intracellular delivery of EpoB. Results: Exposure to hypothermia led to microtubule disassembly concomitant with the destruction of PAMR and the displacement of ZO-1 at the cellular periphery, suggesting a loss in barrier integrity.",hypothermia,DISEASE,lead to microtubule disassembly concomitant with destruction of,displacement,MENTAL_HEALTH
21647386,Taxol is a microtubule stabilizing agent that arrests cells in mitosis leading to cell death.,Taxol,CHEMICAL,be,microtubule stabilizing agent,CHEBI
21647386,"Taxol is widely used to treat breast cancer, but resistance occurs in 25-69% of patients and it is vital to understand how Taxol resistance develops to improve chemotherapy.",Taxol,CHEMICAL,treat,breast cancer,DISEASE
21647386,"We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate.",autotaxin,CHEMICAL,convert,lysophosphatidate,CHEMICAL
21647386,"We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate.",autotaxin,CHEMICAL,convert,lysophosphatidylcholine,CHEMICAL
21647386,"We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate.",autotaxin,CHEMICAL,antagonize taxol-induced killing of,melanoma cells,DISEASE
21647386,"We discovered that autotaxin strongly antagonizes the Taxol-induced killing of breast cancer and melanoma cells by converting the abundant extra-cellular lipid, lysophosphatidylcholine, into lysophosphatidate.",autotaxin,CHEMICAL,antagonize taxol-induced killing of,breast cancer,DISEASE
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",SSRI antidepressants,CHEBI,be suggested,antidepressants,CHEMICAL
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",SSRI antidepressants,CHEBI,be suggested,depressive symptoms,DISEASE
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",SSRI antidepressants,CHEBI,be suggested,schizophrenic patients,DISEASE
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",SSRI antidepressants,CHEBI,be suggested,negative symptoms,DISEASE
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",SSRI antidepressants,CHEBI,be suggested,schizophrenic disorders,DISEASE
12386545,"Because of the similarities between negative and depressive symptoms in schizophrenic patients and the success of antidepressants in the treatment of depressive symptoms in schizophrenic disorders, the augmentation of antipsychotics by SSRI antidepressants has repeatedly been suggested as a promising strategy in schizophrenic patients with negative symptoms.",depressive symptoms,DISEASE,have the treatment in,schizophrenic disorders,DISEASE
12386545,"Neither placebo-controlled studies nor open trials have revealed additional efficacy of antipsychotic/SSRI combination on the positive symptoms or depressive symptoms in comparison with antipsychotic treatment alone, but the patients in the reviewed studies had been generally selected for their prominent negative symptoms, their neuroleptic resistance or their chronicity.",antipsychotic/SSRI combination,CHEMICAL,have additional efficacy on,depressive symptoms,DISEASE
32890773,"Because alcohol induces brain defects, many studies have focused on nervous cells.",alcohol,CHEMICAL,induce,brain defects,DISEASE
32890773,"However, recent reports have shown that alcohol markedly affects cortical angiogenesis in both animal models and infants with fetal alcohol spectrum disorder (FASD).",alcohol,CHEMICAL,affect cortical angiogenesis in animal models and infants with,fetal alcohol spectrum disorder,MENTAL_HEALTH
32890773,This alcohol-induced vascular dysfunction was associated with strong overexpression of the N-methyl-d-aspartate receptor subunit GluN1 and mispositioning of the Gad67-GFP interneurons that normally populate the superficial cortical layers.,alcohol-induced vascular dysfunction,DISEASE,be associated with strong overexpression of,N-methyl-d-aspartate receptor subunit,CHEMICAL
1144482,"The antiparkinsonian drug amantadine HCl caused a dose-dependent depression of electrical self-stimulation, followed by a dose-dependent enhancement.",antiparkinsonian drug amantadine HCl,CHEMICAL,cause,dose-dependent depression,MENTAL_HEALTH
1144482,"The antiparkinsonian drug amantadine HCl caused a dose-dependent depression of electrical self-stimulation, followed by a dose-dependent enhancement.",antiparkinsonian drug amantadine HCl,CHEBI,cause,dose-dependent depression,MENTAL_HEALTH
1144482,"It is concluded that the initial effect of amantadien is caused by impulse-independent release of a pool of intraneuronal CA, causing dissociation between reinforcement signals and the rat's responses.",amantadien,CHEMICAL,cause,dissociation,MENTAL_HEALTH
35334964,"Obesity is a chronic and complex disease associated with metabolic, organ and endocrine complications.",Obesity,DISEASE,associated with,endocrine,CHEBI
35492737,"Vitamin D prevents hypocalcaemia, osteoporosis, and infections, among other problems, and is involved in the prevention and treatment of cardiovascular and neurological diseases.",Vitamin D,CHEBI,be involved in prevention and treatment of,cardiovascular diseases,DISEASE
35492737,"Vitamin D prevents hypocalcaemia, osteoporosis, and infections, among other problems, and is involved in the prevention and treatment of cardiovascular and neurological diseases.",Vitamin D,CHEBI,prevent,hypocalcaemia,DISEASE
35492737,"Vitamin D prevents hypocalcaemia, osteoporosis, and infections, among other problems, and is involved in the prevention and treatment of cardiovascular and neurological diseases.",Vitamin D,CHEBI,prevent,infections,DISEASE
35492737,"Vitamin D prevents hypocalcaemia, osteoporosis, and infections, among other problems, and is involved in the prevention and treatment of cardiovascular and neurological diseases.",Vitamin D,CHEBI,prevent,osteoporosis,DISEASE
35492737,"Recently, vitamin D was shown to improve cognitive dysfunction caused by Alzheimer's disease and vascular dementia.",vitamin D,CHEBI,improve,cognitive dysfunction,DISEASE
35492737,This study aims to explore the correlation between preoperative serum vitamin D and postoperative cognitive disorder (POCD) occurrence in elderly patients with gastrointestinal tumors to guide perioperative medication use and promote early patient recovery.,preoperative serum vitamin D,CHEBI,have the correlation with,postoperative cognitive disorder,MENTAL_HEALTH
35492737,This study aims to explore the correlation between preoperative serum vitamin D and postoperative cognitive disorder (POCD) occurrence in elderly patients with gastrointestinal tumors to guide perioperative medication use and promote early patient recovery.,postoperative cognitive disorder,MENTAL_HEALTH,have the correlation with,preoperative serum vitamin D,CHEBI
31834530,"We conclude that nitrous oxide abuse can cause acute cognitive impairment, and that this diagnosis should be considered if a patient initially presents with acute cognitive decline.",nitrous oxide abuse,CHEMICAL,cause,cognitive impairment,DISEASE
12703660,"A multiple regression analysis revealed a significant correlation of the mercury level with age, sex, amount of daily fish consumption, tuna and bonito as usually consumed fish, artificial waving and Chiba as a residential area.",multiple regression analysis,MENTAL_HEALTH,reveal significant correlation of,mercury level,NUTRITION
8065845,Substance abuse in patients was an independent inverse determinant of TC value (p = 0.05); TG value correlated positively with alcohol use (p < or = 0.1) and substance abuse (p < 0.05).,TG value,DISEASE,correlate with,substance abuse,MENTAL_HEALTH
8065845,Substance abuse in patients was an independent inverse determinant of TC value (p = 0.05); TG value correlated positively with alcohol use (p < or = 0.1) and substance abuse (p < 0.05).,TG value,DISEASE,correlate with,alcohol use,CHEMICAL
30805948,The occurrence of osteoarthritis (OA) of the temporomandibular joint (TMJ) in juveniles could be associated with fluctuating levels of oestrogen and growth hormone (GH) during adolescence.,temporomandibular joint,DISEASE,be associated with fluctuating levels of,oestrogen,CHEBI
30805948,The occurrence of osteoarthritis (OA) of the temporomandibular joint (TMJ) in juveniles could be associated with fluctuating levels of oestrogen and growth hormone (GH) during adolescence.,temporomandibular joint,DISEASE,be associated with fluctuating levels of,growth hormone,CHEBI
2840888,"In these experiments the serotonergic antagonist metergoline was observed to attenuate both the analgesia induced by the opiate agonist morphine and the analgesia induced by isolation from siblings and the dam, an environmental manipulation which has previously been shown to be associated with increases in opiate activity.",serotonergic antagonist metergoline,CHEMICAL,attenuate,analgesia,MENTAL_HEALTH
2840888,"In these experiments the serotonergic antagonist metergoline was observed to attenuate both the analgesia induced by the opiate agonist morphine and the analgesia induced by isolation from siblings and the dam, an environmental manipulation which has previously been shown to be associated with increases in opiate activity.",serotonergic antagonist metergoline,CHEBI,attenuate,analgesia,MENTAL_HEALTH
6873180,Acute injection of THIP potentiates the morphine analgesia and chronic administration of THIP produces a functional tolerance to its analgesic effects.,THIP,CHEMICAL,produce functional tolerance to,analgesic effects,CHEBI
6873180,Acute injection of THIP potentiates the morphine analgesia and chronic administration of THIP produces a functional tolerance to its analgesic effects.,THIP,CHEMICAL,potentiate morphine analgesia and chronic administration of,THIP,CHEMICAL
6873180,Acute injection of THIP potentiates the morphine analgesia and chronic administration of THIP produces a functional tolerance to its analgesic effects.,THIP,CHEMICAL,potentiate,morphine analgesia,MENTAL_HEALTH
6873180,Acute injection of THIP potentiates the morphine analgesia and chronic administration of THIP produces a functional tolerance to its analgesic effects.,THIP,CHEMICAL,potentiate,morphine analgesia,CHEMICAL
6873180,MK 212 antagonizes the analgesia induced by either morphine or THIP.,MK,CHEMICAL,antagonize,analgesia,MENTAL_HEALTH
27856303,"Tibetan turnip (Brassica rapa L.), widely distributed in Tibet region, is an edible and medical plant with effects of ""tonic and anti-hypoxia"" ""heat-clearing and detoxification"" and ""alleviating fatigue"" according to traditional Tibetan medical books.",rapa L.,CHEMICAL,be edible plant with effects of,alleviating fatigue,MENTAL_HEALTH
26818863,"In this disease, acetylcholine shows hypoactivity, noradrenaline first shows hyperactivity, and during the course of the disease an increasing hypoactivity, glutamate shows hyperactivity and excitotoxicity and GABA shows hypoactivity.",glutamate,CHEMICAL,show during course of,GABA,CHEMICAL
26818863,"In this disease, acetylcholine shows hypoactivity, noradrenaline first shows hyperactivity, and during the course of the disease an increasing hypoactivity, glutamate shows hyperactivity and excitotoxicity and GABA shows hypoactivity.",glutamate,CHEMICAL,show during course of,hypoactivity hyperactivity,MENTAL_HEALTH
26818863,"In this disease, acetylcholine shows hypoactivity, noradrenaline first shows hyperactivity, and during the course of the disease an increasing hypoactivity, glutamate shows hyperactivity and excitotoxicity and GABA shows hypoactivity.",noradrenaline,CHEMICAL,show,hyperactivity,MENTAL_HEALTH
15517116,The perception of pruritus is modified by endogenous and exogenous opioids via central opiate receptors and can be suppressed with opioid receptor antagonists.,pruritus,DISEASE,be suppressed with,opioid receptor antagonists,CHEBI
3157881,The opiate antagonist naloxone was suggested for the amelioration of cerebral ischemia after subarachnoid hemorrhage (SAH) following the 1981 report of clinical improvement of ischemic deficits in 2 patients.,opiate antagonist naloxone,CHEMICAL,following report of clinical improvement of,ischemic deficits,DISEASE
3157881,The opiate antagonist naloxone was suggested for the amelioration of cerebral ischemia after subarachnoid hemorrhage (SAH) following the 1981 report of clinical improvement of ischemic deficits in 2 patients.,opiate antagonist naloxone,CHEBI,following report of clinical improvement of,ischemic deficits,DISEASE
11544338,"Curcumin, in addition to its role as a spice, has been used for centuries to treat inflammatory disorders.",spice,CHEMICAL,treat,inflammatory disorders,DISEASE
11544338,"Curcumin, in addition to its role as a spice, has been used for centuries to treat inflammatory disorders.",Curcumin,CHEMICAL,treat,inflammatory disorders,DISEASE
11544338,The results showed that curcumin levels > or =30 microM profoundly inhibited isopentenyl pyrophosphate-induced release of the chemokines macrophage inflammatory protein-1alpha and -1beta and RANTES.,curcumin levels,CHEMICAL,inhibit pyrophosphate-induced release of,macrophage inflammatory protein-1alpha,CHEMICAL
34337892,"In conclusion, sevoflurane affects on the A1 receptor at the neuromuscular junction and delays sugammadex-induced recovery from neuromuscular blockade.",sevoflurane,CHEMICAL,delay sugammadex-induced recovery from,neuromuscular blockade,DISEASE
7205296,Duration of coma (Glasgow Coma Scale) bore little relationship to later cognitive outcome but duration of post-traumatic amnesia significantly predicted cognitive performance.,coma,DISEASE,bear little relationship to cognitive outcome but duration of,post-traumatic amnesia,MENTAL_HEALTH
7205296,Duration of coma (Glasgow Coma Scale) bore little relationship to later cognitive outcome but duration of post-traumatic amnesia significantly predicted cognitive performance.,Glasgow Coma Scale,DISEASE,bear little relationship to cognitive outcome but duration of,post-traumatic amnesia,MENTAL_HEALTH
17177497,"Techniques that used petroleum ether/acetone/water (15:75:10, v/v/v) with 3 h of agitation, or 5 min in an ultrasonic bath, produced the highest extraction yields of total carotenoids (29-30.5 microg g-1).",agitation,MENTAL_HEALTH,produce highest extraction yields of,total carotenoids,CHEBI
16233058,"Utilizing a four-liter fermentor and applying a complete factorial design 2(3), the combined effects of agitation speed, aeration rate, and corn steep liquor concentration on zeaxanthin production by Flavobacterium sp. were studied.",agitation speed,MENTAL_HEALTH,utilize,four-liter fermentor,CHEMICAL
16233058,"Utilizing a four-liter fermentor and applying a complete factorial design 2(3), the combined effects of agitation speed, aeration rate, and corn steep liquor concentration on zeaxanthin production by Flavobacterium sp. were studied.",Flavobacterium sp.,DISEASE,have and corn steep liquor concentration on,zeaxanthin production,CHEBI
8241462,"Intraperitoneal injection of IL-2 significantly enhanced the scopolamine-induced hyperactivity, whereas the cytokine alone was ineffective in modifying locomotor activity.",IL-2,CHEMICAL,enhance,scopolamine-induced hyperactivity,MENTAL_HEALTH
33387701,"Among cardinal symptoms of this disorder, tremor is the least responsive to dopamine replacement therapy and is often undertreated.",tremor,DISEASE,be responsive among cardinal symptoms of disorder to,dopamine replacement therapy,CHEMICAL
33387701,Zuranolone (SAGE-217) is an investigational oral neuroactive steroid (NAS) gamma-aminobutyric acid A (GABAA) receptor-positive allosteric modulator (PAM) that has been investigated for its safety and efficacy in patients with PD.,Zuranolone,CHEMICAL,be,investigational oral neuroactive steroid NAS A GABAA receptor-positive allosteric modulator,CHEMICAL
33387701,"In the current open-label study, zuranolone capsules (20 to 30 mg) were administered for 7 days in 14 patients (mean age, 65.1 years; mean time since PD diagnosis, 9 years).",zuranolone capsules,CHEMICAL,be administered in current open-label study for,PD diagnosis,DISEASE
23162607,"Examples of this are two drug classes developed to treat FXS, Arbaclofen, a GABA(B) agonist, and mGluR5 antagonists, and both may be helpful in autism without FXS.",drug classes,CHEBI,treat,FXS agonist,CHEBI
23162607,"Examples of this are two drug classes developed to treat FXS, Arbaclofen, a GABA(B) agonist, and mGluR5 antagonists, and both may be helpful in autism without FXS.",drug classes,CHEBI,treat,mGluR5 antagonists,CHEBI
23162607,"Examples of this are two drug classes developed to treat FXS, Arbaclofen, a GABA(B) agonist, and mGluR5 antagonists, and both may be helpful in autism without FXS.",drug classes,CHEBI,treat,Arbaclofen,CHEMICAL
23162607,"Examples of this are two drug classes developed to treat FXS, Arbaclofen, a GABA(B) agonist, and mGluR5 antagonists, and both may be helpful in autism without FXS.",drug classes,CHEBI,treat,FXS agonist,DISEASE
23162607,"The mGluR5 antagonists are also likely to have a benefit in the aging problems of fragile X premutation carriers, the fragile X -associated tremor ataxia syndrome (FXTAS) and the Parkinsonism that can occur in aging patients with fragile X syndrome.",antagonists,CHEBI,have benefit in aging problems of,fragile X premutation carriers,CHEBI
20858229,"RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS), in premutation carriers in late life.",RNA toxicity,DISEASE,lead to,tremor,DISEASE
20858229,"RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS), in premutation carriers in late life.",RNA toxicity,DISEASE,lead to,premutation carriers,CHEBI
20858229,"RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS), in premutation carriers in late life.",RNA toxicity,DISEASE,lead to,ataxia,DISEASE
20858229,"RNA toxicity can also lead to aging effects including tremor, ataxia and cognitive decline, termed fragile X-associated tremor ataxia syndrome (FXTAS), in premutation carriers in late life.",RNA toxicity,DISEASE,lead to,cognitive decline,DISEASE
20858229,There is also evidence of mitochondrial dysfunction in premutation carriers.,mitochondrial dysfunction,DISEASE,have evidence in,premutation carriers,CHEBI
28439787,"Summing these items, the SWS was found to have strong internal consistency (Cronbach's alpha = 0.82) and showed a medium to large effect size (d = 0.77) from admission to discharge.",SWS,DISEASE,have,alpha,NUTRITION
7871234,"In a psychiatric population without mental retardation (n = 53), the PIMRA schizophrenia scale had an internal consistency coefficient alpha = 0.52.",schizophrenia scale,MENTAL_HEALTH,have in,psychiatric population,DISEASE
7871234,"In a psychiatric population without mental retardation (n = 53), the PIMRA schizophrenia scale had an internal consistency coefficient alpha = 0.52.",schizophrenia scale,MENTAL_HEALTH,have in,internal consistency coefficient alpha =,NUTRITION
31965145,"Gastric cancer pathogenesis represents a complex interaction of host genetic determinants, microbial virulence factors and environmental exposures.",Gastric cancer pathogenesis,DISEASE,represent complex interaction of,microbial virulence factors,CHEBI
34506856,The correlation of these autoAbs with anthropometric parameters and appetitive traits in young subjects support its role as carriers and modulators of the biologic functions of ghrelin and leptin and suggest a novel role in eating behaviour through appetitive traits.,appetitive traits,DISEASE,support its role as,carriers,CHEBI
34333326,"Medicarpin is a natural pterocarpan-type phytoalexin widely distributed in many traditional Chinese medicines, such as Astragali Radix.",Medicarpin,CHEMICAL,distributed in,Astragali Radix,DISEASE
25654502,The present study evaluates the neuroprotective action of resveratrol on Aβ-induced oxidative stress and memory loss.,resveratrol,CHEMICAL,have the neuroprotective action on,memory loss,DISEASE
34803717,"G. biloba L. and its most frequently used standardized extract (EGb 761), have been used for many years in supportive therapy and in the prevention of cognitive disorders.",G. biloba L.,CHEMICAL,be used for many years in supportive therapy and in prevention of,cognitive disorders,DISEASE
3042913,"At the first stage of a pilot study involving 14 parkinsonians with motor fluctuations, treatment with standard Madopar was substituted by a sustained-release form, Madopar HBS, which attenuated fluctuations in patients with end-of-dose impairment, but achieved only moderate improvement in patients with on-off phenomena.",standard Madopar,CHEMICAL,be substituted at first stage of pilot study by,Madopar HBS,CHEMICAL
35380611,"Previous animal studies have shown that high sucrose/fructose consumption causes insulin resistance in the liver, skeletal muscle and consequent hyperglycemia, mainly because of fructose-induced de novo hepatic lipogenesis.",high sucrose/fructose consumption,CHEMICAL,cause insulin resistance in,fructose-induced de hepatic lipogenesis,DISEASE
35380611,"Previous animal studies have shown that high sucrose/fructose consumption causes insulin resistance in the liver, skeletal muscle and consequent hyperglycemia, mainly because of fructose-induced de novo hepatic lipogenesis.",high sucrose/fructose consumption,CHEMICAL,cause insulin resistance in,consequent hyperglycemia,DISEASE
35380611,"Previous animal studies have shown that high sucrose/fructose consumption causes insulin resistance in the liver, skeletal muscle and consequent hyperglycemia, mainly because of fructose-induced de novo hepatic lipogenesis.",high sucrose/fructose consumption,CHEMICAL,cause,insulin resistance,MENTAL_HEALTH
33384967,"In addition, in genus level, as risk factors for the development of MAFLD, insulin resistance was positively correlated with the abundances of Granulicatella, Veillonella, Streptococcus, and Scardovia, while obesity was positively correlated to the abundances of Streptococcus, Oslenella, Scardovia, and Selenomonas.",insulin resistance,MENTAL_HEALTH,be correlated in addition in,Granulicatella,DISEASE
33384967,"In addition, in genus level, as risk factors for the development of MAFLD, insulin resistance was positively correlated with the abundances of Granulicatella, Veillonella, Streptococcus, and Scardovia, while obesity was positively correlated to the abundances of Streptococcus, Oslenella, Scardovia, and Selenomonas.",obesity,DISEASE,be correlated to abundances of,Selenomonas,DISEASE
30626554,It is well known that opioid analgesics produce side effects including tolerance and constipation.,opioid analgesics,CHEBI,produce,constipation,DISEASE
22352005,The over-diagnosis of bipolar spectrum may cause over-prescription of mood stabilizers.,bipolar spectrum,DISEASE,cause over-prescription of,mood stabilizers,CHEBI
22352005,"If the marketing of mood stabilizer is hidden behind the expansion of bipolar spectrum, clinicians should assess the clinical validity of this concept more carefully.",mood stabilizer,CHEBI,be hidden behind expansion of,bipolar spectrum,DISEASE
17168653,"The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, l-deprenyl (selegiline ), a failed anti depressant in 1975.",neurodegenerative diseases,DISEASE,have its origin in anti parkinson action of,selegiline,CHEMICAL
17168653,"The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, l-deprenyl (selegiline ), a failed anti depressant in 1975.",neurodegenerative diseases,DISEASE,have its origin in anti parkinson action of,selective monoamine oxidase MAO B inhibitor,CHEMICAL
17168653,"The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, l-deprenyl (selegiline ), a failed anti depressant in 1975.",neurodegenerative diseases,DISEASE,have its origin in anti parkinson action of,l-deprenyl,CHEMICAL
17168653,"The therapeutic use of enzyme inhibitors in treatment of neurodegenerative diseases has its origin in the anti Parkinson action of the selective monoamine oxidase (MAO) B inhibitor, l-deprenyl (selegiline ), a failed anti depressant in 1975.",neurodegenerative diseases,DISEASE,have its origin in,anti Parkinson action,DISEASE
17168653,"Since brain MAO and iron increase in AD, PD and ageing, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.",iron,CHEMICAL,develop series of,HLA-20 series,CHEMICAL
17168653,"Since brain MAO and iron increase in AD, PD and ageing, that could lead to iron dependent oxidative stress neurodegeneration, we have developed another series of multifunctional drugs (M30 HLA-20 series) which are brain permeable iron chelators- brain selective MAO inhibitors and possess the propargyl neuroprotective moiety.",iron increase,CHEMICAL,develop series of,HLA-20 series,CHEMICAL
24578778,"Tavaborole, a benzoxaborole compound, has been submitted to the United States Food and Drug Administration for approval for treatment of onychomycosis.",Tavaborole,CHEMICAL,be submitted to united states food and drug administration for approval for treatment of,onychomycosis,DISEASE
24578778,"Tavaborole, a benzoxaborole compound, has been submitted to the United States Food and Drug Administration for approval for treatment of onychomycosis.",Tavaborole,CHEMICAL,be submitted to,Drug,CHEBI
11249551,Olanzapine is a serotonin-dopamine receptor antagonist primarily used in the treatment of psychotic illnesses.,Olanzapine,CHEMICAL,used in treatment of,psychotic illnesses,DISEASE
11249551,"Furthermore, early reports suggest that olanzapine produces less tardive dyskinesia than haloperidol, though longer follow-up data are needed.",olanzapine,CHEMICAL,produce,haloperidol,CHEMICAL
11249551,"Furthermore, early reports suggest that olanzapine produces less tardive dyskinesia than haloperidol, though longer follow-up data are needed.",olanzapine,CHEMICAL,produce,less tardive dyskinesia,MENTAL_HEALTH
11249551,Clinical trials in acute mania have found olanzapine to be more effective than placebo.,acute mania,MENTAL_HEALTH,find,olanzapine,CHEMICAL
11249551,"Although olanzapine has shown a low rate of extrapyramidal symptoms, it is not without adverse effects.",olanzapine,CHEMICAL,show low rate of,extrapyramidal symptoms,DISEASE
11249551,Clinically significant weight gain has been noted with olanzapine in each of the large clinical trials.,significant weight gain,DISEASE,be noted with,olanzapine,CHEMICAL
11249551,The degree of weight gain is similar to clozapine and probably greater than that observed with risperidone.,weight gain,DISEASE,be similar to,clozapine,CHEMICAL
31621892,Valproate is an effective maintenance treatment for bipolar disorder.,Valproate,CHEMICAL,be effective maintenance treatment for,bipolar disorder,MENTAL_HEALTH
31621892,This review is an update of a previous Cochrane Review (last published 2003) on the role of valproate in acute mania.,valproate,CHEMICAL,have the role in,acute mania,MENTAL_HEALTH
31152444,Lithium is an effective maintenance treatment for bipolar disorder.,Lithium,NUTRITION,be effective maintenance treatment for,bipolar disorder,MENTAL_HEALTH
35548283,Our results indicate that the flowering-associated gene GIGANTEA is a possible key factor in AB resistance in chickpea.,AB resistance,MENTAL_HEALTH,have a possible key factor in,chickpea,NUTRITION
8790310,"Although the ratio of deaths to nonfatal inhalation escapades is extremely low, volatile solvent abuse carries the risk of sudden death due to cardiac arrest after a dysrhythmia or vasovagal event, central nervous system respiratory depression, hypoxia and hypercapnia due to the techniques of inhalation, and other mechanisms.",deaths,DISEASE,have the ratio to,nonfatal inhalation escapades,CHEMICAL
11108513,Pyridoxine (vitamin B6) (2q31) dependency is a rare autosomal-recessive disorder that causes a severe seizure disorder of prenatal or neonatal onset.,Pyridoxine dependency,CHEBI,be,rare disorder,DISEASE
11108513,Most patients with pyridoxine-dependent seizures require lifelong treatment with pyridoxine.,pyridoxine-dependent seizures,DISEASE,require lifelong treatment with,pyridoxine,CHEBI
31917143,It has been suggested that pyridoxine can ameliorate LEV-related NPAEs.,pyridoxine,CHEBI,ameliorate,LEV-related NPAEs,DISEASE
35404406,EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non-small cell lung cancer (NSCLC) that harbor EGFR alterations.,EGFR inhibitors,CHEBI,administered to patients with,non-small cell lung cancer,DISEASE
35404406,EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non-small cell lung cancer (NSCLC) that harbor EGFR alterations.,EGFR inhibitors,CHEBI,administered to patients with,NSCLC,DISEASE
35404406,EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non-small cell lung cancer (NSCLC) that harbor EGFR alterations.,EGFRi,CHEMICAL,administered to patients with,non-small cell lung cancer,DISEASE
35404406,EGFR inhibitors (EGFRi) are standard-of-care treatments administered to patients with non-small cell lung cancer (NSCLC) that harbor EGFR alterations.,EGFRi,CHEMICAL,administered to patients with,NSCLC,DISEASE
35404406,"In this study, we identify that loss of an epigenetic factor, lysine methyltransferase 5C (KMT5C), drives resistance of NSCLC to multiple EGFRis, including erlotinib, gefitinib, afatinib, and osimertinib.",lysine methyltransferase 5C,CHEMICAL,drive resistance of nsclc to,gefitinib,CHEMICAL
35404406,"In this study, we identify that loss of an epigenetic factor, lysine methyltransferase 5C (KMT5C), drives resistance of NSCLC to multiple EGFRis, including erlotinib, gefitinib, afatinib, and osimertinib.",lysine methyltransferase 5C,CHEMICAL,drive resistance of nsclc to,erlotinib,CHEMICAL
35404406,"In this study, we identify that loss of an epigenetic factor, lysine methyltransferase 5C (KMT5C), drives resistance of NSCLC to multiple EGFRis, including erlotinib, gefitinib, afatinib, and osimertinib.",lysine methyltransferase 5C,CHEMICAL,drive resistance of nsclc to,afatinib,CHEMICAL
35404406,"In this study, we identify that loss of an epigenetic factor, lysine methyltransferase 5C (KMT5C), drives resistance of NSCLC to multiple EGFRis, including erlotinib, gefitinib, afatinib, and osimertinib.",lysine methyltransferase 5C,CHEMICAL,drive resistance of,NSCLC,DISEASE
35404406,"In this study, we identify that loss of an epigenetic factor, lysine methyltransferase 5C (KMT5C), drives resistance of NSCLC to multiple EGFRis, including erlotinib, gefitinib, afatinib, and osimertinib.",lysine methyltransferase 5C,CHEMICAL,drive,resistance,MENTAL_HEALTH
35404406,"Loss of KMT5C led to upregulation of an oncogenic long noncoding RNA, LINC01510, that promoted transcription of the oncogene MET, a component of a major bypass mechanism involved in EGFRi resistance.",KMT5C,DISEASE,lead to upregulation of,LINC01510,DISEASE
33023947,"SIGNIFICANCE: Hypoxia sensitizes breast cancer cells to EGFR inhibitors in an HIF1α- and a methylation-specific manner, suggesting patients with hypoxic tumors may benefit from EGFR inhibitors already available in the clinic.",Hypoxia,DISEASE,sensitize breast cancer cells to,EGFR inhibitors,CHEBI
33023947,"SIGNIFICANCE: Hypoxia sensitizes breast cancer cells to EGFR inhibitors in an HIF1α- and a methylation-specific manner, suggesting patients with hypoxic tumors may benefit from EGFR inhibitors already available in the clinic.",Hypoxia,DISEASE,sensitize,breast cancer cells,DISEASE
26010107,Mixture modeling revealed 2 groups of youth with differing levels of depersonalization/derealization dissociative symptoms.,Mixture modeling,CHEBI,reveal groups of youth with differing levels of,depersonalization/derealization dissociative symptoms,DISEASE
23692083,Depression of regucalcin expression may be associated with activity progression of carcinogens.,Depression,MENTAL_HEALTH,be associated with activity progression of,carcinogens,CHEBI
34409523,"In addition to this, high corticosterone levels and decreased hippocampal BDNF, 5-HT, dopamine (DA), and acetylcholine (ACh) levels were also observed in depressed animals.",high corticosterone levels,CHEMICAL,decrease,DA,CHEMICAL
34409523,"In addition to this, high corticosterone levels and decreased hippocampal BDNF, 5-HT, dopamine (DA), and acetylcholine (ACh) levels were also observed in depressed animals.",high corticosterone levels,CHEMICAL,decrease,5-HT,CHEMICAL
34409523,"In addition to this, high corticosterone levels and decreased hippocampal BDNF, 5-HT, dopamine (DA), and acetylcholine (ACh) levels were also observed in depressed animals.",high corticosterone levels,CHEMICAL,decrease,dopamine,CHEMICAL
34409523,"In addition to this, high corticosterone levels and decreased hippocampal BDNF, 5-HT, dopamine (DA), and acetylcholine (ACh) levels were also observed in depressed animals.",acetylcholine levels,CHEMICAL,be observed in,depressed animals,DISEASE
19656212,Implications of kynurenine pathway (KP) are suggested in ADC and other inflammatories brain diseases.,kynurenine pathway,CHEMICAL,be suggested in,brain diseases,DISEASE
35575783,"The chlorogenic acid showed in vitro antifungal activity against the strains tested, causing reduced cell viability, increased potential for mitochondrial depolarization and production of reactive oxygen species, DNA fragmentation and phosphatidylserine externalization, indicating an apoptotic process.",chlorogenic acid,CHEMICAL,increased potential for mitochondrial depolarization and production of,reactive oxygen species,CHEMICAL
35575783,"The chlorogenic acid showed in vitro antifungal activity against the strains tested, causing reduced cell viability, increased potential for mitochondrial depolarization and production of reactive oxygen species, DNA fragmentation and phosphatidylserine externalization, indicating an apoptotic process.",chlorogenic acid,CHEMICAL,increased potential for mitochondrial depolarization and production of,DNA fragmentation,MENTAL_HEALTH
35575783,"The chlorogenic acid showed in vitro antifungal activity against the strains tested, causing reduced cell viability, increased potential for mitochondrial depolarization and production of reactive oxygen species, DNA fragmentation and phosphatidylserine externalization, indicating an apoptotic process.",chlorogenic acid,CHEMICAL,increased potential for mitochondrial depolarization and production of,phosphatidylserine externalization,NUTRITION
35297074,"Therefore, we showed in this experimental model that resveratrol is a promising nutraceutical adjuvant and should be deeply studied to mitigate subfertility in varicocele.",resveratrol,CHEMICAL,be,promising nutraceutical adjuvant,CHEBI
34977995,"The potential antitumor activity of MEAC was further confirmed in EAC tumor bearing mice models in which treatment with MEAC increased the levels of antioxidant enzymes, improved the hematological profile towards normal and also augmented the life span of tumor bearing mice.",MEAC,CHEMICAL,augment life span of,tumor,DISEASE
34977995,"The potential antitumor activity of MEAC was further confirmed in EAC tumor bearing mice models in which treatment with MEAC increased the levels of antioxidant enzymes, improved the hematological profile towards normal and also augmented the life span of tumor bearing mice.",MEAC,CHEMICAL,be confirmed in,EAC tumor,DISEASE
31637685,The use of opioid analgesics in the United States has increased nearly fourfold since 1999 resulting in a similar increase in opioid-related overdose deaths.,opioid analgesics,CHEBI,result in similar increase in,overdose deaths,DISEASE
33687725,"Additional group of WT and IFN-γ/KO parkinsonian mice, after 3 weeks of neurotoxin injection, received L-DOPA (intraperitoneally, for 21 days) resulting in dyskinetic-like behavior.",WT parkinsonian mice,DISEASE,result in,dyskinetic-like behavior,DISEASE
33687725,"Additional group of WT and IFN-γ/KO parkinsonian mice, after 3 weeks of neurotoxin injection, received L-DOPA (intraperitoneally, for 21 days) resulting in dyskinetic-like behavior.",WT parkinsonian mice,DISEASE,receive after weeks of,neurotoxin injection,CHEBI
33687725,"Additional group of WT and IFN-γ/KO parkinsonian mice, after 3 weeks of neurotoxin injection, received L-DOPA (intraperitoneally, for 21 days) resulting in dyskinetic-like behavior.",WT parkinsonian mice,DISEASE,receive after weeks of,injection L-DOPA,CHEMICAL
33503872,"Cervical dystonia is a frequent symptom in PS, with anterocollis as a specific entity.",Cervical dystonia,DISEASE,be frequent symptom in ps with,anterocollis,DISEASE
33503872,"A further indication is blepharospasm in the different forms, especially the inhibition of eyelid opening in atypical PS.",eyelid opening,DISEASE,have the inhibition in,atypical PS,CHEMICAL
33897035,"According to the results, the linear, quadratic and interaction effects of the studied factors on total anthocyanin content and antioxidant activity were determined by the response surface methodology, and the optimal conditions for anthocyanin extraction were 586 rpm for agitation speed, 1.26 g/40 mL for sample to solvent ratio, and 9.36 min for extraction time.",anthocyanin extraction,NUTRITION,be rpm for,agitation speed,MENTAL_HEALTH
7760120,"Bath application of the cholinergic agonists, nicotine and muscarine, also depolarized FETi, with nicotine causing a reduction in input resistance, while muscarine caused no detectable change in input resistance.",nicotine,CHEMICAL,cause reduction in,input resistance,MENTAL_HEALTH
16617704,"On the basis of the data from this investigation, it is concluded that WNV caused encephalitis along with many other pathologic changes in the affected wild turkey.",WNV,DISEASE,cause encephalitis along,affected wild turkey,NUTRITION
16617704,"On the basis of the data from this investigation, it is concluded that WNV caused encephalitis along with many other pathologic changes in the affected wild turkey.",WNV,DISEASE,cause,encephalitis,DISEASE
35507965,"Three dominating fragmentation channels are observed, i.e. the loss of a tin atom for N 7 fragment for N 10 fragment for N ≥ 19 with Sn15 subunits constituting recurring geometric motifs for N > 20.",dominating fragmentation channels,MENTAL_HEALTH,be observed loss of,tin atom,NUTRITION
28534439,DNA fragmentation analysis confirmed tissue damage by GM and its amelioration by the extracts.,DNA fragmentation analysis,MENTAL_HEALTH,confirm tissue damage by,GM,CHEMICAL
28534439,DNA fragmentation analysis confirmed tissue damage by GM and its amelioration by the extracts.,DNA fragmentation analysis,MENTAL_HEALTH,confirm,tissue damage,DISEASE
22744955,"Thus, DIME showed its capability to induce apoptosis in cancer cells, signifying its utility in drug design as a possible candidate for chemoprevention.",DIME,CHEMICAL,signify its utility in,drug design,CHEBI
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,headache,MENTAL_HEALTH
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,cold/flu,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,leucoderma,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,rheumatism,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,spasm,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,syphilis,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,boils,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,scabies,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,epilepsy,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,leprosy,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,cancer,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,colic,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,hepatitis,DISEASE
25949238,"Pandanus odoratissimus Linn. (family: Pandanaceae) is traditionally recommended by the Indian Ayurvedic medicines for treatment of headache, rheumatism, spasm, cold/flu, epilepsy, wounds, boils, scabies, leucoderma, ulcers, colic, hepatitis, smallpox, leprosy, syphilis, and cancer and as a cardiotonic, antioxidant, dysuric, and aphrodisiac.",odoratissimus Linn,CHEMICAL,be recommended by indian ayurvedic medicines for treatment of,ulcers,DISEASE
32562659,"Topical vaginal estrogen therapy is considered the gold standard treatment for genitourinary syndrome of menopause-associated dyspareunia, but early investigations of energy-based devices show promise for patients with contraindications or those who are refractory to vaginal estrogen cream therapy.",Topical vaginal estrogen therapy,CHEBI,be considered gold standard treatment for genitourinary syndrome of,menopause-associated dyspareunia,MENTAL_HEALTH
32562659,"Topical vaginal estrogen therapy is considered the gold standard treatment for genitourinary syndrome of menopause-associated dyspareunia, but early investigations of energy-based devices show promise for patients with contraindications or those who are refractory to vaginal estrogen cream therapy.",Topical vaginal estrogen therapy,CHEBI,be considered gold standard treatment for,genitourinary syndrome,DISEASE
16400245,"However, the role of glutamate in anxiety disorders is becoming more recognized with the belief that drugs that modulate glutamatergic function through either ionotropic or metabotropic glutamate receptors have the potential to improve the current treatment of these severe and disabling illnesses.",glutamate,CHEMICAL,have the role in,anxiety disorders,MENTAL_HEALTH
16400245,Animal models of fear and anxiety have provided a method to study the role of glutamate in anxiety.,glutamate,CHEMICAL,have the role in,anxiety,MENTAL_HEALTH
16400245,"Human clinical drug trials have demonstrated the efficacy of glutamatergic drugs for the treatment of obsessive-compulsive disorder, posttraumatic stress disorder, generalized anxiety disorder, and social phobia.",Human clinical drug trials,CHEBI,demonstrate efficacy of glutamatergic drugs for treatment of,posttraumatic stress disorder,MENTAL_HEALTH
16400245,"Human clinical drug trials have demonstrated the efficacy of glutamatergic drugs for the treatment of obsessive-compulsive disorder, posttraumatic stress disorder, generalized anxiety disorder, and social phobia.",Human clinical drug trials,CHEBI,demonstrate efficacy of glutamatergic drugs for treatment of,generalized anxiety disorder,MENTAL_HEALTH
16400245,"Human clinical drug trials have demonstrated the efficacy of glutamatergic drugs for the treatment of obsessive-compulsive disorder, posttraumatic stress disorder, generalized anxiety disorder, and social phobia.",Human clinical drug trials,CHEBI,demonstrate efficacy of glutamatergic drugs for treatment of,social phobia,MENTAL_HEALTH
16400245,"Human clinical drug trials have demonstrated the efficacy of glutamatergic drugs for the treatment of obsessive-compulsive disorder, posttraumatic stress disorder, generalized anxiety disorder, and social phobia.",Human clinical drug trials,CHEBI,demonstrate efficacy of glutamatergic drugs for treatment of,obsessive-compulsive disorder,MENTAL_HEALTH
16400245,Recent data from magnetic resonance imaging studies provide an additional link between the glutamate system and anxiety.,glutamate system,CHEMICAL,have an additional link with,anxiety,MENTAL_HEALTH
16400245,Recent data from magnetic resonance imaging studies provide an additional link between the glutamate system and anxiety.,anxiety,MENTAL_HEALTH,have an additional link with,glutamate system,CHEMICAL
31933104,"In order to evaluate the possible neuroprotective properties of SAK3, human neuroblastoma SH-SY5Y cells were pretreated with the compound (25-100 nM) and further incubated in the presence of scopolamine (2 mM).",human neuroblastoma SH-SY5Y cells,DISEASE,evaluate possible neuroprotective properties of,SAK3,CHEMICAL
31933104,"These results indicate SAK3 possessed protective properties against cholinergic deficit associated with anti-oxidant, anti-apoptotic and anti-inflammatory activities, suggesting that SAK3 might be a potential agent in the development of AD drug therapeutics.",SAK3,CHEMICAL,be potential agent in development of,AD drug therapeutics,CHEBI
1869918,"In this study, microinjections of the mu-opioid agonist [D-Ala2, N-Me-Phe4, Gly5-ol]-enkephalin (DAMGO; 1.6 microM) bilaterally into the LC caused a significant impairment in the development of a heart-rate (HR) conditioned response (CR).",mu-opioid agonist D-Ala2 DAMGO,CHEBI,cause in study significant impairment in development of,heart-rate conditioned response,MENTAL_HEALTH
33084094,"Experiments have affirmed that pretreatment of ACV, Chrysin, and Rivastigmine has displayed protective outcomes in MTT reduction, tau phosphorylation, amyloid aggregation, attenuated memory impairment as well as oxidative stress, and protected cholinergic hippocampal neurons from degeneration.",ACV,CHEMICAL,display protective outcomes in,amyloid aggregation,DISEASE
33084094,"Experiments have affirmed that pretreatment of ACV, Chrysin, and Rivastigmine has displayed protective outcomes in MTT reduction, tau phosphorylation, amyloid aggregation, attenuated memory impairment as well as oxidative stress, and protected cholinergic hippocampal neurons from degeneration.",Chrysin,CHEMICAL,display protective outcomes in,amyloid aggregation,DISEASE
33084094,"Experiments have affirmed that pretreatment of ACV, Chrysin, and Rivastigmine has displayed protective outcomes in MTT reduction, tau phosphorylation, amyloid aggregation, attenuated memory impairment as well as oxidative stress, and protected cholinergic hippocampal neurons from degeneration.",Rivastigmine,CHEMICAL,display protective outcomes in,amyloid aggregation,DISEASE
33084094,Our findings suggest that the addition of ACV as a food additive in the daily diet may reduce the threat of multiple neurodegenerative diseases.,ACV,CHEMICAL,reduce threat of,multiple neurodegenerative diseases,DISEASE
33084094,Our findings suggest that the addition of ACV as a food additive in the daily diet may reduce the threat of multiple neurodegenerative diseases.,food additive,NUTRITION,reduce threat of,multiple neurodegenerative diseases,DISEASE
24928173,"These results indicate that while aclidinium and glycopyrronium are both potent antagonists at muscarinic receptors with similar kinetic selectivity for M3 receptors versus M2, aclidinium has a longer dissociation half-life at M3 receptors and a longer duration of bronchodilator action in vivo than glycopyrronium.",glycopyrronium,CHEMICAL,have,glycopyrronium,CHEMICAL
24928173,"These results indicate that while aclidinium and glycopyrronium are both potent antagonists at muscarinic receptors with similar kinetic selectivity for M3 receptors versus M2, aclidinium has a longer dissociation half-life at M3 receptors and a longer duration of bronchodilator action in vivo than glycopyrronium.",glycopyrronium,CHEMICAL,have,longer dissociation half-life,MENTAL_HEALTH
24928173,"These results indicate that while aclidinium and glycopyrronium are both potent antagonists at muscarinic receptors with similar kinetic selectivity for M3 receptors versus M2, aclidinium has a longer dissociation half-life at M3 receptors and a longer duration of bronchodilator action in vivo than glycopyrronium.",aclidinium,CHEMICAL,have,glycopyrronium,CHEMICAL
24928173,"These results indicate that while aclidinium and glycopyrronium are both potent antagonists at muscarinic receptors with similar kinetic selectivity for M3 receptors versus M2, aclidinium has a longer dissociation half-life at M3 receptors and a longer duration of bronchodilator action in vivo than glycopyrronium.",aclidinium,CHEMICAL,have,longer dissociation half-life,MENTAL_HEALTH
24928173,"These results indicate that while aclidinium and glycopyrronium are both potent antagonists at muscarinic receptors with similar kinetic selectivity for M3 receptors versus M2, aclidinium has a longer dissociation half-life at M3 receptors and a longer duration of bronchodilator action in vivo than glycopyrronium.",aclidinium,CHEMICAL,be,potent antagonists,CHEBI
18508500,A growing body of data describes the role of adenosine A1 and A2A receptors on anxiety.,adenosine A1,CHEMICAL,have the role on,anxiety,MENTAL_HEALTH
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,EPA,CHEMICAL,be added to conventional antidepressant treatment of treatment-resistant depressed and suicidal male patient with seven-year history of,depressive symptoms,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,EPA,CHEMICAL,be added to conventional antidepressant treatment of,depressed patient,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,EPA,CHEMICAL,be added to,conventional antidepressant treatment,CHEMICAL
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,NUTRITION,be added to conventional antidepressant treatment of treatment-resistant depressed and suicidal male patient with seven-year history of,depressive symptoms,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,CHEMICAL,be added to conventional antidepressant treatment of treatment-resistant depressed and suicidal male patient with seven-year history of,depressive symptoms,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,NUTRITION,be added to conventional antidepressant treatment of,depressed patient,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,CHEMICAL,be added to conventional antidepressant treatment of,depressed patient,DISEASE
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,NUTRITION,be added to,conventional antidepressant treatment,CHEMICAL
11695079,The n-3 essential fatty acid eicosapentaenoic acid (EPA) was added to the conventional antidepressant treatment of a treatment-resistant severely depressed and suicidal male patient with a seven-year history of unremitting depressive symptoms.,n-3 essential fatty acid eicosapentaenoic acid,CHEMICAL,be added to,conventional antidepressant treatment,CHEMICAL
11695079,"The addition of ethyl-EPA led to a dramatic and sustained clinical improvement in all the symptoms of depression, including a cessation of previously unremitting severe suicidal ideation, within one month.",ethyl-EPA,CHEMICAL,lead to a dramatic and sustained clinical improvement in symptoms of,depression,MENTAL_HEALTH
11695079,"The addition of ethyl-EPA led to a dramatic and sustained clinical improvement in all the symptoms of depression, including a cessation of previously unremitting severe suicidal ideation, within one month.",ethyl-EPA,CHEMICAL,lead to a dramatic and sustained clinical improvement in symptoms of,unremitting severe suicidal ideation,DISEASE
10934573,Persons in drug treatment with drug dependence were interviewed with the NIMH Diagnostic Interview Schedule to ascertain DSM-III-R disorders.,drug treatment,CHEBI,ascertain,DSM-III-R disorders,DISEASE
10934573,Persons in drug treatment with drug dependence were interviewed with the NIMH Diagnostic Interview Schedule to ascertain DSM-III-R disorders.,drug dependence,MENTAL_HEALTH,ascertain,DSM-III-R disorders,DISEASE
10934573,Persons in drug treatment with drug dependence were interviewed with the NIMH Diagnostic Interview Schedule to ascertain DSM-III-R disorders.,drug treatment,CHEBI,have persons with,drug dependence,MENTAL_HEALTH
28888041,"In animal models, the methyl donor betaine, found in foods such as wheat bran, quinoa, beets, and spinach, ameliorated neurobehavioral deficits associated with PAE, but effects on heart development are unknown.",methyl donor betaine,CHEMICAL,ameliorate in,models neurobehavioral deficits,DISEASE
31565456,"While PJI is a devastating complication following TEA, a fungal infection is a rare complication that imposes difficult challenges to the treating surgeon.",PJI,DISEASE,be,fungal infection,DISEASE
31565456,"While PJI is a devastating complication following TEA, a fungal infection is a rare complication that imposes difficult challenges to the treating surgeon.",PJI,DISEASE,be,TEA,CHEMICAL
24651065,Branched-chain amino acid (BCAA) metabolism plays a central role in the pathophysiology of both rare inborn errors of metabolism and the more common multifactorial diseases.,Branched-chain amino acid BCAA metabolism,NUTRITION,play central role in pathophysiology of,rare inborn errors,DISEASE
24651065,"Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations in the BCAAs and their ketoacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment options for this disorder have been limited to dietary interventions.",BCAAs,CHEMICAL,be recognized as cause of,MSUD,DISEASE
24651065,"Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations in the BCAAs and their ketoacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment options for this disorder have been limited to dietary interventions.",BCAAs,CHEMICAL,be recognized as cause of,disorder,DISEASE
24651065,"Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations in the BCAAs and their ketoacids have been recognized as the cause of maple syrup urine disease (MSUD) for decades, treatment options for this disorder have been limited to dietary interventions.",BCAAs,CHEMICAL,be recognized as cause of,maple syrup urine disease,CHEMICAL
34680782,"The proportion of nonsusceptible isolates from animals was significantly higher than samples taken from marine water (p E. coli (ExPEC)-associated STs [ST10, ST38, ST58, ST69, ST73, ST117, ST131, and ST405].",nonsusceptible isolates,CHEMICAL,be,ST69,DISEASE
34680782,"The proportion of nonsusceptible isolates from animals was significantly higher than samples taken from marine water (p E. coli (ExPEC)-associated STs [ST10, ST38, ST58, ST69, ST73, ST117, ST131, and ST405].",nonsusceptible isolates,CHEMICAL,be,ST10,DISEASE
34680782,"The proportion of nonsusceptible isolates from animals was significantly higher than samples taken from marine water (p E. coli (ExPEC)-associated STs [ST10, ST38, ST58, ST69, ST73, ST117, ST131, and ST405].",nonsusceptible isolates,CHEMICAL,be,ST131,DISEASE
34680782,"The proportion of nonsusceptible isolates from animals was significantly higher than samples taken from marine water (p E. coli (ExPEC)-associated STs [ST10, ST38, ST58, ST69, ST73, ST117, ST131, and ST405].",nonsusceptible isolates,CHEMICAL,be,ST38,DISEASE
16127553,"Agonists of the colecystokinin receptor B, such as the colecystokinin-4 peptide and pentagastrin, increase stress hormones regardless of the occurrence of a panic attack and thus, seem to activate the HPA axis directly.",colecystokinin receptor B,CHEMICAL,increase,stress hormones,CHEBI
16127553,"Agonists of the colecystokinin receptor B, such as the colecystokinin-4 peptide and pentagastrin, increase stress hormones regardless of the occurrence of a panic attack and thus, seem to activate the HPA axis directly.",Agonists,CHEBI,increase,stress hormones,CHEBI
16127553,"Agonists of the colecystokinin receptor B, such as the colecystokinin-4 peptide and pentagastrin, increase stress hormones regardless of the occurrence of a panic attack and thus, seem to activate the HPA axis directly.",colecystokinin-4 peptide,CHEMICAL,increase,stress hormones,CHEBI
3048049,"In contrast to the panic disorder patients, depressed patients demonstrate a neuroendocrine subsensitivity to tryptophan.",disorder patients,MENTAL_HEALTH,demonstrate neuroendocrine subsensitivity to,tryptophan,NUTRITION
3048049,"In contrast to the panic disorder patients, depressed patients demonstrate a neuroendocrine subsensitivity to tryptophan.",depressed patients,DISEASE,demonstrate neuroendocrine subsensitivity to,tryptophan,NUTRITION
33161473,Natural material carnosic acid (CA) has been applied for therapeutics of mental disorders.,material carnosic acid,CHEMICAL,be applied for therapeutics of,mental disorders,MENTAL_HEALTH
26935117,Curcumin is a molecule found in turmeric root that possesses anti-inflammatory and antioxidant properties and has been widely used to treat neurodegenerative diseases.,Curcumin,CHEMICAL,found in,turmeric root,NUTRITION
26935117,We investigated whether curcumin stimulates the neurorepair process and improves locomotor function in a rat model of spinal cord ischemia-reperfusion injury.,curcumin,CHEMICAL,improve locomotor function in rat model of,spinal cord ischemia-reperfusion injury,DISEASE
8733902,A 10-year-old boy with adrenoleukodystrophy was treated with gammaglobulin in conjunction with a mixture of glyceryl trioleate and glyceryl trierucate.,adrenoleukodystrophy,DISEASE,be treated with gammaglobulin in conjunction with mixture of,glyceryl trioleate,CHEMICAL
8733902,A 10-year-old boy with adrenoleukodystrophy was treated with gammaglobulin in conjunction with a mixture of glyceryl trioleate and glyceryl trierucate.,adrenoleukodystrophy,DISEASE,be treated with gammaglobulin in conjunction with mixture of,glyceryl trierucate,CHEMICAL
8733902,A 10-year-old boy with adrenoleukodystrophy was treated with gammaglobulin in conjunction with a mixture of glyceryl trioleate and glyceryl trierucate.,adrenoleukodystrophy,DISEASE,be treated with gammaglobulin in conjunction with,mixture,CHEBI
20675883,"Currently, only donepezil is available for the treatment of Alzheimer disease (AD) in Japan.",donepezil,CHEMICAL,be available for treatment of,Alzheimer disease,MENTAL_HEALTH
20675883,"The herbal medicine yokukansan was found to be effective for behavioral and psychological symptoms of dementia (BPSD) in patients, and juzentaihoto was found to reduce AD pathology in a mouse model.",medicine yokukansan,CHEMICAL,be found to effective for behavioral and psychological symptoms of,BPSD,DISEASE
20675883,"The herbal medicine yokukansan was found to be effective for behavioral and psychological symptoms of dementia (BPSD) in patients, and juzentaihoto was found to reduce AD pathology in a mouse model.",medicine yokukansan,CHEMICAL,be found to effective for behavioral and psychological symptoms of,dementia,MENTAL_HEALTH
17066210,"Dietary omega-3 fatty acids are involved in the prevention of some aspects of ischemic cardiovascular disease (including at the level of cerebral vascularization), and in some neuropsychiatric disorders, particularly depression, as well as in dementia, including Alzheimer's disease and vascular dementia.",Dietary omega-3 fatty acids,NUTRITION,be involved in prevention of aspects of,ischemic cardiovascular disease,DISEASE
17066210,The implication of omega-3 fatty acids in major depression and bipolar disorder (manic-depressive illness) is under evaluation.,omega-3 fatty acids,NUTRITION,have the implication in,major depression,MENTAL_HEALTH
17066210,The implication of omega-3 fatty acids in major depression and bipolar disorder (manic-depressive illness) is under evaluation.,omega-3 fatty acids,NUTRITION,have the implication in,bipolar disorder,MENTAL_HEALTH
19689165,"Therapy with atomoxetine has been associated with statistically significant improvements in symptoms of oppositional defiant disorder in most, but not all, studies.",atomoxetine,CHEMICAL,be associated with significant improvements in symptoms of,oppositional defiant disorder,MENTAL_HEALTH
19689165,The tolerability profile of atomoxetine in patients with ADHD and co-morbid conditions was similar to that of patients with uncomplicated ADHD.,atomoxetine,CHEMICAL,be similar to,uncomplicated ADHD,MENTAL_HEALTH
19689165,The tolerability profile of atomoxetine in patients with ADHD and co-morbid conditions was similar to that of patients with uncomplicated ADHD.,ADHD co-morbid conditions,MENTAL_HEALTH,be similar to,uncomplicated ADHD,MENTAL_HEALTH
19689165,The tolerability profile of atomoxetine in patients with ADHD and co-morbid conditions was similar to that of patients with uncomplicated ADHD.,atomoxetine,CHEMICAL,in patients with,ADHD,MENTAL_HEALTH
19689165,"Atomoxetine was well tolerated, with adverse events generally mild and transient; the most frequent adverse events in patients with ADHD included abdominal pain, decreased appetite, nausea and vomiting.",ADHD,MENTAL_HEALTH,include,abdominal pain,DISEASE
19689165,"Atomoxetine was well tolerated, with adverse events generally mild and transient; the most frequent adverse events in patients with ADHD included abdominal pain, decreased appetite, nausea and vomiting.",Atomoxetine,CHEMICAL,decrease,nausea,DISEASE
19689165,"Atomoxetine was well tolerated, with adverse events generally mild and transient; the most frequent adverse events in patients with ADHD included abdominal pain, decreased appetite, nausea and vomiting.",Atomoxetine,CHEMICAL,decrease,vomiting,DISEASE
17218311,"We show that inherently neurotoxic natural ligands of CXCR4, such as stromal cell-derived factor-1alpha or viral macrophage inflammatory protein-II, can be modified to protect neurons from apoptosis induced by CXCR4-preferring gp120(IIIB), and that the inhibition of CCR5 by antagonist SMM-chemokines, unlike neuroprotective CCR5 natural ligands, leads to neurotoxicity by activating a p38 mitogen-activated protein kinase (MAPK)-dependent pathway.",antagonist SMM-chemokines,CHEMICAL,lead to,neurotoxicity,DISEASE
17218311,"We show that inherently neurotoxic natural ligands of CXCR4, such as stromal cell-derived factor-1alpha or viral macrophage inflammatory protein-II, can be modified to protect neurons from apoptosis induced by CXCR4-preferring gp120(IIIB), and that the inhibition of CCR5 by antagonist SMM-chemokines, unlike neuroprotective CCR5 natural ligands, leads to neurotoxicity by activating a p38 mitogen-activated protein kinase (MAPK)-dependent pathway.",antagonist SMM-chemokines,CHEBI,lead to,neurotoxicity,DISEASE
17148615,"CXCR3 antagonists and siRNA-mediated knockdown of CXCR3 inhibited SDF(5-67)-stimulated neurophysiological changes, neuronal death, and neuroimmune activation (P < 0.05).",CXCR3 antagonists,CHEBI,inhibit,neuronal death,DISEASE
19995130,"Excessive glutamate neurotransmission has been implicated in neuronal injury in many disorders of the central nervous system (CNS), including human immunodeficiency virus (HIV)-associated dementia.",Excessive glutamate neurotransmission,CHEMICAL,be implicated in neuronal injury in many disorders of,(HIV)-associated dementia,DISEASE
19995130,"Excessive glutamate neurotransmission has been implicated in neuronal injury in many disorders of the central nervous system (CNS), including human immunodeficiency virus (HIV)-associated dementia.",Excessive glutamate neurotransmission,CHEMICAL,be implicated in neuronal injury in many disorders of,(HIV)-associated dementia,MENTAL_HEALTH
19995130,"Excessive glutamate neurotransmission has been implicated in neuronal injury in many disorders of the central nervous system (CNS), including human immunodeficiency virus (HIV)-associated dementia.",Excessive glutamate neurotransmission,CHEMICAL,be implicated in,neuronal injury,DISEASE
19995130,"Since the catabolism of the neuropeptide N-acetylaspartylglutamate (NAAG) by glutamate carboxypeptidase (GCP) II increases cellular glutamate, an event associated with excitotoxicity, we hypothesized that inhibition of GCP II may prevent gp120IIIB-induced cell death.",NAAG,CHEMICAL,increase,cellular glutamate,CHEMICAL
19995130,"Since the catabolism of the neuropeptide N-acetylaspartylglutamate (NAAG) by glutamate carboxypeptidase (GCP) II increases cellular glutamate, an event associated with excitotoxicity, we hypothesized that inhibition of GCP II may prevent gp120IIIB-induced cell death.",glutamate carboxypeptidase,CHEMICAL,increase,cellular glutamate,CHEMICAL
19995130,"Since the catabolism of the neuropeptide N-acetylaspartylglutamate (NAAG) by glutamate carboxypeptidase (GCP) II increases cellular glutamate, an event associated with excitotoxicity, we hypothesized that inhibition of GCP II may prevent gp120IIIB-induced cell death.",neuropeptide N-acetylaspartylglutamate,CHEMICAL,increase,cellular glutamate,CHEMICAL
19995130,2-PMPA was found to abrogate gp120IIIB-induced toxicity in a dose-dependent manner.,2-PMPA,CHEMICAL,abrogate gp120iiib-induced,toxicity,DISEASE
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",glyphosate,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,cancer,DISEASE
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",glyphosate,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,Parkinson's Alzheimer's diseases,DISEASE
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",glyphosate,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,autism,MENTAL_HEALTH
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",metabolite aminomethylphosphonic acid,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,cancer,DISEASE
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",metabolite aminomethylphosphonic acid,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,Parkinson's Alzheimer's diseases,DISEASE
29267136,"Recently, glyphosate and its metabolite aminomethylphosphonic acid (AMPA) have been identified as possible contributors to the emergence of various diseases such as autism, Parkinson's and Alzheimer's diseases, as well as cancer.",metabolite aminomethylphosphonic acid,CHEMICAL,be identified as possible contributors to emergence of various diseases such as,autism,MENTAL_HEALTH
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,PD,DISEASE,be associated with decreased levels of,5-HT,CHEMICAL
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,PD,DISEASE,be associated with decreased levels of,noradrenaline,CHEMICAL
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,Depression,MENTAL_HEALTH,be associated with decreased levels of,5-HT,CHEMICAL
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,Depression,MENTAL_HEALTH,be associated with decreased levels of,noradrenaline,CHEMICAL
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,PD,DISEASE,respond to,tricyclic antidepressants,CHEMICAL
1571855,Depression in PD is associated with decreased levels of noradrenaline and 5-HT and responds to tricyclic antidepressants.,Depression,MENTAL_HEALTH,respond to,tricyclic antidepressants,CHEMICAL
1571855,Drug-induced psychosis reflects stimulation of mesolimbic-cortical dopamine receptors.,Drug-induced psychosis,MENTAL_HEALTH,reflect stimulation of,mesolimbic-cortical dopamine receptors,CHEMICAL
10755680,"Alcohol use was the most common type of substance use disorder, followed by cannabis and cocaine use.",Alcohol use,CHEMICAL,be common type of,cannabis,CHEMICAL
10755680,"Alcohol use was the most common type of substance use disorder, followed by cannabis and cocaine use.",Alcohol use,CHEMICAL,be common type of,cocaine,CHEMICAL
35378251,The 5-F quinazolinone 34 demonstrated tumor regression in an H1975 efficacy model upon once daily oral dosing at 25 mg/kg.,5-F quinazolinone,CHEMICAL,demonstrate tumor regression in,mg/kg,CHEMICAL
35378251,The 5-F quinazolinone 34 demonstrated tumor regression in an H1975 efficacy model upon once daily oral dosing at 25 mg/kg.,5-F quinazolinone,CHEMICAL,demonstrate,tumor regression,MENTAL_HEALTH
35378251,The 5-F quinazolinone 34 demonstrated tumor regression in an H1975 efficacy model upon once daily oral dosing at 25 mg/kg.,5-F quinazolinone,CHEMICAL,demonstrate,tumor regression,DISEASE
35530345,Rechallenge with EGFR inhibitors represents a promising strategy for patients with RAS wild type (WT) colorectal cancer (CRC) but definitive selection criteria are lacking.,EGFR inhibitors,CHEBI,represent promising strategy for patients with,cancer selection criteria,DISEASE
35115638,"Lithium (Li+), the archetypal mood stabiliser, is neuroprotective in animal models of stroke, albeit underlying mechanisms remain unknown.",Lithium,NUTRITION,be neuroprotective in animal models of,stroke,DISEASE
35115638,"Lithium (Li+), the archetypal mood stabiliser, is neuroprotective in animal models of stroke, albeit underlying mechanisms remain unknown.",Li+,CHEMICAL,be neuroprotective in animal models of,stroke,DISEASE
35115638,"Lithium (Li+), the archetypal mood stabiliser, is neuroprotective in animal models of stroke, albeit underlying mechanisms remain unknown.",archetypal mood stabiliser,CHEBI,be neuroprotective in animal models of,stroke,DISEASE
35115638,We discover that Li+ inhibits activation of nucleotide-binding oligomerisation domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes in the middle cerebral artery occlusion (MCAO) stroke model in mice.,Li+,CHEMICAL,inhibit activation of,middle cerebral artery occlusion,DISEASE
35115638,We discover that Li+ inhibits activation of nucleotide-binding oligomerisation domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasomes in the middle cerebral artery occlusion (MCAO) stroke model in mice.,Li+,CHEMICAL,inhibit activation of,stroke model,DISEASE
35115638,"Using immunocytochemstry, MRI imaging, and cell sorting with subsequent mRNA and protein quantification, we demonstrate that Li+ decreases the infarct volume, improves motor function, and alleviates associated cognitive and depressive impairments.",Li+,CHEMICAL,alleviate associated,cognitive impairments,DISEASE
2723659,Kinetic analysis demonstrated biphasic rates of association and dissociation for both [3H]bremazocine and [3H]U69593.,dissociation,MENTAL_HEALTH,have biphasic rates for,[3H]bremazocine,CHEMICAL
2723659,Guanine nucleotides promote the dissociation of this ternary complex and the stabilisation of a lower-affinity state of the receptor.,Guanine nucleotides,CHEMICAL,promote,dissociation,MENTAL_HEALTH
35458676,"(2) Methods: Morphine dependence in mice was obtained by administration of increasing doses of morphine for eight consecutive days, twice a day.",Morphine dependence,MENTAL_HEALTH,be obtained by administration of increasing doses of,morphine,CHEMICAL
35458676,"In addition, the cessation of morphine administration induced depressive behavior in mice which were observed during short- and long-term morphine withdrawal.",morphine administration,CHEMICAL,induce in,depressive behavior,DISEASE
35458676,Linagliptin administered during morphine withdrawal significantly reduced the depressive behavior in studied mice.,Linagliptin,CHEMICAL,reduce,depressive behavior,DISEASE
35458676,"Furthermore, the short-term morphine withdrawal evoked anxiety which also was reduced by linagliptin in mice.",short-term morphine withdrawal,CHEMICAL,evoke,anxiety,MENTAL_HEALTH
35458676,(4) Conclusions: The present study reveals that GLP-1 receptors are involved in morphine dependence.,GLP-1 receptors,CHEMICAL,be involved in,morphine dependence,MENTAL_HEALTH
35458676,"What is more, linagliptin might be a valuable drug in attenuating the physical symptoms of morphine dependence.",linagliptin,CHEMICAL,attenuate physical symptoms of,morphine dependence,MENTAL_HEALTH
35458676,"What is more, linagliptin might be a valuable drug in attenuating the physical symptoms of morphine dependence.",linagliptin,CHEMICAL,be,valuable drug,CHEBI
12955099,Nicotinic acetylcholine receptors (nAChRs) have been implicated in a number of neurological disorders.,Nicotinic acetylcholine receptors,CHEMICAL,be implicated in number of,neurological disorders,DISEASE
12955099,"In conclusion, 5-I-A-85380 is clearly a useful ligand for both in vitro and in vivo single photon emission tomography human studies investigating disease symptoms and progression, response to acetylcholinesterase-inhibiting drugs and in differentiating primary degenerative dementia from VaD.",5-I-A-85380,CHEMICAL,differentiate,primary degenerative dementia,DISEASE
12955099,"In conclusion, 5-I-A-85380 is clearly a useful ligand for both in vitro and in vivo single photon emission tomography human studies investigating disease symptoms and progression, response to acetylcholinesterase-inhibiting drugs and in differentiating primary degenerative dementia from VaD.",5-I-A-85380,CHEMICAL,differentiate,primary degenerative dementia,MENTAL_HEALTH
20297872,"Levodopa is the most efficacious treatment; however, higher doses and long-term use are associated with adverse effects such as motor fluctuations and dyskinesia.",Levodopa,CHEMICAL,be associated with adverse effects such as,dyskinesia,MENTAL_HEALTH
20297872,Early treatment of PD with other agents such as dopamine agonists and monoamine oxidase type B inhibitors can provide symptomatic benefit and delay initiation of levodopa therapy.,dopamine agonists,CHEBI,delay initiation of,levodopa therapy,CHEMICAL
20297872,Early treatment of PD with other agents such as dopamine agonists and monoamine oxidase type B inhibitors can provide symptomatic benefit and delay initiation of levodopa therapy.,PD,DISEASE,delay initiation of,levodopa therapy,CHEMICAL
20297872,Early treatment of PD with other agents such as dopamine agonists and monoamine oxidase type B inhibitors can provide symptomatic benefit and delay initiation of levodopa therapy.,dopamine agonists,CHEMICAL,delay initiation of,levodopa therapy,CHEMICAL
11853799,"However, treatment with desmopressin resolved primary nocturnal enuresis completely.",desmopressin,CHEMICAL,resolve,primary nocturnal enuresis,DISEASE
11853799,"However, treatment with desmopressin resolved primary nocturnal enuresis completely.",desmopressin,CHEMICAL,resolve,primary nocturnal enuresis,MENTAL_HEALTH
11853799,This observation questions the notion that desmopressin resolves primary nocturnal enuresis through pharmacological manipulation of renal concentrating ability only.,desmopressin,CHEMICAL,resolve,primary nocturnal enuresis,DISEASE
11853799,This observation questions the notion that desmopressin resolves primary nocturnal enuresis through pharmacological manipulation of renal concentrating ability only.,desmopressin,CHEMICAL,resolve,primary nocturnal enuresis,MENTAL_HEALTH
35489049,"The relative risk of the sexual consequences development, such as gynecomastia, has been documented using lansoprazole and omeprazole in various cohort studies.",gynecomastia,DISEASE,use,lansoprazole,CHEMICAL
35489049,"The relative risk of the sexual consequences development, such as gynecomastia, has been documented using lansoprazole and omeprazole in various cohort studies.",gynecomastia,DISEASE,use,omeprazole,CHEMICAL
29870875,"We found that FO prevented the LPS-mediated body weight loss, anhedonic behavior, reduction of locomotor activity, up-regulation of the proinflammatory cytokines and serotoninergic alterations.",FO,CHEMICAL,prevent,locomotor activity,DISEASE
29870875,"We found that FO prevented the LPS-mediated body weight loss, anhedonic behavior, reduction of locomotor activity, up-regulation of the proinflammatory cytokines and serotoninergic alterations.",FO,CHEMICAL,prevent,anhedonic behavior,DISEASE
29870875,"We found that FO prevented the LPS-mediated body weight loss, anhedonic behavior, reduction of locomotor activity, up-regulation of the proinflammatory cytokines and serotoninergic alterations.",FO,CHEMICAL,prevent,LPS-mediated body weight loss,DISEASE
29870875,"Together, our results indicated that FO may have beneficial effects on LPS induced sickness-behavior in aged mice either by modulating central inflammation, KP and serotonergic signaling (indirectly effect) or by fatty acids incorporation into neuronal membranes (direct effect).",FO,CHEMICAL,have beneficial effects on,LPS,CHEMICAL
19727292,The data suggest that approximately 58 percent of patients with a diagnosis of childhood autism receive some type of pharmaceutical treatment.,childhood autism,MENTAL_HEALTH,receive type of,pharmaceutical treatment,CHEBI
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,dizziness,DISEASE
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,nausea,DISEASE
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,constipation,DISEASE
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,dry mouth,DISEASE
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,diarrhea,DISEASE
23138680,"Treatment-emergent adverse events for duloxetine of at least 5% and twice the rate of placebo were dry mouth, constipation, nausea, diarrhea, dizziness, and fatigue.",duloxetine,CHEMICAL,be,fatigue,MENTAL_HEALTH
26437156,Zoledronic acid is a bisphosphonate that is used in patients with metastatic cancer to prevent bone complications.,Zoledronic acid,CHEMICAL,be,bisphosphonate,CHEMICAL
29883946,"Indirubin, a bis-indole alkaloid used in traditional Chinese medicine has shown remarkable anticancer activity against chronic myelocytic leukemia.",bis-indole alkaloid,CHEMICAL,show remarkable anticancer activity against,chronic myelocytic leukemia,DISEASE
29883946,"Indirubin, a bis-indole alkaloid used in traditional Chinese medicine has shown remarkable anticancer activity against chronic myelocytic leukemia.",Indirubin,CHEMICAL,show remarkable anticancer activity against,chronic myelocytic leukemia,DISEASE
2877414,Doses of APH ranging from 2.7 to 54 micrograms/day were examined for signs of toxicity.,APH,CHEMICAL,be examined for signs of,toxicity,DISEASE
2877414,"However, APH was ineffective in suppressing convulsions induced by the ED50 dose of pentylenetetrazol given subcutaneously.",APH,CHEMICAL,suppress,convulsions,DISEASE
9885387,"To determine the efficacy of the dopamine agonist levodopa for childhood amblyopia, a double-masked, placebo-controlled randomised study was performed on 32 amblyopic children with central fixation between 4 and 17 years.",dopamine agonist levodopa,CHEBI,have the efficacy for,childhood amblyopia,DISEASE
9885387,"To determine the efficacy of the dopamine agonist levodopa for childhood amblyopia, a double-masked, placebo-controlled randomised study was performed on 32 amblyopic children with central fixation between 4 and 17 years.",dopamine agonist levodopa,CHEMICAL,have the efficacy for,childhood amblyopia,DISEASE
23099054,"Therefore, the present study was designed to investigate the effect of curcumin and its co-administration with piperine against chronic unpredictable stress (CUS)-induced cognitive impairment and oxidative stress in mice.",curcumin,CHEMICAL,have the effect with,piperine,CHEMICAL
23099054,Chronic stress significantly impaired memory performance (delayed latency time to reach platform in Morris water maze as well as to reach closed arm in elevated plus maze test) and decreased locomotor activity along with sucrose consumption.,Chronic stress,MENTAL_HEALTH,decrease locomotor activity with,sucrose consumption,CHEMICAL
23099054,The results clearly suggest that piperine enhanced the bioavailability of curcumin and potentiated its protective effects against CUS induced cognitive impairment and associated oxidative damage in mice.,piperine,CHEMICAL,potentiate its protective effects against,CUS,CHEMICAL
23099054,The results clearly suggest that piperine enhanced the bioavailability of curcumin and potentiated its protective effects against CUS induced cognitive impairment and associated oxidative damage in mice.,piperine,CHEMICAL,enhance bioavailability of,curcumin,CHEMICAL
19540859,"The results showed that memory deficits were reversed with curcumin in a dose dependent manner, as were stress-induced increases in serum corticosterone levels.",memory deficits,DISEASE,be reversed with,curcumin,CHEMICAL
19540859,In primary hippocampal neurons it was shown that curcumin or imipramine protected hippocampal neurons against corticosterone-induced toxicity.,imipramine,CHEMICAL,protect hippocampal neurons against,corticosterone-induced toxicity,DISEASE
19540859,In primary hippocampal neurons it was shown that curcumin or imipramine protected hippocampal neurons against corticosterone-induced toxicity.,curcumin,CHEMICAL,protect hippocampal neurons against,corticosterone-induced toxicity,DISEASE
19540859,"Thus, curcumin may be an effective therapeutic for learning and memory disturbances as was seen within these stress models, and its neuroprotective effect was mediated in part by normalizing the corticosterone response, resulting in down-regulating of the pCaMKII and glutamate receptor levels.",curcumin,CHEMICAL,result in down-regulating of,pCaMKII receptor levels,CHEMICAL
19540859,"Thus, curcumin may be an effective therapeutic for learning and memory disturbances as was seen within these stress models, and its neuroprotective effect was mediated in part by normalizing the corticosterone response, resulting in down-regulating of the pCaMKII and glutamate receptor levels.",curcumin,CHEMICAL,result in down-regulating of,glutamate,CHEMICAL
25619176,We conducted a systematic review of randomized-controlled trials (RCTs) to determine the efficacy and safety of aripiprazole augmentation of clozapine for schizophrenia.,clozapine,CHEMICAL,have aripiprazole augmentation for,schizophrenia,MENTAL_HEALTH
25619176,"The pooled standardized mean differences (SMDs, 95% CIs) (Z-test; number of study; I(2)-index) suggested trends of aripiprazole augmentation benefits on overall psychotic [-0.40 (-0.87 to 0.07) (n = 3; Z = 1.68, p = 0.09; I(2) = 68%)], positive [-1.05 (-2.39 to 0.29) (n = 3; Z = 1.54, p = 0.12; I(2) = 94%)], and negative [-0.36 (-0.77 to 0.05) (n = 3; Z = 1.74, p = 0.08; I(2) = 54%)] symptoms.",aripiprazole augmentation,CHEMICAL,have trends on,overall psychotic,DISEASE
28957012,Twenty percent of E. faecalis and 80% of E. faecium isolates were resistant to high-concentration streptomycin.,E. faecium isolates,CHEMICAL,be resistant to,high-concentration streptomycin,CHEMICAL
28957012,Twenty percent of E. faecalis and 80% of E. faecium isolates were resistant to high-concentration streptomycin.,E. faecalis,DISEASE,be resistant to,high-concentration streptomycin,CHEMICAL
28957012,One third of E. faecalis and 70% of E. faecium isolates were intermediately susceptible to erythromycin.,E. faecium isolates,CHEMICAL,be susceptible to,erythromycin,CHEMICAL
28957012,One third of E. faecalis and 70% of E. faecium isolates were intermediately susceptible to erythromycin.,E. faecalis,DISEASE,be susceptible to,erythromycin,CHEMICAL
1662477,"NBQX microinjected into the subthalamic nucleus, internal pallidal segment, and reticular part of the substantia nigra, but not into the laterodorsal neostriatum of the rats, stimulated locomotor activity and reduced muscular rigidity.",NBQX,CHEMICAL,reduce,muscular rigidity,DISEASE
1662477,"In aged Rhesus monkeys with bilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism, intramuscular NBQX produced clinically apparent improvement in akinesia, tremor, posture, and gross motor skills.",intramuscular NBQX,CHEMICAL,"produce in aged rhesus monkeys with bilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement in",tremor,DISEASE
1662477,"In aged Rhesus monkeys with bilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism, intramuscular NBQX produced clinically apparent improvement in akinesia, tremor, posture, and gross motor skills.",intramuscular NBQX,CHEMICAL,"produce in aged rhesus monkeys with bilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement in",akinesia skills,MENTAL_HEALTH
1662477,"In aged Rhesus monkeys with bilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism, intramuscular NBQX produced clinically apparent improvement in akinesia, tremor, posture, and gross motor skills.",intramuscular NBQX,CHEMICAL,produce in aged rhesus monkeys with,"1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism apparent improvement",DISEASE
1662477,Blockade of excitatory synaptic transmission by AMPA receptor antagonists may provide a new therapeutic strategy for Parkinson's disease (PD).,AMPA receptor antagonists,CHEBI,provide new therapeutic strategy for parkinson's,PD,DISEASE
33064217,"The regression tree analyses indicated extracted chlorophyll, CDOM, and NTU were the three most influential parameters on phycocyanin concentrations.",tree analyses,NUTRITION,indicate extracted,chlorophyll,CHEMICAL
33064217,"The regression tree analyses indicated extracted chlorophyll, CDOM, and NTU were the three most influential parameters on phycocyanin concentrations.",tree analyses,NUTRITION,indicate extracted,CDOM,CHEMICAL
33064217,"The regression tree analyses indicated extracted chlorophyll, CDOM, and NTU were the three most influential parameters on phycocyanin concentrations.",regression tree,MENTAL_HEALTH,indicate extracted,chlorophyll,CHEMICAL
33064217,"The regression tree analyses indicated extracted chlorophyll, CDOM, and NTU were the three most influential parameters on phycocyanin concentrations.",regression tree,MENTAL_HEALTH,indicate extracted,CDOM,CHEMICAL
32764428,"Elevated microcystin concentrations were not positively correlated with numbers of cyanobacterial cells, but multiple linear regression analysis suggested temperature and dissolved oxygen explained a significant amount of the variability in microcystin across both reservoirs.",multiple linear regression analysis,MENTAL_HEALTH,suggest,dissolved oxygen,CHEMICAL
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",NAA,CHEMICAL,be quantified,schizophrenia,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",NAA,CHEMICAL,be quantified,bipolar disorder,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",Choline Cho resonance intensities,NUTRITION,be quantified,schizophrenia,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",Choline Cho resonance intensities,NUTRITION,be quantified,bipolar disorder,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",Creatine,CHEMICAL,be quantified,schizophrenia,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",Creatine,CHEMICAL,be quantified,bipolar disorder,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",N-acetyl aspartate,CHEMICAL,be quantified,schizophrenia,MENTAL_HEALTH
18437276,"N-acetyl aspartate (NAA), Creatine (Cr), and Choline (Cho) metabolite resonance intensities were all quantified in the cingulum, a region of interest in schizophrenia and bipolar disorder.",N-acetyl aspartate,CHEMICAL,be quantified,bipolar disorder,MENTAL_HEALTH
18437276,Schizophrenia patients showed a significantly higher Cho/Cre as well as lower NAA/Cho ratios as compared with controls and bipolar patients.,Schizophrenia patients,MENTAL_HEALTH,show,higher Cho/Cre,CHEMICAL
18437276,Schizophrenia patients showed a significantly higher Cho/Cre as well as lower NAA/Cho ratios as compared with controls and bipolar patients.,Schizophrenia patients,MENTAL_HEALTH,show,lower NAA/Cho ratios,CHEMICAL
18437276,Schizophrenia patients showed a significantly higher Cho/Cre as well as lower NAA/Cho ratios as compared with controls and bipolar patients.,Schizophrenia patients,MENTAL_HEALTH,compare with,bipolar patients,DISEASE
1560892,The effects of SDAT on this task are consistent with previous results with anticholinergic agents in rats.,SDAT,DISEASE,be consistent with previous results with,anticholinergic agents,CHEBI
2109766,It is theoretically possible that pharmacologic therapy with anticholinergic agents or imipramine could improve incontinence in this group.,anticholinergic agents,CHEBI,improve,incontinence,DISEASE
2109766,It is theoretically possible that pharmacologic therapy with anticholinergic agents or imipramine could improve incontinence in this group.,imipramine,CHEMICAL,improve,incontinence,DISEASE
17918759,"Today, morphine and related compounds are still used as a first line therapy in the treatment of moderate to severe pain.",morphine compounds,CHEMICAL,be used as first line therapy in treatment of moderate to,severe pain,DISEASE
17918759,"However, despite the clear benefits of mu agonists in pain management, severe side effects such as dependence and respiratory depression are associated with use of these drugs.",respiratory depression,MENTAL_HEALTH,be associated,pain management,DISEASE
17918759,"However, despite the clear benefits of mu agonists in pain management, severe side effects such as dependence and respiratory depression are associated with use of these drugs.",respiratory depression,MENTAL_HEALTH,be associated,mu agonists,CHEBI
17918759,"However, despite the clear benefits of mu agonists in pain management, severe side effects such as dependence and respiratory depression are associated with use of these drugs.",mu agonists,CHEBI,have the clear benefits in,pain management,DISEASE
8214728,"Through the first 12 h postpartum, the BU group achieved significantly greater analgesia than the morphine sulfate (control) (MS), NB, and NX groups, a significantly lower incidence of severe pruritus than the MS group, and significantly greater satisfaction than MS and NX groups.",BU group,CHEMICAL,achieve through,h postpartum greater analgesia,MENTAL_HEALTH
8214728,"Through the first 12 h postpartum, the BU group achieved significantly greater analgesia than the morphine sulfate (control) (MS), NB, and NX groups, a significantly lower incidence of severe pruritus than the MS group, and significantly greater satisfaction than MS and NX groups.",BU group,CHEMICAL,achieve through,severe pruritus,DISEASE
8214728,"Through the first 12 h postpartum, the BU group achieved significantly greater analgesia than the morphine sulfate (control) (MS), NB, and NX groups, a significantly lower incidence of severe pruritus than the MS group, and significantly greater satisfaction than MS and NX groups.",BU group,CHEMICAL,achieve through,NB,DISEASE
8214728,"Through the first 12 h postpartum, the BU group achieved significantly greater analgesia than the morphine sulfate (control) (MS), NB, and NX groups, a significantly lower incidence of severe pruritus than the MS group, and significantly greater satisfaction than MS and NX groups.",BU group,CHEMICAL,achieve through,morphine sulfate,CHEMICAL
8214728,Epidural morphine and BU promoted better analgesia and satisfaction than any previously documented postcesarean regimen.,BU,CHEMICAL,promote,better analgesia,MENTAL_HEALTH
8214728,Epidural morphine and BU promoted better analgesia and satisfaction than any previously documented postcesarean regimen.,Epidural morphine,CHEMICAL,promote,better analgesia,MENTAL_HEALTH
26140267,"Vaccinium Macrocarpon (cranberry), commonly used against UTI in adult women, is also effective in reducing the number of recurrences and related antimicrobial use in children.",cranberry,NUTRITION,reduce number of,related antimicrobial use,CHEBI
11692301,"Specific syndromes may also be addressed by nutritional interventions (for example, cranberry juice consumption to reduce urinary tract infections) and may reduce antibiotic use in older adults, particularly those living in long-term care facilities.",Specific syndromes,MENTAL_HEALTH,be addressed by,cranberry juice,NUTRITION
34867405,"The behavior tests such as sucrose preference test, forced swimming test and novelty-suppressed feeding test were measured to evaluate depressive-like behaviors of model mice.",sucrose preference test,CHEMICAL,evaluate,depressive-like behaviors,DISEASE
34867405,"Results: After 6-weeks of modeling, the behavioral data showed that mice in CUMS group and solvent group had obvious depressive-like behaviors, and the medication of Xiaoyaosan or Nec-1 could improve these behavioral changes.",CUMS group,DISEASE,have,obvious depressive-like behaviors,DISEASE
25560671,"Kai-Xin-San (KXS), a well-known traditional Chinese herbal decoction, has been widely used to treat mental depression and memory loss in China.",KXS,CHEMICAL,treat,mental depression,MENTAL_HEALTH
25560671,"Kai-Xin-San (KXS), a well-known traditional Chinese herbal decoction, has been widely used to treat mental depression and memory loss in China.",KXS,CHEMICAL,treat,memory loss,DISEASE
9413929,"Chronic ethanol abuse during pregnancy can cause fetal injury, including the fetal alcohol syndrome (FAS).",Chronic ethanol abuse,MENTAL_HEALTH,cause,FAS,CHEMICAL
9413929,"Chronic ethanol abuse during pregnancy can cause fetal injury, including the fetal alcohol syndrome (FAS).",Chronic ethanol abuse,MENTAL_HEALTH,cause,fetal alcohol syndrome,MENTAL_HEALTH
1650413,Ethanol affected the ability of murine embryonic palate mesenchymal (MEPM) cells to produce cAMP in response to hormone treatment.,Ethanol,CHEMICAL,affect ability of,mesenchymal,DISEASE
3044173,The role of zinc deficiency in the etiology of ethanol-associated fetotoxicity was assessed by measurement of maternal and newborn hair zinc content in a nonhuman primate model of the fetal alcohol syndrome.,zinc deficiency,CHEMICAL,be assessed by measurement of maternal and newborn hair zinc content in nonhuman primate model of,fetal alcohol syndrome,MENTAL_HEALTH
3044173,The role of zinc deficiency in the etiology of ethanol-associated fetotoxicity was assessed by measurement of maternal and newborn hair zinc content in a nonhuman primate model of the fetal alcohol syndrome.,ethanol-associated fetotoxicity,DISEASE,be assessed by measurement of maternal and newborn hair zinc content in nonhuman primate model of,fetal alcohol syndrome,MENTAL_HEALTH
3044173,The role of zinc deficiency in the etiology of ethanol-associated fetotoxicity was assessed by measurement of maternal and newborn hair zinc content in a nonhuman primate model of the fetal alcohol syndrome.,zinc deficiency,CHEMICAL,be assessed by measurement of,maternal hair zinc content,CHEMICAL
3044173,The role of zinc deficiency in the etiology of ethanol-associated fetotoxicity was assessed by measurement of maternal and newborn hair zinc content in a nonhuman primate model of the fetal alcohol syndrome.,ethanol-associated fetotoxicity,DISEASE,be assessed by measurement of,maternal hair zinc content,CHEMICAL
3044173,The ethanol-exposed infant monkeys had a significantly higher incidence of craniofacial dysmorphology and developmental delay compared to the controls.,ethanol-exposed infant monkeys,CHEMICAL,have higher incidence of,craniofacial dysmorphology,DISEASE
3044173,"Although the findings cannot exclude transient or early gestational zinc deficiency as a factor, they provide further evidence that ethanol (and/or its metabolites) is the proximate toxin in the type of fetal injury seen in the fetal alcohol syndrome.",ethanol,CHEMICAL,be,proximate toxin,CHEBI
30105472,"Finally, we argue that TCAs, and particularly MAOIs, should continue to play an important role in the modern treatment of depression, especially in the treatment-resistant patient.",MAOIs,CHEMICAL,play important role in modern treatment of,depression,MENTAL_HEALTH
30105472,"Finally, we argue that TCAs, and particularly MAOIs, should continue to play an important role in the modern treatment of depression, especially in the treatment-resistant patient.",TCAs,CHEMICAL,play important role in modern treatment of,depression,MENTAL_HEALTH
30176835,Supplementation of N-acetylcysteine (NAC) to ongoing antidepressant therapy may positively influence outcome of depression treatment in these patients.,NAC,CHEMICAL,influence outcome of,depression treatment,MENTAL_HEALTH
30176835,Supplementation of N-acetylcysteine (NAC) to ongoing antidepressant therapy may positively influence outcome of depression treatment in these patients.,ongoing antidepressant therapy,CHEMICAL,influence outcome of,depression treatment,MENTAL_HEALTH
30176835,Supplementation of N-acetylcysteine (NAC) to ongoing antidepressant therapy may positively influence outcome of depression treatment in these patients.,N-acetylcysteine,CHEMICAL,influence outcome of,depression treatment,MENTAL_HEALTH
30176835,"Therefore, this study aims to investigate the efficacy of NAC supplementation in patients with insufficient response to standard antidepressant treatment, and to explore potential roles of inflammation and oxidative stress involved in the alleged pathophysiological processes of TRD.",NAC supplementation,CHEMICAL,in patients with,standard antidepressant treatment,CHEMICAL
31614949,"In conclusion, high-dose NR induces the onset of WAT dysfunction, which may in part explain the deterioration of metabolic health.",high-dose NR,CHEMICAL,induce in conclusion onset of,WAT dysfunction,DISEASE
21450002,"The NA regulatory circuit in P. putida has evolved an additional repression loop based on the NicR-dependent cross regulation of the nicS gene, thus assuring a tight transcriptional control of the catabolic genes that may prevent depletion of this vitamin B3 when needed for the synthesis of essential cofactors.",P. putida,DISEASE,evolve,additional repression loop,MENTAL_HEALTH
21450002,"The NA regulatory circuit in P. putida has evolved an additional repression loop based on the NicR-dependent cross regulation of the nicS gene, thus assuring a tight transcriptional control of the catabolic genes that may prevent depletion of this vitamin B3 when needed for the synthesis of essential cofactors.",NA regulatory circuit,CHEMICAL,evolve,additional repression loop,MENTAL_HEALTH
26340057,"Mammary tumours were induced by N-methyl-N-nitrosourea (50 mg/kg, intraperitoneal, on the 41st postnatal day).",Mammary tumours,DISEASE,be induced by,N-methyl-N-nitrosourea,CHEMICAL
32753819,Wernicke's encephalopathy is an acute neurological disorder caused due to thiamine deficiency.,Wernicke's encephalopathy,DISEASE,caused due to,thiamine deficiency,CHEBI
27325794,"Decitabine (5-aza-2'-deoxycytidine, aza-dCyd) is an anti-cancer drug used clinically for the treatment of myelodysplastic syndromes and acute myeloid leukaemia that can act as a DNA-demethylating or genotoxic agent in a dose-dependent manner.",Decitabine 5-aza-2'-deoxycytidine,CHEMICAL,used for treatment of,acute myeloid leukaemia,DISEASE
27325794,"Decitabine (5-aza-2'-deoxycytidine, aza-dCyd) is an anti-cancer drug used clinically for the treatment of myelodysplastic syndromes and acute myeloid leukaemia that can act as a DNA-demethylating or genotoxic agent in a dose-dependent manner.",Decitabine 5-aza-2'-deoxycytidine,CHEMICAL,used for treatment of,myelodysplastic syndromes,MENTAL_HEALTH
20561600,With the discovery that thymidine phosphorylase deficiency causes destabilization of mitochondrial DNA and a severe multisystemic syndrome the importance of dNTP pool balance was extended to mitochondria.,thymidine phosphorylase deficiency,CHEMICAL,cause with discovery destabilization of mitochondrial dna and severe multisystemic syndrome importance of,dNTP pool balance,CHEMICAL
20561600,With the discovery that thymidine phosphorylase deficiency causes destabilization of mitochondrial DNA and a severe multisystemic syndrome the importance of dNTP pool balance was extended to mitochondria.,thymidine phosphorylase deficiency,CHEMICAL,cause with discovery destabilization of,severe multisystemic syndrome importance,DISEASE
21521362,"Vitamin A has been characterized as a potential neurotoxin, because ingestion of such vitamin - or its derivatives, the retinoids - at moderate to high doses elicits a myriad of deleterious effects, from acute intoxication involving head-ache, confusion, and 'pseudo tumor cerebri' to chronic, and perhaps irreversible, abnormalities, including irritability, anxiety, depression, and suicide ideation.",Vitamin A,CHEBI,be characterized as,potential neurotoxin,CHEBI
21521362,"Nevertheless, it still remains to be found the mechanism by which vitamin A induces cognitive decline.",vitamin A,CHEBI,induce by,cognitive decline,DISEASE
7913073,Hydralazine (1 mM) produced a rightward shift with depression of the maximal tension of the concentration-response curves for all the agonists tested.,Hydralazine,CHEMICAL,produce rightward shift with depression of maximal tension of,agonists,CHEBI
7913073,Hydralazine (1 mM) produced a rightward shift with depression of the maximal tension of the concentration-response curves for all the agonists tested.,Hydralazine,CHEMICAL,produce rightward shift with,depression,MENTAL_HEALTH
1982669,Prazosin (1-50 nM) markedly depressed maximum contractile responses to PE of endothelium-intact (but not denuded) thoracic aortic rings from both non-pregnant and 20-day pregnant rats.,Prazosin,CHEMICAL,depress maximum contractile responses to pe of,endothelium-intact thoracic aortic rings,CHEMICAL
34400791,"Down syndrome (DS) is a disorder characterised by marked immune dysfunction, increased mortality from sepsis, chronic inflammation, increased oxidative stress, sleep disturbance and possibly abnormal endogenous melatonin levels.",Down syndrome,MENTAL_HEALTH,characterised by,marked immune dysfunction,DISEASE
32748152,Saturated fatty acid esters may cause mastalgia via hypersensitivity of breast epithelium to circulating hormones.,Saturated fatty acid esters,NUTRITION,cause mastalgia via hypersensitivity of breast epithelium to,circulating hormones,CHEBI
32748152,Saturated fatty acid esters may cause mastalgia via hypersensitivity of breast epithelium to circulating hormones.,Saturated fatty acid esters,NUTRITION,cause mastalgia via,hypersensitivity,DISEASE
30463345,"Hormones, growth factors, morphogens could unwontedly protect tumour cells or induce cancer cell proliferation and are thus considered incompatible with many chemotherapy regimens.",Hormones,CHEBI,protect,tumour cells,DISEASE
30463345,"In vitro, Annurca Apple Polyphenolic Extract (AAE) protects murine Hair Follicles (HF) from taxanes induced dystrophy.",AAE,DISEASE,protect,HF,DISEASE
30463345,"In vitro, Annurca Apple Polyphenolic Extract (AAE) protects murine Hair Follicles (HF) from taxanes induced dystrophy.",AAE,DISEASE,protect,taxanes,CHEMICAL
30463345,"In vitro, Annurca Apple Polyphenolic Extract (AAE) protects murine Hair Follicles (HF) from taxanes induced dystrophy.",AAE,DISEASE,protect,dystrophy,DISEASE
30463345,"AAE forces HFs to produce ATP using mitochondrial β-oxidation, reducing Pentose Phosphate Pathway (PPP) rate and nucleotides production.",AAE forces,DISEASE,reduce,Pentose Phosphate Pathway,CHEMICAL
30463345,"AAE forces HFs to produce ATP using mitochondrial β-oxidation, reducing Pentose Phosphate Pathway (PPP) rate and nucleotides production.",AAE forces,DISEASE,reduce,Pathway PPP rate,CHEMICAL
30463345,"Moreover, measuring the effect exerted on Poly Unsaturated Fatty Acid (PUFA) metabolism, we prove that AAE promotes hair-growth by increasing the intracellular levels of Prostaglandins F2α (PGF2α) and by hijacking PUFA catabolites toward β-oxidation.",AAE,DISEASE,increase intracellular levels of,Prostaglandins F2α,CHEMICAL
30463345,"Moreover, measuring the effect exerted on Poly Unsaturated Fatty Acid (PUFA) metabolism, we prove that AAE promotes hair-growth by increasing the intracellular levels of Prostaglandins F2α (PGF2α) and by hijacking PUFA catabolites toward β-oxidation.",AAE,DISEASE,hijack,PUFA catabolites,CHEMICAL
28934522,"In anesthetized rats, dronabinol attenuates reflex apnea via activation of cannabinoid (CB) receptors located on vagal afferents; an effect blocked by cannabinoid type 1 (CB1) and/or type 2 (CB2) receptor antagonists.",dronabinol,CHEMICAL,reflex,apnea,DISEASE
23451087,"The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the structural information of TryS from Leishmania major has become available.",trypanothione synthetase,CHEMICAL,catalyse two-step biosynthesis of trypanothione from,glutathione,CHEMICAL
23451087,"The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the structural information of TryS from Leishmania major has become available.",trypanothione synthetase,CHEMICAL,catalyse two-step biosynthesis of trypanothione from,spermidine,CHEMICAL
23451087,"The trypanothione synthetase (TryS) catalyses the two-step biosynthesis of trypanothione from spermidine and glutathione and is an attractive new drug target for the development of trypanocidal and antileishmanial drugs, especially since the structural information of TryS from Leishmania major has become available.",trypanothione synthetase,CHEMICAL,catalyse two-step biosynthesis of,trypanothione,CHEMICAL
7965440,"Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome.",major depressive disorder,MENTAL_HEALTH,have new onset or worsening of,LSD flashback syndrome,MENTAL_HEALTH
7965440,"Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome.",antidepressant therapy,CHEMICAL,have new onset or worsening of,LSD flashback syndrome,MENTAL_HEALTH
7965440,"Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome.",selective serotonin reuptake inhibitor agents,CHEBI,have new onset or worsening of,LSD flashback syndrome,MENTAL_HEALTH
7965440,"Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome.",lysergic acid diethylamide,CHEMICAL,have new onset or worsening of,LSD flashback syndrome,MENTAL_HEALTH
7965440,"Two adolescents with a long history of abuse of lysergic acid diethylamide (LSD) and symptoms consistent with major depressive disorder, on initiation of antidepressant therapy with selective serotonin reuptake inhibitor agents, had the new onset or worsening of LSD flashback syndrome.",antidepressant therapy,CHEMICAL,have initiation with,selective serotonin reuptake inhibitor agents,CHEBI
7965440,The similarity in neuroreceptor physiology for both LSD and serotonin suggests that the LSD flashback syndrome may be induced by these drugs in patients with a history of LSD abuse.,LSD flashback syndrome,MENTAL_HEALTH,be induced by drugs in patients with history of,LSD abuse,DISEASE
28986194,"Triethyl citrate (TEC) was found to be a better liquid plasticizer than PEG 400 both in reducing the glass transition temperature of the coating polymer (cellulose acetate) and in increasing the electrical conductivity of the ODDS cores, both of which led to an enhanced coating powder adhesion and film formation.",Triethyl citrate,NUTRITION,reduce glass transition temperature of,polymer,CHEBI
22355323,The aim of this study was to examine the effects of eight α-adrenoceptor antagonists on ABCG2/BCRP-mediated resistance and transport.,α-adrenoceptor antagonists,CHEBI,have the effects on,ABCG2/BCRP-mediated resistance,MENTAL_HEALTH
20100992,"alpha-Adrenoceptor antagonists have been a rational first choice; nevertheless, calcium channel blockers are primarily used in autonomic dysreflexia management.",calcium channel blockers,CHEMICAL,be used in,autonomic dysreflexia management,DISEASE
20100992,"In spinal cord-injured individuals, phentolamine significantly reduced the leg vascular resistance increase during autonomic dysreflexia (8+/-5 versus 24+/-13 arbitrary units; P=0.04) in contrast to nicardipine (15+/-10 versus 24+/-13 arbitrary units; P=0.12).",phentolamine,CHEMICAL,leg vascular resistance increase during,nicardipine,CHEMICAL
20100992,"In spinal cord-injured individuals, phentolamine significantly reduced the leg vascular resistance increase during autonomic dysreflexia (8+/-5 versus 24+/-13 arbitrary units; P=0.04) in contrast to nicardipine (15+/-10 versus 24+/-13 arbitrary units; P=0.12).",phentolamine,CHEMICAL,leg vascular resistance increase during,autonomic dysreflexia,DISEASE
20100992,"In spinal cord-injured individuals, phentolamine significantly reduced the leg vascular resistance increase during autonomic dysreflexia (8+/-5 versus 24+/-13 arbitrary units; P=0.04) in contrast to nicardipine (15+/-10 versus 24+/-13 arbitrary units; P=0.12).",phentolamine,CHEMICAL,leg,resistance increase,MENTAL_HEALTH
20100992,"In controls, phentolamine completely abolished the leg vascular resistance increase during a cold pressure test (1+/-2 versus 18+/-14 arbitrary units; P=0.02).",phentolamine,CHEMICAL,abolish in,leg vascular resistance,MENTAL_HEALTH
19463021,"Current data suggest that ACE inhibitors or angiotensin receptor blockers with or without a diuretic are important, if not preferred, initial therapies for the patient with diabetes and hypertension.",angiotensin receptor blockers,CHEMICAL,be important initial therapies for patient with,hypertension,DISEASE
19463021,"Current data suggest that ACE inhibitors or angiotensin receptor blockers with or without a diuretic are important, if not preferred, initial therapies for the patient with diabetes and hypertension.",angiotensin receptor blockers,CHEMICAL,be important initial therapies for patient with,diabetes,DISEASE
11110849,"The antioxidant properties of vitamin E were established (P: < 0.01) by the elevation of plasma vitamin E, together with depression in both plasma malondialdehyde and urinary DNA adduct 8-hydroxy-2'-deoxyguanosine after supplementation.",vitamin E,CHEBI,be established,plasma malondialdehyde,CHEMICAL
11110849,"The antioxidant properties of vitamin E were established (P: < 0.01) by the elevation of plasma vitamin E, together with depression in both plasma malondialdehyde and urinary DNA adduct 8-hydroxy-2'-deoxyguanosine after supplementation.",vitamin E,CHEBI,be established,plasma vitamin E,CHEBI
11110849,"The antioxidant properties of vitamin E were established (P: < 0.01) by the elevation of plasma vitamin E, together with depression in both plasma malondialdehyde and urinary DNA adduct 8-hydroxy-2'-deoxyguanosine after supplementation.",vitamin E,CHEBI,be established,depression,MENTAL_HEALTH
11110849,"The antioxidant properties of vitamin E were established (P: < 0.01) by the elevation of plasma vitamin E, together with depression in both plasma malondialdehyde and urinary DNA adduct 8-hydroxy-2'-deoxyguanosine after supplementation.",vitamin E,CHEBI,be established,urinary DNA adduct 8-hydroxy-2'-deoxyguanosine,CHEMICAL
27453335,"Early-life inflammation has been shown to exert profound effects on brain development and behavior, including altered emotional behavior, stress responsivity and neurochemical/neuropeptide receptor expression and function.",Early-life inflammation,DISEASE,exert profound effects on,neurochemical/neuropeptide receptor expression,CHEMICAL
7648849,Studies generally report decreased concentrations of phosphorus for both bulimia and anorexia nervosa.,phosphorus,NUTRITION,have decreased concentrations for,bulimia anorexia nervosa,MENTAL_HEALTH
7648849,"Twenty-four of 30 bulimic patients (80%) were found to have at least one elevated serum phosphorus concentration, whereas all but one of 30 age-matched controls had values within normal limits.",bulimic patients,DISEASE,have,elevated serum phosphorus concentration,NUTRITION
7648849,This preliminary study indicates that elevated serum phosphorus levels may serve as an additional objective marker for the presence of bulimia nervosa.,elevated serum phosphorus levels,NUTRITION,serve as additional objective marker for presence of,bulimia nervosa,MENTAL_HEALTH
32025904,The oral thrombopoietin (TPO) receptor agonist lusutrombopag (Mulpleta®) was developed to improve thrombocytopenia in patients with chronic liver disease prior to elective invasive medical procedures.,oral thrombopoietin TPO receptor agonist lusutrombopag,CHEBI,improve thrombocytopenia in patients with,chronic liver disease,DISEASE
32025904,The oral thrombopoietin (TPO) receptor agonist lusutrombopag (Mulpleta®) was developed to improve thrombocytopenia in patients with chronic liver disease prior to elective invasive medical procedures.,oral thrombopoietin TPO receptor agonist lusutrombopag,CHEBI,improve,thrombocytopenia,DISEASE
32025904,The oral thrombopoietin (TPO) receptor agonist lusutrombopag (Mulpleta®) was developed to improve thrombocytopenia in patients with chronic liver disease prior to elective invasive medical procedures.,thrombocytopenia,DISEASE,in patients with,chronic liver disease prior,DISEASE
35041229,"Curcumin in the female reproductive system attenuates folliculogenesis, promotes apoptosis of oocytes and blastocyst, and decreases embryo implantation and survival.",Curcumin,CHEMICAL,attenuate,folliculogenesis,DISEASE
35041229,"Curcumin inhibits vaginal infections, attenuates the severity of the premenstrual syndrome, ameliorates inflammatory conditions in polycystic ovary syndrome, improves preeclampsia, and prevents ectopic endometrial lesions.",Curcumin,CHEMICAL,ameliorate inflammatory conditions in,polycystic ovary syndrome,DISEASE
35041229,"Curcumin inhibits vaginal infections, attenuates the severity of the premenstrual syndrome, ameliorates inflammatory conditions in polycystic ovary syndrome, improves preeclampsia, and prevents ectopic endometrial lesions.",Curcumin,CHEMICAL,improve,preeclampsia,DISEASE
35041229,"Curcumin inhibits vaginal infections, attenuates the severity of the premenstrual syndrome, ameliorates inflammatory conditions in polycystic ovary syndrome, improves preeclampsia, and prevents ectopic endometrial lesions.",Curcumin,CHEMICAL,attenuate severity of,premenstrual syndrome,MENTAL_HEALTH
35041229,"Curcumin inhibits vaginal infections, attenuates the severity of the premenstrual syndrome, ameliorates inflammatory conditions in polycystic ovary syndrome, improves preeclampsia, and prevents ectopic endometrial lesions.",Curcumin,CHEMICAL,inhibit,vaginal infections,DISEASE
34331682,"Curcumin, a diarylheptanoid derivative found in turmeric, has anti-inflammatory, antioxidant, and anticancer properties; controls obesity and metabolic problems; and improves memory and mood disorders.",Curcumin,CHEMICAL,improve,memory disorders,MENTAL_HEALTH
26687135,Exposure of embryos to TMT for 4 days post fertilization (dpf) elicited a concentration-related decrease in body length and increase in axial malformation.,TMT,CHEMICAL,elicit concentration-related decrease in body length and increase in,axial malformation,DISEASE
26687135,Our study demonstrates that TMT inhibits specific neurodevelopmental stages in zebrafish embryos and suggests a possible mechanism for the toxicity of TMT in vertebrate neurodevelopment.,TMT,CHEMICAL,suggest possible mechanism for toxicity of,TMT,CHEMICAL
26687135,Our study demonstrates that TMT inhibits specific neurodevelopmental stages in zebrafish embryos and suggests a possible mechanism for the toxicity of TMT in vertebrate neurodevelopment.,TMT,CHEMICAL,suggest possible mechanism for,toxicity,DISEASE
14643695,"Inhibition of sodium-potassium adenosine 5'-triphosphatase ((Na(+), K(+))-ATPase) activity causes edema and cell death in the central nervous system, and impairment of learning and memory.",sodium-potassium adenosine 5'-triphosphatase activity,CHEMICAL,cause,edema,DISEASE
14643695,"Treatment with the estradiol receptor antagonists, tamoxifen (TAM) (10 mg kg(-1); s.c. or 0.1 microg; i.cist.) and 4-hydroxytamoxifen (10 mg kg(-1); s.c.), or the androgen receptor antagonist, cyproterone (10 mg kg(-1); s.c. or 1 microg; i.cist.), did not influence the protective effect of betaE2 or TES on ouabain-induced amnesia.",betaE2,CHEMICAL,have the protective effect on,ouabain-induced amnesia,MENTAL_HEALTH
14643695,"Treatment with the estradiol receptor antagonists, tamoxifen (TAM) (10 mg kg(-1); s.c. or 0.1 microg; i.cist.) and 4-hydroxytamoxifen (10 mg kg(-1); s.c.), or the androgen receptor antagonist, cyproterone (10 mg kg(-1); s.c. or 1 microg; i.cist.), did not influence the protective effect of betaE2 or TES on ouabain-induced amnesia.",TES,CHEMICAL,have the protective effect on,ouabain-induced amnesia,MENTAL_HEALTH
14643695,"These results indicate that betaE2 and TES ameliorate the amnesia induced by inhibition of (Na(+), K(+))-ATPase activity, and that the protective effect of betaE2 is caused by a non-genomic, rather than a genomic effect or a radical scavenging action.",betaE2,CHEMICAL,ameliorate,amnesia,MENTAL_HEALTH
14643695,"These results indicate that betaE2 and TES ameliorate the amnesia induced by inhibition of (Na(+), K(+))-ATPase activity, and that the protective effect of betaE2 is caused by a non-genomic, rather than a genomic effect or a radical scavenging action.",TES,CHEMICAL,ameliorate,amnesia,MENTAL_HEALTH
18669034,"We found that the concentrations of hydroxybenzenes causing 50% inhibition of the growth of P falciparum strain FcB1 (IC50) are described by the regression log IC50 (microM) = 0.36 + 1.81 E(2)(7) (V) - 0.10 log D [n = 11, r2 = 0.760, F(2.8) = 12.03].",hydroxybenzenes,CHEMICAL,be described by,regression log,MENTAL_HEALTH
18669034,"We found that the concentrations of hydroxybenzenes causing 50% inhibition of the growth of P falciparum strain FcB1 (IC50) are described by the regression log IC50 (microM) = 0.36 + 1.81 E(2)(7) (V) - 0.10 log D [n = 11, r2 = 0.760, F(2.8) = 12.03].",hydroxybenzenes,CHEMICAL,be described by,(V)-0.10 log D,CHEMICAL
18669034,"We found that the concentrations of hydroxybenzenes causing 50% inhibition of the growth of P falciparum strain FcB1 (IC50) are described by the regression log IC50 (microM) = 0.36 + 1.81 E(2)(7) (V) - 0.10 log D [n = 11, r2 = 0.760, F(2.8) = 12.03].",hydroxybenzenes,CHEMICAL,be described by,E(2)(7,CHEMICAL
12847120,The pattern of mean maximum lateral displacement (z(max)) and mean maximum bending angle (beta(max)) along the body in the bonito differed from that of both chub mackerel Scomber japonicus and kawakawa tuna Euthynnus affinis; z(max) was highest in the bonito.,mean maximum lateral displacement,MENTAL_HEALTH,differ from,mackerel Scomber japonicus,NUTRITION
34883657,"On application in patients receiving HD, the Ge-Ti-π textile significantly reduced the limb numbness/pain (p  0.001) and pain score on the visual analog scale (p  0.001).",Ge-Ti-π textile,CHEMICAL,reduce on application in,pain score,DISEASE
34685271,Sildenafil citrate (SLC) is a frequently used medication (Viagra®) for the treatment of erectile dysfunction (ED).,Sildenafil citrate,CHEMICAL,be used medication for treatment of,erectile dysfunction,MENTAL_HEALTH
34132180,The consistent reemergence and resistance development in the viral strains demand the discovery and development of new antiviral drugs possessing better efficacy.,resistance development,MENTAL_HEALTH,demand discovery and development of,new antiviral drugs,CHEBI
35530281,"JTB protein itself is involved in mitotic spindle pathway by its role in cell division/cytokinesis, and within estrogen response early and late pathways, contributing to discrimination between luminal and mesenchymal breast cancer.",luminal,CHEMICAL,have to discrimination with,mesenchymal breast cancer,DISEASE
35530281,"JTB protein itself is involved in mitotic spindle pathway by its role in cell division/cytokinesis, and within estrogen response early and late pathways, contributing to discrimination between luminal and mesenchymal breast cancer.",mesenchymal breast cancer,DISEASE,have to discrimination with,luminal,CHEMICAL
35453667,"In women with uterine fibroids, there is a correlation between blood Cd levels and fibroid tumor size.",fibroid tumor size,DISEASE,be in women with,uterine fibroids,DISEASE
35453667,"In women with uterine fibroids, there is a correlation between blood Cd levels and fibroid tumor size.",blood Cd levels,CHEMICAL,be in women with,uterine fibroids,DISEASE
35453667,"In women with uterine fibroids, there is a correlation between blood Cd levels and fibroid tumor size.",blood Cd levels,CHEMICAL,have a correlation with,fibroid tumor size,DISEASE
35453667,"In women with uterine fibroids, there is a correlation between blood Cd levels and fibroid tumor size.",fibroid tumor size,DISEASE,have a correlation with,blood Cd levels,CHEMICAL
35453667,"In this study, fibroid cells were exposed to 10 µM CdCl2 for 6 months and a fast-growing Cd-Resistant Leiomyoma culture, termed CR-LM6, was recovered.",fibroid cells,DISEASE,be exposed in study to,µM CdCl2,CHEMICAL
2263649,Intracaudate injections of relatively high doses of apomorphine produce a regression in motor behavior of cats collecting food pellets in a treadmill design (25).,apomorphine,CHEMICAL,produce,regression,MENTAL_HEALTH
2263649,Intracaudate injections of relatively high doses of apomorphine produce a regression in motor behavior of cats collecting food pellets in a treadmill design (25).,Intracaudate injections,CHEMICAL,produce,regression,MENTAL_HEALTH
2263649,Picrotoxin produced dose-dependently a regression in motor behavior which was comparable to that elicited by intrastriatally injected apomorphine.,Picrotoxin,CHEMICAL,produce,regression,MENTAL_HEALTH
2263649,The noted effects were GABA-specific since muscimol attenuated the picrotoxin-induced regression.,muscimol,CHEMICAL,attenuate,picrotoxin-induced regression,MENTAL_HEALTH
2263649,The noted effects were GABA-specific since muscimol attenuated the picrotoxin-induced regression.,muscimol,CHEMICAL,attenuate,picrotoxin-induced regression,DISEASE
35597119,"Bacille Calmette-Guérin (BCG) is the only authorized vaccine used to fight against tuberculosis (TB), it has been hypothesized that BCG may prevent and control COVID-19 based on BCG-induced nonspecific immune responses.",BCG,CHEMICAL,prevent,COVID-19,CHEMICAL
35597119,"Herein, we summarized: 1) The nonspecific protection effects of BCG, such as prophylactic protection effects of BCG on nonmycobacterial infections, immunotherapy effects of BCG vaccine, and enhancement effect of BCG vaccine on unrelated vaccines; 2) Recent evidence of BCG's efficacy against SARS-COV-2 infection from ecological studies, analytical analyses, clinical trials, and animal studies; 3) Three possible mechanisms of BCG vaccine and their effects on COVID-19 control including heterologous immunity, trained immunity, and anti-inflammatory effect.",BCG,CHEMICAL,have prophylactic protection effects on,nonmycobacterial infections,DISEASE
11274962,"Opiates, such as morphine, have been used extensively in the clinical management of pain due to their potent analgesic effect.",morphine,CHEMICAL,be used in clinical management of pain due to,potent analgesic effect,CHEBI
11274962,"Opiates, such as morphine, have been used extensively in the clinical management of pain due to their potent analgesic effect.",morphine,CHEMICAL,be used in clinical management of,pain due,DISEASE
11274962,Morphine also inhibited the nuclear condensation and fragmentation of SIN-1-treated cells that was antagonized by naloxone pretreatment.,Morphine,CHEMICAL,inhibit,fragmentation,MENTAL_HEALTH
34561608,"There is concern that selective serotonin reuptake inhibitor (SSRI) treatment may increase the risk of suicide attempts or deaths, particularly among children and adolescents.",selective serotonin reuptake inhibitor SSRI treatment,CHEBI,increase risk of,suicide attempts,MENTAL_HEALTH
34561608,"There is concern that selective serotonin reuptake inhibitor (SSRI) treatment may increase the risk of suicide attempts or deaths, particularly among children and adolescents.",selective serotonin reuptake inhibitor SSRI treatment,CHEBI,increase risk of,deaths,DISEASE
23578360,"While the reduced monoamine hypothesis is well known but highly controversial and widely considered to be incomplete or simply incorrect, the possibility that elevated monoamines are an etiological factor in some cases of major depression (rather than or in addition to hypomania or mania) has received little attention at all.",elevated monoamines,CHEMICAL,be etiological factor in cases of,major depression,MENTAL_HEALTH
23578360,The etiological basis of the putative effect of monoamines on depression may be mediated both through genetics and exposure to psychological stress.,monoamines,CHEMICAL,have the putative effect on,depression,MENTAL_HEALTH
35598068,"Six species of Aeromonas were confirmed through nucleotide sequencing and phylogenetic analysis of the gyrB gene Aeromonas veronii (72.1%), Aeromonas jandaei (11.6%), Aeromonas schubertii (9.3%), Aeromonas diversa (3.5%), Aeromonas hydrophila (2.3%), and Aeromonas punctata (1.2%).",Aeromonas,DISEASE,be confirmed through nucleotide sequencing and phylogenetic analysis of,gene Aeromonas veronii,DISEASE
35598068,"Six species of Aeromonas were confirmed through nucleotide sequencing and phylogenetic analysis of the gyrB gene Aeromonas veronii (72.1%), Aeromonas jandaei (11.6%), Aeromonas schubertii (9.3%), Aeromonas diversa (3.5%), Aeromonas hydrophila (2.3%), and Aeromonas punctata (1.2%).",Aeromonas,DISEASE,be confirmed through nucleotide sequencing and phylogenetic analysis of,gyrB gene,CHEMICAL
35598068,"Six species of Aeromonas were confirmed through nucleotide sequencing and phylogenetic analysis of the gyrB gene Aeromonas veronii (72.1%), Aeromonas jandaei (11.6%), Aeromonas schubertii (9.3%), Aeromonas diversa (3.5%), Aeromonas hydrophila (2.3%), and Aeromonas punctata (1.2%).",Aeromonas,DISEASE,be confirmed through,nucleotide sequencing,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,ampicillin,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,trimethoprim-sulfamethoxazole,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,amoxicillin,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,enrofloxacin,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,oxytetracycline,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal resistance against,oxolinic acid,CHEMICAL
35598068,"Antimicrobial susceptibility tests for all isolates revealed resistance against amoxicillin (99%), ampicillin (98%), oxolinic acid (81.4%), oxytetracycline (77%), trimethoprim-sulfamethoxazole (24%), and enrofloxacin (21%).",Antimicrobial susceptibility tests,CHEBI,reveal,resistance,MENTAL_HEALTH
35594245,"The Atfdh1 mutants were compromised in nonhost resistance, basal resistance, and gene-for-gene resistance.",Atfdh1 mutants,CHEMICAL,be compromised in,gene-for-gene resistance,MENTAL_HEALTH
35594245,"The Atfdh1 mutants were compromised in nonhost resistance, basal resistance, and gene-for-gene resistance.",Atfdh1 mutants,CHEMICAL,be compromised in,nonhost resistance,MENTAL_HEALTH
35594245,"The Atfdh1 mutants were compromised in nonhost resistance, basal resistance, and gene-for-gene resistance.",Atfdh1 mutants,CHEMICAL,be compromised in,basal resistance,MENTAL_HEALTH
1316077,"In the lomefloxacin group three patients reported nausea, one nervousness, and one pruritus; in the ciprofloxacin group, two patients reported nausea and three pruritus.",lomefloxacin group,CHEMICAL,report,pruritus,DISEASE
1316077,"In the lomefloxacin group three patients reported nausea, one nervousness, and one pruritus; in the ciprofloxacin group, two patients reported nausea and three pruritus.",lomefloxacin group,CHEMICAL,report,nausea,DISEASE
1316077,"In the lomefloxacin group three patients reported nausea, one nervousness, and one pruritus; in the ciprofloxacin group, two patients reported nausea and three pruritus.",lomefloxacin group,CHEMICAL,report,nervousness,MENTAL_HEALTH
1316077,A single daily dose of 400 mg lomefloxacin was comparable to 500 mg ciprofloxacin every 12 hours for the treatment of complicated or recurrent urinary tract infections.,lomefloxacin,CHEMICAL,be comparable to,ciprofloxacin,CHEMICAL
12523876,Atypical antipsychotics such as quetiapine and risperidone are associated with a decreased incidence of adverse events such as EPS.,risperidone,CHEMICAL,be associated with decreased incidence of adverse events such as,EPS,DISEASE
12523876,Atypical antipsychotics such as quetiapine and risperidone are associated with a decreased incidence of adverse events such as EPS.,quetiapine,CHEMICAL,be associated with decreased incidence of adverse events such as,EPS,DISEASE
11195255,This article reviews the evidence that risperidone may be an effective new treatment for disorders other than schizophrenia.,risperidone,CHEMICAL,be effective treatment for,schizophrenia,MENTAL_HEALTH
30388594,"Alterations in hypothalamic-pituitary-adrenal (HPA)-axis activity, fatty acid metabolism, and their relation have been associated with (recurrent) major depressive disorder (MDD), although conflicting findings exist.",fatty acid metabolism,NUTRITION,be associated with,recurrent major depressive disorder,MENTAL_HEALTH
30388594,"Alterations in hypothalamic-pituitary-adrenal (HPA)-axis activity, fatty acid metabolism, and their relation have been associated with (recurrent) major depressive disorder (MDD), although conflicting findings exist.",fatty acid metabolism,NUTRITION,be associated with,MDD,DISEASE
30388594,"Alterations in hypothalamic-pituitary-adrenal (HPA)-axis activity, fatty acid metabolism, and their relation have been associated with (recurrent) major depressive disorder (MDD), although conflicting findings exist.",hypothalamic-pituitary-adrenal (HPA)-axis activity,CHEMICAL,be associated with,recurrent major depressive disorder,MENTAL_HEALTH
30388594,"Alterations in hypothalamic-pituitary-adrenal (HPA)-axis activity, fatty acid metabolism, and their relation have been associated with (recurrent) major depressive disorder (MDD), although conflicting findings exist.",hypothalamic-pituitary-adrenal (HPA)-axis activity,CHEMICAL,be associated with,MDD,DISEASE
33953272,"Although antibiotics can cause taste and smell disorders, a few studies have examined antibiotic-induced taste and smell disorders.",antibiotics,CHEBI,cause,taste smell disorders,DISEASE
35162062,The most frequent resistance mechanism was production of extended-spectrum beta lactamases.,frequent resistance mechanism,MENTAL_HEALTH,be production of,extended-spectrum beta lactamases,CHEBI
32413969,"Pyrrolizidine alkaloids (PAs) are distributed in plant families of Asteraceae, Boraginaceae, and Fabaceae and serve in the chemical defense mechanism against herbivores.",Pyrrolizidine alkaloids,CHEMICAL,serve in,chemical defense mechanism,MENTAL_HEALTH
19554200,"Unadjusted linear regression analyses revealed significant inverse associations between plasma lutein, total xanthophylls and both F(2)-IsoP measures at baseline.",Unadjusted regression analyses,MENTAL_HEALTH,reveal significant inverse associations between,plasma lutein,CHEBI
19554200,"Unadjusted linear regression analyses revealed significant inverse associations between plasma lutein, total xanthophylls and both F(2)-IsoP measures at baseline.",Unadjusted regression analyses,MENTAL_HEALTH,reveal significant inverse associations between,total xanthophylls,CHEBI
33803899,"The increase in the generation of gut microbial uremic toxins, the activation of aryl hydrocarbon (AhRs) and platelet adrenergic (ARs) receptors, and the nuclear factor kappa B (NF-κB) signaling pathway can serve as potential targets during the prevention of thromboembolic events.",gut microbial uremic toxins,CHEBI,serve as potential targets during prevention of,thromboembolic events,DISEASE
33803899,"The increase in the generation of gut microbial uremic toxins, the activation of aryl hydrocarbon (AhRs) and platelet adrenergic (ARs) receptors, and the nuclear factor kappa B (NF-κB) signaling pathway can serve as potential targets during the prevention of thromboembolic events.",aryl hydrocarbon,CHEMICAL,serve as potential targets during prevention of,thromboembolic events,DISEASE
30322010,An increasing number of studies are highlighting the link between such uremic toxins and thrombosis in CKD.,uremic toxins,CHEBI,have the link with,thrombosis,DISEASE
30322010,An increasing number of studies are highlighting the link between such uremic toxins and thrombosis in CKD.,thrombosis,DISEASE,have the link with,uremic toxins,CHEBI
29896715,There is a relationship between mitochondrial dysfunction and cognitive disorder that may be related to certain neurotoxins or mutations in mitochondrial DNA as well as the nuclear.,mitochondrial dysfunction,DISEASE,have a relationship with,cognitive disorder,MENTAL_HEALTH
29896715,There is a relationship between mitochondrial dysfunction and cognitive disorder that may be related to certain neurotoxins or mutations in mitochondrial DNA as well as the nuclear.,cognitive disorder,MENTAL_HEALTH,have a relationship with,mitochondrial dysfunction,DISEASE
12106103,The anoxic depolarization was due to the release of glutamate from presynaptic terminals since it was blocked by tetrodotoxin (TTX) (1 microM) or by the broad spectrum excitatory amino acid antagonist kynurenate (1 mM).,anoxic depolarization,DISEASE,be due to release of,glutamate,CHEMICAL
12106103,"In the presence of TTX (1 microM) or kynurenate (1 mM), anoxia only induced a hyperpolarization which was due to activation of a K+ conductance.",anoxia,DISEASE,induce in presence of,TTX hyperpolarization,CHEMICAL
12106103,"In the presence of TTX (1 microM) or kynurenate (1 mM), anoxia only induced a hyperpolarization which was due to activation of a K+ conductance.",anoxia,DISEASE,induce in presence of,kynurenate,CHEMICAL
12106103,"The anoxic depolarization was blocked by galanin, a hormone which activates ATP sensitive K+ (K+ATP) channels.",anoxic depolarization,DISEASE,be blocked by,hormone,CHEBI
12106103,Anoxic depolarization was increased by the potent sulfonylurea agent glibenclamide (GLIB) which blocks K+ATP channels.,Anoxic depolarization,DISEASE,be increased by,potent sulfonylurea agent glibenclamide,CHEMICAL
12106103,Anoxic depolarization was increased by the potent sulfonylurea agent glibenclamide (GLIB) which blocks K+ATP channels.,Anoxic depolarization,DISEASE,be increased by,GLIB,CHEMICAL
12106103,"Since excessive release of glutamate during anoxia is neurotoxic, agents such as galanin which activate K+ATP channels may provide tissue specific protection against anoxic damage.",glutamate,CHEMICAL,be,neurotoxic agents,CHEBI
12106103,"Since excessive release of glutamate during anoxia is neurotoxic, agents such as galanin which activate K+ATP channels may provide tissue specific protection against anoxic damage.",anoxia,DISEASE,be,neurotoxic agents,CHEBI
8358535,Noradrenaline (100 microM) hyperpolarized the cells and decreased their input resistance.,Noradrenaline,CHEMICAL,decrease,input resistance,MENTAL_HEALTH
31764217,Drug treatment at discharge and rehospitalization rates during follow-up time were compared between bipolar disorder-I patients with (n = 55) or without (n = 285) personality disorder comorbidity.,Drug treatment,CHEBI,be compared between,bipolar disorder-I patients,DISEASE
35421609,The Staphylococcus aureus FADS (SaFADS) produces FMN from riboflavin (RF) by ATP:riboflavin kinase (RFK) activity at its C-terminal domain.,Staphylococcus aureus FADS,DISEASE,produce fmn from,riboflavin,CHEBI
35421609,The Staphylococcus aureus FADS (SaFADS) produces FMN from riboflavin (RF) by ATP:riboflavin kinase (RFK) activity at its C-terminal domain.,Staphylococcus aureus FADS,DISEASE,produce fmn from,ATP kinase activity,CHEMICAL
35421609,The Staphylococcus aureus FADS (SaFADS) produces FMN from riboflavin (RF) by ATP:riboflavin kinase (RFK) activity at its C-terminal domain.,Staphylococcus aureus FADS,DISEASE,produce fmn from,riboflavin kinase,CHEBI
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",prediabetes baseline fasting glucose aged,CHEMICAL,be enrolled in one of arms one-time general advice about,GA group,CHEMICAL
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",prediabetes baseline fasting glucose aged,CHEMICAL,be enrolled in one of arms one-time general advice about,orientation,MENTAL_HEALTH
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",Saudis,DISEASE,be enrolled in one of arms one-time general advice about,GA group,CHEMICAL
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",Saudis,DISEASE,be enrolled in one of arms one-time general advice about,orientation,MENTAL_HEALTH
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",prediabetes baseline fasting glucose aged,DISEASE,be enrolled in one of arms one-time general advice about,GA group,CHEMICAL
31731609,"A total of 160 Saudis with prediabetes (baseline fasting glucose 5.6-6.9 mmol/L), aged 20-60 years, were enrolled in one of the two arms: A one-time general advice about lifestyle modification (GA group) at orientation or a well-structured and monitored nutrition and lifestyle counseling for six months (guidance group).",prediabetes baseline fasting glucose aged,DISEASE,be enrolled in one of arms one-time general advice about,orientation,MENTAL_HEALTH
9628521,GnRH analogues (GnRH-a) are well established in the treatment of endometriosis.,GnRH-a,CHEBI,be established in treatment of,endometriosis,DISEASE
9628521,"The aim of this randomized, double-blind, comparative study was to evaluate whether symptoms and signs of hypooestrogenism, e.g. hot flushes, sweating and sleeplessness, could be avoided by a steroidal add-back regimen, while the beneficial effect of a GnRH-a on endometriosis could be maintained.",GnRH-a,CHEBI,have the beneficial effect on,endometriosis,DISEASE
9628521,"Dysmenorrhoea was significantly reduced in both groups, whereas dyspareunia was only decreased in group P. Variations in laboratory values were within normal ranges and did not give any concern about drug safety.",dyspareunia,MENTAL_HEALTH,be decreased in,group P. Variations,DISEASE
9628521,Loss of bone mineral density caused by the GnRH-a was reduced by the combined oestrogen/progestin add-back therapy.,bone mineral density,DISEASE,be reduced by,combined oestrogen/progestin add-back therapy,CHEMICAL
34965200,"This study tested the hypothesis that among adults with lifetime PTSD, panic attacks would be associated with greater lifetime risk for both AUD and DUD.",panic attacks,DISEASE,be associated among adults with lifetime ptsd with greater lifetime risk for,AUD,CHEMICAL
34965200,"We also explored whether panic attacks were associated with specific DUDs that frequently co-occur with PTSD (cannabis, sedatives/tranquilizers, heroin/opioids, and cocaine).",panic attacks,DISEASE,be associated with,specific DUDs,DISEASE
32767414,Many researchers argue that Alzheimer's disease is at least partly caused by deposition of amyloid beta (Aβ) in the brain.,Alzheimer's disease,DISEASE,be caused by deposition of,amyloid beta,CHEBI
29311923,"Recently, we have showed that adenosine is involved in CB hypersensitization during chronic intermittent hypoxia (CIH), which mimics obstructive sleep apnea, since caffeine, a non-selective adenosine receptor antagonist that inhibits A2A and A2B adenosine receptors, decreased CSN chemosensory activity in animals subjected to CIH.",adenosine,CHEMICAL,be involved in cb hypersensitization during,caffeine,CHEMICAL
29311923,"Recently, we have showed that adenosine is involved in CB hypersensitization during chronic intermittent hypoxia (CIH), which mimics obstructive sleep apnea, since caffeine, a non-selective adenosine receptor antagonist that inhibits A2A and A2B adenosine receptors, decreased CSN chemosensory activity in animals subjected to CIH.",adenosine,CHEMICAL,be involved in cb hypersensitization during,CIH,CHEMICAL
29311923,"Recently, we have showed that adenosine is involved in CB hypersensitization during chronic intermittent hypoxia (CIH), which mimics obstructive sleep apnea, since caffeine, a non-selective adenosine receptor antagonist that inhibits A2A and A2B adenosine receptors, decreased CSN chemosensory activity in animals subjected to CIH.",adenosine,CHEMICAL,be involved in cb hypersensitization during,chronic intermittent hypoxia,DISEASE
29311923,"Recently, we have showed that adenosine is involved in CB hypersensitization during chronic intermittent hypoxia (CIH), which mimics obstructive sleep apnea, since caffeine, a non-selective adenosine receptor antagonist that inhibits A2A and A2B adenosine receptors, decreased CSN chemosensory activity in animals subjected to CIH.",adenosine,CHEMICAL,be involved in cb hypersensitization during,non-selective adenosine receptor antagonist,CHEBI
29311923,"Apart from this involvement of adenosine in CB sensitization in sleep apnea, it was recently found that P2X3 ATP receptor in the CB contributes to increased chemoreflex hypersensitivity and hypertension in spontaneously hypertension rats.",P2X3 ATP receptor,CHEMICAL,contribute to increased chemoreflex hypersensitivity and hypertension in,spontaneously hypertension rats,DISEASE
29311923,"Apart from this involvement of adenosine in CB sensitization in sleep apnea, it was recently found that P2X3 ATP receptor in the CB contributes to increased chemoreflex hypersensitivity and hypertension in spontaneously hypertension rats.",P2X3 ATP receptor,CHEMICAL,contribute to,increased chemoreflex hypersensitivity,DISEASE
29311923,"Apart from this involvement of adenosine in CB sensitization in sleep apnea, it was recently found that P2X3 ATP receptor in the CB contributes to increased chemoreflex hypersensitivity and hypertension in spontaneously hypertension rats.",P2X3 ATP receptor,CHEMICAL,contribute to,hypertension,DISEASE
32279596,"Tamoxifen is widely used for the treatment of hormone-responsive breast cancer, osteoporosis, and post-menopausal symptoms.",Tamoxifen,CHEMICAL,be used for treatment of,hormone-responsive breast cancer,DISEASE
32279596,"Tamoxifen is widely used for the treatment of hormone-responsive breast cancer, osteoporosis, and post-menopausal symptoms.",Tamoxifen,CHEMICAL,be used for treatment of,post-menopausal symptoms,DISEASE
32279596,"Tamoxifen is widely used for the treatment of hormone-responsive breast cancer, osteoporosis, and post-menopausal symptoms.",Tamoxifen,CHEMICAL,be used for treatment of,osteoporosis,DISEASE
26945727,"Ethylmercury exposure from thimerosal in some vaccines has been associated, in some studies, with autism and other neurological disorders in children.",thimerosal,CHEMICAL,be associated in studies with,other neurological disorders,DISEASE
26945727,"Ethylmercury exposure from thimerosal in some vaccines has been associated, in some studies, with autism and other neurological disorders in children.",thimerosal,CHEMICAL,be associated in studies with,autism,MENTAL_HEALTH
25697799,"Hepatotoxicants were defined by rat liver histopathology observed after chronic chemical testing and grouped into hypertrophy (161), injury (101) and proliferative lesions (99).",Hepatotoxicants,CHEBI,be defined by,hypertrophy,DISEASE
19362101,"Idiosyncratic drug hepatotoxicity represents a major problem in drug development due to inadequacy of current preclinical screening assays, but recently established rodent models utilizing bacterial LPS co-administration to induce an inflammatory background have successfully reproduced idiosyncratic hepatotoxicity signatures for certain drugs.",Idiosyncratic drug hepatotoxicity,CHEBI,reproduce,idiosyncratic hepatotoxicity signatures,DISEASE
19362101,"Idiosyncratic drug hepatotoxicity represents a major problem in drug development due to inadequacy of current preclinical screening assays, but recently established rodent models utilizing bacterial LPS co-administration to induce an inflammatory background have successfully reproduced idiosyncratic hepatotoxicity signatures for certain drugs.",Idiosyncratic drug hepatotoxicity,DISEASE,reproduce,idiosyncratic hepatotoxicity signatures,DISEASE
19362101,"Idiosyncratic drug hepatotoxicity represents a major problem in drug development due to inadequacy of current preclinical screening assays, but recently established rodent models utilizing bacterial LPS co-administration to induce an inflammatory background have successfully reproduced idiosyncratic hepatotoxicity signatures for certain drugs.",Idiosyncratic drug hepatotoxicity,CHEBI,represent major problem in,drug development,CHEBI
19362101,"Idiosyncratic drug hepatotoxicity represents a major problem in drug development due to inadequacy of current preclinical screening assays, but recently established rodent models utilizing bacterial LPS co-administration to induce an inflammatory background have successfully reproduced idiosyncratic hepatotoxicity signatures for certain drugs.",Idiosyncratic drug hepatotoxicity,DISEASE,represent major problem in,drug development,CHEBI
19362101,"A larger compendium of drug-cytokine mix hepatotoxicity data demonstrated that hepatotoxicity synergies were largely potentiated by TNF, IL-1 alpha, and LPS within the context of multi-cytokine mixes.",hepatotoxicity synergies,DISEASE,be potentiated by,IL-1 alpha,NUTRITION
19362101,"A larger compendium of drug-cytokine mix hepatotoxicity data demonstrated that hepatotoxicity synergies were largely potentiated by TNF, IL-1 alpha, and LPS within the context of multi-cytokine mixes.",hepatotoxicity synergies,DISEASE,be potentiated by,LPS,CHEMICAL
19964679,"Idiosyncratic drug hepatotoxicity is a hepatotoxicity subset that occurs in a very small fraction of human patients, is poorly predicted by standard preclinical models and in clinical trials, and frequently leads to postapproval drug failure.",Idiosyncratic drug hepatotoxicity,CHEBI,be,hepatotoxicity subset,DISEASE
19964679,"Idiosyncratic drug hepatotoxicity is a hepatotoxicity subset that occurs in a very small fraction of human patients, is poorly predicted by standard preclinical models and in clinical trials, and frequently leads to postapproval drug failure.",Idiosyncratic drug hepatotoxicity,DISEASE,be,hepatotoxicity subset,DISEASE
19964679,"Idiosyncratic drug hepatotoxicity is a hepatotoxicity subset that occurs in a very small fraction of human patients, is poorly predicted by standard preclinical models and in clinical trials, and frequently leads to postapproval drug failure.",hepatotoxicity subset,DISEASE,lead to,postapproval drug failure,DISEASE
19964679,"Idiosyncratic drug hepatotoxicity is a hepatotoxicity subset that occurs in a very small fraction of human patients, is poorly predicted by standard preclinical models and in clinical trials, and frequently leads to postapproval drug failure.",hepatotoxicity subset,DISEASE,lead to,postapproval drug failure,CHEBI
30301303,"Molecular genetic research on PD is specifically focused on neurotransmitters, including serotonin, neuropeptides, glucocorticoids, and neurotrophins.",PD,DISEASE,be focused on,serotonin,CHEMICAL
30301303,"Molecular genetic research on PD is specifically focused on neurotransmitters, including serotonin, neuropeptides, glucocorticoids, and neurotrophins.",PD,DISEASE,be focused on,neurotrophins,CHEMICAL
29259120,"Our data indicate that in demanding building blocks with more versatile redox chemistry, biospheric molecular oxygen triggered the selective fixation of the last amino acids in the genetic code.",biospheric molecular oxygen,CHEMICAL,trigger selective fixation of,last amino acids,CHEMICAL
29259120,"Our data indicate that in demanding building blocks with more versatile redox chemistry, biospheric molecular oxygen triggered the selective fixation of the last amino acids in the genetic code.",biospheric molecular oxygen,CHEMICAL,trigger,selective fixation,MENTAL_HEALTH
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",PAE,CHEMICAL,be conceptualized as fetal alcohol spectrum disorder with,FAS,CHEMICAL
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",PAE,CHEMICAL,be conceptualized as fetal alcohol spectrum disorder with,fetal alcohol syndrome,MENTAL_HEALTH
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",PAE,CHEMICAL,be conceptualized as,fetal alcohol spectrum disorder,MENTAL_HEALTH
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",prenatal alcohol exposure,CHEMICAL,be conceptualized as fetal alcohol spectrum disorder with,FAS,CHEMICAL
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",prenatal alcohol exposure,CHEMICAL,be conceptualized as fetal alcohol spectrum disorder with,fetal alcohol syndrome,MENTAL_HEALTH
32173870,"The effects of prenatal alcohol exposure (PAE) are conceptualized as fetal alcohol spectrum disorder, with fetal alcohol syndrome (FAS) as the most severe.",prenatal alcohol exposure,CHEMICAL,be conceptualized as,fetal alcohol spectrum disorder,MENTAL_HEALTH
26990766,"This phase 2 randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of the nicotinic acetylcholine receptor α7 agonist AQW051 in patients with Parkinson's disease and levodopa-induced dyskinesia.",nicotinic acetylcholine receptor α7 agonist,CHEMICAL,in patients with,Parkinson's disease,DISEASE
26990766,"This phase 2 randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of the nicotinic acetylcholine receptor α7 agonist AQW051 in patients with Parkinson's disease and levodopa-induced dyskinesia.",agonist AQW051,CHEMICAL,in patients with,Parkinson's disease,DISEASE
26990766,"This phase 2 randomized, double-blind, placebo-controlled study evaluated the efficacy and safety of the nicotinic acetylcholine receptor α7 agonist AQW051 in patients with Parkinson's disease and levodopa-induced dyskinesia.",agonist AQW051,CHEBI,in patients with,Parkinson's disease,DISEASE
17194261,Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice.,Selective serotonin reuptake inhibitors,CHEMICAL,be used as first antidepressant for,major depressive disorder,MENTAL_HEALTH
17194261,Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice.,Selective serotonin reuptake inhibitors,CHEMICAL,be used as,first antidepressant,CHEMICAL
17194261,Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice.,SSRIs,CHEMICAL,be used as first antidepressant for,major depressive disorder,MENTAL_HEALTH
17194261,Selective serotonin reuptake inhibitors (SSRIs) are frequently used as a first antidepressant for major depressive disorder but have response rates of 50% to 60% in daily practice.,SSRIs,CHEMICAL,be used as,first antidepressant,CHEMICAL
20498721,The polyunsaturated fatty acid (PUFA) composition of (nerve) cell membranes may be involved in the pathophysiology of depression.,polyunsaturated fatty acid composition,NUTRITION,be involved in pathophysiology of,depression,MENTAL_HEALTH
23504639,"Different psychoactive factors including alcohol, coffee and tobacco, are considered as risk factors for bruxism.",alcohol,CHEMICAL,be considered as risk factors for,bruxism,MENTAL_HEALTH
27710883,Liquid chromatography/high resolution tandem mass spectrometry in combination with principal component analysis and orthogonal projection to latent structures was used to reveal main chemical differences of gasified wine waste mixture from commonly used ones in agricultural biogas plants.,Liquid chromatography/high tandem mass spectrometry,CHEMICAL,reveal main chemical differences of,wine waste mixture,CHEMICAL
27710883,Liquid chromatography/high resolution tandem mass spectrometry in combination with principal component analysis and orthogonal projection to latent structures was used to reveal main chemical differences of gasified wine waste mixture from commonly used ones in agricultural biogas plants.,Liquid chromatography/high tandem mass spectrometry,CHEMICAL,reveal main chemical differences of,wine waste mixture,CHEBI
31597964,"BRD9 is a potent tumour suppressor in uveal melanoma, such that correcting mis-splicing of BRD9 in SF3B1-mutant cells using antisense oligonucleotides or CRISPR-directed mutagenesis suppresses tumour growth.",CRISPR-directed mutagenesis,CHEMICAL,suppress,tumour growth,DISEASE
31597964,"BRD9 is a potent tumour suppressor in uveal melanoma, such that correcting mis-splicing of BRD9 in SF3B1-mutant cells using antisense oligonucleotides or CRISPR-directed mutagenesis suppresses tumour growth.",uveal melanoma,DISEASE,suppress,tumour growth,DISEASE
31597964,"BRD9 is a potent tumour suppressor in uveal melanoma, such that correcting mis-splicing of BRD9 in SF3B1-mutant cells using antisense oligonucleotides or CRISPR-directed mutagenesis suppresses tumour growth.",potent tumour suppressor,DISEASE,suppress,tumour growth,DISEASE
24558115,"Given their lethal nature, colicin production has evolved a sophisticated system for repression and expression.",colicin production,CHEMICAL,evolve given their lethal nature sophisticated system for,repression,MENTAL_HEALTH
35238604,"Cassiicolin (Cas), a toxin produced by Corynespora cassiicola, is responsible for Corynespora leaf fall disease in susceptible rubber trees.",toxin,CHEBI,be responsible for,Corynespora leaf fall disease,DISEASE
35238604,"Cytotoxicity tests on rubber leaves of Rubber Research Institute of Vietnam (RRIV) 1, RRIV 4, and Prang Besar (PB) 255 clones suggest that the toxins cause necrosis of rubber leaves, except for the strong resistance of PB 255 against Cas2.",toxins,CHEBI,cause necrosis of,strong resistance,MENTAL_HEALTH
35238604,"Cytotoxicity tests on rubber leaves of Rubber Research Institute of Vietnam (RRIV) 1, RRIV 4, and Prang Besar (PB) 255 clones suggest that the toxins cause necrosis of rubber leaves, except for the strong resistance of PB 255 against Cas2.",toxins,CHEBI,cause,necrosis,DISEASE
8241176,Purine nucleoside phosphorylase with bound [14C]inosine was mixed with excess unlabeled inosine and arsenate to determine relative rates for reaction or dissociation of bound inosine.,bound [14C]inosine,CHEMICAL,determine relative rates for reaction or dissociation of,bound inosine,CHEMICAL
8241176,Purine nucleoside phosphorylase with bound [14C]inosine was mixed with excess unlabeled inosine and arsenate to determine relative rates for reaction or dissociation of bound inosine.,Purine nucleoside phosphorylase,CHEMICAL,determine relative rates for reaction or dissociation of,bound inosine,CHEMICAL
8241176,Purine nucleoside phosphorylase with bound [14C]inosine was mixed with excess unlabeled inosine and arsenate to determine relative rates for reaction or dissociation of bound inosine.,bound [14C]inosine,CHEMICAL,determine relative rates for,dissociation,MENTAL_HEALTH
8241176,Purine nucleoside phosphorylase with bound [14C]inosine was mixed with excess unlabeled inosine and arsenate to determine relative rates for reaction or dissociation of bound inosine.,Purine nucleoside phosphorylase,CHEMICAL,determine relative rates for,dissociation,MENTAL_HEALTH
9002463,SK&F 97426-A is a novel bile acid sequestrant that is threefold more potent than cholestyramine at increasing bile acid excretion in the hamster.,SK&F 97426-A,CHEMICAL,be,novel bile acid sequestrant,CHEBI
9002463,SK&F 97426-A is a novel bile acid sequestrant that is threefold more potent than cholestyramine at increasing bile acid excretion in the hamster.,SK&F 97426-A,CHEMICAL,be,novel bile acid sequestrant,DISEASE
9002463,"SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids.",cholestyramine,CHEMICAL,have,dihydroxy bile acids,CHEMICAL
9002463,"SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids.",cholestyramine,CHEMICAL,have,slow dissociation rates,MENTAL_HEALTH
9002463,"SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids.",SK&F 97426-A,CHEMICAL,have,dihydroxy bile acids,CHEMICAL
9002463,"SK&F 97426-A and cholestyramine had similar capacities for all the bile acids (between 2.5 and 4 mmol/g) and both had similar, very high affinities and slow dissociation rates for the dihydroxy bile acids.",SK&F 97426-A,CHEMICAL,have,slow dissociation rates,MENTAL_HEALTH
9002463,The higher affinities and slower dissociation rates of the trihydroxy bile acids for and from SK&F 97426-A probably account for the increased potency of SK&F 97426-A over cholestyramine in vivo.,trihydroxy bile acids,CHEMICAL,account for increased potency of sk&f 97426-a over,cholestyramine,CHEMICAL
9002463,The higher affinities and slower dissociation rates of the trihydroxy bile acids for and from SK&F 97426-A probably account for the increased potency of SK&F 97426-A over cholestyramine in vivo.,slower dissociation rates,MENTAL_HEALTH,account for increased potency of sk&f 97426-a over,cholestyramine,CHEMICAL
9002463,The higher affinities and slower dissociation rates of the trihydroxy bile acids for and from SK&F 97426-A probably account for the increased potency of SK&F 97426-A over cholestyramine in vivo.,SK&F 97426-A,CHEMICAL,account for increased potency of sk&f 97426-a over,cholestyramine,CHEMICAL
35590025,The dissociation of CO2 gas hydrates (GH) with amino acid kinetic promoters and without promoters was studied at a high temperature of 90 °C for a period of 20 min to understand the percentage of CO2 gas and to select the best promoter that aids CO2 gas entrapment along with stability at a high temperature.,dissociation,MENTAL_HEALTH,understand percentage of,CO2 gas,CHEMICAL
35590025,The dissociation of CO2 gas hydrates (GH) with amino acid kinetic promoters and without promoters was studied at a high temperature of 90 °C for a period of 20 min to understand the percentage of CO2 gas and to select the best promoter that aids CO2 gas entrapment along with stability at a high temperature.,gas hydrates,CHEMICAL,understand percentage of,CO2 gas,CHEMICAL
35590025,The dissociation of CO2 gas hydrates (GH) with amino acid kinetic promoters and without promoters was studied at a high temperature of 90 °C for a period of 20 min to understand the percentage of CO2 gas and to select the best promoter that aids CO2 gas entrapment along with stability at a high temperature.,amino acid kinetic promoters,CHEMICAL,understand percentage of,CO2 gas,CHEMICAL
30909391,It took until the 1950's for NTM to be recognised as a potential lung pathogen in people with underlying pulmonary disease and another three decades for NTM to be widely regarded by the medical community when Mycobacterium avium complex was identified as the most common group of opportunistic pathogens in AIDS patients.,Mycobacterium avium complex,CHEMICAL,be identified as common group of opportunistic pathogens in,AIDS patients,DISEASE
30909391,It took until the 1950's for NTM to be recognised as a potential lung pathogen in people with underlying pulmonary disease and another three decades for NTM to be widely regarded by the medical community when Mycobacterium avium complex was identified as the most common group of opportunistic pathogens in AIDS patients.,Mycobacterium avium complex,CHEMICAL,be identified as common group of,opportunistic pathogens,DISEASE
30909391,It took until the 1950's for NTM to be recognised as a potential lung pathogen in people with underlying pulmonary disease and another three decades for NTM to be widely regarded by the medical community when Mycobacterium avium complex was identified as the most common group of opportunistic pathogens in AIDS patients.,opportunistic pathogens,DISEASE,have common group in,AIDS patients,DISEASE
30909391,"M. abs is a rapidly growing NTM that is responsible for opportunistic pulmonary infections in patients with structural lung disorders such as cystic fibrosis and bronchiectasis, as well as a wide range of skin and soft tissue infections in humans.",opportunistic pulmonary infections,DISEASE,in patients with,structural lung disorders,DISEASE
35598137,COVID-19 is reported to be inducing Autoimmune Hemolytic Anemia in susceptible individuals.,COVID-19,CHEMICAL,induce,Autoimmune Hemolytic Anemia,DISEASE
35598137,Anemia improved with blood transfusion and steroid administration but patient eventually developed hepatorenal syndrome and expired.,Anemia,DISEASE,improve with,steroid administration,CHEMICAL
35598137,Anemia improved with blood transfusion and steroid administration but patient eventually developed hepatorenal syndrome and expired.,Anemia,DISEASE,develop,hepatorenal syndrome,DISEASE
35598135,Hyperuricemia is defined as serum uric acid of 6.0mg/dl and 7.0mg/dl for females and males respectively.,Hyperuricemia,DISEASE,be defined as,serum uric acid,CHEMICAL
31436889,"Pathogenic variants in polynucleotide kinase 3'-phosphatase (PNKP) gene have been associated with two distinct clinical presentations: autosomal recessive microcephaly, seizures, and developmental delay (MCSZ; MIM 613402) and ataxia with oculomotor apraxia type 4 (AOA4; MIM 616267).",polynucleotide kinase 3'-phosphatase PNKP gene,CHEMICAL,be associated with,seizures,DISEASE
31436889,"Pathogenic variants in polynucleotide kinase 3'-phosphatase (PNKP) gene have been associated with two distinct clinical presentations: autosomal recessive microcephaly, seizures, and developmental delay (MCSZ; MIM 613402) and ataxia with oculomotor apraxia type 4 (AOA4; MIM 616267).",polynucleotide kinase 3'-phosphatase PNKP gene,CHEMICAL,be associated with,autosomal recessive microcephaly,DISEASE
31436889,"Pathogenic variants in polynucleotide kinase 3'-phosphatase (PNKP) gene have been associated with two distinct clinical presentations: autosomal recessive microcephaly, seizures, and developmental delay (MCSZ; MIM 613402) and ataxia with oculomotor apraxia type 4 (AOA4; MIM 616267).",polynucleotide kinase 3'-phosphatase PNKP gene,CHEMICAL,be associated with,ataxia,DISEASE
31436889,"Pathogenic variants in polynucleotide kinase 3'-phosphatase (PNKP) gene have been associated with two distinct clinical presentations: autosomal recessive microcephaly, seizures, and developmental delay (MCSZ; MIM 613402) and ataxia with oculomotor apraxia type 4 (AOA4; MIM 616267).",polynucleotide kinase 3'-phosphatase PNKP gene,CHEMICAL,be associated with,oculomotor apraxia type,MENTAL_HEALTH
18658016,"Glyceryl trinitrate (GTN) ointment (0.2%) has an efficacy of up to 68% in healing chronic anal fissure, but it is associated with headache as the major and most common side effect.",GTN ointment,CHEMICAL,heal,chronic anal fissure,DISEASE
18658016,"Though botulinum toxin injected into the anal sphincter healed over 80% of chronic anal fissures, it is more invasive and expensive than GTN therapy.",botulinum toxin,CHEBI,heal % of,chronic anal fissures,DISEASE
18658016,Diltiazem ointment achieved healing of chronic anal fissure comparable to 0.2% GTN ointment but was associated with fewer side effects.,Diltiazem ointment,CHEMICAL,achieve healing of chronic anal fissure comparable to,GTN ointment,CHEMICAL
18658016,Diltiazem ointment achieved healing of chronic anal fissure comparable to 0.2% GTN ointment but was associated with fewer side effects.,Diltiazem ointment,CHEMICAL,achieve healing of,chronic anal fissure comparable,DISEASE
27539709,"Quadratic regression analysis of WG and LA revealed that, the optimal levels of dietary GMP were 0.45 and 0.48%, respectively, for juvenile red sea bream, which is also in line with the most of the growth performance and health parameters of the fish.",dietary GMP,CHEMICAL,be % for,juvenile red sea bream,NUTRITION
27514786,"Finally it is concluded that, dietary AMP supplementation enhanced the growth, digestibility, immune response and stress resistance of red sea bream.",dietary AMP supplementation,CHEMICAL,enhance,red sea bream,NUTRITION
27514786,"Finally it is concluded that, dietary AMP supplementation enhanced the growth, digestibility, immune response and stress resistance of red sea bream.",dietary AMP supplementation,CHEMICAL,enhance,stress resistance,MENTAL_HEALTH
24877714,"Tenuifoliside A (TFSA) is a bioactive oligosaccharide ester component of Polygala tenuifolia Wild, a traditional Chinese medicine which was used to manage mental disorders effectively.",Tenuifoliside A,CHEMICAL,be,bioactive oligosaccharide ester component,CHEMICAL
19879308,"Furthermore, the curcumin-induced increase in phosphorylated cyclic AMP response element binding protein (CREB), which has been implicated as a possible mediator of antidepressant actions, was prevented by MAPK and PI-3K inhibitors.",antidepressant actions,CHEMICAL,be prevented by,MAPK PI-3 K inhibitors,CHEMICAL
19879308,"Furthermore, the curcumin-induced increase in phosphorylated cyclic AMP response element binding protein (CREB), which has been implicated as a possible mediator of antidepressant actions, was prevented by MAPK and PI-3K inhibitors.",phosphorylated cyclic AMP response element binding protein,CHEMICAL,be prevented by,MAPK PI-3 K inhibitors,CHEMICAL
19879308,"Furthermore, the curcumin-induced increase in phosphorylated cyclic AMP response element binding protein (CREB), which has been implicated as a possible mediator of antidepressant actions, was prevented by MAPK and PI-3K inhibitors.",curcumin-induced increase,DISEASE,be prevented by,MAPK PI-3 K inhibitors,CHEMICAL
15476902,Estrogens play a pivotal role in the development of breast cancer.,Estrogens,CHEBI,play pivotal role in development of,breast cancer,DISEASE
15476902,Endocrine therapy based on estrogen blockade is a well-established treatment in hormone-dependent breast cancer.,Endocrine therapy,CHEBI,be well-established treatment in,hormone-dependent breast cancer,DISEASE
15476902,Endocrine therapy based on estrogen blockade is a well-established treatment in hormone-dependent breast cancer.,estrogen blockade,CHEBI,be well-established treatment in,hormone-dependent breast cancer,DISEASE
28360573,Late-life onset manic attacks generally occur secondary to general medical conditions or drug use.,manic attacks,DISEASE,occur secondary to,drug use,CHEBI
28360573,The patient's manic symptoms started on the seventh day of varenicline treatment.,patient's manic symptoms,DISEASE,start on seventh day of,varenicline treatment,CHEMICAL
28360573,Varenicline may cause manic episodes in patients with bipolar disorder and in healthy individuals.,Varenicline,CHEMICAL,cause manic episodes in patients with,bipolar disorder,MENTAL_HEALTH
28360573,Varenicline may cause manic episodes in patients with bipolar disorder and in healthy individuals.,Varenicline,CHEMICAL,cause,manic episodes,DISEASE
28360573,Varenicline may cause manic episodes in patients with bipolar disorder and in healthy individuals.,manic episodes,DISEASE,in patients with,bipolar disorder,MENTAL_HEALTH
28360573,An increasing number of serious psychiatric disorders are being reported due to varenicline treatment.,serious psychiatric disorders,DISEASE,be reported due to,varenicline treatment,CHEMICAL
21553897,"Structure elucidation and conformation analysis of four proanthocyanidins isolated from the bark of Parapiptadenia rigida were performed by two-dimensional NMR spectroscopy, HRESIMS, CD, and molecular mechanics (MM+) force field calculations.",proanthocyanidins,NUTRITION,be performed by,HRESIMS,CHEMICAL
25721137,"Origanum majorana L., belonging to the Lamiaceae family, has great potential and has been used as a folk medicine against asthma, indigestion, headache and rheumatism; in addition, the essential oils of this plant have been used widely in the food industry.",Origanum majorana L.,CHEMICAL,be used as folk medicine against,indigestion,DISEASE
25721137,"Origanum majorana L., belonging to the Lamiaceae family, has great potential and has been used as a folk medicine against asthma, indigestion, headache and rheumatism; in addition, the essential oils of this plant have been used widely in the food industry.",Origanum majorana L.,CHEMICAL,be used as folk medicine against,headache,MENTAL_HEALTH
25721137,"Origanum majorana L., belonging to the Lamiaceae family, has great potential and has been used as a folk medicine against asthma, indigestion, headache and rheumatism; in addition, the essential oils of this plant have been used widely in the food industry.",Origanum majorana L.,CHEMICAL,be used as folk medicine against,rheumatism,DISEASE
32516634,"The presence of antibiotics, such as sulfadiazine (SDZ), in the aquatic environment contributes to the generation of antimicrobial resistance, which is a matter of great concern.",sulfadiazine,CHEMICAL,contribute in aquatic environment to generation of,antimicrobial resistance,CHEBI
32516634,"The presence of antibiotics, such as sulfadiazine (SDZ), in the aquatic environment contributes to the generation of antimicrobial resistance, which is a matter of great concern.",sulfadiazine,CHEMICAL,contribute in aquatic environment to generation of,antimicrobial resistance,MENTAL_HEALTH
32516634,"The presence of antibiotics, such as sulfadiazine (SDZ), in the aquatic environment contributes to the generation of antimicrobial resistance, which is a matter of great concern.",antibiotics,CHEBI,contribute in aquatic environment to generation of,antimicrobial resistance,CHEBI
32516634,"The presence of antibiotics, such as sulfadiazine (SDZ), in the aquatic environment contributes to the generation of antimicrobial resistance, which is a matter of great concern.",antibiotics,CHEBI,contribute in aquatic environment to generation of,antimicrobial resistance,MENTAL_HEALTH
31917071,"In a new study, Schlomann et al. describes how sublethal antibiotics can trigger the purging of bacteria by the zebrafish.",sublethal antibiotics,CHEBI,trigger,purging,MENTAL_HEALTH
33805826,"Its location, orientation and distribution strongly depend on carotenoid concentration.",orientation,MENTAL_HEALTH,depend on,carotenoid concentration,CHEBI
32846587,"The nanoparticles with a representative polyphenol ((-)-epigallocatechin-3-gallate; EGCG) encapsulated were fabricated through an ethanol-mediated dissociation and re-assembly process of β-CG, with greater particle size and higher surface hydrophilicity observed at higher initial EGCG concentrations.",(-)-epigallocatechin-3-gallate,CHEMICAL,be fabricated through,ethanol-mediated dissociation,MENTAL_HEALTH
32846587,"The nanoparticles with a representative polyphenol ((-)-epigallocatechin-3-gallate; EGCG) encapsulated were fabricated through an ethanol-mediated dissociation and re-assembly process of β-CG, with greater particle size and higher surface hydrophilicity observed at higher initial EGCG concentrations.",representative polyphenol,CHEMICAL,be fabricated through,ethanol-mediated dissociation,MENTAL_HEALTH
35580843,"The Doha 2019 women's World Championship marathon took place in extreme hot (32 °C), humid conditions (74% relative humidity) culminating in unprecedented (41%) failure rates.",Doha women's Championship marathon,DISEASE,take place in,° C,CHEMICAL
22730800,"Gamma-hydroxybutyric acid (GHB) is an old anaesthetic drug which was misused in the 80-90's as an anabolic agent (bodybuilding), recreational drug (drunkenness, euphoric, disinhibiting and aphrodisiac effects) and as a date rape drug (disinhibiting, hypnotic and amnesic effects).",GHB,CHEMICAL,be,old anaesthetic drug,CHEBI
22730800,"Gamma-hydroxybutyric acid (GHB) is an old anaesthetic drug which was misused in the 80-90's as an anabolic agent (bodybuilding), recreational drug (drunkenness, euphoric, disinhibiting and aphrodisiac effects) and as a date rape drug (disinhibiting, hypnotic and amnesic effects).",Gamma-hydroxybutyric acid,CHEMICAL,be,old anaesthetic drug,CHEBI
34711996,"Relative to the NHNES group, a significantly higher proportion of the Veteran PTSD group met criteria for MetS (26.9% vs. 41.7%) with a higher proportion of abnormal values in four out of five MetS domains (excepting glucose).",Veteran PTSD group,DISEASE,meet criteria for,MetS domains,CHEMICAL
34711996,"Relative to the NHNES group, a significantly higher proportion of the Veteran PTSD group met criteria for MetS (26.9% vs. 41.7%) with a higher proportion of abnormal values in four out of five MetS domains (excepting glucose).",Veteran PTSD group,DISEASE,meet criteria for,MetS,CHEMICAL
30470649,Both post-traumatic stress disorder (PTSD) and estrogen receptor alpha (ESR1) gene rs2234693 were reported to influence serum glucose and lipids profiles.,estrogen receptor alpha gene rs2234693,CHEBI,influence,glucose profiles,CHEMICAL
30470649,Both post-traumatic stress disorder (PTSD) and estrogen receptor alpha (ESR1) gene rs2234693 were reported to influence serum glucose and lipids profiles.,estrogen receptor alpha gene rs2234693,NUTRITION,influence,glucose profiles,CHEMICAL
30470649,Both post-traumatic stress disorder (PTSD) and estrogen receptor alpha (ESR1) gene rs2234693 were reported to influence serum glucose and lipids profiles.,post-traumatic stress disorder,MENTAL_HEALTH,influence,glucose profiles,CHEMICAL
30470649,"In female PTSD group, the C allele carriers had significantly higher TC/HDL-C and LDL-C/HDL-C than the TT homozygotes after adjustment for age and BMI.",C allele carriers,CHEBI,have in,female PTSD group,DISEASE
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD,DISEASE,show higher concentrations of,F=10.112,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD,DISEASE,show higher concentrations of,cholesterol,NUTRITION
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD,DISEASE,show higher concentrations of,MDD,DISEASE
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD,DISEASE,show higher concentrations of,F=9.858,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD,DISEASE,show higher concentrations of,p<0.01,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",MDD,DISEASE,show higher concentrations of,F=10.112,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",MDD,DISEASE,show higher concentrations of,cholesterol,NUTRITION
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",MDD,DISEASE,show higher concentrations of,MDD,DISEASE
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",MDD,DISEASE,show higher concentrations of,F=9.858,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",MDD,DISEASE,show higher concentrations of,p<0.01,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD comorbid,DISEASE,show higher concentrations of,F=10.112,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD comorbid,DISEASE,show higher concentrations of,cholesterol,NUTRITION
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD comorbid,DISEASE,show higher concentrations of,MDD,DISEASE
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD comorbid,DISEASE,show higher concentrations of,F=9.858,CHEMICAL
15201512,"Veterans with combat-related PTSD as well as veterans with combat-related PTSD comorbid with MDD showed significantly higher concentrations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C (F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with MDD or healthy control group.",combat-related PTSD comorbid,DISEASE,show higher concentrations of,p<0.01,CHEMICAL
15201512,"Contrary healthy control group and veterans with MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs. veterans with PTSD or PTSD comorbid with MDD.",MDD,DISEASE,show higher concentrations of,HDL-C PTSD comorbid,DISEASE
15201512,"Contrary healthy control group and veterans with MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs. veterans with PTSD or PTSD comorbid with MDD.",MDD,DISEASE,show higher concentrations of,PTSD,DISEASE
15201512,"Contrary healthy control group and veterans with MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs. veterans with PTSD or PTSD comorbid with MDD.",MDD,DISEASE,show higher concentrations of,MDD,DISEASE
15201512,"Contrary healthy control group and veterans with MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs. veterans with PTSD or PTSD comorbid with MDD.",MDD,DISEASE,show higher concentrations of,F=8.421,CHEMICAL
15201512,"Contrary healthy control group and veterans with MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs. veterans with PTSD or PTSD comorbid with MDD.",MDD,DISEASE,show higher concentrations of,p<0.01,CHEMICAL
32754204,"The NBS-encoding genes of the X. sorbifolium, D. longan, and A. yangbiense genomes were derived from 181 ancestral genes (three RNL, 23 TNL, and 155 CNL), which exhibited dynamic and distinct evolutionary patterns due to independent gene duplication/loss events.",X. sorbifolium,CHEMICAL,be derived from,CNL,DISEASE
32754204,"The NBS-encoding genes of the X. sorbifolium, D. longan, and A. yangbiense genomes were derived from 181 ancestral genes (three RNL, 23 TNL, and 155 CNL), which exhibited dynamic and distinct evolutionary patterns due to independent gene duplication/loss events.",X. sorbifolium,CHEMICAL,be derived from,TNL,DISEASE
15591035,"Interestingly, insulin hardly affected G6pc promoter activity in the absence of glucose, suggesting that a reduced capacity of insulin-dependent repression of piscine G6pc may lead to insulin resistance in carnivorous fish.",insulin-dependent repression,MENTAL_HEALTH,lead to,insulin resistance,MENTAL_HEALTH
23030601,"Recently, we reported elevated levels of cerebrospinal fluid (CSF) KYNA in male patients with bipolar disorder.",KYNA,CHEMICAL,in male patients with,bipolar disorder,MENTAL_HEALTH
23030601,"Here, we investigate the relationship between symptomatology and the concentration of CSF KYNA in patients with bipolar I disorder.",CSF KYNA,CHEMICAL,in patients with,bipolar disorder,MENTAL_HEALTH
18797398,Since the discovery of the tryptophan hydroxylase 2 gene (TPH2) several studies reported the association of TPH2 genetic variation with bipolar I (BPI) disorder.,tryptophan hydroxylase gene,NUTRITION,report association of tph2 genetic variation with,I,DISEASE
3618531,This has led to the hypothesis that appetite disturbance is a consequence of an abnormal hypothalamic response to appetite effects of endogenous opiates and opiate antagonist may be a useful treatment.,appetite disturbance,DISEASE,be consequence of abnormal hypothalamic response to appetite effects of,opiate antagonist,CHEBI
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,arecoline,CHEMICAL
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,oxotremorine,CHEMICAL
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,mg/kg,CHEMICAL
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,RS86,CHEMICAL
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,physostigmine,CHEMICAL
3653242,"In contrast, dose-related analgesia was obtained following oxotremorine (0.01-0.3 mg/kg) and arecoline (0.5-4.0 mg/kg) and physostigmine (0.1-0.4 mg/kg), RS86 (0.25-2.5 mg/kg) and pilocarpine (0.5-8.0 mg/kg).",dose-related analgesia,MENTAL_HEALTH,be obtained in,pilocarpine,CHEMICAL
3653242,The effects of acetylcholine antagonists on physostigmine-induced yawning and physostigmine-induced analgesia were also investigated.,acetylcholine antagonists,CHEBI,have the effects on,yawning analgesia,MENTAL_HEALTH
3653242,"Following their s.c. injection, trihexyphenidyl, atropine, dicyclomine, secoverine and methylatropine but not pirenzepine, inhibited both yawning and analgesia; there were clear differences in their potencies on the two responses.",secoverine,CHEMICAL,inhibit,analgesia,MENTAL_HEALTH
3653242,"Pirenzepine, intracerebroventricularly (i.c.v.), inhibited yawning (ED50 value 5.7 micrograms/rat) but not analgesia (3-100 micrograms/rat).",Pirenzepine,CHEMICAL,inhibit,analgesia,MENTAL_HEALTH
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEBI,be endocrine treatment of choice for,estrogen receptor positive breast cancer,DISEASE
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEBI,be endocrine treatment of choice for,estrogen receptor positive breast cancer,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",nonsteroidal antiestrogen drug,CHEMICAL,be endocrine treatment of choice for,estrogen receptor positive breast cancer,DISEASE
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",nonsteroidal antiestrogen drug,CHEMICAL,be endocrine treatment of choice for,estrogen receptor positive breast cancer,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEMICAL,be endocrine treatment of choice for,estrogen receptor positive breast cancer,DISEASE
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEMICAL,be endocrine treatment of choice for,estrogen receptor positive breast cancer,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEBI,be,endocrine treatment,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",nonsteroidal antiestrogen drug,CHEMICAL,be,endocrine treatment,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",drug tamoxifen,CHEMICAL,be,endocrine treatment,CHEBI
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",related estrogen receptor antagonist raloxifene,CHEMICAL,be effective intervention for,osteoporosis,DISEASE
16787364,"The nonsteroidal antiestrogen drug tamoxifen is the endocrine treatment of choice for estrogen receptor positive breast cancer, while the related estrogen receptor antagonist raloxifene is an effective therapeutic intervention for osteoporosis.",related estrogen receptor antagonist raloxifene,CHEBI,be effective intervention for,osteoporosis,DISEASE
12414791,"Treatment of diabetic rodents with the LXR agonist, T0901317, resulted in dramatic reduction of plasma glucose.",diabetic rodents,DISEASE,have treatment with,LXR agonist,CHEBI
12414791,Nuclear run-on studies indicated that transcriptional repression was primarily responsible for the inhibition of PEPCK by the LXR agonist.,transcriptional repression,MENTAL_HEALTH,be responsible for inhibition of pepck by,LXR agonist,CHEBI
29775122,"Chronic intermittent hypoxia (CIH), main feature of obstructive sleep apnea, produces nitro-oxidative stress, which contributes to potentiate carotid body (CB) chemosensory discharges and sympathetic-adrenal-axis activity, leading to hypertension.",obstructive sleep apnea,MENTAL_HEALTH,lead to,hypertension,DISEASE
29775122,"Chronic intermittent hypoxia (CIH), main feature of obstructive sleep apnea, produces nitro-oxidative stress, which contributes to potentiate carotid body (CB) chemosensory discharges and sympathetic-adrenal-axis activity, leading to hypertension.",CIH,CHEMICAL,lead to,hypertension,DISEASE
29775122,"Chronic intermittent hypoxia (CIH), main feature of obstructive sleep apnea, produces nitro-oxidative stress, which contributes to potentiate carotid body (CB) chemosensory discharges and sympathetic-adrenal-axis activity, leading to hypertension.",Chronic intermittent hypoxia,DISEASE,lead to,hypertension,DISEASE
25907792,Whether ascorbic acid has similar effects in OSA patients remains to be prospectively tested.,ascorbic acid,CHEBI,have similar effects in,OSA patients,DISEASE
29278206,Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD).,Serotonin reuptake inhibitors,CHEMICAL,be first-line treatments for,OCD,DISEASE
29278206,Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD).,Serotonin reuptake inhibitors,CHEMICAL,be first-line treatments for,obsessive-compulsive disorder,MENTAL_HEALTH
29278206,Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD).,SRIs,CHEMICAL,be first-line treatments for,OCD,DISEASE
29278206,Serotonin reuptake inhibitors (SRIs) and cognitive-behavioral psychotherapy (CBT) are first-line treatments for obsessive-compulsive disorder (OCD).,SRIs,CHEMICAL,be first-line treatments for,obsessive-compulsive disorder,MENTAL_HEALTH
29061777,"Finally, phenothiazines can also be effective in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",phenothiazines,CHEMICAL,be effective in treatment of,Alzheimer's disease,DISEASE
29061777,"Finally, phenothiazines can also be effective in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",phenothiazines,CHEMICAL,be effective in treatment of,neurodegenerative diseases,DISEASE
29061777,"Finally, phenothiazines can also be effective in the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.",phenothiazines,CHEMICAL,be effective in treatment of,Parkinson's disease,DISEASE
8043872,Iron chelation treatment of red blood cells infected with Plasmodium falciparum selectively intervenes with iron-dependent metabolism of malaria parasites and inhibits their development.,Iron chelation,CHEMICAL,intervene with iron-dependent metabolism of,malaria parasites,DISEASE
28003721,"Cholestasis with disease progression may lead to dyslipidemia, osteodystrophy and fat-soluble vitamin deficiency.",Cholestasis,DISEASE,lead to,osteodystrophy,DISEASE
28003721,"Cholestasis with disease progression may lead to dyslipidemia, osteodystrophy and fat-soluble vitamin deficiency.",Cholestasis,DISEASE,lead to,fat-soluble vitamin deficiency,CHEBI
28003721,"Cholestasis with disease progression may lead to dyslipidemia, osteodystrophy and fat-soluble vitamin deficiency.",Cholestasis,DISEASE,lead to,dyslipidemia,DISEASE
25499313,"While the FO group showed increased n-3 polyunsaturated fatty acid (PUFA) incorporation and reduced n-6/n-3 PUFA ratio, HVF allowed trans fatty acid (TFA) incorporation and increased n-6/n-3 PUFA ratio in the brain-cortex.",FO group,CHEMICAL,show increased,PUFA,CHEMICAL
25499313,"While the FO group showed increased n-3 polyunsaturated fatty acid (PUFA) incorporation and reduced n-6/n-3 PUFA ratio, HVF allowed trans fatty acid (TFA) incorporation and increased n-6/n-3 PUFA ratio in the brain-cortex.",FO group,CHEMICAL,show increased,polyunsaturated fatty acid,NUTRITION
25499313,"While the FO group showed increased n-3 polyunsaturated fatty acid (PUFA) incorporation and reduced n-6/n-3 PUFA ratio, HVF allowed trans fatty acid (TFA) incorporation and increased n-6/n-3 PUFA ratio in the brain-cortex.",FO group,CHEMICAL,show increased,n-3 incorporation,CHEMICAL
25499313,"While the FO group showed increased n-3 polyunsaturated fatty acid (PUFA) incorporation and reduced n-6/n-3 PUFA ratio, HVF allowed trans fatty acid (TFA) incorporation and increased n-6/n-3 PUFA ratio in the brain-cortex.",FO group,CHEMICAL,reduce,PUFA ratio,CHEMICAL
25499313,"In fact, the FO group showed minor AMPH-induced hyperactivity, decreased reactive species (RS) generation per se, causing no changes in protein carbonyl (PC) levels and dopamine transporter (DAT).",FO group,CHEMICAL,show in,AMPH-induced hyperactivity,MENTAL_HEALTH
25499313,"In fact, the FO group showed minor AMPH-induced hyperactivity, decreased reactive species (RS) generation per se, causing no changes in protein carbonyl (PC) levels and dopamine transporter (DAT).",FO group,CHEMICAL,decrease,RS,DISEASE
35302643,"Acquired osmotolerance induced by salt stress is widespread across Arabidopsis (Arabidopsis thaliana) accessions and is conferred by disruption of a nucleotide binding leucine-rich repeat (NLR) gene, designated ACQUIRED OSMOTOLERANCE (ACQOS).",Acquired osmotolerance,DISEASE,be conferred by disruption of,nucleotide binding leucine-rich repeat NLR gene,CHEMICAL
31824540,Hormone measurements and gene expression analyses showed that the jasmonate (JA) pathway is induced early upon P. arrhenomanes infection.,jasmonate pathway,CHEMICAL,be induced,P. arrhenomanes infection,DISEASE
31824540,Exogenous application of methyl-jasmonate (MeJA) on the plant confirmed that JA is needed for basal defense against both P. arrhenomanes and M. graminicola in rice.,JA,CHEMICAL,be needed for basal defense against,P. arrhenomanes,DISEASE
34282950,"In this study, we demonstrated that PAs (or their building block, catechin) could increase the resistance of cucumber seedlings to F. solani both in vitro and in vivo.",catechin,NUTRITION,increase,resistance,MENTAL_HEALTH
15302127,"More specifically, the following effects of thioperamide (1.25-20 mg/kg) were dose-dependently analysed: (1) its potential direct effects on memory consolidation; (2) its potential reversing effects on retrograde amnesia induced by the NMDA antagonist dizocilpine (MK-801, 0.5 mg/kg) and (3) its potential reversing effects on the well-known amnesia induced by the muscarinic antagonist scopolamine (0.25 mg/kg).",thioperamide,CHEMICAL,reversing effects on,amnesia,MENTAL_HEALTH
15302127,"More specifically, the following effects of thioperamide (1.25-20 mg/kg) were dose-dependently analysed: (1) its potential direct effects on memory consolidation; (2) its potential reversing effects on retrograde amnesia induced by the NMDA antagonist dizocilpine (MK-801, 0.5 mg/kg) and (3) its potential reversing effects on the well-known amnesia induced by the muscarinic antagonist scopolamine (0.25 mg/kg).",thioperamide,CHEMICAL,reversing effects on,well-known amnesia,MENTAL_HEALTH
1364134,Receptor agonists administered into the hippocampus had effects opposite to those of the respective antagonists: glutamate (5 micrograms) and oxotremorine (2 micrograms) enhanced memory and muscimol (0.03 microgram) was amnestic.,Receptor agonists,CHEBI,have effects opposite to,antagonists glutamate,CHEBI
1364134,Receptor agonists administered into the hippocampus had effects opposite to those of the respective antagonists: glutamate (5 micrograms) and oxotremorine (2 micrograms) enhanced memory and muscimol (0.03 microgram) was amnestic.,Receptor agonists,CHEBI,have effects opposite to,antagonists glutamate,CHEMICAL
1364134,Receptor agonists administered into the hippocampus had effects opposite to those of the respective antagonists: glutamate (5 micrograms) and oxotremorine (2 micrograms) enhanced memory and muscimol (0.03 microgram) was amnestic.,Receptor agonists,CHEBI,have effects opposite to,oxotremorine,CHEMICAL
26676672,Tolvaptan is an oral antagonist of arginine vasopressin receptor 2 that has been approved in Japan to reduce congestive symptoms in patients with heart failure refractory to loop diuretics.,Tolvaptan,CHEMICAL,be oral antagonist of,arginine vasopressin receptor,CHEMICAL
26676672,Tolvaptan is an oral antagonist of arginine vasopressin receptor 2 that has been approved in Japan to reduce congestive symptoms in patients with heart failure refractory to loop diuretics.,Tolvaptan,CHEMICAL,be,oral antagonist,CHEBI
26676672,A logistic regression analysis revealed that the early use of tolvaptan (within 3 days after admission) was an independent factor associated with tolvaptan responsiveness.,tolvaptan,CHEMICAL,associated with,tolvaptan responsiveness,CHEMICAL
26676672,"However, the early use of tolvaptan was associated with higher tolvaptan responsiveness, a shorter duration of carperitide infusion, earlier initiation of ambulatory cardiac rehabilitation, shorter hospital stay, lower rate of in-hospital death.",tolvaptan,CHEMICAL,be associated with,in-hospital death,DISEASE
26676672,"However, the early use of tolvaptan was associated with higher tolvaptan responsiveness, a shorter duration of carperitide infusion, earlier initiation of ambulatory cardiac rehabilitation, shorter hospital stay, lower rate of in-hospital death.",tolvaptan,CHEMICAL,be associated with,carperitide infusion,CHEMICAL
26676672,"However, the early use of tolvaptan was associated with higher tolvaptan responsiveness, a shorter duration of carperitide infusion, earlier initiation of ambulatory cardiac rehabilitation, shorter hospital stay, lower rate of in-hospital death.",tolvaptan,CHEMICAL,be associated with,higher tolvaptan responsiveness,CHEMICAL
30135647,"It was found that SU5402 itself evoked depressive-like behaviors, induced microglia activation, increased production of pro-inflammatory cytokines including IL-1β, IL-6 and TNF-α, and decreased the expression of CX3CL1.",SU5402,CHEMICAL,increased production of,IL-1β,CHEMICAL
30135647,"It was found that SU5402 itself evoked depressive-like behaviors, induced microglia activation, increased production of pro-inflammatory cytokines including IL-1β, IL-6 and TNF-α, and decreased the expression of CX3CL1.",SU5402,CHEMICAL,increased production of,TNF-α,CHEMICAL
16566531,"However, staff in the BU reported lower rates of depersonalization (P=.049) compared with the CrCU counterparts.",BU,CHEMICAL,report lower rates of,depersonalization,MENTAL_HEALTH
29071217,Purpose: Modafinil is a vigilance-enhancing drug licensed for narcolepsy.,Modafinil,CHEMICAL,be vigilance-enhancing drug licensed purpose for,narcolepsy,MENTAL_HEALTH
29071217,The use of modafinil leads to various neuromodulatory effects with very low abuse potential.,modafinil,CHEMICAL,lead to various neuromodulatory effects with,abuse potential,DISEASE
29071217,This study was designed to evaluate whether modafinil could improve motor dysfunction in the 6-hydroxydopamine (6-OHDA)-induced rat model of Parkinson's disease.,modafinil,CHEMICAL,improve motor dysfunction in,6-hydroxydopamine rat model,CHEMICAL
29071217,This study was designed to evaluate whether modafinil could improve motor dysfunction in the 6-hydroxydopamine (6-OHDA)-induced rat model of Parkinson's disease.,modafinil,CHEMICAL,improve,motor dysfunction,DISEASE
29071217,"Parkinsonian rats received intraperitoneal (ip) injections of modafinil (50, 75, and 100 mg/kg) and catalepsy-like immobility was assessed by the bar test (BT).",Parkinsonian rats,DISEASE,receive,modafinil,CHEMICAL
29071217,"Parkinsonian rats received intraperitoneal (ip) injections of modafinil (50, 75, and 100 mg/kg) and catalepsy-like immobility was assessed by the bar test (BT).",catalepsy-like immobility,CHEMICAL,be assessed by,BT,CHEMICAL
29071217,"For this purpose, parkinsonian animals were pretreated with SCH23390 and raclopride (the dopamine D1 and D2 receptor anatgonists, respectively) or SCH23390 + raclopride, and then assessed by the BT.",parkinsonian animals,DISEASE,assess by,BT,CHEMICAL
29071217,"For this purpose, parkinsonian animals were pretreated with SCH23390 and raclopride (the dopamine D1 and D2 receptor anatgonists, respectively) or SCH23390 + raclopride, and then assessed by the BT.",parkinsonian animals,DISEASE,be pretreated for purpose with,SCH23390,CHEMICAL
29071217,"For this purpose, parkinsonian animals were pretreated with SCH23390 and raclopride (the dopamine D1 and D2 receptor anatgonists, respectively) or SCH23390 + raclopride, and then assessed by the BT.",parkinsonian animals,DISEASE,be pretreated for purpose with,raclopride,CHEMICAL
29071217,"For this purpose, parkinsonian animals were pretreated with SCH23390 and raclopride (the dopamine D1 and D2 receptor anatgonists, respectively) or SCH23390 + raclopride, and then assessed by the BT.",parkinsonian animals,DISEASE,be pretreated for purpose with,dopamine D1,CHEMICAL
29071217,"Notably, the effect of modafinil in the BT was reversed in parkinsonian rats pretreated with raclopride (1.25 mg/kg) and/or SCH23390 + raclopride (0.75 and 1.25 mg/kg, respectively), but not in those pretreated with SCH23390 (0.75 mg/kg).",BT,CHEMICAL,be reversed in,parkinsonian rats,DISEASE
29071217,"Notably, the effect of modafinil in the BT was reversed in parkinsonian rats pretreated with raclopride (1.25 mg/kg) and/or SCH23390 + raclopride (0.75 and 1.25 mg/kg, respectively), but not in those pretreated with SCH23390 (0.75 mg/kg).",modafinil,CHEMICAL,be reversed in,parkinsonian rats,DISEASE
29071217,"Notably, the effect of modafinil in the BT was reversed in parkinsonian rats pretreated with raclopride (1.25 mg/kg) and/or SCH23390 + raclopride (0.75 and 1.25 mg/kg, respectively), but not in those pretreated with SCH23390 (0.75 mg/kg).",modafinil,CHEMICAL,have the effect in,BT,CHEMICAL
34576536,The infrared-ray functional analysis also revealed the isolated NCC possessed a highly exposed cellulose compartment with minimized lignoresidues of lignin and hemicellulose.,NCC,DISEASE,possess exposed cellulose compartment with minimized lignoresidues of,hemicellulose,NUTRITION
34576536,The infrared-ray functional analysis also revealed the isolated NCC possessed a highly exposed cellulose compartment with minimized lignoresidues of lignin and hemicellulose.,NCC,DISEASE,possess exposed cellulose compartment with,lignoresidues,CHEMICAL
31935730,Cortisol is thought to be involved in the pathophysiology of affective disorders.,Cortisol,CHEMICAL,be involved in pathophysiology of,affective disorders,MENTAL_HEALTH
31935730,The aim of the present study was to test the hypothesis that adrenocortical steroids aldosterone and cortisol show different dynamic changes in the course of clinical depression with the assumption that aldosterone is a state marker of depression.,aldosterone,CHEMICAL,be state marker of,depression,MENTAL_HEALTH
31935730,The aim of the present study was to test the hypothesis that adrenocortical steroids aldosterone and cortisol show different dynamic changes in the course of clinical depression with the assumption that aldosterone is a state marker of depression.,steroids aldosterone,CHEMICAL,show different dynamic changes in course of,clinical depression,MENTAL_HEALTH
20345280,"However, sexual dimorphism of diseases may also depend on factors independent of sex hormones (i.e., a gender effect), as demonstrated by our data on differential longevity in females and males.",diseases,DISEASE,depend on factors independent of,sex hormones,CHEBI
15089113,"A number of preclinical studies have shown that selective agonists of sigma-1 receptors affect higher-ordered brain functions such as learning and memory, cognition and mood.",sigma-1 receptors,CHEMICAL,affect higher-ordered brain functions such as,mood,DISEASE
15089113,"A number of preclinical studies have shown that selective agonists of sigma-1 receptors affect higher-ordered brain functions such as learning and memory, cognition and mood.",sigma-1 receptors,CHEMICAL,affect higher-ordered brain functions such as,memory,DISEASE
15089113,"A number of preclinical studies have shown that selective agonists of sigma-1 receptors affect higher-ordered brain functions such as learning and memory, cognition and mood.",selective agonists,CHEBI,affect higher-ordered brain functions such as,mood,DISEASE
15089113,"A number of preclinical studies have shown that selective agonists of sigma-1 receptors affect higher-ordered brain functions such as learning and memory, cognition and mood.",selective agonists,CHEBI,affect higher-ordered brain functions such as,memory,DISEASE
15089113,These studies indicate that sigma-1 receptor agonists may exert therapeutic effects in depression and senile dementia.,sigma-1 receptor agonists,CHEMICAL,exert therapeutic effects in,senile dementia,MENTAL_HEALTH
15089113,These studies indicate that sigma-1 receptor agonists may exert therapeutic effects in depression and senile dementia.,sigma-1 receptor agonists,CHEMICAL,exert therapeutic effects in,depression,MENTAL_HEALTH
15089113,These studies indicate that sigma-1 receptor agonists may exert therapeutic effects in depression and senile dementia.,sigma-1 receptor agonists,CHEBI,exert therapeutic effects in,senile dementia,MENTAL_HEALTH
15089113,These studies indicate that sigma-1 receptor agonists may exert therapeutic effects in depression and senile dementia.,sigma-1 receptor agonists,CHEBI,exert therapeutic effects in,depression,MENTAL_HEALTH
15089113,"Indeed, the sigma-1 receptor agonist igmesine, has been shown to improve depression in a clinical trial.",sigma-1 receptor agonist igmesine,CHEMICAL,improve,depression,MENTAL_HEALTH
15089113,"Indeed, the sigma-1 receptor agonist igmesine, has been shown to improve depression in a clinical trial.",sigma-1 receptor agonist igmesine,CHEBI,improve,depression,MENTAL_HEALTH
1302179,"More recently their pharmacological action on dopamine receptors has been exploited to treat post-partum bleeding, migraine, Parkinson's disease and senile dementia.",dopamine receptors,CHEMICAL,treat,senile dementia,MENTAL_HEALTH
1302179,"More recently their pharmacological action on dopamine receptors has been exploited to treat post-partum bleeding, migraine, Parkinson's disease and senile dementia.",dopamine receptors,CHEMICAL,treat,post-partum bleeding,DISEASE
1302179,"More recently their pharmacological action on dopamine receptors has been exploited to treat post-partum bleeding, migraine, Parkinson's disease and senile dementia.",dopamine receptors,CHEMICAL,treat,Parkinson's disease,DISEASE
1302179,"More recently their pharmacological action on dopamine receptors has been exploited to treat post-partum bleeding, migraine, Parkinson's disease and senile dementia.",dopamine receptors,CHEMICAL,treat,migraine,DISEASE
32956656,"Mercury intoxication is known to be associated with adverse symptoms of fatigue and sleep disturbances, but whether low-level mercury exposure could affect sleep remains unclear.",Mercury intoxication,NUTRITION,be associated with adverse symptoms of,fatigue disturbances,DISEASE
32956656,"Mercury intoxication is known to be associated with adverse symptoms of fatigue and sleep disturbances, but whether low-level mercury exposure could affect sleep remains unclear.",Mercury intoxication,NUTRITION,be associated with adverse symptoms of,fatigue disturbances,MENTAL_HEALTH
32956656,We sought to examine associations between mercury levels and sleep disturbances in Mexican youth.,mercury levels,NUTRITION,have associations with,sleep disturbances,DISEASE
32956656,We sought to examine associations between mercury levels and sleep disturbances in Mexican youth.,sleep disturbances,DISEASE,have associations with,mercury levels,NUTRITION
29079356,"We, therefore, evaluated the effect of the neurotoxicant 6-hydroxydopamine (6-OHDA) on regulated cell death signaling in MSCs and investigated whether overexpression of PARKIN in MSCs was capable of modulating the effect of 6-OHDA.",PARKIN,DISEASE,modulate effect of,6-OHDA,CHEMICAL
28968200,ACR and ALA treatment alone and together caused a signifi-cant increase in hepatic reduced glutathione content while a decrease in hepatic ascorbic content was observed when compared to control group.,ACR,CHEMICAL,cause signifi-cant increase in,hepatic reduced glutathione content,CHEMICAL
28968200,ACR and ALA treatment alone and together caused a signifi-cant increase in hepatic reduced glutathione content while a decrease in hepatic ascorbic content was observed when compared to control group.,ALA treatment,CHEMICAL,cause signifi-cant increase in,hepatic reduced glutathione content,CHEMICAL
32361753,"Here, using the short-lived fish Nothobranchius guentheri, we investigated effects of metformin on life span and aging-related cognitive ability and inflammation.",metformin,CHEMICAL,have effects on,inflammation,DISEASE
22487086,Here we investigate the effects of layer-specific cholinergic drug application in the tree shrew primary visual cortex during visual stimulation with drifting grating stimuli of varying contrast and orientation.,layer-specific cholinergic drug application,CHEBI,have the effects in,tree shrew,NUTRITION
31918019,"Moreover, anti-diabetic properties of flavonoids also encounter diabetic related complications.",flavonoids,CHEMICAL,encounter,diabetic related,DISEASE
9201759,Administration of trazodone for 5 months after tapering of the above agents improved his aggressive behaviors.,trazodone,CHEMICAL,improve,aggressive behaviors,DISEASE
2567048,The literature and the experience show convulsions to occur extremely rarely as a result of antidepressant and neuroleptic medication at standard doses.,convulsions,DISEASE,occur as result of,antidepressant medication,CHEMICAL
12809641,"Six subjects with classical phenylketonuria (PKU) were treated with large neutral amino acid supplements (PreKUnil, Nilab, Dk) at 0.4g/kg/day in equally divided doses three times each day on an increased natural protein diet.",PKU,DISEASE,be treated with,large neutral amino acid supplements,CHEMICAL
12809641,"Six subjects with classical phenylketonuria (PKU) were treated with large neutral amino acid supplements (PreKUnil, Nilab, Dk) at 0.4g/kg/day in equally divided doses three times each day on an increased natural protein diet.",classical phenylketonuria,DISEASE,be treated with,large neutral amino acid supplements,CHEMICAL
12809641,"Blood phenylalanine concentrations remained essentially unchanged, while the brain phenylalanine concentrations gradually decreased toward the carrier range as seen in parents of children with PKU.",brain phenylalanine concentrations,CHEMICAL,see in parents of children with,PKU,DISEASE
35583196,FATP4 deficiency causes ichthyosis premature syndrome in mice and humans associated with suppression of polar lipids but an increase in neutral lipids including triglycerides (TGs).,FATP4 deficiency,DISEASE,cause,ichthyosis premature syndrome,DISEASE
35526493,"In addition, the impact of vitamin D deficiency on oxidative stress and hormone production central to folliculogenesis was explored.",vitamin D deficiency,CHEBI,have the impact on,folliculogenesis,DISEASE
35526493,"In addition, the impact of vitamin D deficiency on oxidative stress and hormone production central to folliculogenesis was explored.",vitamin D deficiency,CHEBI,have the impact on,hormone production,CHEBI
35526493,"Sub-optimal vitamin D levels were implicated in disrupted reproductive hormone balance, including overproduction of anti-mullerian hormone (AMH); accumulation of pro-inflammatory Advanced Glycation End Products (AGEs) and formation of Reactive Oxygen Species (ROS) in ovarian tissue, leading to abnormal folliculogenesis.",Sub-optimal vitamin D levels,CHEBI,including overproduction of,anti-mullerian hormone accumulation,CHEBI
35526493,"Sub-optimal vitamin D levels were implicated in disrupted reproductive hormone balance, including overproduction of anti-mullerian hormone (AMH); accumulation of pro-inflammatory Advanced Glycation End Products (AGEs) and formation of Reactive Oxygen Species (ROS) in ovarian tissue, leading to abnormal folliculogenesis.",Sub-optimal vitamin D levels,CHEBI,including overproduction of,pro-inflammatory Advanced Glycation End Products,DISEASE
35526493,"Sub-optimal vitamin D levels were implicated in disrupted reproductive hormone balance, including overproduction of anti-mullerian hormone (AMH); accumulation of pro-inflammatory Advanced Glycation End Products (AGEs) and formation of Reactive Oxygen Species (ROS) in ovarian tissue, leading to abnormal folliculogenesis.",Sub-optimal vitamin D levels,CHEBI,lead to,abnormal folliculogenesis,DISEASE
28540038,Paliperidone is licensed both as an oral and depot antipsychotic medication in the treatment of schizophrenia.,Paliperidone,CHEMICAL,be licensed as oral and depot antipsychotic medication in treatment of,schizophrenia,MENTAL_HEALTH
28540038,Paliperidone is licensed both as an oral and depot antipsychotic medication in the treatment of schizophrenia.,Paliperidone,CHEMICAL,be licensed as,depot,CHEMICAL
35587348,"Amitriptyline is an established medication used off-label for the treatment of fibromyalgia, but pregabalin, duloxetine, and milnacipran are the only pharmacological agents approved by the US Food and Drug Administration (FDA) to treat fibromyalgia.",Amitriptyline,CHEMICAL,used for treatment of,fibromyalgia,DISEASE
18781666,"Included among the syndromes are ataques de nervios (ADN), which are reported to be bound to the Hispanic culture and closely resemble panic attacks.",syndromes,MENTAL_HEALTH,be,ataques de nervios,CHEMICAL
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",Leukotriene receptor antagonists,CHEBI,be used for,allergic rhinitis,DISEASE
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",LTRAs,CHEMICAL,be used for,allergic rhinitis,DISEASE
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",Leukotriene receptor antagonists,CHEBI,be raised,Drug Safety,CHEBI
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",Leukotriene receptor antagonists,CHEBI,be raised,Drug,CHEBI
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",LTRAs,CHEMICAL,be raised,Drug Safety,CHEBI
35595323,"Leukotriene receptor antagonists (LTRAs) are widely used for asthma and allergic rhinitis (AR), but concerns about the risk of neuropsychiatric events (NPEs) have been raised since the first Drug Safety Communication by the US Food and Drug Administration in 2008.",LTRAs,CHEMICAL,be raised,Drug,CHEBI
35595323,"The incidence rate ratios (IRRs) for exposed period and risk periods (1-3, 4-7, 8-14, 15-30, 31-90, >90 days from initiation of LTRA) compared to unexposed periods were calculated using conditional Poisson regression.",LTRA,CHEBI,use,conditional Poisson regression,MENTAL_HEALTH
32348721,This makes understanding the structural mechanism of these resistance mutations crucial for drug development.,resistance mutations,MENTAL_HEALTH,have the structural mechanism for,drug development,CHEBI
18616663,Heavy alcohol consumption may accelerate the progression of hepatitis C (HCV)-related liver disease and/or limit efforts at antiviral treatment.,alcohol consumption,CHEMICAL,accelerate progression of,C (HCV)-related liver disease,DISEASE
18616663,"As most of the patients in methadone maintenance treatment (MMT) suffer from hepatitis C infection, this study was conducted to identify the alcohol intake among these patients at a Swiss Psychiatric University Clinic by self-reports and direct ethanol metabolites as biomarkers of ethanol consumption.",methadone maintenance treatment,CHEMICAL,suffer from,hepatitis C infection,DISEASE
25516513,A growing number of studies have shown that arginine vasopressin (AVP) plays an analgesia role in the modulation of nociception.,arginine vasopressin,CHEMICAL,play,analgesia role,MENTAL_HEALTH
25516513,A growing number of studies have shown that arginine vasopressin (AVP) plays an analgesia role in the modulation of nociception.,AVP,CHEMICAL,play,analgesia role,MENTAL_HEALTH
25782631,"The AVP analgesia was completely blocked by intrathecal injected SR 49059, a vasopressin-1A (V1A) receptor antagonist.",AVP analgesia,CHEMICAL,be blocked by,SR vasopressin-1A V1A receptor antagonist,CHEBI
25782631,"The AVP analgesia was completely blocked by intrathecal injected SR 49059, a vasopressin-1A (V1A) receptor antagonist.",AVP analgesia,MENTAL_HEALTH,be blocked by,SR vasopressin-1A V1A receptor antagonist,CHEBI
25782631,"The AVP analgesia was also reversed by bicuculline, a GABAA receptor antagonist.",AVP analgesia,CHEMICAL,be reversed by,GABAA receptor antagonist,CHEBI
25782631,"The AVP analgesia was also reversed by bicuculline, a GABAA receptor antagonist.",AVP analgesia,CHEMICAL,be reversed by,bicuculline,CHEMICAL
25782631,"The AVP analgesia was also reversed by bicuculline, a GABAA receptor antagonist.",AVP analgesia,MENTAL_HEALTH,be reversed by,GABAA receptor antagonist,CHEBI
25782631,"The AVP analgesia was also reversed by bicuculline, a GABAA receptor antagonist.",AVP analgesia,MENTAL_HEALTH,be reversed by,bicuculline,CHEMICAL
8123190,"In the neostriatum (caudate nucleus), loss of dopamine and increased HVA:dopamine ratio correlated with the reduction in substantia nigra neurons in LBD but not PD, despite the greater loss of neurones and dopamine and the higher dopamine turnover ratio in PD.",dopamine ratio,CHEMICAL,correlate with reduction in,PD,DISEASE
8123190,"In the neostriatum (caudate nucleus), loss of dopamine and increased HVA:dopamine ratio correlated with the reduction in substantia nigra neurons in LBD but not PD, despite the greater loss of neurones and dopamine and the higher dopamine turnover ratio in PD.",dopamine ratio,CHEMICAL,correlate with reduction in,higher dopamine turnover ratio,CHEMICAL
8123190,"In the neostriatum (caudate nucleus), loss of dopamine and increased HVA:dopamine ratio correlated with the reduction in substantia nigra neurons in LBD but not PD, despite the greater loss of neurones and dopamine and the higher dopamine turnover ratio in PD.",dopamine ratio,CHEMICAL,correlate with reduction in,dopamine,CHEMICAL
28843391,"The 3rd version of the French Phosphorus and Calcium Survey Photo-Graphe (Sanofi) included a cohort of CKD stages 4 and 5 patients, whose aim was to examine the prevalence of CKD-MBD and the quality of its management in patients under the care of 62 nephrologists from over 20 geographical regions in France.",Phosphorus Calcium Survey,CHEMICAL,be examine prevalence of,CKD-MBD,DISEASE
28843391,"The 3rd version of the French Phosphorus and Calcium Survey Photo-Graphe (Sanofi) included a cohort of CKD stages 4 and 5 patients, whose aim was to examine the prevalence of CKD-MBD and the quality of its management in patients under the care of 62 nephrologists from over 20 geographical regions in France.",Phosphorus Calcium Survey,NUTRITION,be examine prevalence of,CKD-MBD,DISEASE
27504865,The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied.,JWH-133,CHEMICAL,induce,analgesia,MENTAL_HEALTH
27504865,The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied.,pilocarpine,CHEMICAL,induce,analgesia,MENTAL_HEALTH
27504865,The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied.,muscarinic agonist,CHEBI,induce,analgesia,MENTAL_HEALTH
27504865,The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied.,atropine,CHEMICAL,induce,analgesia,MENTAL_HEALTH
27504865,The effect of pilocarpine (a muscarinic agonist) and atropine (a muscarinic antagonist) on JWH-133 (a CB2 agonist) induced analgesia in mice was studied.,CB2 agonist,CHEBI,induce,analgesia,MENTAL_HEALTH
22018972,"In conclusion, the data presented show that the nonselective muscarinic agonist xanomeline is analgesic in models of persistent pain and suggest that the activation of supraspinal M1 receptors, and to a lesser extent supraspinal M4 receptors, contributes to that analgesia.",nonselective muscarinic agonist xanomeline,CHEBI,be analgesic in models of,persistent pain,DISEASE
22018972,"In conclusion, the data presented show that the nonselective muscarinic agonist xanomeline is analgesic in models of persistent pain and suggest that the activation of supraspinal M1 receptors, and to a lesser extent supraspinal M4 receptors, contributes to that analgesia.",nonselective muscarinic agonist xanomeline,CHEMICAL,be analgesic in models of,persistent pain,DISEASE
22018972,"In conclusion, the data presented show that the nonselective muscarinic agonist xanomeline is analgesic in models of persistent pain and suggest that the activation of supraspinal M1 receptors, and to a lesser extent supraspinal M4 receptors, contributes to that analgesia.",nonselective muscarinic agonist xanomeline,CHEBI,be,analgesic,CHEBI
22018972,"In conclusion, the data presented show that the nonselective muscarinic agonist xanomeline is analgesic in models of persistent pain and suggest that the activation of supraspinal M1 receptors, and to a lesser extent supraspinal M4 receptors, contributes to that analgesia.",nonselective muscarinic agonist xanomeline,CHEMICAL,be,analgesic,CHEBI
34863788,"Owing to the high load of immunogenic frameshift neoantigens, tumors arising in individuals with Lynch syndrome (LS), the most common inherited colorectal cancer (CRC) syndrome, are characterized by a pronounced immune infiltration.",tumors,DISEASE,owe to high load of,immunogenic frameshift neoantigens,CHEBI
34863788,"Owing to the high load of immunogenic frameshift neoantigens, tumors arising in individuals with Lynch syndrome (LS), the most common inherited colorectal cancer (CRC) syndrome, are characterized by a pronounced immune infiltration.",tumors,DISEASE,be characterized by,pronounced immune infiltration,DISEASE
35112986,Lipopolysaccharide (LPS) is injected into the trachea of mice to generate ALI mouse models.,Lipopolysaccharide,CHEMICAL,generate,ALI mouse models,DISEASE
35112986,Lipopolysaccharide (LPS) is injected into the trachea of mice to generate ALI mouse models.,LPS,CHEMICAL,generate,ALI mouse models,DISEASE
34874915,Knockdown of the clavesin gene in zebrafish (clvs2) produced edema phenotypes due to disruption of podocyte structure and loss of glomerular filtration barrier integrity that could be rescued by WT CLVS1 but not the p.H310Y variant.,clavesin gene,CHEMICAL,produce,edema phenotypes due,DISEASE
34874915,"Analysis of cultured human podocytes with CRISPR/Cas9-mediated CLVS1 knockout or homozygous H310Y knockin revealed deficits in clathrin-mediated endocytosis and increased susceptibility to apoptosis that could be rescued with corticosteroid treatment, mimicking the steroid responsiveness observed in patients with SSNS.",steroid responsiveness,CHEMICAL,in patients with,SSNS,DISEASE
32995728,"Hypothyroidism and growth hormone deficiency should be considered in the differential diagnosis of unexplained perinatal sinus bradycardia because early diagnosis may help to avoid potential complications (ie, mental retardation, severe hypoglycemia, and growth anomaly).",Hypothyroidism,DISEASE,be considered in differential diagnosis of,unexplained perinatal sinus bradycardia,DISEASE
32995728,"Hypothyroidism and growth hormone deficiency should be considered in the differential diagnosis of unexplained perinatal sinus bradycardia because early diagnosis may help to avoid potential complications (ie, mental retardation, severe hypoglycemia, and growth anomaly).",growth hormone deficiency,CHEBI,be considered in differential diagnosis of,unexplained perinatal sinus bradycardia,DISEASE
30238129,Neurodegeneration with brain iron accumulation (NBIA) forms a group of rare hereditary diseases with rapid neurodegenerative progression due to an abnormal accumulation of iron in the basal ganglia.,brain iron accumulation,CHEMICAL,form,iron,CHEMICAL
30238129,Neurodegeneration with brain iron accumulation (NBIA) forms a group of rare hereditary diseases with rapid neurodegenerative progression due to an abnormal accumulation of iron in the basal ganglia.,brain iron accumulation,CHEMICAL,form,rare hereditary diseases,DISEASE
23061635,"Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia.",menthol,CHEMICAL,exhibit from,cold-inducing sensation capabilities,DISEASE
23061635,"Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia.",menthol,CHEMICAL,engage in synergistic excitation of,GABA receptors,CHEMICAL
23061635,"Aside from its cold-inducing sensation capabilities, menthol exhibits cytotoxic effects in cancer cells, induces reduction in malignant cell growth, and engages in synergistic excitation of GABA receptors and sodium ion channels resulting in analgesia.",menthol,CHEMICAL,engage in synergistic excitation of,sodium ion channels,CHEMICAL
27194194,Continued refinements of established μ-opioid agonist formulations have virtually eliminated the centrally mediated side effects of dysphoria and sedation that limited the applicability of previous KOP agonists.,established μ-opioid agonist formulations,CHEBI,eliminate mediated side effects of,dysphoria,MENTAL_HEALTH
34807418,FGF2 or platelet-derived growth factor (PDGF) alone or in combination with IGF-I stimulates regeneration of periodontal ligament: a matter of importance in Marfan patients with periodontitis.,FGF2,CHEMICAL,stimulate regeneration of,Marfan patients,DISEASE
34807418,FGF2 or platelet-derived growth factor (PDGF) alone or in combination with IGF-I stimulates regeneration of periodontal ligament: a matter of importance in Marfan patients with periodontitis.,FGF2,CHEMICAL,stimulate regeneration of,periodontitis,DISEASE
34807418,"Though treatment with PRP and mesenchymal stem cells has met with some success in horses (who experience a lot of tendon injuries and other tendon problems), the use of PRP and mesenchymal stem cells in people has been more problematic and requires more studies before PRP and mesenchymal stem cells can become reliable tools in management of soft tissue injuries and disorders.",PRP,CHEMICAL,become reliable tools in management of,soft tissue injuries,DISEASE
24443021,"FGF2 or PDGF alone or in combination with IGF-I stimulated regeneration of periodontal ligament, a matter of importance in Marfan patients with periodontitis.",FGF2,CHEMICAL,stimulate regeneration of,Marfan patients,DISEASE
24443021,"FGF2 or PDGF alone or in combination with IGF-I stimulated regeneration of periodontal ligament, a matter of importance in Marfan patients with periodontitis.",FGF2,CHEMICAL,stimulate regeneration of,periodontitis,DISEASE
24443021,"Though treatment with PRP and mesenchymal stem cells has met with some success in horses (who experience a lot of tendon injuries and other tendon problems), the use of PRP and mesenchymal stem cells in people has been more problematic and requires more studies before PRP and mesenchymal stem cells can become reliable tools in management of soft tissue injuries and disorders.",PRP,CHEMICAL,become reliable tools in management of,soft tissue injuries,DISEASE
35158798,"It is believed that numerous bioactive components, including alkaloids, polyphenols, terpenoids, steroids, and glycosides, are responsible for its various biological and pharmacological activities, such as antioxidant, anti-inflammatory, immune-modulatory, antiviral, hepatoprotective, cardioprotective, and hypoglycemic activities.",steroids,CHEMICAL,be responsible for,antiviral,CHEBI
35158798,"It is believed that numerous bioactive components, including alkaloids, polyphenols, terpenoids, steroids, and glycosides, are responsible for its various biological and pharmacological activities, such as antioxidant, anti-inflammatory, immune-modulatory, antiviral, hepatoprotective, cardioprotective, and hypoglycemic activities.",steroids,CHEMICAL,be responsible for,hypoglycemic,DISEASE
8985780,Intracavernous injection (ICI) of prostaglandin-E1 (PGE1) is used widely as the first diagnostic test in the study of erectile dysfunction.,ICI,CHEMICAL,be used as first diagnostic test in study of,erectile dysfunction,MENTAL_HEALTH
8985780,Intracavernous injection (ICI) of prostaglandin-E1 (PGE1) is used widely as the first diagnostic test in the study of erectile dysfunction.,prostaglandin-E1,CHEMICAL,be used as first diagnostic test in study of,erectile dysfunction,MENTAL_HEALTH
8985780,The aim of this study was to investigate the influence of emotional disturbances on erectile response to ICI in impotent patients.,emotional disturbances,MENTAL_HEALTH,have the influence on,ICI,CHEMICAL
8985780,"The presence of emotional disturbances was assessed in all patients by the administration of rapid tests (Stai-X1 and Stai-X1r for state-anxiety before and after ICI, respectively; Stai-X2 for trait-anxiety; Zung-test for depression) at the first and at the remaining (Stai-X1 and Stai-X1r) ICI sessions.",emotional disturbances,MENTAL_HEALTH,be assessed in patients by administration of,trait-anxiety,DISEASE
8985780,"The presence of emotional disturbances was assessed in all patients by the administration of rapid tests (Stai-X1 and Stai-X1r for state-anxiety before and after ICI, respectively; Stai-X2 for trait-anxiety; Zung-test for depression) at the first and at the remaining (Stai-X1 and Stai-X1r) ICI sessions.",emotional disturbances,MENTAL_HEALTH,be assessed in patients by administration of,depression,MENTAL_HEALTH
8985780,"The presence of emotional disturbances was assessed in all patients by the administration of rapid tests (Stai-X1 and Stai-X1r for state-anxiety before and after ICI, respectively; Stai-X2 for trait-anxiety; Zung-test for depression) at the first and at the remaining (Stai-X1 and Stai-X1r) ICI sessions.",emotional disturbances,MENTAL_HEALTH,be assessed in patients by administration of,ICI,CHEMICAL
32275214,Ovarian hormones have been implicated as a potential source of variability in the effectiveness of exposure therapy for anxiety disorders in women.,Ovarian hormones,CHEBI,be implicated as potential source of variability in effectiveness of,anxiety disorders,MENTAL_HEALTH
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",clindamycin,CHEMICAL,predispose subjects to overgrowth of such organisms as,Clostridium difficile,DISEASE
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",clindamycin,CHEMICAL,predispose subjects to overgrowth of such organisms as,autism,MENTAL_HEALTH
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",cephalosporins,CHEMICAL,predispose subjects to overgrowth of such organisms as,Clostridium difficile,DISEASE
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",cephalosporins,CHEMICAL,predispose subjects to overgrowth of such organisms as,autism,MENTAL_HEALTH
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",penicillins,CHEMICAL,predispose subjects to overgrowth of such organisms as,Clostridium difficile,DISEASE
22202440,"This shows that penicillins and cephalosporins, as well as clindamycin, have a major impact on the normal bowel flora and therefore might well predispose subjects to overgrowth of such organisms as Clostridium difficile, and of particular importance for autism, to Desulfovibrio.",penicillins,CHEMICAL,predispose subjects to overgrowth of such organisms as,autism,MENTAL_HEALTH
21592674,We had felt that clostridia in the gut might be involved in autism because they are virulent organisms and spore-formers; spores would resist antibacterial agents so that when antibiotics were discontinued the spores would germinate and by toxin production or another mechanism lead to autism.,clostridia,DISEASE,be involved in,autism,MENTAL_HEALTH
17904761,"This manuscript reviews evidence indicating that intestinal bacteria, specifically clostridia, may play a role in certain cases of autism and hypothesizes that the clostridial spores (which are notably resistant to antimicrobial agents and commonly used germicides) are involved in: (1) relapse in the autistic subject after a response to an agent such as oral vancomycin, after the drug is discontinued, (2) the unexplained increased incidence of autism in recent years, and (3) the unexplained increase in numbers of multiple cases in the same family.",antimicrobial agents,CHEBI,increased incidence of,autism,MENTAL_HEALTH
34816248,"Although sexual concerns (e.g., decreased sexual desire, orgasm), are reported by up to 87% of peri- and post-menopausal women, and are associated with adverse impact on functioning and distress, treatment options that directly target this area are limited, and most often involve medication (e.g., hormone replacement).",sexual desire,DISEASE,be reported by % of,peri- women,DISEASE
22921063,"Structure/function studies revealed that antiproliferative activity against 1,25D-resistant squamous carcinoma cells required VDR agonism and HDACi.","1,25D-resistant squamous carcinoma cells",DISEASE,require,HDACi,CHEMICAL
21372722,"However, studies may have underestimated the efficacy of quetiapine for obsessive-compulsive disorder due to concomitant administration of antidepressants and the utilization of treatment-refractory patients.",quetiapine,CHEMICAL,have the efficacy for,obsessive-compulsive disorder,MENTAL_HEALTH
21372722,"Interestingly, however, quetiapine-induced elevations in low-density lipoprotein and total cholesterol seem to be restricted to schizophrenia patients.",total cholesterol,NUTRITION,seem to restricted to,schizophrenia patients,MENTAL_HEALTH
21372722,"Interestingly, however, quetiapine-induced elevations in low-density lipoprotein and total cholesterol seem to be restricted to schizophrenia patients.",quetiapine-induced elevations,DISEASE,seem to restricted to,schizophrenia patients,MENTAL_HEALTH
21372722,"Interestingly, however, quetiapine-induced elevations in low-density lipoprotein and total cholesterol seem to be restricted to schizophrenia patients.",low-density lipoprotein,NUTRITION,seem to restricted to,schizophrenia patients,MENTAL_HEALTH
8632328,In vivo pharmacokinetics in the rat confirmed that SB 217242 was rapidly absorbed from the gastrointestinal tract with a bioavailability of 66%.,SB,CHEMICAL,be absorbed from,gastrointestinal tract,DISEASE
33979944,The burden of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) infection has transformed the African continent into a major consumer of antiretrovirals (ARVs) drugs.,acquired immunodeficiency syndrome,DISEASE,transform african continent into major consumer of,antiretrovirals ARVs drugs,CHEMICAL
33979944,The burden of the human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) infection has transformed the African continent into a major consumer of antiretrovirals (ARVs) drugs.,human immunodeficiency virus infection,DISEASE,transform african continent into major consumer of,antiretrovirals ARVs drugs,CHEMICAL
27706577,"The dry pulp oil content of H. rhamnoides ssp mongolica (27.2 ± 0.9%) was higher than that of hybrids (12.0 ± 1.2%) (P 340, 8251000, 817380, and 8071100) had positive association with high dry pulp oil content (P < 0.01) using stepwise multiple regression analysis.",±,CHEMICAL,use,stepwise multiple regression analysis,MENTAL_HEALTH
30564256,"Callus with embryogenic structures was only obtained in half-cut seeds cultured in the darkness on half-strength Murashige and Skoog culture medium supplemented with 2,4-D, while hypocotyl segments and isolated zygotic embryos failed to produce this type of callus regardless of the 2,4-D and sucrose (30 and 70 g l-1) concentrations tested in this study.",Callus,DISEASE,be obtained in,"2,4-D",CHEMICAL
35392411,The seizure score and survival rate of the treated group showed considerable differences as compared to the PTZ group.,seizure score,DISEASE,compare to,PTZ group,CHEMICAL
32150855,"At six months, the UVB group showed less restless/tense behavior compared to the VD group (mean difference of the mean change scores 2.2, 95% CI 0.8 to 3.6; p = 0.003 for group x time interaction) and lower serum 25(OH)D3 concentration (estimated mean difference - 21.9, 95% CI -32.6 to -11.2; p = 0.003 for group difference).",UVB group,CHEMICAL,show at,restless/tense behavior,DISEASE
32150855,UVB treatment may have a positive effect on the restless/tense behavior characteristic of advanced dementia but more research is needed to confirm this finding.,UVB treatment,CHEMICAL,have positive effect on restless/tense behavior characteristic of,advanced dementia,MENTAL_HEALTH
35390518,Polycystic ovary syndrome (PCOS) is a common gynaecological/endocrine disorder that affects 5%-10% of women of reproductive age.,PCOS,DISEASE,be,common gynaecological/endocrine disorder,DISEASE
35390518,Polycystic ovary syndrome (PCOS) is a common gynaecological/endocrine disorder that affects 5%-10% of women of reproductive age.,Polycystic ovary syndrome,DISEASE,be,common gynaecological/endocrine disorder,DISEASE
26307105,"Similarly, testosterone replacement therapy is contraindicated in prostate cancer.",testosterone replacement therapy,CHEMICAL,be contraindicated in,prostate cancer,DISEASE
25532580,"For men with inflow stenosis, DES placement to bypass arterial lesions has recently been reported with a high technical success rate.",DES placement,CHEMICAL,be reported for men with,inflow stenosis,DISEASE
19409205,NMDA receptor antagonists and nitric oxide synthase inhibitors induce amnesia in animals and therefore have been employed for evaluation of efficacy of several novel antiamnesic agents.,nitric oxide synthase inhibitors,CHEMICAL,induce,amnesia,MENTAL_HEALTH
19409205,NMDA receptor antagonists and nitric oxide synthase inhibitors induce amnesia in animals and therefore have been employed for evaluation of efficacy of several novel antiamnesic agents.,NMDA receptor antagonists,CHEBI,induce,amnesia,MENTAL_HEALTH
7652132,The optimal treatment for IHP psychosis was found to be a combination of ergocalciferol and fairly large doses of antipsychotic medication.,IHP psychosis,MENTAL_HEALTH,be found to combination of,ergocalciferol,CHEBI
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",type cardiorenal syndrome,DISEASE,be linked to,renal venous congestion,DISEASE
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",type cardiorenal syndrome,DISEASE,be linked to,ACE-I/ARB withdrawal,CHEMICAL
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",acute kidney injury,DISEASE,be linked to,renal venous congestion,DISEASE
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",acute kidney injury,DISEASE,be linked to,ACE-I/ARB withdrawal,CHEMICAL
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",CRS,DISEASE,be linked to,renal venous congestion,DISEASE
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",CRS,DISEASE,be linked to,ACE-I/ARB withdrawal,CHEMICAL
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",AKI,DISEASE,be linked to,renal venous congestion,DISEASE
34138673,"Although the etiology of acute kidney injury (AKI) in type 1 cardiorenal syndrome (CRS) has been linked to renal venous congestion, ACE-I/ARB withdrawal (AW) theoretically promotes renal function recovery.",AKI,DISEASE,be linked to,ACE-I/ARB withdrawal,CHEMICAL
30366030,"Additionally, intermediates in PC synthesis, such as CDP-choline, have been suggested to attenuate drug craving during cocaine addiction.",CDP-choline,CHEMICAL,attenuate drug craving during,cocaine addiction,DISEASE
30366030,"Additionally, intermediates in PC synthesis, such as CDP-choline, have been suggested to attenuate drug craving during cocaine addiction.",CDP-choline,CHEMICAL,attenuate,drug craving,CHEBI
30366030,"Additionally, intermediates in PC synthesis, such as CDP-choline, have been suggested to attenuate drug craving during cocaine addiction.",CDP-choline,CHEMICAL,attenuate,drug craving,MENTAL_HEALTH
30457668,"The current report examines the effect of oral citicoline on alcohol use, craving, depressive symptoms, and cognitive outcomes in individuals with alcohol use disorder.",oral citicoline,CHEMICAL,have the effect on,alcohol use,CHEMICAL
16289637,New data on progestin actions on fish gametes suggest a widespread involvement of mPRalpha in oocyte maturation and sperm hyperactivity in this vertebrate group.,progestin actions,CHEBI,suggest widespread involvement of mpralpha in,sperm hyperactivity,MENTAL_HEALTH
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,hypokalemia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,metabolic acidosis,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,hyperglycemia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,agitation,MENTAL_HEALTH
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,tremor,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,tachycardia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,seizures,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",theophylline,CHEMICAL,produce,cardiac arrhythmias,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,hypokalemia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,metabolic acidosis,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,hyperglycemia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,agitation,MENTAL_HEALTH
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,tremor,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,tachycardia,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,seizures,DISEASE
7910556,"Beta-adrenergic agonists and theophylline are both capable of producing tremor, agitation, tachycardia, metabolic acidosis, hypokalemia, hyperglycemia, cardiac arrhythmias, and seizures.",Beta-adrenergic agonists,CHEBI,produce,cardiac arrhythmias,DISEASE
35575577,"MW2 swap variants harboring the nonresponsive mecA genotypes became NaHCO3-nonresponsive (resistant to the β-lactam, oxacillin [OXA]), in the presence of NaHCO3.",MW2 swap variants,DISEASE,become,β-lactam,CHEMICAL
35575577,"MW2 swap variants harboring the nonresponsive mecA genotypes became NaHCO3-nonresponsive (resistant to the β-lactam, oxacillin [OXA]), in the presence of NaHCO3.",MW2 swap variants,DISEASE,become,NaHCO3,CHEMICAL
35575577,"MW2 swap variants harboring the nonresponsive mecA genotypes became NaHCO3-nonresponsive (resistant to the β-lactam, oxacillin [OXA]), in the presence of NaHCO3.",MW2 swap variants,DISEASE,become,OXA,CHEMICAL
35575577,"MW2 swap variants harboring the nonresponsive mecA genotypes became NaHCO3-nonresponsive (resistant to the β-lactam, oxacillin [OXA]), in the presence of NaHCO3.",MW2 swap variants,DISEASE,become,oxacillin,CHEMICAL
35574911,"Indeed, we found that Atg18-retromer is required for PtdIns(3,5)P2-dependent vacuolar fragmentation during hyperosmotic stress.",Atg18-retromer,CHEMICAL,be required for,"PtdIns(3,5)P2-dependent vacuolar fragmentation",MENTAL_HEALTH
35570484,"Sleep disorders may cause dysregulation of cerebral glucose metabolism and synaptic functions, as well as alterations in cerebrospinal fluid (CSF) biomarker levels.",Sleep disorders,DISEASE,cause dysregulation of,cerebral glucose metabolism,CHEMICAL
35505663,"Creatine deficiency disorders are inborn errors of creatine metabolism, an energy homeostasis molecule.",Creatine deficiency disorders,CHEMICAL,be inborn errors of,creatine metabolism,CHEMICAL
35505663,"Creatine deficiency disorders are inborn errors of creatine metabolism, an energy homeostasis molecule.",Creatine deficiency disorders,CHEMICAL,be,inborn errors,DISEASE
35505663,"Along with low creatine levels, guanidinoacetic acid (GAA) toxicity has been implicated in the pathophysiology of the disorder.",guanidinoacetic acid GAA toxicity,CHEMICAL,be implicated along with,low creatine levels,CHEMICAL
34765395,"Lesch-Nyhan syndrome is an x-linked genetic disorder of purine metabolism that results in the overproduction of uric acid and neurologic deficits manifesting as intellectual disability, dystonia, other movement disorders and self-mutilation.",Lesch-Nyhan syndrome,DISEASE,be x-linked genetic disorder of,purine metabolism,CHEMICAL
34765395,"The patient's temperature dysregulation and dysautonomia is likely attributable to abnormal neurotransmitter release, particularly that of dopamine, in the central nervous system.",dysautonomia,DISEASE,be attributable to,dopamine,CHEMICAL
34765395,"Similar to NMS, disruption of dopamine neurotransmission results in dysregulated sympathetic activity and hyperthermia.",dopamine neurotransmission,CHEMICAL,result in,hyperthermia,DISEASE
10560023,"One may hypothesize that another norepinephrine-CRF interaction may occur in the terminal projections of the forebrain norepinephrine systems in the paraventricular nucleus of the hypothalamus, the bed nucleus of the stria terminalis, and the central nucleus of the amygdala where norepinephrine stimulates CRF release.",norepinephrine,CHEMICAL,stimulate,CRF release,DISEASE
3327372,"Clonidine and locus ceruleus lesions, in animals with alcohol dependency as with the opiates, modify alcohol withdrawal.",alcohol dependency,DISEASE,modify,alcohol withdrawal,CHEMICAL
3327372,"Clonidine and locus ceruleus lesions, in animals with alcohol dependency as with the opiates, modify alcohol withdrawal.",Clonidine ceruleus lesions,CHEMICAL,modify,alcohol withdrawal,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",Regression analysis,MENTAL_HEALTH,display importance of,4CL,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",Regression analysis,MENTAL_HEALTH,display importance of,CAD,DISEASE
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",Regression analysis,MENTAL_HEALTH,display importance of,lignin synthesis,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",Regression analysis,MENTAL_HEALTH,display importance of,NO contents,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",lignin,CHEMICAL,display importance of,4CL,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",lignin,CHEMICAL,display importance of,CAD,DISEASE
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",lignin,CHEMICAL,display importance of,lignin synthesis,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",lignin,CHEMICAL,display importance of,NO contents,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",CAD,DISEASE,display importance of,4CL,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",CAD,DISEASE,display importance of,CAD,DISEASE
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",CAD,DISEASE,display importance of,lignin synthesis,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",CAD,DISEASE,display importance of,NO contents,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",NO,CHEMICAL,display importance of,4CL,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",NO,CHEMICAL,display importance of,CAD,DISEASE
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",NO,CHEMICAL,display importance of,lignin synthesis,CHEMICAL
35597486,"Regression analysis between lignin and NO contents or the activities of three enzymes including CAD, 4CL and PAL displayed the importance of NO contents, CAD, 4CL and PAL for lignin synthesis.",NO,CHEMICAL,display importance of,NO contents,CHEMICAL
31353963,"LPS was utilized to administrate HT22 cells to evoke inflammatory injury, meanwhile the involvements of AP in cell proliferation, apoptosis and inflammatory cytokines productions were examined.",LPS,CHEMICAL,evoke,inflammatory injury,DISEASE
28347824,"Because former results indicate that the 5-HT1A-R is involved in the antipanic action of antidepressants, KOR antagonists may be useful as adjunctive or alternative drug treatment of panic disorder.",5-HT1A-R,CHEMICAL,be involved in antipanic action of,antidepressants,CHEMICAL
28347824,"Because former results indicate that the 5-HT1A-R is involved in the antipanic action of antidepressants, KOR antagonists may be useful as adjunctive or alternative drug treatment of panic disorder.",KOR antagonists,CHEBI,be useful as adjunctive or alternative drug treatment of,panic disorder,MENTAL_HEALTH
28347824,"Because former results indicate that the 5-HT1A-R is involved in the antipanic action of antidepressants, KOR antagonists may be useful as adjunctive or alternative drug treatment of panic disorder.",KOR antagonists,CHEBI,be useful as,adjunctive drug treatment,CHEBI
26427507,"γ-Hydroxybutyric acid (GHB) is a powerful central nervous system depressant, currently used in medicine for the treatment of narcolepsy and alcohol dependence.",GHB,CHEMICAL,used in medicine for treatment of,narcolepsy dependence,MENTAL_HEALTH
26427507,"γ-Hydroxybutyric acid (GHB) is a powerful central nervous system depressant, currently used in medicine for the treatment of narcolepsy and alcohol dependence.",γ-Hydroxybutyric acid,CHEMICAL,used in medicine for treatment of,narcolepsy dependence,MENTAL_HEALTH
32956741,"CVRT, motor restlessness at age 15 and attention deficit scores at age 25 were especially low for male C-allele carriers.",motor restlessness,MENTAL_HEALTH,be low for,male C-allele carriers,CHEBI
32956741,"CVRT, motor restlessness at age 15 and attention deficit scores at age 25 were especially low for male C-allele carriers.",age attention deficit scores,DISEASE,be low for,male C-allele carriers,CHEBI
29018204,"Low GABA transmission has been reported in suicide, and GABRA6 rs3219151 T allele has been associated with greater physiological and endocrine stress response in previous studies.",GABRA6 rs3219151 T allele,CHEMICAL,be associated with,endocrine,CHEBI
29018204,"Low GABA transmission has been reported in suicide, and GABRA6 rs3219151 T allele has been associated with greater physiological and endocrine stress response in previous studies.",Low GABA transmission,CHEMICAL,be reported in,suicide,MENTAL_HEALTH
29018204,Our data indicate that stress-associated suicide risk is elevated in carriers of the GABRA6 rs3219151 T allele with several independent markers and predictors of suicidal behaviours converging to this increased risk.,stress-associated suicide risk,MENTAL_HEALTH,be elevated in carriers of,GABRA6 rs3219151 T allele,CHEMICAL
29018204,Our data indicate that stress-associated suicide risk is elevated in carriers of the GABRA6 rs3219151 T allele with several independent markers and predictors of suicidal behaviours converging to this increased risk.,stress-associated suicide risk,MENTAL_HEALTH,be elevated in,carriers,CHEBI
25744621,"In humans, the NPS receptor (NPSR1) gene rs324981 A/T (Asn(107)Ile) polymorphism is associated with fear responses and anxiety.",NPS receptor NPSR1 gene rs324981 Asn(107)Ile polymorphism,CHEMICAL,be associated in humans with,anxiety,MENTAL_HEALTH
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,DISEASE,have higher scores of,motor restlessness,MENTAL_HEALTH
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,DISEASE,have higher scores of,impulsivity,DISEASE
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,DISEASE,have higher scores of,total ADHD scores,MENTAL_HEALTH
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,CHEBI,have higher scores of,motor restlessness,MENTAL_HEALTH
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,CHEBI,have higher scores of,impulsivity,DISEASE
25744621,"NPSR1 T-allele carriers had higher scores of impulsivity, motor restlessness and total ADHD scores.",T-allele carriers,CHEBI,have higher scores of,total ADHD scores,MENTAL_HEALTH
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",dehydroepiandrosterone,CHEMICAL,modulate,MetS,DISEASE
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",dehydroepiandrosterone,CHEMICAL,modulate,metabolic syndrome,DISEASE
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",cortisol,CHEMICAL,modulate,MetS,DISEASE
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",cortisol,CHEMICAL,modulate,metabolic syndrome,DISEASE
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",DHEAS,CHEMICAL,modulate,MetS,DISEASE
32368067,"Both dehydroepiandrosterone (DHEAS) and cortisol are secreted by the adrenal glands and may modulate metabolic syndrome (MetS), which often affects the health of patients with schizophrenia.",DHEAS,CHEMICAL,modulate,metabolic syndrome,DISEASE
29220388,"At TMAHD, patients had significantly higher TAC levels than at admission and discharge, both at 12:00 and 00:00 h. In conclusion, the absence of day/night serum TAC changes when clinically relapsed and the normalization of day/night serum TAC changes at TMHD can be considered as a biological marker of schizophrenia evolution.",day/night serum TAC,CHEMICAL,be considered as biological marker of,schizophrenia evolution,MENTAL_HEALTH
15132238,"However, little was known about the broader biomedical significance of homocysteine until 1962, when children with mental retardation, accelerated growth, dislocated ocular lenses, and frequent vascular thrombosis were found to excrete homocysteine in the urine.",frequent vascular thrombosis,DISEASE,excrete,homocysteine,CHEMICAL
15132238,This discovery led to the conclusion that homocysteine causes vascular disease by a direct effect on the cells and tissues of the arteries.,homocysteine,CHEMICAL,cause,vascular disease,DISEASE
15132238,"This interpretation suggests that homocysteine is important in the pathogenesis of arteriosclerosis in persons with hereditary, dietary, environmental, hormonal, metabolic, and other factors predisposing them to hyperhomocysteinemia.",homocysteine,CHEMICAL,be important in pathogenesis of arteriosclerosis in,hereditary,DISEASE
15132238,"This interpretation suggests that homocysteine is important in the pathogenesis of arteriosclerosis in persons with hereditary, dietary, environmental, hormonal, metabolic, and other factors predisposing them to hyperhomocysteinemia.",homocysteine,CHEMICAL,be important in pathogenesis of,arteriosclerosis,DISEASE
15132238,The dramatic decline in cardiovascular mortality since the 1960s in the United States is attributed to fortification of the food supply by synthetic pyridoxine and folic acid.,cardiovascular mortality,DISEASE,be attributed to fortification of food supply by,folic acid,CHEBI
15132238,The dramatic decline in cardiovascular mortality since the 1960s in the United States is attributed to fortification of the food supply by synthetic pyridoxine and folic acid.,cardiovascular mortality,DISEASE,be attributed to fortification of food supply by,synthetic pyridoxine,CHEBI
15132238,The dramatic decline in cardiovascular mortality since the 1960s in the United States is attributed to fortification of the food supply by synthetic pyridoxine and folic acid.,cardiovascular mortality,DISEASE,be attributed to,fortification,CHEMICAL
15132238,The recent Swiss Heart Study showed that B vitamins slowed restenosis in patients with coronary arteriosclerosis treated with angioplasty.,restenosis,DISEASE,in patients with,coronary arteriosclerosis,DISEASE
35189496,"Cannabis is the most consumed illicit drug globally, with a high risk of developing cannabis use disorder (CUD).",Cannabis,CHEMICAL,be,consumed illicit drug,CHEBI
32160626,"Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins.",kidney disease,DISEASE,address structural abnormalities of,nephrotoxins,CHEBI
32835398,"Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney, urinary tracts, as well as the exposure to environmental risk factors and nephrotoxins.",kidney disease,DISEASE,address structural abnormalities of,nephrotoxins,CHEBI
32588223,"Primary prevention of kidney disease should focus on the modification of risk factors and addressing structural abnormalities of the kidney and urinary tracts, as well as exposure to environmental risk factors and nephrotoxins.",kidney disease,DISEASE,address structural abnormalities of,nephrotoxins,CHEBI
24363103,"The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for RLS without known occurrence of augmentation or impulse control disorders, although sedation and dizziness can occur.",alpha-2-delta ligands,CHEMICAL,be effective for rls without known occurrence of,augmentation control disorders,MENTAL_HEALTH
24363103,"The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for RLS without known occurrence of augmentation or impulse control disorders, although sedation and dizziness can occur.",gabapentin,CHEMICAL,be effective for rls without known occurrence of,augmentation control disorders,MENTAL_HEALTH
24363103,"The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for RLS without known occurrence of augmentation or impulse control disorders, although sedation and dizziness can occur.",gabapentin enacarbil,CHEMICAL,be effective for rls without known occurrence of,augmentation control disorders,MENTAL_HEALTH
24363103,"The alpha-2-delta ligands, including gabapentin, gabapentin enacarbil, and pregabalin, are effective for RLS without known occurrence of augmentation or impulse control disorders, although sedation and dizziness can occur.",pregabalin,CHEMICAL,be effective for rls without known occurrence of,augmentation control disorders,MENTAL_HEALTH
28289650,"A 57-year-old man who was diagnosed with Wernicke-Korsakoff syndrome showed severe impairment of cognitive function and a craving for alcohol, even after sufficient supplementation with thiamine.",Wernicke-Korsakoff syndrome,DISEASE,show severe impairment of cognitive function and craving for alcohol after,thiamine,NUTRITION
28289650,"A 57-year-old man who was diagnosed with Wernicke-Korsakoff syndrome showed severe impairment of cognitive function and a craving for alcohol, even after sufficient supplementation with thiamine.",Wernicke-Korsakoff syndrome,DISEASE,show severe impairment of cognitive function and craving for,alcohol,CHEMICAL
28289650,"A 57-year-old man who was diagnosed with Wernicke-Korsakoff syndrome showed severe impairment of cognitive function and a craving for alcohol, even after sufficient supplementation with thiamine.",Wernicke-Korsakoff syndrome,DISEASE,show severe impairment of,craving,MENTAL_HEALTH
28289650,"After completing 10 sessions of 10 Hz repetitive transcranial magnetic stimulation (rTMS) at 100% of the resting motor threshold over the left dorsolateral prefrontal cortex, dramatic improvement in cognitive function and a reduction in craving for alcohol were noted.",craving,MENTAL_HEALTH,have a reduction for,alcohol,CHEMICAL
17716602,The alcohol withdrawal syndrome is a common but not universal diagnostic feature of alcohol dependence.,alcohol withdrawal syndrome,CHEMICAL,be common diagnostic feature of,alcohol dependence,MENTAL_HEALTH
17716602,"Benzodiazepine detoxification of the alcohol withdrawal syndrome prevents the development of withdrawal seizures and delirium tremens, and makes patients more comfortable, which promotes engagement in treatment.",alcohol withdrawal syndrome,CHEMICAL,prevent development of,delirium tremens,MENTAL_HEALTH
17716602,"Benzodiazepine detoxification of the alcohol withdrawal syndrome prevents the development of withdrawal seizures and delirium tremens, and makes patients more comfortable, which promotes engagement in treatment.",Benzodiazepine detoxification,CHEMICAL,prevent development of,delirium tremens,MENTAL_HEALTH
17716602,Thiamine should be administered routinely before the administration of intravenous fluids to prevent the development of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome.,Thiamine,CHEBI,prevent development of wernicke's,encephalopathy,DISEASE
17716602,Thiamine should be administered routinely before the administration of intravenous fluids to prevent the development of Wernicke's encephalopathy and Wernicke-Korsakoff syndrome.,Thiamine,CHEBI,prevent development of wernicke's,Wernicke-Korsakoff syndrome,DISEASE
17716602,"Naltrexone may be more effective for reduction of loss of control with the first drink and cue-related craving, and acamprosate may be more effective for stabilizing the physiology of post-acute withdrawal.",Naltrexone,CHEMICAL,be effective for reduction of loss of,cue-related craving,MENTAL_HEALTH
17716602,Abstinence from alcohol is recommended for persons with alcohol dependence.,alcohol,CHEMICAL,be recommended for persons with,alcohol dependence,MENTAL_HEALTH
8554714,This pattern of effects suggests that endogenous norepinephrine (NE) influences distractibility and/or selective attention.,NE,CHEMICAL,influence,distractibility,MENTAL_HEALTH
8554714,This pattern of effects suggests that endogenous norepinephrine (NE) influences distractibility and/or selective attention.,endogenous norepinephrine,CHEMICAL,influence,distractibility,MENTAL_HEALTH
28797567,Dietary deficiency of n-3 polyunsaturated fatty acids (PUFAs) is involved in the pathophysiology and etiology of major depressive disorder.,PUFAs,CHEMICAL,be involved in pathophysiology and etiology of,major depressive disorder,MENTAL_HEALTH
28797567,Dietary deficiency of n-3 polyunsaturated fatty acids (PUFAs) is involved in the pathophysiology and etiology of major depressive disorder.,n-3 polyunsaturated fatty acids,NUTRITION,be involved in pathophysiology and etiology of,major depressive disorder,MENTAL_HEALTH
28797567,Dietary deficiency of n-3 polyunsaturated fatty acids (PUFAs) is involved in the pathophysiology and etiology of major depressive disorder.,n-3 polyunsaturated fatty acids,CHEMICAL,be involved in pathophysiology and etiology of,major depressive disorder,MENTAL_HEALTH
28797567,Dietary deficiency of n-3 polyunsaturated fatty acids (PUFAs) is involved in the pathophysiology and etiology of major depressive disorder.,Dietary deficiency,DISEASE,be involved in pathophysiology and etiology of,major depressive disorder,MENTAL_HEALTH
30176966,"Selective serotonin reuptake inhibitors (SSRIs), but not bupropion, increase periodic leg movements in sleep.",Selective serotonin reuptake inhibitors,CHEMICAL,increase,periodic leg movements,DISEASE
30176966,"Selective serotonin reuptake inhibitors (SSRIs), but not bupropion, increase periodic leg movements in sleep.",SSRIs,CHEMICAL,increase,periodic leg movements,DISEASE
21651335,Epilepsy and antiepileptic drugs can also alter sex hormone levels to promote the development of reproductive endocrine disorders.,Epilepsy drugs,DISEASE,alter,sex hormone levels,CHEBI
21651335,Epilepsy and antiepileptic drugs can also alter sex hormone levels to promote the development of reproductive endocrine disorders.,Epilepsy drugs,DISEASE,promote development of,reproductive endocrine disorders,CHEBI
10521384,"Additionally, both DMP754 and XV459 (0.1 mg/kg IV or 0.3 to 0.4 mg/kg PO) demonstrated maximal antithrombotic efficacy in preventing electrically induced carotid and coronary artery thrombosis and significant antithrombotic efficacy (P<0.001) at relatively low doses in different settings of arterial thrombosis in the canine model.",XV459,CHEMICAL,prevent induced,carotid coronary artery thrombosis,DISEASE
10521384,"Additionally, both DMP754 and XV459 (0.1 mg/kg IV or 0.3 to 0.4 mg/kg PO) demonstrated maximal antithrombotic efficacy in preventing electrically induced carotid and coronary artery thrombosis and significant antithrombotic efficacy (P<0.001) at relatively low doses in different settings of arterial thrombosis in the canine model.",XV459,CHEMICAL,prevent induced,arterial thrombosis,DISEASE
34621155,"Both alcohol and nicotine require neuronal nicotinic acetylcholine receptors (nAChRs) to elicit rewarding effects within the mesolimbic system, representing a shared molecular pathway that likely contributes to the frequent comorbidity of alcohol and nicotine dependence.",alcohol,CHEMICAL,require,neuronal nicotinic acetylcholine receptors,CHEMICAL
34621155,"Both alcohol and nicotine require neuronal nicotinic acetylcholine receptors (nAChRs) to elicit rewarding effects within the mesolimbic system, representing a shared molecular pathway that likely contributes to the frequent comorbidity of alcohol and nicotine dependence.",nicotine,CHEMICAL,require,neuronal nicotinic acetylcholine receptors,CHEMICAL
31370907,"Associations between SRS, mood, smoking behavior and sex hormones were estimated using multiple linear regression with adjustment for CPD and pregnancy trimester.",SRS,DISEASE,use multiple linear regression with adjustment for,CPD trimester,CHEMICAL
31370907,"Associations between SRS, mood, smoking behavior and sex hormones were estimated using multiple linear regression with adjustment for CPD and pregnancy trimester.",SRS,DISEASE,use,multiple linear regression,MENTAL_HEALTH
31370907,"Associations between SRS, mood, smoking behavior and sex hormones were estimated using multiple linear regression with adjustment for CPD and pregnancy trimester.",smoking behavior,DISEASE,use multiple linear regression with adjustment for,CPD trimester,CHEMICAL
31370907,"Associations between SRS, mood, smoking behavior and sex hormones were estimated using multiple linear regression with adjustment for CPD and pregnancy trimester.",smoking behavior,DISEASE,use,multiple linear regression,MENTAL_HEALTH
17454704,We also hypothesized that more rapid nicotine metabolism is associated with higher nicotine dependence as indexed by smoking frequency and morning urgency.,rapid nicotine metabolism,CHEMICAL,be associated with,higher nicotine dependence,MENTAL_HEALTH
34965442,"Finally, repression of SmSCARA4 via combined treatment of LPS and overexpression of SmSCARA4 construct in turbot head kidney macrophages further indicated an inhibitory role of SmSCARA4 in LPS-stimulated inflammation.",repression,MENTAL_HEALTH,indicate inhibitory role of smscara4 in,LPS-stimulated inflammation,DISEASE
34965442,"Finally, repression of SmSCARA4 via combined treatment of LPS and overexpression of SmSCARA4 construct in turbot head kidney macrophages further indicated an inhibitory role of SmSCARA4 in LPS-stimulated inflammation.",LPS,CHEMICAL,indicate inhibitory role of smscara4 in,LPS-stimulated inflammation,DISEASE
22141275,"Although further studies are needed on this association between HHcy and ED, the measurement of plasma Hcy and folic acid levels and molecular analysis of the MTHFR genotype might be added to the ED diagnostic procedure, especially in young patients or in those with a family history of cardiovascular disease.",plasma Hcy acid levels,CHEMICAL,be added to,cardiovascular disease,DISEASE
22141275,"Treatment of ED patients with HHcy should first aim to reduce the Hcy level through administration of folic acid, alone or in combination with vitamin B6 or B12, and then proceed to treatment with PDE5i.",HHcy,DISEASE,reduce hcy level through administration of,folic acid,CHEBI
22141275,"Treatment of ED patients with HHcy should first aim to reduce the Hcy level through administration of folic acid, alone or in combination with vitamin B6 or B12, and then proceed to treatment with PDE5i.",HHcy,DISEASE,reduce,Hcy level,CHEMICAL
33314003,Impulse control disorders (ICDs) have been described as a side effect of dopamine agonists (DAs) in neurological as well as endocrine conditions.,control disorders,MENTAL_HEALTH,be described as side effect of,DAs,DISEASE
33314003,Impulse control disorders (ICDs) have been described as a side effect of dopamine agonists (DAs) in neurological as well as endocrine conditions.,control disorders,MENTAL_HEALTH,be described as side effect of,dopamine agonists,CHEMICAL
33314003,Impulse control disorders (ICDs) have been described as a side effect of dopamine agonists (DAs) in neurological as well as endocrine conditions.,control disorders,MENTAL_HEALTH,be described as side effect of,endocrine,CHEBI
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEMICAL,represent cornerstone in management of patients with,hyperprolactinemia,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEBI,represent cornerstone in management of patients with,hyperprolactinemia,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEMICAL,have important role in treatment of,Parkinson's disease,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEMICAL,have important role in treatment of,neurologic disorders,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEMICAL,have important role in treatment of,restless legs syndrome,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEBI,have important role in treatment of,Parkinson's disease,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEBI,have important role in treatment of,neurologic disorders,DISEASE
30324793,"Dopamine agonists (DAs) represent a cornerstone in the management of patients with hyperprolactinemia and have an important role in the treatment of neurologic disorders, including Parkinson's disease and restless legs syndrome.",Dopamine agonists,CHEBI,have important role in treatment of,restless legs syndrome,DISEASE
30324793,"In conclusion, a wide variety of ICDs can occur in patients treated with DA, including those with hyperprolactinemia.",ICDs,DISEASE,occur in conclusion in,hyperprolactinemia,DISEASE
31488737,Ketamine's rapid symptoms relief and reduction of suicide thoughts has aroused growing interests in psychiatric association.,suicide thoughts,MENTAL_HEALTH,arouse growing interests in,psychiatric association,DISEASE
25604802,The fibrates have been used for many years to treat dyslipidemias and have also recently been shown to have anti-inflammatory effects.,fibrates,CHEMICAL,treat,dyslipidemias,DISEASE
34982443,Voriconazole is an antifungal treatment with central neurotoxicity.,Voriconazole,CHEMICAL,be antifungal treatment with,central neurotoxicity,DISEASE
34982443,Voriconazole is an antifungal treatment with central neurotoxicity.,Voriconazole,CHEMICAL,be,antifungal treatment,CHEBI
27313918,"Although voriconazole, a triazole antifungal, is a safe drug, treatment with this agent is associated with certain adverse events such as hepatic, neurologic, and visual disturbances.",voriconazole,CHEMICAL,be,safe drug,CHEBI
23866813,"Children with ADHD have lower blood levels of long-chain Poly Unsaturated Fatty Acids (LC PUFAs) compared with children without ADHD, and following PUFA supplementation, have shown improvements in ADHD-related symptoms.",ADHD,MENTAL_HEALTH,have lower blood levels of,long-chain Poly Unsaturated Fatty Acids,CHEMICAL
23866813,"Children with ADHD have lower blood levels of long-chain Poly Unsaturated Fatty Acids (LC PUFAs) compared with children without ADHD, and following PUFA supplementation, have shown improvements in ADHD-related symptoms.",ADHD,MENTAL_HEALTH,have lower blood levels of,long-chain Poly Unsaturated Fatty Acids,NUTRITION
23866813,"Children with ADHD have lower blood levels of long-chain Poly Unsaturated Fatty Acids (LC PUFAs) compared with children without ADHD, and following PUFA supplementation, have shown improvements in ADHD-related symptoms.",ADHD,MENTAL_HEALTH,have lower blood levels of,LC PUFAs,CHEMICAL
23866813,"The fatty acids in the SE fraction are mainly myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).",fatty acids,NUTRITION,be,myristic acid,CHEMICAL
23866813,"The fatty acids in the SE fraction are mainly myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic acid, linoleic acid, eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA).",SE fraction,DISEASE,be,myristic acid,CHEMICAL
9729831,"Clozapine is a tricyclic dibenzodiazepine derivative used as an ""atypical antipsychotic"" in the treatment of severe paranoid schizophrenia.",Clozapine,CHEMICAL,used as,severe paranoid schizophrenia,MENTAL_HEALTH
9729831,Fluoxetine is a selective serotonin reuptake inhibitor used for the treatment of major depression.,Fluoxetine,CHEMICAL,used for treatment of,major depression,MENTAL_HEALTH
9729831,The death was determined to be a clozapine overdose due to a fatal drug interaction.,death,DISEASE,be determined to,clozapine overdose,CHEMICAL
9729831,The death was determined to be a clozapine overdose due to a fatal drug interaction.,death,DISEASE,be determined to,due fatal drug interaction,CHEBI
29330003,"Moreover, as pro-cognitive efficacy of SB-699551 was reported in the ketamine-model of schizophrenia.",SB-699551,CHEMICAL,be reported in ketamine-model of,schizophrenia,MENTAL_HEALTH
21072493,Vitamin K species [K1 (phylloquinone) and K2 (menaquinone)] have long been associated with bone protective activities and are receiving intense interest as nutritional supplements for the prevention or amelioration of bone disease in humans.,Vitamin K species K1,CHEBI,receive intense interest as nutritional supplements for prevention or amelioration of,bone disease,DISEASE
21072493,Vitamin K species [K1 (phylloquinone) and K2 (menaquinone)] have long been associated with bone protective activities and are receiving intense interest as nutritional supplements for the prevention or amelioration of bone disease in humans.,Vitamin K species K1,CHEMICAL,receive intense interest as nutritional supplements for prevention or amelioration of,bone disease,DISEASE
21072493,Vitamin K species [K1 (phylloquinone) and K2 (menaquinone)] have long been associated with bone protective activities and are receiving intense interest as nutritional supplements for the prevention or amelioration of bone disease in humans.,phylloquinone,CHEBI,receive intense interest as nutritional supplements for prevention or amelioration of,bone disease,DISEASE
21072493,"Furthermore, vitamin K2 prevented repression by tumor necrosis factor α (TNFα) of SMAD signaling induced by either transforming growth factor ß (TGFß) or bone morphogenetic protein-2 (BMP-2).",vitamin K2,CHEBI,prevent repression by,tumor necrosis factor α,DISEASE
21072493,"Furthermore, vitamin K2 prevented repression by tumor necrosis factor α (TNFα) of SMAD signaling induced by either transforming growth factor ß (TGFß) or bone morphogenetic protein-2 (BMP-2).",vitamin K2,CHEBI,prevent,repression,MENTAL_HEALTH
28144708,Cannabinoid CB1 inverse agonists hold therapeutic promise as appetite suppressants but have produced suicidal behaviors among a small subpopulation in clinical trials.,Cannabinoid CB1 inverse agonists,CHEBI,hold therapeutic promise as,appetite suppressants,CHEMICAL
28144708,Anatomical and pharmacological evidence implicate the 5HT1A serotonin receptor in suicide in humans and impulsivity in humans and animals.,suicide,MENTAL_HEALTH,have the 5ht1a serotonin receptor in,impulsivity,DISEASE
11198049,"GABA transmission was potentiated with Vigabatrin (gamma vinyl GABA, GVG), a suicide inhibitor of GABA transaminase.",GABA transmission,CHEMICAL,be potentiated with,GVG,CHEMICAL
11198049,"GABA transmission was potentiated with Vigabatrin (gamma vinyl GABA, GVG), a suicide inhibitor of GABA transaminase.",GABA transmission,CHEMICAL,be potentiated with,GABA transaminase,CHEMICAL
11198049,"GABA transmission was potentiated with Vigabatrin (gamma vinyl GABA, GVG), a suicide inhibitor of GABA transaminase.",GABA transmission,CHEMICAL,be potentiated with,Vigabatrin gamma vinyl GABA,CHEMICAL
11198049,"GABA transmission was potentiated with Vigabatrin (gamma vinyl GABA, GVG), a suicide inhibitor of GABA transaminase.",GABA transmission,CHEMICAL,be potentiated with,suicide inhibitor,MENTAL_HEALTH
11198049,The findings of the present study suggest that response to FG-7142 may be a useful model of the effects of traumatic stressors on limbic system function in anxiety.,FG-7142,CHEMICAL,be useful model of effects of traumatic stressors on,anxiety,MENTAL_HEALTH
11198049,The findings of the present study suggest that response to FG-7142 may be a useful model of the effects of traumatic stressors on limbic system function in anxiety.,FG-7142,CHEMICAL,be useful model of effects of,traumatic stressors,DISEASE
9794220,"The hepatotoxicant thioacetamide (TH) has classically been used as a model to study hepatic necrosis; however, recent studies have shown that TH can also induce apoptosis.",TH,CHEMICAL,study,hepatic necrosis,DISEASE
9794220,"The hepatotoxicant thioacetamide (TH) has classically been used as a model to study hepatic necrosis; however, recent studies have shown that TH can also induce apoptosis.",hepatotoxicant thioacetamide,CHEBI,study,hepatic necrosis,DISEASE
9794220,"In addition, TH could induce apoptosis and necrosis in the L37 albumin-SV40 T-antigen transgenic rat liver-derived cell line.",TH,CHEMICAL,induce in,necrosis,DISEASE
6338009,Such an orientation is consistent with the reception and transport roles of the mannitol Enzyme II in E. coli.,Such orientation,MENTAL_HEALTH,be consistent with reception and transport roles of,mannitol Enzyme,CHEMICAL
30486561,"Objective: The relationship of venous-to-arterial CO(2) difference(Pv-aCO(2))/arterial-central venous O(2) difference (Ca-vO(2)) ratio, peripheral perfusion index(PI) and lactate clearance(LC) were investigated during resuscitation in septic patients.",lactate clearance(LC,CHEMICAL,be investigated during resuscitation in,septic patients,DISEASE
26216321,"The diuretic agent bumetanide has recently been put forward as a novel, promising treatment of behavioral symptoms in autism spectrum disorder (ASD) and related conditions.",diuretic agent bumetanide,CHEMICAL,be put as,autism spectrum disorder,MENTAL_HEALTH
26216321,We hypothesized that a paradoxical response to GABA-enforcing agents such as benzodiazepines may predict the efficacy of bumetanide treatment in neurodevelopmental disorders.,benzodiazepines,CHEMICAL,predict efficacy of bumetanide treatment in,neurodevelopmental disorders,DISEASE
26216321,We hypothesized that a paradoxical response to GABA-enforcing agents such as benzodiazepines may predict the efficacy of bumetanide treatment in neurodevelopmental disorders.,benzodiazepines,CHEMICAL,predict efficacy of,bumetanide treatment,CHEMICAL
26216321,We hypothesized that a paradoxical response to GABA-enforcing agents such as benzodiazepines may predict the efficacy of bumetanide treatment in neurodevelopmental disorders.,bumetanide treatment,CHEMICAL,have the efficacy in,neurodevelopmental disorders,DISEASE
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,EPA,CHEMICAL,be,docosahexaenoic acid,CHEMICAL
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,EPA,CHEMICAL,be,depression treatment,MENTAL_HEALTH
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,EPA,CHEMICAL,be,DHA,CHEMICAL
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,eicosapentaenoic acid,CHEMICAL,be,docosahexaenoic acid,CHEMICAL
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,eicosapentaenoic acid,CHEMICAL,be,depression treatment,MENTAL_HEALTH
32150824,Clinical evidence indicated that eicosapentaenoic acid (EPA) was more effective than docosahexaenoic acid (DHA) in depression treatment.,eicosapentaenoic acid,CHEMICAL,be,DHA,CHEMICAL
32150824,"Here, a chronic unpredictable mild stress (CUMS)-induced model of depression was used to compare EPA and DHA anti-depressant effects.",depression,MENTAL_HEALTH,compare,EPA effects,CHEMICAL
32150824,"EPA was more effective than DHA to ameliorate CUMS-induced body weight loss, and depression-like behaviors, such as increasing sucrose preference, shortening immobility time and increasing locomotor activity.",EPA,CHEMICAL,ameliorate,CUMS-induced body weight loss,DISEASE
32150824,"However, even though CUMS-induced microglial activation and associated increased IL-1β were inhibited by both EPA and DHA supplement, increased IL-6 and TNF-α levels were only reduced by EPA.",CUMS-induced microglial activation,DISEASE,be inhibited by,EPA supplement,CHEMICAL
32150824,"However, even though CUMS-induced microglial activation and associated increased IL-1β were inhibited by both EPA and DHA supplement, increased IL-6 and TNF-α levels were only reduced by EPA.",CUMS-induced microglial activation,DISEASE,be inhibited by,DHA,CHEMICAL
32150824,"Compared to DHA, EPA could improve CUMS-induced suppressive astrocyte biomarkers and associated BDNF-TrkB signaling.",EPA,CHEMICAL,improve,CUMS-induced suppressive astrocyte biomarkers,DISEASE
32150824,"Moreover, EPA was more effective than DHA to attenuate CUMS-induced higher hippocampal NGF, GDNF, NF-κB, p38, p75, and bax expressions, but reversed bcl-2 reduction.",EPA,CHEMICAL,attenuate,CUMS-induced higher hippocampal NGF,DISEASE
32150824,These findings reveal the different mechanisms of EPA and DHA in clinical depression treatment.,EPA,CHEMICAL,have the different mechanisms in,clinical depression treatment,MENTAL_HEALTH
32150824,These findings reveal the different mechanisms of EPA and DHA in clinical depression treatment.,DHA,CHEMICAL,have the different mechanisms in,clinical depression treatment,MENTAL_HEALTH
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,T3,DISEASE,be dissipated after iv injection of,triiodothyroacetic acid,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,T3,DISEASE,be dissipated after iv injection of,triac,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,T3,DISEASE,be dissipated after iv injection of,T3,DISEASE
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,triiodothyronine,CHEMICAL,be dissipated after iv injection of,triiodothyroacetic acid,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,triiodothyronine,CHEMICAL,be dissipated after iv injection of,triac,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,triiodothyronine,CHEMICAL,be dissipated after iv injection of,T3,DISEASE
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,nuclear displacement,MENTAL_HEALTH,be dissipated after iv injection of,triiodothyroacetic acid,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,nuclear displacement,MENTAL_HEALTH,be dissipated after iv injection of,triac,CHEMICAL
177267,Previous studies from this laboratory have shown that nuclear displacement of triiodothyronine (T3) is more rapidly dissipated after iv injection of triiodothyroacetic acid (triac) than after equimolar doses of T3.,nuclear displacement,MENTAL_HEALTH,be dissipated after iv injection of,T3,DISEASE
177267,Noncompartmental analysis showed that the average residence time of tracer triac in the exchangeable compartment was 5.5 h compared with 10.9 h for T3.,tracer triac,CHEMICAL,compared with h for,T3,DISEASE
177267,The metabolic clearance rate of triac was 14.4 ml/h/100 g BW and of T3 17.6 ml/h/100 g. The average distribution space of triac was 78.2 ml/100 g and of T3 190.7 ml/100 g. The fraction of isotope excreted via the fecal route was 0.46 for triac and 0.41 for T3.,triac,CHEMICAL,be ml/h/100 g bw 78.2 g and of t3 190.7 g. fraction of,isotope,CHEMICAL
177267,The metabolic clearance rate of triac was 14.4 ml/h/100 g BW and of T3 17.6 ml/h/100 g. The average distribution space of triac was 78.2 ml/100 g and of T3 190.7 ml/100 g. The fraction of isotope excreted via the fecal route was 0.46 for triac and 0.41 for T3.,triac,CHEMICAL,be ml/h/100 g bw 78.2 g and of,T3 g. fraction,CHEMICAL
177267,"Isotopic studies suggested that a rapid exchange of tracer triac occurred between plasma, cytosol, and nuclei, similar to previously observed relationships for T3.",tracer triac,CHEMICAL,observed relationships for,T3,DISEASE
21985216,"Calcium channel blockers, including nifedipine, are the mainstay of pharmacological therapy for the major nonfreezing cold-induced dermatoses including chilblains and Raynaud phenomenon.",Calcium channel blockers,CHEMICAL,including,chilblains,DISEASE
21985216,"Calcium channel blockers, including nifedipine, are the mainstay of pharmacological therapy for the major nonfreezing cold-induced dermatoses including chilblains and Raynaud phenomenon.",Calcium channel blockers,CHEMICAL,including,Raynaud phenomenon,DISEASE
21985216,"Calcium channel blockers, including nifedipine, are the mainstay of pharmacological therapy for the major nonfreezing cold-induced dermatoses including chilblains and Raynaud phenomenon.",nifedipine,CHEMICAL,including,chilblains,DISEASE
21985216,"Calcium channel blockers, including nifedipine, are the mainstay of pharmacological therapy for the major nonfreezing cold-induced dermatoses including chilblains and Raynaud phenomenon.",nifedipine,CHEMICAL,including,Raynaud phenomenon,DISEASE
12212779,Alzheimer's disease is a progressive neurological disorder characterized by amyloid plaques and neurofibrillary tangles along with memory and cognitive deficits associated with a loss of basal forebrain cholinergic neurons.,Alzheimer's disease,DISEASE,characterized by amyloid plaques and neurofibrillary tangles along,memory deficits,DISEASE
12212779,"Recent studies suggesting a role for muscarinic agonists in regulating the production of A beta raise the possibility that selective M1 agonists could be useful in treating not only the symptoms, but also the underlying cause(s) of Alzheimer's disease.",selective M1 agonists,CHEBI,treat,Alzheimer's disease,DISEASE
12212779,"5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine (CDD-0102) is a potent M1 agonist with a low side effect profile that enhances memory function in animal models of Alzheimer's disease.","5-(3-ethyl-1,2,4-oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidine",CHEMICAL,be,potent M1 agonist,CHEBI
18806903,Rotigotine is approved for early-stage disease in Europe and the U.S. but is only approved in Europe for late-stage disease.,Rotigotine,CHEMICAL,be approved for,early-stage disease,DISEASE
18806903,Rotigotine is approved for early-stage disease in Europe and the U.S. but is only approved in Europe for late-stage disease.,Rotigotine,CHEMICAL,be approved in europe for,late-stage disease,DISEASE
17556796,Antagonists of A2A receptors are known to confer protection against neuronal damage caused by toxins and reactive oxygen species.,Antagonists,CHEBI,confer protection against,neuronal damage,DISEASE
27145228,"In previous studies, the authors reported that a flavonoid, quercetin, reduces the expression of ATF4 and delays memory deterioration in an early-stage AD mouse model.",quercetin,CHEMICAL,delay,memory deterioration,DISEASE
27145228,"Memory recall in early-stage AD patients, determined using the Revised Hasegawa Dementia Scale, was significantly improved by the intake of quercetin-rich onion (Quergold) powder for 4 weeks compared with the intake of control onion ('Mashiro' white onion) powder.",early-stage AD patients,DISEASE,be improved by intake of,quercetin-rich onion,NUTRITION
27145228,"Memory recall in early-stage AD patients, determined using the Revised Hasegawa Dementia Scale, was significantly improved by the intake of quercetin-rich onion (Quergold) powder for 4 weeks compared with the intake of control onion ('Mashiro' white onion) powder.",early-stage AD patients,DISEASE,be improved by intake of,' onion,NUTRITION
34558978,Aims: Neurotoxicity (NT) is a common complication of chimeric antigen receptor (CAR) T-cell therapy.,Neurotoxicity,DISEASE,be common complication of,antigen receptor,CHEBI
34558978,Aims: Neurotoxicity (NT) is a common complication of chimeric antigen receptor (CAR) T-cell therapy.,Neurotoxicity,DISEASE,be common complication of,chimeric receptor CAR T-cell therapy,DISEASE
29338576,It is important to estimate whether the active drug or placebo response has a greater influence in determining the relative efficacy of drugs for psychosis (antipsychotics) and relapse prevention (mood stabilisers) for bipolar depression and mania.,active drug response,CHEBI,determine relative efficacy of drugs for,mania,MENTAL_HEALTH
29338576,It is important to estimate whether the active drug or placebo response has a greater influence in determining the relative efficacy of drugs for psychosis (antipsychotics) and relapse prevention (mood stabilisers) for bipolar depression and mania.,active drug response,CHEBI,determine relative efficacy of drugs for,bipolar depression,MENTAL_HEALTH
29338576,It is important to estimate whether the active drug or placebo response has a greater influence in determining the relative efficacy of drugs for psychosis (antipsychotics) and relapse prevention (mood stabilisers) for bipolar depression and mania.,active drug response,CHEBI,determine relative efficacy of drugs for,mood stabilisers,CHEBI
29338576,It is important to estimate whether the active drug or placebo response has a greater influence in determining the relative efficacy of drugs for psychosis (antipsychotics) and relapse prevention (mood stabilisers) for bipolar depression and mania.,active drug response,CHEBI,determine relative efficacy of drugs for,psychosis,MENTAL_HEALTH
31317957,Depression during pregnancy can be treated with quetiapine or lamotrigine or with antidepressant drug added to a mood-stabilizing drug.,Depression,MENTAL_HEALTH,be treated with quetiapine or lamotrigine or with,antidepressant drug,CHEMICAL
31317957,Depression during pregnancy can be treated with quetiapine or lamotrigine or with antidepressant drug added to a mood-stabilizing drug.,Depression,MENTAL_HEALTH,be treated with quetiapine or lamotrigine or with,antidepressant drug,CHEBI
31317957,Depression during pregnancy can be treated with quetiapine or lamotrigine or with antidepressant drug added to a mood-stabilizing drug.,Depression,MENTAL_HEALTH,be treated with,lamotrigine,CHEMICAL
31317957,Depression during pregnancy can be treated with quetiapine or lamotrigine or with antidepressant drug added to a mood-stabilizing drug.,Depression,MENTAL_HEALTH,be treated with,quetiapine,CHEMICAL
31317957,Depression during pregnancy can be treated with quetiapine or lamotrigine or with antidepressant drug added to a mood-stabilizing drug.,Depression,MENTAL_HEALTH,add to,mood-stabilizing drug,CHEBI
31317957,"In the treatment of postpartum depression, quetiapine can be used or an antidepressant drug added to a mood-stabilizer.",quetiapine,CHEMICAL,be used in treatment of,postpartum depression,MENTAL_HEALTH
11072764,Anticholinergics are widely used to treat extrapyramidal motor symptoms caused by neuroleptics or other drugs with antidopaminergic (dopamine D2) effects.,Anticholinergics,CHEBI,treat,extrapyramidal motor symptoms,DISEASE
11072764,"More commonly, however, patients with schizophrenia take more than the recommended dose of anticholinergics in an attempt to treat the adverse effects of neuroleptics.",schizophrenia,MENTAL_HEALTH,recommended dose of,anticholinergics,CHEBI
35590294,This invitro study aimed to investigate the effect of simulated gastric HCl and extrinsic erosive acids on surface microhardness and fracture toughness of CAD-CAM materials.,simulated gastric HCl,CHEMICAL,have the effect on,fracture toughness,DISEASE
35550957,A modified sodium bentonite geosynthetic clay liner (GCL) designed for acid-and-alkaline resistance was evaluated for its potential application in the containment of bauxite residue leachate.,modified sodium bentonite geosynthetic clay liner,CHEBI,be evaluated for its potential application in containment of,residue leachate,CHEMICAL
35550957,A modified sodium bentonite geosynthetic clay liner (GCL) designed for acid-and-alkaline resistance was evaluated for its potential application in the containment of bauxite residue leachate.,modified sodium bentonite geosynthetic clay liner,CHEMICAL,be evaluated for its potential application in containment of,residue leachate,CHEMICAL
35550957,"A modified fluid loss test was employed to quickly evaluate the hydraulic conductivity (k) of the GCL using distilled water, tap water, and four bauxite liquors (BLs, leachate from bauxite residue reservoirs).",modified fluid loss test,DISEASE,evaluate,GCL,CHEMICAL
34953877,"Besides, a small amount of LDH by mechanically mixing with bentonite (mass ratio 1:99) can also effectively improve the erosion resistance of compacted bentonite.",bentonite,CHEBI,improve erosion resistance of,compacted bentonite,CHEBI
34953877,"Besides, a small amount of LDH by mechanically mixing with bentonite (mass ratio 1:99) can also effectively improve the erosion resistance of compacted bentonite.",bentonite,CHEBI,improve,erosion resistance,MENTAL_HEALTH
6177490,Administration of atropine for bradycardia and hypotension was usually not effective.,atropine,CHEMICAL,have administration for,bradycardia,DISEASE
6177490,Administration of atropine for bradycardia and hypotension was usually not effective.,atropine,CHEMICAL,have administration for,hypotension,DISEASE
6177490,Dopamine is recommended; glucagon for definite signs of shock.,Dopamine,CHEMICAL,be recommended glucagon for definite signs of,shock,DISEASE
6177490,Dopamine is recommended; glucagon for definite signs of shock.,Dopamine,CHEMICAL,be recommended,glucagon,CHEMICAL
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",4-aminoquinoline-based antimalarials,CHEBI,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,DISEASE
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",4-aminoquinoline-based antimalarials,CHEBI,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,CHEMICAL
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",4-aminoquinoline-based antimalarials,CHEBI,have potential use as effective neuroprotective agents against,Alzheimer's disease,DISEASE
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",CQ,CHEMICAL,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,DISEASE
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",CQ,CHEMICAL,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,CHEMICAL
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",CQ,CHEMICAL,have potential use as effective neuroprotective agents against,Alzheimer's disease,DISEASE
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",hydroxychloroquine,CHEMICAL,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,DISEASE
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",hydroxychloroquine,CHEMICAL,have potential use as effective neuroprotective agents against,amyloid-beta-peptide Abeta neurotoxicity,CHEMICAL
16298876,"The results of our studies suggest that 4-aminoquinoline-based antimalarials like CQ and hydroxychloroquine, which are both potent anti-inflammatory agents and inhibitors of cholinesterases, may have potential use as the most effective neuroprotective agents against amyloid-beta-peptide (Abeta) neurotoxicity in Alzheimer's disease.",hydroxychloroquine,CHEMICAL,have potential use as effective neuroprotective agents against,Alzheimer's disease,DISEASE
3880854,"Since their introduction in the United States about 4 years ago, the calcium antagonists have achieved an important place in the medical therapy of several cardiovascular disease entities.",calcium antagonists,CHEBI,achieve important place in medical therapy of,several cardiovascular disease entities,DISEASE
3880854,"Since their introduction in the United States about 4 years ago, the calcium antagonists have achieved an important place in the medical therapy of several cardiovascular disease entities.",calcium antagonists,CHEMICAL,achieve important place in medical therapy of,several cardiovascular disease entities,DISEASE
3880854,"Verapamil is extremely effective in patients with supraventricular tachyarrhythmias, hypertrophic cardiomyopathy, and the various anginal syndromes, but it appears to be ineffective or possibly even deleterious in those with pulmonary hypertension, congestive heart failure of any cause, and Raynaud's phenomenon or disease.",Verapamil,CHEMICAL,be effective in patients with,supraventricular tachyarrhythmias,DISEASE
26199013,"Disturbances in lipid metabolism have been linked to suicidal behaviour, but little is known about the association between suicide risk and abnormal glucose metabolism in depression.",suicide risk,MENTAL_HEALTH,have the association with,abnormal glucose metabolism,CHEMICAL
26199013,"Disturbances in lipid metabolism have been linked to suicidal behaviour, but little is known about the association between suicide risk and abnormal glucose metabolism in depression.",abnormal glucose metabolism,CHEMICAL,have the association with,suicide risk,MENTAL_HEALTH
26199013,"Hyperglycaemia and hyperinsulinaemia may increase the risk of depression and also the risk for suicide, we therefore studied associations between suicidal behaviour and disturbances in glucose metabolism in depressive patients who had been referred to depression nurse case managers.",Hyperglycaemia,DISEASE,increase risk of,depression,MENTAL_HEALTH
26199013,"Hyperglycaemia and hyperinsulinaemia may increase the risk of depression and also the risk for suicide, we therefore studied associations between suicidal behaviour and disturbances in glucose metabolism in depressive patients who had been referred to depression nurse case managers.",hyperinsulinaemia,DISEASE,increase risk of,depression,MENTAL_HEALTH
26199013,"Hyperglycaemia and hyperinsulinaemia may increase the risk of depression and also the risk for suicide, we therefore studied associations between suicidal behaviour and disturbances in glucose metabolism in depressive patients who had been referred to depression nurse case managers.",glucose metabolism,CHEMICAL,have suicidal behaviour and disturbances in,depressive patients,DISEASE
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",hypertriglyceridemia,DISEASE,be associated with chronicity of depression in,antidepressant users,CHEMICAL
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",hypertriglyceridemia,DISEASE,be associated with chronicity of,depression,MENTAL_HEALTH
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",low HDL cholesterol,NUTRITION,be associated with chronicity of depression in,antidepressant users,CHEMICAL
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",low HDL cholesterol,DISEASE,be associated with chronicity of depression in,antidepressant users,CHEMICAL
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",low HDL cholesterol,NUTRITION,be associated with chronicity of,depression,MENTAL_HEALTH
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",low HDL cholesterol,DISEASE,be associated with chronicity of,depression,MENTAL_HEALTH
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",hyperglycemia,DISEASE,be associated with chronicity of depression in,antidepressant users,CHEMICAL
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",hyperglycemia,DISEASE,be associated with chronicity of,depression,MENTAL_HEALTH
24442097,"Elevated IL-6, low HDL cholesterol, hypertriglyceridemia, and hyperglycemia were associated with chronicity of depression in antidepressant users.",depression,MENTAL_HEALTH,have chronicity in,antidepressant users,CHEMICAL
20034331,"Dopamine is one of the most important factors in the pathophysiology of hyperactivity disorder, and the hormone melatonin has an important role in the regulation of dopamine.",hormone melatonin,CHEBI,have important role in regulation of,dopamine,CHEMICAL
20034331,"Dopamine is one of the most important factors in the pathophysiology of hyperactivity disorder, and the hormone melatonin has an important role in the regulation of dopamine.",hormone melatonin,CHEMICAL,have important role in regulation of,dopamine,CHEMICAL
20034331,"Because zinc is necessary in the metabolism of melatonin, it can be assumed that zinc is a very important factor in the treatment of attention deficit and hyperactivity disorder (ADHD).",zinc,CHEMICAL,be important factor in treatment of,hyperactivity disorder,MENTAL_HEALTH
20034331,"Because zinc is necessary in the metabolism of melatonin, it can be assumed that zinc is a very important factor in the treatment of attention deficit and hyperactivity disorder (ADHD).",zinc,CHEMICAL,be important factor in treatment of,ADHD,MENTAL_HEALTH
20034331,"Because zinc is necessary in the metabolism of melatonin, it can be assumed that zinc is a very important factor in the treatment of attention deficit and hyperactivity disorder (ADHD).",zinc,CHEMICAL,be important factor in treatment of,attention deficit,DISEASE
20034331,"Because zinc is necessary in the metabolism of melatonin, it can be assumed that zinc is a very important factor in the treatment of attention deficit and hyperactivity disorder (ADHD).",zinc,CHEMICAL,be necessary in metabolism of,melatonin,CHEMICAL
20034331,It is known that deficit of some minerals and vitamins is connected with hyperkinetic disorder.,minerals,DISEASE,be connected with,hyperkinetic disorder,MENTAL_HEALTH
20034331,It is known that deficit of some minerals and vitamins is connected with hyperkinetic disorder.,vitamins,CHEBI,be connected with,hyperkinetic disorder,MENTAL_HEALTH
20034331,"Zinc sulfate as an adjunct to methylphenidate has favorable effects in the treatment of ADHD children, pointing to the possible association of zinc deficit and ADHD pathophysiology.",Zinc sulfate,CHEMICAL,have favorable effects in treatment of,ADHD children,MENTAL_HEALTH
20034331,"Zinc sulfate as an adjunct to methylphenidate has favorable effects in the treatment of ADHD children, pointing to the possible association of zinc deficit and ADHD pathophysiology.",methylphenidate,CHEMICAL,have favorable effects in treatment of,ADHD children,MENTAL_HEALTH
20034331,"Therefore, zinc supplementation to nutrition or to ADHD therapy may be of great benefit in ADHD children with zinc deficit or low plasma zinc concentration.",zinc supplementation,CHEMICAL,be of great benefit in adhd children with,zinc deficit,CHEMICAL
20034331,"Therefore, zinc supplementation to nutrition or to ADHD therapy may be of great benefit in ADHD children with zinc deficit or low plasma zinc concentration.",zinc supplementation,CHEMICAL,be of great benefit in,ADHD children,MENTAL_HEALTH
20034331,"Therefore, zinc supplementation to nutrition or to ADHD therapy may be of great benefit in ADHD children with zinc deficit or low plasma zinc concentration.",ADHD therapy,MENTAL_HEALTH,be of great benefit in adhd children with,zinc deficit,CHEMICAL
20034331,"Therefore, zinc supplementation to nutrition or to ADHD therapy may be of great benefit in ADHD children with zinc deficit or low plasma zinc concentration.",ADHD therapy,MENTAL_HEALTH,be of great benefit in,ADHD children,MENTAL_HEALTH
20034331,"Therefore, zinc supplementation to nutrition or to ADHD therapy may be of great benefit in ADHD children with zinc deficit or low plasma zinc concentration.",ADHD children,MENTAL_HEALTH,have great benefit with,zinc deficit,CHEMICAL
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,zinc sulfate,CHEMICAL,show beneficial effects of zinc supplementation in treatment of,ADHD,MENTAL_HEALTH
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,ADHD treatment,MENTAL_HEALTH,show beneficial effects of zinc supplementation in treatment of,ADHD,MENTAL_HEALTH
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,methylphenidate,CHEMICAL,show beneficial effects of zinc supplementation in treatment of,ADHD,MENTAL_HEALTH
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,zinc sulfate,CHEMICAL,show beneficial effects of,zinc supplementation,CHEMICAL
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,ADHD treatment,MENTAL_HEALTH,show beneficial effects of,zinc supplementation,CHEMICAL
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,methylphenidate,CHEMICAL,show beneficial effects of,zinc supplementation,CHEMICAL
20034331,A study of ADHD treatment with zinc sulfate as a supplement to methylphenidate showed beneficial effects of zinc supplementation in the treatment of children with ADHD.,ADHD treatment,MENTAL_HEALTH,have a study with,zinc sulfate,CHEMICAL
33603948,Bixin acts as novel Nrf2 (NF-E2 p45-related factor 2) activator with the cytoprotection against oxidative stress and inflammation; this study mainly focused on the mechanism of Nrf2 activation by bixin and explored its potential feasibilities in long-term high-fat diet- (HFD-) caused hepatic steatosis and inflammatory response in vitro and in vivo.,Bixin,CHEBI,act as,inflammation,DISEASE
33603948,"In HFD-fed mice, systemic administration of bixin attenuated lipid accumulation, decreased oxidant inflammatory damage in the liver, and reduced circulating lipid levels through Nrf2.",bixin,CHEBI,decrease,oxidant inflammatory damage,DISEASE
33603948,"Different from most of other established inducers, bixin activated Nrf2 signals through two different mechanisms with safe administration for protection of oxidant inflammatory damage and attenuation of lipid accumulation in the in vivo long-term HFD-fed mice.",bixin,CHEBI,activate nrf2 signals through different mechanisms with safe administration for,oxidant inflammatory damage,DISEASE
33603948,And bixin-based Nrf2-directed systemic intervention may also provide therapeutic benefit in protecting other organs in the process of metabolic syndrome.,bixin-based Nrf2-directed systemic intervention,CHEMICAL,protect other organs in process of,metabolic syndrome,DISEASE
19891958,Insulin resistance is partly due to suppression of insulin-induced glucose uptake into adipocytes.,Insulin resistance,MENTAL_HEALTH,be due to suppression of,insulin-induced glucose uptake,CHEMICAL
19891958,"The observations indicate that bixin acts as an agonist of PPARgamma and enhances insulin sensitivity in 3T3-L1 adipocytes, suggesting that bixin is a valuable food-derived compound as a PPAR ligand to regulate lipid metabolism and to ameliorate metabolic syndrome.",bixin,CHEBI,be valuable food-derived compound as,PPAR ligand,CHEBI
19891958,"The observations indicate that bixin acts as an agonist of PPARgamma and enhances insulin sensitivity in 3T3-L1 adipocytes, suggesting that bixin is a valuable food-derived compound as a PPAR ligand to regulate lipid metabolism and to ameliorate metabolic syndrome.",bixin,CHEBI,act as,agonist,CHEBI
24877704,The gold standard treatment of severe paraphilias in adult males is antiandrogen treatment with cognitive behavioral therapy.,severe paraphilias,MENTAL_HEALTH,be,antiandrogen treatment,CHEBI
24877704,Selective serotonin reuptake inhibitors have been used in mild types of paraphilia and in cases of sexual compulsions and juvenile paraphilias.,Selective serotonin reuptake inhibitors,CHEMICAL,be used in mild types of paraphilia and in cases of,sexual compulsions,DISEASE
24877704,Selective serotonin reuptake inhibitors have been used in mild types of paraphilia and in cases of sexual compulsions and juvenile paraphilias.,Selective serotonin reuptake inhibitors,CHEMICAL,be used in mild types of paraphilia and in cases of,juvenile paraphilias,MENTAL_HEALTH
24877704,Selective serotonin reuptake inhibitors have been used in mild types of paraphilia and in cases of sexual compulsions and juvenile paraphilias.,Selective serotonin reuptake inhibitors,CHEMICAL,be used in mild types of,paraphilia,DISEASE
24877704,Antiandrogen treatments seem to be effective in severe paraphilic subjects committing sexual offenses.,Antiandrogen treatments,CHEBI,seem to effective in,severe paraphilic subjects,DISEASE
23591699,"In 684 lead workers environmentally exposed to uranium, multiple linear regression was used to examine associations of uranium measured in a 4-h urine collection with measured creatinine clearance, serum creatinine- and cystatin-C-based estimated glomerular filtration rates, and N-acetyl-β-D-glucosaminidase (NAG).",multiple linear regression,MENTAL_HEALTH,examine associations of,uranium,CHEMICAL
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",mitomycin,CHEMICAL,use,epithelial,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",mitomycin,CHEMICAL,use,hepatoma Bel-7402 cells,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",cupric chloride,CHEMICAL,use,epithelial,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",cupric chloride,CHEMICAL,use,hepatoma Bel-7402 cells,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",acetaminophen,CHEMICAL,use,epithelial,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",acetaminophen,CHEMICAL,use,hepatoma Bel-7402 cells,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",phenacetin,CHEMICAL,use,epithelial,DISEASE
17376646,"In order to elucidate the feasibility of predicting liver and kidney target-organ toxicity using in vitro cytotoxicity assay, cytotoxicity of selected chemicals, acetaminophen (AAP), mitomycin (MMC), cupric chloride (CuCl2), phenacetin, cadmium chloride (CdCl2) and aristolochic acid (AA), was studied using human hepatoma (Bel-7402) cells and human renal tubular epithelial (HK-2) cells.",phenacetin,CHEMICAL,use,hepatoma Bel-7402 cells,DISEASE
11082479,We have previously proposed that the therapeutic effect of transdermal nicotine in Tourette's syndrome may involve nicotinic receptor inactivation resulting from a prolonged continuous exposure to nicotine.,transdermal nicotine,CHEMICAL,have the therapeutic effect in,Tourette's syndrome,DISEASE
35577192,An in-situ compatibilized starch (St) and polyacrylonitrile (PAN) composite spinning solution was designed by preparing starch-graft-polyacrylonitrile (St-g-PAN) through graft copolymerizing acrylonitrile from soluble starch and using ammonium cerium nitrate (CAN) as initiator.,compatibilized starch,NUTRITION,copolymerizing acrylonitrile from,soluble starch,NUTRITION
35577192,An in-situ compatibilized starch (St) and polyacrylonitrile (PAN) composite spinning solution was designed by preparing starch-graft-polyacrylonitrile (St-g-PAN) through graft copolymerizing acrylonitrile from soluble starch and using ammonium cerium nitrate (CAN) as initiator.,compatibilized starch,NUTRITION,use,ammonium cerium nitrate,CHEMICAL
35577192,An in-situ compatibilized starch (St) and polyacrylonitrile (PAN) composite spinning solution was designed by preparing starch-graft-polyacrylonitrile (St-g-PAN) through graft copolymerizing acrylonitrile from soluble starch and using ammonium cerium nitrate (CAN) as initiator.,compatibilized starch,NUTRITION,use,CAN,DISEASE
34979189,"Lacking amylose, WHB had higher relative crystallinity, gelatinization temperature, enthalpy, level of scattering intensity and uniformity of orientation of double helices than NHB starch.",WHB,CHEMICAL,lack,amylose,CHEMICAL
34979189,"Lacking amylose, WHB had higher relative crystallinity, gelatinization temperature, enthalpy, level of scattering intensity and uniformity of orientation of double helices than NHB starch.",WHB,CHEMICAL,have,orientation,MENTAL_HEALTH
29709423,Antimuscarinic agents are now widely used as the pharmacological therapy for overactive bladder (OAB) because neuronal (parasympathetic nerve) and non-neuronal acetylcholine play a significant role for the bladder function.,Antimuscarinic agents,CHEBI,be used as pharmacological therapy for,non-neuronal acetylcholine,CHEMICAL
29709423,Antimuscarinic agents are now widely used as the pharmacological therapy for overactive bladder (OAB) because neuronal (parasympathetic nerve) and non-neuronal acetylcholine play a significant role for the bladder function.,Antimuscarinic agents,CHEBI,be used as pharmacological therapy for,neuronal parasympathetic nerve,DISEASE
22836615,"COPD pharmacotherapy guidelines are based on a combination of long-acting beta2-agonists (LABA), long-acting antimuscarinic agents (LAMA) and methyloxantins.",COPD pharmacotherapy guidelines,DISEASE,be based on combination of,LAMA,CHEMICAL
22836615,"COPD pharmacotherapy guidelines are based on a combination of long-acting beta2-agonists (LABA), long-acting antimuscarinic agents (LAMA) and methyloxantins.",COPD pharmacotherapy guidelines,DISEASE,be based on combination of,LABA,CHEMICAL
22836615,"COPD pharmacotherapy guidelines are based on a combination of long-acting beta2-agonists (LABA), long-acting antimuscarinic agents (LAMA) and methyloxantins.",COPD pharmacotherapy guidelines,DISEASE,be based on combination of,long-acting beta2-agonists,CHEMICAL
22836615,"COPD pharmacotherapy guidelines are based on a combination of long-acting beta2-agonists (LABA), long-acting antimuscarinic agents (LAMA) and methyloxantins.",COPD pharmacotherapy guidelines,DISEASE,be based on combination of,long-acting antimuscarinic agents,CHEBI
22836615,"Thirty four COPD patients, receiving stable bronchodilator therapy were randomly allocated into two arms of add-on treatment (1:1 - indacaterol:placebo) for 3 months.",COPD patients,DISEASE,be allocated into arms of,1:1-indacaterol,CHEMICAL
22836615,"We also found that the degree of desaturation before and after 6MWD, and fatigue levels significantly improved in the indacaterol group.",fatigue levels,MENTAL_HEALTH,improve in,indacaterol group,CHEMICAL
22836615,"We also found that the degree of desaturation before and after 6MWD, and fatigue levels significantly improved in the indacaterol group.",desaturation,DISEASE,improve in,indacaterol group,CHEMICAL
22836615,We conclude that the add-on therapy with indacaterol exerts positive effects in COPD patients.,indacaterol,CHEMICAL,exert positive effects in,COPD patients,DISEASE
33324669,"Protein malnutrition is a potential risk factor for senile dementia, although the precise link between protein/amino acid nutrition and cognitive function is unknown.",Protein malnutrition,DISEASE,be potential risk factor for,senile dementia,MENTAL_HEALTH
32848886,Dysfunctions of kynurenine pathway of tryptophan metabolism (KPTM) are associated with multiple neuropathologies in vertebrates and invertebrates.,kynurenine pathway,CHEMICAL,be associated with,multiple neuropathologies,DISEASE
32848886,Dysfunctions of kynurenine pathway of tryptophan metabolism (KPTM) are associated with multiple neuropathologies in vertebrates and invertebrates.,tryptophan metabolism,NUTRITION,be associated with,multiple neuropathologies,DISEASE
32848886,Drosophila mutants with altered content of kynurenines are model objects for studying the molecular processes of neurodegeneration and senile dementia.,kynurenines,CHEMICAL,study molecular processes of,neurodegeneration dementia,DISEASE
32848886,Drosophila mutants with altered content of kynurenines are model objects for studying the molecular processes of neurodegeneration and senile dementia.,kynurenines,CHEMICAL,study molecular processes of,neurodegeneration dementia,MENTAL_HEALTH
19011898,"In addition, many projection neurons in layers II-III were found to contain calbindin.",many projection neurons,MENTAL_HEALTH,contain,calbindin,CHEMICAL
24753994,"A number of homeopathic remedy sources from the Banerji Protocols (eg, Calcarea phosphorica; Carcinosin-tumor-derived breast cancer tissue prepared homeopathically) overlap those already under study in nonhomeopathic nanoparticle and nanovesicle tumor exosome cancer vaccine research.",Carcinosin-tumor-derived breast cancer tissue,DISEASE,prepare overlap under study in,nanoparticle tumor exosome cancer vaccine,DISEASE
24753994,"A number of homeopathic remedy sources from the Banerji Protocols (eg, Calcarea phosphorica; Carcinosin-tumor-derived breast cancer tissue prepared homeopathically) overlap those already under study in nonhomeopathic nanoparticle and nanovesicle tumor exosome cancer vaccine research.",Carcinosin-tumor-derived breast cancer tissue,DISEASE,prepare overlap under study in,vaccine research,DISEASE
24753994,"A number of homeopathic remedy sources from the Banerji Protocols (eg, Calcarea phosphorica; Carcinosin-tumor-derived breast cancer tissue prepared homeopathically) overlap those already under study in nonhomeopathic nanoparticle and nanovesicle tumor exosome cancer vaccine research.",Carcinosin-tumor-derived breast cancer tissue,DISEASE,prepare overlap under study in,nonhomeopathic nanoparticle,CHEMICAL
34065253,"Therefore, higher dietary intakes of vitamin E and fats would be associated with a lower prevalence of sarcopenia.",vitamin E,CHEBI,be associated with lower prevalence of,sarcopenia,DISEASE
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,selenium,CHEMICAL
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,thiamin,CHEMICAL
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,α-carotene,CHEMICAL
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,vitamin C,CHEBI
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,lutein zeaxanthin,CHEBI
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,γ-tocopherol,CHEMICAL
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,vitamin A,CHEBI
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,β-tocopherol,CHEMICAL
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,lycopene,CHEBI
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,folate,CHEBI
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,lutein zeaxanthin,NUTRITION
29968964,"Inverse associations with RCC risk were observed for α-carotene, β-carotene, lutein zeaxanthin, lycopene, vitamin A, folate, thiamin, vitamin C, α-tocopherol, β-tocopherol, γ-tocopherol, and selenium.",RCC risk,DISEASE,be observed for,α-tocopherol,CHEMICAL
33978973,Pangenotypic direct-acting antiviral agents (DAAs) glecaprevir/pibrentasvir (GLE/PIB) and sofosbuvir/velpatasvir (SOF/VEL) are effective against all hepatitis C virus (HCV) genotype infections.,Pangenotypic direct-acting antiviral agents,CHEMICAL,be effective against,genotype infections,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",SOF/VEL combination ± ribavirin,CHEMICAL,compensate,decompensated cirrhosis,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",SOF/VEL combination ± ribavirin,CHEMICAL,compensate,hepatocellular carcinoma,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",SOF/VEL combination ± ribavirin,CHEMICAL,compensate,cirrhosis,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",chronic hepatitis C,DISEASE,compensate,decompensated cirrhosis,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",chronic hepatitis C,DISEASE,compensate,hepatocellular carcinoma,DISEASE
33105927,"Conclusion: SOF/VEL combination ± ribavirin in the treatment of various common genotypes of chronic hepatitis C, compensated cirrhosis, decompensated cirrhosis and hepatocellular carcinoma has higher SVR12 in China, and the tolerance and safety are good.",chronic hepatitis C,DISEASE,compensate,cirrhosis,DISEASE
32343472,A total of 5190 HCV patients received DAA treatment during this time period.,HCV patients,DISEASE,receive,DAA treatment,CHEMICAL
35405255,"Cornus officinalis Sieb. et Zucc., traditional Chinese medicine, has been widely used in the treatment of dementia.",officinalis Sieb,CHEMICAL,be used in treatment of,dementia,MENTAL_HEALTH
35064518,"On the other hand, digoxin significantly reduced all of these STZ-induced deleterious effects.",digoxin,CHEMICAL,reduce on,STZ-induced deleterious effects,DISEASE
35064518,These findings suggest that digoxin may be beneficial in treating cognitive impairment and Alzheimer's disease.,digoxin,CHEMICAL,treat,cognitive impairment,DISEASE
1621023,"In addition, a 31-year-old man with obsessive-compulsive disorder developed RBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.",obsessive-compulsive disorder,MENTAL_HEALTH,start,fluoxetine therapy,CHEMICAL
1621023,"In addition, a 31-year-old man with obsessive-compulsive disorder developed RBD soon after starting fluoxetine therapy, which persisted at PSG study 19 months after fluoxetine discontinuation.",obsessive-compulsive disorder,MENTAL_HEALTH,develop in,RBD,DISEASE
26321356,"Hierarchical regression analyses were performed to assess possible effects of coffee consumption on the association of tobacco, alcohol, and marijuana use with IC.",regression analyses,MENTAL_HEALTH,assess possible effects of coffee consumption on association of,alcohol,CHEMICAL
19840958,"Research into pneumonia should include evaluation of new antibacterials and regimens, rapid diagnostic tests and, in pleural infection, antibiotic penetration, fibrinolytics and surveillance.",pneumonia,DISEASE,include evaluation of,antibiotic penetration,CHEBI
19840958,"Research into pneumonia should include evaluation of new antibacterials and regimens, rapid diagnostic tests and, in pleural infection, antibiotic penetration, fibrinolytics and surveillance.",pneumonia,DISEASE,include evaluation of,pleural infection,DISEASE
19840958,"Research into pneumonia should include evaluation of new antibacterials and regimens, rapid diagnostic tests and, in pleural infection, antibiotic penetration, fibrinolytics and surveillance.",pneumonia,DISEASE,include evaluation of,new antibacterials,CHEBI
19840958,"In neuromuscular disorders, the beta-agonists may enhance muscle strength and are in need of evaluation.",beta-agonists,CHEMICAL,enhance in,disorders muscle strength,DISEASE
19840958,"Studies of antibiotic prophylaxis, immunoglobulin and antifungal drugs are needed in immune deficiency.",antibiotic prophylaxis,CHEBI,be needed in,immune deficiency,DISEASE
19840958,"Studies of antibiotic prophylaxis, immunoglobulin and antifungal drugs are needed in immune deficiency.",antifungal drugs,CHEBI,be needed in,immune deficiency,DISEASE
8908412,Drug-dependency insomnia is of interest because chronic sleep disturbances can promote depressive symptoms which could lead to a drug relapse.,chronic sleep disturbances,DISEASE,promote,depressive symptoms,DISEASE
8908412,Methadone (mu-opioid agonist) produced a marked fragmentation of the sleep architecture with frequent awakenings and a decrease in EEG arousals.,mu-opioid agonist,CHEBI,produce marked fragmentation of sleep architecture with frequent awakenings and decrease in,EEG arousals,DISEASE
8908412,Methadone (mu-opioid agonist) produced a marked fragmentation of the sleep architecture with frequent awakenings and a decrease in EEG arousals.,mu-opioid agonist,CHEBI,produce,marked fragmentation,MENTAL_HEALTH
8908412,Methadone (mu-opioid agonist) produced a marked fragmentation of the sleep architecture with frequent awakenings and a decrease in EEG arousals.,Methadone,CHEMICAL,produce marked fragmentation of sleep architecture with frequent awakenings and decrease in,EEG arousals,DISEASE
8908412,Methadone (mu-opioid agonist) produced a marked fragmentation of the sleep architecture with frequent awakenings and a decrease in EEG arousals.,Methadone,CHEMICAL,produce,marked fragmentation,MENTAL_HEALTH
30686791,Both Ashitaba powder and xanthoangelol elevated the expression of the widely expressed heat shock proteins (HSPs) Hspa1a and Hsp40 and the antioxidant enzyme glutathione synthase in non-stressed testes.,Ashitaba powder,CHEMICAL,elevate expression of,heat shock proteins,DISEASE
30686791,Both Ashitaba powder and xanthoangelol elevated the expression of the widely expressed heat shock proteins (HSPs) Hspa1a and Hsp40 and the antioxidant enzyme glutathione synthase in non-stressed testes.,Ashitaba powder,CHEMICAL,elevate expression of,enzyme glutathione synthase,CHEMICAL
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",ceftazidime,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",cefepime,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",levofloxacin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",clarithromycin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",ciprofloxacin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",linezolid,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",metronidazole,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",moxifloxacin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",trimethoprim-sulfamethoxazole,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",azithromycin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",imipenem,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",cefaclor,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",ofloxacin,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",cefuroxime,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",piperacillin-tazobactam,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Ertapenem, cefepime, imipenem, ofloxacin, ceftazidime, clarithromycin, cefaclor, levofloxacin, linezolid, moxifloxacin, azithromycin, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, metronidazole, ciprofloxacin, and cefuroxime are known to be associated with delirium.",Ertapenem,CHEMICAL,be associated with,delirium,MENTAL_HEALTH
34275113,"Other antibiotics may also lead to delirium, but no study has systemically compared delirium associations for many available antibiotics.",Other antibiotics,CHEBI,lead to,delirium,MENTAL_HEALTH
21750641,"The presence of metabolic alkalosis, hypokalemia, hypochloremia, and high renin and aldosterone levels were suggestive of Bartter syndrome and a treatment regimen for Bartter syndrome was started.",metabolic alkalosis levels,DISEASE,be suggestive of,Bartter syndrome,DISEASE
21750641,"The presence of metabolic alkalosis, hypokalemia, hypochloremia, and high renin and aldosterone levels were suggestive of Bartter syndrome and a treatment regimen for Bartter syndrome was started.",hypokalemia,DISEASE,be suggestive of,Bartter syndrome,DISEASE
21750641,"The presence of metabolic alkalosis, hypokalemia, hypochloremia, and high renin and aldosterone levels were suggestive of Bartter syndrome and a treatment regimen for Bartter syndrome was started.",hypochloremia,DISEASE,be suggestive of,Bartter syndrome,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be established based on presence of,polyuria,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be established based on presence of,generalized aminoaciduria,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be established based on presence of,proteinuria,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be established based on presence of,phosphorus,NUTRITION
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be established based on presence of,parental consanguinity,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be confirmed by slit-lamp examination of,cornea,DISEASE
21750641,"Based on the presence of parental consanguinity as well as polyuria, proteinuria, low tubular reabsorption of phosphorus, generalized aminoaciduria, light yellow skin and hair color, the probable diagnosis of cystinosis was established and was confirmed by slit-lamp examination of the cornea showing cystine crystal deposition.",cystinosis,DISEASE,be confirmed by,slit-lamp examination,CHEMICAL
35395239,"A2B adenosine receptor (A2BAR) antagonists have therapeutic potential in inflammation-related diseases such as asthma, chronic obstructive pulmonary disease and cancer.",A2B adenosine receptor A2BAR antagonists,CHEMICAL,have therapeutic potential in inflammation-related diseases such as,chronic obstructive pulmonary disease,DISEASE
35395239,"A2B adenosine receptor (A2BAR) antagonists have therapeutic potential in inflammation-related diseases such as asthma, chronic obstructive pulmonary disease and cancer.",A2B adenosine receptor A2BAR antagonists,CHEBI,have therapeutic potential in inflammation-related diseases such as,chronic obstructive pulmonary disease,DISEASE
11230802,"In conclusion, we showed that the HIV protease inhibitor ritonavir is a more potent inhibitor of P-glycoprotein than the multidrug resistance (MDR)-reversing agent SDZ PSC 833.",HIV protease inhibitor ritonavir,CHEMICAL,be potent inhibitor of,multidrug resistance,MENTAL_HEALTH
11230802,"In conclusion, we showed that the HIV protease inhibitor ritonavir is a more potent inhibitor of P-glycoprotein than the multidrug resistance (MDR)-reversing agent SDZ PSC 833.",HIV protease inhibitor ritonavir,CHEBI,be potent inhibitor of,multidrug resistance,MENTAL_HEALTH
11230802,"The inclusion of this drug in combination regimens may greatly facilitate brain uptake of HIV protease inhibitors, which is especially important in patients suffering from AIDS dementia complex.",drug,CHEBI,facilitate brain uptake of,HIV protease inhibitors,CHEBI
30798780,"The prevalence of liver and skin tumors in brown bullhead ( Ameiurus nebulosus) from the Anacostia River (Washington, DC) and nearby areas was determined in 2014, 2015, and 2016.",liver tumors,DISEASE,have the prevalence in,brown bullhead,NUTRITION
30798780,The causes of skin tumors in bullhead are uncertain.,skin tumors,DISEASE,have the causes in,bullhead,NUTRITION
8572390,"The parasympatholytic drugs increase bladder capacity, decrease the rate of bladder contractions and cause downward trends in urethral resistance.",parasympatholytic drugs,CHEBI,cause downward trends in,urethral resistance,MENTAL_HEALTH
8572390,The barbiturates and halothane produce similar effects on urethral resistance.,halothane,CHEMICAL,produce similar effects on,urethral resistance,MENTAL_HEALTH
8572390,The barbiturates and halothane produce similar effects on urethral resistance.,barbiturates,CHEMICAL,produce similar effects on,urethral resistance,MENTAL_HEALTH
35403437,"All groups of BE mice showed binge-eating behavior, eating up to 60% of their 24-h intake during the WD access period.",BE mice,CHEMICAL,show,binge-eating behavior,DISEASE
11759177,These findings further demonstrate that phospholipid liposomes administered intramuscularly are active against mild anxiety and depressive symptoms in menopausal women.,phospholipid liposomes,NUTRITION,be active against,mild anxiety,MENTAL_HEALTH
11759177,These findings further demonstrate that phospholipid liposomes administered intramuscularly are active against mild anxiety and depressive symptoms in menopausal women.,phospholipid liposomes,NUTRITION,be active against,depressive symptoms,DISEASE
34484270,"Analysis of aphid feeding by Electronic penetration graph (EPG) showed that MeSA exposure resulted in resistance factors in barley plants, including surface factors and induced systemic factors in other tissues including the phloem.",MeSA exposure,CHEMICAL,result in,resistance factors,MENTAL_HEALTH
25958283,"Hair cortisol has been used to measure chronic stress in dairy cows as it offers the advantage of being noninvasive, fast, and able to indicate levels of cortisol over long periods.",Hair cortisol,CHEMICAL,measure,chronic stress,MENTAL_HEALTH
32380702,"AChE and nicotinic receptor α 7 subunit (α7nAChR) gene expression and serum levels of choline, AChE and BuChE were lower in OSA patients than in the HC group.",choline,NUTRITION,be lower in,OSA patients,DISEASE
32380702,"The evaluation of Th17/Treg-related cytokine may provide an additional explanation for OSA pathogenesis and clinical features, opening new directions for the OSA management.",Th17/Treg-related cytokine,CHEMICAL,open new directions for,OSA management,DISEASE
32380702,"The evaluation of Th17/Treg-related cytokine may provide an additional explanation for OSA pathogenesis and clinical features, opening new directions for the OSA management.",Th17/Treg-related cytokine,CHEMICAL,provide additional explanation for,OSA pathogenesis,DISEASE
35074629,"Newer treatments, such as the thrombopoietin receptor agonists, have transformed ITP care.",thrombopoietin receptor agonists,CHEBI,transform,ITP care,DISEASE
10584760,Preliminary open trials suggest that anticonvulsant mood stabilizers may enhance remission rates and outcome for bipolar patients with substance abuse.,anticonvulsant mood stabilizers,CHEBI,enhance remission rates and outcome for bipolar patients with,substance abuse,MENTAL_HEALTH
10584760,Preliminary open trials suggest that anticonvulsant mood stabilizers may enhance remission rates and outcome for bipolar patients with substance abuse.,anticonvulsant mood stabilizers,CHEBI,enhance remission rates and outcome for,bipolar patients,DISEASE
16146720,"After 60 hours of calcinosis treatment, all rats of the InsP6 non-treated group died and the rest were sacrificed.",InsP6 non-treated group,CHEMICAL,die after hours of,calcinosis treatment,DISEASE
16146720,"A highly significant increase in the calcium content of aorta and heart tissue was observed in the InsP6 non-treated rats (21 +/- 1 mg calcium/g dry aorta tissue, 10 +/- 1 mg calcium/g dry heart tissue) when compared with controls (1.3 +/- 0.1 mg calcium/g dry aorta tissue, 0.023 +/- 0.004 mg calcium/g heart dry tissue) and InsP6 treated (0.9 +/- 0.2 mg calcium/g dry aorta tissue, 0.30 +/- 0.03 mg calcium/g dry heart tissue) animals.",calcium content,CHEMICAL,be observed in,InsP6 non-treated rats,CHEMICAL
34922615,"However, many cancer cells develop alterations in the ATP binding cassette transporter responsible for the uptake and efflux process, which leads to resistance.",many cancer cells,DISEASE,develop alterations in,ATP binding cassette transporter responsible,CHEMICAL
34922615,"Bixin and fucoxanthin are well-known carotenoids with known antioxidant properties, however their bioactivity in lung cancer cells, clinically known to develop resistance due to ATP binding cassette transporter, has been minimally studied.",Bixin,CHEBI,be,well-known carotenoids,CHEBI
34922615,"This study is the first to investigate the potential of bixin and fucoxanthin to sensitize human lung cancer cell line, A549 and cervical cancer cell line, HeLa, to cisplatin.",fucoxanthin,CHEMICAL,have the potential to,human lung cancer cell line,DISEASE
34922615,"This study is the first to investigate the potential of bixin and fucoxanthin to sensitize human lung cancer cell line, A549 and cervical cancer cell line, HeLa, to cisplatin.",bixin,CHEBI,have the potential to,human lung cancer cell line,DISEASE
34678694,"Our present study demonstrated that administration of Bixin suppressed allergic airway inflammation and reversed glucocorticoids resistance, as well as alleviated airway remodeling and airway hyperresponsiveness (AHR) in asthmatic mice.",Bixin,CHEBI,suppress,allergic airway inflammation,DISEASE
34678694,"Above all, our findings reveal that Bixin functions as a potent antagonist of PI3K/Akt signaling to protect against allergic asthma, highlighting a novel strategy for asthma treatment based on natural products.",Bixin,CHEBI,protect against,allergic asthma,DISEASE
34079484,"Background: Growing evidences indicate that sex hormones have an effect on cognitive functions, and that Bulimia Nervosa (BN) is associated with cognitive impairment.",Bulimia Nervosa,MENTAL_HEALTH,be associated with,cognitive impairment,DISEASE
18980823,"Sertraline is a widely used antidepressant belonging to the selective serotonin reuptake inhibitor class; its efficacy has been demonstrated not only in the treatment of major depression, obsessive compulsive and panic disorders, but also for eating, premenstrual dysphoric and post-traumatic stress disorders.",Sertraline,CHEMICAL,belonging to,selective serotonin reuptake inhibitor class,CHEBI
28276430,BTP has also been described as a sensitive marker in detecting impaired renal function.,BTP,CHEMICAL,detect,impaired renal function,DISEASE
17489495,"Urofacial syndrome was described by Elejade in 1979, who coined the term ""Ochoa's Syndrome"".",Urofacial syndrome,DISEASE,be described by,Elejade,CHEMICAL
35550931,"Iron starvation is used by professional phagocytes, from Dictyostelium to macrophages, as a form of defense mechanism against intracellular pathogens.",Iron starvation,CHEMICAL,be used by,defense mechanism,MENTAL_HEALTH
26120333,Recent studies have shown that consumption of some fatty acids such as omega-3 fatty acids improves migraine symptoms.,omega-3 fatty acids,NUTRITION,improve,migraine symptoms,DISEASE
26120333,Recent studies have shown that consumption of some fatty acids such as omega-3 fatty acids improves migraine symptoms.,omega-3 fatty acids,CHEMICAL,improve,migraine symptoms,DISEASE
26120333,Recent studies have shown that consumption of some fatty acids such as omega-3 fatty acids improves migraine symptoms.,fatty acids,NUTRITION,improve,migraine symptoms,DISEASE
35569818,"Dyslipidemia, mainly referred to elevated plasma levels of atherogenic lipids or lipoproteins, or functional impairment of anti-atherogenic lipids or lipoproteins, plays a pivotal role both in cellular senescence and atherosclerosis.",Dyslipidemia,DISEASE,play pivotal role in,atherosclerosis,DISEASE
3930760,"Prolonged exposure to E-Ferol was associated with progressive intralobular cholestasis, inflammation of hepatic venules, and extensive sinusoidal veno-occlusion by fibrosis.",E-Ferol,CHEMICAL,be associated with,fibrosis,DISEASE
3930760,"Prolonged exposure to E-Ferol was associated with progressive intralobular cholestasis, inflammation of hepatic venules, and extensive sinusoidal veno-occlusion by fibrosis.",E-Ferol,CHEMICAL,be associated with,progressive intralobular cholestasis,DISEASE
3930760,"Prolonged exposure to E-Ferol was associated with progressive intralobular cholestasis, inflammation of hepatic venules, and extensive sinusoidal veno-occlusion by fibrosis.",E-Ferol,CHEMICAL,be associated with,hepatic venules,DISEASE
31353975,"In addition, erythropoiesis-stimulating agents (ESA) are used to ameliorate anemia.",erythropoiesis-stimulating agents,CHEBI,ameliorate,anemia,DISEASE
1975444,"The contribution that challenge tests with lactate, hyper- and hypocapnia, beta- and alpha-2-adrenoceptor agonists, peptides, pentylenetetrazol, and caffeine make to our understanding of the biological basis of anxiety and these major theories are described and discussed.",pentylenetetrazol,CHEMICAL,make,anxiety,MENTAL_HEALTH
1975444,"The contribution that challenge tests with lactate, hyper- and hypocapnia, beta- and alpha-2-adrenoceptor agonists, peptides, pentylenetetrazol, and caffeine make to our understanding of the biological basis of anxiety and these major theories are described and discussed.",lactate,CHEMICAL,make,anxiety,MENTAL_HEALTH
1975444,"The contribution that challenge tests with lactate, hyper- and hypocapnia, beta- and alpha-2-adrenoceptor agonists, peptides, pentylenetetrazol, and caffeine make to our understanding of the biological basis of anxiety and these major theories are described and discussed.",caffeine,CHEMICAL,make,anxiety,MENTAL_HEALTH
1975444,"The contribution that challenge tests with lactate, hyper- and hypocapnia, beta- and alpha-2-adrenoceptor agonists, peptides, pentylenetetrazol, and caffeine make to our understanding of the biological basis of anxiety and these major theories are described and discussed.",alpha-2-adrenoceptor agonists,CHEBI,make,anxiety,MENTAL_HEALTH
1975444,"The contribution that challenge tests with lactate, hyper- and hypocapnia, beta- and alpha-2-adrenoceptor agonists, peptides, pentylenetetrazol, and caffeine make to our understanding of the biological basis of anxiety and these major theories are described and discussed.",alpha-2-adrenoceptor agonists,CHEMICAL,make,anxiety,MENTAL_HEALTH
21804794,morphine patient-controlled analgesia (PCA) could improve postoperative analgesia while reducing opioid consumption and opioid-related side effects.,patient-controlled analgesia,MENTAL_HEALTH,improve,postoperative analgesia,MENTAL_HEALTH
1736753,"Under clonidine, the level of nocturnal hypoxemia improved in six patients.",nocturnal hypoxemia,DISEASE,improve under,clonidine,CHEMICAL
2482096,In this study we have shown that the expression of the conditioned response was blocked by an injection of naltrexone (NTX) at 10 mg/kg ip when given immediately prior to the two test CS odor exposures.,conditioned response,MENTAL_HEALTH,be blocked by injection of,NTX,CHEMICAL
2482096,In this study we have shown that the expression of the conditioned response was blocked by an injection of naltrexone (NTX) at 10 mg/kg ip when given immediately prior to the two test CS odor exposures.,conditioned response,MENTAL_HEALTH,be blocked by injection of,naltrexone,CHEMICAL
2829265,The present experiments assessed whether morphine-conditioned hyperactivity could be attenuated by either the opiate antagonist naloxone or the dopamine antagonist pimozide.,morphine-conditioned hyperactivity,MENTAL_HEALTH,be attenuated by,dopamine antagonist pimozide,CHEMICAL
2829265,The present experiments assessed whether morphine-conditioned hyperactivity could be attenuated by either the opiate antagonist naloxone or the dopamine antagonist pimozide.,morphine-conditioned hyperactivity,MENTAL_HEALTH,be attenuated by,opiate antagonist naloxone,CHEMICAL
2829265,The present experiments assessed whether morphine-conditioned hyperactivity could be attenuated by either the opiate antagonist naloxone or the dopamine antagonist pimozide.,morphine-conditioned hyperactivity,MENTAL_HEALTH,be attenuated by,opiate antagonist naloxone,CHEBI
2829265,The present experiments assessed whether morphine-conditioned hyperactivity could be attenuated by either the opiate antagonist naloxone or the dopamine antagonist pimozide.,morphine-conditioned hyperactivity,MENTAL_HEALTH,be attenuated by,dopamine antagonist pimozide,CHEBI
2829265,Both of these antagonists were shown to block the unconditioned hyperactivity induced by 2 mg/kg morphine (Experiment 1).,antagonists,CHEBI,block,unconditioned hyperactivity,MENTAL_HEALTH
3038136,Administration of the agonist levorphanol into the medial septal region either preceding or immediately following CS preexposure sessions attenuated latent inhibition of the conditioned response.,agonist levorphanol,CHEBI,attenuate latent inhibition of,conditioned response,MENTAL_HEALTH
3038136,Administration of the agonist levorphanol into the medial septal region either preceding or immediately following CS preexposure sessions attenuated latent inhibition of the conditioned response.,agonist levorphanol,CHEMICAL,attenuate latent inhibition of,conditioned response,MENTAL_HEALTH
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",KA,CHEMICAL,use,EEDQ,CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",KA,CHEMICAL,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",KA,CHEMICAL,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEBI
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",UK-14304,CHEMICAL,use,EEDQ,CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",UK-14304,CHEMICAL,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",UK-14304,CHEMICAL,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEBI
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,MENTAL_HEALTH,use,EEDQ,CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,MENTAL_HEALTH,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,MENTAL_HEALTH,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEBI
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,CHEBI,use,EEDQ,CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,CHEBI,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEMICAL
1673473,"The agonist dissociation constants (KA) and relative efficacies of UK-14304, norepinephrine (NE) and clonidine at presynaptic release-modulating alpha-2 adrenoceptors were determined in rat cerebral cortex slices using the irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) (0.8 mg/kg i.p.) to reduce the receptor pool.",agonist dissociation constants,CHEBI,use,"irreversible alpha-2 adrenoceptor antagonist N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline",CHEBI
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEMICAL,produce long-lasting deficits in several markers of,5-HT,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEMICAL,produce long-lasting deficits in several markers of,serotonin system integrity,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEBI,produce long-lasting deficits in several markers of,5-HT,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEBI,produce long-lasting deficits in several markers of,serotonin system integrity,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEMICAL,produce,long-lasting deficits,DISEASE
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.","drug 3,4-methylenedioxymethamphetamine",CHEBI,produce,long-lasting deficits,DISEASE
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.",MDMA,CHEMICAL,produce long-lasting deficits in several markers of,5-HT,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.",MDMA,CHEMICAL,produce long-lasting deficits in several markers of,serotonin system integrity,CHEMICAL
17609680,"High or repeated doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy') produce long-lasting deficits in several markers of serotonin (5-HT) system integrity and also alter behavioral function.",MDMA,CHEMICAL,produce,long-lasting deficits,DISEASE
31728946,The stimulatory effect of tungstate on metabolic activities could serve as important components of antioxidative defense mechanism against tungstate toxicity.,tungstate,CHEMICAL,serve as important components of antioxidative defense mechanism against,tungstate toxicity,CHEMICAL
31728946,The stimulatory effect of tungstate on metabolic activities could serve as important components of antioxidative defense mechanism against tungstate toxicity.,tungstate,CHEMICAL,serve as important components of,antioxidative defense mechanism,MENTAL_HEALTH
28647606,"Meanwhile, the Zn (40, 14%) and Pb (82, 15%) uptake in the shoot and root were also increased in TG soil.",Zn uptake,CHEMICAL,be increased in,TG soil,DISEASE
28647606,"Shoot/root dry biomass, chlorophyll and carotenoid content in Brassica juncea were significantly influenced by the application of Act12 in FC and TG soil.",Act12,CHEMICAL,have the application in,TG,DISEASE
34975941,"Inhibition of Indoleacetic acid, cytokinin, jasmonate acid, and salicylic acid contents and changes in related gene expression in R-line may play important roles in regulation of clubroot resistance (CR).",salicylic acid contents,CHEMICAL,play important roles in regulation of,clubroot resistance,MENTAL_HEALTH
34975941,"Inhibition of Indoleacetic acid, cytokinin, jasmonate acid, and salicylic acid contents and changes in related gene expression in R-line may play important roles in regulation of clubroot resistance (CR).",cytokinin,CHEBI,play important roles in regulation of,clubroot resistance,MENTAL_HEALTH
34975941,"Inhibition of Indoleacetic acid, cytokinin, jasmonate acid, and salicylic acid contents and changes in related gene expression in R-line may play important roles in regulation of clubroot resistance (CR).",jasmonate acid,CHEMICAL,play important roles in regulation of,clubroot resistance,MENTAL_HEALTH
23145389,Serotonin syndrome (SS) is a rare and potentially life-threatening toxic state caused by an adverse drug reaction that leads to excessive central and peripheral serotonergic activity.,SS,CHEMICAL,caused by,adverse drug reaction,CHEBI
23145389,Serotonin syndrome (SS) is a rare and potentially life-threatening toxic state caused by an adverse drug reaction that leads to excessive central and peripheral serotonergic activity.,Serotonin syndrome,CHEMICAL,caused by,adverse drug reaction,CHEBI
3560971,"In experimental study with rats, cyclazocine is known to increase locomotor activity and to produce a bizarre behavioral syndrome including head swaying, backward walking, circling.",cyclazocine,CHEMICAL,produce,bizarre behavioral syndrome,DISEASE
3560971,"Pretreatment with p-chlorophenylalanine (PCPA, 400 mg/kg, 72, 48, 24 hr) resulted in an inhibition of the three abnormal behaviors.",p-chlorophenylalanine PCPA,CHEMICAL,result in inhibition of,abnormal behaviors,DISEASE
3560971,"L-tryptophan (50 mg/kg), 5-hydroxytryptophan (5-HTP, 50 mg/kg), or pargyline (50 mg/kg) inhibited abnormal behaviors and decreased locomotor activity.",5-hydroxytryptophan 5-HTP,CHEMICAL,inhibit,abnormal behaviors,DISEASE
3560971,"L-tryptophan (50 mg/kg), 5-hydroxytryptophan (5-HTP, 50 mg/kg), or pargyline (50 mg/kg) inhibited abnormal behaviors and decreased locomotor activity.",pargyline,CHEMICAL,inhibit,abnormal behaviors,DISEASE
3560971,"L-tryptophan (50 mg/kg), 5-hydroxytryptophan (5-HTP, 50 mg/kg), or pargyline (50 mg/kg) inhibited abnormal behaviors and decreased locomotor activity.",L-tryptophan,CHEMICAL,inhibit,abnormal behaviors,DISEASE
29805740,Fenfluramine exhibits antiepileptic properties and thus diminishes epileptiform discharges in experimental animal models of Dravet syndrome.,Fenfluramine,CHEMICAL,diminish epileptiform discharges in experimental animal models of,Dravet syndrome,DISEASE
29805740,"In this study, we found that fenfluramine and norfenfluramine disrupted the regulatory association of the sigma 1 receptor (σ1R) with NR1 subunits of glutamate N-methyl-D-aspartate receptors (NMDAR), an effect that was also produced by σ1R antagonists such as S1RA and prevented by σ1R agonists such as PPCC.",fenfluramine,CHEMICAL,disrupt regulatory association of,σ1R,CHEMICAL
29805740,"In this study, we found that fenfluramine and norfenfluramine disrupted the regulatory association of the sigma 1 receptor (σ1R) with NR1 subunits of glutamate N-methyl-D-aspartate receptors (NMDAR), an effect that was also produced by σ1R antagonists such as S1RA and prevented by σ1R agonists such as PPCC.",fenfluramine,CHEMICAL,disrupt regulatory association of,glutamate N-methyl-D-aspartate receptors,CHEMICAL
29805740,"In this study, we found that fenfluramine and norfenfluramine disrupted the regulatory association of the sigma 1 receptor (σ1R) with NR1 subunits of glutamate N-methyl-D-aspartate receptors (NMDAR), an effect that was also produced by σ1R antagonists such as S1RA and prevented by σ1R agonists such as PPCC.",norfenfluramine,CHEMICAL,disrupt regulatory association of,σ1R,CHEMICAL
29805740,"In this study, we found that fenfluramine and norfenfluramine disrupted the regulatory association of the sigma 1 receptor (σ1R) with NR1 subunits of glutamate N-methyl-D-aspartate receptors (NMDAR), an effect that was also produced by σ1R antagonists such as S1RA and prevented by σ1R agonists such as PPCC.",norfenfluramine,CHEMICAL,disrupt regulatory association of,glutamate N-methyl-D-aspartate receptors,CHEMICAL
22185047,An H1 antihistamine would be the first line treatment for allergic conjunctivitis.,H1 antihistamine,CHEBI,be first line treatment for,allergic conjunctivitis,DISEASE
22185047,"Bilastine is a new H1 antihistamine with an excellent safety profile, developed for the treatment of allergic rhinoconjunctivitis and urticaria, with potency similar to that of cetirizine and desloratadine, and superior to that of fexofenadine.",Bilastine,CHEMICAL,developed for treatment of allergic rhinoconjunctivitis and urticaria with potency similar to,cetirizine,CHEMICAL
22185047,"Bilastine is a new H1 antihistamine with an excellent safety profile, developed for the treatment of allergic rhinoconjunctivitis and urticaria, with potency similar to that of cetirizine and desloratadine, and superior to that of fexofenadine.",Bilastine,CHEMICAL,developed for treatment of allergic rhinoconjunctivitis and urticaria with potency similar to,fexofenadine,CHEMICAL
22185047,"Bilastine is a new H1 antihistamine with an excellent safety profile, developed for the treatment of allergic rhinoconjunctivitis and urticaria, with potency similar to that of cetirizine and desloratadine, and superior to that of fexofenadine.",Bilastine,CHEMICAL,developed for treatment of allergic rhinoconjunctivitis and urticaria with potency similar to,desloratadine,CHEMICAL
22185047,"Bilastine is a new H1 antihistamine with an excellent safety profile, developed for the treatment of allergic rhinoconjunctivitis and urticaria, with potency similar to that of cetirizine and desloratadine, and superior to that of fexofenadine.",Bilastine,CHEMICAL,developed for treatment of,allergic rhinoconjunctivitis,DISEASE
22185047,"Bilastine is a new H1 antihistamine with an excellent safety profile, developed for the treatment of allergic rhinoconjunctivitis and urticaria, with potency similar to that of cetirizine and desloratadine, and superior to that of fexofenadine.",Bilastine,CHEMICAL,developed for treatment of,urticaria,DISEASE
18383656,"(7) Vasoconstrictors, ipratropium and montelukast, have negative risk-benefit balances in hay fever.",Vasoconstrictors,CHEMICAL,have negative risk-benefit balances in,hay fever,DISEASE
18383656,"(7) Vasoconstrictors, ipratropium and montelukast, have negative risk-benefit balances in hay fever.",ipratropium,CHEMICAL,have negative risk-benefit balances in,hay fever,DISEASE
18383656,"(10) In practice, when drug therapy is needed to relieve symptoms of seasonal allergic rhinitis, sodium cromoglicate is the first-line treatment.",drug therapy,CHEBI,relieve symptoms of,seasonal allergic rhinitis,DISEASE
28925030,"In addition to reduced noradrenergic and serotonergic neurotransmission in the brain, other coincidence features such as glutamate neurotoxicity, inflammation and/or cerebrovascular insufficiency are implicated in the pathogenesis of major depressive disorder and late-life depression.",glutamate neurotoxicity,CHEMICAL,be implicated in addition to reduced noradrenergic and serotonergic neurotransmission in brain in,major depressive disorder,MENTAL_HEALTH
28925030,"In addition to reduced noradrenergic and serotonergic neurotransmission in the brain, other coincidence features such as glutamate neurotoxicity, inflammation and/or cerebrovascular insufficiency are implicated in the pathogenesis of major depressive disorder and late-life depression.",glutamate neurotoxicity,CHEMICAL,be implicated in addition to reduced noradrenergic and serotonergic neurotransmission in brain in,late-life depression,MENTAL_HEALTH
28925030,"In addition to reduced noradrenergic and serotonergic neurotransmission in the brain, other coincidence features such as glutamate neurotoxicity, inflammation and/or cerebrovascular insufficiency are implicated in the pathogenesis of major depressive disorder and late-life depression.",cerebrovascular insufficiency,DISEASE,be implicated in addition to reduced noradrenergic and serotonergic neurotransmission in brain in,major depressive disorder,MENTAL_HEALTH
28925030,"In addition to reduced noradrenergic and serotonergic neurotransmission in the brain, other coincidence features such as glutamate neurotoxicity, inflammation and/or cerebrovascular insufficiency are implicated in the pathogenesis of major depressive disorder and late-life depression.",cerebrovascular insufficiency,DISEASE,be implicated in addition to reduced noradrenergic and serotonergic neurotransmission in brain in,late-life depression,MENTAL_HEALTH
22549115,"Thiazolidinediones have shown antidepressant effect in animal studies, as well as in some uncontrolled studies evaluating human subjects with concurrent major depressive disorder (MDD) and metabolic syndrome.",Thiazolidinediones,CHEBI,show,antidepressant effect,CHEMICAL
22549115,"Thus, we hypothesized that they would show antidepressant effect in patients with MDD even if it was not accompanied by metabolic disturbances.",antidepressant effect,CHEMICAL,in patients with,MDD,DISEASE
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",DSM-IV-TR,DISEASE,be randomized in double-blind placebo-controlled study to,citalopram,CHEMICAL
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",DSM-IV-TR,DISEASE,be randomized in double-blind placebo-controlled study to,pioglitazone,CHEMICAL
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",MDD,DISEASE,be randomized in double-blind placebo-controlled study to,citalopram,CHEMICAL
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",MDD,DISEASE,be randomized in double-blind placebo-controlled study to,pioglitazone,CHEMICAL
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",Hamilton depression,MENTAL_HEALTH,be randomized in double-blind placebo-controlled study to,citalopram,CHEMICAL
22549115,"In this double-blind placebo-controlled study, 40 patients with MDD (DSM-IV-TR) and Hamilton depression rating scale-17 (Ham-D) score ≥ 22 were randomized to citalopram plus pioglitazone (15 mg every 12 h) (n=20) or citalopram plus placebo (n=20) for 6 weeks.",Hamilton depression,MENTAL_HEALTH,be randomized in double-blind placebo-controlled study to,pioglitazone,CHEMICAL
22549115,Pioglitazone is a safe and effective adjunctive short-term treatment in patients with moderate-to-severe MDD even in the absence of metabolic syndrome and diabetes.,Pioglitazone,CHEMICAL,be safe short-term treatment in patients with moderate-to-severe mdd in,metabolic syndrome,DISEASE
22549115,Pioglitazone is a safe and effective adjunctive short-term treatment in patients with moderate-to-severe MDD even in the absence of metabolic syndrome and diabetes.,Pioglitazone,CHEMICAL,be safe short-term treatment in patients with moderate-to-severe mdd in,diabetes,DISEASE
22549115,Pioglitazone is a safe and effective adjunctive short-term treatment in patients with moderate-to-severe MDD even in the absence of metabolic syndrome and diabetes.,Pioglitazone,CHEMICAL,be safe short-term treatment in patients with,moderate-to-severe MDD,DISEASE
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,require,pyruvate,CHEMICAL
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,require,ATP MgSO(4,CHEMICAL
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,be stimulated by,fixation,MENTAL_HEALTH
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,be stimulated by,2-mercaptoethanol,CHEMICAL
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,be stimulated by,acetyl CoA. Inhibition,CHEMICAL
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,be stimulated by,biotin,CHEBI
4986758,"Fixation by dialyzed cell extracts required pyruvate, ATP, MgSO(4), and was stimulated by biotin, KCl, 2-mercaptoethanol, CoA, and acetyl CoA. Inhibition of fixation occurred when avidin, NaCl, oxalacetate, or aspartate was added to dialyzed extracts.",Fixation,MENTAL_HEALTH,be stimulated by,KCl,CHEMICAL
4986758,"On the basis of the products formed and the effects of substrates and cofactors on the fixation reaction, it was concluded that pyruvate carboxylase is responsible for CO(2) fixation in this microorganism.",pyruvate carboxylase,CHEMICAL,be responsible for,CO(2 fixation,MENTAL_HEALTH
16657299,"With Chlorella ellipsoidea cells, the effect of oxygen was investigated on the products of enhanced dark (14)CO(2) fixation immediately following preillumination in the absence of CO(2).",oxygen,CHEMICAL,be investigated with chlorella ellipsoidea cells on products of,dark (14)CO(2 fixation,CHEMICAL
16657299,"With Chlorella ellipsoidea cells, the effect of oxygen was investigated on the products of enhanced dark (14)CO(2) fixation immediately following preillumination in the absence of CO(2).",oxygen,CHEMICAL,be investigated with chlorella ellipsoidea cells on products of,dark (14)CO(2 fixation,MENTAL_HEALTH
16657299,"With Chlorella ellipsoidea cells, the effect of oxygen was investigated on the products of enhanced dark (14)CO(2) fixation immediately following preillumination in the absence of CO(2).",oxygen,CHEMICAL,be investigated with chlorella ellipsoidea cells on products of,preillumination,CHEMICAL
16657299,"When the reaction mixture was made aerobic by bubbling air (CO(2)-free) throughout preillumination and the following dark (14)CO(2) fixation periods, the initial fixation product was mainly 3-phosphoglyceric acid.",initial fixation product,MENTAL_HEALTH,be,3-phosphoglyceric acid,CHEMICAL
16657299,"When the reaction mixture was made aerobic by bubbling air (CO(2)-free) throughout preillumination and the following dark (14)CO(2) fixation periods, the initial fixation product was mainly 3-phosphoglyceric acid.",reaction mixture,CHEBI,following,dark (14)CO(2 fixation periods,MENTAL_HEALTH
16657299,The pattern of (14)CO(2) fixation products was unaffected by the atmospheric condition during the period of preillumination.,(14)CO(2 fixation products,MENTAL_HEALTH,be unaffected by atmospheric condition during period of,preillumination,CHEMICAL
16657299,The pattern of (14)CO(2) fixation products was unaffected by the atmospheric condition during the period of preillumination.,(14)CO(2 fixation products,CHEMICAL,be unaffected by atmospheric condition during period of,preillumination,CHEMICAL
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,aspartate,CHEMICAL,depend on the presence or absence of oxygen during period of,dark CO(2 fixation,MENTAL_HEALTH
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,aspartate,CHEMICAL,depend on the presence or absence of,oxygen,CHEMICAL
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,alanine,CHEMICAL,depend on the presence or absence of oxygen during period of,dark CO(2 fixation,MENTAL_HEALTH
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,fixed carbon atom,CHEMICAL,depend on the presence or absence of oxygen during period of,dark CO(2 fixation,MENTAL_HEALTH
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,alanine,CHEMICAL,depend on the presence or absence of,oxygen,CHEMICAL
16657299,The preferential flow of the fixed carbon atom to alanine or aspartate depended on the presence or absence of oxygen during the period of dark CO(2) fixation.,fixed carbon atom,CHEMICAL,depend on the presence or absence of,oxygen,CHEMICAL
24813330,"Vitamin D has been attributed roles in the pathogenesis and prevention of several diseases such as cancer, cardiovascular disease, multiple sclerosis, diabetes, autism and autoimmune diseases.",Vitamin D,CHEBI,be attributed roles in pathogenesis and prevention of several diseases such as,autoimmune diseases,DISEASE
24813330,"Vitamin D has been attributed roles in the pathogenesis and prevention of several diseases such as cancer, cardiovascular disease, multiple sclerosis, diabetes, autism and autoimmune diseases.",Vitamin D,CHEBI,be attributed roles in pathogenesis and prevention of several diseases such as,multiple sclerosis,DISEASE
24813330,"Vitamin D has been attributed roles in the pathogenesis and prevention of several diseases such as cancer, cardiovascular disease, multiple sclerosis, diabetes, autism and autoimmune diseases.",Vitamin D,CHEBI,be attributed roles in pathogenesis and prevention of several diseases such as,autism,MENTAL_HEALTH
24813330,"Vitamin D has been attributed roles in the pathogenesis and prevention of several diseases such as cancer, cardiovascular disease, multiple sclerosis, diabetes, autism and autoimmune diseases.",Vitamin D,CHEBI,be attributed roles in pathogenesis and prevention of several diseases such as,cardiovascular disease,DISEASE
24813330,"Vitamin D has been attributed roles in the pathogenesis and prevention of several diseases such as cancer, cardiovascular disease, multiple sclerosis, diabetes, autism and autoimmune diseases.",Vitamin D,CHEBI,be attributed roles in pathogenesis and prevention of several diseases such as,diabetes,DISEASE
32350120,"SIGNIFICANCE STATEMENT: Based on the lessons from the applications of EGFR inhibitors in oncology, it is concluded that EGFR inhibitors can be beneficial in treatment of neurodegenerative diseases and spinal cord injuries.",EGFR inhibitors,CHEBI,be beneficial in treatment of,neurodegenerative diseases,DISEASE
32350120,"SIGNIFICANCE STATEMENT: Based on the lessons from the applications of EGFR inhibitors in oncology, it is concluded that EGFR inhibitors can be beneficial in treatment of neurodegenerative diseases and spinal cord injuries.",EGFR inhibitors,CHEBI,be beneficial in treatment of,spinal cord injuries,DISEASE
32229219,"At the genus level, the MDD group had lower levels of Faecalibacterium and other related members of the family Ruminococcaceae, which was also reduced relative to healthy controls.",MDD group,DISEASE,have at genus level lower levels of,Faecalibacterium,CHEMICAL
32229219,"Accordingly, predicted functional differences between the two groups include a reduced abundance of short-chain fatty acid production pathways in the MDD group.",short-chain fatty acid production pathways,NUTRITION,have a reduced abundance in,MDD group,DISEASE
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,apprehension,MENTAL_HEALTH
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,depressive symptoms,DISEASE
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,anxiety,MENTAL_HEALTH
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,anger,DISEASE
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,impotence,MENTAL_HEALTH
34948584,"Conclusions: Front line care for people with COVID-19 causes fear, anxiety, stress, social isolation, depressive symptoms, uncertainty, frustration, anger, obsessive thoughts, compulsivity, introversion, apprehension, impotence, alteration of space-time perception, somatization, and feeling of betrayal in nurses.",COVID-19,CHEMICAL,cause,obsessive thoughts,DISEASE
12531167,"Ephedra, and its constituent ephedrine, are used in both stimulant and weight loss preparations, sometimes with caffeine; safety concerns have arisen with this practice.",constituent ephedrine,CHEMICAL,be used in stimulant and weight loss preparations with,caffeine,CHEMICAL
12531167,"Ephedra, and its constituent ephedrine, are used in both stimulant and weight loss preparations, sometimes with caffeine; safety concerns have arisen with this practice.",constituent ephedrine,CHEMICAL,be used in,loss,DISEASE
33067719,7KC induces a dose-dependent loss of cell viability and an increase in apoptosis and necrosis in the endothelial cells.,7KC,CHEMICAL,induce dose-dependent loss of cell viability and increase in,necrosis,DISEASE
25540200,"A link between Tau phosphorylation and aggregation has been shown in different models for Alzheimer disease, including yeast.",Tau phosphorylation,CHEMICAL,be shown in different models for,yeast,NUTRITION
25540200,"A link between Tau phosphorylation and aggregation has been shown in different models for Alzheimer disease, including yeast.",Tau phosphorylation,CHEMICAL,be shown in different models for,Alzheimer disease,MENTAL_HEALTH
33503563,"Determination of PPi levels in urine represents a measurable factor for diagnostic, treatment, and monitoring of urolithiasis.",PPi levels,CHEMICAL,represent measurable factor for,urolithiasis,DISEASE
33503563,A wide linear range for PPi was up to 4400 μM. The indicator displacement assay (IDAs) using pyrocatechol violet (PV) as a colorimetric indicator was carried out to detect PPi with the naked eyes.,μM. indicator displacement assay,MENTAL_HEALTH,detect,PPi,CHEMICAL
33490941,"While cytokines such as IL-1β, IL-6 and TNF-α have been detected during the early phases of CRPS, this cannot lead to the conclusion that CRPS is an autoimmune disease, nor that it is an autoinflammatory disorder.",CRPS,DISEASE,be,autoimmune disease,DISEASE
33490941,"While cytokines such as IL-1β, IL-6 and TNF-α have been detected during the early phases of CRPS, this cannot lead to the conclusion that CRPS is an autoimmune disease, nor that it is an autoinflammatory disorder.",IL-1β,CHEMICAL,be detected during early phases of,CRPS,DISEASE
28606865,"The perception of increased muscle mass due to supraphysiologic hormone supplementation, or doping, is widespread among PED users despite a paucity of evidence-based data in humans.",supraphysiologic hormone supplementation,CHEBI,be widespread among,PED users,CHEMICAL
28606865,"The perception of increased muscle mass due to supraphysiologic hormone supplementation, or doping, is widespread among PED users despite a paucity of evidence-based data in humans.",increased muscle mass,DISEASE,be widespread among,PED users,CHEMICAL
6455899,Ten women with essential hirsutism were treated for one year with cyclic administration of cyproterone acetate and ethinyl estradiol.,essential hirsutism,DISEASE,be treated for year with cyclic administration of,acetate ethinyl estradiol,CHEMICAL
6455899,"It is concluded that the anti-androgenic effect is probably the most important in this drug regimen, but that reversibility of hirsutism may depend upon factors not directly related to androgen influence.",hirsutism,DISEASE,depend,androgen influence,CHEBI
25356563,"Ascorbic acid content was higher in the pulps of the varieties Genova and Sutil (60.13 ± 1.28 and 56.53 ± 1.06 mg ascorbic acid per g dry weight, respectively) while total phenolic content was higher in Pica peels followed by Sutil peels (34.59 ± 0.81 and 25.58 ± 1.02 mg/g GAE dry weight, respectively).",Ascorbic acid content,CHEBI,be higher in pulps of,± ascorbic acid,CHEBI
25356563,"Ascorbic acid content was higher in the pulps of the varieties Genova and Sutil (60.13 ± 1.28 and 56.53 ± 1.06 mg ascorbic acid per g dry weight, respectively) while total phenolic content was higher in Pica peels followed by Sutil peels (34.59 ± 0.81 and 25.58 ± 1.02 mg/g GAE dry weight, respectively).",Ascorbic acid content,CHEBI,be higher in pulps of,± ascorbic acid,CHEMICAL
25356563,"Ascorbic acid content was higher in the pulps of the varieties Genova and Sutil (60.13 ± 1.28 and 56.53 ± 1.06 mg ascorbic acid per g dry weight, respectively) while total phenolic content was higher in Pica peels followed by Sutil peels (34.59 ± 0.81 and 25.58 ± 1.02 mg/g GAE dry weight, respectively).",Ascorbic acid content,CHEBI,be higher in pulps of,±,CHEMICAL
29190977,"Peroxisome proliferator-activated receptor-α (PPAR-α), a lipid activated transcription factor of nuclear hormone receptor superfamily, can relieve pain through a rapid-response mechanism.",nuclear hormone receptor superfamily,CHEBI,relieve,pain,DISEASE
16997973,"Here we report that agonists of the nuclear receptor PPAR-alpha (peroxisome proliferator-activated receptor-alpha) suppress pain behaviors induced in mice by chemical tissue injury, nerve damage, or inflammation.",agonists,CHEBI,suppress,pain behaviors,DISEASE
16997973,(i) PEA reduced formalin-induced pain at i.pl.,PEA,CHEMICAL,reduce,i.pl,CHEMICAL
16997973,(i) PEA reduced formalin-induced pain at i.pl.,PEA,CHEMICAL,reduce,formalin-induced pain,DISEASE
16997973,"In addition to modulating nociception, GW7647 and PEA reduced hyperalgesic responses in the chronic constriction injury model of neuropathic pain; these effects were also contingent on PPAR-alpha expression and were observed following either acute or subchronic PPAR-alpha agonist administration.",PEA,CHEMICAL,reduce in addition hyperalgesic responses in chronic constriction injury model of,neuropathic pain,DISEASE
16997973,"In addition to modulating nociception, GW7647 and PEA reduced hyperalgesic responses in the chronic constriction injury model of neuropathic pain; these effects were also contingent on PPAR-alpha expression and were observed following either acute or subchronic PPAR-alpha agonist administration.",PEA,CHEMICAL,reduce in addition hyperalgesic responses in,chronic constriction injury model,DISEASE
16997973,"Finally, acute administration of GW7647 and PEA reduced hyperalgesic responses in the complete Freund's adjuvant and carrageenan models of inflammatory pain.",PEA,CHEMICAL,reduce hyperalgesic responses in complete freund's adjuvant and carrageenan models of,inflammatory pain,DISEASE
35081474,Back pain and inflammation of the epaxial musculature is a significant problem in all equine athletes.,Back pain,DISEASE,be significant problem in,equine athletes,CHEMICAL
2446058,"Ketanserin had no effect on body weight, or biochemical variables, including total serum cholesterol and triglycerides, with the exception of a minor increase in apolipoprotein B. Using a patient self-assessment questionnaire (30 items), the addition of ketanserin was associated with a reduction of most of the symptoms encountered in the placebo phase, including sleep disturbances, general feeling of weakness, headaches, nervousness, and fatigue, but there was a tendency toward increases in stuffy nose and dry mouth.",ketanserin,CHEMICAL,be associated with reduction of most of symptoms general feeling of,nervousness,MENTAL_HEALTH
2446058,"Ketanserin had no effect on body weight, or biochemical variables, including total serum cholesterol and triglycerides, with the exception of a minor increase in apolipoprotein B. Using a patient self-assessment questionnaire (30 items), the addition of ketanserin was associated with a reduction of most of the symptoms encountered in the placebo phase, including sleep disturbances, general feeling of weakness, headaches, nervousness, and fatigue, but there was a tendency toward increases in stuffy nose and dry mouth.",ketanserin,CHEMICAL,be associated with reduction of most of symptoms general feeling of,fatigue,MENTAL_HEALTH
2446058,"Ketanserin had no effect on body weight, or biochemical variables, including total serum cholesterol and triglycerides, with the exception of a minor increase in apolipoprotein B. Using a patient self-assessment questionnaire (30 items), the addition of ketanserin was associated with a reduction of most of the symptoms encountered in the placebo phase, including sleep disturbances, general feeling of weakness, headaches, nervousness, and fatigue, but there was a tendency toward increases in stuffy nose and dry mouth.",ketanserin,CHEMICAL,be associated with reduction of most of symptoms general feeling of,headaches,DISEASE
2446058,"Ketanserin had no effect on body weight, or biochemical variables, including total serum cholesterol and triglycerides, with the exception of a minor increase in apolipoprotein B. Using a patient self-assessment questionnaire (30 items), the addition of ketanserin was associated with a reduction of most of the symptoms encountered in the placebo phase, including sleep disturbances, general feeling of weakness, headaches, nervousness, and fatigue, but there was a tendency toward increases in stuffy nose and dry mouth.",ketanserin,CHEMICAL,be tendency toward increases in,dry mouth,DISEASE
30205091,Methadone is utilized for the treatment of individuals with opiate dependence.,Methadone,CHEMICAL,be utilized for treatment of individuals with,opiate dependence,MENTAL_HEALTH
35585917,"Among therapeutic treatments, dequalinium chloride had the most potent effect on all physiological parameters by reducing acute EEG abnormalities and promoting a full recovery after 24 h from tremors and respiratory depression.",dequalinium chloride,CHEMICAL,promote full recovery after h from,tremors,DISEASE
35585917,"Among therapeutic treatments, dequalinium chloride had the most potent effect on all physiological parameters by reducing acute EEG abnormalities and promoting a full recovery after 24 h from tremors and respiratory depression.",dequalinium chloride,CHEMICAL,promote full recovery after h from,respiratory depression,MENTAL_HEALTH
35585917,Co-treatment with atropine converted the acute 1.4 Hz tonic spikes to 3 Hz tonic spikes in the parietal electrode and promoted a partial recovery after 24 h from theta frequency and respiratory depression.,atropine,CHEMICAL,promote partial recovery after h from,respiratory depression,MENTAL_HEALTH
35585917,HI6 fully removed the parietal delta spike increase and promoted a full recovery in theta frequency and respiratory depression.,HI6,CHEMICAL,promote full recovery in,respiratory depression,MENTAL_HEALTH
35585917,"In summary, while all anticholinergic treatments promoted survival and moderated symptoms of DFP toxicity, the non-selective anti-cholinergic dequalinium chloride had the most potent therapeutic effects in reducing EEG abnormalities, moderating tremors and reducing respiratory depression.",non-selective anti-cholinergic dequalinium chloride,CHEMICAL,reduce,respiratory depression,MENTAL_HEALTH
32459054,"In this study, we examined whether MDD patients with Met/Met, Met/Val, and Val/Val COMT genotypes differed in their response to bupropion in terms of depression scores.",MDD patients,DISEASE,differ in their response to bupropion in terms of,depression scores,MENTAL_HEALTH
32459054,"In this study, we examined whether MDD patients with Met/Met, Met/Val, and Val/Val COMT genotypes differed in their response to bupropion in terms of depression scores.",MDD patients,DISEASE,differ in their response to,bupropion,CHEMICAL
15671136,"Infectious diseases, especially hepatitis C, are prevalent among drug abusers.",hepatitis C,DISEASE,be prevalent among,drug abusers,CHEBI
15671136,"Infectious diseases, especially hepatitis C, are prevalent among drug abusers.",Infectious diseases,DISEASE,be prevalent among,drug abusers,CHEBI
30389321,"Further, when the human condition was simulated in animals, there was deprivation in body weight and glucose levels in starved litchi seed dosed rats, causing hypoglycemia.",glucose,CHEMICAL,have deprivation in,starved litchi seed,NUTRITION
30389321,These results suggest that the cause of hypoglycemic encephalopathy in Muzzaffarpur is related to the consumption of semi ripe and ripe litchi fruits by undernourished children.,hypoglycemic encephalopathy,DISEASE,be related to consumption of,semi litchi fruits,NUTRITION
24661986,"Evidence supporting this panic inhibition system comes from the following observations: (1) serotonergic neurons located in the 'ventrolateral dorsal raphe nucleus' (DRVL) as well as the ventrolateral periaqueductal gray (VLPAG) inhibit dorsal periaqueductal gray-elicited panic-like responses; (2) chronic, but not acute, antidepressant treatment potentiates serotonin's panicolytic effect; (3) contextual fear activates a central nucleus of the amygdala-DRVL/VLPAG circuit implicated in mediating freezing and inhibiting panic-like escape behaviors; (4) DRVL/VLPAG serotonergic neurons are central chemoreceptors and modulate the behavioral and cardiorespiratory response to panicogenic agents such as sodium lactate and CO2.",antidepressant treatment,CHEMICAL,potentiate,serotonin,CHEMICAL
10841793,The beneficial effects of PAF receptor antagonists are evident and give rise to expected therapeutic strategies for neurotrauma.,PAF receptor antagonists,CHEMICAL,give rise to expected therapeutic strategies for,neurotrauma,DISEASE
10841793,The beneficial effects of PAF receptor antagonists are evident and give rise to expected therapeutic strategies for neurotrauma.,PAF receptor antagonists,CHEBI,give rise to expected therapeutic strategies for,neurotrauma,DISEASE
10841793,"Although its mode of action is not clearly defined, these data suggest that PMS 601, which displays no effect on acellular reverse transcriptase or protease tests, deserves further investigation in the treatment of HIV-1-associated dementia.",PMS,CHEMICAL,deserve further investigation in treatment of,HIV-1-associated dementia,MENTAL_HEALTH
28576941,"Previous research demonstrates that Slc6a15, a neutral amino acid transporter, is associated with depression susceptibility.",neutral amino acid transporter,CHEMICAL,be associated with,depression susceptibility,MENTAL_HEALTH
2806864,"It is established that in patients being in a state of the alcoholic abstinence syndrome, the fatty acid content of thrombocytic phospholipids markedly differed from control.",thrombocytic phospholipids,NUTRITION,be in state of,alcoholic abstinence syndrome,MENTAL_HEALTH
2806864,"It is established that in patients being in a state of the alcoholic abstinence syndrome, the fatty acid content of thrombocytic phospholipids markedly differed from control.",fatty acid content,NUTRITION,be in state of,alcoholic abstinence syndrome,MENTAL_HEALTH
2806864,The improvement of the patients' clinical status after egress from the alcoholic abstinence syndrome was coupled with a noticeable normalization of the fatty acid content of thrombocytic phospholipids.,alcoholic abstinence syndrome,MENTAL_HEALTH,be coupled with noticeable normalization of fatty acid content of,thrombocytic phospholipids,NUTRITION
2806864,The improvement of the patients' clinical status after egress from the alcoholic abstinence syndrome was coupled with a noticeable normalization of the fatty acid content of thrombocytic phospholipids.,alcoholic abstinence syndrome,MENTAL_HEALTH,be coupled with noticeable normalization of,fatty acid content,NUTRITION
2806864,"The changes in the lipid and fatty acid content of blood platelets in patients with alcoholism may produce disorders in prostanoid synthesis and functional properties of blood platelets, leading to the impairment of the coagulation and anticoagulation blood systems.",alcoholism,DISEASE,produce disorders in,prostanoid synthesis,CHEMICAL
2806864,"The changes in the lipid and fatty acid content of blood platelets in patients with alcoholism may produce disorders in prostanoid synthesis and functional properties of blood platelets, leading to the impairment of the coagulation and anticoagulation blood systems.",fatty acid content,NUTRITION,produce disorders in,prostanoid synthesis,CHEMICAL
24863217,"These formed Ag-PL NPs showed potential mosquito larvicidal activity against Aedes aegypti (L.), Anopheles stephensi Liston and Culex quinquefasciatus Say.",Ag-PL NPs,CHEMICAL,show potential mosquito larvicidal activity against,Anopheles stephensi Liston,DISEASE
18596619,The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.,methionine variant,NUTRITION,be associated with deficit in attention and aggravation of delusions in,schizophrenia,MENTAL_HEALTH
18596619,The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.,methionine variant,NUTRITION,be associated with deficit in attention and aggravation of,delusions,MENTAL_HEALTH
18596619,The methionine variant of Val66Met brain-derived neurotrophic factor BDNF met and catecholamine-O-methyltransferase (COMT L) is associated with a deficit in attention and aggravation of delusions in schizophrenia.,delusions,MENTAL_HEALTH,have attention and aggravation in,schizophrenia,MENTAL_HEALTH
18596619,"The patients who were BDNF met/met x COMT L carriers had the highest scores of delusion of Positive Symptoms and the Scale for Assessment of Negative Symptoms, word reading of the color word test, and trail-making test B time, compared with the other three genotype interactions.",BDNF met/met COMT L carriers,CHEBI,have highest scores of,delusion,MENTAL_HEALTH
9646150,"The main hypothesis was that subtle vitamin B12 deficiencies occur more commonly in senile dementia of Alzheimer type (SDAT) that in healthy elderly individuals, and may be revealed by elevated total serum homocysteine (tHcy).",subtle vitamin B12 deficiencies,CHEBI,occur in senile dementia of,SDAT,DISEASE
9646150,"The main hypothesis was that subtle vitamin B12 deficiencies occur more commonly in senile dementia of Alzheimer type (SDAT) that in healthy elderly individuals, and may be revealed by elevated total serum homocysteine (tHcy).",subtle vitamin B12 deficiencies,CHEBI,occur in,senile dementia,MENTAL_HEALTH
32543656,Salbutamol treatment improved weight gain and survival in DOK7 myasthenic mice.,Salbutamol treatment,CHEMICAL,improve weight gain and survival in,DOK7 myasthenic mice,DISEASE
32543656,Salbutamol treatment improved weight gain and survival in DOK7 myasthenic mice.,Salbutamol treatment,CHEMICAL,improve,weight gain,DISEASE
31633155,"Acetylcholine receptor deficiency is the most common form of the congenital myasthenic syndromes, a heterogeneous collection of genetic disorders of neuromuscular transmission characterized by fatiguable muscle weakness.",Acetylcholine receptor deficiency,CHEMICAL,be common form of,congenital myasthenic syndromes,MENTAL_HEALTH
31633155,"Acetylcholine receptor deficiency is the most common form of the congenital myasthenic syndromes, a heterogeneous collection of genetic disorders of neuromuscular transmission characterized by fatiguable muscle weakness.",Acetylcholine receptor deficiency,CHEMICAL,be common form of,neuromuscular transmission,DISEASE
31633155,"Acetylcholine receptor deficiency is the most common form of the congenital myasthenic syndromes, a heterogeneous collection of genetic disorders of neuromuscular transmission characterized by fatiguable muscle weakness.",Acetylcholine receptor deficiency,CHEMICAL,be common form of,congenital myasthenic syndromes,DISEASE
31633155,The working mechanism of β2-adrenergic agonists in myasthenic patients is not fully understood.,β2-adrenergic agonists,CHEBI,have the working mechanism in,myasthenic patients,DISEASE
31633155,"Coincidently we used a disease model to mirror the treatment of acetylcholine receptor deficiency, and demonstrate improved muscle fatigue, improved neuromuscular transmission and improved synaptic structure resulting from the addition of the β2-adrenergic agonist salbutamol to the anticholinesterase medication pyridostigmine.",β2-adrenergic agonist salbutamol,CHEMICAL,have the addition to,medication pyridostigmine,CHEMICAL
31633155,"Coincidently we used a disease model to mirror the treatment of acetylcholine receptor deficiency, and demonstrate improved muscle fatigue, improved neuromuscular transmission and improved synaptic structure resulting from the addition of the β2-adrenergic agonist salbutamol to the anticholinesterase medication pyridostigmine.",β2-adrenergic agonist salbutamol,CHEBI,have the addition to,medication pyridostigmine,CHEMICAL
35272713,"While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1G93A model of ALS.",antibiotics,CHEBI,improve models of alzheimer's,amyotrophic lateral sclerosis,DISEASE
35272713,"While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1G93A model of ALS.",antibiotics,CHEBI,improve models of alzheimer's,Parkinson's disease,DISEASE
35272713,"While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1G93A model of ALS.",antibiotics,CHEBI,improve models of alzheimer's,ALS,DISEASE
35272713,"While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1G93A model of ALS.",antibiotics,CHEBI,improve models of alzheimer's,multiple sclerosis C9orf72 model,DISEASE
35272713,"While antibiotics improve models of Alzheimer's disease, Parkinson's disease, multiple sclerosis, and the C9orf72 model of amyotrophic lateral sclerosis (ALS), antibiotics worsen disease progression the in SOD1G93A model of ALS.",antibiotics,CHEBI,worsen,ALS,DISEASE
26742927,Simultaneous administration of an NMDA receptor antagonist and a transcription inhibitor prior to reminder of an aversive event prevented amnesia induction.,NMDA receptor antagonist,CHEBI,prevent,amnesia induction,MENTAL_HEALTH
2750368,"The serum levels of hypophysis-thyroid hormones, trophic hypophyseal hormones (STH and prolactin), and cortisol were studied in depressed patients.",cortisol,CHEMICAL,be studied in,depressed patients,DISEASE
2750368,"The serum levels of hypophysis-thyroid hormones, trophic hypophyseal hormones (STH and prolactin), and cortisol were studied in depressed patients.",hypophysis-thyroid hormones,CHEBI,be studied in,depressed patients,DISEASE
2750368,"The serum levels of hypophysis-thyroid hormones, trophic hypophyseal hormones (STH and prolactin), and cortisol were studied in depressed patients.",hormones STH,CHEBI,be studied in,depressed patients,DISEASE
30714121,"Histamine dysregulation was implicated as a rare cause of Tourette syndrome and other tic disorders a decade ago by a landmark genetic study in a high density family pedigree, which implicated a hypomorphic mutation in the histidine decarboxylase (Hdc) gene as a rare but high penetrance genetic cause.",Histamine dysregulation,CHEMICAL,be implicated as rare cause of,Tourette syndrome,MENTAL_HEALTH
30714121,"Histamine dysregulation was implicated as a rare cause of Tourette syndrome and other tic disorders a decade ago by a landmark genetic study in a high density family pedigree, which implicated a hypomorphic mutation in the histidine decarboxylase (Hdc) gene as a rare but high penetrance genetic cause.",Histamine dysregulation,CHEMICAL,be implicated as rare cause of,other tic disorders,DISEASE
21686798,"A diagnosis of scurvy induced by obsessive-compulsive disorder was suspected, and after vitamin C supplementation there was a marked improvement of symptoms.",scurvy,DISEASE,be after,vitamin C supplementation,CHEBI
10973284,We report that the tumor neurosis factor homolog APRIL (a proliferation-inducing ligand) stimulates in vitro proliferation of primary B and T cells and increases spleen weight due to accumulation of B cells in vivo.,tumor neurosis factor homolog APRIL,MENTAL_HEALTH,stimulate,primary B,DISEASE
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,skeletal malformations,DISEASE,be analyzed by,TRPS1 tricho-rhino-phalangeal syndrome,DISEASE
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,skeletal malformations,DISEASE,be analyzed by,hormone hormone,CHEBI
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,skeletal malformations,DISEASE,be analyzed by,short stature,DISEASE
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,Albright's hereditary osteodystrophy,DISEASE,be analyzed by,TRPS1 tricho-rhino-phalangeal syndrome,DISEASE
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,Albright's hereditary osteodystrophy,DISEASE,be analyzed by,hormone hormone,CHEBI
34897794,Five patients with Albright's hereditary osteodystrophy (AHO)-like skeletal malformations without a clear clinical diagnosis were analyzed by whole-exome sequencing (WES) and novel potentially pathogenic variants in parathyroid hormone like hormone (PTHLH) (BDE with short stature [BDE2]) and TRPS1 (tricho-rhino-phalangeal syndrome [TRPS]) were discovered.,Albright's hereditary osteodystrophy,DISEASE,be analyzed by,short stature,DISEASE
30497198,OBJECTIVEVon Hippel-Lindau disease (VHL) is a tumor predisposition syndrome characterized by CNS hemangioblastomas (HBs) and clear cell renal cell carcinomas (RCCs) due to hypoxia-inducible factor activation (pseudohypoxia).,OBJECTIVEVon Hippel-Lindau disease,CHEMICAL,characterized by,clear cell renal cell carcinomas,DISEASE
30497198,OBJECTIVEVon Hippel-Lindau disease (VHL) is a tumor predisposition syndrome characterized by CNS hemangioblastomas (HBs) and clear cell renal cell carcinomas (RCCs) due to hypoxia-inducible factor activation (pseudohypoxia).,OBJECTIVEVon Hippel-Lindau disease,CHEMICAL,characterized by,CNS hemangioblastomas,DISEASE
30497198,Propranolol is an FDA-approved pan-beta adrenergic antagonist with antitumor effects against infantile hemangiomas (IHs) and possibly VHL HBs.,Propranolol,CHEMICAL,be fda-approved pan-beta adrenergic antagonist with antitumor effects against,infantile hemangiomas,DISEASE
30497198,Propranolol is an FDA-approved pan-beta adrenergic antagonist with antitumor effects against infantile hemangiomas (IHs) and possibly VHL HBs.,Propranolol,CHEMICAL,be,FDA-approved pan-beta adrenergic antagonist,CHEBI
30497198,"RESULTSPropranolol decreased HB and RCC viability in vitro with IC50 (half maximal inhibitory concentration) values of 50 µM and 200 µM, respectively.",RESULTSPropranolol,CHEMICAL,decrease,RCC,DISEASE
30497198,"Similar to prior reports in infantile hemangiomas, propranolol induced apoptosis and paradoxically increased VEGF-A mRNA expression in patient-derived VHL-HBs and 786-O cells.",propranolol,CHEMICAL,increase vegf-a mrna expression in,patient-derived VHL-HBs,CHEMICAL
30497198,"Propranolol attenuated tumor progression compared with control (33% volume reduction at 7 days, p < 0.005) in 786-O xenografted tumor-bearing mice.",Propranolol,CHEMICAL,attenuate,tumor progression,DISEASE
30497198,HBs in these patients tended to grow slower (median growth rate 27.1 mm3/year vs 13.3 mm3/year) during propranolol treatment (p < 0.0004).CONCLUSIONSPropranolol decreases VHL-HB and VHL-related RCC viability in vitro likely by modulation of VEGF expression and by inducing apoptosis.,0.0004).CONCLUSIONSPropranolol,CHEMICAL,decrease,VHL-HB RCC viability,DISEASE
30497198,"Propranolol abrogates 786-O xenograft tumor progression in vivo, and retrospective clinical data suggest that propranolol curtails HB growth.",Propranolol,CHEMICAL,abrogate,786-O xenograft tumor progression,DISEASE
30497198,These results suggest that propranolol may play a role in the treatment of VHL-related tumors.,propranolol,CHEMICAL,play role in treatment of,VHL-related tumors,DISEASE
16472967,"PMS777, both a PAF antagonist and a new potent acetylcholinesterase inhibitor was recently demonstrated to reverse scopolamine-induced amnesia in mice without toxicity.",PMS777,CHEMICAL,reverse scopolamine-induced amnesia in mice without,toxicity,DISEASE
16472967,"PMS777, both a PAF antagonist and a new potent acetylcholinesterase inhibitor was recently demonstrated to reverse scopolamine-induced amnesia in mice without toxicity.",PMS777,CHEMICAL,reverse,scopolamine-induced amnesia,MENTAL_HEALTH
16472967,"PMS777, both a PAF antagonist and a new potent acetylcholinesterase inhibitor was recently demonstrated to reverse scopolamine-induced amnesia in mice without toxicity.",PAF antagonist,CHEBI,reverse scopolamine-induced amnesia in mice without,toxicity,DISEASE
16472967,"PMS777, both a PAF antagonist and a new potent acetylcholinesterase inhibitor was recently demonstrated to reverse scopolamine-induced amnesia in mice without toxicity.",PAF antagonist,CHEBI,reverse,scopolamine-induced amnesia,MENTAL_HEALTH
16472967,THA (> or = 10 microM) induced an oxidative stress as shown by elevated ROS and MDA production and by a decrease in GSH level.,THA microM,DISEASE,induce oxidative stress by decrease in,GSH level,CHEMICAL
16472967,THA (> or = 10 microM) induced an oxidative stress as shown by elevated ROS and MDA production and by a decrease in GSH level.,THA microM,DISEASE,show by,MDA production,CHEMICAL
16472967,THA (> or = 10 microM) induced an oxidative stress as shown by elevated ROS and MDA production and by a decrease in GSH level.,THA microM,DISEASE,show by,elevated ROS,CHEMICAL
16472967,Our results suggest that the toxic effect of THA above 10 microM may be caused by drug-induced mitochondrial energization impairment and destabilisation of membrane phospholipids associated with an oxidative stress.,THA,DISEASE,be caused by drug-induced mitochondrial energization impairment and destabilisation of,membrane phospholipids,NUTRITION
16472967,Our results suggest that the toxic effect of THA above 10 microM may be caused by drug-induced mitochondrial energization impairment and destabilisation of membrane phospholipids associated with an oxidative stress.,THA,DISEASE,be caused by,drug-induced mitochondrial energization impairment,DISEASE
16472967,"In contrast by preventing these dysfunctions, PMS777 could be safer than THA.",PMS777,CHEMICAL,be safer in,THA,DISEASE
12354298,"The pro-inflammatory lipid mediator platelet activating factor (PAF: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) accumulates in ischemia, epilepsy, and human immunodeficiency virus-1-associated dementia and is implicated in neuronal loss.",PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,CHEMICAL,be implicated in,neuronal loss,DISEASE
12354298,"The pro-inflammatory lipid mediator platelet activating factor (PAF: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) accumulates in ischemia, epilepsy, and human immunodeficiency virus-1-associated dementia and is implicated in neuronal loss.",PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,CHEMICAL,accumulate in,human virus-1-associated dementia,DISEASE
12354298,"The pro-inflammatory lipid mediator platelet activating factor (PAF: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) accumulates in ischemia, epilepsy, and human immunodeficiency virus-1-associated dementia and is implicated in neuronal loss.",PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,CHEMICAL,accumulate in,ischemia,DISEASE
12354298,"The pro-inflammatory lipid mediator platelet activating factor (PAF: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) accumulates in ischemia, epilepsy, and human immunodeficiency virus-1-associated dementia and is implicated in neuronal loss.",PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,CHEMICAL,accumulate in,human virus-1-associated dementia,MENTAL_HEALTH
12354298,"The pro-inflammatory lipid mediator platelet activating factor (PAF: 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) accumulates in ischemia, epilepsy, and human immunodeficiency virus-1-associated dementia and is implicated in neuronal loss.",PAF 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine,CHEMICAL,accumulate in,epilepsy,DISEASE
12354298,Apoptosis but not necrosis was inhibited by the PAF antagonist BN52021 (1-100 micro m) but not CV3988 (0.2-20 micro m).,necrosis,DISEASE,be inhibited by,PAF antagonist BN52021,CHEMICAL
12354298,Apoptosis but not necrosis was inhibited by the PAF antagonist BN52021 (1-100 micro m) but not CV3988 (0.2-20 micro m).,necrosis,DISEASE,be inhibited by,PAF antagonist BN52021,CHEBI
29200067,"Methylprednisolone administered intravenously preoperatively has been shown to reduce pain, nausea, and fatigue after elective surgery.",Methylprednisolone,CHEMICAL,reduce,nausea,DISEASE
29200067,"Methylprednisolone administered intravenously preoperatively has been shown to reduce pain, nausea, and fatigue after elective surgery.",Methylprednisolone,CHEMICAL,reduce,fatigue,MENTAL_HEALTH
29200067,"Methylprednisolone administered intravenously preoperatively has been shown to reduce pain, nausea, and fatigue after elective surgery.",Methylprednisolone,CHEMICAL,reduce,pain,DISEASE
29200067,We aimed to show that 125 mg of methylprednisolone given intravenously 30 minutes before laparoscopic surgery for suspected appendicitis would reduce pain at rest during the first 3 postoperative days.,methylprednisolone,CHEMICAL,reduce,pain,DISEASE
29200067,We aimed to show that 125 mg of methylprednisolone given intravenously 30 minutes before laparoscopic surgery for suspected appendicitis would reduce pain at rest during the first 3 postoperative days.,suspected appendicitis,DISEASE,reduce,pain,DISEASE
34243899,"Neuroleptic malignant syndrome (NMS) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death.",Neuroleptic malignant syndrome,DISEASE,cause,death,DISEASE
34243899,"Neuroleptic malignant syndrome (NMS) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death.",Neuroleptic malignant syndrome,DISEASE,cause,muscular rigidity,DISEASE
34243899,"Neuroleptic malignant syndrome (NMS) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death.",Neuroleptic malignant syndrome,DISEASE,cause,hyperthermia,DISEASE
34243899,"Neuroleptic malignant syndrome (NMS) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death.",Neuroleptic malignant syndrome,DISEASE,cause,confusion,DISEASE
34243899,"Neuroleptic malignant syndrome (NMS) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death.",Neuroleptic malignant syndrome,DISEASE,cause,autonomic instability,DISEASE
35380231,"African swine fever virus (ASFV) is the pathogen of African swine fever, a highly contagious and fatal disease of wild boar and domestic pigs.",African swine fever virus,DISEASE,be pathogen of,African swine fever,DISEASE
35380231,"African swine fever virus (ASFV) is the pathogen of African swine fever, a highly contagious and fatal disease of wild boar and domestic pigs.",African swine fever virus,DISEASE,be pathogen of,wild boar,NUTRITION
35466116,"Wild boars (Sus scrofa) captured or found dead in Nagano Prefecture were surveyed for antibodies to Aujeszky's disease virus (ADV), Erysipelothrix rhusiopathiae, porcine reproductive and respiratory syndrome virus (PRRSV), and Toxoplasma gondii.",Sus scrofa,NUTRITION,be surveyed for antibodies to aujeszky's,porcine syndrome virus,DISEASE
35466116,"Wild boars (Sus scrofa) captured or found dead in Nagano Prefecture were surveyed for antibodies to Aujeszky's disease virus (ADV), Erysipelothrix rhusiopathiae, porcine reproductive and respiratory syndrome virus (PRRSV), and Toxoplasma gondii.",Sus scrofa,NUTRITION,be surveyed for antibodies to aujeszky's,virus Toxoplasma gondii,DISEASE
35276298,Findings suggest minimisation of prenatal acetaminophen exposure due to risk for ADHD outcomes.,prenatal acetaminophen exposure due,CHEMICAL,have minimisation for,ADHD outcomes,MENTAL_HEALTH
33813057,"Localized provoked vulvodynia (LPV) is the most common cause of chronic dyspareunia in premenopausal women, characterized by pain with light touch to the vulvar vestibule surrounding the vaginal opening.",LPV,CHEMICAL,be common cause of chronic dyspareunia in,pain,DISEASE
33813057,"Localized provoked vulvodynia (LPV) is the most common cause of chronic dyspareunia in premenopausal women, characterized by pain with light touch to the vulvar vestibule surrounding the vaginal opening.",LPV,CHEMICAL,be common cause of,chronic dyspareunia,MENTAL_HEALTH
33813057,"Localized provoked vulvodynia (LPV) is the most common cause of chronic dyspareunia in premenopausal women, characterized by pain with light touch to the vulvar vestibule surrounding the vaginal opening.",Localized provoked vulvodynia,DISEASE,be common cause of chronic dyspareunia in,pain,DISEASE
33813057,"Localized provoked vulvodynia (LPV) is the most common cause of chronic dyspareunia in premenopausal women, characterized by pain with light touch to the vulvar vestibule surrounding the vaginal opening.",Localized provoked vulvodynia,DISEASE,be common cause of,chronic dyspareunia,MENTAL_HEALTH
33813057,"The devastating impact of LPV includes sexual dysfunction, infertility, depression, and even suicide.",LPV,CHEMICAL,include,sexual dysfunction,MENTAL_HEALTH
33813057,"The devastating impact of LPV includes sexual dysfunction, infertility, depression, and even suicide.",LPV,CHEMICAL,include,infertility,DISEASE
33813057,"The devastating impact of LPV includes sexual dysfunction, infertility, depression, and even suicide.",LPV,CHEMICAL,include,depression,MENTAL_HEALTH
33813057,"The devastating impact of LPV includes sexual dysfunction, infertility, depression, and even suicide.",LPV,CHEMICAL,include,suicide,MENTAL_HEALTH
33813057,"Using a murine vulvar pain model, coupling proinflammatory mediator quantification with mechanical sensitivity threshold determination, topical treatment with the SPM, maresin 1, decreased sensitivity and suppressed PGE2 levels.",SPM,CHEMICAL,suppress,PGE2 levels,CHEMICAL
34941442,"Concomitant with these functional declines, patients with cancer had lower mitochondrial oxidative capacity [25% lower State 3 O2 flux (pmol/s/mg tissue)] and ATP production [23% lower State 3 ATP production (pmol/s/mg tissue)] and alterations in phospholipid metabolite profiles indicative of mitochondrial abnormalities.",cancer,DISEASE,have,mitochondrial abnormalities,DISEASE
34941442,"Concomitant with these functional declines, patients with cancer had lower mitochondrial oxidative capacity [25% lower State 3 O2 flux (pmol/s/mg tissue)] and ATP production [23% lower State 3 ATP production (pmol/s/mg tissue)] and alterations in phospholipid metabolite profiles indicative of mitochondrial abnormalities.",cancer,DISEASE,have,lower State ATP production,CHEMICAL
34941442,"Concomitant with these functional declines, patients with cancer had lower mitochondrial oxidative capacity [25% lower State 3 O2 flux (pmol/s/mg tissue)] and ATP production [23% lower State 3 ATP production (pmol/s/mg tissue)] and alterations in phospholipid metabolite profiles indicative of mitochondrial abnormalities.",cancer,DISEASE,have,phospholipid metabolite profiles indicative,NUTRITION
34941442,"Concomitant with these functional declines, patients with cancer had lower mitochondrial oxidative capacity [25% lower State 3 O2 flux (pmol/s/mg tissue)] and ATP production [23% lower State 3 ATP production (pmol/s/mg tissue)] and alterations in phospholipid metabolite profiles indicative of mitochondrial abnormalities.",cancer,DISEASE,have,ATP production,CHEMICAL
34730480,Inadequate free Mg2+ ion concentration ([Mg2+]) in the brain is associated with several neurological and behavioral disorders.,free Mg2,CHEMICAL,be associated with,neurological disorders,DISEASE
20561180,The data suggest that melatonin might be a second useful agent besides clonazepam in the treatment of RBD.,melatonin,CHEMICAL,be,clonazepam,CHEMICAL
20561180,The data suggest that melatonin might be a second useful agent besides clonazepam in the treatment of RBD.,melatonin,CHEMICAL,be,RBD,DISEASE
12696996,Cataplexy is especially responsive to antidepressants which enhance synaptic levels of noradrenaline (norepinephrine) and/or serotonin.,Cataplexy,MENTAL_HEALTH,be responsive to,antidepressants,CHEMICAL
29753253,Adolescents with trichotillomania exhibit a range of hormone levels but that lower levels of certain hormones may have important clinical associations.,trichotillomania,MENTAL_HEALTH,exhibit range of,hormone levels,CHEBI
35417877,"A case of acute severe concomitant poisoning with narcotic substances of depreciating and psychostimulating action (1,4 - butanediol, 1-phenyl-2- (1-pyrrolidinyl) -1-pentanone, methadone) complicated by the development of severe hypoxic-ischemic changes in the supratentorial white matter of the large brain is presented.",acute concomitant poisoning,DISEASE,have a case with,narcotic substances,CHEBI
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,carbon dioxide,CHEMICAL
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,mixed decompensated respiratory lactic acidosis,DISEASE
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,nosocomial focal lower lobe pneumonia,DISEASE
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,edema,DISEASE
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,coma,DISEASE
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur depression of consciousness to level of,lactate mmol l,CHEMICAL
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,occur,depression,MENTAL_HEALTH
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,"take ml of 1,4-butanediol with",phenyl-2- -1-pentanone,CHEMICAL
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,"take ml of 1,4-butanediol with",convulsive syndrome,DISEASE
35417877,"Acute poisoning occurred after taking 100 ml of 1,4-butanediol together with phenyl-2- (1-pyrrolidinyl) -1-pentanone and 2 g of methadone, clinically manifested in the form of convulsive syndrome, depression of consciousness to the level of coma 3, edema and swelling brain, acute respiratory failure, mixed decompensated respiratory and metabolic lactic acidosis (pH 7.193; partial pressure of carbon dioxide 62.3 mm Hg, lactate 7.4 mmol / l) and complications in the form of nosocomial focal left-sided lower lobe pneumonia.",Acute poisoning,DISEASE,"take ml of 1,4-butanediol with",methadone,CHEMICAL
33833332,"Repetitive uses of antifungals result in a worldwide crisis of drug resistance; therefore, natural fungicides with minimal side-effects are currently sought after.",antifungals,CHEBI,result in worldwide crisis of,drug resistance,MENTAL_HEALTH
33833332,"Repetitive uses of antifungals result in a worldwide crisis of drug resistance; therefore, natural fungicides with minimal side-effects are currently sought after.",antifungals,CHEBI,result in worldwide crisis of,drug resistance,CHEBI
33833332,"Investigation of cytochalasins may provide valuable insight with potential biopharmaceutical applications in treatments of fungal infection, cancer or metabolic disorder.",cytochalasins,CHEMICAL,provide valuable insight with potential biopharmaceutical applications in treatments of,cancer,DISEASE
33833332,"Investigation of cytochalasins may provide valuable insight with potential biopharmaceutical applications in treatments of fungal infection, cancer or metabolic disorder.",cytochalasins,CHEMICAL,provide valuable insight with potential biopharmaceutical applications in treatments of,fungal infection,DISEASE
33833332,"Investigation of cytochalasins may provide valuable insight with potential biopharmaceutical applications in treatments of fungal infection, cancer or metabolic disorder.",cytochalasins,CHEMICAL,provide valuable insight with potential biopharmaceutical applications in treatments of,metabolic disorder,DISEASE
35563672,Chronic kidney disease (CKD) is commonly associated with vitamin K deficiency.,Chronic kidney disease,DISEASE,be associated with,vitamin K deficiency,CHEBI
35563672,"Poor vitamin K status seems to have a key role in the progression of CKD, but also in the onset and advance of both bone and cardiovascular complications.",Poor vitamin K status,CHEBI,have key role in progression of ckd and in,bone complications,DISEASE
35563672,Treatment strategies for CKD-associated osteoporosis and CV disease should include vitamin K supplementation.,CKD-associated osteoporosis,DISEASE,include,vitamin K supplementation,CHEBI
35515708,Hereditary combined vitamin K-dependent clotting factor deficiency (VKCFD) is a rare autosomal recessive congenital bleeding disorder.,vitamin K-dependent,CHEBI,be,rare autosomal congenital bleeding disorder,DISEASE
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",BZDs,CHEMICAL,cause serious adverse effects such as,daytime drowsiness,MENTAL_HEALTH
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",BZDs,CHEMICAL,cause serious adverse effects such as,cognitive decline,DISEASE
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",BZDs,CHEMICAL,be prescribed for,anxiety,MENTAL_HEALTH
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",BZDs,CHEMICAL,be prescribed for,insomnia,MENTAL_HEALTH
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",benzodiazepines,CHEMICAL,be prescribed for,anxiety,MENTAL_HEALTH
29223863,"Although benzodiazepines (BZDs) are commonly prescribed for insomnia or anxiety, long-term use of BZDs causes serious adverse effects such as daytime drowsiness and cognitive decline.",benzodiazepines,CHEMICAL,be prescribed for,insomnia,MENTAL_HEALTH
24158007,"Tramadol is a drug that is widely prescribed because of its low abuse potential, but physicians need to be aware of its significant potential to cause SS because it inhibits serotonin reuptake.",Tramadol,CHEMICAL,be,drug,CHEBI
16050084,"Cannabis abusers generally have poorer oral health than non-users, with an increased risk of dental caries and periodontal diseases.",Cannabis abusers,CHEMICAL,increased risk of,dental caries,DISEASE
1152178,Results of this study indicate American bison have resistance to natural A. marginale infection.,American bison,NUTRITION,have resistance to,natural A. marginale infection,DISEASE
1152178,Results of this study indicate American bison have resistance to natural A. marginale infection.,American bison,NUTRITION,have,resistance,MENTAL_HEALTH
34443414,"Altogether, our findings indicate that P. perfoliatus has anti-inflammatory, antioxidant, analgesic and antipyretic effects, thus supporting its traditional use and promoting its valorization as a potential candidate in treating oxidative stress-associated diseases.",P. perfoliatus,DISEASE,have,analgesic,CHEBI
19131229,"The extract of Ginkgo biloba (EGb), containing 24% flavone glycosides and 6% terpenoids, is widely used to treat early-stage Alzheimer's disease, vascular dementia, peripheral claudication and vascular tinnitus.",Ginkgo biloba,CHEMICAL,treat early-stage alzheimer's,peripheral claudication,DISEASE
19131229,"The extract of Ginkgo biloba (EGb), containing 24% flavone glycosides and 6% terpenoids, is widely used to treat early-stage Alzheimer's disease, vascular dementia, peripheral claudication and vascular tinnitus.",Ginkgo biloba,CHEMICAL,treat early-stage alzheimer's,vascular dementia,MENTAL_HEALTH
34871316,"Taken together, these data suggest that an under-appreciated effect of inhaled budesonide is to maintain or promote airway epithelial barrier integrity during respiratory viral infections.",inhaled budesonide,CHEMICAL,be maintain during,respiratory viral infections,DISEASE
31782814,It is not unequivocally proven whether a combination of an intranasal corticosteroids (INSs) and a cysteinyl leukotriene receptor antagonist has greater efficacy than INSs in the treatment of seasonal allergic rhinitis (SAR).,INSs,CHEMICAL,have,seasonal allergic rhinitis,DISEASE
31782814,It is not unequivocally proven whether a combination of an intranasal corticosteroids (INSs) and a cysteinyl leukotriene receptor antagonist has greater efficacy than INSs in the treatment of seasonal allergic rhinitis (SAR).,INSs,CHEMICAL,have,INSs,CHEMICAL
31782814,It is not unequivocally proven whether a combination of an intranasal corticosteroids (INSs) and a cysteinyl leukotriene receptor antagonist has greater efficacy than INSs in the treatment of seasonal allergic rhinitis (SAR).,cysteinyl leukotriene receptor antagonist,CHEBI,have,seasonal allergic rhinitis,DISEASE
31782814,It is not unequivocally proven whether a combination of an intranasal corticosteroids (INSs) and a cysteinyl leukotriene receptor antagonist has greater efficacy than INSs in the treatment of seasonal allergic rhinitis (SAR).,cysteinyl leukotriene receptor antagonist,CHEBI,have,INSs,CHEMICAL
34472889,"Our findings add to the evidence that anhedonia does not rule out reactive mood brightening, which, for people with OUD being treated on opioid agonist medication, can be elicited by nondrug activities.",OUD,DISEASE,be treated on,opioid agonist medication,CHEBI
34302355,The ability of the muscarinic cholinergic antagonist atropine to inhibit myopia development in humans and animal models would suggest that cholinergic hyperactivity may underlie myopic growth.,muscarinic cholinergic antagonist atropine,CHEMICAL,have the ability to,myopia development,DISEASE
34302355,The ability of the muscarinic cholinergic antagonist atropine to inhibit myopia development in humans and animal models would suggest that cholinergic hyperactivity may underlie myopic growth.,muscarinic cholinergic antagonist atropine,CHEBI,have the ability to,myopia development,DISEASE
35327772,Phenylketonuria (PKU) is the most frequent inborn error in amino acid metabolism caused by a deficiency of the phenylalanine hydroxylase enzyme (PAH).,PKU,DISEASE,be frequent inborn error in,phenylalanine hydroxylase enzyme,CHEMICAL
35327772,Phenylketonuria (PKU) is the most frequent inborn error in amino acid metabolism caused by a deficiency of the phenylalanine hydroxylase enzyme (PAH).,PKU,DISEASE,be frequent inborn error in,amino acid metabolism,CHEMICAL
35327772,Phenylketonuria (PKU) is the most frequent inborn error in amino acid metabolism caused by a deficiency of the phenylalanine hydroxylase enzyme (PAH).,PKU,DISEASE,be frequent inborn error in,PAH,CHEMICAL
35327772,"If PKU is left untreated, high concentrations of phenylalanine (Phe) accumulate in the blood, leading to severe brain dysfunction, neurodevelopmental, behavioral and psychological problems.",PKU,DISEASE,be left,phenylalanine,CHEMICAL
35327772,"If PKU is left untreated, high concentrations of phenylalanine (Phe) accumulate in the blood, leading to severe brain dysfunction, neurodevelopmental, behavioral and psychological problems.",PKU,DISEASE,be left,Phe,CHEMICAL
18805813,"The rate of carbon dioxide release (VCO2) at 20 degrees C in P. capensis is 0.043 ml CO2 h(-1), in keeping with other onychophoran species; suggesting that low metabolic rates in some arthropod groups are derived.",P. capensis,DISEASE,be,ml CO2 h(-1,CHEMICAL
18805813,"The rate of carbon dioxide release (VCO2) at 20 degrees C in P. capensis is 0.043 ml CO2 h(-1), in keeping with other onychophoran species; suggesting that low metabolic rates in some arthropod groups are derived.",carbon dioxide release,CHEMICAL,be,ml CO2 h(-1,CHEMICAL
18805813,"Total water loss in P. capensis is 57 mg H2O h(-1) at 20 degrees C, similar to modern estimates for another onychophoran species.",P. capensis,DISEASE,be,H2O h(-1,CHEMICAL
32205866,"Using a longitudinal design and ultrahigh field 7-T magnetic resonance spectroscopy (MRS) protocol in 53 subjects, we report the association between dorsal anterior cingulate cortex glutamate and glutathione, with time to treatment response in drug naive (34.6% of the sample) or minimally medicated first episode patients with schizophreniform disorder, schizophrenia, and schizoaffective disorder.",dorsal anterior cingulate cortex glutamate,CHEMICAL,have the association with,glutathione,CHEMICAL
32205866,"Using a longitudinal design and ultrahigh field 7-T magnetic resonance spectroscopy (MRS) protocol in 53 subjects, we report the association between dorsal anterior cingulate cortex glutamate and glutathione, with time to treatment response in drug naive (34.6% of the sample) or minimally medicated first episode patients with schizophreniform disorder, schizophrenia, and schizoaffective disorder.",glutathione,CHEMICAL,have the association with,dorsal anterior cingulate cortex glutamate,CHEMICAL
32205866,"Higher glutathione was associated with shorter time to response (F = 4.86, P = 0.017), while higher glutamate was associated with more severe functional impairment (F = 5.33, P = 0.008).",higher glutamate,CHEMICAL,be associated with,severe functional impairment,DISEASE
34817810,"Yohimbine is a highly selective and potent α2-adrenoceptor antagonist, which is usually treated as an adjunction for impotence, as well for weight loss and natural bodybuilding aids.",Yohimbine,CHEMICAL,be,selective α2-adrenoceptor antagonist,CHEBI
34817810,"However, it was recently reported that Yohimbine causes myocardial injury and controversial results were reported in the setting of cardiac diseases.",Yohimbine,CHEMICAL,cause,myocardial injury,DISEASE
34817810,"Here, we show that Yohimbine induces direct cardiotoxic effects on spontaneous action potentials of INa and ICa in hiPSC-CMs.",Yohimbine,CHEMICAL,induce direct cardiotoxic effects on spontaneous action potentials of,ICa,CHEMICAL
34817810,"Here, we show that Yohimbine induces direct cardiotoxic effects on spontaneous action potentials of INa and ICa in hiPSC-CMs.",Yohimbine,CHEMICAL,induce,direct cardiotoxic effects,DISEASE
34817810,These findings are highly relevant for potential application of Yohimbine in patients with atrioventricular conduction disorder.,Yohimbine,CHEMICAL,in patients with,atrioventricular conduction disorder,DISEASE
23845214,Sexual dysfunction is a common and underestimated effect of antidepressants.,Sexual dysfunction,MENTAL_HEALTH,be common effect of,antidepressants,CHEMICAL
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-HT(2C receptor agonist,CHEMICAL,abolish,perseveration,MENTAL_HEALTH
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-hydroxytryptophan,CHEMICAL,abolish,perseveration,MENTAL_HEALTH
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,agonist CP809.101,CHEBI,abolish,perseveration,MENTAL_HEALTH
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-HT synthesis,CHEMICAL,abolish,perseveration,MENTAL_HEALTH
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,agonist CP809.101,CHEMICAL,abolish,perseveration,MENTAL_HEALTH
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-HT(2C receptor agonist,CHEMICAL,reduce,cognitive deficits,DISEASE
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-hydroxytryptophan,CHEMICAL,reduce,cognitive deficits,DISEASE
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,agonist CP809.101,CHEBI,reduce,cognitive deficits,DISEASE
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-HT synthesis,CHEMICAL,reduce,cognitive deficits,DISEASE
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,agonist CP809.101,CHEMICAL,reduce,cognitive deficits,DISEASE
24196946,Pharmacological restoration of 5-HT synthesis with 5-hydroxytryptophan or treatment with the 5-HT(2C) receptor agonist CP809.101 reduced cognitive deficits in Tph2-KI mice and abolished perseveration.,5-HT synthesis,CHEMICAL,have pharmacological restoration with,5-hydroxytryptophan,CHEMICAL
24196946,"In contrast, treatment with the psychostimulant methylphenidate exacerbated cognitive deficits in mutant mice.",psychostimulant methylphenidate,CHEMICAL,exacerbate in,cognitive deficits,DISEASE
35504949,"For spinal cord-related pain, duloxetine and neurotropin had insufficient analgesic effects, whereas mirogabalin was the most effective.",duloxetine,CHEMICAL,have for,insufficient analgesic effects,CHEBI
35504949,"For spinal cord-related pain, duloxetine and neurotropin had insufficient analgesic effects, whereas mirogabalin was the most effective.",neurotropin,CHEMICAL,have for,insufficient analgesic effects,CHEBI
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,duloxetine,CHEMICAL,be recommended in cases of insufficient analgesic effects with,neurotropin,CHEMICAL
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,duloxetine,CHEMICAL,be recommended in cases of,insufficient analgesic effects,CHEBI
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,cauda equina syndrome,DISEASE,be recommended in cases of insufficient analgesic effects with,neurotropin,CHEMICAL
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,Pregabalin,CHEMICAL,be recommended in cases of insufficient analgesic effects with,neurotropin,CHEMICAL
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,radicular pain,DISEASE,be recommended in cases of insufficient analgesic effects with,neurotropin,CHEMICAL
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,cauda equina syndrome,DISEASE,be recommended in cases of,insufficient analgesic effects,CHEBI
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,Pregabalin,CHEMICAL,be recommended in cases of,insufficient analgesic effects,CHEBI
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,radicular pain,DISEASE,be recommended in cases of,insufficient analgesic effects,CHEBI
35504949,Pregabalin or mirogabalin for radicular pain and duloxetine for cauda equina syndrome are recommended in cases of insufficient analgesic effects with neurotropin.,insufficient analgesic effects,CHEBI,have cases with,neurotropin,CHEMICAL
35307453,"Fuel utilization from glucose was affected by DON exposure, as were mitochondrial morphological dynamics leading to increased fragmentation.",glucose,CHEMICAL,be affected by,DON exposure,CHEMICAL
20887163,Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that is under investigation as a treatment for HSDD in women.,Flibanserin,CHEMICAL,be,5-HT(1A antagonist,CHEMICAL
20887163,Flibanserin is a 5-HT(1A) agonist/5-HT(2A) antagonist that is under investigation as a treatment for HSDD in women.,Flibanserin,CHEMICAL,be,5-HT(1A antagonist,CHEBI
19623252,"The human pathogen Group A Streptococcus (Streptococcus pyogenes, GAS) is widely recognized as a major cause of common pharyngitis as well as of severe invasive diseases and non-suppurative sequelae associated with the existence of GAS antigens eliciting host autoantibodies.",GAS,DISEASE,be recognized as major cause of,common pharyngitis,DISEASE
19623252,"Interestingly, these antigens appeared to be, in quantitative terms, more immunogenic in tic than in pharyngitis patients.",antigens,CHEBI,appear to,tic,DISEASE
19623252,"Additionally, a third group of antigens appeared to be preferentially and specifically recognized by tic sera.",antigens,CHEBI,be recognized by,tic sera,DISEASE
34081439,The novel human severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has been identified as an etiological agent for COVID-19.,novel human severe acute respiratory syndrome coronavirus-2,DISEASE,be identified as etiological agent for,COVID-19,CHEMICAL
35467921,"Compared to CBD, ratings for Δ8-THC effects were higher for ""Drug effect,"" ""Good effect,"" ""High,"" ""Relaxed,"" ""Sleepy,"" ""Hunger/Have the Munchies,"" ""Memory Problems,"" ""Trouble Performing Routine Tasks,"" and ""Paranoia"" (d = 0.27-1.02).",Δ8-THC effects,CHEMICAL,be higher for,Drug effect,CHEBI
17629136,"Aim of this study was to investigate plasma lipids, lipoproteins and some hormones levels during olanzapine treatment in patients with psychosis.",olanzapine treatment,CHEMICAL,in patients with,psychosis,MENTAL_HEALTH
17629136,"Treatment of the schizophrenic patients with olanzapine caused a great metabolic impact that is primarily expressed in body mass, cholesterol increase and statistically significant rise of BMI, respectively.",schizophrenic patients,DISEASE,have treatment with,olanzapine,CHEMICAL
12890312,"Twenty-four-hour hypersecretion of cortisol, diurnal hypersecretion of growth hormone, and normal 24-h levels of prolactin have been reported in careful chronobiological studies of depressed patients, along with sleep recordings.",growth hormone,CHEBI,be reported in careful chronobiological studies of,depressed patients,DISEASE
12890312,"Twenty-four-hour hypersecretion of cortisol, diurnal hypersecretion of growth hormone, and normal 24-h levels of prolactin have been reported in careful chronobiological studies of depressed patients, along with sleep recordings.",cortisol,CHEMICAL,be reported in careful chronobiological studies of,depressed patients,DISEASE
12890312,"Twenty-four-hour hypersecretion of cortisol, diurnal hypersecretion of growth hormone, and normal 24-h levels of prolactin have been reported in careful chronobiological studies of depressed patients, along with sleep recordings.",Twenty-four-hour hypersecretion,DISEASE,be reported in careful chronobiological studies of,depressed patients,DISEASE
17923832,"Although reduction of ethinyl estradiol (EE) concentrations has reduced the incidence of negative systemic side effects such as water retention, edema and swollen breasts, the low estrogen dose may be associated with spotting and hypomenorrhea or amenorrhea in the long term, as well as dyspareunia due to reduced vaginal trophism, which may induce women to suspend use of the drug.",ethinyl estradiol EE concentrations,CHEMICAL,reduce incidence of negative systemic side effects such as,edema,DISEASE
17923832,"Although reduction of ethinyl estradiol (EE) concentrations has reduced the incidence of negative systemic side effects such as water retention, edema and swollen breasts, the low estrogen dose may be associated with spotting and hypomenorrhea or amenorrhea in the long term, as well as dyspareunia due to reduced vaginal trophism, which may induce women to suspend use of the drug.",ethinyl estradiol EE concentrations,CHEMICAL,reduce incidence of negative systemic side effects such as,swollen breasts,DISEASE
17923832,"Although reduction of ethinyl estradiol (EE) concentrations has reduced the incidence of negative systemic side effects such as water retention, edema and swollen breasts, the low estrogen dose may be associated with spotting and hypomenorrhea or amenorrhea in the long term, as well as dyspareunia due to reduced vaginal trophism, which may induce women to suspend use of the drug.",low estrogen dose,CHEBI,spotting and hypomenorrhea or amenorrhea in,dyspareunia,MENTAL_HEALTH
17923832,"Although reduction of ethinyl estradiol (EE) concentrations has reduced the incidence of negative systemic side effects such as water retention, edema and swollen breasts, the low estrogen dose may be associated with spotting and hypomenorrhea or amenorrhea in the long term, as well as dyspareunia due to reduced vaginal trophism, which may induce women to suspend use of the drug.",low estrogen dose,CHEBI,spotting,amenorrhea,DISEASE
17923832,"Although reduction of ethinyl estradiol (EE) concentrations has reduced the incidence of negative systemic side effects such as water retention, edema and swollen breasts, the low estrogen dose may be associated with spotting and hypomenorrhea or amenorrhea in the long term, as well as dyspareunia due to reduced vaginal trophism, which may induce women to suspend use of the drug.",low estrogen dose,CHEBI,spotting,hypomenorrhea,DISEASE
17923832,"Women with slight to moderate acne, the formulation with 30 microg EE has been found to be as effective as 2 mg cyproterone acetate combined with 35 micrig EE (Diane).",moderate acne,DISEASE,be found to effective as,cyproterone acetate,CHEMICAL
17923832,"Women with slight to moderate acne, the formulation with 30 microg EE has been found to be as effective as 2 mg cyproterone acetate combined with 35 micrig EE (Diane).",EE,CHEMICAL,be found to effective as,cyproterone acetate,CHEMICAL
17923832,"On the other hand, in cases of chronic headache or headache as a side-effect of oral contraceptive use, a lower dose of estrogen is beneficial, and doses below 20 microg may be used.",estrogen,CHEBI,be beneficial on other hand in cases of,chronic headache,MENTAL_HEALTH
17923832,"On the other hand, in cases of chronic headache or headache as a side-effect of oral contraceptive use, a lower dose of estrogen is beneficial, and doses below 20 microg may be used.",estrogen,CHEBI,be beneficial on other hand in cases of,headache,MENTAL_HEALTH
17923832,"On the other hand, in cases of chronic headache or headache as a side-effect of oral contraceptive use, a lower dose of estrogen is beneficial, and doses below 20 microg may be used.",estrogen,CHEBI,be beneficial on other hand in cases of,oral contraceptive use,CHEMICAL
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",microg EE,CHEMICAL,be indicated in women with,oral contraceptive use,CHEMICAL
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",microg EE,CHEMICAL,be indicated in women with,pre-existing mastodynia,DISEASE
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",microg EE,CHEMICAL,be indicated in women with,fibrocystic breast manifestations,DISEASE
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",drospirenone,CHEMICAL,be indicated in women with,oral contraceptive use,CHEMICAL
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",drospirenone,CHEMICAL,be indicated in women with,pre-existing mastodynia,DISEASE
17923832,"Formulations with 20 microg EE and drospirenone are particularly indicated in women with pre-existing mastodynia, fibrocystic breast manifestations or who develop mastodynia as a side-effect of oral contraceptive use.",drospirenone,CHEMICAL,be indicated in women with,fibrocystic breast manifestations,DISEASE
17923832,"Finally, it is worth recalling that monophasic pills with low estrogen doses, such as the formulations mentioned above, ensure good mood control, reducing the depressive symptoms often associated with oral contraceptive use.",low estrogen doses,CHEBI,reduce,depressive symptoms,DISEASE
16741784,"Comparative trials have shown that paracetamol plus tramadol has comparable efficacy to paracetamol plus codeine, but with reduced somnolence and constipation compared with the codeine combination.",paracetamol,CHEMICAL,have comparable efficacy to,paracetamol,CHEMICAL
16741784,"Comparative trials have shown that paracetamol plus tramadol has comparable efficacy to paracetamol plus codeine, but with reduced somnolence and constipation compared with the codeine combination.",paracetamol,CHEMICAL,have comparable efficacy to,codeine,CHEMICAL
16741784,"Comparative trials have shown that paracetamol plus tramadol has comparable efficacy to paracetamol plus codeine, but with reduced somnolence and constipation compared with the codeine combination.",tramadol,CHEMICAL,have comparable efficacy to,paracetamol,CHEMICAL
16741784,"Comparative trials have shown that paracetamol plus tramadol has comparable efficacy to paracetamol plus codeine, but with reduced somnolence and constipation compared with the codeine combination.",tramadol,CHEMICAL,have comparable efficacy to,codeine,CHEMICAL
3720635,Both enzymorrhea and proteinorrhea are absent in colon dyskinesia.,enzymorrhea,CHEMICAL,be absent in,colon dyskinesia,MENTAL_HEALTH
3720635,Colon motility in man ist actively affected by adrenergic drugs: it is inhibited by adrenomimetics and stimulated by adrenolytics which justifies their prescription in colon dyskinesia.,Colon motility,DISEASE,be inhibited by,adrenomimetics,CHEBI
3720635,Diazepam and phenobarbital inhibit colon motility.,phenobarbital,CHEMICAL,inhibit,colon motility,DISEASE
3720635,Diazepam and phenobarbital inhibit colon motility.,Diazepam,CHEMICAL,inhibit,colon motility,DISEASE
35362325,"Glutamic acid decarboxylase antibody-associated encephalitis occurs with high antibody titres and may cause cognitive dysfunction, seizures and psychiatric symptoms.",Glutamic antibody-associated encephalitis,DISEASE,cause,seizures,DISEASE
35362325,"Glutamic acid decarboxylase antibody-associated encephalitis occurs with high antibody titres and may cause cognitive dysfunction, seizures and psychiatric symptoms.",Glutamic antibody-associated encephalitis,DISEASE,cause,cognitive dysfunction,DISEASE
35362325,"Glutamic acid decarboxylase antibody-associated encephalitis occurs with high antibody titres and may cause cognitive dysfunction, seizures and psychiatric symptoms.",Glutamic antibody-associated encephalitis,DISEASE,cause,psychiatric symptoms,DISEASE
35362325,"However, glutamic acid decarboxylase antibodies are more frequently found in lower titre in association with other autoimmune disorders (such as diabetes mellitus type 1) and in healthy individuals.",glutamic acid decarboxylase antibodies,CHEMICAL,be found in lower titre in association with,other autoimmune disorders,DISEASE
35362325,"However, glutamic acid decarboxylase antibodies are more frequently found in lower titre in association with other autoimmune disorders (such as diabetes mellitus type 1) and in healthy individuals.",glutamic acid decarboxylase antibodies,CHEMICAL,be found in lower titre in association with,diabetes mellitus type,DISEASE
12051847,"Since a rapid dissociation character prevents an antibody fragment from remaining at the site of the antigen, this fact may prevent the successful application of a human mucin-1 specific antibody in diagnosis and therapy.",rapid dissociation character,MENTAL_HEALTH,remain at site of,antigen,CHEBI
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",new ADP antagonists,CHEMICAL,be used as alternative to,heparin heparins,CHEMICAL
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",new ADP antagonists,CHEMICAL,be used as alternative to,hirudin,DISEASE
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",new ADP antagonists,CHEBI,be used as alternative to,heparin heparins,CHEMICAL
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",new ADP antagonists,CHEBI,be used as alternative to,hirudin,DISEASE
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",ASA,CHEMICAL,be used as alternative to,heparin heparins,CHEMICAL
10897939,"As alternatives to ASA, the new ADP antagonists, ticlopidine, clopidogrel, and as an alternative to heparin, hirudin or low-molecular-weight heparins can be used.",ASA,CHEMICAL,be used as alternative to,hirudin,DISEASE
10897939,"If this does not result in rapid clinical stabilisation (here, transient ST-T changes in the ECG and the detection of troponine I or T represent major risk indicators) the new glycoprotein-IIb/IIIa receptor antagonists may be employed as highly potent platelet aggregation inhibitors.",new glycoprotein-IIb/IIIa receptor antagonists,CHEBI,be employed as,potent platelet aggregation inhibitors,DISEASE
24011889,This review summarizes the findings from human and animal studies that provide consistent evidence on the various effects of alcohol abuse on the endocrine system.,alcohol abuse,MENTAL_HEALTH,have the various effects on,endocrine system,CHEBI
28643183,"In the domain of neuropsychiatric disturbances, there is increasing evidence that dopamine agonists can ameliorate depression or anxiety.",dopamine agonists,CHEBI,ameliorate,anxiety,MENTAL_HEALTH
28643183,"In the domain of neuropsychiatric disturbances, there is increasing evidence that dopamine agonists can ameliorate depression or anxiety.",dopamine agonists,CHEBI,ameliorate,depression,MENTAL_HEALTH
28643183,"In the domain of neuropsychiatric disturbances, there is increasing evidence that dopamine agonists can ameliorate depression or anxiety.",dopamine agonists,CHEMICAL,ameliorate,anxiety,MENTAL_HEALTH
28643183,"In the domain of neuropsychiatric disturbances, there is increasing evidence that dopamine agonists can ameliorate depression or anxiety.",dopamine agonists,CHEMICAL,ameliorate,depression,MENTAL_HEALTH
28643183,Other neuropsychiatric symptoms such as psychosis or impulse control disorders can also be worsened or even be induced by dopaminergic agents.,psychosis,MENTAL_HEALTH,be induced by,dopaminergic agents,CHEBI
18323761,"Increased dopaminergic agents can cause dyskinesias and painful dystonia, and undertreatment can cause nighttime akinesia, rigidity, and worse quality of sleep.",Increased dopaminergic agents,CHEBI,cause,dyskinesias,DISEASE
18323761,"Increased dopaminergic agents can cause dyskinesias and painful dystonia, and undertreatment can cause nighttime akinesia, rigidity, and worse quality of sleep.",Increased dopaminergic agents,CHEBI,cause,painful dystonia,DISEASE
35224839,Heterozygous de novo missense pathogenic variants in PTDSS1 that result in gain-of-function of phosphatidylserine synthase 1 are associated with Lenz-Majewski hyperostotic dwarfism (LMHD).,phosphatidylserine synthase,NUTRITION,be associated with,Lenz-Majewski hyperostotic dwarfism,DISEASE
30607218,"By scanning electron microscopy, we analyzed RBC morphology from 22 ASD children and show here that only 47.5 ± 3.33% of RBC displayed the typical biconcave shape, as opposed to 87.5 ± 1.3% (mean ± SD) of RBC from 21 sex- and age-matched healthy typically developing (TD) controls.",±,CHEMICAL,oppose to,mean ±,CHEMICAL
30607218,"By scanning electron microscopy, we analyzed RBC morphology from 22 ASD children and show here that only 47.5 ± 3.33% of RBC displayed the typical biconcave shape, as opposed to 87.5 ± 1.3% (mean ± SD) of RBC from 21 sex- and age-matched healthy typically developing (TD) controls.",±,CHEMICAL,oppose to,±,CHEMICAL
30607218,"By scanning electron microscopy, we analyzed RBC morphology from 22 ASD children and show here that only 47.5 ± 3.33% of RBC displayed the typical biconcave shape, as opposed to 87.5 ± 1.3% (mean ± SD) of RBC from 21 sex- and age-matched healthy typically developing (TD) controls.",±,CHEMICAL,oppose to,sex-,CHEMICAL
30921478,"Although benzodiazepines are frequently used in the treatment of panic disorder, guidelines recommend antidepressants, mainly selective serotonin reuptake inhibitors (SSRIs), as first-line treatment for panic disorder, particularly due to their lower incidence of dependence and withdrawal reaction when compared to benzodiazepines.",benzodiazepines,CHEMICAL,be used in treatment of,panic disorder,MENTAL_HEALTH
30921478,"Despite these recommendations, benzodiazepines are widely used in the treatment of panic disorder, probably because of their rapid onset of action.",benzodiazepines,CHEMICAL,be used,panic disorder,MENTAL_HEALTH
19211980,"Major depression is frequently associated with hyperactivity of the hypothalamic-pituitary-adrenocortical axis, and glucocorticoid synthesis inhibitors have been shown to exert antidepressant action.",Major depression,MENTAL_HEALTH,be associated with,hyperactivity,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,metyrapone,CHEMICAL,be useful for treatment of,depression,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,metyrapone,CHEMICAL,be useful for treatment of,drug-resistant depression,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,antidepressant drug,CHEMICAL,be useful for treatment of,depression,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,antidepressant drug,CHEMICAL,be useful for treatment of,drug-resistant depression,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,antidepressant drug,CHEBI,be useful for treatment of,depression,MENTAL_HEALTH
19211980,These findings suggest that the co-administration of metyrapone and an antidepressant drug may be useful for the treatment of drug-resistant depression and/or depression associated with a high cortisol level.,antidepressant drug,CHEBI,be useful for treatment of,drug-resistant depression,MENTAL_HEALTH
17075068,"Antidepressant therapy, which prevents the behavioral responses to CMS, completely inhibits the decrease in bone formation and markedly attenuates the CMS-induced bone loss.",Antidepressant therapy,CHEMICAL,attenuate,CMS-induced bone loss,DISEASE
2021990,"We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.",H1 antagonist,CHEBI,be useful in part through,H1 receptor,CHEMICAL
2021990,"We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.",H1 antagonist,CHEMICAL,be useful in part through,H1 receptor,CHEMICAL
2021990,"We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.",H1 antagonist,CHEBI,prevent,hypotension,DISEASE
2021990,"We conclude that an H1 antagonist may be useful in preventing hypotension caused by iv cimetidine, since the vasodilating activity of cimetidine is mediated, in part, through the H1 receptor.",H1 antagonist,CHEMICAL,prevent,hypotension,DISEASE
7635633,"Small molecular components of SCW, as well as magnesium chloride offered as pure chemical, may cause a moderate increase in the RCD.",magnesium chloride,CHEMICAL,cause moderate increase in,RCD,DISEASE
24060608,Antidepressant-like effects of CRFR1 antagonists in different animal models of depression have generated a strong interest in the clinical development of CRFR1 antagonist for the treatment of major depressive disorder.,depression,MENTAL_HEALTH,generate strong interest in clinical development of crfr1 antagonist for,major depressive disorder,MENTAL_HEALTH
24060608,Antidepressant-like effects of CRFR1 antagonists in different animal models of depression have generated a strong interest in the clinical development of CRFR1 antagonist for the treatment of major depressive disorder.,CRFR1 antagonists,CHEBI,generate strong interest in clinical development of crfr1 antagonist for,major depressive disorder,MENTAL_HEALTH
24060608,Antidepressant-like effects of CRFR1 antagonists in different animal models of depression have generated a strong interest in the clinical development of CRFR1 antagonist for the treatment of major depressive disorder.,depression,MENTAL_HEALTH,generate strong interest in clinical development of,CRFR1 antagonist,CHEBI
24060608,Antidepressant-like effects of CRFR1 antagonists in different animal models of depression have generated a strong interest in the clinical development of CRFR1 antagonist for the treatment of major depressive disorder.,CRFR1 antagonists,CHEBI,generate strong interest in clinical development of,CRFR1 antagonist,CHEBI
8792511,"Dapsone, a synthetic sulfone with chemical similarities to sulfapyridine, has been used for a number of years to treat leprosy and dermatitis herpetiformis.",synthetic sulfone,CHEMICAL,treat,leprosy herpetiformis,DISEASE
8792511,"Dapsone, a synthetic sulfone with chemical similarities to sulfapyridine, has been used for a number of years to treat leprosy and dermatitis herpetiformis.",sulfapyridine,CHEMICAL,treat,leprosy herpetiformis,DISEASE
8792511,"Dapsone, a synthetic sulfone with chemical similarities to sulfapyridine, has been used for a number of years to treat leprosy and dermatitis herpetiformis.",Dapsone,CHEMICAL,treat,leprosy herpetiformis,DISEASE
8792511,"Recently, a number of prospective, randomized, double-blind trials have shown their success in the management of rheumatoid arthritis, with dapsone being superior to placebo and comparable to chloroquine and hydroxychloroquine.",dapsone,CHEMICAL,be superior to placebo and comparable to,hydroxychloroquine,CHEMICAL
8792511,"Recently, a number of prospective, randomized, double-blind trials have shown their success in the management of rheumatoid arthritis, with dapsone being superior to placebo and comparable to chloroquine and hydroxychloroquine.",dapsone,CHEMICAL,be superior to placebo and comparable to,chloroquine,CHEMICAL
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,cholestatic jaundice,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,leukopenia complaints,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,agranulocytosis,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,peripheral neuropathy,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,severe hypoalbuminemia,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,cutaneous eruptions,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,toxic hepatitis,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,renal papillary necrosis,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,nephrotic syndrome,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,infectious mononucleosis-like syndrome,DISEASE
8792511,"Less common adverse events to dapsone include the idiosyncratic reactions of leukopenia and agranulocytosis, cutaneous eruptions, peripheral neuropathy, psychosis, toxic hepatitis, cholestatic jaundice, nephrotic syndrome, renal papillary necrosis, severe hypoalbuminemia without proteinuria, an infectious mononucleosis-like syndrome, and minor neurological and gastrointestinal complaints.",dapsone,CHEMICAL,include idiosyncratic reactions of,psychosis,MENTAL_HEALTH
8792511,"In this report, two patients with advanced rheumatoid arthritis, who were safely and effectively treated with dapsone after failure with other second-line agents, are described and the literature is reviewed.",advanced rheumatoid arthritis,DISEASE,treat in report with dapsone after failure with,other second-line agents,CHEMICAL
8792511,"In this report, two patients with advanced rheumatoid arthritis, who were safely and effectively treated with dapsone after failure with other second-line agents, are described and the literature is reviewed.",advanced rheumatoid arthritis,DISEASE,treat in report with,dapsone,CHEMICAL
8792511,We suggest that dapsone is an effective second-line agent in the treatment of rheumatoid arthritis.,dapsone,CHEMICAL,be effective second-line agent in treatment of,rheumatoid arthritis,DISEASE
35565948,"While controversial results were found on anxiety and cognition in humans, n-3 PUFA consistently reduced anxiety symptoms and improved cognition in animal studies.",n-3 PUFA,CHEMICAL,reduce,anxiety symptoms,MENTAL_HEALTH
29078101,"Secondarily, associations between GSH and anhedonia, a key symptom of MDD in adolescents, were investigated.",GSH,CHEMICAL,have associations with,anhedonia,MENTAL_HEALTH
29078101,"Secondarily, associations between GSH and anhedonia, a key symptom of MDD in adolescents, were investigated.",anhedonia,MENTAL_HEALTH,have associations with,GSH,CHEMICAL
9255135,The diagnosis of myasthenia gravis was established by the rapid and transient response of this patient to 2 mg of edrophonium.,myasthenia gravis,DISEASE,be established by rapid and transient response of patient to mg of,edrophonium,CHEMICAL
9255135,The botulinus toxin prevents the release of acetylcholine molecules from their storage vesicles in nerve terminals.,botulinus toxin,CHEBI,prevent release of,acetylcholine molecules,CHEMICAL
2576112,"Non-N-methyl-D-aspartate receptor agonists and glutamate induced a membrane depolarization and a reduction in input resistance, while N-methyl-D-aspartate and aspartate induced a prolonged discharge, which in some neurons took the form of a burst firing associated with an apparent increase in membrane input resistance.",Non-N-methyl-D-aspartate receptor agonists,CHEMICAL,induce membrane depolarization and reduction in,input resistance,MENTAL_HEALTH
2576112,"Non-N-methyl-D-aspartate receptor agonists and glutamate induced a membrane depolarization and a reduction in input resistance, while N-methyl-D-aspartate and aspartate induced a prolonged discharge, which in some neurons took the form of a burst firing associated with an apparent increase in membrane input resistance.",Non-N-methyl-D-aspartate receptor agonists,CHEBI,induce membrane depolarization and reduction in,input resistance,MENTAL_HEALTH
2576112,"Non-N-methyl-D-aspartate receptor agonists and glutamate induced a membrane depolarization and a reduction in input resistance, while N-methyl-D-aspartate and aspartate induced a prolonged discharge, which in some neurons took the form of a burst firing associated with an apparent increase in membrane input resistance.",glutamate,CHEMICAL,induce membrane depolarization and reduction in,input resistance,MENTAL_HEALTH
33511092,"Emerging findings from basic science as well as interventional drug trials utilizing GLP-1 agonists have demonstrated success in effective weight loss in obese adults, adolescents, and pediatric patients.",interventional drug trials,CHEBI,demonstrate success in,effective weight loss,DISEASE
32839513,A homozygous mutation in the inositol monophosphatase 1 (IMPA1) gene was recently identified in nine individuals with severe intellectual disability (ID) and disruptive behavior.,inositol monophosphatase IMPA1 gene,CHEMICAL,be identified in individuals with,severe intellectual disability,MENTAL_HEALTH
32839513,A homozygous mutation in the inositol monophosphatase 1 (IMPA1) gene was recently identified in nine individuals with severe intellectual disability (ID) and disruptive behavior.,inositol monophosphatase IMPA1 gene,CHEMICAL,be identified in individuals with,disruptive behavior,DISEASE
814072,Twenty-five depressed patients were examined as to their growth hormone responses to TRH.,depressed patients,DISEASE,be examined as to their growth hormone responses to,TRH,CHEMICAL
814072,Twenty-five depressed patients were examined as to their growth hormone responses to TRH.,depressed patients,DISEASE,be examined as to,growth hormone responses,CHEBI
814072,Bipolar patients exhibited enhanced growth-hormone response more frequently than unipolar patients.,Bipolar patients,DISEASE,exhibit enhanced,growth-hormone response,CHEMICAL
814072,Five patients with involutional depression and neurotic depression who showed the most insufficient thyrotropin release to TRH administration together with lowered thyroid function revealed to be non-responders of growth hormone.,involutional depression,MENTAL_HEALTH,reveal to non-responders of,growth hormone,CHEBI
814072,Five patients with involutional depression and neurotic depression who showed the most insufficient thyrotropin release to TRH administration together with lowered thyroid function revealed to be non-responders of growth hormone.,neurotic depression,MENTAL_HEALTH,reveal to non-responders of,growth hormone,CHEBI
18474024,It is well established that GVL is linked to the occurrence of GVHD.,GVL,CHEMICAL,be linked to occurrence of,GVHD,DISEASE
18474024,Cyclosporin (CsA) and/or methotrexate (MTX) have formed the basis of many GVHD prophylaxis strategies with no major advances on this gold standard for over twenty years.,Cyclosporin,CHEMICAL,form basis of,many GVHD prophylaxis strategies,DISEASE
18474024,Cyclosporin (CsA) and/or methotrexate (MTX) have formed the basis of many GVHD prophylaxis strategies with no major advances on this gold standard for over twenty years.,CsA,CHEMICAL,form basis of,many GVHD prophylaxis strategies,DISEASE
18474024,Cyclosporin (CsA) and/or methotrexate (MTX) have formed the basis of many GVHD prophylaxis strategies with no major advances on this gold standard for over twenty years.,methotrexate,CHEMICAL,form basis of,many GVHD prophylaxis strategies,DISEASE
29563235,"The purpose of present study was to infer the potential effects of testosterone increase in some male-based childhood-onset neuropsychiatric disorders, such as Tourette syndrome.",testosterone increase,CHEMICAL,have the potential effects in,male-based childhood-onset neuropsychiatric disorders,DISEASE
29563235,Haloperidol significantly ameliorated the motor behavioral and grooming behavioral defects induced by early postnatal TP exposure.,Haloperidol,CHEMICAL,ameliorate,behavioral defects,DISEASE
29563235,It was suggested that abnormal increments of testosterone levels during the early postnatal development might be a potential risk factor for the incidence of some male-based childhood-onset neuropsychiatric disorders by affecting the mesodopaminergic system.,testosterone levels,CHEMICAL,be potential risk factor for incidence of,male-based childhood-onset neuropsychiatric disorders,DISEASE
28511232,Blood gas analysis and Doppler sonography are used to establish the form of priapism and determine its further management.,Blood gas analysis,CHEMICAL,establish form of,priapism,DISEASE
26573674,Low-flow or ischemic (veno-occlusive) priapism is an emergency situation and can lead to irreversible erectile dysfunction within 4 h. Treatment consists of blood aspiration and possibly intracavernosal injection of sympathomimetic drugs.,Low-flow veno-occlusive priapism,DISEASE,lead to,irreversible erectile dysfunction,MENTAL_HEALTH
26573674,Management of recurrent priapism (stuttering) includes self-injection of sympathomimetic drugs and preventive long-term administration of erection inhibitory and erection promoting substances.,stuttering,MENTAL_HEALTH,include self-injection of,sympathomimetic drugs,CHEBI
26573674,Management of recurrent priapism (stuttering) includes self-injection of sympathomimetic drugs and preventive long-term administration of erection inhibitory and erection promoting substances.,recurrent priapism,DISEASE,include self-injection of,sympathomimetic drugs,CHEBI
34107278,"Diabetic animals developed mechanical allodynia, depressive and anxious-like behavior, increased plasma HbA1, increased LPO, and decreased GSH levels in tissues analyzed.",Diabetic animals,DISEASE,develop,mechanical allodynia,DISEASE
34107278,"Diabetic animals developed mechanical allodynia, depressive and anxious-like behavior, increased plasma HbA1, increased LPO, and decreased GSH levels in tissues analyzed.",Diabetic animals,DISEASE,develop,depressive behavior,DISEASE
34107278,"Diabetic animals developed mechanical allodynia, depressive and anxious-like behavior, increased plasma HbA1, increased LPO, and decreased GSH levels in tissues analyzed.",Diabetic animals,DISEASE,decrease,GSH levels,CHEMICAL
5384,"Psychotropic medications, particularly the tricyclic antidepressants, sometimes in combination with phenothiazines and antihistamines, are effective in many instances of central pain, and help increase the pain tolerance and decrease the need for narcotics in other pain states.",phenothiazines,CHEMICAL,be effective in many instances of,central pain,DISEASE
5384,"Psychotropic medications, particularly the tricyclic antidepressants, sometimes in combination with phenothiazines and antihistamines, are effective in many instances of central pain, and help increase the pain tolerance and decrease the need for narcotics in other pain states.",tricyclic antidepressants,CHEMICAL,be effective in many instances of,central pain,DISEASE
15981034,"Blood concentrations of Cd and Pb were positively correlated (r2 = 0.49 to 0.84) with the concentration of the same element in carp and catfish carcasses or in carp livers, and the corresponding multiple regression models were highly significant (p < or = 0.001).",Pb,CHEMICAL,be correlated,catfish,NUTRITION
15981034,"Blood concentrations of Cd and Pb were positively correlated (r2 = 0.49 to 0.84) with the concentration of the same element in carp and catfish carcasses or in carp livers, and the corresponding multiple regression models were highly significant (p < or = 0.001).",Cd,CHEMICAL,be correlated,catfish,NUTRITION
16117126,"Statistically significant (p < 0.01) linear regression models that included negative terms for blood Pb explained as much as 68% of the total variation in ALA-D activity, but differences among taxa were highly evident.",p linear regression models,MENTAL_HEALTH,explain much % of total variation in,ALA-D activity,CHEMICAL
28507129,These results provide a proof-of-concept for a mechanistic therapy of narcolepsy-cataplexy by OX2R agonists.,agonists,CHEBI,have a mechanistic therapy of,narcolepsy-cataplexy,DISEASE
6783095,"When mixed with substrate, the interaction of the inhibitor with alpha-chymotrypsin is characterized by substrate-induced dissociation of the complex.",alpha-chymotrypsin,CHEMICAL,be characterized by,substrate-induced dissociation,MENTAL_HEALTH
30609006,Restless legs syndrome (RLS) is a common neurologic disorder that is associated with peripheral iron deficiency in a subgroup of patients.,Restless legs syndrome,DISEASE,be,common disorder,DISEASE
24628996,"Buprenorphine, used for treating opioid dependence, may have a withdrawal syndrome requiring treatment.",Buprenorphine,CHEMICAL,have,withdrawal syndrome,DISEASE
29791238,"Low-dose ketamine infusion may be considered as an adjunct analgesic agent in patients with vaso-occlusive episodes who report continued severe pain despite high-dose opioid therapy, particularly those experiencing opioid-induced adverse effects.",Low-dose ketamine infusion,CHEMICAL,be considered as,adjunct analgesic agent,CHEBI
16734319,"Of the pharmacologic agents used to treat premenstrual symptoms, 3 selective serotonin reuptake inhibitors have received a Food and Drug Administration (FDA) indication for treating premenstrual dysphoric disorder (PMDD).",selective serotonin reuptake inhibitors,CHEMICAL,receive of,Food Drug Administration,CHEBI
2364137,alpha-Tocopherol--antioxidant prevents the breaking of conditioned reflex activity and sharply reduces the mortality rate in AHD.,alpha-Tocopherol antioxidant,CHEBI,reduce mortality rate in,AHD,DISEASE
34204699,"H2S is also involved in pulmonary vascular cell homeostasis via the regulation of hypoxia response and mitochondrial bioenergetics, which are critical phenomena affected during the development of PH.",H2S,CHEMICAL,be involved in pulmonary vascular cell homeostasis via regulation of,hypoxia response,DISEASE
9334896,"Ten (63%) of 16 patients with autistic disorder, 2 (33%) of 6 patients with Asperger's disorder, and 6 (55%) of 11 patients with PDDNOS were considered responders to clomipramine treatment.",PDDNOS,DISEASE,be considered responders to,clomipramine treatment,CHEMICAL
9334896,"Ten (63%) of 16 patients with autistic disorder, 2 (33%) of 6 patients with Asperger's disorder, and 6 (55%) of 11 patients with PDDNOS were considered responders to clomipramine treatment.",autistic disorder,MENTAL_HEALTH,be considered responders to,clomipramine treatment,CHEMICAL
9334896,"Ten (63%) of 16 patients with autistic disorder, 2 (33%) of 6 patients with Asperger's disorder, and 6 (55%) of 11 patients with PDDNOS were considered responders to clomipramine treatment.",Asperger's disorder,DISEASE,be considered responders to,clomipramine treatment,CHEMICAL
9334896,"In those 18 patients, clomipramine significantly reduced total repetitive thoughts and behavior (p < 0.001) and also aggression (p < 0.001), and improved some aspects of social relatedness, such as eye contact and verbal responsiveness (p < 0.001).",clomipramine,CHEMICAL,reduce in,aggression,DISEASE
9334896,"In those 18 patients, clomipramine significantly reduced total repetitive thoughts and behavior (p < 0.001) and also aggression (p < 0.001), and improved some aspects of social relatedness, such as eye contact and verbal responsiveness (p < 0.001).",clomipramine,CHEMICAL,reduce in,behavior,DISEASE
9334896,"The results of this open-label trial suggest that clomipramine may be an effective drug for reducing repetitive thoughts and actions and aggressive behavior and for improving some elements of social behavior, such as eye contact and verbal responsivity in adults with PDDs.",clomipramine,CHEMICAL,reduce,aggressive behavior,DISEASE
9334896,"The results of this open-label trial suggest that clomipramine may be an effective drug for reducing repetitive thoughts and actions and aggressive behavior and for improving some elements of social behavior, such as eye contact and verbal responsivity in adults with PDDs.",clomipramine,CHEMICAL,be,effective drug,CHEBI
9334896,"Although an electroencephalogram (EEG) is not mandatory in patients with PDD prior to clomipramine treatment, we recommend that patients with PDD and a history of seizures be treated initially with a selective serotonin uptake inhibitor rather than with clomipramine.",PDD,DISEASE,be treated with,clomipramine,CHEMICAL
9334896,"Although an electroencephalogram (EEG) is not mandatory in patients with PDD prior to clomipramine treatment, we recommend that patients with PDD and a history of seizures be treated initially with a selective serotonin uptake inhibitor rather than with clomipramine.",PDD,DISEASE,be treated with,selective serotonin uptake inhibitor,CHEBI
9334896,"Although an electroencephalogram (EEG) is not mandatory in patients with PDD prior to clomipramine treatment, we recommend that patients with PDD and a history of seizures be treated initially with a selective serotonin uptake inhibitor rather than with clomipramine.",seizures,DISEASE,be treated with,clomipramine,CHEMICAL
9334896,"Although an electroencephalogram (EEG) is not mandatory in patients with PDD prior to clomipramine treatment, we recommend that patients with PDD and a history of seizures be treated initially with a selective serotonin uptake inhibitor rather than with clomipramine.",seizures,DISEASE,be treated with,selective serotonin uptake inhibitor,CHEBI
29636833,"In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities.",Turner syndrome,DISEASE,include in,abnormalities,DISEASE
29636833,"In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities.",Turner syndrome,DISEASE,include in,sexual infantilism,MENTAL_HEALTH
29636833,"In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities.",Turner syndrome,DISEASE,include in,endocrine,CHEBI
29636833,"In postnatal life, clinical features of Turner syndrome may include typical dysmorphic stigmata, short stature, sexual infantilism, and renal, cardiac, skeletal, endocrine and metabolic abnormalities.",Turner syndrome,DISEASE,include in,short stature,DISEASE
9283688,"Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A.",ACh release,CHEMICAL,be reversed by,CB1-selective cannabinoid receptor antagonist,CHEBI
9283688,"Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A.",twitch responses,DISEASE,be reversed by,CB1-selective cannabinoid receptor antagonist,CHEBI
9283688,"Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A.",CB agonists,CHEBI,be reversed by,CB1-selective cannabinoid receptor antagonist,CHEBI
9283688,"Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A.",CB agonists,CHEBI,have inhibition of,ACh release,CHEMICAL
9283688,"Inhibition of twitch responses and ACh release by CB agonists was reversed by the CB1-selective cannabinoid receptor antagonist, SR141716A.",CB agonists,CHEBI,have inhibition of,twitch responses,DISEASE
21971407,"Additionally, vitamin E is capable of protecting against such neurodegeneration.",vitamin E,CHEBI,protect against,neurodegeneration,DISEASE
15559752,Synapse loss associated with beta amyloid oligomers is a strong determinant of cognitive decline in patients with AD.,Synapse loss,DISEASE,be strong determinant of,cognitive decline,DISEASE
25352008,Obstructive sleep apnea can induce chronic intermittent hypoxia (CIH) during sleep and is associated with obesity and diabetes.,Obstructive sleep apnea,MENTAL_HEALTH,be associated with,diabetes,DISEASE
25352008,Obstructive sleep apnea can induce chronic intermittent hypoxia (CIH) during sleep and is associated with obesity and diabetes.,Obstructive sleep apnea,MENTAL_HEALTH,be associated with,obesity,DISEASE
25352008,Obstructive sleep apnea can induce chronic intermittent hypoxia (CIH) during sleep and is associated with obesity and diabetes.,Obstructive sleep apnea,MENTAL_HEALTH,induce,CIH,CHEMICAL
25352008,Obstructive sleep apnea can induce chronic intermittent hypoxia (CIH) during sleep and is associated with obesity and diabetes.,Obstructive sleep apnea,MENTAL_HEALTH,induce,chronic intermittent hypoxia,DISEASE
25352008,"Resveratrol (RSV), a polyphenolic phytoalexin, can regulate glucose metabolism, thereby reducing insulin resistance.",polyphenolic phytoalexin,CHEBI,regulate,glucose metabolism,CHEMICAL
25352008,"Resveratrol (RSV), a polyphenolic phytoalexin, can regulate glucose metabolism, thereby reducing insulin resistance.",polyphenolic phytoalexin,CHEBI,reduce,insulin resistance,MENTAL_HEALTH
25352008,"Resveratrol (RSV), a polyphenolic phytoalexin, can regulate glucose metabolism, thereby reducing insulin resistance.",Resveratrol,CHEMICAL,reduce,insulin resistance,MENTAL_HEALTH
25352008,"Resveratrol (RSV), a polyphenolic phytoalexin, can regulate glucose metabolism, thereby reducing insulin resistance.",Resveratrol,CHEMICAL,regulate,glucose metabolism,CHEMICAL
34450560,"Inhaled short-acting β2-adrenergic agonists can rarely elicit paradoxical bronchospasm (PB), which may be fatal.",Inhaled β2-adrenergic agonists,CHEBI,elicit,paradoxical bronchospasm,DISEASE
34450560,"Based on spirometry test reports, inhaled β2-adrenergic agonists were discontinued in 2 veterans with COPD and asthma.",inhaled β2-adrenergic agonists,CHEBI,be discontinued based on spirometry test reports in veterans with,COPD,DISEASE
15761179,"Obesity, beta-adrenergic agonists, and inflammation are linked to decreased expression and/or secretion of an adipose tissue-derived antiatherogenic hormone, adiponectin.",Obesity,DISEASE,be linked to decreased expression and/or secretion of,adipose tissue-derived antiatherogenic hormone,CHEBI
15761179,"Obesity, beta-adrenergic agonists, and inflammation are linked to decreased expression and/or secretion of an adipose tissue-derived antiatherogenic hormone, adiponectin.",beta-adrenergic agonists,CHEBI,be linked to decreased expression and/or secretion of,adipose tissue-derived antiatherogenic hormone,CHEBI
3631915,Both the thought disorder and the ocular deviation responded promptly to anticholinergic agents.,thought disorder,MENTAL_HEALTH,respond to,anticholinergic agents,CHEBI
32603934,"Heavy metal toxicity assessment was carried out using agar well diffusion method with eight heavy metals and both the strains were sensitive to As(III), Cd(II), Ce(II), Cr(III), Cu(II), Hg(II) and while they showed resistance to Pb(II) and Sr(II).",toxicity assessment,DISEASE,use agar diffusion method with,heavy metals,CHEMICAL
32603934,"Heavy metal toxicity assessment was carried out using agar well diffusion method with eight heavy metals and both the strains were sensitive to As(III), Cd(II), Ce(II), Cr(III), Cu(II), Hg(II) and while they showed resistance to Pb(II) and Sr(II).",toxicity assessment,DISEASE,use,agar diffusion,CHEBI
32603934,"Based on these results, a study was conducted to demonstrate bio-removal of Pb and Sr by EPS of PBR1 and PBL1.",EPS,DISEASE,have bio-removal of,Pb,CHEMICAL
32603934,"Based on these results, a study was conducted to demonstrate bio-removal of Pb and Sr by EPS of PBR1 and PBL1.",EPS,DISEASE,have bio-removal of,Sr,CHEMICAL
18628169,"Traditionally, morphine has been the prototypical opioid for chronic cancer pain because there is no ceiling effect or upper limit and it is a naturally occurring pure mu-opioid agonist.",morphine,CHEMICAL,be prototypical opioid for,chronic cancer pain,DISEASE
25434453,"With modified FOLFOX6 (mFOLFOX6) therapy, adverse events of an altered mental state with reversible posterior leukoencephalopathy and hypoammonemia have been reported, while lactic acidosis is uncommon.",reversible posterior leukoencephalopathy,DISEASE,be reported with,mFOLFOX6,CHEMICAL
26670173,The objective of this study was to establish if presence of OSA is associated with poor expected benefit from vitamin K antagonist (VKA) therapy as assessed using the SAMe-TT2R2 score.,OSA,DISEASE,expected benefit from,VKA,CHEMICAL
26670173,The objective of this study was to establish if presence of OSA is associated with poor expected benefit from vitamin K antagonist (VKA) therapy as assessed using the SAMe-TT2R2 score.,OSA,DISEASE,expected benefit from,antagonist therapy,CHEBI
27481296,"The preprotective, protective, and postprotective effects of PLE on STZ-induced oxidative stress were studied using biochemical (caspase 3 activity, cytosolic-to-lysosomal ratio of cathepsin B and L, DNA fragmentation levels), ordinary histological and immuno-histochemical investigation parameters.",PLE,DISEASE,use,DNA fragmentation levels,MENTAL_HEALTH
27481296,"The preprotective, protective, and postprotective effects of PLE on STZ-induced oxidative stress were studied using biochemical (caspase 3 activity, cytosolic-to-lysosomal ratio of cathepsin B and L, DNA fragmentation levels), ordinary histological and immuno-histochemical investigation parameters.",PLE,DISEASE,use,cathepsin B,CHEMICAL
27481296,"The preprotective, protective, and postprotective effects of PLE on STZ-induced oxidative stress were studied using biochemical (caspase 3 activity, cytosolic-to-lysosomal ratio of cathepsin B and L, DNA fragmentation levels), ordinary histological and immuno-histochemical investigation parameters.",STZ-induced oxidative stress,DISEASE,use,DNA fragmentation levels,MENTAL_HEALTH
27481296,"The preprotective, protective, and postprotective effects of PLE on STZ-induced oxidative stress were studied using biochemical (caspase 3 activity, cytosolic-to-lysosomal ratio of cathepsin B and L, DNA fragmentation levels), ordinary histological and immuno-histochemical investigation parameters.",STZ-induced oxidative stress,DISEASE,use,cathepsin B,CHEMICAL
35392556,Incubation with BA5 reduced the percentage of Leishmania amazonensis-infected macrophages and the number of intracellular parasites (IC50 = 4.1 ± 0.7 μM).,BA5,CHEMICAL,reduce percentage of,Leishmania amazonensis-infected macrophages,DISEASE
32256269,"However, pharmaceutical drugs used in clinical practice have side effects, such as diarrhea, paronychia, and hepatotoxicity.",pharmaceutical drugs,CHEBI,have,hepatotoxicity,DISEASE
32256269,"However, pharmaceutical drugs used in clinical practice have side effects, such as diarrhea, paronychia, and hepatotoxicity.",pharmaceutical drugs,CHEBI,have,diarrhea,DISEASE
29626263,"This case study suggests that long-term treatment with levodopa/carbidopa and piribedil, along with the progression of the disease itself, could contribute to the emergence of psychotic symptoms in PD.",levodopa/carbidopa,CHEMICAL,contribute along with progression of disease to emergence of,psychotic symptoms,DISEASE
29626263,"This case study suggests that long-term treatment with levodopa/carbidopa and piribedil, along with the progression of the disease itself, could contribute to the emergence of psychotic symptoms in PD.",piribedil,CHEMICAL,contribute along with progression of disease to emergence of,psychotic symptoms,DISEASE
31964210,"However, factors unrelated to sepsis-induced hyperlactatemia, including β-2 adrenergic agonists, can interfere with lactate clearance.",adrenergic agonists,CHEBI,interfere with,lactate clearance,CHEMICAL
31964210,"However, factors unrelated to sepsis-induced hyperlactatemia, including β-2 adrenergic agonists, can interfere with lactate clearance.",sepsis-induced hyperlactatemia,DISEASE,interfere with,lactate clearance,CHEMICAL
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",mu-opioid antagonist,CHEBI,be approved by european medicines agency for reduction of alcohol consumption in,alcohol dependence,MENTAL_HEALTH
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",mu-opioid antagonist,CHEBI,be approved by european medicines agency for reduction of,alcohol consumption,CHEMICAL
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",partial kappa agonist nalmefene,CHEMICAL,be approved by european medicines agency for reduction of alcohol consumption in,alcohol dependence,MENTAL_HEALTH
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",partial kappa agonist nalmefene,CHEBI,be approved by european medicines agency for reduction of alcohol consumption in,alcohol dependence,MENTAL_HEALTH
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",partial kappa agonist nalmefene,CHEMICAL,be approved by european medicines agency for reduction of,alcohol consumption,CHEMICAL
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",partial kappa agonist nalmefene,CHEBI,be approved by european medicines agency for reduction of,alcohol consumption,CHEMICAL
26845589,"Recently, the mu-opioid antagonist and partial kappa agonist nalmefene was approved by the European Medicines Agency for the reduction of alcohol consumption in adult patients with alcohol dependence.",alcohol consumption,CHEMICAL,in adult patients with,alcohol dependence,MENTAL_HEALTH
32169564,"This may be due to AN illness chronicity and the significant changes already made, as well as a reduced potency of zinc to inhibit NMDA receptors in a pathological state.",zinc,CHEMICAL,have a reduced potency to,NMDA receptors,CHEMICAL
30483521,"Here, we show that the bipolar disorder drug lithium inhibits formation of both virulence factors by a mechanism involving dysregulation of the ubiquitin/proteasome system.",bipolar disorder drug lithium,CHEBI,inhibit formation of,virulence factors,CHEBI
30483521,"Here, we show that the bipolar disorder drug lithium inhibits formation of both virulence factors by a mechanism involving dysregulation of the ubiquitin/proteasome system.",bipolar disorder drug lithium,MENTAL_HEALTH,inhibit formation of,virulence factors,CHEBI
30483521,"Here, we show that the bipolar disorder drug lithium inhibits formation of both virulence factors by a mechanism involving dysregulation of the ubiquitin/proteasome system.",bipolar disorder drug lithium,NUTRITION,inhibit formation of,virulence factors,CHEBI
21403468,"Sunitinib, a new vascular endothelial growth factor receptor inhibitor, has demonstrated activity in renal cell carcinoma and is now widely used in the palliative treatment of patients with metastatic renal cell carcinoma.",Sunitinib,CHEMICAL,demonstrate activity in,renal cell carcinoma,DISEASE
21403468,"Sunitinib, a new vascular endothelial growth factor receptor inhibitor, has demonstrated activity in renal cell carcinoma and is now widely used in the palliative treatment of patients with metastatic renal cell carcinoma.",new vascular endothelial growth factor receptor inhibitor,CHEBI,demonstrate activity in,renal cell carcinoma,DISEASE
21403468,"Sunitinib, a new vascular endothelial growth factor receptor inhibitor, has demonstrated activity in renal cell carcinoma and is now widely used in the palliative treatment of patients with metastatic renal cell carcinoma.",new vascular endothelial growth factor receptor inhibitor,CHEBI,be used in palliative treatment of patients with,metastatic renal cell carcinoma,DISEASE
21403468,"Sunitinib, a new vascular endothelial growth factor receptor inhibitor, has demonstrated activity in renal cell carcinoma and is now widely used in the palliative treatment of patients with metastatic renal cell carcinoma.",Sunitinib,CHEMICAL,be used in palliative treatment of patients with,metastatic renal cell carcinoma,DISEASE
21670421,"Unfortunately, this therapy is associated with adverse effects, including hypertension and renal toxicity, referred to as ""preeclampsia."" Recently, we demonstrated in patients and in rats that the multitarget tyrosine kinase inhibitor sunitinib induces a rise in blood pressure (BP), renal dysfunction, and proteinuria associated with activation of the endothelin system.",multitarget tyrosine kinase inhibitor sunitinib,CHEMICAL,induce rise in,renal dysfunction,DISEASE
35142667,"Despite the promising effects of epidermal growth factor receptor inhibitors in Alzheimer's disease, there is no irrefutable neuroprotective evidence in well-established animal models using epidermal growth factor receptor inhibitors due to many un-explored downstream signaling pathways.",epidermal growth factor receptor inhibitors,CHEBI,have the promising effects in,Alzheimer's disease,DISEASE
26145740,"The quantification of apoptosis and necrosis as well as the ratio of these processes in neutrophils and lymphocytes belonging to different subpopulations of palatal tonsil homogenates and peripheral blood was performed by cytofluorometry with the use of the ""BecmenCulter Epi XL"" apparatus (USA).",necrosis,DISEASE,be performed by cytofluorometry with use of,BecmenCulter Epi XL apparatus,CHEMICAL
32924547,"Nephrogenic diabetes insipidus (NDI) is characterized by renal resistance to the antidiuretic hormone arginine vasopressin (AVP), which leads to polyuria, plasma hyperosmolarity, polydipsia, and impaired quality of living.",Nephrogenic diabetes insipidus,DISEASE,be characterized by renal resistance to,antidiuretic hormone arginine vasopressin,CHEBI
32924547,"Nephrogenic diabetes insipidus (NDI) is characterized by renal resistance to the antidiuretic hormone arginine vasopressin (AVP), which leads to polyuria, plasma hyperosmolarity, polydipsia, and impaired quality of living.",Nephrogenic diabetes insipidus,DISEASE,be characterized by renal resistance to,antidiuretic hormone arginine vasopressin,CHEMICAL
32924547,"Nephrogenic diabetes insipidus (NDI) is characterized by renal resistance to the antidiuretic hormone arginine vasopressin (AVP), which leads to polyuria, plasma hyperosmolarity, polydipsia, and impaired quality of living.",Nephrogenic diabetes insipidus,DISEASE,be characterized by renal resistance to,AVP,CHEMICAL
32924547,"Nephrogenic diabetes insipidus (NDI) is characterized by renal resistance to the antidiuretic hormone arginine vasopressin (AVP), which leads to polyuria, plasma hyperosmolarity, polydipsia, and impaired quality of living.",Nephrogenic diabetes insipidus,DISEASE,be characterized by,renal resistance,MENTAL_HEALTH
25243854,"The effects of glucotoxicity on increasing stress fibers and reducing GSIS were reversed by Y-27632, a Rho-associated kinase (ROCK)-specific inhibitor, which caused actin depolymerization and enhanced GSIS.",glucotoxicity,DISEASE,be reversed by,Y-27632,CHEMICAL
35296762,"Titanium alloy has become a promising candidate material for oil country tubular goods (OCTGs) in harsh service environments owing to its high specific strength, low density, low elastic modulus, excellent toughness, excellent anti-fatigue and corrosion resistance.",Titanium alloy,CHEMICAL,owe to,resistance,MENTAL_HEALTH
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,selective MAO-A-inhibitor moclobemide,CHEMICAL,be studied by,major depressive disorder,MENTAL_HEALTH
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,selective MAO-A-inhibitor moclobemide,CHEMICAL,be studied by,clonidine hormone release,CHEMICAL
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,selective MAO-A-inhibitor moclobemide,CHEMICAL,be studied by,clonidine hormone release,CHEBI
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,alpha responsivity,NUTRITION,be studied by,major depressive disorder,MENTAL_HEALTH
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,alpha responsivity,NUTRITION,be studied by,clonidine hormone release,CHEMICAL
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,alpha responsivity,NUTRITION,be studied by,clonidine hormone release,CHEBI
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEBI,be studied by,major depressive disorder,MENTAL_HEALTH
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEBI,be studied by,clonidine hormone release,CHEMICAL
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEBI,be studied by,clonidine hormone release,CHEBI
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEMICAL,be studied by,major depressive disorder,MENTAL_HEALTH
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEMICAL,be studied by,clonidine hormone release,CHEMICAL
1965198,The effect of chronic treatment with the selective and reversible MAO-A-inhibitor moclobemide (MOC) vs. the norepinephrine reuptake inhibitor maprotiline (MAP) on alpha 2-adrenoceptor responsivity was studied by clonidine (CLON)-evoked growth hormone (GH) release in major depressive disorder.,norepinephrine reuptake inhibitor maprotiline,CHEMICAL,be studied by,clonidine hormone release,CHEBI
1965198,Our results support the view that antidepressants with different mechanisms of action may be capable of restoring alpha 2-adrenoceptor function during recovery from a major depressive episode.,antidepressants,CHEMICAL,restore alpha 2-adrenoceptor function during recovery from,major depressive episode,MENTAL_HEALTH
1965198,Our results support the view that antidepressants with different mechanisms of action may be capable of restoring alpha 2-adrenoceptor function during recovery from a major depressive episode.,antidepressants,CHEMICAL,restore,alpha 2-adrenoceptor,NUTRITION
26589093,"Concentrations of ALLO and THDOC in brain tissue from mice with HE resulting from toxic liver injury are sufficient to induce sedation in animals of the same species and significant increases in concentrations of ALLO have been reported in autopsied brain tissue from cirrhotic patients with HE leading to the proposal that ""increased GABAergic tone"" in HE results from that increased brain concentrations of this neurosteroid.",ALLO,CHEMICAL,induce sedation in animals of same species and significant increases in,ALLO,CHEMICAL
26589093,"Concentrations of ALLO and THDOC in brain tissue from mice with HE resulting from toxic liver injury are sufficient to induce sedation in animals of the same species and significant increases in concentrations of ALLO have been reported in autopsied brain tissue from cirrhotic patients with HE leading to the proposal that ""increased GABAergic tone"" in HE results from that increased brain concentrations of this neurosteroid.",THDOC,CHEMICAL,induce sedation in animals of same species and significant increases in,ALLO,CHEMICAL
29866157,"Trichilia catigua A. Juss. (Meliaceae) is a species known as catuaba and used in folk medicine for the treatment of fatigue, stress, impotence and memory deficit.",Trichilia catigua A. Juss,CHEMICAL,used in folk medicine for treatment of,fatigue,MENTAL_HEALTH
29866157,"Trichilia catigua A. Juss. (Meliaceae) is a species known as catuaba and used in folk medicine for the treatment of fatigue, stress, impotence and memory deficit.",Trichilia catigua A. Juss,CHEMICAL,used in folk medicine for treatment of,deficit,DISEASE
29866157,"Trichilia catigua A. Juss. (Meliaceae) is a species known as catuaba and used in folk medicine for the treatment of fatigue, stress, impotence and memory deficit.",Trichilia catigua A. Juss,CHEMICAL,used in folk medicine for treatment of,impotence,MENTAL_HEALTH
24076326,"In addition, tenuifoliside A suppressed the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β.",tenuifoliside A,CHEMICAL,suppress in addition production of,tumor necrosis factor (TNF)-α,DISEASE
24076326,"This study is the first report on the anti-inflammatory effects of tenuifoliside A, and the strong anti-inflammatory effects of tenuifoliside A provide potential compound to be developed as therapeutic for inflammatory diseases.",tenuifoliside A,CHEMICAL,be developed as therapeutic for,inflammatory diseases,DISEASE
23839964,"Cong-Ming-Tang (CMT), named smart-soup in English, is a well-known traditional Chinese medicine formula for the treatment of amnesia in China.",CMT,DISEASE,be well-known traditional medicine formula for treatment of,amnesia,MENTAL_HEALTH
23839964,"Cong-Ming-Tang (CMT), named smart-soup in English, is a well-known traditional Chinese medicine formula for the treatment of amnesia in China.",Cong-Ming-Tang,CHEMICAL,be well-known traditional medicine formula for treatment of,amnesia,MENTAL_HEALTH
33242109,Sexual side effects of chronic treatment with selective serotonin reuptake inhibitors (SSRIs) in humans include anorgasmia and loss of sexual desire and/or arousal which interferes with treatment compliance.,selective serotonin reuptake inhibitors,CHEMICAL,include,anorgasmia,MENTAL_HEALTH
29478387,GC drugs and elevated cortisol level can cause psychiatric disorders including depression.,elevated cortisol level,CHEMICAL,cause,psychiatric disorders,DISEASE
29478387,GC drugs and elevated cortisol level can cause psychiatric disorders including depression.,elevated cortisol level,CHEMICAL,cause,depression,MENTAL_HEALTH
29478387,"The immobility time was measured, in the forced swimming test as an animal model of despair and sucrose preference was measured in order to test anhedonia (Results: DEX dose dependently increased immobility time that denoted animal depression; as it was 177.5 seconds ± 3 following 60 mcg/kg and 188.3 seconds ± 5 following 250 mcg/kg administration (vs. control animals 164 seconds ± 6, P Conclusion: Vitamin B6 prevented DEX-induced depression possibly by altering the GR function.",Vitamin B6,CHEBI,alter,GR function,CHEMICAL
29478387,"The immobility time was measured, in the forced swimming test as an animal model of despair and sucrose preference was measured in order to test anhedonia (Results: DEX dose dependently increased immobility time that denoted animal depression; as it was 177.5 seconds ± 3 following 60 mcg/kg and 188.3 seconds ± 5 following 250 mcg/kg administration (vs. control animals 164 seconds ± 6, P Conclusion: Vitamin B6 prevented DEX-induced depression possibly by altering the GR function.",Vitamin B6,CHEBI,prevent,DEX-induced depression,MENTAL_HEALTH
31299417,"The results showed that chronic OEA treatment significantly lowered hyperglycemia, recovered cognitive performance, reduced dementia markers, and inhibited hippocampal neuron loss and neuroplasticity impairments in diabetic mice.",chronic OEA treatment,CHEMICAL,reduce,dementia markers,MENTAL_HEALTH
31299417,"The results showed that chronic OEA treatment significantly lowered hyperglycemia, recovered cognitive performance, reduced dementia markers, and inhibited hippocampal neuron loss and neuroplasticity impairments in diabetic mice.",chronic OEA treatment,CHEMICAL,inhibit hippocampal neuron loss and neuroplasticity impairments in,diabetic mice,DISEASE
31299417,"The results showed that chronic OEA treatment significantly lowered hyperglycemia, recovered cognitive performance, reduced dementia markers, and inhibited hippocampal neuron loss and neuroplasticity impairments in diabetic mice.",chronic OEA treatment,CHEMICAL,inhibit,loss impairments,DISEASE
35334883,"After adjusting for background factors related to frequent headache (vasomotor, insomnia, anxiety, and depression symptoms), the estimated dietary intake of isoflavones (daidzein + genistein) (mg/1000 kcal/day) was negatively associated with frequent headaches (adjusted odds, 0.974; 95% confidence interval, 0.950-0.999).",isoflavones daidzein,CHEMICAL,be associated with,frequent headaches,DISEASE
35334883,Headache in peri- and post-menopausal women was inversely correlated with the dietary intake of isoflavones.,Headache,MENTAL_HEALTH,be correlated with dietary intake of,isoflavones,CHEMICAL
35334883,Headache in peri- and post-menopausal women was inversely correlated with the dietary intake of isoflavones.,peri- women,DISEASE,be correlated with dietary intake of,isoflavones,CHEMICAL
35334883,Diets rich in isoflavones may improve headaches in middle-aged women.,isoflavones,CHEMICAL,improve,headaches,DISEASE
25405583,The development of polyphenol neuroprotective nutraceuticals useful for functional foods could be a valuable strategy for counteracting oxidative stress relative diseases as Alzheimer's Disease (AD).,polyphenol neuroprotective nutraceuticals useful,CHEMICAL,be valuable strategy for,Alzheimer's Disease,DISEASE
28969903,"Variable Importance in the Projection (VIP) and correlation scores pointed out four volatile compounds as potential markers for shelf-life of our strawberry beverage: 2-phenylethyl acetate, decanoic acid, γ-decalactone and furfural.",Projection,MENTAL_HEALTH,point volatile compounds as potential markers for shelf-life of,strawberry beverage 2-phenylethyl acetate,CHEMICAL
28969903,"Variable Importance in the Projection (VIP) and correlation scores pointed out four volatile compounds as potential markers for shelf-life of our strawberry beverage: 2-phenylethyl acetate, decanoic acid, γ-decalactone and furfural.",Projection,MENTAL_HEALTH,point volatile compounds as potential markers for shelf-life of,γ-decalactone,CHEMICAL
28969903,"Variable Importance in the Projection (VIP) and correlation scores pointed out four volatile compounds as potential markers for shelf-life of our strawberry beverage: 2-phenylethyl acetate, decanoic acid, γ-decalactone and furfural.",Projection,MENTAL_HEALTH,point volatile compounds as potential markers for shelf-life of,decanoic acid,CHEMICAL
28969903,"Variable Importance in the Projection (VIP) and correlation scores pointed out four volatile compounds as potential markers for shelf-life of our strawberry beverage: 2-phenylethyl acetate, decanoic acid, γ-decalactone and furfural.",Projection,MENTAL_HEALTH,point volatile compounds as potential markers for shelf-life of,furfural,CHEMICAL
28969903,"Variable Importance in the Projection (VIP) and correlation scores pointed out four volatile compounds as potential markers for shelf-life of our strawberry beverage: 2-phenylethyl acetate, decanoic acid, γ-decalactone and furfural.",Projection,MENTAL_HEALTH,point volatile compounds as potential markers for shelf-life of,strawberry beverage 2-phenylethyl acetate,NUTRITION
31347066,"The first studies of ASD using MS focused on the identification of external toxins, but current research is more directed at understanding endogenous protein changes that occur in ASD (ASD proteomics).",ASD,DISEASE,focus on identification of,external toxins,CHEBI
24952201,"The first studies of ASD using MS focused on the identification of external toxins, but current research is more directed at understanding endogenous protein changes that occur in ASD (ASD proteomics).",ASD,DISEASE,focus on identification of,external toxins,CHEBI
28178201,"Fecal SCFA concentrations were similar, but RTT samples showed slightly higher concentrations of butyrate and propionate, and significant higher levels in branched-chain fatty acids.",RTT samples,DISEASE,show higher concentrations of,propionate,CHEMICAL
28178201,"Fecal SCFA concentrations were similar, but RTT samples showed slightly higher concentrations of butyrate and propionate, and significant higher levels in branched-chain fatty acids.",RTT samples,DISEASE,show higher concentrations of,butyrate,CHEMICAL
24444280,Ticagrelor is a reversibly binding and selective P2Y12 -receptor antagonist approved for the prevention of atherothrombotic events in patients with acute coronary syndromes.,Ticagrelor,CHEMICAL,approved for prevention of atherothrombotic events in patients with,acute coronary syndromes,DISEASE
24444280,Ticagrelor is a reversibly binding and selective P2Y12 -receptor antagonist approved for the prevention of atherothrombotic events in patients with acute coronary syndromes.,Ticagrelor,CHEMICAL,approved for prevention of atherothrombotic events in patients with,acute coronary syndromes,MENTAL_HEALTH
26245532,"In this survey, we report that HaWRKY76, a divergent sunflower WRKY transcription factor, is able to confer both dehydration and submergence tolerance to Arabidopsis transgenic plants without yield penalty.",sunflower WRKY transcription factor,DISEASE,confer,dehydration tolerance,DISEASE
26245532,"In this survey, we report that HaWRKY76, a divergent sunflower WRKY transcription factor, is able to confer both dehydration and submergence tolerance to Arabidopsis transgenic plants without yield penalty.",HaWRKY76,CHEMICAL,confer,dehydration tolerance,DISEASE
29897029,"Magnesium (Mg2+) has received considerable attention with regards to its potential role in the pathophysiology of the mood disorders, but the available evidence seems inconclusive.",Magnesium Mg2,CHEMICAL,receive considerable attention with regards to its potential role in,mood disorders,MENTAL_HEALTH
1391281,"Erythrocyte and plasma choline parameters were compared in children (n = 63), aged 6-18 years, suffering from Tourette Syndrome (TS), their parents (n = 57), their unaffected siblings (n = 38), and an adult control group (n = 57).",Erythrocyte choline parameters,NUTRITION,suffer from,Tourette Syndrome,MENTAL_HEALTH
1391281,Positive history of TS or CMT in first-degree relatives accounts for the observation of elevated erythrocyte choline in unaffected siblings of TS patients.,CMT,DISEASE,account for observation of,elevated erythrocyte choline,NUTRITION
21663648,"Phytanic acid produced in ruminants from chlorophyll may have preventive effects on the metabolic syndrome, partly due to its reported RXR and PPAR- α agonist activity.",Phytanic acid,CHEMICAL,reported rxr and ppar- α,agonist activity,CHEBI
21663648,"Milk from cows fed increased levels of green plant material, contains increased phytanic acid concentrations, but it is unknown to what extent minor increases in phytanic acid content in dairy fat leads to higher circulating levels of phytanic acid in plasma of the consumers.",phytanic acid content,CHEMICAL,circulating levels of,phytanic acid,CHEMICAL
21663648,"Milk from cows fed increased levels of green plant material, contains increased phytanic acid concentrations, but it is unknown to what extent minor increases in phytanic acid content in dairy fat leads to higher circulating levels of phytanic acid in plasma of the consumers.",Milk,DISEASE,contain increased,phytanic acid concentrations,CHEMICAL
34512340,Descriptive analysis and multivariate logistic regression models were implemented to determine the possible gender disparities in the receipt of anti-dementia medications.,multivariate regression models,MENTAL_HEALTH,determine possible gender disparities in receipt of,anti-dementia medications,CHEMICAL
10689719,The influence of antibiotic sequence therapy on the course of diseases was examined in 41 pediatric patients with malignant diseases.,antibiotic sequence therapy,CHEBI,be examined in pediatric patients with,malignant diseases,DISEASE
24261211,The first recommended treatment for catatonia is benzodiazepines.,catatonia,DISEASE,be,benzodiazepines,CHEMICAL
25081040,"Cholesterol plays a pivotal role in many aspects of brain development; reduced cholesterol levels during brain development, as a consequence of genetic defects in cholesterol biosynthesis, leads to severe brain damage, including microcephaly and mental retardation, both of which are also hallmarks of the fetal alcohol syndrome.",Cholesterol,NUTRITION,lead to,severe brain damage,DISEASE
25081040,"Cholesterol plays a pivotal role in many aspects of brain development; reduced cholesterol levels during brain development, as a consequence of genetic defects in cholesterol biosynthesis, leads to severe brain damage, including microcephaly and mental retardation, both of which are also hallmarks of the fetal alcohol syndrome.",Cholesterol,NUTRITION,lead to,microcephaly,DISEASE
25081040,"Cholesterol plays a pivotal role in many aspects of brain development; reduced cholesterol levels during brain development, as a consequence of genetic defects in cholesterol biosynthesis, leads to severe brain damage, including microcephaly and mental retardation, both of which are also hallmarks of the fetal alcohol syndrome.",Cholesterol,NUTRITION,lead to,mental retardation,MENTAL_HEALTH
25081040,"Cholesterol plays a pivotal role in many aspects of brain development; reduced cholesterol levels during brain development, as a consequence of genetic defects in cholesterol biosynthesis, leads to severe brain damage, including microcephaly and mental retardation, both of which are also hallmarks of the fetal alcohol syndrome.",Cholesterol,NUTRITION,reduce cholesterol levels during brain development as consequence of,cholesterol biosynthesis,NUTRITION
25081040,"Cholesterol plays a pivotal role in many aspects of brain development; reduced cholesterol levels during brain development, as a consequence of genetic defects in cholesterol biosynthesis, leads to severe brain damage, including microcephaly and mental retardation, both of which are also hallmarks of the fetal alcohol syndrome.",Cholesterol,NUTRITION,reduce,cholesterol levels,NUTRITION
11117543,"Compared with 11 age-matched controls, CHAT and pirenzepine levels were most extensively reduced in the temporal and parietal neocortex of DLB patients.",CHAT levels,NUTRITION,be reduced in the temporal and parietal neocortex of,DLB patients,DISEASE
11117543,"In Brodmann area 36, DELs were significantly associated with elevated pirenzepine binding (131.0 vs 93.5, t = 2.7), whereas visual hallucinations were associated with significant reductions in ChAT (1.7 vs 2.5, t = 2.5).",visual hallucinations,MENTAL_HEALTH,be associated with significant reductions in,ChAT,NUTRITION
30813172,This study aimed to investigate whether an orally administered steroid/gel mixture would inhibit restenosis after EBD for benign esophageal stricture.,administered steroid/gel mixture,CHEBI,inhibit restenosis after ebd for,benign esophageal stricture,DISEASE
30813172,This study aimed to investigate whether an orally administered steroid/gel mixture would inhibit restenosis after EBD for benign esophageal stricture.,administered steroid/gel mixture,CHEBI,inhibit,restenosis,DISEASE
35203744,"Inappropriate sales of antibiotics are still common in retail pharmacies, which can be linked to the lack of consistency and enforcement of published policies, the profit-driven nature of retail pharmacies, and the displacement of the demand for antibiotics from clinical into less regulated settings.",antibiotics,CHEBI,be common in,displacement,MENTAL_HEALTH
35203744,"Inappropriate sales of antibiotics are still common in retail pharmacies, which can be linked to the lack of consistency and enforcement of published policies, the profit-driven nature of retail pharmacies, and the displacement of the demand for antibiotics from clinical into less regulated settings.",antibiotics,CHEBI,be common in,antibiotics,CHEBI
35139800,"mGlu5 metabotropic glutamate receptors are considered as candidate drug targets in the treatment of ""monogenic"" forms of autism spectrum disorders (ASD), such as Fragile-X syndrome (FXS).",mGlu5 metabotropic glutamate receptors,CHEMICAL,be considered as candidate drug targets in treatment of,FXS,DISEASE
35139800,"mGlu5 metabotropic glutamate receptors are considered as candidate drug targets in the treatment of ""monogenic"" forms of autism spectrum disorders (ASD), such as Fragile-X syndrome (FXS).",mGlu5 metabotropic glutamate receptors,CHEMICAL,be considered as candidate drug targets in treatment of,autism spectrum disorders,MENTAL_HEALTH
35139800,"mGlu5 metabotropic glutamate receptors are considered as candidate drug targets in the treatment of ""monogenic"" forms of autism spectrum disorders (ASD), such as Fragile-X syndrome (FXS).",mGlu5 metabotropic glutamate receptors,CHEMICAL,be considered as candidate drug targets in treatment of,Fragile-X syndrome,DISEASE
35139800,"mGlu5 metabotropic glutamate receptors are considered as candidate drug targets in the treatment of ""monogenic"" forms of autism spectrum disorders (ASD), such as Fragile-X syndrome (FXS).",mGlu5 metabotropic glutamate receptors,CHEMICAL,be considered as,drug targets,CHEBI
32939596,"Metabotropic glutamate type 5 receptor (mGluR5) antagonists are under development for treating cognitive disorders such as Fragile X syndrome and Alzheimer's disease, largely based on success in mouse models, where post-synaptic mGluR5 stimulation weakens synaptic functions in hippocampus.",Metabotropic glutamate type receptor antagonists,CHEMICAL,treat cognitive disorders such as,Fragile X syndrome,MENTAL_HEALTH
32939596,"Metabotropic glutamate type 5 receptor (mGluR5) antagonists are under development for treating cognitive disorders such as Fragile X syndrome and Alzheimer's disease, largely based on success in mouse models, where post-synaptic mGluR5 stimulation weakens synaptic functions in hippocampus.",Metabotropic glutamate type receptor antagonists,CHEBI,treat cognitive disorders such as,Fragile X syndrome,MENTAL_HEALTH
32939596,"Metabotropic glutamate type 5 receptor (mGluR5) antagonists are under development for treating cognitive disorders such as Fragile X syndrome and Alzheimer's disease, largely based on success in mouse models, where post-synaptic mGluR5 stimulation weakens synaptic functions in hippocampus.",Metabotropic glutamate type receptor antagonists,CHEMICAL,treat,cognitive disorders,DISEASE
32939596,"Metabotropic glutamate type 5 receptor (mGluR5) antagonists are under development for treating cognitive disorders such as Fragile X syndrome and Alzheimer's disease, largely based on success in mouse models, where post-synaptic mGluR5 stimulation weakens synaptic functions in hippocampus.",Metabotropic glutamate type receptor antagonists,CHEBI,treat,cognitive disorders,DISEASE
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",linked intellectual disability,MENTAL_HEALTH,be leading monogenetic cause of,autism spectrum disorder,MENTAL_HEALTH
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",linked intellectual disability,MENTAL_HEALTH,be leading monogenetic cause of,ASD,DISEASE
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",linked intellectual disability,MENTAL_HEALTH,be,monogenetic cause,DISEASE
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",Fragile X syndrome,MENTAL_HEALTH,be leading monogenetic cause of,autism spectrum disorder,MENTAL_HEALTH
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",Fragile X syndrome,MENTAL_HEALTH,be leading monogenetic cause of,ASD,DISEASE
33093534,"Fragile X syndrome (FXS), an X-chromosome linked intellectual disability, is the leading monogenetic cause of autism spectrum disorder (ASD), a neurodevelopmental condition that currently has no specific drug treatment.",Fragile X syndrome,MENTAL_HEALTH,be,monogenetic cause,DISEASE
33093534,"Building upon the demonstrated therapeutic effects on spatial memory of bryostatin-1, a relatively specific activator of protein kinase C (PKC)ε, (also of PKCα) on impaired synaptic plasticity/maturation and spatial learning and memory in FXS mice, we investigated whether bryostatin-1 might affect the autistic phenotypes and other behaviors, including open field activity, activities of daily living (nesting and marble burying), at the effective therapeutic dose for spatial memory deficits.",bryostatin-1,CHEMICAL,affect,spatial memory deficits,DISEASE
33093534,"Building upon the demonstrated therapeutic effects on spatial memory of bryostatin-1, a relatively specific activator of protein kinase C (PKC)ε, (also of PKCα) on impaired synaptic plasticity/maturation and spatial learning and memory in FXS mice, we investigated whether bryostatin-1 might affect the autistic phenotypes and other behaviors, including open field activity, activities of daily living (nesting and marble burying), at the effective therapeutic dose for spatial memory deficits.",bryostatin-1,CHEMICAL,affect,autistic phenotypes,DISEASE
33093534,"The results strongly suggest that, at appropriate dosing and therapeutic period, chronic bryostatin-1 may have great therapeutic value for both ASD and FXS.",chronic bryostatin-1,CHEMICAL,have at appropriate dosing and therapeutic period great therapeutic value for,FXS,DISEASE
33093534,"The results strongly suggest that, at appropriate dosing and therapeutic period, chronic bryostatin-1 may have great therapeutic value for both ASD and FXS.",chronic bryostatin-1,CHEMICAL,have at appropriate dosing and therapeutic period great therapeutic value for,ASD,DISEASE
35429651,"Ketamine and its enantiomer esketamine have gained much attention in recent years as potent, fast-acting agents for the management of treatment-resistant depression.",enantiomer esketamine,CHEMICAL,gain much attention in recent years as,treatment-resistant depression,MENTAL_HEALTH
35429651,"Ketamine and its enantiomer esketamine have gained much attention in recent years as potent, fast-acting agents for the management of treatment-resistant depression.",Ketamine,CHEMICAL,gain much attention in recent years as,treatment-resistant depression,MENTAL_HEALTH
28578952,Chitosan nanoparticles treated rats showed significant increment in high-density lipoprotein cholesterol and reduction in low-density lipoprotein and very low-density lipoprotein cholesterol when compared with levels in nitrosodiethylamine-induced hepatocellular carcinoma.,high-density lipoprotein cholesterol,NUTRITION,have significant increment in,low-density lipoprotein,NUTRITION
28578952,"Nitrosodiethylamine-induced carcinoma changes on circulation and hepatic antioxidant defense mechanism were regulated by chitosan nanoparticles, concluding that the chitosan nanoparticles have a potent protective effect on liver cells which might be due to its robust antioxidant and anti-lipidemic property.",hepatic antioxidant defense mechanism,MENTAL_HEALTH,be regulated by,chitosan nanoparticles due,CHEMICAL
28578952,"Nitrosodiethylamine-induced carcinoma changes on circulation and hepatic antioxidant defense mechanism were regulated by chitosan nanoparticles, concluding that the chitosan nanoparticles have a potent protective effect on liver cells which might be due to its robust antioxidant and anti-lipidemic property.",Nitrosodiethylamine-induced carcinoma changes,DISEASE,be regulated by,chitosan nanoparticles due,CHEMICAL
28099963,"The total skin concentrations of hydrophilic ascorbic and uric acids, as well as lipophilic α-tocopherol, β-carotene, and ubiquinol-10 antioxidants were determined by an HPLC-EC detector from 18 biopsies of human nonmelanoma skin carcinomas and 18 biopsies from skin areas adjacent to carcinomas.",hydrophilic ascorbic acids,CHEMICAL,be determined by hplc-ec detector from biopsies of human nonmelanoma skin carcinomas and biopsies from,carcinomas,DISEASE
28099963,"The total skin concentrations of hydrophilic ascorbic and uric acids, as well as lipophilic α-tocopherol, β-carotene, and ubiquinol-10 antioxidants were determined by an HPLC-EC detector from 18 biopsies of human nonmelanoma skin carcinomas and 18 biopsies from skin areas adjacent to carcinomas.",hydrophilic ascorbic acids,CHEMICAL,be determined by hplc-ec detector from biopsies of,human nonmelanoma skin carcinomas,DISEASE
28099963,"On the contrary, ascorbic and uric acid concentrations were found to be 18 and 36% lower in carcinomas than in normal-looking skin areas, respectively.",ascorbic acid concentrations,CHEBI,be found on contrary to lower in,carcinomas,DISEASE
2179653,"S-Adenosylmethionine (SAMe) proved to be effective in antagonizing bile secretion impairment induced by a wide range of hepatotoxins, including ethynylestradiol, taurolithocholate, chlorpromazine and alpha-naphthyl-isothiocyanate.",S-Adenosylmethionine,CHEMICAL,prove to effective in,antagonizing bile secretion impairment,DISEASE
2179653,"S-Adenosylmethionine (SAMe) proved to be effective in antagonizing bile secretion impairment induced by a wide range of hepatotoxins, including ethynylestradiol, taurolithocholate, chlorpromazine and alpha-naphthyl-isothiocyanate.",SAMe,CHEMICAL,prove to effective in,antagonizing bile secretion impairment,DISEASE
2179653,"In particular, controlled clinical trials have documented that intravenous SAMe (800 mg/day) induced a significant decrease of biochemical parameters of cholestasis (serum total and conjugated bilirubin, serum total bile salts, and aminotransferases), as well as a significant improvement of pruritus in women with ICP compared with placebo.",intravenous SAMe,CHEMICAL,induce significant decrease of biochemical parameters of,pruritus,DISEASE
2179653,"In particular, controlled clinical trials have documented that intravenous SAMe (800 mg/day) induced a significant decrease of biochemical parameters of cholestasis (serum total and conjugated bilirubin, serum total bile salts, and aminotransferases), as well as a significant improvement of pruritus in women with ICP compared with placebo.",intravenous SAMe,CHEMICAL,induce significant decrease of biochemical parameters of,conjugated bilirubin,CHEMICAL
2179653,"In particular, controlled clinical trials have documented that intravenous SAMe (800 mg/day) induced a significant decrease of biochemical parameters of cholestasis (serum total and conjugated bilirubin, serum total bile salts, and aminotransferases), as well as a significant improvement of pruritus in women with ICP compared with placebo.",intravenous SAMe,CHEMICAL,induce significant decrease of biochemical parameters of,cholestasis serum total,DISEASE
2179653,"In addition, other studies provided the evidence that both parenteral (800 mg/day) and oral SAMe (1600 mg/day) significantly improves subjective (pruritus, fatigue, and general discomfort) and objective (serum total and conjugated bilirubin, and serum alkaline phosphatase) parameters of cholestasis in patients with intrahepatic cholestasis complicating chronic liver diseases compared with placebo.",cholestasis,DISEASE,in patients with,intrahepatic cholestasis,DISEASE
2179653,"In addition, other studies provided the evidence that both parenteral (800 mg/day) and oral SAMe (1600 mg/day) significantly improves subjective (pruritus, fatigue, and general discomfort) and objective (serum total and conjugated bilirubin, and serum alkaline phosphatase) parameters of cholestasis in patients with intrahepatic cholestasis complicating chronic liver diseases compared with placebo.",cholestasis,DISEASE,in patients with,chronic liver diseases,DISEASE
2179653,"In conclusion, experimental and clinical investigations indicate that SAMe represents an effective and safe approach to the management of intrahepatic cholestasis.",SAMe,CHEMICAL,represent effective and safe approach to management of,intrahepatic cholestasis,DISEASE
19549897,Early exposure to xenoestrogens may predispose to breast cancer risk later in adult life.,xenoestrogens,CHEBI,predispose to,breast cancer risk,DISEASE
23340223,[(3)H]epibatidine displacement was used to determine if morphine binds competitively to nicotinic acetylcholine receptors.,morphine,CHEMICAL,bind to,nicotinic acetylcholine receptors,CHEMICAL
1646869,The CAP was depressed in a dose-dependent manner by the intravenous administration of the nicotinic antagonist hexamethonium (C6).,CAP,CHEMICAL,be depressed in dose-dependent manner by intravenous administration of,nicotinic antagonist hexamethonium,CHEMICAL
1646869,The CAP was depressed in a dose-dependent manner by the intravenous administration of the nicotinic antagonist hexamethonium (C6).,CAP,CHEMICAL,be depressed in dose-dependent manner by intravenous administration of,nicotinic antagonist hexamethonium,CHEBI
27262936,The synthetic gestagen levonorgestrel (LNG) was previously shown to perturb thyroid hormone-dependent metamorphosis in Xenopus laevis.,LNG,CHEMICAL,perturb,thyroid hormone-dependent metamorphosis,DISEASE
27262936,The synthetic gestagen levonorgestrel (LNG) was previously shown to perturb thyroid hormone-dependent metamorphosis in Xenopus laevis.,synthetic gestagen levonorgestrel,CHEBI,perturb,thyroid hormone-dependent metamorphosis,DISEASE
27262936,"When using an ex vivo organ explant culture approach, direct effects of LNG on both pituitary and thyroid gland gene expression were detecTable Specifically, treatment of pituitary explants with 10nM LNG strongly stimulated dio2 expression and concurrently suppressed tshb expression.",LNG,CHEMICAL,have direct effects on,pituitary expression,DISEASE
27262936,"When thyroid explants were cultured in thyrotropin-containing media, LNG caused similar gene expression changes as seen after 72h in vivo treatment including a very strong repression of thyrotropin-induced slc5a5 expression.",LNG,CHEMICAL,including,strong repression,MENTAL_HEALTH
32966919,Children with autism spectrum disorders (ASD) have lower serum vitamin D and higher serotonin and interleukin (IL)-6 levels compared with healthy children.,autism spectrum disorders,MENTAL_HEALTH,have,D levels,CHEBI
32966919,Children with autism spectrum disorders (ASD) have lower serum vitamin D and higher serotonin and interleukin (IL)-6 levels compared with healthy children.,autism spectrum disorders,MENTAL_HEALTH,have,higher serotonin,CHEMICAL
26497108,"NPSLE patients are more likely to have elevated serum levels of aCL, LA, APL, anti-ribosomal P Abs and anti-neuronal Abs compared with SLE patients.",NPSLE patients,DISEASE,have elevated serum levels of,LA,CHEMICAL
31293404,"The results showed that Fmr1 KO2 mice were hyperactive, had abnormal anxiety-like behavior, were more irritable and aggressive, and had an increased frequency of repetitive behaviors compared to wild-type (WT) littermates, which are all behavioral deficits reminiscent of individuals with FXS.",Fmr1 KO2 mice,CHEMICAL,be,hyperactive,DISEASE
31293404,"The results showed that Fmr1 KO2 mice were hyperactive, had abnormal anxiety-like behavior, were more irritable and aggressive, and had an increased frequency of repetitive behaviors compared to wild-type (WT) littermates, which are all behavioral deficits reminiscent of individuals with FXS.",Fmr1 KO2 mice,CHEMICAL,have increased frequency of,repetitive behaviors,DISEASE
31293404,"We show that the potentiation of extrasynaptic GABA receptors alone, by gaboxadol, is sufficient to normalize numerous behavioral deficits in the FXS model using endpoints that are directly translatable to the clinical presentation of FXS.",extrasynaptic GABA receptors,CHEMICAL,normalize numerous behavioral deficits in,FXS model,DISEASE
31293404,"We show that the potentiation of extrasynaptic GABA receptors alone, by gaboxadol, is sufficient to normalize numerous behavioral deficits in the FXS model using endpoints that are directly translatable to the clinical presentation of FXS.",gaboxadol,CHEMICAL,normalize numerous behavioral deficits in,FXS model,DISEASE
31293404,"We show that the potentiation of extrasynaptic GABA receptors alone, by gaboxadol, is sufficient to normalize numerous behavioral deficits in the FXS model using endpoints that are directly translatable to the clinical presentation of FXS.",extrasynaptic GABA receptors,CHEMICAL,normalize,numerous behavioral deficits,DISEASE
31293404,"We show that the potentiation of extrasynaptic GABA receptors alone, by gaboxadol, is sufficient to normalize numerous behavioral deficits in the FXS model using endpoints that are directly translatable to the clinical presentation of FXS.",gaboxadol,CHEMICAL,normalize,numerous behavioral deficits,DISEASE
30186114,"This reduction of [Cl-]i levels is abolished in rodent models of Fragile X Syndrome and Autism Spectrum Disorders, and its restoration attenuates the severity of the pathological sequels, stressing the importance of the shift at birth (Tyzio et al., 2014).",[Cl-]i levels,CHEMICAL,be abolished in rodent models of,Syndrome Autism Spectrum Disorders,MENTAL_HEALTH
11287050,"CRH concentrations were significantly higher in the CSF than in plasma in both, psychiatric patients and neurological control subjects.",CRH concentrations,CHEMICAL,be higher in,CSF psychiatric patients,DISEASE
22127907,The aim of data presented is to increase knowledge about the morbidity and impact of mental disorders in Spanish psychiatry.,mental disorders,MENTAL_HEALTH,have the morbidity and impact in,Spanish psychiatry,NUTRITION
31476330,A thorough literature search of various databases was conducted to gather data for the alcohol prompted gut microbiome dysbiosis.,alcohol,CHEMICAL,prompt,gut microbiome dysbiosis,DISEASE
21586920,"Clozapine is used for the treatment of refractory schizophrenia, but there are no reports of its use in the above-mentioned situation.",Clozapine,CHEMICAL,be used for treatment of,refractory schizophrenia,MENTAL_HEALTH
7028803,"Acute administration of opiate agonists has sometimes yielded a mild antidepressant response in depression, and naloxone has occasionally been reported beneficial in mania.",opiate agonists,CHEBI,yield mild antidepressant response in,depression,MENTAL_HEALTH
7028803,"Acute administration of opiate agonists has sometimes yielded a mild antidepressant response in depression, and naloxone has occasionally been reported beneficial in mania.",opiate agonists,CHEBI,yield,mild antidepressant response,CHEMICAL
7028803,"Acute administration of opiate agonists has sometimes yielded a mild antidepressant response in depression, and naloxone has occasionally been reported beneficial in mania.",naloxone,CHEMICAL,be reported beneficial in,mania,MENTAL_HEALTH
7028803,Future challenges in depression may rely upon the development of opiate agonists and antagonists with preferential binding to opiate receptor subtypes and preferential distributions to stress particular endogenous opioid systems.,depression,MENTAL_HEALTH,rely,antagonists,CHEBI
7028803,Future challenges in depression may rely upon the development of opiate agonists and antagonists with preferential binding to opiate receptor subtypes and preferential distributions to stress particular endogenous opioid systems.,depression,MENTAL_HEALTH,rely,opiate agonists,CHEBI
35318339,"""Sea urchin lesion syndrome"" is known as sea urchin disease with the progressive development of necrotic epidermal tissue and loss of external organs, including appendages on the outer body surface.",Sea urchin lesion syndrome,NUTRITION,be known as sea urchin disease with progressive development of,necrotic epidermal tissue,DISEASE
35318339,"""Sea urchin lesion syndrome"" is known as sea urchin disease with the progressive development of necrotic epidermal tissue and loss of external organs, including appendages on the outer body surface.",Sea urchin lesion syndrome,NUTRITION,be known as,sea urchin disease,NUTRITION
35318339,"In conclusion, the interaction of V. echinoideorum with injured sea urchin facilitates the development of lesion syndrome and therefore, revealing its potentiality as an opportunistic pathogen.",injured sea urchin,NUTRITION,facilitate in conclusion development of,lesion syndrome,DISEASE
7468100,Persistent hyperosmolality was noted while on 100 mEq sodium intake daily.,Persistent hyperosmolality,DISEASE,be noted,mEq sodium intake,CHEMICAL
7468100,"Nicotine-stimulated neurophysin remained unexpectedly low and below the level of detectability when sampled during the physiologic studies, whereas oestrogen-stimulated neurophysin was elevated during oestrogen stimulation, water loading, and orthostasis procedures.",oestrogen-stimulated neurophysin,CHEMICAL,be elevated during,orthostasis procedures,DISEASE
7468100,"Nicotine-stimulated neurophysin remained unexpectedly low and below the level of detectability when sampled during the physiologic studies, whereas oestrogen-stimulated neurophysin was elevated during oestrogen stimulation, water loading, and orthostasis procedures.",oestrogen-stimulated neurophysin,CHEMICAL,be elevated during,oestrogen stimulation,CHEBI
6835977,Treatment with the mixed dopamine-serotonin agonist lisuride 30 min prior to the test alleviated the memory loss.,mixed dopamine-serotonin agonist lisuride,CHEBI,alleviate,memory loss,DISEASE
6835977,Treatment with the mixed dopamine-serotonin agonist lisuride 30 min prior to the test alleviated the memory loss.,mixed dopamine-serotonin agonist lisuride,CHEMICAL,alleviate,memory loss,DISEASE
33679491,Results: Functional connectivity showed significant interaction effects between AVH Group and ACC-recorded Glu and GABA metabolites.,AVH Group,DISEASE,have significant interaction effects with,ACC-recorded Glu,CHEMICAL
33679491,Results: Functional connectivity showed significant interaction effects between AVH Group and ACC-recorded Glu and GABA metabolites.,ACC-recorded Glu,CHEMICAL,have significant interaction effects with,AVH Group,DISEASE
19418935,"In addition, tactile and visual hallucinations may occur suggesting insect crawling underneath the skin.",visual hallucinations,MENTAL_HEALTH,suggest,insect,NUTRITION
32610494,"Genistein, a soy-derived phytoestrogen, has been shown to exhibit anti-neoplastic activities in various cancers.",soy-derived phytoestrogen,CHEMICAL,exhibit anti-neoplastic activities in,various cancers,DISEASE
32610494,"Genistein, a soy-derived phytoestrogen, has been shown to exhibit anti-neoplastic activities in various cancers.",soy-derived phytoestrogen,CHEBI,exhibit anti-neoplastic activities in,various cancers,DISEASE
32610494,"Genistein, a soy-derived phytoestrogen, has been shown to exhibit anti-neoplastic activities in various cancers.",Genistein,CHEMICAL,exhibit anti-neoplastic activities in,various cancers,DISEASE
32610494,"Aside from the downregulation of epithelial-mesenchymal transition (EMT) in HNC-TICs, genistein restricted their tumor propagating capacities in a dose-dependent fashion.",genistein,CHEMICAL,restrict from downregulation of,tumor propagating capacities,DISEASE
32610494,"Besides, the in vivo study validated that genistein retarded tumor growth through the elevation of miR-34a and suppression of RTCB.",genistein,CHEMICAL,retard,tumor growth,DISEASE
26837765,"Therefore, we investigated whether genistein can promote PpIX accumulation in human lung carcinoma cells.",genistein,CHEMICAL,promote ppix accumulation in,human lung carcinoma cells,DISEASE
26837765,Here we report that treatment of A549 lung carcinoma cells with genistein or a specific ABCG2 inhibitor promoted ALA-mediated accumulation of PpIX by approximately 2-fold.,A549 lung carcinoma cells,DISEASE,have treatment with,genistein,CHEMICAL
26837765,ABCG2 depletion and overexpression studies further revealed that genistein promoted PpIX accumulation via functional repression of ABCG2.,genistein,CHEMICAL,promote ppix accumulation via,functional repression,MENTAL_HEALTH
26837765,"Thus, our results suggest that genistein treatment effectively enhances ALA-induced PpIX accumulation by preventing the ABCG2-mediated efflux of PpIX from lung cancer cells and may represent a promising strategy to improve ALA-based diagnostic approaches in a broader set of malignancies.",genistein treatment,CHEMICAL,prevent abcg2-mediated efflux of ppix from,lung cancer cells,DISEASE
27177910,"To further explore the potential transduction application, this newly isolated shrimp promoter SbaP was comparatively tested with cytomegalovirus (CMV), simian virus 40 (SV40), polyhedrin (Polh), and white spot syndrome virus immediate early gene 1 (WSSV ie1) four constitutive promoters and a beta-actin promoter (TbaP) from tilapia fish to characterize its promoting function in eight different cell lines.",promoter SbaP,CHEMICAL,be tested with,white spot syndrome virus immediate early gene,DISEASE
27177910,"To further explore the potential transduction application, this newly isolated shrimp promoter SbaP was comparatively tested with cytomegalovirus (CMV), simian virus 40 (SV40), polyhedrin (Polh), and white spot syndrome virus immediate early gene 1 (WSSV ie1) four constitutive promoters and a beta-actin promoter (TbaP) from tilapia fish to characterize its promoting function in eight different cell lines.",promoter SbaP,CHEMICAL,be tested with,TbaP,CHEMICAL
27177910,"To further explore the potential transduction application, this newly isolated shrimp promoter SbaP was comparatively tested with cytomegalovirus (CMV), simian virus 40 (SV40), polyhedrin (Polh), and white spot syndrome virus immediate early gene 1 (WSSV ie1) four constitutive promoters and a beta-actin promoter (TbaP) from tilapia fish to characterize its promoting function in eight different cell lines.",promoter SbaP,CHEMICAL,be tested with,polyhedrin,DISEASE
27177910,Comparative analysis revealed that the promoting activity of SbaP was lower (≤10-fold) than CMV but higher (2-20 folds) than Polh in most of these cell lines tested.,SbaP,CHEMICAL,be,≤10-fold,CHEMICAL
27177910,Comparative analysis revealed that the promoting activity of SbaP was lower (≤10-fold) than CMV but higher (2-20 folds) than Polh in most of these cell lines tested.,SbaP,CHEMICAL,be,CMV,DISEASE
33886158,"The endocannabinoids (eCBs), 2-AG and AEA, which act at the primary cannabinoid receptor (CB1), mediate behaviors relevant to neurodevelopmental disorders.",2-AG,CHEMICAL,mediate behaviors relevant to,neurodevelopmental disorders,DISEASE
33886158,"The endocannabinoids (eCBs), 2-AG and AEA, which act at the primary cannabinoid receptor (CB1), mediate behaviors relevant to neurodevelopmental disorders.",endocannabinoids,CHEMICAL,mediate behaviors relevant to,neurodevelopmental disorders,DISEASE
33886158,"These data indicate that reduced 2-AG bioavailability, or CB1 inhibition, each induce unique respective behavioral phenotypes relevant to neurodevelopmental disorders, particularly ASD.",2-AG bioavailability,CHEMICAL,induce unique respective behavioral phenotypes relevant to,neurodevelopmental disorders,DISEASE
33886158,"These data indicate that reduced 2-AG bioavailability, or CB1 inhibition, each induce unique respective behavioral phenotypes relevant to neurodevelopmental disorders, particularly ASD.",2-AG bioavailability,CHEMICAL,induce unique respective behavioral phenotypes relevant to,ASD,DISEASE
32861618,"In European countries, vitamin A toxicity is most often the result of an excessive intake of vitamin supplements and rarely the consequence of the ingestion of a large carnivorous fish liver.",vitamin A toxicity,CHEBI,be result in european countries of excessive intake of,large carnivorous fish liver,DISEASE
32861618,"In European countries, vitamin A toxicity is most often the result of an excessive intake of vitamin supplements and rarely the consequence of the ingestion of a large carnivorous fish liver.",vitamin A toxicity,CHEBI,be result in european countries of excessive intake of,vitamin supplements,CHEBI
29174033,"PfLP has also inducing apoptosis, in cancer cells was revealed by DNA fragmentation assay followed by Giemsa and AO/EBr staining method, showed the apoptotic bodies and condensed nuclei compared to control cells.",cancer cells,DISEASE,be revealed by,DNA fragmentation assay,MENTAL_HEALTH
26556214,This indicated that the combination of lower temperature thermal processes (hot-fill at 75 °C for 15 min) and acidified conditions (pH = 3.8) was sufficient to cause mtDNA fragmentation.,° C,CHEMICAL,cause,mtDNA fragmentation,MENTAL_HEALTH
32892962,Folate is a water-soluble B vitamin that is essential for normal neurodevelopment and abnormalities in the folate and related pathways have been identified in children with ASD.,Folate,CHEBI,be,water-soluble B vitamin,CHEBI
32892962,Autoantibodies which interfere with the function of the folate receptor alpha called folate receptor alpha autoantibodies have been identified in 58%-76% of children with ASD and independent studies have demonstrated that blood titers of these autoantibodies correlate with folate levels in the cerebrospinal fluid.,folate receptor alpha autoantibodies,NUTRITION,be identified in % of children with,ASD studies,DISEASE
32892962,"Most significantly, case-series, open-label, and single and double-blind placebo-controlled studies suggest that d,l-leucovorin, a reduced folate that can bypass the blockage at the folate receptor alpha by using the reduced folate carrier, an alternate pathway, can substantially improve particular symptoms in children with ASD, especially those positive for folate receptor alpha autoantibodies.",reduced folate,NUTRITION,improve particular symptoms in children with,ASD,DISEASE
32892962,"Most significantly, case-series, open-label, and single and double-blind placebo-controlled studies suggest that d,l-leucovorin, a reduced folate that can bypass the blockage at the folate receptor alpha by using the reduced folate carrier, an alternate pathway, can substantially improve particular symptoms in children with ASD, especially those positive for folate receptor alpha autoantibodies.",reduced folate,NUTRITION,improve particular symptoms in children with,folate receptor alpha autoantibodies,NUTRITION
32892962,"Most significantly, case-series, open-label, and single and double-blind placebo-controlled studies suggest that d,l-leucovorin, a reduced folate that can bypass the blockage at the folate receptor alpha by using the reduced folate carrier, an alternate pathway, can substantially improve particular symptoms in children with ASD, especially those positive for folate receptor alpha autoantibodies.",l-leucovorin,CHEMICAL,improve particular symptoms in children with,ASD,DISEASE
32892962,"Most significantly, case-series, open-label, and single and double-blind placebo-controlled studies suggest that d,l-leucovorin, a reduced folate that can bypass the blockage at the folate receptor alpha by using the reduced folate carrier, an alternate pathway, can substantially improve particular symptoms in children with ASD, especially those positive for folate receptor alpha autoantibodies.",l-leucovorin,CHEMICAL,improve particular symptoms in children with,folate receptor alpha autoantibodies,NUTRITION
28770615,Autism spectrum disorder (ASD) has been linked to abnormalities in folate metabolism.,Autism spectrum disorder,MENTAL_HEALTH,be linked to abnormalities in,folate metabolism,CHEBI
28770615,These data suggest that folate pathway abnormalities may be a major metabolic disturbance underlying ASD that can be leveraged as biomarkers to improve symptoms and prevent ASD.,folate pathway abnormalities,CHEBI,be,major metabolic disturbance,DISEASE
35578067,"The ED50 doses (i.e., TPEN ED50: 3.2 μM and TPGS ED50: 34 μM, potency ratio R = 10.62 = TPGS (ED50)/TPEN (ED50)) were identified as dose-effect curve (%DNA fragmentation (sub-G1 phase) versus agent concentration).",TPEN ED50,CHEMICAL,be identified as,curve % DNA fragmentation,MENTAL_HEALTH
35578067,"The apoptotic and oxidative stress effects of combined doses (TPEN 0.1, 0.5, 1 μM) and TPGS (5, 10, 20 μM)) were evaluated by DNA fragmentation (sub-G1 phase), mitochondrial membrane potential, oxidation of stress sensor protein DJ-1, and activation of executer protein CASPASE-3.",TPEN,CHEMICAL,be evaluated by,DNA fragmentation,MENTAL_HEALTH
35569536,"The well diffusion assay, fungal hyphae fragmentation assay and spore germination inhibition assay were used to determine the antifungal activity of the synthesised nanocomposite.",fungal hyphae fragmentation assay,MENTAL_HEALTH,determine,antifungal activity,CHEBI
35569536,"Potential antifungal activity of the synthesised nanocomposite was confirmed by recording zone of inhibition, high rate of hyphae fragmentation and marked spore germination inhibition against the tested fungal strain.",Potential antifungal activity,CHEBI,be confirmed high rate of,hyphae fragmentation,MENTAL_HEALTH
26808641,"Dopamine receptor D2 (DRD2) and catechol-O-methyltransferase (COMT) are important in dopamine system which is proved to be associated with food-anticipatory behavior, food restriction, reward and motivation.",Dopamine receptor D2,CHEMICAL,be important in,dopamine system,CHEMICAL
32745285,"Since these mechanisms are thought to have important roles in the pathophysiology of autism, we hypothesized that Exenatide may have healing effects in autism.",Exenatide,CHEMICAL,have healing effects in,autism,MENTAL_HEALTH
32745285,"We tested this hypothesis by examining the effects of Exenatide in an experimental autism model created by lipopolysaccharide (LPS) exposure in the womb, with behavioral tests, histopathological examinations, and biochemical measurements.",Exenatide,CHEMICAL,have the effects in,experimental autism model,MENTAL_HEALTH
32745285,The autism model was created by administration of LPS (i.p) to pregnant rats on the 10th day of their pregnancy at a dose of 100 µg/kg.,autism model,MENTAL_HEALTH,be created by administration of,LPS,CHEMICAL
32745285,Exenatide therapy shows positive effects on behavioral disorders in an LPS-induced autism model.,Exenatide therapy,CHEMICAL,show positive effects on behavioral disorders in,LPS-induced autism model,MENTAL_HEALTH
32745285,Exenatide therapy shows positive effects on behavioral disorders in an LPS-induced autism model.,Exenatide therapy,CHEMICAL,show positive effects on,behavioral disorders,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,different liver diseases,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,Gilbert disease,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,postnecrotic cirrhosis,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,chronic alcholic hepatitis,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,alcoholic cirrhosis,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,cholestasis syndrome,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,active hepatitis,DISEASE
23644,"Serum gamma-glutamyl transpeptidase (gamma-GT) level was estimated in 132 patients with different liver diseases (chronic persistent and chronic active hepatitis, postnecrotic cirrhosis, chronic alcholic hepatitis and alcoholic cirrhosis, cholestasis syndrome, fatty liver, Gilbert disease) and malignancies with and without liver involvement.",Serum gamma-glutamyl transpeptidase,CHEMICAL,be estimated in patients with,fatty liver,DISEASE
35579204,"Lamotrigine, approved for use as an antiseizure medication (ASM) as well as the treatment of bipolar disorder, inhibits sodium channels in the brain to reduce repetitive neuronal firing and pathological release of glutamate.",Lamotrigine,CHEMICAL,inhibit,sodium channels,CHEMICAL
35579204,"Lamotrigine, approved for use as an antiseizure medication (ASM) as well as the treatment of bipolar disorder, inhibits sodium channels in the brain to reduce repetitive neuronal firing and pathological release of glutamate.",Lamotrigine,CHEMICAL,reduce repetitive neuronal firing and pathological release of,glutamate,CHEMICAL
25907553,"A novel peroxisome proliferator-activated receptor (PPAR) modulator, Z-551, having both PPARα agonistic and PPARγ antagonistic activities, has been developed for the treatment of obesity and obesity-related metabolic disorders.",novel peroxisome proliferator-activated receptor PPAR modulator,CHEBI,be developed for treatment of,obesity-related metabolic disorders,DISEASE
25907553,"A novel peroxisome proliferator-activated receptor (PPAR) modulator, Z-551, having both PPARα agonistic and PPARγ antagonistic activities, has been developed for the treatment of obesity and obesity-related metabolic disorders.",novel peroxisome proliferator-activated receptor PPAR modulator,CHEBI,be developed for treatment of,obesity,DISEASE
9296416,A single dose of epidural morphine (4 mg) decreases postcesarean opioid analgesic requirements and may reduce or prevent neonatal neurobehavioral depression associated with PCA meperidine.,epidural morphine,CHEMICAL,prevent,neonatal neurobehavioral depression,MENTAL_HEALTH
9296416,A single dose of epidural morphine (4 mg) decreases postcesarean opioid analgesic requirements and may reduce or prevent neonatal neurobehavioral depression associated with PCA meperidine.,epidural morphine,CHEMICAL,decrease,opioid analgesic requirements,CHEBI
9296416,"Average PCA opioid consumption through 48 h postpartum was equivalent (0.54 mg/kg morphine and 4.7 mg/kg meperidine); however, even with these small doses, meperidine was associated with significantly poorer neonatal alertness and orientation than morphine.",meperidine,CHEMICAL,be associated with small doses with,orientation,MENTAL_HEALTH
9296416,"Average PCA opioid consumption through 48 h postpartum was equivalent (0.54 mg/kg morphine and 4.7 mg/kg meperidine); however, even with these small doses, meperidine was associated with significantly poorer neonatal alertness and orientation than morphine.",meperidine,CHEMICAL,be associated with small doses with,morphine,CHEMICAL
9296416,Morphine is the PCA opioid of choice for postcesarean analgesia among nursing parturients.,Morphine,CHEMICAL,be pca opioid of choice for,postcesarean analgesia,MENTAL_HEALTH
3033599,"The effect of increasing age on contractile performance and catecholamine receptor activity was investigated in a distal, predominantly fast twitch oxidative glycolytic (FOG) muscle from the plantar surface of the rat hindfoot.",catecholamine receptor activity,CHEMICAL,be investigated in,distal twitch glycolytic FOG muscle,DISEASE
3033599,Contracture tension was approximately 25% of twitch tension and was maintained for 2-10 min in the continued presence of catecholamine.,Contracture tension,DISEASE,be maintained for,catecholamine,CHEMICAL
3033599,Contracture tension was approximately 25% of twitch tension and was maintained for 2-10 min in the continued presence of catecholamine.,Contracture tension,DISEASE,be % of,twitch tension,DISEASE
31977066,Treatment with thyroid hormones is occasionally used in the management of treatment-resistant depression.,thyroid hormones,CHEBI,be used in management of,treatment-resistant depression,MENTAL_HEALTH
32882472,The edge plane pyrolytic graphite sensing platform is recommended as a potential contender for the accurate and fast determination of fluvoxamine in depression medications as well as biological specimens of OCD patients.,fluvoxamine,CHEMICAL,have the accurate and fast determination in,depression medications,MENTAL_HEALTH
22093686,Accidental or intentional subcutaneous and/or intramuscular injection of metallic mercury is an uncommon form of poisoning.,metallic mercury,NUTRITION,be uncommon form of,poisoning,DISEASE
28307396,"For example, the adaptive significance for an association of green coloration of ripe fruit with impersistence (dropping when ripe), as in S. sarrachoides and some S. ptychanthum, may relate more to photosynthesis and carbon balance in detached fruits than to disperser attraction.",impersistence,DISEASE,relate for example more to,carbon balance,CHEMICAL
23179959,"In contrast to CAP patients, NHCAP patients included more elderly patients requiring nursing care and revealed higher rates of poor nutrition, dementia, aspiration, severe cases, detection of drug-resistant bacteria, and mortality.",NHCAP patients,DISEASE,reveal higher rates of,dementia,MENTAL_HEALTH
23179959,"In contrast to CAP patients, NHCAP patients included more elderly patients requiring nursing care and revealed higher rates of poor nutrition, dementia, aspiration, severe cases, detection of drug-resistant bacteria, and mortality.",NHCAP patients,DISEASE,include in contrast to,CAP patients,DISEASE
23179959,"The severity of pneumonia rather than risk of resistant bacteria should be considered, in addition to ethical concerns, in initial treatment strategy in NHCAP to avoid excessive use of broad-spectrum antimicrobials.",pneumonia,DISEASE,avoid excessive use of,broad-spectrum antimicrobials,CHEBI
32696274,"In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain.",auricular electroacupuncture,CHEMICAL,attenuate,chemotherapy-induced neuropathic pain,DISEASE
32696274,"In particular, we demonstrate that VNS via auricular electroacupuncture effectively attenuates chemotherapy-induced neuropathic pain.",VNS,CHEMICAL,attenuate,chemotherapy-induced neuropathic pain,DISEASE
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",used fungicides,CHEBI,be based on,mixture,CHEBI
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Fludioxonil,CHEMICAL,express as,microcephaly,DISEASE
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Fludioxonil,CHEMICAL,express as,marked edema,DISEASE
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Fludioxonil,CHEMICAL,express as,cellular dissociation,MENTAL_HEALTH
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Metalaxyl-M. Maxim ® XL exposure,CHEMICAL,express as,microcephaly,DISEASE
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Metalaxyl-M. Maxim ® XL exposure,CHEMICAL,express as,marked edema,DISEASE
27214195,"Maxim(®) XL, one of the most used fungicides in Argentina, is based on a mixture of two active ingredients: Fludioxonil and Metalaxyl-M. Maxim(®) XL exposure induced severe sublethal effects on the embryos, expressed as general underdevelopment, axial flexures, microcephaly, cellular dissociation, abnormal pigmentation, underdeveloped gills, marked edema and wavy tail.",Metalaxyl-M. Maxim ® XL exposure,CHEMICAL,express as,cellular dissociation,MENTAL_HEALTH
35430210,Barth syndrome (BTHS) and dilated cardiomyopathy with ataxia syndrome (DCMA) are biochemically characterized by high levels of 3-methylglutaric acid (MGA) in the urine and plasma of affected patients.,Barth syndrome,DISEASE,be characterized by high levels of,3-methylglutaric acid,CHEMICAL
35430210,Barth syndrome (BTHS) and dilated cardiomyopathy with ataxia syndrome (DCMA) are biochemically characterized by high levels of 3-methylglutaric acid (MGA) in the urine and plasma of affected patients.,ataxia syndrome,DISEASE,be characterized by high levels of,3-methylglutaric acid,CHEMICAL
35430210,Barth syndrome (BTHS) and dilated cardiomyopathy with ataxia syndrome (DCMA) are biochemically characterized by high levels of 3-methylglutaric acid (MGA) in the urine and plasma of affected patients.,dilated cardiomyopathy,DISEASE,be characterized by high levels of,3-methylglutaric acid,CHEMICAL
33667603,"Conventional wisdom indicates that an ""ounce of prevention is worth a pound of cure,"" a perspective bolstered by some studies demonstrating that psychological interventions for subthreshold depression reduce acute symptoms and prevent the onset of major depressive disorder (MDD) over short-term follow-up.",subthreshold depression,MENTAL_HEALTH,prevent onset of,major depressive disorder,MENTAL_HEALTH
33667603,"Conventional wisdom indicates that an ""ounce of prevention is worth a pound of cure,"" a perspective bolstered by some studies demonstrating that psychological interventions for subthreshold depression reduce acute symptoms and prevent the onset of major depressive disorder (MDD) over short-term follow-up.",subthreshold depression,MENTAL_HEALTH,prevent onset of,MDD,DISEASE
2901266,"A higher incidence of central nervous system side effects (insomnia, bizarre dreams, depression, hallucinations, dizziness), however, was seen with propranolol than with betaxolol.",insomnia,MENTAL_HEALTH,be seen with,propranolol,CHEMICAL
2901266,"A higher incidence of central nervous system side effects (insomnia, bizarre dreams, depression, hallucinations, dizziness), however, was seen with propranolol than with betaxolol.",insomnia,MENTAL_HEALTH,be seen with,betaxolol,CHEMICAL
3836818,"During fractional desynchronization of circadian rhythms by increasing imposed 'day' length (26-29 h, 24 days, 500 lux), 5 mg melatonin per os at lights-out in two subjects resulted in better entrainment of the fatigue rhythm to the zeitgeber than in five out of six control subjects, without major consistent effects on other measured circadian variables.",melatonin,CHEMICAL,result in better entrainment of,fatigue rhythm,MENTAL_HEALTH
3836818,"The results suggest that fatigue (or alertness) may be entrained by melatonin, but whether critical performance rhythms can be suitably manipulated remains to be clarified.",fatigue,MENTAL_HEALTH,be entrained by,melatonin,CHEMICAL
26659384,Attenuation of the neural signals from the leg muscles with intrathecal fentanyl injection reduced the blood pressure of hypertensive men during cycling exercise to a level comparable to that of normotensive men.,intrathecal fentanyl injection,CHEMICAL,reduce blood pressure of,hypertensive men,DISEASE
26659384,"Moreover, fentanyl increased the responses of vascular conductance and stroke volume to exercise (P  0.05).",fentanyl,CHEMICAL,increase responses of,conductance stroke volume,DISEASE
19630686,"ABSTRACT beta-Adrenergic blockers appear to be effective in the management of verbal aggression, physical aggression, or self-injurious behavior associated with mental retardation and other developmental disorders.",ABSTRACT beta-Adrenergic blockers,CHEBI,appear to effective in management of,verbal aggression,DISEASE
19630686,"ABSTRACT beta-Adrenergic blockers appear to be effective in the management of verbal aggression, physical aggression, or self-injurious behavior associated with mental retardation and other developmental disorders.",ABSTRACT beta-Adrenergic blockers,CHEBI,appear to effective in management of,physical aggression,DISEASE
19630686,"ABSTRACT beta-Adrenergic blockers appear to be effective in the management of verbal aggression, physical aggression, or self-injurious behavior associated with mental retardation and other developmental disorders.",ABSTRACT beta-Adrenergic blockers,CHEBI,appear to effective in management of,self-injurious behavior,DISEASE
19630686,"Children and adolescents with mental retardation or developmental disorders appear to respond to particularly low doses (e.g., below propranolol 150 mg daily).",mental retardation,MENTAL_HEALTH,respond to,propranolol,CHEMICAL
19630686,"Propranolol is recommended for central blockade, and nadolol is recommended for peripheral blockade.",nadolol,CHEMICAL,be recommended for,peripheral blockade,DISEASE
8908247,"Analysis of the specific [3H]-prazosin binding indicates that prazosin binds to a single class of high-affinity sites with a dissociation constant, kd, of 2.9 x 10(-9) M and a maximum number of binding sites, Bmax, of 30 fmol/mg dry tissue.",prazosin,CHEMICAL,bind to single class of high-affinity sites with,dissociation constant,MENTAL_HEALTH
6275904,"Displacement by the selective alpha-adrenergic drugs prazosin, clonidine, and yohimbine yielded biphasic curves consistent with binding of [3H]norepinephrine to both alpha 1-(14-22%) and alpha 2-(78-86%) receptor subtypes.",yohimbine,CHEMICAL,yield biphasic curves consistent with binding of,[3H]norepinephrine,CHEMICAL
6275904,"Displacement by the selective alpha-adrenergic drugs prazosin, clonidine, and yohimbine yielded biphasic curves consistent with binding of [3H]norepinephrine to both alpha 1-(14-22%) and alpha 2-(78-86%) receptor subtypes.",drugs prazosin,CHEMICAL,yield biphasic curves consistent with binding of,[3H]norepinephrine,CHEMICAL
6275904,"Displacement by the selective alpha-adrenergic drugs prazosin, clonidine, and yohimbine yielded biphasic curves consistent with binding of [3H]norepinephrine to both alpha 1-(14-22%) and alpha 2-(78-86%) receptor subtypes.",drugs prazosin,CHEBI,yield biphasic curves consistent with binding of,[3H]norepinephrine,CHEMICAL
6275904,"Displacement by the selective alpha-adrenergic drugs prazosin, clonidine, and yohimbine yielded biphasic curves consistent with binding of [3H]norepinephrine to both alpha 1-(14-22%) and alpha 2-(78-86%) receptor subtypes.",Displacement,MENTAL_HEALTH,yield biphasic curves consistent with binding of,[3H]norepinephrine,CHEMICAL
6275904,"Displacement by the selective alpha-adrenergic drugs prazosin, clonidine, and yohimbine yielded biphasic curves consistent with binding of [3H]norepinephrine to both alpha 1-(14-22%) and alpha 2-(78-86%) receptor subtypes.",clonidine,CHEMICAL,yield biphasic curves consistent with binding of,[3H]norepinephrine,CHEMICAL
33485839,Gut microbiota (GM) contribute to obesity and insulin resistance (IR).,GM,CHEMICAL,contribute to,obesity,DISEASE
33485839,Gut microbiota (GM) contribute to obesity and insulin resistance (IR).,GM,CHEMICAL,contribute to,insulin resistance,MENTAL_HEALTH
33485839,"Obstructive sleep apnea (OSA), characterized by intermittent hypoxia (IH), promotes IR and alters GM.",Obstructive sleep apnea,MENTAL_HEALTH,alter,GM,CHEMICAL
30790604,"The Cnd-m3a peptide showed quite low hemolytic activity and weak cytotoxic effect against human primary and tumor cell lines, but high antimicrobial activity against selected Gram - human pathogens.",Cnd-m3a peptide,CHEMICAL,show low hemolytic activity and weak cytotoxic effect against,tumor,DISEASE
30144565,Increased expression of this gene during bacterial infection in channel catfish and rohu suggested its potential involvement in bacterial disease response in fish.,channel catfish,NUTRITION,suggest its potential involvement in,bacterial disease response,DISEASE
30144565,Increased expression of this gene during bacterial infection in channel catfish and rohu suggested its potential involvement in bacterial disease response in fish.,bacterial infection,DISEASE,suggest its potential involvement in,bacterial disease response,DISEASE
27987053,"We present the case of a woman with bipolar I disorder with severe premenstrual mood instability, confusion, and psychosis resembling the clinical features of postpartum psychosis when estrogen levels are expected to be low, and hypomania when estrogen levels are expected to be elevated.",estrogen levels,CHEBI,be expected to,hypomania,MENTAL_HEALTH
18805301,"The treatment of narcolepsy includes stimulants against sleepiness (modafinil, methylphenidate), anticataplectic drugs (antidepressants) and sodium oxybate.",narcolepsy,MENTAL_HEALTH,include stimulants against,sodium oxybate,CHEMICAL
18805301,"The treatment of narcolepsy includes stimulants against sleepiness (modafinil, methylphenidate), anticataplectic drugs (antidepressants) and sodium oxybate.",narcolepsy,MENTAL_HEALTH,include stimulants against,methylphenidate,CHEMICAL
18805301,"The treatment of narcolepsy includes stimulants against sleepiness (modafinil, methylphenidate), anticataplectic drugs (antidepressants) and sodium oxybate.",narcolepsy,MENTAL_HEALTH,include stimulants against,modafinil,CHEMICAL
18805301,"The treatment of narcolepsy includes stimulants against sleepiness (modafinil, methylphenidate), anticataplectic drugs (antidepressants) and sodium oxybate.",narcolepsy,MENTAL_HEALTH,include stimulants against,antidepressants,CHEMICAL
18805301,"The treatment of narcolepsy includes stimulants against sleepiness (modafinil, methylphenidate), anticataplectic drugs (antidepressants) and sodium oxybate.",narcolepsy,MENTAL_HEALTH,include stimulants against,sleepiness,MENTAL_HEALTH
15571485,Hypnagogic hallucinations and sleep paralysis respond to antidepressants.,Hypnagogic hallucinations,MENTAL_HEALTH,respond to,antidepressants,CHEMICAL
2539235,Anticonvulsant activity in a wide variety of experimental seizure models can be obtained by enhancing gamma-aminobutyric acid (GABA) transmission within the pars reticulata of substantia nigra.,experimental seizure models,DISEASE,enhance,gamma-aminobutyric acid GABA transmission,CHEMICAL
35222233,Sleep disorders (SDs) represent an important issue in patients with craniopharyngioma (CP).,Sleep disorders,DISEASE,represent important issue in patients with,craniopharyngioma,DISEASE
33939334,"Embryonic exposure to ethanol leads to a condition of physical, behavioral, and cognitive deficiencies named fetal alcohol spectrum disorders (FASD).",ethanol,CHEMICAL,lead to condition of,deficiencies,DISEASE
29553888,"Lepomis macrochirus (bluegill sunfish) and hybrid sunfish displayed the highest infection intensities, whereas Lepomis cyanellus (green sunfish) and Lepomis gulosus (warmouth sunfish) were significantly less burdened.",bluegill sunfish,NUTRITION,display,highest infection intensities,DISEASE
23606235,"A recommendation for the predictive regression relationship is based on 96-h FET and AFT data: log FET median lethal concentration (LC50) = (0.989 × log fish LC50) - 0.195; n = 72 chemicals, r = 0.95, p < 0.001, LC50 in mg/L. A similar, not statistically different regression was developed for the entire data set (n = 144 chemicals, unreliable studies deleted).",predictive regression relationship,MENTAL_HEALTH,be based on,similar different regression,MENTAL_HEALTH
34517517,"The monoMonokGap method was used to extract the frequency characteristics of presynaptic and postsynaptic neurotoxin sequences and carry out feature selection, then, based on the important features obtained after dimensionality reduction, the prediction model Neu_LR was constructed using a logistic regression algorithm, and ten-fold cross-validation and independent test set validation were used.",Neu_LR,CHEMICAL,use,regression algorithm,MENTAL_HEALTH
35255473,"In addition, there is concern about the increasing abuse of benzodiazepines, which are either diverted from therapeutic use or appear on the illicit market, often as new benzodiazepines.10,12 According to the European Monitoring Center for Drugs and Drug Addiction (EMCDDA), ""the drug market has been remarkably resilient to disruption caused by the pandemic"" … Drug trafficking has adapted to the new conditions with changes in routes and methods of trafficking, and by further enhancing the digital presence of the drug market… ""Any reductions in drug consumption seen during the initial lockdowns rapidly disappeared as social distancing measures were eased.",… Drug trafficking,CHEBI,enhance digital presence of,drug market,CHEBI
21497284,The scopolamine patch is usually used to reduce postoperative nausea and vomiting associated with anesthesia and/or surgery.,scopolamine patch,CHEMICAL,reduce,vomiting,DISEASE
21497284,Transdermal scopolamine patches have been used for decades and there are few reports in the literature of toxic psychosis associated with the product.,scopolamine patches,CHEMICAL,be few reports in literature of,toxic psychosis,MENTAL_HEALTH
26022661,"Although much is known about the characteristics of DA D2 receptor antagonism on effort-related choice behavior, less is known about the effects of D1 antagonism, and agonist/antagonist interactions.",DA D2 receptor antagonism,CHEMICAL,have the characteristics on,effort-related choice behavior,DISEASE
31514310,"In this work, a green method for the extraction of steviol glycosides from stevia leaves was optimized by applying a factorial screening design of five variables (time, temperature, agitation, grinding, and sample-solvent ratio) and the subsequent response surface design of Box-Behnken.",stevia leaves,CHEMICAL,apply factorial screening design of,agitation,MENTAL_HEALTH
31514310,"In this work, a green method for the extraction of steviol glycosides from stevia leaves was optimized by applying a factorial screening design of five variables (time, temperature, agitation, grinding, and sample-solvent ratio) and the subsequent response surface design of Box-Behnken.",steviol glycosides,CHEMICAL,apply factorial screening design of,agitation,MENTAL_HEALTH
34348413,"This is important to know, as individuals with bipolar depression may attempt to treat themselves with psychedelics while on a mood stabilizer, particularly given enthusiastic media reports of the efficacy of psilocybin for depression.",psilocybin,CHEMICAL,have the efficacy for,depression,MENTAL_HEALTH
33759401,"Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs.",Excessive daytime sleepiness,MENTAL_HEALTH,affect large percentage of parkinson's,PD,DISEASE
32869676,"Nonergot dopamine agonists (NEDA) represent an excellent treatment option for Parkinson's disease (PD) patients, in both early and advanced stages of the disease.",Nonergot dopamine agonists,CHEMICAL,represent excellent treatment option for parkinson's,PD,DISEASE
32869676,"Nonergot dopamine agonists (NEDA) represent an excellent treatment option for Parkinson's disease (PD) patients, in both early and advanced stages of the disease.",Nonergot dopamine agonists,CHEBI,represent excellent treatment option for parkinson's,PD,DISEASE
32869676,"Nonergot dopamine agonists (NEDA) represent an excellent treatment option for Parkinson's disease (PD) patients, in both early and advanced stages of the disease.",NEDA,CHEMICAL,represent excellent treatment option for parkinson's,PD,DISEASE
35147699,Zolpidem tartrate is a sedative-hypnotic drug used for the short-term treatment of insomnia in adults and its use has been implicated in many suicide cases worldwide.,sedative-hypnotic drug,CHEBI,be implicated in,many suicide cases,MENTAL_HEALTH
35147699,Zolpidem tartrate is a sedative-hypnotic drug used for the short-term treatment of insomnia in adults and its use has been implicated in many suicide cases worldwide.,Zolpidem tartrate,CHEMICAL,used for short-term treatment of,insomnia,MENTAL_HEALTH
35147699,"Fresh chopped liver of buffalo Bubalus bubalis (Artiodactyla: Bovidae) containing different concentrations of Zolpidem tartrate was given to S. ruficornis larvae to evaluate the effect of Zolpidem tartrate on the developmental rate of the different stages, life cycle duration, and the morphological parameters.",buffalo Bubalus bubalis,DISEASE,evaluate effect of,Zolpidem tartrate,CHEMICAL
35147699,"Thus, when Zolpidem tartrate may be the cause of death, the entomological evidence needs to be analyzed so it takes zolpidem-related changes to the mPMI into account.",Zolpidem tartrate,CHEMICAL,be cause of,death,DISEASE
27291138,"Recent evidences show that activation of serotonin 2A receptors (5-HT2A R) by agonists is significant in improving therapeutic activity of disease conditions, such as obsessive-compulsive disorder (OCD).",serotonin 2A receptors,CHEMICAL,improve therapeutic activity of,OCD,DISEASE
27291138,"Recent evidences show that activation of serotonin 2A receptors (5-HT2A R) by agonists is significant in improving therapeutic activity of disease conditions, such as obsessive-compulsive disorder (OCD).",serotonin 2A receptors,CHEMICAL,improve therapeutic activity of,obsessive-compulsive disorder,MENTAL_HEALTH
27291138,"Recent evidences show that activation of serotonin 2A receptors (5-HT2A R) by agonists is significant in improving therapeutic activity of disease conditions, such as obsessive-compulsive disorder (OCD).",agonists,CHEBI,improve therapeutic activity of,OCD,DISEASE
27291138,"Recent evidences show that activation of serotonin 2A receptors (5-HT2A R) by agonists is significant in improving therapeutic activity of disease conditions, such as obsessive-compulsive disorder (OCD).",agonists,CHEBI,improve therapeutic activity of,obsessive-compulsive disorder,MENTAL_HEALTH
27291138,"Several other reports have also demonstrated association of OCD with lower dopamine receptor (D2 R) availability, primarily in the striatum of the brain along with dysfunction of 5-HT2A R-D2 R heteromer regulation.",OCD,DISEASE,have association with,lower dopamine receptor,CHEMICAL
31483604,"Taking cues from the body's own defense mechanism against infection and blood clotting (thrombosis) via the endogenous gasotransmitter nitric oxide (NO), both of these issues are addressed through the development of a layered S-nitroso-N-acetylpenicillamine (SNAP)-doped polymer with a blended selenium (Se)-polymer interface.",(SNAP)-doped polymer,CHEBI,have the development with,selenium (Se)-polymer,CHEMICAL
18005058,"We show for the first time that brains from Fmr1-knockout mice, a validated model for the syndrome, display higher levels of reactive oxygen species, nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation, lipid peroxidation and protein oxidation than brains from wild-type mice.",Fmr1-knockout mice,DISEASE,display higher levels of,reactive oxygen species,CHEMICAL
18005058,"We show for the first time that brains from Fmr1-knockout mice, a validated model for the syndrome, display higher levels of reactive oxygen species, nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation, lipid peroxidation and protein oxidation than brains from wild-type mice.",Fmr1-knockout mice,DISEASE,display higher levels of,nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation,CHEMICAL
18005058,"We show for the first time that brains from Fmr1-knockout mice, a validated model for the syndrome, display higher levels of reactive oxygen species, nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation, lipid peroxidation and protein oxidation than brains from wild-type mice.",Fmr1-knockout mice,DISEASE,display higher levels of,nicotinamide adenine dinucleotide phosphate (NADPH)-oxidase activation,CHEBI
18005058,FMR1-knockout mice lacking Fragile X mental retardation protein were compared with congenic FVB129 wild-type controls.,FMR1-knockout mice,CHEMICAL,be compared with,congenic FVB129 wild-type controls,CHEMICAL
33849704,"Naldemedine is the newest orally available, peripherally selective μ-opioid receptor antagonist blocker approved for opioid-induced constipation (OIC) treatment in adult patients.",Naldemedine,CHEMICAL,approved for,constipation treatment,DISEASE
33849704,"Naldemedine is the newest orally available, peripherally selective μ-opioid receptor antagonist blocker approved for opioid-induced constipation (OIC) treatment in adult patients.",Naldemedine,CHEMICAL,approved for,OIC,DISEASE
33517900,Naldemedine (NAL) is widely used for the treatment of OIC.,NAL,CHEMICAL,be used for treatment of,OIC,DISEASE
33517900,Naldemedine (NAL) is widely used for the treatment of OIC.,Naldemedine,CHEMICAL,be used for treatment of,OIC,DISEASE
33517900,"However, diarrhea has been reported as the most common treatment-emergent AE of NAL, and little is known about the risk factors associated with the development of diarrhea during NAL administration.",diarrhea,DISEASE,be reported as common treatment-emergent ae of,NAL,CHEMICAL
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",acting μ-opioid receptor antagonist,CHEBI,be effective for,opioid-induced constipation,DISEASE
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",acting μ-opioid receptor antagonist,CHEBI,be effective for,OIC,DISEASE
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",Naldemedine,CHEMICAL,be effective for,opioid-induced constipation,DISEASE
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",Naldemedine,CHEMICAL,be effective for,OIC,DISEASE
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",NAL,CHEMICAL,be effective for,opioid-induced constipation,DISEASE
34334493,"Naldemedine (NAL), a peripherally acting μ-opioid receptor antagonist, is effective for opioid-induced constipation (OIC).",NAL,CHEMICAL,be effective for,OIC,DISEASE
34334493,"The results of multiple logistic regression analyses identified the administration of opioid analgesics for 8 d or longer before the initiation of NAL (odds ratio (OR): 2.20, 95% confidence interval (95% CI): 1.04-4.64, p = 0.039), the combination of a laxative (OR: 2.22, 95%CI: 1.03-4.81, p = 0.042), and the combination of CYP3A4 inhibitors (strong/moderate) (OR: 2.80, 95%CI: 1.02-7.67, p = 0.045) as risk factors.",multiple regression analyses,MENTAL_HEALTH,identify administration of opioid analgesics for,NAL,CHEMICAL
34334493,"The results of multiple logistic regression analyses identified the administration of opioid analgesics for 8 d or longer before the initiation of NAL (odds ratio (OR): 2.20, 95% confidence interval (95% CI): 1.04-4.64, p = 0.039), the combination of a laxative (OR: 2.22, 95%CI: 1.03-4.81, p = 0.042), and the combination of CYP3A4 inhibitors (strong/moderate) (OR: 2.80, 95%CI: 1.02-7.67, p = 0.045) as risk factors.",multiple regression analyses,MENTAL_HEALTH,identify administration of,opioid analgesics,CHEBI
34334493,"Furthermore, diarrhea may be controlled by the initiation of NAL within 7 d of opioid analgesics and, where possible, the discontinuation of or change in the combination of moderate or strong CYP3A4 inhibitors.",diarrhea,DISEASE,be controlled by initiation of nal within,opioid analgesics,CHEBI
34334493,"Furthermore, diarrhea may be controlled by the initiation of NAL within 7 d of opioid analgesics and, where possible, the discontinuation of or change in the combination of moderate or strong CYP3A4 inhibitors.",diarrhea,DISEASE,be controlled by initiation of,NAL,CHEMICAL
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,compete with,agonist,CHEBI
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,compete with,trnas-ACPD,CHEMICAL
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,compete with,1R,CHEMICAL
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,compete with,3S-ACPD,CHEMICAL
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,compete with,equimolecular mixture,CHEBI
12500101,"The following experiments were performed to determine whether acamprosate could compete with trnas-ACPD (+/--1-aminocyclopentane-trans-1,3-dicarboxylic acid, an equimolecular mixture of 1S, 3R and 1R, 3S-ACPD and an agonist at both group I and group II mGluRs) sensitive binding sites and protect against trans-ACPD-induced neurotoxicity in organotypic hippocampal slice cultures.",acamprosate,CHEMICAL,protect against,trans-ACPD-induced neurotoxicity,DISEASE
25158972,"The roles for the carnosine-stimulated/mediated neuronal histamine system are proposed as a danger and physiological response system active in protection from neurodegenerative diseases and in management of cognitive deficits, depression and intellectual disabilities.",carnosine-stimulated/mediated neuronal histamine system,CHEMICAL,be proposed as danger and physiological response system active in protection from neurodegenerative diseases and in,intellectual disabilities,DISEASE
25158972,"The roles for the carnosine-stimulated/mediated neuronal histamine system are proposed as a danger and physiological response system active in protection from neurodegenerative diseases and in management of cognitive deficits, depression and intellectual disabilities.",carnosine-stimulated/mediated neuronal histamine system,CHEMICAL,be proposed as danger and physiological response system active in protection from neurodegenerative diseases and in,cognitive deficits,DISEASE
25158972,"The roles for the carnosine-stimulated/mediated neuronal histamine system are proposed as a danger and physiological response system active in protection from neurodegenerative diseases and in management of cognitive deficits, depression and intellectual disabilities.",carnosine-stimulated/mediated neuronal histamine system,CHEMICAL,be proposed as danger and physiological response system active in protection from neurodegenerative diseases and in,depression,MENTAL_HEALTH
25158972,"The roles for the carnosine-stimulated/mediated neuronal histamine system are proposed as a danger and physiological response system active in protection from neurodegenerative diseases and in management of cognitive deficits, depression and intellectual disabilities.",carnosine-stimulated/mediated neuronal histamine system,CHEMICAL,be proposed as danger and physiological response system active in protection from,neurodegenerative diseases,DISEASE
23292617,Affected patients with hypogonadism have unnaturally low amounts of sex hormones that produce male and female sex characteristics.,hypogonadism,DISEASE,have low amounts of,sex hormones,CHEBI
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",L-3-n-butylphthalide,CHEMICAL,ameliorate cognitive dysfunction in,ischemia,DISEASE
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",L-3-n-butylphthalide,CHEMICAL,ameliorate,cognitive dysfunction,DISEASE
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",graveolens Linn,CHEMICAL,ameliorate cognitive dysfunction in,ischemia,DISEASE
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",graveolens Linn,CHEMICAL,ameliorate,cognitive dysfunction,DISEASE
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",Chinese celery,NUTRITION,ameliorate cognitive dysfunction in,ischemia,DISEASE
30050437,"Recent studies suggest that L-3-n-butylphthalide (NBP), an extract from the seeds of Apium graveolens Linn. (Chinese celery), ameliorates cognitive dysfunction in ischemia and/or Alzheimer's disease animal models.",Chinese celery,NUTRITION,ameliorate,cognitive dysfunction,DISEASE
26184920,Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.,CAH,DISEASE,be exposed to elevated androgen levels in utero as result of,endogenous cortisol deficiency,CHEMICAL
26184920,Congenital adrenal hyperplasia (CAH) is a chronic condition and individuals are exposed to elevated androgen levels in utero as a result of the endogenous cortisol deficiency.,CAH,DISEASE,be exposed to,elevated androgen levels,CHEBI
26184920,"Any psychiatric diagnoses were more common in CAH females compared with female and male population controls [1.9 (1.4-2.5), and 2.2 (1.7-2.9)].",psychiatric diagnoses,DISEASE,be common in,CAH females,CHEMICAL
34505919,Impaired glucose tolerance (IGT) is a pathophysiological condition characterized by insulin resistance with known metabolic consequences such as postprandial hyperglycemia and hypertriglyceridemia.,Impaired glucose tolerance,CHEMICAL,characterized by insulin resistance with known metabolic consequences such as,hypertriglyceridemia,DISEASE
34505919,Impaired glucose tolerance (IGT) is a pathophysiological condition characterized by insulin resistance with known metabolic consequences such as postprandial hyperglycemia and hypertriglyceridemia.,Impaired glucose tolerance,CHEMICAL,characterized by insulin resistance with known metabolic consequences such as,postprandial hyperglycemia,DISEASE
34505919,Impaired glucose tolerance (IGT) is a pathophysiological condition characterized by insulin resistance with known metabolic consequences such as postprandial hyperglycemia and hypertriglyceridemia.,Impaired glucose tolerance,CHEMICAL,characterized by,insulin resistance,MENTAL_HEALTH
35028874,"In patients with RVO, vitamin B12 levels at diagnosis were significantly lower than in controls and independently predicted worse clinical outcome at multivariate analysis (OR 3.2; CIs 1.2-8.2; p = 0.015).",vitamin B12 levels,CHEBI,be lower in patients with,RVO,DISEASE
35028874,Our data suggest the opportunity to prospectively evaluate the effect on visual outcome of cyanocobalamin supplementation in RVO patients.,cyanocobalamin supplementation,CHEBI,have visual outcome in,RVO patients,DISEASE
32766240,"Therefore, its therapeutic effect on diabetic kidney disease was investigated in view of reactive oxygen (ROS) and extracellular matrix (ECM) generation in human glomerular mesangial cells under high glucose.",diabetic kidney disease,DISEASE,be investigated in view of,oxygen generation,CHEMICAL
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",Reactive oxygen species,CHEMICAL,be generated as host defense mechanism for killing of,visceral leishmaniasis,DISEASE
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",Reactive oxygen species,CHEMICAL,be generated as host defense mechanism for killing of,Leishmania donovani,DISEASE
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",superoxide anions,CHEMICAL,be generated as host defense mechanism for killing of,visceral leishmaniasis,DISEASE
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",superoxide anions,CHEMICAL,be generated as host defense mechanism for killing of,Leishmania donovani,DISEASE
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",Reactive oxygen species,CHEMICAL,be generated as,host defense mechanism,MENTAL_HEALTH
23105731,"Reactive oxygen species such as superoxide anions, hydrogen peroxide and hydroxyl radicals are generated as a host defense mechanism for killing of engulfed Leishmania donovani, a causative agent of visceral leishmaniasis, are capable of damaging lipids and other biomolecules when produced in excess.",superoxide anions,CHEMICAL,be generated as,host defense mechanism,MENTAL_HEALTH
23105731,GSH levels in erythrocytes of visceral leishmaniasis patients were increased in spite of significant increased erythrocyte MDA as compared to controls.,visceral leishmaniasis patients,DISEASE,be increased in spite of,significant erythrocyte MDA,CHEMICAL
23105731,GSH levels in erythrocytes of visceral leishmaniasis patients were increased in spite of significant increased erythrocyte MDA as compared to controls.,GSH levels,CHEMICAL,be increased in spite of,significant erythrocyte MDA,CHEMICAL
35051813,The free fatty acid receptor 1 (FFA1/GPR40) and peroxisome proliferator-activated receptor δ (PPARδ) have been widely considered as promising targets for type 2 diabetes mellitus (T2DM) due to their respective roles in promoting insulin secretion and improving insulin sensitivity.,free fatty acid receptor,NUTRITION,be considered as promising targets for,type diabetes mellitus,DISEASE
35051813,The free fatty acid receptor 1 (FFA1/GPR40) and peroxisome proliferator-activated receptor δ (PPARδ) have been widely considered as promising targets for type 2 diabetes mellitus (T2DM) due to their respective roles in promoting insulin secretion and improving insulin sensitivity.,free fatty acid receptor,NUTRITION,be considered as promising targets for,T2DM,DISEASE
32669864,Gestational diabetes mellitus (GDM) is a disorder of glucose metabolism that occurs or is found for the first time during pregnancy.,GDM,DISEASE,be disorder of,glucose metabolism,CHEMICAL
32669864,Gestational diabetes mellitus (GDM) is a disorder of glucose metabolism that occurs or is found for the first time during pregnancy.,Gestational diabetes mellitus,DISEASE,be disorder of,glucose metabolism,CHEMICAL
32669864,GDM is very harmful and urgently needs drug treatment to improve pregnancy outcome.,GDM,DISEASE,need,drug treatment,CHEBI
2858868,"While quipazine may induce in neonates some components of the adult ""serotonergic syndrome"" [8], there are some clear age differences in the response patterns.",quipazine,CHEMICAL,induce in neonates components of,adult serotonergic syndrome,DISEASE
30337036,"Surgical management of constipation includes the use of antegrade continence enemas, sacral nerve stimulation, and colonic resection.",constipation,DISEASE,include use of,antegrade continence enemas,CHEMICAL
23276898,The patient's creatine kinase levels remained elevated for 8 days with constant severe pain under standard treatment for rhabdomyolysis.,patient's creatine kinase levels,CHEMICAL,remain elevated for days with constant severe pain under,rhabdomyolysis,DISEASE
23276898,The patient's creatine kinase levels remained elevated for 8 days with constant severe pain under standard treatment for rhabdomyolysis.,patient's creatine kinase levels,CHEMICAL,remain elevated for days with,constant severe pain,DISEASE
23276898,"In patients with risk factors for rhabdomyolysis, the use of dextroamphetamine should be monitored closely.",dextroamphetamine,CHEMICAL,be monitored in patients with risk factors for,rhabdomyolysis,DISEASE
418446,"Twenty-four to 48 h after withdrawal of either drug, abstinence symptoms (e.g., muscle fasciculation, nuchal twitching, vocalization, increased irritability, ataxia, hyperthermia, and clonic-tonic and grand mal-type convulsions) were evidenced in all animals (N = 6), some of which died after convulsions.",muscle fasciculation,DISEASE,be evidenced twenty-four to h after withdrawal of,drug,CHEBI
32593240,The decrease in the activity of the antioxidant enzymatic system and the decrease in polyunsaturated fatty acids due to their peroxidation revealed in this study indicate an intensification of the OS processes in patients with impaired cognitive functions.,polyunsaturated fatty acids,NUTRITION,indicate intensification of os processes in patients with,impaired cognitive functions,DISEASE
32176647,Oxylipins generated from the cytochrome P450 pathway are enzymatically converted to diols by soluble epoxide hydrolase (sEH); sEH products have been associated with small vessel ischemic disease.,Oxylipins,CHEMICAL,be converted to,diols,CHEMICAL
31645469,The associations between trans fatty acids and dementia have been unclear.,trans fatty acids,NUTRITION,have the associations with,dementia,MENTAL_HEALTH
31645469,The associations between trans fatty acids and dementia have been unclear.,dementia,MENTAL_HEALTH,have the associations with,trans fatty acids,NUTRITION
34166298,Tamoxifen is a selective estrogen receptor modulator widely used for treatment and prevention of estrogenic receptor-positive breast cancer.,Tamoxifen,CHEMICAL,used for treatment and prevention of,estrogenic receptor-positive breast cancer,DISEASE
34166298,"Tamoxifen is an object of growing interest in psychopharmacology as an antimanic drug, because it inhibits the protein kinase C, a molecular target of bipolar disorder.",Tamoxifen,CHEMICAL,be object of growing interest in psychopharmacology as,antimanic drug,CHEBI
34166298,"Tamoxifen is an object of growing interest in psychopharmacology as an antimanic drug, because it inhibits the protein kinase C, a molecular target of bipolar disorder.",Tamoxifen,CHEMICAL,be object of growing interest in psychopharmacology as,antimanic drug,CHEMICAL
27585851,"As the symptoms of amphetamine treatment in rodents are believed to mimic the symptoms of a manic episode, many of the preclinical studies for this indication have demonstrated that tamoxifen inhibits amphetamine action.",tamoxifen,CHEMICAL,inhibit,amphetamine action,CHEMICAL
27585851,"As the symptoms of amphetamine treatment in rodents are believed to mimic the symptoms of a manic episode, many of the preclinical studies for this indication have demonstrated that tamoxifen inhibits amphetamine action.",amphetamine treatment,CHEMICAL,mimic symptoms of,manic episode,MENTAL_HEALTH
27585851,The amphetamine-induced increase in extracellular dopamine which gives rise to the 'manic' effects is due to interaction of amphetamine with the dopamine transporter.,extracellular dopamine,CHEMICAL,be due to interaction of amphetamine with,dopamine transporter,CHEMICAL
27585851,The amphetamine-induced increase in extracellular dopamine which gives rise to the 'manic' effects is due to interaction of amphetamine with the dopamine transporter.,extracellular dopamine,CHEMICAL,be due to interaction of,amphetamine,CHEMICAL
27585851,The amphetamine-induced increase in extracellular dopamine which gives rise to the 'manic' effects is due to interaction of amphetamine with the dopamine transporter.,manic effects,DISEASE,be due to interaction of amphetamine with,dopamine transporter,CHEMICAL
27585851,The amphetamine-induced increase in extracellular dopamine which gives rise to the 'manic' effects is due to interaction of amphetamine with the dopamine transporter.,manic effects,DISEASE,be due to interaction of,amphetamine,CHEMICAL
27585851,The amphetamine-induced increase in extracellular dopamine which gives rise to the 'manic' effects is due to interaction of amphetamine with the dopamine transporter.,amphetamine,CHEMICAL,have due to interaction with,dopamine transporter,CHEMICAL
27585851,"Finally, we will present our hypothesis that tamoxifen, or an analog, could be used therapeutically to reduce amphetamine abuse in addition to treating mania.",tamoxifen,CHEMICAL,reduce,amphetamine abuse,MENTAL_HEALTH
8022904,Olfaction rather than taste was involved in the conditioned response to L-proline because the highest possible contact concentration (3 x 10(-6) M) of L-proline within the stimulus eddies was at least 30 times lower than the estimated L-proline electrophysiological taste threshold (> 10(-4) M).,L-proline,CHEMICAL,be,estimated L-proline electrophysiological taste threshold,CHEMICAL
29054014,"Head shakes during FST, which were fewer in females than in males, were reduced by castration in males and by letrozole treatment in ovariectomized females, suggesting a role of testosterone and extra-gonadal estrogens in the expression of this behavior.",Head shakes,DISEASE,suggest role of,testosterone extra-gonadal estrogens,CHEBI
29054014,"Head shakes during FST, which were fewer in females than in males, were reduced by castration in males and by letrozole treatment in ovariectomized females, suggesting a role of testosterone and extra-gonadal estrogens in the expression of this behavior.",Head shakes,DISEASE,suggest role of,testosterone extra-gonadal estrogens,CHEMICAL
29054014,"Head shakes during FST, which were fewer in females than in males, were reduced by castration in males and by letrozole treatment in ovariectomized females, suggesting a role of testosterone and extra-gonadal estrogens in the expression of this behavior.",Head shakes,DISEASE,be reduced by castration in males and by,letrozole treatment,CHEMICAL
14735921,"Vaccination with bacterial auxotrophs, particularly those with an interruption in the common pathway of aromatic amino-acid biosynthesis, known as the shikimate pathway, has been shown to be effective in the prevention of a variety of bacterial diseases.",aromatic amino-acid biosynthesis,CHEMICAL,be shown to effective in prevention of variety of,bacterial diseases,DISEASE
14735921,"Vaccination with bacterial auxotrophs, particularly those with an interruption in the common pathway of aromatic amino-acid biosynthesis, known as the shikimate pathway, has been shown to be effective in the prevention of a variety of bacterial diseases.",bacterial auxotrophs,DISEASE,be shown to effective in prevention of variety of,bacterial diseases,DISEASE
14735921,"piscicida, the aroA gene of the shikimate pathway was identified from a P. damselae subsp.",shikimate pathway,CHEMICAL,be identified from,P. damselae subsp,DISEASE
19955499,Obstructive sleep apnea (OSA) is a common form of sleep-disordered breathing in which brain serotonin dysfunction may play a role.,Obstructive sleep apnea,MENTAL_HEALTH,be common form of,sleep-disordered breathing,DISEASE
34089090,"The his-tagged recombinant Microbacterium esterase of E. coli BL21 (DE3)/pET21a-EstSIT01 was first immobilized on MCS-NTA-Ni by affinity fixation, giving high immobilization yield (90.1%) and enzyme loading (120 mg/g).",his-tagged recombinant Microbacterium esterase,CHEMICAL,be immobilized on mcs-nta-ni by,affinity fixation,MENTAL_HEALTH
34089090,"The his-tagged recombinant Microbacterium esterase of E. coli BL21 (DE3)/pET21a-EstSIT01 was first immobilized on MCS-NTA-Ni by affinity fixation, giving high immobilization yield (90.1%) and enzyme loading (120 mg/g).",his-tagged recombinant Microbacterium esterase,CHEMICAL,be immobilized on,MCS-NTA-Ni,CHEMICAL
33842153,"PEP medications, in particular raltegravir, are known to have a common side effect of insomnia.",PEP medications,CHEMICAL,have common side effect of,insomnia,MENTAL_HEALTH
33842153,"PEP medications, in particular raltegravir, are known to have a common side effect of insomnia.",particular    raltegravir,CHEMICAL,have common side effect of,insomnia,MENTAL_HEALTH
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",BMA,CHEMICAL,be main aconitum alkaloid in,analgesia,MENTAL_HEALTH
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",BMA,CHEMICAL,be main aconitum alkaloid in,Fuzi aconite roots,CHEMICAL
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",BMA,CHEMICAL,be main aconitum alkaloid in,Aconiti Lateralis Preparata,DISEASE
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",Benzoylmesaconine,CHEMICAL,be main aconitum alkaloid in,analgesia,MENTAL_HEALTH
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",Benzoylmesaconine,CHEMICAL,be main aconitum alkaloid in,Fuzi aconite roots,CHEMICAL
18513409,"Benzoylmesaconine (BMA) is the main Aconitum alkaloid in Radix Aconiti Lateralis Preparata (Fuzi, aconite roots) with potent pharmacological activities, such as analgesia and anti-inflammation.",Benzoylmesaconine,CHEMICAL,be main aconitum alkaloid in,Aconiti Lateralis Preparata,DISEASE
35605954,"Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation.",single-site CuII,CHEMICAL,be reduced to cui by,GSH,CHEMICAL
35605954,"Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation.",single-site CuII,CHEMICAL,be reduced to cui by,tumor-overexpressed glutathione,CHEMICAL
35605954,"Subsequently, the single-site CuII can be reduced to CuI by the tumor-overexpressed glutathione (GSH), which simultaneously impaired the tumor antioxidant defense system and triggered CAI release for inducing intracellular H+ accumulation.",single-site CuII,CHEMICAL,be reduced to,CuI,CHEMICAL
35605918,"Alpinia officinarum Hance, a perennial natural medicine-food herb, has been traditionally used to treat colds, stomachache, and diabetes for thousands of years.",officinarum Hance,NUTRITION,treat,stomachache,DISEASE
35605918,"Alpinia officinarum Hance, a perennial natural medicine-food herb, has been traditionally used to treat colds, stomachache, and diabetes for thousands of years.",officinarum Hance,NUTRITION,treat,diabetes,DISEASE
35605918,"1,7-Diphenyl-4E-en-3-heptanone (DPH5), a diarylheptanoid isolated from the rhizome of A. officinarum has been reported to be safe and to have antioxidant and hypoglycemic effects, suggesting its potential in the treatment of insulin resistance (IR).","1,7-Diphenyl-4E-en-3-heptanone",CHEMICAL,suggest its potential in treatment of,insulin resistance,MENTAL_HEALTH
11080504,It is postulated that the binding of an inappropriate substrate to FTG would lead to inactivation of the enzyme because of the formation of a new disulfide bridge between Cys-272 and the adjacent Cys-333 immediately after the displacement of Tyr-515.,FTG,CHEMICAL,lead to inactivation of,displacement,MENTAL_HEALTH
11080504,It is postulated that the binding of an inappropriate substrate to FTG would lead to inactivation of the enzyme because of the formation of a new disulfide bridge between Cys-272 and the adjacent Cys-333 immediately after the displacement of Tyr-515.,FTG,CHEMICAL,lead to inactivation of,new disulfide bridge,CHEMICAL
27022315,"Inhaled cannabis is more effective than placebo in ameliorating peripheral neuropathy in a number of conditions, and it could prove useful in chemotherapy-induced neuropathy.",Inhaled cannabis,CHEMICAL,ameliorate,peripheral neuropathy,DISEASE
22967188,"Olanzapine is prescribed for a number of psychiatric disorders, including schizophrenia, bipolar mania, and unipolar and bipolar depression.",Olanzapine,CHEMICAL,be prescribed for number of,schizophrenia,MENTAL_HEALTH
22967188,"Olanzapine is prescribed for a number of psychiatric disorders, including schizophrenia, bipolar mania, and unipolar and bipolar depression.",Olanzapine,CHEMICAL,be prescribed for number of,psychiatric disorders,DISEASE
22967188,"Olanzapine is prescribed for a number of psychiatric disorders, including schizophrenia, bipolar mania, and unipolar and bipolar depression.",Olanzapine,CHEMICAL,be prescribed for number of,depression,MENTAL_HEALTH
22967188,"Olanzapine is prescribed for a number of psychiatric disorders, including schizophrenia, bipolar mania, and unipolar and bipolar depression.",Olanzapine,CHEMICAL,be prescribed for number of,bipolar mania,MENTAL_HEALTH
22967188,"Olanzapine treatment is associated with tolerability issues such as metabolic adverse effects (e.g. weight gain, increase in blood glucose, triglycerides and total cholesterol levels), extrapyramidal symptoms [EPS] (e.g. parkinsonism, akathisia, tardive dyskinesia) and sedative adverse effects.",Olanzapine treatment,CHEMICAL,be associated with tolerability issues such as,weight gain,DISEASE
29655116,"Despite controlling for age, sex, and body mass index (BMI) variables, the total cholesterol and LDL levels were significantly higher in the ADHD group than the levels of healthy controls, whereas the TG and HDL cholesterol levels were similar among groups.",total cholesterol levels,NUTRITION,be higher in,ADHD group,MENTAL_HEALTH
32376271,The treatment of depression in an epileptic patient could be very challenging because of drug selection or the fact that some antiepileptic drugs are known to cause depression.,depression,MENTAL_HEALTH,be,drug selection,CHEBI
32376271,The treatment of depression in an epileptic patient could be very challenging because of drug selection or the fact that some antiepileptic drugs are known to cause depression.,epileptic patient,DISEASE,be,drug selection,CHEBI
32376271,The treatment of depression in an epileptic patient could be very challenging because of drug selection or the fact that some antiepileptic drugs are known to cause depression.,depression,MENTAL_HEALTH,have the treatment in,epileptic patient,DISEASE
31686823,"Here, NNT, NNH, and LHH were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation.",NNH,CHEMICAL,evaluate clinical usefulness of aripiprazole lauroxil in patients with,schizophrenia exacerbation,MENTAL_HEALTH
31686823,"Here, NNT, NNH, and LHH were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation.",NNH,CHEMICAL,evaluate clinical usefulness of,aripiprazole lauroxil,CHEMICAL
31686823,"Here, NNT, NNH, and LHH were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation.",NNT,CHEMICAL,evaluate clinical usefulness of aripiprazole lauroxil in patients with,schizophrenia exacerbation,MENTAL_HEALTH
31686823,"Here, NNT, NNH, and LHH were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation.",NNT,CHEMICAL,evaluate clinical usefulness of,aripiprazole lauroxil,CHEMICAL
31686823,"Here, NNT, NNH, and LHH were used to evaluate the clinical usefulness of aripiprazole lauroxil in patients with an acute schizophrenia exacerbation.",aripiprazole lauroxil,CHEMICAL,in patients with,schizophrenia exacerbation,MENTAL_HEALTH
34411814,"Rice was subjected to different concentration of Cd and blueberry anthocyanin, and the effects on rice growth, antioxidative defense, Cd distribution in rice tissues, FTIR and TEM characterization of rice leaves were examined to explain the Cd reductions in rice grains and the protective mechanisms by blueberry anthocyanin.",Cd distribution,CHEMICAL,explain cd reductions in rice grains and protective mechanisms by,blueberry anthocyanin,NUTRITION
34411814,"Rice was subjected to different concentration of Cd and blueberry anthocyanin, and the effects on rice growth, antioxidative defense, Cd distribution in rice tissues, FTIR and TEM characterization of rice leaves were examined to explain the Cd reductions in rice grains and the protective mechanisms by blueberry anthocyanin.",Cd distribution,CHEMICAL,explain,Cd reductions,CHEMICAL
34411814,"Rice was subjected to different concentration of Cd and blueberry anthocyanin, and the effects on rice growth, antioxidative defense, Cd distribution in rice tissues, FTIR and TEM characterization of rice leaves were examined to explain the Cd reductions in rice grains and the protective mechanisms by blueberry anthocyanin.",rice leaves,DISEASE,explain cd reductions in rice grains and protective mechanisms by,blueberry anthocyanin,NUTRITION
34411814,"Rice was subjected to different concentration of Cd and blueberry anthocyanin, and the effects on rice growth, antioxidative defense, Cd distribution in rice tissues, FTIR and TEM characterization of rice leaves were examined to explain the Cd reductions in rice grains and the protective mechanisms by blueberry anthocyanin.",rice leaves,DISEASE,explain,Cd reductions,CHEMICAL
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,prevent,Cd,CHEMICAL
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,be transferred from leaves to rice grains by fixation of,Cd,CHEMICAL
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,be transferred from leaves to rice grains by,fixation,MENTAL_HEALTH
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,reduce h2o2 and mda accumulation in,leaves,DISEASE
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,reduce,H2O2 accumulation,CHEMICAL
34411814,"Blueberry anthocyanin spraying prevents Cd from being transferred from leaves to rice grains mainly by fixation of Cd in soluble and organelle fractions at the tillering and booting stages, and reduces H2O2 and MDA accumulation in rice leaves to decrease Cd toxicity.",Blueberry anthocyanin,NUTRITION,reduce,MDA,CHEMICAL
34411814,"Combined with FTIR and TEM characterization of rice leaves, the results indicated that surface spraying of 7.5 g/L blueberry anthocyanin under 1.0 mg/kg Cd stress could effectively relieve Cd oxidative damage, and form chelates with Cd ions to immobilize Cd in rice leaves.",mg/kg Cd stress,CHEMICAL,relieve,Cd oxidative damage,CHEMICAL
34411814,"Combined with FTIR and TEM characterization of rice leaves, the results indicated that surface spraying of 7.5 g/L blueberry anthocyanin under 1.0 mg/kg Cd stress could effectively relieve Cd oxidative damage, and form chelates with Cd ions to immobilize Cd in rice leaves.",g/L blueberry anthocyanin,NUTRITION,relieve,Cd oxidative damage,CHEMICAL
34411814,"Hence, blueberry anthocyanin could be used as a foliar resistance control agent to reduce Cd accumulation in rice grains through chelate compound synthesis and decrease Cd toxicity by preventing membrane lipid peroxidation and H2O2 accumulation.",blueberry anthocyanin,NUTRITION,be used as,foliar resistance control agent,MENTAL_HEALTH
34411814,"Hence, blueberry anthocyanin could be used as a foliar resistance control agent to reduce Cd accumulation in rice grains through chelate compound synthesis and decrease Cd toxicity by preventing membrane lipid peroxidation and H2O2 accumulation.",blueberry anthocyanin,NUTRITION,reduce cd accumulation in rice grains through,chelate,CHEMICAL
34411814,"Hence, blueberry anthocyanin could be used as a foliar resistance control agent to reduce Cd accumulation in rice grains through chelate compound synthesis and decrease Cd toxicity by preventing membrane lipid peroxidation and H2O2 accumulation.",blueberry anthocyanin,NUTRITION,reduce,Cd accumulation,CHEMICAL
34411814,"Hence, blueberry anthocyanin could be used as a foliar resistance control agent to reduce Cd accumulation in rice grains through chelate compound synthesis and decrease Cd toxicity by preventing membrane lipid peroxidation and H2O2 accumulation.",blueberry anthocyanin,NUTRITION,decrease,Cd toxicity,CHEMICAL
35602377,Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are used to treat depression in patients with PD.,serotonin norepinephrine reuptake inhibitors,CHEMICAL,treat,depression,MENTAL_HEALTH
35602377,Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are used to treat depression in patients with PD.,serotonin norepinephrine reuptake inhibitors,CHEBI,treat,depression,MENTAL_HEALTH
35602377,Selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors are used to treat depression in patients with PD.,Selective serotonin reuptake inhibitors,CHEMICAL,treat,depression,MENTAL_HEALTH
35602377,The best evidence of efficacy in PD psychosis is for clozapine and pimavanserin.,PD psychosis,MENTAL_HEALTH,be for,clozapine,CHEMICAL
35602377,Rivastigmine is the only approved treatment for PD as per the Food and Drug Administration.,Rivastigmine,CHEMICAL,be approved treatment for pd as,Drug,CHEBI
35602377,"Pramipexole, a dopamine agonist (DA), is reported to cause improvement in the symptoms of decreased willingness in apathy.",Pramipexole,CHEMICAL,cause improvement in symptoms of decreased willingness in,apathy,DISEASE
35602377,"Pramipexole, a dopamine agonist (DA), is reported to cause improvement in the symptoms of decreased willingness in apathy.",dopamine agonist,CHEBI,cause improvement in symptoms of decreased willingness in,apathy,DISEASE
24072498,"Isolates MSP9 and MSP10 were most efficient in biofilm formation on polyvinyl chloride, which indicated their potential to withstand various biotic and abiotic stresses, whereas the remaining isolates showed a very poor biofilm formation ability.",biofilm formation,DISEASE,have efficient on,polyvinyl chloride,CHEMICAL
32786316,"Currently, pramipexole is approved to treat signs and symptoms of idiopathic Parkinson's disease and moderate to severe symptoms of primary restless leg syndrome.",pramipexole,CHEMICAL,treat signs and symptoms of idiopathic parkinson's disease and moderate to severe symptoms of,primary restless leg syndrome,DISEASE
32786316,"Parkinson's disease is characterized by tremor, bradykinesia, rigidity, gait disorders, and a disturbance of posture due to a decrease in dopamine stores in the substantia nigra with the consequent presence of Lewy bodies.",Parkinson's disease,DISEASE,decrease in dopamine stores in,Lewy bodies,DISEASE
32786316,"Parkinson's disease is characterized by tremor, bradykinesia, rigidity, gait disorders, and a disturbance of posture due to a decrease in dopamine stores in the substantia nigra with the consequent presence of Lewy bodies.",Parkinson's disease,DISEASE,decrease in,dopamine stores,CHEMICAL
33735708,"Since omega-3 fatty acids (ω-3) show anti-inflammatory/neuroprotective properties, we aim to evaluate whether ω-3 treatment during adolescence in the maternal immune stimulation (MIS) animal model of schizophrenia could prevent the brain and behavioural deficits described in adulthood.",schizophrenia,MENTAL_HEALTH,prevent,brain deficits,DISEASE
33735708,"Our study demonstrates that administration of ω-3 during adolescence prevents PPI behavioural deficits and hippocampal volumetric abnormalities, and partially counteracts IOS deficits via iNOS and Nrf2-ARE pathways in the MIS model.",ω-3,CHEMICAL,prevent,volumetric abnormalities,DISEASE
33735708,"Our study demonstrates that administration of ω-3 during adolescence prevents PPI behavioural deficits and hippocampal volumetric abnormalities, and partially counteracts IOS deficits via iNOS and Nrf2-ARE pathways in the MIS model.",ω-3,CHEMICAL,prevent,PPI behavioural deficits,DISEASE
32440779,Impulse control disorders (ICD) and other impulsive-compulsive behaviours are frequently found in Parkinson's disease (PD) patients treated with dopaminergic agonists.,other impulsive-compulsive behaviours,DISEASE,be found in parkinson's,PD,DISEASE
32440779,Impulse control disorders (ICD) and other impulsive-compulsive behaviours are frequently found in Parkinson's disease (PD) patients treated with dopaminergic agonists.,control disorders,MENTAL_HEALTH,be found in parkinson's,PD,DISEASE
32294747,"In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania.",dopamine agonists,CHEBI,avoid,hypomania,MENTAL_HEALTH
32294747,"In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania.",dopamine agonists,CHEBI,avoid,hyperdopaminergic syndrome,DISEASE
32294747,"In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania.",dopamine agonists,CHEMICAL,avoid,hypomania,MENTAL_HEALTH
32294747,"In patients taking high doses of dopaminergic drugs or with high risk of impulse control disorders, an initial reduction in dopamine agonists after STN DBS is recommended to avoid the hyperdopaminergic syndrome, particularly hypomania.",dopamine agonists,CHEMICAL,avoid,hyperdopaminergic syndrome,DISEASE
32294747,"On the other hand, a rapid reduction of dopaminergic agonists of more than 70% during the first months can lead to dopaminergic agonist withdrawal syndrome, characterized by apathy, pain, and autonomic features.",dopaminergic agonists,CHEBI,lead on other hand to,dopaminergic agonist withdrawal syndrome,DISEASE
32294747,"On the other hand, a rapid reduction of dopaminergic agonists of more than 70% during the first months can lead to dopaminergic agonist withdrawal syndrome, characterized by apathy, pain, and autonomic features.",dopaminergic agonists,CHEBI,lead on other hand to,dopaminergic agonist withdrawal syndrome,CHEBI
32294747,"In a subset of patients with severe dyskinesia before surgery, an initial reduction in levodopa seems to be a more reasonable approach.",levodopa,CHEMICAL,seem in subset of patients with,severe dyskinesia,MENTAL_HEALTH
27705838,"Follicle stimulating hormone (FSH) and luteinizing hormone (LH) were associated with depressive disorders and the present study estimated the levels of serum FSH, LH in postpartum depression and explored them as predictive biomarkers in the development of PPD.",luteinizing hormone,CHEBI,be associated with,depressive disorders,DISEASE
27705838,"Follicle stimulating hormone (FSH) and luteinizing hormone (LH) were associated with depressive disorders and the present study estimated the levels of serum FSH, LH in postpartum depression and explored them as predictive biomarkers in the development of PPD.",Follicle stimulating hormone,NUTRITION,be associated with,depressive disorders,DISEASE
27705838,"Follicle stimulating hormone (FSH) and luteinizing hormone (LH) were associated with depressive disorders and the present study estimated the levels of serum FSH, LH in postpartum depression and explored them as predictive biomarkers in the development of PPD.",Follicle stimulating hormone,CHEBI,be associated with,depressive disorders,DISEASE
22611228,"Bipolar disorder and severe premenstrual syndrome (PMS) have many symptoms in common, but it is important to establish the correct diagnosis between a severe psychiatric disorder and an endocrine disorder appropriately treatable with hormones.",severe psychiatric disorder,DISEASE,have the correct diagnosis with,endocrine disorder,CHEBI
22611228,"Bipolar disorder and severe premenstrual syndrome (PMS) have many symptoms in common, but it is important to establish the correct diagnosis between a severe psychiatric disorder and an endocrine disorder appropriately treatable with hormones.",endocrine disorder,CHEBI,have the correct diagnosis with,severe psychiatric disorder,DISEASE
22611228,"The diagnosis of PMS should come from the history relating the occurrence of cyclical mood and behaviour changes with menstruation, the improvement during pregnancy, postnatal depression and the presence of runs of many good days a month and the somatic symptoms of mastalgia, bloating and headaches.",PMS,CHEMICAL,come from history improvement during,mastalgia,DISEASE
22611228,"The diagnosis of PMS should come from the history relating the occurrence of cyclical mood and behaviour changes with menstruation, the improvement during pregnancy, postnatal depression and the presence of runs of many good days a month and the somatic symptoms of mastalgia, bloating and headaches.",PMS,CHEMICAL,come from history improvement during,headaches,DISEASE
22611228,"The diagnosis of PMS should come from the history relating the occurrence of cyclical mood and behaviour changes with menstruation, the improvement during pregnancy, postnatal depression and the presence of runs of many good days a month and the somatic symptoms of mastalgia, bloating and headaches.",PMS,CHEMICAL,come from history improvement during,bloating,DISEASE
22611228,"The diagnosis of PMS should come from the history relating the occurrence of cyclical mood and behaviour changes with menstruation, the improvement during pregnancy, postnatal depression and the presence of runs of many good days a month and the somatic symptoms of mastalgia, bloating and headaches.",PMS,CHEMICAL,come from history improvement during,postnatal depression,MENTAL_HEALTH
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",FLX,CHEMICAL,reduced responsiveness of gaba(a)-r to,GABA mimetic drugs,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",FLX,CHEMICAL,reduced responsiveness of gaba(a)-r to,pentobarbital,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",selective serotonin reuptake inhibitor SSRI fluoxetine,CHEBI,attenuate,aggressive behavior,DISEASE
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",congener norfluoxetine,CHEMICAL,reduced responsiveness of gaba(a)-r to,GABA mimetic drugs,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",congener norfluoxetine,CHEMICAL,reduced responsiveness of gaba(a)-r to,pentobarbital,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",FLX,CHEMICAL,attenuate,aggressive behavior,DISEASE
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",selective serotonin reuptake inhibitor SSRI fluoxetine,CHEBI,reduced responsiveness of gaba(a)-r to,GABA mimetic drugs,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",selective serotonin reuptake inhibitor SSRI fluoxetine,CHEBI,reduced responsiveness of gaba(a)-r to,pentobarbital,CHEMICAL
17454962,"The selective serotonin reuptake inhibitor (SSRI) fluoxetine (FLX) and its congener norfluoxetine (Nor-FLX), when administered systemically at nmol/kg doses, normalize the reduced content of brain ALLO and the reduced responsiveness of GABA(A)-R to GABA mimetic drugs (i.e. pentobarbital) and also attenuate aggressive behavior in socially isolated mice in a stereospecific manner.",congener norfluoxetine,CHEMICAL,attenuate,aggressive behavior,DISEASE
17454962,"Hence, the normalization of ALLO biosynthesis may be a new target for the development of drugs effective for psychiatric disorders related to neurosteroid biosynthesis downregulation.",ALLO biosynthesis,CHEMICAL,be new target for development of drugs effective for,psychiatric disorders related,DISEASE
29388611,"Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macrophages, resulting in multiple organ dysfunction.",GD,CHEMICAL,caused by,functional defects,DISEASE
29388611,"Gaucher disease (GD) is a heritable storage disorder caused by functional defects of the lysosomal acid β-glucosidase and the accumulation of glucosylceramide within macrophages, resulting in multiple organ dysfunction.",Gaucher disease,DISEASE,caused by,functional defects,DISEASE
30812265,"To investigate probable causes for such physiological disorder, the effect of ethylene on various aspects of metabolism of carrot roots was studied.",ethylene,CHEMICAL,investigate probable causes for,physiological disorder,DISEASE
35138119,"Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses.",Human phospholipid scramblase,NUTRITION,be expressed in response to,interferon IFN treatment,CHEMICAL
35138119,"Human phospholipid scramblase 1 (PLSCR1) is strongly expressed in response to interferon (IFN) treatment and viral infection, and it has been suggested to play an important role in IFN-dependent antiviral responses.",Human phospholipid scramblase,NUTRITION,be expressed in response to,viral infection,DISEASE
9794208,"We previously demonstrated that severe graft-versus-host disease (GvHD), associated with the therapeutic infusion of donor lymphocytes after allogeneic marrow transplantation (BMT), can be efficiently controlled by the SFCMM-2-mediated expression of the herpes simplex virus thymidine kinase (HSV-tk) suicide gene into the allogeneic lymphocytes.",severe graft-versus-host disease,DISEASE,be controlled by sfcmm-2-mediated expression of,kinase HSV-tk suicide gene,MENTAL_HEALTH
9794208,"We previously demonstrated that severe graft-versus-host disease (GvHD), associated with the therapeutic infusion of donor lymphocytes after allogeneic marrow transplantation (BMT), can be efficiently controlled by the SFCMM-2-mediated expression of the herpes simplex virus thymidine kinase (HSV-tk) suicide gene into the allogeneic lymphocytes.",severe graft-versus-host disease,DISEASE,be controlled by sfcmm-2-mediated expression of,herpes simplex virus thymidine kinase,CHEMICAL
9794208,"We previously demonstrated that severe graft-versus-host disease (GvHD), associated with the therapeutic infusion of donor lymphocytes after allogeneic marrow transplantation (BMT), can be efficiently controlled by the SFCMM-2-mediated expression of the herpes simplex virus thymidine kinase (HSV-tk) suicide gene into the allogeneic lymphocytes.",severe graft-versus-host disease,DISEASE,be controlled by sfcmm-2-mediated expression of,herpes simplex virus thymidine kinase,DISEASE
34080659,The present study investigated whether the antidepressant drug amitriptyline could sensitize TRAIL‑resistant A549 lung cancer cells and enhance TRAIL‑induced apoptosis.,antidepressant drug,CHEMICAL,sensitize,TRAIL‑resistant A549 lung cancer cells,DISEASE
34080659,The present study investigated whether the antidepressant drug amitriptyline could sensitize TRAIL‑resistant A549 lung cancer cells and enhance TRAIL‑induced apoptosis.,drug amitriptyline,CHEBI,sensitize,TRAIL‑resistant A549 lung cancer cells,DISEASE
34080659,The present study investigated whether the antidepressant drug amitriptyline could sensitize TRAIL‑resistant A549 lung cancer cells and enhance TRAIL‑induced apoptosis.,drug amitriptyline,CHEMICAL,sensitize,TRAIL‑resistant A549 lung cancer cells,DISEASE
34080659,"Antidepressants are usually prescribed to cancer patients to relieve emotional distress, such as depression or dysthymia.",Antidepressants,CHEMICAL,relieve,depression,MENTAL_HEALTH
34080659,"Antidepressants are usually prescribed to cancer patients to relieve emotional distress, such as depression or dysthymia.",Antidepressants,CHEMICAL,relieve,dysthymia,MENTAL_HEALTH
34080659,"The present study revealed for the first time, to the best of our knowledge, that amitriptyline increased death receptor (DR) 4 and 5 expression, a requirement for TRAIL‑induced cell death.",amitriptyline,CHEMICAL,increase,TRAIL‑induced cell death,DISEASE
34080659,"The present study revealed for the first time, to the best of our knowledge, that amitriptyline increased death receptor (DR) 4 and 5 expression, a requirement for TRAIL‑induced cell death.",amitriptyline,CHEMICAL,increase,death receptor,DISEASE
31740575,"Accordingly, this study aimed to examine in both sexes how individual differences in alcohol intake alter ketamine self-administration and how ketamine self-administration will alter subsequent alcohol-drinking behaviors.",ketamine self-administration,CHEMICAL,alter,subsequent alcohol-drinking behaviors,DISEASE
31740575,"Accordingly, this study aimed to examine in both sexes how individual differences in alcohol intake alter ketamine self-administration and how ketamine self-administration will alter subsequent alcohol-drinking behaviors.",alcohol intake,CHEMICAL,alter,ketamine self-administration,CHEMICAL
30314288,"Mesyl Sal B was assessed for anhedonia (conditioned taste aversion), aversion (conditioned place aversion), pro-depressive effects (forced swim test), anxiety (elevated plus maze) and learning and memory deficits (novel object recognition).",Mesyl Sal B,CHEMICAL,be assessed for,anhedonia,MENTAL_HEALTH
30314288,"Mesyl Sal B (0.3 mg/kg) attenuated cocaine-induced hyperactivity and behavioral sensitization to cocaine without modulating sucrose self-administration and without producing aversion, sedation, anxiety, or learning and memory impairment in rats.",Mesyl Sal B,CHEMICAL,attenuate cocaine-induced hyperactivity and behavioral sensitization to,cocaine,CHEMICAL
30314288,"Mesyl Sal B (0.3 mg/kg) attenuated cocaine-induced hyperactivity and behavioral sensitization to cocaine without modulating sucrose self-administration and without producing aversion, sedation, anxiety, or learning and memory impairment in rats.",Mesyl Sal B,CHEMICAL,attenuate,cocaine-induced hyperactivity,MENTAL_HEALTH
23873176,Subclinical hyperthyroidism is defined as abnormal low TSH level with thyroid hormones within their reference range.,Subclinical hyperthyroidism,DISEASE,be defined as abnormal low tsh level with,thyroid hormones,CHEBI
23873176,Subclinical hyperthyroidism is defined as abnormal low TSH level with thyroid hormones within their reference range.,Subclinical hyperthyroidism,DISEASE,be defined as,abnormal low TSH level,DISEASE
35305404,The orexigenic hormone ghrelin is being increasingly recognized as a stress hormone being involved in anxiety regulation.,stress hormone,CHEBI,be involved in,anxiety regulation,MENTAL_HEALTH
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEBI,inhibit release of,CGRP,CHEMICAL
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEBI,inhibit release of,neurogenic dural vasodilation,DISEASE
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEBI,inhibit release of,calcitonin gene-related peptide,CHEMICAL
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEMICAL,inhibit release of,CGRP,CHEMICAL
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEMICAL,inhibit release of,neurogenic dural vasodilation,DISEASE
11454653,"It has been proposed that clinically effective 5-HT(1B/1D) agonists act peripherally to inhibit the release of calcitonin gene-related peptide (CGRP) and neurogenic dural vasodilation, and to attenuate nociceptive neurotransmission within the TNC.",effective 5-HT(1B/1D agonists,CHEMICAL,inhibit release of,calcitonin gene-related peptide,CHEMICAL
19801555,"In this study, we demonstrate that this versatile protein catalyzes an entirely different chemical reaction with alkylcobalamins using the thiolate of glutathione for nucleophilic displacement to generate cob(I)alamin and the corresponding glutathione thioether.",glutathione,CHEMICAL,have the thiolate for,nucleophilic displacement,MENTAL_HEALTH
33353130,"PLS regression allowed to correlate the differences in lightness (L*) and redness (a*) of wines from 'Jaen' and 'Mencía' to differences in colored anthocyanins, polymeric pigments, total pigments, total anthocyanins, cyanidin-3-acetylglucoside, delphinidin-3-acetylglucoside, delphinidin-3-glucoside, peonidin-3-coumaroylglucoside, petunidin-3-glucoside and malvidin-3-glucoside in wines, and the colorless ferulic, caffeic, and coutaric acids, and ethyl caffeate.",PLS regression,MENTAL_HEALTH,correlate differences in,L total pigments,CHEMICAL
33353130,"PLS regression allowed to correlate the differences in lightness (L*) and redness (a*) of wines from 'Jaen' and 'Mencía' to differences in colored anthocyanins, polymeric pigments, total pigments, total anthocyanins, cyanidin-3-acetylglucoside, delphinidin-3-acetylglucoside, delphinidin-3-glucoside, peonidin-3-coumaroylglucoside, petunidin-3-glucoside and malvidin-3-glucoside in wines, and the colorless ferulic, caffeic, and coutaric acids, and ethyl caffeate.",PLS regression,MENTAL_HEALTH,correlate differences in,colored anthocyanins,NUTRITION
31683996,"A clear separation between GL wine treatments was evident with PLS regression, where specific volatiles were correlated with relevant sensory attributes that dominated the wines.",GL wine treatments,CHEMICAL,be evident with,PLS regression,MENTAL_HEALTH
31233775,These findings suggested that the hepatic-targeted Gal-OSL nanocarriers delivering Res could potentially serve as a safe and promising platform for NAFLD and other liver related diseases.,hepatic-targeted Gal-OSL nanocarriers,CHEMICAL,serve as safe and promising platform for,NAFLD,DISEASE
31080591,The present study investigated whether daily consumption of three gold-fleshed kiwifruit could alleviate constipation and improve gastrointestinal discomfort in mildly constipated individuals with and without pain.,gold-fleshed kiwifruit,CHEMICAL,improve gastrointestinal discomfort in constipated individuals with and without,pain,DISEASE
31080591,The present study investigated whether daily consumption of three gold-fleshed kiwifruit could alleviate constipation and improve gastrointestinal discomfort in mildly constipated individuals with and without pain.,gold-fleshed kiwifruit,CHEMICAL,improve,gastrointestinal discomfort,DISEASE
15081833,"Endosulfan, 4-nonylphenol, and 4-octylphenol displaced 3H-E2 binding to ccfSHBG albeit only at very high concentrations, whereas dieldrin and atrazine showed little displacement activity even at the highest concentrations used.",atrazine,CHEMICAL,show,little displacement activity,MENTAL_HEALTH
15081833,"Endosulfan, 4-nonylphenol, and 4-octylphenol displaced 3H-E2 binding to ccfSHBG albeit only at very high concentrations, whereas dieldrin and atrazine showed little displacement activity even at the highest concentrations used.",dieldrin,CHEMICAL,show,little displacement activity,MENTAL_HEALTH
10377031,"An estrogen receptor (ER) was identified in cytosolic and nuclear fractions of the testis in a marine teleost, Atlantic croaker (Micropogonias undulatus).",estrogen receptor,CHEBI,be identified in cytosolic and nuclear fractions of testis in,Atlantic croaker,NUTRITION
25847618,"Our data indicate that post-training i.p. administration of morphine (2.5, 5 and 7.5mg/kg) dose-dependently reduced the step-through latency, showing an amnesic effect.",morphine,CHEMICAL,show,amnesic effect,DISEASE
20691753,"Amnesia produced by post-training WIN55,212-2 (0.5 μg/rat) was reversed by pre-test administration of the same drug dose.",Amnesia,MENTAL_HEALTH,be reversed by pre-test administration of,same drug dose,CHEBI
14674855,"DL-propranolol infused 5 min, but not 6 hr, posttraining caused a deficit in 48-hr memory for the spatial water maze task, whereas similarly administered D-propranolol, which has an equipotent ""local-anesthetic"" activity but significantly lower beta-blocking activity, induced no amnesia.",DL-propranolol,CHEMICAL,induce,amnesia,MENTAL_HEALTH
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",ornithine,CHEMICAL,be found in,anorexia nervosa patients,MENTAL_HEALTH
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",ornithine,CHEMICAL,be found in,tyrosine,CHEMICAL
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",ornithine,CHEMICAL,be found in,leucine,CHEMICAL
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",ornithine,CHEMICAL,be found in,lysine,CHEMICAL
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",glycine,CHEMICAL,be found in,anorexia nervosa patients,MENTAL_HEALTH
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",glycine,CHEMICAL,be found in,tyrosine,CHEMICAL
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",glycine,CHEMICAL,be found in,leucine,CHEMICAL
17593868,"Total amino acid and total branched-chain amino acid levels were similar in both groups, however significantly higher levels of glycine and ornithine were found in anorexia nervosa patients, as well as significantly lower levels of leucine, tyrosine and lysine compared with controls.",glycine,CHEMICAL,be found in,lysine,CHEMICAL
17593868,The glycine/valine and phenylalanine/tyrosine ratios were significantly higher in anorexia nervosa patients than in control subjects.,phenylalanine/tyrosine,CHEMICAL,be higher in,anorexia nervosa patients,MENTAL_HEALTH
17593868,The glycine/valine and phenylalanine/tyrosine ratios were significantly higher in anorexia nervosa patients than in control subjects.,glycine/valine,CHEMICAL,be higher in,anorexia nervosa patients,MENTAL_HEALTH
17593868,Changes in the plasma amino acid profile in anorexia nervosa patients can be explained by chronic severe malnutrition and prolonged stress.,anorexia nervosa patients,MENTAL_HEALTH,be explained by,chronic severe malnutrition,DISEASE
17593868,Changes in the plasma amino acid profile in anorexia nervosa patients can be explained by chronic severe malnutrition and prolonged stress.,plasma amino acid profile,CHEMICAL,be explained by,chronic severe malnutrition,DISEASE
17593868,Changes in the plasma amino acid profile in anorexia nervosa patients can be explained by chronic severe malnutrition and prolonged stress.,plasma amino acid profile,CHEMICAL,have changes in,anorexia nervosa patients,MENTAL_HEALTH
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,severe liver dysfunction,DISEASE
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,aspartate aminotransferase,CHEMICAL
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,alanine aminotransferase IU/l,CHEMICAL
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,pancreatic dysfunction,DISEASE
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,hypoglycemia,DISEASE
10435364,"A twenty-year-old woman with anorexia nervosa (body mass index=11) suffered from severe liver dysfunction (aspartate aminotransferase 5,000 IU/l, alanine aminotransferase 3,980 IU/l, prothrombin time 32%), hypoglycemia (serum glucose 27 mg/dl), and pancreatic dysfunction (amylase 820 IU/l, lipase 558 IU/l).",anorexia nervosa,MENTAL_HEALTH,suffer from,serum glucose,CHEMICAL
6509858,"Neurotic depression is associated with the oestrogen content of combined oral contraceptives, but the risk is small in general, and there is no excess risk associated with oestrogen doses of 35 micrograms or less.",Neurotic depression,MENTAL_HEALTH,be associated with oestrogen content of,combined oral contraceptives,CHEMICAL
6509858,"Neurotic depression is associated with the oestrogen content of combined oral contraceptives, but the risk is small in general, and there is no excess risk associated with oestrogen doses of 35 micrograms or less.",Neurotic depression,MENTAL_HEALTH,be associated with,oestrogen content,CHEBI
6509858,The progestogen activity of combined oral contraceptives is associated with an increased risk of hypertension and arterial disease.,progestogen activity,CHEBI,be associated with increased risk of,hypertension disease,DISEASE
6509858,The progestogen activity of combined oral contraceptives is associated with an increased risk of hypertension and arterial disease.,combined oral contraceptives,CHEMICAL,be associated with increased risk of,hypertension disease,DISEASE
6509858,Cigarette smoking by oral contraceptive users is the predominant associated risk factor for the occurrence of arterial diseases.,oral contraceptive users,CHEMICAL,associated risk factor for occurrence of,arterial diseases,DISEASE
6509858,"In the author's opinion, there is no convincing evidence that oral contraceptive use increases the risk of breast cancer.",oral contraceptive use,CHEMICAL,increase risk of,breast cancer,DISEASE
28727687,"Both T4 and metformin alleviated contextual fear memory deficit induced by FAE, and reversed the hippocampal expression changes in the thyroid hormone-inactivating enzyme, deiodinase-III (Dio3) and insulin-like growth factor 2 (Igf2), genes that are known to modulate memory processes.",metformin,CHEMICAL,alleviate,fear memory deficit,DISEASE
27090562,Prior studies showed the reversal of these behavioral deficits by low dose thyroxine (T4) supplementation to the ethanol-consuming mothers.,low dose thyroxine,CHEMICAL,have the reversal of,behavioral deficits,DISEASE
27090562,SS F1 PE-exposed females and their SB F2 progeny exhibited fear memory deficits.,SS F1 PE-exposed females,CHEMICAL,exhibit,memory deficits,DISEASE
34631832,"As HF risk cannot be predicted and metabolic defects have been observed in Ohia SV-CHD mice, we hypothesized that respiratory defects in peripheral blood mononuclear cells (PBMCs) may allow HF risk stratification in SV-CHD.",respiratory defects,DISEASE,allow hf risk stratification in,SV-CHD,CHEMICAL
32184123,"However, it is unknown whether administration of ascorbic acid (AA), a potent antioxidant, can prevent oxidative and remodeling dysfunction during MS in these subjects.",ascorbic acid,CHEBI,prevent,oxidative dysfunction,DISEASE
12473531,"For some years, the treatment of priapism in sickle-cell anemia was changed by the use of alpha-adrenergic agonists.",sickle-cell anemia,DISEASE,be changed for years by use of,alpha-adrenergic agonists,CHEBI
12473531,"For some years, the treatment of priapism in sickle-cell anemia was changed by the use of alpha-adrenergic agonists.",priapism,DISEASE,be changed for years by use of,alpha-adrenergic agonists,CHEBI
12473531,"For some years, the treatment of priapism in sickle-cell anemia was changed by the use of alpha-adrenergic agonists.",priapism,DISEASE,have the treatment in,sickle-cell anemia,DISEASE
12473531,These therapeutics (mainly etilefrine and epinephrine) were first reserved for priapism resulting from intrapenile injections of vasoactive drugs which are used for the treatment of impotence.,therapeutics etilefrine,CHEMICAL,be reserved for,priapism,DISEASE
12473531,"In acute priapism, alpha-adrenergic agonists are used in intracavernous injections (ICI).",alpha-adrenergic agonists,CHEBI,be used in acute priapism in,ICI,CHEMICAL
12473531,"However, self-administered ICI associated with the oral treatment protects patients with stuttering priapism against acute strokes.",self-administered ICI,CHEMICAL,protect patients with,acute strokes,DISEASE
12473531,"However, self-administered ICI associated with the oral treatment protects patients with stuttering priapism against acute strokes.",self-administered ICI,CHEMICAL,protect patients with,priapism,DISEASE
12473531,"However, self-administered ICI associated with the oral treatment protects patients with stuttering priapism against acute strokes.",self-administered ICI,CHEMICAL,protect patients with,stuttering,MENTAL_HEALTH
12473531,The excellent efficacy of ICI in sickle-cell priapism leads to suggest that the pathogenic mechanism could involve a neuromuscular dysfunction.,ICI,CHEMICAL,have the excellent efficacy in,sickle-cell priapism,DISEASE
35538250,Histamine H3 receptor (H3R) antagonists are considered as therapeutic factors for treating cognitive impairments.,Histamine H3 receptor H3R antagonists,CHEMICAL,treat,cognitive impairments,DISEASE
35538250,Histamine H3 receptor (H3R) antagonists are considered as therapeutic factors for treating cognitive impairments.,Histamine H3 receptor H3R antagonists,CHEBI,treat,cognitive impairments,DISEASE
35599732,This study aimed to evaluate the efficacy and safety of long-term use of low-dose RTX and MMF in Chinese patients with NMOSD.,MMF,CHEMICAL,in chinese patients with,NMOSD,DISEASE
6151270,"The activity of Mg2+-ATPase was determined in the cortex mitochondrial fraction, limbic system and medulla oblongata under conditions of chronic stress as well as against a background of preliminary therapy by psychotropic drugs.",Mg2,CHEMICAL,be determined in,chronic stress,MENTAL_HEALTH
6684488,"The content of adenylic nucleotides (ATP, ADP and AMP) in different structures of the rat brain (cortex, limbic system, medulla oblongata) was studied in experimental chronic stress (anxiety) as was its correction with psychotropic agents--the derivatives of different chemical compounds.",adenylic nucleotides ATP,CHEMICAL,be studied in,experimental stress anxiety derivatives,MENTAL_HEALTH
1760901,"Gastric emptying time before elective surgery is normal, but premedication with morphine, pethidine (meperidine) and anticholinergics all delay gastric emptying and hence drug absorption.",premedication,CHEMICAL,delay,emptying drug absorption,CHEBI
1760901,"Gastric emptying time before elective surgery is normal, but premedication with morphine, pethidine (meperidine) and anticholinergics all delay gastric emptying and hence drug absorption.",morphine,CHEMICAL,delay,emptying drug absorption,CHEBI
30922102,"Clozapine is the only effective medication for treatment-resistant schizophrenia, but its worldwide use is still limited because of its complex titration protocols.",Clozapine,CHEMICAL,be effective medication for,treatment-resistant schizophrenia,MENTAL_HEALTH
32642294,"Recent population studies indicate that progestin exposure significantly reduces the incidence of ovarian, pancreatic and lung cancers in addition to endometrial cancer in women.",progestin exposure,CHEBI,reduce incidence of,cancers,DISEASE
32642294,"Recent population studies indicate that progestin exposure significantly reduces the incidence of ovarian, pancreatic and lung cancers in addition to endometrial cancer in women.",progestin exposure,CHEBI,reduce incidence of,endometrial cancer,DISEASE
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",MPA,CHEMICAL,increase susceptibility to infections such as,NET-EN,CHEMICAL
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",MPA,CHEMICAL,increase susceptibility to infections such as,injectable contraceptive norethisterone enanthate,CHEMICAL
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",MPA,CHEMICAL,increase susceptibility to,infections,DISEASE
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",injectable contraceptive medroxyprogesterone acetate,CHEMICAL,increase susceptibility to infections such as,NET-EN,CHEMICAL
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",injectable contraceptive medroxyprogesterone acetate,CHEMICAL,increase susceptibility to infections such as,injectable contraceptive norethisterone enanthate,CHEMICAL
24840644,"Clinical studies suggest that the injectable contraceptive medroxyprogesterone acetate (MPA) increases susceptibility to infections such as HIV-1, unlike the injectable contraceptive norethisterone enanthate (NET-EN).",injectable contraceptive medroxyprogesterone acetate,CHEMICAL,increase susceptibility to,infections,DISEASE
24840644,"Dose response analysis shows that MPA has a potency of ∼ 24 nM for transactivation of the anti-inflammatory GILZ gene and ∼ 4-20 nM for repression of the pro-inflammatory genes, suggesting that these effects are likely to be relevant at injectable contraceptive doses of MPA.",MPA,CHEMICAL,have potency of ∼ nm for transactivation of,repression,MENTAL_HEALTH
30193877,"Based on this background, the aim of this study was to investigate the pharmacological effects of PEA on autistic-like behaviour of BTBR T+tf/J mice and to shed light on the contributing mechanisms.",PEA,CHEMICAL,have the pharmacological effects on,autistic-like behaviour,DISEASE
28072841,"Increased production of adiponectin in db/db mice due to dmp effected lowering of circulatory TG and FFA levels, activates AMPK in skeletal muscle and this stimulates mitochondrial biogenesis and bioenergetics.",dmp,CHEMICAL,lowering of,FFA,CHEMICAL
28072841,"Increased production of adiponectin in db/db mice due to dmp effected lowering of circulatory TG and FFA levels, activates AMPK in skeletal muscle and this stimulates mitochondrial biogenesis and bioenergetics.",dmp,CHEMICAL,lowering of,TG levels,DISEASE
34505961,The use of local therapy with antibiotics in a suitable carrier is essential in the treatment and prevention of infections in orthopedic surgery and traumatology.,suitable carrier,CHEBI,be essential in the treatment and prevention of,infections,DISEASE
34505961,The use of local therapy with antibiotics in a suitable carrier is essential in the treatment and prevention of infections in orthopedic surgery and traumatology.,antibiotics,CHEBI,be essential in the treatment and prevention of,infections,DISEASE
34505961,"Therefore, we verified the efficacy of vancomycin in the pre-prepared carrier by an orientation microbiological method and by measuring the concentrations of the vancomycin released in active form and its two crystalline degradation products.",vancomycin,CHEMICAL,have the efficacy in,pre-prepared carrier,CHEBI
34505961,"Although vancomycin concentrations decreased by approximately 32% at the end of 12 days of storage, the concentrations of the released active form of vancomycin are many times higher than the minimum inhibitory concentrations for resistant strains of Staphylococcus aureus.",vancomycin,CHEMICAL,be,Staphylococcus aureus,DISEASE
35350940,It has been widely reported that the key biomarkers of homocysteine metabolic pathways have emerged as markers or independent risk factors for cardiovascular disease and many other diseases.,homocysteine metabolic pathways,CHEMICAL,emerge as markers or independent risk factors for,cardiovascular disease,DISEASE
12507043,"We conclude that lithium intoxication may be associated with variable behavioural and cognitive impairments, some of them potentially persistent.",lithium intoxication,NUTRITION,be associated with,variable behavioural impairments,DISEASE
12507043,"Different from other case studies our findings suggest that lithium intoxication may cause a combined, multifocal functional impairment of subcortical and cortical neural mechanisms in both hemispheres.",lithium intoxication,NUTRITION,cause,subcortical neural mechanisms,DISEASE
27847314,"Consistent with this, infusion of the LH antagonist dg-hCG into the dorsal hippocampus caused an amelioration of memory deficits in ovariectomized females.",LH antagonist dg-hCG,CHEBI,cause amelioration of,memory deficits,DISEASE
33146282,"Thus, the aim of this study was to investigate the protective effect of 4GMV on the imiquimod (IMQ)-induced psoriasis-like lesions in BALB/c mice and the anti-inflammatory effect on the lipopolysaccharide (LPS)-induced inflammation in RAW264.7 macrophages.",4GMV,CHEMICAL,have the protective effect on,imiquimod psoriasis-like lesions,CHEMICAL
33146282,"Taken together, these results demonstrated that 4GMV showed a protective effect in IMQ-induced psoriasis-like mice and inhibited inflammation through the NF-κB and MAPK signaling pathways, indicating that 4GMV might be a potential therapeutic drug for psoriasis.",4GMV,CHEMICAL,be potential therapeutic drug for,psoriasis,DISEASE
33146282,"Taken together, these results demonstrated that 4GMV showed a protective effect in IMQ-induced psoriasis-like mice and inhibited inflammation through the NF-κB and MAPK signaling pathways, indicating that 4GMV might be a potential therapeutic drug for psoriasis.",4GMV,CHEMICAL,be,potential therapeutic drug,CHEBI
30191146,"Omalizumab, a monoclonal antibody against IgE, is an immunomodulatory biological agent, used as new drug in patients with confirmed IgE-mediated allergic asthma, only for patient's specific range of total IgE level.",Omalizumab,CHEMICAL,used as new drug in patients with confirmed ige-mediated allergic asthma for,total IgE level,CHEMICAL
30191146,"Omalizumab, a monoclonal antibody against IgE, is an immunomodulatory biological agent, used as new drug in patients with confirmed IgE-mediated allergic asthma, only for patient's specific range of total IgE level.",Omalizumab,CHEMICAL,used as new drug in patients with,IgE-mediated allergic asthma,DISEASE
30191146,"Omalizumab, a monoclonal antibody against IgE, is an immunomodulatory biological agent, used as new drug in patients with confirmed IgE-mediated allergic asthma, only for patient's specific range of total IgE level.",Omalizumab,CHEMICAL,used as,new drug,CHEBI
32733680,Baló's concentric sclerosis is a rare variant of multiple sclerosis.,Baló's concentric sclerosis,DISEASE,be rare variant of,multiple sclerosis,DISEASE
32733680,"The abuse of cocaine and its most frequent adulterant, levamisole, may induce ischemic or hemorrhagic stroke and metabolic or multifocal inflammatory leukoencephalopathy.",cocaine,CHEMICAL,induce,ischemic stroke,DISEASE
32733680,"The abuse of cocaine and its most frequent adulterant, levamisole, may induce ischemic or hemorrhagic stroke and metabolic or multifocal inflammatory leukoencephalopathy.",cocaine,CHEMICAL,induce,inflammatory leukoencephalopathy,DISEASE
29182995,Levamisole is now frequently used as an ingredient in cocaine and may cause leukoencephalopathy.,Levamisole,CHEMICAL,be used as ingredient in,cocaine,CHEMICAL
29182995,Levamisole is now frequently used as an ingredient in cocaine and may cause leukoencephalopathy.,Levamisole,CHEMICAL,cause,leukoencephalopathy,DISEASE
29182995,It is recommended to check urine levamisole levels in patients with cocaine-induced leukoencephalopathy with or without mimicking Balo's Concentric Sclerosis.,levamisole levels,CHEMICAL,in patients with,cocaine-induced leukoencephalopathy,DISEASE
35002284,"In its clinical application, dexmedetomidine has been reported to present a significant number of benefits including safe sedation for various surgical interventions, improvement of intraoperative and postoperative analgesia, sedation for compromised airways without respiratory depression, nephroprotection and stability of hypotensive hemodynamics, reduction of postoperative nausea and vomiting and postoperative shivering incidence, and decrease of intraoperative blood loss.",dexmedetomidine,CHEMICAL,including safe sedation for,intraoperative analgesia,MENTAL_HEALTH
35002284,"In its clinical application, dexmedetomidine has been reported to present a significant number of benefits including safe sedation for various surgical interventions, improvement of intraoperative and postoperative analgesia, sedation for compromised airways without respiratory depression, nephroprotection and stability of hypotensive hemodynamics, reduction of postoperative nausea and vomiting and postoperative shivering incidence, and decrease of intraoperative blood loss.",dexmedetomidine,CHEMICAL,including safe sedation for,postoperative shivering incidence,DISEASE
35002284,"In its clinical application, dexmedetomidine has been reported to present a significant number of benefits including safe sedation for various surgical interventions, improvement of intraoperative and postoperative analgesia, sedation for compromised airways without respiratory depression, nephroprotection and stability of hypotensive hemodynamics, reduction of postoperative nausea and vomiting and postoperative shivering incidence, and decrease of intraoperative blood loss.",dexmedetomidine,CHEMICAL,including safe sedation for,intraoperative blood loss,DISEASE
35002284,"In its clinical application, dexmedetomidine has been reported to present a significant number of benefits including safe sedation for various surgical interventions, improvement of intraoperative and postoperative analgesia, sedation for compromised airways without respiratory depression, nephroprotection and stability of hypotensive hemodynamics, reduction of postoperative nausea and vomiting and postoperative shivering incidence, and decrease of intraoperative blood loss.",dexmedetomidine,CHEMICAL,including safe sedation for,vomiting,DISEASE
30363004,"However, both the benefits and drawbacks of the use dexmedetomidine in neuroanesthesia should be considered.",use dexmedetomidine,CHEMICAL,have the benefits and drawbacks in,neuroanesthesia,DISEASE
34338396,Paternal Ndn-mutated mice totally lack necdin expression and exhibit various types of neuronal abnormalities throughout the nervous system.,Ndn-mutated mice,CHEMICAL,exhibit various types of,neuronal abnormalities,DISEASE
25667567,Behçet's disease (BD) is a rare vasculitis in sub-Saharan Africa.,Behçet's disease,CHEMICAL,be,rare vasculitis,DISEASE
25080404,"Dietary supplementation with n-3 PUFAs has been suggested as a non-pharmacological therapy for a number of developmental disorders, e.g., autistic spectrum disorders (ASD), but human studies so far have led to conflicting results.",n-3 PUFAs,CHEMICAL,be suggested as non-pharmacological therapy for number of,ASD,DISEASE
25080404,"Dietary supplementation with n-3 PUFAs has been suggested as a non-pharmacological therapy for a number of developmental disorders, e.g., autistic spectrum disorders (ASD), but human studies so far have led to conflicting results.",n-3 PUFAs,CHEMICAL,be suggested as non-pharmacological therapy for number of,autistic spectrum disorders,DISEASE
25080404,"These results demonstrate that n-3 PUFAs dietary supplementation, although not a panacea, has a considerable therapeutic value for FXS and potentially for ASD, suggesting a major mediating role of neuroinflammatory mechanisms.",n-3 PUFAs dietary supplementation,CHEMICAL,have considerable therapeutic value for,FXS,DISEASE
12447823,"The exogenous administration of LAC may affect brain activity in FXS by: I) modulation of fuel partitioning for energy production, which at the mithocondrial level is associated with the Kreb's cycle metabolic role in neurotransmitter synthesis; II) remodelling of lipid membrane in terms of LAC actively determining the production of polyunsaturated fatty acids; III) preferential effect on the attention component of the cholinergic system which relies on its peculiar modality of communication in the CNS.",LAC,CHEMICAL,affect brain activity in fxs by,LAC preferential effect,CHEMICAL
12447823,The objective of this study is to determine the effect of LAC on the hyperactive behaviour of FXS children as evaluated by the administration of the Conners Abbreviated Parent Questionnaire.,LAC,CHEMICAL,have the effect on,hyperactive behaviour,DISEASE
22475394,The anti-angiogenic mechanism of crocetin was evaluated by examining its effects on VEGF-induced proliferation and migration of human retinal microvascular endothelial cells (HRMECs) and phosphorylation of p38.,crocetin,CHEMICAL,examine its effects on vegf-induced proliferation and migration of,human retinal microvascular endothelial cells,DISEASE
22475394,"Therefore, we tested effects of crocetin on adhesion molecule dissociation induced by VEGF.",crocetin,CHEMICAL,have effects on,molecule dissociation,MENTAL_HEALTH
20589782,"In Scatchard analysis, the number of binding sites in each gram of polymer (maximum binding sites) and dissociation constant of crocin to binding sites were 18.4 micromol/g polymer and 11.2 microM, respectively.",polymer,CHEBI,be,micromol/g polymer,CHEBI
21432608,Exposure to a huge overdose of long-acting MPH exhibited acute sympathomimetic toxicity but no life-threatening symptoms in this patient.,long-acting MPH,CHEMICAL,exhibit,acute sympathomimetic toxicity,CHEBI
21432608,Exposure to a huge overdose of long-acting MPH exhibited acute sympathomimetic toxicity but no life-threatening symptoms in this patient.,long-acting MPH,CHEMICAL,exhibit,acute sympathomimetic toxicity,DISEASE
21432608,Exposure to a huge overdose of long-acting MPH exhibited acute sympathomimetic toxicity but no life-threatening symptoms in this patient.,huge overdose,DISEASE,exhibit,acute sympathomimetic toxicity,CHEBI
21432608,Exposure to a huge overdose of long-acting MPH exhibited acute sympathomimetic toxicity but no life-threatening symptoms in this patient.,huge overdose,DISEASE,exhibit,acute sympathomimetic toxicity,DISEASE
34562764,The adjustments (grinding with or without polishing) (ZR: 733-880 N; LD: 1040-1106 N) triggered a detrimental effect on the fatigue behavior in both ceramics compared with the absence of treatment (control group; ZR: 973 N; LD: 1406 N).,ZR,CHEMICAL,trigger detrimental effect on,fatigue behavior,MENTAL_HEALTH
29898070,"It can be concluded that XP-Endo Finisher instruments showed improved performance when compared with XP-Clean instruments, demonstrating higher cyclic fatigue resistance and lower roughness.",XP-Endo Finisher instruments,NUTRITION,demonstrate,higher cyclic fatigue resistance,MENTAL_HEALTH
31955299,"In addition to behavioral therapy, oral medications such as alpha agonists, dopamine depletors, anti-psychotics, and topiramate are used to control the involuntary movements and noises.",alpha agonists,CHEBI,control,involuntary movements,DISEASE
31955299,"In addition to behavioral therapy, oral medications such as alpha agonists, dopamine depletors, anti-psychotics, and topiramate are used to control the involuntary movements and noises.",alpha agonists,NUTRITION,control,involuntary movements,DISEASE
31955299,"In addition to behavioral therapy, oral medications such as alpha agonists, dopamine depletors, anti-psychotics, and topiramate are used to control the involuntary movements and noises.",dopamine depletors,CHEMICAL,control,involuntary movements,DISEASE
31955299,"In addition to behavioral therapy, oral medications such as alpha agonists, dopamine depletors, anti-psychotics, and topiramate are used to control the involuntary movements and noises.",topiramate,CHEMICAL,control,involuntary movements,DISEASE
31955299,"Botulinum toxin injections are particularly effective in patients with troublesome focal motor and phonic tics, including coprolalia.",toxin injections,CHEBI,be effective in patients with,coprolalia,DISEASE
31955299,"Botulinum toxin injections are particularly effective in patients with troublesome focal motor and phonic tics, including coprolalia.",toxin injections,CHEBI,be effective in patients with,motor phonic tics,DISEASE
19341286,"Such morphology was attributed to be the result of significant structural disorder in the carbon skeleton, which originates during the strong oxidation that leads to graphene oxide and remains after chemical reduction.",significant structural disorder,DISEASE,have the result in,carbon skeleton,CHEMICAL
15239663,"A new class of agents with potential utility for the treatment of erectile dysfunction has been discovered, guided by the hypothesis that selective D4 agonists are erectogenic but devoid of the side effects typically associated with dopaminergic agents.",selective D4 agonists,CHEBI,be,erectogenic,CHEMICAL
34948196,"Although guanethidine (GUA) was used in the past as a drug to suppress hyperactivity of the sympathetic nerve fibers, there are no available data concerning the possible action of this substance on the sensory component of the peripheral nervous system supplying the urinary bladder.",guanethidine,CHEMICAL,suppress,hyperactivity,MENTAL_HEALTH
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",specific β2-AR antagonist,CHEBI,show osteoporosis with,hyperactivity,MENTAL_HEALTH
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",specific β2-AR antagonist,CHEBI,show,osteoporosis,DISEASE
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",tooth movement,DISEASE,show osteoporosis with,hyperactivity,MENTAL_HEALTH
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",butoxamine,CHEMICAL,show osteoporosis with,hyperactivity,MENTAL_HEALTH
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",tooth movement,DISEASE,show,osteoporosis,DISEASE
24868013,"In this study, the effects of butoxamine (BUT), a specific β2-AR antagonist, on tooth movement were examined in spontaneously hypertensive rats (SHR) showing osteoporosis with hyperactivity of the sympathetic nervous system.",butoxamine,CHEMICAL,show,osteoporosis,DISEASE
17646510,"Further, adenosine improves postoperative recovery, as indicated by lower pain scores and less opioid consumption.",adenosine,CHEMICAL,indicate by,lower pain scores,DISEASE
17825695,"Tramadol, an atypical opioid, is a narcotic analgesic used for pain management.",Tramadol,CHEMICAL,used for,pain management,DISEASE
17825695,A search of the current literature found no studies examining the efficacy of intravenous tramadol on migraine pain.,intravenous tramadol,CHEMICAL,have the efficacy on,migraine pain,DISEASE
16103274,Higher daily doses of acetaminophen and nonsteroidal anti-inflammatory drugs independently increase the risk of hypertension in women.,acetaminophen drugs,CHEMICAL,increase risk of,hypertension,DISEASE
35074377,"The reduction rates of the sludge capillary suction time (CST), the specific resistance of filtration (SRF), the sludge dry weight, and the fecal coliform bacteria concentration at the optimal reaction time of 14 h were 40.1 ± 0.2%, 69.6 ± 0.7%, 7.7 ± 0.4%, and 78.5 ± 0.4%, respectively, when the mixed liquid suspended solids (MLSS) content was between 10.8 and 29.6 g/L, the input dosage of CLL13 was 8.8 × 106 PFU/mL sludge, and the DO level was 1.2 mg/L. Meanwhile, the viscosity reduction rate, the relative hydrophobicity increasement rate, and the bound water reduction rate were 20.3 ± 1.2%, 6.9 ± 0.7%, and 29.4 ± 1.0%, respectively.",specific resistance,MENTAL_HEALTH,be,solids content,CHEMICAL
35074377,"The reduction rates of the sludge capillary suction time (CST), the specific resistance of filtration (SRF), the sludge dry weight, and the fecal coliform bacteria concentration at the optimal reaction time of 14 h were 40.1 ± 0.2%, 69.6 ± 0.7%, 7.7 ± 0.4%, and 78.5 ± 0.4%, respectively, when the mixed liquid suspended solids (MLSS) content was between 10.8 and 29.6 g/L, the input dosage of CLL13 was 8.8 × 106 PFU/mL sludge, and the DO level was 1.2 mg/L. Meanwhile, the viscosity reduction rate, the relative hydrophobicity increasement rate, and the bound water reduction rate were 20.3 ± 1.2%, 6.9 ± 0.7%, and 29.4 ± 1.0%, respectively.",specific resistance,MENTAL_HEALTH,be,MLSS,CHEMICAL
35074377,"The reduction rates of the sludge capillary suction time (CST), the specific resistance of filtration (SRF), the sludge dry weight, and the fecal coliform bacteria concentration at the optimal reaction time of 14 h were 40.1 ± 0.2%, 69.6 ± 0.7%, 7.7 ± 0.4%, and 78.5 ± 0.4%, respectively, when the mixed liquid suspended solids (MLSS) content was between 10.8 and 29.6 g/L, the input dosage of CLL13 was 8.8 × 106 PFU/mL sludge, and the DO level was 1.2 mg/L. Meanwhile, the viscosity reduction rate, the relative hydrophobicity increasement rate, and the bound water reduction rate were 20.3 ± 1.2%, 6.9 ± 0.7%, and 29.4 ± 1.0%, respectively.",water reduction,NUTRITION,be,±,CHEMICAL
34012873,"The global social expenses of Alzheimer's disease (AD) have been increased to US$1 trillion due to high cost, side-effects, and low efficiency of the current AD-therapies.",Alzheimer's disease,DISEASE,be increased to,current AD-therapies,CHEMICAL
1938802,"Imipramine also improved the boy's insomnia and enuresis, whereas methylphenidate caused an overall worsening of his condition.",Imipramine,CHEMICAL,improve boy's,enuresis,MENTAL_HEALTH
1938802,"Imipramine also improved the boy's insomnia and enuresis, whereas methylphenidate caused an overall worsening of his condition.",Imipramine,CHEMICAL,improve boy's,insomnia,MENTAL_HEALTH
33631001,"We sought to determine if FENM produced similar behavioral effects as memantine and/or if FENM has beneficial effects against fear, avoidance, and behavioral despair.",FENM,CHEMICAL,produce similar behavioral effects as,memantine,CHEMICAL
33631001,"We sought to determine if FENM produced similar behavioral effects as memantine and/or if FENM has beneficial effects against fear, avoidance, and behavioral despair.",FENM,CHEMICAL,have beneficial effects against,behavioral despair,DISEASE
7542489,"Because the metabolism of L-tryptophan through the kynurenine pathway is dependent upon adequate nutrition, we sought to determine whether the impaired nutrition characteristic of eating-disordered patients might be associated with specific disturbances in this metabolic pathway.",kynurenine pathway,CHEMICAL,have the metabolism of,L-tryptophan,CHEMICAL
7542489,"Furthermore, in the eating-disordered patients, kynurenic acid levels in cerebrospinal fluid correlated positively with percent-of-population average body weight.(ABSTRACT TRUNCATED AT 250 WORDS)",kynurenic acid levels,CHEMICAL,correlate in,eating-disordered patients,DISEASE
12620609,"The local, peripheral administration of antidepressants and excitatory amino acid receptor antagonists can cause analgesia in a number of conditions.",excitatory amino acid receptor antagonists,CHEBI,cause,analgesia,MENTAL_HEALTH
12620609,"The local, peripheral administration of antidepressants and excitatory amino acid receptor antagonists can cause analgesia in a number of conditions.",antidepressants,CHEMICAL,cause,analgesia,MENTAL_HEALTH
12620609,"Combination of an inactive dose of dextromethorphan with amitriptyline, and vice versa, resulted in an increase of analgesia so that previously inactive doses now caused significant analgesia.",amitriptyline,CHEMICAL,result in increase of,analgesia,MENTAL_HEALTH
12620609,"Combination of an inactive dose of dextromethorphan with amitriptyline, and vice versa, resulted in an increase of analgesia so that previously inactive doses now caused significant analgesia.",dextromethorphan,CHEMICAL,result in increase of,analgesia,MENTAL_HEALTH
12620609,"Combination of an inactive dose of dextromethorphan with amitriptyline, and vice versa, resulted in an increase of analgesia so that previously inactive doses now caused significant analgesia.",dextromethorphan,CHEMICAL,have an inactive dose with,amitriptyline,CHEMICAL
12620609,"Both dextromethorphan and ketamine increased the paw edema induced by formalin, and this was blocked by low doses of amitriptyline.",ketamine,CHEMICAL,increase,paw edema,DISEASE
12620609,"Both dextromethorphan and ketamine increased the paw edema induced by formalin, and this was blocked by low doses of amitriptyline.",dextromethorphan,CHEMICAL,increase,paw edema,DISEASE
12620609,Amitriptyline also blocked paw edema produced by 5-hydroxytryptamine and compound 48/80.,Amitriptyline,CHEMICAL,block,paw edema,DISEASE
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",Increased analgesia,MENTAL_HEALTH,show involvement of number of,sodium channels,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",Increased analgesia,MENTAL_HEALTH,show involvement of number of,NMDA receptor blockade,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",Increased analgesia,MENTAL_HEALTH,show involvement of number of,biogenic amine receptors,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",drug combinations,CHEBI,show involvement of number of,sodium channels,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",drug combinations,CHEBI,show involvement of number of,NMDA receptor blockade,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",drug combinations,CHEBI,show involvement of number of,biogenic amine receptors,CHEMICAL
12620609,"Increased analgesia by drug combinations (amitriptyline/dextromethorphan) could show the involvement of a number of these mechanisms (e.g. NMDA receptor blockade, blockage of sodium channels, blockage of biogenic amine receptors), while a lack of intensification (amitriptyline/ketamine) could reflect occluded actions due to expression of similar actions by the other drug.",amitriptyline/ketamine,CHEMICAL,reflect occluded actions due to expression of similar actions by,other drug,CHEBI
12620609,"Paw edema induced by dextromethorphan and ketamine involves inhibition of biogenic amine reuptake, and the ability of amitriptyline to block biogenic amine receptors likely accounts for its inhibiton of these actions.",amitriptyline,CHEMICAL,have the ability to,biogenic amine receptors,CHEMICAL
12406529,"Although neither i.t. injection of 0.1 nmol AP5 nor 1 nmol DNQX alone had an effect on the PWL of the carrageenan- and NS-injected paws, both significantly potentiated electroacupuncture-induced analgesia in carrageenan-injected rats, especially 0.1 nmol AP5.",nmol DNQX,CHEMICAL,potentiate electroacupuncture-induced analgesia in,nmol AP5,CHEMICAL
12406529,"Although neither i.t. injection of 0.1 nmol AP5 nor 1 nmol DNQX alone had an effect on the PWL of the carrageenan- and NS-injected paws, both significantly potentiated electroacupuncture-induced analgesia in carrageenan-injected rats, especially 0.1 nmol AP5.",nmol DNQX,CHEMICAL,potentiate,electroacupuncture-induced analgesia,MENTAL_HEALTH
12406529,"Although neither i.t. injection of 0.1 nmol AP5 nor 1 nmol DNQX alone had an effect on the PWL of the carrageenan- and NS-injected paws, both significantly potentiated electroacupuncture-induced analgesia in carrageenan-injected rats, especially 0.1 nmol AP5.",nmol AP5,CHEMICAL,potentiate electroacupuncture-induced analgesia in,nmol AP5,CHEMICAL
12406529,"Although neither i.t. injection of 0.1 nmol AP5 nor 1 nmol DNQX alone had an effect on the PWL of the carrageenan- and NS-injected paws, both significantly potentiated electroacupuncture-induced analgesia in carrageenan-injected rats, especially 0.1 nmol AP5.",nmol AP5,CHEMICAL,potentiate,electroacupuncture-induced analgesia,MENTAL_HEALTH
12406529,These results demonstrate that electroacupuncture and NMDA or AMPA/KA receptor antagonists have a synergetic anti-nociceptive action against inflammatory pain.,NMDA,CHEMICAL,have synergetic anti-nociceptive action against,inflammatory pain,DISEASE
12406529,These results demonstrate that electroacupuncture and NMDA or AMPA/KA receptor antagonists have a synergetic anti-nociceptive action against inflammatory pain.,electroacupuncture AMPA/KA receptor antagonists,CHEBI,have synergetic anti-nociceptive action against,inflammatory pain,DISEASE
12406529,These results demonstrate that electroacupuncture and NMDA or AMPA/KA receptor antagonists have a synergetic anti-nociceptive action against inflammatory pain.,electroacupuncture AMPA/KA receptor antagonists,CHEMICAL,have synergetic anti-nociceptive action against,inflammatory pain,DISEASE
30092813,Smith-Lemli-Opitz syndrome is a rare autosomal recessive disorder of cholesterol biosynthesis which is characterized by multiple congenital malformations and global developmental delay.,Smith-Lemli-Opitz syndrome,DISEASE,be rare autosomal recessive disorder of,cholesterol biosynthesis,NUTRITION
30092813,Smith-Lemli-Opitz syndrome is a rare autosomal recessive disorder of cholesterol biosynthesis which is characterized by multiple congenital malformations and global developmental delay.,Smith-Lemli-Opitz syndrome,DISEASE,be,rare autosomal recessive disorder,DISEASE
21527126,The authors sought to determine the efficacy of antidepressants in dysthymic disorder and to compare antidepressant and placebo response rates between major depressive disorder (MDD) and dysthymic disorder.,antidepressants,CHEMICAL,have the efficacy in,dysthymic disorder,MENTAL_HEALTH
26093587,"In light of their more favourable side effect profile (compared to baclofen), GABAB PAMs may represent a major step forward in a GABAB receptor-based pharmacotherapy of AUD and SUD.",GABAB PAMs,CHEMICAL,represent major step in gabab receptor-based pharmacotherapy of,SUD,DISEASE
26093587,"In light of their more favourable side effect profile (compared to baclofen), GABAB PAMs may represent a major step forward in a GABAB receptor-based pharmacotherapy of AUD and SUD.",GABAB PAMs,CHEMICAL,represent major step in gabab receptor-based pharmacotherapy of,AUD,CHEMICAL
26093587,"In light of their more favourable side effect profile (compared to baclofen), GABAB PAMs may represent a major step forward in a GABAB receptor-based pharmacotherapy of AUD and SUD.",GABAB PAMs,CHEMICAL,compare in light of their favourable side effect profile to,baclofen,CHEMICAL
7770609,"Experiments 4 and 5 investigated whether the potency of MK-801, (+)HA-966 or (-)HA-966 in blocking NMDA-induced convulsions paralleled their potency in producing amnesia.",MK-801,CHEMICAL,produce,amnesia,MENTAL_HEALTH
7770609,"Experiments 4 and 5 investigated whether the potency of MK-801, (+)HA-966 or (-)HA-966 in blocking NMDA-induced convulsions paralleled their potency in producing amnesia.",(+)HA-966,CHEMICAL,produce,amnesia,MENTAL_HEALTH
7770609,"The anticonvulsant potency of MK-801, (+)HA-966, and (-)HA-966 paralleled their amnestic potency.",(+)HA-966,CHEMICAL,parallel,amnestic potency,DISEASE
7770609,"The anticonvulsant potency of MK-801, (+)HA-966, and (-)HA-966 paralleled their amnestic potency.",MK-801,CHEMICAL,parallel,amnestic potency,DISEASE
7770609,These findings suggested that MK-801 and (+)HA-966 produced anterograde amnesia by their specific antagonism of the NMDA receptor complex.,(+)HA-966,CHEMICAL,produce anterograde amnesia by their specific antagonism of,NMDA receptor complex,CHEMICAL
7770609,These findings suggested that MK-801 and (+)HA-966 produced anterograde amnesia by their specific antagonism of the NMDA receptor complex.,(+)HA-966,CHEMICAL,produce,anterograde amnesia,MENTAL_HEALTH
7770609,These findings suggested that MK-801 and (+)HA-966 produced anterograde amnesia by their specific antagonism of the NMDA receptor complex.,MK-801,CHEMICAL,produce anterograde amnesia by their specific antagonism of,NMDA receptor complex,CHEMICAL
7770609,These findings suggested that MK-801 and (+)HA-966 produced anterograde amnesia by their specific antagonism of the NMDA receptor complex.,MK-801,CHEMICAL,produce,anterograde amnesia,MENTAL_HEALTH
34285539,"Grape seed proanthocyanidin extract (GSPE) alleviates senescence-related degenerative disorders; however, the potential effects of GSPE intake on RPE cellular senescence through regulating NAMPT/SIRT1/NLRP3 pathway remain unclear.",proanthocyanidin extract,NUTRITION,alleviate,senescence-related degenerative disorders,DISEASE
34285539,"Grape seed proanthocyanidin extract (GSPE) alleviates senescence-related degenerative disorders; however, the potential effects of GSPE intake on RPE cellular senescence through regulating NAMPT/SIRT1/NLRP3 pathway remain unclear.",seed proanthocyanidin,CHEMICAL,alleviate,senescence-related degenerative disorders,DISEASE
34285539,"Grape seed proanthocyanidin extract (GSPE) alleviates senescence-related degenerative disorders; however, the potential effects of GSPE intake on RPE cellular senescence through regulating NAMPT/SIRT1/NLRP3 pathway remain unclear.",GSPE,CHEMICAL,alleviate,senescence-related degenerative disorders,DISEASE
22215207,The cholinergic theory of depression highlights the involvement of muscarinic acetylcholine receptors in the neurobiology of mood disorders.,depression,MENTAL_HEALTH,highlight involvement of muscarinic acetylcholine receptors in neurobiology of,mood disorders,MENTAL_HEALTH
22215207,The cholinergic theory of depression highlights the involvement of muscarinic acetylcholine receptors in the neurobiology of mood disorders.,depression,MENTAL_HEALTH,highlight involvement of,muscarinic acetylcholine receptors,CHEMICAL
35280547,The Zn may increase plant resistance to water stress by boosting physiological and enzymatic antioxidants defense mechanisms.,Zn,CHEMICAL,increase,plant resistance,MENTAL_HEALTH
32660299,"Low-dose testosterone has been shown to improve depression symptom severity, fatigue, and sexual function in small studies in women not formally diagnosed with major depressive disorder.",Low-dose testosterone,CHEMICAL,improve,depression symptom severity,MENTAL_HEALTH
32660299,"Low-dose testosterone has been shown to improve depression symptom severity, fatigue, and sexual function in small studies in women not formally diagnosed with major depressive disorder.",Low-dose testosterone,CHEMICAL,improve,fatigue,MENTAL_HEALTH
32660299,"The authors sought to determine whether adjunctive low-dose transdermal testosterone improves depression symptom severity, fatigue, and sexual function in women with antidepressant-resistant major depression.",adjunctive low-dose transdermal testosterone,CHEMICAL,improve,antidepressant-resistant major depression,MENTAL_HEALTH
32660299,"The authors sought to determine whether adjunctive low-dose transdermal testosterone improves depression symptom severity, fatigue, and sexual function in women with antidepressant-resistant major depression.",adjunctive low-dose transdermal testosterone,CHEMICAL,improve,antidepressant-resistant major depression,DISEASE
32660299,"The authors sought to determine whether adjunctive low-dose transdermal testosterone improves depression symptom severity, fatigue, and sexual function in women with antidepressant-resistant major depression.",adjunctive low-dose transdermal testosterone,CHEMICAL,improve,depression symptom severity,MENTAL_HEALTH
32660299,"The authors sought to determine whether adjunctive low-dose transdermal testosterone improves depression symptom severity, fatigue, and sexual function in women with antidepressant-resistant major depression.",adjunctive low-dose transdermal testosterone,CHEMICAL,improve,fatigue,MENTAL_HEALTH
32916768,This builds upon decades of research showing that disturbance to neurotransmitter release via toxins can cause acute neurological dysfunction.,toxins,CHEBI,cause,acute neurological dysfunction,DISEASE
31633020,Analyses of LPA receptor-null mice identified LPA1 and LPA3 as key mediators of PHH.,LPA receptor-null mice,CHEMICAL,identify lpa1 and lpa3 as key mediators of,PHH,DISEASE
18221363,C. officinalis TR produced both the isomeric alcohols tropine and pseudotropine from tropinone using NADPH + H(+) as co-substrate.,officinalis TR,DISEASE,use nadph + h(+ as,co-substrate,CHEMICAL
7861307,"This measure, the White Bear Suppression Inventory (WBSI), was found to correlate with measures of obsessional thinking and depressive and anxious affect, to predict signs of clinical obsession among individuals prone toward obsessional thinking, to predict depression among individuals motivated to dislike negative thoughts, and to predict failure of electrodermal responses to habituate among people having emotional thoughts.",Bear Suppression,NUTRITION,predict,depression,MENTAL_HEALTH
7861307,"This measure, the White Bear Suppression Inventory (WBSI), was found to correlate with measures of obsessional thinking and depressive and anxious affect, to predict signs of clinical obsession among individuals prone toward obsessional thinking, to predict depression among individuals motivated to dislike negative thoughts, and to predict failure of electrodermal responses to habituate among people having emotional thoughts.",Bear Suppression,NUTRITION,correlate with measures of,obsessional thinking,DISEASE
7861307,"This measure, the White Bear Suppression Inventory (WBSI), was found to correlate with measures of obsessional thinking and depressive and anxious affect, to predict signs of clinical obsession among individuals prone toward obsessional thinking, to predict depression among individuals motivated to dislike negative thoughts, and to predict failure of electrodermal responses to habituate among people having emotional thoughts.",Bear Suppression,NUTRITION,correlate with measures of,depressive,DISEASE
10084635,A variety of drug treatments have been shown to be effective in the treatment of social phobia.,drug treatments,CHEBI,be shown to effective in treatment of,social phobia,MENTAL_HEALTH
1403693,"However, prolonged hyperammonemia in animals receiving an ip injection of the urease-poloxamer 407 formulation may have potentially resulted from the reduced clearance of ammonia and ammonium ion in the proximal tubules of the rats.(ABSTRACT TRUNCATED AT 250 WORDS)",prolonged hyperammonemia,DISEASE,result from reduced clearance of,ammonia ion,CHEMICAL
1403693,"However, prolonged hyperammonemia in animals receiving an ip injection of the urease-poloxamer 407 formulation may have potentially resulted from the reduced clearance of ammonia and ammonium ion in the proximal tubules of the rats.(ABSTRACT TRUNCATED AT 250 WORDS)",prolonged hyperammonemia,DISEASE,result from reduced clearance of,ammonium,CHEMICAL
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEMICAL,reach greater % displacement in presence of,M SCN-,CHEMICAL
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEBI,reach greater % displacement in presence of,M SCN-,CHEMICAL
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEMICAL,reach,displacement,MENTAL_HEALTH
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEBI,reach,displacement,MENTAL_HEALTH
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEMICAL,show significant displaceable binding in,Tris-citrate buffer,CHEMICAL
6315877,"The radiolabeled GABA receptor antagonist showed significant displaceable binding in Tris-citrate buffer that was improved by high concentrations of chloride, iodide, or thiocyanate, reaching greater than 50% displacement in the presence of 0.1 M SCN-.",radiolabeled GABA receptor antagonist,CHEBI,show significant displaceable binding in,Tris-citrate buffer,CHEMICAL
34492320,"Hence, QWF has been widely used to treat patients with forgetfulness or dementia.",QWF,CHEMICAL,treat patients with,dementia,MENTAL_HEALTH
34492320,"QWF, a classic Chinese formulation, comprises seven herbal drugs: the sclerotium of Poria cocos (Schw.) Wolf, bark of Cinnamomum cassia Presl, root of Polygala tenuifolia Willd., root and rhizome of Panax ginseng C. A. Mey., root of Asparagus cochinchinensis (Lour.) Merr., root and rhizome of Acorus tatarinowii Schott, and root bark of Lycium chinense Mill.",QWF,CHEMICAL,comprise,Poria cocos,CHEMICAL
34492320,"QWF, a classic Chinese formulation, comprises seven herbal drugs: the sclerotium of Poria cocos (Schw.) Wolf, bark of Cinnamomum cassia Presl, root of Polygala tenuifolia Willd., root and rhizome of Panax ginseng C. A. Mey., root of Asparagus cochinchinensis (Lour.) Merr., root and rhizome of Acorus tatarinowii Schott, and root bark of Lycium chinense Mill.",QWF,CHEMICAL,comprise,tenuifolia Willd,CHEMICAL
32590113,"Bajitianwan (BJTW) is a classic Chinese formulation consisting of seven herbal drugs: the root of Morinda officinalis F.C.How., root and rhizome of Acorus tatarinowii Schott, the root bark of Lycium chinense Mill., the sclerotium of Poria cocos (Schw.) Wolf, the root of Polygala tenuifolia Willd., sclerotium with host wood of Poria cocos (Schw.) Wolf and root and rhizome of Panax ginseng C. A. Mey.",BJTW,CHEMICAL,consisting of herbal drugs root of,F.C.How,CHEMICAL
32590113,BJTW has been used for the treatment of osteoporosis and AD for hundreds of years.,BJTW,CHEMICAL,be used for treatment of,osteoporosis,DISEASE
28576588,"Type 12 dystonia is a genetic syndrome characterized by a pathogenic mutation on ATP1A3 gene encoding the subunit alpha 3 of Na-K-ATPase protein, resulting in neuronal dysfunctions.",Type dystonia,DISEASE,characterized by pathogenic mutation on,neuronal dysfunctions,DISEASE
28576588,"Type 12 dystonia is a genetic syndrome characterized by a pathogenic mutation on ATP1A3 gene encoding the subunit alpha 3 of Na-K-ATPase protein, resulting in neuronal dysfunctions.",Type dystonia,DISEASE,characterized by pathogenic mutation on,ATP1A3 gene,DISEASE
30743046,Omega-3 polyunsaturated fatty acids supplementation has shown to lower HODEs levels in RTT.,acids supplementation,NUTRITION,show to,lower HODEs levels,CHEMICAL
31754030,Expression of wild-type NLG-1 in nlg-1 mutant C. elegans rescued their sensory and learning impairments.,wild-type NLG-1,CHEMICAL,rescue,sensory impairments,DISEASE
7694416,"A four-drug vasoactive mixture (papaverine hydrochloride, prostaglandin E1, phentolamine mesylate, atropine sulfate) was used for intracavernous injection therapy in 94 patients with vasculogenic impotence as diagnosed by color Doppler sonography and dynamic infusion cavernosometry-cavernosography.",mixture papaverine hydrochloride,CHEMICAL,be used for intracavernous injection therapy in patients with,vasculogenic impotence,MENTAL_HEALTH
7694416,"A four-drug vasoactive mixture (papaverine hydrochloride, prostaglandin E1, phentolamine mesylate, atropine sulfate) was used for intracavernous injection therapy in 94 patients with vasculogenic impotence as diagnosed by color Doppler sonography and dynamic infusion cavernosometry-cavernosography.",mixture papaverine hydrochloride,CHEBI,be used for intracavernous injection therapy in patients with,vasculogenic impotence,MENTAL_HEALTH
2421014,A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg./ml.) and phentolamine (0.8 mg./ml.).,organic impotence,MENTAL_HEALTH,undergo trial of intracavernous drug-induced erections with mixture of,papaverine,CHEMICAL
2421014,A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg./ml.) and phentolamine (0.8 mg./ml.).,organic impotence,MENTAL_HEALTH,undergo trial of intracavernous drug-induced erections with mixture of,mg./ml,CHEMICAL
2421014,A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg./ml.) and phentolamine (0.8 mg./ml.).,organic impotence,MENTAL_HEALTH,undergo trial of intracavernous drug-induced erections with,mixture,CHEBI
2421014,A total of 100 men with organic impotence underwent a trial of intracavernous drug-induced erections with a mixture of papaverine (25 mg./ml.) and phentolamine (0.8 mg./ml.).,organic impotence,MENTAL_HEALTH,undergo trial of,drug-induced erections,DISEASE
28435002,"These reports illustrate that, similarly to domestic cats, SHT should be suspected in old large felids with CKD and that amlodipine is a well-tolerated antihypertensive drug in these species.",amlodipine,CHEMICAL,be,well-tolerated antihypertensive drug,CHEBI
35483207,Halobenzoquinones (HBQs) as disinfection byproducts (DBPs) in drinking water is prioritized for research due to their prevalent occurrence and high toxicity.,Halobenzoquinones,CHEMICAL,be prioritized for research due,high toxicity,DISEASE
35483207,"The fragmentation mechanism was supported by the changes of Gibbs free energy (ΔG), and a linear relationship between the ΔG and the ionization efficiency of analytes was developed accordingly for quantification of these 46 HBQs, 30 of which were lack of chemical standards.",fragmentation mechanism,MENTAL_HEALTH,be supported by changes of,ΔG efficiency,CHEMICAL
33656317,"Recently, we found that pralidoxime (2-PAM, a currently clinically used nerve-agent antidote) could also detoxify tetrachloro-1,4-benzoquinone (TCBQ), which is a carcinogenic quinoid metabolite of the widely used wood preservative pentachlorophenol under normal physiological conditions, via an unusually mild and facile Beckmann fragmentation mechanism accompanied by radical homolysis.",pralidoxime,CHEMICAL,detoxify,TCBQ,CHEMICAL
33656317,"Recently, we found that pralidoxime (2-PAM, a currently clinically used nerve-agent antidote) could also detoxify tetrachloro-1,4-benzoquinone (TCBQ), which is a carcinogenic quinoid metabolite of the widely used wood preservative pentachlorophenol under normal physiological conditions, via an unusually mild and facile Beckmann fragmentation mechanism accompanied by radical homolysis.",pralidoxime,CHEMICAL,detoxify,mild Beckmann fragmentation mechanism,MENTAL_HEALTH
33656317,"Recently, we found that pralidoxime (2-PAM, a currently clinically used nerve-agent antidote) could also detoxify tetrachloro-1,4-benzoquinone (TCBQ), which is a carcinogenic quinoid metabolite of the widely used wood preservative pentachlorophenol under normal physiological conditions, via an unusually mild and facile Beckmann fragmentation mechanism accompanied by radical homolysis.",pralidoxime,CHEMICAL,detoxify,"tetrachloro-1,4-benzoquinone",CHEMICAL
11986908,"Ganglionic blockers and reserpine were pre-eminent in the 1940s (mydriasis, ileus, impotence, peptic ulcer).",reserpine,CHEMICAL,be pre-eminent in,peptic ulcer,DISEASE
11986908,"Ganglionic blockers and reserpine were pre-eminent in the 1940s (mydriasis, ileus, impotence, peptic ulcer).",reserpine,CHEMICAL,be pre-eminent in,ileus,DISEASE
11986908,"Ganglionic blockers and reserpine were pre-eminent in the 1940s (mydriasis, ileus, impotence, peptic ulcer).",reserpine,CHEMICAL,be pre-eminent in,mydriasis,DISEASE
11986908,"Ganglionic blockers and reserpine were pre-eminent in the 1940s (mydriasis, ileus, impotence, peptic ulcer).",reserpine,CHEMICAL,be pre-eminent in,impotence,MENTAL_HEALTH
11986908,"Reserpine depletes brain (depression) and peripheral (PPH) noradrenaline (NA) storage sites, guanethidine depleted NA storage via blockade of reuptake.",Reserpine,CHEMICAL,deplete,depression,MENTAL_HEALTH
11986908,"Reserpine depletes brain (depression) and peripheral (PPH) noradrenaline (NA) storage sites, guanethidine depleted NA storage via blockade of reuptake.",Reserpine,CHEMICAL,deplete,peripheral PPH noradrenaline NA storage sites,CHEMICAL
11986908,"Reserpine depletes brain (depression) and peripheral (PPH) noradrenaline (NA) storage sites, guanethidine depleted NA storage via blockade of reuptake.",guanethidine,CHEMICAL,deplete,NA storage,CHEMICAL
11986908,Methyldopa lowers pressure via PPH induced NA release (retrograde ejaculation) and via alphamethyl NA on central alpha-2 receptors (depression).,Methyldopa,CHEMICAL,induce,NA release,CHEMICAL
11986908,Methyldopa lowers pressure via PPH induced NA release (retrograde ejaculation) and via alphamethyl NA on central alpha-2 receptors (depression).,Methyldopa,CHEMICAL,induce,depression,MENTAL_HEALTH
11986908,Methyldopa lowers pressure via PPH induced NA release (retrograde ejaculation) and via alphamethyl NA on central alpha-2 receptors (depression).,Methyldopa,CHEMICAL,induce,alphamethyl NA,CHEMICAL
11986908,The alpha-2 and alpha-2 receptor antagonists (alphaRA) cause reflex tachycardia and first-dose hypotension.,alpha-2 receptor antagonists,CHEBI,cause,tachycardia hypotension,CHEMICAL
11986908,The alpha-2 and alpha-2 receptor antagonists (alphaRA) cause reflex tachycardia and first-dose hypotension.,alpha-2 receptor antagonists,CHEBI,cause,tachycardia hypotension,DISEASE
11986908,The alpha-2 and alpha-2 receptor antagonists (alphaRA) cause reflex tachycardia and first-dose hypotension.,alphaRA,CHEMICAL,cause,tachycardia hypotension,CHEMICAL
11986908,The alpha-2 and alpha-2 receptor antagonists (alphaRA) cause reflex tachycardia and first-dose hypotension.,alphaRA,CHEMICAL,cause,tachycardia hypotension,DISEASE
11986908,"The beta RA, with or absent alphaRA, remain premier since the 1970s due to mortality benefit in systolic dysfunction and post myocardial infarction, certifying the role of the SNS in the pathogenesis and sequelae and Rx of PH.",beta RA,CHEBI,remain,systolic dysfunction,DISEASE
11986908,"The beta RA, with or absent alphaRA, remain premier since the 1970s due to mortality benefit in systolic dysfunction and post myocardial infarction, certifying the role of the SNS in the pathogenesis and sequelae and Rx of PH.",absent alphaRA,CHEMICAL,remain,systolic dysfunction,DISEASE
9691633,Sympatholytic antihypertensives seldom cause importence but can cause retrograde ejaculation because of the relaxation of the smooth muscles in the prostatic urethra and bladder neck.,Sympatholytic antihypertensives,CHEBI,cause,importence,DISEASE
35294204,Cocaine addiction is a psychosocial disorder induced by the chronic use of cocaine and causes a large number of deaths around the world.,Cocaine addiction,CHEMICAL,induced by chronic use of,cocaine,CHEMICAL
35294204,Cocaine addiction is a psychosocial disorder induced by the chronic use of cocaine and causes a large number of deaths around the world.,psychosocial disorder,DISEASE,cause large number of,deaths,DISEASE
34561937,Succinate dehydrogenase inhibitors (SDHIs) have been widely used to manage plant diseases caused by phytopathogenic fungi.,Succinate dehydrogenase inhibitors,CHEMICAL,manage,plant diseases,DISEASE
34561937,Succinate dehydrogenase inhibitors (SDHIs) have been widely used to manage plant diseases caused by phytopathogenic fungi.,SDHIs,CHEMICAL,manage,plant diseases,DISEASE
34372699,"Six percent of azole-resistant A. fumigatus isolates from the United States with the TR34 resistance marker had a mixture of clade A and clade B alleles, suggestive of recombination.",TR34 resistance marker,MENTAL_HEALTH,have,mixture,CHEBI
32149549,"Conclusions: Our results were consistent with the published data and indicated that the DS profile in the Spanish population is similar to that in other populations, which would corroborate the homogeneity of DS within the schizophrenia spectrum and contribute to the hypothesis that DS constitutes a separate disease.",Spanish population,NUTRITION,be similar to,schizophrenia spectrum,MENTAL_HEALTH
26107678,"Insulinoma is a rare endocrine tumor that can cause a wide variety of symptoms, including abnormal nocturnal behavior.",Insulinoma,DISEASE,be,rare endocrine tumor,CHEBI
26107678,"In contrast, in case 2, fasting glucose sampling did not indicate hypoglycemia, but continuous glucose monitoring revealed nocturnal hypoglycemia.",continuous glucose monitoring,CHEMICAL,reveal,nocturnal hypoglycemia,DISEASE
14514012,"2. Orthostatic hypotension, neurogenic bladder, laryngeal stridor and sleep apnea, and rapid eye movement (REM) sleep behavior disorder are prominent manifestations of MSA.",Orthostatic hypotension,DISEASE,be prominent manifestations of,MSA,CHEMICAL
14514012,"Loss of cholinergic mesopontine neurons, in the setting of loss of locus ceruleus neurons and preservation of rostral raphe neurons, may contribute to REM sleep abnormalities in MSA.",cholinergic mesopontine neurons,DISEASE,contribute in setting of loss of locus ceruleus neurons and preservation of,REM sleep abnormalities,DISEASE
14514012,"Loss of cholinergic mesopontine neurons, in the setting of loss of locus ceruleus neurons and preservation of rostral raphe neurons, may contribute to REM sleep abnormalities in MSA.",cholinergic mesopontine neurons,DISEASE,contribute in setting of loss of locus ceruleus neurons and preservation of,MSA,DISEASE
27618521,"Different classes of antidepressants have been compared; and the British Association for Psychopharmacology, and National Institute for Health and Care Excellence (NICE) consider antidepressants (mainly selective serotonin reuptake inhibitors (SSRIs)) as the first-line treatment for panic disorder, due to their more favourable adverse effect profile over monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs).",antidepressants,CHEMICAL,be compared as first-line treatment for,panic disorder,MENTAL_HEALTH
27618521,"Different classes of antidepressants have been compared; and the British Association for Psychopharmacology, and National Institute for Health and Care Excellence (NICE) consider antidepressants (mainly selective serotonin reuptake inhibitors (SSRIs)) as the first-line treatment for panic disorder, due to their more favourable adverse effect profile over monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs).",antidepressants,CHEMICAL,be compared as first-line treatment for,TCAs,CHEMICAL
27618521,"Different classes of antidepressants have been compared; and the British Association for Psychopharmacology, and National Institute for Health and Care Excellence (NICE) consider antidepressants (mainly selective serotonin reuptake inhibitors (SSRIs)) as the first-line treatment for panic disorder, due to their more favourable adverse effect profile over monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs).",antidepressants,CHEMICAL,be compared as first-line treatment for,tricyclic antidepressants,CHEMICAL
27618521,"Different classes of antidepressants have been compared; and the British Association for Psychopharmacology, and National Institute for Health and Care Excellence (NICE) consider antidepressants (mainly selective serotonin reuptake inhibitors (SSRIs)) as the first-line treatment for panic disorder, due to their more favourable adverse effect profile over monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs).",antidepressants,CHEMICAL,be compared as first-line treatment for,MAOIs,CHEMICAL
27618521,"In addition to antidepressants, benzodiazepines are widely prescribed for the treatment of panic disorder.",benzodiazepines,CHEMICAL,be prescribed in addition to antidepressants for treatment of,panic disorder,MENTAL_HEALTH
27618521,"In addition to antidepressants, benzodiazepines are widely prescribed for the treatment of panic disorder.",benzodiazepines,CHEMICAL,be prescribed in addition to,antidepressants,CHEMICAL
28525221,"The management of insomnia can be non-drug treatment (exercise, light therapy, acupuncture and self-treatment cognitive behavioral therapy) but also drug treatment (benzodiazepine, Z-DRUGS, melatonin, antidepressants, herbal medicines, neuroleptics and antihistaminics).",insomnia,MENTAL_HEALTH,be,acupuncture,CHEMICAL
17037820,"The symptomatic treatment of insomnia includes sleep hygiene and intermittent administration of sleep promoting drugs such as benzodiazepines, non-benzodiazepine hypnotics of second generation, antidepressants, antipsychotics, antihistaminics or herbal and over the counter agents.",insomnia,MENTAL_HEALTH,include sleep hygiene and intermittent administration of,benzodiazepines,CHEMICAL
17037820,"The symptomatic treatment of insomnia includes sleep hygiene and intermittent administration of sleep promoting drugs such as benzodiazepines, non-benzodiazepine hypnotics of second generation, antidepressants, antipsychotics, antihistaminics or herbal and over the counter agents.",insomnia,MENTAL_HEALTH,include sleep hygiene and intermittent administration of,antihistaminics,CHEBI
17037820,"The symptomatic treatment of insomnia includes sleep hygiene and intermittent administration of sleep promoting drugs such as benzodiazepines, non-benzodiazepine hypnotics of second generation, antidepressants, antipsychotics, antihistaminics or herbal and over the counter agents.",insomnia,MENTAL_HEALTH,include sleep hygiene and intermittent administration of,sleep non-benzodiazepine hypnotics,CHEMICAL
17037820,"The symptomatic treatment of insomnia includes sleep hygiene and intermittent administration of sleep promoting drugs such as benzodiazepines, non-benzodiazepine hypnotics of second generation, antidepressants, antipsychotics, antihistaminics or herbal and over the counter agents.",insomnia,MENTAL_HEALTH,include sleep hygiene and intermittent administration of,antidepressants,CHEMICAL
9601200,The findings suggest that the nature of the symptoms complex--the onset and recovery course; the absence of secondary gain or job-related stress for most of the symptomatic persons; the predominance of males in the symptomatic group; and the baseline emotional stability of all persons examined--are inconsistent with the reported features of psychogenic illness in response to unknown environmental or chemical toxins.,secondary gain,DISEASE,be inconsistent with reported features of psychogenic illness in,environmental toxins,CHEBI
9601200,The findings suggest that the nature of the symptoms complex--the onset and recovery course; the absence of secondary gain or job-related stress for most of the symptomatic persons; the predominance of males in the symptomatic group; and the baseline emotional stability of all persons examined--are inconsistent with the reported features of psychogenic illness in response to unknown environmental or chemical toxins.,secondary gain,DISEASE,be inconsistent with reported features of,psychogenic illness,DISEASE
31525554,"While levetiracetam (LEV) usage is a known risk factor for psychosis in epilepsy, the modulating effect of certain patient and treatment characteristics on the risk of psychosis has yet to be fully elucidated.",levetiracetam LEV usage,CHEMICAL,be known risk factor for psychosis in,epilepsy,DISEASE
31525554,"While levetiracetam (LEV) usage is a known risk factor for psychosis in epilepsy, the modulating effect of certain patient and treatment characteristics on the risk of psychosis has yet to be fully elucidated.",levetiracetam LEV usage,CHEMICAL,be known risk factor for,psychosis,MENTAL_HEALTH
31714906,"Currently, front line treatment for UTIs consists of oral antibiotics, but the rise of antibiotic resistance is leading to higher rates of recurrence, and antibiotics cause collateral damage to other members of the gut microbiota.",antibiotics,CHEBI,cause,collateral damage,DISEASE
31714906,"It is commonly believed that incorporation of the American cranberry, Vaccinium macrocarpon, into the diet is useful for reducing recurrence of UTIs.",American cranberry,NUTRITION,reduce recurrence of,UTIs,DISEASE
31714906,"To identify the specific compounds responsible for this, we tested a panel of compounds isolated from cranberries for activity against E. coli, and found that salicylate exhibited antimicrobial activity against both laboratory E. coli and human UTI E. coli isolates.",salicylate,CHEMICAL,exhibit antimicrobial activity against,human UTI E. coli isolates,DISEASE
31714906,"To identify the specific compounds responsible for this, we tested a panel of compounds isolated from cranberries for activity against E. coli, and found that salicylate exhibited antimicrobial activity against both laboratory E. coli and human UTI E. coli isolates.",salicylate,CHEMICAL,exhibit,antimicrobial activity,CHEBI
31714906,"In a gut simulator, salicylate reduced levels of Enterobacteriaceae and elevated Bacteroidaceae in a dose dependent manner.",salicylate,CHEMICAL,reduce in gut simulator levels of,Enterobacteriaceae,DISEASE
31930406,"Host plant resistance, an important strategy of integrated pest management, was examined in the American cranberry, Vaccinium macrocarpon Aiton (Ericaceae).",plant resistance,MENTAL_HEALTH,be examined in,American cranberry,NUTRITION
31930406,"Host plant resistance, an important strategy of integrated pest management, was examined in the American cranberry, Vaccinium macrocarpon Aiton (Ericaceae).",plant resistance,MENTAL_HEALTH,be examined in,Vaccinium macrocarpon Aiton,CHEMICAL
31930406,"Our findings provide evidence of different levels of resistance in common cranberry cultivars, which should inform future plantings and breeding programs.",resistance,MENTAL_HEALTH,have different levels in,common cranberry cultivars,NUTRITION
35355073,Intracerebroventricular injection of endothelin-A receptor antagonist BQ123 potentiates opioid analgesia and reverses analgesic tolerance.,endothelin-A receptor antagonist BQ123,CHEMICAL,potentiate,opioid analgesia,MENTAL_HEALTH
35355073,Intracerebroventricular injection of endothelin-A receptor antagonist BQ123 potentiates opioid analgesia and reverses analgesic tolerance.,endothelin-A receptor antagonist BQ123,CHEBI,potentiate,opioid analgesia,MENTAL_HEALTH
26440527,We have previously demonstrated that endothelin-A (ETA) receptor antagonists potentiate opioid analgesia and eliminate analgesic tolerance.,endothelin-A ETA receptor antagonists,CHEBI,eliminate,analgesic tolerance,CHEBI
26440527,We have previously demonstrated that endothelin-A (ETA) receptor antagonists potentiate opioid analgesia and eliminate analgesic tolerance.,endothelin-A ETA receptor antagonists,CHEBI,potentiate,opioid analgesia,MENTAL_HEALTH
15694733,"The cause of death was strangulation in 20 cases (17 x hanging, 3 x ligature strangulation), 11 x suffocation (8 x under plastic bags, 3 x with face-masks, 2 x thoracic compression, 1 x positional asphyxia, and 1 x cocaine intoxication).",death,DISEASE,be strangulation in,compression,DISEASE
15694733,"The cause of death was strangulation in 20 cases (17 x hanging, 3 x ligature strangulation), 11 x suffocation (8 x under plastic bags, 3 x with face-masks, 2 x thoracic compression, 1 x positional asphyxia, and 1 x cocaine intoxication).",death,DISEASE,be strangulation in,x positional asphyxia,DISEASE
15694733,"The cause of death was strangulation in 20 cases (17 x hanging, 3 x ligature strangulation), 11 x suffocation (8 x under plastic bags, 3 x with face-masks, 2 x thoracic compression, 1 x positional asphyxia, and 1 x cocaine intoxication).",death,DISEASE,be strangulation in,cocaine,CHEMICAL
15694733,"The cause of death was strangulation in 20 cases (17 x hanging, 3 x ligature strangulation), 11 x suffocation (8 x under plastic bags, 3 x with face-masks, 2 x thoracic compression, 1 x positional asphyxia, and 1 x cocaine intoxication).",death,DISEASE,be,strangulation,DISEASE
33830427,"This study aimed to compare the efficiency and safety of aripiprazole, olanzapine, and L-methyl folate in patients with resistant OCD.",L-methyl folate,NUTRITION,in patients with,resistant OCD,DISEASE
33830427,Augmentation of SRIs with olanzapine or aripiprazole could be a promising option for resistant OCD.,aripiprazole,CHEMICAL,be promising option for,resistant OCD,DISEASE
33830427,Augmentation of SRIs with olanzapine or aripiprazole could be a promising option for resistant OCD.,SRIs,CHEMICAL,be promising option for,resistant OCD,DISEASE
33830427,Augmentation of SRIs with olanzapine or aripiprazole could be a promising option for resistant OCD.,olanzapine,CHEMICAL,be promising option for,resistant OCD,DISEASE
33830427,Augmentation of SRIs with olanzapine or aripiprazole could be a promising option for resistant OCD.,SRIs,CHEMICAL,have augmentation with,aripiprazole,CHEMICAL
33830427,Augmentation of SRIs with olanzapine or aripiprazole could be a promising option for resistant OCD.,SRIs,CHEMICAL,have augmentation with,olanzapine,CHEMICAL
28272220,"To explore the safety and efficacy of the selective 5-serotonin and norepinephrine reuptake inhibitor duloxetine hydrochloride and alpha-adrenergic receptor blocker (alpha-blocker) doxazosin mesylate-controlled tablets in the treatment of pain disorder in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).In all, 150 patients were enrolled and 126 patients completed the study (41 patients in the doxazosin group, 41 patients in the sertraline group, and 44 patients in the duloxetine group).",pain disorder,MENTAL_HEALTH,have the treatment in,chronic syndrome (CP/CPPS).In,DISEASE
28272220,"There were significant differences in the reduction of the HAD score at 3 months between the duloxetine group and the doxazosin group, and there were significant differences in the reduction of the HAD score at 6 months among the groups (P < 0.05).",duloxetine group,CHEMICAL,have 3 months with,doxazosin group,CHEMICAL
28272220,"There were significant differences in the reduction of the HAD score at 3 months between the duloxetine group and the doxazosin group, and there were significant differences in the reduction of the HAD score at 6 months among the groups (P < 0.05).",doxazosin group,CHEMICAL,have 3 months with,duloxetine group,CHEMICAL
28272220,Doxazosin combined with duloxetine exhibited good safety and efficacy in the treatment of pain disorder in CP/CPPS.,Doxazosin,CHEMICAL,exhibit good safety and efficacy in treatment of pain disorder in,CP/CPPS,DISEASE
28272220,Doxazosin combined with duloxetine exhibited good safety and efficacy in the treatment of pain disorder in CP/CPPS.,Doxazosin,CHEMICAL,exhibit good safety and efficacy in treatment of,pain disorder,MENTAL_HEALTH
28272220,Doxazosin combined with duloxetine exhibited good safety and efficacy in the treatment of pain disorder in CP/CPPS.,pain disorder,MENTAL_HEALTH,have the treatment in,CP/CPPS,DISEASE
27096023,"After an unsuccessful medical treatment and surgical removal of mucosal contacts, the decrease of headache severity was more intense in patients with CB and SS (p = 0.000) than in the patients with SD (p = 0.01).",headache severity,MENTAL_HEALTH,be intense after unsuccessful medical treatment and surgical removal of mucosal contacts in,SD,DISEASE
27096023,"After an unsuccessful medical treatment and surgical removal of mucosal contacts, the decrease of headache severity was more intense in patients with CB and SS (p = 0.000) than in the patients with SD (p = 0.01).",headache severity,MENTAL_HEALTH,be intense after unsuccessful medical treatment and surgical removal of mucosal contacts in,SS,CHEMICAL
1353866,"Tardive dystonia is a late-onset side effect of dopamine antagonist, which occurs in approximately 2% of the patients in the course of treatment with neuroleptic medication.",Tardive dystonia,DISEASE,be late-onset side effect of,dopamine antagonist,CHEBI
6342430,"The unusual resistance of the ""unconventional viruses"" to inactivation by the commonly used disinfectants has led to a high degree of apprehension regarding patients with any form of dementia.",used disinfectants,CHEBI,lead to high degree of,apprehension,MENTAL_HEALTH
6342430,"The unusual resistance of the ""unconventional viruses"" to inactivation by the commonly used disinfectants has led to a high degree of apprehension regarding patients with any form of dementia.",unusual resistance,MENTAL_HEALTH,lead to high degree of,apprehension,MENTAL_HEALTH
26322115,"Currently, the only US Food and Drug Administration (FDA)-approved medications for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine.",PTSD,DISEASE,be,paroxetine,CHEMICAL
26322115,"Currently, the only US Food and Drug Administration (FDA)-approved medications for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine.",PTSD,DISEASE,be,sertraline,CHEMICAL
26322115,"Currently, the only US Food and Drug Administration (FDA)-approved medications for PTSD are the selective serotonin reuptake inhibitors (SSRIs) sertraline and paroxetine.",PTSD,DISEASE,be,selective serotonin reuptake inhibitors,CHEMICAL
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEMICAL,enhance,81297-induced acute oral dyskinesia,MENTAL_HEALTH
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEMICAL,enhance,81297-induced acute oral dyskinesia,CHEMICAL
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEBI,enhance,81297-induced acute oral dyskinesia,MENTAL_HEALTH
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEBI,enhance,81297-induced acute oral dyskinesia,CHEMICAL
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEMICAL,suppress,SKF 81297-induced grooming,CHEMICAL
8681313,"The DA D2 receptor antagonist raclopride enhanced SKF 81297-induced acute oral dyskinesia and suppressed SKF 81297-induced grooming, each with bell-shaped dose-effect curves.",DA D2 receptor antagonist raclopride,CHEBI,suppress,SKF 81297-induced grooming,CHEMICAL
8681313,"Quinpirole, 0.1 mg/kg, induced a hyperarousal syndrome (i.e., increased arousal, stereotypy, and locomotion).",Quinpirole,CHEMICAL,induce,hyperarousal syndrome,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",SKF,CHEMICAL,regarding induction of hyperarousal syndrome and antagonism of,acute oral dyskinesia,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",SKF,CHEMICAL,regarding induction of,hyperarousal syndrome,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",SKF,CHEMICAL,antagonize,acute oral dyskinesia,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",quinpirole,CHEMICAL,cause,extreme hyperarousal syndrome,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",quinpirole,CHEMICAL,regarding induction of hyperarousal syndrome and antagonism of,acute oral dyskinesia,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",quinpirole,CHEMICAL,regarding induction of,hyperarousal syndrome,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",SKF,CHEMICAL,cause,extreme hyperarousal syndrome,MENTAL_HEALTH
8681313,"Concomitant treatment with SKF 81297 and quinpirole caused an extreme hyperarousal syndrome but antagonized acute oral dyskinesia and grooming, suggesting a synergistic effect of high-efficacy DA D1 and D2/D3 receptor agonists regarding the induction of the hyperarousal syndrome and the antagonism of acute oral dyskinesia and grooming.",quinpirole,CHEMICAL,antagonize,acute oral dyskinesia,MENTAL_HEALTH
8681313,"Biperiden, 0.25 mg/kg, antagonized both the SKF 81297-induced and raclopride-induced acute oral dyskinesia.",Biperiden,CHEMICAL,antagonize,SKF 81297-induced oral dyskinesia,CHEMICAL
8681313,"Biperiden, 0.25 mg/kg, antagonized both the SKF 81297-induced and raclopride-induced acute oral dyskinesia.",Biperiden,CHEMICAL,antagonize,SKF 81297-induced oral dyskinesia,MENTAL_HEALTH
8681313,"Acute oral dyskinesia is induced by D1 agonists and lower doses of D2 antagonists, but antagonized by D1 antagonists, D2/D3 agonists, and anticholinergics.",oral dyskinesia,MENTAL_HEALTH,be induced by d1 agonists and lower doses of,D2 antagonists,CHEBI
8681313,"Acute oral dyskinesia is induced by D1 agonists and lower doses of D2 antagonists, but antagonized by D1 antagonists, D2/D3 agonists, and anticholinergics.",oral dyskinesia,MENTAL_HEALTH,be induced by,D1 agonists,CHEBI
8681313,"Acute oral dyskinesia is induced by D1 agonists and lower doses of D2 antagonists, but antagonized by D1 antagonists, D2/D3 agonists, and anticholinergics.",oral dyskinesia,MENTAL_HEALTH,antagonize by,D1 antagonists,CHEBI
8681313,"Acute oral dyskinesia is induced by D1 agonists and lower doses of D2 antagonists, but antagonized by D1 antagonists, D2/D3 agonists, and anticholinergics.",oral dyskinesia,MENTAL_HEALTH,antagonize by,D2/D3 agonists,CHEBI
8681313,"Acute oral dyskinesia is induced by D1 agonists and lower doses of D2 antagonists, but antagonized by D1 antagonists, D2/D3 agonists, and anticholinergics.",oral dyskinesia,MENTAL_HEALTH,antagonize by,anticholinergics,CHEBI
31773427,Aprocitentan is an orally active dual endothelin receptor antagonist that targets a novel pathway in the treatment of difficult-to-control (resistant) hypertension.,Aprocitentan,CHEMICAL,be,active dual endothelin receptor antagonist,CHEBI
6522476,Similar perseveration to male conspecific odors was shown in gerbils given injections of L-DOPA (30 mg/kg).,Similar perseveration,MENTAL_HEALTH,given injections of,L-DOPA,CHEMICAL
6522476,"The second, that gonadal hormones are responsible for persistence of attention, cannot be broadly generalized, because castration with resultant elevation of LH and regression of ventral glands resulted in perseveration of attention in male and female gerbils.",ventral glands,DISEASE,result in,perseveration,MENTAL_HEALTH
6522476,"The second, that gonadal hormones are responsible for persistence of attention, cannot be broadly generalized, because castration with resultant elevation of LH and regression of ventral glands resulted in perseveration of attention in male and female gerbils.",regression,MENTAL_HEALTH,result in,perseveration,MENTAL_HEALTH
34255886,"Cadmium (Cd2+ ) is cardiotoxic to fish, but its effect on the electrical excitability of cardiac myocytes is largely unknown.",Cadmium,CHEMICAL,be,cardiotoxic,DISEASE
34255886,"Cadmium (Cd2+ ) is cardiotoxic to fish, but its effect on the electrical excitability of cardiac myocytes is largely unknown.",Cd2,CHEMICAL,be,cardiotoxic,DISEASE
34255886,"The depression of the early plateau is due to the strong Cd2+ -induced inhibition of the L-type calcium (Ca2+ ) current (ICaL ), whereas the prolongation of the AP is an indirect consequence of the ICaL inhibition: at low voltages of the early plateau, the delayed rectifier potassium (K+ ) current (IKr ) remains small, delaying repolarization of AP.",depression,MENTAL_HEALTH,be due to strong cd2 + -induced inhibition of,Ca2 current,CHEMICAL
34255886,"The depression of the early plateau is due to the strong Cd2+ -induced inhibition of the L-type calcium (Ca2+ ) current (ICaL ), whereas the prolongation of the AP is an indirect consequence of the ICaL inhibition: at low voltages of the early plateau, the delayed rectifier potassium (K+ ) current (IKr ) remains small, delaying repolarization of AP.",depression,MENTAL_HEALTH,be due to strong cd2 + -induced inhibition of,L-type calcium,CHEMICAL
34255886,"The depression of the early plateau is due to the strong Cd2+ -induced inhibition of the L-type calcium (Ca2+ ) current (ICaL ), whereas the prolongation of the AP is an indirect consequence of the ICaL inhibition: at low voltages of the early plateau, the delayed rectifier potassium (K+ ) current (IKr ) remains small, delaying repolarization of AP.",depression,MENTAL_HEALTH,be due to,strong Cd2 inhibition,CHEMICAL
34111468,Alpha-linoleic acid (ALA) is an essential unsaturated fatty acid that exhibits neuroprotective outcomes in rat models of ischemic stroke and Parkinson's disease.,ALA,CHEMICAL,be,essential unsaturated fatty acid,NUTRITION
34111468,Alpha-linoleic acid (ALA) is an essential unsaturated fatty acid that exhibits neuroprotective outcomes in rat models of ischemic stroke and Parkinson's disease.,Alpha-linoleic acid,CHEMICAL,be,essential unsaturated fatty acid,NUTRITION
35151217,GABA level was significantly lower in the PTSD group compared with healthy controls.,GABA level,CHEMICAL,be lower in,PTSD group,DISEASE
35151217,"In conclusion, the current data show that cortisol and to some extent testosterone may serve as biomarker of war zone stress per se, even if trauma was experienced at least ten years before, rather than of only PTSD or resistance to PTSD.",trauma,DISEASE,be experienced before,resistance,MENTAL_HEALTH
35151217,"In conclusion, the current data show that cortisol and to some extent testosterone may serve as biomarker of war zone stress per se, even if trauma was experienced at least ten years before, rather than of only PTSD or resistance to PTSD.",trauma,DISEASE,be experienced before,PTSD,DISEASE
33253753,"White spot syndrome virus (WSSV) is currently the most severely viral pathogen for farmed crustaceans such as shrimp and crayfish, which has been causing huge economic losses for crustaceans farming worldwide every year.",White spot syndrome virus,DISEASE,be viral pathogen for farmed crustaceans such as,crayfish,NUTRITION
35505618,Naloxone is an opioid antagonist that rapidly reverses opioid intoxication to prevent death from overdose.,Naloxone,CHEMICAL,be,opioid antagonist,CHEBI
35505618,"This discordance is attributed at least in part to the negative attitude toward naloxone, which is based on the belief that naloxone is only meant for ""addicts"" and ""abusers"" (OUD patients).",naloxone,CHEMICAL,be meant for,OUD patients,DISEASE
35505618,"This article presents evidence that challenges common assertions about OUD stigma being the sole and direct driving force behind naloxone stigma, and the purported magnitude of the barrier that naloxone stigma constitutes for naloxone distribution programs among the stakeholders (patients, pharmacists, and prescribers).",naloxone stigma,CHEMICAL,constitute,naloxone distribution programs,CHEMICAL
35505618,"The case was then made to operationalize and quantify the construct among the stakeholders to determine the extent to which OUD stigma drives naloxone stigma, and the relative impact of naloxone stigma as a barrier for naloxone distribution efforts.",OUD stigma,DISEASE,drive to,naloxone stigma,CHEMICAL
34647651,These cognitive impairments undermine behavioural treatment for drug abuse and lead to poor treatment retention and outcomes.,cognitive impairments,DISEASE,undermine behavioural treatment for,drug abuse,CHEBI
34647651,Systemic modafinil treatment at low dose efficiently ameliorates morphine-induced attention dysfunction and improves motivation and working memory in mice.,Systemic modafinil treatment,CHEMICAL,ameliorate,morphine-induced attention dysfunction,DISEASE
1723696,Measurement of TSI and TBII is useful to assess improvement of immunologic abnormality induced by antithyroid drugs.,TBII,CHEMICAL,assess improvement of,immunologic abnormality,DISEASE
1723696,Recurrence of hyperthyroidism of Graves' disease is generally associated with re-appearance of TRab in the blood in most of the recurrent patients after discontinuation of antithyroid drugs.,Graves disease,DISEASE,be associated with re-appearance of trab in blood in,antithyroid drugs,CHEBI
1723696,Recurrence of hyperthyroidism of Graves' disease is generally associated with re-appearance of TRab in the blood in most of the recurrent patients after discontinuation of antithyroid drugs.,hyperthyroidism,DISEASE,be associated with re-appearance of trab in blood in,antithyroid drugs,CHEBI
233633,"It was also negative in some patients with ""euthyroid ophthalmic Graves' disease."" In patients with Graves' disease controlled with antithyroid drugs, positive TDA accurately predicted the recurrence of hyperthyroidism in eight of nine cases from whom the drugs were withdrawn.",positive TDA,DISEASE,predict in patients with graves ' disease recurrence of,hyperthyroidism,DISEASE
11918513,To examine the efficacy of second-line augmentation with noradrenergic antidepressants (NAs) in depressed patients who partially responded to lithium augmentation of selective serotonin-reuptake inhibitors (SSRIs).,second-line augmentation,CHEMICAL,have the efficacy with,noradrenergic antidepressants,CHEMICAL
34221721,"Taken together, these results suggest that both α- and β-adrenergic receptors contribute to the SNS mediation of inflammatory responses, and adrenergic antagonists may effectively mitigate tissue-specific SF-mediated inflammation.",adrenergic antagonists,CHEBI,mitigate,tissue-specific SF-mediated inflammation,DISEASE
35292378,"Transcutaneous electrical nerve stimulation (TENS) uses endogenous opioids to produce analgesia, and effectiveness can be reduced in opioid-tolerant individuals'.",TENS,CHEMICAL,produce,analgesia,MENTAL_HEALTH
35292378,Active TENS was equally effective in movement-evoked pain in those in the RTO and not-RTO groups.,Active TENS,CHEMICAL,be effective in,movement-evoked pain,DISEASE
35292378,"In summary, regular use of opioid analgesics does not interfere with the effectiveness of TENS for movement-evoked pain.",TENS,CHEMICAL,have the effectiveness for,movement-evoked pain,DISEASE
35292378,PERSPECTIVE: Individuals treated with mixed frequency TENS at a strong but comfortable intensity that was taking prescription opioid analgesics showed a significant reduction in movement-evoked pain and fatigue.,TENS,CHEMICAL,show significant reduction in,movement-evoked pain,DISEASE
35292378,PERSPECTIVE: Individuals treated with mixed frequency TENS at a strong but comfortable intensity that was taking prescription opioid analgesics showed a significant reduction in movement-evoked pain and fatigue.,TENS,CHEMICAL,show significant reduction in,fatigue,MENTAL_HEALTH
28860712,To compare analgesia and adverse effects during oral morphine and oxycodone and transdermal fentanyl and buprenorphine administration in cancer patients with pain.,buprenorphine administration,CHEMICAL,in cancer patients with,pain,DISEASE
32907576,Navafenterol (AZD8871) is an inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist (MABA) in development for the treatment of obstructive airways diseases.,Navafenterol,CHEMICAL,be inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist in development for treatment of,obstructive airways diseases,DISEASE
32907576,Navafenterol (AZD8871) is an inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist (MABA) in development for the treatment of obstructive airways diseases.,Navafenterol,CHEMICAL,be,inhaled long-acting dual-pharmacology muscarinic antagonist/β2-adrenoceptor agonist,CHEBI
32253054,"The triple combination therapy budesonide/glycopyrrolate/formoterol fumarate in a metered dose inhaler (BGF MDI), formulated by using innovative co-suspension delivery technology, is a new inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combination for the maintenance treatment of COPD.",metered dose inhaler,CHEMICAL,be,COPD,DISEASE
32253054,"The triple combination therapy budesonide/glycopyrrolate/formoterol fumarate in a metered dose inhaler (BGF MDI), formulated by using innovative co-suspension delivery technology, is a new inhaled corticosteroid/long-acting muscarinic antagonist/long-acting β2-agonist fixed-dose combination for the maintenance treatment of COPD.",triple combination therapy budesonide/glycopyrrolate/formoterol fumarate,CHEMICAL,be,COPD,DISEASE
34737133,The overuse of antibiotics in aquaculture has led to serious concerns on microbial resistance and chemical residues.,antibiotics,CHEBI,lead to serious concerns on,microbial resistance,MENTAL_HEALTH
26179919,Pelizaeus-Merzbacher disease is an X-linked hypomyelinating leukodystrophy caused by mutations or rearrangements in PLP1.,Pelizaeus-Merzbacher disease,DISEASE,caused by mutations or rearrangements in,PLP1,CHEMICAL
9294313,"The diagnosis of CHMN was confirmed by electron microscopy of his biopsied sural nerve which showed loss of large myelinated fibers, decreased density of myelinated fibers, many naked axons and atypical onion bulb formation.",CHMN,DISEASE,decrease density of,onion bulb,NUTRITION
32075359,"In vitro, OSAS patient-derived MDSC exhibited a stronger suppressive effect on T-cell proliferation [(23.2±1.1)% vs (53.7±3.2)%, P0.05].",OSAS patient-derived MDSC,DISEASE,exhibit stronger suppressive effect on,(53.7±3.2)%,CHEMICAL
32075359,"In vitro, OSAS patient-derived MDSC exhibited a stronger suppressive effect on T-cell proliferation [(23.2±1.1)% vs (53.7±3.2)%, P0.05].",OSAS patient-derived MDSC,DISEASE,exhibit stronger suppressive effect on,(23.2±1.1)%,CHEMICAL
32075359,"Further analysis revealed that OSAS patient-derived MDSC secreted much higher concentrations of IL-6, TNF-α, IL-10 and TGF-β(1) [(1 316±163) vs (642±72) ng/L, (316±35) vs (167±18) ng/L, (385±42) vs (108±26) ng/L and (44 276±4 589) vs (9 557±1 124) ng/L] (all P0.05).",OSAS patient-derived MDSC,DISEASE,secrete higher concentrations of,276±4,CHEMICAL
32075359,"Further analysis revealed that OSAS patient-derived MDSC secreted much higher concentrations of IL-6, TNF-α, IL-10 and TGF-β(1) [(1 316±163) vs (642±72) ng/L, (316±35) vs (167±18) ng/L, (385±42) vs (108±26) ng/L and (44 276±4 589) vs (9 557±1 124) ng/L] (all P0.05).",OSAS patient-derived MDSC,DISEASE,secrete higher concentrations of,TNF-α,CHEMICAL
32075359,"The percentage of membrane molecule PD-L1-positive cells in OSAS patient-derived MDSC was obviously higher than that in healthy people-derived MDSC [(75.6±7.9)% vs (30.6±2.5)%, P0.05].",OSAS patient-derived MDSC,DISEASE,be,healthy people-derived MDSC,CHEMICAL
32075359,"The percentage of membrane molecule PD-L1-positive cells in OSAS patient-derived MDSC was obviously higher than that in healthy people-derived MDSC [(75.6±7.9)% vs (30.6±2.5)%, P0.05].",OSAS patient-derived MDSC,DISEASE,be,(75.6±7.9)%,CHEMICAL
25257397,Seventy-four women (43 non-menopausal and 31 menopausal) and 29 men with a major depressive episode were genotyped for the 5-HTTLPR and assessed prospectively for antidepressant efficacy after 4 weeks of treatment.,major depressive episode,MENTAL_HEALTH,assess for,antidepressant efficacy,CHEMICAL
12908614,"Taurine, aspartate and glutamine levels were increased in the lymphocytes of depressed patients before mirtazapine treatment compared to the control group, and were normalized after treatment.",Taurine glutamine levels,CHEMICAL,be increased in lymphocytes of depressed patients before,mirtazapine treatment,CHEMICAL
12908614,"Taurine, aspartate and glutamine levels were increased in the lymphocytes of depressed patients before mirtazapine treatment compared to the control group, and were normalized after treatment.",Taurine glutamine levels,CHEMICAL,be increased in lymphocytes of,depressed patients,DISEASE
28384886,Cause of death was chest injuries due to pellets discharged from a smooth bore weapon.,death,DISEASE,be,injuries due pellets,DISEASE
28384886,Cause of death was chest injuries due to pellets discharged from a smooth bore weapon.,injuries due pellets,DISEASE,discharge from,smooth bore weapon,NUTRITION
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",glycopeptides,CHEMICAL,be correlated with resistance to,ciprofloxacin,CHEMICAL
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",glycopeptides,CHEMICAL,be correlated with,resistance,MENTAL_HEALTH
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",resistance,MENTAL_HEALTH,have high positive correlation with use of,glycopeptides,CHEMICAL
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",ceftazidime,CHEMICAL,have high positive correlation with use of,glycopeptides,CHEMICAL
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",carbapenems,DISEASE,be correlated with resistance to,ciprofloxacin,CHEMICAL
35586696,"The use of carbapenems and glycopeptides was negatively correlated with the resistance to ciprofloxacin, and the resistance to ceftazidime had a high positive correlation with the use of glycopeptides and carbapenems.",carbapenems,DISEASE,be correlated with,resistance,MENTAL_HEALTH
35586696,The use of antimicrobial drugs is correlated with the resistance rate of Klebsiella pneumoniae.,antimicrobial drugs,CHEBI,be correlated with resistance rate of,Klebsiella pneumoniae,DISEASE
35586696,The use of antimicrobial drugs is correlated with the resistance rate of Klebsiella pneumoniae.,antimicrobial drugs,CHEBI,be correlated with,resistance rate,MENTAL_HEALTH
35586696,"To reduce bacterial drug resistance, the rational use of antimicrobial drugs requires joint control through multiple departments to improve the clinical use of antimicrobial drugs and improve in-hospital control.",antimicrobial drugs,CHEBI,improve clinical use of,antimicrobial drugs,CHEBI
35586696,"To reduce bacterial drug resistance, the rational use of antimicrobial drugs requires joint control through multiple departments to improve the clinical use of antimicrobial drugs and improve in-hospital control.",antimicrobial drugs,CHEBI,reduce,bacterial drug resistance,MENTAL_HEALTH
35586696,"To reduce bacterial drug resistance, the rational use of antimicrobial drugs requires joint control through multiple departments to improve the clinical use of antimicrobial drugs and improve in-hospital control.",antimicrobial drugs,CHEBI,reduce,bacterial drug resistance,CHEBI
35574151,"The highest rate of resistance was observed to ampicillin (95%), amoxicillin (95%), oxacillin (87.5%), and cefotaxime (80%).",resistance,MENTAL_HEALTH,be observed to,oxacillin,CHEMICAL
35574151,"The highest rate of resistance was observed to ampicillin (95%), amoxicillin (95%), oxacillin (87.5%), and cefotaxime (80%).",resistance,MENTAL_HEALTH,be observed to,ampicillin,CHEMICAL
35574151,"The highest rate of resistance was observed to ampicillin (95%), amoxicillin (95%), oxacillin (87.5%), and cefotaxime (80%).",resistance,MENTAL_HEALTH,be observed to,amoxicillin,CHEMICAL
35574151,"The highest rate of resistance was observed to ampicillin (95%), amoxicillin (95%), oxacillin (87.5%), and cefotaxime (80%).",resistance,MENTAL_HEALTH,be observed to,cefotaxime,CHEMICAL
35571285,"Secondary pulmonary bacterial infection is a COVID-19 complication, increasing morbidity and mortality.",Secondary pulmonary bacterial infection,DISEASE,be,COVID-19 complication,CHEMICAL
31075868,The calculated O-H bond dissociation enthalpies (BDE) of characteristic lignin subunits were used to predict the modification pathways of technical lignins.,dissociation enthalpies,MENTAL_HEALTH,predict modification pathways of,technical lignins,CHEMICAL
31075868,The calculated O-H bond dissociation enthalpies (BDE) of characteristic lignin subunits were used to predict the modification pathways of technical lignins.,characteristic lignin subunits,CHEMICAL,predict modification pathways of,technical lignins,CHEMICAL
21207990,"The steric and electronic characteristics of the imidazolium functionalized bipyridine ligands were assessed via the synthesis of rhenium carbonyl complexes, which facilitated the rationalization of the catalytic properties of the nanoparticles.",imidazolium functionalized bipyridine ligands,CHEMICAL,be assessed via synthesis of,rhenium carbonyl complexes,CHEMICAL
2467523,"In a mixed bipolar disorder patient, DST-positive, treated with neuroleptics and antidepressants, the addition of clonidine (up to 0.6 mg/day) caused a rapid improvement in his psychopathology, without any significant side effects.",clonidine,CHEMICAL,cause in,mixed bipolar disorder patient,MENTAL_HEALTH
34337729,Polycystic ovary syndrome (PCOS) is an endo-crine disorder that occurs in 8-10% of women of reproduc-tive age.,PCOS,DISEASE,be,endo-crine disorder,DISEASE
34337729,Polycystic ovary syndrome (PCOS) is an endo-crine disorder that occurs in 8-10% of women of reproduc-tive age.,Polycystic ovary syndrome,DISEASE,be,endo-crine disorder,DISEASE
34337729,"In the last years, among the insulin sensitizers, the use of the two active isoforms of inositols (myo-inositol and d-chiro-inositol) has been spreading for the treatment of PCOS insulin resistance.",inositols myo-inositol,CHEMICAL,spread in last years among insulin sensitizers for treatment of,PCOS insulin resistance,DISEASE
34337729,"In the last years, among the insulin sensitizers, the use of the two active isoforms of inositols (myo-inositol and d-chiro-inositol) has been spreading for the treatment of PCOS insulin resistance.",inositols myo-inositol,CHEMICAL,spread in last years among insulin sensitizers for treatment of,PCOS insulin resistance,MENTAL_HEALTH
34337729,"In the last years, among the insulin sensitizers, the use of the two active isoforms of inositols (myo-inositol and d-chiro-inositol) has been spreading for the treatment of PCOS insulin resistance.",inositols myo-inositol,CHEMICAL,spread in last years among,insulin sensitizers,CHEBI
34337729,"Hence, inositols can positively affect the infertility that characterizes many PCOS patients, acting both on ovarian function and spontaneous ovulation and during IVF procedures, in terms of oocyte quality and pregnancy rate.",inositols,CHEMICAL,affect,infertility,DISEASE
31711893,"Herein, we hypothesized that memory impairment observed during PTSD could be a result of oxidative stress in hippocampal tissues and that prophylactic vitamin C administration may reduce oxidative stress in the hippocampus and prevent memory impairment.",prophylactic vitamin C administration,CHEBI,prevent,memory impairment,DISEASE
31711893,"Intriguingly, vitamin C administration successfully attenuated memory impairment and all of the changes observed in oxidative stress markers.",vitamin C administration,CHEBI,attenuate,memory impairment,DISEASE
31711893,Our findings demonstrate that vitamin C could prevent oxidative stress and memory impairment induced by SPS model of PTSD-like behavior in rat.,vitamin C,CHEBI,prevent,memory impairment,DISEASE
9215989,"Tau and neurofilament proteins are perturbed in a number of neurodegenerative disorders such as Alzheimer's disease, diffuse Lewy body disease, and Parkinson's disease.",Tau proteins,CHEMICAL,be perturbed in number of neurodegenerative disorders such as alzheimer's,diffuse Lewy body disease,MENTAL_HEALTH
9215989,"Tau and neurofilament proteins are perturbed in a number of neurodegenerative disorders such as Alzheimer's disease, diffuse Lewy body disease, and Parkinson's disease.",Tau proteins,CHEMICAL,be perturbed in number of neurodegenerative disorders such as alzheimer's,Parkinson's disease,DISEASE
9215989,"Tau and neurofilament proteins are perturbed in a number of neurodegenerative disorders such as Alzheimer's disease, diffuse Lewy body disease, and Parkinson's disease.",Tau proteins,CHEMICAL,be perturbed in number of,neurodegenerative disorders,DISEASE
16942536,We determined the effect of acidosis on ligand dissociation from adrenergic receptors and assessed the efficacy of high-dose phenylephrine in treating patients with acute ischemic priapism.,acidosis,DISEASE,have the effect on,ligand dissociation,MENTAL_HEALTH
32239759,Appropriately chosen antiepileptic drug treatment can render around 70% of patients free of all seizures.,chosen antiepileptic drug treatment,CHEBI,render % of patients free of,seizures,DISEASE
32239759,"Preventative strategies for SUDEP include reducing the occurrence of GTCS by timely referral for presurgical evaluation in people with lesional epilepsy and advice on lifestyle measures; detecting cardiorespiratory distress through clinical observation and seizure, respiratory, and heart rate monitoring devices; preventing airway obstruction through nocturnal supervision and safety pillows; reducing central hypoventilation through physical stimulation and enhancing serotonergic mechanisms of respiratory regulation using selective serotonin reuptake inhibitors (SSRIs); and reducing adenosine and endogenous opioid-induced brain and brainstem depression.",SUDEP,DISEASE,reduce occurrence of gtcs by timely referral for,lesional epilepsy,DISEASE
32239759,"Preventative strategies for SUDEP include reducing the occurrence of GTCS by timely referral for presurgical evaluation in people with lesional epilepsy and advice on lifestyle measures; detecting cardiorespiratory distress through clinical observation and seizure, respiratory, and heart rate monitoring devices; preventing airway obstruction through nocturnal supervision and safety pillows; reducing central hypoventilation through physical stimulation and enhancing serotonergic mechanisms of respiratory regulation using selective serotonin reuptake inhibitors (SSRIs); and reducing adenosine and endogenous opioid-induced brain and brainstem depression.",SUDEP,DISEASE,reduce occurrence of,GTCS,DISEASE
27434597,Appropriately chosen antiepileptic drug treatment can render around 70% of patients free of all seizures.,chosen antiepileptic drug treatment,CHEBI,render % of patients free of,seizures,DISEASE
27434597,"Preventative strategies for SUDEP include reducing the occurrence of GTCS by timely referral for presurgical evaluation in people with lesional epilepsy and advice on lifestyle measures; detecting cardiorespiratory distress through clinical observation and seizure, respiratory, and heart rate monitoring devices; preventing airway obstruction through nocturnal supervision and safety pillows; reducing central hypoventilation through physical stimulation and enhancing serotonergic mechanisms of respiratory regulation using selective serotonin reuptake inhibitors (SSRIs); reducing adenosine and endogenous opioid-induced brain and brainstem depression.",SUDEP,DISEASE,reduce occurrence of gtcs by timely referral for,lesional epilepsy,DISEASE
27434597,"Preventative strategies for SUDEP include reducing the occurrence of GTCS by timely referral for presurgical evaluation in people with lesional epilepsy and advice on lifestyle measures; detecting cardiorespiratory distress through clinical observation and seizure, respiratory, and heart rate monitoring devices; preventing airway obstruction through nocturnal supervision and safety pillows; reducing central hypoventilation through physical stimulation and enhancing serotonergic mechanisms of respiratory regulation using selective serotonin reuptake inhibitors (SSRIs); reducing adenosine and endogenous opioid-induced brain and brainstem depression.",SUDEP,DISEASE,reduce occurrence of,GTCS,DISEASE
17643398,"Ketamine exerts a robust, rapid, and relatively sustained antidepressant effect in patients with major depression.",Ketamine,CHEMICAL,exert,robust antidepressant effect,CHEMICAL
17643398,"Ketamine exerts a robust, rapid, and relatively sustained antidepressant effect in patients with major depression.",Ketamine,CHEMICAL,exert,major depression,MENTAL_HEALTH
17643398,"Ketamine exerts a robust, rapid, and relatively sustained antidepressant effect in patients with major depression.",sustained antidepressant effect,CHEMICAL,in patients with,major depression,MENTAL_HEALTH
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,iron,CHEMICAL
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,copper,CHEMICAL
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,zinc,CHEMICAL
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,vitamin D,CHEBI
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,folate,NUTRITION
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,micronutrient deficiencies,DISEASE
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,B12,CHEMICAL
25051511,"(6) The basic treatment of CD is a strict, lifelong GFD, enabled by an expert dietitian. (7) Newly diagnosed adults with CD should be assessed for micronutrient deficiencies (iron, B12, folate, zinc, copper), fat soluble vitamin deficiencies (vitamin D), and bone densitometry.",strict lifelong GFD,DISEASE,be assessed for,fat soluble vitamin deficiencies,CHEBI
24365342,"Thus, individuals with genetic vitamin E deficiency and the familial hypocholesterolemias may develop symptoms of peripheral neuropathy, cerebellar ataxia, and other neurologic signs and symptoms.",familial hypocholesterolemias,DISEASE,develop symptoms of,cerebellar ataxia,DISEASE
24365342,"Thus, individuals with genetic vitamin E deficiency and the familial hypocholesterolemias may develop symptoms of peripheral neuropathy, cerebellar ataxia, and other neurologic signs and symptoms.",familial hypocholesterolemias,DISEASE,develop symptoms of,peripheral neuropathy,DISEASE
24365342,"Thus, individuals with genetic vitamin E deficiency and the familial hypocholesterolemias may develop symptoms of peripheral neuropathy, cerebellar ataxia, and other neurologic signs and symptoms.",genetic vitamin E deficiency,CHEBI,develop symptoms of,cerebellar ataxia,DISEASE
24365342,"Thus, individuals with genetic vitamin E deficiency and the familial hypocholesterolemias may develop symptoms of peripheral neuropathy, cerebellar ataxia, and other neurologic signs and symptoms.",genetic vitamin E deficiency,CHEBI,develop symptoms of,peripheral neuropathy,DISEASE
24365342,"Deficiencies of water-soluble vitamins, such as thiamine and niacin, can also develop in the setting of malabsorption and lead to neurologic dysfunction.",water-soluble vitamins,CHEBI,lead to,neurologic dysfunction,DISEASE
24365342,"Deficiencies of water-soluble vitamins, such as thiamine and niacin, can also develop in the setting of malabsorption and lead to neurologic dysfunction.",thiamine,NUTRITION,lead to,neurologic dysfunction,DISEASE
1482282,"This has led to speculation that paraphiliac disorders might belong to an ""obsessive compulsive spectrum."" To address this issue, and because of the striking selective benefit of serotonin reuptake blocking antidepressants (such as clomipramine) in the treatment of OCD, 15 paraphiliacs entered a double-blind crossover comparison of clomipramine vs. desipramine preceded by a 2-week single-blind placebo period.",paraphiliac disorders,DISEASE,belong to,obsessive compulsive spectrum,DISEASE
1482282,"For the 8 subjects completing the protocol, there was no preferential response to the more specific serotonin reuptake inhibitor suggesting a difference in underlying pathophysiology between paraphilia and OCD.",paraphilia,DISEASE,have pathophysiology with,OCD,DISEASE
1482282,"For the 8 subjects completing the protocol, there was no preferential response to the more specific serotonin reuptake inhibitor suggesting a difference in underlying pathophysiology between paraphilia and OCD.",OCD,DISEASE,have pathophysiology with,paraphilia,DISEASE
25215097,Ingestion of potassium permanganate may result in damage to the upper gastrointestinal tract.,potassium permanganate,CHEMICAL,result in damage to,upper gastrointestinal tract,DISEASE
21473600,"The intercluster chemistry was studied using collision-induced dissociation (CID) and electron-induced dissociation (EID) in which the energy of the electrons has been varied from >0 to 30 eV. Experimental results suggest that the zwitterionic binding energy in the clusters follow the order GB > DMSA, which is consistent with theoretical calculations that highlight that the lower dipole moment of DMSA leads to a binding energy of DMSA that is 0.86 times smaller than that for GB.",DMSA,CHEMICAL,lead to binding energy of,DMSA,CHEMICAL
35204932,(1) Objective: Atomoxetine is a selective norepinephrine reuptake inhibitor used to treat attention-deficit/hyperactivity disorder (ADHD) in children over six years old.,Atomoxetine,CHEMICAL,be,selective norepinephrine reuptake inhibitor,CHEBI
35204932,"The QCD results indicated that the atomoxetine treatment could significantly alleviate behavioral difficulties in primary children with ADHD, especially in the morning prior to school (p p p < 0.05) was noted during treatment, but the effect size was slight (r = 0.09).",atomoxetine treatment,CHEMICAL,alleviate behavioral difficulties in primary children with,ADHD,MENTAL_HEALTH
35204932,"The QCD results indicated that the atomoxetine treatment could significantly alleviate behavioral difficulties in primary children with ADHD, especially in the morning prior to school (p p p < 0.05) was noted during treatment, but the effect size was slight (r = 0.09).",atomoxetine treatment,CHEMICAL,alleviate,behavioral difficulties,DISEASE
35204932,(4) Conclusions: Atomoxetine is an effective and safe treatment for primary school children with ADHD.,Atomoxetine,CHEMICAL,be,ADHD,MENTAL_HEALTH
33724252,Statin is a widely used prophylactic for stroke.,Statin,CHEMICAL,be prophylactic for,stroke,DISEASE
33724252,"However, some researchers reported that poststroke statin may lead to a depressive change in stroke patients.",poststroke statin,DISEASE,lead to depressive change in,stroke patients,DISEASE
33724252,"However, some researchers reported that poststroke statin may lead to a depressive change in stroke patients.",poststroke statin,DISEASE,lead to,depressive change,DISEASE
20169198,Entecavir (ETV) is a deoxyguanosine analog competitive inhibitor of hepatitis B virus (HBV) polymerase that exhibits delayed chain termination of HBV DNA.,Entecavir,CHEMICAL,be deoxyguanosine analog competitive inhibitor of,hepatitis B virus,DISEASE
20169198,Entecavir (ETV) is a deoxyguanosine analog competitive inhibitor of hepatitis B virus (HBV) polymerase that exhibits delayed chain termination of HBV DNA.,Entecavir,CHEMICAL,be,deoxyguanosine analog competitive inhibitor,CHEMICAL
26315614,Botulinum toxin may also be helpful in focal tics and in segmental forms of myoclonus.,Botulinum toxin,CHEBI,be helpful in focal tics and in segmental forms of,myoclonus,DISEASE
32925968,Neuroinflammation is a common consequence of toxin intrusion to any part of the central nervous system (CNS).,Neuroinflammation,DISEASE,be common consequence of,toxin intrusion,CHEBI
26035104,"Several NQs are highly active against protozoans, amongst them the causative pathogens of neglected tropical diseases such as human African trypanosomiasis (sleeping sickness), Chagas disease and leishmaniasis.",Several NQs,CHEMICAL,be active against protozoans amongst them causative pathogens of,human African trypanosomiasis,DISEASE
26035104,"Several NQs are highly active against protozoans, amongst them the causative pathogens of neglected tropical diseases such as human African trypanosomiasis (sleeping sickness), Chagas disease and leishmaniasis.",Several NQs,CHEMICAL,be active against protozoans amongst them causative pathogens of,leishmaniasis,DISEASE
26035104,"Several NQs are highly active against protozoans, amongst them the causative pathogens of neglected tropical diseases such as human African trypanosomiasis (sleeping sickness), Chagas disease and leishmaniasis.",Several NQs,CHEMICAL,be active against protozoans amongst them causative pathogens of,Chagas disease,DISEASE
22669927,"Subsequently, intravenous corticoids were administered to exclude the contribution of an underlying autoimmune encephalopathy.",intravenous corticoids,CHEMICAL,exclude contribution of,underlying autoimmune encephalopathy,DISEASE
27602566,The need for accessible cellular biomarkers of neurodegeneration in carriers of the fragile X mental retardation 1 (FMR1) premutation (PM) alleles.,neurodegeneration,DISEASE,have accessible cellular biomarkers in,carriers,CHEBI
12458639,"When he attempted suicide by ingestion of 15 g amobarbital, treatment with charcoal hemoperfusion resulted in rapid disappearance of drug from the blood.",charcoal hemoperfusion,CHEMICAL,result in rapid disappearance of,drug,CHEBI
12458639,Barbiturate withdrawal syndrome is presumed to require a history of abuse; however in patients with a history of treatment with barbiturates physicians treating acute barbiturate poisoning should be alert for the possibility of barbiturate withdrawal syndrome even in the absence of barbiturate abuse.,barbiturates,CHEMICAL,be alert for possibility of,barbiturate withdrawal syndrome,CHEMICAL
1266895,The methadone-maintenance treatment program at this time is the most satisfactory approach to the treatment of heroin addiction.,methadone-maintenance treatment program,CHEMICAL,be satisfactory approach to treatment of,heroin addiction,DISEASE
1266895,"Of the many drugs available for the treatment of the newborn withdrawal syndrome, diazepam is currently favored.",diazepam,CHEMICAL,be favored of many drugs available for treatment of,newborn withdrawal syndrome,DISEASE
35215253,"Through chemical analysis, five fatty acid derivatives (1-5), including two new fatty acid derivatives, omphalotols A and B (1 and 2), were isolated from the CH2Cl2 fraction, and the chemical structures of the new compounds were determined using 1D and 2D nuclear magnetic resonance (NMR) spectroscopy and high resolution electrospray ionization mass spectrometry (HR-ESIMS), as well as fragmentation patterns in MS/MS data and chemical reactions followed by the application of Snatzke's method and competing enantioselective acylation (CEA).",fatty acid derivatives,NUTRITION,be isolated through chemical analysis from,fragmentation patterns,MENTAL_HEALTH
35215253,"Through chemical analysis, five fatty acid derivatives (1-5), including two new fatty acid derivatives, omphalotols A and B (1 and 2), were isolated from the CH2Cl2 fraction, and the chemical structures of the new compounds were determined using 1D and 2D nuclear magnetic resonance (NMR) spectroscopy and high resolution electrospray ionization mass spectrometry (HR-ESIMS), as well as fragmentation patterns in MS/MS data and chemical reactions followed by the application of Snatzke's method and competing enantioselective acylation (CEA).",new fatty acid derivatives,NUTRITION,be isolated through chemical analysis from,fragmentation patterns,MENTAL_HEALTH
24068456,"To determine the OSA prevalence in patients with prolactinoma before and after dopamine agonist (DA) and to evaluate the correlation between the apnea-hypopnea index (AHI) and prolactin levels, body mass index (BMI), waist circumference (WC), visceral fat volume (VFV), subcutaneous fat volume, and other metabolic parameters.",OSA prevalence,DISEASE,in patients with,prolactinoma,DISEASE
17916384,This was in contrast to an inverse association between lower cholesterol and higher impulsivity and anxiety.,lower cholesterol,NUTRITION,have an inverse association with,higher impulsivity,DISEASE
17916384,This was in contrast to an inverse association between lower cholesterol and higher impulsivity and anxiety.,higher impulsivity,DISEASE,have an inverse association with,lower cholesterol,NUTRITION
21890356,The benzothiophene 1f and the indole 1g display the optimal orientation of the carboxylate for enhanced FXR agonist potency.,indole g,CHEMICAL,display optimal orientation of carboxylate for,FXR agonist potency,CHEBI
21890356,The benzothiophene 1f and the indole 1g display the optimal orientation of the carboxylate for enhanced FXR agonist potency.,indole g,CHEMICAL,display,optimal orientation,MENTAL_HEALTH
25857370,Increased level of very low-density lipoprotein (VLDL) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases.,low-density lipoprotein,NUTRITION,be associated with,cardiovascular diseases,DISEASE
25857370,Increased level of very low-density lipoprotein (VLDL) is a key feature of the metabolic syndrome and is associated with cardiovascular diseases.,low-density lipoprotein,NUTRITION,be key feature of,metabolic syndrome,DISEASE
35584252,"Results: Three chamber sociability and passive avoiding test, histopathological results, lactate levels derived from MRS, and biochemical biomarkers revealed significant differences among the PPAV and PPAS groups.",lactate levels,CHEMICAL,reveal significant differences among,PPAV groups,DISEASE
35584252,Conclusion: We concluded that vardenafil improves memory and social behaviors and prevent loss of neuronal and Purkinje cell through its anti-inflammatory and neuroprotective effect.,vardenafil,CHEMICAL,improve,memory behaviors,DISEASE
19811012,It is therefore intuitive that abrupt alterations of these hormones would interfere with mood and behavior.,hormones,CHEBI,interfere with,behavior,DISEASE
11379383,"The bleeding pattern was generally highly satisfactory and similar to that with Kliogest, as were the results of endometrial biopsies after 12 cycles of treatment.",bleeding pattern,DISEASE,be satisfactory with,Kliogest,CHEMICAL
11379383,"Continuous combined HRT with dienogest, therefore, may come to be regarded as the HRT of choice in postmenopausal patients with mood defects.",dienogest,CHEMICAL,be regarded as hrt of choice in postmenopausal patients with,mood defects,DISEASE
11379383,"In summary, HRT with antiandrogenic progestogens has its specific indications with respect to preserving metabolic estrogenicity, specific antiandrogenic effects and specific effects on vigilance and mood disorders.",antiandrogenic progestogens,CHEBI,have in summary its specific indications with respect specific antiandrogenic effects and specific effects on,vigilance mood disorders,MENTAL_HEALTH
33538518,Atomoxetine is a highly selective norepinephrine reuptake inhibitor with nonaddictive properties and limited effects of appetite suppression.,Atomoxetine,CHEMICAL,be selective norepinephrine reuptake inhibitor with nonaddictive properties and limited effects of,appetite suppression,CHEMICAL
33538518,Atomoxetine is a highly selective norepinephrine reuptake inhibitor with nonaddictive properties and limited effects of appetite suppression.,Atomoxetine,CHEMICAL,be,selective norepinephrine reuptake inhibitor,CHEBI
17148744,"Brain neurotransmitters, serotonin and norepinephrine, play an important role in the central nervous control of energy balance and are involved in symptomatology related to both obesity and depression.",serotonin,CHEMICAL,be involved in symptomatology related to,depression,MENTAL_HEALTH
17148744,"Brain neurotransmitters, serotonin and norepinephrine, play an important role in the central nervous control of energy balance and are involved in symptomatology related to both obesity and depression.",serotonin,CHEMICAL,be involved in symptomatology related to,obesity,DISEASE
17148744,"Therefore both serotonin and norepinephrine neural pathways have been paid a special attention as targets for the antiobesity drugs, antidepressants, and drugs used in the treatment of eating disorders.",norepinephrine,CHEMICAL,be paid special attention as targets for,antidepressants,CHEMICAL
17148744,"Therefore both serotonin and norepinephrine neural pathways have been paid a special attention as targets for the antiobesity drugs, antidepressants, and drugs used in the treatment of eating disorders.",serotonin neural pathways,CHEMICAL,be paid special attention as targets for,antidepressants,CHEMICAL
17148744,Selective serotonin reuptake inhibitors (SSRI) have been used in the treatment of depression and eating disorders but have failed to achieve sustained weight loss in the treatment of obesity.,SSRI,CHEBI,be used in treatment of,depression,MENTAL_HEALTH
17148744,Selective serotonin reuptake inhibitors (SSRI) have been used in the treatment of depression and eating disorders but have failed to achieve sustained weight loss in the treatment of obesity.,Selective serotonin reuptake inhibitors,CHEMICAL,be used in treatment of,depression,MENTAL_HEALTH
17148744,"Obesity treatment with sibutramine results, not only in significant weight loss, but also in reduction of abdominal fat and in the improvement of health risks associated with metabolic syndrome (lipid profile, blood glucose, insulin, HbA1c, and uric acid), as well as in the decline in disinhibition score of the EI.",Obesity treatment,DISEASE,result in,significant weight loss,DISEASE
17148744,"Obesity treatment with sibutramine results, not only in significant weight loss, but also in reduction of abdominal fat and in the improvement of health risks associated with metabolic syndrome (lipid profile, blood glucose, insulin, HbA1c, and uric acid), as well as in the decline in disinhibition score of the EI.",sibutramine,CHEMICAL,result in,significant weight loss,DISEASE
35569732,Its resistance was controlled by a Mendelian single dominant gene RSC11K in soybean Kefeng-1.,resistance,MENTAL_HEALTH,be controlled by mendelian single dominant gene rsc11 k in,soybean Kefeng-1,CHEMICAL
35569732,Its resistance was controlled by a Mendelian single dominant gene RSC11K in soybean Kefeng-1.,resistance,MENTAL_HEALTH,be controlled by mendelian single dominant gene rsc11 k in,soybean Kefeng-1,NUTRITION
35569732,Its resistance was controlled by a Mendelian single dominant gene RSC11K in soybean Kefeng-1.,resistance,MENTAL_HEALTH,be controlled by,gene RSC11 K,CHEMICAL
35569732,The novel RSC11K locus and candidate genes may help developing SMV resistance germplasm.,novel RSC11 K locus genes,CHEMICAL,develop,SMV resistance germplasm,MENTAL_HEALTH
20542064,A parkinsonian state was induced with reserpine (3 mg/kg s.c.).,parkinsonian state,DISEASE,be induced with,reserpine,CHEMICAL
20542064,"L-DOPA/benserazide alone reversed reserpine-induced akinesia (4158+/-1125 activity counts/6 h, cf vehicle 1327+/-227).",L-DOPA/benserazide,CHEMICAL,reverse,reserpine-induced akinesia,MENTAL_HEALTH
20542064,"Addition of NSD1015 elicited hyperactive behaviour that was approximately 7-fold higher than L-DOPA/benserazide (35755+/-5226, P<0.001).",NSD1015,CHEMICAL,elicit,hyperactive behaviour,DISEASE
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,agonist MK212,CHEBI
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,agonist MK212,CHEMICAL
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,antagonist SCH23390,CHEMICAL
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,D2 dopamine receptor antagonist remoxipride,CHEBI
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,alpha(2C antagonist rauwolscine,CHEMICAL
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,antagonist SCH23390,CHEBI
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,alpha(2C antagonist rauwolscine,CHEBI
20542064,"The hyperactivity induced by L-DOPA and NSD1015 was reduced by the alpha(2C) antagonist rauwolscine (1 mg/kg) and the 5-HT(2C) agonist MK212 (5 mg/kg), but not by the D2 dopamine receptor antagonist remoxipride (3 mg/kg) or the D1 dopamine receptor antagonist SCH23390 (1 mg/kg).",hyperactivity,MENTAL_HEALTH,be reduced by,D2 dopamine receptor antagonist remoxipride,CHEMICAL
35592510,Calcium was elevated to 12.3 mg/dL with parathyroid hormone (PTH) of 1191 pg/mL. Neck ultrasound revealed no parathyroid adenoma.,Calcium,CHEMICAL,be elevated to mg/dl with,hormone Neck ultrasound,CHEBI
8250645,ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion.,ENA-713,CHEMICAL,be administered to gerbils min before induction of cerebral ischemia by,bilateral carotid occlusion,DISEASE
8250645,ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion.,ENA-713,CHEMICAL,be administered to gerbils min before induction of,cerebral ischemia,DISEASE
8250645,ENA-713 (0.2 mg/kg) or saline was administered intraperitoneally to gerbils 30 min before induction of cerebral ischemia by bilateral carotid occlusion.,bilateral carotid occlusion,DISEASE,have induction of,cerebral ischemia,DISEASE
8250645,These findings suggest that ENA-713 has beneficial effects against ischemia-induced cerebral disorders.,ENA-713,CHEMICAL,have beneficial effects against,ischemia-induced cerebral disorders,DISEASE
8250645,"Thus, ENA-713 seems to be promising as a preventive or therapeutic agent for cerebrovascular dementia due to cerebral ischemia and might be useful for the treatment of Alzheimer-type dementia which is associated with multiple neurotransmitter abnormalities in the brain.",ENA-713,CHEMICAL,be promising as preventive or therapeutic agent for,cerebrovascular dementia,MENTAL_HEALTH
22692588,"Together, these data suggest that curcumin protects hepatocytes from HFFA-induced lipoapoptosis and mitochondrial dysfunction, which partially occurs through the regulation of mitochondrial biogenesis.",curcumin,CHEMICAL,protect hepatocytes from,mitochondrial dysfunction,DISEASE
10950911,"Bromocriptine, a dopamine agonist, was tested on four patients, two men and two women, with nonfluent aphasia.",Bromocriptine,CHEMICAL,be tested on,nonfluent aphasia,MENTAL_HEALTH
10950911,"Bromocriptine, a dopamine agonist, was tested on four patients, two men and two women, with nonfluent aphasia.",dopamine agonist,CHEBI,be tested on,nonfluent aphasia,MENTAL_HEALTH
10950911,Bromocriptine may be a useful adjunct in the treatment of selected patients with a nonfluent aphasia in which retrieval deficits play a major role.,Bromocriptine,CHEMICAL,be useful adjunct in treatment of selected patients with,nonfluent aphasia,MENTAL_HEALTH
22458856,Many structurally different lipid chemicals produce the narcosis response when the lipid concentration exceeds -67 mM. This suggests narcotic or anesthetic dissolution into CNS membranes until the lipid organization is disrupted or perturbed.,mM.,CHEMICAL,suggest,narcotic dissolution,CHEBI
22458856,Narcosis is immediate after gas exposure and requires no chemical activation only absorption into the blood and circulation to CNS narcotic sites.,Narcosis,DISEASE,require chemical activation absorption into blood and circulation to,CNS narcotic sites,CHEBI
22458856,Narcosis is immediate after gas exposure and requires no chemical activation only absorption into the blood and circulation to CNS narcotic sites.,Narcosis,DISEASE,be immediate after,gas exposure,CHEMICAL
26410354,"Genetic deletion of the NMDAR subunit, GluN2A, in mice lacking Mecp2 is sufficient to prevent RTT phenotypes, including regression of vision.",GluN2A,CHEMICAL,including,regression,MENTAL_HEALTH
19751344,"A skin prick test for vitamin B12 was positive, but tests for B1, B6, mannitol and saline were negative, indicating this adverse reaction was one of drug hypersensitivity due to the vitamin B12 in Vitamedin.",drug hypersensitivity due,DISEASE,have one to,vitamin B12,CHEBI
19751344,"A skin prick test for vitamin B12 was positive, but tests for B1, B6, mannitol and saline were negative, indicating this adverse reaction was one of drug hypersensitivity due to the vitamin B12 in Vitamedin.",drug hypersensitivity due,CHEBI,have one to,vitamin B12,CHEBI
19041726,"Results of the 1-day retention tests showed that intra-vSUB infusion of oxotremorine (0.01 microg) or scopolamine (0.3 or 3.0 microg) enhanced or impaired retention, respectively.",scopolamine,CHEMICAL,enhance,impaired retention,DISEASE
19041726,"Results of the 1-day retention tests showed that intra-vSUB infusion of oxotremorine (0.01 microg) or scopolamine (0.3 or 3.0 microg) enhanced or impaired retention, respectively.",oxotremorine,CHEMICAL,enhance,impaired retention,DISEASE
19041726,"Both effects were dose- and time-dependent, and 0.001 microg oxotremorine attenuated the amnesia induced by 3.0 microg scopolamine.",oxotremorine,CHEMICAL,attenuate,amnesia,MENTAL_HEALTH
19041726,The oxotremorine-induced memory enhancement was blocked by intra-BNST infusion of DL-2-amino-5-phosphonovaleric acid or propranolol at a dose not affecting retention; the amnesia induced by scopolamine was blunted by intra-BNST infusion of glutamate or norepinephrine at a dose with a negligible effect on retention.,amnesia,MENTAL_HEALTH,be blunted by intra-bnst infusion of,norepinephrine,CHEMICAL
19041726,The oxotremorine-induced memory enhancement was blocked by intra-BNST infusion of DL-2-amino-5-phosphonovaleric acid or propranolol at a dose not affecting retention; the amnesia induced by scopolamine was blunted by intra-BNST infusion of glutamate or norepinephrine at a dose with a negligible effect on retention.,amnesia,MENTAL_HEALTH,be blunted by intra-bnst infusion of,glutamate,CHEMICAL
19041726,The oxotremorine-induced memory enhancement was blocked by intra-BNST infusion of DL-2-amino-5-phosphonovaleric acid or propranolol at a dose not affecting retention; the amnesia induced by scopolamine was blunted by intra-BNST infusion of glutamate or norepinephrine at a dose with a negligible effect on retention.,amnesia,MENTAL_HEALTH,be blunted by,intra-BNST infusion,CHEMICAL
17310361,"Mercury intoxication should be suspected in a patient with severe hypertension, personality changes and acrodynia.",Mercury intoxication,NUTRITION,be suspected in patient with,severe hypertension,DISEASE
17310361,"Mercury intoxication should be suspected in a patient with severe hypertension, personality changes and acrodynia.",Mercury intoxication,NUTRITION,be suspected in patient with,acrodynia,DISEASE
31727227,"Antipsychotics and other dopamine-antagonist drugs can also cause motor side effects such as akathisia, (tardive) dyskinesia, and dystonia.",other dopamine-antagonist drugs,CHEMICAL,cause motor side effects such as,tardive dyskinesia,DISEASE
31727227,"Antipsychotics and other dopamine-antagonist drugs can also cause motor side effects such as akathisia, (tardive) dyskinesia, and dystonia.",other dopamine-antagonist drugs,CHEMICAL,cause motor side effects such as,tardive dyskinesia,MENTAL_HEALTH
31727227,"Antipsychotics and other dopamine-antagonist drugs can also cause motor side effects such as akathisia, (tardive) dyskinesia, and dystonia.",other dopamine-antagonist drugs,CHEMICAL,cause motor side effects such as,akathisia,DISEASE
31727227,"Antipsychotics and other dopamine-antagonist drugs can also cause motor side effects such as akathisia, (tardive) dyskinesia, and dystonia.",other dopamine-antagonist drugs,CHEMICAL,cause motor side effects such as,dystonia,DISEASE
12021828,"Disruption in brain dopamine function early in life can lead to enhanced susceptibility to the effects of NMDA receptor antagonists in adulthood, suggesting that animals given neonatal 6-OHDA treatment might provide a model for the altered NMDA receptor function associated with human disease.",brain dopamine function,CHEMICAL,lead to enhanced susceptibility to effects of,NMDA receptor antagonists,CHEBI
16163434,"Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists.",Hyperkalemia,DISEASE,be complications of use of,angiotensin converting enzyme inhibitors,CHEMICAL
16163434,"Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists.",Hyperkalemia,DISEASE,be complications of use of,angiotensin receptor antagonists,CHEBI
16163434,"Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists.",Hyperkalemia,DISEASE,be complications of use of,aldosterone antagonists,CHEMICAL
16163434,"Hyperkalemia is a complications of the use of angiotensin converting enzyme inhibitors, angiotensin receptor antagonists and aldosterone antagonists.",Hyperkalemia,DISEASE,be complications of use of,aldosterone antagonists,CHEBI
25011687,"Depersonalization correlated positively with negative mood (p = .019 and p = .006 on WD1 and WD2, respectively).",Depersonalization,MENTAL_HEALTH,correlate with,WD1,CHEMICAL
27247487,"To investigate the efficacy of a stepwise protocol for treating pain (SPTP) on psychosis and agitation measured with the Neuropsychiatric Inventory, Nursing Home version, and to explore the impact of opioid analgesics on psychosis.",opioid analgesics,CHEBI,have the impact on,psychosis,MENTAL_HEALTH
35457049,Methicillin-resistant Staphylococcus aureus (MRSA) infection is challenging to eradicate because of antibiotic resistance and biofilm formation.,Methicillin-resistant Staphylococcus aureus infection,DISEASE,eradicate,biofilm formation,DISEASE
35457049,Methicillin-resistant Staphylococcus aureus (MRSA) infection is challenging to eradicate because of antibiotic resistance and biofilm formation.,Methicillin-resistant Staphylococcus aureus infection,DISEASE,eradicate,antibiotic resistance,CHEBI
35457049,The results indicated that SGB could inhibit biofilm formation and alter cell membrane permeability in MRSA.,SGB,CHEMICAL,inhibit,biofilm formation,DISEASE
35457049,"In addition, SGB was found to exhibit quite low cytotoxicity and hemolysis.",SGB,CHEMICAL,exhibit,hemolysis,DISEASE
34202548,"However, with the wide use of 5-FU, more and more CRC patients have been obtaining drug resistance to 5-FU, which leads to a large amount of treatment failures.",5-FU,CHEMICAL,obtain drug resistance to,5-FU,CHEMICAL
34202548,"However, with the wide use of 5-FU, more and more CRC patients have been obtaining drug resistance to 5-FU, which leads to a large amount of treatment failures.",5-FU,CHEMICAL,obtain,drug resistance,MENTAL_HEALTH
34202548,"However, with the wide use of 5-FU, more and more CRC patients have been obtaining drug resistance to 5-FU, which leads to a large amount of treatment failures.",5-FU,CHEMICAL,obtain,drug resistance,CHEBI
10832377,"The SSRIs, MAOIs, benzodiazepines, and beta-blockers--as well as CBT--can effectively treat social anxiety symptoms.",SSRIs,CHEMICAL,treat,anxiety symptoms,MENTAL_HEALTH
10832377,"The SSRIs, MAOIs, benzodiazepines, and beta-blockers--as well as CBT--can effectively treat social anxiety symptoms.",benzodiazepines,CHEMICAL,treat,anxiety symptoms,MENTAL_HEALTH
10832377,"The SSRIs, MAOIs, benzodiazepines, and beta-blockers--as well as CBT--can effectively treat social anxiety symptoms.",MAOIs,CHEMICAL,treat,anxiety symptoms,MENTAL_HEALTH
3835042,"Their dissociation constants (Kis and/or Kii) were 2-methyl histamine (Kis = 1751 mumol/l, s.e. = 163) less than 4-methyl histamine (Kis = 3551 mumol/l, s.e.",dissociation constants,MENTAL_HEALTH,be,4-methyl histamine,CHEMICAL
3835042,"Their dissociation constants (Kis and/or Kii) were 2-methyl histamine (Kis = 1751 mumol/l, s.e. = 163) less than 4-methyl histamine (Kis = 3551 mumol/l, s.e.",dissociation constants,MENTAL_HEALTH,be,2-methyl histamine,CHEMICAL
3835042,"Their dissociation constants were ranitidine (Kii = 1.56 mumol/l, s.e. = 0.14) less than oxmetidine (Kis = 14.7 mumol/l, s.e.",dissociation constants,MENTAL_HEALTH,be,ranitidine less,CHEMICAL
3835042,"Their dissociation constants were ranitidine (Kii = 1.56 mumol/l, s.e. = 0.14) less than oxmetidine (Kis = 14.7 mumol/l, s.e.",dissociation constants,MENTAL_HEALTH,be,oxmetidine,CHEMICAL
34648605,"Resistance was confirmed in industry-supplied samples of the grasses Digitaria sanguinalis (nicosulfuron, two maize farms), P. minor (iodosulfuron, one farm), and Lolium spp.",Resistance,MENTAL_HEALTH,be confirmed in industry-supplied samples of,iodosulfuron,CHEMICAL
34648605,"Resistance was confirmed in industry-supplied samples of the grasses Digitaria sanguinalis (nicosulfuron, two maize farms), P. minor (iodosulfuron, one farm), and Lolium spp.",Resistance,MENTAL_HEALTH,be confirmed in industry-supplied samples of,P. minor,DISEASE
34648605,"Resistance was confirmed in industry-supplied samples of the grasses Digitaria sanguinalis (nicosulfuron, two maize farms), P. minor (iodosulfuron, one farm), and Lolium spp.",Resistance,MENTAL_HEALTH,be confirmed in industry-supplied samples of,nicosulfuron,CHEMICAL
19091530,"The maximum sorption capacities of BGH for TAP and MP were calculated to be 3.5+/-0.45 and 10.6+/-0.83 mmol g(-1) by Freundlich, 0.0077+/-0.021 and 0.025+/-0.0094 mmol g(-1) by Langmuir and 0.48+/-0.037 and 0.15+/-0.077 mmol g(-1) by D-R isotherms respectively, employing 0.2g of sorbent, at pH 6, 90 min agitation time and at 303 K. Application of first order Lagergren and Morris-Weber equations to the kinetic data yielded correlation coefficients, close to unity and showed partial intra-particle diffusion.",MP,DISEASE,be calculated to,Langmuir,CHEMICAL
19091530,"The maximum sorption capacities of BGH for TAP and MP were calculated to be 3.5+/-0.45 and 10.6+/-0.83 mmol g(-1) by Freundlich, 0.0077+/-0.021 and 0.025+/-0.0094 mmol g(-1) by Langmuir and 0.48+/-0.037 and 0.15+/-0.077 mmol g(-1) by D-R isotherms respectively, employing 0.2g of sorbent, at pH 6, 90 min agitation time and at 303 K. Application of first order Lagergren and Morris-Weber equations to the kinetic data yielded correlation coefficients, close to unity and showed partial intra-particle diffusion.",MP,DISEASE,be calculated to,mmol g(-1,CHEMICAL
19091530,"The maximum sorption capacities of BGH for TAP and MP were calculated to be 3.5+/-0.45 and 10.6+/-0.83 mmol g(-1) by Freundlich, 0.0077+/-0.021 and 0.025+/-0.0094 mmol g(-1) by Langmuir and 0.48+/-0.037 and 0.15+/-0.077 mmol g(-1) by D-R isotherms respectively, employing 0.2g of sorbent, at pH 6, 90 min agitation time and at 303 K. Application of first order Lagergren and Morris-Weber equations to the kinetic data yielded correlation coefficients, close to unity and showed partial intra-particle diffusion.",MP,DISEASE,be calculated to,0.48+/-0.037 mmol g(-1,CHEMICAL
19091530,"The maximum sorption capacities of BGH for TAP and MP were calculated to be 3.5+/-0.45 and 10.6+/-0.83 mmol g(-1) by Freundlich, 0.0077+/-0.021 and 0.025+/-0.0094 mmol g(-1) by Langmuir and 0.48+/-0.037 and 0.15+/-0.077 mmol g(-1) by D-R isotherms respectively, employing 0.2g of sorbent, at pH 6, 90 min agitation time and at 303 K. Application of first order Lagergren and Morris-Weber equations to the kinetic data yielded correlation coefficients, close to unity and showed partial intra-particle diffusion.",MP,DISEASE,be calculated to,min agitation time,MENTAL_HEALTH
19091530,"The maximum sorption capacities of BGH for TAP and MP were calculated to be 3.5+/-0.45 and 10.6+/-0.83 mmol g(-1) by Freundlich, 0.0077+/-0.021 and 0.025+/-0.0094 mmol g(-1) by Langmuir and 0.48+/-0.037 and 0.15+/-0.077 mmol g(-1) by D-R isotherms respectively, employing 0.2g of sorbent, at pH 6, 90 min agitation time and at 303 K. Application of first order Lagergren and Morris-Weber equations to the kinetic data yielded correlation coefficients, close to unity and showed partial intra-particle diffusion.",MP,DISEASE,employ g of,sorbent,CHEMICAL
14604601,"None of the three AMS domain scale scores significantly correlated with testosterone, free testosterone or bioavailable testosterone.",AMS domain scale scores,DISEASE,correlate with,testosterone,CHEMICAL
14604601,"None of the three AMS domain scale scores significantly correlated with testosterone, free testosterone or bioavailable testosterone.",AMS domain scale scores,DISEASE,correlate with,bioavailable testosterone,CHEMICAL
14604601,"None of the three AMS domain scale scores significantly correlated with testosterone, free testosterone or bioavailable testosterone.",AMS domain scale scores,DISEASE,correlate with,free testosterone,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mild serotonin syndrome,CHEMICAL,decrease bioavailability of,digoxin,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mild serotonin syndrome,CHEMICAL,decrease bioavailability of,theophylline,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mild serotonin syndrome,CHEMICAL,decrease bioavailability of,cyclosporin,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mild serotonin syndrome,CHEMICAL,decrease bioavailability of,phenprocoumon,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mania,MENTAL_HEALTH,decrease concentrations of,phenytoin,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",depressed patients,DISEASE,decrease concentrations of,phenytoin,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mania,MENTAL_HEALTH,combine with,Ayurvedic syrup shankhapushpi,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",depressed patients,DISEASE,combine with,Ayurvedic syrup shankhapushpi,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",liquorice,CHEMICAL,decrease blood concentrations of,prednisolone,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mania,MENTAL_HEALTH,increase risk of,hypertension xaio chai hu tang,DISEASE
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mania,MENTAL_HEALTH,increase risk of,hypertension xaio chai hu tang,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",depressed patients,DISEASE,increase risk of,hypertension xaio chai hu tang,DISEASE
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",depressed patients,DISEASE,increase risk of,hypertension xaio chai hu tang,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",Glycyrrhiza glabra,CHEMICAL,decrease blood concentrations of,prednisolone,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",warfarin,CHEMICAL,be combined with,Ginkgo biloba,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",warfarin,CHEMICAL,be combined with,danshen,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",warfarin,CHEMICAL,be combined with,Allium sativum,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",warfarin,CHEMICAL,be combined with,Angelica sinensis,NUTRITION
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",tricyclic antidepressants,CHEMICAL,be combined with,yohimbine,CHEMICAL
10675182,"Plausible cases of herb-drug interactions include: bleeding when warfarin is combined with ginkgo (Ginkgo biloba), garlic (Allium sativum), dong quai (Angelica sinensis), or danshen (Salvia miltiorrhiza); mild serotonin syndrome in patients who mix St John's wort (Hypericum perforatum) with serotonin-reuptake inhibitors; decreased bioavailability of digoxin, theophylline, cyclosporin, and phenprocoumon when these drugs are combined with St John's wort; induction of mania in depressed patients who mix antidepressants and Panax ginseng; exacerbation of extrapyramidal effects with neuroleptic drugs and betel nut (Areca catechu); increased risk of hypertension when tricyclic antidepressants are combined with yohimbine (Pausinystalia yohimbe); potentiation of oral and topical corticosteroids by liquorice (Glycyrrhiza glabra); decreased blood concentrations of prednisolone when taken with the Chinese herbal product xaio chai hu tang (sho-salko-to); and decreased concentrations of phenytoin when combined with the Ayurvedic syrup shankhapushpi.",mania,MENTAL_HEALTH,have induction in,depressed patients,DISEASE
34379974,"Additionally, the inhibitory activity of pyrabactin resistance 1 (PYR1) and PYR1-like (PYL1) proteins against type 2C protein phosphatase increased following incorporation of the 3-cyclopropyl group in all tested 3'-alkyl ABAs.",pyrabactin resistance,MENTAL_HEALTH,following incorporation of 3-cyclopropyl group in,3'-alkyl ABAs,CHEMICAL
32999840,"The information available concerning ABA biosynthesis, transport, perception, and metabolism has enabled detailed functional studies on how the protective ability of ABA in plants might be modified to increase plant resistance to stress.",ABA biosynthesis,CHEMICAL,enable detailed functional studies on protective ability of,ABA,CHEMICAL
14564237,Previous studies have shown that the administration of remifentanil (a micro-agonist opioid) is often accompanied by bradyarrhythmias preventable or manageable by parasympatholytic drugs.,remifentanil,CHEMICAL,be accompanied by bradyarrhythmias preventable or manageable by,parasympatholytic drugs,CHEBI
688892,Two of the three more serious arrhythmias were registered after atropine.,serious arrhythmias,DISEASE,be registered after,atropine,CHEMICAL
7770620,"Noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, including ketamine, MK-801, and phencyclidine (PCP), induce the HSP70 heat shock or stress gene in pyramidal neurons in rat posterior cingulate and retrosplenial cortex.",phencyclidine,CHEMICAL,induce,HSP70 heat shock,DISEASE
7770620,"Noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, including ketamine, MK-801, and phencyclidine (PCP), induce the HSP70 heat shock or stress gene in pyramidal neurons in rat posterior cingulate and retrosplenial cortex.",ketamine,CHEMICAL,induce,HSP70 heat shock,DISEASE
7770620,"Noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, including ketamine, MK-801, and phencyclidine (PCP), induce the HSP70 heat shock or stress gene in pyramidal neurons in rat posterior cingulate and retrosplenial cortex.",Noncompetitive N-methyl-D-aspartate NMDA receptor antagonists,CHEBI,induce,HSP70 heat shock,DISEASE
7770620,"Noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, including ketamine, MK-801, and phencyclidine (PCP), induce the HSP70 heat shock or stress gene in pyramidal neurons in rat posterior cingulate and retrosplenial cortex.",Noncompetitive N-methyl-D-aspartate NMDA receptor antagonists,CHEMICAL,induce,HSP70 heat shock,DISEASE
7770620,"Noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonists, including ketamine, MK-801, and phencyclidine (PCP), induce the HSP70 heat shock or stress gene in pyramidal neurons in rat posterior cingulate and retrosplenial cortex.",MK-801,CHEMICAL,induce,HSP70 heat shock,DISEASE
7770620,"Nifedipine blocked induction of HSP70 by PCP in cingulate, neocortex, and insular cortex but only partially blocked HSP70 in piriform cortex and amygdala.",Nifedipine,CHEMICAL,block induction of hsp70 by,PCP,DISEASE
21614173,"Soy isoflavones, found in soybean and soybean products, have been reported to possess many physiological activities such as antioxidant activity, inhibition of cancer cell proliferation, reduction of cardiovascular risk, prevention of osteoporosis and alleviation of postmenopausal syndrome.",Soy isoflavones,CHEMICAL,possess many physiological activities such as,postmenopausal syndrome,DISEASE
21614173,"Soy isoflavones, found in soybean and soybean products, have been reported to possess many physiological activities such as antioxidant activity, inhibition of cancer cell proliferation, reduction of cardiovascular risk, prevention of osteoporosis and alleviation of postmenopausal syndrome.",Soy isoflavones,CHEMICAL,possess many physiological activities such as,osteoporosis,DISEASE
21614173,"In this study, soy isoflavone extract from soybean cake was further purified and evaluated for the protective effects on UVB-induced damage.",soy isoflavone extract,CHEMICAL,evaluate for protective effects on,UVB-induced damage,DISEASE
21614173,"In this study, soy isoflavone extract from soybean cake was further purified and evaluated for the protective effects on UVB-induced damage.",soybean cake,NUTRITION,evaluate for protective effects on,UVB-induced damage,DISEASE
28515029,Tolvaptan is the only such agent approved in Europe for the treatment of hyponatremia caused by syndrome of inappropriate antidiuretic hormone secretion (SIADH) in adults.,Tolvaptan,CHEMICAL,approved in europe for treatment of,hyponatremia,DISEASE
23489250,"Down's syndrome is a common genetic cause of intellectual disability, for which there are no drug therapies.",Down's syndrome,DISEASE,be common genetic cause of,intellectual disability,MENTAL_HEALTH
32544660,Previous studies demonstrated that fluorine exposure could induce brain injury in fish and human.,fluorine exposure,CHEMICAL,induce,brain injury,DISEASE
31969925,Acute toxic-metabolic encephalopathy (TME) is an acute condition of global cerebral dysfunction in the absence of primary structural brain disease.,TME,CHEMICAL,be acute condition of global cerebral dysfunction in absence of,primary structural brain disease,DISEASE
31969925,Acute toxic-metabolic encephalopathy (TME) is an acute condition of global cerebral dysfunction in the absence of primary structural brain disease.,TME,CHEMICAL,be acute condition of,global cerebral dysfunction,DISEASE
28317615,"Arrhythmias were found in 15.38% of the cats with potassium >8.5mEqL. Creatinine, phosphorus, magnesium, potassium, and lactate concentrations were higher in cats obstructed more than 36 hours.",Arrhythmias,DISEASE,be found in % of cats with,potassium,CHEMICAL
28317615,"Arrhythmias were found in 15.38% of the cats with potassium >8.5mEqL. Creatinine, phosphorus, magnesium, potassium, and lactate concentrations were higher in cats obstructed more than 36 hours.",Arrhythmias,DISEASE,be found in % of cats with,lactate,CHEMICAL
28317615,"Arrhythmias were found in 15.38% of the cats with potassium >8.5mEqL. Creatinine, phosphorus, magnesium, potassium, and lactate concentrations were higher in cats obstructed more than 36 hours.",Arrhythmias,DISEASE,be found in % of cats with,magnesium,CHEMICAL
28317615,"Arrhythmias were found in 15.38% of the cats with potassium >8.5mEqL. Creatinine, phosphorus, magnesium, potassium, and lactate concentrations were higher in cats obstructed more than 36 hours.",Arrhythmias,DISEASE,be found in % of cats with,phosphorus,NUTRITION
28317615,"Arrhythmias were found in 15.38% of the cats with potassium >8.5mEqL. Creatinine, phosphorus, magnesium, potassium, and lactate concentrations were higher in cats obstructed more than 36 hours.",Arrhythmias,DISEASE,be found in % of cats with,Creatinine,CHEMICAL
26318020,"Subsequent lab tests indicated suppressed serum parathyroid hormone, extremely high serum 25-hydroxy vitamin D, and normal serum 1,25-dihydroxy vitamin D. Treatment was started with intravenous infusion of saline and furosemide due to the evidence of hypercalcemia.","normal serum 1,25-dihydroxy vitamin D. Treatment",CHEBI,be started with intravenous infusion of saline and furosemide due to evidence of,hypercalcemia,DISEASE
26318020,"Subsequent lab tests indicated suppressed serum parathyroid hormone, extremely high serum 25-hydroxy vitamin D, and normal serum 1,25-dihydroxy vitamin D. Treatment was started with intravenous infusion of saline and furosemide due to the evidence of hypercalcemia.","normal serum 1,25-dihydroxy vitamin D. Treatment",CHEBI,be started with intravenous infusion of,furosemide,CHEMICAL
32018970,"The C allele carriers were observed to have higher PTSD prevalence than the TT homozygotes in the male subjects, and higher PTSD prevalence and PCL-C scores in the female subjects only at 6 months.",C allele carriers,CHEBI,have,higher PTSD prevalence,DISEASE
32018970,"When compared to that at 12 months, decreased PTSD prevalence was observed at 18 months only in the female C allele carriers, but not in the female TT homozygotes or the male subjects.",PTSD prevalence,DISEASE,be observed at,female C allele carriers,CHEBI
28987899,"Based on studies among primarily male veteran subjects, lipoproteins are thought to mediate the association of posttraumatic stress disorder (PTSD) with cardiovascular disease (CVD).",lipoproteins,CHEMICAL,mediate association of,posttraumatic stress disorder,MENTAL_HEALTH
28987899,"Based on studies among primarily male veteran subjects, lipoproteins are thought to mediate the association of posttraumatic stress disorder (PTSD) with cardiovascular disease (CVD).",lipoproteins,CHEMICAL,mediate association of,cardiovascular disease,DISEASE
28987899,"Based on studies among primarily male veteran subjects, lipoproteins are thought to mediate the association of posttraumatic stress disorder (PTSD) with cardiovascular disease (CVD).",lipoproteins,CHEMICAL,mediate association of,PTSD,DISEASE
28987899,"Gender, diet and sex-specific effects of stress hormones on lipoproteins may explain this dissociation in findings.",stress hormones,CHEBI,explain,dissociation,MENTAL_HEALTH
28987899,"Gender, diet and sex-specific effects of stress hormones on lipoproteins may explain this dissociation in findings.",lipoproteins,CHEMICAL,explain,dissociation,MENTAL_HEALTH
28987899,"Gender, diet and sex-specific effects of stress hormones on lipoproteins may explain this dissociation in findings.",stress hormones,CHEBI,have diet and sex-specific effects on,lipoproteins,CHEMICAL
29081489,"The T allele carriers had significantly higher levels of TG, TC, LDL-C, and glucose than the CC homozygotes of PCSK9 rs7552841 after the adjustment for age and BMI in the female students, but not in the male students.",T allele carriers,CHEBI,have higher levels of,CC homozygotes,CHEMICAL
29081489,"The T allele carriers had significantly higher levels of TG, TC, LDL-C, and glucose than the CC homozygotes of PCSK9 rs7552841 after the adjustment for age and BMI in the female students, but not in the male students.",T allele carriers,CHEBI,have higher levels of,TG,DISEASE
29081489,"The T allele carriers had significantly higher levels of TG, TC, LDL-C, and glucose than the CC homozygotes of PCSK9 rs7552841 after the adjustment for age and BMI in the female students, but not in the male students.",T allele carriers,CHEBI,have higher levels of,TC,DISEASE
29081489,"The T allele carriers had significantly higher levels of TG, TC, LDL-C, and glucose than the CC homozygotes of PCSK9 rs7552841 after the adjustment for age and BMI in the female students, but not in the male students.",T allele carriers,CHEBI,have higher levels of,glucose,CHEMICAL
29081489,"When PTSD was taken into consideration, the female T allele carriers had significantly higher TG, TC, LDL-C and glucose than the female CC homozygotes after the adjustment for age and BMI only in the subjects without PTSD, but not in the PTSD patients.",female T allele carriers,CHEBI,have,glucose,CHEMICAL
29081489,"When PTSD was taken into consideration, the female T allele carriers had significantly higher TG, TC, LDL-C and glucose than the female CC homozygotes after the adjustment for age and BMI only in the subjects without PTSD, but not in the PTSD patients.",female T allele carriers,CHEBI,have,TC,DISEASE
29081489,"When PTSD was taken into consideration, the female T allele carriers had significantly higher TG, TC, LDL-C and glucose than the female CC homozygotes after the adjustment for age and BMI only in the subjects without PTSD, but not in the PTSD patients.",female T allele carriers,CHEBI,have,female CC homozygotes,CHEMICAL
29081489,"When PTSD was taken into consideration, the female T allele carriers had significantly higher TG, TC, LDL-C and glucose than the female CC homozygotes after the adjustment for age and BMI only in the subjects without PTSD, but not in the PTSD patients.",female T allele carriers,CHEBI,have,higher TG,DISEASE
35563544,Insect cuticle is critical for the environmental adaptability and insecticide resistance of insects.,Insect cuticle,NUTRITION,be critical for,adaptability resistance,MENTAL_HEALTH
35307854,Bt toxins are parasporal crystals produced by Bacillus thuringiensis (Bt).,Bt toxins,CHEBI,produced by,Bacillus thuringiensis,DISEASE
35307854,Bt toxins are parasporal crystals produced by Bacillus thuringiensis (Bt).,Bt toxins,CHEMICAL,produced by,Bacillus thuringiensis,DISEASE
35307854,"To maintain the sustainable use of Bt products, the resistance mechanism of insects to Bt toxins must be fully clarified.",resistance mechanism,MENTAL_HEALTH,maintain sustainable use of,Bt products,CHEMICAL
35307854,"To maintain the sustainable use of Bt products, the resistance mechanism of insects to Bt toxins must be fully clarified.",Bt toxins,CHEMICAL,maintain sustainable use of,Bt products,CHEMICAL
35307854,"To maintain the sustainable use of Bt products, the resistance mechanism of insects to Bt toxins must be fully clarified.",Bt toxins,CHEBI,maintain sustainable use of,Bt products,CHEMICAL
26922714,Several studies have proposed the combination of desmopressin and anticholinergic as a treatment regimen to address the pathophysiology of polyuria and bladder dysfunction in pediatric enuresis.,polyuria dysfunction,DISEASE,have the pathophysiology in,pediatric enuresis,MENTAL_HEALTH
23692933,We examined whether N-methyl d-aspartate (NMDA) receptor antagonists as adjunctive therapy have therapeutic potential for schizophrenia treatment.,N-methyl d-aspartate NMDA receptor antagonists,CHEBI,have therapeutic potential for,schizophrenia treatment,MENTAL_HEALTH
23692933,We examined whether N-methyl d-aspartate (NMDA) receptor antagonists as adjunctive therapy have therapeutic potential for schizophrenia treatment.,N-methyl d-aspartate NMDA receptor antagonists,CHEMICAL,have therapeutic potential for,schizophrenia treatment,MENTAL_HEALTH
34528983,"The present study was designed to investigate the in vivo protective value of black rice anthocyanins (BRAN) on hyperlipidemia, liver steatosis and insulin resistance in mice with high-fat-diet (HFD)-induced obesity and elucidate the underlying mechanism.",insulin resistance,MENTAL_HEALTH,in mice with,(HFD)-induced obesity,DISEASE
10516469,"Fortunately, however, since the rate of newly acquired infection is currently too low to influence HCV prevalence in each age group, the total number of HCV carriers (estimated to be 691,852 for the age group 20-64 years) would decrease spontaneously with generation takeover to approximately 50% of the current number during the decade to come.",acquired infection,DISEASE,influence,HCV prevalence,DISEASE
28808084,"For many years, glycopyrronium has been prescribed off-label using the injection solution given orally or tablets crushed and suspended in water, or as unlicensed products that were imported or manufactured as pharmaceutical specials.2,3 In January 2017, a glycopyrronium oral solution (Sialanar-Proveca Limited) became available in the UK as the first licensed product for the treatment of severe drooling (sialorrhoea) in children and adolescents aged 3 years and older with chronic neurological disorders.4-6 Here, we consider the place of this new product in the management of severe drooling.",glycopyrronium,CHEMICAL,become as,severe drooling,DISEASE
28808084,"For many years, glycopyrronium has been prescribed off-label using the injection solution given orally or tablets crushed and suspended in water, or as unlicensed products that were imported or manufactured as pharmaceutical specials.2,3 In January 2017, a glycopyrronium oral solution (Sialanar-Proveca Limited) became available in the UK as the first licensed product for the treatment of severe drooling (sialorrhoea) in children and adolescents aged 3 years and older with chronic neurological disorders.4-6 Here, we consider the place of this new product in the management of severe drooling.",glycopyrronium,CHEMICAL,become as,sialorrhoea,DISEASE
35469019,Infections caused by the fungal pathogen Aspergillus fumigatus are increasingly resistant to first-line azole antifungal drugs.,Infections,DISEASE,be resistant to,first-line azole antifungal drugs,CHEBI
11825595,"The results show that physical disturbance, crowding and anaesthesia produced an occasional increase in glucose and cortisol concentrations.",physical disturbance,DISEASE,produce occasional increase in,cortisol,CHEMICAL
11825595,"The results show that physical disturbance, crowding and anaesthesia produced an occasional increase in glucose and cortisol concentrations.",physical disturbance,DISEASE,produce occasional increase in,glucose concentrations,CHEMICAL
35238686,"Rosaceae allergy has a major impact in context to pollen-food allergy syndrome (PFAS) and lipid transfer protein (LTP) allergies, being greatly influenced by geography, environment, and presence of cofactors.",Rosaceae allergy,DISEASE,have major impact in context to,syndrome allergies,DISEASE
35238686,"Rosaceae allergy has a major impact in context to pollen-food allergy syndrome (PFAS) and lipid transfer protein (LTP) allergies, being greatly influenced by geography, environment, and presence of cofactors.",Rosaceae allergy,DISEASE,have major impact in context to,PFAS,CHEMICAL
32237268,Heparin induced thrombocytopenia (HIT) is likely a misdirected bacterial host defense mechanism.,HIT,DISEASE,be,misdirected bacterial host defense mechanism,MENTAL_HEALTH
32237268,Heparin induced thrombocytopenia (HIT) is likely a misdirected bacterial host defense mechanism.,induced thrombocytopenia,DISEASE,be,misdirected bacterial host defense mechanism,MENTAL_HEALTH
26752517,"Here we show that GNLY delivers Gzms into three protozoan parasites (Trypanosoma cruzi, Toxoplasma gondii and Leishmania major), in which the Gzms generate superoxide and inactivate oxidative defense enzymes to kill the parasite.",GNLY,CHEMICAL,deliver gzms into,Leishmania major,DISEASE
11336225,Fluctuating asymmetry (FA) of tooth traits has been reported to be increased in Down syndrome patients as well as hybrids between chromosomal races of the house mouse differing in several Robertsonian (Rb) fusions.,tooth traits,DISEASE,be increased in,house mouse,NUTRITION
11336225,Fluctuating asymmetry (FA) of tooth traits has been reported to be increased in Down syndrome patients as well as hybrids between chromosomal races of the house mouse differing in several Robertsonian (Rb) fusions.,tooth traits,DISEASE,be increased in,Down syndrome patients,MENTAL_HEALTH
24179849,"The Theory of Structural Dissociation of the Personality (TSDP) proposes that dissociative identity disorder (DID) patients are fixed in traumatic memories as ""Emotional Parts"" (EP), but mentally avoid these as ""Apparently Normal Parts"" of the personality (ANP).",dissociative identity disorder patients,MENTAL_HEALTH,be fixed in,traumatic memories,DISEASE
34356995,We found that patients with suicide behavior had lower levels of FT3 (-0.20 pg/mL; p = 0.02) and TT4 (-0.23 µg/dL; p = 0.045) compared to controls.,suicide behavior,MENTAL_HEALTH,have lower levels of,FT3,CHEMICAL
29984659,Transdermal oestrogens have a lower risk of thrombosis compared with oral regimens.,Transdermal oestrogens,CHEBI,have lower risk of,thrombosis,DISEASE
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",Hormone therapy,CHEBI,be used for management and prevention of,cardiovascular disease,DISEASE
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",Hormone therapy,CHEBI,be used for management and prevention of,dementia,MENTAL_HEALTH
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",Hormone therapy,CHEBI,be used for management and prevention of,osteoporosis,DISEASE
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",HT,DISEASE,be used for management and prevention of,cardiovascular disease,DISEASE
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",HT,DISEASE,be used for management and prevention of,dementia,MENTAL_HEALTH
28093732,"BACKGROUND: 

Hormone therapy (HT) is widely provided for control of menopausal symptoms and has been used for the management and prevention of cardiovascular disease, osteoporosis and dementia in older women.",HT,DISEASE,be used for management and prevention of,osteoporosis,DISEASE
28093732,"HT included oestrogens, with or without progestogens, via the oral, transdermal, subcutaneous or intranasal route.",HT,DISEASE,include oestrogens with or without,progestogens,CHEBI
28093732,"HT included oestrogens, with or without progestogens, via the oral, transdermal, subcutaneous or intranasal route.",HT,DISEASE,include,oestrogens,CHEBI
28093732,"Although HT is considered effective for the prevention of postmenopausal osteoporosis, it is generally recommended as an option only for women at significant risk for whom non-oestrogen therapies are unsuitable.",HT,DISEASE,be considered effective for prevention of,postmenopausal osteoporosis,DISEASE
34970158,We will also detail the gender-specific effects of hormone replacement therapies on metabolic control and sleep apnea.,hormone replacement therapies,CHEBI,have the gender-specific effects on,sleep apnea,MENTAL_HEALTH
15706792,Some of the effects of maternal alcohol consumption on fetal hormone systems may contribute to the adverse effects observed in children with fetal alcohol syndrome and related disorders.,maternal alcohol consumption,CHEMICAL,have the effects on,fetal hormone systems,CHEBI
22010451,"Despite above 40 years the presence of sulpride on the pharmaceutical market, the acute poisonings are poorly reported in the medical literature.",acute poisonings,DISEASE,be reported,pharmaceutical market,CHEBI
22010451,"Despite above 40 years the presence of sulpride on the pharmaceutical market, the acute poisonings are poorly reported in the medical literature.",acute poisonings,DISEASE,be reported,sulpride,CHEMICAL
22010451,"Despite above 40 years the presence of sulpride on the pharmaceutical market, the acute poisonings are poorly reported in the medical literature.",sulpride,CHEMICAL,have the presence on,pharmaceutical market,CHEBI
32937143,GBF1 encodes a guanine-nucleotide exchange factor that facilitates the activation of members of the ARF (ADP-ribosylation factor) family of small GTPases.,GBF1,CHEMICAL,encode,guanine-nucleotide exchange factor,CHEMICAL
32937143,Our results not only reinforce the existing link between Golgi fragmentation and neurodegeneration but also demonstrate that pathogenic variants in GBF1 are associated with HMN/CMT2.,GBF1,CHEMICAL,be associated with,HMN/CMT2,CHEMICAL
32937143,Our results not only reinforce the existing link between Golgi fragmentation and neurodegeneration but also demonstrate that pathogenic variants in GBF1 are associated with HMN/CMT2.,Golgi fragmentation,MENTAL_HEALTH,have link with,neurodegeneration,DISEASE
32937143,Our results not only reinforce the existing link between Golgi fragmentation and neurodegeneration but also demonstrate that pathogenic variants in GBF1 are associated with HMN/CMT2.,neurodegeneration,DISEASE,have link with,Golgi fragmentation,MENTAL_HEALTH
22677000,"AIs are well tolerated and cause a lower incidence of gynecological symptoms (vaginal bleeding, discharge, and endometrial neoplasia), venous thromboembolic events, and hot flashes compared with tamoxifen.",AIs,CHEMICAL,cause lower incidence of,tamoxifen,CHEMICAL
22677000,"AIs are well tolerated and cause a lower incidence of gynecological symptoms (vaginal bleeding, discharge, and endometrial neoplasia), venous thromboembolic events, and hot flashes compared with tamoxifen.",AIs,CHEMICAL,cause lower incidence of,endometrial neoplasia,DISEASE
22677000,"AIs are well tolerated and cause a lower incidence of gynecological symptoms (vaginal bleeding, discharge, and endometrial neoplasia), venous thromboembolic events, and hot flashes compared with tamoxifen.",AIs,CHEMICAL,cause lower incidence of,vaginal bleeding,DISEASE
22677000,"AIs are well tolerated and cause a lower incidence of gynecological symptoms (vaginal bleeding, discharge, and endometrial neoplasia), venous thromboembolic events, and hot flashes compared with tamoxifen.",AIs,CHEMICAL,cause lower incidence of,venous thromboembolic events,DISEASE
22677000,"However, the use of AIs have been associated with loss of bone density, arthralgia, myalgia, a negative effect on lipid metabolism, and cardiovascular risk (Tomao et al., 2011).",AIs,CHEMICAL,be associated with loss of,arthralgia,DISEASE
22677000,"However, the use of AIs have been associated with loss of bone density, arthralgia, myalgia, a negative effect on lipid metabolism, and cardiovascular risk (Tomao et al., 2011).",AIs,CHEMICAL,be associated with loss of,myalgia,DISEASE
34098286,"Benzodiazepine use among patients receiving opioid agonist treatment (OAT) presents a conundrum: benzodiazepines increase overdose risk, yet can treat anxiety and insomnia.",benzodiazepines,CHEMICAL,treat,anxiety,MENTAL_HEALTH
34098286,"Benzodiazepine use among patients receiving opioid agonist treatment (OAT) presents a conundrum: benzodiazepines increase overdose risk, yet can treat anxiety and insomnia.",benzodiazepines,CHEMICAL,treat,insomnia,MENTAL_HEALTH
26623152,"When studies were evaluated, it was observed that BTX injections to the detrusor muscle are a necessary and effective option in patients with incontinence caused by NDO.",detrusor muscle,DISEASE,be necessary option in patients with,incontinence,DISEASE
26623152,"When studies were evaluated, it was observed that BTX injections to the detrusor muscle are a necessary and effective option in patients with incontinence caused by NDO.",BTX injections,CHEMICAL,be necessary option in patients with,incontinence,DISEASE
14999367,This case is unique in that anticholinergic syndrome-related respiratory depression was promptly reversed with physostigmine.,anticholinergic syndrome-related respiratory depression,MENTAL_HEALTH,be reversed with,physostigmine,CHEMICAL
12083983,"However, tolterodine IR is significantly better tolerated, particularly with respect to the incidence and severity of dry mouth.",tolterodine IR,CHEMICAL,be tolerated with respect to incidence and severity of,dry mouth,DISEASE
18167612,We also hypothesized that differences between high and low tree pollen periods in self reported allergy symptoms would correlate positively with differences in self reported depression scores.,allergy symptoms,DISEASE,report,depression scores,MENTAL_HEALTH
18167612,"Linear regression models were developed to examine associations of changes in depression scores (dependent variable) with tree pollen sensitization, changes in the allergy symptom severity score, adjusted for gender and order of testing.",regression models,MENTAL_HEALTH,examine associations of changes in,tree pollen,NUTRITION
18167612,"Linear regression models were developed to examine associations of changes in depression scores (dependent variable) with tree pollen sensitization, changes in the allergy symptom severity score, adjusted for gender and order of testing.",regression models,MENTAL_HEALTH,examine associations of changes in,depression scores,MENTAL_HEALTH
33434705,Exposure to Cd caused ultrastructural changes along with reduced head kidney somatic index (HKSI).,Cd,CHEMICAL,cause ultrastructural changes with,head kidney somatic index,DISEASE
31256308,"In the present study, the extent of oxidative stress and genetic toxicity induced by low arsenic exposure was explored in freshwater fish Channa punctatus.",genetic toxicity,DISEASE,be explored in present study in,fish Channa punctatus,NUTRITION
34607242,The effects of dietary β-glucan supplementation on resistance to V. botryosa infection was examined in controlled challenges by exposing immunostimulated and control fish to ~7.25 × 105 fungal spores/fish via intra-muscular injection.,dietary β-glucan supplementation,CHEMICAL,have the effects on,resistance,MENTAL_HEALTH
16434615,"The serotonin transporter (SERT), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety.",serotonin transporter,CHEMICAL,be major pharmacological target in treatment of,anxiety,MENTAL_HEALTH
16434615,"The serotonin transporter (SERT), which belongs to a family of sodium/chloride-dependent transporters, is the major pharmacological target in the treatment of several clinical disorders, including depression and anxiety.",serotonin transporter,CHEMICAL,be major pharmacological target in treatment of,depression,MENTAL_HEALTH
33432444,The purpose of this study was to determine whether deficiencies of water-soluble vitamin intake predicted health-related quality of life (HRQOL) and the composite end point of all-cause mortality or cardiac- or heart failure (HF)-related hospitalization in HF patients.,water-soluble vitamin intake,CHEBI,predict health-related quality of,life failure,DISEASE
12734391,"To elucidate whether donepezil shows neuroprotective action in addition to amelioration of cognitive deficits, we examined the effects of donepezil on glutamate-induced neurotoxicity using primary cultures of rat cortical neurons.",donepezil,CHEMICAL,show neuroprotective action in addition to amelioration of,cognitive deficits,DISEASE
12734391,Exposure of 100 microM glutamate to cortical neurons for 24 h induced apoptotic neuronal death and nuclear fragmentation.,microM glutamate,CHEMICAL,induce,apoptotic neuronal death,DISEASE
12734391,Exposure of 100 microM glutamate to cortical neurons for 24 h induced apoptotic neuronal death and nuclear fragmentation.,microM glutamate,CHEMICAL,induce,nuclear fragmentation,MENTAL_HEALTH
12734391,Donepezil for 24 h before and 24 h during glutamate exposure prevented nuclear fragmentation and glutamate-induced apoptosis.,glutamate exposure,CHEMICAL,prevent,nuclear fragmentation,MENTAL_HEALTH
12734391,Donepezil for 24 h before and 24 h during glutamate exposure prevented nuclear fragmentation and glutamate-induced apoptosis.,Donepezil,CHEMICAL,prevent,nuclear fragmentation,MENTAL_HEALTH
12734391,These results suggest that donepezil not only protects cortical neurons against glutamate neurotoxicity via alpha4beta2- and alpha7-nAChRs but also prevents apoptotic neuronal death.,donepezil,CHEMICAL,protect cortical neurons against,glutamate neurotoxicity,CHEMICAL
12734391,These results suggest that donepezil not only protects cortical neurons against glutamate neurotoxicity via alpha4beta2- and alpha7-nAChRs but also prevents apoptotic neuronal death.,donepezil,CHEMICAL,prevent,apoptotic neuronal death,DISEASE
33803144,Supplementation with xanthophylls also provides additional benefits for the prevention of age-related macular degeneration (AMD) and attenuation of Alzheimer's disease symptoms.,xanthophylls,CHEBI,provide additional benefits for prevention of,Alzheimer's disease symptoms,DISEASE
33803144,Supplementation with xanthophylls also provides additional benefits for the prevention of age-related macular degeneration (AMD) and attenuation of Alzheimer's disease symptoms.,xanthophylls,CHEBI,provide additional benefits for prevention of,AMD,DISEASE
33803144,Supplementation with xanthophylls also provides additional benefits for the prevention of age-related macular degeneration (AMD) and attenuation of Alzheimer's disease symptoms.,xanthophylls,CHEBI,provide additional benefits for prevention of,age-related macular degeneration,DISEASE
32859768,"This is supposedly associated with some common genetic polymorphisms, for example, Apolipoprotein-E ε4 allele carriers with Alzheimer's disease can also develop atherosclerosis.",Alzheimer's disease,DISEASE,develop for,example atherosclerosis,DISEASE
32859768,"This is supposedly associated with some common genetic polymorphisms, for example, Apolipoprotein-E ε4 allele carriers with Alzheimer's disease can also develop atherosclerosis.",Apolipoprotein-E ε4 allele carriers,CHEBI,develop for,example atherosclerosis,DISEASE
34852669,The risk of invasive fungal rhinosinusitis is increased in Coronavirus disease 2019 (COVID-19) because of its direct impact in altering innate immunity and is further exacerbated by widespread use of steroids/antibiotics/monoclonal antibodies.,invasive fungal rhinosinusitis,DISEASE,be increased in,COVID-19,CHEMICAL
30637900,"To study whether androgen deprivation therapy (ADT), the mainstay treatment for advanced and disseminated prostate cancer, is associated with risk of dementia.",advanced prostate cancer,DISEASE,be associated with risk of,dementia,MENTAL_HEALTH
30637900,"To study whether androgen deprivation therapy (ADT), the mainstay treatment for advanced and disseminated prostate cancer, is associated with risk of dementia.",androgen deprivation therapy,CHEBI,be associated with risk of,dementia,MENTAL_HEALTH
16389294,"In animals with sustained nociception, atipamezole increased pain-related responses by blocking the noradrenergic feedback inhibition of pain.",atipamezole,CHEMICAL,block noradrenergic feedback inhibition of,pain,DISEASE
16389294,"At higher doses atipamezole impaired performance in tests of cognitive functions, probably due to noradrenergic overactivity.",atipamezole,CHEMICAL,impair at higher doses performance in tests of,noradrenergic overactivity,DISEASE
16389294,Recent experimental animal studies suggest that atipamezole might have beneficial effects in the recovery from brain damage and might potentiate the anti-Parkinsonian effects of dopaminergic drugs.,atipamezole,CHEMICAL,have beneficial effects in recovery from,brain damage,DISEASE
31162591,"Sylvian fissure was dissected to expose the supraclinoid ICA, ICA bifurcation, A1, and M1.",Sylvian fissure,DISEASE,expose,ICA bifurcation,CHEMICAL
34718274,"Unlike in female population, the effect of testosterone on aggression in men has been investigated countless times so far.",testosterone,CHEMICAL,have the effect on,aggression,DISEASE
34718274,A scarce number of studies have examined the effect of testosterone on aggression in women.,testosterone,CHEMICAL,have the effect on,aggression,DISEASE
34718274,"Since testosterone turned out to be an important factor related to aggression in men, the aim of our study was to investigate whether this correlation existed in aggressive female patients with schizophrenia.",testosterone,CHEMICAL,turn to important factor related to,aggression,DISEASE
2775438,The frequency for antigen Aw32 was significantly higher in the group of patients with major depression (14%) than in the demented (0%) and control (3%) groups.,antigen Aw32,CHEBI,be higher in group of patients with,depression groups,MENTAL_HEALTH
2775438,The frequencies for antigens Aw32 (22%) and Bw51 (22%) were significantly higher in the subgroup of 23 patients with endogenous depression than in the demented (Aw32 = 0%; Bw51 = 11%) and the control (Aw32 = 3%; Bw51 = 0%) groups.,antigens Aw32,CHEBI,be higher in subgroup of patients with,endogenous depression,MENTAL_HEALTH
2775438,The frequencies for antigens Aw32 (22%) and Bw51 (22%) were significantly higher in the subgroup of 23 patients with endogenous depression than in the demented (Aw32 = 0%; Bw51 = 11%) and the control (Aw32 = 3%; Bw51 = 0%) groups.,antigens Aw32,CHEMICAL,be higher in subgroup of patients with,endogenous depression,MENTAL_HEALTH
2775438,"Although these results were derived from a relatively small sample (n = 101) and become nonsignificant when corrected for multiple comparisons, they suggest that HLA antigen associations may be present for only certain depressive subtypes in geriatric depression.",HLA antigen associations,CHEBI,be present for certain depressive subtypes in,geriatric depression,MENTAL_HEALTH
2775438,"Although these results were derived from a relatively small sample (n = 101) and become nonsignificant when corrected for multiple comparisons, they suggest that HLA antigen associations may be present for only certain depressive subtypes in geriatric depression.",HLA antigen associations,CHEBI,be present for,certain depressive subtypes,DISEASE
34035686,"Therefore, the use of pitolisant should be considered in patients with Prader-Willi syndrome who fail a psychostimulant trial.",pitolisant,CHEMICAL,be considered in patients with,Prader-Willi syndrome,MENTAL_HEALTH
34658805,"Given that there is increasing evidence that the monoamines have u-shaped or Janus-faced dose-response properties, in which a mid-range value is ""optimal"" in a variety of behavioral and physiological processes, it is plausible that either too much or too little synaptic norepinephrine in key circuits may exacerbate MDD in some individuals.",much synaptic norepinephrine,CHEMICAL,exacerbate,MDD,DISEASE
30147322,Several studies have documented that treatment with various antidepressant agents can result in mood switching during major depressive episodes.,various antidepressant agents,CHEMICAL,result in mood switching during,major depressive episodes,DISEASE
25732836,"Using this animal model, we next examined the effects of yokukansan on drug-induced hallucination-like behaviors.",yokukansan,CHEMICAL,have the effects on,drug-induced hallucination-like behaviors,DISEASE
32819265,"Exposure to mycotoxins may delay and/or negatively influence the development of neurological, gastrointestinal and inflammatory mechanisms in individuals with Autism Spectrum Disorder (ASD).",mycotoxins,CHEBI,influence development of,ASD,DISEASE
32819265,"Exposure to mycotoxins may delay and/or negatively influence the development of neurological, gastrointestinal and inflammatory mechanisms in individuals with Autism Spectrum Disorder (ASD).",mycotoxins,CHEBI,influence development of,neurological mechanisms,DISEASE
32819265,"Exposure to mycotoxins may delay and/or negatively influence the development of neurological, gastrointestinal and inflammatory mechanisms in individuals with Autism Spectrum Disorder (ASD).",mycotoxins,CHEBI,influence development of,Autism Spectrum Disorder,MENTAL_HEALTH
31901578,"While methadone is beneficial in the treatment of opiate abuse and chronic pain, side effects of the medication include hormonal and sexual function changes.",methadone,CHEMICAL,be beneficial in treatment of,chronic pain,DISEASE
35567153,The mega wheat variety HD2967 was improved for leaf and stripe rust resistance by marker-assisted backcross breeding.,wheat variety,NUTRITION,be improved for,leaf rust resistance,MENTAL_HEALTH
35567153,The leaf rust resistance gene LrTrk was transferred into HD2967 from the durum wheat genotype Trinakria.,leaf rust resistance gene,MENTAL_HEALTH,be transferred into hd2967 from,durum wheat genotype,NUTRITION
35482212,Identified novel resistance sources and also novel QTLs for resistance to different Z. tritici isolates can be used for gene pyramiding and development of durable resistance cultivars in future wheat breeding programs.,durable resistance cultivars,MENTAL_HEALTH,have gene pyramiding and development in,wheat breeding,NUTRITION
15905360,"A salt bridge between the CoR and a conserved lysine in helix 4 of the NR is central to this interaction, but also helix 12 was stabilized by direct contacts with residues of the CoR. Fixation of helix 12 in the antagonistic/inverse agonistic conformation prevents an energetically unfavorable free floatation of the C terminus.",conserved lysine,CHEMICAL,be stabilized by direct contacts with residues of,CoR. Fixation,MENTAL_HEALTH
33824380,Rainbow trout fry syndrome (RTFS) and bacterial coldwater disease (BCWD) is a globally distributed freshwater fish disease caused by Flavobacterium psychrophilum.,bacterial coldwater disease,DISEASE,caused by,Flavobacterium psychrophilum,DISEASE
33824380,Rainbow trout fry syndrome (RTFS) and bacterial coldwater disease (BCWD) is a globally distributed freshwater fish disease caused by Flavobacterium psychrophilum.,trout fry,NUTRITION,caused by,Flavobacterium psychrophilum,DISEASE
33824380,Rainbow trout fry syndrome (RTFS) and bacterial coldwater disease (BCWD) is a globally distributed freshwater fish disease caused by Flavobacterium psychrophilum.,fry syndrome,DISEASE,caused by,Flavobacterium psychrophilum,DISEASE
26911419,"Galantamine, an acetylcholine esterase (AChE) inhibitor used to treat dementia symptoms, also acts as an allosteric potentiating ligand (APL) at nicotinic acetylcholine receptors (nAChRs).",Galantamine inhibitor,CHEMICAL,act as,nicotinic acetylcholine receptors,CHEMICAL
34959925,"Thus, our findings suggest that phytate-mediated dysregulation of calcium and phosphate is a substantial risk factor for elevated Aβ accumulation and apoptotic neuronal cell death in rats.",calcium,CHEMICAL,be substantial risk factor for,apoptotic neuronal cell death,DISEASE
31619615,"Bacillus subtilis was genetically modified in its inositol metabolism and phytase secretion, to develope the bioconversion processes to produce SI from rice bran.",Bacillus subtilis,DISEASE,be modified in,inositol metabolism,CHEMICAL
31619615,"Another B. subtilis strain was constructed with the constitutive and simultaneous overexpression of IolG and IolW, which are the two inositol dehydrogenases responsible for the conversion, to demonstrate an efficient conversion of MI into SI with a rate up to 10 g/L/48 h. In order to devise further elevation in the conversion efficiency, we attempted to improve the substrate uptake by overexpressing iolT for the major MI transporter.",B. subtilis strain,DISEASE,be constructed with constitutive and simultaneous overexpression of,IolG,CHEMICAL
19689308,"Several treatments of RBD are available including clonazepam, melatonin and more recently pramipexole.",RBD,DISEASE,be,clonazepam,CHEMICAL
19689308,"Several treatments of RBD are available including clonazepam, melatonin and more recently pramipexole.",RBD,DISEASE,be,melatonin,CHEMICAL
19689308,"Several treatments of RBD are available including clonazepam, melatonin and more recently pramipexole.",RBD,DISEASE,be,pramipexole,CHEMICAL
35309288,"Additionally, fear of COVID-19 was positively related to health anxiety.",COVID-19,CHEMICAL,be related to,health anxiety,MENTAL_HEALTH
35309288,"Mixture analysis classified participants into six latent classes: 1) Risk-Aversive Healthy Group, 2) Incautious Healthy Group, 3) Infection Obsessions Group, 4) Health Anxiety Group, 5) Negative Affect Group, and 6) General Psychopathology Group.",Mixture analysis,CHEBI,classify participants into,Health Anxiety Group,MENTAL_HEALTH
35309288,"Mixture analysis classified participants into six latent classes: 1) Risk-Aversive Healthy Group, 2) Incautious Healthy Group, 3) Infection Obsessions Group, 4) Health Anxiety Group, 5) Negative Affect Group, and 6) General Psychopathology Group.",Mixture analysis,CHEBI,classify participants into,Infection Obsessions Group,DISEASE
17316826,"Insulin sensitivity (euglycemic insulin clamp), basal energy expenditure (indirect calorimetry), and CSF 5-hydroxyindoleacetic acid (5-HIAA) measurements were performed on 96 habitually violent antisocial male alcoholic offenders and on 40 normal male controls.",CSF 5-hydroxyindoleacetic acid 5-HIAA measurements,CHEMICAL,be performed on,habitually violent antisocial male alcoholic offenders,DISEASE
29860786,"We present a case of beta-propeller protein-associated neurodegeneration, a form of neurodegeneration with brain iron accumulation.",neurodegeneration,DISEASE,have a form with,brain iron accumulation,CHEMICAL
35598522,New antimalarial agents are needed to combat emerging resistance to the currently available drugs.,New antimalarial agents,CHEBI,emerging,resistance,MENTAL_HEALTH
31652355,"Selective negative allosteric modulators (NAMs) of α5-containing GABAA receptors such as the α5 inverse agonist (α5IA) restore learning and memory deficits in Ts65Dn mice, a model of DS.",NAMs,CHEMICAL,restore,learning deficits,DISEASE
25600365,"The study of the psychopharmacology of benzodiazepines continues to provide new insights into diverse brain functions related to vigilance, anxiety, mood, epileptiform activity, schizophrenia, cognitive performance, and autism-related social behavior.",benzodiazepines,CHEMICAL,provide new insights into diverse brain functions related to,anxiety,MENTAL_HEALTH
25600365,"The study of the psychopharmacology of benzodiazepines continues to provide new insights into diverse brain functions related to vigilance, anxiety, mood, epileptiform activity, schizophrenia, cognitive performance, and autism-related social behavior.",benzodiazepines,CHEMICAL,provide new insights into diverse brain functions related to,schizophrenia,MENTAL_HEALTH
25600365,"The study of the psychopharmacology of benzodiazepines continues to provide new insights into diverse brain functions related to vigilance, anxiety, mood, epileptiform activity, schizophrenia, cognitive performance, and autism-related social behavior.",benzodiazepines,CHEMICAL,provide new insights into diverse brain functions related to,mood,DISEASE
25600365,"The study of the psychopharmacology of benzodiazepines continues to provide new insights into diverse brain functions related to vigilance, anxiety, mood, epileptiform activity, schizophrenia, cognitive performance, and autism-related social behavior.",benzodiazepines,CHEMICAL,provide new insights into diverse brain functions related to,autism-related social behavior,DISEASE
27431363,Benzoxazin-3-ones from the different subclasses showed distinctly different ionization and fragmentation behaviors.,Benzoxazin-3-ones,CHEMICAL,show,fragmentation,MENTAL_HEALTH
26573558,"However, treatment with resveratrol (12.5 µM) for 48 h significantly alleviated ioxitalamate (30 mg/ml)-induced cytotoxicity, by reducing cytosolic DNA fragmentation, increasing the expression of the anti-apoptotic protein, Bcl-2 (B-cell lymphoma 2), and survivin, activating caspase-3, preventing autophagic death and suppressing the production of reactive oxygen species (ROS).",resveratrol,CHEMICAL,reduce,cytosolic DNA fragmentation,MENTAL_HEALTH
26573558,"However, treatment with resveratrol (12.5 µM) for 48 h significantly alleviated ioxitalamate (30 mg/ml)-induced cytotoxicity, by reducing cytosolic DNA fragmentation, increasing the expression of the anti-apoptotic protein, Bcl-2 (B-cell lymphoma 2), and survivin, activating caspase-3, preventing autophagic death and suppressing the production of reactive oxygen species (ROS).",resveratrol,CHEMICAL,prevent,autophagic death,DISEASE
26573558,"However, treatment with resveratrol (12.5 µM) for 48 h significantly alleviated ioxitalamate (30 mg/ml)-induced cytotoxicity, by reducing cytosolic DNA fragmentation, increasing the expression of the anti-apoptotic protein, Bcl-2 (B-cell lymphoma 2), and survivin, activating caspase-3, preventing autophagic death and suppressing the production of reactive oxygen species (ROS).",resveratrol,CHEMICAL,alleviate,ioxitalamate,CHEMICAL
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,DISEASE,be leading cause of accidental death in u.s. with,opioid overdose,DISEASE
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,DISEASE,be leading cause of accidental death in u.s. with,deaths,DISEASE
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,CHEBI,be leading cause of accidental death in u.s. with,opioid overdose,DISEASE
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,CHEBI,be leading cause of accidental death in u.s. with,deaths,DISEASE
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,DISEASE,be leading cause of,accidental death,DISEASE
35512612,Drug overdose is the leading cause of accidental death in the U.S. with deaths from opioid overdose occurring at a higher rate in rural areas.,Drug overdose,CHEBI,be leading cause of,accidental death,DISEASE
31882339,"The bioavailability-based model WHAM-FTOX explained more than 88 % and 85 % of the toxicity of binary and ternary REE treatments, respectively.",model WHAM-FTOX,CHEMICAL,explain more % and % of,toxicity,DISEASE
33116702,Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of chronic liver disease characterized by aberrant accumulation of triglycerides (TG) in hepatocytes without excessive alcohol consumption.,Non-alcoholic fatty liver disease,DISEASE,represent broad spectrum of,chronic liver disease,DISEASE
33116702,Non-alcoholic fatty liver disease (NAFLD) represents a broad spectrum of chronic liver disease characterized by aberrant accumulation of triglycerides (TG) in hepatocytes without excessive alcohol consumption.,NAFLD,DISEASE,represent broad spectrum of,chronic liver disease,DISEASE
26722518,"Lipid metabolism disturbance can result in insulin resistance and glucose intolerance; however, the features of glucose metabolism are still elusive in different dyslipidemia.",glucose metabolism,CHEMICAL,be elusive in,different dyslipidemia,DISEASE
26722518,"Lipid metabolism disturbance can result in insulin resistance and glucose intolerance; however, the features of glucose metabolism are still elusive in different dyslipidemia.",metabolism disturbance,DISEASE,result in,glucose intolerance,DISEASE
26722518,"Lipid metabolism disturbance can result in insulin resistance and glucose intolerance; however, the features of glucose metabolism are still elusive in different dyslipidemia.",metabolism disturbance,DISEASE,result in,insulin resistance,MENTAL_HEALTH
26722518,Our study intended to explore the characteristics and molecular mechanisms of glucose metabolism abnormal in hypercholesterolemia and hypertriglyceridemia models.,glucose metabolism,CHEMICAL,have the characteristics and molecular mechanisms in,hypercholesterolemia models,DISEASE
26722518,Our study intended to explore the characteristics and molecular mechanisms of glucose metabolism abnormal in hypercholesterolemia and hypertriglyceridemia models.,glucose metabolism,CHEMICAL,have the characteristics and molecular mechanisms in,hypertriglyceridemia,DISEASE
25929424,"A cluster of inter-related conditions such as central obesity, dyslipidemia, impaired glucose metabolism, and hypertension is referred to as Metabolic Syndrome, which is a risk factor for the development of type-2 diabetes.",central obesity,DISEASE,be referred to as,Metabolic Syndrome,DISEASE
25929424,"Benfotiamine, a derivative of thiamine, and pyridoxamine, a vitamer of vitamin B6, both have anti-AGE properties, making them valuable therapeutic adjuvants in the treatment of diabetic complications.",vitamin B6,CHEBI,make valuable therapeutic adjuvants in treatment of,diabetic complications,DISEASE
25929424,"Benfotiamine, a derivative of thiamine, and pyridoxamine, a vitamer of vitamin B6, both have anti-AGE properties, making them valuable therapeutic adjuvants in the treatment of diabetic complications.",thiamine,CHEBI,make valuable therapeutic adjuvants in treatment of,diabetic complications,DISEASE
25929424,"Benfotiamine, a derivative of thiamine, and pyridoxamine, a vitamer of vitamin B6, both have anti-AGE properties, making them valuable therapeutic adjuvants in the treatment of diabetic complications.",pyridoxamine,CHEMICAL,make valuable therapeutic adjuvants in treatment of,diabetic complications,DISEASE
25929424,"Benfotiamine, a derivative of thiamine, and pyridoxamine, a vitamer of vitamin B6, both have anti-AGE properties, making them valuable therapeutic adjuvants in the treatment of diabetic complications.",Benfotiamine,CHEMICAL,make valuable therapeutic adjuvants in treatment of,diabetic complications,DISEASE
25929424,"Thus, various vitamins and their derivatives have profound therapeutic potential in the prevention and treatment of type-2 diabetes.",various vitamins,CHEBI,have profound therapeutic potential in the prevention and treatment of,type-2 diabetes,DISEASE
15288089,"Intrathecal baclofen was proved effective in the treatment of secondary dystonia, especially in patients with cerebral palsy.",Intrathecal baclofen,CHEMICAL,be proved effective in treatment of secondary dystonia in,cerebral palsy,DISEASE
15288089,"Intrathecal baclofen was proved effective in the treatment of secondary dystonia, especially in patients with cerebral palsy.",Intrathecal baclofen,CHEMICAL,be proved effective in treatment of,secondary dystonia,DISEASE
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",peripheral vascular impairment,DISEASE,be known among,sideropaenia,CHEMICAL
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",peripheral vascular impairment,DISEASE,be known among,hypochromic anaemia,DISEASE
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",arthritic deformities,DISEASE,be known among,sideropaenia,CHEMICAL
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",arthritic deformities,DISEASE,be known among,hypochromic anaemia,DISEASE
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",distal joints,DISEASE,be known among,sideropaenia,CHEMICAL
17134427,"Among the acquired general causes, hypochromic anaemia and sideropaenia, arthritic deformities of the distal joints, peripheral vascular impairment and endocrinopathies are the best known.",distal joints,DISEASE,be known among,hypochromic anaemia,DISEASE
32990167,"Common adverse effects from gabapentin include somnolence, sedation, and dizziness.",gabapentin,CHEMICAL,include,dizziness,DISEASE
32990167,"Common adverse effects from gabapentin include somnolence, sedation, and dizziness.",gabapentin,CHEMICAL,include,somnolence,MENTAL_HEALTH
32990167,Hyperglycemia is listed as a possible adverse drug reaction in the labeling.,Hyperglycemia,DISEASE,be listed as,possible adverse drug reaction,CHEBI
9274991,"This antagonist is a potent antiantidiuretic, antivasopressor and antioxytocic peptide with pA2 values of 7.69-7.94 and affinities of 1.12-11.0 nM. When radioiodinated at the phenyl moiety of the tyrosylamide residue at position 9, this peptide was demonstrated to bind to vasopressin V2 and V1a receptors with a dissociation constant of 0.22-0.75 nM. This ligand is a good tool for further studies on human vasopressin V2 receptor localization and characterization, when used in combination with a selective vasopressin V1a ligand.",antagonist,CHEBI,be,antiantidiuretic peptide,CHEMICAL
7009786,More than a decade of scientific inquiry into the biochemistry of schizophrenia has been organized by the dopamine hypothesis.,schizophrenia,MENTAL_HEALTH,be organized by,dopamine hypothesis,CHEMICAL
7009786,"However, a major problem with the dopamine hypothesis is the lack of strong direct evidence of altered dopamine concentrations or metabolism when measured in large groups of schizophrenic subjects.",dopamine hypothesis,CHEMICAL,be lack of strong direct evidence of,altered dopamine concentrations,CHEMICAL
7009786,"These hypotheses propose that neurotransmitters, other than dopamine, may be involved in schizophrenic symptoms.",dopamine,CHEMICAL,be involved in,schizophrenic symptoms,DISEASE
7009786,Reports of elevated concentrations of norepinephrine is specific areas of the brain and in the spinal fluid have led to the hypothesis that norepinephrine may be involved in schizophrenia.,norepinephrine,CHEMICAL,be involved in,schizophrenia,MENTAL_HEALTH
7009786,At least two groups of investigators have suggested that phenylethylamine might be involved in schizophrenia.,phenylethylamine,CHEMICAL,be involved in,schizophrenia,MENTAL_HEALTH
7009786,Studies with the reversible acetylcholinesterase inhibitor physostigmine and the dopamine agonist methylphenidate have led to the suggestion that acetylcholine and dopamine imbalance may be involved in schizophrenia.,acetylcholine imbalance,CHEMICAL,be involved in,schizophrenia,MENTAL_HEALTH
7009786,The recent discovery of the endorphins has led to speculations about the possible role of these substances in schizophrenia.,endorphins,CHEMICAL,lead to speculations about possible role of substances in,schizophrenia,MENTAL_HEALTH
7009786,"Both an excess and a deficiency of endorphin activity have been implicated in schizophrenia, and speculative evidence has been used to support both hypotheses.",endorphin activity,CHEMICAL,be implicated in,schizophrenia,MENTAL_HEALTH
7009786,"The ultimate aim of the search for biochemical defects in schizophrenia is the development of rational drug treatments which will correct these defects and in doing so, these drugs will provide effective treatments for patients with schizophrenic symptoms.",schizophrenia,MENTAL_HEALTH,be development of,rational drug treatments,CHEBI
23994581,"In the body, estrogen protects against adiposity, insulin resistance, and type II diabetes, and regulates energy intake and expenditure.",estrogen,CHEBI,protect in body against,type diabetes,DISEASE
23994581,"In the body, estrogen protects against adiposity, insulin resistance, and type II diabetes, and regulates energy intake and expenditure.",estrogen,CHEBI,protect in body against,insulin resistance,MENTAL_HEALTH
34870583,"Studies of sleep-disordered breathing (SDB) in children with Prader-Willi syndrome (PWS) have focused on early childhood and growth hormone (GH)-naïve children, but little is known about older children, including those on long-term GH therapy.",Prader-Willi syndrome,MENTAL_HEALTH,focus on,growth hormone (GH)-naïve,CHEBI
34870583,"Studies of sleep-disordered breathing (SDB) in children with Prader-Willi syndrome (PWS) have focused on early childhood and growth hormone (GH)-naïve children, but little is known about older children, including those on long-term GH therapy.",sleep-disordered breathing,DISEASE,focus on,growth hormone (GH)-naïve,CHEBI
34870583,"Studies of sleep-disordered breathing (SDB) in children with Prader-Willi syndrome (PWS) have focused on early childhood and growth hormone (GH)-naïve children, but little is known about older children, including those on long-term GH therapy.",SDB,DISEASE,focus on,growth hormone (GH)-naïve,CHEBI
33670584,"A screening polysomnography-polygraphy (PSG), the oral glucose tolerance test (OGTT) and homeostasis model assessment of insulin resistance (HOMA-IR) were analysed in three groups of patients-with simple obesity (group 1, n = 30, mean age 14.2 years), patients with PWS without the rhGH therapy (group 2, n = 8, mean age 13.0 years) and during the rhGH treatment (group 3, n = 17, mean age 8.9 years).",insulin resistance,MENTAL_HEALTH,be analysed in groups of,patients-with simple obesity,DISEASE
33930379,"Since many mental disorders have linked to the monoaminergic system, the level of SAMe in blood and cerebrospinal fluid is important in the treatment of major depression.",SAMe,CHEMICAL,be important in treatment of,major depression,MENTAL_HEALTH
33930379,Overall results suggest that SLN is a promising carrier to passive lymphatic targeting of SAMe and novel SLN nanocomposite particles which presented efficient oral bioavailability is a potential way for oral delivery of SAMe and treatment of major depression.,SLN,CHEMICAL,be promising carrier to passive lymphatic targeting of,SAMe,CHEMICAL
33930379,Overall results suggest that SLN is a promising carrier to passive lymphatic targeting of SAMe and novel SLN nanocomposite particles which presented efficient oral bioavailability is a potential way for oral delivery of SAMe and treatment of major depression.,SLN,CHEMICAL,be,promising carrier,CHEBI
33480616,"The antidepressant venlafaxine, as a serotonin noradrenaline reuptake inhibitor, is applied to MDD relief.",serotonin noradrenaline reuptake inhibitor,CHEMICAL,be applied to,MDD relief,DISEASE
33480616,"The antidepressant venlafaxine, as a serotonin noradrenaline reuptake inhibitor, is applied to MDD relief.",antidepressant venlafaxine,CHEMICAL,be applied to,MDD relief,DISEASE
33480616,Solute carrier family 6 member 4 (SLC6A4) has been reported to promote the reuptake of serotonin and to be closely correlated to depression.,carrier family,CHEBI,promote reuptake of,serotonin,CHEMICAL
33480616,Solute carrier family 6 member 4 (SLC6A4) has been reported to promote the reuptake of serotonin and to be closely correlated to depression.,carrier family,CHEBI,be correlated to,depression,MENTAL_HEALTH
35397670,Aflatoxin B1 (AFB1) is a food-borne toxin produced by Aspergillus flavus and a few similar fungi.,Aflatoxin B1,CHEMICAL,produced by,Aspergillus flavus,DISEASE
35397670,Aflatoxin B1 (AFB1) is a food-borne toxin produced by Aspergillus flavus and a few similar fungi.,AFB1,CHEMICAL,produced by,Aspergillus flavus,DISEASE
31040836,"During AHL degradation, this repression is released by the binding of the γ-butyrolactone ring of the pathogen signaling molecules to QsdR. We show here that a lactone designed to mimic quorum signals, γ-caprolactone, can act as an effector ligand of QsdR, triggering the synthesis of qsd operon-encoded enzymes.",repression,MENTAL_HEALTH,be released during,AHL degradation,CHEMICAL
34540646,"N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus.",N-methyl-d-aspartate NMDA receptor antagonists,CHEBI,be viable option for patients with opioid resistance and neuropathic pain due to their affinity to,neurotransmitter glutamate,CHEMICAL
34540646,"N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus.",N-methyl-d-aspartate NMDA receptor antagonists,CHEBI,be viable option for patients with,opioid resistance due,MENTAL_HEALTH
34540646,"N-methyl-d-aspartate (NMDA) receptor antagonists are a viable option for patients with opioid resistance and neuropathic pain due to their affinity to the neurotransmitter glutamate, which is released when patients experience a noxious stimulus.",N-methyl-d-aspartate NMDA receptor antagonists,CHEBI,be viable option for patients with,neuropathic pain,DISEASE
29228978,Methamphetamine (METH) is a commonly abused drug that may result in neurotoxic effects.,Methamphetamine,CHEMICAL,be,abused drug,CHEBI
29228978,Methamphetamine (METH) is a commonly abused drug that may result in neurotoxic effects.,METH,CHEMICAL,be,abused drug,CHEBI
29228978,Recent studies have suggested that involvement of neuroinflammatory processes in brain dysfunction is induced by misuse of this drug.,brain dysfunction,DISEASE,be induced by misuse of,drug,CHEBI
17128884,Two potential causes of hyponatremia in this patient were the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or cerebral salt wasting syndrome (CSWS).,hyponatremia,DISEASE,be syndrome of inappropriate secretion of,antidiuretic hormone,CHEBI
17128884,Two potential causes of hyponatremia in this patient were the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or cerebral salt wasting syndrome (CSWS).,hyponatremia,DISEASE,be syndrome of inappropriate secretion of,CSWS,DISEASE
17128884,Two potential causes of hyponatremia in this patient were the syndrome of inappropriate secretion of antidiuretic hormone (SIADH) or cerebral salt wasting syndrome (CSWS).,hyponatremia,DISEASE,be syndrome of inappropriate secretion of,cerebral salt wasting syndrome,DISEASE
17128884,"After treatment with vigorous sodium and volume replacement for over 4 weeks, hyponatremia as well as meningoencephalitis were improved without any complication.",meningoencephalitis,DISEASE,be improved after treatment with,sodium volume replacement,CHEMICAL
17128884,"After treatment with vigorous sodium and volume replacement for over 4 weeks, hyponatremia as well as meningoencephalitis were improved without any complication.",hyponatremia,DISEASE,be improved after treatment with,sodium volume replacement,CHEMICAL
34681715,"Moreover, the potential clinical implications of KP modulation in chronic pain therapy as well as the directions of new research initiatives are discussed.",KP modulation,CHEMICAL,have the potential clinical implications in,chronic pain therapy,DISEASE
35342201,Implicated in the causation of stuttering are overactive presynaptic dopamine systems in the region of the brain that modulate verbalization.,stuttering,MENTAL_HEALTH,be,overactive presynaptic dopamine systems,CHEMICAL
24247862,"Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of Parkinson's disease (PD), and therefore, most PD patients receive antidepressant drugs.",Major Depressive Disorder,MENTAL_HEALTH,receive,antidepressant drugs,CHEMICAL
24247862,"Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of Parkinson's disease (PD), and therefore, most PD patients receive antidepressant drugs.",MDD,DISEASE,receive,antidepressant drugs,CHEMICAL
24247862,"Major Depressive Disorder (MDD) is among the most frequent comorbidities occurring in the course of Parkinson's disease (PD), and therefore, most PD patients receive antidepressant drugs.",most PD patients,DISEASE,receive,antidepressant drugs,CHEMICAL
23195679,"We questioned whether a similar age-dependent injury occurs following exposure to hemoglobin, a known nephrotoxin.",similar age-dependent injury,DISEASE,occur following exposure to,known nephrotoxin,CHEBI
2906947,Recent reports suggest that beta-adrenergic antagonists may be effective in the treatment of akathisia.,beta-adrenergic antagonists,CHEBI,be effective in treatment of,akathisia,DISEASE
33894724,"Olanzapine and clozapine are atypical antipsychotics (AAPs) with the greatest risk of weight gain, and changes in feeding behavior are among the most important underlying mechanisms.",clozapine,CHEMICAL,be atypical antipsychotics with greatest risk of,weight gain,DISEASE
33894724,"Olanzapine and clozapine are atypical antipsychotics (AAPs) with the greatest risk of weight gain, and changes in feeding behavior are among the most important underlying mechanisms.",Olanzapine,CHEMICAL,be atypical antipsychotics with greatest risk of,weight gain,DISEASE
32517920,"The projection to latent structure method, using the partial least squares method, was applied to predict the flavonoid content in soybean seed, which indicated that sucrose, threonic acid, citric acid, and fatty acids are important in predicting the antioxidant content of samples.",projection,MENTAL_HEALTH,predict flavonoid content in,soybean seed,NUTRITION
17354267,The catecholamine norepinephrine is a critical effector of the mammalian stress response and has been implicated in the pathophysiology of posttraumatic stress disorder (PTSD)-a syndrome intrinsically related to the experience of extraordinary stress.,catecholamine norepinephrine,CHEMICAL,be implicated in pathophysiology of,disorder syndrome related,MENTAL_HEALTH
28937913,"Aqueous and methanol extracts of lemon Citrus limon peel, Euphorbia hirta (aerial parts), and fenugreek Trigonella foenum-graecum seeds were tested for their in vitro antimicrobial activities against the bacterium Aeromonas hydrophila.",fenugreek Trigonella foenum-graecum seeds,CHEMICAL,be tested for,Aeromonas hydrophila,DISEASE
28937913,"Aqueous and methanol extracts of lemon Citrus limon peel, Euphorbia hirta (aerial parts), and fenugreek Trigonella foenum-graecum seeds were tested for their in vitro antimicrobial activities against the bacterium Aeromonas hydrophila.",fenugreek Trigonella foenum-graecum seeds,CHEMICAL,be tested for,in antimicrobial activities,CHEBI
28937913,"Six treatments were conducted in triplicate groups of 30 fish (mean weight ± SE = 9.0 ± 0.3 g); the Control fish were fed the control diet and were not injected with A. hydrophila, while the Control-AH and OTC-AH groups were infected with A. hydrophila and were fed either the control diet or the diet containing OTC at 1 g/199 g. The other three treatments included fish that were injected with A. hydrophila but fed diets with increasing EHE at 2, 5, or 7 g/kg.",Control-AH groups,CHEMICAL,be infected with,A. hydrophila,DISEASE
7718674,"Central nervous system serotonin functions may differ between certain subgroups of alcoholics, patients with panic disorder, and healthy volunteers.",system serotonin functions,CHEMICAL,differ between certain subgroups of,panic disorder,MENTAL_HEALTH
7718674,"Central nervous system serotonin functions may differ between certain subgroups of alcoholics, patients with panic disorder, and healthy volunteers.",system serotonin functions,DISEASE,differ between certain subgroups of,panic disorder,MENTAL_HEALTH
7718674,"In contrast, patients with panic disorder exhibited marked dysphoric reactions and/or panic attacks following low-dose i.v.",panic disorder,MENTAL_HEALTH,exhibit in,low-dose,CHEMICAL
7718674,"In contrast, patients with panic disorder exhibited marked dysphoric reactions and/or panic attacks following low-dose i.v.",panic disorder,MENTAL_HEALTH,exhibit in,panic attacks,DISEASE
7718674,"In contrast, patients with panic disorder exhibited marked dysphoric reactions and/or panic attacks following low-dose i.v.",panic disorder,MENTAL_HEALTH,exhibit in,marked dysphoric reactions,DISEASE
7718674,"Patients with panic disorder may have super-sensitive postsynaptic serotonin receptors in areas of their central nervous system, which are important for mood regulation.",panic disorder,MENTAL_HEALTH,have,super-sensitive postsynaptic serotonin receptors,CHEMICAL
2120029,Interest of fluvoxamine in panic patients with obsessive compulsive symptoms who do not respond to common antipanic medication is suggested.,panic patients,DISEASE,have fluvoxamine with,obsessive compulsive symptoms,DISEASE
2120029,Interest of fluvoxamine in panic patients with obsessive compulsive symptoms who do not respond to common antipanic medication is suggested.,fluvoxamine,CHEMICAL,in panic patients with,obsessive compulsive symptoms,DISEASE
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,panic disorder,MENTAL_HEALTH,be treated with,serotonin uptake inhibitor fluoxetine,CHEMICAL
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,panic disorder,MENTAL_HEALTH,be treated with,serotonin uptake inhibitor fluoxetine,CHEBI
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,primary DSM-III-R diagnosis,DISEASE,be treated with,serotonin uptake inhibitor fluoxetine,CHEMICAL
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,primary DSM-III-R diagnosis,DISEASE,be treated with,serotonin uptake inhibitor fluoxetine,CHEBI
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,agoraphobia,MENTAL_HEALTH,be treated with,serotonin uptake inhibitor fluoxetine,CHEMICAL
2341585,Twenty-five patients with a primary DSM-III-R diagnosis of panic disorder with or without agoraphobia were treated openly with the serotonin uptake inhibitor fluoxetine for up to 12 months.,agoraphobia,MENTAL_HEALTH,be treated with,serotonin uptake inhibitor fluoxetine,CHEBI
31399587,"The formicamycin biosynthetic gene cluster encodes two groups of type 2 polyketide antibiotics: the formicamycins and their biosynthetic precursors the fasamycins, both of which have activity against methicillin-resistant Staphylococcus aureus.",formicamycin biosynthetic gene cluster,CHEMICAL,encode groups of,biosynthetic precursors fasamycins,CHEMICAL
31399587,"The formicamycin biosynthetic gene cluster encodes two groups of type 2 polyketide antibiotics: the formicamycins and their biosynthetic precursors the fasamycins, both of which have activity against methicillin-resistant Staphylococcus aureus.",formicamycin biosynthetic gene cluster,CHEMICAL,encode groups of,formicamycins,CHEMICAL
31399587,"The formicamycin biosynthetic gene cluster encodes two groups of type 2 polyketide antibiotics: the formicamycins and their biosynthetic precursors the fasamycins, both of which have activity against methicillin-resistant Staphylococcus aureus.",formicamycin biosynthetic gene cluster,CHEMICAL,encode groups of,type polyketide antibiotics,CHEBI
31399587,"The formicamycin biosynthetic gene cluster encodes two groups of type 2 polyketide antibiotics: the formicamycins and their biosynthetic precursors the fasamycins, both of which have activity against methicillin-resistant Staphylococcus aureus.",formicamycin biosynthetic gene cluster,CHEMICAL,have activity against,methicillin-resistant Staphylococcus aureus,DISEASE
35398393,Estrogen deficiency-induced female depression is closely related to 5-hydroxytriptamine (5-HT) deficiency.,deficiency-induced female depression,MENTAL_HEALTH,be related to,5-HT,CHEMICAL
35398393,Estrogen deficiency-induced female depression is closely related to 5-hydroxytriptamine (5-HT) deficiency.,deficiency-induced female depression,MENTAL_HEALTH,be related to,5-hydroxytriptamine deficiency,CHEMICAL
30653316,"Recent reports demonstrate that green tea may exert a positive effect on the reduction of medical chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease, Parkinson's disease, and diabetes.",green tea,CHEMICAL,exert positive effect on reduction of medical chronic conditions such as,Alzheimer's disease,DISEASE
30653316,"Recent reports demonstrate that green tea may exert a positive effect on the reduction of medical chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease, Parkinson's disease, and diabetes.",green tea,CHEMICAL,exert positive effect on reduction of medical chronic conditions such as,cardiovascular disease,DISEASE
30653316,"Recent reports demonstrate that green tea may exert a positive effect on the reduction of medical chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease, Parkinson's disease, and diabetes.",green tea,CHEMICAL,exert positive effect on reduction of medical chronic conditions such as,diabetes,DISEASE
30653316,"Recent reports demonstrate that green tea may exert a positive effect on the reduction of medical chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease, Parkinson's disease, and diabetes.",green tea,CHEMICAL,exert positive effect on reduction of medical chronic conditions such as,cancer,DISEASE
30653316,"Recent reports demonstrate that green tea may exert a positive effect on the reduction of medical chronic conditions such as cardiovascular disease, cancer, Alzheimer's disease, Parkinson's disease, and diabetes.",green tea,CHEMICAL,exert positive effect on reduction of medical chronic conditions such as,Parkinson's disease,DISEASE
30696093,"Theaflavins, a polyphenol found in black tea, are known to have anti-oxidative and anti-inflammation effects, but the effects of theaflavins on cognitive decline and depression induced by inflammation have not been investigated.",theaflavins,CHEMICAL,have the effects on,depression,MENTAL_HEALTH
30696093,"Theaflavins, a polyphenol found in black tea, are known to have anti-oxidative and anti-inflammation effects, but the effects of theaflavins on cognitive decline and depression induced by inflammation have not been investigated.",theaflavins,CHEMICAL,have the effects on,cognitive decline,DISEASE
30696093,"To address this research gap, the present study assessed whether theaflavins could protect synapses and dendrites damaged by inflammation and prevent concomitant memory impairment and depression-like behavior in mice.",theaflavins,CHEMICAL,prevent,concomitant memory impairment,DISEASE
30696093,"To address this research gap, the present study assessed whether theaflavins could protect synapses and dendrites damaged by inflammation and prevent concomitant memory impairment and depression-like behavior in mice.",theaflavins,CHEMICAL,prevent,depression-like behavior,DISEASE
30696093,"Intracerebroventricular injection with lipopolysaccharide (LPS) induces neural inflammation associated with reduced spontaneous alternations in the Y-maze test and increased immobility in the tail suspension test, indicating impaired spatial memory and depression-like behavior, respectively.",lipopolysaccharide,CHEMICAL,indicate,memory behavior,DISEASE
30696093,"Intracerebroventricular injection with lipopolysaccharide (LPS) induces neural inflammation associated with reduced spontaneous alternations in the Y-maze test and increased immobility in the tail suspension test, indicating impaired spatial memory and depression-like behavior, respectively.",LPS,CHEMICAL,indicate,memory behavior,DISEASE
30696093,Theaflavins also suppressed productions of inflammatory cytokines and prevented dendritic atrophy and spine loss in the brain.,Theaflavins,CHEMICAL,prevent,spine loss,DISEASE
30696093,Theaflavins also suppressed productions of inflammatory cytokines and prevented dendritic atrophy and spine loss in the brain.,Theaflavins,CHEMICAL,prevent,dendritic atrophy,DISEASE
30696093,These results suggest that theaflavins can suppress neural inflammation and prevent the symptoms of inflammation-related brain disorders.,theaflavins,CHEMICAL,prevent symptoms of,inflammation-related brain disorders,DISEASE
35288347,Chimeric antigen receptor (CAR) T cell therapy is a novel therapy for patients with relapsed or refractory hematologic malignancies.,Chimeric antigen receptor CAR T cell therapy,CHEMICAL,be novel therapy for patients with,relapsed hematologic malignancies,DISEASE
35288347,Chimeric antigen receptor (CAR) T cell therapy is a novel therapy for patients with relapsed or refractory hematologic malignancies.,Chimeric antigen receptor CAR T cell therapy,CHEBI,be novel therapy for patients with,relapsed hematologic malignancies,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,burns,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,sciatica,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,migraine headaches,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,dyspepsia,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,depression,MENTAL_HEALTH
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,abdominal pains,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,bacterial infections,DISEASE
26510970,"One traditional medicines, Hypericum perforatum L. (Hypericaceae), possesses several beneficial effects against depression, ulcers, dyspepsia, abdominal pains, burns, bacterial infections, migraine headaches, and sciatica.",Hypericum perforatum L.,CHEMICAL,possess several beneficial effects against,ulcers,DISEASE
8767355,"(S)-10-[(S)-(8-Amino-6-azaspiro[3,4]octan-6-yl)]-9-fluoro-2, 3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyli c acid hemihydrate (CAS 151390-79-3, DV-7751a) a new quinolone antibacterial agent, was examined for LD50 value, phototoxicity and convulsion inducing potential in laboratory animals.","3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyli c acid hemihydrate",CHEMICAL,be examined for,convulsion,DISEASE
8767355,A single oral administration of DV-7751a induced soft stool in rats at 1000 and 2000 mg/ kg and in monkeys at 250 mg/kg and vomiting in monkeys at 500 mg/kg or more.,DV-7751a,CHEMICAL,induce soft stool in rats at and 2000 mg/ kg and in,vomiting,DISEASE
10209671,Lycopene was also reduced in PDem compared to AD (p < 0.001) and VaD (p < 0.001).,Lycopene,CHEBI,be reduced in,VaD,DISEASE
10209671,"The reduction in plasma chain-breaking antioxidants in patients with dementia may reflect an increased free-radical activity, and a common role in cognitive impairment in these conditions.",chain-breaking antioxidants,CHEMICAL,in patients with,dementia,MENTAL_HEALTH
7858369,"Furthermore, physical diagnoses, such as chronic obstructive lung disease, congestive heart failure, stroke and endocrine disorders, are frequently associated with depressive symptoms.",congestive heart failure,DISEASE,be associated with,depressive symptoms,DISEASE
7858369,"Furthermore, physical diagnoses, such as chronic obstructive lung disease, congestive heart failure, stroke and endocrine disorders, are frequently associated with depressive symptoms.",chronic obstructive lung disease,DISEASE,be associated with,depressive symptoms,DISEASE
18034659,"Adenosine, adenosine receptor agonists, and adenosine uptake blockers are known to reduce the severity and duration of amygdala-kindled seizures.",Adenosine adenosine uptake blockers,CHEMICAL,reduce severity and duration of,amygdala-kindled seizures,DISEASE
18034659,Chronic PTZ treatment progressively increased the seizure score with the maximum score reached on day 9.,Chronic PTZ treatment,CHEMICAL,increase,seizure score,DISEASE
35597115,These findings might contribute to better understand the therapeutic potential of PEA on anxio-depressive symptoms.,PEA,CHEMICAL,have the therapeutic potential on,anxio-depressive symptoms,DISEASE
34205930,Benzodiazepines enhance GABA-ergic transmission and this has led to a study of the role of GABA in anxiety.,GABA,CHEMICAL,have the role in,anxiety,MENTAL_HEALTH
34604382,This study is aimed at evaluating the correlation of sleep quality and vitamin D levels in 80 HD patients.,vitamin D,CHEBI,have the correlation in,HD patients,DISEASE
33133571,Vitamin D appears to be associated with sleep disorders.,Vitamin D,CHEBI,be associated with,sleep disorders,DISEASE
33133571,"Simultaneously, the influence of vitamin D replenishment on sleep disorders remains controversial.",D replenishment,CHEBI,have the influence on,sleep disorders,DISEASE
32250212,"Recent studies have also shown Vitamin D deficiency in patients with severe psychiatric disorders, including MDD.",Vitamin D deficiency,CHEBI,in patients with,severe psychiatric disorders,DISEASE
32250212,Nutraceutical supplementation with Vitamin D and NAC in treatment-resistant MDD patients may be important not only for improving depressive clinical manifestations but also for their safety and tolerability profile.,NAC,CHEMICAL,improve,depressive clinical manifestations,DISEASE
32250212,Nutraceutical supplementation with Vitamin D and NAC in treatment-resistant MDD patients may be important not only for improving depressive clinical manifestations but also for their safety and tolerability profile.,Nutraceutical supplementation,CHEBI,improve,depressive clinical manifestations,DISEASE
32250212,Nutraceutical supplementation with Vitamin D and NAC in treatment-resistant MDD patients may be important not only for improving depressive clinical manifestations but also for their safety and tolerability profile.,Vitamin D,CHEBI,improve,depressive clinical manifestations,DISEASE
32250212,Nutraceutical supplementation with Vitamin D and NAC in treatment-resistant MDD patients may be important not only for improving depressive clinical manifestations but also for their safety and tolerability profile.,treatment-resistant MDD patients,DISEASE,improve,depressive clinical manifestations,DISEASE
31214267,The seed of Nigella sativa (N. sativa) has been used in different civilization around the world for centuries to treat various animal and human ailments.,N. sativa,CHEMICAL,treat,animal ailments,DISEASE
31214267,The seed of Nigella sativa (N. sativa) has been used in different civilization around the world for centuries to treat various animal and human ailments.,Nigella sativa,CHEMICAL,treat,animal ailments,DISEASE
31214267,"In spite of limited studies conducted so far, the promising efficacy of N. sativa against HIV/AIDS can be explored as an alternative option for the treatment of this pandemic disease after substantiating its full therapeutic efficacy.",N. sativa,CHEMICAL,be explored in spite of limited studies as alternative option for,pandemic disease,DISEASE
28827068,"In the present review, it has been analyzed how steroids, particularly estrogens, androgens and progestagens are involved in the etiopathogenesis of hyperplasia and endometrial endometrioid adenocarcinoma.",estrogens,CHEBI,be involved in etiopathogenesis of,endometrial endometrioid adenocarcinoma,DISEASE
28827068,"In the present review, it has been analyzed how steroids, particularly estrogens, androgens and progestagens are involved in the etiopathogenesis of hyperplasia and endometrial endometrioid adenocarcinoma.",androgens,CHEBI,be involved in etiopathogenesis of,endometrial endometrioid adenocarcinoma,DISEASE
28827068,"In the present review, it has been analyzed how steroids, particularly estrogens, androgens and progestagens are involved in the etiopathogenesis of hyperplasia and endometrial endometrioid adenocarcinoma.",steroids,CHEMICAL,be involved in etiopathogenesis of,endometrial endometrioid adenocarcinoma,DISEASE
21339485,We previously showed that the progression of atherosclerosis in the Reversa mouse (Ldlr(-/-Apob100/100Mttpfl/fl) Mx1Cre(+/+)) was arrested when the hyperlipidemia was normalized by inactivating the gene for microsomal triglyceride transfer protein.,hyperlipidemia,DISEASE,inactivate gene for,microsomal triglyceride transfer protein,CHEMICAL
22009032,Lithium is a major drug for bipolar disorder and mania.,Lithium,NUTRITION,be major drug for,mania,MENTAL_HEALTH
22009032,Lithium is a major drug for bipolar disorder and mania.,Lithium,NUTRITION,be major drug for,bipolar disorder,MENTAL_HEALTH
22009032,Lithium is a major drug for bipolar disorder and mania.,Lithium,NUTRITION,be,major drug,CHEBI
22009032,"Lithium decreased thermal hyperalgesia scores with dose of 5, 10 and 15 mg/kg and cold and mechanical allodynia scores with dose of 10 and 15 mg/kg, significantly.",Lithium,NUTRITION,decrease thermal hyperalgesia scores with dose of,cold allodynia scores,DISEASE
22009032,"Lithium decreased thermal hyperalgesia scores with dose of 5, 10 and 15 mg/kg and cold and mechanical allodynia scores with dose of 10 and 15 mg/kg, significantly.",Lithium,NUTRITION,decrease,hyperalgesia scores,DISEASE
22009032,The opioid antagonist naloxone prevented the effect of lithium on thermal hyperalgesia and mechanical allodynia while it did not show any effect on the acetone-induced cold allodynia.,lithium,NUTRITION,have the effect on,mechanical allodynia,DISEASE
22009032,The opioid antagonist naloxone prevented the effect of lithium on thermal hyperalgesia and mechanical allodynia while it did not show any effect on the acetone-induced cold allodynia.,lithium,NUTRITION,have the effect on,thermal hyperalgesia,DISEASE
22009032,Our results suggest that lithium can be considered as a therapeutic potential for the treatment of some aspects of neuropathic pain and that the opioid system may be involved in the lithium-induced attenuation of thermal hyperalgesia and mechanical allodynia.,lithium,NUTRITION,be considered as therapeutic potential for treatment of aspects of,neuropathic pain,DISEASE
35507284,"The dopamine transporter (DAT) is the main target of methylphenidate (MPH), which remains the number one drug prescribed worldwide for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD).",dopamine transporter,CHEMICAL,be main target of,methylphenidate,CHEMICAL
35507284,"The dopamine transporter (DAT) is the main target of methylphenidate (MPH), which remains the number one drug prescribed worldwide for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD).",dopamine transporter,CHEMICAL,be main target of,MPH,CHEMICAL
35507284,"Moreover, chronic treatment of MPH has been shown to increase brain DAT expression in both animals and ADHD patients, suggesting that findings of overexpressed levels of DAT in ADHD patients are possibly attributable to the effects of long-term MPH treatment rather than the pathology of the condition itself.",ADHD patients,MENTAL_HEALTH,be attributable to effects of,long-term MPH treatment,CHEMICAL
35507284,"Moreover, chronic treatment of MPH has been shown to increase brain DAT expression in both animals and ADHD patients, suggesting that findings of overexpressed levels of DAT in ADHD patients are possibly attributable to the effects of long-term MPH treatment rather than the pathology of the condition itself.",MPH,CHEMICAL,increase brain dat expression in,ADHD patients,MENTAL_HEALTH
35358768,"The current study investigated whether and how anticipatory alpha oscillations, the subsequent target-elicited N2 posterior-contralateral component (N2pc) and their relationship contributed to attention problems in children with ADHD.",anticipatory alpha oscillations,NUTRITION,contribute to attention problems in children with,ADHD,MENTAL_HEALTH
2559184,"The selectivity of binding of 125I-iodocyanopindolol (125I-ICYP) to beta 1-, beta 2-adrenergic and 5HT1B-serotonergic receptors were analysed using both the Scatchard and displacement methods.",beta 5HT1B-serotonergic receptors,CHEBI,use,displacement,MENTAL_HEALTH
2559184,In the case of 125I-ICYP the separation of beta 1- and beta 2-adrenergic receptors becomes feasible only with the displacement method.,beta receptors,CHEBI,become in case of 125i-icyp feasible with,displacement method,MENTAL_HEALTH
2879033,This indicates a possible displacement of alpha adrenergic agonists with the beta antagonists.,adrenergic agonists,CHEBI,have a possible displacement with,beta antagonists,CHEBI
22764552,"The long-term goal for patients with inadequate estrogen stimulation is to maintain the serum concentration of sex steroids within the normal adult range to promote the development of secondary sexual characteristics, prevent premature bone loss, and ultimately to induce fertility when indicated.",inadequate estrogen stimulation,CHEBI,maintain serum concentration of,sex steroids,CHEMICAL
14988760,"In addition, it is worthwhile to emphasize that in spite of the publicity of progesterone treatment for PMS, in most well-controlled studies it has not been shown to be more effective than placebo for the treatment of these syndromes.",progesterone treatment,CHEMICAL,have the publicity for,PMS,CHEMICAL
34826558,"The fact that mood-stabilizers and/or benzodiazepines were more frequently co-administered with SGAs may represent a requirement of an overall refined psychopharmacotherapy including additional fast-acting agents with potent AD, tranquilizing and anti-suicidal effects in MDD patients experiencing challenging clinical manifestations.",mood-stabilizers,CHEMICAL,be co-administered with,SGAs,CHEMICAL
34826558,"The fact that mood-stabilizers and/or benzodiazepines were more frequently co-administered with SGAs may represent a requirement of an overall refined psychopharmacotherapy including additional fast-acting agents with potent AD, tranquilizing and anti-suicidal effects in MDD patients experiencing challenging clinical manifestations.",benzodiazepines,CHEMICAL,be co-administered with,SGAs,CHEMICAL
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",BaZiBuShen formula,CHEMICAL,be used as,impotence infertility,MENTAL_HEALTH
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",BaZiBuShen formula,CHEMICAL,be used as,impotence infertility,DISEASE
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",BaZiBuShen formula,CHEMICAL,be used as,kidney-tonifying drug,CHEBI
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",Radix Morindae Officinalis,DISEASE,be used as,impotence infertility,MENTAL_HEALTH
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",Radix Morindae Officinalis,DISEASE,be used as,impotence infertility,DISEASE
33508368,"BaZiBuShen formula (BZBS), a patented Chinese herbal prescription composed of Semen Cuscutae, Fructus Lycii, Epimedii Folium, Fructus Schisandrae Sphenantherae, Fructus Cnidii, Fructus Rosae Laevigatae, Semen Allii Tuberosi., Radix Morindae Officinalis, Herba Cistanches, Fructus Rubi, Radix Rehmanniae Recens, Radix Cyathulae, Radix Ginseng, Cervi Cornu Pantotrichum, Hippocampus, and Fuctus Toosendan, has been used as a kidney-tonifying and anti-aging drug as well as for the treatment of impotence and male infertility in traditional Chinese medicine.",Radix Morindae Officinalis,DISEASE,be used as,kidney-tonifying drug,CHEBI
31467570,"Eucommia ulmoides Oliv. is used as a traditional medicine for male impotence, but no systematic study has examined its effect on diabetes-associated ED.",ulmoides Oliv,CHEMICAL,be used as traditional medicine for,male impotence,MENTAL_HEALTH
31467570,Serum superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels were markedly higher and serum malondialdehyde (MDA) levels were lower in the EULE-treated groups than in the diabetic model group.,serum malondialdehyde levels,CHEMICAL,be lower in,diabetic model group,DISEASE
23703920,"Based on the notion that extracellular adenosine signaling is terminated by uptake from the extracellular towards the intracellular compartment by way of equilibrative nucleoside transporters (ENTs), we hypothesized a functional role of ENTs in liver protection from ischemia.",extracellular adenosine signaling,CHEMICAL,be terminated by uptake from extracellular towards intracellular compartment by,equilibrative nucleoside transporters,CHEMICAL
23703920,Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion.,pharmacologic ENT inhibitor dipyridamole,CHEMICAL,reveal elevations of hepatic adenosine levels and robust liver protection in murine model of,liver ischemia,DISEASE
23703920,Treatment with the pharmacologic ENT inhibitor dipyridamole revealed elevations of hepatic adenosine levels and robust liver protection in a murine model of liver ischemia and reperfusion.,pharmacologic ENT inhibitor dipyridamole,CHEMICAL,reveal elevations of,hepatic adenosine levels,CHEMICAL
33845223,"Recent meta-analyses suggest that high eicosapentaenoic acid (EPA, 20:5n-3) supplements may be beneficial in managing the symptoms of major depression.",high acid EPA supplements,CHEMICAL,manage symptoms of,major depression,MENTAL_HEALTH
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,febrile disease,DISEASE
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,consumptive disease,DISEASE
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,thoracic obstruction,DISEASE
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,cholera,DISEASE
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,bellyache due spleen Qi deficiency,DISEASE
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat restlessness after,Yin-Yang toxin syndrome,CHEBI
30989964,"In addition to be used to treat light exterior wind-cold syndrome,Fistular Onion Stalk is also used extensively and uniquely to treat restlessness after cholera,febrile disease,thoracic obstruction,Yin-Yang toxin syndrome,consumptive disease,bellyache due to spleen Qi deficiency according to Zhouhou Beiji Fang.",Onion Stalk,NUTRITION,treat,restlessness,MENTAL_HEALTH
34962714,Romiplostim is a thrombopoietin receptor agonist that may be useful in the treatment of chemotherapy-induced thrombocytopenia (CIT).,Romiplostim,CHEMICAL,be,thrombopoietin receptor agonist,CHEBI
23694703,"The inadequacies of monoamine deficiency hypothesis, the emerging evidence of altered glutamate neurotransmission in mood disorders, as well as our previous studies inspired us to assess the potential role of glutamatergic system in the pathogenesis of juvenile depression.",mood disorders,MENTAL_HEALTH,assess potential role of glutamatergic system in pathogenesis of,juvenile depression,MENTAL_HEALTH
23694703,"The inadequacies of monoamine deficiency hypothesis, the emerging evidence of altered glutamate neurotransmission in mood disorders, as well as our previous studies inspired us to assess the potential role of glutamatergic system in the pathogenesis of juvenile depression.",altered glutamate neurotransmission,CHEMICAL,assess potential role of glutamatergic system in pathogenesis of,juvenile depression,MENTAL_HEALTH
23694703,"The inadequacies of monoamine deficiency hypothesis, the emerging evidence of altered glutamate neurotransmission in mood disorders, as well as our previous studies inspired us to assess the potential role of glutamatergic system in the pathogenesis of juvenile depression.",monoamine deficiency hypothesis,DISEASE,assess potential role of glutamatergic system in pathogenesis of,juvenile depression,MENTAL_HEALTH
23694703,"The inadequacies of monoamine deficiency hypothesis, the emerging evidence of altered glutamate neurotransmission in mood disorders, as well as our previous studies inspired us to assess the potential role of glutamatergic system in the pathogenesis of juvenile depression.",altered glutamate neurotransmission,CHEMICAL,have the emerging evidence in,mood disorders,MENTAL_HEALTH
23694703,We also detected that PS significantly altered the expression of glutamate receptor and glutamate transporters of these depressed rats.,PS,CHEMICAL,alter expression of glutamate receptor and glutamate transporters of,depressed rats,DISEASE
23694703,We also detected that PS significantly altered the expression of glutamate receptor and glutamate transporters of these depressed rats.,PS,CHEMICAL,alter expression of,glutamate receptor,CHEMICAL
23694703,We also detected that PS significantly altered the expression of glutamate receptor and glutamate transporters of these depressed rats.,PS,CHEMICAL,alter expression of,receptor glutamate transporters,CHEMICAL
18640689,There is evidence that increased inflammatory activity contributes to treatment non-response in depression and studies suggest that omega-3 fatty acid supplementation is effective in antidepressant non-responders.,omega-3 fatty acid supplementation,NUTRITION,be effective in,antidepressant,CHEMICAL
18640689,We tested the hypotheses that in major depression (1) the plasma omega-6:omega-3 fatty acid ratio is greater in antidepressant non-responders than responders and (2) higher omega-6:omega-3 ratios are associated with a pro-inflammatory cytokine profile.,plasma omega-6:omega-3 fatty acid ratio,NUTRITION,be greater in,antidepressant non-responders,CHEMICAL
18640689,We tested the hypotheses that in major depression (1) the plasma omega-6:omega-3 fatty acid ratio is greater in antidepressant non-responders than responders and (2) higher omega-6:omega-3 ratios are associated with a pro-inflammatory cytokine profile.,plasma omega-6:omega-3 fatty acid ratio,NUTRITION,be greater in,major depression,MENTAL_HEALTH
34474662,The current study examined dietary intakes of magnesium and vitamin B6 in relation to antisocial behavior and CU traits.,magnesium vitamin B6,CHEMICAL,have dietary intakes in,antisocial behavior,DISEASE
34474662,The current study examined dietary intakes of magnesium and vitamin B6 in relation to antisocial behavior and CU traits.,magnesium vitamin B6,CHEBI,have dietary intakes in,antisocial behavior,DISEASE
32841196,"The serotonin level in children with depression was 1,03 ± 0,37 μmol/L, and it was lower to compare with children without depression (1,30 ± 0,27 μmol/L) (95% CI, 0,15 - 0,39 μmol/L, p0,05).",depression,MENTAL_HEALTH,be,±,CHEMICAL
32841196,"The serotonin level in children with depression was 1,03 ± 0,37 μmol/L, and it was lower to compare with children without depression (1,30 ± 0,27 μmol/L) (95% CI, 0,15 - 0,39 μmol/L, p0,05).",serotonin level,CHEMICAL,be,±,CHEMICAL
32841196,"Low levels of serotonin were associated with a negative mood (95% CI, 0,02 - 0,30 μmol/L, p<0,02), anhedonia (95% CI, 0,11 - 0,36 μmol/L, p<0,0003).",serotonin,CHEMICAL,be associated with,μmol/L,CHEMICAL
32841196,"Low levels of serotonin were associated with a negative mood (95% CI, 0,02 - 0,30 μmol/L, p<0,02), anhedonia (95% CI, 0,11 - 0,36 μmol/L, p<0,0003).",serotonin,CHEMICAL,be associated with,anhedonia,MENTAL_HEALTH
32841196,"It was found the moderate and inverse correlation between serotonin and tryptophan in SD in children with depression (r = -0,342; 95% CI for r, -0,65 to -0,034, p<0,05).",serotonin,CHEMICAL,have inverse correlation with,tryptophan,NUTRITION
32841196,"It was found the moderate and inverse correlation between serotonin and tryptophan in SD in children with depression (r = -0,342; 95% CI for r, -0,65 to -0,034, p<0,05).",tryptophan,NUTRITION,have inverse correlation with,serotonin,CHEMICAL
32908661,"With increase in incidence of tick-borne diseases (TBDs), use of antibiotics for control of TBDs and other opportunistic diseases has raisedserious concerns.",antibiotics,CHEBI,have with increase in incidence of,diseases raisedserious concerns,DISEASE
32908661,"East Coast fever (ECF) was identified as the most common TBD in both regions, though cases of coinfection were more common in HARA.",Coast fever,DISEASE,be identified as,common TBD,CHEMICAL
32908661,Acaricide resistance and practice of reading drug use instructions were significantly associated with antibiotic residues in milk at farm level.,drug use,CHEBI,be associated with,antibiotic residues,CHEBI
32908661,Acaricide resistance and practice of reading drug use instructions were significantly associated with antibiotic residues in milk at farm level.,Acaricide resistance,CHEMICAL,be associated with,antibiotic residues,CHEBI
32908661,Acaricide resistance and practice of reading drug use instructions were significantly associated with antibiotic residues in milk at farm level.,Acaricide resistance,MENTAL_HEALTH,be associated with,antibiotic residues,CHEBI
22928360,"The physiological effect of caffeine and the lack of nutrition value causes a great interest its impact on health, especially with reference to the risk of cardiovascular diseases.",caffeine,CHEMICAL,cause,cardiovascular diseases,DISEASE
22928360,"Excessive caffeine consumption can cause negative health consequences such as psychomotor agitation, insomnia, headache, gastrointestinal complaints.",Excessive caffeine consumption,CHEMICAL,cause negative health consequences such as,gastrointestinal complaints,DISEASE
22928360,"Excessive caffeine consumption can cause negative health consequences such as psychomotor agitation, insomnia, headache, gastrointestinal complaints.",Excessive caffeine consumption,CHEMICAL,cause negative health consequences such as,headache,MENTAL_HEALTH
22928360,"Excessive caffeine consumption can cause negative health consequences such as psychomotor agitation, insomnia, headache, gastrointestinal complaints.",Excessive caffeine consumption,CHEMICAL,cause negative health consequences such as,psychomotor agitation,MENTAL_HEALTH
22928360,"Excessive caffeine consumption can cause negative health consequences such as psychomotor agitation, insomnia, headache, gastrointestinal complaints.",Excessive caffeine consumption,CHEMICAL,cause negative health consequences such as,insomnia,MENTAL_HEALTH
24651609,In vivo studies in rats showed that OEA and CC7 had anorectic and antiobesity activity and induced both lipopenia and decreases in hepatic fat content.,OEA,CHEMICAL,induce,lipopenia,DISEASE
24651609,"However, different effects were observed when measuring visceral pain; OEA produced visceral analgesia whereas CC7 showed no effects.",OEA,CHEMICAL,produce,visceral analgesia,MENTAL_HEALTH
24651609,"These results suggest that OEA activity on the PPARα receptor (e.g., lipid metabolism and feeding behavior) may be dissociated from other actions at alternative targets (e.g., pain) because other non cannabimimetic ligands that interact with PPARα, such as CC7, do not reproduce the full spectrum of the pharmacological activity of OEA.",OEA activity,CHEMICAL,be dissociated from other actions at,pain,DISEASE
28607752,"Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors.",AAP,CHEMICAL,antagonize,serotonin,CHEMICAL
28607752,"Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors.",AAP,CHEMICAL,antagonize,dopamine receptors,CHEMICAL
28607752,"Atypical antipsychotic agents (AAP) alleviate the symptoms of severe mental health disorders, such as schizophrenia, by antagonizing dopamine and serotonin receptors.",AAP,CHEMICAL,alleviate symptoms of,schizophrenia,MENTAL_HEALTH
29186931,"The mixture of bensulfuron-methyl and acetochlor (MBA) has been widely applied as a rice herbicide in China, but the mixture toxicity of MBA to aquatic organisms is largely unknown.",bensulfuron-methyl,CHEMICAL,be applied as,rice herbicide,CHEMICAL
29186931,"The mixture of bensulfuron-methyl and acetochlor (MBA) has been widely applied as a rice herbicide in China, but the mixture toxicity of MBA to aquatic organisms is largely unknown.",mixture,CHEBI,be applied as,rice herbicide,CHEMICAL
29186931,"The mixture of bensulfuron-methyl and acetochlor (MBA) has been widely applied as a rice herbicide in China, but the mixture toxicity of MBA to aquatic organisms is largely unknown.",acetochlor,CHEMICAL,be applied as,rice herbicide,CHEMICAL
29186931,"MBA-exposed crayfish showed body jerk, belly arch, equilibrium loss, body and appendage sway, and lethargy; and the dead crayfish showed dark gray or grayish-white body color and separated cephalothorax and abdomen.",MBA-exposed crayfish,CHEMICAL,show,lethargy,DISEASE
29186931,"MBA-exposed crayfish showed body jerk, belly arch, equilibrium loss, body and appendage sway, and lethargy; and the dead crayfish showed dark gray or grayish-white body color and separated cephalothorax and abdomen.",MBA-exposed crayfish,NUTRITION,show,lethargy,DISEASE
29186931,"Our results indicate that MBA can cause behavioral, morphological and histopathological effects on juvenile P. clarkii at relatively high concentrations, but its acute toxicity is low compared with many other common herbicides.",MBA,CHEMICAL,cause,juvenile P. clarkii,DISEASE
2715902,Patients with tuberculous meningitis were treated with isoniazid and rifampicin for 12 months.,tuberculous meningitis,DISEASE,be treated with,isoniazid,CHEMICAL
2715902,Patients with tuberculous meningitis were treated with isoniazid and rifampicin for 12 months.,tuberculous meningitis,DISEASE,be treated with,rifampicin,CHEMICAL
33388702,"Polyunsaturated fatty acids (PUFAs) and cytokines, two types of inflammatory biomarkers, have been associated with suicide, independent of depression severity.",PUFAs,CHEMICAL,be associated with suicide independent of,depression severity,MENTAL_HEALTH
33388702,"Polyunsaturated fatty acids (PUFAs) and cytokines, two types of inflammatory biomarkers, have been associated with suicide, independent of depression severity.",Polyunsaturated fatty acids,NUTRITION,be associated with suicide independent of,depression severity,MENTAL_HEALTH
24158519,The peroxisome proliferator-activated receptor (PPAR) δ regulates systemic lipid homeostasis and inflammation.,peroxisome proliferator-activated receptor PPAR δ,CHEBI,regulate,inflammation,DISEASE
24158519,"Here, we examine whether intervention with a selective PPARδ agonist corrects metabolic dysregulation and attenuates aortic inflammation and atherosclerosis.",selective PPARδ agonist,CHEBI,attenuate,aortic inflammation,DISEASE
24158519,"Here, we examine whether intervention with a selective PPARδ agonist corrects metabolic dysregulation and attenuates aortic inflammation and atherosclerosis.",selective PPARδ agonist,CHEBI,attenuate,atherosclerosis,DISEASE
22988930,Peroxisome-proliferator activated receptor (PPAR) agonists are insulin sensitizers that can restore hepatic insulin responsiveness in both alcohol and non-alcohol-related steatohepatitis.,Peroxisome-proliferator activated receptor agonists,CHEBI,be,insulin sensitizers,CHEBI
22988930,"Herein, we demonstrate that treatment with a PPAR-δ agonist enhances insulin signaling and reduces the severities of ER stress and ceramide accumulation in an experimental model of ethanol-induced steatohepatitis.",PPAR-δ agonist,CHEBI,reduce severities of er stress and ceramide accumulation in experimental model of,ethanol-induced steatohepatitis,DISEASE
18832428,This review investigated whether pindolol enhances the efficacy of serotonergic antidepressant treatment in adult patients with depressive disorders at sequential time points up to 6 weeks.,pindolol,CHEMICAL,enhance efficacy of serotonergic antidepressant treatment in adult patients with,depressive disorders,DISEASE
18832428,This review investigated whether pindolol enhances the efficacy of serotonergic antidepressant treatment in adult patients with depressive disorders at sequential time points up to 6 weeks.,pindolol,CHEMICAL,enhance efficacy of,serotonergic antidepressant treatment,CHEMICAL
18832428,This review investigated whether pindolol enhances the efficacy of serotonergic antidepressant treatment in adult patients with depressive disorders at sequential time points up to 6 weeks.,serotonergic antidepressant treatment,CHEMICAL,in adult patients with,depressive disorders,DISEASE
35329280,"Digital mental health services (DMHSs) have great potential for mitigating the mental health burden related to COVID-19, but public accessibility (ease of acquiring services when needed) to DMHSs during the pandemic is largely unknown.",DMHSs,CHEMICAL,mitigate mental health burden related to,COVID-19,CHEMICAL
35167282,"Naturally, the dissociation of Mg2+ from the MtbEF-Tu is facilitated by the nucleotide exchange factor EF-Ts, and this prior release of magnesium makes the dissociation process of destabilized GDP easy, similar to that observed in the umbrella sampling and SMD study.",Mg2,CHEMICAL,be facilitated by,nucleotide exchange factor EF-Ts,CHEMICAL
35167282,"Naturally, the dissociation of Mg2+ from the MtbEF-Tu is facilitated by the nucleotide exchange factor EF-Ts, and this prior release of magnesium makes the dissociation process of destabilized GDP easy, similar to that observed in the umbrella sampling and SMD study.",dissociation,MENTAL_HEALTH,be facilitated by,nucleotide exchange factor EF-Ts,CHEMICAL
35403701,"In this study, we show that ABA affects the Polycomb Repressive Complex 2 (PRC2)-mediated Histone H3 Lys 27 trimethylation (H3K27me3) through VIN3-LIKE1/VERNALIZATION 5 (VIL1/VRN5) to fine-tune the timely repression of ABSCISIC ACID INSENSITIVE 3 (ABI3) and ABSCISIC ACID INSENSITIVE 4 (ABI4) in Arabidopsis thaliana.",ABA,CHEMICAL,fine-tune,timely repression,MENTAL_HEALTH
21484883,"Pharmacological antagonism of the metabotropic glutamate receptors (mGluRs), in particular, the subtype mGluR5, can inhibit the expression of dyskinesia in both rodent and nonhuman primate models of PD.",metabotropic glutamate receptors,CHEMICAL,inhibit expression of,dyskinesia,MENTAL_HEALTH
21484883,"The administration of MPEP significantly attenuated LID and decreased the levels of VGlut2, but not the VGlut1, in the striatum ipsilateral to the lesion (P < 0.05).",MPEP,CHEMICAL,decrease levels of,VGlut2,CHEMICAL
21484883,"The administration of MPEP significantly attenuated LID and decreased the levels of VGlut2, but not the VGlut1, in the striatum ipsilateral to the lesion (P < 0.05).",MPEP,CHEMICAL,attenuate,LID,DISEASE
21484883,Our results suggest that the effects of MPEP on LID might be mediated by a modulating effect on VGlut 2 expression.,MPEP,CHEMICAL,have the effects on,LID,DISEASE
11701195,Central administration of norepinephrine (NE) suppressed food intake with narcolepsy as GLP-1 in chicks.,norepinephrine,CHEMICAL,suppress food intake with narcolepsy as,GLP-1,CHEMICAL
11701195,Central administration of norepinephrine (NE) suppressed food intake with narcolepsy as GLP-1 in chicks.,norepinephrine,CHEMICAL,suppress food intake with,narcolepsy,MENTAL_HEALTH
11701195,Central administration of norepinephrine (NE) suppressed food intake with narcolepsy as GLP-1 in chicks.,NE,CHEMICAL,suppress food intake with narcolepsy as,GLP-1,CHEMICAL
11701195,Central administration of norepinephrine (NE) suppressed food intake with narcolepsy as GLP-1 in chicks.,NE,CHEMICAL,suppress food intake with,narcolepsy,MENTAL_HEALTH
7795891,Narcolepsy is a neurological disorder known to be associated with human leukocyte antigen (HLA)-DQB1*0602 in humans.,Narcolepsy,MENTAL_HEALTH,be,neurological disorder,DISEASE
31579184,Ketamine is an N-methyl-D aspartate receptor antagonist having rapid action on depressive symptoms.,Ketamine,CHEMICAL,be,N-methyl-D aspartate receptor antagonist,CHEMICAL
31579184,Ketamine is an N-methyl-D aspartate receptor antagonist having rapid action on depressive symptoms.,Ketamine,CHEMICAL,be,N-methyl-D aspartate receptor antagonist,CHEBI
27188896,"Trans fatty acids in Western diets increase health risks, and have been associated with the risk of depression.",Trans fatty acids,NUTRITION,be associated with risk of,depression,MENTAL_HEALTH
27188896,"The associations between dietary intakes of fatty acids to positive and negative affect were tested with linear regression analysis controlling for age, gender, ethnicity, education, body mass index, exercise, sleep, sleep squared, Mediterranean diet, total energy intake and alcohol.",fatty acids,NUTRITION,be tested with,linear regression analysis,MENTAL_HEALTH
30797122,"In this study, we examined the associations of objectively-measured plasma TFA concentrations with depression in a large population-based cross-sectional study among U.S. adults.",objectively-measured plasma TFA concentrations,CHEMICAL,have the associations with,depression,MENTAL_HEALTH
34009025,"We previously reported that mature Bombyx mori silkworm (SW) ameliorated scopolamine (Sco)-induced amnesia, and Angelica gigas (AG) prevented cognitive impairment.",mature Bombyx mori silkworm,NUTRITION,ameliorate,scopolamine (Sco)-induced amnesia,MENTAL_HEALTH
34009025,"We previously reported that mature Bombyx mori silkworm (SW) ameliorated scopolamine (Sco)-induced amnesia, and Angelica gigas (AG) prevented cognitive impairment.",mature Bombyx mori silkworm,NUTRITION,ameliorate,scopolamine (Sco)-induced amnesia,CHEMICAL
34009025,"We previously reported that mature Bombyx mori silkworm (SW) ameliorated scopolamine (Sco)-induced amnesia, and Angelica gigas (AG) prevented cognitive impairment.",Angelica gigas,NUTRITION,prevent,cognitive impairment,DISEASE
34009025,SWA-1 also significantly reversed Sco-induced spatial learning and memory impairment.,SWA-1,CHEMICAL,reverse,learning impairment,DISEASE
34009025,Our results suggest that SWA-1 may be administered as alternative therapy for cognitive impairment and neurodegenerative diseases and should be studied further in human trials.,SWA-1,CHEMICAL,be administered as alternative therapy for,cognitive impairment,DISEASE
34009025,Our results suggest that SWA-1 may be administered as alternative therapy for cognitive impairment and neurodegenerative diseases and should be studied further in human trials.,SWA-1,CHEMICAL,be administered as alternative therapy for,neurodegenerative diseases,DISEASE
29153295,"The purpose of this study was to investigate the effect of a single intra-cutaneous injection of ropivacaine plus methylprednisolone on acute thoracic herpes zoster (HZ) pain intensity and duration, eruptive duration, and PHN incidence.",methylprednisolone,CHEMICAL,have a single intra-cutaneous injection on,acute thoracic herpes zoster,DISEASE
29153295,"The purpose of this study was to investigate the effect of a single intra-cutaneous injection of ropivacaine plus methylprednisolone on acute thoracic herpes zoster (HZ) pain intensity and duration, eruptive duration, and PHN incidence.",ropivacaine,CHEMICAL,have a single intra-cutaneous injection on,acute thoracic herpes zoster,DISEASE
29153295,"A total of 97 patients with acute thoracic HZ diagnosed 1-7 days after the onset of the rash were randomly assigned to receive either 15 mL of 37.5 mg ropivacaine plus 40 mg methylprednisolone (active group, n = 49) or 15 mL of saline (placebo group, n = 48).",acute thoracic HZ,DISEASE,diagnose,rash,DISEASE
29153295,Acetaminophen was used as a rescue analgesia when visual analog scale ≥4.,Acetaminophen,CHEMICAL,be used as,rescue analgesia,MENTAL_HEALTH
29153295,"Pain intensity was measured with visual analog scale and the amount of analgesic taken was evaluated at the initial visit and at weeks 1, 4, 12, and 24 after the intra-cutaneous injection.",Pain intensity,DISEASE,be measured with visual analog scale and amount of,analgesic,CHEBI
33304720,Antihistamines are known risk factors for restless legs syndrome (RLS).,Antihistamines,CHEBI,be known risk factors for,restless legs syndrome,DISEASE
34100089,"However, transgenic poplars with dominant suppression of PtrMYB120 function achieved by fusing the ERF-associated amphiphilic repression motif to PtrMYB120 (i.e., 35S::PtrMYB120-SRDX) had a dramatic decrease in not only anthocyanin but also Klason lignin content with downregulation of both anthocyanin and lignin biosynthetic genes.",PtrMYB120 function,CHEMICAL,have dramatic decrease in anthocyanin and klason lignin content with downregulation of,anthocyanin biosynthetic genes,NUTRITION
34100089,"However, transgenic poplars with dominant suppression of PtrMYB120 function achieved by fusing the ERF-associated amphiphilic repression motif to PtrMYB120 (i.e., 35S::PtrMYB120-SRDX) had a dramatic decrease in not only anthocyanin but also Klason lignin content with downregulation of both anthocyanin and lignin biosynthetic genes.",PtrMYB120 function,CHEMICAL,have dramatic decrease in anthocyanin and klason lignin content with downregulation of,lignin,CHEMICAL
34100089,"However, transgenic poplars with dominant suppression of PtrMYB120 function achieved by fusing the ERF-associated amphiphilic repression motif to PtrMYB120 (i.e., 35S::PtrMYB120-SRDX) had a dramatic decrease in not only anthocyanin but also Klason lignin content with downregulation of both anthocyanin and lignin biosynthetic genes.",PtrMYB120 function,CHEMICAL,have dramatic decrease in,anthocyanin lignin content,CHEMICAL
34100089,"However, transgenic poplars with dominant suppression of PtrMYB120 function achieved by fusing the ERF-associated amphiphilic repression motif to PtrMYB120 (i.e., 35S::PtrMYB120-SRDX) had a dramatic decrease in not only anthocyanin but also Klason lignin content with downregulation of both anthocyanin and lignin biosynthetic genes.",PtrMYB120 function,CHEMICAL,have dramatic decrease in,anthocyanin lignin content,NUTRITION
34999507,"Furthermore, PpWRKY46 interacted with PpWRKY53 to attenuate the transcriptional repression of PpWRKY53 to PpSDH and PpCOX15.",PpWRKY46,CHEMICAL,attenuate,transcriptional repression,MENTAL_HEALTH
31437433,Cannabidiol (CBD) is a U.S. FDA-approved cannabinoid for the treatment of epilepsy and recently was reported to have therapeutic potential for other disorders.,Cannabidiol,CHEMICAL,be fda-approved cannabinoid for treatment of,epilepsy,DISEASE
31437433,Cannabidiol (CBD) is a U.S. FDA-approved cannabinoid for the treatment of epilepsy and recently was reported to have therapeutic potential for other disorders.,CBD,CHEMICAL,be fda-approved cannabinoid for treatment of,epilepsy,DISEASE
31437433,"In vivo microdialysis indicated that pretreatment with CBD (10-20 mg/kg) attenuated cocaine-induced increases in extracellular dopamine (DA) in the nucleus accumbens, while CBD alone failed to alter extracellular DA.",CBD,CHEMICAL,attenuate cocaine-induced increases in,DA,CHEMICAL
31437433,"In vivo microdialysis indicated that pretreatment with CBD (10-20 mg/kg) attenuated cocaine-induced increases in extracellular dopamine (DA) in the nucleus accumbens, while CBD alone failed to alter extracellular DA.",CBD,CHEMICAL,attenuate cocaine-induced increases in,extracellular dopamine,CHEMICAL
31437433,"In vivo microdialysis indicated that pretreatment with CBD (10-20 mg/kg) attenuated cocaine-induced increases in extracellular dopamine (DA) in the nucleus accumbens, while CBD alone failed to alter extracellular DA.",CBD,CHEMICAL,attenuate,cocaine-induced increases,DISEASE
33968518,Prucalopride is a selective serotonin receptor agonist that can be used to treat chronic constipation.,Prucalopride,CHEMICAL,be,selective serotonin    receptor agonist,CHEMICAL
33968518,Prucalopride is a selective serotonin receptor agonist that can be used to treat chronic constipation.,Prucalopride,CHEMICAL,be,selective serotonin    receptor agonist,CHEBI
33968518,"In two four-week trials, prucalopride showed improvement in gastric emptying and the gastroparesis cardinal symptom index over placebo, with a 1-4 mg/day dosage.",prucalopride,CHEMICAL,show in four-week trials improvement in,gastroparesis,DISEASE
33968518,Further long-term and comparative data would be beneficial to show that prucalopride can be an advantageous treatment option for patients with chronic idiopathic constipation (CIC) or gastroparesis.,prucalopride,CHEMICAL,be advantageous treatment option for patients with,chronic idiopathic constipation,DISEASE
33968518,Further long-term and comparative data would be beneficial to show that prucalopride can be an advantageous treatment option for patients with chronic idiopathic constipation (CIC) or gastroparesis.,prucalopride,CHEMICAL,be advantageous treatment option for patients with,gastroparesis,DISEASE
33968518,Further long-term and comparative data would be beneficial to show that prucalopride can be an advantageous treatment option for patients with chronic idiopathic constipation (CIC) or gastroparesis.,prucalopride,CHEMICAL,be advantageous treatment option for patients with,CIC,DISEASE
33793809,The purpose of this study was to estimate the ability of antimalarial medications to induce local infiltration analgesia.,antimalarial medications,CHEBI,have the ability to,local infiltration analgesia,MENTAL_HEALTH
11145003,"Severe falciparum malaria, with its associated hyperpyrexia, distorts plasma levels of large neutral amino acids (NAA) and consequently, brain uptake of individual NAA.",associated hyperpyrexia,DISEASE,distort plasma levels of,NAA,CHEMICAL
11145003,"Severe falciparum malaria, with its associated hyperpyrexia, distorts plasma levels of large neutral amino acids (NAA) and consequently, brain uptake of individual NAA.",associated hyperpyrexia,DISEASE,distort plasma levels of,individual NAA,CHEMICAL
11145003,"Severe falciparum malaria, with its associated hyperpyrexia, distorts plasma levels of large neutral amino acids (NAA) and consequently, brain uptake of individual NAA.",associated hyperpyrexia,DISEASE,distort plasma levels of,acids brain uptake,CHEMICAL
11145003,"Since brain levels of NAA determine cerebral synthesis of monoamines (serotonin, histamine, catecholamines), we measured plasma concentrations of NAA, and also plasma histamine (Hm) in children with falciparum malaria and in uninfected controls.",NAA,CHEMICAL,determine cerebral synthesis of,histamine,CHEMICAL
11145003,"Since brain levels of NAA determine cerebral synthesis of monoamines (serotonin, histamine, catecholamines), we measured plasma concentrations of NAA, and also plasma histamine (Hm) in children with falciparum malaria and in uninfected controls.",NAA,CHEMICAL,determine cerebral synthesis of,serotonin,CHEMICAL
11145003,"Since brain levels of NAA determine cerebral synthesis of monoamines (serotonin, histamine, catecholamines), we measured plasma concentrations of NAA, and also plasma histamine (Hm) in children with falciparum malaria and in uninfected controls.",NAA,CHEMICAL,determine cerebral synthesis of,monoamines,CHEMICAL
11145003,"Since brain levels of NAA determine cerebral synthesis of monoamines (serotonin, histamine, catecholamines), we measured plasma concentrations of NAA, and also plasma histamine (Hm) in children with falciparum malaria and in uninfected controls.",NAA,CHEMICAL,determine cerebral synthesis of,catecholamines,CHEMICAL
21679091,Its sodium salt (sodium oxybate: SXB) was approved by the Food and Drug Administration (FDA) for the treatment of narcolepsy.,sodium oxybate,CHEMICAL,be approved by,narcolepsy,MENTAL_HEALTH
21679091,Its sodium salt (sodium oxybate: SXB) was approved by the Food and Drug Administration (FDA) for the treatment of narcolepsy.,sodium oxybate,CHEMICAL,be approved by,Drug,CHEBI
21679091,Its sodium salt (sodium oxybate: SXB) was approved by the Food and Drug Administration (FDA) for the treatment of narcolepsy.,sodium salt,CHEMICAL,be approved by,narcolepsy,MENTAL_HEALTH
21679091,Its sodium salt (sodium oxybate: SXB) was approved by the Food and Drug Administration (FDA) for the treatment of narcolepsy.,sodium salt,CHEMICAL,be approved by,Drug,CHEBI
21679091,SXB has shown to improve disrupted sleep and increase NR3 (slow-wave restorative) sleep in patients with narcolepsy.,SXB,CHEMICAL,increase,narcolepsy,MENTAL_HEALTH
17140279,"Furthermore, multiple measures of daytime sleepiness and cataplexy demonstrated consistent short- and long-term improvement in response to night-time sodium oxybate therapy.",daytime sleepiness,MENTAL_HEALTH,demonstrate consistent short- and long-term improvement in response to,night-time sodium oxybate therapy,CHEMICAL
17140279,"Furthermore, multiple measures of daytime sleepiness and cataplexy demonstrated consistent short- and long-term improvement in response to night-time sodium oxybate therapy.",cataplexy,MENTAL_HEALTH,demonstrate consistent short- and long-term improvement in response to,night-time sodium oxybate therapy,CHEMICAL
34824327,"The serum As, Cd, Pb, and Hg levels increased and the serum glutathione (GSH) and superoxide dismutase (SOD) levels diminished significantly in the PCOS group compared to the control group at P < 0.001.",serum glutathione levels,CHEMICAL,diminish in,PCOS group,DISEASE
34824327,"Additionally, the PCOS group exhibited a strong negative correlation between the GSH and As levels (P < 0.01), GSH and Pb levels (P < 0.05) and GSH and Hg levels (P < 0.01).",PCOS group,DISEASE,exhibit strong negative correlation between gsh and as,GSH,CHEMICAL
34824327,"Additionally, the PCOS group exhibited a strong negative correlation between the GSH and As levels (P < 0.01), GSH and Pb levels (P < 0.05) and GSH and Hg levels (P < 0.01).",PCOS group,DISEASE,exhibit strong negative correlation between gsh and as,Pb,CHEMICAL
34824327,"Additionally, the PCOS group exhibited a strong negative correlation between the GSH and As levels (P < 0.01), GSH and Pb levels (P < 0.05) and GSH and Hg levels (P < 0.01).",PCOS group,DISEASE,exhibit strong negative correlation between gsh and as,Hg levels,CHEMICAL
34824327,"Additionally, the PCOS group exhibited a strong negative correlation between the GSH and As levels (P < 0.01), GSH and Pb levels (P < 0.05) and GSH and Hg levels (P < 0.01).",PCOS group,DISEASE,exhibit strong negative correlation between,GSH,CHEMICAL
15337753,The stimulation of lipolysis by beta-adrenergic agonists triggers rapid phosphorylation of perilipin and translocation of hormone-sensitive lipase to the surfaces of lipid droplets and more gradual fragmentation and dispersion of micro-lipid droplets.,beta-adrenergic agonists,CHEBI,trigger rapid phosphorylation of perilipin and translocation of hormone-sensitive lipase to surfaces of,gradual fragmentation,MENTAL_HEALTH
15337753,The stimulation of lipolysis by beta-adrenergic agonists triggers rapid phosphorylation of perilipin and translocation of hormone-sensitive lipase to the surfaces of lipid droplets and more gradual fragmentation and dispersion of micro-lipid droplets.,beta-adrenergic agonists,CHEBI,trigger rapid phosphorylation of perilipin and translocation of hormone-sensitive lipase to surfaces of,micro-lipid droplets,DISEASE
15337753,The stimulation of lipolysis by beta-adrenergic agonists triggers rapid phosphorylation of perilipin and translocation of hormone-sensitive lipase to the surfaces of lipid droplets and more gradual fragmentation and dispersion of micro-lipid droplets.,beta-adrenergic agonists,CHEBI,trigger rapid phosphorylation of perilipin and translocation of,hormone-sensitive lipase,DISEASE
20629126,"The imaging, neuropsychological and olfactory markers suggest the GD phenotype includes PD with and without features of DLB, marked olfactory loss, nigral hyperechogenicity on TCS, and F-dopa and FDG PET abnormalities.",GD phenotype,CHEMICAL,include pd with and without features of,FDG,CHEMICAL
20629126,"The imaging, neuropsychological and olfactory markers suggest the GD phenotype includes PD with and without features of DLB, marked olfactory loss, nigral hyperechogenicity on TCS, and F-dopa and FDG PET abnormalities.",GD phenotype,CHEMICAL,include pd with and without features of,DLB abnormalities,DISEASE
20629126,"The imaging, neuropsychological and olfactory markers suggest the GD phenotype includes PD with and without features of DLB, marked olfactory loss, nigral hyperechogenicity on TCS, and F-dopa and FDG PET abnormalities.",GD phenotype,CHEMICAL,include pd with and without features of,marked olfactory loss,DISEASE
32167970,Chronic kidney disease (CKD) with tubular injury and fibrosis occurs in HIV infection treated with certain protease inhibitor-based antiretroviral therapies.,tubular injury,DISEASE,occur in,HIV infection,DISEASE
32167970,Chronic kidney disease (CKD) with tubular injury and fibrosis occurs in HIV infection treated with certain protease inhibitor-based antiretroviral therapies.,Chronic kidney disease,DISEASE,occur in,HIV infection,DISEASE
32167970,Chronic kidney disease (CKD) with tubular injury and fibrosis occurs in HIV infection treated with certain protease inhibitor-based antiretroviral therapies.,fibrosis,DISEASE,occur in,HIV infection,DISEASE
26912411,"Finally, lopinavir/ritonavir caused significant increases in expression of markers of brain inflammation and decreases in synaptic markers in WT, but not in ADTg mice.",lopinavir/ritonavir,CHEMICAL,cause significant increases in expression of markers of,brain inflammation,DISEASE
18417989,Some studies of children with Down syndrome have found mild abnormalities in the metabolism of pyridoxine (vitamin B(6)); therefore the present question is whether such abnormalities might also be present in the amniotic fluid of fetuses with Down syndrome.,Down syndrome,MENTAL_HEALTH,find mild abnormalities in metabolism of,vitamin,CHEBI
18417989,Some studies of children with Down syndrome have found mild abnormalities in the metabolism of pyridoxine (vitamin B(6)); therefore the present question is whether such abnormalities might also be present in the amniotic fluid of fetuses with Down syndrome.,Down syndrome,MENTAL_HEALTH,find mild abnormalities in metabolism of,pyridoxine,CHEBI
32801080,The antioxidative defense mechanism was also boosted up via enhanced content of total phenolics and carotenoids.,antioxidative defense mechanism,MENTAL_HEALTH,be boosted via enhanced content of,carotenoids,CHEBI
32098385,"The results revealed that exogenous application of NO and H2O2 was effective in increasing the tolerance of wheat plants under drought stress in terms of growth and grain yield by regulating plant-water relations, the antioxidative defense mechanism, and accumulation of osmolytes, and by reducing the membrane lipid peroxidation.",H2O2,CHEMICAL,increase tolerance of wheat plants under drought stress in,growth grain yield,DISEASE
32098385,"The results revealed that exogenous application of NO and H2O2 was effective in increasing the tolerance of wheat plants under drought stress in terms of growth and grain yield by regulating plant-water relations, the antioxidative defense mechanism, and accumulation of osmolytes, and by reducing the membrane lipid peroxidation.",H2O2,CHEMICAL,increase tolerance of,wheat plants,NUTRITION
32098385,"The results revealed that exogenous application of NO and H2O2 was effective in increasing the tolerance of wheat plants under drought stress in terms of growth and grain yield by regulating plant-water relations, the antioxidative defense mechanism, and accumulation of osmolytes, and by reducing the membrane lipid peroxidation.",NO,CHEMICAL,increase tolerance of wheat plants under drought stress in,growth grain yield,DISEASE
32098385,"The results revealed that exogenous application of NO and H2O2 was effective in increasing the tolerance of wheat plants under drought stress in terms of growth and grain yield by regulating plant-water relations, the antioxidative defense mechanism, and accumulation of osmolytes, and by reducing the membrane lipid peroxidation.",NO,CHEMICAL,increase tolerance of,wheat plants,NUTRITION
29154107,"Aripiprazole is a dopamine D2- and serotonin 5-hydroxytryptamine (5-HT)1A receptor partial agonist and 5-HT2A receptor antagonist primarily used for the treatment of schizophrenia, bipolar disorder or depression with psychotic ideation.",Aripiprazole,CHEMICAL,used for treatment of,schizophrenia,MENTAL_HEALTH
29154107,"Aripiprazole is a dopamine D2- and serotonin 5-hydroxytryptamine (5-HT)1A receptor partial agonist and 5-HT2A receptor antagonist primarily used for the treatment of schizophrenia, bipolar disorder or depression with psychotic ideation.",Aripiprazole,CHEMICAL,used for treatment of,psychotic ideation,DISEASE
29154107,"Aripiprazole is a dopamine D2- and serotonin 5-hydroxytryptamine (5-HT)1A receptor partial agonist and 5-HT2A receptor antagonist primarily used for the treatment of schizophrenia, bipolar disorder or depression with psychotic ideation.",Aripiprazole,CHEMICAL,used for treatment of,depression,MENTAL_HEALTH
29154107,"Aripiprazole is a dopamine D2- and serotonin 5-hydroxytryptamine (5-HT)1A receptor partial agonist and 5-HT2A receptor antagonist primarily used for the treatment of schizophrenia, bipolar disorder or depression with psychotic ideation.",Aripiprazole,CHEMICAL,used for treatment of,bipolar disorder,MENTAL_HEALTH
29154107,"As a consequence, aripiprazole had been registered by Food and Drug Administration (FDA) for the treatment of tics and represents new therapeutic option in treatment of GTS.",aripiprazole,CHEMICAL,be registered as consequence by,Drug,CHEBI
34830098,The evolution of resistance in Salmonella to fluoroquinolones (FQs) under a broad range of sub-inhibitory concentrations (sub-MICs) has not been systematically studied.,resistance,MENTAL_HEALTH,have the evolution in,fluoroquinolones,CHEMICAL
34830098,It was shown that the resistance rate and resistance level of S. Enteritidis varied with the increase in ENR concentration and duration of selection.,resistance level,MENTAL_HEALTH,vary with increase in,ENR concentration,CHEMICAL
34830098,It was shown that the resistance rate and resistance level of S. Enteritidis varied with the increase in ENR concentration and duration of selection.,resistance rate,MENTAL_HEALTH,vary with increase in,ENR concentration,CHEMICAL
34830098,It was shown that the resistance rate and resistance level of S. Enteritidis varied with the increase in ENR concentration and duration of selection.,S. Enteritidis,DISEASE,vary with increase in,ENR concentration,CHEMICAL
34830098,"qRT-PCR results demonstrated that the expression of outer membrane porin (OMP) genes, ompC, ompD and ompF, were down-regulated first to rapidly adapt and develop the resistance of 4×MIC, and as the resistance level increased (≥8×MIC), the up-regulated expression of efflux pump genes, acrB, emrB amd mdfA, along with mutations in quinolone resistance-determining region (QRDR) gradually played a decisive role.",outer membrane porin OMP genes,CHEMICAL,develop,resistance,MENTAL_HEALTH
7876406,"The most frequently reported adverse events after CI-977 administration were dizziness, fatigue, paresthesia, headache, vasodilatation (facial flushing), emotional lability, high feeling, and abnormal thinking.",CI-977 administration,CHEMICAL,be,dizziness,DISEASE
30094087,"The major public health significances of antimicrobial residues include the development of antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, bone marrow depression, and disruption of normal intestinal flora.",antimicrobial residues,CHEBI,include development of,antimicrobial drug resistance,MENTAL_HEALTH
30094087,"The major public health significances of antimicrobial residues include the development of antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, bone marrow depression, and disruption of normal intestinal flora.",antimicrobial residues,CHEBI,include development of,bone marrow depression,DISEASE
30094087,"The major public health significances of antimicrobial residues include the development of antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, bone marrow depression, and disruption of normal intestinal flora.",antimicrobial residues,CHEBI,include development of,antimicrobial drug resistance,CHEBI
30094087,"The major public health significances of antimicrobial residues include the development of antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, bone marrow depression, and disruption of normal intestinal flora.",antimicrobial residues,CHEBI,include development of,bone marrow depression,MENTAL_HEALTH
30094087,"The major public health significances of antimicrobial residues include the development of antimicrobial drug resistance, hypersensitivity reaction, carcinogenicity, mutagenicity, teratogenicity, bone marrow depression, and disruption of normal intestinal flora.",antimicrobial residues,CHEBI,include development of,hypersensitivity reaction,DISEASE
29242704,"Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells.",Co-trimoxazole,CHEMICAL,cause dose-dependent depression of serum thyroxine levels with,hypertrophy,DISEASE
29242704,"Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells.",Co-trimoxazole,CHEMICAL,cause dose-dependent depression of serum thyroxine levels with,hyperplasia,DISEASE
29242704,"Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells.",Co-trimoxazole,CHEMICAL,cause dose-dependent depression of serum thyroxine levels with,intrafollicular hemorrhage,DISEASE
29242704,"Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells.",Co-trimoxazole,CHEMICAL,cause dose-dependent depression of,serum thyroxine levels,CHEMICAL
29242704,"Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells.",Co-trimoxazole,CHEMICAL,cause,dose-dependent depression,MENTAL_HEALTH
29242704,The study revealed that thyroid hemorrhage and lowered epididymal sperm reserve were new findings in co-trimoxazole toxicity in dogs.,thyroid hemorrhage,DISEASE,be new findings in,co-trimoxazole toxicity,CHEMICAL
26964715,"KETO, on the other hand, completely inhibited depression, anorexia and fever.",KETO,CHEMICAL,inhibit on,fever,DISEASE
26964715,"KETO, on the other hand, completely inhibited depression, anorexia and fever.",KETO,CHEMICAL,inhibit on,other hand depression,MENTAL_HEALTH
26964715,"KETO, on the other hand, completely inhibited depression, anorexia and fever.",KETO,CHEMICAL,inhibit on,anorexia,DISEASE
26964715,"This remarkable influence was associated with a significant reduction of PGE2 synthesis by KETO, while the effect on TNF-α, IL-6 and SAA was not straightforward.",KETO,CHEMICAL,have a significant reduction of,PGE2 synthesis,CHEMICAL
11334868,We further examined the effect of this agonist on the hypersensitivity of the flexor reflex induced by intraplantar injection of Freund's adjuvant.,agonist,CHEBI,have the effect on,hypersensitivity,DISEASE
11731107,"Noxious electrical shock, pinch and heat stimuli evoked a mean response of 20.8+/-2.5 (n=10, P<0.005), 30.1+/-5.4 (n=58, P<0.005) and 40.9+/-6.3 (n=29, P<0.005) spikes per stimulus respectively.",Noxious electrical shock,DISEASE,evoke mean response of,30.1+/-5.4,CHEMICAL
11731107,"Noxious electrical shock, pinch and heat stimuli evoked a mean response of 20.8+/-2.5 (n=10, P<0.005), 30.1+/-5.4 (n=58, P<0.005) and 40.9+/-6.3 (n=29, P<0.005) spikes per stimulus respectively.",Noxious electrical shock,DISEASE,evoke mean response of,n=58,CHEMICAL
23889005,"Recently, prucalopride, a highly selective 5-HT4 receptor agonist has been shown to improve the symptoms of chronic constipation and to have a beneficial effect on social and healthcare impact.",selective 5-HT4 receptor agonist,CHEBI,improve symptoms of,chronic constipation,DISEASE
23889005,"Recently, prucalopride, a highly selective 5-HT4 receptor agonist has been shown to improve the symptoms of chronic constipation and to have a beneficial effect on social and healthcare impact.",prucalopride,CHEMICAL,improve symptoms of,chronic constipation,DISEASE
23889005,"The drug was approved by the European Medicine Agency, in 2009 at a dose of 2 mg/day, 'for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief'.",drug,CHEBI,be approved by european medicine agency in 2009 at dose of,chronic constipation,DISEASE
20816418,"In addition, intake of alcohol, caffeine withdrawal, skipping meals, and possibly dehydration may trigger migraine and TTH in some patients.",caffeine withdrawal,CHEMICAL,trigger in,TTH,DISEASE
20816418,"In addition, intake of alcohol, caffeine withdrawal, skipping meals, and possibly dehydration may trigger migraine and TTH in some patients.",caffeine withdrawal,CHEMICAL,trigger in,addition migraine,DISEASE
20816418,"In addition, intake of alcohol, caffeine withdrawal, skipping meals, and possibly dehydration may trigger migraine and TTH in some patients.",alcohol,CHEMICAL,trigger in,TTH,DISEASE
20816418,"In addition, intake of alcohol, caffeine withdrawal, skipping meals, and possibly dehydration may trigger migraine and TTH in some patients.",alcohol,CHEMICAL,trigger in,addition migraine,DISEASE
20816418,Scientific evidence is lacking that any other food or food additive plays a relevant role as a trigger factor of headaches.,other food additive,NUTRITION,play relevant role as trigger factor of,headaches,DISEASE
35609060,"The LCA model identified 4 comorbidity classes-""relatively healthy"" class with 31% of the patients, ""medically-comorbid with SUD"" class with 15% of the patients, ""substance use disorder (SUD)"" class with 39%, and ""Medically comorbid"" class with 15% of the patients.",LCA model,CHEMICAL,identify,SUD,DISEASE
28939187,"In this study, we aim to systematically investigate the ameliorative effects of dopamine D1-like receptor agonist SKF38393 on cognitive dysfunction and explore its underlying mechanisms.",dopamine D1-like receptor agonist,CHEMICAL,have the ameliorative effects on,cognitive dysfunction,DISEASE
28939187,"In this study, we aim to systematically investigate the ameliorative effects of dopamine D1-like receptor agonist SKF38393 on cognitive dysfunction and explore its underlying mechanisms.",agonist SKF38393,CHEMICAL,have the ameliorative effects on,cognitive dysfunction,DISEASE
28939187,"In this study, we aim to systematically investigate the ameliorative effects of dopamine D1-like receptor agonist SKF38393 on cognitive dysfunction and explore its underlying mechanisms.",agonist SKF38393,CHEBI,have the ameliorative effects on,cognitive dysfunction,DISEASE
28939187,The Aβ1-42 was injected intracerebroventricularly to establish cognitive disorder model.,Aβ1,CHEMICAL,establish,cognitive disorder model,MENTAL_HEALTH
28939187,"These results indicated that SKF38393 could ameliorate Aβ1-42-induced cognitive dysfunction in mice, which may be related to D1 receptor activation.",SKF38393,CHEMICAL,ameliorate,42-induced cognitive dysfunction,DISEASE
28939187,Our findings suggest that dopamine D1-like receptor may be a potential target for the treatment of AD and its agonists may become a novel drug in the future.,dopamine D1-like receptor,CHEMICAL,be potential target for treatment of,agonists,CHEBI
26935863,"Since, exenatide improves cognitive ability in STZ/NA-induced diabetic mice and activates molecular mechanisms of memory storage in response to a learning experience, it may be a candidate for alleviation of mood and cognitive disorder.",exenatide,CHEMICAL,improve cognitive ability in,STZ/NA-induced diabetic mice,DISEASE
33479273,"Clozapine (CLZ), the sole antipsychotic with superior efficacy for ultra-treatment resistant schizophrenia (TRS), is limited by adverse effects, including metabolic dysregulation.",Clozapine,CHEMICAL,be limited by,metabolic dysregulation,DISEASE
33479273,"Clozapine (CLZ), the sole antipsychotic with superior efficacy for ultra-treatment resistant schizophrenia (TRS), is limited by adverse effects, including metabolic dysregulation.",CLZ,CHEMICAL,be limited by,metabolic dysregulation,DISEASE
33479273,"Clozapine (CLZ), the sole antipsychotic with superior efficacy for ultra-treatment resistant schizophrenia (TRS), is limited by adverse effects, including metabolic dysregulation.",ultra-treatment resistant schizophrenia,MENTAL_HEALTH,be limited by,metabolic dysregulation,DISEASE
33479273,"Clozapine's main metabolite, N-desmethylclozapine (NDMC), has potent 5-HT2C antagonist properties which may explain this metabolic dysfunction, thus the CLZ:NDMC ratio is of particular interest.",N-desmethylclozapine,CHEMICAL,have,CLZ,CHEMICAL
33479273,"Clozapine's main metabolite, N-desmethylclozapine (NDMC), has potent 5-HT2C antagonist properties which may explain this metabolic dysfunction, thus the CLZ:NDMC ratio is of particular interest.",N-desmethylclozapine,CHEMICAL,have,potent 5-HT2C antagonist properties,CHEBI
27710762,"Illicit drug use, in particular, has been associated with acute agitation, and questions can be raised as to what lasting effects drug use prior to admission may have throughout a patient's hospital stay.",drug use,CHEBI,be associated with,acute agitation,MENTAL_HEALTH
26725721,Elevated cortisol secretion has been positively linked with symptom severity in people with psychosis.,Elevated cortisol secretion,CHEMICAL,be linked with symptom severity in people with,psychosis,MENTAL_HEALTH
29201206,"The application of alprostadil combined with calcium dobesilate in patients with diabetic nephropathy can effectively relieve clinical symptoms, improve renal functions, reduce blood levels small proteins, alleviate the inflammatory response, and regulate the levels of BDNF and IGF-1, thus improving the clinical treatment effect.",calcium dobesilate,CHEMICAL,in patients with,diabetic nephropathy,DISEASE
28915355,"Thiamin deficiency leads to brain dysfunction because thiamin is involved in the synthesis of myelin and neurotransmitters (e.g., acetylcholine, γ-aminobutyric acid, glutamate), and its deficiency increases oxidative stress by decreasing the production of reducing agents.",thiamin,CHEMICAL,be involved in synthesis of,acetylcholine,CHEMICAL
28915355,"Thiamin deficiency leads to brain dysfunction because thiamin is involved in the synthesis of myelin and neurotransmitters (e.g., acetylcholine, γ-aminobutyric acid, glutamate), and its deficiency increases oxidative stress by decreasing the production of reducing agents.",thiamin,CHEMICAL,be involved in synthesis of,glutamate,CHEMICAL
28915355,"Thiamin deficiency leads to brain dysfunction because thiamin is involved in the synthesis of myelin and neurotransmitters (e.g., acetylcholine, γ-aminobutyric acid, glutamate), and its deficiency increases oxidative stress by decreasing the production of reducing agents.",Thiamin deficiency,CHEMICAL,lead to,brain dysfunction,DISEASE
28915355,"Similarly, in-utero exposure to alcohol leads to fetal brain dysfunction, resulting in negative effects such as fetal alcohol spectrum disorder (FASD).",alcohol,CHEMICAL,lead to,fetal brain dysfunction,DISEASE
28915355,"Similarly, in-utero exposure to alcohol leads to fetal brain dysfunction, resulting in negative effects such as fetal alcohol spectrum disorder (FASD).",alcohol,CHEMICAL,result in negative effects such as,fetal alcohol spectrum disorder,MENTAL_HEALTH
28131994,"Linalool might act not only as a direct antibacterial agent, but also as a signal molecule involved in triggering a non-host resistance response against Xcc.",Linalool,CHEMICAL,act as,direct antibacterial agent,CHEBI
2211549,"The presentation of these cases, as well as research evidence indicating that estrogens influence dopamine receptor function, leads the authors to hypothesize that dopamine receptor supersensitivity may have been induced by prepartum increases in endogenous estrogens and unmasked by postpartum estrogen withdrawal.",dopamine receptor supersensitivity,CHEMICAL,be induced by prepartum increases in,endogenous estrogens,CHEBI
2211549,"The presentation of these cases, as well as research evidence indicating that estrogens influence dopamine receptor function, leads the authors to hypothesize that dopamine receptor supersensitivity may have been induced by prepartum increases in endogenous estrogens and unmasked by postpartum estrogen withdrawal.",estrogens,CHEBI,influence,dopamine receptor function,CHEMICAL
27455455,"Optimal fixation for frozen sections was achieved by freezing the cephalothorax with liquid nitrogen, followed by fixation of the section with 60% isopropanol.",Optimal fixation,MENTAL_HEALTH,be achieved followed by fixation of section with,% isopropanol,CHEMICAL
27455455,"Optimal fixation for frozen sections was achieved by freezing the cephalothorax with liquid nitrogen, followed by fixation of the section with 60% isopropanol.",Optimal fixation,MENTAL_HEALTH,be achieved followed by,fixation,MENTAL_HEALTH
25959066,"Here, we determined if a single paradigm of amphetamine sensitization would be sufficient to produce both manic- and depressive-related behaviors in mice.",amphetamine sensitization,CHEMICAL,produce,manic- behaviors,DISEASE
35103387,"Therefore, we examined whether intakes of three B vitamins (folate, B12 , and B6 ) modified the association between PM2.5 exposure and incidence of all-cause dementia.",vitamins folate,NUTRITION,modify association between pm2.5 exposure and incidence of,all-cause dementia,MENTAL_HEALTH
35103387,"Therefore, we examined whether intakes of three B vitamins (folate, B12 , and B6 ) modified the association between PM2.5 exposure and incidence of all-cause dementia.",vitamins folate,CHEBI,modify association between pm2.5 exposure and incidence of,all-cause dementia,MENTAL_HEALTH
35276958,Disruptions in one-carbon metabolism and elevated homocysteine have been previously implicated in the development of dementia associated with Alzheimer's disease (AD) and Parkinson's disease (PD).,elevated homocysteine,CHEMICAL,be implicated in development of,dementia,MENTAL_HEALTH
34718372,"We have previously reported that the long-term exposure of Isocarbophos, a kind of organophosphorus compounds, induces vascular dementia (VD) in rats.",Isocarbophos,CHEMICAL,induce,vascular dementia,MENTAL_HEALTH
34718372,"However, whether S1P is involved in the therapeutic effects of Vitamin B6 on posterior cerebral artery injury has yet to be further answered.",S1P,CHEMICAL,be involved in therapeutic effects of vitamin b6 on,posterior cerebral artery injury,DISEASE
34718372,"However, whether S1P is involved in the therapeutic effects of Vitamin B6 on posterior cerebral artery injury has yet to be further answered.",S1P,CHEMICAL,be involved in therapeutic effects of,Vitamin B6,CHEBI
34718372,"However, whether S1P is involved in the therapeutic effects of Vitamin B6 on posterior cerebral artery injury has yet to be further answered.",Vitamin B6,CHEBI,have the therapeutic effects on,posterior cerebral artery injury,DISEASE
34718372,"In the present study, we aimed to explore the potential influence of Vitamin B6 on Isocarbophos-induced posterior cerebral artery injury in offspring rats and the role of the S1P receptor in this process.",Vitamin B6,CHEBI,have the potential influence on,Isocarbophos-induced posterior cerebral artery injury,DISEASE
34718372,"By performing immunofluorescence and the western blot assay, we revealed that Vitamin B6 prevents the down-regulation of S1P in posterior cerebral artery injury.",Vitamin B6,CHEBI,prevent down-regulation of s1p in,posterior cerebral artery injury,DISEASE
34718372,"By performing immunofluorescence and the western blot assay, we revealed that Vitamin B6 prevents the down-regulation of S1P in posterior cerebral artery injury.",Vitamin B6,CHEBI,prevent down-regulation of,S1P,CHEMICAL
34718372,"By performing immunofluorescence and the western blot assay, we revealed that Vitamin B6 prevents the down-regulation of S1P in posterior cerebral artery injury.",S1P,CHEMICAL,have the down-regulation in,posterior cerebral artery injury,DISEASE
34718372,"It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury.",Fingolimod,CHEMICAL,inhibit b6-induced up-regulation of s1p in,posterior cerebral artery injury,DISEASE
34718372,"It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury.",Fingolimod,CHEMICAL,inhibit b6-induced up-regulation of,S1P,CHEMICAL
34718372,"It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury.",S1P inhibitor,CHEMICAL,inhibit b6-induced up-regulation of s1p in,posterior cerebral artery injury,DISEASE
34718372,"It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury.",S1P inhibitor,CHEMICAL,inhibit b6-induced up-regulation of,S1P,CHEMICAL
34718372,"It is worth noting that Fingolimod, the S1P inhibitor, significantly inhibits the Vitamin B6-induced up-regulation of S1P in posterior cerebral artery injury.",S1P,CHEMICAL,have the vitamin b6-induced up-regulation in,posterior cerebral artery injury,DISEASE
34718372,"Collectively, our data indicate that Vitamin B6 may be a novel drug for the treatment of posterior cerebral artery injury and that S1P may be a drug target for its treatment.",S1P,CHEMICAL,be,drug target,CHEBI
34718372,"Collectively, our data indicate that Vitamin B6 may be a novel drug for the treatment of posterior cerebral artery injury and that S1P may be a drug target for its treatment.",Vitamin B6,CHEBI,be novel drug for treatment of,posterior cerebral artery injury,DISEASE
34718372,"Collectively, our data indicate that Vitamin B6 may be a novel drug for the treatment of posterior cerebral artery injury and that S1P may be a drug target for its treatment.",Vitamin B6,CHEBI,be,novel drug,CHEBI
31785534,"Rosmarinus officinalis L., rosemary, is traditionally used to treat headache and improve cardiovascular disease partly due to its vasorelaxant activity, while the vasorelaxant ingredients remain unclear.",Rosmarinus officinalis L.,NUTRITION,treat,headache,MENTAL_HEALTH
31785534,"Rosmarinus officinalis L., rosemary, is traditionally used to treat headache and improve cardiovascular disease partly due to its vasorelaxant activity, while the vasorelaxant ingredients remain unclear.",Rosmarinus officinalis L.,NUTRITION,improve,cardiovascular disease due,DISEASE
16316848,Successful intraoperative ovarian venous sampling demonstrated significantly elevated testosterone levels (>260 nmol/l) from the right ovarian vein.,Successful intraoperative ovarian venous sampling,DISEASE,demonstrate,elevated testosterone levels,CHEMICAL
16316848,Successful intraoperative ovarian venous sampling demonstrated significantly elevated testosterone levels (>260 nmol/l) from the right ovarian vein.,Successful intraoperative ovarian venous sampling,DISEASE,demonstrate,right ovarian vein,DISEASE
1327393,"The antagonism of strychnine seizures by MDL 27,531 occurred at doses that did not produce signs of sedation (suppression of spontaneous motor activity), motor ataxia (disruption of rotarod performance), muscle relaxation (inhibition of morphine-induced Straub tail), or CNS depression (potentiation of hexobarbitone sleep time).",strychnine seizures,CHEMICAL,occur at,hexobarbitone sleep time,CHEMICAL
1327393,"The antagonism of strychnine seizures by MDL 27,531 occurred at doses that did not produce signs of sedation (suppression of spontaneous motor activity), motor ataxia (disruption of rotarod performance), muscle relaxation (inhibition of morphine-induced Straub tail), or CNS depression (potentiation of hexobarbitone sleep time).",strychnine seizures,CHEMICAL,occur at,CNS depression,MENTAL_HEALTH
1327393,"The antagonism of strychnine seizures by MDL 27,531 occurred at doses that did not produce signs of sedation (suppression of spontaneous motor activity), motor ataxia (disruption of rotarod performance), muscle relaxation (inhibition of morphine-induced Straub tail), or CNS depression (potentiation of hexobarbitone sleep time).",strychnine seizures,CHEMICAL,occur at,motor ataxia,DISEASE
20817254,"The results indicated that a significant decrease in total protein, albumin, globulin, testosterone and DNA content in liver, gills and testis accompanied with a significant increase in number of micronucleated erythrocytes (MnRBCs), total chromosomal aberrations in kidney and DNA fragmentation in testis and liver of fish received AFB(1) alone.",kidney fragmentation,MENTAL_HEALTH,have total chromosomal aberrations in,testis,DISEASE
20817254,It could be concluded that EB and EM have the ability to tightly bind AFB(1) in the gastrointestinal tract of fish resulting in decreasing its bioavailability.,EB,CHEMICAL,have ability in,gastrointestinal tract,DISEASE
20817254,"Moreover, the two tested clays were safe and can be used as potential aflatoxin binders in animal feed.",clays,DISEASE,be used as,potential aflatoxin binders,CHEMICAL
8323938,"Recently, we have shown that polarization of an electrogenic H+/K(+)-ATPase pump located in the secretory (luminal) membrane of the frog gastric mucosa is the major factor contributing to the increase in open circuit potential difference (OCPD) induced by voltage clamping.",secretory luminal membrane,CHEMICAL,contributing to,OCPD,MENTAL_HEALTH
28087447,"Over the past decade, it has been demonstrated that H. erinaceus polysaccharides possess various promising bioactivities, including antitumor and immunomodulation, anti-gastric ulcer, neuroprotection and neuroregeneration, anti-oxidation and hepatoprotection, anti-hyperlipidemia, anti-hyperglycemia, anti-fatigue and anti-aging.",erinaceus polysaccharides,CHEMICAL,possess,anti-gastric ulcer,DISEASE
28087447,"Over the past decade, it has been demonstrated that H. erinaceus polysaccharides possess various promising bioactivities, including antitumor and immunomodulation, anti-gastric ulcer, neuroprotection and neuroregeneration, anti-oxidation and hepatoprotection, anti-hyperlipidemia, anti-hyperglycemia, anti-fatigue and anti-aging.",erinaceus polysaccharides,CHEMICAL,possess,anti-hyperlipidemia,DISEASE
28087447,"Over the past decade, it has been demonstrated that H. erinaceus polysaccharides possess various promising bioactivities, including antitumor and immunomodulation, anti-gastric ulcer, neuroprotection and neuroregeneration, anti-oxidation and hepatoprotection, anti-hyperlipidemia, anti-hyperglycemia, anti-fatigue and anti-aging.",erinaceus polysaccharides,CHEMICAL,possess,anti-hyperglycemia,DISEASE
28087447,"Over the past decade, it has been demonstrated that H. erinaceus polysaccharides possess various promising bioactivities, including antitumor and immunomodulation, anti-gastric ulcer, neuroprotection and neuroregeneration, anti-oxidation and hepatoprotection, anti-hyperlipidemia, anti-hyperglycemia, anti-fatigue and anti-aging.",erinaceus polysaccharides,CHEMICAL,possess,neuroregeneration,DISEASE
8309856,"Weight reduction to near ideal body weight and avoidance of benzodiazepines, opiates, and alcohol should be emphasized in all patients with suspected or confirmed sleep apnea.",alcohol,CHEMICAL,be emphasized in,apnea,MENTAL_HEALTH
8309856,"Weight reduction to near ideal body weight and avoidance of benzodiazepines, opiates, and alcohol should be emphasized in all patients with suspected or confirmed sleep apnea.",Weight reduction,DISEASE,be emphasized in,apnea,MENTAL_HEALTH
8309856,"Weight reduction to near ideal body weight and avoidance of benzodiazepines, opiates, and alcohol should be emphasized in all patients with suspected or confirmed sleep apnea.",benzodiazepines,CHEMICAL,be emphasized in,apnea,MENTAL_HEALTH
34785162,"Although serotonin 1A (5-HT1A) receptor agonists are widely used as the additive compound to reduce l-dopa-induced dyskinesia in Parkinson's disease (PD), few studies focused on the effect and mechanism of 5-HT1A receptor agonist on the motor symptoms of PD.",serotonin 1A 5-HT1A receptor agonists,CHEBI,reduce l-dopa-induced dyskinesia in parkinson's,PD,DISEASE
34785162,"Although serotonin 1A (5-HT1A) receptor agonists are widely used as the additive compound to reduce l-dopa-induced dyskinesia in Parkinson's disease (PD), few studies focused on the effect and mechanism of 5-HT1A receptor agonist on the motor symptoms of PD.",serotonin 1A 5-HT1A receptor agonists,CHEMICAL,reduce l-dopa-induced dyskinesia in parkinson's,PD,DISEASE
34785162,"Although serotonin 1A (5-HT1A) receptor agonists are widely used as the additive compound to reduce l-dopa-induced dyskinesia in Parkinson's disease (PD), few studies focused on the effect and mechanism of 5-HT1A receptor agonist on the motor symptoms of PD.",serotonin 1A 5-HT1A receptor agonists,CHEBI,reduce,l-dopa-induced dyskinesia,MENTAL_HEALTH
34785162,"Although serotonin 1A (5-HT1A) receptor agonists are widely used as the additive compound to reduce l-dopa-induced dyskinesia in Parkinson's disease (PD), few studies focused on the effect and mechanism of 5-HT1A receptor agonist on the motor symptoms of PD.",serotonin 1A 5-HT1A receptor agonists,CHEMICAL,reduce,l-dopa-induced dyskinesia,MENTAL_HEALTH
34785162,"In contrast, subthreshold NMDA receptor antagonist MK-801 obviously elevated the 8-OH-DPAT-mediated-motor behaviors, while NMDA receptor agonist DCS partially impaired the 8-OH-DPAT-mediated symptoms in 6-OHDA-lesioned rats.",NMDA receptor agonist DCS,DISEASE,impair,8-OH-DPAT-mediated symptoms,CHEMICAL
34785162,"In contrast, subthreshold NMDA receptor antagonist MK-801 obviously elevated the 8-OH-DPAT-mediated-motor behaviors, while NMDA receptor agonist DCS partially impaired the 8-OH-DPAT-mediated symptoms in 6-OHDA-lesioned rats.",NMDA receptor agonist DCS,CHEBI,impair,8-OH-DPAT-mediated symptoms,CHEMICAL
34785162,This study suggests that 5-HT1A receptor agonist 8-OH-DPAT improves motor activity and modulates the oscillations in the motor cortex of parkinsonian rats.,8-OH-DPAT,CHEMICAL,modulate oscillations in motor cortex of,parkinsonian rats,DISEASE
34785162,This study suggests that 5-HT1A receptor agonist 8-OH-DPAT improves motor activity and modulates the oscillations in the motor cortex of parkinsonian rats.,5-HT1A receptor agonist,CHEBI,modulate oscillations in motor cortex of,parkinsonian rats,DISEASE
34399565,Clinical trials have found that the A2AR antagonist istradefylline decreases dyskinesia in PD and could be used as an adjuvant to levodopa treatment.,A2AR antagonist istradefylline,CHEBI,decrease,dyskinesia,MENTAL_HEALTH
34399565,Clinical trials have found that the A2AR antagonist istradefylline decreases dyskinesia in PD and could be used as an adjuvant to levodopa treatment.,A2AR antagonist istradefylline,CHEMICAL,decrease,dyskinesia,MENTAL_HEALTH
34399565,Clinical trials have found that the A2AR antagonist istradefylline decreases dyskinesia in PD and could be used as an adjuvant to levodopa treatment.,A2AR antagonist istradefylline,CHEBI,be used as adjuvant to,levodopa treatment,CHEMICAL
34399565,Clinical trials have found that the A2AR antagonist istradefylline decreases dyskinesia in PD and could be used as an adjuvant to levodopa treatment.,A2AR antagonist istradefylline,CHEMICAL,be used as adjuvant to,levodopa treatment,CHEMICAL
32238708,Previous studies have shown that green tea catechins (GTCs) have beneficial effects on obesity and metabolic syndromes.,tea catechins,CHEMICAL,have beneficial effects on,metabolic syndromes,MENTAL_HEALTH
32238708,Previous studies have shown that green tea catechins (GTCs) have beneficial effects on obesity and metabolic syndromes.,tea catechins,CHEMICAL,have beneficial effects on,obesity,DISEASE
32238708,Previous studies have shown that green tea catechins (GTCs) have beneficial effects on obesity and metabolic syndromes.,tea catechins,NUTRITION,have beneficial effects on,metabolic syndromes,MENTAL_HEALTH
32238708,Previous studies have shown that green tea catechins (GTCs) have beneficial effects on obesity and metabolic syndromes.,tea catechins,NUTRITION,have beneficial effects on,obesity,DISEASE
2113857,"The effects of cholinergic muscarinic receptor antagonist pirenzepine on the GHRH-induced GH release were studied in 10 adolescent females with anorexia nervosa at different stages of the disease, in 5 adolescent females with eating disorders and in 5 normal adolescents.",cholinergic muscarinic receptor antagonist pirenzepine,CHEMICAL,be studied in adolescent females with,anorexia nervosa,MENTAL_HEALTH
2113857,"The effects of cholinergic muscarinic receptor antagonist pirenzepine on the GHRH-induced GH release were studied in 10 adolescent females with anorexia nervosa at different stages of the disease, in 5 adolescent females with eating disorders and in 5 normal adolescents.",cholinergic muscarinic receptor antagonist pirenzepine,CHEBI,be studied in adolescent females with,anorexia nervosa,MENTAL_HEALTH
7880938,"Pirenzepine, a muscarinic antagonist probably acting via stimulation of hypothalamic somatostatin release, abolishes the growth hormone releasing hormone (GHRH)-stimulated growth hormone (GH) rise in normal subjects but only blunts it in patients with anorexia nervosa (AN).",Pirenzepine,CHEMICAL,blunt it in patients with,anorexia nervosa,MENTAL_HEALTH
7880938,"Pirenzepine, a muscarinic antagonist probably acting via stimulation of hypothalamic somatostatin release, abolishes the growth hormone releasing hormone (GHRH)-stimulated growth hormone (GH) rise in normal subjects but only blunts it in patients with anorexia nervosa (AN).",muscarinic antagonist,CHEBI,blunt it in patients with,anorexia nervosa,MENTAL_HEALTH
34697161,Recent experimental studies have reported that leukotriene receptor antagonists (LTRAs) might protect against dementia.,LTRAs,CHEMICAL,protect against,dementia,MENTAL_HEALTH
34697161,Recent experimental studies have reported that leukotriene receptor antagonists (LTRAs) might protect against dementia.,leukotriene receptor antagonists,CHEBI,protect against,dementia,MENTAL_HEALTH
34697161,This study assessed whether the use of LTRAs can prevent the onset of dementia in humans.,LTRAs,CHEMICAL,prevent onset of,dementia,MENTAL_HEALTH
14996144,Current guidelines for the initial treatment of bipolar type II (BP II) major depressive episode (MDE) recommend using either a mood stabilizer alone or a combination of a mood stabilizer plus a selective serotonin re-uptake inhibitor (SSRI).,bipolar type BP major depressive episode,MENTAL_HEALTH,use mood stabilizer or combination of,SSRI,CHEBI
14996144,Current guidelines for the initial treatment of bipolar type II (BP II) major depressive episode (MDE) recommend using either a mood stabilizer alone or a combination of a mood stabilizer plus a selective serotonin re-uptake inhibitor (SSRI).,bipolar type BP major depressive episode,MENTAL_HEALTH,use mood stabilizer or combination of,selective serotonin re-uptake inhibitor,CHEMICAL
14996144,Current guidelines for the initial treatment of bipolar type II (BP II) major depressive episode (MDE) recommend using either a mood stabilizer alone or a combination of a mood stabilizer plus a selective serotonin re-uptake inhibitor (SSRI).,bipolar type BP major depressive episode,MENTAL_HEALTH,use mood stabilizer or combination of,mood stabilizer,CHEBI
14996144,Current guidelines for the initial treatment of bipolar type II (BP II) major depressive episode (MDE) recommend using either a mood stabilizer alone or a combination of a mood stabilizer plus a selective serotonin re-uptake inhibitor (SSRI).,bipolar type BP major depressive episode,MENTAL_HEALTH,use,mood stabilizer,CHEBI
14996144,"However, recent evidence suggests that the manic switch rate may be low in BP II MDE during SSRI therapy.",manic switch rate,DISEASE,be low in bp mde during,SSRI therapy,CHEBI
9168482,"The neurochemical correlates of dopamine synapse activity were studied during the retrieval of memory traces and in the absence of retrieval (""psychogenic"" amnesia).",dopamine synapse activity,CHEMICAL,be studied during retrieval of memory traces and in absence of,psychogenic amnesia,MENTAL_HEALTH
10231172,"Fatty acid ethyl esters (FAEE), nonoxidative ethanol metabolites present in human organs commonly damaged by ethanol abuse, have been implicated as mediators of organ damage.",Fatty acid ethyl esters,NUTRITION,be implicated as mediators of,organ damage,DISEASE
10231172,"Fatty acid ethyl esters (FAEE), nonoxidative ethanol metabolites present in human organs commonly damaged by ethanol abuse, have been implicated as mediators of organ damage.",FAEE,CHEMICAL,be implicated as mediators of,organ damage,DISEASE
10231172,"Fatty acid ethyl esters (FAEE), nonoxidative ethanol metabolites present in human organs commonly damaged by ethanol abuse, have been implicated as mediators of organ damage.",nonoxidative ethanol metabolites present,CHEMICAL,be implicated as mediators of,organ damage,DISEASE
28786528,PRS showed nominal associations with violent behaviors and depressive symptoms.,PRS,CHEMICAL,show nominal associations with,violent behaviors,DISEASE
28786528,PRS showed nominal associations with violent behaviors and depressive symptoms.,PRS,CHEMICAL,show nominal associations with,depressive symptoms,DISEASE
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",silver,CHEMICAL,lead to issued regulations by,Food Drug Administration,CHEBI
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",silver,CHEMICAL,lead to issued regulations by,silver,CHEMICAL
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",silver,CHEMICAL,lead to issued regulations by,US EPA,CHEMICAL
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",possible toxicity,DISEASE,lead to issued regulations by,Food Drug Administration,CHEBI
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",possible toxicity,DISEASE,lead to issued regulations by,silver,CHEMICAL
35493157,"Growing concerns about the possible toxicity of silver to aquatic organisms, bacteria, and humans have led to newly issued regulations by the United States Environmental Protection Agency (US EPA) and the Food and Drug Administration (FDA) regarding the use of silver.",possible toxicity,DISEASE,lead to issued regulations by,US EPA,CHEMICAL
35493157,"However, the increase in bacterial resistance to antibiotics has led to a resurgence in the use of silver as a biocidal agent in applications ranging from washing machine additives to the drinking water treatment system on the International Space Station (ISS).",bacterial resistance,MENTAL_HEALTH,lead to resurgence in use of,silver,CHEMICAL
35493157,"However, the increase in bacterial resistance to antibiotics has led to a resurgence in the use of silver as a biocidal agent in applications ranging from washing machine additives to the drinking water treatment system on the International Space Station (ISS).",antibiotics,CHEBI,lead to resurgence in use of,silver,CHEMICAL
32846401,Alpha-cyano-4-hydroxycinnamic acid (CHC) and the monoclonal antibody (mAb) cetuximab (CTX) are explored worldwide for their therapeutic benefits against multiple cancer cells.,CHC,DISEASE,be explored for their therapeutic benefits against,multiple cancer cells,DISEASE
32846401,Alpha-cyano-4-hydroxycinnamic acid (CHC) and the monoclonal antibody (mAb) cetuximab (CTX) are explored worldwide for their therapeutic benefits against multiple cancer cells.,monoclonal antibody mAb cetuximab,CHEMICAL,be explored for their therapeutic benefits against,multiple cancer cells,DISEASE
32846401,Alpha-cyano-4-hydroxycinnamic acid (CHC) and the monoclonal antibody (mAb) cetuximab (CTX) are explored worldwide for their therapeutic benefits against multiple cancer cells.,Alpha-cyano-4-hydroxycinnamic acid,CHEMICAL,be explored for their therapeutic benefits against,multiple cancer cells,DISEASE
27770750,"To further the understanding of how Salicornia grows and develops under high saline conditions, Salicornia herbacea (S. herbacea) was grown under varying saline concentrations (0, 50, 100, 200, 300, and 400mM), and the resulting phenotype, ion levels, and metabolites were investigated.",Salicornia herbacea,DISEASE,be grown under,400mM,CHEMICAL
18996648,"If we accept that pure cortisol exposure leads to depressive mood, while simultaneous brain exposure to cortisol and an anabolic (growth hormone or somatomammotropin) is less mood affecting, the occurrence of depression an be more likely in persons: with altered sleep patterns and thus reduced GH secretion, in individuals with increased chronic cortisol exposure (any individual under repeated or sustained stress, older individuals with stressful memories, etc.).",depression,MENTAL_HEALTH,be likely in persons with altered sleep patterns and in,increased chronic cortisol exposure,CHEMICAL
18996648,"If we accept that pure cortisol exposure leads to depressive mood, while simultaneous brain exposure to cortisol and an anabolic (growth hormone or somatomammotropin) is less mood affecting, the occurrence of depression an be more likely in persons: with altered sleep patterns and thus reduced GH secretion, in individuals with increased chronic cortisol exposure (any individual under repeated or sustained stress, older individuals with stressful memories, etc.).",pure cortisol exposure,CHEMICAL,lead to,depressive mood,DISEASE
18996648,"If we accept that pure cortisol exposure leads to depressive mood, while simultaneous brain exposure to cortisol and an anabolic (growth hormone or somatomammotropin) is less mood affecting, the occurrence of depression an be more likely in persons: with altered sleep patterns and thus reduced GH secretion, in individuals with increased chronic cortisol exposure (any individual under repeated or sustained stress, older individuals with stressful memories, etc.).",anabolic growth hormone,CHEBI,lead to,depressive mood,DISEASE
33809564,"However, the GPR18 agonist is likely to affect body weight by inducing gastrointestinal disorders such as nausea.",GPR18 agonist,CHEBI,induce gastrointestinal disorders such as,nausea,DISEASE
33809564,"However, the GPR18 agonist is likely to affect body weight by inducing gastrointestinal disorders such as nausea.",GPR18 agonist,CHEBI,induce,gastrointestinal disorders,DISEASE
7918791,"A variety of studies indicate that folate deficiency is associated with the appearance of problems of a neuromuscular or neurological nature such as depression, muscular and mental fatigue, states of confusion and non-senile dementia, and that these processes improve fully or partly when the deficiency is corrected.",folate deficiency,CHEBI,be associated with appearance of problems of neuromuscular or neurological nature such as,mental,DISEASE
7918791,"A variety of studies indicate that folate deficiency is associated with the appearance of problems of a neuromuscular or neurological nature such as depression, muscular and mental fatigue, states of confusion and non-senile dementia, and that these processes improve fully or partly when the deficiency is corrected.",folate deficiency,CHEBI,be associated with appearance of problems of neuromuscular or neurological nature such as,depression,MENTAL_HEALTH
7918791,"A variety of studies indicate that folate deficiency is associated with the appearance of problems of a neuromuscular or neurological nature such as depression, muscular and mental fatigue, states of confusion and non-senile dementia, and that these processes improve fully or partly when the deficiency is corrected.",folate deficiency,CHEBI,be associated with appearance of problems of neuromuscular or neurological nature such as,muscular fatigue,MENTAL_HEALTH
7918791,"A variety of studies indicate that folate deficiency is associated with the appearance of problems of a neuromuscular or neurological nature such as depression, muscular and mental fatigue, states of confusion and non-senile dementia, and that these processes improve fully or partly when the deficiency is corrected.",folate deficiency,CHEBI,be associated with appearance of problems of,neuromuscular nature,DISEASE
7918791,An alternative mechanism for explaining the etiopathogenesis of folate deficiency in depression and other mental disorders involves the regeneration of tetrahydrobiopterin (THB) which is an essential cofactor in hydroxylation process in the brains of mammals.,folate deficiency,CHEBI,have the etiopathogenesis in,other mental disorders,MENTAL_HEALTH
7918791,An alternative mechanism for explaining the etiopathogenesis of folate deficiency in depression and other mental disorders involves the regeneration of tetrahydrobiopterin (THB) which is an essential cofactor in hydroxylation process in the brains of mammals.,folate deficiency,CHEBI,have the etiopathogenesis in,depression,MENTAL_HEALTH
35588917,"In some individuals, the use of cannabis leads to psychotic disorders.",cannabis,CHEMICAL,lead in individuals to,psychotic disorders,DISEASE
16421104,(ii) Restoration of activity regulation is not possible if the correct conformation or orientation of the C-terminal domain is compromised by a proline residue at position 572 or 550.,orientation,MENTAL_HEALTH,be compromised by,proline residue,CHEMICAL
29035848,"For Babesia sp., final multivariate logistic regression analysis showed a significant association between the infection and irregular use of antiprotozoal drugs (P = 0.003; OR: 0.28; 95% CI: 0.12-0.65), management practice (P = 0.029; OR: 6.66; 95% CI: 1.21-36.59) and ecology area (P = 0.006; OR: 5.62; 95% CI: 1.63-19.31).",final multivariate logistic regression analysis,MENTAL_HEALTH,show for babesia sp. significant association between infection and irregular use of,antiprotozoal drugs,CHEBI
29035848,"For Babesia sp., final multivariate logistic regression analysis showed a significant association between the infection and irregular use of antiprotozoal drugs (P = 0.003; OR: 0.28; 95% CI: 0.12-0.65), management practice (P = 0.029; OR: 6.66; 95% CI: 1.21-36.59) and ecology area (P = 0.006; OR: 5.62; 95% CI: 1.63-19.31).",final multivariate logistic regression analysis,MENTAL_HEALTH,show for babesia sp. significant association between,infection,DISEASE
31955763,"As for biogenic amine, RU contained the highest total amount and RS had the least.",RU,CHEMICAL,contain,RS,DISEASE
35534825,Esketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDA receptor) that is widely used for multimodal analgesia.,Esketamine,CHEMICAL,be antagonist of,NMDA receptor,CHEMICAL
35534825,Esketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDA receptor) that is widely used for multimodal analgesia.,Esketamine,CHEMICAL,be antagonist of,N-methyl-D-aspartate receptor,CHEMICAL
35534825,Esketamine is an antagonist of the N-methyl-D-aspartate receptor (NMDA receptor) that is widely used for multimodal analgesia.,Esketamine,CHEMICAL,be,antagonist,CHEBI
29367933,The aim of this study was to determine the effect of timolol on corneal neovascularization in rabbits.,timolol,CHEMICAL,have the effect on,corneal neovascularization,DISEASE
29367933,"After 2 weeks, the mean area of corneal neovascularization was 0.85 ± 1.33% in the timolol group and 1.73 ± 2.06% in the saline group (P = 0.315).",corneal neovascularization,DISEASE,be ± after weeks in,timolol group,CHEMICAL
29367933,"After 2 weeks, the mean area of corneal neovascularization was 0.85 ± 1.33% in the timolol group and 1.73 ± 2.06% in the saline group (P = 0.315).",corneal neovascularization,DISEASE,be,±,CHEMICAL
29367933,Timolol may increase the rate of recovery from corneal neovascularization.,Timolol,CHEMICAL,increase rate of recovery from,corneal neovascularization,DISEASE
34254328,Methylphenidate is a drug widely prescribed to treat ADHD.,Methylphenidate,CHEMICAL,be,drug,CHEBI
35113310,Results displayed that liver injury degree in protein-injected groups was lower than that of PBS group under cadmium stress.,liver injury degree,DISEASE,be,cadmium stress,CHEMICAL
34687881,"Under hypoxic stress, the transcript levels of genes involved in the NOD-like receptor signaling pathway initially increased rapidly but then decreased over time, suggesting that the NOD-like receptor-mediated immune response plays an essential role in hypoxia tolerance and resistance in hybrid yellow catfish.",resistance,MENTAL_HEALTH,have an essential role in,hybrid yellow catfish,NUTRITION
34687881,"Under hypoxic stress, the transcript levels of genes involved in the NOD-like receptor signaling pathway initially increased rapidly but then decreased over time, suggesting that the NOD-like receptor-mediated immune response plays an essential role in hypoxia tolerance and resistance in hybrid yellow catfish.",hypoxia tolerance,DISEASE,have an essential role in,hybrid yellow catfish,NUTRITION
16222487,High concentrations of tannins in fodder plants inhibit gastrointestinal bacteria and reduce ruminant performance.,tannins,CHEMICAL,inhibit,gastrointestinal bacteria,DISEASE
16222487,"The reason for the protective effect is unclear, but could be elucidated if the mechanism(s) by which tannins inhibit bacteria and the mechanisms of tannin resistance were understood.",tannins,CHEMICAL,inhibit by which bacteria and mechanisms of,tannin resistance,MENTAL_HEALTH
16222487,"The reason for the protective effect is unclear, but could be elucidated if the mechanism(s) by which tannins inhibit bacteria and the mechanisms of tannin resistance were understood.",tannins,CHEMICAL,inhibit by which bacteria and mechanisms of,tannin resistance,CHEMICAL
25425322,"In addition, the performance of conditioned approach behavior, but not conditioned orientation, was attenuated by pretreatment with the dopamine receptor antagonist, flupenthixol, into the core of the nucleus accumbens.",conditioned orientation,MENTAL_HEALTH,be attenuated in addition by pretreatment with,flupenthixol,CHEMICAL
25425322,"In addition, the performance of conditioned approach behavior, but not conditioned orientation, was attenuated by pretreatment with the dopamine receptor antagonist, flupenthixol, into the core of the nucleus accumbens.",conditioned orientation,MENTAL_HEALTH,be attenuated in addition by pretreatment with,dopamine receptor antagonist,CHEBI
2900897,The substituted benzamides metoclopramide (1) and clebopride (3) are stimulants of gastric motility.,benzamides metoclopramide,CHEMICAL,be stimulants of,gastric motility,DISEASE
2900897,The substituted benzamides metoclopramide (1) and clebopride (3) are stimulants of gastric motility.,clebopride,CHEMICAL,be stimulants of,gastric motility,DISEASE
3434732,Preliminary data of a postmortem brain study in a single case with Rett syndrome compared to a single control case showed a severe reduction of ascorbic acid and reduced glutathione in most brain regions studied.,Rett syndrome,MENTAL_HEALTH,show severe reduction of,ascorbic acid,CHEBI
3434732,Preliminary data of a postmortem brain study in a single case with Rett syndrome compared to a single control case showed a severe reduction of ascorbic acid and reduced glutathione in most brain regions studied.,Rett syndrome,MENTAL_HEALTH,reduce,glutathione,CHEMICAL
3434732,These findings suggest a secondary disturbance of ascorbic acid and glutathione metabolism in the Rett syndrome.,acid metabolism,CHEBI,have a secondary disturbance in,Rett syndrome,MENTAL_HEALTH
3434732,These findings suggest a secondary disturbance of ascorbic acid and glutathione metabolism in the Rett syndrome.,glutathione,CHEMICAL,have a secondary disturbance in,Rett syndrome,MENTAL_HEALTH
33891540,"In short, based on our understanding of the relevant physiological factors, risk factors of brachiocephalic trunk injury, and the effects of DEX, low-dose DEX provides a good option for preoperative management in a patient with blunt brachiocephalic trunk injury.",brachiocephalic trunk injury,DISEASE,provide in short good option for preoperative management in patient with,blunt trunk injury,DISEASE
10073395,Underprescription of antidepressants and failure of antidepressant therapy appear to be of greater practical importance than the toxicity of individual compounds.,antidepressant therapy,CHEMICAL,appear to of,toxicity,DISEASE
10073395,Underprescription of antidepressants and failure of antidepressant therapy appear to be of greater practical importance than the toxicity of individual compounds.,antidepressants,CHEMICAL,appear to of,toxicity,DISEASE
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,selective serotonin reuptake inhibitors,CHEMICAL,energize,depressed patients,DISEASE
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,Several antidepressants,CHEMICAL,energize,depressed patients,DISEASE
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,selective serotonin reuptake inhibitors,CHEMICAL,increase,suicidal behavior,MENTAL_HEALTH
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,Several antidepressants,CHEMICAL,increase,suicidal behavior,MENTAL_HEALTH
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,SSRIs,CHEMICAL,energize,depressed patients,DISEASE
10073395,Several antidepressants including the selective serotonin reuptake inhibitors (SSRIs) may increase suicidal behavior by energizing depressed patients to act along preexisting suicidal thoughts or by inducing akathisia with associated self-destructive impulses.,SSRIs,CHEMICAL,increase,suicidal behavior,MENTAL_HEALTH
10073395,There is evidence from large international data sources and a large multicenter controlled trial that lithium prophylaxis decreases the suicide risk and overall mortality in affective disorders.,lithium prophylaxis,NUTRITION,decrease suicide risk and overall mortality in,affective disorders,MENTAL_HEALTH
10073395,There is evidence from large international data sources and a large multicenter controlled trial that lithium prophylaxis decreases the suicide risk and overall mortality in affective disorders.,lithium prophylaxis,NUTRITION,decrease,suicide risk,MENTAL_HEALTH
18823982,This data suggests that reduced transcription of the mRNA coding for nicotinic acetylcholine receptor subunits that form the pyrantel-sensitive receptors may be a component of the pyrantel resistance mechanism in A. caninum.,pyrantel resistance mechanism,MENTAL_HEALTH,have a component in,A. caninum,DISEASE
18823982,This data suggests that reduced transcription of the mRNA coding for nicotinic acetylcholine receptor subunits that form the pyrantel-sensitive receptors may be a component of the pyrantel resistance mechanism in A. caninum.,pyrantel resistance mechanism,CHEMICAL,have a component in,A. caninum,DISEASE
2238443,"Clinical signs of depression, ataxia, stupor, and coma were most attributable to the xylene and propylene oxide components.",ataxia,DISEASE,be attributable to,xylene oxide components,CHEMICAL
2238443,"Clinical signs of depression, ataxia, stupor, and coma were most attributable to the xylene and propylene oxide components.",depression,MENTAL_HEALTH,be attributable to,xylene oxide components,CHEMICAL
2238443,"Clinical signs of depression, ataxia, stupor, and coma were most attributable to the xylene and propylene oxide components.",coma,DISEASE,be attributable to,xylene oxide components,CHEMICAL
2238443,"Hyperglycemia, hypotension, and bradycardia were probably attributable to the alpha-2 adrenoceptor agonist action of amitraz.",hypotension,DISEASE,be attributable to,alpha-2 adrenoceptor agonist action,CHEBI
2238443,"Hyperglycemia, hypotension, and bradycardia were probably attributable to the alpha-2 adrenoceptor agonist action of amitraz.",Hyperglycemia,DISEASE,be attributable to,alpha-2 adrenoceptor agonist action,CHEBI
2238443,"Hyperglycemia, hypotension, and bradycardia were probably attributable to the alpha-2 adrenoceptor agonist action of amitraz.",bradycardia,DISEASE,be attributable to,alpha-2 adrenoceptor agonist action,CHEBI
8140867,Bradycardia and hypotension not attributable to sympathetic blockade have been reported following bupivacaine extradurally in verapamil-treated patients.,hypotension,DISEASE,be reported following,bupivacaine,CHEMICAL
8140867,"Sulfonamides and the ester group of local anaesthetics, such as prilocaine in combination, may result in severe methaemoglobinaemia in infants.",prilocaine,CHEMICAL,result in,severe methaemoglobinaemia,DISEASE
8140867,"Sulfonamides and the ester group of local anaesthetics, such as prilocaine in combination, may result in severe methaemoglobinaemia in infants.",Sulfonamides,CHEMICAL,result in,severe methaemoglobinaemia,DISEASE
7716700,"The chlorhexidine and arginine groups showed significant reductions (p < 0.05 and p < 0.01, respectively) in the number of S. mutans.",chlorhexidine groups,CHEMICAL,show,S. mutans,DISEASE
7716700,The arginine group showed a nonsignificant increase in the number of S. sanguis.,arginine group,CHEMICAL,show nonsignificant increase in number of,S. sanguis,DISEASE
7716700,These results suggest that the topical antimicrobial agents may have some relevance to plaque control among patients with mental retardation.,topical antimicrobial agents,CHEBI,have relevance to plaque control among patients with,mental retardation,MENTAL_HEALTH
34164855,"This study aims to assess the effects of crocin administration during doxorubicin-based chemotherapy of breast cancer on anxiety, depression, and chemotherapy toxicity profile.",breast cancer,DISEASE,have doxorubicin-based chemotherapy on,anxiety,MENTAL_HEALTH
7831994,"Previous studies have suggested that depression and suicide are related to alterations in total cholesterol serum concentrations, and that an altered distribution of haptoglobin (Hp) phenotypes in major depression indicates that variation on chromosome 16 may be associated with that illness.",suicide,MENTAL_HEALTH,be related to alterations in,total cholesterol serum concentrations,NUTRITION
7831994,"Previous studies have suggested that depression and suicide are related to alterations in total cholesterol serum concentrations, and that an altered distribution of haptoglobin (Hp) phenotypes in major depression indicates that variation on chromosome 16 may be associated with that illness.",depression,MENTAL_HEALTH,be related to alterations in,total cholesterol serum concentrations,NUTRITION
7831994,Depressed subjects (regardless of subtype) and relatives of depressed subjects had a significantly lower esterified cholesterol ratio than normal controls.,Depressed subjects,DISEASE,have,lower esterified cholesterol ratio,CHEMICAL
7831994,Depressed subjects (regardless of subtype) and relatives of depressed subjects had a significantly lower esterified cholesterol ratio than normal controls.,Depressed subjects,DISEASE,have,lower esterified cholesterol ratio,NUTRITION
7831994,Depressed subjects (regardless of subtype) and relatives of depressed subjects had a significantly lower esterified cholesterol ratio than normal controls.,depressed subjects,DISEASE,have,lower esterified cholesterol ratio,CHEMICAL
7831994,Depressed subjects (regardless of subtype) and relatives of depressed subjects had a significantly lower esterified cholesterol ratio than normal controls.,depressed subjects,DISEASE,have,lower esterified cholesterol ratio,NUTRITION
7831994,It is hypothesized that lower esterification in serum cholesterol may constitute a vulnerability factor for depression through alterations in cell membrane microviscosity.,serum cholesterol,NUTRITION,constitute vulnerability factor for,depression,MENTAL_HEALTH
6360259,Theophylline increased the diaphragmatic activity during REM sleep-related mixed apnea but had no impact on upper airway apnea in the studied population.,Theophylline,CHEMICAL,increase diaphragmatic activity during,sleep-related mixed apnea,DISEASE
18089320,It is well documented that drug abuse can cause renal diseases.,drug abuse,CHEBI,cause,renal diseases,DISEASE
18089320,The predominant lesions in heroin-associated nephropathy are segmental glomerulosclerosis in African-Americans and membranous glomerulonephritis (MGN) in the Caucasian population.,heroin-associated nephropathy,CHEMICAL,be segmental glomerulosclerosis in,MGN,DISEASE
18089320,The predominant lesions in heroin-associated nephropathy are segmental glomerulosclerosis in African-Americans and membranous glomerulonephritis (MGN) in the Caucasian population.,heroin-associated nephropathy,CHEMICAL,be segmental glomerulosclerosis in,membranous glomerulonephritis,DISEASE
18089320,"Cocaine may induce kidney damage, predominantly acute renal failure in the course of rhabdomyolysis.",Cocaine,CHEMICAL,induce,acute renal failure,DISEASE
18089320,"Cocaine may induce kidney damage, predominantly acute renal failure in the course of rhabdomyolysis.",Cocaine,CHEMICAL,induce,rhabdomyolysis,DISEASE
18089320,"Cocaine may induce kidney damage, predominantly acute renal failure in the course of rhabdomyolysis.",Cocaine,CHEMICAL,induce,kidney damage,DISEASE
18089320,The long period and high level of narcotic intoxication suggested that de novo MGN may have been associated with heavy marijuana abuse.,de MGN,DISEASE,be associated with,marijuana abuse,MENTAL_HEALTH
32333900,CSF tau phosphorylated at threonine 181 (p-tau181) is a highly specific biomarker for Alzheimer's disease pathology.,p-tau181,CHEMICAL,phosphorylate at,p-tau181,CHEMICAL
32333900,CSF tau phosphorylated at threonine 181 (p-tau181) is a highly specific biomarker for Alzheimer's disease pathology.,p-tau181,CHEMICAL,phosphorylate at,threonine,NUTRITION
31127768,"Metabolite and pathway alterations specific for dementia and pre-diagnostic dementia were identified, in particular a disturbed threonine catabolism at the pre-diagnostic stage that extends to several threonine-linked pathways at the dementia stage.",dementia,MENTAL_HEALTH,disturbed,threonine catabolism,NUTRITION
11600146,"Dexamethasone was unable to block the effects of B. jararacussu in the kidney, while WEB 2086 blocked its effect in glomerular filtration rate, urinary flow and in the percentage of total tubular potassium reabsorption.",WEB,CHEMICAL,block its effect in,total tubular potassium reabsorption,CHEMICAL
10522748,"Cholera toxin caused a decrease of urinary flow (toxin = 0.034+/-0.004 versus control = 0.145+/-0.02 ml x g(-1) x min.(-1); P<0.025), this effect was also completely abolished by WEB 2086 when it was injected previously to toxin.",Cholera toxin,DISEASE,cause decrease of,toxin = control,CHEBI
10522748,"Cholera toxin caused a decrease of urinary flow (toxin = 0.034+/-0.004 versus control = 0.145+/-0.02 ml x g(-1) x min.(-1); P<0.025), this effect was also completely abolished by WEB 2086 when it was injected previously to toxin.",Cholera toxin,CHEBI,cause decrease of,toxin = control,CHEBI
9375313,"This increased peak pulmonary vascular resistance was attenuated similarly by pretreatment with indomethacin (1.1 x 10(-4) M; cyclooxygenase inhibitor), AA-2414 (10(-5) M; thromboxane-receptor antagonist), or a combination of TCV-309 (10(-5) M; platelet-activating factor-receptor antagonist), diphenhydramine (1.7 x 10(-4) M, histamine H1-receptor antagonist), and indomethacin but not by pretreatment with TCV-309 or diphenhydramine alone.",increased peak pulmonary vascular resistance,MENTAL_HEALTH,be attenuated by pretreatment with,TCV-309 M,CHEMICAL
9375313,"This increased peak pulmonary vascular resistance was attenuated similarly by pretreatment with indomethacin (1.1 x 10(-4) M; cyclooxygenase inhibitor), AA-2414 (10(-5) M; thromboxane-receptor antagonist), or a combination of TCV-309 (10(-5) M; platelet-activating factor-receptor antagonist), diphenhydramine (1.7 x 10(-4) M, histamine H1-receptor antagonist), and indomethacin but not by pretreatment with TCV-309 or diphenhydramine alone.",increased peak pulmonary vascular resistance,MENTAL_HEALTH,be attenuated by pretreatment with,AA-2414,CHEMICAL
9375313,"This increased peak pulmonary vascular resistance was attenuated similarly by pretreatment with indomethacin (1.1 x 10(-4) M; cyclooxygenase inhibitor), AA-2414 (10(-5) M; thromboxane-receptor antagonist), or a combination of TCV-309 (10(-5) M; platelet-activating factor-receptor antagonist), diphenhydramine (1.7 x 10(-4) M, histamine H1-receptor antagonist), and indomethacin but not by pretreatment with TCV-309 or diphenhydramine alone.",increased peak pulmonary vascular resistance,MENTAL_HEALTH,be attenuated by pretreatment with,thromboxane-receptor antagonist,CHEBI
9375313,"This increased peak pulmonary vascular resistance was attenuated similarly by pretreatment with indomethacin (1.1 x 10(-4) M; cyclooxygenase inhibitor), AA-2414 (10(-5) M; thromboxane-receptor antagonist), or a combination of TCV-309 (10(-5) M; platelet-activating factor-receptor antagonist), diphenhydramine (1.7 x 10(-4) M, histamine H1-receptor antagonist), and indomethacin but not by pretreatment with TCV-309 or diphenhydramine alone.",increased peak pulmonary vascular resistance,MENTAL_HEALTH,be attenuated by pretreatment with,indomethacin,CHEMICAL
9375313,"This increased peak pulmonary vascular resistance was attenuated similarly by pretreatment with indomethacin (1.1 x 10(-4) M; cyclooxygenase inhibitor), AA-2414 (10(-5) M; thromboxane-receptor antagonist), or a combination of TCV-309 (10(-5) M; platelet-activating factor-receptor antagonist), diphenhydramine (1.7 x 10(-4) M, histamine H1-receptor antagonist), and indomethacin but not by pretreatment with TCV-309 or diphenhydramine alone.",increased peak pulmonary vascular resistance,MENTAL_HEALTH,be attenuated by pretreatment with,platelet-activating factor-receptor antagonist,CHEBI
10607089,PS always followed SWS and was fragmented.,PS,CHEMICAL,follow,SWS,DISEASE
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",SSRIs,CHEMICAL,introduce for treatment of,depression,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",SSRIs,CHEMICAL,prove effective for broad range of,several anxiety disorders,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",SSRIs,CHEMICAL,prove effective for broad range of,psychiatric illnesses,DISEASE
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",SSRIs,CHEMICAL,prove effective for broad range of,dysthymia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",SSRIs,CHEMICAL,prove effective for broad range of,bulimia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",selective serotonin reuptake inhibitors,CHEMICAL,prove effective for broad range of,several anxiety disorders,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",selective serotonin reuptake inhibitors,CHEMICAL,prove effective for broad range of,psychiatric illnesses,DISEASE
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",selective serotonin reuptake inhibitors,CHEMICAL,prove effective for broad range of,dysthymia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",selective serotonin reuptake inhibitors,CHEMICAL,prove effective for broad range of,bulimia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",serotonin/norepinephrine reuptake inhibitors,CHEMICAL,prove effective for broad range of,several anxiety disorders,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",serotonin/norepinephrine reuptake inhibitors,CHEMICAL,prove effective for broad range of,psychiatric illnesses,DISEASE
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",serotonin/norepinephrine reuptake inhibitors,CHEMICAL,prove effective for broad range of,dysthymia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",serotonin/norepinephrine reuptake inhibitors,CHEMICAL,prove effective for broad range of,bulimia,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",serotonin/norepinephrine reuptake inhibitors,CHEMICAL,introduce for treatment of,depression,MENTAL_HEALTH
10086481,"Originally studied and introduced for the treatment of depression, the selective serotonin reuptake inhibitors (SSRIs) and serotonin/norepinephrine reuptake inhibitors (SNRIs) have proven effective for a broad range of psychiatric illnesses, including several anxiety disorders, bulimia, and dysthymia.",selective serotonin reuptake inhibitors,CHEMICAL,introduce for treatment of,depression,MENTAL_HEALTH
27256196,We propose that voiding dysfunction (VD) may also justify this symptom and detail a clinical case of recurring stuttering priapism associated to overactive bladder that completely resolved after usage of anticholinergics and urotherapy.,voiding dysfunction,DISEASE,recurring,stuttering priapism,MENTAL_HEALTH
30322771,"After normalizing patient 2D:4D against control 2D:4D, we found that normalized 2D:4D ratios were lower in male 118G patients than male AA patients, suggesting prenatal androgens interact with OPRM1 to influence alcohol dependence risk.",prenatal androgens,CHEBI,influence,dependence risk,MENTAL_HEALTH
28383757,The evidence for how prenatal and adult androgens influence alcohol dependence is limited.,prenatal androgens,CHEBI,influence,alcohol dependence,MENTAL_HEALTH
28383757,We investigated the effects of prenatal and adult androgen activity on alcohol dependence.,prenatal androgen activity,CHEBI,have the effects on,alcohol dependence,MENTAL_HEALTH
19231085,Studies show that alcoholism is associated with dysregulation of sexual hormones.,alcoholism,DISEASE,be associated with dysregulation of,sexual hormones,CHEBI
35151797,"Although impairments in mesolimbic dopamine are sometimes labeled as being due to ""anhedonia"", a detailed deconstruction of the findings in this area of research point to a much more complex and nuanced picture of the role that dopamine plays in regulating instrumental behavior.",mesolimbic dopamine,CHEMICAL,be labeled due to,anhedonia detailed deconstruction,MENTAL_HEALTH
19433114,"We tentatively suggest that these models represent four domains of pathology in schizophrenia: DA agonist and muscarinic antagonist-induced disrupted LI represents a domain of positive symptoms that respond to typical and atypical APDs and some cognitive enhancers; NMDA antagonist-induced persistent LI represents a domain of negative/cognitive symptoms that respond to atypical APDs and cognitive enhancers but not typical APDs; antimuscarinic-induced persistent LI represents a domain of cognitive symptoms that are responsive to cognitive enhancers but are resistant to typical and atypical APDs; finally, DA antagonist-induced persistent LI represents a domain of negative symptoms that are treatable by atypical APDs but are resistant to cognitive enhancers.",antimuscarinic-induced persistent LI,DISEASE,represent domain of,cognitive symptoms,DISEASE
19433114,"We tentatively suggest that these models represent four domains of pathology in schizophrenia: DA agonist and muscarinic antagonist-induced disrupted LI represents a domain of positive symptoms that respond to typical and atypical APDs and some cognitive enhancers; NMDA antagonist-induced persistent LI represents a domain of negative/cognitive symptoms that respond to atypical APDs and cognitive enhancers but not typical APDs; antimuscarinic-induced persistent LI represents a domain of cognitive symptoms that are responsive to cognitive enhancers but are resistant to typical and atypical APDs; finally, DA antagonist-induced persistent LI represents a domain of negative symptoms that are treatable by atypical APDs but are resistant to cognitive enhancers.",antimuscarinic-induced persistent LI,CHEMICAL,represent domain of,cognitive symptoms,DISEASE
28694630,Persisting mood symptoms had responded to mood stabilizer and antipsychotic treatment.,mood symptoms,DISEASE,respond to,stabilizer antipsychotic treatment,CHEBI
26857796,Deficits in N-methyl-D-aspartate receptor (NMDAR) function are increasingly linked to persistent negative symptoms and cognitive deficits in schizophrenia.,N-methyl-D-aspartate receptor function,CHEMICAL,be linked to persistent negative symptoms and cognitive deficits in,schizophrenia,MENTAL_HEALTH
26857796,Deficits in N-methyl-D-aspartate receptor (NMDAR) function are increasingly linked to persistent negative symptoms and cognitive deficits in schizophrenia.,N-methyl-D-aspartate receptor function,CHEMICAL,be linked to,cognitive deficits,DISEASE
26857796,"Accordingly, clinical studies have been targeting the modulatory site of the NMDA receptor, based on the decreased function of NMDA receptor, to see whether increasing NMDA function can potentially help treat the negative and cognitive deficits seen in the disease.",NMDA function,CHEMICAL,treat,negative deficits,DISEASE
26857796,The findings support an effect of D-serine on PCP-induced hyperactivity.,D-serine,CHEMICAL,have an effect on,PCP-induced hyperactivity,MENTAL_HEALTH
26347250,"Several diseases of the nervous system, such as Parkinson's disease, attention deficit hyperactivity disorder, restless legs syndrome, are believed to be related to deficiency of dopamine.",nervous system,DISEASE,be believed to related to deficiency of,dopamine,CHEMICAL
26347250,"Several diseases of the nervous system, such as Parkinson's disease, attention deficit hyperactivity disorder, restless legs syndrome, are believed to be related to deficiency of dopamine.",Parkinson's disease,DISEASE,be believed to related to deficiency of,dopamine,CHEMICAL
29921531,"Similarly, a SAM-accumulating S. pastorianus mutant strain, with enhanced resistance to the adenosine analog cordycepin, exhibited a higher fermentation rate in both high-maltose synthetic medium and high-gravity wort.",adenosine analog cordycepin,CHEMICAL,exhibit higher fermentation rate in,high-maltose synthetic medium,CHEMICAL
29921531,"Similarly, a SAM-accumulating S. pastorianus mutant strain, with enhanced resistance to the adenosine analog cordycepin, exhibited a higher fermentation rate in both high-maltose synthetic medium and high-gravity wort.",enhanced resistance,MENTAL_HEALTH,exhibit higher fermentation rate in,high-maltose synthetic medium,CHEMICAL
25996521,"Then, the thermal resistance of ascospores of three S. cerevisiae strains (DSMZ 1848, DSMZ 70487, Ethanol Red(®)) and one strain of S. pastorianus (ATCC 9080) was determined in 4% (v/v) ethanol lager beer.",thermal resistance,MENTAL_HEALTH,be determined in,% v/v ethanol lager beer,CHEMICAL
25996521,"Lastly, experiments with 0 and 7% (v/v) beers were carried out to investigate the effect of ethanol content on the thermal resistance of S. cerevisiae (DSMZ 1848).",ethanol content,CHEMICAL,have the effect on,thermal resistance,MENTAL_HEALTH
25996521,"D55 °C-values of 34.2 and 15.3 min were obtained for 0 and 7% beers, respectively, indicating lower thermal resistance in the more alcoholic beer.",°,CHEMICAL,indicate lower thermal resistance in,alcoholic beer,CHEMICAL
25996521,"D55 °C-values of 34.2 and 15.3 min were obtained for 0 and 7% beers, respectively, indicating lower thermal resistance in the more alcoholic beer.",°,CHEMICAL,indicate,lower thermal resistance,MENTAL_HEALTH
34797427,SIBO was evaluated using lactulose hydrogen breath test.,SIBO,DISEASE,use,lactulose hydrogen breath test,CHEMICAL
35528169,"This study suggested that baicalin might be a useful therapeutic agent for senile dementia, especially AD.",baicalin,CHEMICAL,be useful therapeutic agent for,senile dementia,MENTAL_HEALTH
32956901,"Linear regression models revealed a significant negative association between the infants' mercury exposure during lactation and the TONI Quotient (β = -0.298, 95%CI = -4.677, -0.414) and Beery VMI Age Equivalent scores at age 5-8 (β = -0.437, 95%CI = -6.383, -1.844).",regression models,MENTAL_HEALTH,reveal significant negative association between infants ',mercury exposure,NUTRITION
30071252,"Intravenous injection of a murine xenograft model with a low dose of paclitaxel within the micelles, one-milligram drug per kg (mouse), corresponding to an amount less than that of Taxol by one order of magnitude, induces dramatic tumor regression without any acute systemic inflammation responses or organ toxicity under low-power irradiation (55 mW cm-2) at 650 nm.",paclitaxel,CHEMICAL,induce,dramatic tumor regression,MENTAL_HEALTH
30071252,"Intravenous injection of a murine xenograft model with a low dose of paclitaxel within the micelles, one-milligram drug per kg (mouse), corresponding to an amount less than that of Taxol by one order of magnitude, induces dramatic tumor regression without any acute systemic inflammation responses or organ toxicity under low-power irradiation (55 mW cm-2) at 650 nm.",paclitaxel,CHEMICAL,induce,dramatic tumor regression,DISEASE
30071252,"Intravenous injection of a murine xenograft model with a low dose of paclitaxel within the micelles, one-milligram drug per kg (mouse), corresponding to an amount less than that of Taxol by one order of magnitude, induces dramatic tumor regression without any acute systemic inflammation responses or organ toxicity under low-power irradiation (55 mW cm-2) at 650 nm.",one-milligram drug,CHEBI,induce,dramatic tumor regression,MENTAL_HEALTH
30071252,"Intravenous injection of a murine xenograft model with a low dose of paclitaxel within the micelles, one-milligram drug per kg (mouse), corresponding to an amount less than that of Taxol by one order of magnitude, induces dramatic tumor regression without any acute systemic inflammation responses or organ toxicity under low-power irradiation (55 mW cm-2) at 650 nm.",one-milligram drug,CHEBI,induce,dramatic tumor regression,DISEASE
29776573,"Acute coronary syndromes (ACS) represent a context of higher thrombotic risk, where larger advantages have been achieved by the administration of dual antiplatelet therapy (DAPT).",Acute coronary syndromes,MENTAL_HEALTH,represent context of,higher thrombotic risk,DISEASE
29776573,"Acute coronary syndromes (ACS) represent a context of higher thrombotic risk, where larger advantages have been achieved by the administration of dual antiplatelet therapy (DAPT).",ACS,DISEASE,represent context of,higher thrombotic risk,DISEASE
29776573,"In addition, the initial fear of late thrombotic events emerged with first generation drug-eluting stents (DES), that suggested the need of a prolonged DAPT prescription, has been completely overcome by the recent technological evolution of DES, that have shown faster re-endothelization and lower rates of late thrombotic complications.",late thrombotic events,DISEASE,be overcome by recent technological evolution of,DES,CHEMICAL
29776573,"In addition, the initial fear of late thrombotic events emerged with first generation drug-eluting stents (DES), that suggested the need of a prolonged DAPT prescription, has been completely overcome by the recent technological evolution of DES, that have shown faster re-endothelization and lower rates of late thrombotic complications.",late thrombotic events,DISEASE,emerge in addition with,DES,CHEMICAL
29776573,"By keeping in mind the balance between thrombotic and bleeding complications, and due to the paucity of dedicated randomized trials, the identification of the optimal duration of DAPT after ACS is still matter of debate, and is therefore the aim of the present meta-analysis.",thrombotic,DISEASE,have the balance with,bleeding complications,DISEASE
29776573,"By keeping in mind the balance between thrombotic and bleeding complications, and due to the paucity of dedicated randomized trials, the identification of the optimal duration of DAPT after ACS is still matter of debate, and is therefore the aim of the present meta-analysis.",bleeding complications,DISEASE,have the balance with,thrombotic,DISEASE
18058349,"Physiological effects and subjective effects on withdrawal and craving were comparable among Exalt, Ariva, and the MNL.",craving,MENTAL_HEALTH,be comparable among,Exalt,CHEMICAL
35595026,Post-training and/or pre-test microinjections of ACPA (1 and 2 ng/mouse) and 8-OH-DPAT (0.5 and 1 μg/mouse) dose-dependently induced amnesia.,8-OH-DPAT,CHEMICAL,induce,amnesia,MENTAL_HEALTH
26836415,"Before treatment, amygdala GM volume correlated positively with anticipatory speech anxiety (P(FWE)=0.04), and CBT-induced reduction of amygdala GM volume (pre-post) correlated positively with reduced anticipatory anxiety after treatment (P(FWE) ⩽ 0.05).",amygdala GM volume,CHEMICAL,correlate before treatment with,amygdala GM volume,CHEMICAL
26836415,"Before treatment, amygdala GM volume correlated positively with anticipatory speech anxiety (P(FWE)=0.04), and CBT-induced reduction of amygdala GM volume (pre-post) correlated positively with reduced anticipatory anxiety after treatment (P(FWE) ⩽ 0.05).",amygdala GM volume,CHEMICAL,correlate before treatment with,speech anxiety,MENTAL_HEALTH
26836415,Further analysis indicated that diminished amygdala GM volume mediated the relationship between decreased neural responsivity and reduced social anxiety after treatment (P=0.007).,diminished amygdala GM volume,CHEMICAL,reduce,social anxiety,MENTAL_HEALTH
18331426,It is demonstrated for the first time that invertase activity can be introduced in an S101L mutant of chicory (Cichorium intybus) 1-FEH IIa by influencing the orientation of Trp 82.,invertase activity,NUTRITION,be introduced in s101l mutant of,chicory intybus 1-FEH IIa,NUTRITION
18331426,It is demonstrated for the first time that invertase activity can be introduced in an S101L mutant of chicory (Cichorium intybus) 1-FEH IIa by influencing the orientation of Trp 82.,invertase activity,NUTRITION,influence orientation of,Trp,CHEMICAL
18331426,It is demonstrated for the first time that invertase activity can be introduced in an S101L mutant of chicory (Cichorium intybus) 1-FEH IIa by influencing the orientation of Trp 82.,invertase activity,NUTRITION,influence,orientation,MENTAL_HEALTH
35474589,"This work tested the hypothesis that mercury exacerbates the effects of fragmentation by affecting the movement of the marsh periwinkle, Littoraria irrorata, and reducing the probability of snails crossing fragmented microlandscape experimental systems.",mercury,NUTRITION,exacerbate effects of,fragmentation,MENTAL_HEALTH
35474589,"Mercury exacerbated the effects of habitat fragmentation by affecting the cognition (e.g., route planning, orientation and spatial learning) and movement of L. irrorata.",Mercury,NUTRITION,affect,orientation,MENTAL_HEALTH
35474589,"Mercury exacerbated the effects of habitat fragmentation by affecting the cognition (e.g., route planning, orientation and spatial learning) and movement of L. irrorata.",Mercury,NUTRITION,affect,L. irrorata,CHEMICAL
35474589,"Mercury exacerbated the effects of habitat fragmentation by affecting the cognition (e.g., route planning, orientation and spatial learning) and movement of L. irrorata.",Mercury,NUTRITION,exacerbate effects of,habitat fragmentation,MENTAL_HEALTH
17622578,"Despite high homology and conserved atomic contact residues within the agonist binding pocket of NR2A and NR2D, glutamate adopts a different binding orientation that could be exploited for the development of subunit selective agonists and competitive antagonists.",glutamate,CHEMICAL,conserved atomic contact residues within agonist binding pocket of,NR2A different binding orientation,MENTAL_HEALTH
17622578,"Despite high homology and conserved atomic contact residues within the agonist binding pocket of NR2A and NR2D, glutamate adopts a different binding orientation that could be exploited for the development of subunit selective agonists and competitive antagonists.",glutamate,CHEMICAL,conserved atomic contact residues within agonist binding pocket of,NR2A different binding orientation,CHEMICAL
17622578,"Despite high homology and conserved atomic contact residues within the agonist binding pocket of NR2A and NR2D, glutamate adopts a different binding orientation that could be exploited for the development of subunit selective agonists and competitive antagonists.",glutamate,CHEMICAL,conserved atomic contact residues within,agonist binding pocket,CHEBI
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to severe drug dependence in patients with,alcohol dependence,MENTAL_HEALTH
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to severe drug dependence in patients with,methamphetamine dependence,CHEMICAL
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to severe drug dependence in patients with,alcohol dependence,MENTAL_HEALTH
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to severe drug dependence in patients with,methamphetamine dependence,CHEMICAL
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to,severe drug dependence,MENTAL_HEALTH
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to,severe drug dependence,MENTAL_HEALTH
24946391,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence score on a personality questionnaire in healthy subjects.",severe drug dependence,MENTAL_HEALTH,in patients with,methamphetamine dependence,CHEMICAL
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to severe drug dependence in patients with,alcohol dependence,MENTAL_HEALTH
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to severe drug dependence in patients with,methamphetamine dependence,CHEMICAL
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to severe drug dependence in patients with,alcohol dependence,MENTAL_HEALTH
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to severe drug dependence in patients with,methamphetamine dependence,CHEMICAL
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",carriers,CHEBI,exhibit in addition less vulnerability to,severe drug dependence,MENTAL_HEALTH
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,exhibit in addition less vulnerability to,severe drug dependence,MENTAL_HEALTH
23183491,"In addition, carriers of the C allele in this SNP exhibited less vulnerability to severe drug dependence in patients with methamphetamine dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",severe drug dependence,MENTAL_HEALTH,in patients with,methamphetamine dependence,CHEMICAL
25069259,"In addition, the SNP also showed significant association with vulnerability to severe drug dependence in patients with METH dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,show in addition significant association with vulnerability to severe drug dependence in patients with,alcohol dependence,MENTAL_HEALTH
25069259,"In addition, the SNP also showed significant association with vulnerability to severe drug dependence in patients with METH dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,show in addition significant association with vulnerability to severe drug dependence in patients with,METH dependence,CHEMICAL
25069259,"In addition, the SNP also showed significant association with vulnerability to severe drug dependence in patients with METH dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",SNP,CHEMICAL,show in addition significant association with vulnerability to,severe drug dependence,MENTAL_HEALTH
25069259,"In addition, the SNP also showed significant association with vulnerability to severe drug dependence in patients with METH dependence, alcohol dependence, and eating disorders and a lower 'Reward Dependence' score on a personality questionnaire in healthy subjects.",severe drug dependence,MENTAL_HEALTH,in patients with,METH dependence,CHEMICAL
11072265,Dementia in PD may result from a mixture of cortical and subcortical dementia syndromes caused by a variety of underlying pathologic processes and neurochemical deficits.,PD,DISEASE,result from mixture of,cortical dementia syndromes,MENTAL_HEALTH
11072265,Dementia in PD may result from a mixture of cortical and subcortical dementia syndromes caused by a variety of underlying pathologic processes and neurochemical deficits.,Dementia,MENTAL_HEALTH,result from mixture of,cortical dementia syndromes,MENTAL_HEALTH
11072265,Dementia in PD may result from a mixture of cortical and subcortical dementia syndromes caused by a variety of underlying pathologic processes and neurochemical deficits.,PD,DISEASE,result from,mixture,CHEBI
11072265,Dementia in PD may result from a mixture of cortical and subcortical dementia syndromes caused by a variety of underlying pathologic processes and neurochemical deficits.,Dementia,MENTAL_HEALTH,result from,mixture,CHEBI
32748293,"Delayed QT prolongation (i.e., hysteresis) was predominantly observed in subjects with nausea and vomiting, potentially caused by vagal reaction and/or decreases in potassium concentration.",Delayed QT prolongation,DISEASE,be observed in subjects with,nausea,DISEASE
32748293,"Delayed QT prolongation (i.e., hysteresis) was predominantly observed in subjects with nausea and vomiting, potentially caused by vagal reaction and/or decreases in potassium concentration.",Delayed QT prolongation,DISEASE,be observed in subjects with,potassium concentration,CHEMICAL
32748293,"Delayed QT prolongation (i.e., hysteresis) was predominantly observed in subjects with nausea and vomiting, potentially caused by vagal reaction and/or decreases in potassium concentration.",Delayed QT prolongation,DISEASE,be observed in subjects with,vomiting,DISEASE
28544528,"In addition, the fingerprint-efficacy relationship between the chemical fingerprints and antioxidant activities was investigated utilizing orthogonal projection to latent structures, which provided important medicinal efficacy information for quality control.",fingerprint-efficacy relationship,CHEMICAL,utilize,orthogonal projection,MENTAL_HEALTH
15862185,"The apolipoprotein E epsilon4 allele, oestrogen deficiency, high levels of Abeta1-42 peptide, elevated expression of BACE2, and valine polymorphism of prion protein gene are associated with earlier onset of dementia in DS individuals.",oestrogen deficiency,CHEBI,be associated with earlier onset of,dementia,MENTAL_HEALTH
15862185,"The apolipoprotein E epsilon4 allele, oestrogen deficiency, high levels of Abeta1-42 peptide, elevated expression of BACE2, and valine polymorphism of prion protein gene are associated with earlier onset of dementia in DS individuals.",valine polymorphism,CHEMICAL,be associated with earlier onset of,dementia,MENTAL_HEALTH
27839782,"Antidepressant response to a single subanesthetic dose infusion of the glutamatergic modulator ketamine is transient in most depressed patients; however, a minority continue to experience an extended response.",modulator ketamine,CHEMICAL,be transient in,depressed patients,DISEASE
27839782,"Antidepressant response to a single subanesthetic dose infusion of the glutamatergic modulator ketamine is transient in most depressed patients; however, a minority continue to experience an extended response.",Antidepressant response,CHEMICAL,be transient in,depressed patients,DISEASE
27839782,"Antidepressant response to a single subanesthetic dose infusion of the glutamatergic modulator ketamine is transient in most depressed patients; however, a minority continue to experience an extended response.",single subanesthetic dose infusion,CHEMICAL,be transient in,depressed patients,DISEASE
22329473,"Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD-D); however, only 40-50% of patients have a full response.",Lamotrigine,CHEMICAL,be shown to effective in depressive phase of,BD-D,DISEASE
22329473,"Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD-D); however, only 40-50% of patients have a full response.",Lamotrigine,CHEMICAL,be shown to effective in depressive phase of,bipolar disorder,MENTAL_HEALTH
22329473,"Lamotrigine, an anticonvulsant which decreases presynaptic glutamate release, has been shown to be effective in the depressive phase of bipolar disorder (BD-D); however, only 40-50% of patients have a full response.",Lamotrigine,CHEMICAL,be shown to effective in,depressive phase,DISEASE
22329473,"This pilot study investigated whether memantine, a low-affinity N-methyl-D-aspartate (NMDA) receptor antagonist approved for Alzheimer's disease, can augment the effects of lamotrigine.",memantine,CHEMICAL,augment effects of,lamotrigine,CHEMICAL
22329473,"This pilot study investigated whether memantine, a low-affinity N-methyl-D-aspartate (NMDA) receptor antagonist approved for Alzheimer's disease, can augment the effects of lamotrigine.",low-affinity N-methyl-D-aspartate NMDA receptor antagonist,CHEBI,augment effects of,lamotrigine,CHEMICAL
22329473,"This pilot study investigated whether memantine, a low-affinity N-methyl-D-aspartate (NMDA) receptor antagonist approved for Alzheimer's disease, can augment the effects of lamotrigine.",low-affinity N-methyl-D-aspartate NMDA receptor antagonist,CHEMICAL,augment effects of,lamotrigine,CHEMICAL
24374069,"Dopamine (DA) is involved in the regulation of motivation, volition, interest/pleasure, and attention/concentration, all of which are likely to be impaired in depressed patients.",Dopamine,CHEMICAL,be involved in regulation of,interest/pleasure,DISEASE
24374069,"Dopamine (DA) is involved in the regulation of motivation, volition, interest/pleasure, and attention/concentration, all of which are likely to be impaired in depressed patients.",DA,CHEMICAL,be involved in regulation of,interest/pleasure,DISEASE
24374069,"Several previous reports suggest that depression may often be accompanied by a relative hypo-dopaminergic state, and some DA receptor agonists are beneficial effects in the treatment for refractory and bipolar depression.",DA receptor agonists,CHEBI,be beneficial effects in treatment for,refractory depression,MENTAL_HEALTH
24374069,"Several previous reports suggest that depression may often be accompanied by a relative hypo-dopaminergic state, and some DA receptor agonists are beneficial effects in the treatment for refractory and bipolar depression.",DA receptor agonists,CHEMICAL,be beneficial effects in treatment for,refractory depression,MENTAL_HEALTH
24374069,"These results suggested that DA might play, at least in part, a role in adult hippocampal neurogenesis via D1-like receptor and the activation of D1-like receptor has a therapeutic potential for depression.",DA,CHEMICAL,play in part role in adult hippocampal neurogenesis via d1-like receptor and activation of,D1-like receptor,CHEMICAL
24374069,"These results suggested that DA might play, at least in part, a role in adult hippocampal neurogenesis via D1-like receptor and the activation of D1-like receptor has a therapeutic potential for depression.",DA,CHEMICAL,play in part role in adult hippocampal neurogenesis via,D1-like receptor,CHEMICAL
34683056,"Phytoestrogens may cause not only hormonal imbalance or disruption of the normal biological function of the organ systems, but also uterine cancer or breast cancer if absorbed and accumulated in the body for a long period of time, depending on the estrogen receptor binding capacity.",Phytoestrogens,CHEBI,cause hormonal imbalance or disruption of normal biological function of,breast cancer,DISEASE
34683056,"Phytoestrogens may cause not only hormonal imbalance or disruption of the normal biological function of the organ systems, but also uterine cancer or breast cancer if absorbed and accumulated in the body for a long period of time, depending on the estrogen receptor binding capacity.",Phytoestrogens,CHEBI,cause hormonal imbalance or disruption of normal biological function of,uterine cancer,DISEASE
18296328,L-theanine significantly increases activity in the alpha frequency band which indicates that it relaxes the mind without inducing drowsiness.,L-theanine,CHEMICAL,increase activity in,alpha frequency band,NUTRITION
31936641,"Mercury is a cumulative neurotoxic agent, exposure to high levels of which may increase the risk of psychiatric symptoms.",Mercury,NUTRITION,increase risk of,psychiatric symptoms,DISEASE
31936641,"Mercury is a cumulative neurotoxic agent, exposure to high levels of which may increase the risk of psychiatric symptoms.",Mercury,NUTRITION,be,cumulative neurotoxic agent,CHEBI
31936641,The purpose of this study was to examine the associations between blood mercury and depression risk in Korean adults.,blood mercury,NUTRITION,have the associations with,depression risk,MENTAL_HEALTH
31936641,The purpose of this study was to examine the associations between blood mercury and depression risk in Korean adults.,depression risk,MENTAL_HEALTH,have the associations with,blood mercury,NUTRITION
31936641,The associations of blood mercury with risk of depression were estimated using multivariate logistic regression after adjustment for potential confounders.,blood mercury,NUTRITION,use,multivariate logistic regression,MENTAL_HEALTH
31936641,The associations of blood mercury with risk of depression were estimated using multivariate logistic regression after adjustment for potential confounders.,depression,MENTAL_HEALTH,use,multivariate logistic regression,MENTAL_HEALTH
31936641,A stratification analysis by fish intake showed that the association between depression and blood mercury was strengthened (OR = 4.00; 95% CI = 1.51-10.6; P trend = 0.015) among females with the lowest tertile of fish intake.,depression,MENTAL_HEALTH,have the association with,blood mercury,NUTRITION
31936641,A stratification analysis by fish intake showed that the association between depression and blood mercury was strengthened (OR = 4.00; 95% CI = 1.51-10.6; P trend = 0.015) among females with the lowest tertile of fish intake.,blood mercury,NUTRITION,have the association with,depression,MENTAL_HEALTH
31936641,"The results of this study suggest that higher levels of blood mercury, especially in cases of lower fish intake, are positively associated with the risk of depression in Korean women.",blood mercury,NUTRITION,be associated with risk of,depression,MENTAL_HEALTH
24894460,"Fourteen adults with neurological memory impairment completed PM tasks under four counterbalanced conditions: EL of EBPM, EL of TBPM, EF of EBPM, and EF of TBPM.",neurological memory impairment,DISEASE,counterbalanced conditions el of,TBPM,CHEMICAL
15712624,Adjuvant sympatholytics can be used to treat hyperadrenergic symptoms that persist despite adequate sedation.,Adjuvant sympatholytics,CHEBI,treat,hyperadrenergic symptoms,DISEASE
33582266,"The anti-HIV agents are critical for the HIV/AIDS therapy, but the generation of viral mutants and the severe side effects of the anti-HIV agents pose serious hurdles in the treatment of HIV infection, and creat an urgent need to develop novel anti-HIV agents.",anti-HIV agents,CHEBI,pose serious hurdles in treatment of,HIV infection,DISEASE
34103111,Breast milk vitamin E (BMVE) adequacy was based on the quantity of the vitamin in the estimated intake volume.,Breast milk vitamin E BMVE adequacy,DISEASE,be based on quantity of,vitamin,CHEBI
34103111,Breast milk vitamin E (BMVE) adequacy was based on the quantity of the vitamin in the estimated intake volume.,Breast milk vitamin E BMVE adequacy,CHEBI,be based on quantity of,vitamin,CHEBI
34103111,"Thus, higher dietary shares of ultra-processed foods had an impact on vitamin E biomarkers, suggesting that inadequate dietary intake practices during lactation may reduce the supply of vitamin E to women and breast milk.",vitamin E,CHEBI,have the supply to,breast milk,DISEASE
11071278,"To aid our investigation of tubulin as an antileishmanial drug target, the effects of the mammalian antimicrotubule agents ansamitocin P3, taxol, and hemiasterlin on Leishmania donovani promastigotes were described.",Leishmania donovani promastigotes,DISEASE,aid our investigation of tubulin as,antileishmanial drug target,CHEBI
11071278,"To aid our investigation of tubulin as an antileishmanial drug target, the effects of the mammalian antimicrotubule agents ansamitocin P3, taxol, and hemiasterlin on Leishmania donovani promastigotes were described.",ansamitocin P3,CHEMICAL,aid our investigation of tubulin as,antileishmanial drug target,CHEBI
11071278,"To aid our investigation of tubulin as an antileishmanial drug target, the effects of the mammalian antimicrotubule agents ansamitocin P3, taxol, and hemiasterlin on Leishmania donovani promastigotes were described.",Leishmania donovani promastigotes,DISEASE,aid our investigation of,tubulin,CHEMICAL
11071278,"To aid our investigation of tubulin as an antileishmanial drug target, the effects of the mammalian antimicrotubule agents ansamitocin P3, taxol, and hemiasterlin on Leishmania donovani promastigotes were described.",ansamitocin P3,CHEMICAL,aid our investigation of,tubulin,CHEMICAL
11071278,"Treatment of parasites with WR85915 did not produce the unusual cell types described above and did not cause the accumulation of parasites in G2 + M, suggesting that WR85915 acts on target(s) in Leishmania in addition to tubulin.",WR85915,CHEMICAL,act on target(s in leishmania in addition to,tubulin,CHEMICAL
11071278,"Treatment of parasites with WR85915 did not produce the unusual cell types described above and did not cause the accumulation of parasites in G2 + M, suggesting that WR85915 acts on target(s) in Leishmania in addition to tubulin.",WR85915,CHEMICAL,act on target(s in,Leishmania,DISEASE
33768603,"Adjusted sleep disturbance index was significantly lower with triprolidine 2.5 and 5 mg versus placebo on night 3 (P = .0017 and P = .011, respectively) and for the mean of all 3 nights (P = .01 and P = .015, respectively).",Adjusted disturbance index,DISEASE,be lower with,triprolidine,CHEMICAL
32540057,"Steroid profile evaluated in matrices such as urine, saliva and plasma provide one-off moment information about the hormonal status and is highly affected by different factors such as circadian rhythm or apprehension to needles.",Steroid profile,CHEMICAL,be affected by different factors such as,apprehension,MENTAL_HEALTH
22922230,"PPARγ agonists are effective in the treatment of metabolic diseases and, more recently, neurodegenerative diseases, in which they show promising neuroprotective effects.",PPARγ agonists,CHEBI,be effective in treatment of,diseases neurodegenerative diseases,DISEASE
22922230,"Bezafibrate therefore exerts neuroprotective effects in a mouse model of tauopathy, as shown by decreased tau pathology and behavioral improvement.",Bezafibrate,CHEMICAL,exert neuroprotective effects in mouse model of,tauopathy,DISEASE
22922230,Bezafibrate is therefore a promising agent for the treatment of neurodegenerative diseases associated with tau pathology.,Bezafibrate,CHEMICAL,be promising agent for treatment of,neurodegenerative diseases,DISEASE
28505210,"This shuffling of amino acids and their H-bond interactions is likely to disturb the secondary structure orientation of the polypeptide and induces the gain-of-function in nucleoside phosphate kinase activity of AK5, which may eventually down-regulates the reactivity potential of CD4+ T-cells against gluten antigens.",amino acids,CHEMICAL,disturb,secondary structure orientation,MENTAL_HEALTH
8391269,The 5'-terminal guanine of all these ligands is placed in the primary base binding site of the enzyme in an orientation similar to that of 2'-GMP in the RNase T1-2'-GMP complex.,5'-terminal guanine,CHEMICAL,be placed in primary base binding site of enzyme in,orientation similar,MENTAL_HEALTH
8391269,"However, the orientation of the 2'-terminal pyrimidines is different from that of 2'-terminal purines.",2'-terminal pyrimidines,CHEMICAL,be different from,2'-terminal purines,CHEMICAL
8391269,"However, the orientation of the 2'-terminal pyrimidines is different from that of 2'-terminal purines.",orientation,MENTAL_HEALTH,be different from,2'-terminal purines,CHEMICAL
17437673,Calcium and vitamin D are the mainstays of nutritional intervention for the prevention and treatment of osteoporosis.,Calcium vitamin D,CHEBI,be mainstays of nutritional intervention for prevention and treatment of,osteoporosis,DISEASE
17437673,Calcium and vitamin D are the mainstays of nutritional intervention for the prevention and treatment of osteoporosis.,Calcium vitamin D,CHEMICAL,be mainstays of nutritional intervention for prevention and treatment of,osteoporosis,DISEASE
17437673,"Diets high in fruits and vegetables contribute nutrients such as magnesium associated with bone health and may also produce an alkaline environment, reducing calcium excretion and thus improving bone density.",Diets high,DISEASE,contribute nutrients such as,magnesium,CHEMICAL
14749742,To investigate glutathione and amino acids related to glutathione metabolism in patients with anorexia nervosa in order to test the hypothesis that these patients exhibit a deficiency of glutathione and therefore might be at an increased risk of developing toxic liver injury.,glutathione metabolism,CHEMICAL,in patients with,anorexia nervosa,MENTAL_HEALTH
14749742,To investigate glutathione and amino acids related to glutathione metabolism in patients with anorexia nervosa in order to test the hypothesis that these patients exhibit a deficiency of glutathione and therefore might be at an increased risk of developing toxic liver injury.,amino acids related,CHEMICAL,in patients with,anorexia nervosa,MENTAL_HEALTH
31350149,"The transient beneficial effects of calcium administration (increase in arterial blood pressure, systemic vascular resistance, cardiac index, stroke volume, and coronary perfusion pressure) might be helpful in cases of moderate contractility reduction or vasoplegia.",calcium administration,CHEMICAL,be helpful in cases of,vasoplegia,DISEASE
25596911,Deficiencies of niacin may contribute to neuropsychiatric and neurodegenerative disorders.,niacin,CHEBI,contribute to,neuropsychiatric disorders,DISEASE
2898156,Restriction of ethanol intake by SKV therapy resulted in the reversal of organ enlargement and membrane composition in alcoholics.,SKV therapy,DISEASE,have restriction of,ethanol intake,CHEMICAL
20631179,"Genetic reduction of Drosophila metabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP(3)R), or inositol polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits.",Drosophila metabotropic glutamate receptor,CHEMICAL,prevent,age-onset cognitive deficits,DISEASE
20631179,"Genetic reduction of Drosophila metabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP(3)R), or inositol polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits.",inositol trisphosphate receptor,CHEMICAL,prevent,age-onset cognitive deficits,DISEASE
20631179,"Genetic reduction of Drosophila metabotropic glutamate receptor (DmGluRA), the inositol trisphosphate receptor (InsP(3)R), or inositol polyphosphate 1-phosphatase also prevented these age-onset cognitive deficits.",inositol polyphosphate 1-phosphatase,CHEMICAL,prevent,age-onset cognitive deficits,DISEASE
23574156,The inception of n-3 PUFA as a putative depression therapeutic may have stemmed from reports suggesting that dietary n-3 PUFA deficiency is linked to both altered membrane PUFA content as well as clinical depression.,dietary n-3 PUFA deficiency,CHEMICAL,be linked to,clinical depression,MENTAL_HEALTH
23574156,The inception of n-3 PUFA as a putative depression therapeutic may have stemmed from reports suggesting that dietary n-3 PUFA deficiency is linked to both altered membrane PUFA content as well as clinical depression.,dietary n-3 PUFA deficiency,CHEMICAL,be linked to,altered membrane PUFA content,CHEMICAL
20620876,Abnormal signaling by retinoids or n-3 polyunsaturated fatty acids has been implicated in clinical depression.,n-3 polyunsaturated fatty acids,NUTRITION,be implicated in,clinical depression,MENTAL_HEALTH
20620876,Abnormal signaling by retinoids or n-3 polyunsaturated fatty acids has been implicated in clinical depression.,n-3 polyunsaturated fatty acids,CHEMICAL,be implicated in,clinical depression,MENTAL_HEALTH
20620876,"Conversely, NAc infusion of raclopride, a D2r antagonist prevents AAV2-Rxrgamma-mediated rescue of despair behaviors in Rxrgamma(-/-) mice.",raclopride,CHEMICAL,prevent aav2-rxrgamma-mediated rescue of,despair behaviors,DISEASE
20620876,"Conversely, NAc infusion of raclopride, a D2r antagonist prevents AAV2-Rxrgamma-mediated rescue of despair behaviors in Rxrgamma(-/-) mice.",D2r antagonist,CHEBI,prevent aav2-rxrgamma-mediated rescue of,despair behaviors,DISEASE
12617697,"Cannabinoids can alleviate tremor and spasticity in animal models of multiple sclerosis, and clinical trials of the use of these compounds for these symptoms are in progress.",Cannabinoids,CHEMICAL,alleviate tremor and spasticity in animal models of,multiple sclerosis,DISEASE
12617697,"Cannabinoids can alleviate tremor and spasticity in animal models of multiple sclerosis, and clinical trials of the use of these compounds for these symptoms are in progress.",Cannabinoids,CHEMICAL,alleviate,tremor,DISEASE
12617697,"Cannabinoids can alleviate tremor and spasticity in animal models of multiple sclerosis, and clinical trials of the use of these compounds for these symptoms are in progress.",Cannabinoids,CHEMICAL,alleviate,spasticity,DISEASE
12617697,The cannabinoid nabilone is currently licensed for use as an antiemetic agent in chemotherapy-induced emesis.,cannabinoid nabilone,CHEMICAL,be licensed for use as antiemetic agent in,chemotherapy-induced emesis,DISEASE
12617697,"Dexanabinol (HU-211), a synthetic cannabinoid, is currently being assessed in clinical trials for traumatic brain injury and stroke.",HU-211,CHEMICAL,be assessed in clinical trials for,traumatic brain injury,DISEASE
12617697,"Dexanabinol (HU-211), a synthetic cannabinoid, is currently being assessed in clinical trials for traumatic brain injury and stroke.",HU-211,CHEMICAL,be assessed in clinical trials for,stroke,DISEASE
12617697,"Dexanabinol (HU-211), a synthetic cannabinoid, is currently being assessed in clinical trials for traumatic brain injury and stroke.",Dexanabinol,CHEMICAL,be assessed in clinical trials for,traumatic brain injury,DISEASE
12617697,"Dexanabinol (HU-211), a synthetic cannabinoid, is currently being assessed in clinical trials for traumatic brain injury and stroke.",Dexanabinol,CHEMICAL,be assessed in clinical trials for,stroke,DISEASE
12617697,"Dronabinol, a commercially available form of delta(9)-THC, has been used successfully for increasing appetite in patients with HIV wasting disease, and cannabinoid receptor antagonists may reduce obesity.",delta(9)-THC,CHEMICAL,be used for increasing appetite in patients with,HIV wasting disease,DISEASE
12617697,"Dronabinol, a commercially available form of delta(9)-THC, has been used successfully for increasing appetite in patients with HIV wasting disease, and cannabinoid receptor antagonists may reduce obesity.",cannabinoid receptor antagonists,CHEBI,reduce,obesity,DISEASE
12617697,"Dronabinol, a commercially available form of delta(9)-THC, has been used successfully for increasing appetite in patients with HIV wasting disease, and cannabinoid receptor antagonists may reduce obesity.",Dronabinol,CHEMICAL,be used for increasing appetite in patients with,HIV wasting disease,DISEASE
12617697,Acute adverse effects following cannabis usage include sedation and anxiety.,cannabis usage,CHEMICAL,include,anxiety,MENTAL_HEALTH
12617697,The use of nonpsychoactive cannabinoids such as cannabidiol and dexanabinol may allow the dissociation of unwanted psychoactive effects from potential therapeutic benefits.,cannabidiol,CHEMICAL,allow,dissociation,MENTAL_HEALTH
24472399,"Patients aged 18 - 80 years with a musculoskeletal disorder, attended ambulatory healthcare settings > 25 times, and were prescribed pain relievers such as non-steroidal anti-inflammatory drugs and narcotic analgesics in an oral formulation for ≥ 14 days or in an injection formulation ≥ 3 times during the study period were included in the study.",musculoskeletal disorder,DISEASE,be prescribed pain relievers such as non-steroidal anti-inflammatory drugs and narcotic analgesics in oral formulation for,≥,CHEMICAL
24472399,"Patients aged 18 - 80 years with a musculoskeletal disorder, attended ambulatory healthcare settings > 25 times, and were prescribed pain relievers such as non-steroidal anti-inflammatory drugs and narcotic analgesics in an oral formulation for ≥ 14 days or in an injection formulation ≥ 3 times during the study period were included in the study.",musculoskeletal disorder,DISEASE,be prescribed pain relievers such as,narcotic analgesics,CHEBI
24472399,"Patients aged 18 - 80 years with a musculoskeletal disorder, attended ambulatory healthcare settings > 25 times, and were prescribed pain relievers such as non-steroidal anti-inflammatory drugs and narcotic analgesics in an oral formulation for ≥ 14 days or in an injection formulation ≥ 3 times during the study period were included in the study.",musculoskeletal disorder,DISEASE,be prescribed,pain relievers,DISEASE
19339768,"The obstructive sleep apnea syndrome (OSAS) is characterized by repeated upper airway obstruction during sleep together with decreases in oxygen saturation leading to a series of pathological events, primarily in the cardiovascular system.",obstructive sleep apnea syndrome,MENTAL_HEALTH,be characterized by repeated upper airway obstruction during sleep with decreases in,oxygen saturation,CHEMICAL
19339768,"The obstructive sleep apnea syndrome (OSAS) is characterized by repeated upper airway obstruction during sleep together with decreases in oxygen saturation leading to a series of pathological events, primarily in the cardiovascular system.",obstructive sleep apnea syndrome,MENTAL_HEALTH,be characterized by,repeated upper airway obstruction,DISEASE
19339768,"Elevated plasma homocysteine levels have recently been considered as an independent risk factor for vascular disease, and increased levels are attributed to cardiovascular diseases.",Elevated plasma homocysteine levels,CHEMICAL,be considered as independent risk factor for,vascular disease,DISEASE
17126615,Consequences of chronic intermittent hypoxia (CIH) exposure were examined after 21 consecutive days of hypoxia protocol from 10:00 to 16:00 followed by a sleep restriction (SR) period of 18h (16:00-10:00).,chronic intermittent hypoxia CIH exposure,DISEASE,be examined after consecutive days of,hypoxia protocol,DISEASE
12193244,"The high frequency of DMX3 supports the clinical usefulness of the definition, as well as observations that antidepressants may worsen its hypomanic symptoms, whereas antipsychotics and mood stabilisers may treat them.",antidepressants,CHEMICAL,worsen,hypomanic symptoms,DISEASE
26440412,"Hypostomus punctatus was registered at all sample sites both before and after the introduction of P. maculicauda, but its density decreased at all upstream sites after the arrival of the exotic species.",Hypostomus punctatus,CHEMICAL,be registered at sample sites before and after introduction of,P. maculicauda,DISEASE
23995949,We studied the effect of NO and catecholamines on the pigment displacement by observing the changes in the melanophore index.,catecholamines,CHEMICAL,have the effect on,pigment displacement,MENTAL_HEALTH
23995949,We studied the effect of NO and catecholamines on the pigment displacement by observing the changes in the melanophore index.,NO,CHEMICAL,have the effect on,pigment displacement,MENTAL_HEALTH
21532601,"Although all pharmaceutical treatments for PE are currently used 'off-label', some novel oral agents and some newer methods of drug administration now provide important relief to PE patients.",pharmaceutical treatments,CHEBI,be used,drug administration,CHEBI
21532601,"Although all pharmaceutical treatments for PE are currently used 'off-label', some novel oral agents and some newer methods of drug administration now provide important relief to PE patients.",PE,DISEASE,be used,drug administration,CHEBI
10668577,The pharmacological treatment of premature ejaculation is now receiving increased attention from both physicians with an interest in sexual medicine and from the pharmaceutical industry.,premature ejaculation,MENTAL_HEALTH,receive increased attention from physicians with interest in,pharmaceutical industry,CHEBI
23098797,"We previously revealed that the activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor and mammalian target of rapamycin signaling contributed to the antidepressant-like effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists, suggesting that the signaling pathway may be similar to the molecular mechanisms underlying the antidepressant-like action of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist that exertes rapid and sustained antidepressant effects in patients with depressive disorder.",α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,CHEMICAL,contribute to antidepressant-like effects of,group metabotropic mGlu2/3 receptor antagonists,CHEBI
23098797,"We previously revealed that the activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor and mammalian target of rapamycin signaling contributed to the antidepressant-like effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists, suggesting that the signaling pathway may be similar to the molecular mechanisms underlying the antidepressant-like action of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist that exertes rapid and sustained antidepressant effects in patients with depressive disorder.",α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor,CHEMICAL,contribute to antidepressant-like effects of,glutamate,CHEMICAL
23098797,"We previously revealed that the activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor and mammalian target of rapamycin signaling contributed to the antidepressant-like effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists, suggesting that the signaling pathway may be similar to the molecular mechanisms underlying the antidepressant-like action of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist that exertes rapid and sustained antidepressant effects in patients with depressive disorder.",rapamycin signaling,CHEMICAL,contribute to antidepressant-like effects of,group metabotropic mGlu2/3 receptor antagonists,CHEBI
23098797,"We previously revealed that the activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor and mammalian target of rapamycin signaling contributed to the antidepressant-like effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists, suggesting that the signaling pathway may be similar to the molecular mechanisms underlying the antidepressant-like action of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist that exertes rapid and sustained antidepressant effects in patients with depressive disorder.",rapamycin signaling,CHEMICAL,contribute to antidepressant-like effects of,glutamate,CHEMICAL
23098797,"We previously revealed that the activation of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor and mammalian target of rapamycin signaling contributed to the antidepressant-like effects of group II metabotropic glutamate (mGlu2/3) receptor antagonists, suggesting that the signaling pathway may be similar to the molecular mechanisms underlying the antidepressant-like action of ketamine, a noncompetitive N-methyl-D-aspartate receptor antagonist that exertes rapid and sustained antidepressant effects in patients with depressive disorder.",sustained antidepressant effects,CHEMICAL,in patients with,depressive disorder,MENTAL_HEALTH
35389015,Itraconazole is a widely accepted oral medication used for onychomycosis while fractional CO2 laser along with a topical anti-fungal has shown promising results for nail plate clearance in onychomycosis.,Itraconazole,CHEMICAL,show promising results for nail plate clearance in,onychomycosis,DISEASE
35389015,Itraconazole is a widely accepted oral medication used for onychomycosis while fractional CO2 laser along with a topical anti-fungal has shown promising results for nail plate clearance in onychomycosis.,Itraconazole,CHEMICAL,used for,onychomycosis,DISEASE
35389015,Aim To compare the efficacy of fractional CO2 laser with 1% terbinafine cream versus itraconazole in the management of onychomycosis.,fractional CO2 laser,CHEMICAL,have the efficacy with,% terbinafine cream,CHEMICAL
35389015,Aim To compare the efficacy of fractional CO2 laser with 1% terbinafine cream versus itraconazole in the management of onychomycosis.,fractional CO2 laser,CHEMICAL,have the efficacy with,itraconazole,CHEMICAL
35389015,Conclusion Fractional CO2 laser with 1% terbinafine cream is an effective and safe method for inducing nail clearance in onychomycosis and has efficacy similar to itraconazole pulse therapy.,% terbinafine cream,CHEMICAL,have efficacy similar to,itraconazole pulse therapy,CHEMICAL
35389015,Conclusion Fractional CO2 laser with 1% terbinafine cream is an effective and safe method for inducing nail clearance in onychomycosis and has efficacy similar to itraconazole pulse therapy.,Conclusion Fractional CO2 laser,CHEMICAL,have efficacy similar to,itraconazole pulse therapy,CHEMICAL
35389015,Conclusion Fractional CO2 laser with 1% terbinafine cream is an effective and safe method for inducing nail clearance in onychomycosis and has efficacy similar to itraconazole pulse therapy.,% terbinafine cream,CHEMICAL,be effective method for,onychomycosis,DISEASE
35389015,Conclusion Fractional CO2 laser with 1% terbinafine cream is an effective and safe method for inducing nail clearance in onychomycosis and has efficacy similar to itraconazole pulse therapy.,Conclusion Fractional CO2 laser,CHEMICAL,be effective method for,onychomycosis,DISEASE
30555279,"As a calcium sensitizer and inodilator that augments cardiac contractility without increasing myocardial oxygen demand or exacerbating ischaemia, levosimendan may be well configured to deliver inotropic support in cases of acute heart failure (AHF).",levosimendan,CHEMICAL,deliver inotropic support in cases of,AHF,DISEASE
30555279,"As a calcium sensitizer and inodilator that augments cardiac contractility without increasing myocardial oxygen demand or exacerbating ischaemia, levosimendan may be well configured to deliver inotropic support in cases of acute heart failure (AHF).",levosimendan,CHEMICAL,deliver inotropic support in cases of,acute heart failure,DISEASE
30555279,"Effects of levosimendan on systemic haemodynamics include its significant, dose-dependent increases in cardiac output, stroke volume and heart rate, and decreases in right and left ventricular filling and total peripheral resistance.",levosimendan,CHEMICAL,include,stroke volume,DISEASE
30555279,"Effects of levosimendan on systemic haemodynamics include its significant, dose-dependent increases in cardiac output, stroke volume and heart rate, and decreases in right and left ventricular filling and total peripheral resistance.",levosimendan,CHEMICAL,include,cardiac output,DISEASE
30555279,"Effects of levosimendan on systemic haemodynamics include its significant, dose-dependent increases in cardiac output, stroke volume and heart rate, and decreases in right and left ventricular filling and total peripheral resistance.",levosimendan,CHEMICAL,leave,filling peripheral resistance,MENTAL_HEALTH
30555279,"Levosimendan has repeatedly been shown to be effective in relief of symptoms of AHF, notably dyspnoea and fatigue, while mortality data from clinical trials and registries suggest that levosimendan is markedly less likely than catecholaminergic inotropes to worsen prognosis.",Levosimendan,CHEMICAL,be shown to effective in relief of symptoms of,AHF,DISEASE
30555279,"Levosimendan has repeatedly been shown to be effective in relief of symptoms of AHF, notably dyspnoea and fatigue, while mortality data from clinical trials and registries suggest that levosimendan is markedly less likely than catecholaminergic inotropes to worsen prognosis.",Levosimendan,CHEMICAL,be shown to effective in relief of symptoms of,dyspnoea,DISEASE
30555279,"Levosimendan has repeatedly been shown to be effective in relief of symptoms of AHF, notably dyspnoea and fatigue, while mortality data from clinical trials and registries suggest that levosimendan is markedly less likely than catecholaminergic inotropes to worsen prognosis.",Levosimendan,CHEMICAL,be shown to effective in relief of symptoms of,fatigue,MENTAL_HEALTH
30555279,"The vasodilator pharmacology of levosimendan is also pertinent to the drug's use in AHF, in which setting organ under-perfusion is often a key pathology.",levosimendan key pathology,CHEMICAL,be pertinent to drug's use in,AHF,DISEASE
30555279,"The vasodilator pharmacology of levosimendan is also pertinent to the drug's use in AHF, in which setting organ under-perfusion is often a key pathology.",levosimendan key pathology,CHEMICAL,be pertinent to,drug,CHEBI
30555279,These considerations suggest that levosimendan may have a more favourable impact on the circumstances of the majority of AHF patients than adrenergic agents that act only or primarily as cardiac stimulants.,levosimendan,CHEMICAL,have favourable impact on circumstances of majority of,AHF patients,DISEASE
30555279,These considerations suggest that levosimendan may have a more favourable impact on the circumstances of the majority of AHF patients than adrenergic agents that act only or primarily as cardiac stimulants.,levosimendan,CHEMICAL,have favourable impact on circumstances of majority of,adrenergic agents,CHEBI
1183731,Reactive hypoglycemia was documented in ten postgastrectomy patients by a control oral glucose tolerance test (OGTT).,Reactive hypoglycemia,DISEASE,be documented in postgastrectomy patients by,oral glucose tolerance test,CHEMICAL
1183731,Reactive hypoglycemia was documented in ten postgastrectomy patients by a control oral glucose tolerance test (OGTT).,Reactive hypoglycemia,DISEASE,be documented in,postgastrectomy patients,DISEASE
1183731,Neuroglycopenic or adrenergic symptoms of hypoglycemia occurred in eight patients two to five hours after oral glucose.,hypoglycemia,DISEASE,occur in patients two to hours after,oral glucose,CHEMICAL
1183731,It is concluded that propranolol ameliorated the symptoms and chemical hypoglycemia after oral glucose and merits more detailed study as a long-term therapy for this disorder.,propranolol,CHEMICAL,ameliorate symptoms and chemical hypoglycemia after,oral glucose,CHEMICAL
1183731,It is concluded that propranolol ameliorated the symptoms and chemical hypoglycemia after oral glucose and merits more detailed study as a long-term therapy for this disorder.,propranolol,CHEMICAL,ameliorate,chemical hypoglycemia,DISEASE
32690613,"SCI-induced pain in a rat model has been shown to depend on persistent hyperactivity in primary nociceptors (injury-detecting sensory neurons), associated with a decrease in the sensitivity of adenylyl cyclase production of cAMP to inhibitory Gαi proteins in DRGs.",SCI-induced pain,DISEASE,depend on,persistent hyperactivity,MENTAL_HEALTH
30839350,Chronic use of μ-opioid receptor agonists paradoxically causes both hyperalgesia and the loss of analgesic efficacy.,μ-opioid receptor agonists,CHEBI,cause hyperalgesia and loss of,analgesic efficacy,CHEBI
30839350,Chronic use of μ-opioid receptor agonists paradoxically causes both hyperalgesia and the loss of analgesic efficacy.,μ-opioid receptor agonists,CHEBI,cause,hyperalgesia,DISEASE
30839350,This study tested the hypothesis that α2δ-1-bound N-methyl-D-aspartate receptors contribute to presynaptic N-methyl-D-aspartate receptor hyperactivity associated with opioid-induced hyperalgesia and analgesic tolerance.,α2δ-1-bound N-methyl-D-aspartate receptors,CHEMICAL,contribute to,presynaptic N-methyl-D-aspartate receptor hyperactivity,MENTAL_HEALTH
30839350,This study tested the hypothesis that α2δ-1-bound N-methyl-D-aspartate receptors contribute to presynaptic N-methyl-D-aspartate receptor hyperactivity associated with opioid-induced hyperalgesia and analgesic tolerance.,α2δ-1-bound N-methyl-D-aspartate receptors,CHEMICAL,contribute to,presynaptic N-methyl-D-aspartate receptor hyperactivity,CHEMICAL
31373522,Context: Serotonin toxicity is a reported complication associated with both therapeutic use and overdose of metaxalone while on therapeutic doses of serotonergic drugs such as serotonin reuptake inhibitors.,Serotonin toxicity,CHEMICAL,associated with therapeutic use and overdose of,metaxalone,CHEMICAL
31373522,Context: Serotonin toxicity is a reported complication associated with both therapeutic use and overdose of metaxalone while on therapeutic doses of serotonergic drugs such as serotonin reuptake inhibitors.,Serotonin toxicity,CHEMICAL,associated with,overdose,DISEASE
31373522,Monoamine oxidase A (MAO-A) inhibition by metaxalone has been proposed as the etiology of this toxicity.,Monoamine A inhibition,CHEMICAL,be proposed as etiology of,toxicity,DISEASE
31373522,Monoamine oxidase A (MAO-A) inhibition by metaxalone has been proposed as the etiology of this toxicity.,metaxalone,CHEMICAL,be proposed as etiology of,toxicity,DISEASE
31773191,Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS).,oral antiplatelets,CHEMICAL,prevent thrombotic events in patients with,acute coronary syndrome,DISEASE
31773191,Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS).,oral antiplatelets,CHEMICAL,prevent thrombotic events in patients with,ACS,DISEASE
31773191,Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS).,oral antiplatelets,CHEMICAL,prevent,thrombotic events,DISEASE
31773191,Use of oral antiplatelets (OAPs) is essential for preventing thrombotic events in patients with acute coronary syndrome (ACS).,thrombotic events,DISEASE,in patients with,acute coronary syndrome,DISEASE
11584099,"Using multivariate linear regression with stepwise selection, we found that the significant predictors for serum sphingosine included total tocopherols, age, serum selenium and retinol, with a final R(2) = 0.22; for sphinganine, tooth loss was the sole correlate, with R(2) = 0.015.",serum sphingosine,CHEMICAL,include,serum selenium,CHEMICAL
11584099,"Using multivariate linear regression with stepwise selection, we found that the significant predictors for serum sphingosine included total tocopherols, age, serum selenium and retinol, with a final R(2) = 0.22; for sphinganine, tooth loss was the sole correlate, with R(2) = 0.015.",serum sphingosine,CHEMICAL,include,retinol,CHEBI
11584099,"Using multivariate linear regression with stepwise selection, we found that the significant predictors for serum sphingosine included total tocopherols, age, serum selenium and retinol, with a final R(2) = 0.22; for sphinganine, tooth loss was the sole correlate, with R(2) = 0.015.",serum sphingosine,CHEMICAL,include,total tocopherols,NUTRITION
2181516,"The three major levels of enquiry regarding possible mechanisms for the transmission of alcoholism and the involvement of genes and gene products in its development are factors related to exposure, metabolism, or pharmacological effects of ethanol.",alcoholism,DISEASE,be factors related to,ethanol,CHEMICAL
2181516,The key to alcoholism is likely to reside in the effects of alcohol on the brain.,alcoholism,DISEASE,reside in effects of,alcohol,CHEMICAL
2181516,"Alternately, alcohol may produce dependence by normalizing abnormal baseline states such as irritability, hyperexcitability, dysphoria, impulsiveness, or stress/tension level.",alcohol,CHEMICAL,normalize abnormal baseline states such as,hyperexcitability,DISEASE
2181516,"Alternately, alcohol may produce dependence by normalizing abnormal baseline states such as irritability, hyperexcitability, dysphoria, impulsiveness, or stress/tension level.",alcohol,CHEMICAL,normalize abnormal baseline states such as,irritability,DISEASE
2181516,"Alternately, alcohol may produce dependence by normalizing abnormal baseline states such as irritability, hyperexcitability, dysphoria, impulsiveness, or stress/tension level.",alcohol,CHEMICAL,normalize abnormal baseline states such as,dysphoria,MENTAL_HEALTH
31498127,Opicapone is a catechol O-methyltransferase (COMT) inhibitor indicated for use as adjunct to levodopa therapy in patients with Parkinson's disease (PD) and motor fluctuations.,levodopa therapy,CHEMICAL,in patients with,Parkinson's disease,DISEASE
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",GHB,CHEMICAL,reduce,alcohol craving,MENTAL_HEALTH
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",GHB,CHEMICAL,reduce,alcohol craving,CHEMICAL
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",GHB,CHEMICAL,act as,alcohol,CHEMICAL
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",GHB,CHEMICAL,be related to ethanol-mimicking action of,drug,CHEBI
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",alcohol dependence,MENTAL_HEALTH,be related to ethanol-mimicking action of,drug,CHEBI
18293241,"It has been hypothesized that the therapeutic effects of Gamma-hydroxybutyrate (GHB) in alcohol dependence could be related to ethanol-mimicking action of the drug and that GHB could reduce alcohol craving, intake and withdrawal by acting as a ""substitute"" of the alcohol in the central nervous system.",Gamma-hydroxybutyrate,CHEMICAL,be related to ethanol-mimicking action of,drug,CHEBI
18293241,"Nevertheless, alcohol being the strongest trigger of craving and intake, it is difficult to ascribe reduction of craving and intake to ethanol-mimicking activity of GHB.",alcohol,CHEMICAL,be strongest trigger of,craving,MENTAL_HEALTH
18293241,"I have recently proposed that alcohol/substance dependence could result from a GHB-deficiency-related dysphoric syndrome in which alcohol/substances would be sought to ""substitute"" for insufficient GHB effect.",alcohol/substance dependence,DISEASE,result from,GHB-deficiency-related dysphoric syndrome,DISEASE
11522462,"Importantly, in subsequent logistic regression analyses, fast beta power was found to be superior to severity of illness, depression level, and childhood conduct problems in predicting relapse.",fast beta power,CHEBI,be found in subsequent logistic regression analyses to superior to severity of,depression level,MENTAL_HEALTH
11522462,"Importantly, in subsequent logistic regression analyses, fast beta power was found to be superior to severity of illness, depression level, and childhood conduct problems in predicting relapse.",fast beta power,CHEBI,be found in,subsequent regression analyses,MENTAL_HEALTH
29181030,Removal of this epoxy fatty acid from the locus of the N-formyl peptide receptors was associated with recovery from cogwheel rigidity and akinesia as well as with improvement in vibration sense and olfactory perception.,N-formyl peptide receptors,CHEMICAL,be associated with recovery from,akinesia,MENTAL_HEALTH
29181030,Removal of this epoxy fatty acid from the locus of the N-formyl peptide receptors was associated with recovery from cogwheel rigidity and akinesia as well as with improvement in vibration sense and olfactory perception.,N-formyl peptide receptors,CHEMICAL,be associated with recovery from,cogwheel rigidity,DISEASE
29181030,Removal of this epoxy fatty acid from the locus of the N-formyl peptide receptors was associated with recovery from cogwheel rigidity and akinesia as well as with improvement in vibration sense and olfactory perception.,epoxy fatty acid,NUTRITION,be associated with recovery from,akinesia,MENTAL_HEALTH
29181030,Removal of this epoxy fatty acid from the locus of the N-formyl peptide receptors was associated with recovery from cogwheel rigidity and akinesia as well as with improvement in vibration sense and olfactory perception.,epoxy fatty acid,NUTRITION,be associated with recovery from,cogwheel rigidity,DISEASE
32691696,Hemolysis assay clearly revealed the cytotoxic potential of CRM while Allium cepa and seed germination tests for phytotoxicity of CRM were also positive.,Hemolysis assay,DISEASE,reveal cytotoxic potential of,CRM,CHEMICAL
27741280,We developed a novel hydrogel derived from sodium carboxymethylcellulose (CMC) in which phosphatidylethanolamine (PE) was introduced into the carboxyl groups of CMC to prevent perineural adhesions.,phosphatidylethanolamine,NUTRITION,prevent,perineural adhesions,DISEASE
27741280,We developed a novel hydrogel derived from sodium carboxymethylcellulose (CMC) in which phosphatidylethanolamine (PE) was introduced into the carboxyl groups of CMC to prevent perineural adhesions.,phosphatidylethanolamine,NUTRITION,be introduced in,CMC,CHEMICAL
27741280,We developed a novel hydrogel derived from sodium carboxymethylcellulose (CMC) in which phosphatidylethanolamine (PE) was introduced into the carboxyl groups of CMC to prevent perineural adhesions.,phosphatidylethanolamine,NUTRITION,be introduced in,carboxyl groups,CHEMICAL
23640727,"While chronic obesity is associated with alterations in circulating glycerolipids, sphingolipids and plasmalogens, the effects of short-term overfeeding in humans are unclear.",chronic obesity,DISEASE,be associated with alterations in,plasmalogens,CHEMICAL
23640727,"While chronic obesity is associated with alterations in circulating glycerolipids, sphingolipids and plasmalogens, the effects of short-term overfeeding in humans are unclear.",chronic obesity,DISEASE,be associated with alterations in,circulating glycerolipids,CHEMICAL
34943773,"However, there is a knowledge gap between antibiotic and heavy metal resistance and virulence potential when it is part of the microbiota from marine invertebrates.",antibiotic,CHEBI,have a knowledge gap with,metal resistance,MENTAL_HEALTH
34943773,"However, there is a knowledge gap between antibiotic and heavy metal resistance and virulence potential when it is part of the microbiota from marine invertebrates.",metal resistance,MENTAL_HEALTH,have a knowledge gap with,antibiotic,CHEBI
34943773,The resistance gene for copper and silver (cusB) was detected in one sea urchin isolate.,silver,CHEMICAL,be detected in,sea urchin isolate,NUTRITION
34943773,The resistance gene for copper and silver (cusB) was detected in one sea urchin isolate.,resistance gene,MENTAL_HEALTH,be detected in,sea urchin isolate,NUTRITION
32181255,Background: The thrombopoietin receptor agonist eltrombopag has been shown to be safe and effective for children with chronic immune thrombocytopenia (ITP).,thrombopoietin receptor agonist eltrombopag,CHEMICAL,be shown to safe and effective for children with,ITP,DISEASE
32181255,Background: The thrombopoietin receptor agonist eltrombopag has been shown to be safe and effective for children with chronic immune thrombocytopenia (ITP).,thrombopoietin receptor agonist eltrombopag,CHEBI,be shown to safe and effective for children with,ITP,DISEASE
31529283,"Lusutrombopag (Mulpleta®), an orally bioavailable, small molecule thrombopoietin receptor agonist, is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.",bioavailable small molecule thrombopoietin receptor agonist,CHEBI,be approved for treatment of thrombocytopenia in adult patients with,chronic liver disease,DISEASE
31529283,"Lusutrombopag (Mulpleta®), an orally bioavailable, small molecule thrombopoietin receptor agonist, is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.",bioavailable small molecule thrombopoietin receptor agonist,CHEBI,be approved for treatment of,thrombocytopenia,DISEASE
31529283,"Lusutrombopag (Mulpleta®), an orally bioavailable, small molecule thrombopoietin receptor agonist, is approved for the treatment of thrombocytopenia in adult patients with chronic liver disease who are scheduled to undergo a procedure.",thrombocytopenia,DISEASE,in adult patients with,chronic liver disease,DISEASE
30059955,"Behaviorally, binge-ethanol treated females displayed increased anxiety (thigmotaxis) and demonstrated learning deficits in the water maze.",binge-ethanol treated females,CHEMICAL,display increased,anxiety,MENTAL_HEALTH
30059955,"Behaviorally, binge-ethanol treated females displayed increased anxiety (thigmotaxis) and demonstrated learning deficits in the water maze.",binge-ethanol treated females,CHEMICAL,demonstrate,deficits,DISEASE
30059955,Varenicline/ethanol co-treatment was effective at reducing these behavioral deficits.,Varenicline/ethanol co-treatment,CHEMICAL,reduce,behavioral deficits,DISEASE
24341463,Cocaine is a potent sympathomimetic agent associated with the development of possible fatal cardiovascular complications.,Cocaine,CHEMICAL,associated with development of,possible fatal cardiovascular complications,DISEASE
30799780,"The discovery of C. bolteae PS immunogen opens the door to the creation of non-evasive diagnostic tools to evaluate the frequency and role of this microbe in autistic subjects and to a vaccine to reduce colonization levels in the GI tract, thus impeding the concentration of neurotoxins.",C. bolteae PS immunogen,CHEBI,evaluate frequency and role of microbe in,autistic subjects,DISEASE
30799780,"The discovery of C. bolteae PS immunogen opens the door to the creation of non-evasive diagnostic tools to evaluate the frequency and role of this microbe in autistic subjects and to a vaccine to reduce colonization levels in the GI tract, thus impeding the concentration of neurotoxins.",C. bolteae PS immunogen,CHEBI,impede concentration of,neurotoxins,CHEBI
28220797,Increased levels of GPC+PC suggest alterations in the membrane phospholipids metabolism in bipolar disorder.,GPC+PC,CHEMICAL,suggest alterations in membrane phospholipids metabolism in,bipolar disorder,MENTAL_HEALTH
28220797,Increased levels of GPC+PC suggest alterations in the membrane phospholipids metabolism in bipolar disorder.,GPC+PC,CHEMICAL,suggest alterations in,phospholipids metabolism,NUTRITION
28220797,Increased levels of GPC+PC suggest alterations in the membrane phospholipids metabolism in bipolar disorder.,phospholipids metabolism,NUTRITION,have alterations in,bipolar disorder,MENTAL_HEALTH
28220797,"Rapid cycling (RC) bipolar disorder is considered as a severe course of bipolar disorder, but it is unclear whether rapid cycling bipolar disorder is linked to highly altered membrane phospholipid metabolism.",Rapid cycling RC bipolar disorder,MENTAL_HEALTH,be considered as severe course of,bipolar disorder,MENTAL_HEALTH
28220797,"Rapid cycling (RC) bipolar disorder is considered as a severe course of bipolar disorder, but it is unclear whether rapid cycling bipolar disorder is linked to highly altered membrane phospholipid metabolism.",rapid cycling bipolar disorder,MENTAL_HEALTH,be linked to,altered membrane phospholipid metabolism,NUTRITION
8801333,"In order to enhance and sustain the flux of ketorolac through human skin, various compositions of isopropyl alcohol (IPA), water, and isopropyl myristate (IPM) were evaluated.",human skin,DISEASE,have the flux of,ketorolac,CHEMICAL
1765883,"Finally, methadone is placed in a current context describing a second wave of acceptance based not solely on the reduction of crime but on the prevention of the spread of AIDS.",methadone,CHEMICAL,be placed in current context on prevention of spread of,AIDS,DISEASE
12231467,"However, mCPP also caused a significant decrease in body weight gain.",mCPP,CHEMICAL,cause significant decrease in,body weight gain,DISEASE
2923931,"m-Chlorophenylpiperazine (m-CPP), a serotonin receptor agonist, is currently being investigated as a probe of serotonergic responsivity in various neuropsychiatric disorders.",serotonin receptor agonist,CHEBI,be be investigated as probe of serotonergic responsivity in,various neuropsychiatric disorders,DISEASE
2923931,"m-Chlorophenylpiperazine (m-CPP), a serotonin receptor agonist, is currently being investigated as a probe of serotonergic responsivity in various neuropsychiatric disorders.",serotonin receptor agonist,CHEMICAL,be be investigated as probe of serotonergic responsivity in,various neuropsychiatric disorders,DISEASE
2923931,"m-Chlorophenylpiperazine (m-CPP), a serotonin receptor agonist, is currently being investigated as a probe of serotonergic responsivity in various neuropsychiatric disorders.",m-CPP,CHEMICAL,be be investigated as probe of serotonergic responsivity in,various neuropsychiatric disorders,DISEASE
2923931,"m-Chlorophenylpiperazine (m-CPP), a serotonin receptor agonist, is currently being investigated as a probe of serotonergic responsivity in various neuropsychiatric disorders.",m-Chlorophenylpiperazine,CHEMICAL,be be investigated as probe of serotonergic responsivity in,various neuropsychiatric disorders,DISEASE
2923931,"The safety of m-CPP in elderly populations and its potential usefulness in exploring possible serotonergic dysfunction in Alzheimer's disease and normal aging were assessed by examining the behavioral, neuroendocrine, and physiological effects of this agent in 15 elderly subjects (mean age 69 +/- 2 years): 9 Alzheimer patients and 6 healthy normal volunteers.",m-CPP,CHEMICAL,examine,Alzheimer patients,DISEASE
2923931,"The safety of m-CPP in elderly populations and its potential usefulness in exploring possible serotonergic dysfunction in Alzheimer's disease and normal aging were assessed by examining the behavioral, neuroendocrine, and physiological effects of this agent in 15 elderly subjects (mean age 69 +/- 2 years): 9 Alzheimer patients and 6 healthy normal volunteers.",possible serotonergic dysfunction,DISEASE,have elderly populations and its potential usefulness in,Alzheimer's disease,DISEASE
2923931,"The behavioral effects were modest; in particular, minimal anxiety was observed, a finding that contrasted to results from an earlier study reporting that intravenous m-CPP at a slightly higher dose induced marked anxiety and panic attacks in younger subjects.",intravenous m-CPP,CHEMICAL,induce,anxiety panic attacks,DISEASE
2923931,"The behavioral effects were modest; in particular, minimal anxiety was observed, a finding that contrasted to results from an earlier study reporting that intravenous m-CPP at a slightly higher dose induced marked anxiety and panic attacks in younger subjects.",intravenous m-CPP,CHEMICAL,induce,anxiety panic attacks,MENTAL_HEALTH
27263227,An 86-year-old woman with severe dementia had been treated with oral prednisolone at 2 mg/day for autoimmune bullous dermatosis for several years.,severe dementia,MENTAL_HEALTH,be treated with,oral prednisolone,CHEMICAL
7587953,It was recently demonstrated that limonene exhibits both chemopreventive and therapeutic effects against chemically induced mammary tumors in rats (4-10).,limonene,CHEMICAL,exhibit chemopreventive and therapeutic effects against,induced mammary tumors,DISEASE
7587953,"Furthermore, one of the metabolic precursors of these compounds, perillyl alcohol (16), is considerably more potent than limonene against the in vivo rat mammary tumor models (19).",perillyl alcohol,CHEMICAL,be,limonene,CHEMICAL
7587953,"Furthermore, one of the metabolic precursors of these compounds, perillyl alcohol (16), is considerably more potent than limonene against the in vivo rat mammary tumor models (19).",perillyl alcohol,CHEMICAL,be,in rat mammary tumor models,DISEASE
7587953,"Thus, perillyl alcohol is currently being developed as a clinical candidate at the National Cancer Institute because of its greater potency than limonene, which may enable potentially effective systemic concentrations of the active principals to be achieved at considerably lower doses.(ABSTRACT TRUNCATED AT 250 WORDS)",perillyl alcohol,CHEMICAL,be be developed as clinical candidate at,limonene,CHEMICAL
7587953,"Thus, perillyl alcohol is currently being developed as a clinical candidate at the National Cancer Institute because of its greater potency than limonene, which may enable potentially effective systemic concentrations of the active principals to be achieved at considerably lower doses.(ABSTRACT TRUNCATED AT 250 WORDS)",perillyl alcohol,CHEMICAL,be be developed as clinical candidate at,National Cancer Institute,DISEASE
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,calcium antagonists,CHEBI
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,sympatholytic drugs,CHEBI
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,known potential hypotensive effects,DISEASE
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,logistic regression model,MENTAL_HEALTH
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,calcium antagonists,CHEMICAL
18370507,"The association between drug use and low blood pressure was examined for drugs with known potential hypotensive effects (sympatholytic drugs, diuretics, beta-receptor blocking drugs, calcium antagonists, angiotensin-converting enzyme inhibiting drugs, nitrates, antiparkinsonian drugs, neuroleptics, anxiolytics, sedatives-hypnotics and antidepressant drugs) in a logistic regression model controlling for the possible confounders age, gender, housing, dementia status, cardiovascular disease, body mass index and dehydration.",drug use,CHEBI,be examined for drugs with,antidepressant drugs,CHEMICAL
27322827,The inoculation of S. marcescens enhanced the growth of wheat plant under salinity stress (150-200 mM).,S. marcescens,DISEASE,enhance growth of,wheat plant,NUTRITION
27322827,"Application of CDP-13 also modulated concentration (20 to 75%) of different osmoprotectants (proline, malondialdehyde, total soluble sugar, total protein content, and indole acetic acid) in plants suggesting its role in enabling plants to tolerate salt stressors.",CDP-13,CHEMICAL,modulate,indole acetic acid,CHEMICAL
27322827,"Application of CDP-13 also modulated concentration (20 to 75%) of different osmoprotectants (proline, malondialdehyde, total soluble sugar, total protein content, and indole acetic acid) in plants suggesting its role in enabling plants to tolerate salt stressors.",CDP-13,CHEMICAL,modulate,proline,CHEMICAL
27322827,"Application of CDP-13 also modulated concentration (20 to 75%) of different osmoprotectants (proline, malondialdehyde, total soluble sugar, total protein content, and indole acetic acid) in plants suggesting its role in enabling plants to tolerate salt stressors.",CDP-13,CHEMICAL,modulate,malondialdehyde,CHEMICAL
21376806,Fetal alcohol spectrum disorders (FASD) result from ethanol exposure to the developing fetus and are the most common cause of mental retardation in the United States.,Fetal alcohol spectrum disorders,DISEASE,result from,ethanol exposure,CHEMICAL
21376806,"In composite, these studies suggest that PPAR-γ agonists may be effective in limiting ethanol-induced toxicity to the developing CNS.",PPAR-γ agonists,CHEBI,limit,ethanol-induced toxicity,DISEASE
21376806,"In composite, these studies suggest that PPAR-γ agonists may be effective in limiting ethanol-induced toxicity to the developing CNS.",PPAR-γ agonists,CHEMICAL,limit,ethanol-induced toxicity,DISEASE
19418264,Vitamin C inhibits the withdrawal syndrome in morphine-dependent subjects and prevents apoptosis in experimental models.,Vitamin C,CHEBI,inhibit withdrawal syndrome in,morphine-dependent subjects,CHEMICAL
19418264,Vitamin C inhibits the withdrawal syndrome in morphine-dependent subjects and prevents apoptosis in experimental models.,Vitamin C,CHEBI,inhibit,withdrawal syndrome,DISEASE
3446808,Baclofen had a characteristic effect on vestibular and optokinetic nystagmus in rhesus monkeys.,Baclofen,CHEMICAL,have characteristic effect on,vestibular nystagmus,DISEASE
3446808,Each aspect of nystagmus that is dependent on the velocity-storage mechanism in the vestibulo-ocular reflex (v.o.r.) was altered by the drug: (a) Baclofen reduced the dominant time constant of the v.o.r.,nystagmus,DISEASE,be altered by,drug,CHEBI
34022694,"Transcriptome sequencing revealed that the hypoxia-inducible factor (HIF-1) signaling pathway, apoptosis, and purine metabolism transcripts were significantly enriched under hypoxia and re-oxygenation conditions.",purine metabolism transcripts,CHEMICAL,be enriched under,hypoxia conditions,DISEASE
34022694,"Unexpectedly, the serum uric acid level significantly increased during hypoxia and significantly decreased under re-oxygenation, indicating the presence of purine metabolic disorder in the liver of L. maculatus.",serum uric acid level,CHEMICAL,indicate presence of,purine metabolic disorder,CHEMICAL
26136476,The sleep disorder narcolepsy is linked to the HLA-DQB1*0602 haplotype and dysregulation of the hypocretin ligand-hypocretin receptor pathway.,disorder narcolepsy,MENTAL_HEALTH,be linked to,hypocretin ligand-hypocretin receptor pathway,CHEMICAL
31762569,"Present study revealed that black rice anthocyanins improve the biomarker of the metabolic syndrome, such as tumor necrosis factor alpha (TNF-α).",rice anthocyanins,NUTRITION,improve biomarker of,metabolic syndrome,DISEASE
31762569,"Present study revealed that black rice anthocyanins improve the biomarker of the metabolic syndrome, such as tumor necrosis factor alpha (TNF-α).",rice anthocyanins,NUTRITION,improve biomarker of,tumor necrosis factor alpha,NUTRITION
31762569,"Present study revealed that black rice anthocyanins improve the biomarker of the metabolic syndrome, such as tumor necrosis factor alpha (TNF-α).",rice anthocyanins,NUTRITION,improve biomarker of,tumor necrosis factor alpha,DISEASE
31762569,"However, the mechanism of anthocyanin in preventing metabolic syndrome has not been elucidated.",anthocyanin,NUTRITION,have the mechanism in,metabolic syndrome,DISEASE
32329240,"In line with previous findings that revealed a role of 5-HT6 receptor-operated mTOR activation in cognitive deficits of rodent developmental models of schizophrenia, we show that chronic administration of ∆9-tetrahydrocannabinol (THC) to mice during adolescence induces a long-lasting activation of mTOR in prefrontal cortex (PFC), alterations of excitatory/inhibitory balance, intrinsic properties of layer V pyramidal neurons, and long-term depression, as well as cognitive deficits in adulthood.",∆9-tetrahydrocannabinol,CHEMICAL,induce long-lasting activation of mtor in,long-term depression,MENTAL_HEALTH
32329240,"In line with previous findings that revealed a role of 5-HT6 receptor-operated mTOR activation in cognitive deficits of rodent developmental models of schizophrenia, we show that chronic administration of ∆9-tetrahydrocannabinol (THC) to mice during adolescence induces a long-lasting activation of mTOR in prefrontal cortex (PFC), alterations of excitatory/inhibitory balance, intrinsic properties of layer V pyramidal neurons, and long-term depression, as well as cognitive deficits in adulthood.",∆9-tetrahydrocannabinol,CHEMICAL,induce long-lasting activation of mtor in,cognitive deficits,DISEASE
32329240,"In line with previous findings that revealed a role of 5-HT6 receptor-operated mTOR activation in cognitive deficits of rodent developmental models of schizophrenia, we show that chronic administration of ∆9-tetrahydrocannabinol (THC) to mice during adolescence induces a long-lasting activation of mTOR in prefrontal cortex (PFC), alterations of excitatory/inhibitory balance, intrinsic properties of layer V pyramidal neurons, and long-term depression, as well as cognitive deficits in adulthood.",THC,CHEMICAL,induce long-lasting activation of mtor in,long-term depression,MENTAL_HEALTH
32329240,"In line with previous findings that revealed a role of 5-HT6 receptor-operated mTOR activation in cognitive deficits of rodent developmental models of schizophrenia, we show that chronic administration of ∆9-tetrahydrocannabinol (THC) to mice during adolescence induces a long-lasting activation of mTOR in prefrontal cortex (PFC), alterations of excitatory/inhibitory balance, intrinsic properties of layer V pyramidal neurons, and long-term depression, as well as cognitive deficits in adulthood.",THC,CHEMICAL,induce long-lasting activation of mtor in,cognitive deficits,DISEASE
35248526,"A multiplex assay for the quantitation of immunoglobulin G (IgG) serum antibodies directed against Clostridium tetani toxin (TT), Corynebacterium diphtheriae toxoid (DTxd), and the Bordetella pertussis antigens pertussis toxin (PT), filamentous hemagglutinin (FHA) and pertactin (Prn) was developed on an Evalution® platform to enhance the evaluation of the specific antibody response towards protein antigens in suspected humoral immunodeficiencies.",antigens pertussis toxin,CHEBI,enhance evaluation of specific antibody response towards protein antigens in,suspected humoral immunodeficiencies,DISEASE
35248526,"A multiplex assay for the quantitation of immunoglobulin G (IgG) serum antibodies directed against Clostridium tetani toxin (TT), Corynebacterium diphtheriae toxoid (DTxd), and the Bordetella pertussis antigens pertussis toxin (PT), filamentous hemagglutinin (FHA) and pertactin (Prn) was developed on an Evalution® platform to enhance the evaluation of the specific antibody response towards protein antigens in suspected humoral immunodeficiencies.",antigens pertussis toxin,CHEBI,enhance evaluation of specific antibody response towards,protein antigens,CHEBI
23937585,"Solanum torvum Sw is worldwide employed as rootstock for eggplant cultivation because of its vigour and resistance/tolerance to the most serious soil-borne diseases as bacterial, fungal wilts and root-knot nematodes.",Solanum torvum Sw,CHEMICAL,be employed as rootstock for,bacterial nematodes,DISEASE
23937585,"Solanum torvum Sw is worldwide employed as rootstock for eggplant cultivation because of its vigour and resistance/tolerance to the most serious soil-borne diseases as bacterial, fungal wilts and root-knot nematodes.",Solanum torvum Sw,CHEMICAL,be employed as rootstock for,resistance/tolerance,DISEASE
22033600,Medicationrelated hallucinations are seen in many PD patients who are treated with dopaminergic agents for motor symptoms.,Medicationrelated hallucinations,MENTAL_HEALTH,be seen in,many PD patients,DISEASE
25320048,"In particular, although κ-opioid receptor (KOR) agonists are analgesic with a low risk of dependence and abuse, their use is limited by a propensity to induce sedation, motor incoordination, hallucinations, and dysphoria-like states.",κ-opioid receptor KOR agonists,CHEBI,be,analgesic,CHEBI
35256673,"Global metabolic profiling of (R,S')-MNF-treated tumor tissues revealed decreased glycolytic metabolism, with a shift towards normoxic processes, attenuated glutamate metabolism, and increased levels of ophthalmic acid and its precursor, 2-aminobutyric acid, indicative of elevated oxidative stress.",R,CHEMICAL,attenuate,glutamate metabolism,CHEMICAL
23042643,Bolus plus constant infusion experiments with displacement at equilibrium using six different doses of atomoxetine (0.03-0.85 mg/kg) and four different doses of reboxetine (0.5-3.0 mg/kg) were carried out in several baboons to obtain occupancy measurements as a function of dose for the two NET selective drugs.,displacement,MENTAL_HEALTH,use different doses of,atomoxetine,CHEMICAL
23042643,Bolus plus constant infusion experiments with displacement at equilibrium using six different doses of atomoxetine (0.03-0.85 mg/kg) and four different doses of reboxetine (0.5-3.0 mg/kg) were carried out in several baboons to obtain occupancy measurements as a function of dose for the two NET selective drugs.,displacement,MENTAL_HEALTH,use different doses of,mg/kg,CHEMICAL
23042643,Bolus plus constant infusion experiments with displacement at equilibrium using six different doses of atomoxetine (0.03-0.85 mg/kg) and four different doses of reboxetine (0.5-3.0 mg/kg) were carried out in several baboons to obtain occupancy measurements as a function of dose for the two NET selective drugs.,displacement,MENTAL_HEALTH,use different doses of,reboxetine,CHEMICAL
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,Antidepressants,CHEMICAL,be implicated in reduced bmd and/or fracture in,older depressed patients,DISEASE
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,imipramine,CHEMICAL,be implicated in reduced bmd and/or fracture in,older depressed patients,DISEASE
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,Antidepressants,CHEMICAL,be implicated in,fracture,DISEASE
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,imipramine,CHEMICAL,be implicated in,fracture,DISEASE
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,specific serotonin reuptake inhibitors,CHEMICAL,be implicated in reduced bmd and/or fracture in,older depressed patients,DISEASE
26035060,Antidepressants such as imipramine (IMIP) and specific serotonin reuptake inhibitors (SSRIs) have been implicated in reduced BMD and/or fracture in older depressed patients.,specific serotonin reuptake inhibitors,CHEMICAL,be implicated in,fracture,DISEASE
18437564,Serotonin transporters (SERT) have been implicated in the etiology of depression and drugs acting on SERT can be effective in treating depression.,Serotonin transporters,CHEMICAL,be implicated in etiology of,depression,MENTAL_HEALTH
24126731,"In 2010, the American Urological Association (AUA) reported that bladder and bowel dysfunction (BBD), which is common in patients with VUR, increases the risk of breakthrough UTI in children receiving antibiotic prophylaxis, reduces the success rate for endoscopic injection therapy, and increases the risk of postoperative UTI, irrespective of the surgical success rate for VUR.",VUR,DISEASE,increase risk of,postoperative UTI,DISEASE
24126731,"In 2010, the American Urological Association (AUA) reported that bladder and bowel dysfunction (BBD), which is common in patients with VUR, increases the risk of breakthrough UTI in children receiving antibiotic prophylaxis, reduces the success rate for endoscopic injection therapy, and increases the risk of postoperative UTI, irrespective of the surgical success rate for VUR.",VUR,DISEASE,increase risk of,UTI,DISEASE
26343602,"7,8-Dihydroxyflavone (DHF) is a recently identified small molecule Trk B agonist that has been reported to ameliorate depression, attenuate the fear response, improve memory consolidation, and exert neuroprotective effects.","7,8-Dihydroxyflavone",CHEMICAL,be,identified small molecule Trk B agonist,CHEBI
29738549,Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL).,GCs,CHEMICAL,be cornerstone in treatment of lymphoid malignancies such as,ALL,DISEASE
29738549,Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL).,GCs,CHEMICAL,be cornerstone in treatment of lymphoid malignancies such as,MM,DISEASE
29738549,Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL).,GCs,CHEMICAL,be cornerstone in treatment of lymphoid malignancies such as,acute lymphoblastic leukemia,DISEASE
29738549,Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL).,GCs,CHEMICAL,be cornerstone in treatment of lymphoid malignancies such as,multiple myeloma,DISEASE
29738549,Glucocorticoids (GCs) are a cornerstone in the treatment of lymphoid malignancies such as multiple myeloma (MM) and acute lymphoblastic leukemia (ALL).,GCs,CHEMICAL,be cornerstone in treatment of,lymphoid malignancies,DISEASE
29738549,"Here, we examined whether the combination of CpdA with the classic GC dexamethasone (Dex) may improve GC responsiveness of MM and ALL cell lines.",Dex,CHEMICAL,improve gc responsiveness of,ALL,DISEASE
29738549,"Here, we examined whether the combination of CpdA with the classic GC dexamethasone (Dex) may improve GC responsiveness of MM and ALL cell lines.",classic GC dexamethasone,CHEMICAL,improve gc responsiveness of,ALL,DISEASE
26576332,Acquired or de novo resistance to the selective estrogen receptor modulators tamoxifen and fulvestrant (ICI) is a major barrier to successful treatment of breast cancer.,selective estrogen receptor modulators,CHEBI,be major barrier to successful treatment of,breast cancer,DISEASE
26576332,Acquired or de novo resistance to the selective estrogen receptor modulators tamoxifen and fulvestrant (ICI) is a major barrier to successful treatment of breast cancer.,tamoxifen,CHEMICAL,be major barrier to successful treatment of,breast cancer,DISEASE
26576332,Acquired or de novo resistance to the selective estrogen receptor modulators tamoxifen and fulvestrant (ICI) is a major barrier to successful treatment of breast cancer.,Acquired resistance,MENTAL_HEALTH,be major barrier to successful treatment of,breast cancer,DISEASE
26576332,These data support a role for altered regulation of PDH by PDK4 and altered substrate utilization in the development of drug resistance in human breast cancer cells.,drug resistance,MENTAL_HEALTH,have the development in,human breast cancer cells,DISEASE
26576332,These data support a role for altered regulation of PDH by PDK4 and altered substrate utilization in the development of drug resistance in human breast cancer cells.,drug resistance,CHEBI,have the development in,human breast cancer cells,DISEASE
33536021,The oral IP receptor agonist selexipag is approved for the long-term treatment of pulmonary arterial hypertension (PAH).,oral IP receptor agonist selexipag,CHEMICAL,be approved for long-term treatment of,pulmonary arterial hypertension,DISEASE
33536021,The oral IP receptor agonist selexipag is approved for the long-term treatment of pulmonary arterial hypertension (PAH).,oral IP receptor agonist selexipag,CHEMICAL,be approved for long-term treatment of,PAH,CHEMICAL
33536021,The oral IP receptor agonist selexipag is approved for the long-term treatment of pulmonary arterial hypertension (PAH).,oral IP receptor agonist selexipag,CHEBI,be approved for long-term treatment of,pulmonary arterial hypertension,DISEASE
33536021,The oral IP receptor agonist selexipag is approved for the long-term treatment of pulmonary arterial hypertension (PAH).,oral IP receptor agonist selexipag,CHEBI,be approved for long-term treatment of,PAH,CHEMICAL
31042010,"Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular changes, leads to elevated pulmonary artery pressures, dyspnoea, a reduction in exercise tolerance, right heart failure, and ultimately death.",PAH,CHEMICAL,lead to,elevated pulmonary artery pressures,DISEASE
31042010,"Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular changes, leads to elevated pulmonary artery pressures, dyspnoea, a reduction in exercise tolerance, right heart failure, and ultimately death.",PAH,CHEMICAL,lead to,dyspnoea,DISEASE
31042010,"Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular changes, leads to elevated pulmonary artery pressures, dyspnoea, a reduction in exercise tolerance, right heart failure, and ultimately death.",Pulmonary arterial hypertension,DISEASE,lead to,elevated pulmonary artery pressures,DISEASE
31042010,"Pulmonary arterial hypertension (PAH) is characterised by pulmonary vascular changes, leads to elevated pulmonary artery pressures, dyspnoea, a reduction in exercise tolerance, right heart failure, and ultimately death.",Pulmonary arterial hypertension,DISEASE,lead to,dyspnoea,DISEASE
31042010,"Prostacyclin analogue drugs mimic endogenous prostacyclin which leads to vasodilation, inhibition of platelet aggregation, and reversal of vascular remodelling.",Prostacyclin analogue drugs,CHEMICAL,mimic endogenous prostacyclin inhibition of,vascular remodelling,DISEASE
31042010,"Prostacyclin analogue drugs mimic endogenous prostacyclin which leads to vasodilation, inhibition of platelet aggregation, and reversal of vascular remodelling.",Prostacyclin analogue drugs,CHEMICAL,mimic endogenous prostacyclin inhibition of,platelet aggregation,DISEASE
31042010,"Prostacyclin analogue drugs mimic endogenous prostacyclin which leads to vasodilation, inhibition of platelet aggregation, and reversal of vascular remodelling.",Prostacyclin analogue drugs,CHEMICAL,mimic,endogenous prostacyclin inhibition,CHEMICAL
10096825,The direct passage of CO2 into the muscle chamber led to adiabatic cooling of the physiological fluid and inhibition of muscle contraction.,CO2,CHEMICAL,lead to adiabatic cooling of physiological fluid and inhibition of,muscle contraction,DISEASE
26653343,"Some cases of Wernicke encephalopathy are related to appetite loss; however, the degree to which loss of appetite leads to thiamine deficiency is not known.",appetite,DISEASE,lead to,thiamine deficiency,CHEBI
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",Kami-ondam-tang,CHEMICAL,treat,neurosis,MENTAL_HEALTH
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",Kami-ondam-tang,CHEMICAL,treat,neuropsychiatric disorders,DISEASE
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",Kami-ondam-tang,CHEMICAL,treat,insomnia,MENTAL_HEALTH
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",KODT,CHEMICAL,treat,neurosis,MENTAL_HEALTH
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",KODT,CHEMICAL,treat,neuropsychiatric disorders,DISEASE
23376282,"Kami-ondam-tang (KODT) has been used to treat neuropsychiatric disorders, including neurosis and insomnia, in traditional herbal medicine.",KODT,CHEMICAL,treat,insomnia,MENTAL_HEALTH
33263242,"Evidence suggests that vitamin C acts against inflammation, oxidative stress, autophagy chaos, and immune dysfunction.",vitamin C,CHEBI,act against,immune dysfunction,DISEASE
33263242,Severe infections need higher doses of the vitamin to compensate for the augmented inflammatory response and metabolic demand that commonly occur during COVID-19.,Severe infections,DISEASE,need higher doses of,vitamin,CHEBI
35489781,Mu opioid receptor (MOR) agonists produce locomotor hyperactivity in mice as one sign of opioid-induced motor disruption.,opioid receptor MOR agonists,CHEBI,produce,locomotor hyperactivity,MENTAL_HEALTH
35489781,Maximal hyperactivity produced by each drug and mixture in the present study correlated with previously published data for maximal stimulation of GTPɣS binding in MOR-expressing Chinese hamster ovary cells as an in vitro measure of relative efficacy.,Maximal hyperactivity,MENTAL_HEALTH,correlate with published data for maximal stimulation of,GTPɣS binding,CHEMICAL
35489781,"Additionally, the EP50 value for hyperactivity induced by fentanyl/naltrexone mixtures indicated that opioid-induced hyperactivity in mice has a relatively high efficacy requirement in comparison to some other MOR agonist effects, and in particular is higher than the efficacy requirement for thermal antinociception in mice or fentanyl discrimination in rats.",opioid-induced hyperactivity,MENTAL_HEALTH,have high efficacy requirement in comparison to,other MOR agonist effects,CHEBI
35489781,"Taken together, these data show that MOR agonist-induced hyperactivity in mice is efficacy dependent and requires relatively high levels of MOR agonist efficacy for its full expression.",agonist-induced hyperactivity,MENTAL_HEALTH,require high levels of,MOR agonist efficacy,CHEBI
35489781,Significance Statement Mu opioid receptor (MOR) agonist-induced hyperlocomotion in mice is dependent on the MOR efficacy of the agonist and requires a relatively high degree of efficacy for its full expression.,agonist-induced hyperlocomotion,DISEASE,be dependent on mor efficacy of,agonist,CHEBI
35340223,"In conclusion, mosapride citrate tablets combined with Shenqu Xiaoshi oral liquid can achieve good therapeutic effects in children with functional dyspepsia, reduce symptom scores, improve serum cytokine levels, and have high drug safety, which is worthy of promotion and application.",mosapride citrate tablets,CHEMICAL,have,high drug safety,CHEBI
35340223,"In conclusion, mosapride citrate tablets combined with Shenqu Xiaoshi oral liquid can achieve good therapeutic effects in children with functional dyspepsia, reduce symptom scores, improve serum cytokine levels, and have high drug safety, which is worthy of promotion and application.",mosapride citrate tablets,CHEMICAL,achieve in conclusion good therapeutic effects in children with,functional dyspepsia,DISEASE
35583495,"Persistent carriers were defined by the presence of S. aureus of the same spa-type at both time points, intermittent carriers were S. aureus-positive for 1 of 2 swabs, and noncarriers were negative for S. aureus at both time points.",Persistent carriers,CHEBI,be defined by presence of,S. aureus,DISEASE
19304771,"Aberrant Hh signaling pathway activation has been implicated in a variety of cancers, and small-molecule antagonists of Smo have entered human clinical trials for the treatment of cancer.",Hh signaling pathway activation,CHEMICAL,be implicated in variety of,cancers,DISEASE
28532261,Odds ratios (ORs) and 95% conﬁdence intervals (CIs) for PPDS were obtained using binary logistic regression.,% conﬁdence intervals,CHEMICAL,use,binary logistic regression,MENTAL_HEALTH
1647700,"In response to environmental anoxia, the activity of PFK-2 dropped in all organs to 34-56% of the corresponding aerobic value (half-time was 2 h in gill), and the Michaelis constant for fructose 6-phosphate increased by 50% (to 92 microM in gill).",PFK-2,CHEMICAL,drop in response to,environmental anoxia,DISEASE
35563342,"Meanwhile, epoxy fatty acids such as epoxyeicosatrienoic acids (EETs), epoxyeicosatetraenoic acids (EEQs), and epoxyeicosapentaenoic acids (EDPs) have been found to exert neuroprotective effects in animal models of neuropsychiatric disorders through potent anti-inflammatory actions.",epoxyeicosatetraenoic acids,CHEMICAL,exert neuroprotective effects in animal models of,neuropsychiatric disorders,DISEASE
35563342,"Meanwhile, epoxy fatty acids such as epoxyeicosatrienoic acids (EETs), epoxyeicosatetraenoic acids (EEQs), and epoxyeicosapentaenoic acids (EDPs) have been found to exert neuroprotective effects in animal models of neuropsychiatric disorders through potent anti-inflammatory actions.",epoxy fatty acids,NUTRITION,exert neuroprotective effects in animal models of,neuropsychiatric disorders,DISEASE
35563342,"Meanwhile, epoxy fatty acids such as epoxyeicosatrienoic acids (EETs), epoxyeicosatetraenoic acids (EEQs), and epoxyeicosapentaenoic acids (EDPs) have been found to exert neuroprotective effects in animal models of neuropsychiatric disorders through potent anti-inflammatory actions.",epoxyeicosatrienoic acids,CHEMICAL,exert neuroprotective effects in animal models of,neuropsychiatric disorders,DISEASE
29685207,Lithium is a medication used to treat bipolar disorder and may also prevent cognitive decline and suicide.,Lithium,NUTRITION,prevent,cognitive decline,DISEASE
29685207,Lithium is a medication used to treat bipolar disorder and may also prevent cognitive decline and suicide.,Lithium,NUTRITION,prevent,suicide,MENTAL_HEALTH
241124,"The ""group 2"" drugs (halothane, methoxyflurane, etc.) produce dose-related depression in cardiac function, but reasonable caridac outputs and blood pressure can be maintained at light anethetic levels.",drugs halothane,CHEMICAL,produce,dose-related depression,MENTAL_HEALTH
241124,"In fact, low concentrations of fluroxene have been shown to produce significant depression of stroke volume in patients with aortic vavular disease in contrast to the effects on healthy volunteers.",fluroxene,CHEMICAL,produce significant depression of stroke volume in patients with,aortic vavular disease,DISEASE
241124,"In fact, low concentrations of fluroxene have been shown to produce significant depression of stroke volume in patients with aortic vavular disease in contrast to the effects on healthy volunteers.",fluroxene,CHEMICAL,produce significant depression of,stroke volume,DISEASE
241124,"In fact, low concentrations of fluroxene have been shown to produce significant depression of stroke volume in patients with aortic vavular disease in contrast to the effects on healthy volunteers.",fluroxene,CHEMICAL,produce,significant depression,MENTAL_HEALTH
241124,"In fact, low concentrations of fluroxene have been shown to produce significant depression of stroke volume in patients with aortic vavular disease in contrast to the effects on healthy volunteers.",stroke volume,DISEASE,in patients with,aortic vavular disease,DISEASE
15232334,"The 20-mg/d group experienced more insomnia, dizziness, and confusion, while the 5-mg group also had more dizziness and the 40-mg group had more nausea than the placebo group.",5-mg group,CHEMICAL,have,more dizziness,DISEASE
15232334,"The 20-mg/d group experienced more insomnia, dizziness, and confusion, while the 5-mg group also had more dizziness and the 40-mg group had more nausea than the placebo group.",5-mg group,CHEMICAL,have,40-mg group,CHEMICAL
15232334,"The 20-mg/d group experienced more insomnia, dizziness, and confusion, while the 5-mg group also had more dizziness and the 40-mg group had more nausea than the placebo group.",5-mg group,CHEMICAL,have,more nausea,DISEASE
34699919,Lycopene (LYC) is a carotenoid that has protective roles against cellular damage in different organs.,Lycopene,CHEBI,be,carotenoid,CHEBI
34608470,"Furthermore, DEHP induced mitochondria-associated endoplasmic reticulum membrane (MAM) disorder-induced ER stress through the ER unfolded protein response (UPRER), but LYC alleviated these alterations.",DEHP,CHEMICAL,induce,mitochondria-associated membrane MAM disorder-induced ER stress,CHEMICAL
26955276,"Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia.",Tetrabenazine,CHEMICAL,be used in treatment of,tardive dyskinesia,MENTAL_HEALTH
26955276,"Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia.",Tetrabenazine,CHEMICAL,be used in treatment of,chorea,DISEASE
26955276,"Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia.",Tetrabenazine,CHEMICAL,be used in treatment of,tics,DISEASE
26955276,"Tetrabenazine is used in the treatment of chorea, tardive dyskinesia, tics, and dystonia.",Tetrabenazine,CHEMICAL,be used in treatment of,dystonia,DISEASE
28628909,A transient activation of CYP4F2 gene followed by a repression response was observed in HepG2 cells during the exposure to increasing levels of the lipogenic and cytotoxic agent palmitic acid; such gene repression effect was further exacerbated by the co-treatment with oleic acid and α-tocopherol and was also observed for PPAR-γ and the SREBP isoforms 1 and 2.,gene repression effect,MENTAL_HEALTH,be observed for,PPAR-γ,CHEMICAL
28628909,A transient activation of CYP4F2 gene followed by a repression response was observed in HepG2 cells during the exposure to increasing levels of the lipogenic and cytotoxic agent palmitic acid; such gene repression effect was further exacerbated by the co-treatment with oleic acid and α-tocopherol and was also observed for PPAR-γ and the SREBP isoforms 1 and 2.,gene repression effect,MENTAL_HEALTH,be exacerbated by co-treatment with,oleic acid,CHEMICAL
28628909,"In conclusion, the liver metabolism and gene response of α-tocopherol are impaired in experimental NAFLD.",α-tocopherol,CHEMICAL,be impaired in conclusion in,experimental NAFLD,DISEASE
20856918,"The most consistent evidence for association with ADHD relates to a dopamine D4 receptor (DRD4) gene variable number tandem repeat (VNTR), a dopamine D5 receptor (DRD5) gene microsatellite and a dopamine transporter (DAT1) gene VNTR.",ADHD,MENTAL_HEALTH,relate to,dopamine D5 receptor,CHEMICAL
20856918,"The most consistent evidence for association with ADHD relates to a dopamine D4 receptor (DRD4) gene variable number tandem repeat (VNTR), a dopamine D5 receptor (DRD5) gene microsatellite and a dopamine transporter (DAT1) gene VNTR.",ADHD,MENTAL_HEALTH,relate to,dopamine D4 receptor,CHEMICAL
20856918,"The most consistent evidence for association with ADHD relates to a dopamine D4 receptor (DRD4) gene variable number tandem repeat (VNTR), a dopamine D5 receptor (DRD5) gene microsatellite and a dopamine transporter (DAT1) gene VNTR.",ADHD,MENTAL_HEALTH,relate to,dopamine transporter,CHEMICAL
25153621,"The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h.",infection,DISEASE,be unresponsive to,cefazolin g,CHEMICAL
25153621,"The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h.",infection,DISEASE,be unresponsive to,g q12h,CHEMICAL
25153621,"The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h.",concomitant low grade fever suggestive,DISEASE,be unresponsive to,cefazolin g,CHEMICAL
25153621,"The concomitant low grade fever suggestive of infection was unresponsive to cefazolin 1 g q12h, and refractory to piperacillin (PIPC) 2 g q8h.",concomitant low grade fever suggestive,DISEASE,be unresponsive to,g q12h,CHEMICAL
25153621,"The constellation of the clinical, pharmacological and microbiological outcome in our case provides scientific evidence that the antibiotic therapy given to our case is the best available strategy as an antimicrobial treatment of severe enterococcal endocarditis complicated by disseminated lesion as infected intracranial aneurysm.",antibiotic therapy,CHEBI,be available strategy as,antimicrobial treatment,CHEBI
22074583,"Melatonin replacement is effective to treat sundowning and other sleep wake disorders in fully developed AD, although controversial data on this point exist.",Melatonin replacement,CHEMICAL,treat,disorders,DISEASE
22074583,"Theoretically the effect of melatonin could be more consistent at an earlier stage of the disease, i.e., mild cognitive impairment (MCI), an etiologically heterogeneous syndrome that precedes dementia.",melatonin,CHEMICAL,be consistent at earlier stage of,mild cognitive impairment,DISEASE
22074583,"Theoretically the effect of melatonin could be more consistent at an earlier stage of the disease, i.e., mild cognitive impairment (MCI), an etiologically heterogeneous syndrome that precedes dementia.",melatonin,CHEMICAL,be consistent at earlier stage of,heterogeneous syndrome,DISEASE
22074583,"Theoretically the effect of melatonin could be more consistent at an earlier stage of the disease, i.e., mild cognitive impairment (MCI), an etiologically heterogeneous syndrome that precedes dementia.",melatonin,CHEMICAL,be consistent at earlier stage of,MCI,DISEASE
22074583,"Five double blind, randomized placebo-controlled trials and 1 open-label retrospective study (N = 651) all agree in indicating that treatment with daily evening melatonin improves sleep quality and cognitive performance in MCI.",melatonin,CHEMICAL,improve sleep quality and cognitive performance in,MCI,DISEASE
7757983,"In contrast to taxol, epothilones retain a much greater toxicity against P-glycoprotein-expressing multiple drug resistant cells.",epothilones,CHEMICAL,retain in contrast to,taxol greater toxicity,DISEASE
7757983,"In contrast to taxol, epothilones retain a much greater toxicity against P-glycoprotein-expressing multiple drug resistant cells.",epothilones,CHEMICAL,retain in contrast to,taxol greater toxicity,CHEMICAL
12614189,"The hypermetabolic response, which is mediated by hugely increased levels of circulating catecholamines, prostaglandins, glucagon and cortisol, causes profound skeletal muscle catabolism, immune deficiency, peripheral lipolysis, reduced bone mineralisation, reduced linear growth, and increased energy expenditure.",circulating catecholamines,CHEMICAL,cause,peripheral lipolysis,DISEASE
12614189,"The hypermetabolic response, which is mediated by hugely increased levels of circulating catecholamines, prostaglandins, glucagon and cortisol, causes profound skeletal muscle catabolism, immune deficiency, peripheral lipolysis, reduced bone mineralisation, reduced linear growth, and increased energy expenditure.",circulating catecholamines,CHEMICAL,cause,immune deficiency,DISEASE
12614189,"The hypermetabolic response, which is mediated by hugely increased levels of circulating catecholamines, prostaglandins, glucagon and cortisol, causes profound skeletal muscle catabolism, immune deficiency, peripheral lipolysis, reduced bone mineralisation, reduced linear growth, and increased energy expenditure.",hypermetabolic response,DISEASE,cause,peripheral lipolysis,DISEASE
12614189,"The hypermetabolic response, which is mediated by hugely increased levels of circulating catecholamines, prostaglandins, glucagon and cortisol, causes profound skeletal muscle catabolism, immune deficiency, peripheral lipolysis, reduced bone mineralisation, reduced linear growth, and increased energy expenditure.",hypermetabolic response,DISEASE,cause,immune deficiency,DISEASE
12614189,"Despite judicious use of topical and systemic antibiotics, opportunistic nosocomial bacterial resistance threatens to annul the improved survival of patients with severe burns.",opportunistic nosocomial bacterial resistance,MENTAL_HEALTH,annul improved survival of patients with,severe burns,DISEASE
12614189,"Despite judicious use of topical and systemic antibiotics, opportunistic nosocomial bacterial resistance threatens to annul the improved survival of patients with severe burns.",opportunistic nosocomial bacterial resistance,DISEASE,annul improved survival of patients with,severe burns,DISEASE
12614189,"Patterns of emerging resistance encountered in burn units need to be considered, in light of a decreasing antibiotic armamentarium.",emerging resistance,MENTAL_HEALTH,be considered in light of,antibiotic armamentarium,CHEBI
12614189,"Better analgesics, newer antibiotics and immune stimulating drugs are required to reduce mortality and morbidity in large burns.",newer antibiotics,CHEBI,reduce mortality and morbidity in,large burns,DISEASE
32901578,"Dual orexin receptor antagonists (DORAs) have been approved for the treatment of insomnia disorders (suvorexant, lemborexant) and drugs with a distinctive profile (daridorexant) or orexin-2 receptor selectivity (seltorexant) are in development.",Dual orexin receptor antagonists,CHEBI,be approved be for treatment of,suvorexant,CHEMICAL
32901578,"Dual orexin receptor antagonists (DORAs) have been approved for the treatment of insomnia disorders (suvorexant, lemborexant) and drugs with a distinctive profile (daridorexant) or orexin-2 receptor selectivity (seltorexant) are in development.",Dual orexin receptor antagonists,CHEBI,be approved be for treatment of,insomnia disorders,MENTAL_HEALTH
24194527,Atypical dopamine-uptake inhibitors have low abuse potential and may serve as leads for development of cocaine-abuse treatments.,Atypical dopamine-uptake inhibitors,CHEMICAL,have,abuse potential,DISEASE
19483071,Drugs that inhibit dopamine (DA) reuptake through actions at the dopamine transporter (DAT) have been proposed as candidates for development as pharmacotherapies for cocaine abuse.,dopamine transporter,CHEMICAL,be proposed as candidates for development as pharmacotherapies for,cocaine abuse,MENTAL_HEALTH
17897630,"The dopamine transporter has historically been a primary target for cocaine abuse medication development, but addictive liability and other confounds of such inhibitors of dopamine uptake have limited clinical evaluation and validation.",dopamine transporter,CHEMICAL,be primary target for,abuse medication,MENTAL_HEALTH
31788342,"We searched Medline, Embase, the Cochrane library, and clinicaltrials.gov from inception through June 23, 2017, to identify randomized controlled trials of the safety of DPP-4Is or GLP-1 RAs versus placebo or other antidiabetic drugs in T2DM patients.",DPP-4Is,CHEMICAL,have the safety in,T2DM patients,DISEASE
31788342,"We searched Medline, Embase, the Cochrane library, and clinicaltrials.gov from inception through June 23, 2017, to identify randomized controlled trials of the safety of DPP-4Is or GLP-1 RAs versus placebo or other antidiabetic drugs in T2DM patients.",GLP-1,CHEMICAL,have the safety in,T2DM patients,DISEASE
31788342,"Compared to insulin, thiazolidinediones, or placebo, GLP-1 RAs statistically significantly increased the risk of dizziness (odds ratios [ORs]: 1.92, 1.57, and 1.40, respectively) and headache (ORs: 1.34, 1.41, and 1.18, respectively).",GLP-1 RAs,CHEMICAL,compare to,thiazolidinediones,CHEBI
31788342,"Compared to insulin, thiazolidinediones, or placebo, GLP-1 RAs statistically significantly increased the risk of dizziness (odds ratios [ORs]: 1.92, 1.57, and 1.40, respectively) and headache (ORs: 1.34, 1.41, and 1.18, respectively).",GLP-1 RAs,CHEMICAL,increase risk of,headache,MENTAL_HEALTH
31788342,"Compared to insulin, thiazolidinediones, or placebo, GLP-1 RAs statistically significantly increased the risk of dizziness (odds ratios [ORs]: 1.92, 1.57, and 1.40, respectively) and headache (ORs: 1.34, 1.41, and 1.18, respectively).",GLP-1 RAs,CHEMICAL,increase risk of,dizziness,DISEASE
31788342,"DPP-4Is increased the risk of headache (OR: 1.22, 95% confidence interval [CI]: 1.02 to 1.46; moderate quality) and dizziness (OR: 1.46, 95% CI: 1.05 to 2.03; moderate quality) compared to insulin.",DPP-4Is,CHEMICAL,increase risk of,headache,MENTAL_HEALTH
31788342,"DPP-4Is increased the risk of headache (OR: 1.22, 95% confidence interval [CI]: 1.02 to 1.46; moderate quality) and dizziness (OR: 1.46, 95% CI: 1.05 to 2.03; moderate quality) compared to insulin.",DPP-4Is,CHEMICAL,increase risk of,dizziness,DISEASE
31788342,"Of the incretin-based therapies, DPP-4Is had a lower risk of dizziness than GLP-1 RAs (OR: 0.76, 95% CI: 0.67 to 0.87; high quality).",DPP-4Is,CHEMICAL,have,dizziness,DISEASE
31788342,"Of the incretin-based therapies, DPP-4Is had a lower risk of dizziness than GLP-1 RAs (OR: 0.76, 95% CI: 0.67 to 0.87; high quality).",DPP-4Is,CHEMICAL,have,GLP-1 RAs,CHEMICAL
31788342,"Ranking probability analysis indicated that GLP-1 RAs may have the greatest risk of both dizziness and headache among the nine treatments (22.5% and 23.4%, respectively), whereas DPP-4Is were in the middle (46.2% and 45.0%, respectively).",GLP-1 RAs,CHEMICAL,have greatest risk of,headache,MENTAL_HEALTH
31788342,"Ranking probability analysis indicated that GLP-1 RAs may have the greatest risk of both dizziness and headache among the nine treatments (22.5% and 23.4%, respectively), whereas DPP-4Is were in the middle (46.2% and 45.0%, respectively).",GLP-1 RAs,CHEMICAL,have greatest risk of,dizziness,DISEASE
26177483,Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of injective anti-diabetic drugs that improve glycemic control and many other atherosclerosis-related parameters in patients with type 2 diabetes (T2D).,many other atherosclerosis-related parameters,DISEASE,in patients with,type diabetes,DISEASE
26177483,"Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer.",drug databases,CHEBI,indicate association of glp-1 receptor agonists with,pancreatitis,DISEASE
26177483,"Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer.",drug databases,CHEBI,indicate association of glp-1 receptor agonists with,pancreatic cancer,DISEASE
26177483,"Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer.",drug databases,CHEBI,indicate association of glp-1 receptor agonists with,thyroid cancer,DISEASE
26177483,"Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer.",drug databases,CHEBI,indicate association of,GLP-1 receptor agonists,CHEBI
26177483,"Concerns have been expressed regarding the effects of these drugs on pancreatic and thyroid tissue, since animal studies and analyses of drug databases indicate an association of GLP-1 receptor agonists with pancreatitis, pancreatic cancer, and thyroid cancer.",drug databases,CHEBI,indicate association of,GLP-1 receptor agonists,CHEMICAL
30537101,"Although FGFR inhibitors are undergoing clinical trials for treatment of several cancer types, little is known about the mechanism by which they induce cell death.",FGFR inhibitors,CHEBI,undergo clinical trials for treatment of,several cancer types,DISEASE
19499625,The third study was an open-label add-on trial of EPA in bipolar depression.,EPA,CHEMICAL,have an open-label add-on trial in,bipolar depression,MENTAL_HEALTH
19499625,Twelve bipolar outpatients with depressive symptoms were treated with 1.5-2.0 g/day of EPA for up to 6 months.,bipolar outpatients,DISEASE,be treated with,EPA,CHEMICAL
19499625,Twelve bipolar outpatients with depressive symptoms were treated with 1.5-2.0 g/day of EPA for up to 6 months.,depressive symptoms,DISEASE,be treated with,EPA,CHEMICAL
19499625,Omega-3 fatty acids were shown to be more effective than placebo for depression in both adults and children in small controlled studies and in an open study of bipolar depression.,Omega-3 fatty acids,NUTRITION,controlled studies and in open study of,bipolar depression,MENTAL_HEALTH
23635459,"Reiter's syndrome was diagnosed, and subsequently, an antitubercular agent, a nonsteroidal antiinflammatory drug and a corticosteroid were administered.",Reiter's syndrome,DISEASE,be diagnosed,nonsteroidal antiinflammatory drug,CHEBI
23635459,"Reiter's syndrome was diagnosed, and subsequently, an antitubercular agent, a nonsteroidal antiinflammatory drug and a corticosteroid were administered.",Reiter's syndrome,DISEASE,be diagnosed,antitubercular agent,CHEBI
23635459,Reiter syndrome is an uncommon complication after intravesical BCG immunotherapy.,Reiter syndrome,DISEASE,be uncommon complication after,intravesical BCG immunotherapy,CHEMICAL
24008068,"Kawasaki disease is an acute, self-limiting vasculitis of unknown origin, characterized by fever, palms and soles edema, cervical lymphadenopathy, strawberry tongue, and non-exudative conjunctivitis.",Kawasaki disease,DISEASE,be acute vasculitis of,non-exudative conjunctivitis,DISEASE
24008068,"Kawasaki disease is an acute, self-limiting vasculitis of unknown origin, characterized by fever, palms and soles edema, cervical lymphadenopathy, strawberry tongue, and non-exudative conjunctivitis.",Kawasaki disease,DISEASE,be acute vasculitis of,fever,DISEASE
24008068,"Kawasaki disease is an acute, self-limiting vasculitis of unknown origin, characterized by fever, palms and soles edema, cervical lymphadenopathy, strawberry tongue, and non-exudative conjunctivitis.",Kawasaki disease,DISEASE,be acute vasculitis of,soles edema,DISEASE
24008068,"Kawasaki disease is an acute, self-limiting vasculitis of unknown origin, characterized by fever, palms and soles edema, cervical lymphadenopathy, strawberry tongue, and non-exudative conjunctivitis.",Kawasaki disease,DISEASE,be acute vasculitis of,strawberry tongue,NUTRITION
24008068,"Kawasaki disease is an acute, self-limiting vasculitis of unknown origin, characterized by fever, palms and soles edema, cervical lymphadenopathy, strawberry tongue, and non-exudative conjunctivitis.",Kawasaki disease,DISEASE,be,acute vasculitis,DISEASE
22748970,"A sprinkle capsule formulation containing enteric-coated, delayed-release rabeprazole granules is being developed for the treatment of children with gastrointestinal reflux disease.",sprinkle,CHEMICAL,be developed for treatment of children with,gastrointestinal reflux disease,DISEASE
35421841,The ongoing emergence of severe acute respiratory syndrome caused by the new coronavirus (SARS-CoV-2) variants requires swift actions in identifying specific antigens and optimizing vaccine development to maximize the humoral response of the patient.,severe acute respiratory syndrome,DISEASE,identify,specific antigens,CHEBI
32812241,Acetoanaerobium sticklandii DSM 519 is a hyperammonia-producing anaerobe that catabolizes proteins and amino acids into organic solvents and volatile acids via the Stickland reactions.,Acetoanaerobium sticklandii DSM,CHEMICAL,be,hyperammonia-producing anaerobe,DISEASE
30283705,"In this study, we investigated the effects of auraptene on tumor migration, invasion and matrix metalloproteinase (MMP)-2 and -9 enzymes activity.",auraptene,CHEMICAL,have the effects on,tumor migration,DISEASE
23478692,"In Brazil, a mixture of cereals known as ""Human Ration"" (HR) has been consumed as a substitute for meals due to effects in satiation and weight loss.",mixture,CHEBI,substitute for meals due effects in,satiation weight loss,DISEASE
20446691,A few three-dimensional structures of these carotenoid complexes have been determined by X-ray crystallography.,carotenoid complexes,CHEBI,be determined by,X-ray crystallography,DISEASE
20446691,The carotenoids in these pigment-protein complexes transfer energy with high efficiency by optimizing both the distance and orientation of the carotenoid donor and chlorophyll acceptor molecules.,carotenoids,CHEBI,optimize distance and orientation of,carotenoid donor,CHEBI
20446691,The carotenoids in these pigment-protein complexes transfer energy with high efficiency by optimizing both the distance and orientation of the carotenoid donor and chlorophyll acceptor molecules.,carotenoids,CHEBI,optimize distance and orientation of,chlorophyll,CHEMICAL
20446691,The carotenoids in these pigment-protein complexes transfer energy with high efficiency by optimizing both the distance and orientation of the carotenoid donor and chlorophyll acceptor molecules.,carotenoids,CHEBI,optimize,orientation,MENTAL_HEALTH
11115641,The calculated efficiency of excitation energy transfer from the violaxanthin pool assumed to remain in conformation all-trans was found to be almost independent on the orientation angle within a variability range.,all-trans,CHEMICAL,be found to independent on,orientation angle,MENTAL_HEALTH
29558000,Cobalamin C (Cbl C) defect is a genetic disorder of cobalamin metabolism and is a rare cause of HUS.,Cobalamin C Cbl C defect,CHEMICAL,be genetic disorder of,cobalamin metabolism,CHEMICAL
25845692,"REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed.",REM sleep behavior disorder,MENTAL_HEALTH,be induced by,SSRI,CHEBI
25845692,"REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed.",REM sleep behavior disorder,MENTAL_HEALTH,be induced by,serotonin reuptake inhibitors,CHEMICAL
25845692,"REM sleep behavior disorder (RBD) can be induced by antidepressants, especially serotonin reuptake inhibitors (SSRI), thus a role of the serotonergic system in the pathogenesis of RBD has been proposed.",REM sleep behavior disorder,MENTAL_HEALTH,be induced by,antidepressants,CHEMICAL
24532378,"We favor the selective serotonin reuptake inhibitors (SSRIs) in general for both depression and anxiety because of their relative freedom from side effects but will often choose mirtazapine if insomnia or weight loss is a problem, clonazepam for anxiety without depression if an SSRI is insufficient or if REM sleep behavior disorder is a problem, or a tricyclic antidepressant if drooling is troubling and the patient is not demented.",weight loss,DISEASE,choose,mirtazapine,CHEMICAL
23350261,"Appropriate estro-progestagen therapy improves the quality of life and prevents complications such as cardiovascular diseases, osteoporosis, stroke etc.",Appropriate estro-progestagen therapy,CHEMICAL,prevent complications such as,cardiovascular diseases,DISEASE
23350261,"Appropriate estro-progestagen therapy improves the quality of life and prevents complications such as cardiovascular diseases, osteoporosis, stroke etc.",Appropriate estro-progestagen therapy,CHEMICAL,prevent complications such as,stroke,DISEASE
23350261,"Appropriate estro-progestagen therapy improves the quality of life and prevents complications such as cardiovascular diseases, osteoporosis, stroke etc.",Appropriate estro-progestagen therapy,CHEMICAL,prevent complications such as,osteoporosis,DISEASE
33685864,Vitamin D receptor activators and calcimimetics (calcium-sensing receptor agonists) are two major options for medical treatment of secondary hyperparathyroidism.,Vitamin D receptor activators,CHEBI,be major options for medical treatment of,secondary hyperparathyroidism,DISEASE
23791617,"While AMPH caused hyperlocomotion in HVF and, to a less extent, in SO- and FO-groups, a better memory performance was observed in FO group.",AMPH,CHEMICAL,cause hyperlocomotion in,HVF,DISEASE
23791617,"Among vehicle-groups, HVF increased reactive species (RS) generation and protein-carbonyl (PC) levels in cortex; FO reduced RS generation in hippocampus and decreased PC levels in hippocampus and striatum.",FO,CHEMICAL,reduce,RS generation,DISEASE
23791617,"Among AMPH-treated animals, HVF exacerbated RS generation in all evaluated brain areas and increased PC levels in cortex and striatum; FO reduced RS generation in hippocampus and decreased PC levels in hippocampus and striatum.",FO,CHEMICAL,reduce,RS generation,DISEASE
23791617,"FO was related to higher percentage of polyunsaturated fatty acids (PUFA) and docosahexaenoic acid (DHA) in cortex and striatum, while HVF was associated to higher incorporation of TFA in cortex, hippocampus and striatum, besides increased n-6/n-3 FA ratio in striatum.",FO,CHEMICAL,be related to higher percentage of,docosahexaenoic acid,CHEMICAL
23791617,"FO was related to higher percentage of polyunsaturated fatty acids (PUFA) and docosahexaenoic acid (DHA) in cortex and striatum, while HVF was associated to higher incorporation of TFA in cortex, hippocampus and striatum, besides increased n-6/n-3 FA ratio in striatum.",FO,CHEMICAL,be related to higher percentage of,PUFA,CHEMICAL
23791617,"FO was related to higher percentage of polyunsaturated fatty acids (PUFA) and docosahexaenoic acid (DHA) in cortex and striatum, while HVF was associated to higher incorporation of TFA in cortex, hippocampus and striatum, besides increased n-6/n-3 FA ratio in striatum.",FO,CHEMICAL,be related to higher percentage of,increased n-6/n-3 FA ratio,CHEMICAL
23791617,"FO was related to higher percentage of polyunsaturated fatty acids (PUFA) and docosahexaenoic acid (DHA) in cortex and striatum, while HVF was associated to higher incorporation of TFA in cortex, hippocampus and striatum, besides increased n-6/n-3 FA ratio in striatum.",FO,CHEMICAL,be related to higher percentage of,DHA,CHEMICAL
23791617,"FO was related to higher percentage of polyunsaturated fatty acids (PUFA) and docosahexaenoic acid (DHA) in cortex and striatum, while HVF was associated to higher incorporation of TFA in cortex, hippocampus and striatum, besides increased n-6/n-3 FA ratio in striatum.",FO,CHEMICAL,be related to higher percentage of,polyunsaturated fatty acids,NUTRITION
23040317,"In a monkey model, injections of GABA-antagonist into the striatum enabled us to produce tic-like movements, hyperactivity and stereotyped behaviours.",GABA-antagonist,CHEMICAL,produce,tic-like movements,DISEASE
23040317,"In a monkey model, injections of GABA-antagonist into the striatum enabled us to produce tic-like movements, hyperactivity and stereotyped behaviours.",GABA-antagonist,CHEMICAL,produce,hyperactivity,MENTAL_HEALTH
34906709,"In this work, a novel flat-panel photobioreactor (FPP) was used for maximization of biomass and lutein production and CO2 fixation by a lutein-rich C. sorokiniana TH01.",FPP,CHEMICAL,be used in work for maximization of,lutein,CHEBI
34906709,"In this work, a novel flat-panel photobioreactor (FPP) was used for maximization of biomass and lutein production and CO2 fixation by a lutein-rich C. sorokiniana TH01.",FPP,CHEMICAL,be used in work for maximization of,CO2 fixation,MENTAL_HEALTH
34906709,"In this work, a novel flat-panel photobioreactor (FPP) was used for maximization of biomass and lutein production and CO2 fixation by a lutein-rich C. sorokiniana TH01.",FPP,CHEMICAL,be used in work for maximization of,CO2 fixation,CHEMICAL
33525716,"The most effective solvent for lutein recovery was identified as 100% methanol, and the optimum condition was determined (42.4 °C, 4.0 h and 125 g/L biomass loading) by calculation of the multiple regression model.",lutein recovery,CHEBI,be identified as,% methanol,CHEMICAL
9134211,"administration of both MCCG and MAP4 significantly decreased the time spent in withdrawal, MCPG and MCCG reduced the frequency of jumps and wet dog shakes and attenuated the severity of agitation.",MCCG,CHEMICAL,attenuate severity of,agitation,MENTAL_HEALTH
9134211,"administration of both MCCG and MAP4 significantly decreased the time spent in withdrawal, MCPG and MCCG reduced the frequency of jumps and wet dog shakes and attenuated the severity of agitation.",MCCG,CHEMICAL,decrease,MCPG,CHEMICAL
9134211,"administration of both MCCG and MAP4 significantly decreased the time spent in withdrawal, MCPG and MCCG reduced the frequency of jumps and wet dog shakes and attenuated the severity of agitation.",MCCG,CHEMICAL,decrease,MCCG,CHEMICAL
23179164,"Three individuals of silver carp (Hypophthalmichthys molitrix) were collected biweekly from Paranoá Lake (DF, Brazil) for analysis of microcystin (MC) concentrations in their muscle and liver tissue.",Hypophthalmichthys molitrix,NUTRITION,be collected from,liver tissue,DISEASE
23179164,"Three individuals of silver carp (Hypophthalmichthys molitrix) were collected biweekly from Paranoá Lake (DF, Brazil) for analysis of microcystin (MC) concentrations in their muscle and liver tissue.",silver carp,CHEMICAL,be collected from,liver tissue,DISEASE
35165338,Site markers displacement assay projected subdomain IIA as the binding site of trans-resveratrol to HSA.,displacement assay,MENTAL_HEALTH,binding site of,trans-resveratrol,CHEMICAL
34308039,The competing capability of warfarin for AFB1 was higher than ibuprofen as calculated from site marker displacement assay.,warfarin,CHEMICAL,calculate from,site marker displacement assay,MENTAL_HEALTH
34308039,The competing capability of warfarin for AFB1 was higher than ibuprofen as calculated from site marker displacement assay.,AFB1,CHEMICAL,calculate from,site marker displacement assay,MENTAL_HEALTH
34308039,The competing capability of warfarin for AFB1 was higher than ibuprofen as calculated from site marker displacement assay.,warfarin,CHEMICAL,be,ibuprofen,CHEMICAL
34308039,The competing capability of warfarin for AFB1 was higher than ibuprofen as calculated from site marker displacement assay.,AFB1,CHEMICAL,be,ibuprofen,CHEMICAL
34308039,The competing capability of warfarin for AFB1 was higher than ibuprofen as calculated from site marker displacement assay.,warfarin,CHEMICAL,have the competing capability for,AFB1,CHEMICAL
35336684,"Moreover, the genotypes of 271-58-24, 261-65-19, 77-1-47, and 'Jonkheer van Tets' were found to have less cold damage during the cold periods.",Jonkheer van Tets,CHEMICAL,have,cold damage,DISEASE
22675118,We found that the extracellular plant immune receptor protein Cf-2 of the red currant tomato (Solanum pimpinellifolium) has acquired dual resistance specificity by sensing perturbations in a common virulence target of two independently evolved effectors of a fungus and a nematode.,red currant tomato,NUTRITION,acquire,dual resistance specificity,MENTAL_HEALTH
33771554,"Adenosine receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), blocked the intracisternal ghrelin-induced improvement of intestinal hyperpermeability while dopamine, cannabinoid or opioid receptor antagonist failed to prevent it.","1,3-dipropyl-8-cyclopentylxanthine",CHEMICAL,block intracisternal ghrelin-induced improvement of,intestinal hyperpermeability,DISEASE
33771554,"Adenosine receptor antagonist, 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), blocked the intracisternal ghrelin-induced improvement of intestinal hyperpermeability while dopamine, cannabinoid or opioid receptor antagonist failed to prevent it.",Adenosine receptor antagonist,CHEBI,block intracisternal ghrelin-induced improvement of,intestinal hyperpermeability,DISEASE
33771554,"Intracisternal injection of adenosine A2B agonist but not adenosine A1 agonist improved colonic hyperpermeability, while peripheral injection of adenosine A2B agonist failed to improve it.",adenosine A2B agonist adenosine A1 agonist,CHEBI,improve,colonic hyperpermeability,DISEASE
33771554,"Intracisternal injection of adenosine A2B agonist but not adenosine A1 agonist improved colonic hyperpermeability, while peripheral injection of adenosine A2B agonist failed to improve it.",adenosine A2B agonist adenosine A1 agonist,CHEMICAL,improve,colonic hyperpermeability,DISEASE
33771554,"Adenosine A2B specific antagonist, alloxazine blocked the ghrelin- or central vagal stimulation by 2-deoxy-d-glucose-induced improvement of intestinal hyperpermeability.",alloxazine,CHEMICAL,block ghrelin- or central vagal stimulation by 2-deoxy-d-glucose-induced improvement of,intestinal hyperpermeability,DISEASE
33771554,"Adenosine A2B specific antagonist, alloxazine blocked the ghrelin- or central vagal stimulation by 2-deoxy-d-glucose-induced improvement of intestinal hyperpermeability.",specific antagonist,CHEBI,block ghrelin- or central vagal stimulation by 2-deoxy-d-glucose-induced improvement of,intestinal hyperpermeability,DISEASE
33646165,"Adenosine, a ubiquitous nucleoside, plays a key role in neurodegeneration, through interaction with four receptor subtypes.",Adenosine,CHEMICAL,play key role in,neurodegeneration,DISEASE
33646165,"Adenosine, a ubiquitous nucleoside, plays a key role in neurodegeneration, through interaction with four receptor subtypes.",ubiquitous nucleoside,CHEMICAL,play key role in,neurodegeneration,DISEASE
23241554,"Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors.",caffeine,CHEMICAL,modify course of,memory impairment,DISEASE
23241554,"Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors.",adenosine receptor antagonist,CHEBI,modify course of,memory impairment,DISEASE
23241554,"Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors.",adenosine A2A receptors,CHEMICAL,modify course of,memory impairment,DISEASE
23241554,"Since caffeine (an adenosine receptor antagonist) and selective antagonists of adenosine A2A receptors modify the course of memory impairment in different amyloid-β-based experimental models of AD, we now tested the impact of caffeine on STZ-induced dementia and associated neurodegeneration in the hippocampus as well as on the expression and density of adenosine receptors.",selective antagonists,CHEBI,modify course of,memory impairment,DISEASE
23241554,Caffeine consumption (1 g/L in the drinking water starting 2 weeks before the STZ challenge) prevented the STZ-induced memory impairment and neurodegeneration as well as the upregulation of A2AR.,Caffeine consumption,CHEMICAL,prevent,STZ-induced memory impairment,DISEASE
23241554,Caffeine consumption (1 g/L in the drinking water starting 2 weeks before the STZ challenge) prevented the STZ-induced memory impairment and neurodegeneration as well as the upregulation of A2AR.,Caffeine consumption,CHEMICAL,prevent,neurodegeneration,DISEASE
23241554,These findings provide the first demonstration that caffeine prevents sporadic dementia and implicate the control of central A2AR as its likely mechanism of action.,caffeine,CHEMICAL,prevent,sporadic dementia,MENTAL_HEALTH
30791771,Linaclotide is approved for treating irritable bowel syndrome with constipation (IBS-C; 290 µg QD) and chronic idiopathic constipation (CIC; 145 µg or 72 µg QD).,Linaclotide,CHEMICAL,treat,irritable bowel syndrome,DISEASE
30791771,Linaclotide is approved for treating irritable bowel syndrome with constipation (IBS-C; 290 µg QD) and chronic idiopathic constipation (CIC; 145 µg or 72 µg QD).,Linaclotide,CHEMICAL,be approved,IBS-C,DISEASE
34944695,"A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson's disease (PD) patients.",low-dose daily niacin supplementation,CHEMICAL,improve motor symptoms in parkinson's,PD,DISEASE
34944695,"A six-month double-blind, placebo-controlled randomized study was conducted to ascertain whether low-dose daily niacin supplementation would improve motor symptoms in Parkinson's disease (PD) patients.",low-dose daily niacin supplementation,CHEBI,improve motor symptoms in parkinson's,PD,DISEASE
34944695,A total of 47 PD patients were assigned to receive low-dose niacin or a placebo.,PD patients,DISEASE,receive,low-dose niacin,CHEBI
3803759,"At pH 7.40 and 25 degrees C the dissociation constant Kd of this complex and the rate constant k2 of cleavage of soman by beta-cyclodextrin are (0.53 +/- 0.05) mM and (5.9 +/- 0.6) X 10(-2) min-1, respectively.",beta-cyclodextrin,NUTRITION,have cleavage of,soman,CHEMICAL
32992000,Therapy with oral fucose led to the disappearance of the chronic skin infections and improvements in behavior and attention span.,oral fucose,CHEMICAL,lead to disappearance of,chronic skin infections,DISEASE
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",Analgesic efficacy,CHEBI,appear comparable to,pentazocine,CHEMICAL
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",Analgesic efficacy,CHEBI,appear comparable to,acute pain,DISEASE
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",Analgesic efficacy,CHEBI,appear comparable to,pethidine,CHEMICAL
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",Analgesic efficacy,CHEBI,appear comparable to,meperidine,CHEMICAL
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",propiram,CHEMICAL,appear comparable to,pentazocine,CHEMICAL
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",propiram,CHEMICAL,appear comparable to,acute pain,DISEASE
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",propiram,CHEMICAL,appear comparable to,pethidine,CHEMICAL
7693433,"Analgesic efficacy of propiram, usually 50 or 100mg, appears comparable to that of standard dosages of other oral opioid drugs [i.e. pentazocine, pethidine (meperidine)] in patients with acute pain of moderate to severe intensity arising from various gynaecological and surgical procedures, and may be superior to codeine in gynaecological and postoperative dental pain.",propiram,CHEMICAL,appear comparable to,meperidine,CHEMICAL
7693433,"The tolerability profile of propiram resembles those of others in its class, with drowsiness, nausea and vomiting, and dizziness experienced most frequently in controlled trials.",propiram,CHEMICAL,resemble,nausea,DISEASE
7693433,"The tolerability profile of propiram resembles those of others in its class, with drowsiness, nausea and vomiting, and dizziness experienced most frequently in controlled trials.",propiram,CHEMICAL,resemble,vomiting,DISEASE
7693433,"The tolerability profile of propiram resembles those of others in its class, with drowsiness, nausea and vomiting, and dizziness experienced most frequently in controlled trials.",propiram,CHEMICAL,resemble,drowsiness,MENTAL_HEALTH
8412493,Both amnesia and improvement of performance have been reported after treatment with GABA antagonists.,amnesia,MENTAL_HEALTH,be reported after treatment with,GABA antagonists,CHEBI
8412493,Picrotoxin did not modify the conditioned response while bicuculline induced amnesia only with the lower doses at both low and high footshock intensities.,bicuculline,CHEMICAL,induce,amnesia,MENTAL_HEALTH
30117095,Carbachol also induced long-term depression of evoked inhibitory postsynaptic currents and a short-term depression of evoked excitatory postsynaptic currents.,Carbachol,CHEMICAL,induce long-term depression of,short-term depression,MENTAL_HEALTH
30117095,Carbachol also induced long-term depression of evoked inhibitory postsynaptic currents and a short-term depression of evoked excitatory postsynaptic currents.,Carbachol,CHEMICAL,induce,long-term depression,MENTAL_HEALTH
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",PEA,CHEMICAL,induce peripheral biosynthesis of,acidergic neurosteroid,CHEMICAL
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",PEA,CHEMICAL,induce peripheral biosynthesis of,allopregnanolone,CHEMICAL
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",endocannabinoid congener N-palmitoylethanolamine,CHEMICAL,regulate,inflammation,DISEASE
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",PEA,CHEMICAL,regulate,inflammation,DISEASE
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",endocannabinoid congener N-palmitoylethanolamine,CHEMICAL,induce peripheral biosynthesis of,acidergic neurosteroid,CHEMICAL
30955840,"Activation of peroxisome proliferator-activated receptor (PPAR)-α by the endocannabinoid congener N-palmitoylethanolamine (PEA) regulates pathophysiological systems (e.g., inflammation, oxidative stress) and induces peripheral biosynthesis of allopregnanolone, a gamma-aminobutyric acidergic neurosteroid implicated in mood disorders.",endocannabinoid congener N-palmitoylethanolamine,CHEMICAL,induce peripheral biosynthesis of,allopregnanolone,CHEMICAL
26080315,"In human subjects with (n = 28) or without PTSD (n = 31), significant over-expression of CPT1B in PTSD was also observed in the two common dysregulated pathways: fatty acid metabolism (P = 0.0027, false discovery rate (FDR) = 0.043) and PPAR (P = 0.006, FDR = 0.08).",PTSD,DISEASE,be observed in human subjects with,PTSD,DISEASE
26080315,"In human subjects with (n = 28) or without PTSD (n = 31), significant over-expression of CPT1B in PTSD was also observed in the two common dysregulated pathways: fatty acid metabolism (P = 0.0027, false discovery rate (FDR) = 0.043) and PPAR (P = 0.006, FDR = 0.08).",PTSD,DISEASE,be observed in human subjects with,PPAR,CHEBI
27650436,"Moreover, behavioral changes in carps exposed to CuO NP and TiO2 NP mixture such as hyperactivity, loss of balance, and convulsions were higher than those to CuO NPs and TiO2 NPs alone.",convulsions,DISEASE,be,TiO2 NPs,CHEMICAL
27650436,"Moreover, behavioral changes in carps exposed to CuO NP and TiO2 NP mixture such as hyperactivity, loss of balance, and convulsions were higher than those to CuO NPs and TiO2 NPs alone.",convulsions,DISEASE,be,CuO NPs,CHEMICAL
27650436,"Moreover, behavioral changes in carps exposed to CuO NP and TiO2 NP mixture such as hyperactivity, loss of balance, and convulsions were higher than those to CuO NPs and TiO2 NPs alone.",balance,DISEASE,be,TiO2 NPs,CHEMICAL
27650436,"Moreover, behavioral changes in carps exposed to CuO NP and TiO2 NP mixture such as hyperactivity, loss of balance, and convulsions were higher than those to CuO NPs and TiO2 NPs alone.",balance,DISEASE,be,CuO NPs,CHEMICAL
23524854,"The energy used by neurons is derived largely from tissue oxidative metabolism, and neural hyperactivity and cell death are reflected by corresponding changes in cerebral oxygen metabolism (CMRO₂).",neural hyperactivity,MENTAL_HEALTH,be reflected by corresponding changes in,cerebral oxygen metabolism,CHEMICAL
34466144,Alcohol abstinence is an absolute recommendation and prevents the extension of neural damage.,Alcohol abstinence,CHEMICAL,prevent extension of,neural damage,DISEASE
21217196,Wernicke's encephalopathy (WE) is caused by thiamine (vitamin B1) deficiency and most commonly found in individuals with chronic alcoholism and malnutrition.,Wernicke's encephalopathy,DISEASE,be caused by,thiamine vitamin B1 deficiency,CHEBI
10715360,"Impulsive aggression in patients with personality disorders is associated with diminished levels of cerebrospinal fluid (CSF) 5-HIAA, blunted neuroendocrine responses to serotonergic agonists, and decreased glucose utilization in the prefrontal cortex.",Impulsive aggression,DISEASE,be associated with diminished levels of,5-HIAA,CHEMICAL
10715360,"Impulsive aggression in patients with personality disorders is associated with diminished levels of cerebrospinal fluid (CSF) 5-HIAA, blunted neuroendocrine responses to serotonergic agonists, and decreased glucose utilization in the prefrontal cortex.",personality disorders,MENTAL_HEALTH,be associated with diminished levels of,5-HIAA,CHEMICAL
10715360,"Impulsive aggression in patients with personality disorders is associated with diminished levels of cerebrospinal fluid (CSF) 5-HIAA, blunted neuroendocrine responses to serotonergic agonists, and decreased glucose utilization in the prefrontal cortex.",Impulsive aggression,DISEASE,decrease,glucose utilization,CHEMICAL
10715360,"Impulsive aggression in patients with personality disorders is associated with diminished levels of cerebrospinal fluid (CSF) 5-HIAA, blunted neuroendocrine responses to serotonergic agonists, and decreased glucose utilization in the prefrontal cortex.",personality disorders,MENTAL_HEALTH,decrease,glucose utilization,CHEMICAL
10715360,"Impulsive aggression in patients with personality disorders is associated with diminished levels of cerebrospinal fluid (CSF) 5-HIAA, blunted neuroendocrine responses to serotonergic agonists, and decreased glucose utilization in the prefrontal cortex.",Impulsive aggression,DISEASE,in patients with,personality disorders,MENTAL_HEALTH
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",impulsive aggression,DISEASE,use,FEN,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",impulsive aggression,DISEASE,use,l fenfluramine,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",impulsive aggression,DISEASE,use,positron-emission tomography,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",borderline personality disorder,MENTAL_HEALTH,use,FEN,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",borderline personality disorder,MENTAL_HEALTH,use,l fenfluramine,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",borderline personality disorder,MENTAL_HEALTH,use,positron-emission tomography,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",BPD,DISEASE,use,FEN,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",BPD,DISEASE,use,l fenfluramine,CHEMICAL
10715360,"We tested the hypothesis that impulsive aggression in borderline personality disorder (BPD) may be associated with diminished serotonergic regulation in the prefrontal cortex, using positron-emission tomography (PET) neuroimaging during pharmacologic challenge with d,l fenfluramine (FEN).",BPD,DISEASE,use,positron-emission tomography,CHEMICAL
31967341,"Oestrogen has been reported to mediate pain modulation via its receptor, and mast cells are known to participate in the development of visceral hypersensitivity.",Oestrogen,CHEBI,mediate,pain modulation,DISEASE
31967341,"Our previous studies showed that the G-protein-coupled oestrogen receptor (GPER, also known as GPR30) was expressed by mast cells in human colonic tissues and was associated with IBS type and severity of visceral pain.",G-protein-coupled oestrogen receptor,CHEBI,be associated with ibs type and severity of,visceral pain,DISEASE
31967341,"Our previous studies showed that the G-protein-coupled oestrogen receptor (GPER, also known as GPR30) was expressed by mast cells in human colonic tissues and was associated with IBS type and severity of visceral pain.",GPER,CHEMICAL,be associated with ibs type and severity of,visceral pain,DISEASE
31967341,"However, whether GPER is involved in oestrogen-dependent visceral hypersensitivity via mast cell degranulation is still unknown.",GPER,CHEMICAL,be involved in,oestrogen-dependent visceral hypersensitivity,DISEASE
31967341,Rats were subjected to wrap partial restraint stress to induce visceral hypersensitivity and were ovariectomized (OVX) to eliminate the effects of oestrogen on visceral hypersensitivity.,oestrogen,CHEBI,have the effects on,visceral hypersensitivity,DISEASE
31967341,"GPER plays a pivotal role in the regulation of mast cell degranulation, mast cell tryptase expression, and histamine levels and contributes to the development of colonic hypersensitivity in a female rat model of IBS.",GPER,CHEMICAL,play pivotal role in regulation of,histamine levels,CHEMICAL
25170596,Selenium (Se) has been shown to antagonize mercury (Hg) toxicity.,Se,CHEMICAL,antagonize,mercury toxicity,DISEASE
25170596,Selenium (Se) has been shown to antagonize mercury (Hg) toxicity.,Se,CHEMICAL,antagonize,mercury toxicity,NUTRITION
25170596,Selenium (Se) has been shown to antagonize mercury (Hg) toxicity.,Selenium,CHEMICAL,antagonize,mercury toxicity,DISEASE
25170596,Selenium (Se) has been shown to antagonize mercury (Hg) toxicity.,Selenium,CHEMICAL,antagonize,mercury toxicity,NUTRITION
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active metabolic transformation,DISEASE,indicate by gradual increase in,blood Sec,CHEMICAL
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active Se forms,CHEMICAL,indicate by gradual increase in,blood Sec,CHEMICAL
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active metabolic transformation,DISEASE,be seen in presence of mehg in,Se metabolites,CHEMICAL
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active metabolic transformation,DISEASE,be seen in presence of mehg in,liver SeMet ratios,DISEASE
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active metabolic transformation,DISEASE,be seen in presence of,MeHg,CHEMICAL
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active Se forms,CHEMICAL,be seen in presence of mehg in,Se metabolites,CHEMICAL
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active Se forms,CHEMICAL,be seen in presence of mehg in,liver SeMet ratios,DISEASE
25170596,"In the presence of MeHg, however, active metabolic transformation and de novo synthesis of biologically active Se forms are seen in the liver and kidneys, as indicated by a gradual increase in blood Sec:SeMet ratios and Se metabolites.",active Se forms,CHEMICAL,be seen in presence of,MeHg,CHEMICAL
19926712,"Anorexia nervosa (AN), a state of chronic nutritional deprivation, is characterized by GH resistance with elevated GH levels and decreased levels of IGF-I. Fibroblast growth factor (FGF)-21, a hormone produced in the liver and adipocytes, is induced in the liver by fasting and peroxisome proliferator-activated receptor-alpha agonists.",Anorexia nervosa,MENTAL_HEALTH,decrease levels of,hormone,CHEBI
19926712,"Anorexia nervosa (AN), a state of chronic nutritional deprivation, is characterized by GH resistance with elevated GH levels and decreased levels of IGF-I. Fibroblast growth factor (FGF)-21, a hormone produced in the liver and adipocytes, is induced in the liver by fasting and peroxisome proliferator-activated receptor-alpha agonists.",Anorexia nervosa,MENTAL_HEALTH,be characterized by,GH resistance,MENTAL_HEALTH
19926712,"Anorexia nervosa (AN), a state of chronic nutritional deprivation, is characterized by GH resistance with elevated GH levels and decreased levels of IGF-I. Fibroblast growth factor (FGF)-21, a hormone produced in the liver and adipocytes, is induced in the liver by fasting and peroxisome proliferator-activated receptor-alpha agonists.",Anorexia nervosa,MENTAL_HEALTH,be induced in liver by,fasting agonists,CHEBI
34205729,"Treatment with antidepressants is often insufficiently effective, especially in treatment-resistant depression.",antidepressants,CHEMICAL,be effective in,treatment-resistant depression,MENTAL_HEALTH
27836391,"In contrast, the effectiveness of antidepressant drugs for depression in epilepsy is unknown.",antidepressant drugs,CHEMICAL,have the effectiveness for,depression,MENTAL_HEALTH
27836391,"However, if modern antidepressants are used (e.g. SSRI, SNRI, NaSSA), concerns about an aggravation of seizures and or problematic interactions with antiepileptic drugs seem unwarranted.",modern antidepressants,CHEMICAL,be used,NaSSA,CHEMICAL
27836391,"However, if modern antidepressants are used (e.g. SSRI, SNRI, NaSSA), concerns about an aggravation of seizures and or problematic interactions with antiepileptic drugs seem unwarranted.",modern antidepressants,CHEMICAL,be used,SNRI,CHEMICAL
27836391,"However, if modern antidepressants are used (e.g. SSRI, SNRI, NaSSA), concerns about an aggravation of seizures and or problematic interactions with antiepileptic drugs seem unwarranted.",modern antidepressants,CHEMICAL,be used,SSRI,CHEBI
16974196,Antidepressant use seems to be problematic in bipolar disorder.,Antidepressant use,CHEMICAL,seem to problematic in,bipolar disorder,MENTAL_HEALTH
34808751,"Secondary outcomes including scores of pain scales (ID-pain, DN4), Patient Health Questionnaire (PHQ-9), 7-item Generalized Anxiety Disorder (GAD-7) at 1, 2, 3, 4, 8, 12 weeks after treatment were applied to evaluate the efficacy and safety of the combination of bulleyaconitine A tablets with first-line drug in the treatment of PHN.",pain scales,DISEASE,evaluate efficacy and safety of combination of bulleyaconitine a tablets with,PHN,DISEASE
34808751,"Secondary outcomes including scores of pain scales (ID-pain, DN4), Patient Health Questionnaire (PHQ-9), 7-item Generalized Anxiety Disorder (GAD-7) at 1, 2, 3, 4, 8, 12 weeks after treatment were applied to evaluate the efficacy and safety of the combination of bulleyaconitine A tablets with first-line drug in the treatment of PHN.",pain scales,DISEASE,evaluate efficacy and safety of combination of bulleyaconitine a tablets with,first-line drug,CHEBI
34808751,"Secondary outcomes including scores of pain scales (ID-pain, DN4), Patient Health Questionnaire (PHQ-9), 7-item Generalized Anxiety Disorder (GAD-7) at 1, 2, 3, 4, 8, 12 weeks after treatment were applied to evaluate the efficacy and safety of the combination of bulleyaconitine A tablets with first-line drug in the treatment of PHN.",scales ID-pain,CHEMICAL,evaluate efficacy and safety of combination of bulleyaconitine a tablets with,PHN,DISEASE
34808751,"Secondary outcomes including scores of pain scales (ID-pain, DN4), Patient Health Questionnaire (PHQ-9), 7-item Generalized Anxiety Disorder (GAD-7) at 1, 2, 3, 4, 8, 12 weeks after treatment were applied to evaluate the efficacy and safety of the combination of bulleyaconitine A tablets with first-line drug in the treatment of PHN.",scales ID-pain,CHEMICAL,evaluate efficacy and safety of combination of bulleyaconitine a tablets with,first-line drug,CHEBI
34808751,"Cox regression analysis indicated that the grouping factor of oral bulleyaconitine A tablets was an independent factor for improving the outcome of PHN (HR=2.063, 95%CI: 1.059-4.018, PP6 months) was only 0.201 times that of the short disease course group (HR=0.201, 95%CI: 0.073-0.551, PP>0.05).",Cox regression analysis,MENTAL_HEALTH,indicate,HR=0.201,CHEMICAL
34808751,"Conclusion: Bulleyaconitine A tablet can promote the therapeutic efficacy of gabapentin, and improve the outcome of PHN in a short period of 3 months.",Bulleyaconitine A tablet,CHEMICAL,improve outcome of,PHN,DISEASE
34808751,"Conclusion: Bulleyaconitine A tablet can promote the therapeutic efficacy of gabapentin, and improve the outcome of PHN in a short period of 3 months.",Bulleyaconitine A tablet,CHEMICAL,promote therapeutic efficacy of,gabapentin,CHEMICAL
35152044,"At the legal level, the review suggested that the effectiveness of current enforcement approaches to drug driving vary among jurisdictions around the world due to differences in the level of perceived certainty of apprehension and the chances of punishment avoidance.",drug driving,CHEBI,vary among jurisdictions around world due differences in level of,apprehension,MENTAL_HEALTH
35253555,"In 2019, intranasal esketamine, the S-isomer of racemic ketamine, was approved for TRD, garnering significant excitement about the potential for the drug to act as an alternative treatment to ECT.",intranasal esketamine,CHEMICAL,garner significant excitement about potential for,drug,CHEBI
35253555,"In 2019, intranasal esketamine, the S-isomer of racemic ketamine, was approved for TRD, garnering significant excitement about the potential for the drug to act as an alternative treatment to ECT.",intranasal esketamine,CHEMICAL,be approved in 2019 for,TRD,DISEASE
35253555,"In 2019, intranasal esketamine, the S-isomer of racemic ketamine, was approved for TRD, garnering significant excitement about the potential for the drug to act as an alternative treatment to ECT.",racemic ketamine,CHEMICAL,be approved in 2019 for,TRD,DISEASE
35253555,"In 2019, intranasal esketamine, the S-isomer of racemic ketamine, was approved for TRD, garnering significant excitement about the potential for the drug to act as an alternative treatment to ECT.",racemic ketamine,CHEMICAL,garner significant excitement about potential for,drug,CHEBI
35253555,"The field awaits the results of two ongoing large comparative effectiveness trials of ECT and IV ketamine for TRD, which should help guide clinicians and patients as to the relative risk and benefit of these interventions.",ketamine,CHEMICAL,have two ongoing large comparative effectiveness trials for,TRD,DISEASE
33882663,A diet rich in saturated fatty acids and branched-chain amino acids (BCAA) promotes the progression of dementia.,saturated fatty acids,NUTRITION,promote progression of,dementia,MENTAL_HEALTH
31513729,"l-α-Glycerylphosphorylcholine (l-α-GPC) is a biosynthetic precursor for the neurotransmitter acetylcholine in humans, making it a useful as a cognitive enhancer for treating patients with stroke and dementia, including Alzheimer's disease.",l-α-Glycerylphosphorylcholine,CHEMICAL,be biosynthetic precursor for,neurotransmitter acetylcholine,CHEMICAL
30122708,Emulsification with egg yolk lecithin may possibly contribute to improvement of nutrition during biliary excretion disorders such as external drainage.,yolk lecithin,CHEBI,contribute to improvement of nutrition during,biliary excretion disorders,DISEASE
23624001,Sinusoidal obstruction syndrome (SOS) following oxaliplatin based chemotherapy can have a significant impact on post-operative outcome following resection of colorectal liver metastases.,Sinusoidal obstruction syndrome,DISEASE,have significant impact on,colorectal liver metastases,DISEASE
35381505,"Our analyses suggest that during the first year of the COVID-19 pandemic that insomnia symptoms predicted depression symptoms one year later, and conversely that depression symptoms predicted subsequent insomnia symptoms.",insomnia symptoms,MENTAL_HEALTH,predict,depression symptoms,MENTAL_HEALTH
35381505,"Our analyses suggest that during the first year of the COVID-19 pandemic that insomnia symptoms predicted depression symptoms one year later, and conversely that depression symptoms predicted subsequent insomnia symptoms.",depression symptoms,MENTAL_HEALTH,predict,subsequent insomnia symptoms,MENTAL_HEALTH
34201747,We previously reported that the behavioural phenotype and brain mitochondria dysfunction are widely rescued by a single intracerebroventricular injection of the bacterial toxin CNF1 in a RTT mouse model carrying a truncating mutation of the MeCP2 gene (MeCP2-308 mice).,bacterial toxin CNF1,CHEBI,have a single intracerebroventricular injection in,RTT mouse model,DISEASE
26457896,"The results herein reported show that a single dose of CNF1 induces a remarkable amelioration of the seizure phenotype, with a significant augmentation in neuroplasticity markers and in cortex mitochondrial ATP content.",CNF1,DISEASE,induce remarkable amelioration of seizure phenotype with significant augmentation in,cortex mitochondrial ATP content,CHEMICAL
26457896,"The results herein reported show that a single dose of CNF1 induces a remarkable amelioration of the seizure phenotype, with a significant augmentation in neuroplasticity markers and in cortex mitochondrial ATP content.",CNF1,DISEASE,induce remarkable amelioration of,seizure phenotype,DISEASE
11495685,Several functional studies suggest that CGRP could be involved in the vasodilatation of different vascular beds during neurogenic inflammation.,CGRP,CHEMICAL,be involved in vasodilatation of different vascular beds during,neurogenic inflammation,DISEASE
11495685,CGRP 8-37 and 27-37 appear to be potential contributors to the study of CGRP and its physiological role in neurogenic inflammation.,CGRP,CHEMICAL,appear to potential contributors to study of cgrp and its physiological role in,neurogenic inflammation,DISEASE
11495685,CGRP 8-37 and 27-37 appear to be potential contributors to the study of CGRP and its physiological role in neurogenic inflammation.,CGRP,CHEMICAL,appear to potential contributors to study of,CGRP,CHEMICAL
11495685,CGRP 8-37 and 27-37 appear to be potential contributors to the study of CGRP and its physiological role in neurogenic inflammation.,CGRP,CHEMICAL,have the study in,neurogenic inflammation,DISEASE
35290650,"Commonly, clotrimazole as a broad-spectrum antimitotic drug applied for treatment of Candida albicans infections.",broad-spectrum antimitotic drug,CHEBI,apply for treatment of,infections,DISEASE
35290650,"Commonly, clotrimazole as a broad-spectrum antimitotic drug applied for treatment of Candida albicans infections.",clotrimazole,CHEMICAL,apply for treatment of,infections,DISEASE
32707118,"Evidence also exists for relations between bisphenols and adult diabetes, reduced semen quality, and polycystic ovarian syndrome; phthalates and prematurity, reduced anogenital distance in boys, childhood obesity, and impaired glucose tolerance; organophosphate pesticides and reduced semen quality; and occupational exposure to pesticides and prostate cancer.",prematurity,DISEASE,reduce anogenital distance in,childhood obesity,DISEASE
32707118,"Evidence also exists for relations between bisphenols and adult diabetes, reduced semen quality, and polycystic ovarian syndrome; phthalates and prematurity, reduced anogenital distance in boys, childhood obesity, and impaired glucose tolerance; organophosphate pesticides and reduced semen quality; and occupational exposure to pesticides and prostate cancer.",bisphenols,CHEMICAL,have relations with,adult diabetes,DISEASE
32707118,"Evidence also exists for relations between bisphenols and adult diabetes, reduced semen quality, and polycystic ovarian syndrome; phthalates and prematurity, reduced anogenital distance in boys, childhood obesity, and impaired glucose tolerance; organophosphate pesticides and reduced semen quality; and occupational exposure to pesticides and prostate cancer.",adult diabetes,DISEASE,have relations with,bisphenols,CHEMICAL
17651468,"It has been also shown that combination of caffeine and glucose, fundamental constituents of ED, can ameliorate deficits in cognitive performance and subjective fatigue during extended periods of cognitive demand.",caffeine,CHEMICAL,ameliorate deficits in cognitive performance and subjective fatigue during extended periods of,cognitive demand,DISEASE
17651468,"It has been also shown that combination of caffeine and glucose, fundamental constituents of ED, can ameliorate deficits in cognitive performance and subjective fatigue during extended periods of cognitive demand.",caffeine,CHEMICAL,ameliorate deficits in,subjective fatigue,MENTAL_HEALTH
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of well-recognized antidepressant drugs such as,desipramine,CHEMICAL
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of well-recognized antidepressant drugs such as,sertraline,CHEMICAL
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of well-recognized antidepressant drugs such as,rolipram,CHEMICAL
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of well-recognized antidepressant drugs such as,imipramine,CHEMICAL
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of well-recognized antidepressant drugs such as,newer generation antidepressants,CHEMICAL
8455816,"This behavioral abnormality has been normalized by a number of well-recognized antidepressant drugs such as imipramine and desipramine, as well as newer generation antidepressants with promising clinical effects such as sertraline and rolipram.",behavioral abnormality,DISEASE,be normalized by number of,well-recognized antidepressant drugs,CHEMICAL
32552565,"Based on available data, naldemedine appears to be an effective and safe first-line therapy for the treatment of opioid-induced constipation in adults with chronic noncancer pain.",naldemedine,CHEMICAL,appear based on available data to effective and safe first-line therapy for treatment of opioid-induced constipation in,chronic noncancer pain,DISEASE
32552565,"Based on available data, naldemedine appears to be an effective and safe first-line therapy for the treatment of opioid-induced constipation in adults with chronic noncancer pain.",naldemedine,CHEMICAL,appear based on available data to effective and safe first-line therapy for treatment of,opioid-induced constipation,DISEASE
29391826,"A novel class of therapeutics, the peripherally acting μ-opioid receptor antagonists (PAMORAs), has been developed to mitigate the deleterious effects of opioids in the gastrointestinal tract while maintaining central analgesia and minimizing opioid withdrawal.",acting μ-opioid receptor antagonists,CHEBI,maintain,central analgesia,MENTAL_HEALTH
29391826,"A novel class of therapeutics, the peripherally acting μ-opioid receptor antagonists (PAMORAs), has been developed to mitigate the deleterious effects of opioids in the gastrointestinal tract while maintaining central analgesia and minimizing opioid withdrawal.",acting μ-opioid receptor antagonists,CHEBI,mitigate deleterious effects of opioids in,gastrointestinal tract,DISEASE
29391826,"Based on the available data, naldemedine appears to be an effective and safe drug for the treatment of OIC in adults with chronic noncancer pain.",naldemedine,CHEMICAL,appear based on available data to effective and safe drug for treatment of oic in,chronic noncancer pain,DISEASE
29391826,"Based on the available data, naldemedine appears to be an effective and safe drug for the treatment of OIC in adults with chronic noncancer pain.",naldemedine,CHEMICAL,appear based on available data to effective and safe drug for treatment of,OIC,DISEASE
29391826,"Based on the available data, naldemedine appears to be an effective and safe drug for the treatment of OIC in adults with chronic noncancer pain.",naldemedine,CHEMICAL,appear based on available data to,effective drug,CHEBI
35409462,"The reviewed studies suggest that first-time psychotic disorder in COVID-19 patients is statistically significantly more frequent compared to influenza, as well as to other respiratory infections.",first-time psychotic disorder,MENTAL_HEALTH,compared to,other respiratory infections,DISEASE
35409462,"The reviewed studies suggest that first-time psychotic disorder in COVID-19 patients is statistically significantly more frequent compared to influenza, as well as to other respiratory infections.",COVID-19 patients,CHEMICAL,compared to,other respiratory infections,DISEASE
33086117,Novel antifungal agents such as essential oils of cumin seeds (EOCS) are tested against vulvovaginal candidiasis (VVC).,cumin seeds,CHEMICAL,be tested against,VVC,DISEASE
33086117,Novel antifungal agents such as essential oils of cumin seeds (EOCS) are tested against vulvovaginal candidiasis (VVC).,cumin seeds,CHEMICAL,be tested against,vulvovaginal candidiasis,DISEASE
33086117,Novel antifungal agents such as essential oils of cumin seeds (EOCS) are tested against vulvovaginal candidiasis (VVC).,Novel antifungal agents,CHEBI,be tested against,VVC,DISEASE
33086117,Novel antifungal agents such as essential oils of cumin seeds (EOCS) are tested against vulvovaginal candidiasis (VVC).,Novel antifungal agents,CHEBI,be tested against,vulvovaginal candidiasis,DISEASE
8852528,"Relapse to serotonin depletion or to catecholamine depletion (CD) was found to be specific to the type of antidepressant treatment, i.e., patients responding to selective serotonin reuptake inhibilitors relapsed more frequently following SD than CD and patients responding to selective catecholamine reuptake inhibitors relapsed more frequently following CD than SD.",catecholamine depletion,CHEMICAL,be found to specific to type of,antidepressant treatment,CHEMICAL
8852528,"Relapse to serotonin depletion or to catecholamine depletion (CD) was found to be specific to the type of antidepressant treatment, i.e., patients responding to selective serotonin reuptake inhibilitors relapsed more frequently following SD than CD and patients responding to selective catecholamine reuptake inhibitors relapsed more frequently following CD than SD.",serotonin depletion,CHEMICAL,be found to specific to type of,antidepressant treatment,CHEMICAL
8852528,"Patients with obsessive compulsive disorder who improved on SSRI treatment, did not have an increase in OCD symptoms but those with prior depressive symptoms did have an increase in depressive symptoms with SD.",prior depressive symptoms,DISEASE,have increase in,depressive symptoms,DISEASE
19269893,"We report three deaths associated with use of Xyrem (sodium oxybate), a pharmaceutical preparation of GHB initially approved for treatment of narcolepsy with cataplexy.",narcolepsy,MENTAL_HEALTH,have treatment with,cataplexy,MENTAL_HEALTH
18254030,"Together with stimulant drugs (used to control EDS), antidepressants are usually recommended to counteract cataplexy.",antidepressants,CHEMICAL,counteract,cataplexy,MENTAL_HEALTH
17889041,"Anhedonia is a characteristic of clinical depression and has been associated with dysfunction of the mesolimbic dopaminergic system, a system also involved in mediating nicotine reward.",Anhedonia,MENTAL_HEALTH,be characteristic of,clinical depression,MENTAL_HEALTH
17889041,"Whereas both nicotine doses (0.4 and 0.8 mg/kg) initially induced hypoactivity, only the moderate nicotine dose (0.4 mg/kg) induced hyperactivity with repeated administration and produced a CPP in Wistar rats.",moderate nicotine dose,CHEMICAL,induce,hyperactivity,MENTAL_HEALTH
2287148,"Under the description of each drug category, therapeutic and side effects are briefly discussed in the context of psychiatric practice in America.",drug category,CHEBI,be discussed in context of,psychiatric practice,DISEASE
34525389,"Also, ethanol-induced hepatic inflammation was gradually decreased during the 3 weeks of ethanol withdrawal.",ethanol-induced hepatic inflammation,DISEASE,be decreased during weeks of,ethanol withdrawal,CHEMICAL
22749259,"Despite acceptance and usage worldwide, TBZ was only recently approved in the United States for the treatment of Huntington chorea.",TBZ,CHEMICAL,be approved,Huntington chorea,DISEASE
22749259,"This review focuses on the use of TBZ in various hyperkinetic movement disorders, which are considered ""rare"" or ""orphan"" diseases, to help practitioners better understand its clinical role and use.",TBZ,CHEMICAL,have the use in,hyperkinetic movement,DISEASE
22749259,"This review focuses on the use of TBZ in various hyperkinetic movement disorders, which are considered ""rare"" or ""orphan"" diseases, to help practitioners better understand its clinical role and use.",TBZ,CHEMICAL,have the use in,various movement disorders,DISEASE
25694077,"Benzodiazepines (BZ or BZD) are a class of gabaminergic psychoactive chemicals used in hypnotics, sedation, in the treatment of anxiety, and in other CNS disorders.",Benzodiazepines BZ,CHEMICAL,be class of gabaminergic psychoactive chemicals in treatment of,anxiety,MENTAL_HEALTH
25694077,"Olanzapine is an atypical antipsychotic agent, structurally related to clozapine, and extensively used for the treatment of schizophrenia, bipolar disorder-associated mania, and the behavioral symptoms of Alzheimer's disease.",Olanzapine,CHEMICAL,be atypical antipsychotic agent related to,clozapine,CHEMICAL
2987906,These effects may represent the biochemical basis for the therapeutic action of GABA mimetics in iatrogenic dyskinesias.,GABA mimetics,CHEMICAL,have the therapeutic action in,iatrogenic dyskinesias,DISEASE
35313341,"This paper investigates mechanisms of resistance to the VEGF receptor inhibitor cediranib in high-grade serous ovarian cancer, HGSOC, and defines rational combination therapies.",resistance,MENTAL_HEALTH,have mechanisms to,VEGF receptor inhibitor cediranib,CHEMICAL
35313341,"This paper investigates mechanisms of resistance to the VEGF receptor inhibitor cediranib in high-grade serous ovarian cancer, HGSOC, and defines rational combination therapies.",resistance,MENTAL_HEALTH,have mechanisms to,VEGF receptor inhibitor cediranib,CHEBI
35313341,"After 4-5 weeks treatment of established tumors, cediranib had anti-tumor activity with increased tumor T cell infiltrates and alterations in myeloid cells.",established tumors,DISEASE,have anti-tumor activity with,increased tumor T cell infiltrates,DISEASE
35313341,"After 4-5 weeks treatment of established tumors, cediranib had anti-tumor activity with increased tumor T cell infiltrates and alterations in myeloid cells.",established tumors,DISEASE,have anti-tumor activity with,alterations,DISEASE
35313341,"After 4-5 weeks treatment of established tumors, cediranib had anti-tumor activity with increased tumor T cell infiltrates and alterations in myeloid cells.",cediranib,CHEMICAL,have anti-tumor activity with,increased tumor T cell infiltrates,DISEASE
35313341,"After 4-5 weeks treatment of established tumors, cediranib had anti-tumor activity with increased tumor T cell infiltrates and alterations in myeloid cells.",cediranib,CHEMICAL,have anti-tumor activity with,alterations,DISEASE
24376421,"A computer model was used to analyze data on cardiac and vascular mechanics from C57BL6/J mice exposed to 0 (n = 4), 14 (n = 6), 21 (n = 8) and 28 (n = 7) days of chronic hypoxia and treatment with the VEGF receptor inhibitor SUGEN (HySu) to induce pulmonary hypertension.",chronic hypoxia,DISEASE,have days with,VEGF receptor inhibitor SUGEN,CHEBI
21738953,"Galantamine treatment of obese mice significantly reduced body weight, food intake, abdominal adiposity, plasma cytokine and adipokine levels, and significantly improved blood glucose, insulin resistance and hepatic steatosis.",Galantamine treatment,CHEMICAL,reduce,adipokine,CHEMICAL
21738953,"Galantamine treatment of obese mice significantly reduced body weight, food intake, abdominal adiposity, plasma cytokine and adipokine levels, and significantly improved blood glucose, insulin resistance and hepatic steatosis.",Galantamine treatment,CHEMICAL,reduce,abdominal adiposity,DISEASE
21738953,"Galantamine treatment of obese mice significantly reduced body weight, food intake, abdominal adiposity, plasma cytokine and adipokine levels, and significantly improved blood glucose, insulin resistance and hepatic steatosis.",Galantamine treatment,CHEMICAL,improve,hepatic steatosis,DISEASE
21738953,"Galantamine treatment of obese mice significantly reduced body weight, food intake, abdominal adiposity, plasma cytokine and adipokine levels, and significantly improved blood glucose, insulin resistance and hepatic steatosis.",Galantamine treatment,CHEMICAL,improve,blood glucose,CHEMICAL
21738953,"Galantamine treatment of obese mice significantly reduced body weight, food intake, abdominal adiposity, plasma cytokine and adipokine levels, and significantly improved blood glucose, insulin resistance and hepatic steatosis.",Galantamine treatment,CHEMICAL,improve,insulin resistance,MENTAL_HEALTH
21738953,"In addition, galantamine alleviated impaired insulin sensitivity and glucose intolerance significantly.",galantamine,CHEMICAL,alleviate in,glucose intolerance,DISEASE
21738953,"These results indicate a previously unrecognized potential of galantamine in alleviating obesity, inflammation and other obesity-related complications in mice.",galantamine,CHEMICAL,have unrecognized potential in,alleviating obesity,DISEASE
27757515,"The methionine cycle is a key pathway contributing to the regulation of human health, with well-established involvement in cardiovascular diseases and cognitive function.",methionine cycle,NUTRITION,contributing to regulation of human health with well-established involvement in,cardiovascular diseases,DISEASE
26648686,"β-Adrenoceptor antagonists (particularly 0.5% timolol) are the most commonly used agents in combination with other classes of drugs as fixed-combination eyedrops, but they are contraindicated in many patients, owing to local allergy or systemic side effects.",% timolol,CHEMICAL,be used agents in combination with other classes of,fixed-combination eyedrops,CHEMICAL
26648686,"β-Adrenoceptor antagonists (particularly 0.5% timolol) are the most commonly used agents in combination with other classes of drugs as fixed-combination eyedrops, but they are contraindicated in many patients, owing to local allergy or systemic side effects.",β-Adrenoceptor antagonists,CHEBI,be used agents in combination with other classes of,fixed-combination eyedrops,CHEMICAL
26648686,"The safety profile of BBFC was consistent with that of its individual components, the most common ocular adverse events being ocular hyperemia, visual disturbances, and ocular allergic reactions.",BBFC,CHEMICAL,be consistent with,visual disturbances,DISEASE
26648686,"The safety profile of BBFC was consistent with that of its individual components, the most common ocular adverse events being ocular hyperemia, visual disturbances, and ocular allergic reactions.",BBFC,CHEMICAL,be consistent with,ocular allergic reactions,DISEASE
26648686,BBFC seems to be a promising new fixed combination for use in glaucoma patients.,BBFC,CHEMICAL,fixed combination for use in,glaucoma patients,DISEASE
30725030,Vasculitic midline destructive lesions can be a complication of cocaine use.,midline destructive lesions,DISEASE,be complication of,cocaine use,CHEMICAL
12774502,"Nufarin, an active antibiotic, was isolated from the roots of white water lily when studying nitrogen fixation processes, special attention was given to interaction of hydrogenase and enzymes, taking part in nitrogen fixation, to the effect of ATP on these processes, ways of its synthesis, localization of ATPase in the cell membranes.",active antibiotic,CHEBI,study,nitrogen fixation processes,MENTAL_HEALTH
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",Ketamine,CHEMICAL,reduce depressive symptoms in,depressed patients,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",Ketamine,CHEMICAL,reduce,depressive symptoms,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",N-methyl-d-aspartate glutamate receptor antagonist,CHEMICAL,reduce depressive symptoms in,depressed patients,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",N-methyl-d-aspartate glutamate receptor antagonist,CHEBI,reduce depressive symptoms in,depressed patients,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",N-methyl-d-aspartate glutamate receptor antagonist,CHEMICAL,reduce,depressive symptoms,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",N-methyl-d-aspartate glutamate receptor antagonist,CHEBI,reduce,depressive symptoms,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",enantiomer esketamine,CHEMICAL,reduce depressive symptoms in,depressed patients,DISEASE
35219097,"Ketamine, a N-methyl-d-aspartate glutamate receptor antagonist, and its enantiomer esketamine rapidly reduce depressive symptoms in depressed patients with current suicidal ideation.",enantiomer esketamine,CHEMICAL,reduce,depressive symptoms,DISEASE
35219097,"Recently, esketamine has been approved for use in patients with depression at risk of suicide and for psychiatric emergency by major medical agencies in the United States and Europe, whereas ketamine is increasingly used off-label.",esketamine,CHEMICAL,be approved for use in patients with depression at,psychiatric emergency,DISEASE
35219097,"Recently, esketamine has been approved for use in patients with depression at risk of suicide and for psychiatric emergency by major medical agencies in the United States and Europe, whereas ketamine is increasingly used off-label.",esketamine,CHEMICAL,be approved for use in patients with depression at,suicide,MENTAL_HEALTH
35219097,"Recently, esketamine has been approved for use in patients with depression at risk of suicide and for psychiatric emergency by major medical agencies in the United States and Europe, whereas ketamine is increasingly used off-label.",esketamine,CHEMICAL,be approved for use in patients with,depression,MENTAL_HEALTH
856838,The physiology and pharmacology of a depolarizing dopamine response was studied in the vertebrate neuronal somatic cell hybrid TCX11.,depolarizing dopamine response,CHEMICAL,be studied in,vertebrate neuronal somatic cell hybrid TCX11,DISEASE
33790287,"We find that, in addition to longer lifespan, disruption of HDA results in resistance to DNA damage and osmotic stresses.",HDA,CHEMICAL,result in addition to longer lifespan in,resistance,MENTAL_HEALTH
26282120,A controlled study of an H3R antagonist in Tourette syndrome is ongoing.,H3R antagonist,CHEBI,have a controlled study in,Tourette syndrome,MENTAL_HEALTH
26282120,"Preclinical studies of H3R antagonists in schizophrenia, attention deficit disorder, and narcolepsy have all shown promise.",H3R antagonists,CHEBI,have preclinical studies in,schizophrenia,MENTAL_HEALTH
26282120,"Recently reported controlled studies have been disappointing in schizophrenia and attention deficit disorder, but the H3R antagonist pitolisant shows promise in the treatment of narcolepsy and excessive daytime sleepiness and is currently under regulatory review for these conditions.",H3R antagonist pitolisant,CHEBI,show promise in treatment of,narcolepsy excessive daytime sleepiness,MENTAL_HEALTH
26282120,"Recently reported controlled studies have been disappointing in schizophrenia and attention deficit disorder, but the H3R antagonist pitolisant shows promise in the treatment of narcolepsy and excessive daytime sleepiness and is currently under regulatory review for these conditions.",H3R antagonist pitolisant,CHEMICAL,show promise in treatment of,narcolepsy excessive daytime sleepiness,MENTAL_HEALTH
19187703,"Vitamin D, a multipurpose steroid hormone vital to health, has been increasingly implicated in the pathology of cognition and mental illness.",multipurpose steroid hormone vital,NUTRITION,be implicated in pathology of,mental illness,MENTAL_HEALTH
19187703,"Vitamin D, a multipurpose steroid hormone vital to health, has been increasingly implicated in the pathology of cognition and mental illness.",Vitamin D,CHEBI,be implicated in pathology of,mental illness,MENTAL_HEALTH
15576061,"We also hypothesized that estrogen receptor alpha (ERalpha) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness.",estrogen receptor alpha mRNA expression,NUTRITION,be altered in amygdala on basis of observed gender differences in,mental illness,MENTAL_HEALTH
15576061,"We also hypothesized that estrogen receptor alpha (ERalpha) mRNA expression might be altered in the amygdala, on the basis of observed gender differences in mental illness.",estrogen receptor alpha mRNA expression,CHEBI,be altered in amygdala on basis of observed gender differences in,mental illness,MENTAL_HEALTH
34436443,"In the context of liver diseases, high plasma estrogen levels are observed in fatty liver hemorrhagic syndrome (FLHS) in chicken implicating estrogens in the disease progression.",high plasma estrogen levels,CHEBI,implicate,estrogens,CHEBI
33473342,"TMA is a tertiary amine derived from the enterobacterial metabolism of precursors such as choline and phosphatidylcholine present in the diet, and is also a bacterial metabolite of TMAO, a normal constituent of saltwater fish.",TMA,DISEASE,derived from enterobacterial metabolism of precursors such as,phosphatidylcholine,CHEMICAL
33473342,"TMA is a tertiary amine derived from the enterobacterial metabolism of precursors such as choline and phosphatidylcholine present in the diet, and is also a bacterial metabolite of TMAO, a normal constituent of saltwater fish.",TMA,DISEASE,derived from enterobacterial metabolism of precursors such as,choline present,NUTRITION
9489723,The PAF antagonist lacked any protective effect against ischemia-induced cell death.,PAF antagonist,CHEBI,lack protective effect against,ischemia-induced cell death,DISEASE
15540638,This study's aims were to determine: (1) prevalence of periodic leg movements (PLMs) in walking prepubertal children consulting a sleep clinic for any sleep disorder; (2) associations between PLMs and other sleep and medical disorders; and (3) the response of other sleep disorders to treatment with the dopamine agonist pramipexol.,other sleep disorders,DISEASE,have the response with,dopamine agonist pramipexol,CHEBI
15540638,This study's aims were to determine: (1) prevalence of periodic leg movements (PLMs) in walking prepubertal children consulting a sleep clinic for any sleep disorder; (2) associations between PLMs and other sleep and medical disorders; and (3) the response of other sleep disorders to treatment with the dopamine agonist pramipexol.,other sleep disorders,DISEASE,have the response with,dopamine agonist pramipexol,CHEMICAL
24406376,Exposure to different toxic substances can have acute and chronic neurological and neuropsychiatric health effects on humans.,different toxic substances,CHEBI,have,acute health effects,DISEASE
20154339,"Targeted suicide gene therapy exploits the enzymatic conversion of a prodrug, such as a nucleoside analog, into a cytotoxic compound.",Targeted suicide gene therapy,MENTAL_HEALTH,exploit enzymatic conversion of,nucleoside analog,CHEMICAL
20154339,The efficiency of the toTK1/AZT system was confirmed when toTK1-transduced human glioblastoma (GBM) cells displayed a 500-fold increased sensitivity to AZT compared with wild-type cells.,toTK1-transduced human glioblastoma GBM cells,DISEASE,display increased sensitivity to,AZT,CHEMICAL
20154339,The novel toTK1/AZT suicide gene therapy system in combination with stem cell-mediated gene delivery promises new treatment of malignant gliomas.,novel toTK1/AZT suicide gene therapy system,MENTAL_HEALTH,promise new treatment of,malignant gliomas,DISEASE
20154339,The novel toTK1/AZT suicide gene therapy system in combination with stem cell-mediated gene delivery promises new treatment of malignant gliomas.,novel toTK1/AZT suicide gene therapy system,CHEMICAL,promise new treatment of,malignant gliomas,DISEASE
3991769,"The long-term effects of perinatal hypothyroidism on spontaneous locomotor behaviors were assessed after exposure to the antithyroid drug, methimazole.",perinatal hypothyroidism,DISEASE,be assessed after exposure to,methimazole,CHEMICAL
3991769,"The long-term effects of perinatal hypothyroidism on spontaneous locomotor behaviors were assessed after exposure to the antithyroid drug, methimazole.",perinatal hypothyroidism,DISEASE,be assessed after exposure to,antithyroid drug,CHEBI
3991769,"The long-term effects of perinatal hypothyroidism on spontaneous locomotor behaviors were assessed after exposure to the antithyroid drug, methimazole.",spontaneous locomotor behaviors,DISEASE,be assessed after exposure to,methimazole,CHEMICAL
3991769,"The long-term effects of perinatal hypothyroidism on spontaneous locomotor behaviors were assessed after exposure to the antithyroid drug, methimazole.",spontaneous locomotor behaviors,DISEASE,be assessed after exposure to,antithyroid drug,CHEBI
3991769,"The long-term effects of perinatal hypothyroidism on spontaneous locomotor behaviors were assessed after exposure to the antithyroid drug, methimazole.",perinatal hypothyroidism,DISEASE,have the long-term effects on,spontaneous locomotor behaviors,DISEASE
34748862,"Traditionally, nutritional dermatoses are taught in the context of developing countries, famine, population displacement, and poor health care access; however, in the United States, common risk factors include chronic liver disease, alcoholism, psychiatric disease, bariatric surgery, inflammatory bowel disease, and hemodialysis.",nutritional dermatoses,DISEASE,be taught in context of,famine,CHEMICAL
34748862,"Traditionally, nutritional dermatoses are taught in the context of developing countries, famine, population displacement, and poor health care access; however, in the United States, common risk factors include chronic liver disease, alcoholism, psychiatric disease, bariatric surgery, inflammatory bowel disease, and hemodialysis.",nutritional dermatoses,DISEASE,be taught in context of,population displacement,MENTAL_HEALTH
29371615,"Loading of RA to Bos d 5 could be achieved in vitro, as demonstrated by ANS displacement assay, but had no effect on serum IgE binding in tolerant or challenge-positive milk allergic children.",RA,DISEASE,demonstrate by,ANS displacement assay,MENTAL_HEALTH
9015916,"All of them were clinically indistinguishable from paranoid schizophrenia, but the psychotic symptoms often resolved promptly with the cessation of cough mixture use or a small dose of haloperidol.",psychotic symptoms,DISEASE,resolve with cessation of cough mixture use or small dose of,haloperidol,CHEMICAL
9015916,"All of them were clinically indistinguishable from paranoid schizophrenia, but the psychotic symptoms often resolved promptly with the cessation of cough mixture use or a small dose of haloperidol.",psychotic symptoms,DISEASE,resolve with cessation of,cough mixture use,CHEBI
9015916,"All of them were clinically indistinguishable from paranoid schizophrenia, but the psychotic symptoms often resolved promptly with the cessation of cough mixture use or a small dose of haloperidol.",psychotic symptoms,DISEASE,resolve with cessation of,cough mixture use,DISEASE
19411165,ANTIPSYCHOTICS IN MAJOR DEPRESSION: Some atypical antipsychotics have been shown to induce remission when added to an antidepressant (usually a SSRI or SNRI) in unipolar patients in a major depressive episode unresponsive to the antidepressant monotherapy.,major depressive episode unresponsive,MENTAL_HEALTH,have unipolar patients to,antidepressant monotherapy,CHEMICAL
19411165,OBSESSIVE-COMPULSIVE DISORDER: SSRI monotherapy has moderate overall average benefit in OCD and can take as long as 3 months for benefit to be decided.,DISORDER,MENTAL_HEALTH,have moderate overall average benefit in,OCD,DISEASE
19411165,OBSESSIVE-COMPULSIVE DISORDER: SSRI monotherapy has moderate overall average benefit in OCD and can take as long as 3 months for benefit to be decided.,SSRI monotherapy,CHEBI,have moderate overall average benefit in,OCD,DISEASE
11488255,"The secretion of neuropituitary hormones is also discussed in various psychiatric diseases such an anorexia nervosa, bipolar disorder, schizophrenia and obsessive-compulsive disorder.",neuropituitary hormones,CHEBI,be discussed in,bipolar disorder,MENTAL_HEALTH
11488255,"The secretion of neuropituitary hormones is also discussed in various psychiatric diseases such an anorexia nervosa, bipolar disorder, schizophrenia and obsessive-compulsive disorder.",neuropituitary hormones,CHEBI,be discussed in,diseases anorexia nervosa,MENTAL_HEALTH
11488255,"The secretion of neuropituitary hormones is also discussed in various psychiatric diseases such an anorexia nervosa, bipolar disorder, schizophrenia and obsessive-compulsive disorder.",neuropituitary hormones,CHEBI,be discussed in,diseases anorexia nervosa,DISEASE
11488255,"The secretion of neuropituitary hormones is also discussed in various psychiatric diseases such an anorexia nervosa, bipolar disorder, schizophrenia and obsessive-compulsive disorder.",neuropituitary hormones,CHEBI,be discussed in,schizophrenia,MENTAL_HEALTH
11488255,"The secretion of neuropituitary hormones is also discussed in various psychiatric diseases such an anorexia nervosa, bipolar disorder, schizophrenia and obsessive-compulsive disorder.",neuropituitary hormones,CHEBI,be discussed in,obsessive-compulsive disorder,MENTAL_HEALTH
11488255,AVP and OT have been shown to modulate the effect of Corticotropin-Releasing Factor (CRF) on ACTH secretion and appear to play a key role in mediating the ACTH response to stress.,AVP,CHEMICAL,modulate effect of,CRF,DISEASE
11488255,Underweight patients with anorexia nervosa have abnormally high levels of centrally directed AVP and reduced OT levels.,anorexia nervosa,MENTAL_HEALTH,have high levels of,directed AVP,CHEMICAL
11488255,Patients with bipolar disorder show a biphasic secretion of AVP.,bipolar disorder,MENTAL_HEALTH,show biphasic secretion of,AVP,CHEMICAL
11488255,These findings are consistent with the beneficial role of AVP on schizophrenic symptoms noted in several trials.,AVP,CHEMICAL,have the beneficial role on,schizophrenic symptoms,DISEASE
21407849,Treatment with lithium resulted in a considerable reduction in the severity of tics and self-injurious behaviour.,lithium,NUTRITION,result in considerable reduction in severity of,self-injurious behaviour,DISEASE
21407849,Treatment with lithium resulted in a considerable reduction in the severity of tics and self-injurious behaviour.,lithium,NUTRITION,result in considerable reduction in severity of,tics,DISEASE
27232853,"Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial.",ADT,CHEMICAL,have the association with,cognitive impairment,DISEASE
27232853,"Prior studies suggested that the use of androgen deprivation therapy (ADT) in patients with prostate cancer (PC) might cause the impairment of cognitive function which is one of the common symptoms of dementia; however, the association between ADT and cognitive impairment still remains controversial.",cognitive impairment,DISEASE,have the association with,ADT,CHEMICAL
17186379,"Highly polar xanthophylls of 9'-cis-neoxanthin (neoxanthin) and fucoxanthin, which have the characteristic structure of an epoxy group and an allenic bond, were previously found to induce apoptosis in human prostate cancer cells.",polar xanthophylls,NUTRITION,induce apoptosis in,human prostate cancer cells,DISEASE
32548120,"While it is well-established that overexpression of wild type α-synuclein (α-syn-140) leads to cellular toxicity and neurodegeneration, much less is known about other naturally occurring α-synuclein splice isoforms.",α-syn-140,CHEMICAL,lead to,neurodegeneration,DISEASE
32548120,"While it is well-established that overexpression of wild type α-synuclein (α-syn-140) leads to cellular toxicity and neurodegeneration, much less is known about other naturally occurring α-synuclein splice isoforms.",α-syn-140,CHEMICAL,lead to,cellular toxicity,DISEASE
32548120,"α-Syn-112 is upregulated in the substantia nigra, frontal cortex, and cerebellum of parkinsonian brains and higher expression levels are correlated with susceptibility to Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple systems atrophy (MSA).",α-Syn-112,CHEMICAL,be upregulated in,parkinsonian brains,DISEASE
34597835,"To better understand this phenomenon, we developed a suite of isothermal titration calorimetry (ITC) kinetics methods to characterize ATP hydrolysis by the antibiotic resistance enzyme aminoglycoside-3'-phosphotransferase-IIIa (APH(3')-IIIa).",antibiotic resistance enzyme,MENTAL_HEALTH,have kinetics methods to to,ATP hydrolysis,CHEMICAL
34597835,"To better understand this phenomenon, we developed a suite of isothermal titration calorimetry (ITC) kinetics methods to characterize ATP hydrolysis by the antibiotic resistance enzyme aminoglycoside-3'-phosphotransferase-IIIa (APH(3')-IIIa).",antibiotic resistance enzyme,CHEBI,have kinetics methods to to,ATP hydrolysis,CHEMICAL
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,lithium,NUTRITION,prolong time to mood episode recurrence in patients with,rapid-cycling bipolar disorder,MENTAL_HEALTH
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,lithium,NUTRITION,prolong time to mood episode recurrence in patients with,comorbid substance abuse,MENTAL_HEALTH
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,lithium,NUTRITION,be,lithium monotherapy,NUTRITION
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,divalproex,CHEMICAL,prolong time to mood episode recurrence in patients with,rapid-cycling bipolar disorder,MENTAL_HEALTH
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,divalproex,CHEMICAL,prolong time to mood episode recurrence in patients with,comorbid substance abuse,MENTAL_HEALTH
19192457,To assess whether combination treatment with lithium and divalproex is more effective than lithium monotherapy in prolonging the time to mood episode recurrence in patients with rapid-cycling bipolar disorder and comorbid substance abuse and/or dependence.,divalproex,CHEMICAL,be,lithium monotherapy,NUTRITION
35372122,Neutrophil elastase (NE) is associated with sepsis occurrence and progression.,NE,CHEMICAL,be associated with,sepsis occurrence,DISEASE
35372122,We hypothesized that the NE inhibitor Sivelestat might modulate abnormal gut microbiota and metabolites during sepsis.,NE inhibitor Sivelestat,CHEMICAL,modulate abnormal gut microbiota and metabolites during,sepsis,DISEASE
35372122,We hypothesized that the NE inhibitor Sivelestat might modulate abnormal gut microbiota and metabolites during sepsis.,NE inhibitor Sivelestat,CHEMICAL,modulate,abnormal gut microbiota,DISEASE
7324866,"The cerebral blood flow (CBF) and cerebral metabolic rate (CMR) of oxygen, glucose, lactate, pyruvate, ketone bodies and 24 amino acids were examined in 12 patients with presenile dementia and in seven with normal-pressure hydrocephalus.",oxygen,CHEMICAL,be examined in patients with presenile dementia and in seven with,normal-pressure hydrocephalus,DISEASE
7324866,"The cerebral blood flow (CBF) and cerebral metabolic rate (CMR) of oxygen, glucose, lactate, pyruvate, ketone bodies and 24 amino acids were examined in 12 patients with presenile dementia and in seven with normal-pressure hydrocephalus.",oxygen,CHEMICAL,be examined in patients with,presenile dementia,MENTAL_HEALTH
35420377,LIG (20 or 40 mg/kg/day) and Nimodipine (20 mg/kg) were orally administered to the VaD rats for four weeks.,Nimodipine,CHEMICAL,be administered to,VaD rats,DISEASE
35420377,LIG (20 or 40 mg/kg/day) and Nimodipine (20 mg/kg) were orally administered to the VaD rats for four weeks.,LIG,CHEMICAL,be administered to,VaD rats,DISEASE
35420377,Morris water maze test showed that LIG effectively ameliorated learning and memory impairment in VaD rats.,LIG,CHEMICAL,ameliorate learning and memory impairment in,VaD rats,DISEASE
35420377,Morris water maze test showed that LIG effectively ameliorated learning and memory impairment in VaD rats.,LIG,CHEMICAL,ameliorate,learning impairment,DISEASE
35420377,LIG obviously reduced neuronal oxidative stress damage and the level of homocysteine in the brain of VaD rats.,LIG,CHEMICAL,reduce neuronal oxidative stress damage and level of homocysteine in brain of,VaD rats,DISEASE
35420377,LIG obviously reduced neuronal oxidative stress damage and the level of homocysteine in the brain of VaD rats.,LIG,CHEMICAL,reduce neuronal oxidative stress damage and level of,homocysteine,CHEMICAL
35420377,LIG obviously reduced neuronal oxidative stress damage and the level of homocysteine in the brain of VaD rats.,LIG,CHEMICAL,reduce,neuronal oxidative stress damage,DISEASE
35420377,"Moreover, Nissl staining result showed that LIG could reduce neuronal degeneration in VaD rats.",LIG,CHEMICAL,reduce neuronal degeneration in,VaD rats,DISEASE
35420377,"Moreover, Nissl staining result showed that LIG could reduce neuronal degeneration in VaD rats.",LIG,CHEMICAL,reduce,neuronal degeneration,DISEASE
35420377,"Furthermore, LIG enhanced the expressions of P-AMPK and Sirtuin1(SIRT1) in VaD rats.",LIG,CHEMICAL,enhance expressions of,VaD rats,DISEASE
35420377,"In conclusion, these studies indicated that LIG could ameliorate cognitive impairment in VaD rats, which might be related to AMPK/SIRT1 pathway activation.",LIG,CHEMICAL,ameliorate cognitive impairment in,VaD rats,DISEASE
35420377,"In conclusion, these studies indicated that LIG could ameliorate cognitive impairment in VaD rats, which might be related to AMPK/SIRT1 pathway activation.",LIG,CHEMICAL,ameliorate,cognitive impairment,DISEASE
31905851,"(2) Methods: Angelica gigas (AG) extract 1 mg/kg was administered to mildly cognitive impaired mice, models based on mild traumatic brain injury and chronic mild stress.",Angelica gigas extract,CHEMICAL,be administered to,cognitive impaired mice,DISEASE
31905851,"(2) Methods: Angelica gigas (AG) extract 1 mg/kg was administered to mildly cognitive impaired mice, models based on mild traumatic brain injury and chronic mild stress.",Angelica gigas extract,NUTRITION,be administered to,cognitive impaired mice,DISEASE
31905851,"(3) Result: Angelica gigas improved spatial learning, working memory, and suppressed fear memory in the mild traumatic brain injury model.",Angelica gigas,NUTRITION,suppress fear memory in,mild traumatic brain injury model,DISEASE
31905851,(4) Conclusions: Angelica gigas can improve cognitive symptoms in mild cognitive impairment model mice.,Angelica gigas,NUTRITION,improve,mild cognitive impairment model mice,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEMICAL,alleviate symptoms of,tremor,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEMICAL,alleviate symptoms of,parkinsonian monkey,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEMICAL,alleviate symptoms of,rigidity,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEMICAL,alleviate symptoms of,akinesia,MENTAL_HEALTH
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEBI,alleviate symptoms of,tremor,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEBI,alleviate symptoms of,parkinsonian monkey,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEBI,alleviate symptoms of,rigidity,DISEASE
2250573,"Intracerebral injections of the broad spectrum excitatory amino acid antagonist kynurenic acid (50 ug) alleviated the symptoms of akinesia, tremor and rigidity in a severely parkinsonian monkey.",broad spectrum excitatory amino acid antagonist kynurenic acid,CHEBI,alleviate symptoms of,akinesia,MENTAL_HEALTH
2250573,"In addition unilateral injections of the NMDA antagonist MK-801 (5, 25 and 50 ug) within the medial pallidum also produced dose-related rotational behaviour, with alleviation of parkinsonian symptoms in the contralateral limbs.",NMDA antagonist MK-801,CHEBI,produce in addition dose-related rotational behaviour with alleviation of parkinsonian symptoms in,contralateral limbs,DISEASE
2250573,"In addition unilateral injections of the NMDA antagonist MK-801 (5, 25 and 50 ug) within the medial pallidum also produced dose-related rotational behaviour, with alleviation of parkinsonian symptoms in the contralateral limbs.",NMDA antagonist MK-801,CHEMICAL,produce in addition dose-related rotational behaviour with alleviation of parkinsonian symptoms in,contralateral limbs,DISEASE
2250573,"In addition unilateral injections of the NMDA antagonist MK-801 (5, 25 and 50 ug) within the medial pallidum also produced dose-related rotational behaviour, with alleviation of parkinsonian symptoms in the contralateral limbs.",NMDA antagonist MK-801,CHEBI,produce in addition dose-related rotational behaviour with alleviation of,parkinsonian symptoms,DISEASE
2250573,"In addition unilateral injections of the NMDA antagonist MK-801 (5, 25 and 50 ug) within the medial pallidum also produced dose-related rotational behaviour, with alleviation of parkinsonian symptoms in the contralateral limbs.",NMDA antagonist MK-801,CHEMICAL,produce in addition dose-related rotational behaviour with alleviation of,parkinsonian symptoms,DISEASE
27866173,Triazole antifungals are essential to the treatment and prophylaxis of fungal infections.,Triazole antifungals,CHEBI,be essential to treatment and prophylaxis of,fungal infections,DISEASE
25224009,"The binding affinity of VT-1161 for Candida albicans CYP51 was high (dissociation constant [Kd], ≤ 39 nM) and similar to that of the pharmaceutical azole antifungals (Kd, ≤ 50 nM).",CYP51,DISEASE,be,high dissociation constant,MENTAL_HEALTH
12031086,"The cause of the background liver disease was hepatitis B surface antigen (HBsAg)(+) in eight cases, antihepatitis C virus antibody (HCVAb)(+) in 13 cases, both HBsAg(+) and HCVAb(+) in one case, and both HBsAg(-) and HCVAb(-) in 46 cases.",background liver disease,DISEASE,be,hepatitis B surface antigen,DISEASE
12031086,"The cause of the background liver disease was hepatitis B surface antigen (HBsAg)(+) in eight cases, antihepatitis C virus antibody (HCVAb)(+) in 13 cases, both HBsAg(+) and HCVAb(+) in one case, and both HBsAg(-) and HCVAb(-) in 46 cases.",background liver disease,DISEASE,be,hepatitis B surface antigen,CHEBI
12031086,"Immunohistochemically, CC arising in the HBsAg(+) and HCVAb(+) groups was correlated with coexpression of NCAM/bcl-2 in the tumor cells (P = 0.0068 and P = 0.0382, respectively).",CC HCVAb(+,CHEMICAL,be correlated with coexpression of ncam/bcl-2 in,tumor cells,DISEASE
12031086,"Immunohistochemically, CC arising in the HBsAg(+) and HCVAb(+) groups was correlated with coexpression of NCAM/bcl-2 in the tumor cells (P = 0.0068 and P = 0.0382, respectively).",CC HCVAb(+,CHEMICAL,be correlated with coexpression of,NCAM/bcl-2,CHEMICAL
12031086,"Immunohistochemically, CC arising in the HBsAg(+) and HCVAb(+) groups was correlated with coexpression of NCAM/bcl-2 in the tumor cells (P = 0.0068 and P = 0.0382, respectively).",NCAM/bcl-2,CHEMICAL,have coexpression in,tumor cells,DISEASE
12031086,"Among the 12 cases of CC coexpressing NCAM/bcl-2, 11 were of mass-forming and peripheral type (P = 0.0437), and lymph node metastasis was a rare finding compared with CC showing negative coexpression of NCAM/bcl-2 (P = 0.0213).",CC,CHEMICAL,compared with,CC,CHEMICAL
33891333,HTL0009936 is a selective M1 muscarinic receptor agonist in development for cognitive dysfunction in Alzheimer's disease.,HTL0009936,CHEMICAL,be selective m1 muscarinic receptor agonist in development for cognitive dysfunction in,Alzheimer's disease,DISEASE
33891333,HTL0009936 is a selective M1 muscarinic receptor agonist in development for cognitive dysfunction in Alzheimer's disease.,HTL0009936,CHEMICAL,be selective m1 muscarinic receptor agonist in development for,cognitive dysfunction,DISEASE
33891333,HTL0009936 is a selective M1 muscarinic receptor agonist in development for cognitive dysfunction in Alzheimer's disease.,HTL0009936,CHEMICAL,be,selective M1 muscarinic receptor agonist,CHEBI
34645507,"The polycystic ovary syndrome (PCOS) is the most common endocrine associated with insulin resistance, even in the absence of overweight.",polycystic ovary syndrome,DISEASE,associated with,insulin resistance,MENTAL_HEALTH
34645507,"The polycystic ovary syndrome (PCOS) is the most common endocrine associated with insulin resistance, even in the absence of overweight.",PCOS,DISEASE,associated with,insulin resistance,MENTAL_HEALTH
21142024,"Coenzyme B(12)-dependent ethanolamine ammonia-lyase acts on both enantiomers of the substrate 2-amino-1-propanol [Diziol, P., et al. (1980) Eur. J. Biochem. 106, 211-224].",B(12)-dependent ethanolamine ammonia-lyase,CHEMICAL,act on enantiomers of,substrate 2-amino-1-propanol,CHEMICAL
21142024,"Coenzyme B(12)-dependent ethanolamine ammonia-lyase acts on both enantiomers of the substrate 2-amino-1-propanol [Diziol, P., et al. (1980) Eur. J. Biochem. 106, 211-224].",B(12)-dependent ethanolamine ammonia-lyase,CHEMICAL,act on enantiomers of,Diziol P.,DISEASE
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,narcotic heroine,CHEBI
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,Diazepam Chlordiazepoxide,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,drug narcotic,CHEBI
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,alcohol,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,narcotic heroine,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",Drug addiction,CHEBI,be due to passive exposure to,methadone,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,narcotic heroine,CHEBI
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,Diazepam Chlordiazepoxide,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,drug narcotic,CHEBI
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,alcohol,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,narcotic heroine,CHEMICAL
6985425,"Drug addiction, like postnatale withdrawal syndrome, are mainly due to passive exposure to drug narcotic (heroine, methadone), to sedative-hypnotic agents (barbiturates Diazepam Chlordiazepoxide) and to alcohol.",postnatale withdrawal syndrome,DISEASE,be due to passive exposure to,methadone,CHEMICAL
34979106,"Moreover, treatment with ciglitazone, a potent and selective peroxisome proliferator-activated receptor γ (PPARγ) agonist, modulated hypoxia-enhanced motion in cells via the repression of NHE1.",ciglitazone,CHEMICAL,modulate hypoxia-enhanced motion in cells via,repression,MENTAL_HEALTH
34979106,"Moreover, treatment with ciglitazone, a potent and selective peroxisome proliferator-activated receptor γ (PPARγ) agonist, modulated hypoxia-enhanced motion in cells via the repression of NHE1.",potent peroxisome proliferator-activated receptor agonist,CHEBI,modulate hypoxia-enhanced motion in cells via,repression,MENTAL_HEALTH
26168725,"Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor gamma (PPARγ) agonists that improve insulin resistance but trigger side effects such as weight gain, edema, congestive heart failure and bone loss.",TZDs,CHEMICAL,be,gamma agonists,CHEBI
26168725,"Thiazolidinediones (TZDs) are peroxisome proliferator-activated receptor gamma (PPARγ) agonists that improve insulin resistance but trigger side effects such as weight gain, edema, congestive heart failure and bone loss.",Thiazolidinediones,CHEBI,be,gamma agonists,CHEBI
26168725,GQ-16 is a PPARγ partial agonist that improves glucose tolerance and insulin sensitivity in mouse models of obesity and diabetes without inducing weight gain or edema.,GQ-16,CHEMICAL,be,PPARγ partial agonist,CHEBI
26168725,PPARγ partial agonists MLR24 and SR1664 also exhibit disproportionately strong effects on transcriptional repression.,MLR24,CHEMICAL,exhibit strong effects on,transcriptional repression,MENTAL_HEALTH
26168725,PPARγ partial agonists MLR24 and SR1664 also exhibit disproportionately strong effects on transcriptional repression.,PPARγ partial agonists,CHEBI,exhibit strong effects on,transcriptional repression,MENTAL_HEALTH
18023318,"We investigated the hypothesis that folate administration would prevent hyperhomocysteinemia-induced memory deficits and Na(+),K(+)-ATPase activity inhibition.",folate administration,CHEBI,prevent,hyperhomocysteinemia-induced memory deficits,DISEASE
18023318,"Chronic hyperhomocysteinemia was induced from the 6th to the 28th day of life by subcutaneous injection of homocysteine (0.3-0.6 micromol/g), twice a day; control Wistar rats received the same volume of saline solution (0.9% NaCl).",Chronic hyperhomocysteinemia,DISEASE,be induced from 6th to 28th day of life by,homocysteine,CHEMICAL
25168395,"Patients with Parkinson's disease (PD) treated with oral levodopa have a higher prevalence of chronic, prevalently sensory, usually mild axonal polyneuropathy (PNP).",Parkinson's disease,DISEASE,have higher prevalence of,mild axonal polyneuropathy,DISEASE
10547078,"Increased levels of plasma catecholamine lead to cardiac hypertrophy via the alpha-, beta-adrenergic receptors, and partially, type 1 angiotensin II (AT1) receptor.",plasma catecholamine,CHEMICAL,lead to,cardiac hypertrophy,DISEASE
35466449,"In hypoparathyroidism (HypoPT), calcium supplementation is virtually always required although the disease is likely to be associated with an increased risk of nephrolithiasis.",calcium supplementation,CHEMICAL,be required in,HypoPT,DISEASE
35466449,"In hypoparathyroidism (HypoPT), calcium supplementation is virtually always required although the disease is likely to be associated with an increased risk of nephrolithiasis.",calcium supplementation,CHEMICAL,be required in,hypoparathyroidism,DISEASE
35466449,The use of calcium citrate (Ca-Cit) theoretically could have a positive impact on the nephrolithiasis risk because citrate salts are used to reduce this risk.,calcium citrate,CHEMICAL,have positive impact on,nephrolithiasis risk,DISEASE
35466449,The use of calcium citrate (Ca-Cit) theoretically could have a positive impact on the nephrolithiasis risk because citrate salts are used to reduce this risk.,Ca-Cit,CHEMICAL,have positive impact on,nephrolithiasis risk,DISEASE
33652997,"Abnormal levels of folate, homocysteine, and SAMe have been shown to be associated with a higher risk of depression.",folate,NUTRITION,be associated with higher risk of,depression,MENTAL_HEALTH
33652997,"Abnormal levels of folate, homocysteine, and SAMe have been shown to be associated with a higher risk of depression.",SAMe,CHEMICAL,be associated with higher risk of,depression,MENTAL_HEALTH
33652997,"Abnormal levels of folate, homocysteine, and SAMe have been shown to be associated with a higher risk of depression.",homocysteine,CHEMICAL,be associated with higher risk of,depression,MENTAL_HEALTH
33652997,"Additionally, the amino acids L-acetylcarnitine, alpha-lipoic acid, N-acetylcysteine, and L-tryptophan have been implicated in the development of depression and shown to exert antidepressant effects.",acids L-acetylcarnitine,CHEMICAL,be implicated in development of,depression,MENTAL_HEALTH
33652997,"Medical foods, particularly L-methylfolate, and other supplements may play a role in managing depression in patients with inadequate response to antidepressant therapies.",L-methylfolate,CHEMICAL,manage depression in patients with inadequate response to,antidepressant therapies,CHEMICAL
33652997,"Medical foods, particularly L-methylfolate, and other supplements may play a role in managing depression in patients with inadequate response to antidepressant therapies.",L-methylfolate,CHEMICAL,manage,depression,MENTAL_HEALTH
33652997,"Medical foods, particularly L-methylfolate, and other supplements may play a role in managing depression in patients with inadequate response to antidepressant therapies.",depression,MENTAL_HEALTH,in patients with,antidepressant therapies,CHEMICAL
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",m6A,CHEMICAL,regulate hcc sensitivity to chemotherapy via,p53 activator RG7112,CHEMICAL
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",m6A,CHEMICAL,regulate hcc sensitivity to chemotherapy via,vascular endothelial growth factor receptor inhibitor apatinib,CHEBI
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",m6A,CHEMICAL,regulate hcc sensitivity to chemotherapy via,vascular endothelial growth factor receptor inhibitor apatinib,CHEMICAL
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",m6A,CHEMICAL,regulate,HCC sensitivity,DISEASE
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",p53 n6-methyladenosine,CHEMICAL,regulate hcc sensitivity to chemotherapy via,p53 activator RG7112,CHEMICAL
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",p53 n6-methyladenosine,CHEMICAL,regulate hcc sensitivity to chemotherapy via,vascular endothelial growth factor receptor inhibitor apatinib,CHEBI
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",p53 n6-methyladenosine,CHEMICAL,regulate hcc sensitivity to chemotherapy via,vascular endothelial growth factor receptor inhibitor apatinib,CHEMICAL
35503144,"Here, we found that p53 n6-methyladenosine (m6A) played a decisive role in regulating HCC sensitivity to chemotherapy via the p53 activator RG7112 and the vascular endothelial growth factor receptor inhibitor apatinib.",p53 n6-methyladenosine,CHEMICAL,regulate,HCC sensitivity,DISEASE
29978839,Kinetic parameters V b and K 1 were extracted to quantify changes in tumor vasculature and the 18F-FLT flux constant K i was calculated to quantify changes in tumor cell proliferation.,18F-FLT flux constant K,CHEMICAL,quantify changes in,tumor cell proliferation,DISEASE
3762521,"The GABA agonist, muscimol, in the concentration range of 20 and 200 nM, progressively accelerated the rate of TBPS dissociation.",GABA agonist,CHEBI,accelerate rate of,TBPS dissociation,CHEMICAL
3762521,"The GABA agonist, muscimol, in the concentration range of 20 and 200 nM, progressively accelerated the rate of TBPS dissociation.",GABA agonist,CHEBI,accelerate rate of,TBPS dissociation,MENTAL_HEALTH
3762521,"The GABA agonist, muscimol, in the concentration range of 20 and 200 nM, progressively accelerated the rate of TBPS dissociation.",muscimol,CHEMICAL,accelerate rate of,TBPS dissociation,CHEMICAL
3762521,"The GABA agonist, muscimol, in the concentration range of 20 and 200 nM, progressively accelerated the rate of TBPS dissociation.",muscimol,CHEMICAL,accelerate rate of,TBPS dissociation,MENTAL_HEALTH
3762521,"GABA antagonists, bicuculline methochloride (20 microM) and R 5135 (20 nM), alone decelerated the rate of TBPS dissociation.",bicuculline methochloride,CHEMICAL,decelerate rate of,TBPS dissociation,CHEMICAL
3762521,"GABA antagonists, bicuculline methochloride (20 microM) and R 5135 (20 nM), alone decelerated the rate of TBPS dissociation.",bicuculline methochloride,CHEMICAL,decelerate rate of,TBPS dissociation,MENTAL_HEALTH
3762521,"GABA antagonists, bicuculline methochloride (20 microM) and R 5135 (20 nM), alone decelerated the rate of TBPS dissociation.",GABA antagonists,CHEBI,decelerate rate of,TBPS dissociation,CHEMICAL
3762521,"GABA antagonists, bicuculline methochloride (20 microM) and R 5135 (20 nM), alone decelerated the rate of TBPS dissociation.",GABA antagonists,CHEBI,decelerate rate of,TBPS dissociation,MENTAL_HEALTH
3762521,"Replacement of Cl- by Br- ions (0.5 molar) accelerated the rate of dissociation, whereas replacement of K+ by Na+ ions had no effect.",Br- ions,CHEMICAL,accelerate rate of,dissociation,MENTAL_HEALTH
3762521,"Replacement of Cl- by Br- ions (0.5 molar) accelerated the rate of dissociation, whereas replacement of K+ by Na+ ions had no effect.",Cl-,CHEMICAL,accelerate rate of,dissociation,MENTAL_HEALTH
3762521,"Replacement of Cl- by Br- ions (0.5 molar) accelerated the rate of dissociation, whereas replacement of K+ by Na+ ions had no effect.",Br- ions,CHEMICAL,have replacement of,Cl-,CHEMICAL
35609230,The Cannabis Consultation Service (CCS) is an innovative pharmacist-led resource at the Sunnybrook Odette Cancer Centre.,Cannabis Consultation Service,CHEMICAL,be innovative pharmacist-led resource at,Sunnybrook Odette Cancer Centre,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",protein-bound uremic toxins,CHEBI,increase risk of cardiovascular events in,disease patients,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",protein-bound uremic toxins,CHEBI,increase risk of cardiovascular events in,CKD,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",Indoxyl sulfate,CHEMICAL,increase risk of cardiovascular events in,disease patients,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",Indoxyl sulfate,CHEMICAL,increase risk of cardiovascular events in,CKD,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",p-cresyl sulfate,CHEMICAL,increase risk of cardiovascular events in,disease patients,DISEASE
34905018,"Indoxyl sulfate (IS) and p-cresyl sulfate (PCS), protein-bound uremic toxins, exacerbate the deterioration of renal function and increase the risk of cardiovascular events in chronic kidney disease (CKD) patients.",p-cresyl sulfate,CHEMICAL,increase risk of cardiovascular events in,CKD,DISEASE
29540737,"Here, we demonstrate that the absence of Gpr17 enhances remyelination in vivo with a toxin-induced model whereby focal demyelinated lesions are generated in spinal cord white matter of adult mice by localized injection of LPC(L-a-lysophosphatidylcholine).",focal demyelinated lesions,DISEASE,be generated in spinal cord white matter of adult mice by localized injection of,LPC(L-a-lysophosphatidylcholine,CHEMICAL
29540737,"The absence of Gpr17 enhances remyelination is correlate with the activated Erk1/2 (phospho-Erk1/2).Being a membrane receptor, Gpr17 represents an ideal druggable target to be exploited for innovative regenerative approaches to acute and chronic CNS diseases.",Gpr17,CHEMICAL,be exploited for innovative regenerative approaches to,acute CNS diseases,DISEASE
2126219,The addition of pimozide dramatically reduced both OCD and Tourette's symptoms.,pimozide,CHEMICAL,reduce,OCD,DISEASE
2126219,The addition of pimozide dramatically reduced both OCD and Tourette's symptoms.,pimozide,CHEMICAL,reduce,Tourette,DISEASE
2126219,Double-blind sequential discontinuation of fluvoxamine and pimozide confirmed that pimozide alone reduced only tics and the combination of fluvoxamine and pimozide was required for the improvement in OCD.,pimozide,CHEMICAL,reduce only tics and combination of,pimozide,CHEMICAL
2126219,Double-blind sequential discontinuation of fluvoxamine and pimozide confirmed that pimozide alone reduced only tics and the combination of fluvoxamine and pimozide was required for the improvement in OCD.,pimozide,CHEMICAL,reduce only tics and combination of,fluvoxamine,CHEMICAL
2126219,Double-blind sequential discontinuation of fluvoxamine and pimozide confirmed that pimozide alone reduced only tics and the combination of fluvoxamine and pimozide was required for the improvement in OCD.,pimozide,CHEMICAL,reduce,only tics,DISEASE
2126219,Double-blind sequential discontinuation of fluvoxamine and pimozide confirmed that pimozide alone reduced only tics and the combination of fluvoxamine and pimozide was required for the improvement in OCD.,pimozide,CHEMICAL,be required for improvement in,OCD,DISEASE
25095803,"Since the second part of the twentieth century, the industrialization of pharmacotherapy, the development of antimicrobial chemotherapy and the introduction of new antibiotics (streptomycin, isoniazid, para-aminosalicylic acid, ethambutol and pyrazinamide) deeply revolutionized treatment for tuberculosis, allowing to achieve important successes.",antimicrobial chemotherapy,CHEBI,revolutionize,tuberculosis,DISEASE
25095803,"Since the second part of the twentieth century, the industrialization of pharmacotherapy, the development of antimicrobial chemotherapy and the introduction of new antibiotics (streptomycin, isoniazid, para-aminosalicylic acid, ethambutol and pyrazinamide) deeply revolutionized treatment for tuberculosis, allowing to achieve important successes.",new antibiotics,CHEBI,revolutionize,tuberculosis,DISEASE
25095803,"Since the second part of the twentieth century, the industrialization of pharmacotherapy, the development of antimicrobial chemotherapy and the introduction of new antibiotics (streptomycin, isoniazid, para-aminosalicylic acid, ethambutol and pyrazinamide) deeply revolutionized treatment for tuberculosis, allowing to achieve important successes.",streptomycin,CHEMICAL,revolutionize,tuberculosis,DISEASE
35484639,Sleep disturbance is common in long-COVID (LC).,Sleep disturbance,DISEASE,be common in,long-COVID,CHEMICAL
35144718,"Glucose metabolic and hypoxic brain issues likely predispose subjects with pre-existing diabetes, cardiovascular or lung problems to long COVID as well.",Glucose metabolic,CHEMICAL,predispose subjects with,pre-existing diabetes,DISEASE
35144718,"Glucose metabolic and hypoxic brain issues likely predispose subjects with pre-existing diabetes, cardiovascular or lung problems to long COVID as well.",Glucose metabolic,CHEMICAL,predispose subjects with,cardiovascular problems,DISEASE
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",antihistamines,CHEBI,support role of sigma and histamine receptors in,infections,DISEASE
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",antihistamines,CHEBI,support role of,histamine,CHEMICAL
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",antihistamines,CHEBI,support role of sigma and histamine receptors in,infections,DISEASE
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",antihistamines,CHEBI,support role of,histamine,CHEMICAL
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",post-mortem schizophrenic brains,DISEASE,support role of sigma and histamine receptors in,infections,DISEASE
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",sigma-1 receptors,CHEMICAL,support role of sigma and histamine receptors in,infections,DISEASE
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",post-mortem schizophrenic brains,DISEASE,support role of,histamine,CHEMICAL
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",sigma-1 receptors,CHEMICAL,support role of,histamine,CHEMICAL
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",many antidepressant drugs,CHEMICAL,be,antihistamines,CHEBI
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",COVID-19,CHEMICAL,be,antihistamines,CHEBI
35144718,"The reported protective effects of psychotropics and antihistamines against COVID-19, the earlier reports of reduced number of sigma-1 receptors in post-mortem schizophrenic brains, with many antidepressant and antipsychotic drugs being antihistamines with significant affinity for the sigma-1 receptor, support the role of sigma and histamine receptors in neuroinflammation and viral infections.",sigma-1 receptors,CHEMICAL,have number in,post-mortem schizophrenic brains,DISEASE
32728087,"Therefore, analysis of the red king crab transcriptome and identification and characterization of its AMPs could potentially contribute to the development of novel antimicrobial drug candidates when antibiotic resistance has become a global health threat.",red king crab transcriptome,NUTRITION,contribute to development of,novel antimicrobial drug candidates,CHEBI
34514909,"Amide, formyl, or nitrile groups at the indole 3-position provided drug-like properties for reduced toxicity, with Polar Surface Areas (PSA) above a desirable 75 Å2.",indole 3-position,CHEMICAL,provide drug-like properties for,reduced toxicity,DISEASE
28012625,"Doxycycline at 0.25 and 0.125 μg/mL inhibited the growth of P. multocida and M. haemolytica, respectively, whereas tilmicosin MIC values were 1.0 and 4.0 μg/mL for P. multocida and M. haemolytica, respectively.",Doxycycline,CHEMICAL,inhibit growth of,multocida M. haemolytica,DISEASE
28012625,"Doxycycline at 0.25 and 0.125 μg/mL inhibited the growth of P. multocida and M. haemolytica, respectively, whereas tilmicosin MIC values were 1.0 and 4.0 μg/mL for P. multocida and M. haemolytica, respectively.",μg/mL,CHEMICAL,inhibit growth of,multocida M. haemolytica,DISEASE
28012625,"Carvacrol MIC values were 2.5 and 1.25 mM for P. multocida and M. haemolytica, respectively, whereas thymol MIC values were 1.25 and 0.625 mM for P. multocida and M. haemolytica, respectively.",Carvacrol MIC values,CHEMICAL,be mm for,multocida M. haemolytica,DISEASE
28012625,"Carvacrol MIC values were 2.5 and 1.25 mM for P. multocida and M. haemolytica, respectively, whereas thymol MIC values were 1.25 and 0.625 mM for P. multocida and M. haemolytica, respectively.",thymol MIC values,CHEMICAL,be mm for,multocida M. haemolytica,DISEASE
16784542,Antimicrobial peptides are the most ubiquitous in nature as part of the innate immune system and host defense mechanism.,Antimicrobial peptides,CHEBI,be ubiquitous in nature as part of,system mechanism,MENTAL_HEALTH
2983630,"The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder.",3-methoxy-4-hydroxyphenethyleneglycol,CHEMICAL,be determined in healthy subjects and patients with,panic disorder,MENTAL_HEALTH
2983630,"The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder.",3-methoxy-4-hydroxyphenethyleneglycol,CHEMICAL,be determined in healthy subjects and patients with,panic attacks,DISEASE
2983630,"The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder.",caffeine,CHEMICAL,be determined in healthy subjects and patients with,panic disorder,MENTAL_HEALTH
2983630,"The effects of oral administration of caffeine (10 mg/kg) on behavioral ratings, somatic symptoms, blood pressure and plasma levels of 3-methoxy-4-hydroxyphenethyleneglycol (MHPG) and cortisol were determined in 17 healthy subjects and 21 patients meeting DSM-III criteria for agoraphobia with panic attacks or panic disorder.",caffeine,CHEMICAL,be determined in healthy subjects and patients with,panic attacks,DISEASE
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,palpitations,DISEASE
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,nausea,DISEASE
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,subject-rated anxiety,MENTAL_HEALTH
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,restlessness,MENTAL_HEALTH
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,nervousness,MENTAL_HEALTH
2983630,"Caffeine produced significantly greater increases in subject-rated anxiety, nervousness, fear, nausea, palpitations, restlessness, and tremors in the patients compared with healthy subjects.",Caffeine,CHEMICAL,produce greater increases in,tremors,DISEASE
2983630,"Because caffeine is an adenosine receptor antagonist, these results suggest that some panic disorder patients may have abnormalities in neuronal systems involving adenosine.",caffeine,CHEMICAL,be,adenosine receptor antagonist,CHEBI
35320002,"The genetic inactivation of Hcar2 in 5xFAD mice, a model of AD, results in impairment of the microglial response to amyloid deposition, including deficits in gene expression, proliferation, envelopment of amyloid plaques, and uptake of amyloid-β (Aβ), ultimately leading to exacerbation of amyloid burden, neuronal loss, and cognitive deficits.",Hcar2,CHEMICAL,result in impairment of microglial response to,amyloid deposition,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",niacin,CHEBI,lead in contrast to,working memory deficits,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",niacin,CHEBI,lead in contrast to,neuronal loss,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",niacin,CHEBI,lead in contrast to,neuronal dystrophy,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",5xFAD mice,CHEMICAL,lead in contrast to,working memory deficits,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",5xFAD mice,CHEMICAL,lead in contrast to,neuronal loss,DISEASE
35320002,"In contrast, activation of HCAR2 with an FDA-approved formulation of niacin (Niaspan) in 5xFAD mice leads to reduced plaque burden and neuronal dystrophy, attenuation of neuronal loss, and rescue of working memory deficits.",5xFAD mice,CHEMICAL,lead in contrast to,neuronal dystrophy,DISEASE
34171402,"Ferroptosis, a new type of programmed cell death discovered in recent years, plays an important role in many neurodegenerative diseases.",programmed cell death,DISEASE,play important role in,many neurodegenerative diseases,DISEASE
34171402,"Ferroptosis, a new type of programmed cell death discovered in recent years, plays an important role in many neurodegenerative diseases.",Ferroptosis,CHEMICAL,play important role in,many neurodegenerative diseases,DISEASE
33022487,"Clinicians are advised to consider daily sodium intake in patients with narcolepsy who are treated with SO and have comorbid disorders associated with increased cardiovascular (CV) risk, in whom sodium intake may be a concern.",daily sodium intake,CHEMICAL,in patients with,narcolepsy,MENTAL_HEALTH
33022487,It remains unclear whether all patients with narcolepsy treated with SO should modify or restrict their sodium intake.,narcolepsy,MENTAL_HEALTH,restrict,sodium intake,CHEMICAL
35592103,Anti-IFN-γ autoantibodies (AIGAs) are closely related to the disseminated infection of multiple pathogens.,Anti-IFN-γ autoantibodies,CHEMICAL,be related to,disseminated infection,DISEASE
35592103,"Mycobacterium phlei (M. phlei) is a nonpathogenic nontuberculous mycobacteria (NTM), and M. phlei infection of the bone is extremely rare.",Mycobacterium phlei,CHEMICAL,be,nonpathogenic nontuberculous mycobacteria,DISEASE
27672545,Allan-Herndon-Dudley syndrome (AHDS) is an X-linked disorder caused by impaired thyroid hormone transporter.,AHDS,DISEASE,caused by,impaired thyroid hormone transporter,CHEBI
27672545,Allan-Herndon-Dudley syndrome (AHDS) is an X-linked disorder caused by impaired thyroid hormone transporter.,Allan-Herndon-Dudley syndrome,DISEASE,caused by,impaired thyroid hormone transporter,CHEBI
27672545,"Patients with AHDS usually exhibit severe motor developmental delay, delayed myelination of the brain white matter, and elevated T3 levels in thyroid tests.",AHDS,DISEASE,elevate,T3 levels,CHEMICAL
6187275,"The repeated administration of meperidine was associated with adverse alterations in various elements of mood (e.g., apprehension, sadness, restlessness).",meperidine,CHEMICAL,be associated with adverse alterations in various elements of,restlessness,MENTAL_HEALTH
6187275,"The repeated administration of meperidine was associated with adverse alterations in various elements of mood (e.g., apprehension, sadness, restlessness).",meperidine,CHEMICAL,be associated with adverse alterations in various elements of,apprehension,MENTAL_HEALTH
6629505,"Frequency of the arterial hypertension was the same in both groups, whereas acroparesthesias, Raynaud's syndrome, and increased gamma GTP serum activity were significantly more frequent in workers with neurological disturbances.",arterial hypertension,DISEASE,be same in,acroparesthesias,DISEASE
6629505,"Frequency of the arterial hypertension was the same in both groups, whereas acroparesthesias, Raynaud's syndrome, and increased gamma GTP serum activity were significantly more frequent in workers with neurological disturbances.",arterial hypertension,DISEASE,be same in,Raynaud's syndrome,DISEASE
6629505,"Frequency of the arterial hypertension was the same in both groups, whereas acroparesthesias, Raynaud's syndrome, and increased gamma GTP serum activity were significantly more frequent in workers with neurological disturbances.",arterial hypertension,DISEASE,increase,gamma GTP serum activity,CHEMICAL
6629505,The neurological injury may be both a direct neurotoxic effect of vinyl chloride and secondary to vascular disorders.,neurological injury,DISEASE,be direct neurotoxic effect of,vinyl chloride,CHEMICAL
6629505,The neurological injury may be both a direct neurotoxic effect of vinyl chloride and secondary to vascular disorders.,neurological injury,DISEASE,be,direct neurotoxic effect,DISEASE
35052591,"On tissue damage, the non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) is converted to allicin in an enzyme-mediated process catalysed by alliinase.",non-proteinogenic amino acid alliin,CHEMICAL,be converted on tissue damage to,allicin,CHEMICAL
35052591,"On tissue damage, the non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) is converted to allicin in an enzyme-mediated process catalysed by alliinase.",non-proteinogenic amino acid alliin,CHEMICAL,be converted on,tissue damage,DISEASE
35052591,"On tissue damage, the non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) is converted to allicin in an enzyme-mediated process catalysed by alliinase.",S-allylcysteine sulfoxide,CHEMICAL,be converted on tissue damage to,allicin,CHEMICAL
35052591,"On tissue damage, the non-proteinogenic amino acid alliin (S-allylcysteine sulfoxide) is converted to allicin in an enzyme-mediated process catalysed by alliinase.",S-allylcysteine sulfoxide,CHEMICAL,be converted on,tissue damage,DISEASE
35052591,"Allicin has shown anticancer, antimicrobial, antioxidant properties and also serves as an efficient therapeutic agent against cardiovascular diseases.",Allicin,CHEMICAL,serve as efficient therapeutic agent against,cardiovascular diseases,DISEASE
35052591,"Allicin has shown anticancer, antimicrobial, antioxidant properties and also serves as an efficient therapeutic agent against cardiovascular diseases.",Allicin,CHEMICAL,show,antimicrobial,CHEBI
35052591,Metal induced neurodegeneration can also be attenuated and cognitive abilities of patients suffering from neurological diseases can be ameliorates by allicin administration.,induced neurodegeneration,DISEASE,be ameliorates by,allicin administration,CHEMICAL
34867555,"Rates of antimicrobial use were lower for mothers of children with ASD compared to mothers of controls (49.0 vs. 55.1%, respectively; p = 0.02), especially during the third trimester of pregnancy (18.8 vs. 22.9%, respectively; p = 0.03), and for the use of penicillins (15.7 vs. 19.7%, respectively; p = 0.06).",antimicrobial use,CHEBI,be lower for mothers of children with,penicillins,CHEMICAL
2906459,Central nervous system side effects are occasionally associated with the administration of H2-receptor antagonists.,Central nervous side effects,DISEASE,be associated with administration of,H2-receptor antagonists,CHEBI
32259145,This study aimed to observe if intravenous low-dose ketamine reduces the pain scores along with lowering the incidence of bradycardia and hypotension during hysteroscopy.,intravenous low-dose ketamine,CHEMICAL,reduce,pain scores,DISEASE
19847886,"However, the high density cultivation of C. cohnii required for an economically feasible process inevitably results in high oxygen demand.",C. cohnii,DISEASE,result in,high oxygen demand,CHEMICAL
30181699,"Post-traumatic stress disorder (PTSD) is a trauma-induced psychiatric disorder characterized by impaired fear extermination, hyperarousal, and anxiety that may involve the release of monoamines in the fear circuit.",Post-traumatic stress disorder,MENTAL_HEALTH,characterized by,anxiety,MENTAL_HEALTH
30181699,"Post-traumatic stress disorder (PTSD) is a trauma-induced psychiatric disorder characterized by impaired fear extermination, hyperarousal, and anxiety that may involve the release of monoamines in the fear circuit.",Post-traumatic stress disorder,MENTAL_HEALTH,characterized by,hyperarousal,MENTAL_HEALTH
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,5-HT concentration,CHEMICAL,be attribute to the tryptophan and 5-hydroxyindoleacetic acid mrna level expression in hippocampus of,PTSD,DISEASE
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,TMP treatment,CHEMICAL,be attribute to the tryptophan and 5-hydroxyindoleacetic acid mrna level expression in hippocampus of,PTSD,DISEASE
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,5-HT concentration,CHEMICAL,be attribute to,tryptophan acid level expression,CHEMICAL
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,5-HT concentration,CHEMICAL,be attribute to,tryptophan acid level expression,NUTRITION
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,TMP treatment,CHEMICAL,be attribute to,tryptophan acid level expression,CHEMICAL
30181699,The increased 5-HT concentration during TMP treatment might be partially attribute to the tryptophan and 5-hydroxyindoleacetic acid mRNA level expression in the hippocampus of rats with PTSD.,TMP treatment,CHEMICAL,be attribute to,tryptophan acid level expression,NUTRITION
15289752,"Vitamin E supports the correct differentiation and function of epidydimal epithelium, spermatid maturation and secretion of proteins by the prostate.",Vitamin E,CHEBI,support correct differentiation and function of,prostate,DISEASE
32686969,"Asthma chronic obstructive pulmonary disease overlap syndrome (ACOS), a combination of atopy-mediated airway hyper-responsiveness and a history of smoking or other environmental noxious exposures, can lead to some fixed airway obstruction and is also common in elderly patients.",Asthma chronic obstructive pulmonary disease overlap syndrome,DISEASE,lead to,fixed airway obstruction,DISEASE
32686969,"Asthma chronic obstructive pulmonary disease overlap syndrome (ACOS), a combination of atopy-mediated airway hyper-responsiveness and a history of smoking or other environmental noxious exposures, can lead to some fixed airway obstruction and is also common in elderly patients.",atopy-mediated airway hyper-responsiveness,DISEASE,lead to,fixed airway obstruction,DISEASE
32686969,"Asthma chronic obstructive pulmonary disease overlap syndrome (ACOS), a combination of atopy-mediated airway hyper-responsiveness and a history of smoking or other environmental noxious exposures, can lead to some fixed airway obstruction and is also common in elderly patients.",ACOS,DISEASE,lead to,fixed airway obstruction,DISEASE
33642973,The current study strengthens previous research that suggests the role of elevated dopamine activity and striatal hypometabolism in stuttering.,elevated dopamine activity,CHEMICAL,have the role in,stuttering,MENTAL_HEALTH
35395562,Impulse control disorder (ICD) has been linked to dopamine agonist use in patients with Parkinson's disease.,control disorder,MENTAL_HEALTH,be linked to,dopamine agonist use,CHEBI
35395562,Impulse control disorder (ICD) has been linked to dopamine agonist use in patients with Parkinson's disease.,dopamine agonist use,CHEBI,in patients with,Parkinson's disease,DISEASE
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,methylphenidate,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,Adderall ®,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,AMP,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,MPH,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,Strattera ®,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,atomoxetine,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,ATX,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,amphetamine,CHEMICAL
35606638,"Based on core symptoms of inattention and deficient impulse control, and the identification of effective pharmacotherapies such as amphetamine (AMP; Adderall®), methylphenidate (MPH; Ritalin®), and atomoxetine (ATX; Strattera®), ADHD is a clinical condition which provides opportunity for translational research.",ADHD,MENTAL_HEALTH,based on core symptoms of,Ritalin ®,CHEMICAL
35606638,"In contrast, any pro-attentive effects of ATX appear to be less consistent, the most reliable effects of ATX are recorded in tests of impulsivity.",ATX,CHEMICAL,be recorded in tests of,impulsivity,DISEASE
35579123,Pharmacological treatment with stimulants or non-stimulants is used most commonly to reduce ADHD symptoms.,non-stimulants,CHEMICAL,reduce,ADHD symptoms,MENTAL_HEALTH
12192555,"In rare cases, orthostatic hypotension, impotence, constipation and urinary retention have been attributed to autonomic nervous system dysfunction due to vitamin B(12) deficiency.",impotence,MENTAL_HEALTH,be attributed in,autonomic nervous system dysfunction,DISEASE
12192555,"In rare cases, orthostatic hypotension, impotence, constipation and urinary retention have been attributed to autonomic nervous system dysfunction due to vitamin B(12) deficiency.",impotence,MENTAL_HEALTH,be attributed in,vitamin B(12 deficiency,CHEBI
12192555,"In rare cases, orthostatic hypotension, impotence, constipation and urinary retention have been attributed to autonomic nervous system dysfunction due to vitamin B(12) deficiency.",orthostatic hypotension,DISEASE,be attributed in,autonomic nervous system dysfunction,DISEASE
12192555,"In rare cases, orthostatic hypotension, impotence, constipation and urinary retention have been attributed to autonomic nervous system dysfunction due to vitamin B(12) deficiency.",orthostatic hypotension,DISEASE,be attributed in,vitamin B(12 deficiency,CHEBI
7200931,"The pathogenesis of infertility and sexual dysfunction in coeliac disease remains unclear, suggesting that factors such as endocrine dysfunction or other specific nutritional deficiency may be involved.",infertility,DISEASE,have the pathogenesis in,coeliac disease,DISEASE
7200931,"The pathogenesis of infertility and sexual dysfunction in coeliac disease remains unclear, suggesting that factors such as endocrine dysfunction or other specific nutritional deficiency may be involved.",sexual dysfunction,MENTAL_HEALTH,have the pathogenesis in,coeliac disease,DISEASE
8573660,"Benzodiazepines, the most widely prescribed psychotropic drugs, are often used in patients with depressive disorders, either alone or in combination with standard antidepressants.",Benzodiazepines,CHEMICAL,be used in patients with,standard antidepressants,CHEMICAL
8573660,"Benzodiazepines, the most widely prescribed psychotropic drugs, are often used in patients with depressive disorders, either alone or in combination with standard antidepressants.",Benzodiazepines,CHEMICAL,be used in patients with,depressive disorders,DISEASE
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",antidepressant efficacy,CHEMICAL,be consistent with gaba theory of,depression,MENTAL_HEALTH
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",benzodiazepines,CHEMICAL,be consistent with gaba theory of,depression,MENTAL_HEALTH
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",antidepressant efficacy,CHEMICAL,be consistent with,GABA theory,CHEMICAL
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",benzodiazepines,CHEMICAL,be consistent with,GABA theory,CHEMICAL
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",GABAA receptor agonists,CHEBI,be consistent with gaba theory of,depression,MENTAL_HEALTH
8573660,"The antidepressant efficacy of benzodiazepines, which are GABAA receptor agonists, is consistent with the GABA theory of depression.",GABAA receptor agonists,CHEBI,be consistent with,GABA theory,CHEMICAL
29492862,Oral oxybutynin has been associated with the development of cognitive impairment.,Oral oxybutynin,CHEMICAL,be associated with development of,cognitive impairment,DISEASE
29703135,The ammonia contained in tobacco fillers and mainstream and sidestream cigarette smoke accelerates nicotine dependence in cigarette smokers.,ammonia,CHEMICAL,accelerate,nicotine dependence,MENTAL_HEALTH
33719824,"In order to cover this gap, different doses (suitable for human administration) of a maqui-berry powder (1.6% anthocyanin), using enteral and parenteral routes of administration, were compared at central and peripheral levels using a nociceptive pain model (formalin test) in mice.",% anthocyanin,NUTRITION,use,nociceptive pain model,DISEASE
32738494,"Protocatechuic acid has a wide range of pharmacological activities including antioxidant, anti-inflammatory, neuroprotective, antibacterial, antiviral, anticancer, antiosteoporotic, analgesia, antiaging activties; protection from metabolic syndrome; and preservation of liver, kidneys, and reproductive functions.",Protocatechuic acid,CHEMICAL,have wide range of,antiviral,CHEBI
32738494,"Protocatechuic acid has a wide range of pharmacological activities including antioxidant, anti-inflammatory, neuroprotective, antibacterial, antiviral, anticancer, antiosteoporotic, analgesia, antiaging activties; protection from metabolic syndrome; and preservation of liver, kidneys, and reproductive functions.",Protocatechuic acid,CHEMICAL,have wide range of,analgesia,MENTAL_HEALTH
32738494,"Protocatechuic acid has a wide range of pharmacological activities including antioxidant, anti-inflammatory, neuroprotective, antibacterial, antiviral, anticancer, antiosteoporotic, analgesia, antiaging activties; protection from metabolic syndrome; and preservation of liver, kidneys, and reproductive functions.",Protocatechuic acid,CHEMICAL,have wide range of,metabolic syndrome,DISEASE
35207756,"Carriers of the HTR1A rs6295 GC genotype (OR = 2.58; 95% CI = 1.15-5.78; p = 0.021), TPH2 rs4290270 AA genotype (OR = 2.78; 95% CI = 1.08-7.03; p = 0.034), and at least one TPH2 rs4570625 T allele (OR = 1.86; 95% CI = 1.00-3.44; p = 0.047) had increased risk for visual hallucinations (VH).",TPH2 rs4290270 AA genotype,CHEMICAL,increase risk for,visual hallucinations,MENTAL_HEALTH
3507211,"Because of their narrow therapeutic ranges and differing patient tolerances, the monitoring of tricyclic antidepressants (TADs) commonly prescribed for control of endogenous depression is highly desirable for the satisfactory treatment of patients.",tricyclic antidepressants,CHEMICAL,differing patient tolerances for control of,endogenous depression,MENTAL_HEALTH
30658584,Emergence of bacterial resistance caught our attention to consider the combination of antimicrobial agents.,bacterial resistance,MENTAL_HEALTH,consider combination of,antimicrobial agents,CHEBI
30658584,"Concerning the effect of combining paromomycin with different antimicrobial agents, it was tested using the checkerboard assay against six multidrug resistant (MDR) pathogens including; Pseudomonas (P.) aeruginosa (2 isolates), Klebsiella (K.) pneumoniae, Escherichia (E.) coli, methicillin sensitive Staphylococcus aureus (MSSA) and methicillin resistant Staphylococcus aureus (MRSA).",paromomycin,CHEMICAL,have the effect with,different antimicrobial agents,CHEBI
34090459,Tristetraprolin (TTP) family proteins contain conserved tandem CCCH zinc-finger binding to AU-rich elements and C-terminal NOT1-binding domain.,Tristetraprolin TTP family proteins,DISEASE,contain conserved tandem ccch zinc-finger binding to,C-terminal NOT1-binding domain,CHEMICAL
32405245,"Higher body temperature, heart rate, and respiratory rate as well as higher of lactate dehydrogenase (LDH), aspartate aminotransferase (AST), and C-reactive protein (CRP) levels and lower serum albumin level and lymphocyte count were associated with the presence of pneumonia.",lactate dehydrogenase,CHEMICAL,be associated with presence of,pneumonia,DISEASE
32405245,The severity of COVID-19 depends on the presence of pneumonia.,COVID-19,CHEMICAL,depend on presence of,pneumonia,DISEASE
16388723,The aim of our study was to evaluate the effect of mirtazapine on thyroid hormones after 6 months of therapy in a sample of adult outpatients with Major Depression (MD).,mirtazapine,CHEMICAL,have the effect on,thyroid hormones,CHEBI
16388723,Long-term treatment with mirtazapine increases FT3 levels and decreases FT4 maybe involving the deiodination process of T4 into T3.,mirtazapine,CHEMICAL,increase,FT3 levels,CHEMICAL
9172706,"In 13 patients fulfilling DSM-III-R criteria for a major depressive episode, hormone serum levels were measured at 8 AM on the day before and on the first and second days after partial sleep deprivation (PSD) late in the night during a 4-week course of therapy with amitriptyline in combination with 6 PSDs.",hormone serum levels,CHEBI,be measured in patients at am on day before,amitriptyline,CHEMICAL
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",diencephalic damage,DISEASE,be in wernicke-korsakoff's,WKS,DISEASE
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",diencephalic damage,DISEASE,be in wernicke-korsakoff's,disorder,DISEASE
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",diencephalic damage,DISEASE,be in wernicke-korsakoff's,pyrithiamine-induced thiamine deficiency,NUTRITION
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",amnesic state,DISEASE,be in wernicke-korsakoff's,WKS,DISEASE
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",amnesic state,DISEASE,be in wernicke-korsakoff's,disorder,DISEASE
19264109,"In Wernicke-Korsakoff's syndrome (WKS) and the animal model of the disorder, pyrithiamine-induced thiamine deficiency (PTD), there is both diencephalic damage and basal forebrain cell loss that could contribute to the amnesic state.",amnesic state,DISEASE,be in wernicke-korsakoff's,pyrithiamine-induced thiamine deficiency,NUTRITION
19264109,"Unbiased stereological assessment of neuronal populations revealed that ChAT-positive neurons were significantly reduced in PTD rats, relative to control pair-fed rats, and thalamic mass and behavioral performance correlated with ChAT neuronal estimates.",thalamic mass,DISEASE,correlate with,ChAT neuronal estimates,NUTRITION
31396719,"Though dopaminergic agents are quite efficient in managing the motor aspects of the disease, chronic pharmacotherapy specifically with dopamine receptor agonists has been highly linked to the occurrence of Impulse Compulsive disorder (ICD), which can be problematic for individual patients.",dopaminergic agents,CHEBI,manage motor aspects of,dopamine receptor agonists,CHEMICAL
31396719,"Though dopaminergic agents are quite efficient in managing the motor aspects of the disease, chronic pharmacotherapy specifically with dopamine receptor agonists has been highly linked to the occurrence of Impulse Compulsive disorder (ICD), which can be problematic for individual patients.",dopaminergic agents,CHEBI,manage motor aspects of,dopamine receptor agonists,CHEBI
35163829,Extracellular adenosine 5'-triphosphate (ATP) in the brain is suggested to be an etiological factor of major depressive disorder (MDD).,Extracellular adenosine 5'-triphosphate,CHEMICAL,be suggested to etiological factor of,major depressive disorder,MENTAL_HEALTH
35163829,Extracellular adenosine 5'-triphosphate (ATP) in the brain is suggested to be an etiological factor of major depressive disorder (MDD).,Extracellular adenosine 5'-triphosphate,CHEMICAL,be suggested to etiological factor of,MDD,DISEASE
35163829,"The TST and FST resulted in learned helplessness manifested as a prolongation of the immobility time, while inescapable foot shock caused lower sucrose consumption as a sign of anhedonia.",inescapable foot shock,DISEASE,cause lower sucrose consumption as sign of,anhedonia,MENTAL_HEALTH
35163829,"The TST and FST resulted in learned helplessness manifested as a prolongation of the immobility time, while inescapable foot shock caused lower sucrose consumption as a sign of anhedonia.",inescapable foot shock,DISEASE,cause,lower sucrose consumption,CHEMICAL
35163829,"In hippocampal slices of mice and rats, only foot shock increased the current responses to locally applied dibenzoyl-ATP (Bz-ATP) in CA1 astrocytes; in contrast, TST and restraint depressed these responses.",only foot shock,DISEASE,applied,Bz-ATP,CHEMICAL
35163829,"In hippocampal slices of mice and rats, only foot shock increased the current responses to locally applied dibenzoyl-ATP (Bz-ATP) in CA1 astrocytes; in contrast, TST and restraint depressed these responses.",only foot shock,DISEASE,applied,dibenzoyl-ATP,CHEMICAL
33834276,Nalfurafine has been used clinically in Japan for treatment of itch in kidney dialysis patients and in patients with chronic liver diseases.,Nalfurafine,CHEMICAL,be used in japan for treatment of itch in,chronic liver diseases,DISEASE
33834276,"In addition, nalfurafine showed antinociceptive effects in several pain models at doses that did not cause the side effects mentioned above.",nalfurafine,CHEMICAL,show in addition antinociceptive effects in,several pain models,DISEASE
33834276,"Because of its lack of side effects associated with typical KOR agonists, nalfurafine has been investigated as a combination therapy with an MOR ligand for pain treatment and for its effects on opioid use disorder and alcohol use disorder, and results indicate potential usefulness for these indications.",nalfurafine,CHEMICAL,be investigated,pain treatment,DISEASE
33834276,"Because of its lack of side effects associated with typical KOR agonists, nalfurafine has been investigated as a combination therapy with an MOR ligand for pain treatment and for its effects on opioid use disorder and alcohol use disorder, and results indicate potential usefulness for these indications.",nalfurafine,CHEMICAL,be investigated,alcohol,CHEMICAL
35571085,"In addition, early treatment with iv high dose vitamin C seems to reduce the risks of severe courses of the disease such as pneumonia and also mortality.",iv high dose vitamin C,CHEBI,reduce risks of severe courses of disease such as,pneumonia,DISEASE
35193745,"Adapter proteins for transcriptional activation or repression via recruitment of co-activators and co-repressors, respectively, E2 ubiquitin ligases, miRNA processing complex, and DNA methylation/demethylation factors have been recently discovered in various plants to play key roles in fine-tuning flavonoids synthesis.",E2 ubiquitin ligases,CHEMICAL,play key roles in,fine-tuning flavonoids synthesis,CHEMICAL
35193745,"Adapter proteins for transcriptional activation or repression via recruitment of co-activators and co-repressors, respectively, E2 ubiquitin ligases, miRNA processing complex, and DNA methylation/demethylation factors have been recently discovered in various plants to play key roles in fine-tuning flavonoids synthesis.",repression,MENTAL_HEALTH,play key roles in,fine-tuning flavonoids synthesis,CHEMICAL
33744591,Epidemiological studies conducted in Japan have shown that green tea consumption improves cognitive impairment.,tea consumption,CHEMICAL,improve,cognitive impairment,DISEASE
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,reduce,g potassium chloride,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",urea,CHEMICAL,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",urea,CHEMICAL,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",urea,CHEMICAL,reduce,g potassium chloride,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",urea,CHEMICAL,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",urea,CHEMICAL,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,reduce,ammonia B2:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,reduce,g potassium chloride,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,NUTRITION
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,reduce,g urea B3:0.4 g potassium dihydrogen phosphate,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",cumulative ammonia volatilization,CHEMICAL,be,M-YM YM JG,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium chloride,CHEMICAL,have the addition in,urea,CHEMICAL
33372500,"The addition of potassium chloride and potassium dihydrogen phosphate in urea reduced ammonia volatilization, and the cumulative ammonia volatilization and volatilization rate of different biochars under all chemical fertilizer ratios was JZ > M-YM > YM > JG; ② The amount of phosphorus by biochars fixation under the B1, B2, and B3 treatments (B1:0.4 g potassium dihydrogen phosphate; B2:0.4 g potassium dihydrogen phosphate +0.3 g urea; B3:0.4 g potassium dihydrogen phosphate +0.3 g potassium chloride) all increased and then decreased.",potassium dihydrogen phosphate,NUTRITION,have the addition in,urea,CHEMICAL
33372500,"Among four biochar, the fixation rate of phosphorus was the highest under the B1 treatment.",phosphorus,NUTRITION,be highest among,biochar,DISEASE
33372500,"Among four biochar, the fixation rate of phosphorus was the highest under the B1 treatment.",fixation rate,MENTAL_HEALTH,be highest among,biochar,DISEASE
33372500,"With the ratios of B1, B2, and B3 fertilizers, the order of the fixation rate of the four biochars to phosphorus was:M-YM > YM > JG > JZ.",phosphorus,NUTRITION,be,M-YM YM JG JZ,CHEMICAL
33372500,"With the ratios of B1, B2, and B3 fertilizers, the order of the fixation rate of the four biochars to phosphorus was:M-YM > YM > JG > JZ.",fixation rate,MENTAL_HEALTH,be,M-YM YM JG JZ,CHEMICAL
33835367,"This review highlights the use of undecanoic acid in antifungal treatments, reinforcing its known activity against dermatophytes.",undecanoic acid,CHEMICAL,have the use in,antifungal treatments,CHEBI
33835367,"Specifically, in Trichophyton rubrum, against which the activity of undecanoic acid has been most widely studied, undecanoic acid elicits profound effects on pivotal processes in the cell wall, membrane assembly, lipid metabolism, pathogenesis, and even mRNA processing.",undecanoic acid,CHEMICAL,elicit in,Trichophyton rubrum,DISEASE
33835367,"Considering the known antifungal activities and associated mechanisms of undecanoic acid, its potential use in combination therapy, and the ability to modify the parent compound structure, undecanoic acid shows promise as a novel therapeutic against fungal infections.",undecanoic acid,CHEMICAL,promise as novel therapeutic against,fungal infections,DISEASE
11405995,Vitamin B1 (thiamine) plays an important role in Wernicke-Korsakoff syndrome (a form of amnesia caused by brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition).,Vitamin B1,CHEBI,play important role in,amnesia,MENTAL_HEALTH
11405995,Vitamin B1 (thiamine) plays an important role in Wernicke-Korsakoff syndrome (a form of amnesia caused by brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition).,Vitamin B1,CHEBI,play important role in,Wernicke-Korsakoff syndrome,DISEASE
11405995,Vitamin B1 (thiamine) plays an important role in Wernicke-Korsakoff syndrome (a form of amnesia caused by brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition).,thiamine,CHEBI,play important role in,amnesia,MENTAL_HEALTH
11405995,Vitamin B1 (thiamine) plays an important role in Wernicke-Korsakoff syndrome (a form of amnesia caused by brain damage occurring in long-term alcoholics who rely mainly on alcohol for nutrition).,thiamine,CHEBI,play important role in,Wernicke-Korsakoff syndrome,DISEASE
11405995,"The acute syndrome is normally reversible but may proceed to profound dementia, although its progress can be stopped by a timely injection of a large dose of thiamine.",acute syndrome,DISEASE,proceed to,profound dementia,MENTAL_HEALTH
27142294,"The CCK2 selective antagonist 18 was found to potentiate analgesia in the tail flick assay in mice, for the strong opiate morphine, the partial opiate agonist tramadol and the tricyclic antidepressant desimipramine.",CCK2 selective antagonist,CHEBI,potentiate analgesia in tail flick assay in mice for,partial opiate agonist tramadol,CHEBI
27142294,"The CCK2 selective antagonist 18 was found to potentiate analgesia in the tail flick assay in mice, for the strong opiate morphine, the partial opiate agonist tramadol and the tricyclic antidepressant desimipramine.",CCK2 selective antagonist,CHEBI,potentiate analgesia in tail flick assay in mice for,partial opiate agonist tramadol,CHEMICAL
27142294,"The CCK2 selective antagonist 18 was found to potentiate analgesia in the tail flick assay in mice, for the strong opiate morphine, the partial opiate agonist tramadol and the tricyclic antidepressant desimipramine.",CCK2 selective antagonist,CHEBI,potentiate analgesia in tail flick assay in mice for,desimipramine,CHEMICAL
27142294,"The CCK2 selective antagonist 18 was found to potentiate analgesia in the tail flick assay in mice, for the strong opiate morphine, the partial opiate agonist tramadol and the tricyclic antidepressant desimipramine.",CCK2 selective antagonist,CHEBI,potentiate,analgesia,MENTAL_HEALTH
34536498,Obstructive sleep apnea hypopnea syndrome (OSAHS) and chronic intermittent hypoxia (CIH) may be linked with the pathogenesis and the severity of NAFLD.,OSAHS,DISEASE,be linked with pathogenesis and severity of,NAFLD,DISEASE
34536498,Obstructive sleep apnea hypopnea syndrome (OSAHS) and chronic intermittent hypoxia (CIH) may be linked with the pathogenesis and the severity of NAFLD.,chronic intermittent hypoxia,DISEASE,be linked with pathogenesis and severity of,NAFLD,DISEASE
34536498,Obstructive sleep apnea hypopnea syndrome (OSAHS) and chronic intermittent hypoxia (CIH) may be linked with the pathogenesis and the severity of NAFLD.,Obstructive sleep apnea hypopnea syndrome,DISEASE,be linked with pathogenesis and severity of,NAFLD,DISEASE
34536498,Obstructive sleep apnea hypopnea syndrome (OSAHS) and chronic intermittent hypoxia (CIH) may be linked with the pathogenesis and the severity of NAFLD.,Obstructive sleep apnea hypopnea syndrome,MENTAL_HEALTH,be linked with pathogenesis and severity of,NAFLD,DISEASE
23774255,"The FTDP-17 model displays spontaneous epileptic activity and seizures with spike-wave complexes in the EEG, and a higher sensitivity to the GABAA receptor antagonist pentylenetetrazol (PTZ) when compared to age-matched controls, showing a notably increased seizure length and a shorter latency to develop severe seizures.",FTDP-17 model,CHEMICAL,display,seizures,DISEASE
23774255,"The FTDP-17 model displays spontaneous epileptic activity and seizures with spike-wave complexes in the EEG, and a higher sensitivity to the GABAA receptor antagonist pentylenetetrazol (PTZ) when compared to age-matched controls, showing a notably increased seizure length and a shorter latency to develop severe seizures.",FTDP-17 model,CHEMICAL,display,spontaneous epileptic activity,DISEASE
23774255,"The FTDP-17 model displays spontaneous epileptic activity and seizures with spike-wave complexes in the EEG, and a higher sensitivity to the GABAA receptor antagonist pentylenetetrazol (PTZ) when compared to age-matched controls, showing a notably increased seizure length and a shorter latency to develop severe seizures.",FTDP-17 model,CHEMICAL,show increased,seizure latency,DISEASE
23774255,FTDP-17 human mutant tau over-expression produces epilepsy and increased GABAA receptor-mediated hyperexcitability in the absence of Aβ pathology.,FTDP-17 human mutant tau over-expression,CHEMICAL,produce,epilepsy,DISEASE
23774255,FTDP-17 human mutant tau over-expression produces epilepsy and increased GABAA receptor-mediated hyperexcitability in the absence of Aβ pathology.,FTDP-17 human mutant tau over-expression,CHEMICAL,increase,receptor-mediated hyperexcitability,DISEASE
35406126,Histamine Intolerance (HIT) is a multifaceted pseudoallergic disorder possibly due to defective histamine metabolism.,HIT,DISEASE,be multifaceted pseudoallergic disorder due to,defective histamine metabolism,CHEMICAL
35406126,Histamine Intolerance (HIT) is a multifaceted pseudoallergic disorder possibly due to defective histamine metabolism.,HIT,DISEASE,be,multifaceted pseudoallergic disorder due,DISEASE
35406126,Histamine Intolerance (HIT) is a multifaceted pseudoallergic disorder possibly due to defective histamine metabolism.,Histamine Intolerance,CHEMICAL,be multifaceted pseudoallergic disorder due to,defective histamine metabolism,CHEMICAL
35406126,Histamine Intolerance (HIT) is a multifaceted pseudoallergic disorder possibly due to defective histamine metabolism.,Histamine Intolerance,CHEMICAL,be,multifaceted pseudoallergic disorder due,DISEASE
9930994,This enzyme has already been established as a target for novel antibacterial agents through suicide inactivation by a number of compounds.,suicide inactivation,MENTAL_HEALTH,have a target for,novel antibacterial agents,CHEBI
2529981,"The patients with anorexia nervosa had obvious endocrine disturbances, such as low serum FSH, LH and Ts levels and high basal serum GH and midnight serum cortisol concentrations.",anorexia nervosa,MENTAL_HEALTH,have,obvious endocrine disturbances,CHEBI
2529981,"The patients with anorexia nervosa had obvious endocrine disturbances, such as low serum FSH, LH and Ts levels and high basal serum GH and midnight serum cortisol concentrations.",anorexia nervosa,MENTAL_HEALTH,have,midnight serum cortisol concentrations,CHEMICAL
9310524,"1) To evaluate the relationships between urinary sodium (UNa), potassium (UK), and calcium (UCa) excretion in the pediatric population; and 2) to determine the effect of increasing potassium intake in patients with idiopathic hypercalciuria and investigate whether this intervention can be offered as another mode of therapy in this patient population.",potassium intake,CHEMICAL,in patients with,idiopathic hypercalciuria,DISEASE
32847029,Raspberry juice only suppressed P. gingivalis significantly.,Raspberry juice,NUTRITION,suppress,P. gingivalis,DISEASE
16001603,Increased central nervous system norepinephrine outflow and alpha1-adrenergic receptor responsiveness appear to be involved in the pathophysiologic processes of trauma-related nightmares in post-traumatic stress disorder.,Increased central nervous system norepinephrine outflow,CHEMICAL,be involved in pathophysiologic processes of trauma-related nightmares in,post-traumatic stress disorder,MENTAL_HEALTH
16001603,"On the basis of reports that the brain-accessible alpha1-adrenergic antagonist Prazosin substantially reduced chronic combat-related nightmares among Vietnam War veterans, we evaluated Prazosin effects on combat-related nightmares among combat soldiers returning from Operation Iraqi Freedom.",brain-accessible alpha1-adrenergic antagonist Prazosin,CHEBI,reduce,chronic combat-related nightmares,DISEASE
16001603,"On the basis of reports that the brain-accessible alpha1-adrenergic antagonist Prazosin substantially reduced chronic combat-related nightmares among Vietnam War veterans, we evaluated Prazosin effects on combat-related nightmares among combat soldiers returning from Operation Iraqi Freedom.",brain-accessible alpha1-adrenergic antagonist Prazosin,CHEMICAL,reduce,chronic combat-related nightmares,DISEASE
33988479,"Elevated serum testosterone not only causes virilizing effects, but also will lead to hypercholesterolemia, insulin resistance, hypertension and cardiac disease.",Elevated serum testosterone,CHEMICAL,lead to,hypertension,DISEASE
33988479,"Elevated serum testosterone not only causes virilizing effects, but also will lead to hypercholesterolemia, insulin resistance, hypertension and cardiac disease.",Elevated serum testosterone,CHEMICAL,lead to,hypercholesterolemia disease,DISEASE
33988479,"Elevated serum testosterone not only causes virilizing effects, but also will lead to hypercholesterolemia, insulin resistance, hypertension and cardiac disease.",Elevated serum testosterone,CHEMICAL,lead to,insulin resistance,MENTAL_HEALTH
33988479,"Measurement of serum testosterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstenedione and inhibin B is necessary in postmenopausal women with the complaints and signs of hyperandrogenism.",androstenedione,CHEMICAL,be necessary in postmenopausal women with complaints and signs of,hyperandrogenism,DISEASE
33988479,"Measurement of serum testosterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstenedione and inhibin B is necessary in postmenopausal women with the complaints and signs of hyperandrogenism.",sex hormone-binding globulin,DISEASE,be necessary in postmenopausal women with complaints and signs of,hyperandrogenism,DISEASE
33988479,"Measurement of serum testosterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstenedione and inhibin B is necessary in postmenopausal women with the complaints and signs of hyperandrogenism.",serum testosterone,CHEMICAL,be necessary in postmenopausal women with complaints and signs of,hyperandrogenism,DISEASE
33988479,"Measurement of serum testosterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstenedione and inhibin B is necessary in postmenopausal women with the complaints and signs of hyperandrogenism.",inhibin B,DISEASE,be necessary in postmenopausal women with complaints and signs of,hyperandrogenism,DISEASE
33988479,"Measurement of serum testosterone, sex hormone-binding globulin, dehydroepiandrosterone sulfate, androstenedione and inhibin B is necessary in postmenopausal women with the complaints and signs of hyperandrogenism.",dehydroepiandrosterone sulfate,CHEMICAL,be necessary in postmenopausal women with complaints and signs of,hyperandrogenism,DISEASE
33937527,"Differences in insulin sensitivity (1/[fasting insulin], homeostatic model of insulin resistance [HOMA-IR]), glycemia (hemoglobin A1C [HbA1c], fasting glucose), and body composition (dual-energy X-ray absorptiometry) were evaluated using a mixed linear regression model.",insulin resistance,MENTAL_HEALTH,use,mixed regression model,MENTAL_HEALTH
31808569,"Palovarotene, an agonist of nuclear retinoic acid receptor γ (RARγ) has shown therapeutic action for treatment of heterotopic ossification and osteochondroma without serious adverse effects in animal models.",Palovarotene,CHEMICAL,show therapeutic action for treatment of,heterotopic ossification,DISEASE
31808569,"Palovarotene, an agonist of nuclear retinoic acid receptor γ (RARγ) has shown therapeutic action for treatment of heterotopic ossification and osteochondroma without serious adverse effects in animal models.",agonist,CHEBI,show therapeutic action for treatment of,heterotopic ossification,DISEASE
31808569,"Palovarotene, an agonist of nuclear retinoic acid receptor γ (RARγ) has shown therapeutic action for treatment of heterotopic ossification and osteochondroma without serious adverse effects in animal models.",nuclear retinoic acid receptor,CHEMICAL,show therapeutic action for treatment of,heterotopic ossification,DISEASE
31808569,"Furthermore, local injection of RARγ agonist-loaded poly-lactic acid nanoparticles induced regression of the mass size of the transplants.",RARγ agonist-loaded poly-lactic acid nanoparticles,CHEMICAL,induce,regression,MENTAL_HEALTH
31808569,Histologic analysis demonstrated that RARγ agonist treatment inhibited cell proliferation activity and stimulated encapsulation of the tumor.,RARγ agonist treatment,CHEBI,stimulate encapsulation of,tumor,DISEASE
31808569,"These findings indicate that RARγ agonists, including palovarotene, may have an anti-tumor effect on low-grade chondrosarcomas.",palovarotene,CHEMICAL,have anti-tumor effect on,low-grade chondrosarcomas,DISEASE
31808569,"These findings indicate that RARγ agonists, including palovarotene, may have an anti-tumor effect on low-grade chondrosarcomas.",RARγ agonists,CHEBI,have anti-tumor effect on,low-grade chondrosarcomas,DISEASE
30820351,"Drug combinations have been shown to improve durability and reduce resistance to available first-line therapies in a variety of cancers; however, traditional drug discovery approaches are prohibitively cost and labor-intensive to evaluate large-scale matrices of potential drug combinations.",Drug combinations,CHEBI,reduce resistance to available first-line therapies in variety of,cancers,DISEASE
30820351,"Drug combinations have been shown to improve durability and reduce resistance to available first-line therapies in a variety of cancers; however, traditional drug discovery approaches are prohibitively cost and labor-intensive to evaluate large-scale matrices of potential drug combinations.",Drug combinations,CHEBI,reduce,resistance,MENTAL_HEALTH
27529178,"Although strategic thinking on water, sanitation and hygiene (WASH) has prioritized reducing exposure to human feces in order to limit diarrheal infections, recent research suggests that elevated exposure to livestock-particularly poultry and poultry feces-may be an important risk factor for diarrhea, environmental enteric disorder (EED) and respiratory infections, all of which may seriously retard linear growth in young children.",poultry feces-may,CHEMICAL,be important risk factor for,respiratory infections,DISEASE
27529178,"Although strategic thinking on water, sanitation and hygiene (WASH) has prioritized reducing exposure to human feces in order to limit diarrheal infections, recent research suggests that elevated exposure to livestock-particularly poultry and poultry feces-may be an important risk factor for diarrhea, environmental enteric disorder (EED) and respiratory infections, all of which may seriously retard linear growth in young children.",poultry feces-may,CHEMICAL,be important risk factor for,environmental enteric disorder,DISEASE
27529178,"Although strategic thinking on water, sanitation and hygiene (WASH) has prioritized reducing exposure to human feces in order to limit diarrheal infections, recent research suggests that elevated exposure to livestock-particularly poultry and poultry feces-may be an important risk factor for diarrhea, environmental enteric disorder (EED) and respiratory infections, all of which may seriously retard linear growth in young children.",poultry feces-may,CHEMICAL,be important risk factor for,diarrhea,DISEASE
34871985,"The effect of herbal additives on avian coccidiosis is based on diminishing the oocyst output through inhibition or impairment of the invasion, replication, and development of Eimeria species in the gut tissues of chickens; lowering oocyst counts due to the presence of phenolic compounds in herbal extracts which reacts with cytoplasmic membranes causing coccidial cell death; ameliorating the degree of intestinal lipid peroxidation; facilitating the repair of epithelial injuries; and decreasing the intestinal permeability induced by Eimeria species through the upregulation of epithelial turnover.",avian coccidiosis,DISEASE,be based due to presence of,phenolic compounds,CHEMICAL
34871985,"The effect of herbal additives on avian coccidiosis is based on diminishing the oocyst output through inhibition or impairment of the invasion, replication, and development of Eimeria species in the gut tissues of chickens; lowering oocyst counts due to the presence of phenolic compounds in herbal extracts which reacts with cytoplasmic membranes causing coccidial cell death; ameliorating the degree of intestinal lipid peroxidation; facilitating the repair of epithelial injuries; and decreasing the intestinal permeability induced by Eimeria species through the upregulation of epithelial turnover.",avian coccidiosis,DISEASE,facilitate repair of,epithelial injuries,DISEASE
23131487,We report a sympathomimetic syndrome with metabolic acidosis and hyperlactatemia after intentional inhalation of salmeterol in a suicide attempt.,salmeterol,CHEMICAL,have intentional inhalation in,suicide attempt,MENTAL_HEALTH
23131487,We hypothesize that stimulation of β2-adrenergic receptors by inhalation of salmeterol caused this patient's lactic acidosis.,salmeterol,CHEMICAL,cause patient's,lactic acidosis,DISEASE
23131487,This observation is consistent with the hypothesis that the hyperlactatemia observed during asthma attacks is due in part to the administration of high doses of β2-agonists.,hyperlactatemia,DISEASE,be due in part to administration of high doses of,β2-agonists,CHEMICAL
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",trimethylamine N-oxide,CHEMICAL,be associated with,fish-odor's syndrome,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",trimethylamine N-oxide,CHEMICAL,be associated with,primary trimethylaminuria,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",trimethylamine,CHEMICAL,be associated with,fish-odor's syndrome,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",trimethylamine,CHEMICAL,be associated with,primary trimethylaminuria,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",human flavin,CHEMICAL,be associated with,fish-odor's syndrome,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",human flavin,CHEMICAL,be associated with,primary trimethylaminuria,DISEASE
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",human flavin,CHEMICAL,have impaired conversion of,trimethylamine N-oxide,CHEMICAL
17531949,"Impaired conversion of trimethylamine to trimethylamine N-oxide by human flavin containing monooxygenase 3 (FMO3) is strongly associated with primary trimethylaminuria, also known as 'fish-odor' syndrome.",human flavin,CHEMICAL,have impaired conversion of,trimethylamine,CHEMICAL
29167401,"Previous work, using models of acute nociceptive pain, indicated that analgesia by acetaminophen involves an indirect activation of CB1 receptors by the acetaminophen metabolite and endocannabinoid reuptake inhibitor AM 404.",acetaminophen,CHEMICAL,involve indirect activation of cb1 receptors by,acetaminophen metabolite,CHEMICAL
29167401,"Previous work, using models of acute nociceptive pain, indicated that analgesia by acetaminophen involves an indirect activation of CB1 receptors by the acetaminophen metabolite and endocannabinoid reuptake inhibitor AM 404.",analgesia,MENTAL_HEALTH,involve indirect activation of cb1 receptors by,acetaminophen metabolite,CHEMICAL
29167401,Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.,acetaminophen metabolite AM,CHEMICAL,suggest rostral ventromedial medulla as important site of cannabinoid-mediated analgesia by,acetaminophen,CHEMICAL
29167401,Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.,acetaminophen metabolite AM,CHEMICAL,suggest rostral ventromedial medulla as important site of,cannabinoid-mediated analgesia,MENTAL_HEALTH
29167401,Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.,cannabinoid receptor antagonists,CHEBI,suggest rostral ventromedial medulla as important site of cannabinoid-mediated analgesia by,acetaminophen,CHEMICAL
29167401,Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.,cannabinoid receptor antagonists,CHEBI,suggest rostral ventromedial medulla as important site of,cannabinoid-mediated analgesia,MENTAL_HEALTH
29167401,Local injections of the acetaminophen metabolite AM 404 and of cannabinoid receptor antagonists as well as data from tissue-specific CB1 receptor-deficient mice suggest the rostral ventromedial medulla as an important site of the cannabinoid-mediated analgesia by acetaminophen.,acetaminophen,CHEMICAL,have an important site of,cannabinoid-mediated analgesia,MENTAL_HEALTH
16919265,"The analgesic and anti-hyperalgesic effects of cannabinoid- and vanilloid-like compounds, plus the fatty acid amide hydrolase (FAAH) inhibitor Cyclohexylcarbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597), and acetaminophen, were evaluated in the phenyl-p-quinone (PPQ) pain model, using different routes of administration in combination with opioid and cannabinoid receptor antagonists.",analgesic effects,CHEBI,use different routes of administration in combination with,opioid receptor antagonists,CHEBI
16919265,"The analgesic and anti-hyperalgesic effects of cannabinoid- and vanilloid-like compounds, plus the fatty acid amide hydrolase (FAAH) inhibitor Cyclohexylcarbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597), and acetaminophen, were evaluated in the phenyl-p-quinone (PPQ) pain model, using different routes of administration in combination with opioid and cannabinoid receptor antagonists.",fatty acid amide hydrolase FAAH inhibitor Cyclohexylcarbamic acid ester,NUTRITION,use different routes of administration in combination with,opioid receptor antagonists,CHEBI
16919265,"The analgesic and anti-hyperalgesic effects of cannabinoid- and vanilloid-like compounds, plus the fatty acid amide hydrolase (FAAH) inhibitor Cyclohexylcarbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597), and acetaminophen, were evaluated in the phenyl-p-quinone (PPQ) pain model, using different routes of administration in combination with opioid and cannabinoid receptor antagonists.",fatty acid amide hydrolase FAAH inhibitor Cyclohexylcarbamic acid ester,CHEMICAL,use different routes of administration in combination with,opioid receptor antagonists,CHEBI
21447967,Common buckwheat (Fagopyrum esculentum) is known to cause severe anaphylactic reactions in adult individuals.,Common buckwheat,NUTRITION,cause,severe anaphylactic reactions,DISEASE
28244984,"In understanding the mechanism of schizophrenia pathogenesis, a significant finding is that drug abuse of phencyclidine or its analog ketamine causes symptoms similar to schizophrenia.",analog ketamine,CHEMICAL,cause symptoms similar to,schizophrenia,MENTAL_HEALTH
28244984,"In understanding the mechanism of schizophrenia pathogenesis, a significant finding is that drug abuse of phencyclidine or its analog ketamine causes symptoms similar to schizophrenia.",drug abuse,CHEBI,cause symptoms similar to,schizophrenia,MENTAL_HEALTH
28244984,"In understanding the mechanism of schizophrenia pathogenesis, a significant finding is that drug abuse of phencyclidine or its analog ketamine causes symptoms similar to schizophrenia.",phencyclidine,CHEMICAL,cause symptoms similar to,schizophrenia,MENTAL_HEALTH
28244984,"Both drugs are N-methyl-d-aspartate receptor (NMDAR) antagonists, leading to a major hypothesis that glutamate hypofunction underlies schizophrenia pathogenesis.",glutamate hypofunction,CHEMICAL,underlie,schizophrenia pathogenesis,MENTAL_HEALTH
28244984,"Notably, restoring NMDARs in the adult ILN rescued some of the behavioral abnormalities.",NMDARs,CHEMICAL,rescue,behavioral abnormalities,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",schizophrenia,MENTAL_HEALTH,cause,weight gain,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",schizophrenia,MENTAL_HEALTH,cause,metabolic syndrome,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",Olanzapine,CHEMICAL,cause,weight gain,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",Olanzapine,CHEMICAL,cause,metabolic syndrome,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",OLZ,CHEMICAL,cause,weight gain,DISEASE
23926289,"Olanzapine (OLZ), an effective treatment of schizophrenia and other disorders, causes weight gain and metabolic syndrome.",OLZ,CHEMICAL,cause,metabolic syndrome,DISEASE
17075688,"The review of published scientific data suggests that most of the atypical antipsychotics, excluding clozapine, have a favourable risk/benefit profile and effectively reduce disabling behaviours in paediatric psychiatric patients.",clozapine,CHEMICAL,reduce disabling behaviours in,paediatric psychiatric patients,DISEASE
15518916,Treatment with 6-OHDA caused significant hyperactivity during the dark phase in rats aged 4-5 weeks.,6-OHDA,CHEMICAL,cause,significant hyperactivity,MENTAL_HEALTH
34667535,Sweet cherry fruit cracking is a complex physiological disorder that causes significant economic losses.,Sweet cherry fruit,NUTRITION,be,complex physiological disorder,DISEASE
18067366,The three isomeric dimethylxanthines and trimethylxanthine are studied by neutron spectroscopy up to energy transfers of 100 meV at energy resolutions ranging from 0.7 microeV to some meV. The loss of elastic intensity with increasing temperature can be modeled by quasielastic methyl rotation.,trimethylxanthine,NUTRITION,be studied by neutron spectroscopy at energy resolutions to,meV. loss,CHEMICAL
25770856,It has been suggested that the development of depressive symptoms as a result of cytokine therapy is attributable to cytokine-induced elevated activity of the kynurenine pathway.,depressive symptoms,DISEASE,be attributable to cytokine-induced elevated activity of,kynurenine pathway,CHEMICAL
16474201,"Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant, is also an effective analgesic agent in neuropathic and inflammatory, but not acute, pain systemically and intrathecally.",gamma-aminobutyric acid GABA analogue anticonvulsant,CHEMICAL,be effective analgesic agent in,neuropathic,DISEASE
16474201,"Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant, is also an effective analgesic agent in neuropathic and inflammatory, but not acute, pain systemically and intrathecally.",gamma-aminobutyric acid GABA analogue anticonvulsant,CHEMICAL,be,effective analgesic agent,CHEBI
16474201,"Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant, is also an effective analgesic agent in neuropathic and inflammatory, but not acute, pain systemically and intrathecally.",Gabapentin,CHEMICAL,be effective analgesic agent in,neuropathic,DISEASE
16474201,"Gabapentin, a gamma-aminobutyric acid (GABA) analogue anticonvulsant, is also an effective analgesic agent in neuropathic and inflammatory, but not acute, pain systemically and intrathecally.",Gabapentin,CHEMICAL,be,effective analgesic agent,CHEBI
33843970,"Besides gender identity disorder (GID) diagnoses, a combination of non-GID data elements were used to identify potential transgender veterans, including: 1) endocrine disorder, unspecified or not otherwise specified codes, 2) receipt of sex hormones not associated with the sex documented in the veteran's records (gender-affirming hormone therapy), and 3) change in the administratively recorded sex.",disorder diagnoses,MENTAL_HEALTH,identify,endocrine disorder,CHEBI
35225756,Response to lithium in patients with bipolar disorder is associated with clinical and transdiagnostic genetic factors.,lithium,NUTRITION,in patients with,bipolar disorder,MENTAL_HEALTH
23462228,"In susceptible users, however, consumption of this drug is conducive to panic, paranoia and dysphoria.",drug,CHEBI,be conducive in susceptible users to,panic,DISEASE
23462228,"In susceptible users, however, consumption of this drug is conducive to panic, paranoia and dysphoria.",drug,CHEBI,be conducive in susceptible users to,paranoia,MENTAL_HEALTH
23462228,"In susceptible users, however, consumption of this drug is conducive to panic, paranoia and dysphoria.",drug,CHEBI,be conducive in susceptible users to,dysphoria,MENTAL_HEALTH
23462228,We hypothesized that the up-regulation of CB₁ receptors (CB₁Rs) in select brain regions may enhance the vulnerability to cannabinoid-induced anxiety.,CB₁Rs,CHEMICAL,enhance vulnerability to,cannabinoid-induced anxiety,MENTAL_HEALTH
23462228,We hypothesized that the up-regulation of CB₁ receptors (CB₁Rs) in select brain regions may enhance the vulnerability to cannabinoid-induced anxiety.,CB₁ receptors,CHEMICAL,enhance vulnerability to,cannabinoid-induced anxiety,MENTAL_HEALTH
23219968,Data suggest that kinin B(1)R is upregulated in midbrain DA system in hypertensive rats and its i.c.v.,kinin B(1)R,CHEMICAL,be upregulated in midbrain da system in,hypertensive rats,DISEASE
23219968,Data suggest that kinin B(1)R is upregulated in midbrain DA system in hypertensive rats and its i.c.v.,kinin B(1)R,CHEMICAL,be upregulated in,midbrain DA system,CHEMICAL
32620421,"Echinocandins are frequent use antifungals in the treatment of invasive candidiasis, and it is important to update information on their efficacy and safety for optimal antifungal drug treatment.",Echinocandins,CHEMICAL,be frequent use antifungals in treatment of,invasive candidiasis,DISEASE
32620421,"Echinocandins are frequent use antifungals in the treatment of invasive candidiasis, and it is important to update information on their efficacy and safety for optimal antifungal drug treatment.",Echinocandins,CHEMICAL,be,frequent use antifungals,CHEBI
32620421,The aim of this study is to clarify whether echinocandins are superior to non-echinocandins for the treatment of invasive candidiasis.,echinocandins,CHEMICAL,be superior to non-echinocandins for treatment of,invasive candidiasis,DISEASE
32620421,The aim of this study is to clarify whether echinocandins are superior to non-echinocandins for the treatment of invasive candidiasis.,echinocandins,CHEMICAL,be superior to,non-echinocandins,CHEMICAL
32796824,"To investigate the prophylactic role of antifungal agent in the AD development, a lipopolysaccharide-induced memory disorder mouse model was used, and cognitive function was assessed by Morris water maze test and passive avoidance test.",disorder mouse model,DISEASE,investigate prophylactic role of,antifungal agent,CHEBI
31443953,Reduction or withdrawal of levodopa should be considered if there is a close relationship between the onset of dystonia with periods of high dopaminergic tone.,levodopa,CHEMICAL,be close relationship between onset of,dystonia,DISEASE
24338664,"MSA is characterized by autonomic failure, levodopa-unresponsive parkinsonism, cerebellar ataxia and pyramidal signs in any combination.",MSA,CHEMICAL,be characterized by,autonomic failure,DISEASE
24338664,"MSA is characterized by autonomic failure, levodopa-unresponsive parkinsonism, cerebellar ataxia and pyramidal signs in any combination.",MSA,CHEMICAL,be characterized by,levodopa-unresponsive parkinsonism,DISEASE
24338664,"MSA is characterized by autonomic failure, levodopa-unresponsive parkinsonism, cerebellar ataxia and pyramidal signs in any combination.",MSA,CHEMICAL,be characterized by,cerebellar ataxia,DISEASE
24338664,"MSA belongs to a group of neurodegenerative disorders termed α-synucleinopathies, which also include Parkinson's disease and dementia with Lewy bodies.",MSA,CHEMICAL,belong to group of,neurodegenerative disorders,DISEASE
24338664,"The development of animal models of MSA is justified by the limited understanding of the mechanisms of neurodegeneration and GCIs formation, which is paralleled by a lack of therapeutic strategies.",MSA,CHEMICAL,be justified by limited understanding of mechanisms of,neurodegeneration formation,DISEASE
35602005,"For timing of developmental milestone acquisition in C. elegans, meHgCl was 2 to 4-fold more toxic than HgCl2, and NaAsO2 was 20-fold more toxic than DMA, ranking the four compounds meHgCl > HgCl2 > NaAsO2 ≫ DMA for developmental toxicity.",NaAsO2,CHEMICAL,be,DMA,CHEMICAL
17181902,There is some initial evidence that fatty acids may influence hyperactivity in children with specific learning disabilities.,fatty acids,NUTRITION,influence hyperactivity in children with,specific learning disabilities,DISEASE
17181902,There is some initial evidence that fatty acids may influence hyperactivity in children with specific learning disabilities.,fatty acids,NUTRITION,influence,hyperactivity,MENTAL_HEALTH
17181902,"The findings also suggest that some food additives (colourings, flavourings and preservatives) may increase hyperactivity in children with behaviour problems.",food additives,CHEBI,increase,hyperactivity,MENTAL_HEALTH
35126824,"Therefore, this study is aimed at evaluating whether a mixture comprising Ginkgo biloba L. leaf (GL) and Hericium erinaceus (Bull.) Pers. (HE) fruit extract (GH mixture) alleviated cognitive impairment induced in a scopolamine-induced model.",mixture Pers,CHEBI,alleviate,cognitive impairment,DISEASE
34829535,Hericium erinaceus administration reduced behavioral changes and hippocampal neuronal degeneration.,Hericium erinaceus administration,NUTRITION,reduce,hippocampal neuronal degeneration,DISEASE
